<SEC-DOCUMENT>0001628280-25-017767.txt : 20250415
<SEC-HEADER>0001628280-25-017767.hdr.sgml : 20250415
<ACCEPTANCE-DATETIME>20250415073054
ACCESSION NUMBER:		0001628280-25-017767
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250415
DATE AS OF CHANGE:		20250415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adverum Biotechnologies, Inc.
		CENTRAL INDEX KEY:			0001501756
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				205258327
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36579
		FILM NUMBER:		25837569

	BUSINESS ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		(650) 649-1004

	MAIL ADDRESS:	
		STREET 1:		100 CARDINAL WAY
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avalanche Biotechnologies, Inc.
		DATE OF NAME CHANGE:	20100921
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>advm-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe,d:354d6e8aa86547e4a49e0ebd73a9c63c-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:advm="http://www.adverum.com/20241231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>advm-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-33">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-35">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-36">0001501756</ix:nonNumeric><ix:nonNumeric contextRef="c-35" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-442">P3Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-454">0.10</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-719">one</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="advm-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>advm:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="security"><xbrli:measure>advm:security</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>advm:lease</xbrli:measure></xbrli:unit><xbrli:unit id="director"><xbrli:measure>advm:director</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">advm:RedwoodCaliforniaFacilityLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">advm:CashEquivalentsAndShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">advm:CashEquivalentsAndShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LexeoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-25</xbrli:startDate><xbrli:endDate>2021-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">advm:LexeoTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">advm:RayTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-08</xbrli:startDate><xbrli:endDate>2021-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:LandlordMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:SubleaseTenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:LandlordMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:SubleaseTenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:SubleaseTenantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LandlordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:SubleaseTenantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LandlordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-07</xbrli:startDate><xbrli:endDate>2024-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">advm:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">advm:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:TwoDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:TwoDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-07</xbrli:startDate><xbrli:endDate>2024-02-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:A2024EquityIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">advm:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandSeventeenInducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandFourteenPlanAndInducementPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">advm:IncentiveStockOptionsAndNonQualifiedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandFourteenPlanAndInducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">advm:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">advm:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001501756</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December 31</ix:nonNumeric>, 2024</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-36579</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:23pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Adverum Biotechnologies, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">20-5258327</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">100 Cardinal Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Redwood City</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">94063</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">650</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">656-9323</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:110%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.967%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.0001&#160;per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ADVM</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">Nasdaq</ix:nonNumeric> Stock Market LLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Nasdaq Capital Market)</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files):&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:19.574%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.354%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-24">x</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-true" id="f-26">x</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" format="ixt:fixed-true" id="f-27">x</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-28">x</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">x</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="dei:EntityPublicFloat" scale="6" id="f-30">136.7</ix:nonFraction> million, based on the closing price of the registrant&#8217;s common stock on the Nasdaq Capital Market on June 30, 2024 of $6.86 per share.&#160;Shares of the registrant&#8217;s common stock held by each officer and director and each person known to the registrant to be affiliated with an officer or director have been excluded in that such persons may be deemed affiliates. This determination of affiliate status is not a determination for other purposes.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of April&#160;4, 2025, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">20,890,540</ix:nonFraction>&#160;shares of common stock, par value $0.0001&#160;par value, outstanding.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true">Portions of the definitive proxy statement (the Proxy Statement) for the 2025 Annual Meeting of Stockholders of the registrant are incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed by April 30, 2025, then the registrant will file an amendment to this Form 10-K on Form 10-K/A to include the Part III information in this Form 10-K.</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_16">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_19">Item 1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_19">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_22">Item 1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_22">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_22">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_52">Item 1B</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_52">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_52">85</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_52">Item 1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_52">C</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_55">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_55">85</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_58">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_58">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_58">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_61">Item 3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_61">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_61">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_64">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_64">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_64">86</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_70">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_70">87</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_73">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_73">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_73">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_85">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">[</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_82">Reserved</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">]</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_82">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_88">Item 7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_88">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_118">Item 7A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_118">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_121">Item 8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_121">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_121">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_205">Item 9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_205">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_205">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_208">Item 9A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_208">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_208">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_211">Item 9B</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_211">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_211">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_214">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_214">135</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_217">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_217">136</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_220">Item 10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_220">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_220">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_226">Item 11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_226">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_226">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_232">Item 12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_232">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_232">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_238">Item 13</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_238">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_238">136</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_244">Item 14</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_244">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_244">136</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_250">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_250">137</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_253">Item 15</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_253">Exhibit and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_253">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_256">Item 16</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_256">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_256">140</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_259">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_259">141</a></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, unless otherwise stated or the context otherwise indicates, references to &#8220;Adverum,&#8221; &#8220;Adverum Biotechnologies,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar references refer to Adverum Biotechnologies, Inc., a Delaware corporation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum, the Adverum logo and other trademarks or service marks of Adverum that may appear in this Annual Report on Form 10-K are the property of Adverum. This Annual Report on Form 10-K contains additional trade names, trademarks, and service marks of other companies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum does not intend its use or display of other companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of Adverum by, these other companies, and all such third-party trade names, trademarks, and service marks are the property of their respective owners.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 28, 2025, the Audit Committee of the Board of Directors (the &#8220;Audit Committee&#8221;) of Adverum Biotechnologies, Inc. (the &#8220;Company&#8221;), following consultation with the Company&#8217;s management and independent registered public accounting firm, Ernst &amp; Young LLP, concluded that certain of the Company&#8217;s previously issued financial statements should no longer be relied upon due to non-cash errors identified in the accounting for tenant improvement allowances associated with an operating lease and sublease related to a building in North Carolina (the &#8220;NC Premises&#8221;).</span></div><div style="margin-top:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the Company entered into the operating lease for the NC Premises, and in October 2021, the Company entered into the sublease agreement with Jaguar Gene Therapy, LLC, who subsequently assigned the sublease to Advanced Medicine Partners, LLC as the subtenant for the NC Premises, through the remainder of the lease term. While preparing the consolidated financial statements as of and for the year ended December 31, 2024, management discovered non-cash errors in the Company&#8217;s accounting for its operating lease and sublease of the NC Premises. The errors relate solely to the Company&#8217;s accounting for tenant improvement allowances provided by the landlord to the Company under its operating lease, which were subsequently conveyed from the Company to the subtenant under the sublease, and to a lesser extent, to the assessment of the probability of collection of the lease payments from the subtenant over the remaining term of the sublease. The errors affect the reported amounts of non-cash assets and liabilities, and non-cash general and administrative expenses, related to the lease and sublease (the &#8220;Misstatements&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Misstatements relate solely to the NC Premises and require non-cash corrections to the Company&#8217;s previously issued audited consolidated financial statements as of and for the years ended December 31, 2022 and 2023, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2023 (the &#8220;2023 Annual Report&#8221;), as well as the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024 (collectively the &#8220;Restated Periods&#8221;), included in the Company&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods within those years (&#8220;Quarterly Reports&#8221; and, together with the 2023 Annual Report, the &#8220;Affected Reports&#8221;). The Audit Committee concluded that it is appropriate to correct the Misstatements by restating the financial statements for the Restated Periods.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The previously issued financial statements included in the Affected Reports should no longer be relied upon. The Company does not intend to separately amend the Affected Reports. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, investors and other readers should rely only on the financial statements for the Restated Periods included in this Annual Report on Form 10-K and in any other future filings with the SEC (as applicable).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restatement of Financial Statements </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K includes restated financial statements for the Restated Periods. In these restated financial statements, the Company has corrected the Misstatements, and has corrected certain other immaterial errors. For additional information, see Note 2, Restatement of Previously Issued Financial Statements and Note 14, Quarterly Financial Information (Unaudited), to the consolidated financial statements included in this Annual Report on Form 10-K. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Control Considerations </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the restatement, management has concluded that the Misstatements are indicative of a material weakness in the Company's internal control over financial reporting as of December 31, 2024, with respect to the operating effectiveness of the Company&#8217;s controls over lease accounting. For a discussion of management's considerations of the Company&#8217;s disclosure controls and procedures, internal control over financial reporting, and material weakness identified, see Part II, Item 9A of this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical facts contained in this Annual Report on Form 10-K are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;contemplate,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to mitigate the substantial doubt about our ability to continue as a going concern;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our estimates regarding expenses, future revenue, capital requirements, uses of cash and needs for additional financing and the period for which our resources will be sufficient to meet our operational requirements;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to enter into collaborations, or other strategic arrangements, or obtain additional funding;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the initiation, progress, timing, costs and results of nonclinical studies and any clinical trials for our product candidates;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to advance our viral vector manufacturing and delivery capabilities;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our research and development expenses could fluctuate and may increase;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timing or likelihood of regulatory submissions, designations and approvals;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our plans to explore potential applications of our gene therapy platform in other indications in highly prevalent diseases;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding the clinical effectiveness of our product candidates;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our commercialization, marketing and manufacturing capabilities and strategy;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the pricing and reimbursement of our product candidates, if approved;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding the potential market sizes for our product candidates;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our intellectual property position;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the potential benefits of our strategic collaborations;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">developments and projections relating to our competitors and our industry; </span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the safety, efficacy and projected development timeline and commercial potential of any product candidates; and </span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to remediate the material weakness in our internal control over financial reporting described in Part II, Item 9A of this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in &#8220;Risk Factors Summary&#8221; below and under the heading &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this Annual Report on Form 10-K reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, industry and future growth. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date of this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Annual Report on Form 10-K may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains estimates, projections and other information concerning our industry, our business and the markets for certain drugs, including data regarding the estimated size of those markets, their projected growth rates and the incidence of certain medical conditions. Information that is based on estimates, forecasts, projections or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, medical and general </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_13"></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS SUMMARY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in common stock involves numerous risks, including the risks described in &#8220;Item 1A. Risk Factors&#8221; of this Annual Report on Form 10-K. Below are some of these risks, any one of which could materially adversely affect our business, financial condition, results of operations, and prospects. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is substantial doubt regarding our ability to continue as a going concern. We will need to raise substantial additional funding to finance our operations through regulatory approval of our lead program and beyond, which may not be available on acceptable terms, or at all. If we fail to obtain additional capital necessary to fund our operations, we could be forced to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations, or to cease operations or liquidate our assets. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">If we sell shares of our common stock or securities convertible into or exercisable for shares of our common stock in future financings, or pursuant to licensing, collaboration or other arrangements, stockholders may experience immediate dilution and, as a result, our stock price may decline.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The report of our independent registered public accounting firm for the year ended December 31, 2024  contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred significant operating losses since inception, and we expect to incur significant losses for the foreseeable future. We may never become profitable or, if achieved, be able to sustain profitability. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks associated with subletting our leased premises, including risks associated with subtenant defaults, which have occurred and we expect to continue to occur.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business will depend substantially on the success of one or more of our product candidates. If we are unable to develop, obtain regulatory approval for, or successfully commercialize, any or all of our product candidates, our business will be materially harmed.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drug development is a long, expensive and uncertain process, and delay or failure can occur at any stage of development, including after commencement of any of our clinical trials or any clinical trials using our proprietary viral vectors.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The occurrence of serious complications or side effects that outweigh the therapeutic benefit in connection with or during use of our product candidates, whether in nonclinical studies or clinical trials or post-approval, could lead to discontinuation of our clinical development program, refusal of regulatory authorities to approve our product candidates or, post-approval, revocation of marketing authorizations or refusal to approve new indications, which could severely harm our business prospects, financial condition and results of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The results of nonclinical studies and early clinical trials are not always predictive of future results. Any product candidate we or any of our future development partners advance into clinical trials may not have favorable results in later clinical trials, if any, or receive regulatory approval.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to successfully develop and maintain robust and reliable manufacturing processes for our product candidates, we may be unable to advance clinical trials or licensure applications and may be forced to delay or terminate a program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in methods of manufacturing or formulation of our product candidates may result in additional costs or delays.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to produce sufficient quantities of our products and product candidates at acceptable costs, we may be unable to meet clinical or potential commercial demand, face delayed timelines, lose potential revenue, have reduced margins, or be forced to terminate a program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our contractors are subject to significant regulation with respect to manufacturing and testing our product candidates. We have a limited number of vendors on which we rely, including, in some cases, single source vendors, and the contract vendors on which we rely may not continue to meet regulatory requirements, may have limited capacity, or may have other factors limiting their ability to comply with their contracts with us.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to many manufacturing and distribution risks, any of which could substantially increase our costs and limit supply of our product candidates.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have relied, and expect to continue to rely, on third parties under contracts and partnerships to conduct some or all aspects of our research and development, including vector production, process development, assay development, product candidates and product manufacturing and testing, protocol development, clinical trials, product distribution, commercialization, nonclinical studies, research and related activities, and these third parties may not perform satisfactorily.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will rely on third parties to conduct some nonclinical testing and all of our ongoing and planned clinical trials. If these third parties do not meet our deadlines or otherwise fail to conduct the trials as required, our clinical development programs could be delayed or unsuccessful and we may not be able to obtain regulatory approval for or commercialize our product candidates when expected or at all.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our success depends on our ability to protect our intellectual property and our proprietary technologies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims by third parties that we infringe their proprietary rights may result in liability for damages or prevent or delay our developmental and commercialization efforts.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be successful in obtaining or maintaining necessary rights to our product candidates through acquisitions and in-licenses.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our rights to develop and commercialize our product candidates are subject in part to the terms and conditions of licenses granted to us by other companies and universities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The patent protection and patent prosecution for some of our product candidates are dependent on third parties.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third-party patent rights could delay or otherwise adversely affect our planned development and sale of product candidates of our programs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to obtain intellectual property rights or protect our intellectual property rights throughout the world.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not obtain patent term extensions for patents covering our product candidates, our business may be materially harmed.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any suspension of, or delays in the commencement or completion of, clinical trials for our product candidates could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Final marketing approval for our product candidates by the FDA or other regulatory authorities outside the U.S. for commercial use may be delayed, limited or denied, any of which would adversely affect our ability to generate operating revenue.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if we receive regulatory approval, we still may not be able to successfully commercialize any of our product candidates, and the revenue that we generate from product sales, if any, could be limited.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our competitors develop treatments for the target indications of our product candidates that are approved, marketed more successfully, or demonstrated to be safer or more effective or easier to administer than our product candidates, our commercial opportunity will be reduced or eliminated.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if we obtain marketing approval for any of our product candidates, they could be subject to restrictions or withdrawal from the market, and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidates, when and if any of them are approved.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coverage and reimbursement may be limited or unavailable in certain market segments for our product candidates, which could make it difficult for us to sell our product candidates profitably. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare and other reform legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and, if approved, may affect the prices we may obtain.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative public opinion and increased regulatory scrutiny of gene therapy and genetic research may damage public perception of our product candidates or adversely affect our ability to conduct our business or obtain marketing approvals for our product candidates.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent on the services of our key executives and clinical and scientific staff, and if we are not able to retain these members of our management or recruit additional management, clinical and scientific personnel, our business will suffer.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter difficulties in managing our growth and expanding our operations successfully.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our information technology systems or those third parties with whom we work, or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; material disruption of our product development programs; and other adverse consequences.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The trading price of the shares of our common stock has been and could continue to be highly volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have identified a material weakness in our internal control over financial reporting. If we are unable to remedy the material weakness, or if we fail to maintain an effective system of internal control over financial reporting in the future, we may not be able to accurately report our financial condition, results of operations or cash flows, which may adversely affect investor confidence in us and, as a result, the value of our common stock.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART 1.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Business</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. We discover and develop gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Our lead product candidate, ixoberogene soroparvovec (&#8220;Ixo-vec&#8221;), formerly referred to as ADVM-022, is a single, in-office intravitreal (&#8220;IVT&#8221;) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (&#8220;VEGF&#8221;) IVT injections. Ixo-vec is currently being developed for the treatment of patients with wet age-related macular degeneration (&#8220;wet AMD&#8221;), also known as neovascular AMD. In November 2024 we announced top-line 52 week results from the ongoing LUNA Phase 2 clinical trial. In March 2025, we initiated ARTEMIS, the first of two Phase 3 clinical trials of Ixo-vec in wet AMD.  We intend to initiate AQUARIUS, the second phase 3 trial of Ixo-vec in wet AMD, in the second half of 2025. We intend to conduct ARTEMIS at U.S. sites and AQUARIUS globally.  We are also developing an early-stage pipeline of gene therapy programs targeting the treatment of other highly prevalent ocular diseases. Our core capabilities include novel vector evaluation, cassette engineering, ocular IND-enabling nonclinical and clinical development, scalable process development, assay development, and current Good Manufacturing Practices (&#8220;GMP&#8221;) quality control.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ixo-vec (formerly known as ADVM-022)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ixo-vec utilizes an engineered, proprietary capsid, AAV.7m8, which along with a proprietary expression cassette is capable of transducing retinal cells and expressing aflibercept after a single in-office IVT injection. This product candidate is intended to improve both real-world vision outcomes and quality of life for patients. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wet AMD is a leading cause of blindness in patients over 65 years of age, with a prevalence of approximately 20 million individuals worldwide living with wet AMD. Age-related macular degeneration (&#8220;AMD&#8221;) is expected to impact 288 million people worldwide by 2040, with wet AMD accounting for approximately ten percent of those cases. Up to 42% of patients with wet AMD experience neovascularization in the second eye in the first two to three years following diagnosis in the first eye.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current standard of care for wet AMD requires frequent and lifelong anti-VEGF IVT injections. Undertreatment is associated with persistent macular fluid and resulting in loss of vision over time. Additionally, fluid fluctuations associated with bolus anti-VEGF therapy may impair vision over time even in well treated wet AMD patients. A significant proportion of patients discontinue anti-VEGF treatment within two to five years. Key unmet needs in the treatment of wet AMD include therapeutics with greater durability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we initiated the OPTIC trial, designed as an open-label, dose-ranging trial evaluating the safety and efficacy of Ixo-vec in subjects with wet AMD who have demonstrated responsiveness to anti-VEGF treatment. Subjects in OPTIC are treatment experienced and previously required frequent anti-VEGF injections to manage their wet AMD and to maintain functional vision. OPTIC was a two-year trial, which the last subject completed in June 2022, and we continue to follow subjects in the OPTIC extension trial for an additional three years, for a total of five years. Through the most recent data cut-off date of August 21, 2024, we have seen strong signals of therapeutic efficacy in OPTIC in both the 6 x 10&#x5E;11 vg/eye (&#8220;6E11&#8221;) and 2 x 10&#x5E;11 vg/eye (&#8220;2E11&#8221;) doses, including maintenance to improvement in best-corrected visual acuity (&#8220;BCVA&#8221;) and maintenance to improvement of central subfield thickness (&#8220;CST&#8221;), currently out to four years, and stable aflibercept protein levels through latest reported follow-up, which is currently up to five years. Following Ixo-vec treatment, OPTIC patients experienced a robust treatment burden reduction, with subjects who had received the 2E11 dose seeing an 86% reduction in annualized anti-VEGF injections through four years. Nearly 50% of patients were injection free through four years following Ixo-vec treatment. Ixo-vec has been generally well tolerated, with the most common adverse events being dose-related anterior inflammation and pigmentary changes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we dosed the first subject in our LUNA Phase 2 trial of Ixo-vec. The LUNA trial is a multicenter, double-masked, randomized, parallel-group trial evaluating two doses of Ixo-vec - 2E11, the lower dose used in the OPTIC trial, and a new, lower 6 x 10&#x5E;10 vg/eye dose (&#8220;6E10&#8221;) dose. In addition, LUNA assesses enhanced prophylactic corticosteroid regimens, including local corticosteroids and combinations of local and systemic corticosteroids, to test the relative contribution of local versus systemic adeno-associated virus (&#8220;AAV&#8221;) exposure on ocular inflammation. The endpoints are similar to the OPTIC trial and focus on mean change in BCVA and CST from baseline to one year, and incidence and severity of adverse events. LUNA enrolled 60 subjects who were randomized equally between the 2E11 and 6E10 doses. LUNA subjects were assessed for the primary and other endpoints at 52 weeks, and we will continue to follow them for an additional four years, for a total of five years. In November 2024, we announced top-line 52 week results with a data cut-off date of August 29, 2024 from the LUNA Phase 2 trial demonstrating that both the 2E11 and 6E10 doses maintained visual and anatomic outcomes. Notably, both doses resulted in favorable reductions in annualized anti-VEGF injections and percentages of subjects remaining free of injections which were consistent with results observed in the OPTIC trial. In those subjects who had completed 52 weeks of follow-up, at the 6E10 (n=28) and 2E11 (n=29) doses, Ixo-vec demonstrated reduction in annualized anti-VEGF injection rates of 88% and 92%, respectively, and injection free rates of 54% and 69%, respectively. In addition, Ixo-vec was well-tolerated, with the most common adverse events being dose-related anterior</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inflammation and pigmentary changes. Data demonstrated that difluprednate eye drops alone is a promising prophylactic regimen for our planned pivotal studies. Additionally, our LUNA pre-specified patient preference survey demonstrated a strong preference for Ixo-vec over prior anti-VEGF therapies and acceptability of the topical eye drops steroid regimen. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Phase 3 program is planned to include two registrational trials in wet AMD. We have selected the 6E10 dose and a difluprednate topical-eye-drops-only prophylactic regimen to evaluate in the Phase 3 program. In March 2025, we initiated ARTEMIS, the first of two Phase 3 clinical trials of Ixo-vec in wet AMD.  We intend to initiate AQUARIUS, the second phase 3 trial of Ixo-vec in wet AMD, in the second half of 2025. We intend to conduct ARTEMIS at U.S. sites and AQUARIUS globally.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Designations for Ixo-vec</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, we announced that the FDA had granted Ixo-vec Fast Track designation. Fast Track is a process designed to facilitate the development and expedite the review of drugs and biologics to treat serious conditions and fill unmet medical needs. In June 2022, we announced that the European Medicines Agency (&#8220;EMA&#8221;) had granted Ixo-vec Priority Medicines (&#8220;PRIME&#8221;) designation. PRIME is a voluntary scheme aimed at enhancing the EMA&#8217;s support for the development of medicinal products that target unmet medical needs. Eligible products must target conditions for which there is an unmet medical need (there is no satisfactory method of diagnosis, prevention or treatment in the EU or, if there is, the new medicinal product will bring a major therapeutic advantage) and they must demonstrate the potential to address the unmet medical need by introducing new methods of therapy or improving existing ones. In April 2023, we announced that the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) had granted Ixo-vec an Innovation Passport under the Innovative Licensing and Access Pathway (&#8220;ILAP&#8221;). The Innovation Passport is the first step in the ILAP process, triggering the MHRA and its partner agencies to partner with Adverum to charter a roadmap for regulatory and development milestones with the goal of early patient access in the United Kingdom (&#8220;UK&#8221;). Additionally, in August 2024, the FDA granted Ixo-vec the Regenerative Medicine Advanced Therapy designation (&#8220;RMAT&#8221;). RMAT is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies. RMAT provides the benefits of intensive FDA guidance on efficient drug development, including potential priority review of the biologics license application (&#8220;BLA&#8221;), and other opportunities to expedite development and review. </span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ixo-vec Manufacturing</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we advance Ixo-vec for wet AMD, we are continuing to develop our manufacturing expertise for ongoing supply and implementing strategies for large-scale manufacturing and supply. We collaborate with external vendors to manufacture our viral banks, drug supply and drug product, while maintaining control of key aspects of the manufacturing process including development of scalable processes, assay development, and GMP quality controls. This approach to large-scale production is essential for addressing the needs of highly prevalent diseases like wet AMD and sets us apart from many existing gene therapies, which are approved or in development for conditions affecting smaller patient populations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strengths</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have the capabilities, resources, and expertise to enable Adverum to become a leading ocular gene therapy company. These strengths include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Ixo-vec, for which we have reported top-line 52 week results from the LUNA Phase 2 trial demonstrating that Ixo-vec maintained visual and anatomic outcomes, while being generally well tolerated and achieving a robust treatment burden reduction and high patient preference over prior anti-VEGF injections, and for which we have seen in our OPTIC clinical trial strong signals of therapeutic efficacy out to four years and stable aflibercept protein levels through the latest reported follow-up, which is currently up to five years;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">industry-leading development capabilities in AAV ocular gene therapy and AAV product optimization, including cassette engineering and vectorizing therapeutic biologics;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">deep understanding of how immunogenicity impacts ocular gene therapy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a pipeline of early stage gene therapy programs targeting the treatment of other highly prevalent ocular diseases;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">deep expertise developing and conducting clinical trials with a focus on regulatory compliance in the U.S and Europe;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">gene therapy manufacturing expertise, specifically in scalable process development, assay development, and cGMP quality control;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">maturing a portfolio of proprietary vectors with specific ocular cell tropism;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a robust patent portfolio; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">an experienced leadership team with expertise in ophthalmology, gene therapy, manufacturing, drug development, regulatory approval, and commercialization.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to discover, develop, and commercialize novel gene therapies with the potential to treat patients living with highly prevalent ocular diseases. The key elements of our strategy to achieve this goal are to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Target large patient populations, such as those impacted by wet AMD.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There are approximately 20 million individuals worldwide living with wet AMD, and the incidence of new cases is expected to continue to grow significantly worldwide as populations age. AMD is expected to impact 288 million people worldwide by 2040, with wet AMD accounting for approximately ten percent of those cases and a large percentage of wet AMD patients experiencing neovascularization in the second eye.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">With Ixo-vec, target a well characterized and proven mechanism of action, leveraging anti-VEGF within a gene therapy for wet AMD, a retinal condition that is known to respond to anti-VEGF therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unlike with many gene therapies designed to replace a defective or missing gene, with Ixo-vec we are leveraging gene therapy to deliver an already approved drug. For wet AMD, Ixo-vec is designed for continuous delivery of aflibercept anti-VEGF therapy by a single IVT injection. This innovative method allows us to harness the benefits of gene therapy while providing a well-understood and established therapeutic agent. We estimate that the standard-of-care anti-VEGF therapies used to treat wet AMD and other chronic retinal conditions that respond to anti-VEGF therapy generated approximately $14 billion worldwide in sales in 2023, underscoring the demand for this class of therapy.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Develop single-intravitreal-injection gene therapy treatments, which in wet AMD have the potential to relieve the burden of frequent, chronic injections and improve real-world vision outcomes and quality of life. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are designed as a single, in-office IVT injection therapy to address the unmet needs of patients with highly prevalent ocular diseases. The current standard of care for wet AMD requires frequent injections for the duration of the disease. A significant proportion of patients discontinue anti-VEGF treatment, estimated at up to 40% within two years and up to 57% within five years. In addition, even well-treated wet AMD patients can experience a loss of vision over time, which is thought to arise from fluctuations in macular fluid that can be pronounced with standard-of-care bolus anti-VEGF therapy. We believe that a durable treatment option has the potential to reduce injection frequency and thereby mitigate challenges with treatment compliance and to control fluid fluctuations and to improve long-term visual outcomes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Pursue indications with well-defined clinical and regulatory paths where possible, to mitigate the development risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In wet AMD, we have selected an indication that has prior clinical validation, including established endpoints, standard-of-care administration methods, and established regulatory paths. In wet AMD, aflibercept is an approved standard-of-care IVT injection treatment both as Eylea</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Eylea HD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Ixo-vec utilizes our proprietary vector capsid, AAV.7m8, which is designed to provide a codon optimized cassette of aflibercept enabling patients to generate their own aflibercept through a single IVT injection. In February 2023, the FDA published a draft guidance document (for comment purposes only) for drugs being developed for the treatment of wet AMD, which offered the FDA&#8217;s recommendations for clinical trials including eligibility criteria, clinical trial designs, and efficacy endpoints. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Expand our process capabilities to support commercialization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing process is based on the Baculovirus/Sf9 production system, which has been used for a number of vaccines and recombinant protein therapies approved by the FDA and European Commission and is capable of producing large quantities of AAVs. Our strategy is to develop scalable processes to transfer to our global GMP contract manufacturers, providing a flexible manufacturing strategy to support a potential global supply. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prepare for commercialization of Ixo-vec and our other programs, including by building a U.S. commercial organization and/or leveraging partnerships for the U.S. and global distribution. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to build a specialty sales force for our ocular gene therapies to target the approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> retina specialists in the U.S. Alternatively, we may seek to leverage partnerships in the U.S. and/or to extend our reach, ensuring global access to our therapies. We are open to partnering with one or more pharmaceutical companies to develop and commercialize Ixo-vec and our other programs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Advance our pipeline by leveraging our industry-leading capabilities in AAV vector and cassette optimization and moving our early-stage research assets into our development pipeline.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Integrating our AAV engineering, cassette optimization, and innovation together with our manufacturing expertise, we have the capability to generate high-quality recombinant AAV product candidates for ocular gene therapy. By expanding our understanding of AAV-induced inflammation and ocular inflammatory responses, we are better able to generate optimal prophylaxis strategies to support IVT product candidates with favorable attributes. We plan to use this expertise to expand our pipeline and manage the life cycle of our novel gene therapies. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Collaborate with partners to leverage our industry-leading AAV vector expertise and ocular vector development and product delivery capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We explore opportunities to work collaboratively with potential new partners that may benefit from our capabilities and expertise in AAV vector development or may be interested in licensing our programs. Our AAV.7m8 vector is part of three clinical-stage gene therapy product candidates, including Ixo-vec.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gene Therapy Background</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gene therapy is a powerful treatment modality to address disease biology in a targeted, efficient and sustained way. Instead of dosing patients with proteins or other therapies repeatedly over a long period, gene therapy offers the possibility of dosing once to achieve long-term, durable benefits. In many gene therapies, patients receive viral vectors containing a new gene, called a transgene, that encodes for the desired therapeutic protein or functional version of a mutated protein, and a promoter to control expression of the transgene. Once a patient&#8217;s cells are transduced with the transgene, the cells have the potential to continue to produce the therapeutic protein encoded by that transgene for years. We are currently advancing this field by focusing on localized ocular gene therapies. We believe this approach is particularly promising due to the ocular environment's privileged immune status and presents several advantages over systemic gene therapies. For instance, our product candidates require smaller doses than systemic gene therapies, which reduces the manufacturing burden and would result in lower cost of goods sold.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy takes a 'biofactory' approach.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unlike many gene therapies designed to replace a defective or missing gene, with Ixo-vec we are leveraging gene therapy to deliver an already approved drug. For wet AMD, Ixo-vec is designed for continuous delivery of aflibercept anti-VEGF therapy by a single IVT injection. This innovative method allows us to harness the benefits of gene therapy while providing a well-understood and established therapeutic agent.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to existing classes of protein or biologic therapies such as monoclonal antibodies and antibody-drug conjugates, gene therapy has taken a number of years to evolve from a research tool into a viable and compelling treatment modality.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Novel AAV Vector Platform</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ocular gene therapy platform relies on vectors derived from AAV, a small, non-pathogenic virus carrying DNA encoding a therapeutic gene instead of viral genes. These AAV vectors are utilized to deliver the transgene into a targeted cell population, ensuring sustained protein production upon expression. We believe AAV vectors offer distinct advantages in ocular gene therapy, including enhancing safety, applicability across various indications, and potential long-term efficacy. Noteworthy features include high efficiency in transferring the gene of interest, non-pathogenic nature, non-replicating behavior, provision of long-term expression, and low integrating potential. These characteristics collectively contribute to the potential success and safety of AAV-based vectors in ocular gene therapy, making them a promising choice for sustained therapeutic benefits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, natural capsid-based vectors exhibit inherent limitations, stemming either from their limited tropism or constrained permeation through biological barriers. Directed evolution, a multi-step process, addresses these limitations by utilizing a library of engineered AAV capsid genes with properties distinct from natural AAVs. Millions of AAV variants are created and screened </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for novel properties, such as specific cell type transduction. The identified capsids undergo further optimization, resulting in a select number of engineered AAVs with desired characteristics.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum utilizes the AAV.7m8 capsid as a key platform for IVT delivery. This engineered variant, derived from natural AAV2, was developed through directed evolution for its ability to transduce neural retinal cells upon IVT administration. AAV.7m8 capsid has a 10-amino acid insertion that has been reported to reduce the binding of AAV2 to heparan sulfate proteoglycan (HSPG). The altered HSPG binding is believed to facilitate spread of the vector in the retina. More specifically, AAV.7m8 has exhibited the capability to cross the inner limiting membrane in the retina, a hurdle for naturally occurring AAV serotypes, including its parental AAV2, which displays limited penetration from vitreous. The AAV.7m8 vector has demonstrated widespread transduction of the retina and robust transgene expression in animal models post IVT delivery. As shown in non-human primates (&#8220;NHPs&#8221;), retinal transduction is primarily located in the macula, or central retina, and retinal periphery. AAV.7m8-based vectors have also been demonstrated to transduce retinal ganglion cells, cells in the inner nuclear layer, and photoreceptors, particularly foveal cones. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key advantages of the AAV.7m8 capsid over standard AAV2 include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Enables Intravitreal Delivery: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAV.7m8 capsid has been engineered to achieve retinal transduction through IVT injection, the standard in-office procedure for wet AMD standard of care. The IVT route of administration is a routine and less invasive alternative to both the sub-retinal and suprachoroidal routes. The former can pose risks to the structure and function of the retina, particularly in cases where the patient's retina is already compromised or undergoing degeneration, while the latter relies on a novel specialized medical device and can be associated with complications related to the device or the procedure.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Enhanced Retinal Transduction:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AAV.7m8 has been engineered to achieve widespread retinal transduction through IVT administration, facilitating the delivery of the gene of interest to cells in the deeper retinal layers. This capability is crucial for therapies targeting retinal diseases.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Potential for Lower Dosing, Increased Efficacy:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AAV.7m8's efficient IVT dosing overcomes therapy barriers, enabling high gene expression in the retina. This allows for lower doses, potentially enhancing efficacy and reducing the immune response and inflammation associated with higher doses of vectors with limited permeability from the vitreous to the retina.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Efficacy and Inflammation Balance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> With its highly efficient retinal transduction profile, AAV.7m8-based vectors, when coupled with appropriate corticosteroid prophylaxis, may provide an optimal therapeutic window and a favorable benefit/risk profile.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Retina as a Biofactory:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AAV.7m8-based vectors, administered intravitreally, leverage ocular cells as a biofactory to release secretable therapeutic proteins. This approach can eliminate the necessity for repetitive IVT dosing, as a single injection may sustain the continuous delivery of therapeutic proteins throughout an individual's lifetime.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Benchmark for IVT Delivery:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> AAV.7m8 has set the standard for IVT delivery of therapeutic vectors, given its optimal retinal transduction profile. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Well Studied: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several gene therapy product candidates using AAV.7m8 have shown positive results in clinical and/or non-clinical studies. As of December 31, 2024, three product candidates using AAV.7m8 are in clinical development.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ixo-vec, Our Single Intravitreal Injection Gene Therapy Candidate for Treating Wet AMD</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ixo-vec, formerly referred to as ADVM-022, is our lead gene therapy product candidate being developed for the treatment of patients with wet AMD. Ixo-vec is designed to deliver long-term, durable therapeutic levels of aflibercept associated with a robust, sustained treatment response and reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-VEGF IVT injections. Ixo-vec utilizes an engineered, proprietary capsid, AAV.7m8, carrying a codon-optimized aflibercept coding sequence under the control of a proprietary expression cassette capable of transducing retinal cells after a single in-office IVT injection. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ixo-vec is designed to provide long-term efficacy, which would address one of the major challenges in managing wet AMD &#8211; the frequent need for anti-VEGF injections. By potentially reducing or eliminating the need for these regular injections, if approved, Ixo-vec would offer a more convenient and less burdensome treatment regimen. This product is intended to improve both real-world vision outcomes and quality of life for patients. This approach could optimize patient compliance and lead to better overall vision outcomes, making it a significant advancement in the treatment of wet AMD.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current Market for Wet AMD and Unmet Medical Needs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Age-related macular degeneration is a progressive disease affecting the retinal cells in the macula, the region of the retina at the back of the eye responsible for central vision. Disease progression results in the death of retinal cells and the gradual loss of vision. Wet AMD, also known as neovascular AMD, is an advanced form of AMD, affecting approximately 10% of patients living with AMD. In patients with wet AMD, the abnormal blood vessels invade the space between layers of cells in the retina. These new blood vessels are often leaky, which results in fluid and blood in the retina and causes vision loss.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wet AMD is a leading cause of blindness in patients over 65 years of age, with a prevalence of approximately 20 million individuals worldwide. The incidence of new cases of wet AMD is expected to grow significantly worldwide as populations age. AMD is expected to impact 288 million people worldwide by 2040, with wet AMD accounting for approximately ten percent of those cases. Up to 42% of wet AMD patients experience neovascularization in the second eye in the first two to three years following diagnosis in the primary eye.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater durability of therapeutics is a key unmet need in wet AMD. The current standard of care for wet AMD requires frequent and lifelong anti-VEGF injections. Most patients with wet AMD are commonly treated with bevacizumab, often used off-label, or with specific wet AMD therapies. Bevacizumab, while not originally developed for wet AMD, has found widespread use due to its efficacy and cost-effectiveness. In contrast, Lucentis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ranibizumab), Eylea (aflibercept), Vabysmo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (faricimab), and the high-dose formulation Eylea HD are FDA-approved treatments specifically designed for wet AMD. While effective for many patients, these options typically require eye injections every 4-16 weeks in order to maintain vision. Real world evidence shows that this regimen can be difficult to adhere to for patients, caregivers, and healthcare systems, leading to undertreatment associated with persistent macular fluid and resulting in loss of vision over time. A significant proportion of patients discontinue anti-VEGF treatment, estimated at up to 40% within two years and up to 57% within 5 years. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even well-treated wet AMD patients can experience a loss of vision over time. This is thought to arise from fluctuations in macular fluid. These fluctuations can be pronounced with standard-of-care bolus anti-VEFG therapy, in which patients see fluid levels fall after receiving an injection only to rise before their next injection. A growing scientific consensus views controlling fluid fluctuations as crucial for maintaining visual acuity in patients undergoing anti-VEGF therapy for wet AMD.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the standard-of-care anti-VEGF therapies used to treat wet AMD and other chronic retinal conditions that respond to anti-VEGF therapy generated in approximately $14 billion worldwide in sales in 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Ixo-Vec Addresses Unmet Medical Needs for Wet AMD</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gene therapies are designed as a single, in-office IVT injection therapy to address the unmet needs of patients with highly prevalent ocular diseases. We believe that durable treatment to reduce injection frequency, reduce fluctuations of macular fluid, and improve long term visual outcomes is the largest unmet need for wet AMD patients and their caregivers. Lifetime need for frequent injections burdens patients, caregivers, healthcare providers and healthcare systems. Real world evidence shows reduction in patients&#8217; vision over time associated with insufficient treatment, and the persistence of macular fluid between anti-VEGF injections, including as a result of poor adherence to the frequent injection regimen. Furthermore, bolus anti-VEGF injections may result in fluctuations in macular fluid that have been shown to have negative impacts on visual outcomes over time. Ixo-vec has the potential to revolutionize this paradigm, shifting from the traditional &#8220;treat-and-extend&#8221; approach to a model focused on sustained anti-VEGF delivery, potentially effective for the patient&#8217;s lifetime. A gene therapy administered as a single, in-office IVT injection has the potential to deliver long-term efficacy, reduce the burden of frequent anti-VEGF injections, minimize macular fluid and macular fluid fluctuation and improve vision outcomes for patients. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advantages over Other Biofactory Approaches</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe IVT injection of ocular gene therapy for the treatment of wet AMD, as with Ixo-vec, offers substantial advantages compared to subretinal and suprachoroidal administration. The earliest ophthalmic gene therapies have been delivered subretinally. Subretinal administration requires that a victrectomy be performed via intraocular surgery, which carries inherent risks such as retinal detachment or infection and involves a recovery period that can be uncomfortable for the patient. In addition, subretinal gene therapy may be administered only to pseudophakic patients, that is, those patients who have had an artificial lens implanted, typically during cataract surgery.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The more recently developed suprachoroidal approach, while less invasive than subretinal surgery, relies on specialized medical devices to inject into a highly vascularized virtual space. This approach can be associated with complications related to the device or the procedure itself, and systemic absorption may lead to off-target effects. In animal models it has been observed that suprachoroidal delivery may result in higher potential for development of the immune response against the transgenic protein, potentially linked to the vector's exposure to inflammatory cells outside the blood-retinal barrier within scleral and uveal tissue. Furthermore, suprachoroidal administration in NHPs revealed a diffuse, peripheral, and circumferential pattern of transduction, with the retinal pigment epithelium, and scleral tissues identified as primary targets. Thus, when suprachoroidal delivery is utilized as a biofactory method for delivering therapeutic proteins to the retina, these proteins must overcome barriers by diffusing effectively to reach the targeted disease site in the retina, to provide optimal effectiveness. Suprachoroidal gene therapy appears to require higher doses than subretinal IVT gene therapy, which increases manufacturing costs and may have implications for potential inflammation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast, Ixo-vec is administered via a straightforward, one-time IVT injection. This simple procedure is performed during an office visit and is the mode of administration for current standard-of-care therapies for wet AMD. The IVT method significantly reduces the procedural risks and potential complications associated with the more invasive surgical techniques. It simplifies the treatment process and fits into existing retina practice workflows, making it more patient-friendly and accessible.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OPTIC Clinical Trial in Wet AMD</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we initiated the Ixo-vec clinical trial entitled &#8220;An Open Label Phase 1 Study of Ixo-vec (AAV.7m8-aflibercept) in Neovascular (Wet) Age-Related Macular Degeneration&#8221; (&#8220;OPTIC&#8221;). The last subject completed the two-year OPTIC trial in June 2022. We will continue to follow subjects enrolled in the OPTIC three-year extension out to a total of five years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OPTIC Trial Design. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OPTIC trial was designed as a multi-center, open-label, Phase 1, dose-ranging safety trial of Ixo-vec in subjects with wet AMD who have demonstrated responsiveness to anti-VEGF treatment. Subjects in OPTIC are treatment-experienced and previously required frequent anti&#8209;VEGF injections to manage their wet AMD and to maintain functional vision.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In OPTIC, subjects were dosed with a single IVT injection of Ixo-vec. Subjects in cohort 1 (n=6) were treated with a 6E11 dose of Ixo-vec. Subjects in cohort 2 (n=6) were treated with a three-fold lower 2E11 dose of Ixo-vec. Subjects in cohorts 1 and 2 received a 13-day tapering course of prophylactic oral corticosteroids following Ixo-vec administration. Subjects in cohort 3 (n=9) were treated with a 2E11 dose of Ixo-vec, and subjects in cohort 4 (n=9) were treated with a 6E11 dose of Ixo-vec. Subjects in cohorts 3 and 4 received a 6&#8209;week tapering course of prophylactic topical corticosteroids in place of the oral corticosteroids.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary endpoint of the trial was the safety and tolerability of Ixo-vec after a single IVT administration. Secondary endpoints included changes in BCVA, measurement of CST (a measure of retinal thickness), as well as mean number of anti-VEGF supplemental injections and percentage of subjects needing anti-VEGF supplemental injections. Each subject enrolled was followed for a total of two years in OPTIC. Most of the subjects have enrolled in a three-year extension study to continue to monitor safety and efficacy out to a total of five years. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OPTIC Two-Year Data. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The last subject completed the OPTIC study in June 2022. On average, subjects had significant disease, having received an average of approximately 10 annualized injections of anti-VEGF therapy in the year prior to receiving Ixo-vec. In OPTIC, Ixo-vec showed a robust treatment response from both doses through 104 weeks. Subjects who received the 6E11 dose of Ixo-vec, Cohorts 1 and 4, experienced a 98% reduction in annualized anti-VEGF injections and 80% remained supplemental anti-VEGF injection free. Subjects who received the 2E11 dose of Ixo-vec, Cohorts 2 and 3, experienced an 80% reduction in annualized anti-VEGF injections and 53% remained supplemental anti-VEGF injection free. Subjects also experienced maintenance of BCVA and a reduction of CST, followed by maintenance of those lower CST levels. Subjects experienced sustained stable aflibercept protein levels from 10 weeks through the end of the study. Despite the short duration of prophylactic corticosteroid therapy, Ixo-vec was generally well tolerated, with the most common adverse event (&#8220;AE&#8221;) of dose-related anterior inflammation and asymptomatic pigmentary changes, including iris hyperpigmentation and iris transillumination defects. In December 2023, the OPTIC two-year results were published in the Lancet&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">eClinical Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OPTIC Four-Year Data. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, we presented four-year results from the OPTIC parent and extension trials. Following Ixo-vec treatment, subjects who had received the 2E11 dose, the dose taken forward into LUNA, experienced an 86% reduction in annualized anti-VEGF injections through four years, with a robust treatment burden reduction demonstrated in each year and nearly half of the subjects injection free through four years. Subjects continued to experience maintenance of BCVA and CST levels. Subjects also demonstrated sustained aflibercept protein levels, measured through the latest reported follow-up, which is currently up to five years in the earliest subjects enrolled. Ixo-vec at the 2E11 dose continues to be generally well tolerated in the extension study. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a schematic of the OPTIC and OPTIC extension trial and selected OPTIC four-year data showing treatment burden reduction and BCVA and CST reduction and maintenance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="advm-20241231_g1.jpg" alt="Slide 15.jpg" style="height:376px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="advm-20241231_g2.jpg" alt="P11S1OPTIC.jpg" style="height:379px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><img src="advm-20241231_g3.jpg" alt="P13S2OPTIC.jpg" style="height:377px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LUNA Phase 2 Clinical Trial in Wet AMD</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we dosed the first subject in our LUNA Phase 2 trial of Ixo-vec. LUNA is a multicenter, double-masked, randomized, parallel-group Phase 2 trial evaluating two doses of Ixo-vec - 2E11, the lower dose used in the OPTIC trial, and a new, lower 6E10 dose. LUNA is assessing four new enhanced prophylactic corticosteroid regimens, including difluprednate drops alone or in combination with IVT Ozurdex, a bioerodable implant of dexamethasone, and both local regimens with or without oral prednisone. Participants were randomized approximately 2:1 to receive local versus local plus oral prophylaxis. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary endpoints are similar to the OPTIC trial and focus on mean change in BCVA and CST from baseline to one year, and incidence and severity of adverse events. Other endpoints include aflibercept protein levels at 14 weeks, reductions in fluctuations in CST and in treatment burden, and patient preferences. The study is also evaluating the effectiveness and tolerability of the prophylactic corticosteroid regimens. In August 2023, we announced that the Phase 2 LUNA trial was fully enrolled, with a total of 60 subjects randomized equally between the 2E11 and 6E10 doses across 34 sites in the U.S. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, we announced top-line 52 week results from the LUNA Phase 2 trial with a data cut-off date of August 29, 2024, demonstrating that both the 2E11 and 6E10 doses maintained visual and anatomic outcomes. Notably, both doses resulted in favorable reductions in annualized anti-VEGF injections and the percentage of subjects remaining free of injections was consistent with results observed in the OPTIC trial at one year. Subjects enrolled in the study had a high treatment burden, receiving an average of approximately 10 anti-VEGF injections in the year prior to receiving Ixo-vec.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment Burden Reduction. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those subjects who had completed 52 weeks of follow-up, at the 6E10 (n=28) and 2E11 (n=29) doses, Ixo-vec demonstrated reduction in annualized anti-VEGF injection rates of 88% and 92%, respectively, and injection free rates of 54% and 69%, respectively. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Visual and Anatomic Outcomes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Visual acuity (BCVA) and anatomic endpoints (CST) were maintained at both dose levels. In a sub-group analysis of patients with higher baseline CST, a greater reduction in CST was demonstrated, indicating the efficacy potential of Ixo-vec gene therapy.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aflibercept Levels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Aqueous humor aflibercept protein levels at 14 weeks suggest that both doses deliver aflibercept levels that are within the therapeutic range observed in OPTIC. Importantly, early aflibercept levels are associated with sustained long-term protein levels in OPTIC through the latest reported follow-up, which is currently through four years at the 2E11 dose. No minimum aqueous humor aflibercept threshold for clinical benefit was observed. We revised the LUNA study to stop the collection of aqueous humor samples.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Safety Profile and &#8220;Go-Forward&#8221; Corticosteroid Prophylaxis Regimen.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Ixo-vec was well-tolerated, and when present inflammation was responsive to local corticosteroids. No Ixo-vec related serious adverse events were reported. No Ixo-vec related episcleritis, vasculitis, retinitis, choroiditis, vascular occlusion or hypotony were reported. Consistent with OPTIC 2E11, the most common Ixo-vec related AEs observed in LUNA were dose-related anterior inflammation and asymptomatic pigmentary changes, including iris transillumination defects and anterior chamber pigmentation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data suggest corticosteroid prophylaxis optimization at both the 2E11 and 6E10 doses appears to result in improved inflammatory profiles in LUNA as compared to OPTIC trial results. Specifically, data demonstrated that difluprednate topical eye drops alone is a promising prophylactic regimen. Data indicated that Ozurdex alone or with oral corticosteroids does not provide  prophylaxis of sufficient duration, and oral corticosteroids showed no incremental benefit. We have selected difluprednate eye drops alone as the &#8220;go-forward&#8221; prophylactic regimen for the pivotal studies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient Preference Survey. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from our pre-specified LUNA patient preference survey demonstrate strong preference for Ixo-vec over prior anti-VEGF therapies, plus the acceptability of local prophylactic steroid regimens. 93% (n=56) of LUNA patients at 52 weeks preferred Ixo-vec, including accompanying steroid regimen, over prior treatments, up from 88% (n=57) at 26 weeks; 95% (n=56) would elect to receive Ixo-vec in the other eye if both eyes had wet AMD; and 96% (n=56) would recommend Ixo-vec to their family or friends with wet AMD. 100% (n=10) of patients who received the 6E10 dose and topical-eye-drop-only steroid regimen preferred Ixo-vec over their prior treatments for wet AMD, would elect to receive Ixo-vec in the other eye if both eyes had wet AMD, and would recommend Ixo-vec to their family or friends with wet AMD. No patients receiving topical eye drop alone prophylaxis (n=20) stated it was difficult to manage.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graphics below show a schematic of the LUNA trial design and selected data from the November 2024 LUNA data announcement including treatment burden reduction; BCVA and CST maintenance; the greater reduction in CST levels in a subgroup of patients with higher baseline CST levels; aflibercept levels overlaid onto aflibercept levels observed at the 2E11 dose in OPTIC through the latest reported follow-up, which is currently through four years at the 2E11 dose; and results from the patient preference survey. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g4.jpg" alt="Slide 28.jpg" style="height:381px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g5.jpg" alt="P13S2LUNAOPTIC.jpg" style="height:385px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g6.jpg" alt="P14S1LUNA.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g7.jpg" alt="P14S2LUNA.jpg" style="height:385px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g8.jpg" alt="Slide 37 updated.jpg" style="height:381px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g9.jpg" alt="Slide 47 updated.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><img src="advm-20241231_g10.jpg" alt="Slide 48 updated.jpg" style="height:384px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phase 3 Program for Ixo-vec in Wet AMD</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to conduct two, double-masked, randomized Phase 3 clinical trials evaluating Ixo-vec in wet AMD. We are conducting the first Phase 3 trial, ARTEMIS, at U.S. sites and intend to conduct the second Phase 3 trial, AQUARIUS, at both U.S. and non-U.S. sites.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 284-patient ARTEMIS Phase 3 trial is designed to enroll a broad patient population, including both treatment-na&#239;ve and treatment-experienced wet AMD patients. The primary endpoint, measured at an average of weeks 52 and 56, is non-inferiority in mean BCVA change from baseline between Ixo-vec (6E10) and aflibercept (2mg Q8W). The non-inferiority margin for this study is -4.5 letters. All patients will receive three monthly loading doses of aflibercept prior to Ixo-vec. The study will utilize sham injections in the control arm to support masking. Patients in both arms will be eligible for supplemental injections of aflibercept and will receive topical steroid eye drops. We initiated ARTEMIS in March 2025. The schematic below shows the ARTEMIS trial design.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><img src="advm-20241231_g11.jpg" alt="Slide 55.jpg" style="height:385px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INFINITY Phase 2 Clinical Trial in DME</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we initiated the INFINITY trial, a multi-center, Phase 2, randomized, double-masked, active comparator-controlled study evaluating a single IVT injection of Ixo-vec in subjects with diabetic macular edema (&#8220;DME&#8221;). A dose limiting toxicity at the 6E11 dose in this population with poorly controlled diabetes and microvascular complications was identified in April of 2021. Consequently, we are no longer pursuing Ixo-vec for DME, nor are we evaluating the 6E11 dose in wet AMD. We have not seen similar subject safety concerns in any of our subjects at either the 2E11 dose in the INFINITY, OPTIC, or LUNA trials or the 6E11 dose in the OPTIC trial.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Immunogenicity to AAV therapy has been broadly reported to be associated both with systemic and ocular gene therapies, regardless of route of administration, and is generally understood to be dose related. Based on an extensive evaluation of data from all of our subjects treated with Ixo-vec in LUNA, OPTIC and INFINITY and all of our nonclinical data by internal and external experts, we believe that utilizing the 6E10 dose along with enhanced topical-eye-drop steroid prophylaxis, as we are currently evaluating in the ongoing LUNA and ARTEMIS trials, may allow us to minimize post-prophylaxis inflammation in our wet AMD trial subjects going forward.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ixo-vec Regulatory Designations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2018, we announced that the FDA had granted Ixo-vec Fast Track designation. Fast Track is a process designed to facilitate the development and expedite the review of drugs and biologics to treat serious conditions and fill unmet medical needs. The designation enables more frequent meetings and communication with the FDA throughout a product candidate&#8217;s development and review process, often leading to earlier drug approval and access by patients. The designation also provides eligibility for Priority Review, Accelerated Approval, and Rolling Review, which may potentially result in a shorter FDA review process. The purpose of the Fast Track process is to get important new drugs and biologics to patients earlier.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we announced that the European Medicines Agency EMA granted Ixo-vec Priority Medicines PRIME designation. PRIME voluntary scheme intended to enhance the EMA&#8217;s support for the development of medicinal products that target unmet medical needs. Eligible products must target conditions for which there is an unmet medical need (i.e. there is no satisfactory method of diagnosis, prevention or treatment in the EU or, if such a method exists, the new medicinal product will bring a major therapeutic advantage) and they must be demonstrated to have the potential to address the unmet medical need by introducing new methods of therapy or improving existing ones.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, we announced that the MHRA granted Ixo-vec an Innovation Passport under the ILAP. The Innovation Passport is the first step in the ILAP process, triggering the MHRA and its partner agencies, including the All Wales Therapeutics and Toxicology Centre, the National Institute for Health and Care Excellence, and the Scottish Medicines Consortium to partner with Adverum to charter a roadmap for regulatory and development milestones with the goal of early patient access in the U.K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, we announced the FDA had granted Ixo-vec the Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;) designation. RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies. The RMAT designation provides the benefits of intensive FDA guidance on efficient drug development, including potential priority review of the BLA, and other opportunities to expedite development and review.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Programs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dry AMD / Geographic Atrophy Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we presented nonclinical data on an IVT gene therapy for the treatment of geographic atrophy secondary to dry age-related macular degeneration (&#8220;dry AMD&#8221;) via expression of Complement Factor I at the American Society of Gene &amp; Cell Therapy&#8217;s (&#8220;ASGCT&#8221;) 2023 Annual Meeting. Dry AMD is a highly prevalent disease in which patients experience a chronic progressive deterioration of the macula, leading to central blind spots and permanent vision loss. Geographic atrophy can be seen as part of late-stage AMD.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optogenetics Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, we presented data on an optogenetic approach to vision restoration at ASGCT&#8217;s 2023 Annual Meeting. Melanopsin, through its ability to regenerate chromophore, has the potential to be an effective light sensor candidate by generating pseudo-photoreceptors. Our engineered melanopsin demonstrated favorable kinetics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and may have utility as a therapeutic transgene for optogenetic vision restoration.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Partnered Programs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BGTF-027 (AAV.7m8-L-opsin), formerly known as ADVM-062, is a novel gene therapy product candidate designed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy (&#8220;BCM&#8221;) via a single IVT injection. BGTF-027 utilizes Adverum&#8217;s propriety vector capsid, AAV.7m8. In January 2022, we announced that the FDA granted Orphan Drug Designation to BGTF-027. In September 2023, we granted an exclusive license for the rights to BGTF-027 to Blue Gen Therapeutics Foundation, a non-profit organization dedicated to advancing gene therapy treatments for rare inherited retinal diseases, that will now lead all research and development activities for the program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have licensed to GenSight rights to use AAV.7m8 for GS030, GenSight&#8217;s gene therapy encoding for channelrhodopsin protein. In October 2018, GenSight began its PIONEER Phase 1/2 clinical trial in retinitis pigmentosa in the U.S., France, and U.K. and in February 2023 announced one-year safety data and efficacy signals from the trial. In October 2021, GenSight announced it had been granted Fast Track Designation by the FDA for GS030. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have licensed to Ray Therapeutics rights to use AAV.7m8 in conjunction with Ray&#8217;s RTx-015 optogenetics payload for ocular diseases. Ray Therapeutics is developing RTx-015 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need. In September 2024, Ray Therapeutics advanced RTx-015 into a Phase 1 clinical trial in retinitis pigmentosa. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have licensed to LEXEO Therapeutics rights to the intellectual property and pre-clinical data package for LX2006, an investigational gene therapy for Friedreich&#8217;s ataxia.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we advance Ixo-vec for wet AMD, we are continuing to develop our manufacturing expertise for ongoing supply. We currently have no operational clinical or commercial manufacturing facilities, and all of our clinical manufacturing activities are currently contracted out to third parties. We maintain control of key aspects of the manufacturing process, specifically in development of scalable processes, assay development, and GMP quality controls. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AAV vector manufacturing process is based on the Baculovirus Expression Vector System (&#8220;BEVS&#8221;), which has been used in a number of FDA- and European-approved products. This approach is well suited for the production of large quantities of AAVs, as it takes advantage of the efficiency of viral infection coupled with the high density and scalability of insect cells grown in serum-free suspension cultures. Compared to the mammalian cell-based approaches commonly used in the field, our manufacturing process is designed to produce higher yields of vectors per manufacturing campaign in a cost-effective manner.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AAV manufacturing method is industrialized, highly scalable and ready for adaptation for commercial stage. We believe our process provides the following advantages over competing systems:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Industrial-scale biologics production.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our BEVS system can produce quantities of product required at commercial stage by incorporating scalable, well-established process steps used throughout the industry for biologic products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Safety advantages.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our BEVS system does not use mammalian cell cultures or tumorigenic cell lines, and the DNA sequences used to allow AAV vector production are inactive in mammalian cells, which lowers the risk of off-target expression from our products and infection by adventitious agents in humans.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">High yield and cost effectiveness.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Because of its scalability, our BEVS system may allow the production of large quantities of AAV vectors, up to the 2000-liter scale, providing further economies of scale.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">High purity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our BEVS system coupled with our proprietary downstream purification process produces a highly pure drug substance.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Precedent regulatory framework.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Several other vaccines and recombinant protein therapies have been approved using a manufacturing process similar to our BEVS technology.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are manufactured using cell banks and a scalable process developed internally and externally that are transferred to approved Contract Manufacturing Organizations (&#8220;CMOs&#8221;). These CMOs produce investigational drugs under GMP conditions to support our clinical trials. High quality raw materials are purchased from various suppliers and are used throughout the manufacturing process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate new raw material suppliers, as well as additional CMOs, in order to provide manufacturing flexibility. As we prepare for larger, late-stage clinical trials and potential commercialization, we have in-house process development capabilities, allowing us to develop larger-scale processes together with our global GMP contract manufacturers. We leverage GMP contract manufacturer partnerships for flexible clinical and future commercial supply. This strategy capitalizes on our internal AAV manufacturing expertise while providing both security, expandibility and flexibility as we prepare to potentially deliver one of the first gene therapies for large indications.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CMOs have produced multiple batches of Ixo-vec at our proposed commercial scale that we have used in LUNA and intend to use in our Phase 3 clinical trials.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biopharmaceutical industry is characterized by intense and dynamic competition to develop new proprietary technologies and therapies and a strong emphasis on intellectual property. We believe that our single-administration IVT approach for the treatment of wet AMD, our AAV-based platform, our nonclinical and clinical development experience, our gene therapy manufacturing experience and our expertise in the field of gene therapy provide us with competitive advantages. However, we face actual or potential competition from various sources, including larger and better-funded pharmaceutical, specialty pharmaceutical, and biotechnology companies, as well as from academic institutions, governmental agencies, and public and private research institutions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Ixo-vec gene therapy product candidate for wet AMD utilizes a proprietary vector, is administered through a single IVT injection, and will compete with a variety of therapies currently marketed and in development, including biologics, small molecules, long-acting delivery devices and gene therapy. The key factors that contribute to success of any approved product include safety profile, efficacy, durability, mode of administration and cost of goods. Existing anti-VEGF therapies are well-established therapies and are widely accepted by physicians, patients and third-party payers as the standard-of-care treatment of patients with wet AMD. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, most patients receive off-label bevacizumab, including as a first-line treatment. Many patients go on to receive Eylea, Eylea HD and Vabysmo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (faricimab). We know of a number of additional product candidates in development or approved for chronic retinal conditions that respond to anti-VEGF therapy, including wet AMD. These product candidates and products include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biosimilar anti-VEGFs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bispecific / combination / add-on therapies for efficacy or durability improvement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-acting delivery devices and tyrosine kinase inhibitor implants to lower treatment frequency;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">gene therapy to lower treatment frequency and offer the potential for lifelong injection freedom; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other molecules that inhibit neovascularization in wet AMD.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are several other companies in the U.S. or Europe with marketed products or products in development for the treatment of chronic retinal conditions that respond to anti-VEGF therapy, including wet AMD. These companies include 4D Molecular Therapeutics, AbbVie, Bayer, Clearside Biomedical, EyePoint Pharmaceuticals, Kodiak Sciences, Novartis, Ocular Therapeutix, Opthea, Outlook Therapeutics, Regeneron, REGENXBIO and Roche. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These companies, as well as any other competitors we may face, either alone or with their partners, for our other product candidates, may have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and development of product candidates, obtaining FDA and other regulatory approvals of treatments, and commercializing those treatments. Accordingly, our competitors may be more successful than we in obtaining approval for treatments and achieving widespread market acceptance. Our competitors&#8217; treatments may be more effective, have fewer side effects, or be more effectively marketed and sold, than any treatment we may commercialize and may render our treatments obsolete or non-competitive before we can recover the expenses of developing and commercializing any of our treatments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will face intense and increasing competition as new drugs enter the market and advanced technologies become available. We expect any treatments that we develop and commercialize to compete on the basis of, among other things, efficacy, safety, convenience of administration and delivery, price, the level of generic competition and the availability of reimbursement from government and other third-party payers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License and Collaboration Agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">University of California</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AAV.7m8 License Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In June 2013, we entered into an exclusive worldwide sublicensable license agreement with the Regents of University of California (&#8220;Regents&#8221;) to certain intellectual property related to improved AAV vectors, including the AAV.7m8 capsid. Under this license agreement, we are obligated to make certain de minimis license payments, certain milestone payments totaling up to $1.0 million upon reaching certain stages of development of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the licensed products for a first indication, and totaling up to $0.5 million for each subsequent indication for which licensed products are developed, for up to a maximum of two additional indications.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are obligated to pay Regents royalties on sales of licensed products in the low single-digits, subject to adjustments and minimum thresholds.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, this agreement will be in effect on a country-by-country, licensed product-by-licensed product basis until the expiration of the last claim of the licensed intellectual property covering the manufacture, use, or sale of such product in such country. We may terminate this agreement in whole or in party by giving Regents 30 days&#8217; prior written notice. Regents may terminate this agreement for breach by us that remains uncured for 60 days, if we become insolvent, if we directly or through a third-party file a claim that a licensed patent right is invalid or unenforceable, or if we fail to meet or extend the date for meeting certain diligence milestones.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GenSight Biologics</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we entered into an agreement with GenSight Biologics (&#8220;GenSight&#8221;), in which we granted GenSight a non-exclusive license to our proprietary AAV.7m8 vector to develop gene therapy products to deliver certain therapeutic transgenes. Under the agreement, we are eligible to receive development, regulatory and commercial milestones. Also, we are eligible to receive low to mid-single digit royalties on sales of GenSight&#8217;s licensed products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GenSight is currently developing GS030, a gene therapy encoding channelrhodopsin protein which incorporates the AAV.7m8 capsid. GenSight is conducting a phase 1/2 trial with GS030 to treat retinitis pigmentosa in the U.S., France, and the U.K., which began in October 2018. In October 2021, GenSight announced it had been granted Fast Track Designation by the FDA for GS030 and in February 2023, announced one-year safety data and efficacy signals from its PIONEER Phase 1/2 clinical trial for retinitis pigmentosa. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ray Therapeutics</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we entered into an agreement with Ray Therapeutics (&#8220;Ray&#8221;), pursuant to which we granted Ray a non-exclusive license to our proprietary AAV.7m8 vector to be used in conjunction with Ray&#8217;s optogenetics payload. Under the agreement, we are eligible to receive development, regulatory and commercial milestones. Also, we are eligible to receive low to mid-single digit royalties on sales of Ray&#8217;s licensed products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ray is currently developing RTx-015, an optogenetic gene therapy which incorporates our AAV.7m8 capsid. Ray is conducting a Phase 1 trial with RTx-015 to treat retinitis pigmentosa.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lexeo Therapeutics </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into an agreement with Lexeo Therapeutics (&#8220;Lexeo&#8221;), pursuant to which we granted Lexeo an exclusive license to the intellectual property rights, pre-clinical data and know-how associated with our Friedrich&#8217;s Ataxia program. Under the agreement, we are eligible to receive development and commercial milestones and royalties related to sales of a product containing our licensed rights. Lexeo is currently developing LX2006, an adeno-associated virus mediated treatment. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Virovek</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 12, 2011, we entered into an agreement with Virovek, Inc. (&#8220;Virovek&#8221;), in which we received a non-exclusive license to certain Virovek technology and know-how related to methods and materials for manufacturing AAV. Under the agreement, Virovek is entitled to certain license payments and low-single digit royalty payments. This license with Virovek continues in effect until expiration of the last-to-expire patent.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to protect and enhance the proprietary technology, inventions and improvements that are commercially important to the development of our business, including seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. We also rely on trade secrets relating to our proprietary technology platform and on know-how, continuing technological innovation and in-licensing opportunities to develop, strengthen and maintain our proprietary position in the field of gene therapy that may be important for the development of our business. Additionally, we may rely on regulatory protection afforded through orphan drug designations, data exclusivity, market exclusivity, and patent term extensions where available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success may depend in part on our ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business; defend and enforce our patents; preserve the confidentiality of our trade secrets; obtain regulatory exclusivity and operate without infringing the valid enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell or importing our products may depend on the extent to which we have rights under valid and enforceable licenses, patents or trade secrets that cover these activities. In some cases, these rights may need to be enforced by third-party licensors. With respect to both licensed and company-owned intellectual property, we cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our existing patents or any patents that may be granted to us in the future will be commercially useful in protecting our commercial products and methods of manufacturing the same.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 7, 2025, we own or license more than 430 issued patents that are still in force, including more than 30 issued U.S. patents and 15 European patents validated cumulatively in more than 275 countries, as well as more than 197 patent applications pending in the U.S. and foreign jurisdictions, 10 of which have been allowed. These numbers include more than 44 patents and 8 pending applications filed by or on behalf of universities which have granted us exclusive license rights to the technology. Our policy is to file patent applications to protect technology, inventions and improvements to inventions that are commercially important to the development of our business. We seek patent protection in the U.S. and abroad for a variety of technologies, including research tools and methods, AAV-based biological products, methods for treating diseases of interest and methods for manufacturing our AAV-based products. We also intend to seek patent protection or rely upon trade secret rights to protect other technologies that may be used to discover and validate targets and that may be used to identify and develop novel biological products. We seek protection, in part, through confidentiality and proprietary information agreements. We are a party to various other license agreements that give us rights to use specific technologies in our research and development.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company-owned Intellectual Property</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own at least five patent families that are directed to AAV-based compositions and methods for treating or preventing eye diseases associated with neovascularization. Patents and applications in the first of these families relate to compositions and methods for the AAV-based delivery of anti-VEGF proteins, for use in treating neovascular diseases of the eye, including wet AMD and diabetic retinopathy, in patients who respond to anti-VEGF protein therapy. Twenty patents in this family have issued in the U.S., elsewhere in North America, Europe and the Asia/Pacific region, and seven corresponding applications are pending in the U.S., elsewhere in North America, Europe, and the Asia/Pacific region. Patents in this family are generally expected to expire in 2033, subject to possible patent term adjustments and patent term extensions. Patents and applications in the second of these families relate to AAV gene therapy for the treatment of neovascular diseases of the eye, including wet AMD and diabetic retinopathy, using the AAV.7m8 vector to deliver aflibercept. One issued European patent is validated in thirty-seven countries, eight patents are issued in North America, the Asia/Pacific region, Israel and South Africa, and at least sixteen corresponding applications are pending in the U.S., elsewhere in North America, Europe, and Asia/Pacific region. Patents in this family are generally expected to expire in 2037, subject to possible patent term adjustment and patent term extensions. The third of these families contains granted applications in Australia, Europe (validated in 37 countries), Hong Kong, and Japan, and pending U.S. and corresponding foreign applications directed to AAV gene therapy for the treatment of neovascular diseases of the eye, including wet AMD and diabetic retinopathy, using the AAV.7m8 vector to deliver ranibizumab. Patents that may eventually issue from this patent family, if any, are generally expected to expire in 2037, subject to possible patent term adjustments and patent term extensions. The fourth family contains 28 pending applications, and is directed to methods of treating neovascular diseases of the eye, including wet AMD and diabetic retinopathy, with AAV.7m8-aflibercept. Patents that may eventually issue from this family, if any, are generally expected to expire in 2039 to 2040 subject to possible patent term adjustments and patent term extensions. The fifth family is an international application (i.e., Patent Cooperation Treaty (&#8220;PCT&#8221;) application) directed to methods of treating neovascular diseases of the eye, including wet AMD and diabetic retinopathy, with low dose AAV.7m8-aflibercept. Patents that may eventually issue from this family, if any, are generally expected to expire in 2043.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own over 20 patent families that are directed to various aspects of our proprietary technology platform. Fourteen patents in these families have issued patents in the U.S., Europe, and the Asia/Pacific region, including one issued European patent validated in six countries, as well as at least forty-nine pending applications, including PCT applications or national phase applications in the U.S., elsewhere in North America, Europe, and the Asia/Pacific region. Patents that may eventually issue from these families, if any, are generally expected to expire between 2035 and 2043, subject to possible patent term extensions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensed Intellectual Property</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained both exclusive and non-exclusive licenses to patents directed to both compositions of matter and methods of use, and to other intellectual property.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we have exclusively licensed several families of patents and patent applications that relate to variant rAAV virions having desirable characteristics, such as increased infectivity, as well as novel methods to screen for such variants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One patent family directed to improved rAAV virions that we have exclusively licensed in the ocular field includes two granted patents in the U.S. The patents in this family are projected to expire between 2027 and 2029 in the U.S., subject to possible patent term extensions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another patent family directed to improved rAAV virions that we have exclusively licensed includes three granted U.S. patents that are expected to expire in 2031, subject to possible patent term extensions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A third patent family that we have exclusively licensed includes claims directed to the novel AAV.7m8 vector, which allows delivery of transgenes to the retina via IVT injection, and which we utilize in our product candidate ADVM&#8209;022. This family includes at least thirty-four issued patents in the U.S., elsewhere in North America, Europe, Asia, and the Pacific, including three European patents each validated in thirty-seven countries. Seven corresponding applications are pending in the U.S. and elsewhere in North America, Europe, Asia and the Pacific. Patents that issue from this patent family are generally expected to expire in 2032, subject to possible patent term extensions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also non-exclusively licensed rights to a patent family related to the Baculovirus/SF9 production system that includes eight issued patents in the U.S., Europe, and Asia, including a European patent validated in three countries. These patents are expected to expire in 2027 and 2030.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have exclusively licensed a family of patents and applications related to the treatment of cardiomyopathy associated with Friedreich&#8217;s Ataxia. This family includes two patents granted in the U.S., one in India, one in Mexico, one in New Zealand and two in South Africa. There are ten pending applications in the U.S. and elsewhere in North America, Europe, Asia, and the Pacific. Patents that grant from this patent family are generally expected to expire in 2033, subject to possible patent term extensions and adjustments. In January 2021, we granted an exclusive (even as to us) sublicense to this patent family, which does not relate to ADVM-022, to Lexeo Therapeutics.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Secret Protection</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances we may rely on trade secrets to protect aspects of our technology and product candidates, including aspects for which we do not obtain patent protection. We seek to protect our trade secrets and confidential information, in part, by entering into confidentiality agreements with our employees, consultants, scientific advisors and contractors. We also seek to preserve the integrity and confidentiality of our confidential information and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology systems. However, trade secrets can be difficult to protect. For more information regarding the risks related to our intellectual property, see &#8220;Risk Factors&#8212;Risks Relating to Our Intellectual Property.&#8221; of this Annual Report on Form 10-K. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., biological products, including gene therapy products, are primarily regulated under the Federal Food, Drug, and Cosmetic Act (&#8220;FD&amp;C Act&#8221;) and the Public Health Service Act (&#8220;PHS Act&#8221;), as well as corresponding implementing regulations promulgated by the FDA. These laws and regulations govern, among other things, the testing, manufacturing, safety, efficacy, purity, potency, labeling, packaging, storage, record keeping, reporting, advertising and promotion, distribution, post-approval monitoring and reporting, sampling, and export and import of biological products. Prior to conducting human clinical testing of our gene therapy products, we must submit an investigational new drug application (&#8220;IND&#8221;) to the FDA, and the IND must be cleared by the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the FDA, the Center for Biologics Evaluation and Research (&#8220;CBER&#8221;) regulates gene therapy products. Within CBER, the review of gene therapy and related products is consolidated in the Office of Therapeutic Products (&#8220;OTP&#8221;). The FDA has also established the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER in its review.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process required by the FDA before our product candidates may be marketed in the U.S. generally involves the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Completion of nonclinical laboratory tests, including evaluations of product chemistry, formulations, and toxicity and animal studies in accordance with current Good Laboratory Practice (&#8220;GLP&#8221;), regulations and applicable requirements for the humane use of laboratory animals or other applicable regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Submission of an IND to the FDA, which must go into effect before human clinical trials may begin;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approval by the independent institutional review board (&#8220;IRB&#8221;) of each clinical protocol and each clinical trial site before the trial may be initiated at that site;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approval by the institutional biosafety committee (&#8220;IBC&#8221;) of each clinical trial site, which assesses the safety of research involving, among other things, recombinant DNA, and identifies any potential risks to public health or the environment;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generation of substantial evidence from human clinical trials, conducted in accordance with Good Clinical Practice (&#8220;GCP&#8221;) regulations, and any additional requirements for the protection of human research subjects and their health information, to establish the safety and potency of the biological product for its proposed indication;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Submission to the FDA of a Biologics License Application (&#8220;BLA&#8221;) for marketing approval that demonstrates adequate efficacy and acceptable safety profile of the biological product based on results of nonclinical testing and clinical trials, as well as providing information on the chemistry, manufacturing and controls to ensure product identity, purity, potency and quality, as well as proposed labeling;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Satisfactory completion of an FDA inspection of each manufacturing facility at which the biologic product is produced, to assure that the product is produced in compliance with GMP, regulations, and any additional requirements made by the agency to assure that the facilities, methods and controls used during manufacturing are adequate to preserve the biological product&#8217;s safety, identity, strength, quality, purity, and potency;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Successful completion of FDA inspection(s) of the nonclinical and clinical trial sites and the clinical study sponsor that generated the data in support of the BLA;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Successful completion of an advisory committee review if the FDA convenes an advisory committee; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment of user fees and the FDA review and licensure of the BLA prior to any commercial marketing, sale or shipment of the biological product.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before testing any biological product candidate, including a gene therapy product, in humans, the product candidate enters the nonclinical testing stage. Nonclinical tests include animal studies to assess the characteristics and potential safety and efficacy of the product. The conduct of the nonclinical tests must comply with federal regulations and requirements, including GLPs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of nonclinical tests, together with manufacturing information, such as laboratory evaluation of product chemistry, formulation, and stability, as well as any available clinical data or literature and a proposed clinical protocol, are submitted as part of an IND to the FDA. Some nonclinical testing may continue even after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions relating to the content of the IND during the review period or places the clinical study on a clinical hold. In that case, the IND sponsor and the FDA must resolve any outstanding concerns before the IND goes into effect and the clinical trial begins. The FDA can impose clinical holds on a biologic product candidate at any time before or during clinical trials due to safety concerns or non-compliance. If the FDA imposes a clinical hold on an IND, clinical trials may not commence or proceed without FDA authorization, and then only under terms authorized by the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials involve administering of the investigational biological product candidate to human subjects under the supervision of qualified investigators, who are generally physicians not employed by or under the study sponsor&#8217;s control. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria, the parameters to be used in monitoring subject safety, including stopping rules that assure a clinical trial will be stopped if certain adverse events should occur, and the effectiveness criteria to be used. Each protocol (and its amendments) must be submitted to the FDA as part of the IND. An independent IRB, and IBC, at each institution where the clinical trial will be conducted must also review and approve the plan for any clinical trial before it can begin at that institution, and the IRB must monitor the clinical trial until it is completed. For gene therapy products, the IBC will also assess the safety of the research and identify any potential risk to public health or the environment, until the research is completed. Clinical testing also must satisfy GCP requirements, including the requirements for informed consent from all subjects. Some studies employ a Data Monitoring Committee (DMC), independent from the study sponsor, to monitor clinical trial conduct and safety, assess risks and benefits, and make recommendations to protect the study participants of clinical trials.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All clinical research performed in the U.S. in support of a BLA must be authorized in advance by the FDA as described above. However, a sponsor who wishes to conduct a clinical trial outside the U.S. may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, the FDA will accept a well-designed, well-conducted, non-IND foreign clinical trial as support for a BLA if (i) the clinical trial was conducted in accordance with GCP as further detailed in the regulation, including review and approval by an independent ethics committee, and (ii) if the FDA is able to validate the data from the clinical trial through an onsite inspection, if necessary. In addition, when an applicant submits data from a foreign clinical trial not conducted under an IND to support a BLA, the FDA requires a description of the actions the applicant took to ensure that the research conformed to GCP. Further, additional requirements apply when a sponsor intends to base marketing approval of a new drug solely on foreign clinical data.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Trials</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are typically conducted in three sequential phases, which may overlap or be combined.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 1 includes the initial introduction of an investigational new drug into human subjects and tested for safety. In the case of some product candidates for severe or life-threatening diseases, the initial human testing is often conducted in patients. Phase 1 clinical trials of gene therapies are typically conducted in patients rather than healthy volunteers.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 2 clinical trials are typically conducted in a larger subject population than Phase 1 trials to evaluate dosage tolerance and appropriate dosage, identify possible adverse effects and safety risks, and to preliminarily evaluate the efficacy of the product candidate for specific targeted indications. For Phase 2 clinical trials in gene therapy, although the subject population may be larger than the Phase 1 trials, the subject population may still remain relatively limited.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 3 clinical trials are typically conducted when Phase 2 clinical trials demonstrate that a dose range of the biological product candidate is effective and has an acceptable safety profile. Phase 3 clinical trials are generally undertaken to further evaluate dosage, clinical efficacy, potency, and safety in an expanded patient population at geographically dispersed clinical study sites. These clinical studies are intended to establish the overall risk/benefit ratio of the product and to provide an adequate basis for product approval and labeling. Phase 3 clinical trials are commonly referred to as &#8220;pivotal&#8221; studies, which typically denotes a study which presents the data that the FDA or other relevant regulatory agency will use to determine whether or not to approve a product candidate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Post-approval clinical trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial approval. These clinical trials are used to gain additional data from the treatment of patients in the intended therapeutic indication, particularly for long-term safety follow-up. Phase 4 clinical trials may be required by the FDA as a condition of approval. Additionally, FDA recommends that sponsors observe study participants for potential gene therapy-related delayed adverse events for as long as 15 years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data, and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA and the investigators for any serious and unexpected adverse event that occurs during the study, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the clinical protocol or Investigator&#8217;s Brochure, as well as any findings from other studies using the proprietary 7m8 capsid, tests in laboratory animals or in vitro testing that suggest a significant risk for human subjects from the product candidate. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for expedited reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor's initial receipt of the information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1, Phase 2, and Phase 3 clinical trials may not be completed successfully within any specified period, if at all. The FDA or the sponsor or its DMC may suspend a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB's requirements or if the biological product has been associated with unexpected serious harm to patients. Similar rules govern the conduct of clinical trials in the European Economic Area (&#8220;EEA&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the U.S., the&#160;various phases of nonclinical and clinical research in the European Union (&#8220;EU&#8221;) are subject to significant regulatory controls. In the EU, clinical trials are governed by the EU Clinical Trial Regulation 536/2014 (&#8220;CTR&#8221;), which entered into application on January 31, 2022 repealing and replacing the former Clinical Trials Directive 2001/20 (&#8220;CTD&#8221;). The CTR is intended to harmonize and streamline clinical trial authorizations, simplify adverse-event reporting procedures, improve the supervision of clinical trials and increase transparency. Specifically, the Regulation, which is directly applicable in all EU Member States, introduces a streamlined application procedure through a single-entry point, the &#8220;EU&#160;portal&#8221;, the Clinical Trials Information System; a single set of documents to be prepared and submitted for the application; as well as simplified reporting procedures for clinical trial sponsors. A harmonized procedure for the assessment of applications for clinical trials has been introduced and is divided into two parts. Part I assessment is led by the competent authorities of a reference Member State selected by the trial sponsor and relates to clinical trial aspects that are considered to be scientifically harmonized across EU Member States. This assessment is then submitted to the competent authorities of all concerned Member States in which the trial is to be conducted for their review. Part II is assessed separately by the competent authorities and Ethics Committees in each concerned EU Member State. Individual EU Member States retain the power to authorize the conduct of clinical trials on their territory.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which on-going clinical trials will be governed by the CTR will depend on the duration of the individual clinical trial. For clinical trials in relation to which an application for approval was made on the basis of the CTD before January 31, 2023, the CTD continued to apply on a transitional basis until January 31, 2025. All ongoing trials are now subject to the provisions of the CTR. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all cases, clinical trials must be conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. Medicines used in clinical trials, including ATMPs, must be manufactured in accordance with the guidelines on cGMP and in a GMP licensed facility, which can be subject to GMP inspections.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and the National Institutes of Health (&#8220;NIH&#8221;) developed a publicly accessible database, the Genetic Modification Clinical Research Information System, designed to facilitate safety reporting, assist researchers and others involved in human gene therapy clinical studies, and manages information about science and safety of gene therapy clinical trials.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the regulations discussed above, there are a number of additional standards that apply to clinical trials involving the use of gene therapy. The FDA has issued various guidance documents regarding gene therapies, which outline additional factors that the FDA will consider at each of the above stages of clinical development and the FDA usually recommends that sponsors observe subjects for potential gene therapy-related delayed adverse events for up to five years for nonintegrating vectors such as AAV vectors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The responsible party for an applicable clinical trial must register the clinical trial of FDA-regulated products on the ClinicalTrials.gov website, including the registry of new, on-going, and completed clinical trials of drugs, biologics, and device products, including the publication of the study results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biologics License Applications and Marketing Authorization Applications</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of nonclinical studies and clinical trials, together with detailed information on the quality of the product, are submitted to the FDA in the form of a BLA requesting approval to market the product for one or more specified indications. Under the Prescription Drug User Fee Act (&#8220;PDUFA&#8221;), the submission of a BLA must be accompanied by a substantial user fee unless a waiver applies and is subject to a sixty-day filing review period to determine if the application is sufficiently complete to permit substantive review.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under PDUFA, the FDA has a performance goal to review applications within six months from successful filing of the application for priority reviews or ten months for standard reviews. The review timeline begins upon the FDA&#8217;s acceptance of the original application submission for filing, no later than 60 calendar days from the date the FDA receives the application. In some instances, the review process and the PDUFA goal date may be extended depending on the information required for the FDA reviewers to complete their review of the BLA. As with new BLAs, the review process could also be extended by FDA requests for additional information or clarification.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may refer the application to an advisory committee for review, evaluation, and recommendation as to whether the application should be approved. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendations. The FDA may deny licensure of a BLA by issuing a complete response letter if the applicable statutory and regulatory criteria are not satisfied and may require additional clinical data or an additional Phase 3 clinical trial. During the biological product approval process, the FDA also will determine whether a Risk Evaluation and Mitigation Strategy (REMS) is necessary to assure the safe use of the biological product upon marketing. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS; the FDA will not approve the BLA without a REMS, if required. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the FDA licenses a BLA, or supplement thereto, the FDA may withdraw the licensure if ongoing regulatory requirements are not met or if safety problems are identified after the product reaches the market. Even where a withdrawal is not required, the FDA still may seize existing inventory of such product or require a recall of product already on the market. In addition, the FDA may require testing, including Phase 4 clinical trials and surveillance programs to monitor the effect of licensed biologics that have been commercialized. The FDA has the authority to prevent or limit further marketing of a biologic based on the results of these post-marketing programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Biologics may be marketed only for the FDA-approved indications and in accordance with the provisions of the approved labeling. Further, if there are any modifications to the product, including changes in indications, labeling, or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new BLA or BLA supplement, which may require the sponsor to develop additional data or conduct additional nonclinical studies and clinical trials.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving a BLA, the FDA will inspect the facilities at which the biologic is manufactured and will not license the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. For a gene therapy product, the FDA also will not approve the product if the manufacturer is not in compliance with cGMPs. Additionally, before approving a BLA, the FDA may also inspect one or more clinical sites to assure that the clinical studies were conducted in compliance with IND study requirements and GCP requirements. The FDA may also inspect the facilities of the sponsor to ensure that processes and procedures are in compliance with GMP/GCP requirements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. After approval, certain changes to the approved product, such as adding new indications, manufacturing changes, or additional labeling claims are subject to further FDA review and approval. Depending on the nature of the change proposed, a BLA supplement must be filed and approved before the change may be implemented. For many proposed post-approval changes to a BLA that include new efficacy data, the FDA intends to review and act on the supplemental application within 10 months of receipt. FDA intends to review and act on the manufacturing supplement within six months of receipt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A biological product approved under section 351(a) of the PHS Act (a &#8220;reference product&#8221;) can receive 12 years of marketing exclusivity, four years of which constitute data exclusivity. In other words, no biosimilar application that cites the reference product can be submitted to the FDA until four years after approval of the reference product, and no biosimilar application that cites the reference product can be approved during the full 12-year period. These exclusivity provisions only apply to biosimilars&#8212;companies that rely on their own data and file a full BLA may be approved earlier than 12 years.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA (which is comprised of the 27 Member States of the EU plus Norway, Iceland, and Liechtenstein), medicinal products can only be commercialized after a related Marketing Authorization (&#8220;MA&#8221;) has been granted. To obtain an MA for a product in the EU, an applicant must submit a Marketing Authorization Application (&#8220;MAA&#8221;), either a centralized procedure administered by the European Medicines Agency (&#8220;EMA&#8221;), or one of the procedures administered by the competent authorities of EU Member States (mutual recognition procedure, decentralized procedure, or national procedure). An MA may be granted only to an applicant established in the EEA. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The centralized procedure allows a company to submit a single application to the EMA. If a related positive opinion is provided by the EMA, the European Commission will grant a single centralized MA that is valid throughout the EEA.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, advanced therapy medicinal products (ATMPs, such as gene therapy products), orphan medicinal products, and medicinal products containing a new active substance to treat some diseases like HIV/AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune and other immune dysfunctions and viral diseases. For products with a new active substance indicated for the treatment of other diseases and products that are highly innovative or for which a centralized process is in the interest of patients, authorization through the centralized procedure is optional on related approval.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the centralized procedure, the EMA&#8217;s Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;) conducts the initial assessment of a product. The CHMP is also responsible for several post-authorization and maintenance activities, such as the assessment of modifications or extensions to an existing MA. The maximum timeframe for the evaluation of an MAA under the centralized procedure is 210 days, excluding clock stops when additional information or written or oral explanation is to be provided by the applicant in response to questions of the CHMP. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unlike the centralized authorization procedure, the decentralized MA procedure requires a separate application to, and leads to separate approval by, the competent authorities of each EU Member State in which the product is to be marketed. This application is identical to the application that would be submitted to the EMA for authorization through the centralized procedure. The reference EU Member State prepares a draft assessment and drafts of the related materials within 120 days after receipt of a valid application. The resulting assessment report is submitted to the concerned EU Member States who, within 90 days of receipt, must decide whether to approve the assessment report and related materials. If a concerned EU Member State cannot approve the assessment report and related materials due to concerns relating to a potential serious risk to public health, disputed elements may be referred to the Heads of Medicines Agencies&#8217; Coordination Group for Mutual Recognition and Decentralised Procedures &#8211; Human (&#8220;CMDh&#8221;), for review. The subsequent decision of the European Commission is binding on all EU Member States. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The mutual recognition procedure allows companies that have a medicinal product already authorized in one EU Member State to apply for this authorization to be recognized by the competent authorities in other EU Member States. Like the decentralized procedure, the mutual recognition procedure is based on the acceptance by the competent authorities of the EU Member States of the MA of a medicinal product by the competent authorities of other EU Member States. The holder of a national MA may submit an application to the competent authority of an EU Member State requesting that this authority recognize the MA delivered by the competent authority of another EU Member State. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An MA has, in principle, an initial validity of five years. The MA may be renewed after five years on the basis of a re-evaluation of the risk-benefit balance by the EMA or by the competent authority of the EU Member State in which the original MA was granted. To support the application, the MA holder must provide the EMA or the competent authority with a consolidated version of the Common Technical Document providing up-to-date data concerning the quality, safety and efficacy of the product, including all variations introduced since the MA was granted, at least nine months before the MA ceases to be valid. The European Commission or the competent authorities of the EU Member States may decide on justified grounds relating to pharmacovigilance, to proceed with one further five-year renewal period for the MA. Once subsequently renewed, the MA shall be valid for an unlimited period. Any authorization which is not followed by the actual placing of the medicinal product on the EU market (for a centralized MA) or on the market of the authorizing EU Member State within three years after authorization ceases to be valid (the so-called sunset clause). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, a &#8220;conditional&#8221; MA may be granted in cases where all the required safety and efficacy data are not yet available. The European Commission may grant a conditional MA for a medicinal product if it is demonstrated that all of the following criteria are met: (i) the benefit-risk balance of the medicinal product is positive; (ii) it is likely that the applicant will be able to provide comprehensive data post-authorization; (iii) the medicinal product fulfills an unmet medical need; and (iv) the benefit of the immediate availability to patients of the medicinal product is greater than the risk inherent in the fact that additional data are still required. The conditional MA is subject to conditions to be fulfilled for generating the missing data or ensuring increased safety measures. It is valid for one year and must be renewed annually until all related conditions have been fulfilled. Once any pending studies are provided, the conditional MA can be converted into a traditional MA. However, if the conditions are not fulfilled within the timeframe set by the EMA and approved by the European Commission, the MA will cease to be renewed. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An MA may also be granted &#8220;under exceptional circumstances&#8221; where the applicant can show that it is unable to provide comprehensive data on efficacy and safety under normal conditions of use even after the product has been authorized and subject to specific procedures being introduced. These circumstances may arise in particular when the intended indications are very rare and, in the state of scientific knowledge at that time, it is not possible to provide comprehensive information, or when generating data may be contrary to generally accepted ethical principles. Like a conditional MA, an MA granted in exceptional circumstances is reserved for medicinal products intended to be authorized for treatment of rare diseases or unmet medical needs for which the applicant does not hold a complete data set that is required for the grant of a standard MA. However, unlike the conditional MA, an applicant for authorization in exceptional circumstances is not subsequently required to provide the missing data. Although the MA &#8220;under exceptional circumstances&#8221; is granted definitively, the risk-benefit balance of the medicinal product is reviewed annually, and the MA will be withdrawn if the risk-benefit ratio is no longer favorable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU provides opportunities for data and market exclusivity related to MAs. Upon receiving an MA, innovative medicinal products are generally entitled to receive eight years of data exclusivity and 10 years of market exclusivity. Data exclusivity, if granted, prevents regulatory authorities in the EU from referencing the innovator&#8217;s data to assess a generic application or biosimilar application for eight years from the date of authorization of the innovative product, after which a generic or biosimilar MAA can be submitted, and the innovator&#8217;s data may be referenced. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until 10 years have elapsed from the initial MA of the reference product in the EU. The overall ten-year period may, occasionally, be extended for a further year to a maximum of 11 years if, during the first eight years of those ten years, the MA holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. However, there is no guarantee that a product will be considered by the EU&#8217;s regulatory authorities to be a new chemical/biological entity, and products may not qualify for data exclusivity&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, there is a special regime for biosimilars, or biological medicinal products that are similar to a reference medicinal product but that do not meet the definition of a generic medicinal product. For such products, the results of appropriate preclinical or clinical trials must be provided in support of an application for MA. Guidelines from the EMA detail the type of quantity of supplementary data to be provided for different types of biological products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Therapy Medicinal Products in the EU</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Therapy Medicinal Products, (&#8220;ATMPs&#8221;) include gene therapy products as well as somatic cell therapy products and tissue engineered products. The grant of marketing authorization in the EU for products containing viable human tissues or cells such as gene therapy medicinal products is governed by Regulation (EC) No. 1394/2007 on ATMPs, read in combination with Directive (EC) No. 2001/83 of the European Parliament and of the Council, commonly known as the Community code on medicinal products. Regulation (EC) No. 1394/2007 establishes specific rules concerning the authorization, supervision and pharmacovigilance of gene therapy medicinal products, somatic cell therapy medicinal products and tissue engineered products. Manufacturers of advanced therapy medicinal products must demonstrate the quality, safety and efficacy of their products to the EMA which is required to provide an opinion regarding the application for marketing authorization. The European Commission grants or refuses marketing authorization in light of the opinion delivered by the EMA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cell-based products must also comply with Directive (EC) No. 2004/23 of the European Parliament and of the Council of March&#160;31, 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells (&#8220;the Tissues and Cells Directive&#8221;), as well as its technical implementing directives. This Directive describes the conditions and quality requirements which must be applied when sourcing the cells intended for manufacturing of the cell-based medicinal product. The EU Member States have transposed the Tissues and Cells Directive into their national laws. However, various interpretations of the Tissue and Cells Directive have occurred and are reflected in individual EU Member States national implementing legislation which have led to diverging approaches.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pediatric Development in the EU</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, Regulation (EC) No 1901/2006 provides that all MAAs for new medicinal products have to include the results of trials conducted in the pediatric population, in compliance with a pediatric investigation plan (&#8220;PIP&#8221;), agreed with the EMA&#8217;s Pediatric Committee (&#8220;PDCO&#8221;). The PIP sets out the timing and measures proposed to generate data to support a pediatric indication of the medicinal product for which MA is being sought. The PDCO can grant a deferral of the obligation to implement some or all of the measures provided in the PIP until there are sufficient data to demonstrate the efficacy and safety of the product in adults. Further, the obligation to provide pediatric clinical trial data can be waived by the PDCO when these data are not needed or appropriate because the product is likely to be ineffective or unsafe in children, the disease or condition for which the product is intended occurs only in adult populations, or when the product does not represent a significant therapeutic benefit over existing treatments for pediatric patients. Once the MA is obtained in all EU Member States and study results are included in the product information, even when negative, the product is eligible for a six-month extension to the Supplementary Protection Certificate ("SPC"), if any is in effect at the time of authorization or, in the case of orphan medicinal products, a two-year extension of orphan market exclusivity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expedited Development and Review Programs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has created programs intended to facilitate and expedite the development and review of new drugs to address the unmet medical need in the treatment of a serious or life-threatening condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fast Track designation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for fast track designation, a product candidate must be intended to treat a serious condition and address an unmet medical need. Advantages of fast track designation include the possibility for a rolling review, eligibility for priority review (under which FDA sets a target date for FDA action of the BLA at six months after FDA accepts that application for filing), and the ability to have greater interactions with the FDA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product submitted to the FDA for marketing approval, including under a Fast Track program, may be eligible for other types of FDA programs intended to expedite development and review, such as breakthrough therapy designation, regenerative medicine advanced therapy (&#8220;RMAT&#8221;) designation, priority review designation, and accelerated approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breakthrough therapy designation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A product candidate intended to treat a serious or life-threatening disease or condition may also be eligible for breakthrough therapy designation to expedite its development and review, if preliminary clinical data indicate that the product provides a substantial improvement on one or more clinically significant endpoints over existing therapies. The FDA will seek to ensure the sponsor of a breakthrough therapy product candidate receives intensive guidance on an efficient drug development program; intensive involvement of senior managers and experienced staff on a proactive, collaborative and cross&#8209;disciplinary review; and rolling review.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RMAT designation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A designation given to a product candidate that is a regenerative medicine therapy intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the candidate has the potential to address the unmet medical needs for the disease or condition. The FDA has indicated that gene therapies may qualify as regenerative medicine therapies. Advantages of RMAT designation include all the benefits of breakthrough therapy designation, early and frequent interactions with the FDA to discuss any potential surrogate or intermediate endpoints and address potential ways to support accelerated approval and satisfy post-approval requirements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Priority review. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A product, including those that receive fast track, breakthrough therapy, or RMAT designations, may be eligible for priority review, if the product meets the criteria for priority review at the time the BLA is submitted. If priority review is granted, the FDA has a six-month goal for reviewing the marketing application or efficacy supplement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accelerated approval. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Accelerated Approval Program is a drug development pathway that offers an approval based on a &#8220;surrogate&#8221; marker in a clinical trial. A surrogate marker is a biomarker or clinical marker that can be measured at an earlier point in a trial than the type of endpoints that may be used in a traditional approval. Drug or biologic products with evidence showing that they provide meaningful therapeutic benefit over existing treatments for serious or life&#8209;threatening illnesses may receive accelerated approval. As a condition of approval, the FDA may require that a sponsor conduct post&#8209;marketing clinical trials.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, innovative products that target an unmet medical need and are expected to be of major public health interest may be eligible for a number of expedited development and review programs, such as the Priority Medicines (&#8220;PRIME&#8221;) scheme, which provides incentives similar to the breakthrough therapy designation in the U.S. PRIME is a voluntary scheme aimed at enhancing the EMA&#8217;s support for the development of medicinal products that target unmet medical needs. Eligible products must target conditions for which there is an unmet medical need (there is no satisfactory method of diagnosis, prevention or treatment in the EU or, if there is, the new medicinal product will bring a major therapeutic advantage) and they must demonstrate the potential to address the unmet medical need by introducing new methods of therapy or improving existing ones. Benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and potentially accelerated MAA assessment once a dossier has been submitted. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated assessment may be granted by the CHMP in exceptional cases, when a medicinal product targeting an unmet medical need is expected to be of major interest from the point of view of public health and, in particular, from the viewpoint of therapeutic innovation. If the CHMP accepts a request for accelerated assessment, the time limit of 210 days will be reduced to 150 days (excluding clock stops). The CHMP can, however, revert to the standard time limit for the centralized procedure if it considers that it is no longer appropriate to conduct an accelerated assessment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orphan Drug Designation (&#8220;ODD&#8221;)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant orphan drug designation to a drug or biological product intended to treat a rare disease or condition&#8212;generally a disease or condition that affects fewer than 200,000 individuals in the U.S., or if there is no reasonable expectation that the cost of developing and making the product available in the U.S. will be recovered from sales of the product.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ODD must be requested before submitting a BLA. After the FDA grants orphan product designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. ODD does not affect the regulatory review and approval process. However, if a product that has orphan designation subsequently receives the first BLA applicant to receive FDA approval for that product for the disease or condition for which it has such designation, that product is entitled to a seven-year exclusive marketing period in the U.S. for that product in the approved indication. During the seven-year marketing exclusivity period, the FDA may not approve any other applications to market the same drug or biological product for the same indication, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Among the other benefits of ODD are tax credits for certain research and a waiver of the user fee. In September 2021, the FDA finalized Guidance For Industry on determining &#8220;sameness&#8221; for gene therapy products for purposes of orphan drug exclusivity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan drug products are also eligible for Rare Pediatric Disease Designation if greater than 50% of patients living with the disease are under age 18. A priority review voucher will be given to the sponsor of a product with a Rare Pediatric Disease Designation at the time of product approval that is transferable to another company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, Regulation (EC) No. 141/2000, as implemented by Regulation (EC) No. 847/2000 provides that a medicinal product can be designated as an orphan medicinal product by the European Commission if its sponsor can establish that: (i)&#160;the product is intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions; (ii)&#160;either (a)&#160;such conditions affect not more than 5 in 10,000 persons in the EU when the application is made, or (b)&#160;the product without the benefits derived from orphan status, would not generate sufficient return in the EU to justify the necessary investment in developing the medicinal product; and (iii)&#160;there exists no satisfactory authorized method of diagnosis, prevention, or treatment of the condition that has been authorized in the EU, or even if such method exists, the product will be of significant benefit to those affected by that condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation (EC) No 847/2000 sets out further provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product. An application for the designation of a medicinal product as an orphan medicinal product must be submitted at any stage of development of the medicinal product but before filing of an MAA. An MA for an orphan medicinal product may only include indications designated as orphan. For non-orphan indications treated with the same active pharmaceutical ingredient, a separate marketing authorization has to be sought.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan medicinal product designation entitles an applicant to incentives such fee reductions or fee waivers, protocol assistance, and access to the centralized marketing authorization procedure. Upon grant of a marketing authorization, orphan medicinal products are entitled to a ten-year period of market exclusivity for the approved therapeutic indication, which means that the EMA cannot accept another marketing authorization application or accept an application to extend for a similar product and the European Commission cannot grant a marketing authorization for the same indication for a period of ten years. The period of market exclusivity is extended by two years for orphan medicinal products that have also complied with an agreed PIP. No extension to any supplementary protection certificate can be granted on the basis of pediatric studies for orphan indications. Orphan medicinal product designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The period of market exclusivity may, however, be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria on the basis of which it received orphan medicinal product destination, including where it can be demonstrated on the basis of available evidence that the original orphan medicinal product is sufficiently profitable not to justify maintenance of market exclusivity or where the prevalence of the condition has increased above the threshold. Additionally, an MA may be granted to a similar medicinal product with the same orphan indication during the 10-year period if: (i) if the applicant consents to a second original orphan medicinal product application, (ii) if the manufacturer of the original orphan medicinal product is unable to supply sufficient quantities; or (iii) if the second applicant can establish that its product, although similar, is safer, more effective or otherwise clinically superior to the original orphan medicinal product. A company may voluntarily remove a product from the register of orphan products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulatory Requirements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any biologics manufactured or distributed by us or our collaborators pursuant to FDA or European Commission and other regulatory authorities&#8217; approvals would be subject to continuing regulation by the FDA, the EMA, the European Commission, the national competent authorities of EU Member States and other regulatory authorities, including in relation to regulatory requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies and comparable foreign regulatory authorities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to an MA, various other requirements apply to the manufacturing and placing on the EU market of medicinal products. The manufacturing of medicinal products in the EU requires a manufacturing authorization and import of medicinal products into the EU requires a manufacturing authorization allowing for import. The manufacturing authorization holder must comply with various requirements set out in the applicable EU laws, regulations and guidance, including EU cGMP standards. Similarly, the distribution of medicinal products within the EU is subject to compliance with the applicable EU laws, regulations and guidelines, including the requirement to hold appropriate authorizations for distribution granted by the competent authorities of EU Member States. Marketing authorization holders and/or manufacturing and import authorization, or MA holders and/or distribution authorization holders may be subject to civil, criminal or administrative sanctions, including suspension of manufacturing authorization, in case of non-compliance with the EU or EU Member States&#8217; requirements applicable to the manufacturing of medicinal products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, or our third-party manufacturers may be subject to periodic unannounced inspections by the FDA, certain state agencies, national competent authorities of EU Member States and comparable foreign regulatory authorities for compliance with ongoing regulatory requirements, including GMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Failure to comply with the statutory and regulatory requirements can subject a manufacturer to possible legal or regulatory action, such as warning letters, suspension of manufacturing, seizure of product, injunctive action or possible civil penalties. We cannot be certain that we or our present or future third-party manufacturers or suppliers will be able to comply with the GMP regulations and other ongoing FDA, EU or other comparable foreign regulatory requirements. If we or our present or future third-party manufacturers or suppliers are not able to comply with these requirements, the FDA, national competent authorities of EU Member State or other regulatory authorities may impose sanctions on us, including shutdown of the third-party vendor or invalidation of drug product lots or processes, fines, injunctions, civil penalties, delays, suspension, variation or withdrawal of approvals, license revocation, seizures or recalls of product candidates or drugs, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products, if approved, and significantly harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA closely regulates the post-approval marketing and promotion of biologics, including standards and regulations for direct-to-consumer advertising, off-label promotion, industry-sponsored scientific and educational activities and promotional activities involving the internet. For example, under the FDA&#8217;s current interpretation of the relevant laws, in proactively promoting a biologic, a company generally can make only those substantiated claims relating to safety and efficacy that are for indications approved by the FDA and that are otherwise consistent with the FDA-approved label for the biologic. Claims must be truthful and non-misleading. Failure to comply with these requirements can result in fines, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians may prescribe legally available biologics for uses that are not described in the product&#8217;s labeling and that differ from those tested by the sponsor and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, impose stringent restrictions on manufacturers&#8217; communications regarding off-label use. If the FDA finds that we have promoted off-label use of any product that is eventually approved, sanctions could include refusal to approve pending applications, withdrawal of an approval, warning or untitled letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, mandated corrective advertising or communications with doctors, debarment, restitution, disgorgement of profits, or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where an MA is granted in relation to a medicinal product in the EU, the holder of the MA is required to comply with a range of regulatory requirements applicable to the manufacturing, marketing, promotion and sale of medicinal products. Similar to the United States, both MA holders and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the competent regulatory authorities of the individual EU Member States. The holder of an MA must establish and maintain a pharmacovigilance system and appoint an individual qualified person for pharmacovigilance who is responsible for oversight of that system. Key obligations include expedited reporting of suspected serious adverse reactions and submission of periodic safety update reports (&#8220;PSURs&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All new MAAs must include a risk management plan, describing the risk management system that the company will put in place and documenting measures to prevent or minimize the risks associated with the product. The regulatory authorities may also impose specific obligations as a condition of the MA. Such risk- minimization measures or post-authorization obligations may include additional safety monitoring, more frequent submission of PSURs, or the conduct of additional clinical trials or post-authorization safety studies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, the advertising and promotion of pharmaceutical products are subject to EU and EU Member States' laws governing promotion of medicinal products, interactions with physicians and other healthcare professionals, misleading and comparative advertising and unfair commercial practices. General requirements for advertising and promotion of medicinal products, such as direct-to-consumer advertising of prescription medicinal products are established in EU law. However, the details are governed by regulations in individual EU Member States and can differ from one country to another. For example, applicable laws require that promotional materials and advertising in relation to medicinal products comply with the product&#8217;s Summary of Product Characteristics (&#8220;SmPC&#8221;), as approved by the competent authorities in connection with a marketing authorization approval. The SmPC is the document that provides information to physicians and other healthcare professionals concerning the safe and effective use of the product. Promotional activity that does not comply with the SmPC is considered off-label and is prohibited in the EU. Other relevant laws at EU level and in the individual EU Member States also apply to the advertising and promotion of medicinal products, including laws that prohibit the direct-to-consumer advertising of prescription-only medicinal products and further limit or restrict the advertising and promotion of our products to the general public and to health care professionals. Violations of the rules governing the promotion of medicinal products in the EU could result in reputational risk, public reprimands, administrative measures, fines and imprisonment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Privacy and Security Laws</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we process confidential, sensitive, and proprietary information, including personal data. Accordingly, we are, or may become, subject to numerous data privacy and security obligations, including federal, state, local, and foreign laws, regulations, guidance, and industry standards related to data privacy, security, and protection. Such obligations may include, without limitation, the Federal Trade Commission Act, the Telephone Consumer Protection Act of 1991, the Controlling the Assault of Non-Solicited Pornography And Marketing Act of 2003, the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;), the European Union&#8217;s General Data Protection Regulation 2016/679 (&#8220;EU GDPR&#8221;), the EU GDPR as it forms part of UK law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (&#8220;UK GDPR&#8221;), the ePrivacy Directive, and the Health Insurance Portability and Accountability Act, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and their implementing regulations (collectively, &#8220;HIPAA&#8221;). Several states within the United States have enacted or proposed data privacy laws. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA and EU GDPR are examples of the increasingly stringent and evolving regulatory frameworks related to personal data processing that may increase our compliance obligations and exposure for any noncompliance. For example, the CCPA imposes obligations on covered businesses to provide specific disclosures related to a business&#8217;s collecting, using, and disclosing personal data and to respond to certain requests from California residents related to their personal data (for example, requests to know of the business&#8217;s personal data processing activities, to delete the individual&#8217;s personal data, and to opt out of certain personal data disclosures). Also, the CCPA provides for civil penalties and a private right of action for data breaches which may include an award of statutory damages. </span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign data privacy and security laws (including but not limited to the EU GDPR and UK GDPR) impose significant and complex compliance obligations on entities that are subject to those laws. As one example, the EU GDPR applies to any company established in the EEA and to companies established outside the EEA that process personal data in connection with the offering of goods or services to data subjects in the EEA or the monitoring of the behavior of data subjects in the EEA. These obligations may include limiting personal data processing to only what is necessary for specified, explicit, and legitimate purposes; requiring a legal basis for personal data processing; requiring the appointment of a data protection officer in certain circumstances; increasing transparency obligations to data subjects; requiring data protection impact assessments in certain circumstances; limiting the collection and retention of personal data; increasing rights for data subjects; formalizing a heightened and codified standard of data subject consents; requiring the implementation and maintenance of technical and organizational safeguards for personal data; mandating notice of certain personal data breaches to the relevant supervisory authority(ies) and affected individuals; and mandating the appointment of representatives in the UK and/or the EU in certain circumstances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding the risks to our business related to laws and regulations to which we are or may become subject, see &#8220;Risk Factors&#8212;Risks Related to Our Business Operations.&#8221; </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Healthcare Laws and Regulations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we obtain regulatory approval for any of our product candidates, we may also be subject to healthcare regulation and enforcement by the federal government and the states and foreign governments in which we conduct our business. These laws may impact, among other things, our research activities, as well as our proposed sales, marketing, and education programs. The laws that may affect our ability to operate include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in cash or in kind, to induce or reward the purchasing, leasing, ordering, or arranging for or recommending the purchase, lease, or order of any health care item or service for which payment may be made, in whole or in part, by federal healthcare programs such as the Medicare and Medicaid programs. This statute has been interpreted to apply to arrangements between pharmaceutical companies on one hand and prescribers, purchasers and formulary managers on the other. Liability may be established under the federal Anti-Kickback Statute without proving actual knowledge of the statute or specific intent to violate it. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Law constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Although there are a number of statutory exemptions and regulatory safe harbors to the federal Anti-Kickback Statute protecting certain common business arrangements and activities from prosecution or regulatory sanctions, the exemptions and safe harbors are drawn narrowly, and practices that do not fit squarely within an exemption or safe harbor, or for which no exception or safe harbor is available, may be subject to scrutiny;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal civil False Claims Act, which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds, or knowingly making, using or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly concealing or knowingly and improperly avoiding, decreasing or concealing an obligation to pay money to the federal government. Actions under the False Claims Act may be brought by the U.S. Attorney General or as a qui tam action by a private individual (a whistleblower) in the name of the government and the individual, and the whistleblower may share in any monetary recovery. Many pharmaceutical and other healthcare companies have been investigated and have reached substantial financial settlements with the federal government under the civil False Claims Act for a variety of alleged improper marketing activities, including: providing free product to customers with the expectation that the customers would bill federal programs for the product; providing sham consulting fees, grants, free travel and other benefits to physicians to induce them to prescribe the company&#8217;s products; and inflating prices reported to private price publication services, which are used to set drug payment rates under government healthcare programs. In addition, the government has pursued civil False Claims Act cases against a number of pharmaceutical companies for causing false claims to be submitted as a result of the marketing of their products for unapproved, and thus non-reimbursable, uses. Because of the threat of treble damages and mandatory penalties per false or fraudulent claim or statement, healthcare and pharmaceutical companies often resolve allegations without admissions of liability for significant and material amounts. Pharmaceutical and other healthcare companies also are subject to other federal false claim laws, including, among others, federal criminal healthcare fraud and false statement statutes that extend to non-government health benefit programs; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which also, prohibits, among other things, executing, or attempting to execute, a scheme to defraud any healthcare benefit program or making false, fictitious, or fraudulent statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Physician Payment Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies to report annually to the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) information related to direct and indirect payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physicians assistants and nurse practitioners), and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Outside the U.S., interactions between pharmaceutical companies and physicians and other healthcare professionals are also governed by strict laws, such as national anti-bribery laws of European countries, national sunshine rules, regulations, industry self-regulation codes of conduct and physicians&#8217; codes of professional conduct. Certain EU member states, or industry codes of conduct, require that payments made to physicians be publicly disclosed. Moreover, agreements with healthcare professionals may require prior notification and approval by the healthcare professional&#8217;s employer, his/her competent professional organization, and/or the competent authorities of the individual EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payer, including commercial insurers; state and foreign laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to healthcare professionals and other potential referral sources; state and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; state laws that restrict the ability of manufacturers to offer co-pay support to patients for certain prescription drugs; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that apply to us, we may be subject to significant penalties, including civil, criminal, and administrative penalties, damages, fines, the curtailment or restructuring of our operations, the exclusion from participation in federal and state healthcare programs (such as Medicare and Medicaid), imprisonment, and additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, any of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Although compliance programs can mitigate the risk of investigation and prosecution for violations of these laws, the risks cannot be entirely eliminated. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security, and fraud laws may prove costly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the pharmaceutical and biotechnology industry have received increased public and governmental scrutiny for the cost of drugs. In particular, U.S. federal prosecutors have issued subpoenas to pharmaceutical companies seeking information about drug pricing practices and the U.S. Senate is investigating several pharmaceutical companies relating to drug price increases and pricing practices. If we obtain regulatory approval of any of our product candidates, our revenue and future profitability could be negatively affected if these inquiries were to result in legislative or regulatory proposals that limit our ability to increase the prices of our products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA imposes requirements on &#8220;covered entities,&#8221; including certain healthcare providers, health plans, and healthcare clearinghouses, as well as their respective &#8220;business associates&#8221; that create, receive, maintain and transmit individually identifiable health information for or on behalf of a covered entity relating to the privacy, security and transmission of individually identifiable health information and their covered subcontractors. We may obtain health information from third parties, such as research institutions, that are subject to privacy and security requirements under HIPAA. Although we are not directly subject to HIPAA other than with respect to providing certain employee benefits, we could potentially be subject to penalties if we, our affiliates, or our agents obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coverage and Reimbursement and Healthcare Reform Legislation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uncertainty exists as to the coverage and reimbursement status of gene therapy products. In the U.S. and other countries, sales of any products for which we receive marketing approval will depend in part on the availability of coverage and adequate reimbursement from third-party payers. Third-party payers include government authorities, managed care providers, private health insurers and other organizations. The process for determining whether a payer will provide coverage for a drug product may be separate from the process for setting the reimbursement rate that the payer will pay for the drug product. Third-party payers may limit coverage to specific drug products on an approved list, or formulary, which might not include all of the FDA-approved drugs for a particular indication. Moreover, a payer&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. A number of gene or cell therapy products have been approved over the past several years by the FDA. For example, although CMS has approved coverage for Chimeric Antigen Receptor T-cell therapies, such as Yescarta and Kymriah, and has established reimbursement methods for these therapies, these policies could be changed in the future. CMS&#8217;s decision as to coverage and reimbursement for one product does not mean that all similar products will be eligible for analogous coverage and reimbursement. As there is no uniform policy for coverage and reimbursement amongst third-party payers in the U.S., even if CMS approves coverage and reimbursement for any of our product candidates, it is unclear what affect, if any, such a decision will have on our ability to obtain and maintain coverage and adequate reimbursement from other private payers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payers are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain regulatory approvals. Our product candidates may not be considered medically necessary or cost-effective. If third-party payers do not consider a product to be cost-effective compared to other available therapies, they may not cover the product after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow a company to sell its products at a profit. Further, coverage policies and third-party payer reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained more products for which we receive marketing approval, less favorable coverage policies and reimbursement rates may be implemented in the future. The U.S. government, state legislatures and foreign governments have shown significant interest in implementing cost containment programs to limit the growth of government-paid healthcare costs, including price controls, restrictions on reimbursement and requirements for substitution of generic products for branded prescription drugs. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively, the Affordable Care Act, contains provisions that may reduce the profitability of drug products, including, for example, by increasing the minimum rebates owed by manufacturers under the Medicaid Drug Rebate Program, extending the rebate program to individuals enrolled in Medicaid managed care plans, addressing a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, and imposing annual fees based on pharmaceutical companies&#8217; share of sales to federal health care programs. Adoption of government controls and other measures, and tightening of restrictive policies in jurisdictions with existing controls and other measures, could limit coverage of or payments for pharmaceuticals, or affect rebates or other price concessions owed on such products. The Affordable Care Act has been subject to legislative and judicial challenges and amendments, including efforts to repeal, replace, or otherwise modify or to alter its interpretation and implementation. For example, on August 16, 2022, the Inflation Reduction Act of 2022 &#8220;Inflation Reduction Act&#8221; was signed into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The Inflation Reduction Act also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional legislative changes, regulatory changes, and judicial challenges related to the Affordable Care Act remain possible. Any such changes could affect the number of individuals with health coverage. It is possible that the Affordable Care Act, as currently enacted or as it may be amended in the future, and other healthcare reform measures that may be adopted in the future could have a material adverse effect on our industry generally and on our ability to successfully commercialize our product candidates, if approved. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, it is unclear whether such legislative changes, regulatory changes, or judicial challenges related to the Affordable Care Act, or other health care reform measures will also have an impact on biologic product exclusivity, or the biosimilar product licensure pathway established under the Biologics Price Competition and Innovation Act (&#8220;BPCIA&#8221;), which was enacted as part of the Affordable Care Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have also been proposed and adopted in the U.S. since the Affordable Care Act was enacted. For example, on August 2, 2011, the Budget Control Act of 2011 created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013, and due to subsequent legislative changes to the statute, will stay in effect through 2032 unless additional congressional action is taken. Further, Congress may consider additional health reform measures. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there has been increasing legislative, regulatory, and enforcement interest in the U.S. with respect to drug pricing practices. For example, the Inflation Reduction Act also, among other things, (1) directs the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) to negotiate the price of certain single-source biologics that have been on the market for at least 11 years covered under Medicare (the &#8220;Medicare Drug Price Negotiation Program&#8221;) and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions began to take effect progressively in fiscal year 2023. On August 15, 2024, HHS announced the agreed-upon price of the first ten drugs that were subject to price negotiations, although the Medicare Drug Price Negotiation Program is currently subject to legal challenges. On January 17, 2025, HHS selected fifteen additional products covered under Part D for price negotiation in 2025. Each year thereafter more products covered under Part B and Part D will become subject to the Medicare Drug Price Negotiation Program. Further, on December 7, 2023, an initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act was announced. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework. It is possible that the Affordable Care Act, as currently enacted or may be amended in the future, as well as other healthcare reform measures that may be adopted in the future, may result in additional reductions in Medicare and other healthcare financing, more rigorous coverage criteria, and new payment methodologies and in additional downward pressure on coverage and payment and the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from commercial payers. Coverage policies and reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, pricing and reimbursement schemes vary widely from country to country. Some EU Member States may approve a specific price for a product, or they may instead adopt a system of direct or indirect controls on the profitability of the company placing the product on the market. Other EU Member States allow companies to fix their own prices for products but monitor and control prescription volumes and issue guidance to physicians to limit prescriptions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some EU Member States may require the completion of additional studies that compare the cost-effectiveness of a particular medicinal product candidate to currently available therapies. This Health Technology Assessment, or HTA, process is the procedure according to which the assessment of the public health impact, therapeutic impact and the economic and societal impact of use of a given medicinal product in the national healthcare systems of the individual country is conducted. The outcome of HTA regarding specific medicinal products will often influence the pricing and reimbursement status granted to these medicinal products by the competent authorities of individual EU Member States. In December 2021, Regulation No. 2021/2282 on Health Technology Assessment, or HTA Regulation, was adopted. This Regulation, which entered into force in January 2022 and began to apply on January 12, 2025, through a phased implementation, is intended to boost cooperation among EU Member States in assessing health technologies, including new medicinal products, and provides the basis for cooperation at EU level for joint clinical assessments in these areas. The Regulation permits EU Member States to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising technologies early, and continuing voluntary cooperation in other areas. Individual EU Member States continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technologies, and making decisions on pricing and reimbursement. If we are unable to maintain favorable pricing and reimbursement status in EU Member States for drug candidates that we may successfully develop and for which we may obtain regulatory approval, any anticipated revenue from and growth prospects for those products in the EU could be negatively affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to what is occurring in the U.S., political, economic and regulatory developments outside of the U.S. are also subjecting the healthcare industry to fundamental changes and challenges. Pressure by governments and other stakeholders on prices and reimbursement levels continue to exist. In various EU member states, we expect to be subject to continuous cost-cutting measures, such as lower maximum prices, lower or lack of reimbursement coverage and incentives to use cheaper, usually generic, products as an alternative.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The making available or placing on the EU market of unauthorized medicinal products is generally prohibited. However, the competent authorities of the EU Member States may, in specific circumstances, exceptionally and temporarily allow and reimburse the supply of such unauthorized products, either on a named patient basis or through a compassionate use process, to individual patients or a group of patients with a chronically or seriously debilitating disease or whose disease is considered to be life-threatening, and who cannot be treated satisfactorily by an authorized medicinal product. Such reimbursement may no longer be available if authorization for named patient or compassionate use programs expire or is terminated or if marketing authorization is granted for the product. In some EU Member States, authorization and reimbursement policies may also delay commercialization of our products or may adversely affect our ability to sell our products on a profitable basis. After initial price and reimbursement approvals, reductions in prices and changes in reimbursement levels can be triggered by multiple factors, including reference pricing systems and publication of discounts by third-party payers or authorities in other countries. In the EU, prices can be reduced further by parallel distribution and parallel trade, or arbitrage between low-priced and high-priced EU Member States.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of adequate government reimbursement for our products may also be subject to regulatory changes and controls.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to regulations in the U.S., we or our collaborators will be subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of our future drugs. Whether or not we obtain FDA approval for a drug, we or our collaborators must obtain approval from the comparable regulatory authorities of foreign countries before commencing clinical trials or marketing of the drug in those countries. Many countries outside of the U.S. have a similar process that requires the submission of a clinical study application much like the IND prior to the commencement of human clinical studies. To obtain regulatory approval of a biological medicinal product under EU regulatory systems, we must submit a marketing authorization application. The approval process varies from country to country, and the time may be longer or shorter than that required for FDA approval. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to regulations in the EU and the U.S., we or our collaborators will be subject to a variety of foreign regulations governing clinical trials and commercial distribution of our future products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brexit. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s, or UK, withdrawal from the EU on January 31, 2020, commonly referred to as Brexit, has changed the regulatory relationship between the UK and the EU. The Medicines and Healthcare products Regulatory Agency, or MHRA, is now the UK&#8217;s standalone regulator for medicinal products and medical devices. The United Kingdom is no longer subject to EU regulations (Northern Ireland continues to follow certain limited EU regulatory rules, including in relation to medical devices, but not in relation to medicinal products). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK regulatory framework in relation to clinical trials is governed by the Medicines for Human Use (Clinical Trials) Regulations 2004, as amended, which is derived from the CTD, as implemented into UK national law through secondary legislation. On January 17, 2022, the UK Medicines and Healthcare products Regulatory Agency, or MHRA, launched an eight-week consultation on reframing the UK legislation for clinical trials. The UK Government published its response to the consultation on March 21, 2023 confirming that it would bring forward changes to the legislation and such changes were laid in parliament on December 12, 2024. These resulting legislative amendments will, if implemented in their current form, bring the UK into closer alignment with the EU CTR. In October 2023, the MHRA announced a new Notification Scheme for clinical trials which enables a more streamlined and risk-proportionate approach to initial clinical trial applications for Phase 4 and low-risk Phase 3 clinical trial applications.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing authorizations in the UK are governed by the Human Medicines Regulations (SI 2012/1916), as amended. Since January 1, 2021, an applicant for the EU centralized procedure marketing authorization can no longer be established in the UK. As a result, since this date, companies established in the UK cannot use the EU centralized procedure and instead must follow one of the UK national authorization procedures or one of the remaining post-Brexit international cooperation procedures to obtain a marketing authorization to market products in the UK. All existing EU marketing authorizations for centrally authorized products were automatically converted or grandfathered into UK marketing authorization, effective in Great Britain only, free of charge on January 1, 2021, unless the marketing authorization holder opted-out of this possibility. Northern Ireland remained within the scope of EU authorizations in relation to centrally authorized medicinal products until January 1, 2025. However, on January 1, 2025, a new arrangement as part of the so-called &#8220;Windsor Framework&#8221; came into effect and reintegrated Northern Ireland under the regulatory authority of the MHRA with respect to medicinal products. The Windsor Framework removes EU licensing processes and EU labelling and serialization requirements in relation to Northern Ireland and introduces a UK -wide licensing process for medicines.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MHRA has also introduced changes to national marketing authorization procedures. This includes introduction of procedures to prioritize access to new medicines that will benefit patients, including a 150-day assessment route, a rolling review procedure and the International Recognition Procedure. Since January 1, 2024, the MHRA may rely on the International Recognition Procedure, or IRP, when reviewing certain types of marketing authorization applications. This procedure is available for applicants for marketing authorization who have already received an authorization for the same product from a reference regulator. These include the FDA, the EMA, and national competent authorities of individual EEA countries. A positive opinion from the EMA and CHMP, or a positive end of procedure outcome from the mutual recognition or decentralized procedures are considered to be authorizations for the purposes of the IRP.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no pre-marketing authorization orphan designation for medicinal products in the UK. Instead, the MHRA reviews applications for orphan designation in parallel to the corresponding marketing authorization application. The criteria are essentially the same as those in the EU, but have been tailored for the market. This includes the criterion that prevalence of the condition in the UK, rather than the EU, must not be more than five in 10,000. Upon the grant of a marketing authorization with orphan status, the medicinal product will benefit from up to 10 years of market exclusivity from similar products in the approved orphan indication. The start of this market exclusivity period will be set from the date of first approval of the product in the UK.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, Health and Safety Regulation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous foreign, federal, state and local environmental, health and safety (&#8220;EHS&#8221;) laws and regulations relating to, among other matters, safe working conditions, product stewardship, environmental protection, and handling or disposition of products, including those governing the generation, storage, handling, use, transportation, release, and disposal of hazardous or potentially hazardous materials, medical waste, and infectious materials. Some of these laws and regulations also require us to obtain licenses or permits to conduct our operations. If we fail to comply with such laws or obtain and comply with the applicable permits, we could face substantial fines or possible revocation of our permits or limitations on our ability to conduct our operations. Certain of our development and manufacturing activities involve use of hazardous materials, and we believe we are in compliance with the applicable environmental laws, regulations, permits, and licenses. However, we cannot ensure that EHS liabilities will not develop in the future. EHS laws and regulations are complex, change frequently and have tended to become more stringent over time. Although the costs to comply with applicable laws and regulations, including requirements in the EU relating to the restriction of use of hazardous substances in products, have not been material, we cannot predict the impact on our business of new or amended laws or regulations or any changes in the way existing and future laws and regulations are interpreted or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2024, we had approximately 155 full-time employees. Of these employees, 35 hold Ph.D. or M.D. degrees, 114 are engaged in research and development, and 41 are engaged in business development, finance, legal, human resources, facilities, information technology, and general management and administration. We also engage temporary employees and consultants. Our employees are not represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. Our employee engagement is highly favorable, which we attribute to our shared mission of transforming the lives of those affected by highly prevalent ocular diseases and has led to our being named a Top Workplace in 2021, 2022, 2023 and 2024 by the San Francisco Chronicle.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our employees are one of our most valuable assets and are essential to our success. We have been purposeful in our efforts to hire, develop and retain diverse talent as well as create an inclusive culture. We are investing in the creation of a work environment that values the health, safety and wellness of our team, and where our employees are inspired to deliver their best every day. All employees are responsible for upholding the Adverum Code of Business Conduct and Ethics, as well as complying with our Employee Handbook, which together form the foundation of our policies and practices. We continue to expand our systems to track key human capital metrics such as demographics, diversity, compensation and benefits, and engagement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity, Inclusion and Diversity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to inclusion across all aspects of our company, including hiring, promotion and development practices. Our employees bring diverse perspectives to our workplace across many critical categories, and we believe our company is stronger as a result of our diverse experiences and backgrounds. We are committed to creating and maintaining a diverse, inclusive and safe work environment where our employees can bring their best selves to work each day. We continue to support employee-led resource groups (&#8220;ERGs&#8221;) and provide resources for our employees to support equity and engagement. We currently have one ERG that represents and supports women in our workforce: SOAR (Supporting Women of All Ranks ERG), providing support and mentorship for our female workforce, including guidance on career advancement. Overall, the goal of ERG programs at Adverum are to mentor, foster, encourage and inspire employees in all stages of their careers by providing access to senior leadership, peer groups, mentoring and other valuable resources to help them pursue their career ambitions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitment to our employees starts with benefit and compensation programs that value their contributions and offer physical, financial and personal health programs to them and their families. We strive to provide pay, benefits and services that are competitive to market and create incentives to attract and retain employees. Our compensation package includes market-competitive pay, broad-based stock grants and bonuses, healthcare and retirement benefits, and paid time off. We also offer an Employee Stock Purchase Program through which employees can purchase company stock at a discounted price and offer stipends to cover expenses associated with working from home and the use of personal devices for work purposes. Additionally, we continue to advance transparency in our pay and representation data by complying with all applicable statutory filing requirements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Communication and Engagement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strongly believe that Adverum&#8217;s success depends on our employees understanding how their work contributes to the company&#8217;s overall strategy. We strive to foster open and direct communication and seek to empower our employees to be our greatest ambassadors. We use a variety of channels to facilitate this exchange of information, including quarterly business updates from the senior management team; regular all hands meetings, open forums and company-wide written communications; postings on our company intranet; and employee engagement surveys.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate and Available Information </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in Delaware in 2006 under the name &#8220;Avalanche Biotechnologies, Inc.&#8221; We completed the initial public offering of our common stock in August 2014. On May 11, 2016, upon the completion of our acquisition of Annapurna Therapeutics SAS, we changed our name to &#8220;Adverum Biotechnologies, Inc.&#8221; Our common stock is currently listed on The Nasdaq Capital Market under the symbol &#8220;ADVM.&#8221;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 100 Cardinal Way, Redwood City, CA 94063, and our telephone number is (650)&#160;656&#8209;9323. Our website address is www.adverum.com. We make available on our website, free of charge, our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission, or the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding our filings at www.sec.gov. The information found on our website is not incorporated by reference into this Annual Report on Form 10-K or any other report we file with or furnish to the SEC.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. Risk Factors</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should consider carefully the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. The risks described below are not the only risks facing us. Risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, results of operations and prospects.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_25"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Capital</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is substantial doubt regarding our ability to continue as a going concern. We will need to raise substantial additional funding to finance our operations through regulatory approval of our lead program and beyond, which may not be available on acceptable terms, or at all. If we fail to obtain additional capital necessary to fund our operations, we could be forced to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations, or to cease operations or liquidate our assets. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#8239;31, 2024, our cash, cash equivalents and short-term investments totaled $125.7 million, which we expect to fund our operations into the second half of 2025. We have determined that our existing cash and cash equivalents as of December 31, 2024 would be insufficient to fund our operations through one year from the filing date of this Annual Report on Form 10-K. Because our cash and cash equivalents will not be adequate to fund our operations through at least 12 months from the date the consolidated financial statements in this Annual Report on Form 10-K are issued, there is substantial doubt regarding our ability to continue as a going concern. As a result, the report from our independent registered public accounting firm issued in connection with this Annual Report on Form 10-K contains statements expressing substantial doubt about our ability to continue as a going concern.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future clinical trials or ongoing clinical trials of our product candidates could cause an increase in our spending levels, as could other corporate activities, such as expenses related to manufacturing supply of our product candidates. The amount and timing of any expenditure needed to implement our development and commercialization programs will depend on numerous factors, including: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the type, number, scope, progress, costs, results of and timing of any future nonclinical studies and clinical trials of any of our product candidates that we are pursuing or may choose to pursue in the future; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the need for, and the progress, costs and results of, any additional clinical trials or nonclinical studies of our product candidates we may initiate based on the results of any clinical trials that we may plan or discussions with the United States Food and Drug Administration or other regulatory authorities outside the United States, including any additional clinical trials or nonclinical studies the FDA or other regulatory authorities outside the U.S. may require evaluating the safety of our product candidates; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs of obtaining, maintaining and enforcing our patents and other intellectual property rights; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs and timing of obtaining or maintaining manufacturing for our product candidates, including commercial validation and internal and external commercial manufacturing; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the availability and cost of acquiring and shipping of supplies necessary for manufacturing and clinical trials;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs and timing of establishing sales, marketing, distribution and other commercial capabilities; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the terms and timing of establishing collaborations, license agreements and other partnerships; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">costs associated with any new product candidates that we may develop, in-license or acquire; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the effects of competing technological and market developments; </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to establish and maintain partnering arrangements for development and/or commercialization;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the cost and timing of establishing enhanced internal controls over financial reporting; and </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs associated with being a public company. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may never generate the necessary data or results required to obtain regulatory approval in order to generate revenue from product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for several years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. We will need to raise substantial additional funding to finance our operations through clinical development of our product candidates and potentially to commercialize these candidates. We continue to analyze various alternatives, including public or private equity or debt financings, third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches. Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our product candidates. We may experience difficulties in accessing the capital markets due to external factors beyond our control, such as volatility in the equity markets for emerging biotechnology companies and general economic and market conditions both in the U.S. and abroad. For example, our ability to raise additional capital may be adversely impacted by global economic conditions and disruptions to and volatility in the credit and financial markets in the U.S. and worldwide, such as have been experienced recently due in part to, among other things, the impacts of inflation, ongoing overseas conflicts, and disruptions in access to bank deposits and lending commitments due to bank failures. We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain additional capital necessary to fund our operations, we could be forced to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations, or to cease operations or liquidate our assets. Although we have been successful in raising capital in the past, there is no assurance that we will be successful in obtaining additional financing. Therefore, we cannot be certain that our plans to raise additional capital will be successful in alleviating the substantial doubt regarding our ability to continue as a going concern. Failure to manage discretionary spending or raise additional financing, as needed, may adversely impact our ability to achieve our intended business objectives. If we do not obtain additional financing and are required to terminate our operations, our stockholders will lose all or a part of their investment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we sell shares of our common stock or securities convertible into or exercisable for shares of our common stock in future financings or pursuant to licensing, collaboration or other arrangements, stockholders may experience immediate dilution and, as a result, our stock price may decline. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of public or private equity or debt financings, third-party funding, revenue interest arrangements, as well as other collaborations, strategic alliances and licensing arrangements or any combination of these approaches, grants, debt and other financings. We do not have any committed external source of funds. To the extent that we raise additional capital, if available, through the sale of equity or convertible debt securities, including through our &#8220;at-the-market&#8221; offering program, the ownership interests of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect such holders' rights as a holder of our common stock. Debt and revenue interest financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends or other distributions. Furthermore, we may issue common stock as consideration in acquisitions. If we issue common stock or securities convertible into common stock, our common stockholders would experience additional dilution and, as a result, our stock price may decline. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic alliances, third-party licensing arrangements or similar arrangements, we may have to relinquish valuable rights to our technologies, future revenue streams, research and development programs or product candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The report of our independent registered public accounting firm for the year ended December 31, 2024 contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the uncertainty of our ability to meet our current operating and capital expenses, in the auditor&#8217;s report on our audited annual financial statements as of and for the year ended December 31, 2024, our independent auditors included a paragraph regarding our ability to continue as going concern. Substantial doubt about our ability to continue as a going concern may materially and adversely affect the price per share of our common stock and we may have a more difficult time obtaining financing. Further, the perception that we may be unable to continue as a going concern may impede our ability to raise additional funds or operate our business due to concerns regarding our ability to discharge our contractual obligations. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant operating losses since inception, and we expect to incur significant losses for the foreseeable future. We may never become profitable or, if achieved, be able to sustain profitability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since we were founded in 2006 and expect to incur significant losses for the foreseeable future as we continue development of our product candidates. Losses have resulted principally from costs incurred in our research and development programs and from our general and administrative expenses. In the future, we intend to continue to conduct research and development, regulatory compliance activities and, if any of our product candidates is approved, sales, marketing and other activities that, together with anticipated general and administrative expenses, will likely result in us incurring significant losses for the next several years or longer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently generate no revenue from sales, and we may never be able to commercialize any of our product candidates. We do not currently have the required approvals to market any of our product candidates, and we may never receive such approvals. We may not be profitable even if we or any development partners succeed in commercializing any of our product candidates. Because of the numerous risks and uncertainties associated with developing and commercializing our product candidates, we are unable to predict the extent of any future losses or when we will become profitable, if at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with subletting our leased premises, including risks associated with subtenant defaults, which have occurred and we expect to continue to occur. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into an operating lease agreement for a building in North Carolina (&#8220;NC Premises&#8221;) and in October 2021, we entered into a sublease agreement with Jaguar Gene Therapy, LLC, (&#8220;Jaguar&#8221;), who subsequently assigned the sublease to Advanced Medicine Partners, LLC (&#8220;AMP&#8221; or the &#8220;subtenant&#8221;) as the subtenant for the NC Premises, through the remainder of the lease term (ending in October 2037). Pursuant to the sublease and the notice and waiver of assignment (the &#8220;assignment agreement&#8221;), Jaguar remained obligated for AMP&#8217;s proper performance under the sublease. In February 2025, a lien in the amount of $4.8 million was filed by a third-party contractor against the subtenant&#8217;s interest in the NC Premises. We discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Further liens by third-party subcontractors or other contractors have been or may in the future be filed against the subtenant&#8217;s interest in the NC Premises, and we may need to also discharge such liens to avoid a default under the head lease. The subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. As a result, we assumed responsibility for such payments in March 2025. As of April 7, 2025, we have made payments in the total amount of $1.9&#160;million to satisfy outstanding rent and common area management fee obligation, and we remain obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $119.7&#160;million for the remainder of the head lease term, of which $5.7&#160;million is due between April 8 and December 31, 2025. As a result of the uncured defaults, we terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce our rights under the sublease and to seek recovery of losses and damages due to the defaults by the subtenant and Jaguar. In the event we are unsuccessful in collecting from the subtenant or Jaguar or are unable to obtain a new subtenant on acceptable terms or at all, we will be required to satisfy our obligations directly to the landlord under the head lease in accordance with its terms. </span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_28"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Discovery and Development of Our Product Candidates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business will depend substantially on the success of one or more of our product candidates. If we are unable to develop, obtain regulatory approval for, or successfully commercialize, any or all of our product candidates, our business will be materially harmed. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have one product candidate in clinical trials, and if that product candidate is not successful, our business could be materially impacted. Our other product candidates are in the early stages of development and will require substantial nonclinical and/or clinical development and testing, manufacturing process improvement and validation, clinical studies and regulatory approval prior to commercialization. It is critical to our business to successfully develop and ultimately obtain regulatory approval for one or more of these product candidates. Our ability to commercialize our product candidates effectively will depend on several factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful completion of nonclinical studies and clinical trials, including the ability to demonstrate safety and efficacy of our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of marketing approvals for any future products for which we complete clinical trials, including securing regulatory exclusivity to the extent available;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing commercial manufacturing capabilities, for example, by engaging third-party manufacturers, partnering with a pharmaceutical licensee with manufacturing capabilities, or developing our own manufacturing capabilities that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">can provide products and services to support clinical development and the market demand for our product candidates, if approved;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful launch and commercial sales of the product, whether alone or in collaboration with potential partners;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of the product as a viable treatment option by patients, the medical community and third-party payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing market share while competing with other therapies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a continued acceptable safety profile of our products following regulatory approval;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining compliance with post-approval regulations and other requirements; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">qualifying for, identifying, registering, maintaining, enforcing and defending intellectual property rights and claims covering our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our collaborators do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to commercialize our product candidates, which would materially and adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the large number of gene therapies, biologics and drugs in development in the pharmaceutical industry, only a small percentage result in the submission of a BLA to the FDA or marketing authorization application (&#8220;MAA&#8221;) to the European Medicines Agency (&#8220;EMA&#8221;), and even fewer are approved for commercialization. Furthermore, even if we do receive regulatory approval to market any of our product candidates, any such approval may be subject to limitations on the indicated uses for which we may market the product, or limitations related to its distribution, or be conditional on future development activities and clinical results. Accordingly, even if we are able to obtain the requisite financing to continue to fund our development programs, there can be no assurance that any of our product candidates will be successfully developed or commercialized. If we or any of our future development partners are unable to develop, or obtain regulatory approval, or, if approved, successfully commercialize, any of our product candidates, we may not be able to generate sufficient revenue to continue the operation of our business. In addition, difluprednate eye drops are not approved or commercially available in certain geographies where we intend or may choose to conduct Phase 3 clinical trials and to commercialize Ixo-vec, if approved, which could have an adverse effect on our ability to complete Phase 3 clinical trials or commercialize Ixo-vec in such jurisdictions or on our expected timelines.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug development is a long, expensive and uncertain process, and delay or failure can occur at any stage of development, including after commencement of any of our clinical trials or any clinical trials using our proprietary viral vectors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drug development has inherent risk. Our lead product candidate, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ixoberogene soroparvovec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Ixo-vec&#8221;), formerly referred to as ADVM-022, for the treatment of wet age-related macular degeneration (&#8220;wet AMD&#8221;), uses a proprietary vector, AAV.7m8, which has undergone limited human testing, and may generate unexpected results in clinical trials in the future, such as the dose-limiting toxicity at the 6 x 10&#x5E;11 vg/eye (&#8220;6E11&#8221;) dose tested in the INFINITY trial in diabetic macular edema (&#8220;DME&#8221;) subjects. Although we will be bound by the generally applicable laws governing approval, the fact that Ixo-vec is a gene therapy and the broad patient population that it is intended to treat mean that the safety and efficacy of our product and the related clinical data will be under increased scrutiny by competent authorities. There have been several significant adverse side effects in gene therapy treatments in the past, including reported cases of leukemia and death seen in other trials using other genomic therapies. Gene therapy is still a relatively new approach to disease treatment and additional adverse side effects could develop. There also is the potential risk of significantly delayed adverse events following exposure to gene therapy products due to persistent biologic activity of the genetic material or other components of products used to carry the genetic material. Possible adverse side effects that could occur with treatment with gene therapy products include an immunologic reaction early after administration that, while not necessarily adverse to the patient&#8217;s health, could substantially limit the effectiveness of the treatment. Results in trials of competing product candidates or of other companies in our market sector may influence the perception of our product candidates. In addition, we may be adversely impacted if adverse events are reported for our or another party&#8217;s product or product candidate containing one of our proprietary viral vectors. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We, or any licensee or development partner, will be required to demonstrate through adequate and well-controlled clinical trials that our product candidate or another party&#8217;s product candidate containing one of our proprietary viral vectors is safe and effective for use in its target indications before seeking regulatory approvals for commercial sale. Drug development is a long, expensive and uncertain process, and delay or failure can occur at any stage of development, including after commencement of any of our clinical trials or any clinical trials using our proprietary viral vectors. Any such delay or failure could significantly harm our business prospects, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The occurrence of serious complications or side effects that outweigh the therapeutic benefit in connection with or during use of our product candidates, whether in nonclinical studies or clinical trials or post-approval, could lead to discontinuation of our clinical development program, refusal of regulatory authorities to approve our product candidates or, post-approval, revocation of marketing authorizations or refusal to approve new indications, which could severely harm our business prospects, financial condition and results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the conduct of nonclinical studies and clinical trials, animal models and human subjects may experience changes in their health, including illnesses, injuries and discomforts. It is not always possible to accurately determine whether or not the product candidate being studied caused these conditions. In addition, subjects may not comply with the requirements of the study, such as missing physician visits or not taking eye drops as prescribed, which may result in changes to their health or vision that could then be attributed to the product candidate. Various illnesses, injuries, and discomfort may be reported from time-to-time in clinical trials of our product candidates. For example, a dose-limiting toxicity at the 6E11 dose tested in our INFINITY trial in DME subjects resulted in our announcement on July 22, 2021 that we were discontinuing development of Ixo-vec for the DME indication. It is possible that as we test Ixo-vec and other product candidates, in current and future clinical programs, or if use of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomfort and other adverse events that were observed in earlier trials, including the dose-limiting toxicity at the 6E11 dose tested in the INFINITY trial, as well as conditions that did not occur or went undetected in previous trials, will be reported by subjects. In some cases, side effects are only detectable after investigational products are tested in large-scale, Phase 3 clinical trials or later stage clinical trials, or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that one or more of our product candidates causes serious or life-threatening side effects, or side effects that outweigh the therapeutic benefit of the product candidate, the development of one or more of our product candidates may fail or be delayed, or, if one or more of our product candidates has received regulatory approval, such approval may be revoked, varied or suspended which would severely harm our business prospects, financial condition and results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to understand the safety of our product candidates, when a subject experiences a negative health event during a clinical trial, we must determine if it is related to our product candidate. The subjects we enroll in our clinical trials for our current product candidates are generally less healthy than the general population, which increases the likelihood that a negative health event, unrelated to our product candidate, may occur. These health events may be misattributed to our product candidate, either by us, our investigators, or by regulators. Such misattribution could cause regulatory approval of our product candidates to be denied or delayed. For example, the subjects enrolled in our wet AMD trials are often geriatric and have other health conditions unrelated to wet AMD. We cannot assure you that we will be able to accurately determine whether or not a negative health event experienced by a subject in any of these or subsequent trials was related to Ixo-vec, nor can we assure you that the FDA or other regulatory authorities outside the U.S. responsible for reviewing the safety of Ixo-vec will agree with our determination. If a subject in one of our clinical trials experiences a negative health event, and that event is attributed to Ixo-vec, the trial and any other trials of Ixo-vec may be placed on clinical hold, and regulatory approval of Ixo-vec may be delayed or denied.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if a subject enrolled in one of our clinical trials experiences a negative health event, the subject may be forced to withdraw from our trial, or may become temporarily unavailable for follow-up visits, which may impact the amount or quality of data we obtain from our trial, which in turn may delay or prevent regulatory approval of our product candidate. Because subjects we enroll in our clinical trials for any of our product candidates are likely to be less healthy than the general population, and particularly in trials like OPTIC and LUNA that enroll a small number of subjects, this risk is increased.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates built on adeno-associated viral vector (&#8220;AAV&#8221;) vectors have similar risks to other gene therapy vectors, including inflammation, pigmentary changes, including iris transillumination defects and anterior chamber pigmentation, cytotoxic T-cell responses, anti-AAV antibodies and immune response to the transgene product, such as T-cell responses and/or antibodies against the expressed protein. For example, based on our current clinical experience, dose-related inflammation is a known side effect of Ixo-vec administration, but the duration of inflammation caused by Ixo-vec, our ability to prevent or manage that inflammation using corticosteroids or other anti-inflammatory or immunomodulatory treatments, and any potential clinical sequelae of that inflammation and treatments used to manage inflammation are not fully understood. Our LUNA trial is evaluating prophylactic corticosteroid regimens, including local corticosteroids and combinations of local and systemic corticosteroids to test the relative contribution of local versus systemic AAV exposure on ocular inflammation. In November 2024, we announced LUNA 52-week data with a cut-off date of August 29, 2024. Ixo-vec was well-tolerated, and when present inflammation was responsive to per protocol local corticosteroids. Our 52-week data suggest that difluprednate eye drops alone are a promising "go forward" prophylactic regimen for our future pivotal studies. The use of a difluprednate eye drop prophylactic regimen may not be as successful in managing or mitigating inflammation in future, larger clinical trials or commercial use, and our reliance on the availability of these corticosteroids makes us vulnerable to drug shortage or other supply problems. In addition, difluprednate eye drops are not approved or commercially available in certain geographies where we intend or choose to conduct Phase 3 clinical trials, which could have an adverse effect on our ability to complete Phase 3 clinical trials in these jurisdictions on our expected timelines. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we achieve marketing approval, doctors may not prescribe, and patients may not use, Ixo-vec or our other product candidates if they deem the levels or risk of inflammation to be unacceptable or if they are unwilling or unable to use the required prophylactic corticosteroid regimen. Further, patients treated with Ixo-vec could develop antibodies against AAV.7m8 capsid and/or aflibercept protein. These antibodies could preclude these patients from receiving other AAV-based gene therapies in the future. In addition, patients previously treated with or exposed to other AAV-based gene therapies could develop antibodies against AAV.7m8 and/or the aflibercept protein, which could reduce or eliminate the effectiveness of Ixo-vec or could cause unanticipated adverse reactions to Ixo-vec. Studies have also found that intravenous delivery of certain AAV vectors at high doses may result in adverse events and have prompted the recommendation that studies involving high doses of AAV vectors should be monitored carefully for such adverse events. In addition, patients given infusions of any therapeutic protein or injection of gene therapies that cause expression of a therapeutic protein may develop severe hypersensitivity reactions, infusion reactions, or serious side effects including transaminitis. With respect to our product candidates that are being or may be studied in diseases of the eye, there are additional potential serious complications related to IVT injection and taking aqueous fluid samples from the eye (&#8220;aqueous tap&#8221;), such as retinal detachment, endophthalmitis, ocular inflammation, cataract formation, glaucoma, damage to the retina or cornea, and bleeding in the eye. Serious complications or serious, unexpected side effects in connection with the use of our product candidates could materially harm our business prospects, financial condition and results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our lead product candidate, Ixo-vec, is designed for long-term, sustained expression of an exogenous protein, aflibercept. Even though Eylea</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (aflibercept) has been approved by several regulatory authorities, including the FDA, for the treatment of wet AMD, there may be side effects associated with aflibercept being expressed via a gene therapy treatment modality. If such side effects are serious or life threatening, the development of our product candidate and future product candidates may fail or be delayed, or, if such product candidate(s) have received regulatory approval, such approval may be revoked, which would severely harm our business prospects, financial condition and results of operation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of nonclinical studies and early clinical trials are not always predictive of future results. Any product candidate we or any of our future development partners advance into clinical trials may not have favorable results in later clinical trials, if any, or receive regulatory approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our product candidates are not shown to be safe and effective, we may not realize the value of our investment in our technology or product candidates. Promising nonclinical results generated with a product candidate in animal models do not guarantee similar results when the candidate is tested in humans. For example, the levels of protein expression achieved from a vector in a nonclinical model, including non-human primate models, may be significantly different than the level of protein expression achieved in humans. Similarly, human subjects administered our product candidates may develop side effects that were not observed in animal models and/or are more severe than those observed in animal models. In addition, even industry-accepted animal models may not accurately replicate human disease. Success in nonclinical studies or in early clinical trials does not mean that later clinical trials will be successful, because product candidates in later-stage clinical trials may fail to demonstrate sufficient safety or efficacy despite having progressed through nonclinical and initial clinical testing. Further, safety and/or efficacy issues with a product candidate may become apparent only when the product candidate is tested in human subjects suffering from the relevant disease. Furthermore, the initiation of future trials for a product candidate will be dependent upon demonstrating sufficient safety and efficacy to the relevant regulatory authorities in preceding or other ongoing trials using the same product candidate. We will still need to conduct Phase 3 pivotal trials in which we anticipate Ixo-vec will be compared to available therapies and utilize longer-term endpoints in order to support submission and approval of a BLA or equivalent outside of the U.S. Companies frequently suffer significant setbacks in advanced clinical trials, even after earlier clinical trials have shown promising results. In addition, only a small percentage of products under development result in the submission of a marketing application and even fewer are approved for commercialization. Even if our clinical trials successfully meet their endpoints for safety and efficacy, the FDA and/or other regulatory authorities outside the U.S. may still conclude that the product candidate has not demonstrated a beneficial benefit-risk profile or otherwise does not meet the relevant standard for approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that results from any clinical trials that we plan will be successful, and any safety or efficacy concerns observed in any one of our clinical trials in our targeted indications could limit the prospects for regulatory approval of our product candidates in those and other indications.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our gene therapy platform is based on a novel technology, which makes it difficult to predict the time and cost of product candidate development and the time, cost, and probability of subsequently obtaining regulatory approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have concentrated our research and development efforts on our gene therapy platform and in product candidates based on this platform, and our future success depends on the successful development of such product candidates. There can be no assurance that any development problems we have experienced or may experience in the future related to our platform will not cause significant delays or unanticipated costs, or that such development problems can be solved. We may also experience delays in developing a sustainable, reproducible, and scalable manufacturing process or transferring that process to external commercial manufacturing sites, which may prevent us from completing our clinical trials or commercializing our product candidates on a timely or profitable basis, if at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the clinical trial requirements of the FDA, EU competent authorities and other regulatory authorities outside the U.S. and the criteria these regulators may use to determine the quality, safety and efficacy of a product candidate vary substantially according to the type, complexity, novelty and intended use and market of the potential product. The regulatory approval process for novel gene therapy products such as ours can be more expensive and take longer than for other treatment modalities, which are better known or more extensively studied to date. To date, approvals for gene therapy products by the FDA have been generally for rare diseases with limited treatment options. Because we are targeting a broad population of patients with wet AMD, for which there are multiple approved and widely adopted standard-of-care therapies, the benefit-risk profile of Ixo-vec may be subject to greater scrutiny by regulatory authorities. Regulatory approaches and requirements for gene therapy products continue to evolve, and any changes could create significant delay and unpredictability for product development and approval as compared to technologies with which regulatory authorities have more substantial experience, including, for example, reevaluating whether to require a companion diagnostic for gene therapy products.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before a clinical trial can begin to enroll at a clinical site, the site&#8217;s Institutional Review Board (&#8220;IRB&#8221;) or Ethics Committee and its Institutional Biosafety Committee must review the proposed clinical trial to assess the appropriateness to conduct the clinical trial at that site. In addition, adverse events in clinical trials of gene therapy products conducted by others may cause the FDA or other regulatory authorities outside the U.S. to change the requirements for human research on or for approval of any of our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These regulatory authorities, review committees and advisory groups, and the guidelines they promulgate, may lengthen our regulatory review process, require us to perform additional studies, increase our development costs, increase or otherwise change chemistry, manufacturing, and controls requirements, lead to changes in our regulatory positions and interpretations, delay or prevent approval and commercialization of our product candidates or lead to significant post-approval limitations or restrictions. As we advance our product candidates, we will usually be required to consult with these, and potentially other, regulatory and advisory groups and comply with applicable guidelines or recommendations. If we fail to do so or the consultations take longer than we expect, we may be required to delay or discontinue development of our product candidates. Delay or failure to obtain, or unexpected costs incurred in obtaining, the regulatory approval necessary to bring a potential product to market could decrease our ability to generate sufficient product revenue to maintain our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifying and qualifying patients to participate in our clinical trials will be critical to our success. The timing of current and future clinical trials will depend on the speed at which we can recruit patients to participate in future testing of these product candidates. We have in the past and may in the future experience difficulties or delays enrolling patients in our clinical trials.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient enrollment, a significant factor in the timing of clinical trials, is affected by many factors including the size and nature of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the trial, the design of the clinical trial, competing clinical trials, clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new drugs that may be approved for the indications we are investigating and patient&#8217;s safety concerns over participating in a clinical trial. We will be required to identify and enroll a sufficient number of patients for any clinical trial for our product candidates. Potential patients may not be adequately diagnosed or identified with the diseases which we are targeting or may not meet the entry criteria for our trials. Additionally, some patients may meet exclusion criteria that would prevent them from being enrolled in a clinical trial for any of our product candidates. As a consequence, enrollment in our clinical trials may be limited or slowed. We also may encounter difficulties in identifying and enrolling patients with a stage of disease appropriate for such future clinical trials. We may not be able to identify, recruit and enroll a sufficient number of patients, or those with required or desired characteristics to achieve diversity in a trial.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to seek initial marketing approval of our product candidates in the U.S., EU and/or other countries and we may not be able to successfully conduct clinical trials if we cannot enroll a sufficient number of eligible patients to participate in the clinical trials required by the FDA, the EU or other regulatory authorities outside the U.S. In addition, the process of finding and diagnosing patients may prove costly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if patients and investigators are unwilling to participate in our gene therapy studies because of the dose-limiting toxicity at the 6E11 dose tested in the INFINITY trial, negative publicity from other adverse events in the biotechnology or gene therapy sector, inadequate results in our nonclinical studies or clinical trials, or for other reasons, including competitive clinical trials for similar patient populations or available approved therapies, our recruitment of patients, or conduct of clinical trials and ability to obtain regulatory approval of our product candidates may be hindered.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials using early versions of retroviral vectors, which integrate into, and thereby alter, the host cell&#8217;s DNA, have led to several well-publicized adverse events. Our product candidates use an AAV delivery system, with which host integration has been less of a concern. Nonetheless, if patients negatively associate our product candidates with the adverse events caused by previous gene therapy products, they may choose not to enroll in our clinical trials, which would have a material adverse effect on our business and operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we have difficulty enrolling a sufficient number of patients to conduct clinical trials on our product candidates as planned, we may need to delay, limit or terminate future clinical trials, any of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product candidates are subject to extensive regulation, compliance with which is costly and time consuming, and such regulation may cause unanticipated delays or prevent the receipt of the required approvals to commercialize our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nonclinical and clinical development, manufacturing, analytical testing, labeling, storage, record-keeping, advertising, promotion, import, export, marketing and distribution of our product candidates are subject to extensive regulation by the FDA and by comparable regulatory authorities outside the U.S. In the U.S., we are not permitted to market our product candidates until we receive regulatory approval from the FDA. Similar approvals are required to market our product candidates outside of the U.S. The process of obtaining regulatory approval is expensive, often takes many years and can vary substantially based upon the type, complexity and novelty of the products involved, as well as the target indications and patient population. Approval policies or regulations may change, and the regulatory authorities have discretion in the drug approval process, including the ability to delay, limit or deny approval of a product candidate for many reasons. Despite the time and expense invested in clinical development of product candidates, regulatory approval is never guaranteed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA or comparable regulatory authorities outside the U.S. can delay, limit or deny approval of a product candidate for many reasons, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such authorities may disagree with the design or implementation of our or any of our future development partners&#8217; clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or any of our future development partners may be unable to demonstrate to the satisfaction of the FDA or other regulatory authorities outside the U.S. that a product candidate is safe and effective for any indication;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or other regulatory authorities outside the U.S. may not accept clinical data from trials which are conducted at multinational clinical facilities or in countries where the standard of care is potentially different from that of the U.S. or the other regulatory authorities outside the U.S.;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of clinical trials may not demonstrate the safety or efficacy required by such authorities for approval;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or any of our future development partners may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such authorities may disagree with our interpretation of data from nonclinical studies or clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval may be granted only for indications that are significantly more limited than what we apply for and/or with other significant restrictions on distribution and use;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such authorities may find deficiencies in our manufacturing processes, analytical testing, or facilities or in the manufacturing processes, analytical testing or facilities of third-party manufacturers or testing laboratories with which we or any of our future development partners contract for clinical and commercial supplies;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the approval policies or regulations of such authorities may significantly change in a manner rendering our or any of our future development partners&#8217; clinical data insufficient for approval; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">approval from such authorities may be conditioned on the collection of additional data or otherwise contain significant post-marketing obligations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to foreign markets, approval procedures vary among countries and, in addition to the aforementioned risks, can involve additional product testing, administrative review periods and agreements with pricing authorities. In addition, events raising questions about the safety of related products, including those already on the market, may result in increased cautiousness by the FDA and comparable regulatory authorities outside the U.S. in reviewing our product candidates based on safety, efficacy or other regulatory considerations and may result in significant delays in obtaining regulatory approvals. Any delay in obtaining, or inability to obtain, applicable regulatory approvals would prevent us or any of our future development partners from commercializing our product candidates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preliminary and interim data from our clinical trials that we may announce or publish from time to time may change as each clinical trial progresses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may announce or publish preliminary or interim data from our clinical trials. Preliminary and interim results of a clinical trial are not necessarily predictive of final results. Preliminary and interim data are subject to the risk that one or more of the clinical outcomes may materially change as subject enrollment continues or further subject follow up occurs and more subject data become available. In addition, in certain clinical trials, such as our OPTIC trial, individual cohorts of subjects were enrolled with different dosages and other treatment conditions under our protocol. These different doses, populations, and other treatment conditions may affect clinical outcomes, including safety profiles or efficacy, such as the number of supplemental injections required, in each of the cohorts. As a result, preliminary and interim data should be viewed with caution and not relied upon until the final data from a locked database for the entire clinical trial are available. Material changes in the final data compared to preliminary or interim data could significantly harm our business prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fast Track and Regenerative Medicine Advanced Therapy (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RMAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">) designations by the FDA, PRIME designation by the EMA and the Innovation Passport by the MHRA for Ixo-vec may not lead to a faster development, regulatory review or approval, and they do not increase the likelihood that Ixo-vec will receive marketing approval in the U.S.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received Fast Track designation for Ixo-vec in September 2018 for the treatment of wet AMD. The FDA may grant Fast Track designation to a drug that is intended to treat a serious condition and nonclinical or clinical data demonstrate the potential to address an unmet medical need. The FDA provides opportunities for frequent interactions with the review team for a Fast Track product, including pre-investigational new drug application (&#8220;IND&#8221;) meetings, end-of-phase 1 meetings, and end-of-phase 2 meetings to discuss study design, extent of safety data required to support approval, dose-response concerns, and use of biomarkers. A Fast Track product may also be eligible for Priority Review and Rolling Review, which may potentially result in a shorter FDA review process.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, FDA granted RMAT designation for Ixo-vec for the treatment of wet AMD.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investigational drug product is eligible for the RMAT designation if: (1) it meets the definition of a regenerative therapy medicine, which includes cell therapies, therapeutic tissue engineering products, human cell and tissue products, or combination products using such therapies or products, with limited exceptions; (2) the product is intended to treat, modify, reverse, or cure a serious disease or condition; and (3) preliminary clinical evidence indicates that the regenerative medicine therapy has the potential to address unmet medical needs for such disease or condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RMAT designation offers potential benefits that include increased collaboration with the FDA to accelerate development including the potential for Priority Review.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EMA granted Ixo-vec Priority Medicines (&#8220;PRIME&#8221;) designation in June 2022 for the treatment of wet AMD. PRIME is a program launched by the EMA to enhance support for research on and development of medicines that have demonstrated the potential to target a significant unmet medical need on the basis of data showing a meaningful improvement of clinical outcomes. This regulatory program offers sponsors enhanced interaction and early dialogue with the EMA and is designed to optimize development plans and speed evaluation ensuring these medicines reach patients as early as possible.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United Kingdom&#8217;s MHRA granted Ixo-vec an Innovation Passport under the Innovative Licensing and Access Pathway (&#8220;ILAP&#8221;) in April 2023. ILAP is a pathway supporting innovative approaches to the safe, timely, and efficient development of medicines aiming to accelerate the time to market, facilitating patient access to medicines. ILAP is comprised of the Innovation Passport designation and a Target Development Profile and provides applicants with access to a toolkit to support the design, development and approvals process. The Innovation Passport is the first step in the ILAP process, triggering the MHRA and its partner agencies, including the All Wales Therapeutics and Toxicology Centre, the National Institute for Health and Care Excellence, and the Scottish Medicines Consortium to partner with Adverum to charter a roadmap for regulatory and development milestones with the goal of early patient access in the United Kingdom (&#8220;UK&#8221;).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, Fast Track, RMAT, PRIME and ILAP designations for Ixo-vec may not result in a faster development process, review or approval compared to products considered for approval under conventional FDA procedures and do not assure ultimate approval by the FDA, the European Commission, or MHRA. In addition, the FDA and MHRA can rescind or revoke the designations for Ixo-vec if the regulatory agencies later determine that Ixo-vec no longer meets the qualifying criteria for such designation. The EMA can remove Ixo-vec from the PRIME eligibility list if Ixo-vec no longer meets the eligibility criteria.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in our efforts to identify or discover additional product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business depends primarily upon our ability to identify, develop and commercialize products based on our platform technology. Our research programs may fail to identify other potential product candidates for clinical development for a number of reasons. For example, our research methodology may be unsuccessful in identifying potential product candidates or our potential product candidates may be shown to lack efficacy, have harmful side effects, or may have other characteristics that may make the products unmarketable or unlikely to receive marketing approval.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these events occur, we may be forced to abandon our development efforts for a program or programs, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Research programs to identify new product candidates require substantial technical, financial and human resources. We may focus our efforts and resources on potential programs or product candidates that may ultimately prove to be unsuccessful.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_31"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Manufacturing</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully develop and maintain robust and reliable manufacturing processes for our product candidates, we may be unable to advance clinical trials or licensure applications and may be forced to delay or terminate a program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of commercially viable manufacturing processes typically is very difficult to achieve, is often very expensive and may require extended periods of time. As we develop, seek to optimize, and operate the Ixo-vec manufacturing process, internally and/or through third parties such as CMOs or potential partners, we will likely face technical and scientific challenges, considerable capital costs, and potential difficulty in recruiting and hiring experienced, qualified personnel. There may also be unexpected technical or operational issues during clinical manufacturing campaigns or process validation campaigns. For example, all Good Manufacturing Practices (&#8220;GMP&#8221;) activities, whether conducted at our Redwood City facility, or by external manufacturing, testing, and distribution vendors or potential partners are subject to significant health authority regulation with respect to manufacturing and testing our product candidates. If we are unable to satisfy these regulatory requirements, or if we are unable to solve the technical, scientific, and other challenges described above, we may be unable to manufacture a sufficient supply of our product candidates for our clinical trials and may be forced to delay or terminate our development programs. Additionally, changes in manufacturing processes (including cell lines and viral banks), equipment or facilities (including moving manufacturing or testing from one of our facilities to another one of our facilities or a third-party facility, such as CMOs or potential partners, or from a third-party facility, such as CMOs or potential partners, to one of our facilities) may require us to conduct additional studies to demonstrate comparability in order to receive regulatory approval of any manufacturing modifications. As a result, we could experience manufacturing delays that prevent us from commencing or completing our clinical studies on the timelines we anticipate, if at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may revise the process that we use to manufacture Ixo-vec for clinical trials. Before we use a revised process in clinical trials, we must submit analytical comparability data to the FDA and comparable regulatory authorities outside the U.S. to demonstrate that the process changes have not altered Ixo-vec in a manner that undermines the applicability of the clinical data from our clinical trials. If the FDA and comparable regulatory authorities outside the U.S. do not find our analytical comparability data sufficient, the FDA and comparable regulatory authorities outside the U.S. could place our IND or equivalent on clinical hold until we conduct additional nonclinical or clinical comparability studies demonstrating that the Ixo-vec manufactured by our revised process and our previous process are materially equivalent, which could substantially delay the development process. If we make further changes to the manufacturing process, equipment or facilities of Ixo-vec in the future, the FDA and comparable regulatory authorities outside the U.S. may require us to demonstrate comparability between Ixo-vec manufactured before and after the change. For example, the FDA and comparable regulatory authorities outside the U.S. could require comparability studies to demonstrate that Ixo-vec manufactured in its current facilities is comparable to Ixo-vec manufactured at future commercial supply sites, which could delay our commencement or completion of clinical trials.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not know whether any required comparability studies will begin as planned, will need to be restructured or will be completed on schedule, or at all. If the results of these comparability studies are not positive or are only modestly positive or if there are safety concerns, we may be delayed in obtaining marketing approval for Ixo-vec or not obtain marketing approval at all. Our product development costs will also increase if we experience delays in testing or regulatory approvals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to produce sufficient quantities of our products and product candidates at acceptable costs, we may be unable to meet clinical or potential commercial demand, face delayed timelines, lose potential revenue, have reduced margins, or be forced to terminate a program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the complexity of manufacturing our products, we may not be able to manufacture sufficient quantities to meet clinical or potential commercial demand. Our inability to produce enough of a product meeting all release acceptance criteria at acceptable costs may cause us to be unable to meet clinical or potential commercial demand, to delay our clinical and/or commercialization timelines, to lose potential revenue, to have reduced margins, or to be forced to discontinue such product.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As we develop, seek to optimize and operate the Ixo-vec manufacturing process internally or through third parties, we will likely face technical and scientific challenges, considerable costs, and potential difficulty in recruiting and hiring experienced, qualified personnel. We have in the past and may in the future experience unexpected technical or operational issues during clinical or commercial manufacturing campaigns. As a result, we could experience manufacturing delays that prevent us from commencing or completing clinical studies or commercializing Ixo-vec, if approved, on a profitable basis, if at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our manufacturing processes will subject us to a variety of U.S. federal, state and local laws and regulations governing the use, generation, manufacture, storage, handling and disposal of hazardous materials and wastes resulting from their use, as well as comparable legislation and regulations outside of the U.S. We will incur significant costs in complying with these laws and regulations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gene therapy products are novel and complex and have only in limited cases been manufactured at scales sufficient for pivotal trials and commercialization. Few pharmaceutical contract manufacturers specialize in gene therapy products and those that do are still developing appropriate processes and facilities for large-scale production. If we are unable to secure adequate manufacturing capacity from our contract manufacturing partners, or if our contracted slots are canceled or delayed in order to prioritize other projects, we may be unable to produce sufficient quantities of our product candidates for our development programs and for commercialization.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in methods of manufacturing or formulation of our product candidates may result in additional costs or delays.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our product candidates progress through preclinical to late-stage clinical trials to marketing approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods, formulation, and manufacturing sites are altered along the way in an effort to optimize yield and manufacturing batch size, reduce costs and achieve consistent quality and results. Such changes carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of our ongoing and planned clinical trials or other future clinical trials conducted with the altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and jeopardize our ability to commercialize our product candidates, if approved, and generate revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our contractors are subject to significant regulation with respect to manufacturing and testing our product candidates. We have a limited number of vendors on which we rely, including, in some cases, single source vendors, and the contract vendors on which we rely may not continue to meet regulatory requirements, may have limited capacity, or may have other factors limiting their ability to comply with their contracts with us. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have relationships with a limited number of suppliers for the manufacturing and testing of our vector product candidates. Our suppliers may require licenses to manufacture or test such components if such processes are not owned by the suppliers or in the public domain and may be unable to transfer or sublicense the intellectual property rights we may have with respect to such activities, and may be unable to acquire such rights, to the extent that we do not already have them.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All entities involved in the preparation of therapeutics for clinical trials or commercial sale, including our existing contract vendors for our product candidates, are subject to extensive regulation. Components of a finished therapeutic product used in clinical trials or approved for commercial sale must be manufactured and tested in accordance with GMP regulations. These regulations govern manufacturing processes and procedures (including record keeping) and the implementation and operation of quality systems to control and assure the quality of investigational products and products approved for sale. Poor control of production processes can lead to the introduction of adventitious agents or other contaminants, or to inadvertent changes in the properties or stability of our product candidates that may not be detectable in final product testing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We or our contract manufacturers must supply all necessary documentation in support of a BLA on a timely basis. If we or a contract manufacturer are unable to do so, we may experience clinical or commercialization delays or be required to expend significant resources to work with an alternative contract manufacturer. We and our contract manufacturers must also adhere to the FDA&#8217;s GMP regulations enforced by the FDA through its facilities inspection program as well as other comparable regulations enforced by other regulatory authorities outside the U.S. Our contract manufacturers have not produced a commercially approved AAV product and therefore have not yet demonstrated compliance with GMP regulations to the satisfaction of the FDA or other regulatory authorities outside the U.S. Our facilities and quality systems and the facilities and quality systems of some or all of our third-party contractors must pass a pre-approval inspection for compliance with the applicable regulations as a condition of regulatory approval of our product candidates. If the facility does not pass a pre-approval plant inspection, the FDA or other regulatory approval of the products will not be granted. In addition, the regulatory authorities may, at any time, audit or inspect any manufacturing facility we may have or those of our third-party contractors involved with the preparation of our product candidates or the associated quality systems for compliance with the regulations applicable to the activities being conducted. Should the FDA or other regulatory authorities outside the U.S. determine that the facility is not in compliance with applicable regulations, the manufacture and release of our product candidates may not be possible, and our business could be harmed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory authorities also may, at any time, inspect any manufacturing facility we may have or those of our third-party contractors. If any such inspection or audit identifies a failure to comply with applicable regulations or if we become aware of a violation of our product specifications or applicable regulations, independent of an inspection or audit, we or the relevant regulatory authority may require remedial measures that may be costly and/or time-consuming for us or a third-party to implement and which may include the temporary or permanent suspension of a clinical trial or commercial sales or the temporary or permanent closure of a facility. Such violations could also result in civil and/or criminal penalties. Any such remedial measures or other civil and/or criminal penalties imposed upon us or third parties with whom we contract could materially harm our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our third-party contractors fail to maintain regulatory compliance, the FDA or other regulatory authorities outside the U.S. can impose regulatory sanctions including shutdown of the third-party vendor or invalidation of drug product lots or processes, fines, injunctions, civil penalties, delays, suspension, variation or withdrawal of approvals, license revocation, seizures or recalls of product candidates or drugs, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products, if approved, and significantly harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if the service provided by an approved manufacturing or testing contractor is interrupted, there could be a significant disruption in commercial supply. Alternative contractors could need to be qualified through a BLA supplement, which could result in further delay. The regulatory authorities may also require additional studies showing comparability between approved product or testing and the product or testing provided after a contractor change, if a new manufacturing or testing contractor is relied upon for commercial production. Changing contractors may involve substantial costs and is likely to result in a delay in our desired clinical and commercial timelines.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors could cause the delay of clinical trials, regulatory submissions, required approvals or commercialization of our product candidates, causing us to incur higher costs, and preventing us from commercializing our product candidates successfully. Furthermore, if our suppliers fail to meet contractual requirements, and we are unable to secure one or more replacement suppliers capable of production at a substantially equivalent cost, our clinical trials may be delayed, or we could lose potential revenue.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face difficulties from changes to current regulations and future legislation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the U.S. or abroad. The policies of the FDA, the competent authorities of the EU Member States, the EMA, the European Commission and other comparable regulatory authorities responsible for clinical trials may change and additional government regulations may be enacted. For instance, the regulatory landscape related to clinical trials in the EU recently evolved. The EU Clinical Trials Regulation (&#8220;CTR&#8221;), which was adopted in April 2014 and repeals the EU Clinical Trials Directive, became applicable on January 31, 2022. The CTR allows sponsors to make a single submission to both the competent authority and an ethics committee in each EU Member State, leading to a single decision for each EU Member State. The assessment procedure for the authorization of clinical trials has been harmonized as well, including a joint assessment by all EU Member States concerned, and a separate assessment by each EU Member State with respect to specific requirements related to its own territory, including ethics rules. Each EU Member State&#8217;s decision is communicated to the sponsor via the centralized EU portal. Once the clinical trial approved, clinical study development may proceed. The CTR foresaw a three-year transition period that ended on January 31, 2025. Since this date, all new or ongoing trials are subject to the provisions of the CTR. Compliance with the CTR requirements by us and our third-party service providers, such as CROs, may impact our developments plans.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 26, 2023, the European Commission adopted a proposal for a new Directive and Regulation to revise the existing pharmaceutical legislation and on April 10, 2024, the Parliament adopted its related position. The proposed revisions remain to be agreed and adopted by the European Council. Moreover, on December 1, 2024, a new European Commission took office. The proposal could, therefore, still be subject to revision. If adopted in the form proposed, the recent European Commission proposals to revise the existing EU laws governing authorization of medicinal products may result in a decrease in data and market exclusivity opportunities for our product candidates in the EU and make them open to generic or biosimilar competition earlier than is currently the case with a related reduction in reimbursement status.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The United Kingdom&#8217;s withdrawal from the EU may have a negative effect on global economic conditions, financial markets and our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Brexit, the UK and the EU signed a EU-UK Trade and Cooperation Agreement, which became provisionally applicable on January 1, 2021 and entered into force on May 1, 2021. This agreement provides details on how some aspects of the UK and EU&#8217;s relationship will operate going forwards however there are still uncertainties. The EU-UK Trade and Cooperation Agreement primarily focuses on ensuring free trade between the EU and the UK in relation to goods, including medicinal products. Among the changes that have occurred are that the UK is treated as a &#8220;third country&#8221;, a country that is not a member of the EU and whose citizens do not enjoy the EU right to free movement (Northern Ireland continues to follow certain limited EU regulatory rules, including in relation to medical devices, but not in relation to medicinal products). As part of the EU-UK Trade and Cooperation Agreement, the EU and the UK recognize GMP inspections carried out by the other party and the acceptance of official GMP documents issued by the other party. The EU-UK Trade and Cooperation Agreement also encourages, although it does not oblige, the parties to consult one another on proposals to introduce significant changes to technical regulations or inspection procedures. Among the areas of absence of mutual recognition are batch testing and batch release. The UK has unilaterally agreed to accept EU batch testing and batch release. However, the EU continues to apply EU laws that require batch testing and batch release to take place in the EU territory. This means that medicinal products that are tested and released in the UK must be retested and re-released when entering the EU market for commercial use.&#8239;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2023, the UK Government and the European Commission reached a political agreement on the so-called &#8220;Windsor Framework&#8221;. The Windsor Framework is intended to revise the Northern Ireland Protocol to address some of the perceived shortcomings in its operation. The agreement was adopted at the Withdrawal Agreement Joint Committee on March 24, 2023 and the arrangements under the Windsor Framework relating to medicinal products took effect on January 1, 2025.&#8239; As it relates to marketing authorizations, the United Kingdom has a separate regulatory submission process, approval process and a separate national marketing authorization. Northern Ireland continued, until January 1, 2025 to be covered by the marketing authorizations granted by the European Commission but the Windsor Framework provides that the UK MHRA is the sole regulatory body responsible for granting marketing authorizations for Northern Ireland as of January 1, 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant proportion of the regulatory framework in the UK applicable to medicinal products is currently derived from EU Directives and Regulations. The potential for UK legislation to diverge from EU legislation following Brexit could materially impact the regulatory regime with respect to the development, manufacture, import, approval, and commercialization of our product candidates in the UK or the EU. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies governing clinical trials, our development plans may be impacted.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these changes could increase our costs and otherwise adversely affect our business. Any delay in obtaining, or an inability to obtain, any regulatory approvals, as a result of Brexit or otherwise, would prevent us from commercializing our product candidates in the UK or the EU and restrict our ability to generate revenue and achieve and sustain profitability. In addition, we may be required to pay taxes or duties or be subjected to other hurdles in connection with the importation of our product candidates into the EU. If any of these outcomes occur, we may be forced to restrict or delay efforts to seek regulatory approval in the UK or the EU for our product candidates, or incur significant additional expenses to operate our business, which could significantly and materially harm or delay our ability to generate revenues or achieve profitability of our business. Any further changes in international trade, tariff and import/export regulations as a result of Brexit or otherwise may impose unexpected duty costs or other non-tariff barriers on us. These developments, or the perception that any of them could occur, may significantly reduce global trade and, in particular, trade between the impacted nations and the UK. It is also possible that Brexit may negatively affect our ability to attract and retain employees, particularly those from the EU.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to many manufacturing and distribution risks, any of which could substantially increase our costs and limit supply of our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of manufacturing our product candidates is complex, highly regulated and subject to several risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Due to the complexity of manufacturing our product candidates, we may not be able to manufacture sufficient quantities to support our clinical trials. Delays in manufacture and supply by our contract manufacturing partners may also cause delays in their ability to supply the amount of our product that we have ordered and on which we have based our expected development timelines. Our inability to produce enough of a product candidate at acceptable costs may result in the delay or termination of development programs. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The manufacturing and distribution of biologics is extremely susceptible to product loss due to contamination, equipment failure, improper installation or operation of equipment, vendor or operator error, or transportation or storage conditions of the product. Even minor deviations from prescribed manufacturing processes could result in reduced production yields, product defects, and other supply disruptions. If microbial, viral, or other contamination is discovered in our product candidates or in a manufacturing facility in which our product candidates are made, such manufacturing facility may need to be closed for an extended period of time to investigate and remedy the contamination.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The manufacturing facilities in which our product candidates are made could be adversely affected by equipment failures, labor shortages, contaminants, raw materials shortages, natural disasters, power failures, and numerous other factors.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our contract manufacturers must comply with the FDA&#8217;s and comparable foreign regulatory authorities&#8217; GMP regulations and guidelines. We and our contract manufacturers may encounter difficulties in achieving quality control and quality assurance and may experience shortages in qualified personnel. We and our contract manufacturers are subject to inspections by the FDA and comparable regulatory authorities in other jurisdictions to confirm compliance with applicable regulatory requirements. Any failure to follow GMP or other regulatory requirements or any delay, interruption, or other issues that arise in the manufacture, fill-finish, packaging, storage, or distribution of our product candidates as a result of a failure of our facilities, or the facilities or operations of third parties, to comply with regulatory requirements or pass any regulatory authority inspection could significantly impair our ability to develop and commercialize our product candidates. This may lead to significant delays in the availability of sufficient supply of the product candidate substance for our clinical trials or the termination or hold on a clinical trial, or the delay or prevention of a filing or approval of marketing applications for our product candidates.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant noncompliance could also result in the imposition of sanctions, including fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approvals for our product candidates, delays, suspension, variation or withdrawal of approvals, license revocation, seizures or recalls of products, operating restrictions, and criminal prosecutions, any of which could be costly and damage our reputation. If we are not able to maintain regulatory compliance, we may not be permitted to market our product candidates, if approved, and/or may be subject to product recalls, seizures, injunctions, or criminal prosecution.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our product candidates are biologics and require processing steps that are more complex than those required for most chemical pharmaceuticals. Moreover, unlike chemical pharmaceuticals, the physical and chemical properties of a biologic such as our product candidates generally cannot be adequately characterized prior to manufacturing the final product. As a result, an assay of the finished product is not sufficient to ensure that the product will perform in the intended manner. Accordingly, we expect to employ multiple steps to attempt to control our manufacturing process and assure that the product or product candidate is made strictly and consistently in compliance with the process.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to develop the manufacturing process, and our current process has not been fully characterized and therefore is open to potential variations that could lead to defective product substance that does not meet specification.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Problems with the manufacturing, storage or distribution of our product candidates, including even minor deviations from our established parameters, could result in product defects or manufacturing failures that result in lot failures, product recalls, product liability claims and insufficient inventory.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Some of the raw materials required in our manufacturing process are derived from biological sources. Such raw materials are difficult to procure and may also be subject to contamination or recall. A material shortage, contamination, recall or restriction on the use of biologically derived substances in the manufacture of our product candidates could adversely impact or disrupt commercialization.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse developments affecting manufacturing operations for our product candidates may result in shipment delays, inventory shortages, lot failures, product withdrawals or recalls, or other interruptions in the supply of our product candidates, which could affect the timing of our commencement and completion of clinical studies. We may also have to take inventory write-offs and incur other charges and expenses for product that fails to meet specifications, undertake costly remediation efforts, or seek more costly manufacturing alternatives. We may encounter problems manufacturing sufficient research-, clinical-, or commercial-grade materials that meet FDA, EU or other applicable standards or specifications with consistent and acceptable production yields and costs.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_34"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Reliance on Third Parties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have relied, and expect to continue to rely, on third parties under contracts and partnerships to conduct some or all aspects of our research and development, including vector production, process development, assay development, product candidates and product manufacturing and testing, protocol development, clinical trials, product distribution, commercialization, nonclinical studies, research and related activities, and these third parties may not perform satisfactorily.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to independently conduct all aspects of our vector production, product and product candidate manufacturing and testing, protocol development, clinical trials, product distribution, commercialization, nonclinical studies, research and related activities. We currently rely, and expect to continue to rely, on third parties with respect to these items. We may not be able to enter into agreements or partnerships with these third parties and if we do enter into agreements with these third parties, we cannot be assured these agreements will be on favorable economic terms or that any of these third parties will be successful at fulfilling their contractual obligations, and it is possible they may choose to terminate their engagements with us. If we need to enter into alternative arrangements, it could delay or jeopardize our product development activities or regulatory filings or be more costly. Our reliance on these third parties for vector production, process development, assay development, product and product candidate manufacturing and testing, protocol development, clinical trials, product distribution, commercialization, nonclinical studies, research and related activities reduces our control over these activities but does not relieve us of our responsibility to ensure compliance with all required regulations. If any of these third parties on which we rely do not perform satisfactorily, we will remain responsible for ensuring that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our nonclinical studies and clinical trials are conducted in accordance with the study plan and protocols and applicable regulatory requirements;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vector production, product and product candidate manufacturing and testing are conducted in accordance with applicable GMP requirements and other applicable regulatory requirements; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other research, process development, and assay development are conducted in accordance with applicable industry and regulatory standards and norms;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of which we may not be able to do.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to rely on third-party manufacturers and suppliers, and may enter into partnerships and other business development arrangements, which entail risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to negotiate manufacturing, supplier agreements, partnerships or other agreements with third parties under commercially reasonable terms;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced control as a result of using third-party manufacturers or partners for some or all aspects of manufacturing activities;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination or nonrenewal of manufacturing agreements, partnerships, or supplier agreements with third parties in a manner or at a time that is costly or damaging to us; and </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions to the operations of our third-party manufacturers or suppliers caused by conditions unrelated to our business or operations, including the acquisition, change in control, or bankruptcy of the manufacturer, supplier or partner, or their commitments to other vaccine and therapeutics production projects that may reduce available manufacturing capacity.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could lead to clinical trial delays, failure to obtain regulatory approval, or impact our ability to successfully commercialize future products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely and will continue to rely on third parties to conduct some nonclinical testing and all of our ongoing and planned clinical trials. If these third parties do not meet our deadlines or otherwise fail to conduct the trials as required, our clinical development programs could be delayed or unsuccessful and we may not be able to obtain regulatory approval for or commercialize our product candidates when expected or at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have the ability to conduct all aspects of our nonclinical testing, clinical testing, or clinical trials ourselves. We are dependent on third parties to conduct nonclinical studies and clinical trials for our product candidates, and, therefore, the timing of the initiation and completion of these studies or trials is controlled in part by these third parties and may occur at times substantially different from our estimates. Specifically, we use and rely on medical institutions, clinical investigators, contract research organizations (&#8220;CROs&#8221;) and consultants to conduct our trials in accordance with our clinical protocols and regulatory requirements. Our CROs, investigators and other third parties play a significant role in the conduct of these trials and subsequent collection and analysis of data.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that any CROs, investigators or other third parties on which we rely for administration and conduct of our clinical trials will devote adequate time and resources to such trials or perform as contractually required. If any of these third parties fails to meet expected deadlines, fails to adhere to our clinical protocols, fails to meet regulatory requirements, or otherwise performs in a substandard manner, our clinical trials may be extended, delayed or terminated. If any of our clinical trial sites terminates for any reason, we may experience the loss of follow-up information on subjects enrolled in our ongoing clinical trials unless we are able to transfer those subjects to another qualified clinical trial site.</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and may receive compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, the utility of certain data from the clinical trial may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection of any IND or BLA we submit to the FDA, or equivalent submissions to other regulatory authorities outside the U.S. Any such delay or rejection could prevent us from commercializing our product candidates.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Intellectual Property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on our ability to protect our intellectual property and our proprietary technologies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to obtain and maintain patent protection and trade secret protection for our product candidates, proprietary technologies, and their uses as well as our ability to operate without infringing upon the proprietary rights of others. There can be no assurance that any of our product candidates will have patent protection, that our patent applications or those of our licensors will result in patents being issued or that issued patents, if any, will afford sufficient protection against competitors with similar technology, nor is there any assurance that the patents issued will not be infringed, designed around or invalidated by third parties. Issued patents may later be found unenforceable or may be modified or revoked in proceedings instituted by third parties before various patent offices or in courts. The degree of future protection for our proprietary rights is uncertain. Only limited protection may be available and may not adequately protect our rights or permit us to gain or keep any competitive advantage. This failure to properly protect the intellectual property rights relating to our product candidates could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and license certain composition-of-matter patents and applications covering components of our product candidates. Composition-of-matter patents on the biological or chemical active pharmaceutical ingredient are generally considered to be the strongest form of intellectual property protection for pharmaceutical products, as such patents provide protection without regard to any method of use. We cannot be certain that the claims in our patent applications covering composition-of-matter of any of our product candidates will be considered patentable by the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) and courts in the U.S. or by the patent offices and courts in foreign countries, nor can we be certain that the claims in our issued composition-of-matter patents will not be found invalid or unenforceable if challenged.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and license certain method-of-use patents and applications covering methods of treating certain diseases with our product candidates. Method-of-use patents protect the use of a product for the specified method or for treatment of a particular indication. However, methods of treating human diseases are considered unpatentable in many jurisdictions, and even where available this type of patent does not prevent a competitor from making and marketing a product that is identical to our product candidate for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for our targeted indications, physicians may prescribe these products &#8220;off-label.&#8221; Although off-label prescriptions may infringe or contribute to the infringement of method-of-use patents, the practice is common and such infringement is difficult to prevent or prosecute.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or any of our future development partners will be successful in protecting our product candidates by obtaining and defending patents. These risks and uncertainties include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. There are situations in which noncompliance can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patent applications may not result in any patents being issued;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patents that may be issued or in-licensed may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise may not provide any competitive advantage;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patents may expire before or soon after the product they cover is commercialized;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitors, many of whom have substantially greater resources than we do and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with, or eliminate our ability to make, use, and sell our product candidates;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the U.S. for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">countries other than the U.S. may have patent laws less favorable to patentees than those upheld by the U.S. courts, allowing foreign competitors a better opportunity to create, develop and market competing product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on the protection of our trade secrets and know-how. Although we have taken steps to protect our trade secrets and know-how, including entering into confidentiality agreements with third parties, and confidential information and inventions agreements with employees, consultants and advisors, we cannot provide any assurances that all such agreements have been duly executed, and third parties may still obtain this information or may come upon this or similar information independently. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade secrets do not provide any protection against the independent development of the trade secret by a competitor or other third-party. If a competitor independently obtains or develops our trade secret, either by reverse engineering our product or other legal means, we would be unable to prevent them from using the trade secret, and our competitive position would be harmed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating our trade secrets. If any of these events occurs or if we otherwise lose protection for our trade secrets or proprietary know-how, the value of this information may be greatly reduced.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on third parties requires us to share our trade secrets and other confidential information, which increases the possibility that a competitor will discover them or that our confidential information, including trade secrets, will be misappropriated or disclosed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we rely on third parties to conduct research and to develop and manufacture our product candidates, we must, at times, share confidential information, including trade secrets, with them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements containing confidentiality provisions with our advisors, employees, third-party contractors and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that they become known by our competitors, are purposefully or inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Public disclosure of our confidential information also prevents us from seeking patent protection for that or related discoveries. Given that our proprietary position is based, in part, on our know-how and trade secrets, the unauthorized use or disclosure of our trade secrets would impair our competitive position and may have a material adverse effect on our business, financial conditions, results of operations and prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our confidential information and trade secrets, although our agreements may contain certain limited publication rights. For example, academic institutions that we collaborate with often require rights to publish data arising out of such collaboration, provided that we are notified in advance and given the opportunity to delay publication for a limited time period in order for us to secure patent protection of intellectual property rights arising from the collaboration, in addition to the opportunity to remove confidential information or trade secrets from any such publication. However, we may fail to recognize or identify to our collaborator such confidential information or trade secrets during the appropriate timeframe prior to publication, and they may be publicly disclosed without us filing for patent or other protection. In the future we may also conduct joint research and development programs that may require us to share trade secrets under the terms of our research and development or similar agreements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to protect our trade secrets, our competitors may discover our trade secrets, including through breach of our agreements with third parties, failure of our security measures or publication of information by any of our third-party collaborators, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our consultants, contractors or collaborators use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. A competitor&#8217;s discovery of our trade secrets could impair our competitive position and have an adverse impact on our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Claims by third parties that we infringe their proprietary rights may result in liability for damages or prevent or delay our developmental and commercialization efforts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology industry has been characterized by frequent litigation regarding patent and other intellectual property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing product candidates. As the biotechnology industry expands, especially in the field of gene therapy, and more patents are issued, the risk increases that our product candidates may be subject to claims of infringement of the patent rights of third parties. Because patent applications are maintained in secrecy until the application is published, we may be unaware of third-party patents that may be infringed by commercialization of our product candidates. Moreover, because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents that our product candidates may infringe. In addition, identification of third-party patent rights that may be relevant to our technology is difficult because patent searching is imperfect due to differences in terminology among patents, incomplete databases and the difficulty in assessing the meaning of patent claims. Any claims of patent infringement asserted by third parties would be time consuming to defend against and could:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">result in costly litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">divert the time and attention of our technical personnel and management;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cause development delays;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prevent us from commercializing our product candidates until the asserted patent expires or is held finally invalid or not infringed in a court of law;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to develop non-infringing technology, which may not be possible on a cost-effective basis; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to enter into royalty or licensing agreements, which may not be available on commercially reasonable terms, or at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Others may hold proprietary rights that could prevent our product candidates from being marketed. Any patent-related legal action against us claiming damages and seeking to enjoin commercial activities relating to our product candidate or processes could subject us to potential liability for damages and require us to obtain a license to continue to manufacture or market our product candidates. We cannot predict whether we would prevail in any such actions or that any license required under any of these patents would be made available on commercially acceptable terms, if at all. In addition, we cannot be sure that we could redesign our product candidate or processes to avoid infringement, if necessary. Accordingly, an adverse determination in a judicial or administrative proceeding, or the failure to obtain necessary licenses, could prevent us from developing and commercializing our product candidates, which could harm our business, financial condition, results of operations and prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining or maintaining necessary rights to our product candidates through acquisitions and in-licenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have rights to intellectual property, through licenses from third parties and under patents that we own, to develop our product candidates. Because our programs may require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license, or use these proprietary rights. For example, our product candidates may require specific formulations to work effectively and efficiently and the rights to these formulations may be held by others. We may be unable to acquire or in-license any compositions, methods of use, processes, or other intellectual property rights from third parties that we identify as necessary for our product candidates. The licensing and acquisition of third-party intellectual property rights is a competitive area, and a number of more established companies are also pursuing strategies to license or acquire third-party intellectual property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, cash resources, and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sometimes collaborate with U.S. and foreign academic institutions to accelerate our research or development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to other parties, potentially blocking our ability to pursue our program.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of that program and our business, financial condition, results of operations and prospects could be materially and adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our rights to develop and commercialize our product candidates are subject in part to the terms and conditions of licenses granted to us by other companies and universities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently are heavily reliant upon licenses of certain patent rights and proprietary technology from third parties that are important or necessary to the development of our technology and products, including technology related to our manufacturing process and our gene therapy product candidates. These and other licenses may not provide adequate rights to use such intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and products in the future, or may contain other limitations on our ability to use such intellectual property or technology. As a result, our ability to develop or commercialize our processes and product candidates may be limited by the terms of such agreements. Further, the third parties from whom we license certain patent rights and proprietary technology have in the past attempted and may in the future attempt to terminate their agreements with us. We may be unable to obtain a new license to that technology on commercially reasonable terms.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we need to develop or acquire alternative manufacturing technology, our product development activities may be significantly delayed, and if we were unable to develop or acquire alternative manufacturing technology, it could have a material adverse effect on our business. In addition, we may not be able to prevent competitors from developing and commercializing competitive products to the extent our licenses to patents are non-exclusive or limited with respect to fields of use or territories.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that licenses to additional third-party technology will be required to advance our current development programs, as well as additional development programs we may initiate in the future. If these licenses are not available on commercially reasonable terms or at all, we may not be able to commercialize our current and future development programs, which will have a material adverse effect on our business and financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The patent protection and patent prosecution for some of our product candidates are dependent on third parties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we normally seek to obtain the right to control the prosecution and maintenance of the patents relating to our product candidates, there may be times when the filing and prosecution activities for platform technology patents that relate to our product candidates are controlled by our licensors. For example, we do not have the right to prosecute and maintain the patent rights licensed to us under agreements with Regents of the University of California and Virovek, and our ability to have input into such filing and prosecution activities is limited. If these licensors or any of our future licensors fail to appropriately prosecute and maintain patent protection for patents covering any of our product candidates, our ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors from making, using and selling competing products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be subject to claims that former employees, collaborators or other third parties have an ownership interest in our patents or other intellectual property. We require all employees to sign proprietary information and invention assignment agreements, but they may fail to do so, or our agreements may be found invalid or unenforceable. We may be subject to ownership disputes in the future arising, for example, from conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third-party patent rights could delay or otherwise adversely affect our planned development and sale of product candidates of our programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are aware of patent rights held by third parties that could be construed to cover certain aspects of our product candidates. In addition, changes to our product candidates or their uses or manufacture may cause them to infringe patents held by third parties. A patent holder has the right to prevent others from making, using, importing or selling a drug that incorporates the patented compositions while the patent remains in force. While we believe that third-party patent rights will not affect our planned development, regulatory clearance, and eventual marketing, commercial production, and sale of our product candidates, there can be no assurance that this will be the case. In addition, the Drug Price Competition and Patent Term Restoration Act of 1984 (&#8220;Hatch-Waxman Act&#8221;) exemption provided by U.S. patent law permits uses of compounds and biologics in clinical trials and for other purposes reasonably related to obtaining FDA approval of drugs and biologics that will be sold only after patent expiration, so our use of our product candidates in those FDA-related activities does not infringe any patent holder&#8217;s rights. However, were a patent holder to assert its rights against us before expiration of such patent holder&#8217;s patent for activities unrelated to seeking FDA approval, the development and ultimate sale of our product candidates could be significantly delayed, and we could incur the expense of defending a patent infringement suit and potential liability for damages for periods prior to the patent&#8217;s expiration.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain intellectual property rights or protect our intellectual property rights throughout the world.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting, obtaining and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Further, following Russia&#8217;s invasion of Ukraine in February 2022, the U.S. government has levied sanctions against Russia and Belarus, Russia has issued a decree that removes protections for some patent holders who are registered in unfriendly countries, including the U.S., and the USPTO has terminated its engagement with officials from intellectual property agencies in Russia, Belarus and Eurasia, so we are not currently maintaining certain intellectual property filings in these jurisdictions. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing as patents and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded to us, if any, may not be commercially meaningful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the complexity and uncertainty of European patent laws have also increased in recent years. In Europe, a new unitary patent system was introduced in 2023. Under the unitary patent system, European applications will have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the Unitary Patent Court (UPC). As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty of any litigation. Patents granted before the implementation of the UPC will have the option of opting out of the jurisdiction of the UPC and remaining as national patents in the UPC countries. Patents that remain under the jurisdiction of the UPC will be potentially vulnerable to a single UPC-based revocation challenge that, if successful, could invalidate the patent in all countries who are signatories to the UPC. We cannot predict with certainty the long-term effects of any potential changes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve a high degree of technological and legal complexity. Therefore, obtaining and enforcing biopharmaceutical patents is costly, time consuming and inherently uncertain. In addition, Congress may pass patent reform legislation that is unfavorable to us. The Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents we might obtain in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not obtain patent term extensions for patents covering our product candidates, our business may be materially harmed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent terms may not be able to protect our competitive position for an adequate period of time with respect to our current or future technologies or product candidates. Patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. As a result, our owned and in-licensed patent portfolio provides us with limited rights that may not last for a sufficient period of time to exclude others from commercializing product candidates similar or identical to ours. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. For example, given the large amount of time required for the research, development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Extensions of patent term may be available, but there is no guarantee that we would have patents eligible for extension, or that we would succeed in obtaining any particular extension&#8212;and no guarantee any such extension would confer a patent term for a sufficient period of time to exclude others from commercializing product candidates similar or identical to ours. If we are able to secure FDA marketing approval for one of our product candidates that is covered by an issued U.S. patent, that patent may be eligible for limited patent term restoration under the Hatch-Waxman Act. Depending upon the timing, duration and specifics of FDA marketing approval of product candidates, the Hatch-Waxman Act permits a patent restoration term of up to five years beyond the normal expiration of the patent, which is limited to the approved product or approved indication. In the U.S., patent term extension cannot extend the remaining term of a patent beyond 14 years from the date of product approval; only one patent may be extended; and extension is available for only those claims covering the approved drug, a method for using it, or a method for manufacturing it. Similar extensions of patent term are available in Europe and other jurisdictions. However, we may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or restoration or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial conditions and results of operations may be materially and adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interpretation by the regulatory authorities in the EU of applicable EU regulations governing data and market exclusivity may impact our entitlement to data and market exclusivity. The revisions to the orphan drug legislation in the EU and the EU rules governing Supplementary Protection Certificates that are currently being discussed may also impact our entitlement to this exclusivity. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time consuming, and unsuccessful. Further, our issued patents could be found invalid or unenforceable if challenged administratively or in court.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or any of our future development partners were to initiate or threaten legal proceedings against a third-party to enforce a patent directed at one of our product candidates, or one of our future product candidates, the accused infringer could claim that our patent is invalid and/or unenforceable in whole or in part. In patent litigation in the U.S., defendant counterclaims alleging invalidity and/or unenforceability are commonplace, as are claims seeking declaratory judgment of invalidity. Grounds for a validity challenge include an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grounds for an unenforceability assertion could include an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a false or misleading statement during prosecution. Third parties may also raise similar claims before the USPTO, even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on such product candidate. Such a loss of patent protection would have a material adverse impact on our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interference proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our defense of litigation or patent office proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our research and development programs, license necessary technology from third parties, or enter into development or manufacturing partnerships that would help us bring our product candidates to market.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if resolved in our favor, litigation or other legal or patent office proceedings relating to our intellectual property rights may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some intellectual property that we have in-licensed or may in-license may have been discovered through government funded programs and thus may be subject to federal regulations such as &#8220;march-in&#8221; rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights and limit our ability to contract with non-U.S. manufacturers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property rights we have licensed, including certain rights related to our proprietary AAV.7m8 capsid, were generated through the use of U.S. government funding and are therefore subject to certain federal regulations. As a result, the U.S. government may have certain rights to intellectual property embodied in our current or future product candidates pursuant to the Bayh-Dole Act of 1980 (&#8220;Bayh-Dole Act&#8221;) and implementing regulations. These U.S. government rights in certain inventions developed under a government-funded program include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right to require us or our licensors to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third-party if it determines that: (i) adequate steps have not been taken to commercialize the invention; (ii) government action is necessary to meet public health or safety needs; or (iii) government action is necessary to meet requirements for public use under federal regulations (also referred to as &#8220;march-in rights&#8221;). The U.S. government also has the right to take title to these inventions if we, or the applicable licensor, fail to disclose the invention to the government and fail to file an application to register the intellectual property within specified time limits. These time limits have recently been changed by regulation, and may change in the future. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us or the applicable licensor to expend substantial resources. In addition, the U.S. government requires that any products embodying the subject invention or produced through the use of the subject invention be manufactured substantially in the U.S. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the U.S. or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. manufacturers may limit our ability, or that of our sublicensees, to contract with non-U.S. product manufacturers for products covered by such intellectual property. To the extent any of our current or future intellectual property is generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail to comply with any of our obligations under existing agreements pursuant to which we license or have otherwise acquired intellectual property rights or technology, which could result in the loss of rights or technology that are material to our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Licensing of intellectual property is of critical importance to our business and involves complex legal, business, and scientific issues. Disputes may arise regarding our rights to intellectual property licensed to us from a third-party, including but not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sublicensing of patent and other rights;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our diligence obligations under the license agreement, what activities satisfy those diligence obligations, and to what extent those obligations are relieved or delayed by external factors beyond our control;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ownership of inventions and know-how resulting from the creation or use of intellectual property by us, alone or with our licensors and collaborators;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and duration of our payment obligations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our rights upon termination of such agreement; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and duration of exclusivity obligations of each party to the agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If disputes over intellectual property and other rights that we have licensed or acquired from third parties prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats to our competitive advantage.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may be able to make gene therapies that are similar to our product candidates but that are not covered by the claims of any patents that we own or have exclusively licensed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our licensors or future collaborators might not have been the first to make the inventions covered by the issued patent or pending patent application that we own or have exclusively licensed;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or our licensors or future collaborators might not have been the first to file patent applications covering certain of our inventions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any patent applications that we have filed or may file in the future may not lead to issued patents;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of the issued patents that we own or have exclusively licensed may be held invalid or unenforceable, as a result of legal challenges by our competitors;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of the issued patents that we have filed or may file in the future may expire before or shortly after commercialization of the covered product;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitors might conduct research and development activities in countries where, or for products for which, we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may have an adverse effect on our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that we have wrongfully hired an employee from a competitor or that we or our employees have wrongfully used or disclosed alleged confidential information or trade secrets of their former employers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is common in the biotechnology and pharmaceutical industry, in addition to our employees, we engage the services of consultants to assist us in the development of our product candidates. Many of our employees and consultants were previously employed at, or may have previously provided or may be currently providing consulting services to, other biotechnology or pharmaceutical companies including our competitors or potential competitors. We may become subject to claims that our company, our employees or a consultant inadvertently or otherwise used or disclosed trade secrets or other information proprietary to their former employers or their former or current clients. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to our management team.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could materially and adversely impact our business, financial condition, results of operations, or prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Commercialization of Our Product Candidates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any suspension of, or delays in the commencement or completion of, clinical trials for our product candidates could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have one product candidate in clinical trials. Before we can initiate clinical trials for other product candidates in the U.S., we need to submit the results of nonclinical testing to the FDA, along with other information about the product candidate&#8217;s chemistry, manufacturing, and controls and our proposed clinical trial protocol, as part of an IND. Similar requirements may apply to conduct clinical trials outside the U.S. We may rely in part on nonclinical, clinical and quality data generated by CROs and other third parties for regulatory submissions for our product candidates. If these third parties do not provide timely data for our product candidates, it will delay our plans for our IND submissions or comparable foreign applications and clinical trials. If those third parties do not make this data available to us, we will likely have to develop all necessary nonclinical and clinical data on our own, which will lead to significant delays and increase development costs of the product candidate. In addition, the FDA or other regulatory authorities outside the U.S. may require us to conduct additional nonclinical testing for any of our product candidates before they allow us to initiate clinical trials under any IND or equivalent, or at any stage of clinical development of Ixo-vec or other new product candidates based on concerns that arise as the clinical program progresses or if significant manufacturing process changes are made to the program, which may lead to additional delays and increase the costs of our nonclinical development. Delays with any regulatory authority or agency may significantly affect our product development timeline. Delays in the commencement or completion of any clinical trials that we plan for our product candidates could significantly affect our product development costs. We do not know whether any clinical trials that we plan will begin on time or be completed on schedule, if at all. The commencement and completion of clinical trials can be delayed or terminated for a number of reasons, including delays or terminations related to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or other regulatory authorities outside the U.S. failing to grant permission to proceed or placing the clinical trial on hold;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients failing to enroll or remain in our trial at the rate we expect;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients choosing an alternative treatment for the indication for which we are developing our product candidates, or participating in competing clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of adequate funding to continue the clinical trial;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients experiencing severe or unexpected drug-related adverse effects;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a facility manufacturing any of our product candidates or any of their components being ordered by the FDA or other government or regulatory authorities outside the U.S., to temporarily or permanently shut down due to violations of GMP or other applicable requirements, or infections or cross-contaminations of product candidates in the manufacturing process, or in the manufacturing facilities in which our product candidates are made;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of non-investigational materials or supplies required for the clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of appropriate prophylaxis in geographies where we intend to conduct our Phase 3 clinical trials and to commercialize Ixo-vec, if approved;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any changes to our manufacturing process that may be necessary or desired;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of non-investigational materials or supplies required for manufacturing; </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party clinical investigators losing the licenses, permits or resources necessary to perform our clinical trials, lacking the ability or resources to appropriately handle our product candidates, not performing our clinical trials on our anticipated schedule or consistent with the clinical trial protocol, Good Clinical Practice or regulatory requirements, or other third parties not performing data collection, sample testing or analysis in a timely and accurate manner;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inspections of clinical trial sites by the FDA or other regulatory authorities outside the U.S., or the finding of regulatory violations by the FDA or other regulatory authorities outside the U.S., or an IRB or Ethics Committee that requires us to undertake corrective action resulting in suspension or termination of one or more clinical sites or the imposition of a clinical hold on the IND or foreign equivalent or that prohibits us from using some or all of the data in support of our marketing applications;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party contractors becoming debarred or suspended or otherwise penalized by the FDA or other government or regulatory authorities outside the U.S. for violations of regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or all of the data produced by such contractors in support of our marketing applications; or</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">one or more IRBs or Ethics Committees refusing to approve, suspending or terminating the trial at a clinical site, precluding enrollment of additional patients, or withdrawing its approval of the trial.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product development costs will increase if we have delays in testing or approval of any of our product candidates, or if we need to perform more or larger clinical trials than planned. Additionally, changes in regulatory requirements and policies may occur, and we may need to amend clinical trial protocols to reflect these changes. Amendments may require us to resubmit our clinical trial protocols to competent authorities, IRBs or Ethics Committees for review and approval, which may impact the costs, timing or successful completion of a clinical trial. If we experience delays in the completion of our clinical trials, or if we, the FDA or other regulatory authorities outside the U.S., the IRB or Ethics Committee, other reviewing entities, or any of our clinical trial sites, suspend or terminate any of our clinical trials, the commercial prospects for our product candidate may be harmed and our ability to generate product revenue may be delayed. In addition, many of the factors that cause, or lead to, the termination or suspension of, or a delay in the commencement or completion of, clinical trials, may also ultimately lead to the denial of regulatory approval of a product candidate. If we make manufacturing or formulation changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions. Further, if one or more clinical trials are delayed or terminated, our competitors may be able to bring products to market before we do, and the commercial viability of our product candidates could be significantly reduced.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have amended our clinical trial protocols and from time to time may further amend our clinical trial protocols based on a variety of factors, and these changes may have unanticipated consequences on our clinical trial outcomes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Final marketing approval for our product candidates by the FDA or other regulatory authorities outside the U.S. for commercial use may be delayed, limited or denied, any of which would adversely affect our ability to generate operating revenue.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to successfully complete our clinical trials and submit a BLA, and/or an MAA, we cannot predict whether or when we will obtain regulatory approval to commercialize our product candidates, and we cannot, therefore, predict the timing of any future revenue. We cannot commercialize our product candidates until the appropriate regulatory authorities have reviewed and approved the applicable applications. We cannot assure you that the regulatory authorities will complete their review processes in a timely manner or that we will obtain regulatory approval for our product candidates. For example, difluprednate eye drops are not approved or commercially available in certain geographies where we intend or may choose to seek regulatory approval for Ixo-vec, and we cannot assure you that the appropriate prophylaxis will be available in such jurisdictions to enable us to obtain regulatory approval to commercialize Ixo-vec. In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative action or changes in policies from the FDA or other regulatory authorities outside the U.S. during the period of product development, clinical trials and FDA&#8217;s or comparable foreign regulatory authorities&#8217; regulatory review. If marketing approval for any product candidate is delayed, limited or denied, our ability to market the product candidate and our ability to generate product sales, would be adversely affected. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA or other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government shut down several times and certain regulatory agencies, such as the FDA, furloughed critical employees and ceased critical activities. More recently, such agencies, including the FDA, have conducted layoffs and may, from time to time, conduct additional layoffs. If a prolonged government shutdown or significant layoffs occur, it could significantly impact the ability of the FDA and applicable foreign authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we receive regulatory approval, we still may not be able to successfully commercialize any of our product candidates, and the revenue that we generate from product sales, if any, could be limited.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if one or more of our product candidates receive regulatory approval, they may not gain market acceptance among physicians, patients, healthcare payers or the medical community. Coverage and reimbursement of our product candidates by third-party payers, including government payers, is also generally necessary for commercial success. The degree of market acceptance of our product candidates will depend on a number of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstration of clinical efficacy, including duration of efficacy, and safety compared to competitive products, some of which are more established than our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability and market acceptance of an appropriate prophylaxis regimen in geographies where we intend to commercialize Ixo-vec, if approved;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the limitation of our targeted patient population and other limitations or warnings contained in any labeling approved for our product candidates by the FDA or other applicable regulatory authorities outside the U.S., including the possible inclusion of a &#8220;black box warning&#8221; from the FDA or other applicable regulatory authorities outside the U.S., alerting healthcare providers to potential serious side effects associated with using a product or the imposition of a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) or comparable foreign strategies;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of new therapeutic options by healthcare providers and their patients;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence and severity of any adverse effects;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new procedures or methods of treatment that may be more effective in treating or may reduce the incidence of wet AMD, or other conditions that our product candidates are intended to treat;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing and cost-effectiveness;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of our or any future collaborators&#8217; sales and marketing strategies;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain sufficient third-party coverage and reimbursement from government health care programs, including Medicare and Medicaid or foreign equivalents, private health insurers and other third-party payers; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of patients to pay out-of-pocket in the absence of third-party coverage and reimbursement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any product candidate is approved but does not achieve an adequate level of acceptance by physicians, hospitals, healthcare payers or patients, we may not generate sufficient revenue from that product candidate and may not become or remain profitable. Our efforts to educate the medical community and third-party payers on the benefits of such a product candidate may require significant resources and may never be successful. In addition, our ability to successfully commercialize any of our product candidates will depend on our ability to manufacture our products, differentiate our products from competing products, and defend and enforce our intellectual property rights relating to our products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our competitors develop treatments for the target indications of our product candidates that are approved, marketed more successfully, or demonstrated to be safer or more effective or easier to administer than our product candidates, our commercial opportunity will be reduced or eliminated.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in highly competitive segments of the biopharmaceutical markets. We face competition from many different sources, including larger and better-funded pharmaceutical, specialty pharmaceutical, biotechnology, and gene therapy companies, as well as from academic institutions, government agencies and private and public research institutions. Our product candidates, if successfully developed and approved, will compete with established therapies as well as with new treatments that may be introduced by our competitors. There are a variety of drug candidates and gene therapies in development or being commercialized by our competitors for the indications that we intend to test. Many of our competitors have significantly greater financial, product candidate development, manufacturing, and marketing resources than we do. Large pharmaceutical and biotechnology companies have extensive experience in clinical testing and obtaining regulatory approval for drugs. In addition, universities and private and public research institutes may be active in our target disease areas, and some could be in direct competition with us. We also may compete with these organizations to recruit management, scientists, and clinical development personnel. We will also face competition from these third parties in establishing clinical trial sites, registering patients for clinical trials, and in identifying and in-licensing new product candidates. For example, 4D Molecular Therapeutics is developing 4D-150, an AAV-based gene therapy delivering two transgenes and encoding a therapeutic antibody fragment similar to aflibercept (Eylea) for the treatment of wet AMD and diabetic macular edema, which competes for the same patients, study site resources and personnel as Ixo-vec. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New developments, including the development of other biotechnology and gene therapy technologies and methods of treating disease, occur in the pharmaceutical, biotechnology and gene therapy industries at a rapid pace. Developments by competitors may render our product candidates obsolete or noncompetitive. Competition in drug development is intense. In addition, we believe that duration of efficacy is an important consideration by physicians and patients when choosing a therapy. However, we do not know and may not know prior to any potential approval the duration of efficacy of our product candidates. We anticipate that we will face intense and increasing competition as new treatments enter the market and advanced technologies become available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain regulatory approval for our product candidates, the availability and price of our competitors&#8217; products could limit the demand, and the price we are able to charge for our product candidates. For example, LUCENTIS (and biosimilars thereto), EYLEA (and any biosimilars thereto) and VABYSMO (and any biosimilars thereto) are currently available or will become available in the U.S. and the EU for treatment of wet AMD. We may not achieve our business plan if the acceptance of our product candidates is inhibited by price competition or the reluctance of physicians to switch from existing methods of treatment to our product candidates, or if physicians switch to other new drug products or choose to reserve our product candidates for use in limited circumstances. Our inability to compete with existing or subsequently introduced drug products or other therapies would have a material adverse impact on our business, prospects, financial condition and results of operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential competitors in these diseases may be developing novel therapies that may be safer or more effective or easier to administer than our product candidates. For example, if we continue clinical development of, and seek to commercialize, Ixo-vec for the treatment of wet AMD, it will compete with a variety of therapies currently marketed and in development for wet AMD, using therapeutic modalities such as biologics, small molecules, long-acting delivery devices and gene therapy.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, most patients receive off-label bevacizumab, including as a first-line treatment. Many patients go on to receive Eylea, Eylea HD or Vabysmo&#174; (faricimab-svoa). We know of a number of additional product candidates in development or approved for chronic retinal conditions that respond to anti-VEGF therapy, including wet AMD:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biosimilar anti-VEGFs;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bispecific / combination / add-on therapy for efficacy or durability improvement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">long-acting delivery device and tyrosine kinase inhibitor implants to lower treatment frequency; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">gene therapy to lower treatment frequency and offer the potential for lifelong injection freedom; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other molecules that inhibit neovascularization in wet AMD.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are several other companies in the U.S. or Europe with marketed products or products in development for the treatment of chronic retinal conditions that respond to anti-VEGF therapy, including wet AMD. These companies include 4D Molecular Therapeutics, AbbVie, Bayer, Clearside Biomedical, EyePoint Pharmaceuticals, Kodiak Sciences, Novartis, Ocular Therapeutix, Opthea, Outlook Therapeutics, Regeneron, REGENXBIO and Roche. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain marketing approval for any of our product candidates, they could be subject to restrictions or withdrawal from the market, and we may be subject to penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our product candidates, when and if any of them are approved.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval is obtained, the FDA or comparable foreign regulatory authorities may still impose significant restrictions on a product&#8217;s indicated uses, marketing or distribution or impose ongoing requirements for potentially costly and time-consuming post-approval studies, post-market surveillance or clinical trials. Following approval, if at all, of any of our product candidates, such candidate will also be subject to ongoing FDA and comparable foreign requirements governing the labeling, packaging, storage, distribution, safety surveillance, advertising, promotion, recordkeeping and reporting of safety and other post-market information. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic inspections by the FDA and other regulatory authorities outside the U.S. for compliance with GMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents. If we or a regulatory authority discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, a regulatory authority may impose restrictions on that product, the manufacturing facility or us, including requesting recall or withdrawal of the product from the market or suspension of manufacturing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or the manufacturing facilities for any product candidate that may receive regulatory approval fail to comply with applicable regulatory requirements, a regulatory authority may:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue warning letters or untitled letters;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek an injunction or impose civil or criminal penalties or monetary fines;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend, vary or withdraw regulatory approval;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend any ongoing clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to approve pending applications or supplements or applications filed by us;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">institute import holds;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or impose restrictions on operations, including costly new manufacturing requirements; or</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seize or detain products, refuse to permit the import or export of product or request us to initiate a product recall.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and generate revenue. The FDA has the authority to require a REMS plan as part of a BLA or after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria and requiring treated patients to enroll in a registry. Similar restrictions may be imposed by foreign regulatory authorities outside the U.S.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if any of our product candidates is approved, our product labeling, advertising and promotion would be subject to regulatory requirements and ongoing regulatory review. The FDA and other regulatory authorities outside the U.S. strictly regulate the promotional claims that may be made about prescription products. In particular, a product may not be promoted for uses that are not approved by the competent regulatory authority as reflected in the product&#8217;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. The FDA and regulatory and enforcement authorities outside the U.S. actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant sanctions. The U.S. federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees or be subject to permanent injunctions under which specified promotional conduct is changed or curtailed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coverage and reimbursement may be limited or unavailable in certain market segments for our product candidates, which could make it difficult for us to sell our product candidates profitably. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market acceptance and sales of our product candidates will depend significantly on the availability of adequate coverage and reimbursement from third-party payers for any of our product candidates and may be affected by existing and future health care reform measures. Government authorities and third-party payers, such as private health insurers and health maintenance organizations, decide which drugs they will pay for and establish reimbursement levels.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement by a third-party payer may depend upon a number of factors including the third-party payer&#8217;s determination that use of a product candidate is:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a covered benefit under its health plan;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safe, effective and medically necessary;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriate for the specific patient; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost-effective.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining coverage and reimbursement approval for a product candidate from a government or other third-party payer is a time-consuming and costly process that could require us to provide supporting scientific, clinical and cost effectiveness data for the use of the applicable product candidate to the payer. We may not be able to provide data sufficient to gain acceptance with respect to coverage and reimbursement. While there is no uniform coverage and reimbursement policy among payers in the U.S., private payers often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates. We cannot be sure that coverage or adequate reimbursement will be available for any of our product candidates. Further, reimbursement amounts may reduce the demand for, or the price of, our product candidates. If reimbursement is not available or is available only in limited levels, we may not be able to commercialize certain of our product candidates profitably, or at all, even if approved.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of cell and gene therapy products recently have been approved by the FDA. Although the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) approved its first method of coverage and reimbursement for gene therapy products, the methodology has been subject to challenge by members of Congress. CMS&#8217;s decision as to coverage and reimbursement for one product does not mean that all similar products will be eligible for analogous coverage and reimbursement. As there is no uniform policy for coverage and reimbursement amongst third-party payers in the U.S., even if CMS approves coverage and reimbursement for any of our product candidates, it is unclear what affect, if any, such a decision will have on our ability to obtain and maintain coverage and adequate reimbursement from other private payers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payers are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. In order to obtain coverage and reimbursement for any product that might be approved for sale, we may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain regulatory approvals. Our product candidates may not be considered medically necessary or cost-effective. If third-party payers do not consider a product to be cost-effective compared to other available therapies, they may not cover the product after approval as a benefit under their plans. or, if they do, the level of payment may not be sufficient to allow us to sell our products at a profit. Further, coverage policies and third-party payer reimbursement rates may change at any time. Therefore, even if favorable coverage and reimbursement status is attained for one or more products for which we receive marketing approval, less favorable coverage policies and reimbursement rates may be implemented in the future. The U.S. government, state legislatures, and foreign governments have shown significant interest in implementing cost containment programs to limit the growth of government-paid health care costs, including price controls, restrictions on reimbursement, and requirements for substitution of generic products for branded prescription drugs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the &#8220;Affordable Care Act&#8221;), was enacted with a goal of reducing the cost of healthcare and substantially changing the way healthcare is financed by both government and private insurers. The Affordable Care Act, among other things, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program, extended the rebate program to individuals enrolled in Medicaid managed care organizations and established annual fees and taxes on manufacturers of certain prescription drugs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions of the Affordable Care Act have been subject to amendments and executive, Congressional, and judicial challenges as well as efforts to repeal, replace, or otherwise modify them or alter their interpretation and implementation. For example, on August 16, 2022, the Inflation Reduction Act of 2022 (the &#8220;Inflation Reduction Act&#8221;) was signed into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The Inflation Reduction Act also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program. Additional legislative changes, regulatory changes, and judicial challenges related to the Affordable Care Act remain possible. Any such changes could affect the number of individuals with health coverage. It is possible that the Affordable Care Act, as currently enacted or as it may be amended in the future, and other healthcare reform measures that may be adopted in the future could have a material adverse effect on our industry generally and on our ability to successfully commercialize our product candidates, if approved.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific products and therapies. The EU provides options for EU Member States to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. An EU Member State may approve a specific price for the medicinal product, it may refuse to reimburse a product at the price set by the manufacturer or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. Many EU Member States also periodically review their reimbursement procedures for medicinal products, which could have an adverse impact on reimbursement status. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, in order to obtain reimbursement for our products in some European countries, including some EU Member States, we may be required to compile additional data comparing the cost-effectiveness of our products to other available therapies. This Health Technology Assessment (&#8220;HTA&#8221;) of medicinal products is becoming an increasingly common part of the pricing and reimbursement procedures in some EU Member States, including those representing the larger markets. The HTA process is the procedure to assess therapeutic, economic and societal impact of a given medicinal product in the national healthcare systems of the individual country. The outcome of an HTA will often influence the pricing and reimbursement status granted to these medicinal products by the competent authorities of individual EU Member States. The extent to which pricing and reimbursement decisions are influenced by the HTA of the specific medicinal product currently varies between EU Member States.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislators, policymakers and healthcare insurance funds in the EU and the United Kingdom may continue to propose and implement cost-containing measures to keep healthcare costs down. These measures could include limitations on the prices we would be able to charge for product candidates that we may successfully develop and for which we may obtain regulatory approval or the level of reimbursement available for these products from governmental authorities or third-party payers. Further, an increasing number of EU and other foreign countries use prices for medicinal products established in other countries as &#8220;reference prices&#8221; to help determine the price of the product in their own territory. Consequently, a downward trend in prices of medicinal products in some countries could contribute to similar downward trends elsewhere.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare and other reform legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates and, if approved, may affect the prices we may obtain.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative changes have also been proposed and adopted in the U.S. since the Affordable Care Act was enacted. For example, on August 2, 2011, the Budget Control Act of 2011 created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This included aggregate reductions of Medicare payments to providers of, on average, 2% per fiscal year, which went into effect on April 1, 2013 and due to subsequent legislative changes to the statute, will stay in effect until 2032 unless additional congressional action is taken. Further, there may be additional health reform measures, particularly in light of recent U.S. presidential and congressional elections.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These cost reduction initiatives could decrease the coverage and reimbursement that we receive for any approved products and could seriously harm our business. For example, the Inflation Reduction Act, among other things, (1) directs the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) to negotiate the price of certain single-source biologics that have been on the market for at least 11 years covered under Medicare (the &#8220;Medicare Drug Price Negotiation Program&#8221;) and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions began to take effect beginning fiscal year 2023. On August 15, 2024, HHS announced the agreed-upon reimbursement price of the first ten drugs that were subject to price negotiations, although the Medicare Drug Price Negotiation Program is currently subject to legal challenges. On January 17, 2025, HHS selected fifteen additional products covered under Part D for price negotiation in 2025. Each year thereafter more products covered under Part B and Part D will become subject to the Medicare Drug Price Negotiation Program. The Inflation Reduction Act permits HHS to implement many of these provisions through guidance, as opposed to regulation, for the initial years. HHS has and will continue to issue and update guidance as these programs are implemented. Further, on December 7, 2023, an initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act was announced. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that additional healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal, state and foreign governments will pay for healthcare products and services, which could result in reduced demand for our product candidates, if approved, or additional pricing pressures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuing efforts of the government, insurance companies, managed care organizations and other payers of healthcare services to contain or reduce costs of health care may adversely affect:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the demand for any product candidates for which we may obtain regulatory approval;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to set a price that we believe is fair for our product candidates;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to generate revenue and achieve or maintain profitability;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of taxes that we are required to pay; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of capital.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2021, Regulation No 2021/2282 on HTA amending Directive 2011/24/EU, was adopted in the EU. This Regulation, which entered into force in January 2022 and began to apply on January 12, 2025, through a phased implementation, is intended to boost cooperation among EU Member States in assessing health technologies, including new medicinal products, and providing the basis for cooperation at EU level for joint clinical assessments in these areas. The Regulation foresees a three-year transitional period and permits EU Member States to use common HTA tools, methodologies, and procedures across the EU, working together in four main areas, including joint clinical assessment of the innovative health technologies with the most potential impact for patients, joint scientific consultations whereby developers can seek advice from HTA authorities, identification of emerging health technologies to identify promising technologies early, and continuing voluntary cooperation in other areas. Individual EU Member States will continue to be responsible for assessing non-clinical (e.g., economic, social, ethical) aspects of health technologies, and making decisions on pricing and reimbursement. If we are unable to maintain favorable pricing and reimbursement status in EU Member States for product candidates that we may successfully develop and for which we may obtain regulatory approval, any anticipated revenue from and growth prospects for those products in the EU could be negatively affected. In light of the fact that the United Kingdom has left the EU, Regulation No 2021/2282 on HTA will not apply in the United Kingdom. However, the UK MHRA is working with UK HTA bodies and other national organizations, such as the Scottish Medicines Consortium (&#8220;SMC&#8221;), the National Institute for Health and Care Excellence (&#8220;NICE&#8221;), and the All-Wales Medicines Strategy Group, to introduce new pathways supporting innovative approaches to the safe, timely and efficient development of medicinal products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market for Ixo-vec, if approved, in the treatment of wet AMD or any other indication we seek to treat is smaller than we believe it is, or if our product candidate is approved with limitations that reduce the market size, or if this occurs for any of our other product candidates, our future revenue may be adversely affected, and our business may suffer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are advancing the development of Ixo-vec for the treatment of wet AMD, which is a leading cause of blindness in patients over 65 years of age. If the size of the market for wet AMD or any other indication we seek to treat is smaller than we anticipate, we may not be able to achieve profitability and growth. Our projections of the number of people who have wet AMD and other indications, as well as the subset of people with the disease who have the potential to benefit from treatment with Ixo-vec or other future product candidates, are based on estimates. These estimates have been derived from a variety of sources, including the scientific literature, surveys of clinics, patient foundations and market research and may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these diseases. The number of patients may turn out to be lower than expected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effort to identify patients with diseases we seek to treat is in its early stages. We cannot accurately predict the number of patients for whom treatment for wet AMD using Ixo-vec or any of our other product candidates might be possible or whether the FDA or other regulatory authorities outside the U.S. may approve indications for Ixo-vec or any of our other product candidates that are more limited than we expect due to efficacy or safety concerns. For example, some patients have neutralizing antibodies at titer levels that may prevent them from benefiting from Ixo-vec. If this patient population is larger than we estimate, the market for Ixo-vec may be smaller than we anticipate, and our future revenue may be adversely affected. In addition, we expect prophylactic corticosteroid treatment will be required to manage inflammation associated with treatment with Ixo-vec, and certain patients cannot be treated with prophylactic corticosteroids. If this proportion of the patient population is larger than we estimate, the market for Ixo-vec may be smaller than we anticipate. Additionally, the potentially addressable patient population may be limited or may not be amenable to treatment with our product candidates for other reasons, and new patients may become increasingly difficult to identify or gain access to, which would adversely affect our results of operations and our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve our projected development goals in the time frames we announce and expect, the commercialization of our product candidates, if approved, may be delayed and the credibility of our management team may be adversely affected and, as a result, our stock price may decline.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include the commencement or completion of, or the availability of data from, scientific studies and clinical trials and the submission of regulatory filings. From time to time, we may publicly announce the expected timing of some of these milestones. All of these milestones will be based on a variety of assumptions. The actual timing of these milestones can vary dramatically compared to our estimates, in some cases for reasons beyond our control. If we do not meet these milestones as publicly announced, the commercialization of our products may be delayed and the credibility of our management team may be adversely affected and, as a result, our stock price may decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to the novel nature of our technology and the potential for our product candidates to offer therapeutic benefit in a single administration, we face uncertainty related to pricing and reimbursement for these product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates are designed to provide potential therapeutic benefit after a single administration and, therefore, the pricing and reimbursement of our product candidates, if approved, must be adequate to support commercial infrastructure. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell our product candidates will be adversely affected. The manner and level at which reimbursement is provided for services related to our product candidates (e.g., for administration of our product to patients) is also important. Inadequate reimbursement for such services may lead to physician resistance and adversely affect our ability to market or sell our product candidates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in establishing and maintaining development, commercialization or other strategic collaborations, which could adversely affect our ability to develop and commercialize product candidates and receive milestone and/or royalty payments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into development or other strategic collaborations with biotechnology and pharmaceutical companies in the past, and may in the future enter into additional development, commercialization or other strategic collaborations. Research activities under our collaboration agreements may be subject to mutually agreed-on research plans and budgets, and if we and our strategic partners are unable to agree on the research plan or research budget in a timely fashion or at all, performance of research activities will be delayed. In addition, some of our strategic partners may terminate any agreements they enter into with us or allow such agreements to expire by their terms. If we fail to maintain our current or future strategic collaborations, we may not realize milestone and royalty payments or other revenues under the collaboration agreements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governments may impose price controls, which may adversely affect our future profitability. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek approval to market our product candidates in both the U.S. and in foreign jurisdictions. If we obtain approval in one or more jurisdictions, we will be subject to rules and regulations in those jurisdictions relating to our product candidates. In some countries, including Member States of the European Economic Area (&#8220;EEA&#8221;), the pricing of prescription pharmaceuticals is subject to governmental control. Additional countries may adopt similar approaches to the pricing of prescription drugs. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product candidate. There can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after coverage and reimbursement have been obtained. Reference pricing used by various countries and parallel distribution, or arbitrage between low-priced and high-priced countries, can further reduce prices. Publication of discounts by third-party payers or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If reimbursement of our future products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, we may be unable to achieve or sustain profitability.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may form strategic alliances in the future, and we may not realize the benefits of such alliances.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may form strategic alliances, create joint ventures or collaborations, or enter into licensing arrangements with third parties that we believe will complement or augment our existing business, including for the continued development or commercialization of our product candidates. These relationships or those like them may require us to incur non-recurring and other charges, increase our near-and long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because third parties may view the risk of failure in future clinical trials as too significant, or the commercial opportunity for our product candidate as too limited. We cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction. Even if we are successful in our efforts to establish development partnerships, the terms that we agree upon may not be favorable to us, and we may not be able to maintain such development partnerships if, for example, development or approval of a product candidate is delayed or sales of an approved product candidate are disappointing. Any delay in entering into development partnership agreements related to our product candidates could delay the development and commercialization of our product candidates and reduce their competitiveness if they reach the market.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have no sales, marketing, distribution, or market access and reimbursement capabilities, and we would have to establish a partnering arrangement and/or invest significant resources to develop these capabilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no internal sales, marketing, distribution, or market access and reimbursement capabilities. If any of our product candidates ultimately receives regulatory approval, we may not be able to effectively market and distribute the product candidate. We would have to establish a partnering arrangement for commercialization and/or invest significant amounts of financial and management resources to develop internal sales, marketing, distribution, or market access and reimbursement capabilities, some of which will be committed prior to any confirmation that any of our product candidates will be approved, if at all. We may not be able to hire consultants or external service providers to assist us in sales, marketing, distribution, or market access and reimbursement functions on acceptable financial terms or at all. Even if we determine to perform sales, marketing, distribution, or market access and reimbursement functions ourselves, we could face a number of additional related risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to attract and build an effective marketing department, sales force, or distribution capabilities;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of establishing a marketing department or sales force may exceed our available financial resources and the revenue generated by any product candidates that we may develop, in-license or acquire; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our direct sales and marketing efforts may not be successful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Negative public opinion and increased regulatory scrutiny of gene therapy and genetic research may damage public perception of our product candidates or adversely affect our ability to conduct our business or obtain marketing approvals for our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public perception may be influenced by claims that gene therapy is unsafe, and gene therapy may not gain the acceptance of the public or the medical community. In particular, our success will depend upon physicians specializing in the treatment of those diseases that our product candidates target prescribing treatments that involve the use of our product candidates in lieu of, or in addition to, existing symptomatic treatments they are already familiar with and for which greater clinical data may be available.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More restrictive government regulations or negative public opinion would have a negative effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for any products we may develop. Trials using early versions of retroviral vectors, which integrate into, and thereby alter, the host cell&#8217;s DNA, have led to several well-publicized adverse events. Although none of our current product candidates utilize retroviruses and we believe AAVs used in our product candidates have low-integrating potential and are not known to cause disease in humans, our product candidates do use a viral vector delivery system. The risk of serious adverse events, such as the dose-limiting toxicity at the 6E11 dose tested in our INFINITY trial, remains a concern for gene therapy and we cannot assure that it will not occur in any of our current or future clinical trials. In addition, there is the potential risk of delayed adverse events following exposure to gene therapy products due to persistent biological activity of the genetic material or other components of products used to carry the genetic material.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse events in trials or studies conducted by us or other parties, in particular involving the same or similar AAV serotypes to the ones we are using, even if not ultimately attributable to our product candidates or to an AAV serotype that we employ, and resulting publicity, could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of our product candidates, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates. Similarly, our lead product candidate, Ixo-vec, leads to expression of a codon-optimized version of the aflibercept protein, which is also the active component in Eylea. If safety or efficacy issues occur relating to Eylea, even if not ultimately attributable to aflibercept, this may negatively impact our product candidate. If any such adverse events or issues occur, development and commercialization of our product candidates or advancement of any potential clinical trials could be halted or delayed, which would have a material adverse effect on our business and operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on the services of our key executives and clinical and scientific staff, and if we are not able to retain these members of our management or recruit additional management, clinical and scientific personnel, our business will suffer.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on the principal members of our management, clinical and scientific staff. The loss of service of any of our management or clinical or scientific staff could harm our business. In addition, we are dependent on our continued ability to attract, retain and motivate highly qualified additional management, clinical and scientific personnel. If we are not able to retain our management, and to attract, on acceptable terms, additional qualified personnel necessary for the continued development of our business, we may not be able to sustain our operations or grow. Although we have executed employment agreements with each member of our current executive management team, these agreements are terminable at will with or without notice and, therefore, we may not be able to retain their services as expected. Previously, we have had significant changes in our executive management team, and from time to time, may experience additional changes in our executive management team resulting from the hiring or departure of executives. While we seek to manage these transitions carefully, these and any other such changes may result in a loss of institutional knowledge and cause disruptions to our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to attract or retain qualified management, scientific and clinical personnel in the future due to the intense competition for qualified personnel among biotechnology, pharmaceutical and other businesses, particularly in the San Francisco Bay Area. At various times in recent years, our industry has experienced a high rate of turnover of management and scientific personnel. If we are not able to attract, retain and motivate necessary personnel to accomplish our business objectives, we may experience constraints that will significantly impede the achievement of our development objectives, our ability to raise additional capital and our ability to implement our business strategy.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we do not currently maintain &#8220;key person&#8221; life insurance on the lives of our executives or any of our employees. This lack of insurance means that we may not have adequate compensation for the loss of the services of these individuals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may encounter difficulties in managing our growth and expanding our operations successfully.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we will need to grow our organization, or certain functions within our organization, substantially and potentially establish partnering agreements to continue development and pursue the potential commercialization of our product candidates, as well as function as a public company. As we seek to advance our product candidates, we may need to expand our financial, development, regulatory, manufacturing, marketing and sales capabilities or contract with third parties to provide these capabilities for us. As our operations expand, we expect that we will need to manage additional relationships with various strategic partners, suppliers and other third parties. Future growth will impose significant added responsibilities on members of management and require us to retain or otherwise manage additional internal capabilities. Our future financial performance and our ability to commercialize our product candidates and to compete effectively will depend, in part, on our ability to manage any future growth effectively. To that end, we must be able to manage our development efforts and clinical trials effectively and hire, train and integrate any additional management, clinical and regulatory, financial, administrative and sales and marketing personnel. We may not be able to accomplish these tasks, and our failure to accomplish them could prevent us from successfully growing our company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our information technology systems or those third parties with whom we work, or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; material disruption of our product development programs; and other adverse consequences. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we and the third parties with whom we work, process, collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit and share (collectively, process) proprietary, confidential, and sensitive data, including personal data (such as health-related data), intellectual property and trade secrets (collectively, sensitive information).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cyber-attacks, malicious internet-based activity, online and offline fraud, and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, and those of the third parties with whom we work. Such threats are prevalent and continue to rise, are increasingly difficult to detect, and come from a variety of sources, including traditional computer &#8220;hackers,&#8221; threat actors, &#8220;hacktivists,&#8221; organized criminal threat actors, personnel (such as through theft or misuse), sophisticated nation states, and nation-state-supported actors. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we, and the third parties with whom we work, may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and the third parties with whom we work are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), denial-of-service attacks, credential stuffing attacks, credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, attacks enhanced or facilitated by AI, and other similar threats. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, disruptions of clinical trials, ability to provide our services, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remote work has increased risks to our information technology systems and data, as more of our employees utilize network connections, computers, and devices outside our premises or network, including working at home, while in transit and in public locations. Future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies. Furthermore, we may discover security issues that were not found during due diligence of such acquired or integrated entities, and it may be difficult to integrate companies into our information technology environment and security program.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, CROs, CMOs, collaborators, cloud-based infrastructure, data center facilities, encryption and authentication technology, employee email, content delivery to customers, and other functions. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If the third parties with whom we work experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if the third parties with whom we work fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or that of the third parties with whom we work have not been compromised. While we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take steps designed to detect, mitigate, and remediate vulnerabilities in our information systems (such as our hardware and/or software, including that of third parties with whom we work). We may not, however, detect and remediate all such vulnerabilities including on a timely basis. Further, we may experience delays in developing and deploying remedial measures and patches designed to address identified vulnerabilities. Vulnerabilities could be exploited and result in a security incident.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the previously identified or similar threats could cause a security incident or other interruption that could result in the unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information or our information technology systems, or those of the third parties with whom we work. For example, in December 2024, we were the target of nine unsuccessful phishing attempts and expect such attempts will continue in the future and we cannot guarantee that our employees will not succumb to, or that our security measures will adequately detect or prevent, such phishing attacks. A security incident or other interruption could disrupt our ability (and that of third parties with whom we work) to provide our services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expend significant resources or modify our business activities (including our clinical trial activities) to try to protect against security incidents. Certain data privacy and security obligations require us to implement and maintain specific security measures, industry-standard or reasonable security measures to protect our information technology systems and sensitive information. For example, the loss of clinical trial information from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable data privacy and security obligations may require us, or we may voluntarily choose, to notify relevant stakeholders, including partners, affected individuals, regulators, and investors of security incidents, or to take other actions, such as providing credit monitoring and identity theft protection services. Such disclosures and related actions can be costly, and the disclosures or the failure to comply with such applicable requirements could lead to adverse consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we (or a third-party with whom we work) experience a security incident or are perceived to have experienced a security incident, we may experience material adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; diversion of management attention; interruptions in our operations (including availability of data); financial loss; and other similar harms.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Security incidents and attendant material consequences may prevent or cause customers to stop using our services, deter new customers from using our services, and negatively impact our ability to grow and operate our business. A security incident could also disrupt our operations, including our ability to conduct research and development activities, process and prepare company financial information, manage various general and administrative aspects of our business, delay or impede the development of our products, and damage our reputation, any of which could adversely affect our business. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security incident were to result in a loss of, or damage to, our sensitive information or applications, or inappropriate disclosure of such sensitive information, we could incur liability, and the further development and commercialization of our product candidates could be delayed. In addition, there can be no assurance that we will promptly detect any such disruption or security incident, if at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our data privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to experiencing a security incident, third parties may gather, collect, or infer sensitive information about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position. Additionally, our sensitive information could be leaked, disclosed, or revealed as a result of or in connection with employees&#8217;, contractors&#8217; or vendors&#8217; use of generative artificial intelligence (&#8220;AI&#8221;) technologies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we fail to comply with applicable state and federal healthcare laws and regulations, we may be subject to civil or criminal penalties and/or exclusion from federal and/or state healthcare programs, or foreign equivalents.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to FDA restrictions on the marketing of pharmaceutical products, several other types of state and federal healthcare fraud and abuse laws restrict certain practices, including research and marketing, in the pharmaceutical industry, and foreign equivalents. These laws include anti-kickback, false claims, and healthcare professional payment transparency laws and regulations. Because of the breadth of these laws and the narrowness of their exceptions and safe harbors, it is possible that some of our business activities could be subject to challenge under one or more of these laws.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or in kind, to induce or reward the purchasing, leasing, ordering, arranging for, or recommending the purchase, lease or order of any healthcare item or service for which payment may be made, in whole or in part, under Medicare, Medicaid or other federally financed healthcare programs. Remuneration has been broadly defined to include anything of value, including cash, improper discounts, and free or reduced-price items and services. This statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formula managers on the other. Although there are several statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution, the exceptions and safe harbors are drawn narrowly, and practices may be subject to scrutiny if they do not qualify for an exception or safe harbor. Liability may be established under the federal Anti-Kickback Statute without proving actual knowledge of the statute or specific intent to violate it. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute, constitutes a false or fraudulent claim for purposes of the False Claims Act. Many states have similar laws that apply to their state health care programs as well as private payers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) imposes criminal liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payers; knowingly and willfully embezzling or stealing from a healthcare benefit program; willfully obstructing a criminal investigation of a healthcare offense; and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;) and their respective implementing regulations, which impose obligations on covered health care providers, health plans, and health care clearinghouses, as well as their business associates that create, receive, maintain, or transmit individually identifiable health information for or on behalf of a covered entity and their subcontractors that use, disclose, access, or otherwise process protected health information, with respect to safeguarding the privacy, security and transmission of individually identifiable health information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal civil False Claims Act, which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds, or knowingly making, using or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly concealing or knowingly and improperly avoiding, decreasing or concealing an obligation to pay money to the federal government. Actions under the False Claims Act may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. Violations of the False Claims Act can result in significant monetary penalties and treble damages. Pharmaceutical and other healthcare companies have faced enforcement actions under the federal civil False Claims Act for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product and for allegedly causing false claims to be submitted because of the companies&#8217; marketing of the product for unapproved, and thus non-reimbursable, uses. In addition, a claim can be deemed to be false due to failure to comply with legal or regulatory requirements material to the government&#8217;s payment decision. False Claims Act liability is potentially significant in the healthcare industry because the statute provides for treble damages and significant mandatory penalties per false claim or statement. Pharmaceutical and other healthcare companies also are subject to other federal false claims laws, including, among others, federal criminal healthcare fraud and false statement statutes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there is an increase in federal and state regulation of payments made to physicians and other healthcare providers. The Affordable Care Act, among other things, imposed new reporting requirements on drug manufacturers, under the federal Physician Payments Sunshine Act, for payments and other transfers of value made by them to physicians (defined to include doctors, dentists, optometrists, podiatrists, and chiropractors), certain other healthcare professionals (such as a physician assistants and nurse practitioners), and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Failure to submit required information may result in significant civil monetary penalties, for all payments, transfers of value or ownership or investment interests that are not timely, accurately and completely reported in an annual submission. Certain states and localities also mandate implementation of commercial compliance programs, restrict the ability of manufacturers to offer co-pay support to patients for certain prescription drugs, impose restrictions on drug manufacturer marketing practices, require the tracking and reporting of gifts, compensation and other remuneration to physicians and/or require the registration of pharmaceutical sales representatives.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, interactions between pharmaceutical companies and health care professionals are also governed by strict laws, such as national anti-bribery laws of European countries, national sunshine rules, regulations, industry self-regulation codes of conduct and physicians&#8217; codes of professional conduct. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will need to build and maintain a robust compliance program with different compliance and/or reporting requirements. We cannot ensure that our compliance controls, policies, and procedures will be sufficient to protect against acts of our employees, vendors, or other third parties that may violate such laws. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to significant penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, exclusion from participation in federal and state healthcare programs, imprisonment, and additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability as a result of the clinical testing of our product candidates and will face an even greater risk if we commercialize our product candidates. For example, we may be sued if our product candidates allegedly caused or cause injury or are found to be otherwise unsuitable during product testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product candidate, negligence, strict liability, and a breach of warranties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims could also be asserted under state consumer protection acts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit or cease the commercialization of our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even a successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for our products or product candidates;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of clinical trial participants;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs to defend the related litigation;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a diversion of management&#8217;s time and our resources;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to trial participants or patients;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls, withdrawals or labeling, marketing or promotional restrictions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenue;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize our product candidates; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decline in our stock price.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently hold $10 million in product liability insurance, which may not adequately cover all liabilities that we may incur. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. Our inability to obtain and retain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims could prevent or inhibit the commercialization of our product candidates. Although we plan to maintain such insurance, any claim that may be brought against us could result in a court judgment or settlement in an amount that is not covered, in whole or in part, by our insurance or that is in excess of the limits of our insurance coverage. Our insurance policies will also have various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and the third parties with whom we work are subject to stringent and evolving U.S. and foreign laws, regulations, rules, contractual obligations, industry standards, policies, and other obligations related to data privacy and security. Our (or the third parties with whom we work) actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions, litigation (including class claims) and mass arbitration demands, fines and penalties, disruptions of our business operations, reputational harm, loss of revenue or profits, interruption of our clinical trials, and other adverse business consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we process sensitive information, including personal data, business data, trade secrets, intellectual property, and data we collect about trial participants in connection with clinical trials. Our data processing activities subject us to numerous data privacy and security obligations, such as various laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations relating to data privacy and security, including information that we collect or will collect about clinical trial subjects and healthcare providers in connection with clinical trials. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., federal, state, and local governments have enacted numerous data privacy and security laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). For example, HIPAA, as amended by the HITECH, imposes specific requirements relating to the privacy, security, and transmission of individually identifiable protected health information. We obtain health information from third parties, such as research institutions, that are subject to privacy and security requirements under HIPAA. Although we are not directly subject to HIPAA other than with respect to providing certain employee benefits, we could potentially be subject to penalties if we, our affiliates, or our agents obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous U.S. states have enacted comprehensive privacy laws that impose certain obligations on covered businesses, including providing specific disclosures in privacy notices and affording residents with certain rights concerning their personal data. As applicable, such rights may include the right to access, correct, or delete certain personal data, and to opt-out of certain data processing activities, such as targeted advertising, profiling, and automated decision-making. The exercise of these rights may impact our business and ability to provide our products and services. Certain states also impose stricter requirements for processing certain personal data, including sensitive information, such as conducting data privacy impact assessments. These state laws allow for statutory fines for noncompliance. For example, the California Consumer Privacy Act of 2018 (the &#8220;CCPA&#8221;) applies to personal data of consumers, business representatives, and employees who are California residents, and requires businesses to provide specific disclosures in privacy notices and honor requests of such individuals to exercise certain privacy rights. The CCPA provides for fines and allows private litigants affected by certain data breaches to recover significant statutory damages. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA and other comprehensive U.S. privacy laws exempt some data processed in the context of clinical trials, but these developments may further complicate compliance efforts, and increase legal risk and compliance costs for us, and the third parties with whom we work. Similar laws are being considered in several other states, as well as at the federal and local levels, and we expect more states to pass similar laws in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the U.S., an increasing number of laws, regulations, and industry standards govern data privacy and security. For example, the European Union&#8217;s General Data Protection Regulation 2016/679 (&#8220;EU GDPR&#8221;), the United Kingdom&#8217;s GDPR (&#8220;UK GDPR&#8221;, and, together with the EU GDPR, the &#8220;GDPR&#8221;), Brazil&#8217;s General Data Protection Law (Lei Geral de Prote&#231;&#227;o de Dados Pessoais, or &#8220;LGPD&#8221;) (Law No. 13,709/2018), and China&#8217;s Personal Information Protection Law (&#8220;PIPL&#8221;) impose strict requirements for processing personal data. For example, under the GDPR, companies may face temporary or definitive bans on data processing and other corrective actions; fines of up to 20 million Euros under the EU GDPR, 17.5 million pounds sterling under the UK GDPR or, in each case, 4% of annual global revenue, whichever is greater; or private litigation related to processing of personal data brought by classes of data subjects or consumer protection organizations authorized by law to represent their interests. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we transfer personal data from Europe and other jurisdictions to the U.S. or other countries. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the EEA and the UK have significantly restricted the transfer of personal data to the U.S. and other countries whose privacy laws it generally believes are inadequate. Other jurisdictions may adopt or have already adopted similarly stringent data localization and cross-border data transfer laws. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the U.S. in compliance with law, such as the EEA&#8217;s standard contractual clauses, the UK&#8217;s International Data Transfer Agreement / Addendum, and the EU-U.S. Data Privacy Framework and the UK extension thereto (which allows for transfers to relevant U.S.-based organizations who self-certify compliance and participate in the Framework), these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the U.S. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there is no lawful manner for us to transfer personal data from the EEA, the UK or other jurisdictions to the U.S., or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions (such as Europe) at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies that transfer personal data out of the EEA and UK to other jurisdictions, particularly to the U.S., are subject to increased scrutiny from regulators, individual litigants, and activist groups. Some European regulators have ordered certain companies to suspend or permanently cease certain transfers of personal data out of Europe for allegedly violating the GDPR&#8217;s cross-border data transfer limitations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to data privacy and security laws, we are contractually subject to industry standards adopted by industry groups and, we are, or may become subject to such obligations in the future. We are also bound by contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. For example, certain privacy laws, such as the GDPR and the CCPA, require our customers to impose specific contractual restrictions on their service providers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees and contractors use generative AI technologies to perform work, and the disclosure and use of personal data in generative AI technologies is subject to various privacy laws and other privacy obligations. Governments have passed and are likely to pass additional laws regulating generative AI. Our use of this technology could result in additional compliance, costs, regulatory investigations and actions, and lawsuits. If we are unable to use generative AI, it could make our business less efficient and result in competitive disadvantages.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obligations related to data privacy and security (and consumers&#8217; data privacy expectations) are quickly changing, becoming increasingly stringent, and creating uncertainty. Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions. Preparing for and complying with these obligations requires us to devote significant resources, which may necessitate changes to our services, information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. In addition, these obligations may require us to change our business model.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We publish privacy policies, marketing materials, presentations, and other statements regarding data privacy and security. If these policies, materials or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators or other adverse consequences.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may at times fail (or be perceived to have failed) in our efforts to comply with our data privacy and security obligations. Moreover, despite our efforts, our personnel or third parties with whom we work may fail to comply with such obligations, which could negatively impact our business operations. If we or the third parties with whom we work fail, or are perceived to have failed, to address or comply with applicable data privacy and security obligations, we could face significant consequences, including but not limited to: government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar); litigation (including class-action claims) and mass arbitration demands; additional reporting requirements and/or oversight; bans or restrictions on processing personal data; orders to destroy or not use personal data; and imprisonment of company officials. In particular, plaintiffs have become increasingly more active in bringing privacy-related claims against companies, including class claims and mass arbitration demands. Some of these claims allow for the recovery of statutory damages on a per violation basis, and, if viable, carry the potential for monumental statutory damages, depending on the volume of data and the number of violations. Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: loss of customers; interruptions or stoppages in our business operations (including, as relevant, clinical trials); interruptions or stoppages of data collection needed to train our algorithms; inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize our products; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or substantial changes to our business model or operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations (collectively, &#8220;Trade Laws&#8221;). We can face serious consequences for violations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other matters, Trade Laws prohibit companies and their employees, agents, CROs, legal counsel, accountants, consultants, contractors, and other partners from authorizing, promising, offering, provide, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else or anything of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax assessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our non-U.S. activities to increase in time. We engage third parties for clinical trials and/or obtain necessary permits, licenses, registrations, and other regulatory approvals. We can be held liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our development partners, third-party manufacturers and suppliers use biological materials and use or may use hazardous materials, and any claims relating to improper handling, storage or disposal of these materials could be time consuming or costly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our development partners, third-party manufacturers and suppliers use or may use hazardous materials, including chemicals and biological agents and compounds that could be dangerous to human health and safety or the environment. Our operations and the operations of our third-party manufacturers and suppliers also produce hazardous waste products. Federal, state and local laws and regulations govern the use, generation, manufacture, storage, handling and disposal of these materials and wastes. Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our product development efforts. In addition, we cannot entirely eliminate the risk of accidental injury or contamination from these materials or wastes. We do not carry specific biological or hazardous waste insurance coverage, and our property, casualty and general liability insurance policies specifically exclude coverage for damages and fines arising from biological or hazardous waste exposure or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and any of our development partners will be required to report to regulatory authorities if any of our approved products cause or contribute to adverse medical events, and any failure to do so would result in sanctions that would materially harm our business.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we and any of our development partners are successful in commercializing our products, the FDA and foreign regulatory authorities will require that we and any of our future development partners report certain information about adverse medical events if those products may have caused or contributed to those adverse events. The timing of our obligation to report would be triggered by the date we become aware of the adverse event as well as the nature of the event. We and any of our future development partners may fail to report adverse events we become aware of within the prescribed timeframe. We and any of our future development partners may also fail to appreciate that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of our product candidates. If we and any of our future development partners fail to comply with our or their reporting obligations, the FDA or a foreign regulatory authority could take action, including criminal prosecution, the imposition of civil monetary penalties, seizure of the product and delay in approval or clearance of other products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, principal investigators, CROs, CMOs, consultants and vendors may engage in misconduct or other improper activities, including noncompliance with our code of conduct or regulatory standards and requirements. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, principal investigators, CROs, CMOs, consultants and vendors may engage in misconduct including code of conduct violations, fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct, or disclosure of unauthorized activities to us that violates: (1) FDA or comparable foreign regulations, including those laws requiring the reporting of true, complete and accurate information to regulatory authorities, (2) manufacturing standards, (3) federal, state and foreign health care fraud and abuse laws and regulations or (4) laws that require the reporting of financial information or data accurately. Specifically, sales, marketing, and business arrangements in the health care industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws also involve improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid, and other federal healthcare programs or comparable foreign programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating loss carryforwards and other tax attributes may be limited by the Code. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred substantial losses during our history and do not expect to become profitable in the near future and we may never achieve profitability. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire, except as described below.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Cuts and Jobs Act, federal net operating losses (&#8220;NOL&#8221;) incurred in taxable years beginning after 2017 and in future years may be carried forward indefinitely, but the deductibility of such federal NOLs for taxable years beginning after 2020 is limited. In addition, under Section 382 of the Internal Revenue Code of 1986, our ability to utilize NOL carryforwards or other tax attributes, such as research tax credits, in any taxable year may be limited if we experience an &#8220;ownership change.&#8221; Generally, a Section 382 ownership change occurs if there is a cumulative increase of more than 50 percentage points in the stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#8217;s stock within a specified testing period. Similar rules may apply under state tax laws. We are conducting a Section 382 study, which is still subject to finalization, but which may show that we experienced an ownership change in 2024. If such ownership change has occurred, up to the vast majority of the NOLs, capital losses and research credit carryforwards presented in our consolidated financial statements would be subject to limitations and therefore may expire unutilized. In addition, states may suspend the ability to use NOLs and research credits which could further limit our ability to use our NOLs and research credits to offset state taxable income and taxes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, California has enacted legislation that, with certain exceptions, suspends the ability to use California net operating losses to offset California income and limits the ability to use California business tax credits to offset California taxes, for taxable years beginning on or after January 1, 2024, and before January 1, 2027.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential natural disasters, some possibly related to the increasing effects of climate change, could damage, destroy or disrupt operations at our office and laboratories, CMO premises, study sites, and/or other third-party vendor sites, which could have a significant negative impact on our operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are vulnerable to the increasing impact of climate change and other natural disasters. Volatile changes in weather conditions, including extreme heat or cold, could increase the risk of wildfires, floods, blizzards, hurricanes and other weather-related disasters. Such extreme weather events, or other natural disasters such as earthquakes, can cause power outages and network disruptions that may result in damage, destruction or disruption to operations at our offices, laboratories, CMO premises, or other third-party vendor sites and may impact our ability to continue or complete our clinical studies or to produce, characterize or otherwise develop our product candidate which could negatively impact our operations and delay our plans to commercialize our product candidates. They could also cause significant damage to or destruction of our clinical study sites resulting in temporary or long-term closures of these facilities. Such disasters could also result in loss or damage to our office buildings, laboratories, CMO premises, employee and/or patient homes, employees and/or patients relocating to other parts of the country or being unwilling to travel to the clinical study site locations, and the inability to recruit key employees and/or enroll patients. This could result in adverse impacts to the available workforce and/or patient enrollment in our clinical studies, damage to or destruction of materials and/or data, or the inability to conduct clinical studies and deliver new data.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_46"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of the shares of our common stock has been and could continue to be highly volatile, and purchasers of our common stock could incur substantial losses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price has been and is likely to continue to be volatile. The stock market in general and the market for biotechnology companies in particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. The market price for our common stock may be influenced by many factors, including those discussed above and others such as:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll and dose subjects in any clinical trials that are on-going, or that we plan to conduct in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain regulatory approvals for our product candidates and delays or failure to obtain such approvals;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to conduct nonclinical studies to determine the best gene therapy candidates to advance in development;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of any clinical trials of our product candidates and the results of trials of competing product candidates or of other companies in our market sector;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor perception and analysis of the results of our clinical trials, which may be different than our own;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments in the U.S. and foreign countries;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial results, variations in our financial results and the adequacy of our cash runway to achieve key milestones, or those of companies that are perceived to be similar to us;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of healthcare payment systems, especially in light of current reforms to the U.S. healthcare system;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to maintain our existing third-party license and collaboration agreements;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in manufacturing adequate supply of our product candidates;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse publicity relating to gene therapy and to biotechnology generally, including with respect to other products and potential products in such markets;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the pharmaceutical and biotechnology sectors and issuance of securities analysts&#8217; reports or recommendations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our stock by insiders and stockholders;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our common stock;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry and market conditions other events or factors, many of which are beyond our control;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key personnel; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property, product liability or other litigation against us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the past, stockholders have initiated class action lawsuits against biotechnology and pharmaceutical companies following periods of volatility in the market prices of these companies&#8217; stock, and similar litigation has been instituted against us. Such litigation could cause us to incur substantial costs and divert management&#8217;s attention and resources, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may delay or prevent an acquisition of us or a change in our management. These provisions include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the authorization of the issuance of &#8220;blank check&#8221; preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the limitation of the removal of directors by the stockholders;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a staggered board of directors;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prohibition of stockholder action by written consent, thereby requiring all stockholder actions to be taken at a meeting of our stockholders;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the elimination of the ability of stockholders to call a special meeting of stockholders;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our board of directors to accelerate the vesting of outstanding option grants, restricted stock units or other equity awards upon certain transactions that result in a change of control; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the establishment of advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted upon at stockholder meetings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us. Although we believe these provisions collectively provide for an opportunity to obtain greater value for stockholders by requiring potential acquirers to negotiate with our board of directors, they would apply even if an offer rejected by our board were considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified a&#8239;material weakness&#8239;in our internal control over financial reporting.&#8239;If we are unable to remedy the material weakness, or if we fail to maintain an effective system of internal control over financial reporting in the future, we may not be able to accurately report our financial condition, results of operations or cash flows, which may adversely affect investor confidence in our company and, as a result, the value of our common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. We are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complying with Section 404 requires a rigorous compliance program as well as adequate time and resources. We may not be able to complete our internal control evaluation, testing and any required remediation in a timely fashion. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Part II, Item 9A, in connection with our preparation of the consolidated financial statements for the year ended December 31, 2024 we have identified non-cash errors in the accounting for tenant improvement allowances that resulted in the restatement of our consolidated financial statements as of and for the year ended December 31, 2023, as well as the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024. These errors were indicative of a material weakness in our controls over lease accounting as of December 31, 2024. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. We previously identified a material weakness as of December 31, 2022, related to a non-cash lease accounting error related to another operating lease in previously issued financial statements. We have also identified other control deficiencies. We cannot be certain that additional material weaknesses and control deficiencies will not be discovered in the future. If our efforts to remediate the material weakness are not successful, material weaknesses are identified in the future or we are not able to comply with the requirements of Section 404 in a timely manner, our reported financial results could be materially misstated, and we could be subject to investigations or sanctions by regulatory authorities, which would require additional financial and management resources, and the value of our common stock could decline. To the extent we identify future weaknesses or deficiencies, there could be material misstatements in our consolidated financial statements, and we could fail to meet our financial reporting obligations. As a result of failure to remediate the material weakness or future weaknesses or deficiencies, our ability to obtain additional financing, or obtain additional financing on favorable terms, could be materially and adversely affected, which, in turn, could materially and adversely affect our business, our financial condition and the value of our common stock. If we are or remain unable to assert that our internal control over financial reporting is effective in the future, investor confidence in the accuracy and completeness of our financial reports could be further eroded, which would have a material adverse effect on the price of our common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly operating results may fluctuate significantly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our operating results to be subject to quarterly fluctuations. Our net loss and other operating results will be affected by numerous factors, which may include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in the level of expenses related to our clinical trial and development programs;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">addition, termination or modification of clinical trials;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any intellectual property infringement lawsuit or other litigation in which we may become involved;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments affecting our product candidates;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our execution of any collaborative, licensing or similar arrangements and the timing of payments we may make or receive under these arrangements;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the nature and terms of stock-based compensation grants; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">derivative instruments recorded at fair value.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our quarterly operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our certificate of incorporation and bylaws provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America. will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a breach of fiduciary duty;</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim against us arising under the Delaware General Corporation Law; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim against us that is governed by the internal-affairs doctrine.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision would not apply to suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated bylaws provide</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our certificate of incorporation and bylaws. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our certificate of incorporation or bylaws to be inapplicable or unenforceable in an action, we may incur </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further significant </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional costs associated with resolving the dispute in other jurisdictions, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all of </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which could seriously harm our business.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. Cybersecurity</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-37" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-38" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-39">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third-party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data (&#8220;Information Systems and Data&#8221;).</ix:nonNumeric></span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information security function, which includes our Vice President of Information Technology (&#8220;IT&#8221;) and third-party service providers, legal department and security committee, helps identify, assess, and manage the Company&#8217;s cybersecurity threats and risks. Our information security function identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example: using automated tools, conducting audits, evaluating threats, and performing vulnerability assessments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the environment, systems, and data at issue, we implement and maintain various technical, physical, and organizational measures, processes, and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: cybersecurity insurance, physical security, incident detection and response, access controls, employee training, penetration testing, and systems monitoring.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assessment and management of material risks from cybersecurity threats are integrated into the Company&#8217;s overall risk management processes. For example, our Vice President of IT, works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-40">We use third-party service providers to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats, including for example: cybersecurity software providers, managed cybersecurity service providers, penetration testing firms, and cybersecurity consultants.</ix:nonNumeric> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-41">We use third-party service providers to perform a variety of functions throughout our business, such as contract research organizations, contract manufacturing organizations, and supply chain resources. We have a vendor management process to manage cybersecurity risks associated with certain of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of diligence designed to help identify cybersecurity risks associated with a provider such as risk assessments and reviewing security assessments and reports.</ix:nonNumeric> </span></div><div style="margin-top:6pt"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-42"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including the risk factor entitled: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our information technology systems or those third parties with whom we work, or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; material disruption of our product development programs; and other adverse consequences.</span></ix:nonNumeric></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-43" continuedAt="f-43-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-45" continuedAt="f-45-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-44" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-46" continuedAt="f-46-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-45-1"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-47" escape="true">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies</ix:nonNumeric>.</ix:continuation> </span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-48" continuedAt="f-48-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-46-1">Our management, including our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-49">Chief Operating Officer and Vice President of IT</ix:nonNumeric>, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#8217;s overall risk management strategy, and helping prepare for cybersecurity incidents.</ix:continuation> </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><ix:continuation id="f-48-1" continuedAt="f-48-2"><ix:continuation id="f-43-1" continuedAt="f-43-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-50" escape="true">Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#8217;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#8217;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents.</ix:nonNumeric> </span></div></ix:continuation></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-48-2"><ix:continuation id="f-43-2"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-51">The Board of Directors receives periodic reports from the management concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Board of Directors also has access to various reports, summaries or presentations related to cybersecurity threats, risk, and mitigation.</ix:nonNumeric></ix:continuation></ix:continuation> </span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Redwood City, California, consisting of approximately 79,675 square feet of office and laboratory space under a lease that will expire in December 2031. </span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we lease a manufacturing facility in North Carolina, consisting of approximately 173,820 square feet, under a lease that will expire in October 2037.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our properties are adequate and suitable for our current needs; however, we are continuing to evaluate our real estate strategy in response to the changing needs of our in-office, hybrid and remote workforce.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 26, 2021, we entered into a sublease agreement with Jaguar, who subsequently assigned the sublease to AMP, as the subtenant for the NC Premises, for the remainder of the underlying lease term (ending in October 2037). Pursuant to the sublease and the assignment agreement, Jaguar remained obligated for AMP&#8217;s proper performance under the sublease. In February 2025, a lien in the amount of $4.8 million was filed by a third-party contractor against the subtenant&#8217;s interest in the NC Premises. We discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Further liens by third-party subcontractors or other contractors have been or may in the future be filed against the subtenant&#8217;s interest in the NC Premises and we may need to also discharge such liens to avoid a default under the head lease. The subtenant and Jaguar failed to remit March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. As a result, we assumed responsibility for such payments in March 2025. As of April 7, 2025, we have made payments in the total amount of $1.9&#160;million to satisfy outstanding rent and common area management fee obligation, and we remain obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $119.7&#160;million for the remainder of the head lease term, of which $7.1 million is due between April 8 and December 31, 2025. As a result of the uncured defaults, we terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce our rights under the sublease and seek recovery of losses and damages due to the defaults by the subtenant and Jaguar.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_64"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on the Nasdaq Capital Market under the symbol &#8220;ADVM&#8221;.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Record</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;4, 2025, we had approximately 10 holders of record of our common stock. The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. [Reserved]</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion of our financial condition and results of operations in conjunction with the financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; and &#8220;Risk Factors.&#8221;</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Overview </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not generated positive cash flow or net income from operations since our inception and, as of December&#160;31, 2024, we had an accumulated deficit of $1.1 billion. We expect to incur substantial expenses and continuing losses from operations in the foreseeable future as we conduct our research and development efforts, advance our product candidates through nonclinical and clinical development, manufacture clinical study materials, seek regulatory approval, and prepare for and, if approved, proceed to commercialization. We are still in clinical development and may never be successful in developing or commercializing our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we may in the future generate revenue from a variety of sources, including license fees, milestone, and research and development payments in connection with strategic partnerships, and potentially revenue from product sales if any of our product candidates are approved, to date we have not generated any revenue from product sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have no operational clinical or commercial manufacturing facilities, and all of our clinical manufacturing activities are currently contracted out to third parties. Additionally, we use third-party contract research organizations (&#8220;CROs&#8221;) to carry out our clinical development and we do not have a sales organization.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2024, we effected a 1-for-10 reverse stock split of our common stock. The par value and the authorized shares of our common stock were not adjusted as a result of the reverse stock split. All equity-related information including per share amounts for all periods presented in this Annual Report on Form 10-K have been adjusted retroactively, where applicable, to reflect this reverse stock split.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, we completed a private placement of 10.5 million shares of our common stock and, in lieu of common stock, prefunded warrants to purchase an aggregate of 75,000 shares of common stock (the &#8220;Pre-Funded Warrants&#8221;) to certain institutional and accredited investors and a concurrent private placement to certain directors of 23,000 shares of our common stock for total gross proceeds of $127.8 million, before deducting placement agent fees and offering expenses (the &#8220;Private Placements&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement of Previously Issued Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 28, 2025, the Audit Committee of our Board of Directors (the &#8220;Audit Committee&#8221;), following consultation management and our independent registered public accounting firm, Ernst &amp; Young LLP, concluded that certain of our previously issued financial statements should no longer be relied upon due to non-cash errors identified in the accounting for tenant improvement allowances associated with an operating lease and sublease related to a building in North Carolina (the &#8220;NC Premises&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into the operating lease for the NC Premises, and in October 2021, we entered into the sublease agreement with Jaguar Gene Therapy, LLC (&#8220;Jaguar&#8221;), who subsequently assigned the sublease to Advanced Medicine Partners, LLC (&#8220;AMP&#8221; or the &#8220;subtenant&#8221;) as the subtenant for the NC Premises, through the remainder of the lease term. While preparing the consolidated financial statements as of and for the year ended December 31, 2024, management discovered non-cash errors in our accounting for our operating lease and sublease of the NC Premises. The errors relate solely to our accounting for tenant improvement allowances provided by the landlord to the Company under the operating lease, which were subsequently conveyed from the Company to the subtenant under the sublease, and to a lesser extent, to the assessment of the probability of collection of the lease payments from the subtenant over the remaining term of the sublease. The errors affect the reported amounts of non-cash assets and liabilities, and non-cash general and administrative expenses, related to the lease and sublease (the &#8220;Misstatements&#8221;).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Misstatements relate solely to the NC Premises and require non-cash corrections to our previously issued audited consolidated financial statements as of and for the years ended December 31, 2022 and 2023, included in our Annual Report on Form 10-K for the year ended December 31, 2023 (the &#8220;2023 Annual Report&#8221;), as well as the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024 (collectively the &#8220;Restated Periods&#8221;), included in the Company&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods within those years (&#8220;Quarterly Reports&#8221; and, together with the 2023 Annual Report, the &#8220;Affected Reports&#8221;). The Audit Committee concluded that it is appropriate to correct the Misstatements by restating the financial statements for the Restated Periods.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restated financial statements for the Restated Periods are included in this Annual Report on Form 10-K and we do not intend to separately amend the Affected Reports.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date we have not generated any revenue from the sale of our products. We have generated revenue through research, collaboration and license arrangements with strategic partners. Our ability to generate product revenue and become profitable depends upon our ability to successfully develop and commercialize our product candidates. Because of the numerous risks and uncertainties associated with product development, we are unable to predict the amount or timing of product revenue. Even if we are able to generate revenue from the sale of our products, our sales may not be sufficient to generate cash from operations, in which case we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting a significant amount of research and development is central to our business model. Research and development expenses primarily include personnel-related costs, stock-based compensation expenses, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with CROs, the cost of acquiring, developing and manufacturing clinical study materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense research and development costs as incurred. We defer and expense advance payments for goods or services for future research and development activities as the goods are delivered or the related services are performed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate nonclinical study and clinical trial expenses based on the services performed pursuant to contracts with research institutions and CROs that conduct and manage nonclinical studies and clinical trials on our behalf. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. We estimate the amounts incurred through communications with third-party service providers and our estimates of accrued expenses as of each balance sheet date are based on information available at the time. If the actual timing of the performance of services or the level of effort varies from the estimate, we will need to adjust the accrual accordingly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, we cannot reasonably estimate the nature, timing or aggregate costs of the efforts that will be necessary to complete the development of any of our product candidates. The successful development and commercialization of a product candidate is highly uncertain, and clinical development timelines, the probability of success, and development and commercialization costs can differ materially from expectations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses primarily include personnel-related costs, stock-based compensation, professional fees for legal, consulting, audit and tax services, overhead expenses, such as rent, equipment depreciation, insurance and utilities, and other general operating expenses not otherwise included in research and development expenses. Our general and administrative expenses may increase in future periods if and to the extent we elect to increase our investment in infrastructure to support continued research and development activities and potential commercialization of our product candidates. We will continue to evaluate the need for such investment in conjunction with our ongoing consideration of our pipeline of product candidates. We may require increased expenses related to audit, legal and regulatory functions, as well as director and officer insurance premiums and investor relations costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net primarily comprises interest income on our cash equivalents and investments in marketable securities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Judgments and Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. We base our estimates on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Research and Development Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our accrued research and development expenses as of each balance sheet date. This process involves reviewing contracts and purchase orders, reviewing the terms of our license agreements, communicating with our applicable personnel to identify services that have been performed on our behalf, and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual cost. The majority of our service providers invoice us monthly in arrears for services performed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of estimated accrued research and development expenses include fees to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">contract manufacturers in connection with the production of clinical trial materials;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">vendors in connection with nonclinical development activities; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">service providers for professional service fees such as consulting and related services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our understanding of the status and timing of services performed relative to the actual status and timing may vary and may result in our reporting changes in estimates in any particular period. Due to the nature of these estimates, we cannot assure you that we will not materially adjust our estimates in the future as we become aware of additional information about the status or conduct of our clinical studies or other research activities. For the years ended December&#160;31, 2024 and 2023, there were no material changes from our prior estimates of accrued research and development expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our long-term operating leases, we recognize a right-of-use asset and a lease liability on our consolidated balance sheets. We determine if an arrangement contains a lease and the classification of the lease at inception based on the unique facts and circumstances present in the arrangement. Lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when we are reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, we determine our credit rating, adjust the credit rating for the nature of the collateral, and benchmark the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. We elected to combine lease and non-lease components for all underlying assets groups. We determine the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, we do not recognize a right-of-use asset and lease liability and recognize the lease expense over the term of the lease on a straight-line basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. Variable lease payments include lease operating expenses.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the probability of collecting lease payments under our sublease at each reporting date. We currently believe that collection of lease payments is improbable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding recent accounting pronouncements applicable to us is included in Note 3. Summary of Significant Accounting Policies to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Results of Operations for the Years Ended December&#160;31, 2024 and 2023</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/<br/>(Decrease)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,733)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,116)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,811)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.0 million of license revenue for the year ended December&#160;31, 2024 was related to a milestone payment received from Ray Therapeutics, Inc. (&#8220;Ray&#8221;) pursuant to a license agreement we had entered into with Ray in February 2023. The $3.6&#160;million of license revenue for the year ended December&#160;31, 2023 was primarily related to a milestone payment received from Lexeo Therapeutics, Inc.(&#8220;Lexeo&#8221;) pursuant to a license agreement we had entered into with Lexeo in January 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses for the years ended December&#160;31, 2024 and 2023:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase/<br/>(Decrease)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ixo-vec</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indirect research and development expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personnel related (including stock-based compensation)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,041&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and other unallocated research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,486&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased by $0.5&#160;million to $77.0 million for the year ended December&#160;31, 2024 from $77.5&#160;million for the year ended December&#160;31, 2023. This overall decrease was primarily related to a decrease of $8.3&#160;million in rent expense driven by a lease termination in the prior year, partially offset by an increase of $5.3&#160;million in spending on Ixo-vec in preparation for Phase 3 clinical development, an increase of $2.3&#160;million in personnel-associated costs due to higher headcount, and an increase of $0.2&#160;million related to other programs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods presented, our research and development activities were attributable to Ixo-vec and our earlier-stage research programs. We expect that research and development expenses will increase in future periods as we focus on advancing Ixo-vec for the treatment of wet AMD into Phase 3.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense increased by $8.1 million to $63.1 million for the year ended December&#160;31, 2024 from $55.1&#160;million for the year ended December&#160;31, 2023, primarily related to an increase of $14.3&#160;million in facilities expenses driven by non-cash tenant improvement allowances made available to the subtenant of the NC Premises and a $0.6&#160;million increase in professional services. These increases were partially offset by a&#160;$6.3 million decrease in depreciation expense and rent expense driven by the lease termination in the prior year and a decrease of $0.7&#160;million in insurance costs due to a decrease in premiums.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that general and administrative expenses will increase in future periods as we focus on advancing Ixo-vec for the treatment of wet AMD.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $2.5 million in other income, net for the year ended December&#160;31, 2024 as compared to 2023 was primarily due to higher average yields on investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Benefit</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no income tax benefit during the year ended December&#160;31, 2024. We derecognized the liability of $1.1 million for the year ended December&#160;31, 2023 arising from an uncertain tax position related to foreign operations.</span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity, Capital Resources and Plan of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have funded our operations primarily through the sale of equity. We have not generated positive cash flow or net income from operations since our inception and as of December&#160;31, 2024, we had an accumulated deficit of $1.1 billion. As of December&#160;31, 2024, we had $125.7 million in cash, cash equivalents and short-term investments compared to $96.5 million as of December&#160;31, 2023. Based on our available cash resources and current operating plan, there is substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that our financial statements for the year ended December&#160;31, 2024 are issued.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Private Placements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, we completed the Private Placements of 10.6 million shares of our common stock and, in lieu of common stock, Pre-Funded Warrants to purchase an aggregate of 75,000 shares of common stock to certain institutional and accredited investors and directors for total gross proceeds of $127.8&#160;million, before deducting placement agent fees and offering expenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">At-the-Market Offering Program</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to a sales agreement (the &#8220;Sales Agreement&#8221;) with Cowen &amp; Company, LLC (&#8220;Cowen&#8221;) pursuant to which we may, from time to time, sell up to an aggregate amount of $100.0&#160;million of our common stock through Cowen in an &#8220;at-the-market&#8221; offering. We are not required to sell shares under the Sales Agreement. We will pay Cowen a commission of up to 3.0% of the aggregate gross proceeds of any shares of common stock sold pursuant to the Sales Agreement. As of April&#160;15, 2025, no sales have been made pursuant to the Sales Agreement. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Going Concern</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2024, we have devoted substantially all of our efforts to product development and have not realized product sales revenue from our planned principal operations. We have a limited operating history, and the sales and income potential of our business and market are unproven. We have experienced net losses since our inception and, as of December&#160;31, 2024, we had an accumulated deficit of $1.1 billion. We used $92.5 million of cash in operations during the year ended December 31, 2024. We expect to continue to incur net losses and operating cash outflows for at least the next several years as we continue development of our product candidates. Losses have resulted principally from costs incurred in our research and development programs and from our general and administrative expenses. In the future, we intend to continue to conduct research and development, regulatory compliance activities and, if any of our product candidates is approved, sales, marketing and other activities that, together with anticipated general and administrative expenses, will likely result in us incurring significant losses for the next several years or longer. As of December 31, 2024, we had cash, cash equivalents and short-term investments of $125.7 million, which we expect to fund our operations into the second half of 2025. We have determined that our existing cash and cash equivalents as of December 31, 2024 would be insufficient to fund our operations through at least 12&#160;months from the date the consolidated financial statements in this Annual Report on Form 10-K are issued, and therefore there is substantial doubt regarding our ability to continue as a going concern. Accordingly, the report from our independent registered public accounting firm for the years ended December 31, 2024 includes an explanatory paragraph stating that our recurring losses since inception raise substantial doubt about our ability to continue as a going concern. See Part I, Item 1A. Risk Factors under the header &#8220;Risks Related to Our Financial Position and Need for Capital&#8221;  for additional information.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will need to raise substantial additional funding to finance our operations through clinical development of our product candidates and potentially to commercialize these candidates. We continue to analyze various alternatives, including public or private equity or debt financings, third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches. There is no assurance, however, that we will receive any additional financing or any revenue-generating collaboration will be available when needed, that management will be able to obtain financing or enter into a collaboration on terms acceptable to us, or that any additional financing or revenue generated through third-party collaborations will be sufficient to fund our operations for at least 12 months from the date the consolidated financial statements in this Annual Report on Form 10-K are issued. If we fail to obtain additional capital necessary to fund our operations, we could be forced to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations, or to cease operations or liquidate our assets. Although we have been successful in raising capital in the past, there is no assurance that we will be successful in obtaining such additional financing. Therefore, it is not considered probable that our plans to raise additional capital will alleviate the substantial doubt regarding our ability to continue as a going concern. Failure to manage discretionary spending or raise additional financing, as needed, may adversely impact our ability to achieve our intended business objective. The actual amount of cash that we will need to operate is subject to many factors, including those described in the section titled &#8220;Risk Factors.&#8221; Our consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Funding Requirements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur substantial expenditures in the foreseeable future, contingent upon receipt of additional funding, for the development and potential commercialization of our product candidates and ongoing internal research and development programs. At this time, we cannot reasonably estimate the nature, timing or aggregate amount of costs for our development, potential commercialization, and internal research and development programs. However, in order to complete our planned nonclinical trials and current and future clinical trials, and to complete the process of obtaining regulatory approval for our product candidates, as well as to build the sales, marketing and distribution infrastructure that we believe will be necessary to commercialize our product candidates, if approved, we will require substantial additional funding in the future.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and when we seek additional funding, we will do so through public or private equity or debt financings, third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches. Adequate additional funding may not be available to us on acceptable terms or at all. As a result, we have concluded that management&#8217;s plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as a going concern. Our failure to raise capital in the future could have a negative impact on our financial condition and our ability to pursue our business strategies. To complete development and commercialization of any of our product candidates, we anticipate that we will need to raise substantial additional capital, the requirements of which will depend on many factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to realize savings from any restructuring plans or cost-containment measures we have implemented or additional measures we may implement; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">security breaches, data losses or other disruptions affecting our information systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our need and ability to retain key management and hire scientific, technical, business, and engineering personnel; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, progress, timing, costs and results of nonclinical studies and any clinical trials for our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome, timing of and costs involved in, seeking and obtaining approvals from the FDA and other regulatory authorities, including the potential for the FDA and other regulatory authorities to require that we perform more studies than those that we currently expect;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our product candidates to progress through clinical development activities successfully;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our need to expand our research and development activities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of progress and cost of commercialization of our products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of preparing to manufacture our products on a larger scale;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of commercialization activities including product sales, marketing, manufacturing and distribution;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the degree and rate of market acceptance of any products launched by us or future partners;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our need to implement additional infrastructure and internal systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to hire additional personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enter into additional collaboration, licensing, commercialization or other arrangements and the terms and timing of such arrangements; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the emergence of competing technologies or other adverse market developments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce, or terminate our product development programs, commercialization efforts or other operations, or to cease operations or liquidate our assets. We may also be required to sell or license other technologies or clinical product candidates or programs that we would prefer to develop and commercialize ourselves.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Material Cash Requirements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material cash requirements as of December&#160;31, 2024 included operating lease commitments, including the lease of our headquarters office in Redwood City, CA, and the NC Premises. As of December&#160;31, 2024, we had fixed lease payment obligations of $167.2 million, with $12.1 million payable within 12 months. See Note 6, Leases to our financial statements for additional information. As described in Note 15, Subsequent Events to our financial statements, the subtenant, AMP, and Jaguar defaulted, and failed to cure such defaults, under the sublease and the notice and waiver of assignment (the "assignment agreement") for the NC Premises. In February 2025, a lien in the amount of $4.8 million was filed by a third-party contractor against the subtenant&#8217;s interest in the NC Premises. We discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid default under the head lease. Further liens by third-party subcontractors or other contractors have been or may in the future be filed against the subtenant&#8217;s interest in the NC Premises and we may need to also discharge such liens to avoid a default under the head lease. The subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments. As a result, we assumed responsibility for such payments in March 2025. As of April 7, 2025, we had made payments in the total amount of $1.9 million to satisfy outstanding rent and common area management fee obligation, and we remain obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $119.7 million for the remainder of the head lease term, of which $5.7 million is due between April 8 and December 31, 2025. As a result of the uncured defaults, we terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce our rights under the sublease and seek recovery of losses and damages incurred due the defaults by the subtenant and Jaguar.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as disclosed above, we have no long-term debt and no material non-cancelable purchase commitments with service providers, as we have generally contracted on a cancelable, purchase-order basis. We enter into contracts in the normal course of business with CROs, CMOs and other third parties for clinical trials, preclinical research studies and testing, and manufacturing services. These contracts are cancelable by us upon prior notice. Payments due upon cancellation consist of payments for services provided or expenses incurred, including noncancelable obligations of our service providers, up to the date of cancellation. These payments are not determinable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the primary sources and uses of cash for each of the periods presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash (used in) provided by:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,875&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></div></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,348)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Used in Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, net cash used in operating activities was $92.5&#160;million, primarily as a result of net loss of $130.9&#160;million due to the continued activities developing our product candidates, partially offset by $37.6&#160;million of non-cash charges mainly related to $14.4&#160;million of stock-based compensation expense, $14.0&#160;million of non-cash sublease loss, $7.5&#160;million of non-cash lease expense, $3.7 million of depreciation and amortization expenses, and $0.9&#160;million of net increase in cash from changes in operating assets and liabilities, which fluctuate due to timing of expenses and payments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, net cash used in operating activities was $90.9 million, primarily as a result of net loss of $122.1 million due to the continued activities developing our product candidates, partially offset by $39.7 million of non-cash charges mainly related to $18.3 million of non-cash lease expense, $17.6 million of stock-based compensation expense, and $5.6 million of depreciation and amortization expenses; partially offset by $8.5&#160;million of net decrease in cash from changes in operating assets and liabilities, which fluctuate due to timing of expenses and payments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash (Used In) Provided by Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the year ended December&#160;31, 2024 consisted of $41.5&#160;million of net purchases of marketable securities and by $0.4 million of purchases of property and equipment primarily related to facilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the year ended December 31, 2023 consisted of $97.7 million of net maturities of marketable securities, partially offset by $0.8 million of purchases of property and equipment primarily related to facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Provided by Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December&#160;31, 2024 consisted of $119.4 million of proceeds from issuance of common stock and pre-funded warrants in the Private Placements, $0.5&#160;million in proceeds from our employee stock purchase plan and $0.1 million in proceeds from the exercise of stock options.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December 31, 2023 consisted of $0.5 million in proceeds from employee stock purchase plan, almost entirely offset by $0.4 million in payments for deferred offering costs.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under SEC rules and regulations, as a smaller reporting company, we are not required to provide the information required by this item.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8. Financial Statements and Supplementary Data.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_124"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:91.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.672%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_127">Report of Independent Registered Public Accounting Firm (PCAOB ID No. </a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-52">42</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_127">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_127">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_130">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_130">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_133">Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_133">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_136">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_136">101</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_139">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_139">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_142">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_142">103</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Stockholders and Board of Directors of Adverum Biotechnologies, Inc.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Opinion on the Financial Statements </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Adverum Biotechnologies, Inc. (the &#8220;Company&#8221;) as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s Ability to Continue as a Going Concern</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred recurring losses from operations and negative cash flows from operating activities and has stated that substantial doubt exists about the Company&#8217;s ability to continue as a going concern. Management&#8217;s evaluation of the events and conditions and management&#8217;s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restatement of 2023 Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, the 2023 consolidated financial statements have been restated to correct certain misstatements.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1)&#160;relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:75.655%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accrued research and development expenses &#8211; clinical trials</span></div></td></tr><tr style="height:53pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recorded accrued research and development expenses of $2.6&#160;million as of December 31, 2024. As described in Note 3, the Company estimates clinical trial expenses based on the services performed pursuant to contracts with contract research organizations that conduct and manage clinical trials on the Company&#8217;s behalf.</span></div></td></tr><tr style="height:75pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the Company&#8217;s accrued research and development expenses for clinical trials was challenging due to the complex nature of evaluating the completeness and accuracy of the information used to estimate clinical trial expenses. Research and development expenses are incurred as the services are performed by vendors. This requires management to accurately monitor the activity of the vendors to determine the level of effort incurred during the reporting period.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the completeness and accuracy of information used to estimate clinical trial expenses, our audit procedures included, among others, confirming with a sample of vendors the progress of activities under research and development contracts at period end, testing a sample of cash disbursements after period end to assess the completeness of accrued expenses, and making inquiries of individuals outside the finance function.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.485%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accounting for North Carolina leases </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At December 31, 2024, the Company&#8217;s operating lease right-of-use assets and operating lease liabilities were $33.6 million and $91.7 million, respectively. The Company recorded rent expense of $13.3 million and sublease loss of $14.0 million for the year ended December 31, 2024. As discussed in Note 6, the Company has an operating lease agreement (&#8220;head lease&#8221;) for use of a building in North Carolina that it subleased to a subtenant (&#8220;sublease&#8221;). Tenant improvement allowances provided by the landlord to the Company under the head lease were subsequently conveyed from the Company to the subtenant under the sublease.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the Company&#8217;s accounting for the head lease and sublease was challenging due to the complex nature of the tenant improvement allowances provided under the head lease and sublease and because of the judgment involved in assessing the collectibility of future lease payments from the subtenant</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the accounting for the effects of the tenant improvement allowances provided under the head lease and sublease, our procedures included, among others, reviewing the head lease and sublease agreement to understand the terms and conditions related to the tenant improvement allowances and evaluating whether the tenant improvements related to the incentives were lessor or lessee assets. To test the sublease loss recognized, we performed audit procedures that included, among others, confirming tenant improvement allowance payments and rent payments directly with the landlord and evaluating the collectibility of future lease payments. For example, we assessed the subtenant&#8217;s payment history and factors contributing to the financial strength of the subtenant.</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-53">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2018.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-54">San Francisco, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;15, 2025</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-55">60,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-56">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-57">65,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-58">21,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">5,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">131,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">102,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-63">33,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-64">35,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-65">11,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-66">14,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-71">179,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-72">155,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-75">15,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-76">12,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-77">5,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">5,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">22,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">19,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">86,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">68,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-83">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-85">109,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-86">88,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 8)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-87"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-88"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-89"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-90">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-91"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-92">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-93"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-95"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-96">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-99"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-100">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-102">300,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2024: <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-103"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-104">20,848</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-105"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-106">10,143</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-107">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-108">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-109">1,138,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-110">1,003,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-111">407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-112">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-113">1,066,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-114">936,024</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-115">70,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-116">67,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-117">179,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-118">155,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-119">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-120">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-121">77,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-122">77,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-123">63,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-124">55,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-125">140,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-126">132,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-127">139,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-128">128,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-129">8,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-131">130,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-132">123,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-133">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-134">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-135">130,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-136"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">122,116</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain (loss):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-138">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-139">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-140">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-141">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-142">130,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-143">121,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-144"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-145">6.62</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-146"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-147">12.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-149">19,782</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-151">10,082</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"/><td style="width:47.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.345%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.628%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022 As Restated</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-152">10,012</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-153">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-154">985,660</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-155">1,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-156">813,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-157">170,222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-158">17,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-159">17,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued upon exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-161">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-162">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-163">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-164">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-165">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued upon release of restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-166">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-167">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-168">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-169">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-170">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-171"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-172">122,116</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-173">122,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2023 As Restated</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-174">10,143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-175">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">1,003,718</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-177">473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-178">936,024</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-179">67,222</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-180">14,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-181">14,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and warrants for cash in private placement, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-182">8,449</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-183">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-184">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-185">119,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-186">119,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-187">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-188">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-189">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-190">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-191">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-192">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued upon release of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-193">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-194">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-195">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-196">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-197">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-198">130,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-199">130,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-200">20,848</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-201">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-202">1,138,070</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-203">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">1,066,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">70,714</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-206">130,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-207">122,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-208">3,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-209">5,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-210">14,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-211">17,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accretion of discount on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-212">1,907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-213">1,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-214">7,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-215">18,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash sublease loss/(income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-216">14,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="advm:NonCashSubleaseLossIncome" scale="3" id="f-217">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-218">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-219">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-220">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-221">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-222">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-223">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" scale="3" id="f-224">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" scale="3" id="f-225">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-226">262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-227">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-228">3,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-229">5,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-230">2,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-231">3,222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-232">92,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-233">90,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-234">101,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-235">36,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-236">60,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-237">134,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-238">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-239">808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-240">41,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-241">96,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-242">119,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:fixed-zero" scale="3" id="f-243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-245">420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to option exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-246">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-247">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="f-248">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="f-249">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-250">120,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-251">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-252">14,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-253">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-254">76,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-255">70,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-256">62,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-257">76,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-258">60,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-259">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-260">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-261">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-262">62,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-263">76,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash settlement of operating lease liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" format="ixt:fixed-zero" scale="3" id="f-264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" format="ixt:num-dot-decimal" scale="3" id="f-265">14,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets and liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:fixed-zero" scale="3" id="f-266">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-267"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-268">7,632</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets in accounts payable and current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-269">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-270">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVERUM BIOTECHNOLOGIES, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_145"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-271" continuedAt="f-271-1" escape="true">Description of the Business </ix:nonNumeric></span></div><ix:continuation id="f-271-1" continuedAt="f-271-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Adverum Biotechnologies, Inc. (the &#8220;Company&#8221; or &#8220;Adverum&#8221;) was incorporated in Delaware on July 17, 2006 and is headquartered in Redwood City, California. The Company aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. The Company develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Going Concern, Liquidity, Risks and Uncertainties&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has devoted substantially all of its efforts to product development and has not realized product sales revenues from its planned principal operations. The Company has a limited operating history, and the sales and income potential of the Company&#8217;s business and market are unproven. The Company has experienced net losses since its inception and, as of December&#160;31, 2024, had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="9" id="f-272">1.1</ix:nonFraction> billion. The Company used $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-273">92.5</ix:nonFraction> million of cash in operations during the year ended December&#160;31, 2024. The Company expects to continue to incur net losses and operating cash outflows for at least the next several years. A successful transition to attaining profitable operations is dependent upon achieving a level of revenue adequate to support the Company&#8217;s cost structure. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had cash, cash equivalents and short-term investments of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="f-274">125.7</ix:nonFraction> million, which are expected to fund the Company&#8217;s operations into the second half of 2025. The Company has determined that its cash and cash equivalents as of December&#160;31, 2024 would be insufficient to fund its operations for a period of at least twelve months from the date these financial statements are issued, which raises substantial doubt regarding the Company&#8217;s ability to continue as a going concern. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements have been prepared using the going concern basis of accounting, which contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.</span></div></ix:continuation><div style="margin-top:6pt"><ix:continuation id="f-271-2" continuedAt="f-271-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management expects operating losses to continue for the foreseeable future. The Company plans to raise substantial additional capital to continue as a going concern, including through </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">public or private </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equity or debt financings, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. If the Company is unable to raise capital or enter into such agreements as and when needed, it may have to delay, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limit, reduce or terminate its product development programs, commercialization efforts or other operations, or to cease operations or liquidate its assets</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-271-3">. Although the Company has been successful in raising capital in the past, there is no assurance that it will be successful in obtaining such additional financing. Therefore, it is not considered probable that the Company&#8217;s plans to raise additional capital will alleviate the substantial doubt regarding its ability to continue as a going concern.</ix:continuation> </span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_1956"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:ErrorCorrectionTextBlock" id="f-275" continuedAt="f-275-1" escape="true">Restatement of Previously Issued Financial Statements</ix:nonNumeric></span></div><ix:continuation id="f-275-1" continuedAt="f-275-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has restated herein its audited consolidated financial statements for the year ended December&#160;31, 2023 in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 250, Accounting Changes and Error Corrections. In March 2025, the Company discovered that there were errors in its lease accounting related to tenant improvement allowances in connection with an operating lease agreement for a building in North Carolina, which the Company entered into in January 2021 and subsequently subleased in October 2021 (the operating lease agreement and sublease agreements, with their respective amendments, collectively, the &#8220;NC Leases&#8221;). The Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for tenant improvement allowances that were conveyed to the subtenant, resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also restated interim period financial statements for the first, second and third quarters of 2024 and 2023 as a result of these errors. See Note 14 Quarterly Financial Information (Unaudited) for additional information on the restated interim financial statements for the first, second, and third quarters of 2024 and 2023.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-275-2" continuedAt="f-275-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this restatement, the Company has corrected certain other immaterial errors. While these other errors are quantitatively and qualitatively immaterial, individually and in the aggregate, because the Company is restating its consolidated financial statements for material errors, the Company has corrected other immaterial errors as well. These adjustments are described in more detail in references (b) and (c) and elsewhere in the section titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Other Adjustments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Adjustments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjustments to correct other errors that are quantitatively and qualitatively immaterial, individually and in the aggregate are as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-276">0.2</ix:nonFraction>&#160;million in 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company had previously understated its right-of-use assets and lease liability by $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-277"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-278">0.3</ix:nonFraction></ix:nonFraction>&#160;million related to its facilities in Redwood City, California at each balance sheet in 2024 and 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also identified certain errors as a result of imprecise calculations related to its research and development tax credits that should have been corrected in the consolidated financial statements for the year ended December 31, 2023. Such amounts are deemed immaterial to the Company&#8217;s income tax provision for the years ended December 31, 2024 and 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remainder of the notes to the Company&#8217;s financial statements have been restated, as applicable, to reflect the impacts from the restatement discussed above. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impact of the Restatement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represent the restated amounts in the Consolidated Balance Sheet, Statement of Operations and Comprehensive Loss, and Statement of Cash Flows for the year ended December&#160;31, 2023 (in thousands, except per share data).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts as previously reported for fiscal year 2023 were derived from the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, filed on March 18, 2024 and the amounts previously reported for the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024 were derived from the Company&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods within those years (the &#8220;Previously Reported Amounts&#8221;). The Previously Reported Amounts are labeled as &#8220;As Reported&#8221; in the tables below. The amounts labeled &#8220;Adjustment&#8221; represent the effects of this restatement described above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative effect of the error on periods prior to 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-279">11.3</ix:nonFraction>&#160;million which is included in the beginning balance of the accumulated deficit of the restated Consolidated Balance Sheet for the year ended December 31, 2023. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="f-280" continuedAt="f-280-1" escape="true"><ix:continuation id="f-275-3" continuedAt="f-275-4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Balance Sheet</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-281">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-283">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-284">21,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-286">21,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-287">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-32" xsi:nil="true" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="f-288"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-289">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-290">102,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-292">102,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-293">52,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-294">17,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-295">35,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-296">14,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-298">14,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-299">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-301">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-302">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-32" xsi:nil="true" name="us-gaap:OtherAssetsNoncurrent" id="f-303"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-304">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-305">173,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-306">17,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-307">155,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-308">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-310">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-311">12,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-313">12,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-314">10,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-315">4,933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-316">5,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-317">24,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-318">4,933</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-319">19,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-320">64,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-321">3,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-322">68,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-323">89,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:Liabilities" scale="3" id="f-324">995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-325">88,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-31" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-326"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-32" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-327"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-328"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-329"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-330">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-331"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-332">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-333"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-334"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-335"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-336">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-340"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-341">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-342"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-343">300,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2023: <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-344"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-345">10,143</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-346">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-348">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-349">1,003,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-351">1,003,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-352">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-354">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-355">919,777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-356">16,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-357">936,024</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-358">83,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-359">16,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-360">67,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-361">173,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-362">17,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-363">155,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-275-4"><ix:continuation id="f-280-1" continuedAt="f-280-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-364">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-365">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-366">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-367">77,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-368">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-369">77,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-370">49,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-371">5,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-372">55,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-373">127,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-374">4,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-375">132,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-376">123,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-377">4,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-378">128,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-379">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-381">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-382">118,243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-383">4,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-384">123,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-385">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-387">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-388">117,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-389">4,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-390">122,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-391">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-393">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-394">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-396">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-397">116,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-398">4,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-399">121,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-33" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-400"><ix:nonFraction unitRef="usdPerShare" contextRef="c-33" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-401">11.62</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-34" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-402"><ix:nonFraction unitRef="usdPerShare" contextRef="c-34" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-403">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-404"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-405">12.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-406"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-407">10,082</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-408"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-409">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-410"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-411">10,082</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Cash Flows</span></div></ix:continuation><div style="margin-top:12pt"><ix:continuation id="f-280-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-412">117,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-413">4,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-414">122,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-415">13,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-416">5,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-417">18,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="advm:NonCashSubleaseLossIncome" scale="3" id="f-419">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="advm:NonCashSubleaseLossIncome" scale="3" id="f-420">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-421">5,206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-422">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-423">5,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-424">13,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-425">6,079</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-426"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-427">7,632</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impact on net cash used in operating activities or within any line items within investing and financing activities.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_148"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-428" continuedAt="f-428-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-429" escape="true"><ix:continuation id="f-428-1" continuedAt="f-428-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company&#8217;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United&#160;States of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-428-2" continuedAt="f-428-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-430" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain, and the actual results could differ from these estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityPolicyTextBlock" id="f-431" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 2024 Reverse Stock Split</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;On March 21, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the reverse stock split. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity related information including per share amounts for all periods presented in these consolidated financial statements and the notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-432" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where the local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Upon sale or upon complete or substantially complete liquidation of an investment in a foreign entity, the amount attributable to that entity and accumulated in the translation adjustment component of equity is removed from the separate component of equity and reported as part of the gain or loss on sale or liquidation of the investment for the period during which the sale or liquidation occurs. Income and expense accounts are translated at average exchange rates for the period. Transactions which are not in the functional currency of the entity are remeasured into the functional currency and gains or losses resulting from the remeasurement recorded in other income, net.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-433" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company considers all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks, money market accounts and highly liquid debt securities. Cash equivalents are stated at fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-434" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Restricted cash primarily consists of cash collateral to letter of credit provided to the landlord in relation to a lease agreement. See Note 6, Leases for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-435" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Short-Term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;All short-term investments in debt securities have been classified as &#8220;available for sale&#8221; and are carried at fair value. Unrealized gains and losses, net of any related tax effects, are excluded from earnings and are included in other comprehensive loss and reported as a separate component of stockholders&#8217; equity until realized. The cost of securities sold is based on the specific-identification method. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Interest on short-term investments is included in other income, net in the Company&#8217;s consolidated statements of operations and comprehensive loss. In accordance with the Company&#8217;s investment policy, management invests to diversify credit risk and only invests in securities with high credit quality, including U.S. government securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses available-for-sale debt securities on a quarterly basis to see whether any unrealized loss is due to credit-related factors. Factors considered in determining whether an impairment is credit-related include the extent to which the investment&#8217;s fair value is less than its cost basis, declines in published credit ratings, changes in interest rates, and any other adverse factors related to the security. If it is determined that a credit-related impairment exists, the Company will measure the credit loss based on a discounted cash flow model. Credit-related impairments on available-for-sale debt securities are recognized as an allowance for credit losses with a corresponding adjustment to other income, net in the Company&#8217;s consolidated statement of operations. The unrealized loss position that is not credit-related is recorded, net of any related tax effects, in other comprehensive income until realized. There were no credit-related losses recognized for the periods presented.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="advm:AccruedInterestReceivablePolicyTextBlock" id="f-436" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Interest Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Accrued interest receivable related to the Company&#8217;s available-for-sale debt securities is presented within prepaid expenses and other current assets on the Company&#8217;s consolidated balance sheets. The Company has elected to exclude accrued interest receivable from both the fair value and the amortized cost basis of available-for-sale debt securities for the purposes of identifying and measuring any impairment. The Company writes off accrued interest receivable once it has determined that the asset is not realizable. Any write offs of accrued interest receivable are recorded by reversing interest income, recognizing credit loss expense, or a combination of both. To date, the Company has not written off any accrued interest receivables associated with its available-for-sale debt securities.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-428-3" continuedAt="f-428-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-437" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company operates and manages its business as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-438"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-439">one</ix:nonFraction></ix:nonFraction> reporting and operating segment, which is the business of developing and commercializing gene therapeutics. The Company&#8217;s chief executive officer, who is the chief operating decision maker (&#8220;CODM&#8221;), assesses segment performance and decides how to allocate resources based on total operating expenses as reported on the consolidated statements of operations and comprehensive loss. See Note 11, Segment Reporting, for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-440" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Risks associated with cash, cash equivalents, short-term investments are mitigated by the Company&#8217;s investment policy, which limits the Company&#8217;s investing to securities having specified credit ratings. Management believes that the Company is not exposed to significant credit risk.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to certain risks and uncertainties, including, but not limited to changes in any of the following areas that the Company believes could have a material adverse effect on future financial position or results of operations: the ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, the Company&#8217;s product candidates; performance of third-party clinical research organizations and manufacturers; development of sales channels; protection of intellectual property; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; and the Company&#8217;s ability to attract and retain employees necessary to support growth.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-441" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets, generally <span style="-sec-ix-hidden:f-442">three</span> to <ix:nonNumeric contextRef="c-36" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-443">five years</ix:nonNumeric>. Leasehold improvements are capitalized and amortized over the shorter period of their expected lives or the lease term. Major replacements and improvements are capitalized, while general repairs and maintenance are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-444" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there is an indication of impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-445" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For long-term operating leases, the Company recognizes a right-of-use asset and a lease liability on the Company's consolidated balance sheets. The Company determines if an arrangement contains a lease and the classification of the lease at inception. An arrangement contains a lease if there is an identified asset and if the Company controls the use of the identified asset throughout the period of use. The lease liability is determined as the present value of future lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when the Company is reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, the Company determines its credit rating, adjusts the credit rating for the nature of the collateral, and benchmarks the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. It bases the ROU asset on the lease liability adjusted for any prepaid or deferred rent. The Company elected to combine lease and non-lease components for all underlying assets groups. The Company determines the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, the Company does not recognize a right-of-use asset and lease liability and recognizes the lease expense over the term of the lease on a straight-line basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. The variable lease payments primarily consist of common area maintenance and other operating costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the probability of collecting lease payments under its sublease at each reporting date. The Company currently does not deem the collection of lease payments probable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-446" continuedAt="f-446-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-428-4" continuedAt="f-428-5"><ix:continuation id="f-446-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, Revenue from Contracts with Customers, the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-447" continuedAt="f-447-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Research and development expenses are charged to expense as incurred. Research and development expenses include</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily personnel-related costs, stock-based compensation expense, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with contract research organizations (&#8220;CROs&#8221;), the cost of acquiring, developing and manufacturing clinical trial materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advance payments for goods or services for future research and development activities are deferred and expensed as the goods are delivered or the related services are performed.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-447-1">The Company estimates research and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage nonclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers and the Company&#8217;s estimates of accrued expenses and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual accordingly.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-448" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The carrying amounts of the Company&#8217;s financial instruments, including cash equivalents approximate their fair values due to their short-term maturities. See Note 4, Fair Value Measurements for the methodologies and assumptions used in valuing financial instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-449" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Stock-based compensation expense related to stock awards to employees is measured at fair value of the award on the date of the grant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the grant-date fair value, and the resulting stock-based compensation expense, using the Black-Scholes valuation model for stock options and employee stock purchase and using intrinsic value, which is the closing price of its common stock on the date of the grant, for restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense recognition of PSU and performance-based options commences when the associated performance-based criteria are determined to be probable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes valuation model requires the use of following assumptions:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term assumption represents the period that the Company&#8217;s stock-based awards are expected to be outstanding and is determined using the simplified method.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Expected volatility is based on the Company&#8217;s historical stock price volatility. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero-coupon issues in effect at the time of grant for periods corresponding with the expected term of option.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-450" continuedAt="f-450-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company accounts for income taxes using the asset and liability method. The Company records deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-428-5"><ix:continuation id="f-450-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As of December&#160;31, 2024 and 2023, the Company has recorded a full valuation allowance on its deferred tax assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained upon examination. Interest and penalties related to unrecognized tax liabilities are included within the provision for income tax.</span></div></ix:continuation><div style="margin-top:12pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-451" continuedAt="f-451-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-451-1">&#8212;Comprehensive loss comprises net loss and other comprehensive loss. Other comprehensive loss consists of foreign currency translation adjustments and unrealized gain or loss on marketable securities.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-452" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic and Diluted Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. Outstanding stock options, RSUs, and employee stock purchase plan (&#8220;ESPP&#8221;) are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-453" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires disaggregated disclosures of certain categories of expenses in the notes to the financial statements that are included in expense line items on the face of the income statement in annual and interim periods. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2023-07&#8221;). The amendments in ASU 2023-07 are intended to improve reportable segment disclosure, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company retrospectively adopted ASU 2023-07 on December 31, 2024. The adoption of ASU 2023-07 did not have a material financial impact on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_151"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-455" continuedAt="f-455-1" escape="true">Fair Value Measurements and Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-455-1" continuedAt="f-455-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-455-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Level 1 securities is determined using quoted prices in active markets for identical assets. Level 1 securities consist of highly liquid money market funds. Financial assets and liabilities are considered Level 2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level 2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. government and agency securities, commercial paper and corporate bonds are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level 2.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="f-456" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s cash equivalents and short-term investments (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="f-457">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="f-460">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-461">78,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-462">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-463">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-464">78,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-465">41,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-466">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-467">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-468">41,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-469">119,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-470">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-471">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-472">119,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:CashAndCashEquivalentAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="f-473">54,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:CashAndCashEquivalentGrossUnrealizedGain" format="ixt:fixed-zero" scale="3" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:CashAndCashEquivalentGrossUnrealizedLoss" scale="3" id="f-475">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-476">54,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-477">64,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-478">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-479">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-480">65,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-481">10,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-484">10,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-485">64,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-487">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-488">64,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-489">17,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-490">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-491">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-492">17,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-493">92,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-494">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-495">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-496">92,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:CashAndCashEquivalentAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="f-497">70,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:CashAndCashEquivalentGrossUnrealizedGain" format="ixt:fixed-zero" scale="3" id="f-498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:CashAndCashEquivalentGrossUnrealizedLoss" scale="3" id="f-499">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-500">70,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-501">21,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-502">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-503">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-504">21,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company may sell these securities at any time for use in current operations even if the securities have not yet reached maturity, all marketable securities are classified as current assets in the Company&#8217;s consolidated balance sheets. As of December&#160;31, 2024, all marketable securities had a remaining maturity of less than one year. The Company held <ix:nonFraction unitRef="security" contextRef="c-4" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="f-505">14</ix:nonFraction> debt securities in an unrealized loss position with an aggregate fair value at December&#160;31, 2024 of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="f-506">54.2</ix:nonFraction>&#160;million. These are highly liquid funds with high credit ratings with final maturity of less than one year from the balance sheet date. There were no individual securities that were in a significant unrealized loss position as of December&#160;31, 2024 and 2023. The Company has <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-507"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-508">not</ix:nonFraction></ix:nonFraction> recorded an allowance for credit losses as of December&#160;31, 2024 or 2023 related to these securities. The accrued interest receivable on available-for-sale marketable securities was immaterial at December&#160;31, 2024 or 2023. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. The Company has <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" format="ixt:fixed-zero" scale="0" id="f-509"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" format="ixt:fixed-zero" scale="0" id="f-510">not</ix:nonFraction></ix:nonFraction> recorded any impairment charges on available-for-sale securities.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-511" continuedAt="f-511-1" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="f-511-1" continuedAt="f-511-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lexeo</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2021, the Company and Lexeo Therapeutics, Inc (&#8220;Lexeo&#8221;) entered into a License Agreement pursuant to which the Company granted Lexeo an exclusive, worldwide, royalty-bearing license to certain of the Company&#8217;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat cardiomyopathy due to Friedreich&#8217;s Ataxia. Upon execution of the agreement, Lexeo paid the Company a one-time, non-creditable and non-refundable upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:ProceedsFromLicenseFeesReceived" format="ixt:num-dot-decimal" scale="6" id="f-512">7.5</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-511-2"><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, the Company is eligible to receive additional payments upon the achievement of certain milestones. Additionally, the Company will receive royalty payments on net sales subject to a cap and reductions based on patent expiry, anti-stacking, and a defined royalty floor percentage.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, Lexeo notified the Company that it had achieved the first development milestone; accordingly, the Company received and recognized $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-513">3.5</ix:nonFraction>&#160;million of license revenue during the year ended December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ray</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2023, the Company and Ray Therapeutics, Inc (&#8220;Ray&#8221;) entered into a License Agreement pursuant to which the Company granted Ray a non-exclusive, worldwide, royalty-bearing license to certain of the Company&#8217;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat retinitis pigmentosa and the right to develop the technology to treat other ocular diseases and disorders. Under the terms of the agreement, the Company is eligible to receive development, regulatory and commercial milestone payments and royalties on net sales once commercialized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, Ray notified the Company that it achieved the first development milestone. Accordingly, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-514">1.0</ix:nonFraction>&#160;million of license revenue during the year ended December&#160;31, 2024.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-515" continuedAt="f-515-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-515-1" continuedAt="f-515-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redwood City</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a lease for facilities in Redwood City, California (&#8220;Redwood City Premises&#8221;), which expires December&#160;31, 2031, with an option to extend for a period of <ix:nonNumeric contextRef="c-48" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-516">eight years</ix:nonNumeric>. Related to this lease, the Company provided the landlord with a letter of credit, as amended, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-517">2.0</ix:nonFraction>&#160;million, which is classified as restricted cash under long-term assets on the Company&#8217;s consolidated balance sheets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to September 30, 2023, the Company had <ix:nonFraction unitRef="lease" contextRef="c-50" decimals="INF" name="advm:LesseeOperatingLeaseNumberOfLease" format="ixt-sec:numwordsen" scale="0" id="f-518">two</ix:nonFraction> facility leases in Redwood City. In March 2023, the Company entered into an amendment to accelerate the expiration of the lease for one of the facilities in its Redwood City Premises from December 31, 2031 to September 30, 2023. Concurrently, the Company entered into an agreement for additional tenant improvement allowance towards its other Redwood City Premises. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). As a result of the modification the Company revalued the lease liability based on the new and remaining lease terms, which resulted in a reduction to the lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-519">7.9</ix:nonFraction>&#160;million, and recognized the remeasurement to the lease liabilities as an adjustment to the right-of-use asset. The estimated value of non-cash consideration, composed primarily of leasehold improvements and furniture and fixtures, was $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-5" name="advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" format="ixt:num-dot-decimal" scale="6" id="f-520">14.9</ix:nonFraction>&#160;million, which was fully amortized as of September 30, 2023. There was no charge recognized in the consolidated statement of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North Carolina</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has restated amounts related to this lease. See Notes 2 and 14.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 8, 2021, the Company entered into an operating lease agreement for a building in North Carolina (&#8220;NC Premises&#8221;). The lease commenced in April 2021, when the Company obtained control of the NC Premises, and the lease term expires in October 2037 with <ix:nonFraction unitRef="segment" contextRef="c-53" decimals="INF" name="advm:LesseeOperatingLeaseNumberOfRenewalContracts" format="ixt-sec:numwordsen" scale="0" id="f-521">two</ix:nonFraction> options to extend the lease term for a period of <ix:nonNumeric contextRef="c-54" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-522">five years</ix:nonNumeric> each.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2021, the Company entered into a sublease agreement with Jaguar Gene Therapy, LLC (&#8220;Jaguar&#8221;) for the NC Premises through October 2037, the remainder of the lease term, and concurrently changed the terms of the head lease. In addition, the remainder of the tenant improvement allowance under the original lease of approximately $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="advm:LesseeOperatingLeaseLeaseholdImprovementAllowance" format="ixt:num-dot-decimal" scale="6" id="f-523">22.7</ix:nonFraction>&#160;million was transferred to Jaguar.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2023, the Company entered into an amendment of the lease of its NC Premises with the landlord and subtenant. Under this amendment, the parties agreed to substantially reduce the total tenant improvement allowance in exchange for lower monthly rent. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). The Company remeasured the lease liability, resulting in an increase in the lease liability with a corresponding increase of the right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="advm:IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" format="ixt:num-dot-decimal" scale="6" id="f-524"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-5" name="advm:IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" format="ixt:num-dot-decimal" scale="6" id="f-525">0.3</ix:nonFraction></ix:nonFraction>&#160;million in the quarter ended June 30, 2023. There was no charge recognized in the consolidated statement of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, management reassessed the probability of collection of the lease payments from Jaguar over the remaining term of a sublease. At that time, management assessed the collectibility to be less than probable and recognized an adjustment to eliminate the deferred rent receivable as a current period adjustment during the year ended December 31, 2022. Deferred rent receivable was&#160;<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:DeferredRentReceivablesNet" format="ixt:fixed-zero" scale="0" id="f-526">zero</ix:nonFraction>&#160;as of December&#160;31, 2024 and 2023. In April 2023, Jaguar assigned the sublease to Advanced Medicine Partners, LLC (at that time, a wholly-owned subsidiary of Jaguar, &#8220;AMP&#8221; or the &#8220;subtenant&#8221;) as the subtenant for the NC Premises for the remainder of the lease term. Pursuant to the sublease and the notice and waiver of assignment (the &#8220;assignment agreement&#8221;), Jaguar remained obligated for AMP&#8217;s proper performance under the sublease. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-515-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, a lien totaling $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="f-527">4.8</ix:nonFraction>&#160;million was filed by a third&#8211;party contractor against the subtenant&#8217;s interest in the NC&#160;Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. Subsequent to December 31, 2024, the subtenant made payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="f-528">1.4</ix:nonFraction>&#160;million for January and February 2025 rent and drew $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="us-gaap:TenantImprovements" format="ixt:num-dot-decimal" scale="6" id="f-529">2.3</ix:nonFraction>&#160;million from the available tenant improvement allowance, at which point the subtenant discontinued rent payments. The Company assumed responsibility for rent payments in March 2025 and as of April 7, 2025 had made payments in the total payment of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="f-530">1.9</ix:nonFraction>&#160;million to satisfy outstanding rent and common area management fee obligations. See Note 15 Subsequent Events.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded sublease loss of $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-531">14.0</ix:nonFraction>&#160;million and sublease income of $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-532">0.1</ix:nonFraction>&#160;million for the years ended December 31, 2024 and 2023, respectively, which was recognized in general and administrative expense.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the weighted-average remaining lease term was <ix:nonNumeric contextRef="c-63" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-533">11.2</ix:nonNumeric> years for the Company&#8217;s leases and the weighted-average Incremental Borrowing Rate (&#8220;IBR&#8221;) was <ix:nonFraction unitRef="number" contextRef="c-63" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-534">11.6</ix:nonFraction>%. As of December 31, 2023, the weighted-average remaining lease term was <ix:nonNumeric contextRef="c-64" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-535">11.6</ix:nonNumeric> years for the Company&#8217;s leases and the weighted-average IBR was <ix:nonFraction unitRef="number" contextRef="c-64" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-536">11.7</ix:nonFraction>%.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-537" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the undiscounted future non-cancellable lease payments under the lease agreements as of December&#160;31, 2024 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-538">12,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-539">14,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-540">15,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-541">15,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-542">16,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-543">93,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-544">167,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-545">75,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-546">91,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Rent expense for the years ended December&#160;31, 2024, and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-547">13.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-548">25.3</ix:nonFraction>&#160;million, respectively. Included in rent expense for the years ended December&#160;31, 2024, and 2023 were variable lease costs for utilities, parking, maintenance, and real estate taxes of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-549">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-550">2.4</ix:nonFraction> million, respectively. Cash paid for amounts included in the measurement of lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="f-551">5.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="f-552">7.5</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2024 and 2023, respectively. During the years ended December&#160;31, 2024 and 2023, the landlord made payments to the subtenant on the Company&#8217;s behalf for tenant improvement allowances in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:PaymentsForTenantImprovements" format="ixt:num-dot-decimal" scale="6" id="f-553">20.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:PaymentsForTenantImprovements" format="ixt:num-dot-decimal" scale="6" id="f-554">5.4</ix:nonFraction>&#160;million and the subtenant made rent payments to the landlord on the Company&#8217;s behalf in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="f-555">6.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="f-556">5.5</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-557" continuedAt="f-557-1" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="f-557-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-558" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-559">14,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-560">14,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-561">13,779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-562">13,586</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-563">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-564">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-565">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-566">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-567">29,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-568">29,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-569">18,045</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-570">14,512</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-571">11,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-572">14,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-573" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-574">9,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-575">8,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued nonclinical, clinical and process development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-576">4,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-577">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-578">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-579">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-580">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-581">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-582">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-583">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-584">15,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-585">12,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_166"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-586" continuedAt="f-586-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-586-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various agreements, principally relating to licensed technology that requires future payments relating to milestones or royalties on future sales of specified products. The Company recognized license revenue of $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-587">1.0</ix:nonFraction>&#160;million for the first development milestone in the Ray License Agreement and $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-588">3.5</ix:nonFraction>&#160;million for the first development milestone in the Lexeo License Agreement during the years ended December&#160;31, 2024 and 2023, respectively. See Note 5, Revenue, for additional information. Because achievement of these future milestones is not fixed and determinable, such amounts have not been included on the Company&#8217;s consolidated statements of operations and comprehensive loss.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_169"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-589" continuedAt="f-589-1" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="f-589-1" continuedAt="f-589-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">February 2024 Private Placements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company entered into a securities purchase agreement, pursuant to which the Company sold <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="6" id="f-590">10.5</ix:nonFraction>&#160;million shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-78" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-591">75,000</ix:nonFraction> shares of common stock (the &#8220;Pre-Funded Warrants&#8221;) to certain institutional and accredited investors in a private placement. The purchase price per share was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-79" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-592">12.00</ix:nonFraction>, or $<ix:nonFraction unitRef="usdPerShare" contextRef="c-78" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-593">11.999</ix:nonFraction> per Pre-Funded Warrant, which represents the purchase price per share minus the $<ix:nonFraction unitRef="usdPerShare" contextRef="c-78" decimals="3" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-594">0.001</ix:nonFraction> per share exercise price of each Pre-Funded Warrant. Such Pre-Funded Warrants can be exercised at any time and have no expiration date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise of the outstanding Pre-Funded Warrants is subject to a beneficial ownership limitation of <ix:nonFraction unitRef="number" contextRef="c-80" decimals="4" name="advm:BeneficialOwnershipInterestLimitationPercent" scale="-2" id="f-595">9.99</ix:nonFraction>%. The Pre-Funded Warrants were classified as a component of stockholders&#8217; equity. As of December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-80" decimals="INF" name="advm:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-596">none</ix:nonFraction> of the Pre-Funded Warrants had been exercised.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-589-2" continuedAt="f-589-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently, the Company also entered into a securities purchase agreement with <ix:nonFraction unitRef="director" contextRef="c-81" decimals="INF" name="advm:SecuritiesPurchaseAgreementNumberOfDirectors" format="ixt-sec:numwordsen" scale="0" id="f-597">two</ix:nonFraction> directors of the Company (together with the private placement to certain institutional and accredited investors, the &#8220;Private Placements&#8221;). The Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-598">23,000</ix:nonFraction> shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-81" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-599">13.50</ix:nonFraction> per share on otherwise substantially the same terms as those set forth in the Securities Purchase Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the close of the Private Placements on February 7, 2024, the Company received total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" format="ixt:num-dot-decimal" scale="6" id="f-600">127.8</ix:nonFraction>&#160;million, before deducting placement agent fees and offering expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss included $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-601">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="f-602">0.4</ix:nonFraction> million of accumulated currency translation adjustments as of December&#160;31, 2024 and 2023, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company&#8217;s board of directors and its stockholders approved the establishment of the 2014 Equity Incentive Award Plan (the &#8220;2014 Plan&#8221;). The 2014 Plan provided for annual increases in the number of shares available for issuance thereunder on the first business day of each fiscal year, beginning with the year ended December 31, 2015, equal to four percent (<ix:nonFraction unitRef="number" contextRef="c-83" decimals="2" name="advm:ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" scale="-2" id="f-603">4</ix:nonFraction>%) of the number of shares of the Company&#8217;s common stock outstanding as of such date or a lesser number of shares as determined by the Company&#8217;s board of directors. In June 2024, the Company adopted the 2024 Equity Incentive Award Plan (the &#8220;2024 Plan&#8221;). The Company reserved <ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-604">4,688,345</ix:nonFraction> shares for issuance pursuant to awards under the 2024 Plan. As of the effective date of the 2024 Plan, <ix:nonFraction unitRef="shares" contextRef="c-85" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="f-605">no</ix:nonFraction> further awards may be granted under the 2014 Plan. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, the Company adopted the 2017 Inducement Plan (the &#8220;Inducement Plan&#8221;). The Company originally reserved <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-606">600,000</ix:nonFraction> shares for issuance pursuant to stock options and RSUs under the Inducement Plan. The only persons eligible to receive grants of stock options and RSUs under the Inducement Plan are individuals who satisfy the standards for inducement grants under Nasdaq guidance, that is, generally, a person not previously an employee or director of Adverum, or following a bona fide period of non-employment, as an inducement material to the individual&#8217;s entering into employment with Adverum.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2014 Plan, 2024 Plan and Inducement Plan are referred to collectively as the Plans. As of December&#160;31, 2024, a total of <ix:nonFraction unitRef="shares" contextRef="c-87" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-607">1,277,999</ix:nonFraction> shares were available for future issuance under the Plans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options under the 2024 Plan and the Inducement Plan may be granted for periods of up to <ix:nonNumeric contextRef="c-88" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-608">10</ix:nonNumeric> years and at prices no less than <ix:nonFraction unitRef="number" contextRef="c-89" decimals="INF" name="advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" scale="-2" id="f-609">100</ix:nonFraction>% of the estimated fair value of the shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an ISO and NSO granted to a <ix:nonFraction unitRef="number" contextRef="c-90" decimals="INF" name="advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" scale="-2" id="f-610">10</ix:nonFraction>% stockholder may not be less than <ix:nonFraction unitRef="number" contextRef="c-90" decimals="INF" name="advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" scale="-2" id="f-611">110</ix:nonFraction>% of the estimated fair value of the shares on the date of grant. Stock options granted to employees and non-employees generally vest ratably over <ix:nonNumeric contextRef="c-91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-612">four years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-613" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining Contract<br/>Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(a)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-614">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-615">48.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-616">6.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-617">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-618">1,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-619">10.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-620">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-621">9.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-622">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-623">50.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-624">3,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-625">29.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-626">8.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="f-628">3,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-629">29.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-630">8.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:fixed-zero" scale="3" id="f-631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="f-632">1,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-633">58.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-634">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="3" id="f-635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company&#8217;s common stock as quoted on a national exchange.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised during the years ended December&#160;31, 2024 and 2023 was <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="f-636"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:fixed-zero" scale="0" id="f-637">not</ix:nonFraction></ix:nonFraction> material.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-589-3" continuedAt="f-589-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-638" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-639">95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-640">90</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-641">83</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-642">78</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-89" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-643">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-92" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-644">6.0</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-93" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-645">1.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-94" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-646">1.3</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="f-647">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="f-648">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="f-649">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="f-650">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-651">3.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-652">4.2</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-653">4.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-654">5.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair values of options granted during the years ended December&#160;31, 2024 and 2023 were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-655">8.12</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-656">7.96</ix:nonFraction>, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, there was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-657">17.1</ix:nonFraction> million of unrecognized stock-based compensation expense related to stock options that was expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-658">2.6</ix:nonNumeric> years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#8217;s common stock upon vesting. The fair value of RSUs is based upon the closing sales price of the Company&#8217;s common stock on the grant date. RSUs granted to employees generally vest over a <ix:nonNumeric contextRef="c-95" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-659">three-year</ix:nonNumeric> period.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="f-660" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the RSU activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except grant date fair value and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term<br/>(in years)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-661">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-662">21.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-97" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-663">1.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-664">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-665">12.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="3" id="f-666">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-667">26.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-668">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-669">14.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-670">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-98" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-671">16.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-95" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-672">1.2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2024 and 2023, total fair value of RSUs vested was $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-673">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-674">1.5</ix:nonFraction>&#160;million, respectively. The number of RSUs vested includes shares of common stock that the Company withheld on behalf of employees or sold to cover to satisfy the minimum statutory tax withholding requirements. As of December&#160;31, 2024, there was $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-675">1.7</ix:nonFraction>&#160;million of unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-95" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-676">1.8</ix:nonNumeric> years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company approved the establishment of the 2014 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The Company reserved <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-677">208,833</ix:nonFraction>&#160;shares of its common stock for issuance and provided for annual increases in the number of shares available for issuance on the first business day of each fiscal year, beginning in 2015, equal to the lesser of one percent (<ix:nonFraction unitRef="number" contextRef="c-99" decimals="INF" name="advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" scale="-2" id="f-678">1</ix:nonFraction>%)&#160;of the number of the Company&#8217;s common stock shares outstanding as of such date or a number of shares as determined by the Company&#8217;s board of directors. During the years ended December&#160;31, 2024 and 2023, <ix:nonFraction unitRef="shares" contextRef="c-100" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-679">88,199</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-101" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-680">82,422</ix:nonFraction> shares were issued under the ESPP, respectively. As of December&#160;31, 2024, a total of <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-681">533,978</ix:nonFraction> shares of common stock were available for future issuance under the ESPP. As of December&#160;31, 2024, there was $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-682">0.5</ix:nonFraction>&#160;million of unrecognized compensation cost related to the ESPP.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-589-4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Recognized in the Consolidated Statements of Operations and Comprehensive Loss</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-683" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s stock-based compensation expense:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-684">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-685">4,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-686">9,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-687">12,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-688">14,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-689">17,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="f-690" continuedAt="f-690-1" escape="true">401(k) Savings Plan</ix:nonNumeric></span></div><ix:continuation id="f-690-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established a defined-contribution savings plan under Section 401(k) of the Code. The 401(k) Plan covers all employees who meet defined minimum age and service requirements, and allows participants to defer a portion of their annual compensation on a pretax basis. The amount of contributions that the Company made to the 401(k) Plan during the years ended December&#160;31, 2024 and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-691"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-692">0.9</ix:nonFraction></ix:nonFraction> million.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_1907"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-693" continuedAt="f-693-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-693-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM assesses performance for the Company&#8217;s single reportable segment and decides how to allocate resources based on the Company&#8217;s total operating expenses as reported on the consolidated statements of operations and comprehensive loss. The CODM&#8217;s review of total operating expenses at the consolidated level is used to monitor the Company&#8217;s spending as well as budget versus actual results. The Company&#8217;s reportable segment primarily generates revenue through its license agreements (see Note 5).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the CODM&#8217;s review of the segment&#8217;s performance, the CODM reviews the Company&#8217;s operating expense information, grouped by certain detailed line items from the internal income statement reporting. This includes research and development costs as well as general and administrative expenses. Based upon the operating expense information, the CODM can reconcile to net loss as reported on the consolidated statements of operations and comprehensive loss, shown in the table below.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-694" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the segment loss, including significant segment expenses, for the years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License Revenue</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-695">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-696">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-697">56,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-698">54,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial and manufacturing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="advm:ClinicalTrialExpenses" format="ixt:num-dot-decimal" scale="3" id="f-699">22,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="advm:ClinicalTrialExpenses" format="ixt:num-dot-decimal" scale="3" id="f-700">20,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and IT</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="advm:AllocatedFacilitiesAndInformationTechnologyExpenses" format="ixt:num-dot-decimal" scale="3" id="f-701">37,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="advm:AllocatedFacilitiesAndInformationTechnologyExpenses" format="ixt:num-dot-decimal" scale="3" id="f-702">39,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-703">4,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-704">4,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-705">18,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-706">13,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-707">140,159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-708">132,542</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-709">139,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-710">128,942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-711">8,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-712">5,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-713">130,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-714">123,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (provision)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-716">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment and consolidated net loss</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-717">130,927</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-718">122,116</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other segment expenses include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, all of the Company&#8217;s property and equipment was maintained in the United States. For each of the years ended December&#160;31, 2024 and 2023, all of the Company&#8217;s license revenue was generated in the United States.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-720" continuedAt="f-720-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-720-1" continuedAt="f-720-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the restatement, the Company adjusted the 2023 California research and development tax credit amounts as a result of a research and development credit study performed during 2024. This resulted in a net decrease of $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="f-721">3.4</ix:nonFraction>&#160;million in the deferred tax asset balance related to the California research and development tax credit (net of a decrease in unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" sign="-" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-722">1.9</ix:nonFraction>&#160;million) and a corresponding decrease in valuation allowance in 2023. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-723" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents domestic and foreign components of loss before provision for income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-724">130,768</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="f-725">123,040</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-726">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="f-727">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-728">130,927</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-729">123,194</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-730" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s income tax (benefit) provision were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-732">1,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-734">1,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-737">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit) provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-740">1,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-741" escape="true"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for the years ended December&#160;31, 2024 and 2023 differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax loss as a result of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-742">27,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-743">25,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-744">3,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-745">6,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="f-746">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" id="f-747">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-748">5,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-749">1,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-750">23,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-751">19,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-752">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-753">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of internal reorganization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" format="ixt:fixed-zero" scale="3" id="f-754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-755">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" format="ixt:num-dot-decimal" scale="3" id="f-756">6,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" format="ixt:num-dot-decimal" scale="3" id="f-757">1,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-758">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="f-759">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax (benefit) provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-761">1,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-720-2" continuedAt="f-720-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-762" continuedAt="f-762-1" escape="true">The following table presents significant components of the Company&#8217;s deferred tax assets and liabilities:</ix:nonNumeric></span><ix:continuation id="f-762-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-763">137,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-764">128,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserve and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-765">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="f-766">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-767">29,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-768">21,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-769">6,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-770">7,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="f-771">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="f-772">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:DeferredTaxAssetsLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="f-773">19,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:DeferredTaxAssetsLeaseObligation" format="ixt:num-dot-decimal" scale="3" id="f-774">17,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-775">9,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-776">9,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;D capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="advm:DeferredTaxAssetsCapitalizedCosts" format="ixt:num-dot-decimal" scale="3" id="f-777">35,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="advm:DeferredTaxAssetsCapitalizedCosts" format="ixt:num-dot-decimal" scale="3" id="f-778">29,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-779">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-780">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-781">240,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-782">215,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-783">232,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-784">205,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-785">7,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-786">9,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-787">7,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-788">8,153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-789">843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-790">1,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-791">7,992</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-792">9,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. Based on the Company&#8217;s history of operating losses, the Company has concluded that it is more likely than not that the benefit of its deferred tax assets will not be realized. Accordingly, the Company has provided a full valuation allowance for deferred tax assets as of December&#160;31, 2024 and 2023. The valuation allowance increased approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-795">26.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-796">17.7</ix:nonFraction>&#160;million during the years ended December&#160;31, 2024 and 2023, respectively, mainly driven by net operating losses (&#8220;NOLs&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had U.S. federal NOLs carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-797">552.7</ix:nonFraction>&#160;million to offset any future federal income. Approximately $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="advm:OperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-798">57.3</ix:nonFraction>&#160;million of NOLs expire at various years beginning with 2032. As of December&#160;31, 2024, the Company also had U.S. state NOL carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-799">345.2</ix:nonFraction>&#160;million to offset any future state income. U.S. state NOLs expire at various years beginning with 2037. At December&#160;31, 2024, the Company also had approximately $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-800">49.5</ix:nonFraction>&#160;million of foreign net operating loss carryforwards which may be available to offset future foreign income; these carryforwards do not expire.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had federal research and development tax credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-801">25.1</ix:nonFraction>&#160;million available to reduce future tax liabilities which expire at various years beginning with 2036. As of December&#160;31, 2024, the Company had state credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-802">13.8</ix:nonFraction>&#160;million available to reduce future tax liabilities which do not expire.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section 382 and 383 of the Code, our ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company has experienced an &#8220;ownership change.&#8221; Generally, a Section 382 ownership change occurs if there is a cumulative increase of more than 50 percentage points in the stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#8217;s stock within a specified testing period. Similar rules may apply under state tax laws. The Company is conducting a Section 382 study, which is still subject to finalization, but which may show that the Company experienced an ownership change in 2024. If such an ownership change has occurred then up to vast majority of the NOLs, capital losses and research credit carryforwards presented in the consolidated financial statements would be subject to limitations and therefore may expire unutilized.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-720-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal, state, and foreign jurisdictions. The federal, state and foreign income tax returns are open under the statute of limitations subject to tax examinations for the tax years ended December&#160;31, 2019 through December&#160;31, 2023. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state or foreign tax authorities to the extent utilized in a future period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has total unrecognized tax benefits as of December&#160;31, 2024 and 2023 of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-803">27.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-804">22.8</ix:nonFraction>&#160;million, respectively. If the unrecognized tax benefits for uncertain tax positions as of December 31, 2023, is recognized, there will be no impact to the effective tax rate as the tax benefit would increase the net deferred tax assets, which is currently offset with a full valuation allowance. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-805" continuedAt="f-805-1" escape="true">A&#160;reconciliation of the unrecognized tax benefits is as follows:</ix:nonNumeric></span><ix:continuation id="f-805-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the beginning of the year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-806">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-807">23,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax positions taken during the prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-809">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax positions taken during the prior year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-810">2,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax position taken during the current year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-812">7,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-813">3,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax position taken during the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-815">3,475</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the end of the year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-816">27,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-817">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></ix:continuation></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2024 and 2023, the Company had <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-818"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:fixed-zero" scale="0" id="f-819">no</ix:nonFraction></ix:nonFraction> accrued interest and penalties related to uncertain tax positions and <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="f-820"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:fixed-zero" scale="0" id="f-821">no</ix:nonFraction></ix:nonFraction> amount has been recognized in the Company's consolidated statement of operations and comprehensive loss. There are no ongoing examinations by taxing authorities at this time.</span></div></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_181"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-822" continuedAt="f-822-1" escape="true">Net Loss per Share</ix:nonNumeric></span></div><ix:continuation id="f-822-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2024, the Pre-Funded Warrants to purchase the Company's shares of common stock issued in the Private Placements were included in the basic and diluted net loss per share calculation as the exercise price is non-substantive and virtually assured.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-823" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents outstanding at the end of the periods presented were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-114" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-824">3,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-825">2,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-116" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-826">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-117" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-827">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-118" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-828">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-119" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-829">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-830">4,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-831">2,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_1975"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="f-832" continuedAt="f-832-1" escape="true">Quarterly Financial Information (Unaudited)</ix:nonNumeric></span></div><ix:continuation id="f-832-1" continuedAt="f-832-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The previously reported financial information for the three months ended March&#160;31, 2024, three and six months ended June&#160;30, 2024 and the three and nine months ended September&#160;30, 2024 and the comparable periods in 2023, has been restated. Relevant restated financial information for each period is included in this restatement and for other immaterial adjustments in the tables that follow. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restatement Related to NC Premises</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 2, the Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for a tenant improvement allowances that were conveyed to the subtenant resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-832-2" continuedAt="f-832-3"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2024, the Company inappropriately assessed the collectibility of the sublease payments as probable and recorded a deferred rent receivable of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="f-833">7.0</ix:nonFraction>&#160;million. The Company corrected its collectibility assessment and recognized an adjustment to eliminate the $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" sign="-" name="us-gaap:DeferredRentReceivablesNet" scale="6" id="f-834">7.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" sign="-" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="6" id="f-835">7.1</ix:nonFraction>&#160;million deferred rent receivable in the second and third quarters of 2024, respectively, the amounts of which are included in the tables below with reference (b).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Adjustments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this restatement, the Company has corrected certain other immaterial errors. These adjustments are described in more detail references (c) and (d) as follows:</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-836">0.2</ix:nonFraction>&#160;million in 2022.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company had previously understated its right-of-use assets and lease liability by $<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-837"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-838">0.3</ix:nonFraction></ix:nonFraction>&#160;million related to its facilities in Redwood City, California at each balance sheet date in 2024 and 2023.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="f-839" continuedAt="f-839-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented (in thousands, except per share data).</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-1" continuedAt="f-839-2"><ix:continuation id="f-832-3" continuedAt="f-832-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-840">92,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-842">92,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-843">60,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-845">60,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-846">7,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-848">7,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-849">161,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-851">161,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-852">50,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-853">17,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-854">33,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-855">12,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-857">12,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-858">7,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-859">7,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:fixed-zero" scale="3" id="f-860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-861">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-863">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-864">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-866">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-867">234,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-868">24,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-869">210,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-870">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-872">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-873">14,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-875">14,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-876">10,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-877">5,044</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-878">5,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-879">27,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-880">5,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-881">22,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-882">62,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-883">16,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-884">79,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-885">90,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-886">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-887">101,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-123" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-888"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-122" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-889"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-124" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-890"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-894">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-896">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-897">1,134,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-899">1,134,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-900">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-902">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-903">990,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-904">35,846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-905">1,026,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-906">144,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-907">35,846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-908">108,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-909">234,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-910">24,131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-911">210,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-2" continuedAt="f-839-3"><ix:continuation id="f-832-4" continuedAt="f-832-5"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-912">127,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-914">127,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-915">46,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-917">46,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-918">5,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-920">5,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-921">179,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-923">179,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-924">51,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-925">17,241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-926">33,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-927">13,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-121" xsi:nil="true" name="us-gaap:PropertyPlantAndEquipmentNet" id="f-928"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-929">13,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-930">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:DeferredRentReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-931">6,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:DeferredRentReceivablesNet" format="ixt:fixed-zero" scale="3" id="f-932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-933">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-935">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-936">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-938">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-939">253,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-940">24,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-941">229,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-942">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-944">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-945">9,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-947">9,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-948">10,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-949">5,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-950">5,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-951">22,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-952">5,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-953">17,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-954">63,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-955">11,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-956">74,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-957">85,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-958">6,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-959">92,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-120" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-960"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-121" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-961"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-2" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-962"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-966">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-968">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-969">1,131,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-970">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-971">1,131,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-972">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-974">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-975">963,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-976">30,629</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-977">993,669</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-978">168,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-979">30,629</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-980">137,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-981">253,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-982">24,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-983">229,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-3" continuedAt="f-839-4"><ix:continuation id="f-832-5" continuedAt="f-832-6"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-984">149,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-986">149,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-987">43,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-988">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-989">43,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-990">5,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-991">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-992">5,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-993">199,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-994">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-995">199,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-996">51,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-997">17,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-998">34,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-999">13,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-1000">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1001">13,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1002">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1003">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1004">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1005">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1007">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1008">267,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1009">17,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1010">250,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1011">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-1012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1013">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1014">9,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-1015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1016">9,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1017">10,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1018">4,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1019">5,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1020">21,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1021">4,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1022">16,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1023">63,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1024">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1025">70,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1026">85,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1027">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1028">86,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-125" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1029"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-126" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1030"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-127" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1031"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1032">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1035">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-1036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1037">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1038">1,127,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-1039">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1040">1,127,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1041">533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-1042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1043">533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1044">944,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1045">18,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1046">963,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1047">182,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1048">18,607</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1049">163,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1050">267,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1051">17,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1052">250,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-4" continuedAt="f-839-5"><ix:continuation id="f-832-6" continuedAt="f-832-7"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1053">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-1054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1055">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1056">11,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-1057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1058">11,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1059">7,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1060">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1061">7,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1062">124,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1063">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1064">124,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1065">52,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1066">17,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1067">35,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1068">15,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-1069">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1070">15,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1071">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1073">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1074">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1076">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1077">196,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1078">17,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1079">179,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1080">2,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-1081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1082">2,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1083">16,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-1084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1085">16,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1086">10,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1087">4,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1088">5,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1089">28,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1090">4,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1091">23,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1092">65,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1093">3,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1094">68,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1095">94,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1096">1,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1097">92,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-128" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1098"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-129" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1099"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-130" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1100"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1102">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1104">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-1105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1106">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1107">999,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-1108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1109">999,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1110">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-1111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1112">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1113">896,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1114">15,457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1115">911,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1116">102,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1117">15,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1118">87,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1119">196,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1120">17,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1121">179,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-5" continuedAt="f-839-6"><ix:continuation id="f-832-7" continuedAt="f-832-8"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1122">111,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-1123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1124">111,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1125">30,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-1126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1127">30,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1128">5,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1130">5,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1131">147,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1132">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1133">147,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1134">58,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1135">17,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1136">41,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1137">32,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-1138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1139">32,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1140">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1141">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1142">2,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1143">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1145">1,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1146">241,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1147">17,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1148">224,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1149">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-1150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1151">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1152">17,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-1153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1154">17,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1155">25,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1156">4,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1157">20,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1158">44,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1159">4,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1160">39,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1161">65,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1162">2,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1163">68,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1164">110,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1165">2,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1166">108,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-131" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1167"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-132" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1168"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-133" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1169"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1173">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-1174">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1175">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1176">994,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-1177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1178">994,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1179">606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-1180">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1181">606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1182">863,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1183">14,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1184">878,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1185">131,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1186">14,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1187">116,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1188">241,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1189">17,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1190">224,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-6" continuedAt="f-839-7"><ix:continuation id="f-832-8" continuedAt="f-832-9"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.646%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.584%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1191">67,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="3" id="f-1192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1193">67,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1194">96,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-1195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1196">96,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1197">4,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1199">4,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1200">168,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1202">168,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1203">69,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1204">22,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1205">46,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1206">33,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="3" id="f-1207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1208">33,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1209">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1211">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1212">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1214">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1215">275,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1216">22,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1217">252,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1218">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:fixed-zero" scale="3" id="f-1219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1220">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1221">17,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="f-1222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="advm:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1223">17,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1224">26,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1225">5,531</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1226">20,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1227">46,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1228">5,531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1229">40,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1230">71,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1231">3,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1232">67,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1233">117,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1234">8,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1235">108,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-134" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1236"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-135" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1237"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-52" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-1238"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-1241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1242">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-1243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-1244">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1245">990,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="3" id="f-1246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-1247">990,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1248">799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-1249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-1250">799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1251">831,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1252">13,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-1253">845,580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1254">157,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1255">13,912</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1256">143,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1257">275,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1258">22,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-1259">252,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_2059"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-7" continuedAt="f-839-8"><ix:continuation id="f-832-9" continuedAt="f-832-10"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly and Year to Date Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.412%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1260">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1262">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1263">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1265">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1266">20,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1268">20,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1269">52,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1271">52,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1272">9,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1273">5,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1274">14,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1275">24,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1276">19,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1277">44,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1278">30,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1279">5,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1280">35,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1281">77,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1282">19,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1283">97,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1284">29,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1285">5,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1286">34,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1287">76,942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1288">19,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1289">96,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1290">2,087</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1292">2,087</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1293">6,545</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1295">6,545</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1296">27,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1297">5,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1298">32,351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1299">70,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1300">19,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1301">89,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1302">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1304">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1305">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1307">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1308">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1310">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1311">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1313">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1314">26,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1315">5,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1316">32,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1317">70,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1318">19,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1319">89,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1320"><ix:nonFraction unitRef="usdPerShare" contextRef="c-136" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1321">1.30</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1322"><ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1323">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1324"><ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1325">1.55</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1326"><ix:nonFraction unitRef="usdPerShare" contextRef="c-139" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1327">3.63</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1328"><ix:nonFraction unitRef="usdPerShare" contextRef="c-140" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1329">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-141" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1330"><ix:nonFraction unitRef="usdPerShare" contextRef="c-141" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1331">4.64</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1332"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1333">20,876</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1334"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1335">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1336"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1337">20,876</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1338"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1339">19,408</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-140" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1340"><ix:nonFraction unitRef="shares" contextRef="c-140" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1341">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1342"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1343">19,408</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1344">17,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1346">17,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1347">32,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1348">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1349">32,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1350">3,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1351">12,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1352">15,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1353">15,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1354">14,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1355">29,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1356">20,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1357">12,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1358">32,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1359">47,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1360">14,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1361">62,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1362">20,882</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1363">12,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1364">32,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1365">47,721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1366">14,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1367">62,103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1368">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1370">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1371">4,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1373">4,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1374">18,476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1375">12,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1376">30,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1377">43,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1378">14,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1379">57,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1380">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1382">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1383">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1385">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1386">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1388">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1389">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1391">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1392">18,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1393">12,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1394">30,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1395">43,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1396">14,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1397">57,697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-142" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1398"><ix:nonFraction unitRef="usdPerShare" contextRef="c-142" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1399">0.89</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-143" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1400"><ix:nonFraction unitRef="usdPerShare" contextRef="c-143" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1401">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1402"><ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1403">1.46</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-145" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1404"><ix:nonFraction unitRef="usdPerShare" contextRef="c-145" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1405">2.31</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1406"><ix:nonFraction unitRef="usdPerShare" contextRef="c-146" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1407">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1408"><ix:nonFraction unitRef="usdPerShare" contextRef="c-147" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1409">3.08</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-142" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1410"><ix:nonFraction unitRef="shares" contextRef="c-142" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1411">20,852</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1412"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1413">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1414"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1415">20,852</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-145" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1416"><ix:nonFraction unitRef="shares" contextRef="c-145" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1417">18,713</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1418"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1419">&#8212;</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1420"><ix:nonFraction unitRef="shares" contextRef="c-147" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1421">18,713</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-8" continuedAt="f-839-9"><ix:continuation id="f-832-10" continuedAt="f-832-11"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1422">15,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1424">15,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1425">11,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1426">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1427">13,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1428">26,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1429">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1430">29,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1431">26,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1432">2,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1433">29,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1434">2,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1436">2,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1437">24,787</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1438">2,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1439">27,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1440">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1442">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1443">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1445">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1446">24,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1447">2,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1448">27,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1449"><ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1450">1.50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1451"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1452">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-150" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1453"><ix:nonFraction unitRef="usdPerShare" contextRef="c-150" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1454">1.65</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-148" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1455"><ix:nonFraction unitRef="shares" contextRef="c-148" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1456">16,479</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-149" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1457"><ix:nonFraction unitRef="shares" contextRef="c-149" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1458">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1459"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1460">16,479</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.618%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1464">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1466">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1467">20,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1469">20,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1470">62,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1471">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1472">62,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1473">13,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="f-1474">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1475">14,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1476">39,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1477">4,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1478">43,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1479">34,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:OperatingExpenses" scale="3" id="f-1480">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1481">35,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1482">101,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1483">4,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1484">105,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1485">34,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1486">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1487">35,059</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1488">97,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1489">4,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1490">101,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1491">1,661</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1493">1,661</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1494">4,437</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1495">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1496">4,437</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1497">32,868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-1498">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1499">33,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1500">93,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1501">4,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1502">97,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1503">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-152" xsi:nil="true" name="us-gaap:IncomeTaxExpenseBenefit" id="f-1504"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1505">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1506">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-155" xsi:nil="true" name="us-gaap:IncomeTaxExpenseBenefit" id="f-1507"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1508">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1509">32,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="f-1510">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1511">33,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1512">93,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1513">4,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1514">97,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1515">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1517">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1518">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1519">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1520">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1521">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1523">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1524">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1526">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1527">32,831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="f-1528">530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1529">33,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1530">92,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1531">4,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1532">96,633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1533"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1534">3.26</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-152" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1535"><ix:nonFraction unitRef="usdPerShare" contextRef="c-152" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1536">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1537"><ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1538">3.31</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1539"><ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1540">9.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-155" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1541"><ix:nonFraction unitRef="usdPerShare" contextRef="c-155" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1542">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-156" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1543"><ix:nonFraction unitRef="usdPerShare" contextRef="c-156" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1544">9.69</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1545"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1546">10,099</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1547"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1548">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-153" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1549"><ix:nonFraction unitRef="shares" contextRef="c-153" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1550">10,099</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-154" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1551"><ix:nonFraction unitRef="shares" contextRef="c-154" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1552">10,069</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-155" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1553"><ix:nonFraction unitRef="shares" contextRef="c-155" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1554">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-156" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1555"><ix:nonFraction unitRef="shares" contextRef="c-156" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1556">10,069</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-9" continuedAt="f-839-10"><ix:continuation id="f-832-11" continuedAt="f-832-12"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.738%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.618%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.437%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1560">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1562">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1563">20,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="3" id="f-1564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1565">20,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1566">41,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1567">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1568">41,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1569">12,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1570">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1571">13,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1572">25,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1573">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1574">29,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1575">33,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1576">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1577">34,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1578">66,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1579">3,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1580">70,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1581">33,065</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1582">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1583">34,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1584">63,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1585">3,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1586">66,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1587">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1589">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1590">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1592">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1593">31,489</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1594">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1595">32,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1596">60,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1597">3,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1598">64,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1599">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-158" xsi:nil="true" name="us-gaap:IncomeTaxExpenseBenefit" id="f-1600"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1601">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1602">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-161" xsi:nil="true" name="us-gaap:IncomeTaxExpenseBenefit" id="f-1603"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1604">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1605">31,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1606">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1607">32,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1608">60,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1609">3,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1610">64,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1611">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1613">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1614">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1616">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1617">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1619">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1620">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1622">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1623">31,317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1624">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1625">32,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1626">59,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1627">3,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1628">63,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-157" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1629"><ix:nonFraction unitRef="usdPerShare" contextRef="c-157" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1630">3.13</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-158" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1631"><ix:nonFraction unitRef="usdPerShare" contextRef="c-158" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1632">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1633"><ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1634">3.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1635"><ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1636">6.02</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1637"><ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1638">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1639"><ix:nonFraction unitRef="usdPerShare" contextRef="c-162" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1640">6.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-157" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1641"><ix:nonFraction unitRef="shares" contextRef="c-157" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1642">10,076</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-158" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1643"><ix:nonFraction unitRef="shares" contextRef="c-158" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1644">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-159" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1645"><ix:nonFraction unitRef="shares" contextRef="c-159" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1646">10,076</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1647"><ix:nonFraction unitRef="shares" contextRef="c-160" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1648">10,053</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1649"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1650">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1651"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1652">10,053</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1653">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1654">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1655">3,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1656">21,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-1657">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1658">20,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1659">12,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1660">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1661">15,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1662">33,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1663">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1664">36,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1665">30,239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1666">2,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1667">32,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1668">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-1669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-1670">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1671">29,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1672">2,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1673">31,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1674">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1675">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1676">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1677">29,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1678">2,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1679">31,672</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1680">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="f-1681">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="3" id="f-1682">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1683">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-1684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-1685">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1686">28,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1687">2,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1688">30,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1689"><ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1690">2.90</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-28" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="3" id="f-1691"><ix:nonFraction unitRef="usdPerShare" contextRef="c-28" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="3" id="f-1692">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-164" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1693"><ix:nonFraction unitRef="usdPerShare" contextRef="c-164" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1694">3.16</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1695"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1696">10,030</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-1697"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:fixed-zero" scale="3" id="f-1698">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1699"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1700">10,030</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_2043"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-10" continuedAt="f-839-11"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated <ix:continuation id="f-832-12" continuedAt="f-832-13">Statements of Cash Flows</ix:continuation></span></div><ix:continuation id="f-832-13" continuedAt="f-832-14"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of this restatement on certain line items of the condensed consolidated statements of cash flows are summarized in the following tables (in thousands). There was no impact on net cash used in operating activities or within any line items within investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1701">70,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1702">19,599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1703">89,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1704">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1705">4,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1706">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1708">8,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1709">8,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1710">7,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1711">7,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" scale="3" id="f-1712">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1713">43,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1714">14,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1715">57,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1716">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1717">2,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1718">3,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1720">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1721">4,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1722">6,894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1723">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets" scale="3" id="f-1724">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1725">24,787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1726">2,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1727">27,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-1728">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1729">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1730">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1732">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1733">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><ix:continuation id="f-839-11"><ix:continuation id="f-832-14"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1734">93,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1735">4,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1736">97,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1737">12,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1738">3,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1739">16,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="advm:NonCashSubleaseLossIncome" scale="3" id="f-1741">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="advm:NonCashSubleaseLossIncome" scale="3" id="f-1742">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1743">1,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1744">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1745">1,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1746">13,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1747">6,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1748">7,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1749">60,566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1750">3,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1751">64,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1752">6,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1753">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1754">9,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1756">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1757">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1758">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1759">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1760">715</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1761">13,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1762">6,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1763">7,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.600%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1764">29,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1765">2,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1766">31,672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1767">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1768">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1769">2,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="advm:NonCashSubleaseLossIncome" format="ixt:fixed-zero" scale="3" id="f-1770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1771">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="advm:NonCashSubleaseLossIncome" format="ixt:num-dot-decimal" scale="3" id="f-1772">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1773">749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1774">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="f-1775">939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1776">8,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" scale="3" id="f-1777">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="advm:ReMeasurementOfOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1778">7,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1779" continuedAt="f-1779-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-1779-1"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, a lien in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="f-1780">4.8</ix:nonFraction>&#160;million was filed by a third-party contractor against the subtenant's interest in the NC Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Company assumed responsibility for such payments in March 2025 and as of April 7, 2025 had made a total amount of $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="6" id="f-1781">1.9</ix:nonFraction>&#160;million to satisfy outstanding rent and common area management fee obligations. The Company remains obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="f-1782">119.7</ix:nonFraction>&#160;million for the remainder of the head lease term, of which $<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-1783">5.7</ix:nonFraction>&#160;million is due between April 8 and December 31, 2025. As a result of the uncured defaults, the Company terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce its rights under the sublease and to seek recovery of losses and damages incurred due to the defaults by the subtenant and Jaguar.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_208"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, including Laurent Fischer, our Chief Executive Officer and Linda Rubinstein, our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of December&#160;31, 2024. The evaluation of our disclosure controls and procedures included a review of our processes and implementation and the effect on the information generated for use in this Annual Report on Form 10-K. We conduct this type of evaluation quarterly so that our conclusions concerning the effectiveness of these controls can be reported in our periodic reports filed with the SEC. The overall goals of these evaluation activities are to monitor our disclosure controls and procedures and to make modifications as necessary. We intend to maintain these disclosure controls and procedures, modifying them as circumstances warrant.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the existence of the material weakness in our internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we assessed our internal control over financial reporting as of December 31, 2024, the end of our fiscal year, based on the framework in &#8220;Internal Control&#8212;Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management's assessment included evaluation of such elements as the operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment. This assessment is supported by testing and monitoring performed by our internal accounting and finance organization.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management identified a material weakness in the Company&#8217;s internal control over financial reporting as of December 31, 2024 with respect to the design and operating effectiveness of the Company&#8217;s controls over lease accounting. The material weakness resulted in misstatements in the Company&#8217;s previously issued financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our assessment, management has concluded that our internal control over financial reporting was not effective as of December&#160;31, 2024 due to the material weakness. The results of management's assessment were reviewed with the Audit Committee.</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address our material weakness, we have implemented and continue to implement increased rigor to ensure controls operate with regard to lease accounting. Consistent with past practice, the preparation of technical accounting memos will occur for all material lease agreements, including modifications of existing agreements. Management will engage additional outside financial reporting and technical accounting expertise to assist in the analysis of potential accounting impacts of new or amended lease agreements and will improve the process to monitor accounting conclusions for existing lease agreements. In addition, management will enhance the process to monitor creditworthiness of subtenants and increase the oversight over any subtenant activities, including obtaining robust support of lease payments and tenant improvement allowance payments.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that these efforts will improve our internal control over financial reporting, the implementation of our remediation is ongoing and will require validation and testing of the operating effectiveness of our internal controls over a sustained period of financial reporting cycles. The actions that we are taking are subject to ongoing senior management review, as well as Audit Committee oversight. We will not be able to conclude whether the steps we are taking will fully remediate the material weakness in our internal control over financial reporting until we have completed our remediation efforts and subsequent evaluation of their effectiveness.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described under the &#8220;Remediation Plan&#8221; above, we have implemented increased rigor to ensure controls operated over lease accounting during the quarter ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Such remediation actions were changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_211"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Termination of Sublease for NC Premises</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into the operating lease related to the &#8220;NC Premises&#8221;, and in October 2021, we entered into a sublease agreement with Jaguar, who subsequently assigned the sublease to AMP as the subtenant for the NC Premises, through the remainder of the lease term (ending in October 2037). Pursuant to the sublease and the assignment agreement, Jaguar remained obligated for AMP&#8217;s proper performance under the sublease. In February 2025, a lien in the amount of  $4.8&#160;million was filed by a third-party contractor against the subtenant's interest in the NC Premises. We discharged the lien in March 2025 by depositing cash in the full amount with the applicable court to avoid a default under the head lease. Further liens by third-party subcontractors or other contractors have been or may in the future be filed against the subtenant's interest in the NC Premises and we may need to also discharge such liens to avoid a default under the head lease. The subtenant and Jaguar failed to remit March 2025 rent and subsequent rent payments, and defaulted and failed to cure such defaults under the sublease for the NC Premises. As a result, we assumed responsibility for such payments in March 2025. As of April 7, 2025, we had made payments in the total amount of $1.9&#160;million to satisfy outstanding rent and common area management fee obligation, and we remain obligated under the head lease, including for all future rent payments in an aggregate amount of up to $119.7&#160;million for remainder of the head lease term, of which $5.7&#160;million is due between April 8 and December 31, 2025. As a result of the uncured defaults, we terminated the sublease on April 9, 2025 and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce our rights under the sublease and to seek recovery of losses and damages incurred due to the defaults by the subtenant and Jaguar. In the event we are unsuccessful in collecting from the subtenant or identify a new subtenant on acceptable terms or at all, we will be required to satisfy our obligations directly to the landlord under such original lease in accordance with its terms.</span></div><div style="margin-top:6pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">10b5-1 Plans</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-167" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1784"><ix:nonNumeric contextRef="c-167" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1785"><ix:nonNumeric contextRef="c-167" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1786"><ix:nonNumeric contextRef="c-167" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1787">None</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> of our directors or officers (as defined in Section 16 of the Securities Exchange Act of 1934, as amended) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as defined in Item 408(a) of Regulation S-K.</span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_214"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Not applicable</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_217"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_220"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in our definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A in connection with our 2025 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;), which is expected to be filed not later than 120 days after the end of our fiscal year ended December&#160;31, 2024, under the headings &#8220;Executive Officers,&#8221; &#8220;Election of Directors,&#8221; &#8220;Corporate Governance,&#8221; and, if applicable, &#8220;Delinquent Section 16(a) Reports,&#8221; and is incorporated herein by reference.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Business Conduct and Ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. The Code of Business Conduct and Ethics is publicly available on our website at http://investors.adverum.com. We intend to promptly disclose on our website or in a Current Report on Form 8-K in the future (i) the date and nature of any amendment (other than technical, administrative or other non-substantive amendments) to the Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions and relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation S-K and (ii) the nature of any waiver, including an implicit waiver, from a provision of the Code of Business Conduct and Ethics that is granted to one of these specified individuals that relates to one or more of the elements of the code of ethics definition enumerated in Item 406(b) of Regulation S-K, the name of such person who is granted the waiver and the date of the waiver.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1788">We have adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees. In addition, it is the Company&#8217;s intent to comply with the applicable laws and regulations relating to insider trading. A copy of our insider trading policy is filed as an exhibit to this Form 10-K.</ix:nonNumeric></span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_226"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Executive Compensation&#8221; and &#8220;Non-employee Director Compensation,&#8221; and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_232"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information,&#8221; and is incorporated herein by reference.</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_238"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in the Proxy Statement under the headings &#8220;Certain Relationships and Related Party Transactions&#8221; and &#8220;Corporate Governance,&#8221; and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_244"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accountant Fees and Services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in the Proxy Statement under the proposal titled, &#8220;Ratification of Selection of Independent Registered Public Accounting Firm&#8221; and is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_253"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Exhibit and Financial Statement Schedules.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The financial statements schedules and exhibits filed as part of this Annual Report on Form 10-K are as follows:</span></div><div style="margin-top:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Index to Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K. No financial statement schedules are provided because the information called for is not required or is shown in the consolidated financial statements or related notes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The following exhibits are included herein or incorporated by reference:</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCORPORATED BY REFERENCE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FILE NUMBER</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DATE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PROVIDED<br/>HEREWITH</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828024045033/advm-20240930ex31.htm">Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/d917807dex31.htm">Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 29, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524024156/d739306dex41.htm">Form of Pre-Funded Warrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524024156/d739306dex102.htm">Form of Registration Rights Agreement, dated February 5, 2024, by and among Adverum Biotechnologies, Inc. and the investors party thereto.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021003623/advm-20201231xexx42.htm">Description of Common Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1A&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459016023738/advm-ex109_293.htm">License Agreement between AAVLife and Inserm Transfert, dated as of July 4, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1B&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459016023738/advm-ex1010_292.htm">Amendment No. 1 to License Agreement between AAVLife and Inserm Transfert, dated as of October&#160;5,&#160;2015.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 9, 2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/advm-ex1046_908.htm">Exclusive License Agreement between Avalanche Biotechnologies, Inc. and the Regents of the University of California, dated as of June 17, 2013.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 6, 2019</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/advm-ex1047_912.htm">License Agreement between Avalanche Biotechnologies, Inc. and Virovek, Inc., dated as of October 12, 2011.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 6, 2019</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/advm-ex102_101.htm">Lease Agreement between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/advm-ex102_101.htm">dated as of June 28, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 8, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021015877/ex101firstamendment-health.htm">First Lease Amendment between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of April 19, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 5, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4C</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828022007698/advm-20211231xex104c.htm">Second Amendment to Lease (Partial Lease Termination) between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of November 1, 2021. </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4C</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828023009899/advm-20221231xexx104d.htm">Third Amendment to Lease (Partial Lease Termination) between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of March 24, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4E</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828023009899/advm-20221231xexx104e.htm">Fourth Amendment to Lease between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of March 24, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4E</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021009293/advm-20210331ex105leasenor.htm">Lease Agreement between Adverum NC, LLC (a wholly owned subsidiary of the Company) and ARE-NC REGION NO. 21, LLC, dated as of January 8, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCORPORATED BY REFERENCE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FILE NUMBER</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DATE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PROVIDED<br/>HEREWITH</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828022007698/advm-20211231xexx105b.htm">Sublease Agreement between Adverum NC, LLC and Jaguar Gene Therapy, LLC, dated as of October 26, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5C</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828023017564/advm-20230331ex103.htm">Third Amendment to Lease and First Amendment to Consent to Sublease between Adverum NC, LLC (a wholly owned subsidiary of the Company), ARE-NC REGION NO. 21, LLC and Jaguar Gene Therapy, LLC, dated as of April 3, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6A(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312525039358/d871552dex991.htm">2017 Inducement Plan, as amended and restated</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">333-285358</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6B(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312517307248/d463313dex992.htm">Form of Stock Option Grant Notice and Option Agreement under the 2017 Inducement Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-220894</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6C(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312517307248/d463313dex993.htm">Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2017 Inducement Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-220894</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 11, 2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828022022469/ex1042014esppplanamended.htm">Adverum Biotechnologies, Inc. 2014 Employee Stock Purchase Plan, as amended and restated.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 11, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8A(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit1082014eip.htm">Adverum Biotechnologies, Inc. 2014 Equity Incentive Award Plan, as amended and restated.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 10, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8B(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459018004560/advm-ex1014_1087.htm">Form of Stock Option Grant Notice and Stock Option Agreement under the 2014 Equity Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 6, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8C(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459018004560/advm-ex1016_1089.htm">Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2014 Equity Incentive </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 6, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8D(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312514280644/d729335dex1018.htm">Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2014 Equity Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-197133</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 25, 2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8E(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828022007698/advm-20211231xexx108e.htm">Form of Performance Stock Unit Award Grant Notice and Performance Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8E</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9A(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">Adverum Biotechnologies, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">02</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">4 Equity Incentive </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">Award Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex991.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-280567</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9B(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex992.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex992.htm">orm of Stock Option Grant Notice and S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex992.htm">tock Option Agreement under the 2024 Equity Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-280567</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9C(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex993.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex993.htm">orm of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex993.htm">Restricted</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312524172227/d623076dex993.htm"> Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2024 Equity Incentive Award Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-280567</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828023028851/advm-20230630ex106.htm">Form of Change in Control and Severance Agreement for executive officers other than the chief executive officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 10, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020008534/advm-20200331xex101.htm">Form of Indemnification Agreement for directors and executive officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 28, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021009293/advm-20210331ex107nonxempl.htm">Non-Employee Director Compensation Policy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021009293/advm-20210331ex107nonxempl.htm">, ad</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021009293/advm-20210331ex107nonxempl.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828021009293/advm-20210331ex107nonxempl.htm">pted May 5, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCORPORATED BY REFERENCE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FILE NUMBER</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DATE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PROVIDED<br/>HEREWITH</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.13(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828024036769/advm-20240630ex104.htm">Non-Employee Director Compensation Policy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828024036769/advm-20240630ex104.htm">, adopted May 22, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.14A(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit101laurentfisch.htm">Offer Letter between Adverum Biotechnologies, Inc. and Laurent Fischer, dated as of June 11, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 10, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.14B(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm">Change</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm"> in Control and Severance Agreement between Adverum Biotechnologies, Inc. and Laure</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm">n</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm">t Fischer, dated </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm">as</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/exhibit102laurentfisch.htm"> of June 11, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 10, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.15(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000156459019041787/advm-ex102_241.htm">Offer Letter between Adverum Biotechnologies, Inc. and Peter Soparkar, dated as of October 11, 2019.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 7, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.16(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828022007698/advm-20211231xexx1021.htm">Offer Letter between Adverum Biotechnologies, Inc. and Setareh Seyedkazemi, dated as of December 3, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 29, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.17(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828023028851/advm-20230630ex105.htm">Offer Letter between Adverum Biotechnologies, Inc. and Linda Rubinstein, dated as of August 3, 2023.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 10, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.18(#)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">O</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">ffer Letter between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">Adverum Biotechnologies, Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">. and Rab</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">ia </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">Gu</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">rses</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm"> Ozden</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm"> dated as of June </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx1018.htm">10, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">10.19</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000119312523142114/d494076dex11.htm">Sales Agreement, dated May 11, 2023, by and between Adverum Biotechnologies, Inc. and Cowen and Company, LLC.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1789"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx191.htm">I</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx191.htm">nsider Trading P</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx191.htm">olicy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx191.htm">.</a></ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx211.htm">List of subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_259">Power of Attorney (included on signature page hereto)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx311.htm">Certification of Principal Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx312.htm">Certification of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx312.htm">Prin</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx312.htm">cipal</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx312.htm"> Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx321.htm">Certification of Principal Executive Officer pursuant to 18&#160;U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="advm-20241231xexx322.htm">Certification of Principal Financial and Accounting Officer pursuant to 18&#160;U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1501756/000162828024011648/advm-20231231xexx971.htm">Incentive Compensation Recoupment Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-36579</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 18, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.856%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.111%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">INCORPORATED BY REFERENCE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FILE NUMBER</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DATE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">EXHIBIT<br/>NUMBER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PROVIDED<br/>HEREWITH</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page of the Company's Annual Report on Form 10-K has been formatted in Inline XBRL.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This certification attached to this Annual Report on Form 10-K is not deemed filed with the SEC and is not to be incorporated by reference into any filing of Adverum Biotechnologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.</span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_256"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i354d6e8aa86547e4a49e0ebd73a9c63c_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i354d6e8aa86547e4a49e0ebd73a9c63c_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date: April&#160;15, 2025 </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.305%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADVERUM BIOTECHNOLOGIES, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Laurent Fischer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Laurent Fischer, M.D.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Linda Rubinstein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Linda Rubinstein</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Principal Accounting Officer)</span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Power of Attorney</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each person whose individual signature appears below hereby authorizes and appoints Laurent Fischer and Linda Rubinstein, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form&#160;10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this annual report on Form&#160;10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.481%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.481%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TITLE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DATE</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Laurent Fischer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer and Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laurent Fischer, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Linda Rubinstein</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Linda Rubinstein</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Patrick Machado</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patrick Machado</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Soo Hong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soo Hong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Szil&#225;rd Kiss, M.D. </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Szil&#225;rd Kiss, M.D. </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Mark Lupher</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Lupher, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ C. David Nicholson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">C. David Nicholson, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ James Scopa</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">James Scopa</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Dawn Svoronos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dawn Svoronos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Reed Tuckson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reed Tuckson, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Scott Whitcup</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 4.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scott Whitcup, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>2
<FILENAME>advm-20241231xexx1018.htm
<DESCRIPTION>EX-10.18
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4e3490e458a045dd9a96c38278573369_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div><font><br></font></div><div style="padding-left:28.95pt;padding-right:40.5pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="padding-left:46pt"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 4, 2024</font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font><br></font></div><div style="padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rabia Gurses Ozden, M.D.  </font></div><div style="padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Address&#93; </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Re&#58; Chief Medical Officer (CMO)  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dear Rabia, </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">I am pleased to offer you a position with Adverum Biotechnologies, Inc. (the &#8220;Company&#8221;) as Chief  Medical Officer (CMO), reporting to the President and Chief Executive Officer, Laurent Fischer,  M.D.  Although you will be based out of our office located in Redwood City, California, this is a  remote role so you will maintain your residence in Edgewater, New Jersey and telecommute. Our  Telecommuting Policy is attached at Exhibit A. You acknowledge that your position as CMO, and  associated responsibilities may sometimes require you be present in the Redwood City office. The  details of your telecommuting arrangement, in particular the frequency of travel to Redwood City,  will  be  as  arranged  between  you  and  your  manager  taking  into  account  the  duties  and  responsibilities of your role consistent with the Company&#8217;s Telecommuting Policy at Exhibit A.  </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you decide to join us, this letter agreement (the &#8220;Agreement&#8221;) memorializes your compensation  and other employment terms. These terms will become effective on the date you join the Company  (the &#8220;Hire Date&#8221;).     </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Compensation and Benefits.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Base Compensation&#58;  </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Your base salary will be $500,000.00 annually ($20,833.34 per pay period), subject to payroll  deductions and all required withholdings, reflecting your full-time employment with the Company.  Your salary will be paid in accordance with the Company&#8217;s standard payroll schedule (currently  the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and last calendar day of each month).  As an exempt salaried employee, you will be  expected to work the Company&#8217;s normal business hours as well as additional hours as required by  the nature of your work assignments, and you will not be eligible for overtime compensation.  </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Annual Bonus&#58;  </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, for each calendar year starting with 2024 you will be eligible to earn an annual  performance bonus with a target bonus amount equal to 40% of your base salary (as of January 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  of the bonus year). Your annual bonus for the calendar year in which you were hired will be  prorated based on your Hire Date, so long as you joined the Company prior to October 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of that  year. If you join on or after October 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, you will not be eligible for a bonus for that year.  Your  annual bonus will be calculated based on the Company&#8217;s achievement of the annual corporate  goals to be determined by the Company&#8217;s management each year, as well as such other criteria  </font></div><div style="margin-bottom:6.75pt;padding-right:27pt"><font><br></font></div><div style="padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2019  </font></div><div style="padding-right:27pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="padding-left:46pt;padding-right:27pt"><font><br></font></div><div style="margin-top:6pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">deemed relevant by the Company.  Bonus payments will be in the form of cash and will be granted  entirely at the discretion of the Company&#8217;s CEO and Board of Directors or its Compensation  Committee.  Any  cash  bonus  payments  will  be  less  payroll  deductions  and  all  required  withholdings. The bonus is not earned until paid (that is, you must be employed by the Company  on the date the bonus is paid in order to be entitled to receive the bonus) and no pro-rated amount  will be paid if your employment terminates for any reason prior to the payment date.   </font></div><div style="margin-top:12pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Annual Equity Award&#58;  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For each calendar year starting with the year after you complete one full year of service, you may  be eligible for a discretionary annual equity grant, provided that you are actively employed with  the  Company  through  and  including  the  date  of  such  annual  equity  grant.    Whether  any  discretionary annual equity grant is granted, and the terms of any such equity grant, is entirely at  the discretion of the Company&#8217;s Board of Directors or its Compensation Committee.   </font></div><div style="margin-top:12pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signing Bonus&#58;  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A  one-time  signing  bonus  of  $150,000.00  will be  advanced  within  the first  30  days  of  your  employment  and  will  be  subject  to  payroll  deductions  and  all  required  withholdings  (the  &#8220;Signing&#47;Retention  Bonus&#8221;).  You  will  earn  the  Signing&#47;Retention  Bonus  if  you  remain  continuously employed by the Company for 12 months after your Hire Date. If your employment  ends within 12 months of your Hire Date for any reason other than death, disability, or &#8220;Covered  Termination&#8221; (as defined in the Change of Control and Severance Agreement attached as Exhibit  A (the &#8220;Change of Control and Severance Agreement&#8221;),  you agree to repay, within 30 days of  your last day of employment with the Company, the entire gross amount of the Sign-On&#47;Retention  Bonus paid to you by the Company in advance of being earned.   </font></div><div style="margin-top:12pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Benefits  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a regular, full time employee, you will be eligible to participate in the Company&#8217;s employee  benefits programs in accordance with the terms, conditions and limitations of the benefit plans,  including health, dental and vision plans, retirement, paid time off, and other benefits, to the extent  such plans have been established by the Company. Our employee benefits are described in the  Benefits Booklet.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All  forms  of  compensation  referred  to  in  this  Agreement  are  subject  to  all  applicable  taxes,  withholding and any other deductions required by applicable law.  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may change compensation and benefits from time to time in its discretion.  </font></div><div style="margin-top:12pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;New Hire Equity Grant.  </font></div><div style="margin-top:12pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">New Hire Equity Grant.  </font></div><div style="margin-bottom:10.1pt;margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div style="padding-right:27pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="padding-left:46pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, if you join the Company, it will be recommended  at the first meeting of the Company&#8217;s  Board of Directors or its Compensation Committee following your Hire Date, that the Company  grant you options to purchase 85,000 shares of the Company&#8217;s common stock with an exercise  price per share equal to the closing price of the common stock on the date of grant (the &#8220;Option&#8221;).   The Option will vest and become exercisable as follows&#58; subject to you continuing employment  with the Company through each vesting date, 25% of the shares of common stock subject to the  award of the Option shall vest on the first anniversary of the vesting commencement date (your  Hire Date) and 1&#47;48th of the total shares granted shall vest and become exercisable monthly  following such anniversary such that the entire award shall be vested and exercisable on the fourth  anniversary  of  the  vesting  commencement  date.  Subject  to  your  continued  service  with  the  Company  on  the  applicable  vesting  dates,  thirty-three  and  thirty  three  thousandths  percent  (33.33%) of the Shares subject to this award of RSUs shall vest and be released on each anniversary  of the Vesting Commencement Date such that all of the Shares subject to this award of RSUs are  vested and released on the third (3rd) anniversary of the Vesting Commencement Date. The Option  will be an incentive stock option to the maximum extent allowed by the tax code and shall be  subject to the other terms and conditions set forth in the Company&#8217;s 2024 Equity Incentive Plan  and the Company&#8217;s standard form of Stock Option Agreement. You should consult with your own  tax advisor concerning the risks associated with accepting the Option.   </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;Confidentiality and Proprietary Information Obligations.  </font></div><div style="margin-top:9pt;padding-left:117pt;padding-right:27pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Company  Policies  and  Proprietary  Information  Agreement.  As  a  condition  of  employment, you will be required to sign the employee Proprietary Information  and Invention Assignment Agreement (the &#8220;PIIAA&#8221;) attached hereto as Exhibit B,  which requires, among other provisions, the assignment of patent rights to any  invention made during your employment at the Company, and non-disclosure of  Company proprietary information. Similarly, you agree not to bring any third-party  confidential information to the Company, including that of your former employer,  and that in performing your duties for the Company you will in no way utilize any  such information.  You agree to honor all obligations to former employers during  your employment with the Company.   </font></div><div style="margin-top:9pt;padding-left:117pt;padding-right:27pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Adverse or Outside Business Activities. Throughout your employment with the  Company, you may engage in civic, academic teaching and lectures, and not-for- profit activities so long as such activities do not interfere with the performance of  your duties hereunder or present a conflict of interest with the Company. You may  not  engage  in  other  employment  or  undertake  any  other  commercial  business  activities unless you obtain the prior written consent of the Company&#8217;s CEO. The  Company  may  rescind  its  consent  to  your  service  as  a  director  of  all  other  corporations or participation in other business or public activities, if the Company,  in its sole discretion, determines that such activities compromise or threaten to  compromise the Company&#8217;s reputational or business interests or conflict with your  duties to the Company. In addition, throughout the term of your employment with  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="margin-top:9pt;padding-left:117.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company, you agree not to, directly or indirectly, without the prior written  consent of the Company, own, manage, operate, join, control, finance or participate  in the ownership, management, operation, control or financing of, or be connected  as an officer, director, executive, partner, employee, principal, agent, representative, consultant, licensor, licensee or otherwise with, any business or  enterprise  engaged  in  any  business  which  is  competitive  with  or  which  is  reasonably anticipated to be competitive with the Company&#8217;s business&#59; provided,  however, that you may purchase or otherwise acquire up to (but not more than) 1%  of any class of securities of any enterprise (but without participating in the activities  of such enterprise) if such securities are listed on any national or regional securities  exchange. You hereby represent and warrant that you have disclosed previously to  the Company all other employment or other commercial business activities that you  already undertake, or intend to undertake (to the extent currently known by you),  during your period of employment with the Company.  </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;No Conflicts.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By  signing  this  Agreement  you  hereby  represent  to  the  Company  that,  except  as  previously disclosed to the Company&#58; (a) your employment with the Company is not prohibited under any employment agreement or other contractual arrangement&#59; and (b) you do not know of any conflicts which would restrict your employment with the Company. You hereby represent that you have disclosed to the Company any contract you have signed that may restrict your activities on behalf of the Company, and that you are presently in compliance with such contracts, if any.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;Reserved.   </font></div><div style="margin-top:9pt;padding-left:45pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.  &#160;&#160;&#160;&#160;At Will Employment.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is excited about your joining as a full time, regular, exempt employee and looks  forward to a beneficial and productive relationship.  Nevertheless, your employment relationship  with the Company will be an &#8220;at-will&#8221; arrangement and is for no specific period. This means that  either you or the Company may terminate your employment at any time, with or without cause,  and with or without advance notice. This &#8220;at-will&#8221; employment relationship cannot be changed  except  in  a  written  agreement  approved  by  the  Company  and  signed  by  you  and  by  a  duly  authorized officer of the Company. We request that, in the event of resignation, you give the  Company at least two weeks notice. You should note that the Company may modify job titles,  salaries and benefits from time to time as it deems necessary.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;Miscellaneous.  </font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1. &#160;&#160;&#160;&#160;Conditions of employment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This offer is contingent upon a satisfactory reference check and satisfactory proof of your right to work in the United States.  If the Company informs</font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div style="padding-right:27pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">you that you are required to complete a background check, this offer is contingent upon satisfactory  clearance  of  such  background  check.  You  agree  to  assist  as  needed  and  to  complete  any  documentation at the Company&#8217;s request to meet these conditions.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dispute Resolution.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To ensure the rapid and economical resolution of disputes  that may arise in connection with your employment with the Company, you and the Company  agree that any and all disputes, claims, or causes of action, in law or equity, including but not  limited to statutory claims, arising from or relating to the enforcement, breach, performance, or  interpretation of this Agreement, your employment with the Company, or the termination of your  employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. &#167; 1-16, to the  fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS  or its successor, under JAMS&#8217; then applicable rules and procedures for employment disputes  before a single arbitrator (available upon request and also currently available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.jamsadr.com&#47;rules-employment-arbitration&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">You acknowledge that by agreeing to  this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  In addition, all claims,  disputes, or causes of action under this section, whether by you or the Company, must be brought  in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in  any purported class or representative proceeding, nor joined or consolidated with the claims of any  other person or entity.  The arbitrator may not consolidate the claims of more than one person or  entity, and may not preside over any form of representative or class proceeding.  To the extent that  the preceding sentences regarding class claims or proceedings are found to violate applicable law  or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall  proceed in a court of law rather than by arbitration.  This paragraph shall not apply to any action  or claim that cannot be subject to mandatory arbitration as a matter of law, including, without  limitation, claims brought pursuant to the California Private Attorneys General Act of 2004, as  amended,  to  the  extent  such  claims  are  not  permitted  by  applicable  law  to  be  submitted  to  mandatory arbitration (collectively, the &#8220;Excluded Claims&#8221;).  In the event you intend to bring  multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be  publicly filed with a court, while any other claims will remain subject to mandatory arbitration.   You will have the right to be represented by legal counsel at any arbitration proceeding. Questions  of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator.   Likewise, procedural questions which grow out of the dispute and bear on the final disposition are  also matters for the arbitrator.  The arbitrator shall&#58; (a) have the authority to compel adequate  discovery for the resolution of the dispute and to award such relief as would otherwise be permitted  by law&#59; and (b) issue a written statement signed by the arbitrator regarding the disposition of each  claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#8217;s  essential findings and conclusions on which the award is based. The arbitrator shall be authorized  to award all relief that you or the Company would be entitled to seek in a court of law. The  Company shall pay all JAMS arbitration fees in excess of the administrative fees that you would  be required to pay if the dispute were decided in a court of law. Nothing in this letter agreement is  intended to prevent either you or the Company from obtaining injunctive relief in court to prevent  irreparable harm pending the conclusion of any such arbitration.  Any awards or orders in such  </font></div><div style="margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="margin-top:9pt;padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="margin-top:9pt;padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">arbitrations may be entered and enforced as judgments in the federal and state courts of any  competent jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3.  &#160;&#160;&#160;&#160;Succession and assignment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement is personal to you and shall not be  assigned by you. Any purported assignment by you shall be null and void from the initial date of  the purported assignment. The Company may assign this Agreement to any successor or assign  (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially  all of the business or assets of the Company. This Agreement shall inure to the benefit of the  Company and permitted successors and assigns.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4.  &#160;&#160;&#160;&#160;Enforceability.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any provision of this Agreement is determined to be invalid or  unenforceable, in whole or in part, this determination shall not affect any other provision of this  Agreement and the provision in question shall be modified so as to be rendered enforceable in a  manner consistent with the intent of the parties insofar as possible under applicable law.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.5.  &#160;&#160;&#160;&#160;Governing law and jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be construed and enforced  <br>in accordance with the laws of the State of California without regard to conflicts of law principles.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.6.  &#160;&#160;&#160;&#160;Headings and captions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The captions of the sections of this Agreement are for  convenience of reference only and in no way define, limit or affect the scope or substance of any  section of this Agreement.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.7.  &#160;&#160;&#160;&#160;No construction against drafter.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any ambiguity in this Agreement shall not be  construed against either party as the drafter.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.8.  &#160;&#160;&#160;&#160;Waiver.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any waiver of a breach of this Agreement, or rights hereunder, shall be  in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> This letter may be delivered and executed via facsimile, electronic  mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of  2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method  and shall be deemed to have been duly and validly delivered and executed and be valid and  effective for all purposes.   </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.10 &#160;&#160;&#160;&#160;Entire agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement, together with the Change of Control and  Severance Agreement (Exhibit A) and your PIIAA (Exhibit B), forms the complete and exclusive  statement  of  your  employment  agreement  with  the  Company.  The  employment  terms  in  this  Agreement supersede any other agreements or promises made to you by anyone concerning your  employment  terms,  including,  but  not  limited  to,  any  representations  made  during  your  recruitment, interviews or pre employment negotiations, whether written or oral.  </font></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.  &#160;&#160;&#160;&#160;Acknowledgement  of  Full  Understanding.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">YOU  ACKNOWLEDGE  AND  AGREE  THAT YOU HAVE FULLY READ, UNDERSTAND AND VOLUNTARILY ENTER INTO  THIS AGREEMENT. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE HAD AN  </font></div><div style="margin-top:9pt;padding-right:27pt;text-align:justify"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div style="padding-right:27pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"></div></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.18</font></div><div style="margin-bottom:5.2pt;padding-left:18pt;text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.746%"><div style="padding-left:28.95pt;padding-right:27pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverum Biotechnologies, Inc.   </font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 Cardinal Way  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redwood City, CA 94063  </font></div><div style="padding-left:28.95pt;padding-right:27pt"><font style="color:#808080;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O&#58; 650.656-9323</font><font style="color:#000000;font-family:'Lato',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div></div><div style="display:inline-block;max-width:6.506%;min-width:5.506%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.748%"><div style="padding-left:18pt;padding-right:27pt"><img alt="advm-20241231_g13a.jpg" src="advm-20241231_g13a.jpg" style="height:73px;margin-bottom:5pt;vertical-align:text-bottom;width:326px"></div></div></div><div style="margin-top:9pt;padding-left:45.95pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF YOUR  CHOICE BEFORE SIGNING THIS AGREEMENT.   </font></div><div style="margin-top:9pt;padding-left:178.45pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Remainder of page intentionally left blank  </font></div><div style="margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-right:27pt"><font><br></font></div><div style="margin-top:9pt;padding-left:46pt;padding-right:27pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Please sign and date this letter, and the attached Change of Control Agreement and the Proprietary  Information and Invention Assignment Agreement, and return them to me by the close of business  on  June  4,  2024  in  order  to  confirm  your  acceptance  of  our  offer  and  agreement  to  these  employment terms. This offer of employment will terminate if it is not accepted, signed and  returned by the specified date. If you accept our offer, your first day of employment will be no  later than June 10, 2024.  </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We look forward to a favorable reply and a productive and enjoyable work relationship with you.</font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Sincerely,   </font></div><div style="margin-top:9pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Adverum Biotechnologies, Inc.&#58;  </font></div><div style="margin-top:9pt;padding-left:46pt"><font><br></font></div><div style="margin-bottom:11.15pt;padding-left:45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.256%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Laurent Fischer, M.D. </font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Laurent Fischer, M.D</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President and Chief Executive Officer  </font></td></tr></table></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Understood and Accepted&#58;</font></div><div style="padding-left:46pt"><font><br></font></div><div style="padding-left:46pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.663%"><tr><td style="width:1.0%"></td><td style="width:16.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Rabia Gurses Ozden, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; </font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Rabia Gurses Ozden, M.D.  </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; </font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2024-06-06 &#124; 07&#58;42&#58;07 PDT  </font></td></tr></table></div><div style="padding-left:46pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:3.05pt"><font><br></font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adverum Offer Ltr Tier II (signing) Oct 2019  </font></div><div><font><br></font></div><div style="height:20.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>3
<FILENAME>advm-20241231xexx191.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1f116d1e9330435cb8099b09bbf46b26_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:1.55pt;padding-left:489.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:16.60pt">Exhibit 19.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.60pt"> </font></div><div><font><br></font></div><div style="padding-left:42.75pt;padding-right:42.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:13.80pt">ADVERUM BIOTECHNOLOGIES, INC. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:13.80pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:13.80pt">INSIDER TRADING COMPLIANCE POLICY </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Insider Trading Compliance Policy (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) consists of six sections&#58; </font></div><div style="margin-top:6pt;padding-left:112.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Section I provides an overview&#59; </font></div><div style="margin-top:1pt;padding-left:144pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Section II sets forth Adverum Biotechnologies, Inc.&#8217;s policies prohibiting insider trading&#59; </font></div><div style="margin-top:1pt;padding-left:112.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Section III explains insider trading&#59; </font></div><div style="margin-top:1pt;padding-left:144pt;padding-right:40.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.75pt">&#8226;&#160;&#160;&#160;&#160;Section IV consists of procedures that have been put in place by Adverum Biotechnologies, Inc. to prevent insider trading&#59; </font></div><div style="margin-top:1pt;padding-left:144pt;padding-right:40.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.85pt">&#8226;&#160;&#160;&#160;&#160;Section V sets forth additional transactions that are prohibited by this Policy&#59; and </font></div><div style="margin-top:1pt;padding-left:144pt;padding-right:40.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.80pt">&#8226;&#160;&#160;&#160;&#160;Section VI explains Rule 10b5-1 trading plans and provides information about Section 16 and Rule 144. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SUMMARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Preventing insider trading is necessary to comply with securities laws and to preserve the reputation and integrity of Adverum Biotechnologies, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as well as that of all persons affiliated with the Company. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insider trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; occurs when any person purchases or sells a security while in possession of inside information relating to the security. As explained in Section III below, when we refer to &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">inside information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; we mean information that is both &#8220;material&#8221; and &#8220;non-public.&#8221; Insider trading is a crime. The penalties for violating insider trading laws include imprisonment, disgorgement of profits, civil fines and criminal fines of up to $5 million for individuals and $25 million for entities. Insider trading is also prohibited by this Policy, and violation of this Policy may result in Company-imposed sanctions, including removal or dismissal for cause. </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Policy applies to all officers, directors and employees of the Company. Individuals subject to this Policy are responsible for ensuring that members of their households also comply with this Policy. This Policy also applies to any entities controlled by individuals subject to the Policy, including any corporations, partnerships or trusts, and transactions by these entities should be treated for the purposes of this Policy and applicable securities laws as if they were for the individual&#8217;s own account. This Policy extends to all activities within and outside an individual&#8217;s Company duties. Every officer, director and employee must review this Policy. Questions regarding the Policy should be directed to the Company&#8217;s Chief Legal Officer. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">II.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">STATEMENT OF POLICIES PROHIBITING INSIDER TRADING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No officer, director or employee shall purchase or sell any type of security while in possession of material, non-public information relating to the security, whether the issuer of such security is the Company or any other company.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><div id="i1f116d1e9330435cb8099b09bbf46b26_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:46pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:13.80pt">Additionally, no officer, director or employee shall purchase or sell any security of the Company during a Black-Out Period (as defined in Section IV.B below).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.80pt"> </font></div><div style="margin-top:6pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">These prohibitions do not apply to&#58; </font></div><div style="margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;purchases of the Company&#8217;s securities from the Company or sales of the Company&#8217;s securities to the Company&#59; </font></div><div style="margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;exercises of stock options or other equity awards or vesting of equity-based awards that do not involve a market sale of the Company&#8217;s securities (the &#8220;cashless exercise&#8221; of a Company stock option does involve a market sale of the Company&#8217;s securities, and therefore would not qualify under this exception)&#59; </font></div><div style="margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> gifts of the Company&#8217;s securities&#59; or </font></div><div style="margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;purchases or sales of the Company&#8217;s securities made pursuant to any binding contract, specific instruction or written plan entered into while the purchaser or seller, as applicable, was unaware of any material, non-public information and which contract, instruction or plan (i) meets all requirements of the affirmative defense provided by Rule 10b5-1 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Rule 10b5-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">1934 Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (ii) was pre-cleared in advance pursuant to this Policy and (iii) has not been amended or modified in any respect after such initial pre-clearance without such amendment or modification being pre-cleared in advance pursuant to this Policy. For more information about Rule 10b5-1 trading plans, see Section VI below. </font></div><div style="margin-top:9pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.75pt">No officer, director or employee shall directly or indirectly communicate (or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:13.75pt;text-decoration:underline">tip</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.75pt">&#8221;) material, non- public information to anyone outside the Company (except in accordance with the Company&#8217;s policies regarding the protection or authorized external disclosure of Company information) or to anyone within the Company other than on a need-to-know basis. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">III. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXPLANATION OF INSIDER TRADING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insider trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; refers to the purchase or sale of a security while in possession of &#8220;material,&#8221; &#8220;non-public&#8221; information relating to the security. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; includes stocks, bonds, notes, debentures, options, warrants and other convertible securities, as well as derivative instruments. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Purchase&#8221; and &#8220;sale&#8221; are defined broadly under the federal securities law. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; includes not only the actual purchase of a security, but any contract to purchase or otherwise acquire a security. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; includes not only the actual sale of a security, but any contract to sell or otherwise dispose of a security. These definitions extend to a broad range of transactions, including conventional cash-for-stock transactions, conversions, the exercise of stock options and acquisitions and exercises of warrants or puts, calls or other derivative securities. </font></div><div style="margin-top:6pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">It is generally understood that insider trading includes the following&#58; </font></div><div style="margin-top:6pt;padding-left:100pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;Trading by insiders while in possession of material, non-public information&#59;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;Trading by persons other than insiders while in possession of material, non- public information, if the information either was given in breach of an insider&#8217;s fiduciary duty to keep it confidential or was misappropriated&#59; and </font></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226; &#160;&#160;&#160;&#160;Communicating or tipping material, non-public information to others, including recommending the purchase or sale of a security while in possession of such information. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">What Facts are Material&#63;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The materiality of a fact depends upon the circumstances. A fact is considered &#8220;material&#8221; if there is a substantial likelihood that a reasonable investor would consider it important in making a decision to buy, sell or hold a security, or if the fact is likely to have a significant effect on the market price of the security. Material information can be positive or negative and can relate to virtually any aspect of a company&#8217;s business or to any type of security, debt or equity. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Examples of material information include (but are not limited to) information about&#58; the results of clinical trials&#59; U.S. Food and Drug Administration and foreign regulatory approvals&#59; corporate financial results or forecasts&#59; possible mergers, acquisitions, tender offers or dispositions&#59; major new product candidates or product candidate developments&#59; important business developments such as entering into, or cancelations of, major contracts&#59; management or control changes&#59; significant borrowing or financing developments including pending public sales or offerings of debt or equity securities&#59; defaults on borrowings&#59; bankruptcies&#59; and significant litigation or regulatory actions. Moreover, material information does not have to be related to a company&#8217;s business. For example, the contents of a forthcoming newspaper column that is expected to affect the market price of a security can be material. </font></div><div style="margin-top:6pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A good general rule&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">When in doubt, do not trade.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">What is Non-public&#63;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Information is &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">non-public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; if it is not available to the general public. In order for information to be considered public, it must be widely disseminated in a manner making it generally available to investors through such media as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Dow Jones, Business Wire, Reuters, The Wall Street Journal, Associated Press or United Press International</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a broadcast on widely available radio or television programs, publication in a widely available newspaper, magazine or news web site, a Regulation FD-compliant conference call or public disclosure documents filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) that are available on the SEC&#8217;s web site. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The circulation of rumors, even if accurate and reported in the media, does not constitute effective public dissemination. In addition, even after a public announcement, a reasonable period of time must lapse in order for the market to react to the information. Generally, one should allow at least one full trading day following publication as a reasonable waiting period before such information is deemed to be public. For the purposes of this Policy, a &#8220;trading day&#8221; is a day on which national stock exchanges are open for trading.</font></div><div style="padding-left:46pt"><font><br></font></div><div style="padding-left:46pt"><font><br></font></div><div style="padding-left:46pt"><font><br></font></div><div style="padding-left:46pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Who is an Insider&#63;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Insiders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; include officers, directors and employees of a company and anyone else who has material, non-public information about a company. Insiders have independent fiduciary duties to the company and its stockholders not to trade on material, non-public information relating to the company&#8217;s securities. All officers, directors and employees of the Company should consider themselves insiders with respect to material, non-public information about the Company&#8217;s business, activities and securities. Officers, directors and employees may not trade in the Company&#8217;s securities while in possession of material, non-public information relating to the Company, nor may they tip such information to anyone outside the Company (except in accordance with the Company&#8217;s policies regarding the protection or authorized external disclosure of Company information) or to anyone within the Company other than on a need-to- know basis. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Individuals subject to this Policy are responsible for ensuring that members of their households also comply with this Policy. This Policy also applies to any entities controlled by individuals subject to the Policy, including any corporations, partnerships or trusts, and transactions by these entities should be treated for the purposes of this Policy and applicable securities laws as if they were for the individual&#8217;s own account. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Trading by Persons Other than Insiders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Insiders may be liable for communicating or tipping material, non-public information to a third party (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">tippee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and insider trading violations are not limited to trading or tipping by insiders. Persons other than insiders also can be liable for insider trading, including tippees who trade on material, non-public information tipped to them or individuals who trade on material, non-public information that has been misappropriated. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tippees inherit an insider&#8217;s duties and are liable for trading on material, non-public information illegally tipped to them by an insider. Similarly, just as insiders are liable for the insider trading of their tippees, so are tippees who pass the information along to others who trade. In other words, a tippee&#8217;s liability for insider trading is no different from that of an insider. Tippees can obtain material, non-public information by receiving overt tips from others or through, among other things, conversations at social, business or other gatherings. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Penalties for Engaging in Insider Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Penalties for trading on or tipping material, non-public information can extend significantly beyond any profits made or losses avoided, both for individuals engaging in such unlawful conduct and their employers. The SEC and Department of Justice have made the civil and criminal prosecution of insider trading violations a top priority. Enforcement remedies available to the government or private plaintiffs under the federal securities laws include&#58; </font></div><div style="margin-top:1pt;padding-left:100pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;SEC administrative sanctions&#59; </font></div><div style="margin-top:1pt;padding-left:100pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Securities industry self-regulatory organization sanctions&#59;</font></div><div style="margin-top:1pt;padding-left:100pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Civil injunctions&#59; </font></div><div style="margin-top:1pt;padding-left:100pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Damage awards to private plaintiffs&#59; </font></div><div style="margin-bottom:12.25pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Disgorgement of all profits&#59; </font></div><div style="margin-top:1pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Civil fines for the violator of up to three times the amount of profit gained or loss avoided&#59; </font></div><div style="margin-top:1pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Civil fines for the employer or other controlling person of a violator (i.e., where the violator is an employee or other controlled person) of up to the greater of $1,000,000, as adjusted for inflation from time to time, or three times the amount of profit gained or loss avoided by the violator&#59; </font></div><div style="margin-top:1pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.75pt">&#8226;&#160;&#160;&#160;&#160;Criminal fines for individual violators of up to $5,000,000 ($25,000,000 for an entity)&#59; and </font></div><div style="margin-top:1pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">&#8226;&#160;&#160;&#160;&#160;Jail sentences of up to 20 years. </font></div><div style="margin-top:6pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, insider trading could result in serious sanctions by the Company, including dismissal. Insider trading violations are not limited to violations of the federal securities laws. Other federal and state civil or criminal laws, such as the laws prohibiting mail and wire fraud and the Racketeer Influenced and Corrupt Organizations Act (RICO), also may be violated in connection with insider trading.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Size of Transaction and Reason for Transaction Do Not Matter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The size of the transaction or the amount of profit received does not have to be significant to result in prosecution. The SEC has the ability to monitor even the smallest trades, and the SEC performs routine market surveillance. Brokers or dealers are required by law to inform the SEC of any possible violations by people who may have material, non-public information. The SEC aggressively investigates even small insider trading violations.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">G.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Examples of Insider Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Examples of insider trading cases include actions brought against&#58; corporate officers, directors and employees who traded in a company&#8217;s securities after learning of significant confidential corporate developments&#59; friends, business associates, family members and other tippees of such officers, directors and employees who traded in the securities after receiving such information&#59; government employees who learned of such information in the course of their employment&#59; and other persons who misappropriated, and took advantage of, confidential information from their employers.</font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following are illustrations of insider trading violations. These illustrations are hypothetical and, consequently, not intended to reflect on the actual activities or business of the Company or any other entity.</font></div><div style="margin-top:6pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Trading by Insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt"> </font></div><div style="margin-top:6pt;padding-left:64pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An officer of X Corporation learns that earnings to be reported by X Corporation will increase dramatically. Prior to the public announcement of such earnings, the officer purchases X Corporation&#8217;s stock. The officer, an insider, is liable for all profits as well as penalties of up to three times the amount of all profits. The officer also is subject to, among other things, criminal prosecution, including up to $5,000,000 in additional fines and 20 years in jail. Depending upon the circumstances, X Corporation and the individual to whom the officer reports also could be liable as controlling persons. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:82pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Trading by Tippee </font></div><div style="margin-top:6pt;padding-left:64pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An officer of X Corporation tells a friend that X Corporation is about to publicly announce that it has concluded an agreement for a major acquisition. This tip causes the friend to purchase X Corporation&#8217;s stock in advance of the announcement. The officer is jointly liable with his friend for all of the friend&#8217;s profits, and each is liable for all civil penalties of up to three times the amount of the friend&#8217;s profits. The officer and his friend are also subject to criminal prosecution and other remedies and sanctions, as described above.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">H.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Prohibition of Records Falsification and False Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 13(b)(2) of the 1934 Act requires companies subject to the Act to maintain proper internal books and records and to devise and maintain an adequate system of internal accounting controls. The SEC has supplemented the statutory requirements by adopting rules that prohibit (i) any person from falsifying records or accounts subject to the above requirements and (ii) officers or directors from making any materially false, misleading or incomplete statement to any accountant in connection with any audit or filing with the SEC. These provisions reflect the SEC&#8217;s intent to discourage officers, directors and other persons with access to the Company&#8217;s books and records from taking action that might result in the communication of materially misleading financial information to the investing public.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IV.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">STATEMENT OF PROCEDURES PREVENTING INSIDER TRADING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following procedures have been established, and will be maintained and enforced, by the Company to prevent insider trading. Every officer, director and employee is required to follow these procedures.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Pre-Clearance of All Trades by All Officers, Directors and Certain Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To provide assistance in preventing inadvertent violations of applicable securities laws and to avoid the appearance of impropriety in connection with the purchase and sale of the Company&#8217;s securities, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">all transactions in the Company&#8217;s securities (including without limitation, acquisitions and dispositions of Company stock, the exercise of stock options and the sale of Company stock issued upon exercise of stock options) by officers, directors and employees listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> (as amended from time to time) must be pre-cleared </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by the Company&#8217;s Chief Legal Officer. As part of the pre-clearance process, the individual requesting pre-clearance must confirm that he or she is not in possession of material, non-public information. Pre-clearance does not relieve anyone of his or her responsibility under SEC rules. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Black-Out Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">From time to time, the Company, through the Board of Directors, the Company&#8217;s Disclosure Committee or Chief Financial Officer, may require that officers, directors, employees or others suspend trading in the Company&#8217;s securities because .of developments that have not yet been disclosed to the public.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> No officer, director or employee shall purchase or sell any security of the Company during any trading suspension period declared by the Company (any such period, a &#8220;Black-Out Period&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, except for&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;purchases of the Company&#8217;s securities from the Company or sales of the Company&#8217;s securities to the Company&#59;</font></div><div style="margin-top:6pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;exercises of stock options or other equity awards or vesting of equity-based awards that do not involve a market sale of the Company&#8217;s securities (the &#8220;cashless exercise&#8221; of a Company stock option does involve a market sale of the Company&#8217;s securities, and therefore would not qualify under this exception)&#59;</font></div><div style="margin-top:6pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> gifts of the Company&#8217;s securities&#59; and </font></div><div style="margin-top:6pt;padding-left:135pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;purchases or sales of the Company&#8217;s securities made pursuant to any binding contract, specific instruction or written plan entered into while the purchaser or seller, as applicable, was unaware of any material, non-public information and which contract, instruction or plan (i) meets all requirements of the affirmative defense provided by Rule 10b5-1, (ii) was pre-cleared in advance pursuant to this Policy and (iii) has not been amended or modified in any respect after such initial pre-clearance without such amendment or modification being pre-cleared in advance pursuant to this Policy. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exceptions to the Black-Out Period policy may be approved only by the Company&#8217;s Chief Legal Officer or, in the case of exceptions for directors, the Board of Directors or Audit Committee of the Board of Directors. For the purposes of this Policy, a &#8220;trading day&#8221; is a day on which national stock exchanges are open for trading.</font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the exceptions noted above, all those affected may not trade in our securities while a Black-Out Period is in effect, and may not disclose to others that we have suspended trading. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Post-Termination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With the exception of the pre-clearance requirement, this Policy continues to apply to transactions in the Company&#8217;s securities even after termination of service to the Company. If an individual is in possession of material, non-public information when his or her service terminates, that individual may not trade in the Company&#8217;s securities until that information has become public or is no longer material.</font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Information Relating to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:12pt;padding-left:190pt;padding-right:40.5pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Access to material, non-public information about the Company, including the Company&#8217;s business, earnings or prospects, should be limited to officers, directors and employees of the Company on a need-to-know basis. In addition, such information should not be communicated to anyone outside the Company under any circumstances (except in accordance with the Company&#8217;s policies regarding the protection or authorized external disclosure of Company information) or to anyone within the Company on an other than need-to-know basis. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:46pt;padding-right:40.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In communicating material, non-public information to employees of the Company, all officers, directors and employees must take care to emphasize the need for confidential treatment of such information and adherence to the Company&#8217;s policies with regard to confidential information. </font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">2. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Inquiries From Third Parties</font></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">Inquiries from third parties, such as industry analysts or members of the media, about the Company should be directed to Adverum Investor Relations, at ir&#64;adverum.com or (650) 656-9323. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Limitations on Access to Company Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following procedures are designed to maintain confidentiality with respect to the Company&#8217;s business operations and activities. </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All officers, directors and employees should take all steps and precautions necessary to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">restrict access to, and secure, material, non-public information by, among other things&#58; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Maintaining the confidentiality of Company-related transactions&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.8pt">Conducting their business and social activities so as not to risk inadvertent disclosure of confidential information. Review of confidential documents in public places should be conducted so as to prevent access by unauthorized persons&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Restricting access to documents and files (including computer files) containing material, non-public information to individuals on a need-to-know basis (including maintaining control over the distribution of documents and drafts of documents)&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Promptly removing and cleaning up all confidential documents and other materials from conference rooms following the conclusion of any meetings&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Disposing of all confidential documents and other papers, after there is no longer any business or other legally required need, through shredders when appropriate&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Restricting access to areas likely to contain confidential documents or material, non-public information&#59; </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Safeguarding laptop computers, tablets, memory sticks, CDs and other items that contain confidential information&#59; and </font></div><div style="margin-top:6pt;padding-left:135pt;padding-right:40.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Avoiding the discussion of material, non-public information in places where the information could be overheard by others such as in elevators, restrooms, hallways, restaurants, airplanes or taxicabs. </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.80pt">Personnel involved with material, non-public information, to the extent feasible, should conduct their business and activities in areas separate from other Company activities. </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">V.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">ADDITIONAL PROHIBITED TRANSACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has determined that there is a heightened legal risk and&#47;or the appearance of improper or inappropriate conduct if the persons subject to this Policy engage in certain types of transactions. Therefore, officers, directors and employees shall comply with the following policies with respect to certain transactions in the Company securities&#58; </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Short Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Short sales of the Company&#8217;s securities evidence an expectation on the part of the seller that the securities will decline in value, and therefore signal to the market that the seller has no confidence in the Company or its short-term prospects. In addition, short sales may reduce the seller&#8217;s incentive to improve the Company&#8217;s performance. For these reasons, short sales of the Company&#8217;s securities are prohibited by this Policy. In addition, as noted below, Section 16(c) of the 1934 Act absolutely prohibits Section 16 reporting persons from making short sales of the Company&#8217;s equity securities, i.e., sales of shares that the insider does not own at the time of sale, or sales of shares against which the insider does not deliver the shares within 20 days after the sale. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Publicly Traded Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A transaction in options is, in effect, a bet on the short-term movement of the Company&#8217;s stock and therefore creates the appearance that an officer, director or employee is trading based on inside information. Transactions in options also may focus an officer&#8217;s, director&#8217;s or employee&#8217;s attention on short-term performance at the expense of the Company&#8217;s long-term objectives. Accordingly, transactions in puts, calls or other derivative securities involving the Company&#8217;s equity securities, on an exchange or in any other organized market, are prohibited by this Policy. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Hedging Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain forms of hedging or monetization transactions, such as zero-cost collars and forward sale contracts, allow an officer, director or employee to lock in much of the value of his or her stock holdings, often in exchange for all or part of the potential for upside appreciation in the stock. These transactions allow the officer, director or employee to continue to own the covered securities, but without the full risks and rewards of ownership. When that occurs, the officer, director or employee may no longer have the same objectives as the Company&#8217;s other stockholders. Therefore, such transactions involving the Company&#8217;s equity securities are prohibited by this Policy. </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Purchases of the Company&#8217;s Securities on Margin&#59; Pledging the Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Securities to Secure Margin or Other Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Purchasing on margin means borrowing from a brokerage firm, bank or other entity in order to purchase the Company&#8217;s securities (other than in connection with a cashless exercise of stock options under the Company&#8217;s equity plans). Margin purchases of the Company&#8217;s securities are prohibited by this Policy. Pledging the Company&#8217;s securities as collateral to secure loans is prohibited. This prohibition means, among other things, that you cannot hold the Company&#8217;s securities in a &#8220;margin account&#8221; (which would allow you to borrow against your holdings to buy securities). </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:46pt;padding-right:37.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VI.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">RULE 10b5-1 TRADING PLANS, SECTION 16 AND RULE 144</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:37.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Rule 10b5-1 Trading Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Overview</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rule 10b5-1 will protect directors, officers and employees from insider trading liability under Rule 10b5-1 for transactions under a previously established contract, plan or instruction to trade in the Company&#8217;s stock (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Trading Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) entered into in good faith and in accordance with the terms of Rule 10b5-1 and all applicable state laws and will be exempt from the trading restrictions set forth in this Policy. The initiation of, and any modification to, any such Trading Plan will be deemed to be a transaction in the Company&#8217;s securities, and such initiation or modification is subject to all limitations and prohibitions relating to transactions in the Company&#8217;s securities. Each such Trading Plan, and any modification thereof, must be submitted to and pre-approved by the Company&#8217;s Chief Legal Officer, or such other person as the Company&#8217;s board of directors may designate from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Authorizing Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), who may impose such conditions on the implementation and operation of the Trading Plan as the Authorizing Officer deems necessary or advisable. However, compliance of the Trading Plan to the terms of Rule 10b5-1 and the execution of transactions pursuant to the Trading Plan are the sole responsibility of the person initiating the Trading Plan, not the Company or the Authorizing Officer. </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:37.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Trading Plans do not exempt individuals from complying with Section 16 short-swing profit rules or liability. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rule 10b5-1 presents an opportunity for insiders to establish arrangements to sell (or purchase) Company stock without the restrictions of Black-Out Periods, even when there is undisclosed material information. A Trading Plan may also help reduce negative publicity that may result when key executives sell the Company&#8217;s stock. Rule 10b5-1 only provides an &#8220;affirmative defense&#8221; in the event there is an insider trading lawsuit. It does not prevent someone from bringing a lawsuit. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A director, officer or employee may enter into a Trading Plan only when he or she is not in possession of material, non-public information, and only outside of a Black-Out Period. Although transactions effected under a Trading Plan will not require further pre-clearance at the time of the trade, any transaction (including the quantity and price) made pursuant to a Trading Plan of a Section 16 reporting person must be reported to the Company promptly on the day of each trade to permit the Company&#8217;s filing coordinator to assist in the preparation and filing of a required Form 4. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Officers, directors and employees may adopt Trading Plans with brokers that outline a pre-set plan for trading of the Company&#8217;s stock, including the exercise of options. Trades pursuant to a Trading Plan generally may occur at any time. However, the Company and Rule 10b5-1 require a cooling- off period of 30 days between the establishment of a Trading Plan and commencement of any transactions under such plan&#59; provided, however, that for directors and officers, the cooling off period will be the later of 90 days after the adoption or modification or two business days following the disclosure of the Company&#8217;s financial results in a periodic report for the fiscal quarter in which the Trading Plan was adopted or modified, not to exceed 120 days). An individual may not have more than one Trading Plan in place at a time, subject to certain exceptions permitted in Rule 10b5-1. Please review the following description of how a Trading Plan works. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:46pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Rule 10b5-1, an individual&#8217;s purchase or sale of securities will not be &#8220;on the basis of&#8221; material, non-public information if&#58; </font></div><div style="margin-top:6pt;padding-left:136pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;First, before becoming aware of the information, the individual enters into a binding contract to purchase or sell the securities, provides instructions to another person to sell the securities or adopts a written plan for trading the securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Trading Plan). </font></div><div style="margin-top:6pt;padding-left:100pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Second, the Trading Plan must either&#58; </font></div><div style="margin-top:6pt;padding-left:172pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;specify the amount of securities to be purchased or sold, the price at which the securities are to be purchased or sold and the date on which the securities are to be purchased or sold&#59; </font></div><div style="margin-top:6pt;padding-left:172pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;include a written formula or computer program for determining the amount, price and date of the transactions&#59; or </font></div><div style="margin-top:6pt;padding-left:172pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;prohibit the individual from exercising any subsequent influence over the purchase or sale of the Company&#8217;s stock under the Trading Plan in question. </font></div><div style="margin-top:6pt;padding-left:136pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Third, the purchase or sale must occur pursuant to the Trading Plan and the individual must act in good faith and not enter into a corresponding hedging transaction or alter or deviate from the Trading Plan. </font></div><div style="margin-top:1pt;padding-left:136pt;padding-right:40.5pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:118pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Revocation of and Amendments to Trading Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revocation of Trading Plans should occur only in unusual circumstances. Effectiveness of any revocation or amendment of a Trading Plan will be subject to the prior review and approval of the Authorizing Officer. Revocation is effected upon written notice to the broker. Once a Trading Plan has been revoked, the participant should wait at least 30 days before trading outside of a Trading Plan and 180 days before establishing a new Trading Plan. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A person acting in good faith may amend a prior Trading Plan so long as such amendments are made outside of a Black-Out Period and at a time when the Trading Plan participant does not possess material, non-public information. Trading Plan amendments constituting material modifications (e.g., amount, price, or timing of the purchase or sale of securities) will be considered a termination of the original Trading Plan and adoption of a new Trading Plan, triggering a new cooling-off period&#59; administrative changes will not trigger a new cooling-off period. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under certain circumstances, a Trading Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> be revoked. This includes circumstances such as the announcement of a merger or the occurrence of an event that would cause the transaction either to violate the law or to have an adverse effect on the Company. The Authorizing Officer or administrator of the Company&#8217;s stock plans is authorized to notify the broker in such circumstances, thereby insulating the insider in the event of revocation. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt;text-decoration:underline">Discretionary Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Although non-discretionary Trading Plans are preferred, discretionary Trading Plans, where the discretion or control over trading is transferred to a broker, are permitted if pre-approved by the Authorizing Officer. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Authorizing Officer of the Company must pre-approve any Trading Plan, arrangement or trading instructions, etc., involving potential sales or purchases of the Company&#8217;s stock or option exercises, including but not limited to, blind trusts, discretionary accounts with banks or brokers, or limit orders. The actual transactions effected pursuant to a pre-approved Trading Plan will not be subject to further pre-clearance for transactions in the Company&#8217;s stock once the Trading Plan or other arrangement has been pre-approved. </font></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reporting (if Required) </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If required, an SEC Form 144 will be filled out and filed by the individual&#47;brokerage firm in accordance with the existing rules regarding Form 144 filings. A footnote at the bottom of the Form 144 should indicate that the trades &#8220;are in accordance with a Trading Plan that complies with Rule 10b5-1 and expires _____.&#8221; For Section 16 reporting persons, Form 4s should be filed before the end of the second business day following the date that the broker, dealer or plan administrator informs the individual that a transaction was executed, provided that the date of such notification is not later than the third business day following the trade date. The checkbox on the form indicating that the trade was made pursuant to a Trading Plan must be checked and the date of adoption of the Trading Plan must be provided. </font></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Options </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exercises of options for cash may be executed at any time. &#8220;Cashless exercise&#8221; option exercises are subject to Black-Out Periods. However, the Company will permit same day sales under Trading Plans. If a broker is required to execute a cashless exercise in accordance with a Trading Plan, then the Company must have exercise forms attached to the Trading Plan that are signed, undated and with the number of shares to be exercised left blank. Once a broker determines that the time is right to exercise the option and dispose of the shares in accordance with the Trading Plan, the broker will notify the Company in writing and the administrator of the Company&#8217;s stock plans will fill in the number of shares and the date of exercise on the previously signed exercise form. The insider should not be involved with this part of the exercise. </font></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Trades Outside of a Trading Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During an open trading window (i.e., when no Black-Out Period is in effect), trades differing from Trading Plan instructions that are already in place are allowed as long as the Trading Plan continues to be followed. </font></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ublic Announcements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may make a public announcement that Trading Plans are being implemented in accordance with Rule 10b5-1. It will consider in each case whether a public announcement of a particular Trading Plan should be made. It may also make public announcements or respond to inquiries from the media as transactions are made under a Trading Plan. In any event, the Company will make all disclosures regarding Trading Plans as required by SEC Rules. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Prohibited Transactions </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transactions prohibited under Section V of this Policy, including among others short sales and hedging transactions, may not be carried out through a Trading Plan or other arrangement or trading instruction involving potential sales or purchases of the Company&#8217;s securities. </font></div><div style="margin-top:12pt;padding-left:46pt;padding-right:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 16&#58; Insider Reporting Requirements, Short-Swing Profits and Short Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">(Applicable to Officers, Directors and 10% Stockholders)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Reporting Obligations Under Section 16(a)&#58; SEC Forms 3, 4 and 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 16(a) of the 1934 Act generally requires all officers, directors and 10% stockholders (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">insiders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), within 10 days after the insider becomes an officer, director or 10% stockholder, to file with the SEC an &#8220;Initial Statement of Beneficial Ownership of Securities&#8221; on SEC Form 3 listing the amount of the Company&#8217;s stock, options and warrants which the insider beneficially owns. Following the initial filing on SEC Form 3, changes in beneficial ownership of the Company&#8217;s stock, options and warrants must be reported on SEC Form 4, generally within two days after the date on which such change occurs, or in certain cases on Form 5, within 45 days  after fiscal year end. A Form 4 must be filed even if, as a result of balancing transactions, there has been no net change in holdings. In certain situations, purchases or sales of Company stock made within six months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to the filing of a Form 3 must be reported on Form 4. Similarly, certain purchases or sales of Company stock made within six months </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">after</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> an officer or director ceases to be an insider must be reported on Form 4. </font></div><div style="margin-top:6pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Recovery of Profits Under Section 16(b) </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the purpose of preventing the unfair use of information which may have been obtained by an insider, any profits realized by any officer, director or 10% stockholder from any &#8220;purchase&#8221; and &#8220;sale&#8221; of Company stock during a six-month period, so called &#8220;short-swing profits,&#8221; may be recovered by the Company. When such a purchase and sale occurs, good faith is no defense. The insider is liable even if compelled to sell for personal reasons, and even if the sale takes place after full disclosure and without the use of any inside information. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The liability of an insider under Section 16(b) of the 1934 Act is only to the Company itself. The Company, however, cannot waive its right to short swing profits, and any Company stockholder can bring suit in the name of the Company. Reports of ownership filed with the SEC on Form 3, Form 4 or Form 5 pursuant to Section 16(a) (discussed above) are readily available to the public, and certain attorneys carefully monitor these reports for potential Section 16(b) violations. In addition, liabilities under Section 16(b) may require separate disclosure in the Company&#8217;s annual report to the SEC on Form 10-K or its proxy statement for its annual meeting of stockholders. No suit may be brought more than two years after the date the profit was realized. However, if the insider fails to file a report of the transaction under Section 16(a), as required, the two-year limitation period does not begin to run until after the transactions giving rise to the profit have been disclosed. Failure to report transactions and late filing of reports require separate disclosure in the Company&#8217;s proxy statement. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Officers and directors should consult the attached &#8220;Short-Swing Profit Checklist&#8221; attached hereto </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">as Attachment A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in addition to consulting the Company&#8217;s Chief Legal Officer prior to engaging in any transactions involving the Company&#8217;s securities, including without limitation, the Company&#8217;s stock, options or warrants. </font></div><div style="margin-top:12pt;padding-left:118pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Short Sales Prohibited Under Section 16(c) </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 16(c) of the 1934 Act prohibits insiders absolutely from making short sales of the Company&#8217;s equity securities. Short sales include sales of stock which the insider does not own at the time of sale, or sales of stock against which the insider does not deliver the shares within 20 days after the sale. Under certain circumstances, the purchase or sale of put or call options, or the writing of such options, can result in a violation of Section 16(c). Insiders violating Section 16(c) face criminal liability. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Legal Officer should be consulted if you have any questions regarding reporting obligations, short-swing profits or short sales under Section 16. </font></div><div style="margin-top:12pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Rule 144 (Applicable to Officers, Directors and 10% Stockholders)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rule 144 provides a safe harbor exemption to the registration requirements of the Securities Act of 1933, as amended, for certain resales of &#8220;restricted securities&#8221; and &#8220;control securities.&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Restricted securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; are securities acquired from an issuer, or an affiliate of an issuer, in a transaction or chain of transactions not involving a public offering. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Control securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; are </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> securities owned by directors, executive officers or other &#8220;affiliates&#8221; of the issuer, including stock purchased in the open market and stock received upon exercise of stock options. Sales of Company securities by affiliates (generally, directors, officers and 10% stockholders of the Company) must comply with the requirements of Rule 144, which are summarized below&#58;</font></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Current Public Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company must have filed all SEC-required reports during the last 12 months. </font></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Volume Limitations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Total sales of Company common stock by a covered individual for any three-month period may not exceed the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">greater</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of&#58; (i) 1% of the total number of outstanding shares of Company common stock, as reflected in the most recent report or statement published by the Company, or (ii) the average weekly reported volume of such shares traded during the four calendar weeks preceding the filing of the requisite Form 144. </font></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Method of Sale.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The shares must be sold either in a &#8220;broker&#8217;s transaction&#8221; or in a transaction directly with a &#8220;market maker.&#8221; A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">broker&#8217;s transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; is one in which the broker does no more than execute the sale order and receive the usual and customary commission. Neither the broker nor the selling person can solicit or arrange for the sale order. In addition, the selling person or Board member must not pay any fee or commission other than to the broker. A&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">market maker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; includes a specialist permitted to act as a dealer, a dealer acting in the position of a block positioner, and a dealer who holds himself out as being willing to buy and sell Company common stock for his own account on a regular and continuous basis. </font></div><div><font><br></font></div><div style="margin-bottom:1.7pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:136pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Notice of Proposed Sale.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> A notice of the sale (a Form 144) must be filed with the SEC at the time of the sale. Brokers generally have internal procedures for executing sales under Rule 144 and will assist you in completing the Form 144 and in complying with the other requirements of Rule 144. </font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are subject to Rule 144, you must instruct your broker who handles trades in Company securities to follow the brokerage firm&#8217;s Rule 144 compliance procedures in connection with all trades. </font></div><div style="margin-top:6pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Approved&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">December 15, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:16.60pt">SCHEDULE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:16.60pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:16.60pt">I</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:37.727%"><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:16.15pt">All employees</font></div></div><div style="display:inline-block;max-width:38.067%;min-width:37.067%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:24.206%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:230.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:16.60pt">ATTACHMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:16.60pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:16.60pt">A</font></div><div style="margin-top:12pt;padding-left:193.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SHORT-SWING PROFIT CHECKLIST</font></div><div style="margin-top:12pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any combination of a purchase and sale, or a sale and purchase, within six months of each other by an officer, director, or beneficial owner of more than 10% of any registered class of securities of a company (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) could result in a violation of Section 16(b) of the Securities Exchange Act of 1934, as amended. In such an event, the insider&#8217;s &#8220;profit&#8221; (as determined in accordance with Section 16(b)) may be recovered by the company. The holding period of such shares makes no difference, and in some circumstances, one of the transactions may have occurred before or after a person was an insider. The amount to be disgorged is calculated by matching the highest priced sale with the lowest priced purchase, regardless of the order in which the transactions occurred or whether the individual actually realized any economic profit from the transactions.</font></div><div style="margin-top:6pt;padding-left:46pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Before a director or officer of The Company (or any immediate family members or controlled entities of such director or officer) purchases or sells any Company securities, the following questions should be considered&#58;</font></div><div style="padding-left:46pt"><font><br></font></div><div style="padding-left:46pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.366%"><tr><td style="width:1.0%"></td><td style="width:6.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.52pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Yes  </font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.97pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No  </font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 142.97pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Proposed Sales of Company Stock  </font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Have there been any purchases of Company securities by the director or officer  </font></div><div style="padding-left:3.02pt;padding-right:-5.38pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.80pt">(or any immediate family members or controlled entities) within the past six  months&#63;  </font></div><div style="margin-top:6.3pt;padding-left:3.02pt;padding-right:-5.38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:13.80pt">When answering this question, the director or officer may ignore issuances of  Company stock upon exercise of options or settlement of restricted stock units  granted by The Company if they were approved by either (a) the Company&#8217;s  board of directors or (b) a committee composed solely of two or more &#8220;non- employee directors&#8221; within the meaning of Rule 16b-3 under the Securities  Exchange Act.  </font></div><div style="margin-top:6.3pt;padding-left:3.02pt;padding-right:-5.38pt;text-align:justify"><font><br></font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If yes, or if in doubt, please contact the Chief Legal Officer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Are any purchases anticipated or required within the next six months&#63; </font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If yes, or if in doubt, please contact the Chief Legal Officer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723; </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Has it been determined whether a Form 144 must be filed&#63;</font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:3.02pt;padding-right:-5.38pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:13.75pt">Sales by executive officers and directors typically must be made in accordance  with  Rule  144.  Please  contact  the  Chief  Legal  Officer  with  any  questions.  Typically the executing broker would prepare and file this form in advance.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:46pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.366%"><tr><td style="width:1.0%"></td><td style="width:6.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 2.52pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Yes  </font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.97pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No  </font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Form 144 must be filed, has the broker been reminded to sell pursuant to Rule 144&#63;  </font></div><div style="padding-left:3.02pt;padding-right:-3.53pt"><font><br></font></div><div style="margin-top:2.55pt;padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If no, contact the broker.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div></td></tr><tr><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 128.92pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Proposed Purchases of Company Stock  </font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Have there been any sales of Company securities by the director or officer (or any immediate  family  members  or  controlled  entities) within the past six months&#63;    </font></div><div style="padding-left:3.02pt;padding-right:-3.53pt"><font><br></font></div><div style="margin-top:2.6pt;padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If yes, or if in doubt, please contact the Chief Legal Officer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Are any sales anticipated or required within the next six months&#63;  </font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font><br></font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If yes, or if in doubt, please contact the Chief Legal Officer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div></td></tr><tr><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 186.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">All Transactions  </font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:400;line-height:11.90pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:700;line-height:11.90pt">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:400;line-height:11.90pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:700;line-height:11.90pt">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.12pt;padding-right:-4.43pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:11.90pt">Has the officer or director notified the Chief Legal Officer and received any  necessary pre-clearance approval consistent with the pre-clearance and advance- notification requirements in the Insider Trading Compliance Policy&#63;</font></div><div style="padding-left:2.12pt;padding-right:-4.43pt;text-align:justify"><font><br></font></div><div style="margin-top:9.05pt;padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If no, the Chief Legal Officer should be notified.  </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Has the Chief Legal Officer been advised as to all transactions for preparing the  </font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form 4&#63;  </font></div><div style="padding-left:3.02pt;padding-right:-2.63pt"><font><br></font></div><div style="margin-top:2.65pt;padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If no, all transactions need to be disclosed to the Chief Legal Officer.  </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:400;line-height:11.90pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:700;line-height:11.90pt">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:400;line-height:11.90pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.9pt;font-weight:700;line-height:11.90pt">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.12pt;padding-right:-4.43pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:11.90pt">If the insider is a beneficial owner of more than 5% of any registered class of  Company securities, has it been determined whether an amended Schedule 13D  or 13G is required to be filed&#63;  </font></div><div style="padding-left:2.12pt;padding-right:-4.43pt;text-align:justify"><font><br></font></div><div style="margin-top:8.85pt;padding-left:3.02pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If no, or if in doubt, consult the Chief Legal Officer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.02pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Is the insider aware of any material nonpublic information such that a sale would violate the Insider Trading Compliance Policy&#63;</font></div><div style="padding-left:3.02pt;padding-right:-3.53pt"><font><br></font></div><div style="padding-left:3.02pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If yes, the transaction is not permitted.  </font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.52pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:10.00pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:10.00pt">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.97pt;padding-right:-3.53pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:10.00pt">&#9723;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:10.00pt">  </font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.12pt;padding-right:-4.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:10.00pt">Is the window period open, as defined by the Insider Trading Compliance Policy&#63;</font></div><div style="padding-left:2.12pt;padding-right:-4.43pt"><font><br></font></div><div style="margin-top:9.05pt;padding-left:2.12pt;padding-right:-4.43pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:13.75pt">If no, the Chief Legal Officer should be contacted to determine whether the  transaction may be permitted.</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>advm-20241231xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib502a88afbb5447db449bae4aed8916a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUBSIDIARIES OF ADVERUM BIOTECHNOLOGIES, INC.</font></div><div style="margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Country of Incorporation</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avalanche Australia PTY LTD</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annapurna Therapeutics, LTD</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adverum NC, LLC</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina, USA</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>advm-20241231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iec6836c39be14880b9bd6aa0d841c6db_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit  23.1</font></div><div><font><br></font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statements (Form S-3 Nos. 333-271431, 333-277634 and 333-278157) of Adverum Biotechnologies, Inc.,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-199296) pertaining to the Amended and Restated 2006 Equity Incentive Plan, as amended, the 2014 Equity Incentive Award Plan and the 2014 Employee Stock Purchase Plan,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-203398) pertaining to the 2014 Equity Incentive Award Plan and the 2014 Employee Stock Purchase Plan,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-211439) pertaining to the 2014 Equity Incentive Award Plan, the 2014 Employee Stock Purchase Plan, and Inducement Stock Option Awards,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-218465) pertaining to the 2014 Equity Incentive Award Plan, the 2014 Employee Stock Purchase Plan, and Inducement Restricted Stock Unit and Stock Option Awards,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-220894) pertaining to the 2017 Inducement Plan and Inducement Stock Option Awards,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-223894) pertaining to the 2014 Equity Incentive Award Plan, the 2014 Employee Stock Purchase Plan, and Inducement Restricted Stock Unit Awards,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-230138) pertaining to the 2014 Equity Incentive Award Plan, as amended and restated, the 2014 Employee Stock Purchase Plan, as amended and restated, and the 2017 Inducement Plan, as amended and restated,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">Registration Statement (Form S-8 No. 333-237136) pertaining to the 2014 Equity Incentive Award Plan, as amended and restated, and the 2014 Employee Stock Purchase Plan, as amended and restated,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.22pt">Registration Statements (Form S-8 Nos. 333-233135, 333-243761, 333-283935 and 333-285358) pertaining to the 2017 Inducement Plan, as amended and restated,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.22pt">Registration Statement (Form S-8 No. 333-253727) pertaining to the 2014 Equity Incentive Award Plan, as amended and restated, the 2014 Employee Stock Purchase Plan, as amended and restated, and the 2017 Inducement Plan, as amended and restated,</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.22pt">Registration Statements (Form S-8 Nos. 333-263954, 333-271001 and 333-278046) pertaining to the 2014 Equity Incentive Award Plan, as amended and restated, </font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.22pt">Registration Statement (Form S-8 No. 333-266794) pertaining to the Amended and Restated 2014 Employee Stock Purchase Plan, and</font></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.22pt">Registration Statement (Form S-8 No. 333- 280567) pertaining to the 2024 Equity Incentive Award Plan&#59;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our report dated April 15, 2025, with respect to the consolidated financial statements of Adverum Biotechnologies Inc. included in this Annual Report (Form 10-K) of Adverum Biotechnologies Inc. for the year ended December 31, 2024.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;15, 2025</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>advm-20241231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i3c3fe338131e4f07953d182f1df02aa3_1"></div><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Laurent Fischer, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this Form 10-K of Adverum Biotechnologies, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;15, 2025</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laurent Fischer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laurent Fischer, M.D.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>advm-20241231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i495856aede4d4193b6d18f50b3cb7ed7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF&#160;2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Linda Rubinstein, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this Form 10-K of Adverum Biotechnologies, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:47.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;15, 2025</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rubinstein</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rubinstein</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>advm-20241231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7216e3717b8f42118bb5cfee2165c574_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Adverum Biotechnologies, Inc. for the year ended December&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), Laurent Fischer, as President and Chief Executive Officer of Adverum Biotechnologies, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Adverum Biotechnologies, Inc.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;15, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Laurent Fischer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laurent Fischer, M.D.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>advm-20241231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie9ec8743c1a047e689defa9342d1da9a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Adverum Biotechnologies, Inc. for the year ended December&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), Linda Rubinstein, as Chief Financial Officer of Adverum Biotechnologies, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of her knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Adverum Biotechnologies, Inc.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:4.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.939%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.046%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April&#160;15, 2025</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Linda Rubinstein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Rubinstein<br>Chief Financial Officer<br>(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>advm-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:advm="http://www.adverum.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.adverum.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="advm-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.adverum.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.adverum.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.adverum.com/role/DescriptionoftheBusiness">
        <link:definition>9952157 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatements" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements">
        <link:definition>9952158 - Disclosure - Restatement of Previously Issued Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952159 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandFairValueofFinancialInstruments" roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments">
        <link:definition>9952160 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.adverum.com/role/Revenue">
        <link:definition>9952161 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.adverum.com/role/Leases">
        <link:definition>9952162 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.adverum.com/role/BalanceSheetComponents">
        <link:definition>9952163 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.adverum.com/role/CommitmentsandContingencies">
        <link:definition>9952164 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.adverum.com/role/StockholdersEquity">
        <link:definition>9952165 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kSavingsPlan" roleURI="http://www.adverum.com/role/A401kSavingsPlan">
        <link:definition>9952166 - Disclosure - 401(k) Savings Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.adverum.com/role/SegmentReporting">
        <link:definition>9952167 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.adverum.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShare" roleURI="http://www.adverum.com/role/NetLossperShare">
        <link:definition>9952169 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnaudited" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited">
        <link:definition>9952170 - Disclosure - Quarterly Financial Information (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.adverum.com/role/SubsequentEvents">
        <link:definition>9952171 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsTables" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables">
        <link:definition>9955512 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandFairValueofFinancialInstrumentsTables" roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.adverum.com/role/LeasesTables">
        <link:definition>9955514 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.adverum.com/role/BalanceSheetComponentsTables">
        <link:definition>9955515 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.adverum.com/role/StockholdersEquityTables">
        <link:definition>9955516 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.adverum.com/role/SegmentReportingTables">
        <link:definition>9955517 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.adverum.com/role/IncomeTaxesTables">
        <link:definition>9955518 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareTables" roleURI="http://www.adverum.com/role/NetLossperShareTables">
        <link:definition>9955519 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedTables" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables">
        <link:definition>9955520 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessAdditionalInformationDetails" roleURI="http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails">
        <link:definition>9955521 - Disclosure - Description of the Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsDetails" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails">
        <link:definition>9955522 - Disclosure - Restatement of Previously Issued Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails">
        <link:definition>9955523 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails">
        <link:definition>9955524 - Disclosure - Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails">
        <link:definition>9955525 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails" roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails">
        <link:definition>9955526 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>9955527 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails">
        <link:definition>9955528 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails" roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>9955529 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.adverum.com/role/RevenueDetails">
        <link:definition>9955530 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.adverum.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9955531 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails" roleURI="http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails">
        <link:definition>9955532 - Disclosure - Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955533 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>9955534 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.adverum.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955535 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>9955536 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsActivityDetails" roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails">
        <link:definition>9955537 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails" roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails">
        <link:definition>9955538 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails" roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails">
        <link:definition>9955539 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockbasedCompensationExpenseDetails" roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails">
        <link:definition>9955540 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kSavingsPlanDetails" roleURI="http://www.adverum.com/role/A401kSavingsPlanDetails">
        <link:definition>9955541 - Disclosure - 401(k) Savings Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.adverum.com/role/SegmentReportingDetails">
        <link:definition>9955542 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails" roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails">
        <link:definition>9955543 - Disclosure - Income Taxes - Schedule of Components of Loss Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails" roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails">
        <link:definition>9955544 - Disclosure - Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails" roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails">
        <link:definition>9955545 - Disclosure - Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsDetails" roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails">
        <link:definition>9955546 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>9955547 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails">
        <link:definition>9955548 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareDetails" roleURI="http://www.adverum.com/role/NetLossperShareDetails">
        <link:definition>9955549 - Disclosure - Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedAdditionalInformationDetails" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails">
        <link:definition>9955550 - Disclosure - Quarterly Financial Information (Unaudited) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails">
        <link:definition>9955551 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails">
        <link:definition>9955552 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails" roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails">
        <link:definition>9955553 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.adverum.com/role/SubsequentEventsDetails">
        <link:definition>9955554 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="advm_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="advm_AccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="AccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_NonCashSubleaseLossIncome" abstract="false" name="NonCashSubleaseLossIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" abstract="false" name="IncreaseDecreaseInDepositAndOtherNoncurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" abstract="false" name="OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" abstract="false" name="ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_AccruedInterestReceivablePolicyTextBlock" abstract="false" name="AccruedInterestReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="advm_RedwoodCaliforniaFacilityLeaseMember" abstract="true" name="RedwoodCaliforniaFacilityLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="advm_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="advm_CashEquivalentsAndShortTermInvestmentsMember" abstract="true" name="CashEquivalentsAndShortTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_CashAndCashEquivalentAmortizedCost" abstract="false" name="CashAndCashEquivalentAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_CashAndCashEquivalentGrossUnrealizedGain" abstract="false" name="CashAndCashEquivalentGrossUnrealizedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_CashAndCashEquivalentGrossUnrealizedLoss" abstract="false" name="CashAndCashEquivalentGrossUnrealizedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_LexeoTherapeuticsIncMember" abstract="true" name="LexeoTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_RayTherapeuticsIncMember" abstract="true" name="RayTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" abstract="true" name="LossContingencyLienOnSubtenantsLeaseholdInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_SubleaseTenantMember" abstract="true" name="SubleaseTenantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_LandlordMember" abstract="true" name="LandlordMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_LesseeOperatingLeaseNumberOfLease" abstract="false" name="LesseeOperatingLeaseNumberOfLease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="advm_LesseeOperatingLeaseNumberOfRenewalContracts" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" abstract="false" name="LesseeOperatingLeaseLeaseholdImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" abstract="false" name="AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_TwoDirectorsMember" abstract="true" name="TwoDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_TwoThousandAndFourteenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndFourteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_TwoThousandSeventeenInducementPlanMember" abstract="true" name="TwoThousandSeventeenInducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_TwoThousandFourteenPlanAndInducementPlanMember" abstract="true" name="TwoThousandFourteenPlanAndInducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandAndFourteenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_A2024EquityIncentiveAwardPlanMember" abstract="true" name="A2024EquityIncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_StockOptionsAndRestrictedStockUnitsMember" abstract="true" name="StockOptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" abstract="true" name="IncentiveStockOptionsAndNonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="advm_BeneficialOwnershipInterestLimitationPercent" abstract="false" name="BeneficialOwnershipInterestLimitationPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="advm_ClassOfWarrantOrRightWarrantsExercised" abstract="false" name="ClassOfWarrantOrRightWarrantsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="advm_SecuritiesPurchaseAgreementNumberOfDirectors" abstract="false" name="SecuritiesPurchaseAgreementNumberOfDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" abstract="false" name="ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="advm_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="advm_ClinicalTrialExpenses" abstract="false" name="ClinicalTrialExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_AllocatedFacilitiesAndInformationTechnologyExpenses" abstract="false" name="AllocatedFacilitiesAndInformationTechnologyExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_DeferredTaxAssetsLeaseObligation" abstract="false" name="DeferredTaxAssetsLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_DeferredTaxAssetsCapitalizedCosts" abstract="false" name="DeferredTaxAssetsCapitalizedCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="advm_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="advm_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" abstract="false" name="ReMeasurementOfOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>advm-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ad69aac9-b615-45b0-8190-778dc6b6e9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0ae29630-c942-4f1e-8281-ffba946b1ead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ad69aac9-b615-45b0-8190-778dc6b6e9f4" xlink:to="loc_us-gaap_AccountsPayableCurrent_0ae29630-c942-4f1e-8281-ffba946b1ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_1fffe3c2-1e57-49dd-bd48-a4b30e961b89" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ad69aac9-b615-45b0-8190-778dc6b6e9f4" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_1fffe3c2-1e57-49dd-bd48-a4b30e961b89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_31c7b657-8ee2-430d-83d0-7e724a543858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ad69aac9-b615-45b0-8190-778dc6b6e9f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_31c7b657-8ee2-430d-83d0-7e724a543858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f19374d-05d4-44a9-bff6-30fb1b9f78e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_786d07b2-b361-44d5-b605-5095a0290957" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f19374d-05d4-44a9-bff6-30fb1b9f78e1" xlink:to="loc_us-gaap_Liabilities_786d07b2-b361-44d5-b605-5095a0290957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_09358e45-f728-4dfc-8f7a-b0a1bae368ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f19374d-05d4-44a9-bff6-30fb1b9f78e1" xlink:to="loc_us-gaap_StockholdersEquity_09358e45-f728-4dfc-8f7a-b0a1bae368ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_07243ea5-e833-42ef-86de-c88fd918ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8f19374d-05d4-44a9-bff6-30fb1b9f78e1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_07243ea5-e833-42ef-86de-c88fd918ddce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ca743adc-423c-42e3-91a5-ab8b552a3d87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d37587f2-1ddf-4c9b-9837-cc6d18eb32e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ca743adc-423c-42e3-91a5-ab8b552a3d87" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d37587f2-1ddf-4c9b-9837-cc6d18eb32e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_61d98875-8548-43e1-b15e-ff1bcffd99b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ca743adc-423c-42e3-91a5-ab8b552a3d87" xlink:to="loc_us-gaap_ShortTermInvestments_61d98875-8548-43e1-b15e-ff1bcffd99b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95675669-68b9-4d07-a2d2-31e8d16f7f10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ca743adc-423c-42e3-91a5-ab8b552a3d87" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95675669-68b9-4d07-a2d2-31e8d16f7f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f8873a1b-c949-48cc-a74b-dc4d9d0472cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5c69a92f-beaf-426f-a41c-c032da91f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f8873a1b-c949-48cc-a74b-dc4d9d0472cb" xlink:to="loc_us-gaap_LiabilitiesCurrent_5c69a92f-beaf-426f-a41c-c032da91f13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d25bc27e-8393-4aaa-9199-711c793a76f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f8873a1b-c949-48cc-a74b-dc4d9d0472cb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d25bc27e-8393-4aaa-9199-711c793a76f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_38389980-d393-4202-bd39-b2ff57072fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f8873a1b-c949-48cc-a74b-dc4d9d0472cb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_38389980-d393-4202-bd39-b2ff57072fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_215ed198-9b13-4845-9de9-fb739f41eec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_215ed198-9b13-4845-9de9-fb739f41eec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d984f9c8-4be3-49c1-b49c-d4cd65f7e664" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d984f9c8-4be3-49c1-b49c-d4cd65f7e664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6903b5ef-69c6-4707-bf2c-71168232a820" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_AssetsCurrent_6903b5ef-69c6-4707-bf2c-71168232a820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb5c1a5-d7d7-40d1-8a62-ed89d0523874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2cb5c1a5-d7d7-40d1-8a62-ed89d0523874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_b1f3a3c6-0c71-4209-96ea-998b0d16506c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_b1f3a3c6-0c71-4209-96ea-998b0d16506c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_f34df767-6f21-4307-8db3-24bcf62ab22f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_77c6f7cb-fa6b-4f00-ac79-a67c853d7e11" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_f34df767-6f21-4307-8db3-24bcf62ab22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d6244395-b999-46a9-8844-873548641615" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:to="loc_us-gaap_PreferredStockValue_d6244395-b999-46a9-8844-873548641615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_60c44045-d9e6-43aa-93b9-7b2da6132449" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:to="loc_us-gaap_CommonStockValue_60c44045-d9e6-43aa-93b9-7b2da6132449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b81439d9-fe98-4b35-91fe-9ce680032cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b81439d9-fe98-4b35-91fe-9ce680032cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d453d91-bdfe-4b47-8ad8-e48596eac917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d453d91-bdfe-4b47-8ad8-e48596eac917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f983d23a-a6e9-4f66-abc5-aaf53ae0a75f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fc0b4488-d418-44a3-97dd-f36404726c39" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f983d23a-a6e9-4f66-abc5-aaf53ae0a75f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2ea5f0c-c454-4ea6-b91a-727d292293fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_308b3c29-81fd-4fcf-8ef8-2423126061b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2ea5f0c-c454-4ea6-b91a-727d292293fb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_308b3c29-81fd-4fcf-8ef8-2423126061b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7a8351b3-fa95-4e4d-89e6-10437f6c27e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e2ea5f0c-c454-4ea6-b91a-727d292293fb" xlink:to="loc_us-gaap_OperatingIncomeLoss_7a8351b3-fa95-4e4d-89e6-10437f6c27e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f5670f27-7da7-4ec1-9175-78063f1cd382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57136e95-1dab-4ace-8935-3045798857cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f5670f27-7da7-4ec1-9175-78063f1cd382" xlink:to="loc_us-gaap_NetIncomeLoss_57136e95-1dab-4ace-8935-3045798857cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f8499eb4-45a2-4fd7-9aaf-2a13ae09142a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f5670f27-7da7-4ec1-9175-78063f1cd382" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f8499eb4-45a2-4fd7-9aaf-2a13ae09142a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_846c1c4f-9c50-46a3-8a50-3d5af06733c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f5670f27-7da7-4ec1-9175-78063f1cd382" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_846c1c4f-9c50-46a3-8a50-3d5af06733c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9dd45f6d-a3bc-4a36-aeb2-8245bd9d643d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cd30fbd-d9d9-4a2e-8bbe-e66f22d9e6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9dd45f6d-a3bc-4a36-aeb2-8245bd9d643d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cd30fbd-d9d9-4a2e-8bbe-e66f22d9e6ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7b85a9cb-641e-4e6d-b7eb-f89947f21bae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9dd45f6d-a3bc-4a36-aeb2-8245bd9d643d" xlink:to="loc_us-gaap_OperatingExpenses_7b85a9cb-641e-4e6d-b7eb-f89947f21bae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f52ea99f-bce4-424f-9b22-66beda0f7ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_62d3ba9d-4322-44ed-b4a3-1dc6c79ba9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f52ea99f-bce4-424f-9b22-66beda0f7ef5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_62d3ba9d-4322-44ed-b4a3-1dc6c79ba9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a80e0627-67a7-49a7-98d9-5a67e043e905" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f52ea99f-bce4-424f-9b22-66beda0f7ef5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a80e0627-67a7-49a7-98d9-5a67e043e905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_82e8164c-0427-49cc-9081-f2163a922d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9e30e826-6a5a-4991-ae50-c247b8835570" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_82e8164c-0427-49cc-9081-f2163a922d63" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9e30e826-6a5a-4991-ae50-c247b8835570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_17caf5b6-8a91-4405-b974-24110080207d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_82e8164c-0427-49cc-9081-f2163a922d63" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_17caf5b6-8a91-4405-b974-24110080207d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8c08098-769a-4adf-9dd9-733ae5f7783e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_dda4efd0-de73-4299-8929-88b05e7774c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8c08098-769a-4adf-9dd9-733ae5f7783e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_dda4efd0-de73-4299-8929-88b05e7774c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d40ac6e-2ae0-48dd-9e5b-648dc8998b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b8c08098-769a-4adf-9dd9-733ae5f7783e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d40ac6e-2ae0-48dd-9e5b-648dc8998b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_1155277f-e87d-4f1b-add1-bad546bb6523" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_1155277f-e87d-4f1b-add1-bad546bb6523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_9ee10477-2f6c-4f37-9862-3b92583e6024" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_advm_NonCashSubleaseLossIncome_9ee10477-2f6c-4f37-9862-3b92583e6024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_95a8c1a8-1338-4fdb-9ecc-805595941288" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_95a8c1a8-1338-4fdb-9ecc-805595941288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_300d4e1e-e91e-4394-bc3c-90dd056735ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_300d4e1e-e91e-4394-bc3c-90dd056735ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_db56ae74-073b-4ade-983b-4b429f330c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_DepreciationAndAmortization_db56ae74-073b-4ade-983b-4b429f330c2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a970b01b-e2ef-4fb0-a741-d5310edf89c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a970b01b-e2ef-4fb0-a741-d5310edf89c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c39aaa23-7580-4b90-8a5a-fff3d8cf1348" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c39aaa23-7580-4b90-8a5a-fff3d8cf1348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_56407547-6b93-431d-bd7a-beb2c1a0db42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_56407547-6b93-431d-bd7a-beb2c1a0db42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_77c303fc-c09c-46a0-bcb7-e8bba76777be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_ShareBasedCompensation_77c303fc-c09c-46a0-bcb7-e8bba76777be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0b288798-578c-4523-8e39-57afab97d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0b288798-578c-4523-8e39-57afab97d4ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_00c6fd96-ace9-4eea-8a62-6daeb8971aef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_NetIncomeLoss_00c6fd96-ace9-4eea-8a62-6daeb8971aef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_003aa9f5-fcb9-441b-a6dc-8625d7303393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_003aa9f5-fcb9-441b-a6dc-8625d7303393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e516c77b-d29f-4308-8ac8-a1075b8e287d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4c2f04ee-9de0-443a-8244-5db0590c5abd" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e516c77b-d29f-4308-8ac8-a1075b8e287d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ff3875e-7ce0-4f17-ab65-49d6aa053673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82c1acd6-a8c3-46da-871f-df86221e2ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ff3875e-7ce0-4f17-ab65-49d6aa053673" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82c1acd6-a8c3-46da-871f-df86221e2ae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e552dee3-652f-42bd-ac45-218ca5e6997d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ff3875e-7ce0-4f17-ab65-49d6aa053673" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e552dee3-652f-42bd-ac45-218ca5e6997d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fce22217-04fc-4c4c-a78a-17832f6daf36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2ff3875e-7ce0-4f17-ab65-49d6aa053673" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fce22217-04fc-4c4c-a78a-17832f6daf36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_692d7274-8934-45f8-8b3b-72055bf4f020" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8a106296-98e4-45ca-957b-4b84509ba93b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_692d7274-8934-45f8-8b3b-72055bf4f020" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8a106296-98e4-45ca-957b-4b84509ba93b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d043fb4e-13b6-4759-82b2-707d8990f2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_692d7274-8934-45f8-8b3b-72055bf4f020" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_d043fb4e-13b6-4759-82b2-707d8990f2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b86f7ff3-7c70-43e2-aacf-b99d3d5a253b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_692d7274-8934-45f8-8b3b-72055bf4f020" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b86f7ff3-7c70-43e2-aacf-b99d3d5a253b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f6d94e3-9f3c-40bf-986a-185f62169be5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_15207a92-098c-4ba8-ae33-3c4bd1bec548" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f6d94e3-9f3c-40bf-986a-185f62169be5" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_15207a92-098c-4ba8-ae33-3c4bd1bec548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_44159145-3b8d-487e-8eee-d05fa4d88bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f6d94e3-9f3c-40bf-986a-185f62169be5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_44159145-3b8d-487e-8eee-d05fa4d88bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0ee9160b-d592-48fd-9bc0-f4e7286c4aad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f6d94e3-9f3c-40bf-986a-185f62169be5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0ee9160b-d592-48fd-9bc0-f4e7286c4aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f38900da-9d08-468b-ac6b-3357d81c7a85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6f6d94e3-9f3c-40bf-986a-185f62169be5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f38900da-9d08-468b-ac6b-3357d81c7a85" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0a0ddc76-4fa6-418c-80d6-2aa6684282ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ebd986fb-b5e5-481e-a692-32d9e12533d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0a0ddc76-4fa6-418c-80d6-2aa6684282ce" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ebd986fb-b5e5-481e-a692-32d9e12533d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_981df43b-5062-43a6-9582-88f3667fa848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0a0ddc76-4fa6-418c-80d6-2aa6684282ce" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_981df43b-5062-43a6-9582-88f3667fa848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f92064bc-be1c-4121-afa4-9e25913f9621" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0a0ddc76-4fa6-418c-80d6-2aa6684282ce" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f92064bc-be1c-4121-afa4-9e25913f9621" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c101e413-13b1-44c0-8a1f-7a9d6af17b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c101e413-13b1-44c0-8a1f-7a9d6af17b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d0ecdd7a-c6b7-4e1e-9aad-fed25ec872e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d0ecdd7a-c6b7-4e1e-9aad-fed25ec872e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de2cb076-6622-405a-9535-a29443f43b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de2cb076-6622-405a-9535-a29443f43b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3dc4a5b6-ec5f-48c0-9c0d-7b8f691c8a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3dc4a5b6-ec5f-48c0-9c0d-7b8f691c8a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_07dfca1e-35eb-44ae-892e-ae89dcb946a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_07dfca1e-35eb-44ae-892e-ae89dcb946a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d8ec18ac-1514-4f3b-9c45-ff17e3f9c02f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ca579f35-645a-47fa-bb31-9a648aff804d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d8ec18ac-1514-4f3b-9c45-ff17e3f9c02f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_750cd32e-b1bf-485e-a2bb-5853b5ba34b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8cdf821d-5046-4f50-917f-1bf773b24d79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_750cd32e-b1bf-485e-a2bb-5853b5ba34b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8cdf821d-5046-4f50-917f-1bf773b24d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_412d779d-6b88-4c28-99e8-192c28580283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_750cd32e-b1bf-485e-a2bb-5853b5ba34b5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_412d779d-6b88-4c28-99e8-192c28580283" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8a5bbc74-c929-4583-a3e5-7c738ec24314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8a5bbc74-c929-4583-a3e5-7c738ec24314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_8c42c505-5768-4797-bf96-417bb6f5bd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:to="loc_us-gaap_TaxesPayableCurrent_8c42c505-5768-4797-bf96-417bb6f5bd5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_a3ffac1c-d83c-4204-879f-fb3df521ddad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_a3ffac1c-d83c-4204-879f-fb3df521ddad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_1661ea9d-8147-4af6-8984-a1ed100de53b" xlink:href="advm-20241231.xsd#advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:to="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_1661ea9d-8147-4af6-8984-a1ed100de53b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_785a33b7-7de4-45ad-b40f-396841915303" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_ee5d6725-0f8f-490c-bb24-1a9aaabae164" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_785a33b7-7de4-45ad-b40f-396841915303" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SegmentReportingDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_c03f7960-a0a5-4d8d-8690-64086594fdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_c03f7960-a0a5-4d8d-8690-64086594fdac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClinicalTrialExpenses_96acb25f-95e0-4809-b853-49c96a9eadc0" xlink:href="advm-20241231.xsd#advm_ClinicalTrialExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:to="loc_advm_ClinicalTrialExpenses_96acb25f-95e0-4809-b853-49c96a9eadc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_637971ba-08b0-4510-bd35-c0a54b99d6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:to="loc_us-gaap_LaborAndRelatedExpense_637971ba-08b0-4510-bd35-c0a54b99d6ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_896349b5-097a-42b3-8257-381571e22e32" xlink:href="advm-20241231.xsd#advm_AllocatedFacilitiesAndInformationTechnologyExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:to="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_896349b5-097a-42b3-8257-381571e22e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_b08439e5-c325-4c2b-832b-f13f1261d6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_39c067da-0273-4d13-a5fd-055f69775a9d" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_b08439e5-c325-4c2b-832b-f13f1261d6a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_57c38f04-2c4d-4dd9-9567-53ccfb71186c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2edc227b-010c-45aa-8457-5ccc8078443d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_57c38f04-2c4d-4dd9-9567-53ccfb71186c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2edc227b-010c-45aa-8457-5ccc8078443d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3ed656a9-bf81-466d-9f6e-5c4af221aa89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_57c38f04-2c4d-4dd9-9567-53ccfb71186c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3ed656a9-bf81-466d-9f6e-5c4af221aa89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5c07b768-e164-4736-9044-6e93d9ea1f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dd5ff44b-de55-47c8-869f-a1e92c6c09ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5c07b768-e164-4736-9044-6e93d9ea1f5a" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_dd5ff44b-de55-47c8-869f-a1e92c6c09ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8164a4ea-b69b-4904-943b-ce3ebd4e5414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_12706701-3f24-4197-ab5d-ef9288ee72ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8164a4ea-b69b-4904-943b-ce3ebd4e5414" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_12706701-3f24-4197-ab5d-ef9288ee72ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4ccd24a6-c577-42d4-ba5e-0f2b9bec148d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_beefa304-3316-4275-8fdf-2b7e4b779852" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4ccd24a6-c577-42d4-ba5e-0f2b9bec148d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_beefa304-3316-4275-8fdf-2b7e4b779852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd70596c-40ef-4f3a-9646-e7d8fd2efad5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_4ccd24a6-c577-42d4-ba5e-0f2b9bec148d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd70596c-40ef-4f3a-9646-e7d8fd2efad5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a03e048a-f42f-45ab-a31e-4173b480b7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a03e048a-f42f-45ab-a31e-4173b480b7a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_336ab442-15bc-46fb-9527-1eb8cc9dc25e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_336ab442-15bc-46fb-9527-1eb8cc9dc25e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_514e7011-a576-4649-8249-3e2b89ef516f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_514e7011-a576-4649-8249-3e2b89ef516f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e6803cae-9edc-44c1-97d4-8f34c0ef6eae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e6803cae-9edc-44c1-97d4-8f34c0ef6eae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a878cf0e-69bc-4dfb-a42c-5db623a99326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a878cf0e-69bc-4dfb-a42c-5db623a99326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bf9582e5-7040-48fa-a5b2-79f0b7d62c60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_bf9582e5-7040-48fa-a5b2-79f0b7d62c60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_57a4a396-2208-4106-a19c-08eff8f7cd54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_57a4a396-2208-4106-a19c-08eff8f7cd54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_3bc19805-b92f-4e44-bc05-cfa4210eb1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_3bc19805-b92f-4e44-bc05-cfa4210eb1b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_4525077c-293d-4457-9c3d-9cac326d5089" xlink:href="advm-20241231.xsd#advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e8ccc672-52e0-4d4d-a7a1-c4d2d6d1be12" xlink:to="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_4525077c-293d-4457-9c3d-9cac326d5089" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fb665fed-f9d9-4c44-8342-179e1d6a38b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_effd1c50-5fb4-4226-a6d6-971360715132" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fb665fed-f9d9-4c44-8342-179e1d6a38b3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_effd1c50-5fb4-4226-a6d6-971360715132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ee7d5aed-f1f4-4d7d-bb71-0997402cac49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fb665fed-f9d9-4c44-8342-179e1d6a38b3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ee7d5aed-f1f4-4d7d-bb71-0997402cac49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_369b8319-bf78-4cc9-818a-bbaa8a3c3fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ad83ea99-8d95-4b7f-a7c9-27f15c7e2edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_369b8319-bf78-4cc9-818a-bbaa8a3c3fa7" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_ad83ea99-8d95-4b7f-a7c9-27f15c7e2edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_98cfcb95-44d7-4af5-acbc-d9b6dced557c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_369b8319-bf78-4cc9-818a-bbaa8a3c3fa7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_98cfcb95-44d7-4af5-acbc-d9b6dced557c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_3a80b2ab-f08e-4e97-b292-7aa6d72929ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_3a80b2ab-f08e-4e97-b292-7aa6d72929ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0660ca4c-e9b9-475f-9103-5f9f090265ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0660ca4c-e9b9-475f-9103-5f9f090265ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ff604e43-934e-4d29-8814-c864867d3798" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ff604e43-934e-4d29-8814-c864867d3798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_359dad52-2368-4a7b-8ef3-df391f6cbaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_359dad52-2368-4a7b-8ef3-df391f6cbaa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsLeaseObligation_c9d7ff8d-b018-4e81-ae39-176b1163e622" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsLeaseObligation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_advm_DeferredTaxAssetsLeaseObligation_c9d7ff8d-b018-4e81-ae39-176b1163e622" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsCapitalizedCosts_a57b7a71-6e92-4ba4-902c-3d02c04e1400" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsCapitalizedCosts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_advm_DeferredTaxAssetsCapitalizedCosts_a57b7a71-6e92-4ba4-902c-3d02c04e1400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_a8d3d99d-d8a1-4649-a8e1-5996ccd28cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_a8d3d99d-d8a1-4649-a8e1-5996ccd28cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2c7ef49e-e7a8-4253-8c8e-b558a46bc74d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2c7ef49e-e7a8-4253-8c8e-b558a46bc74d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_51ad32e3-b826-4801-8f1b-f2e0a1c8e096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_3f5f7320-6650-47bf-8864-037436a636d5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_51ad32e3-b826-4801-8f1b-f2e0a1c8e096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6e5cb4ad-dee8-4172-8f2b-ab8f084c4aca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5fa80d86-fae2-4125-9729-30015ea9107b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6e5cb4ad-dee8-4172-8f2b-ab8f084c4aca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5fa80d86-fae2-4125-9729-30015ea9107b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8f35e4d8-3ac6-4bc6-b26c-b810a26e4ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6e5cb4ad-dee8-4172-8f2b-ab8f084c4aca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8f35e4d8-3ac6-4bc6-b26c-b810a26e4ad8" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>advm-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:to="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8f18c423-d40d-4953-b90f-70126e30de7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:to="loc_us-gaap_EquityComponentDomain_8f18c423-d40d-4953-b90f-70126e30de7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:to="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5024969c-7e83-41ea-be2a-76a084d25fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_CommonStockMember_5024969c-7e83-41ea-be2a-76a084d25fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7ffa72cf-7a3c-49a2-a1bb-45a02f22bcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7ffa72cf-7a3c-49a2-a1bb-45a02f22bcfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bdcc7310-7a5a-4c22-99a4-c7d0747910cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bdcc7310-7a5a-4c22-99a4-c7d0747910cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eef53fbe-a063-4fa3-8ea9-912ed19f7ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_RetainedEarningsMember_eef53fbe-a063-4fa3-8ea9-912ed19f7ceb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2dfb1dc0-9ef1-40c5-9882-7957647473f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2dfb1dc0-9ef1-40c5-9882-7957647473f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88dc1cbd-b617-4a1d-ade5-2210667be588" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockholdersEquity_88dc1cbd-b617-4a1d-ade5-2210667be588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_279e89ab-2693-4460-bb0b-96bc98d5ba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_279e89ab-2693-4460-bb0b-96bc98d5ba3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8c9d64a6-c594-49f6-8306-55811f5e2519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8c9d64a6-c594-49f6-8306-55811f5e2519" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9b68005-c124-43a8-8c9a-c90d64fec7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9b68005-c124-43a8-8c9a-c90d64fec7e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ed628b7-b92e-4a4a-a92f-ee9f1b8a18eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ed628b7-b92e-4a4a-a92f-ee9f1b8a18eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0a30c2fe-a995-4bd1-ba4a-604565a3692d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0a30c2fe-a995-4bd1-ba4a-604565a3692d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9e54a287-1610-4a62-9fef-7efb57d126d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9e54a287-1610-4a62-9fef-7efb57d126d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c1818b34-9ead-49a1-9986-92ea5950faf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c1818b34-9ead-49a1-9986-92ea5950faf4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_52b59158-4567-4b2f-bae0-ee37234dcee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_52b59158-4567-4b2f-bae0-ee37234dcee3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_6e67bf6c-458c-469b-b928-2b00b104a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_6e67bf6c-458c-469b-b928-2b00b104a66d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d54875be-dfe8-4254-ba1d-28d858446222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d54875be-dfe8-4254-ba1d-28d858446222" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f98aed1a-3f27-44ff-b36f-942296c86ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_NetIncomeLoss_f98aed1a-3f27-44ff-b36f-942296c86ca9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_02348a71-21fa-4e8a-bbf6-e7c468e9d6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66fde7d9-c7d2-47b8-a3dc-73b0a6aace44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:to="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4bdee620-a0bd-4700-8723-d3be5f0c12cc_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:to="loc_srt_RestatementDomain_4bdee620-a0bd-4700-8723-d3be5f0c12cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:to="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_5217c8b1-08ea-4ac0-9133-3dffd146c06a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:to="loc_srt_RestatementAdjustmentMember_5217c8b1-08ea-4ac0-9133-3dffd146c06a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_375bbff5-0e5b-44c1-82d2-ac3e8fda9080_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:to="loc_us-gaap_LeaseContractualTermDomain_375bbff5-0e5b-44c1-82d2-ac3e8fda9080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:to="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RedwoodCaliforniaFacilityLeaseMember_833ea63a-8e48-44b8-ae68-63556809b672" xlink:href="advm-20241231.xsd#advm_RedwoodCaliforniaFacilityLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:to="loc_advm_RedwoodCaliforniaFacilityLeaseMember_833ea63a-8e48-44b8-ae68-63556809b672" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_774e56a7-633b-4b4f-9dd4-16cb841fc6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_774e56a7-633b-4b4f-9dd4-16cb841fc6d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ae6b7f37-56c3-43dc-99e5-376ec4b777e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ae6b7f37-56c3-43dc-99e5-376ec4b777e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c12e78dd-ea34-436f-8dea-bb32255243af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_OperatingLeaseLiability_c12e78dd-ea34-436f-8dea-bb32255243af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b49cbb2f-5dce-49e5-8d34-0436b644614b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b49cbb2f-5dce-49e5-8d34-0436b644614b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:to="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_10dce007-6448-4485-87ed-49b9ba57663b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:to="loc_srt_RestatementDomain_10dce007-6448-4485-87ed-49b9ba57663b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:to="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_91863f9b-b1cb-4001-9415-ef1b43bb0636" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_91863f9b-b1cb-4001-9415-ef1b43bb0636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_3dcac058-3f99-4fb0-9160-927403ae1f90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:to="loc_srt_RestatementAdjustmentMember_3dcac058-3f99-4fb0-9160-927403ae1f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_838bb818-7494-45ef-8fd8-3328c06e9ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_838bb818-7494-45ef-8fd8-3328c06e9ecb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_44322b11-5c03-4e6b-af6a-512c493a14f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_ShortTermInvestments_44322b11-5c03-4e6b-af6a-512c493a14f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b4411395-c7bc-4c39-a694-5937b7550d44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b4411395-c7bc-4c39-a694-5937b7550d44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8feba38f-9858-435f-928a-b70bbd82bae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_AssetsCurrent_8feba38f-9858-435f-928a-b70bbd82bae9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9bf12be0-a0a8-422a-ba88-b2578d991338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9bf12be0-a0a8-422a-ba88-b2578d991338" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f192db84-5999-40c7-ba87-f4aee62ee9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f192db84-5999-40c7-ba87-f4aee62ee9b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2097ee17-c1f4-45d2-bffc-ec0ac53c2aef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2097ee17-c1f4-45d2-bffc-ec0ac53c2aef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c5e76d54-381f-44d5-ba21-4b09441036ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c5e76d54-381f-44d5-ba21-4b09441036ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8039d4ad-71e9-41b4-b9dd-095b3d045bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_Assets_8039d4ad-71e9-41b4-b9dd-095b3d045bf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a6c3233e-4411-4837-b4f6-b51ce67cd0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_AccountsPayableCurrent_a6c3233e-4411-4837-b4f6-b51ce67cd0d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_fc00dd8b-7f61-40d7-b67d-1dee1838e52e" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_fc00dd8b-7f61-40d7-b67d-1dee1838e52e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb01f5f7-cb51-4366-bb19-40088eae7ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb01f5f7-cb51-4366-bb19-40088eae7ebd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e348ee1-1152-4e4e-9690-127605323d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e348ee1-1152-4e4e-9690-127605323d8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4f40d094-cfe0-4f50-a420-b1b6bcbc0d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4f40d094-cfe0-4f50-a420-b1b6bcbc0d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_583e322a-a1f2-43b1-849b-283640acc87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:to="loc_us-gaap_Liabilities_583e322a-a1f2-43b1-849b-283640acc87e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fe2c2909-0e58-45d2-baca-c1a52cad937c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fe2c2909-0e58-45d2-baca-c1a52cad937c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_35eb5d47-1bf1-413a-ba33-f0d823cce2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_PreferredStockValue_35eb5d47-1bf1-413a-ba33-f0d823cce2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_99d91dbd-0278-4cbb-a6b0-3a74dc41bfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_CommonStockValue_99d91dbd-0278-4cbb-a6b0-3a74dc41bfe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5321cbe-0e50-4d4e-9be8-2a7be6c8b056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5321cbe-0e50-4d4e-9be8-2a7be6c8b056" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d950923-8043-4527-9dc5-bf22a088c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d950923-8043-4527-9dc5-bf22a088c92b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c5967991-23ea-4fe3-a340-3de6fbd87706" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c5967991-23ea-4fe3-a340-3de6fbd87706" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_626eaba2-a159-4011-8ccb-3ec00ac68ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_StockholdersEquity_626eaba2-a159-4011-8ccb-3ec00ac68ea0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_49b92dfe-f5af-4415-8380-32f2c3296db0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_49b92dfe-f5af-4415-8380-32f2c3296db0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:to="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:to="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_1c00bc09-384a-4c52-8e19-fcd6592b277d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:to="loc_srt_RestatementDomain_1c00bc09-384a-4c52-8e19-fcd6592b277d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:to="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_df9a60f2-008f-4069-9517-c01405bea6e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_df9a60f2-008f-4069-9517-c01405bea6e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_58fe1689-6077-43dd-89a9-5801c5930768" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:to="loc_srt_RestatementAdjustmentMember_58fe1689-6077-43dd-89a9-5801c5930768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:to="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5fa46cf-e646-4279-8e75-08167a89f158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5fa46cf-e646-4279-8e75-08167a89f158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ab327b8e-d7da-4394-855f-c33a188d7e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ab327b8e-d7da-4394-855f-c33a188d7e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_67938590-a104-4659-9a24-e811eb1237ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_67938590-a104-4659-9a24-e811eb1237ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_52abc791-b077-4295-aa62-5a2c787aa961" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_OperatingExpenses_52abc791-b077-4295-aa62-5a2c787aa961" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dda238fa-6b8e-4f6f-8f4d-d13c5b752811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OperatingIncomeLoss_dda238fa-6b8e-4f6f-8f4d-d13c5b752811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f8b5c5e8-e2f7-482d-8f39-f10cff645bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f8b5c5e8-e2f7-482d-8f39-f10cff645bad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d55afb-bb76-4fa3-bec8-8d4877d6626d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d55afb-bb76-4fa3-bec8-8d4877d6626d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d3fbf531-d4be-45d5-8dfd-9e3e5d81f64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d3fbf531-d4be-45d5-8dfd-9e3e5d81f64f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6074fd74-b5f8-438c-b996-24617694ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_NetIncomeLoss_6074fd74-b5f8-438c-b996-24617694ff55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_d6734e7f-1edd-4f35-8829-7f4c6d6c1180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_d6734e7f-1edd-4f35-8829-7f4c6d6c1180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ac3730f5-98b7-4314-9eb6-8b8493ba6385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ac3730f5-98b7-4314-9eb6-8b8493ba6385" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7f6abea-670d-457f-bb98-744e43a29c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7f6abea-670d-457f-bb98-744e43a29c9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_926ea90c-ac91-4e1d-8b2e-49417c8ac3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_EarningsPerShareBasic_926ea90c-ac91-4e1d-8b2e-49417c8ac3f2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7ada9410-6325-460e-afa8-0421b20a708b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7ada9410-6325-460e-afa8-0421b20a708b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0845a2a-1510-45d5-a1a4-3e1c631d4c38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0845a2a-1510-45d5-a1a4-3e1c631d4c38" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e6a009d-4e9f-4dc1-bdce-bf2d0a4f45dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e6a009d-4e9f-4dc1-bdce-bf2d0a4f45dd" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:to="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:to="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4e2b988d-3754-4f2a-8415-6cc899b8d360_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:to="loc_srt_RestatementDomain_4e2b988d-3754-4f2a-8415-6cc899b8d360_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:to="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_74613a93-3e7e-4bb2-a52c-0caf86210b2a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_74613a93-3e7e-4bb2-a52c-0caf86210b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a164641c-6b71-497e-a878-40200ad0d6a0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:to="loc_srt_RestatementAdjustmentMember_a164641c-6b71-497e-a878-40200ad0d6a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16851fc0-9e9e-4d6c-979c-00000ec81cac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_NetIncomeLoss_16851fc0-9e9e-4d6c-979c-00000ec81cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8527754-815d-408d-9063-775b39e0ee58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8527754-815d-408d-9063-775b39e0ee58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_115f40ca-4929-4066-a900-b6265be60e85" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:to="loc_advm_NonCashSubleaseLossIncome_115f40ca-4929-4066-a900-b6265be60e85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f48b7ee0-d61e-46c6-9636-024cd23eab12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f48b7ee0-d61e-46c6-9636-024cd23eab12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_c435de14-c9a6-414d-9207-90d66f74ac82" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:to="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_c435de14-c9a6-414d-9207-90d66f74ac82" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:to="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6d183e84-ca27-4f48-b725-60d3e1b5bc70_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:to="loc_srt_RangeMember_6d183e84-ca27-4f48-b725-60d3e1b5bc70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:to="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c37e71e-1d44-4eac-b236-0fecec4650a3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:to="loc_srt_MinimumMember_0c37e71e-1d44-4eac-b236-0fecec4650a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2b1695c-2d3c-42e4-bb52-e87889e0ede3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:to="loc_srt_MaximumMember_c2b1695c-2d3c-42e4-bb52-e87889e0ede3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_864cfe06-70af-4d23-bf51-54e9269a7c14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_864cfe06-70af-4d23-bf51-54e9269a7c14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b665acda-e752-4e6c-8084-dfe39f33ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_NumberOfReportableSegments_b665acda-e752-4e6c-8084-dfe39f33ce8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_57621fbb-164b-4afd-a607-7a2468ab2d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_57621fbb-164b-4afd-a607-7a2468ab2d2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_919fad38-47a7-4dae-ade2-6bbf05c6dcee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_919fad38-47a7-4dae-ade2-6bbf05c6dcee" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f0affe2e-4b16-48c5-9b7a-418db16fd3c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f0affe2e-4b16-48c5-9b7a-418db16fd3c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2b062f94-2223-4ef5-b892-a40897f379f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2b062f94-2223-4ef5-b892-a40897f379f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a3301f9a-bde8-438b-a9c8-c8f9780b410a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a3301f9a-bde8-438b-a9c8-c8f9780b410a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:to="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_896f7139-f0a4-4be5-91f3-8d518109e5cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_896f7139-f0a4-4be5-91f3-8d518109e5cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_189636b5-054c-4af7-bd70-d718d05ffd07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_MoneyMarketFundsMember_189636b5-054c-4af7-bd70-d718d05ffd07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bae7f137-7345-4484-bae8-4e1518232165" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_CommercialPaperMember_bae7f137-7345-4484-bae8-4e1518232165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_faab164c-6e48-4abd-8537-ede4dcdab4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_faab164c-6e48-4abd-8537-ede4dcdab4d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashEquivalentsAndShortTermInvestmentsMember_d705bf30-c4d1-40b0-adfa-f701b9ae1a3d" xlink:href="advm-20241231.xsd#advm_CashEquivalentsAndShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_advm_CashEquivalentsAndShortTermInvestmentsMember_d705bf30-c4d1-40b0-adfa-f701b9ae1a3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7bacae44-2aec-4715-bc63-b3e6d18b10e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7bacae44-2aec-4715-bc63-b3e6d18b10e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc996456-2d5f-47f8-8cb3-b1e221d413b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc996456-2d5f-47f8-8cb3-b1e221d413b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_51e4e48f-c7ff-423d-9e85-1e0b28c8a71a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_51e4e48f-c7ff-423d-9e85-1e0b28c8a71a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99da9bd1-0f7f-441e-91d4-422f0f9483e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99da9bd1-0f7f-441e-91d4-422f0f9483e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentAmortizedCost_667af40d-938f-40a5-874d-fbb0c66dd52e" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentAmortizedCost_667af40d-938f-40a5-874d-fbb0c66dd52e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedGain_5321da63-6e39-4a8c-9e8a-4e4f57a3646c" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentGrossUnrealizedGain_5321da63-6e39-4a8c-9e8a-4e4f57a3646c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss_7962d75a-29bc-47d5-b834-5c4adae6275d" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss_7962d75a-29bc-47d5-b834-5c4adae6275d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_523a5101-0d99-4848-a79a-f1809c89e138" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_523a5101-0d99-4848-a79a-f1809c89e138" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RevenueDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:to="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc5ff8a2-9303-4091-b2f4-4f786c486b94_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cc5ff8a2-9303-4091-b2f4-4f786c486b94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LexeoTherapeuticsIncMember_3a88f29c-4912-4c79-bb9b-3ea475bbf02a" xlink:href="advm-20241231.xsd#advm_LexeoTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:to="loc_advm_LexeoTherapeuticsIncMember_3a88f29c-4912-4c79-bb9b-3ea475bbf02a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:to="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_edf43afa-5e13-4419-b38f-c830d2f68e48_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:to="loc_srt_NameOfMajorCustomerDomain_edf43afa-5e13-4419-b38f-c830d2f68e48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:to="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RayTherapeuticsIncMember_c7226b6d-8180-413b-b8da-122f02e3f724" xlink:href="advm-20241231.xsd#advm_RayTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:to="loc_advm_RayTherapeuticsIncMember_c7226b6d-8180-413b-b8da-122f02e3f724" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLicenseFeesReceived_be50dcc8-f879-4787-b0bd-cde9400fb4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLicenseFeesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:to="loc_us-gaap_ProceedsFromLicenseFeesReceived_be50dcc8-f879-4787-b0bd-cde9400fb4e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8bfcc78-9bb0-4a17-a6d6-f4845e369169" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8bfcc78-9bb0-4a17-a6d6-f4845e369169" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_497ae037-ea66-4699-88ca-cb9c66c45394_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_497ae037-ea66-4699-88ca-cb9c66c45394_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_a2ae036f-9cc2-4b39-afba-3d7c38a64d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:to="loc_us-gaap_BuildingMember_a2ae036f-9cc2-4b39-afba-3d7c38a64d7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_df76fc4a-8040-4449-a97b-db6b4ff93a35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:to="loc_us-gaap_ManufacturingFacilityMember_df76fc4a-8040-4449-a97b-db6b4ff93a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fb950673-ed3f-45b9-bdee-614f11d6d8d1_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:to="loc_srt_SegmentGeographicalDomain_fb950673-ed3f-45b9-bdee-614f11d6d8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:to="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_71de5229-e875-428b-8d42-ab5025707293" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:to="loc_stpr_NC_71de5229-e875-428b-8d42-ab5025707293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_803e1a66-cf53-4710-8770-9c0e0a291c0c" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:to="loc_stpr_CA_803e1a66-cf53-4710-8770-9c0e0a291c0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a46e9249-2f40-4606-b49a-7217e7733565_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a46e9249-2f40-4606-b49a-7217e7733565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_27685e6d-0e5e-4807-aa36-14b147561c75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:to="loc_us-gaap_SubsequentEventMember_27685e6d-0e5e-4807-aa36-14b147561c75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_564bc0b6-d83a-4037-b389-3aabca052276_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:to="loc_us-gaap_LossContingencyNatureDomain_564bc0b6-d83a-4037-b389-3aabca052276_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:to="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_7a3f7efe-8745-4fee-8a9b-ed658b3452ef" xlink:href="advm-20241231.xsd#advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:to="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_7a3f7efe-8745-4fee-8a9b-ed658b3452ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c6fcf38-9f19-4deb-90c4-98acd7a715a7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6c6fcf38-9f19-4deb-90c4-98acd7a715a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SubleaseTenantMember_c0f3d832-50de-4b56-82b2-c6200cd12def" xlink:href="advm-20241231.xsd#advm_SubleaseTenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:to="loc_advm_SubleaseTenantMember_c0f3d832-50de-4b56-82b2-c6200cd12def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LandlordMember_cf80a007-81c8-4aae-81c8-27d5439e32cb" xlink:href="advm-20241231.xsd#advm_LandlordMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:to="loc_advm_LandlordMember_cf80a007-81c8-4aae-81c8-27d5439e32cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f5f074f-9f56-414d-b35e-d250e76b38cf_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:to="loc_dei_EntityDomain_3f5f074f-9f56-414d-b35e-d250e76b38cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:to="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LandlordMember_812b6e62-47f0-4171-9b3b-8b5e6e3eeab1" xlink:href="advm-20241231.xsd#advm_LandlordMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:to="loc_advm_LandlordMember_812b6e62-47f0-4171-9b3b-8b5e6e3eeab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SubleaseTenantMember_e470b267-3cc6-4236-b7da-af3228412896" xlink:href="advm-20241231.xsd#advm_SubleaseTenantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:to="loc_advm_SubleaseTenantMember_e470b267-3cc6-4236-b7da-af3228412896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_61766104-633c-4823-806d-a42adef9e990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_61766104-633c-4823-806d-a42adef9e990" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_08f272ea-8ed7-4b16-acac-f210701af806" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_08f272ea-8ed7-4b16-acac-f210701af806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfLease_7acdef7b-35ed-478e-9541-118acbc1d9a4" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseNumberOfLease_7acdef7b-35ed-478e-9541-118acbc1d9a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_66bae250-eb56-437f-9fcc-4af7c5ed583d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_66bae250-eb56-437f-9fcc-4af7c5ed583d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_5fbed259-667b-4b39-b6e0-ec016e6a9da0" xlink:href="advm-20241231.xsd#advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_5fbed259-667b-4b39-b6e0-ec016e6a9da0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts_946e07f7-b3a8-4681-971f-7d0e06ce765b" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfRenewalContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts_946e07f7-b3a8-4681-971f-7d0e06ce765b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_7791f867-8b23-4c8d-8cf3-42a800aefa30" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseLeaseholdImprovementAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_7791f867-8b23-4c8d-8cf3-42a800aefa30" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_465cc31f-14b0-43f1-b125-2d5819ed4b6b" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_465cc31f-14b0-43f1-b125-2d5819ed4b6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_d5e7112c-929d-407a-8e48-848db4f09913" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_d5e7112c-929d-407a-8e48-848db4f09913" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_f18246ee-051a-412b-82bb-248dcdf5690d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_f18246ee-051a-412b-82bb-248dcdf5690d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_25f55daf-a285-46ad-aa2a-bb215c4da863" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_25f55daf-a285-46ad-aa2a-bb215c4da863" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_ece098e0-653b-4e01-8179-df26d7627b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_PaymentsForRent_ece098e0-653b-4e01-8179-df26d7627b08" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_0d820b88-cee5-44ac-adb8-57875d6ba3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_TenantImprovements_0d820b88-cee5-44ac-adb8-57875d6ba3b7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_53566d4a-8c6a-4d3f-882c-0cfdeb18f853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_SubleaseIncome_53566d4a-8c6a-4d3f-882c-0cfdeb18f853" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_57ae10ac-ff30-4802-82e4-44967f7f7351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_57ae10ac-ff30-4802-82e4-44967f7f7351" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_df0a52d6-9493-479c-afe0-a26d3eb17ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_df0a52d6-9493-479c-afe0-a26d3eb17ce6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1fec2596-8321-4ec9-a875-b4e7d8c865cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseCost_1fec2596-8321-4ec9-a875-b4e7d8c865cd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_d84e04dd-78de-4206-895d-34c90fa61faa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_VariableLeaseCost_d84e04dd-78de-4206-895d-34c90fa61faa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_17143e3c-008c-4c0c-ac50-2512abb6b2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeasePayments_17143e3c-008c-4c0c-ac50-2512abb6b2d1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements_9d2c1e7a-6ef6-4b4d-8faa-21c350ec9283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_PaymentsForTenantImprovements_9d2c1e7a-6ef6-4b4d-8faa-21c350ec9283" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a094c1d3-df21-4ee2-9c54-7079d562d125_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a094c1d3-df21-4ee2-9c54-7079d562d125_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_373b86a3-6961-4b74-9dd8-5a24c0379158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_EquipmentMember_373b86a3-6961-4b74-9dd8-5a24c0379158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ca1ac72b-1aea-4e5d-9053-329341573316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ca1ac72b-1aea-4e5d-9053-329341573316" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d92121d7-a9c8-41da-a697-9a665ae083d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_ComputerEquipmentMember_d92121d7-a9c8-41da-a697-9a665ae083d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_589301e5-0e81-4551-94a2-85b8d81c038f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_ConstructionInProgressMember_589301e5-0e81-4551-94a2-85b8d81c038f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e50ef4ed-8eac-4318-8b4f-c8272690b801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e50ef4ed-8eac-4318-8b4f-c8272690b801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bcb8ee98-f464-4161-b520-af8a88d05f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bcb8ee98-f464-4161-b520-af8a88d05f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7e7fe22b-b9a3-4747-9697-80dce7c53b31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7e7fe22b-b9a3-4747-9697-80dce7c53b31" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:to="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:to="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:to="loc_srt_NameOfMajorCustomerDomain_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:to="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RayTherapeuticsIncMember_290fb535-0ca8-48d8-8366-2d7e4f1ef7cb" xlink:href="advm-20241231.xsd#advm_RayTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:to="loc_advm_RayTherapeuticsIncMember_290fb535-0ca8-48d8-8366-2d7e4f1ef7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LexeoTherapeuticsIncMember_cd2e3c74-c351-469d-b9ee-42b5edd8b286" xlink:href="advm-20241231.xsd#advm_LexeoTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:to="loc_advm_LexeoTherapeuticsIncMember_cd2e3c74-c351-469d-b9ee-42b5edd8b286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ade4870-81d0-44ed-9b70-1b73e618fa35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ade4870-81d0-44ed-9b70-1b73e618fa35" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2dbab063-89ed-4235-ad87-d8d298e6b736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2dbab063-89ed-4235-ad87-d8d298e6b736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8323622e-c26b-45e7-b689-afc679823dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:to="loc_us-gaap_PrivatePlacementMember_8323622e-c26b-45e7-b689-afc679823dc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_PreFundedWarrantsMember_3cf857a5-5a67-474f-af02-f1fd31db9be7" xlink:href="advm-20241231.xsd#advm_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:to="loc_advm_PreFundedWarrantsMember_3cf857a5-5a67-474f-af02-f1fd31db9be7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f399c01-b50c-4fbe-8201-33bd52fe8e1d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f399c01-b50c-4fbe-8201-33bd52fe8e1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoDirectorsMember_c163677d-57a9-4661-acb5-3ebc42f77b1e" xlink:href="advm-20241231.xsd#advm_TwoDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:to="loc_advm_TwoDirectorsMember_c163677d-57a9-4661-acb5-3ebc42f77b1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3aaad242-eb36-4fe3-b36e-f35986fe523b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:to="loc_us-gaap_PlanNameDomain_3aaad242-eb36-4fe3-b36e-f35986fe523b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:to="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember_a97d7572-4bd2-4830-9728-79687f40f95e" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember_a97d7572-4bd2-4830-9728-79687f40f95e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandSeventeenInducementPlanMember_7fc7f334-76ed-4be2-b89b-e19aaf3df373" xlink:href="advm-20241231.xsd#advm_TwoThousandSeventeenInducementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandSeventeenInducementPlanMember_7fc7f334-76ed-4be2-b89b-e19aaf3df373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember_1e0ab450-e1fb-4759-9247-46bb4c1d9f5d" xlink:href="advm-20241231.xsd#advm_TwoThousandFourteenPlanAndInducementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember_1e0ab450-e1fb-4759-9247-46bb4c1d9f5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_16ef85f7-4750-4058-bc2b-2517f62b514b" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_16ef85f7-4750-4058-bc2b-2517f62b514b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_A2024EquityIncentiveAwardPlanMember_62373eab-bc08-44fa-bbb4-49b44f754f53" xlink:href="advm-20241231.xsd#advm_A2024EquityIncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_A2024EquityIncentiveAwardPlanMember_62373eab-bc08-44fa-bbb4-49b44f754f53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_13c5ca66-1756-4043-b4f1-2485fddb1301_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_13c5ca66-1756-4043-b4f1-2485fddb1301_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_StockOptionsAndRestrictedStockUnitsMember_66a0c240-ca27-4fe6-8344-41f49e9a1a3f" xlink:href="advm-20241231.xsd#advm_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_advm_StockOptionsAndRestrictedStockUnitsMember_66a0c240-ca27-4fe6-8344-41f49e9a1a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_170d181e-7003-4bce-bd5d-b816267f2d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_StockCompensationPlanMember_170d181e-7003-4bce-bd5d-b816267f2d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_39c85429-1d6c-4899-9f1b-b0792ba5fb75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_39c85429-1d6c-4899-9f1b-b0792ba5fb75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_72deb8a3-28e2-4194-9620-86b004b3fdc3" xlink:href="advm-20241231.xsd#advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_72deb8a3-28e2-4194-9620-86b004b3fdc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_10d1a7f2-4cc9-44ff-ae90-97ad1f77499c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_10d1a7f2-4cc9-44ff-ae90-97ad1f77499c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c0f0cd09-87a7-4157-a513-1f2a7a63cbea_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:to="loc_srt_RangeMember_c0f0cd09-87a7-4157-a513-1f2a7a63cbea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:to="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6cfb90d0-9784-4cd4-a0ea-daaf5211920a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:to="loc_srt_MaximumMember_6cfb90d0-9784-4cd4-a0ea-daaf5211920a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b7d8b216-ad05-42fc-803a-672be4a63fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b7d8b216-ad05-42fc-803a-672be4a63fc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7ff8ce23-f3f4-419e-ab83-c0e22c28b55e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7ff8ce23-f3f4-419e-ab83-c0e22c28b55e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cc197e4e-29fe-4dac-a676-8f7a1a7a2d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cc197e4e-29fe-4dac-a676-8f7a1a7a2d63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcd77ab0-c15f-44af-ac2b-b58446e6be74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcd77ab0-c15f-44af-ac2b-b58446e6be74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_BeneficialOwnershipInterestLimitationPercent_dae0e0ba-9a12-401a-8219-20550d075db2" xlink:href="advm-20241231.xsd#advm_BeneficialOwnershipInterestLimitationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_BeneficialOwnershipInterestLimitationPercent_dae0e0ba-9a12-401a-8219-20550d075db2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClassOfWarrantOrRightWarrantsExercised_bdc9787d-f0a5-4d78-9098-bd39b19ba3a0" xlink:href="advm-20241231.xsd#advm_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ClassOfWarrantOrRightWarrantsExercised_bdc9787d-f0a5-4d78-9098-bd39b19ba3a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors_3d2879b4-f690-49f3-9bf6-8dc0ab85f88d" xlink:href="advm-20241231.xsd#advm_SecuritiesPurchaseAgreementNumberOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors_3d2879b4-f690-49f3-9bf6-8dc0ab85f88d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4855fc0c-98ab-44c5-97fd-b77b16139d55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4855fc0c-98ab-44c5-97fd-b77b16139d55" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_57cd0265-9bdf-4dfa-aece-45d464ff014c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_57cd0265-9bdf-4dfa-aece-45d464ff014c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_5fc5711e-2f8d-4260-9542-a24e1cde4f02" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_5fc5711e-2f8d-4260-9542-a24e1cde4f02" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_946e1183-83c1-4a4a-a6f6-889854873297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_946e1183-83c1-4a4a-a6f6-889854873297" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4f99de3c-48a0-4199-a280-efde37e716b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4f99de3c-48a0-4199-a280-efde37e716b6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_825133c2-4f1c-4dae-aed3-c0a2c3b7a429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_825133c2-4f1c-4dae-aed3-c0a2c3b7a429" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8270bd16-0877-427f-87a6-32f640f1eedb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8270bd16-0877-427f-87a6-32f640f1eedb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_373e1bde-debf-4958-853d-82807012f962" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_373e1bde-debf-4958-853d-82807012f962" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_648d3231-4423-4ef4-8248-cf689dd29611" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_648d3231-4423-4ef4-8248-cf689dd29611" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2de53ca1-fc97-4269-8280-062f8e8bd227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2de53ca1-fc97-4269-8280-062f8e8bd227" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a098b515-32b1-4826-90cd-0162602a2df9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a098b515-32b1-4826-90cd-0162602a2df9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84f4b3c1-17c1-43b0-9c7b-b3f49fa78a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84f4b3c1-17c1-43b0-9c7b-b3f49fa78a41" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fb1c94ce-4cc7-4f5b-bc69-fe1eb6e73728" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fb1c94ce-4cc7-4f5b-bc69-fe1eb6e73728" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4cd9b672-0c5c-4137-bae7-3319190ae26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4cd9b672-0c5c-4137-bae7-3319190ae26e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f806d982-440b-4b4a-b9c6-7e98679a17bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f806d982-440b-4b4a-b9c6-7e98679a17bd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3edcf690-383b-45fb-a866-2011144f5906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3edcf690-383b-45fb-a866-2011144f5906" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_7c9f630a-dc1e-48ea-a8d9-af6e538e0191" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_7c9f630a-dc1e-48ea-a8d9-af6e538e0191" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c4bcf7f9-f80c-45de-b2f8-a17d6201c6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c4bcf7f9-f80c-45de-b2f8-a17d6201c6f6" xlink:type="arc" order="24"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:to="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_852b05fb-e7b8-4186-a226-6f55e05c98d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_852b05fb-e7b8-4186-a226-6f55e05c98d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_de73dac6-bcba-4f06-bea3-9f6464b13c35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_de73dac6-bcba-4f06-bea3-9f6464b13c35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_698d7f2a-d3ca-4e49-891c-7db62b6bf443" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:to="loc_us-gaap_EmployeeStockMember_698d7f2a-d3ca-4e49-891c-7db62b6bf443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03ece3a9-08af-4f16-9157-5194d9ac30de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03ece3a9-08af-4f16-9157-5194d9ac30de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e495d1b3-f722-4704-97cf-00efe0cfc15d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e495d1b3-f722-4704-97cf-00efe0cfc15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36c7ed97-88a8-4ed8-b8e4-3ea2b6f6c02b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36c7ed97-88a8-4ed8-b8e4-3ea2b6f6c02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e6f04351-10bd-49f3-b40d-d0f06d5f3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e6f04351-10bd-49f3-b40d-d0f06d5f3af7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:to="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2af0bfb2-c084-4b52-95b4-f38af5bc4260" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2af0bfb2-c084-4b52-95b4-f38af5bc4260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b62aedbf-5819-495d-a31f-821e77332d55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b62aedbf-5819-495d-a31f-821e77332d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99ad8480-df83-4226-bcf7-5917c8b5784d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99ad8480-df83-4226-bcf7-5917c8b5784d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_24640981-e799-4329-9c37-b69f69921535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_24640981-e799-4329-9c37-b69f69921535" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08b65c5b-d3a0-4271-bebb-29a7c53b1ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08b65c5b-d3a0-4271-bebb-29a7c53b1ddc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db4fe2fa-93d8-415e-90cd-1fd9bcdd8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ccdb8f11-c825-4561-bf9a-2add3315d459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ccdb8f11-c825-4561-bf9a-2add3315d459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7dcad4e5-7704-4084-9a1a-f191b2335f46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7dcad4e5-7704-4084-9a1a-f191b2335f46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1fe350ab-e6ad-4b01-98e4-7dd10ca2c97b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1fe350ab-e6ad-4b01-98e4-7dd10ca2c97b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bf0505fc-e39b-45c9-8229-80338444901f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bf0505fc-e39b-45c9-8229-80338444901f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59126faf-01ef-40a5-b69a-0e49075f2b80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c8aee6a9-2dc3-427e-9361-1d88c2741b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c8aee6a9-2dc3-427e-9361-1d88c2741b9c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98915906-6733-49eb-8778-3e2fa8a19d99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98915906-6733-49eb-8778-3e2fa8a19d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f42df903-b157-4dad-864a-772fff3b4ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f42df903-b157-4dad-864a-772fff3b4ef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3695aa4b-609e-4957-9c80-52d507d3dea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3695aa4b-609e-4957-9c80-52d507d3dea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ed25da29-66e8-4c50-8ec8-2f8a133d6b76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ed25da29-66e8-4c50-8ec8-2f8a133d6b76" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6672fe8f-271a-4808-b9f8-3d5cdff7b37b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:to="loc_us-gaap_SegmentDomain_6672fe8f-271a-4808-b9f8-3d5cdff7b37b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:to="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReportableSegmentMember_9bcfe7fe-21bc-4918-8e2e-303836186b3b" xlink:href="advm-20241231.xsd#advm_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:to="loc_advm_ReportableSegmentMember_9bcfe7fe-21bc-4918-8e2e-303836186b3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a263a5bb-203a-450b-a0b3-df52424cec71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_NumberOfReportableSegments_a263a5bb-203a-450b-a0b3-df52424cec71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce682d76-51f8-4c8b-848a-0506fb92d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce682d76-51f8-4c8b-848a-0506fb92d15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_e2fa4859-b1ad-4198-b5a1-17c0fc0714b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_LaborAndRelatedExpense_e2fa4859-b1ad-4198-b5a1-17c0fc0714b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClinicalTrialExpenses_91fae1d0-2ca4-4789-92d7-51fc600e81d3" xlink:href="advm-20241231.xsd#advm_ClinicalTrialExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_advm_ClinicalTrialExpenses_91fae1d0-2ca4-4789-92d7-51fc600e81d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_948de696-a852-4ea6-97b5-71173fab03a1" xlink:href="advm-20241231.xsd#advm_AllocatedFacilitiesAndInformationTechnologyExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_948de696-a852-4ea6-97b5-71173fab03a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_66b2f68d-d2e9-4d68-a19e-7f14836a5f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_66b2f68d-d2e9-4d68-a19e-7f14836a5f21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_53a86a2e-45b4-41da-982c-db3825ffd275" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_53a86a2e-45b4-41da-982c-db3825ffd275" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b6f9fba2-e25b-4567-90b0-0546ace4b543" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OperatingExpenses_b6f9fba2-e25b-4567-90b0-0546ace4b543" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0a45f328-5a78-4093-9d1e-36b972f2a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OperatingIncomeLoss_0a45f328-5a78-4093-9d1e-36b972f2a3b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_56386b80-9e52-4705-a8b9-6a2b96a1338f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_56386b80-9e52-4705-a8b9-6a2b96a1338f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3860531-e10b-4f75-919e-354c295048bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3860531-e10b-4f75-919e-354c295048bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dce069f5-42da-4f9f-b39b-e3e290f5c608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dce069f5-42da-4f9f-b39b-e3e290f5c608" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_118a3009-7685-4f04-add9-16335fd7252d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_NetIncomeLoss_118a3009-7685-4f04-add9-16335fd7252d" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:href="advm-20241231.xsd#advm_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:href="advm-20241231.xsd#advm_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_da6241fb-811b-4a3c-b562-291b56801d82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_da6241fb-811b-4a3c-b562-291b56801d82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_f7ae5411-3075-446c-a0cb-305aa0dbffe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_DomesticCountryMember_f7ae5411-3075-446c-a0cb-305aa0dbffe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_a3fbbdd7-a719-4f1d-8a0c-a3ab0519116e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_a3fbbdd7-a719-4f1d-8a0c-a3ab0519116e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f0ae5856-90b6-49a1-81dc-7e827186cc24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_ForeignCountryMember_f0ae5856-90b6-49a1-81dc-7e827186cc24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1e173a0-a496-49c6-9a90-c6a14450c0cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_d1e173a0-a496-49c6-9a90-c6a14450c0cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_0a49fcbc-be54-48c0-b2dd-563fcf87d936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:to="loc_us-gaap_ResearchMember_0a49fcbc-be54-48c0-b2dd-563fcf87d936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_06ba567f-0332-44e0-9cc9-2e909a930553_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:to="loc_srt_SegmentGeographicalDomain_06ba567f-0332-44e0-9cc9-2e909a930553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:to="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_b58da6aa-92c9-4b8e-94e8-91c6369ff10b" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:to="loc_stpr_CA_b58da6aa-92c9-4b8e-94e8-91c6369ff10b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ac87805b-9b69-4013-8f3f-42c4366168b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ac87805b-9b69-4013-8f3f-42c4366168b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_132dd23e-ae94-4a13-84de-b6780aad74a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_132dd23e-ae94-4a13-84de-b6780aad74a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8931354-f758-47e0-98a7-05eea2d85b73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8931354-f758-47e0-98a7-05eea2d85b73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8db338ac-e844-45a9-a575-6d1261ecc579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8db338ac-e844-45a9-a575-6d1261ecc579" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLossCarryforwardsSubjectToExpiration_dfad329d-57dc-4485-9f35-91964eb56a97" xlink:href="advm-20241231.xsd#advm_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_advm_OperatingLossCarryforwardsSubjectToExpiration_dfad329d-57dc-4485-9f35-91964eb56a97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_56f62005-6dd6-474e-99a6-86e24ab0139f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_56f62005-6dd6-474e-99a6-86e24ab0139f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8a893914-0bae-4f9c-a6c5-9fbf65698678" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8a893914-0bae-4f9c-a6c5-9fbf65698678" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f19433e7-bcac-4b1b-ad04-ea571b129507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f19433e7-bcac-4b1b-ad04-ea571b129507" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a3fd6017-c666-401f-b6ed-d8f3fd6ec884" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a3fd6017-c666-401f-b6ed-d8f3fd6ec884" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/NetLossperShareDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#NetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/NetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b5c006d2-2a57-4169-b904-f04fd097528a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b5c006d2-2a57-4169-b904-f04fd097528a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a073d792-32b6-473c-8475-0e8b26e8f366" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a073d792-32b6-473c-8475-0e8b26e8f366" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d148c0b8-20ef-4da2-a86c-2aec5daf86d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d148c0b8-20ef-4da2-a86c-2aec5daf86d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_271ac199-3068-43ee-ba0a-f1e1b7360811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_EmployeeStockMember_271ac199-3068-43ee-ba0a-f1e1b7360811" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2b80e2ff-2fa6-4146-8b45-ad74969914fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2b80e2ff-2fa6-4146-8b45-ad74969914fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:to="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ef79a3f2-7028-4e56-a29f-3ec5136df7ff_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:to="loc_srt_RestatementDomain_ef79a3f2-7028-4e56-a29f-3ec5136df7ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:to="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_fa80d4a2-f2ce-4ec8-bd7d-9bbf0260f629" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:to="loc_srt_RestatementAdjustmentMember_fa80d4a2-f2ce-4ec8-bd7d-9bbf0260f629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_6cd9fe6a-2446-482e-8f13-1c746a3624ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:to="loc_us-gaap_LeaseContractualTermDomain_6cd9fe6a-2446-482e-8f13-1c746a3624ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:to="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RedwoodCaliforniaFacilityLeaseMember_bb71c8ae-2d1c-40e2-a74a-82b2518ab4bf" xlink:href="advm-20241231.xsd#advm_RedwoodCaliforniaFacilityLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:to="loc_advm_RedwoodCaliforniaFacilityLeaseMember_bb71c8ae-2d1c-40e2-a74a-82b2518ab4bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_1b5b21d2-8dc6-45da-8e78-8cdc6500646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_1b5b21d2-8dc6-45da-8e78-8cdc6500646d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_10f86aab-09c6-47a2-a753-d1b809b67a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_10f86aab-09c6-47a2-a753-d1b809b67a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2fabee18-4796-4ec5-81cb-19a3b36c6c01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2fabee18-4796-4ec5-81cb-19a3b36c6c01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d661456a-d2a0-4c0f-b27f-9358a23e8a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_OperatingLeaseLiability_d661456a-d2a0-4c0f-b27f-9358a23e8a0e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:to="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c90822c5-5512-4a91-8d22-e6532986576b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:to="loc_srt_RestatementDomain_c90822c5-5512-4a91-8d22-e6532986576b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:to="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c0486d5f-0b5e-418f-8b56-f0aa809f9ce2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c0486d5f-0b5e-418f-8b56-f0aa809f9ce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_8034fb7a-8c7c-4d75-b496-0e5f962156ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:to="loc_srt_RestatementAdjustmentMember_8034fb7a-8c7c-4d75-b496-0e5f962156ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cb8956c-5623-4c79-b78e-35abffcac0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cb8956c-5623-4c79-b78e-35abffcac0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_61cebc69-333c-4a95-acfe-5e579643d1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_ShortTermInvestments_61cebc69-333c-4a95-acfe-5e579643d1bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_824c01fa-2ed8-46fe-8a58-9da3a0d1ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_824c01fa-2ed8-46fe-8a58-9da3a0d1ccef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d73d5c20-bab6-4028-82df-6b58f5fc67b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_AssetsCurrent_d73d5c20-bab6-4028-82df-6b58f5fc67b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_aae9ee15-c066-4a68-80e8-026fd3e0a064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_aae9ee15-c066-4a68-80e8-026fd3e0a064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0a8b123e-d387-4162-abf9-a6b09dbc49de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0a8b123e-d387-4162-abf9-a6b09dbc49de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_eab1304d-381d-42f3-8aa3-7eefb37d0d79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_eab1304d-381d-42f3-8aa3-7eefb37d0d79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7f2ae2d4-2d41-4053-9146-ea7f4222dde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7f2ae2d4-2d41-4053-9146-ea7f4222dde0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d259d907-0cdd-4aa8-af1d-43f3822a9e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d259d907-0cdd-4aa8-af1d-43f3822a9e42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e663148a-0a3b-47bf-9001-d8dcdd241f16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_Assets_e663148a-0a3b-47bf-9001-d8dcdd241f16" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_88004338-eb94-4d02-908e-0a903924a26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_AccountsPayableCurrent_88004338-eb94-4d02-908e-0a903924a26e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_266b5a36-4ac0-44d2-9f28-714e6b3a06fe" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_266b5a36-4ac0-44d2-9f28-714e6b3a06fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_32711f5f-5db1-4664-b185-092bf14614c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_32711f5f-5db1-4664-b185-092bf14614c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1fccedaa-f682-48d7-8024-4ec441eba529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_LiabilitiesCurrent_1fccedaa-f682-48d7-8024-4ec441eba529" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a12ae053-5bf7-4148-9ec8-af94da3623e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a12ae053-5bf7-4148-9ec8-af94da3623e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cb874fa3-947a-44c1-bd31-54fd9cc3c782" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:to="loc_us-gaap_Liabilities_cb874fa3-947a-44c1-bd31-54fd9cc3c782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e76ef472-bfa4-453b-9cb5-ec2db3ec7d74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e76ef472-bfa4-453b-9cb5-ec2db3ec7d74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2a6fcb83-5b22-468b-879c-cb45da393bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_PreferredStockValue_2a6fcb83-5b22-468b-879c-cb45da393bbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_650b4460-358a-4738-b4e1-d521e6ffad80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_CommonStockValue_650b4460-358a-4738-b4e1-d521e6ffad80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9d3d2df9-2741-4183-851e-3bf0122cd6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9d3d2df9-2741-4183-851e-3bf0122cd6d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_502022d0-6115-4472-b200-f6b017853b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_502022d0-6115-4472-b200-f6b017853b0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3feb8746-64ab-4186-a6cc-9ef434b55342" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3feb8746-64ab-4186-a6cc-9ef434b55342" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13a0294f-59db-4e69-8f46-dbeaf3aac83d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_StockholdersEquity_13a0294f-59db-4e69-8f46-dbeaf3aac83d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5cb68de-5512-4667-a6b2-8bf74af62c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5cb68de-5512-4667-a6b2-8bf74af62c06" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:to="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_df1a5b55-f9bc-4e30-a949-2c3546d624f5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:to="loc_srt_RestatementDomain_df1a5b55-f9bc-4e30-a949-2c3546d624f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:to="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_aaf62875-4d23-4b6c-87b9-fc12d19ab025" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_aaf62875-4d23-4b6c-87b9-fc12d19ab025" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_84eba175-bab7-4a55-98f6-d7ddebb4f79d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:to="loc_srt_RestatementAdjustmentMember_84eba175-bab7-4a55-98f6-d7ddebb4f79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:to="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a858d1af-fdbf-451d-a268-ab3996891351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a858d1af-fdbf-451d-a268-ab3996891351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94b5fc49-c8c2-406f-aede-0784b7ec3136" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94b5fc49-c8c2-406f-aede-0784b7ec3136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1a24e8c9-ab02-4e63-96b6-44ac4e609146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1a24e8c9-ab02-4e63-96b6-44ac4e609146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d7973e36-871b-48b8-85ad-0fc2d5dfa693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_OperatingExpenses_d7973e36-871b-48b8-85ad-0fc2d5dfa693" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b7694fa-19bd-4ae9-80e2-ab1476306059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OperatingIncomeLoss_0b7694fa-19bd-4ae9-80e2-ab1476306059" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_70bbc067-aa1f-4a78-8ad8-16270abf831c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_70bbc067-aa1f-4a78-8ad8-16270abf831c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96d1ada1-1343-4e8f-b729-8213a40e6b10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96d1ada1-1343-4e8f-b729-8213a40e6b10" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_04f7b741-3c4e-4a33-95b5-89b5cdc51e57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_04f7b741-3c4e-4a33-95b5-89b5cdc51e57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c074bbc-3809-4a2b-9eff-e46581cdb047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_NetIncomeLoss_2c074bbc-3809-4a2b-9eff-e46581cdb047" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_84674cba-303f-41b0-b600-06f6ba2afea2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_84674cba-303f-41b0-b600-06f6ba2afea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_042d09c2-c4ec-4c34-89f6-a3aec93e5cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_042d09c2-c4ec-4c34-89f6-a3aec93e5cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b0ab022-5ea2-4aad-a6ef-90bd15034eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b0ab022-5ea2-4aad-a6ef-90bd15034eeb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0488128b-19bc-4bf1-8ada-61f3708f1ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_EarningsPerShareBasic_0488128b-19bc-4bf1-8ada-61f3708f1ef5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_460c0d7b-7aee-4460-9b75-86519c1d4323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_EarningsPerShareDiluted_460c0d7b-7aee-4460-9b75-86519c1d4323" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4db13e70-033a-427b-89b3-3045670b373d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4db13e70-033a-427b-89b3-3045670b373d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f928315e-9263-40fc-a7f8-685add5599ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f928315e-9263-40fc-a7f8-685add5599ae" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:to="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_e681a69b-8d20-4d9e-97af-fcd7fcdf921b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:to="loc_srt_RestatementDomain_e681a69b-8d20-4d9e-97af-fcd7fcdf921b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:to="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_106eeef1-1d64-4c73-b5a1-c1cdf69fd8c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_106eeef1-1d64-4c73-b5a1-c1cdf69fd8c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_7cde98d0-fa96-494f-9fb8-44692b58a29f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:to="loc_srt_RestatementAdjustmentMember_7cde98d0-fa96-494f-9fb8-44692b58a29f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_834366d5-d2df-46c5-97b3-6fff9fa4c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:to="loc_us-gaap_NetIncomeLoss_834366d5-d2df-46c5-97b3-6fff9fa4c39a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_36efcbcc-af04-49d7-8590-250749ca2d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_36efcbcc-af04-49d7-8590-250749ca2d31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_dd519975-3708-47a8-8cdf-f2afb3a67487" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:to="loc_advm_NonCashSubleaseLossIncome_dd519975-3708-47a8-8cdf-f2afb3a67487" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_66eebf1f-f08a-4bf0-856f-80c3aff89225" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:to="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_66eebf1f-f08a-4bf0-856f-80c3aff89225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17c66c23-4df2-4ad2-8428-91b2ef08dce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17c66c23-4df2-4ad2-8428-91b2ef08dce6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_1d9c9c0a-7aa1-4315-9b1e-7be482b8c30b" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:to="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_1d9c9c0a-7aa1-4315-9b1e-7be482b8c30b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.adverum.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15970fb8-e8f8-486f-8553-a65c450c6b2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15970fb8-e8f8-486f-8553-a65c450c6b2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fba4e270-7e7c-426b-bb93-a9a35eec031a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:to="loc_us-gaap_SubsequentEventMember_fba4e270-7e7c-426b-bb93-a9a35eec031a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ed345703-77de-4c40-926e-d9f8db84d320_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:to="loc_srt_SegmentGeographicalDomain_ed345703-77de-4c40-926e-d9f8db84d320_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:to="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_854bb74c-1d67-4520-8493-bd1c3eaa0526" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:to="loc_stpr_NC_854bb74c-1d67-4520-8493-bd1c3eaa0526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_70d57703-b097-486d-989e-4b98cbda884f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:to="loc_us-gaap_ManufacturingFacilityMember_70d57703-b097-486d-989e-4b98cbda884f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1a340d6c-6f8b-43b3-a952-dc246789d521_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1a340d6c-6f8b-43b3-a952-dc246789d521_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:to="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_86eae42d-c74f-4ac5-b78f-7614441179c1" xlink:href="advm-20241231.xsd#advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:to="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_86eae42d-c74f-4ac5-b78f-7614441179c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c0e6ee31-2bb9-429f-8910-32288be61f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c0e6ee31-2bb9-429f-8910-32288be61f6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_85fb274e-6fec-4752-875e-0f8f2af1dc54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_PaymentsForRent_85fb274e-6fec-4752-875e-0f8f2af1dc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0da9bdbc-1d46-4397-922b-ee0339a737fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0da9bdbc-1d46-4397-922b-ee0339a737fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7a884fb3-7bb6-48db-a32f-13ca3f300271" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7a884fb3-7bb6-48db-a32f-13ca3f300271" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>advm-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_193d3fd7-70ed-4dc1-8ae6-6caf0fcfe57c_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationLineItems_3437e324-63ce-4d7d-befe-f596fa1995c0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationLineItems" xlink:to="lab_us-gaap_ReclassificationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d8b94d99-86cc-4fd3-9143-31583ecc6568_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_DeferredTaxAssetsCapitalizedCosts_8430f34a-e0c0-4a19-b1b0-75bb08bca75c_terseLabel_en-US" xlink:label="lab_advm_DeferredTaxAssetsCapitalizedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 174 R&amp;D capitalization</link:label>
    <link:label id="lab_advm_DeferredTaxAssetsCapitalizedCosts_label_en-US" xlink:label="lab_advm_DeferredTaxAssetsCapitalizedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Costs</link:label>
    <link:label id="lab_advm_DeferredTaxAssetsCapitalizedCosts_documentation_en-US" xlink:label="lab_advm_DeferredTaxAssetsCapitalizedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capitalized Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsCapitalizedCosts" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsCapitalizedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_DeferredTaxAssetsCapitalizedCosts" xlink:to="lab_advm_DeferredTaxAssetsCapitalizedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f11a2aef-41e8-46e5-95e4-7f6bce043ef0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a5b6cf65-3bef-460f-95ba-c9db9a362f90_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7cf25774-9a57-44fb-9041-4242b9dfe82d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e986a9c9-0a85-46eb-923d-f4b5eafab943_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1743fc56-26f6-4ff9-a000-37a76ad0cf6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal income tax benefit at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_d646c5d8-2ec5-433a-82a5-18c9d74fb770_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash Equivalents and Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d0ca7d58-ba5c-42f9-8e02-e01a5ceb7dc9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_e6ff9d4f-d12e-409d-9b5e-f6a70c9a6611_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3a4d0675-d11d-4e1e-bbc1-b70d55c87e89_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0fd1280a-a636-4355-8b6c-bd9e96f7ee2b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5574e73b-2c7a-4d37-b0d9-8cec89fb0ce5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Undiscounted Future Lease Payments under Operating Lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_9208b10c-c158-4fbe-8dd6-972b3e5d4d4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_881608bf-5dd8-4cfc-882e-c7cbe79a7d24_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a3455984-ffd4-403e-a0f0-0e98f566c1df_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_73768518-ebb0-48b1-8a18-ad098799a9fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards granted to employees and non-employees vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_75afc5fb-220a-4514-9e51-8c760efd5ed3_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_117b30f7-3f1a-4f2d-9233-bf3fbcda5ddb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_25943fb4-7186-417a-890b-0294331924c3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d6c62354-6ba3-483a-9dd9-482ff9471cad_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_ba4bad94-386c-4964-845c-6bf475a3488f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1a415256-91ae-4eb4-bf64-0b17cda8a8c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_689739aa-ee44-4b46-86f6-ae08c6f54884_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued upon release of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d45212fd-b27e-4739-bff7-0dbc1c6d494d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_0e1af139-17f0-4bcd-9f4b-939a220b588b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements and Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a7175373-b64b-45d1-b48d-42955d27990e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock pursuant to option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_183604b5-5a62-4486-8956-d7a70d634a9b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_TwoThousandSeventeenInducementPlanMember_65861ea1-6295-4712-b871-afa90a9ee6fd_terseLabel_en-US" xlink:label="lab_advm_TwoThousandSeventeenInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017 Inducement Plan</link:label>
    <link:label id="lab_advm_TwoThousandSeventeenInducementPlanMember_label_en-US" xlink:label="lab_advm_TwoThousandSeventeenInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Inducement Plan [Member]</link:label>
    <link:label id="lab_advm_TwoThousandSeventeenInducementPlanMember_documentation_en-US" xlink:label="lab_advm_TwoThousandSeventeenInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand seventeen inducement plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandSeventeenInducementPlanMember" xlink:href="advm-20241231.xsd#advm_TwoThousandSeventeenInducementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_TwoThousandSeventeenInducementPlanMember" xlink:to="lab_advm_TwoThousandSeventeenInducementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8026c072-788a-4668-9a94-1466a3f569b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a7c90525-4d2a-46c1-8c3f-9e9911fccafc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7e287ee3-d8d4-430c-8dec-69f0050611e4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5e5fa3b7-9de9-41b8-abba-984cadb253cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_057f1b08-281a-4e73-9ae7-8bbae6b5c880_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated By Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_2148155d-6d12-4e8c-bfd7-bdb3455b9489_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease related to tax position taken during the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_9e8a473b-3701-46e5-8648-e93ba792b053_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_c28cfa13-ed45-4ce6-8ce5-36b1364ed316_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6888d158-9a0a-4476-b58d-e2fc35c436a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d84a1a14-f0f9-4a79-ad79-90e496dcb5a3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_ee65a6cc-4371-4af8-8ee3-058a617998e4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_7196eb3c-fce0-48c9-a4dc-174e962e079c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a2d2811d-a2b8-4c87-bc68-74e297c37405_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_82c27f38-2935-4a4b-b50b-4fca6536cf95_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2912d7ec-b49c-458c-924d-d2a4bb1acf4a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ad4c8e33-b473-4a9f-a7c2-053e97bc6832_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total gross proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_A2024EquityIncentiveAwardPlanMember_f529f051-b435-4b3c-be3e-bf1e73659fe3_terseLabel_en-US" xlink:label="lab_advm_A2024EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Award Plan</link:label>
    <link:label id="lab_advm_A2024EquityIncentiveAwardPlanMember_label_en-US" xlink:label="lab_advm_A2024EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Award Plan [Member]</link:label>
    <link:label id="lab_advm_A2024EquityIncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_advm_A2024EquityIncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Equity Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_A2024EquityIncentiveAwardPlanMember" xlink:href="advm-20241231.xsd#advm_A2024EquityIncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_A2024EquityIncentiveAwardPlanMember" xlink:to="lab_advm_A2024EquityIncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_79cd5e12-10d0-41f3-b8c9-78ab7bc3be3e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposit and other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_338a0675-67b2-4c36-aa87-a0028e634947_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_4a099abd-7f35-452b-a770-f343e506d19d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b61147fb-1ccd-4e1b-b518-f5947a51e5ca_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase related to tax positions taken during the prior year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9f130df3-24fa-43d3-ae01-0c7740112770_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_52c242f2-a68c-43d8-9260-cdcdb833c1eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_fe04bd37-b55e-4b52-86be-0a3350cbdf88_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f80cb309-91ef-4e52-9382-c6c9c790d900_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4da6424d-4e13-42e2-a91b-3755faa5cb00_negatedLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash used in operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2ae00b1c-d23c-413f-bc16-ee22f02af37f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_333700ec-9970-4bca-ab71-8976f3be0a95_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_e21ce043-edaa-4082-9db3-9b432ae2b182_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_7ccbf73b-062d-463f-8cb4-73b43c009a93_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b1c9e4ef-93d1-45ca-bc85-f9d12c6934bc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_6c5acee4-11d0-4543-83cb-ccd8b44b8af4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_d8d08d5e-5d5f-40ee-bcbd-4e437a023f66_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_16388796-da67-4373-aca9-bc8cd8d91c2b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5f53897a-ee24-455c-be8c-d9929dd4f744_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_277e554e-76e7-4433-9f73-99d5217a013f_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_968f22d0-96d3-4462-9c6f-1bbfc85bd9a4_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f7b58624-ce25-41d7-98b0-4f75a6220ca6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a1a2fcfb-b25b-43a3-b5ee-24365be84d13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_5bdf41d0-2b09-4ac5-ad2d-d5e84b55c0e4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_9219ab15-f789-49c4-bf58-f245833b691f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less:</link:label>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_30e77d3f-4c0b-450d-b8f6-25863d89e3e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental schedule of noncash information</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_3fb8f54d-cea6-4c28-8ff9-a4b3a1829886_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_ddcac28e-80ab-421e-bfd8-d51a208bd95f_verboseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ab7b60e2-86eb-41c8-aec7-74f9f9695e7e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_1bb3f38c-999c-492e-bae4-c5b42b27aeb2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_7f59c081-1904-4900-843e-7b8fc4b918f5_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e2810c00-b9b1-4953-8b93-7ece4f831c01_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_3a1db89f-4a89-4b8e-8186-73314b3e1e65_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_85d90afd-09fd-4dd6-9306-b72e7d5ff095_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_e4f3956f-99a5-495f-a6cb-c8455b453c96_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in valuation allowance due to net operating loss</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4dde30e9-9925-414b-8439-6065aed636a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_007092c7-8a5e-4259-a6d9-3b170d6e0592_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_69e42626-29fb-4bfc-966b-edea99e5bed4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2b923bb8-cfae-4cf4-9e37-33d7ead9ef2f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued upon exercise of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_03c81197-a103-42b2-b5fe-ae3b0f20667a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f67b2ecc-76d4-4b98-b21e-eafb2f3735cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0fa3b8e2-35bb-4049-8d14-dc180d4b7ec0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50da6966-f1a0-4994-b581-629984a1d0f1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts_5f4e9c58-e716-4c6a-864b-1d1aa91c1407_terseLabel_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal contracts</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts_label_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Contracts</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts_documentation_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfRenewalContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:to="lab_advm_LesseeOperatingLeaseNumberOfRenewalContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d076ddcb-345e-4ae6-b5d8-e0d5617e458b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities in an unrealized loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1389a7b-d5ce-4967-97cc-fcf0362a7df6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf4817cd-a9c0-4f83-bdf8-57e21b2f9e47_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47aa5e0c-d92f-4167-a324-8a4f730be2e7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_c1eddfbb-9e5a-41db-9003-935583a77afe_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net accretion of discount on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_41e02ee8-ee41-44f4-9c01-4caaf4d7bcfa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and released (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_99559e1e-edca-4866-9cea-f2702d8127f6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bbb921f1-5a8a-4dea-8ce1-c7bb90b92c4a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3f802d03-e519-441b-9b57-845537e3c5ce_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_601bee2b-4ba4-4a29-a500-0fb74de0e92c_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ab06b67e-ed9f-420a-b747-be4c7050639c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8c4cf8ca-b017-4995-9fc1-cfb4ad659d13_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_41155374-ec6c-4d15-8a09-418f7215a85f_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease obligation due between April 8 and December 31, 2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ea7dd3b0-f124-4a9f-a95d-31608a850c28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_77223f34-983c-443c-8bf6-ddedd644cc99_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_28d9ef61-0d0b-44c2-bd24-804fa5a59498_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_StockOptionsAndRestrictedStockUnitsMember_71bc1347-9b3d-4228-8e89-b643379f3f6c_terseLabel_en-US" xlink:label="lab_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options and Restricted Stock Units</link:label>
    <link:label id="lab_advm_StockOptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Options And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_advm_StockOptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock options and restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:href="advm-20241231.xsd#advm_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:to="lab_advm_StockOptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6a4a0237-7135-4d86-9d31-2b8480d22e23_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_62ae4a1c-9b56-460c-ad66-729181144b35_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_edaf960e-229b-43fd-96f9-8e3462ecf663_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b047f39a-4350-47f1-bdf7-0df9a7e880ff_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d8e5272d-87c1-4c44-9ffb-5d9c0bf26d4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_26024c16-737f-4954-914e-1a5d95fceaf4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_38b65e38-4266-4db7-b7dd-522b2c96f452_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e7064370-63ff-47c5-a3c3-be1470a84317_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_25b58c85-5bc8-4047-80a6-22757cd317d8_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_764520bd-7fc3-4723-917b-691b4747b009_terseLabel_en-US" xlink:label="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvement allowance</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_label_en-US" xlink:label="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Leasehold Improvement Allowance</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_documentation_en-US" xlink:label="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Leasehold Improvement Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseLeaseholdImprovementAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:to="lab_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_08b68ee7-8b0b-4d89-bd08-091f6b50cdb2_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_11417a9d-5348-4188-b24d-d7ff59574989_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation and benefits expenses</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_077e9732-dfbd-4217-b132-e44e78f41abb_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0f3b39b1-c5ea-43dc-943a-56552c362b59_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a7f0cc0a-3f17-4365-b9e6-5eee3a899be7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_706856ef-3b6a-4343-927f-14b1db4ee644_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development expense reversal</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95294cb2-f7b6-47e4-bb5d-edd62ed3e00c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c13903e0-713e-4ad7-b8b8-4d645be44a67_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3d17c8d3-c68e-40e4-a286-2c4df07ffbbc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_05147c7a-ebad-4da6-9837-17c5b424b8e8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5a309cef-04cb-46b2-bcc8-4baaeca1ffd7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_b34bffdf-51e6-40b3-a269-2426bd23d556_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges on available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_99dca200-1b10-486b-908f-93ff54ed30c7_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b2de0ccd-d37b-44ba-ae19-8444749c5f30_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_859d73f1-1264-48f6-b42d-ff23375f83a2_terseLabel_en-US" xlink:label="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs)</link:label>
    <link:label id="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_label_en-US" xlink:label="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incentive Stock Options And Non-Qualified Stock Options [Member]</link:label>
    <link:label id="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_documentation_en-US" xlink:label="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incentive Stock Options And Non-Qualified Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:href="advm-20241231.xsd#advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:to="lab_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_719994f6-e51b-4a8b-984e-6bc0077864ba_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_77d7b738-1734-4f3e-8341-9f06fc23964c_terseLabel_en-US" xlink:label="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_label_en-US" xlink:label="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation Change In State Uncertain Tax Position</link:label>
    <link:label id="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_documentation_en-US" xlink:label="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income tax reconciliation change in state uncertain tax position.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:href="advm-20241231.xsd#advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:to="lab_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_ee1fccbd-70b4-4821-8560-9aaaed11c4eb_terseLabel_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage increase in shares issued</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_label_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Increase Decrease In Number Of Shares Issued Percentage</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_documentation_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award increase decrease in number of shares issued percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:to="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_e34ee79b-27cd-484c-9657-0096173028c6_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_89139831-6ef0-4aa8-860f-a6f40c750f6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_aedaa958-ff7a-41c4-9e12-93bdcbdd8f2b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Error Correction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Error Correction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3d36247b-32e9-4eb4-9bcf-93403095b69c_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_221b7313-7713-4d38-8f7b-b44c3205070a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_14d4402d-4070-4499-ae2e-929363fbad54_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae11b3d9-df29-456d-9968-065ca9334ce7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued upon exercise of stock options, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_310b7e1f-0e1a-4ae7-aaa2-0ac8c050bb5e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_8e718603-2b02-4d13-ab7f-3e23d194177e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_42a2828a-12c8-4860-adaf-c9ae4c30bcfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4e1c27a8-8eff-4c97-b055-499c1953879c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9484f864-cf18-491f-8b9f-860e1d2781b4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_14b7f0d6-6834-4ebb-b484-c5e4d21fcd41_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherResearchAndDevelopmentExpense_642a7a51-d085-4c99-948f-2e93ed80d5e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other research and development expense</link:label>
    <link:label id="lab_us-gaap_OtherResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_OtherResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_OtherResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fa9d7938-4667-46d5-a3a3-97222e97c0a4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_37202b46-e907-4551-9eae-028584a1a50e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e4617807-cdf4-450d-bf89-a3e1345f8ae8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_d75df856-bfbd-4d3b-a480-d94ae5e9016f_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets before valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_57cb9963-3269-4b30-8bdb-42a40265b4c7_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_f9662ec5-1cb8-4c1a-8536-5b4d441de93d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease renewal term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a5dc2179-3b05-4247-b560-ef36adacd2d4_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_05edec7c-17e7-4407-893c-60fab8c0d231_negatedLabel_en-US" xlink:label="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deposit and other long-term assets</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_98be330f-44d3-492f-8ae0-21b550a4b468_negatedTerseLabel_en-US" xlink:label="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deposit and other long-term assets and deferred rent receivable</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_label_en-US" xlink:label="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Deposit And Other Noncurrent Assets</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_documentation_en-US" xlink:label="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) in deposits and other noncurrent assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:to="lab_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_f55c3ce8-9c85-4fe4-9581-0939696ee30e_terseLabel_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Re-measurement of operating lease liabilities</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_label_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Liability Due To Lease Modification,</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_documentation_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Liability Due To Lease Modification,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:to="lab_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember_536c9e94-b51f-4fe2-8f1e-bb96ab65312e_terseLabel_en-US" xlink:label="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Plan And Inducement Plan</link:label>
    <link:label id="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember_label_en-US" xlink:label="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Fourteen Plan And Inducement Plan [Member]</link:label>
    <link:label id="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember_documentation_en-US" xlink:label="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand fourteen plan and inducement plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:href="advm-20241231.xsd#advm_TwoThousandFourteenPlanAndInducementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:to="lab_advm_TwoThousandFourteenPlanAndInducementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b830d4fe-dd88-4a49-951f-9e2b0c9e95b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LexeoTherapeuticsIncMember_56b776f6-1b78-4939-914d-5c929656fe0c_terseLabel_en-US" xlink:label="lab_advm_LexeoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lexeo Therapeutics, Inc</link:label>
    <link:label id="lab_advm_LexeoTherapeuticsIncMember_label_en-US" xlink:label="lab_advm_LexeoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lexeo Therapeutics, Inc [Member]</link:label>
    <link:label id="lab_advm_LexeoTherapeuticsIncMember_documentation_en-US" xlink:label="lab_advm_LexeoTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lexeo Therapeutics, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LexeoTherapeuticsIncMember" xlink:href="advm-20241231.xsd#advm_LexeoTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LexeoTherapeuticsIncMember" xlink:to="lab_advm_LexeoTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ed052d0f-8d8a-4243-92f6-ee8dba7657d4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_89c32b21-2398-44e1-8781-66e5ddcf339b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_3101ff76-8cf9-47b9-a365-e2760f203fa1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c52f4427-1b73-4882-af16-381e44a8b68a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3ab69350-8223-40c9-bda5-ce68a665f6e4_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Contract Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_592501fb-55d3-47fa-b166-939dc96b7b23_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_BeneficialOwnershipInterestLimitationPercent_14b337b9-151d-408c-a45c-104462b58c20_terseLabel_en-US" xlink:label="lab_advm_BeneficialOwnershipInterestLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Beneficial ownership interest limitation (percent)</link:label>
    <link:label id="lab_advm_BeneficialOwnershipInterestLimitationPercent_label_en-US" xlink:label="lab_advm_BeneficialOwnershipInterestLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beneficial Ownership Interest Limitation, Percent</link:label>
    <link:label id="lab_advm_BeneficialOwnershipInterestLimitationPercent_documentation_en-US" xlink:label="lab_advm_BeneficialOwnershipInterestLimitationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Beneficial Ownership Interest Limitation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_BeneficialOwnershipInterestLimitationPercent" xlink:href="advm-20241231.xsd#advm_BeneficialOwnershipInterestLimitationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_BeneficialOwnershipInterestLimitationPercent" xlink:to="lab_advm_BeneficialOwnershipInterestLimitationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b3894682-8680-4245-aa1e-d785b9b2535f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7a79728e-4535-483e-af0b-ee36b97cc9d0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_7fa8ee4d-acf2-40de-a813-1cb15f5ca8db_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_49ba09b0-e8cc-42a4-bbb7-ee04eef25b27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_9d2ae865-33ea-4b50-879c-861dc01a6a01_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_25098503-87de-4b2c-95f1-46826363da20_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_83600f48-a04a-4f3e-a2db-eb5f4153bfea_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost Basis</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9a095a5-ac05-4608-8d67-88bf617300be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_e6b5472e-91ac-4d4b-8bd6-8e4be2c22378_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_8a4f870d-b47f-4e71-9d64-c7570fd20c6a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e1d4cd21-323e-4a9d-bd72-0c502af20d1e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d40ddd85-7e1f-4db0-ac62-45141d3c10d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_73bfe86f-4a90-4dae-9302-318077cc72e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_e8c2189f-fe78-47b9-ac6b-b09d75261e99_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a81b05ba-f5f6-410f-8fc5-0c8cdc0f45f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Option Issued Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c809e436-f9e4-4661-b00b-db3633b9bfbc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b636f120-8d03-4ccc-8a58-ff3e63a46120_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f0f1b401-856a-4f24-b698-7f799b171fdf_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_05861e8c-e47a-4abe-adc4-7fe78bb039df_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9014f386-a997-433c-9f39-e3e7dad6429f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68677a56-ab4a-467e-b512-adb71bc075d6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_960ad504-310b-4cb5-9b66-32b0522ff9a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_54f7bf1b-2b25-4177-96ea-79dbfb41833a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_SubleaseTenantMember_c8653eed-6a36-459e-a4b2-08ee79221d83_terseLabel_en-US" xlink:label="lab_advm_SubleaseTenantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease Tenant</link:label>
    <link:label id="lab_advm_SubleaseTenantMember_label_en-US" xlink:label="lab_advm_SubleaseTenantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Tenant [Member]</link:label>
    <link:label id="lab_advm_SubleaseTenantMember_documentation_en-US" xlink:label="lab_advm_SubleaseTenantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease Tenant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SubleaseTenantMember" xlink:href="advm-20241231.xsd#advm_SubleaseTenantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_SubleaseTenantMember" xlink:to="lab_advm_SubleaseTenantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9822fa3d-9b9d-4f47-be41-0c806c27ebc5_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_1fe31c41-1ab3-4fa3-8dc0-e9b945aeb1bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6b620a80-4ac4-40ef-b74c-881ec1503d45_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4f893163-ee90-4ea7-85e3-0e3e4a18658b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_dfb91e3d-6039-4288-8eac-d2f406fb8eec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_640f7a11-f185-4a23-90a3-74db6123e91d_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3f64e285-7f6e-4fdf-9e46-8763d9718dfd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_37209978-5b78-41e9-a778-df9d0ae87e3f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_5c90a38b-70e2-42b7-b5ea-6142aaf9e997_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_6a8c0bde-9841-4943-a016-c13bded72971_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_80b520f1-16fa-4ea7-b8f3-364ca129a0d3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_00c2723e-6e25-449c-83c0-1a5a74b352c9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share - diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_aa30d5ae-8298-4ea4-b7c4-7d2b9d980988_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_20c739fe-09a7-452a-b74f-af9bf7509223_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_d10aa42c-1645-4a0a-a7dc-ea672d1e4207_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State credit carryforwards</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_cb0153e7-5c35-4de5-85c8-7a33367d08b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_84ed1c7e-ed4e-4bdb-941f-c0ad8f2c9e69_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_74a04a68-c282-443c-9d0e-f7d9110fa8cf_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_4a3ecbbf-cab0-41a3-8549-ef2ab0d7d12e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_ea71d2c2-87eb-4d32-86e0-f65896b57832_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember_f456c4ae-034a-4310-91c5-23ecca6e39ec_terseLabel_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Equity Incentive Award Plan</link:label>
    <link:label id="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Fourteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and fourteen equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:to="lab_advm_TwoThousandAndFourteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems_f3cc25ab-817e-4813-b6f0-9411130f5830_terseLabel_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_advm_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5c56500a-b6ed-423a-9c60-a6e45129e232_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_cb1d867a-550b-467c-bf8f-6f46aa24f2ec_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_e05a96df-660e-4e28-9215-4a22da6d751b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_914dd69d-e60f-4cee-9437-a97cf9d506ee_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_7cc4ce6d-b62b-4667-bc95-f2c6623ab5e2_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_09a71a30-c8a5-42ac-b272-7948888a7331_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b1340f3a-b807-4608-b21f-acbed94cf082_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive gain (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_887bba57-23a6-4a6c-9442-ea7bbe0ff60e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive gain:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c6064377-c91c-4d2d-beeb-94cb4f16905a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_886af861-e8f2-4435-b0cd-95f0e865052d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_2b524f1c-18bb-42e4-bfa0-a0b8bd9e1add_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_9a371967-5cdf-4b6f-a162-2400fdbab8bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_75eb9c76-3fe6-463d-a23d-e2bd7b55e709_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4f4f40ac-ae63-4d26-9123-c888f019fa99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair values of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_RedwoodCaliforniaFacilityLeaseMember_01d2bbb2-28d1-43f1-a87f-710c77145458_terseLabel_en-US" xlink:label="lab_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redwood, California Facility Lease</link:label>
    <link:label id="lab_advm_RedwoodCaliforniaFacilityLeaseMember_label_en-US" xlink:label="lab_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redwood, California Facility Lease [Member]</link:label>
    <link:label id="lab_advm_RedwoodCaliforniaFacilityLeaseMember_documentation_en-US" xlink:label="lab_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redwood, California Facility Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:href="advm-20241231.xsd#advm_RedwoodCaliforniaFacilityLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:to="lab_advm_RedwoodCaliforniaFacilityLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TenantImprovements_3eb96165-b1cb-47b9-a63f-8cbe7f0560c4_verboseLabel_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Tenant Improvements</link:label>
    <link:label id="lab_us-gaap_TenantImprovements_label_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TenantImprovements" xlink:to="lab_us-gaap_TenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ed264f23-be81-4f88-a593-6d8250507afd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_42d0e0e2-e9fb-407c-aa05-9dedb740b88d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (provision)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a37a9cdd-d9f7-4d6c-bad6-a9722d6de55e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_49563e68-5e1c-4b39-bbd8-650b7ac222dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_51626547-0717-437b-9f20-40d7a10342d4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized stock-based compensation, weighted-average period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfLease_d9639ef7-66a0-4b2c-840b-b39fbc92bebc_terseLabel_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of facility leases</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfLease_label_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Lease</link:label>
    <link:label id="lab_advm_LesseeOperatingLeaseNumberOfLease_documentation_en-US" xlink:label="lab_advm_LesseeOperatingLeaseNumberOfLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfLease" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LesseeOperatingLeaseNumberOfLease" xlink:to="lab_advm_LesseeOperatingLeaseNumberOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f8e29744-a039-4781-8b6d-d12504280998_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_77f88623-9120-4b5a-9f4b-6124223028b0_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_74292fe9-847c-44f8-b071-1dd6c105fbd0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_be605eb6-2e0f-4459-8898-d765e6872b3a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_775fb21b-b2ca-4ab0-9ff3-9beb7bacb7cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_737a7cf9-ca5e-420b-8a7e-2473433942bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0556cef0-6c9f-4989-bd8c-941b1ecc3a8d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_5341917f-860b-44d9-b4da-8baa20a5198e_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6b4f5083-cf2f-4047-9d9c-2e304120370f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_82a20c81-1791-4951-885d-eaf0b241b4ec_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_CashEquivalentsAndShortTermInvestmentsMember_b7962774-cce4-466c-942c-7fd0587273a4_terseLabel_en-US" xlink:label="lab_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cash equivalents and short-term investments</link:label>
    <link:label id="lab_advm_CashEquivalentsAndShortTermInvestmentsMember_label_en-US" xlink:label="lab_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents And Short Term Investments [Member]</link:label>
    <link:label id="lab_advm_CashEquivalentsAndShortTermInvestmentsMember_documentation_en-US" xlink:label="lab_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash equivalents and short term investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:href="advm-20241231.xsd#advm_CashEquivalentsAndShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:to="lab_advm_CashEquivalentsAndShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a95d4f2-b4e6-4a10-9667-30e24d20d1b3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ee0d425a-b1a8-4bd0-91d4-e85e45f943de_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_PreFundedWarrantsMember_3c2be9fd-2a60-4a54-a969-f78c9acaeedc_terseLabel_en-US" xlink:label="lab_advm_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:label id="lab_advm_PreFundedWarrantsMember_label_en-US" xlink:label="lab_advm_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_advm_PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_advm_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_PreFundedWarrantsMember" xlink:href="advm-20241231.xsd#advm_PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_PreFundedWarrantsMember" xlink:to="lab_advm_PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_aa692469-40ab-468e-8f54-2dfdb6a8879f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b34816d2-dc45-4c0d-8273-16abb6befe4e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_56d885ea-83a8-4e58-8999-a97aab3c945e_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_a64203a2-8ab4-4ec9-9984-acf73bfcbd63_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacturing Facility</link:label>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_label_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturingFacilityMember" xlink:to="lab_us-gaap_ManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors_cfa35d79-c2c6-4bb1-be4a-6c79b9315417_terseLabel_en-US" xlink:label="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of directors</link:label>
    <link:label id="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors_label_en-US" xlink:label="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement, Number of Directors</link:label>
    <link:label id="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors_documentation_en-US" xlink:label="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement, Number of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:href="advm-20241231.xsd#advm_SecuritiesPurchaseAgreementNumberOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:to="lab_advm_SecuritiesPurchaseAgreementNumberOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_f40065ed-76be-440a-878c-833b285d4a1f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2efda0af-86e5-43d8-9a24-796572409110_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c2a37fac-468e-4493-b499-0f84840814be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cancelled/forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_aa49f9c2-af2d-44cc-aa3b-6e0fedfce5d1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1e2c490f-a3c1-4fd4-8e4c-c8fe1c1d2e1f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_00abb3bf-b987-4d04-88cb-48df81769ed0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_5a26ab98-fc9f-4f2f-862d-d6da93d08ec7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_58edf345-af37-40e6-bcdd-6c49f2f4696b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_NonCashSubleaseLossIncome_a3dffe30-28bd-4ce0-82e2-71d6db6aa3ca_terseLabel_en-US" xlink:label="lab_advm_NonCashSubleaseLossIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash sublease loss/(income)</link:label>
    <link:label id="lab_advm_NonCashSubleaseLossIncome_5464b3b3-ab0b-4d5b-9504-bbc9fc5c6b52_verboseLabel_en-US" xlink:label="lab_advm_NonCashSubleaseLossIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-cash sublease income</link:label>
    <link:label id="lab_advm_NonCashSubleaseLossIncome_label_en-US" xlink:label="lab_advm_NonCashSubleaseLossIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Cash Sublease Loss (Income)</link:label>
    <link:label id="lab_advm_NonCashSubleaseLossIncome_documentation_en-US" xlink:label="lab_advm_NonCashSubleaseLossIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Cash Sublease Loss (Income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_NonCashSubleaseLossIncome" xlink:to="lab_advm_NonCashSubleaseLossIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ebc7fab1-f9d9-44df-b6bd-e6bf4572220b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_47c128d8-fd50-4ddb-89c1-059d813ef77e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75107e11-53da-4ef0-881a-4611de7eed54_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_b223bae5-f196-4105-ac19-8b1518fc85e4_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c4d15291-10be-4a73-928c-b9d149512677_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bef77ba1-439f-4660-9f1c-b3f8a0e8ac5d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3c5d18d9-473c-4e78-a1c3-8e3ec060c6ef_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_11a4325e-4623-467b-a560-999ad8b0cb4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement of Previously Issued Financial Statements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f4b464a5-b116-4e36-9583-886791504691_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationTable_35b6392d-a092-49ad-9eb5-6a4722aa3675_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationTable" xlink:to="lab_us-gaap_ReclassificationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b872f72b-89c5-41c7-b74a-429de46d5ce1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1691e026-e901-4205-af9f-c9a468e2c2ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_417ad4cc-baeb-448d-8040-e98e501783f6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_72c75438-23a3-498f-b98e-e76a5645d5b4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e747bbef-7e38-4efb-900b-9af7c6e52a3c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-to-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0f7d62e7-e9a7-44a4-9357-432d0ac4f335_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5836d94-1af0-45ad-a4bd-c3b7562f35ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a8fb6822-35bf-41c8-bb64-508dfc7826e7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss_65311cf2-64f3-4fec-8e0d-4bcf88cf56db_terseLabel_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Cash equivalents, unrealized losses</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss_label_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Gross Unrealized Loss</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss_documentation_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Gross Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:to="lab_advm_CashAndCashEquivalentGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_d4dea92c-2453-47fb-a9d6-193b93a63449_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_0f38750c-7b05-4471-a9fe-9ead3b57f0c1_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_cb00434f-070f-48a9-b435-b3cc32f88889_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_e03f905b-9c65-4b21-80c2-e130fd274e46_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_83fcecac-34df-459e-9d46-cd10639ab9be_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_dc9b903e-40ae-4109-b494-9978dd62f1c5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_80d4866b-8fbe-4e39-a67f-b7913f7022f1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOL carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_2b11ad3d-a355-47b8-8b4c-b3be31722523_terseLabel_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant stockholder threshold ownership percentage</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_label_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Significant Stockholder Threshold</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_documentation_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Significant Stockholder Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:to="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7bf4548e-bf21-4e52-922e-c88b2bb8d460_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_78c0b3d2-b4ae-4a33-83f9-767addf6b8cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_602368f1-2f43-481e-8f93-f6c9fc193275_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_92cad9e4-3ed6-44b2-80ef-b551748c61f7_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic tax authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_5ba059a2-9d86-49c0-9e43-0618cfe9e2f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_5563e1b3-8222-4f19-91a4-1e31a92ce7a5_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_33ce9ad9-0ff4-4861-aeed-e6f502e0aa4d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_a07c8662-8023-45e0-9e51-6879e832ff0e_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_964b9f2f-0419-430b-99dc-4782ee46a6fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_fde37ea6-b5b7-4a50-9ca1-87da7051a5e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_53e2ecc6-66fd-4e6d-b498-83bc184b8058_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7d449080-b06a-4f45-9750-59fb3df237ac_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8b15ef92-fa65-497d-a132-7703039c7a4c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_e524b7e9-c3ad-4bcd-8176-3b1dc73f0a6e_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_35ea7952-0887-4146-86ca-a1549999e2be_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_6e89dff3-cfbd-463f-9dfa-daeae0054e1d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0e4aa55a-9d36-4ce2-88b4-98993d01a6e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_aca4c5ba-71ba-4c16-8213-668e7dce866c_terseLabel_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Fourteen Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and fourteen employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:to="lab_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b590fcbd-23c5-4c60-95ad-565846eebbb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_55aa70ec-ed8c-41b5-bb8b-6983ebc795a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares available for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9ed56354-832c-4a0f-a67a-07d901eeeb94_negatedLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Cash equivalents, estimated fair value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_OperatingLossCarryforwardsSubjectToExpiration_9c26bc17-fc1c-4fd4-95de-1b5c7adfd7a1_terseLabel_en-US" xlink:label="lab_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NOL carryforwards subject to expiration</link:label>
    <link:label id="lab_advm_OperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards Subject To Expiration</link:label>
    <link:label id="lab_advm_OperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards subject to expiration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:href="advm-20241231.xsd#advm_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_advm_OperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2988aec2-b106-4d63-a77a-b0d84a6a3e47_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0d9e48a5-82ad-4c7b-a0cf-7932cd03ce97_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_759b207f-d38f-4a89-b98f-a8d7dd4512d6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncomeTaxesTable_75c6d660-5b70-4295-9536-5ad81881467e_terseLabel_en-US" xlink:label="lab_advm_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_advm_IncomeTaxesTable_label_en-US" xlink:label="lab_advm_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_advm_IncomeTaxesTable_documentation_en-US" xlink:label="lab_advm_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesTable" xlink:href="advm-20241231.xsd#advm_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncomeTaxesTable" xlink:to="lab_advm_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0eecb9b8-169c-4bf2-a2dc-b90f6ce9979c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_cf03d88c-c1db-4d0e-aafd-17204ae4eefe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8c08eb2a-f68f-4376-adb0-2d74b856d3d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of securities, unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c988786d-5050-43ce-8a9c-5f6cb5e00259_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Contract Life (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5d7ab6be-a779-4438-840c-fabf257f1941_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_954b571c-872f-4eb7-9963-5bcbb03960b5_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_45514f4f-824d-461d-9115-911844d34fcd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_b6277235-09c7-46be-ab32-2e88952d8ef5_terseLabel_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of operating lease right-of-use assets and liabilities</link:label>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_label_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities</link:label>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_documentation_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:to="lab_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_ecb3cb19-ef5a-495c-a5b1-637a701ea5da_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_AccruedExpensesAndOtherCurrentLiabilities_f8e6cec4-f5f2-45c1-bb19-7f83a48bbc47_terseLabel_en-US" xlink:label="lab_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_advm_AccruedExpensesAndOtherCurrentLiabilities_6304b273-74b3-4393-a901-61e07d0aaa31_totalLabel_en-US" xlink:label="lab_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses and other current liabilities</link:label>
    <link:label id="lab_advm_AccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_advm_AccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_advm_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7fe02291-94ca-41a0-9552-60b2ab719f96_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3184e39d-156e-4b9b-9636-ba7273deb14d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d5add20e-c5a7-43d1-8507-c2f53c2415ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_14ae6a5e-1e23-4115-bf38-16083d71c5b4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_cbbee062-d3e4-4bef-8cf0-22f83beb991b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b7c4dbd7-5970-463f-8a0d-2c9bd5bc1adf_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_57e30fb8-65c9-4e3a-b6b9-b63bc194e4e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_0312206e-18a1-444f-816c-e79736b33576_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_71134204-8d5b-459a-b8c9-bf3181c5cb77_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase related to tax position taken during the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_66306382-ecc7-44c4-b0e2-eaa5b8e50477_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reverse stock split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_d3fafb55-3e01-4150-b40d-774b4b011586_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_a3ba1f5c-85cf-4bab-944d-5c1c5e300ab7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs of $9 (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fb485c3a-7db4-4107-b9f7-aa32f653429e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_f6e50486-c33e-4ed3-b7ad-53942216e6e9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_422cbdda-f0de-4579-881c-2dac9a3c0547_verboseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_09ba79b5-9ef6-4603-853d-0451e4278dd8_terseLabel_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Re-measurement of operating lease right-of-use assets</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_label_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Right Of Use Asset Due To Lease Modification,</link:label>
    <link:label id="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_documentation_en-US" xlink:label="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Right Of Use Asset Due To Lease Modification,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:to="lab_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_f866bfb0-bda7-46c5-abde-a29187f01ef8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of lien filed against subtenant</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_27468dfa-bebf-4228-afed-e3191e1e3f2e_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amounts due</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_7cefc2e4-7134-40c2-9aed-ce64dbaba6c0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment expenses</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3c56973e-5d07-45d1-98cd-338643d91d1b_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_0056cce0-a5e7-41c1-a5a4-55807f14a91b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_cc3e9911-6d64-483f-80a9-af245b862e3f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest or penalties related to uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_c249afb1-58cc-44b2-90e3-306d8e2ca8f0_terseLabel_en-US" xlink:label="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lien On Subtenant's Leasehold Interest</link:label>
    <link:label id="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_label_en-US" xlink:label="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lien On Subtenant's Leasehold Interest [Member]</link:label>
    <link:label id="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_documentation_en-US" xlink:label="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lien On Subtenant's Leasehold Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:href="advm-20241231.xsd#advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:to="lab_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_59a29552-78d9-4110-b18f-5b96d1cc6414_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_824e881b-d98c-4f91-9eaf-61e26bce7a1f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_15db942e-8bec-4a5a-b4a3-8275d04c2b95_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5e4bb0cc-4c01-454a-83ff-68f612b52d5e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_CashAndCashEquivalentAmortizedCost_c4c444d3-27d3-4edd-83b2-26637abb49eb_negatedLabel_en-US" xlink:label="lab_advm_CashAndCashEquivalentAmortizedCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Cash equivalents, amortized cost basis</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentAmortizedCost_label_en-US" xlink:label="lab_advm_CashAndCashEquivalentAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Amortized Cost</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentAmortizedCost_documentation_en-US" xlink:label="lab_advm_CashAndCashEquivalentAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentAmortizedCost" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_CashAndCashEquivalentAmortizedCost" xlink:to="lab_advm_CashAndCashEquivalentAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a65f63d1-e0ae-47b4-9228-dfb3a6e21c59_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c69355ef-1b40-4e1b-a523-43ccf575ef8b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_14409b08-9c7b-4dfb-806c-0f5929e37581_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_347e0c55-fa5a-4ba9-a13a-f2f916e7813a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_6b91d6c2-17af-4f1b-83ca-1d93843b6a70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of internal reorganization</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesTable_f5ba0214-48ae-481f-b095-ae8472037e9e_terseLabel_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_advm_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_advm_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c234f03e-5978-4d2e-8c59-0127df6c7099_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_44b28d9a-79e6-4b58-a656-5ce96ffe0282_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_b0fe6471-b49d-4681-90a8-060671604b75_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_IncomeTaxesLineItems_8b99c157-d253-4b7f-bd8b-c5bc6029a0fe_terseLabel_en-US" xlink:label="lab_advm_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_advm_IncomeTaxesLineItems_label_en-US" xlink:label="lab_advm_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_advm_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_advm_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesLineItems" xlink:href="advm-20241231.xsd#advm_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_IncomeTaxesLineItems" xlink:to="lab_advm_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_933bc998-7657-41a0-b650-8cdf7041de04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Loss Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_cb8053df-535a-4796-931b-8453115a07bd_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_77511602-2c37-4dc2-9f78-07ad59320eed_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits as of the beginning of the year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_51945913-93e8-40b9-817c-cf1dbcec26f5_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits as of the end of the year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_30e9442f-cb43-4bdb-81d6-9ae25bb7316c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_808488b8-a5fb-47ec-9846-4a8767268d9c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_b79fd85c-2d58-479c-8e6b-c39995ca028b_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_558b4d0d-96bf-419e-8970-bf1742c2308b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3cbda81c-e426-4831-98fd-45a1a4e27222_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_92ac7f18-0f5d-4f20-9fac-009d871086cc_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_26cbfed9-bc0c-400b-a618-ed472ff4d3a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_52bff450-6e36-467f-9fbf-aa7cea0c5844_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_406dd8f5-be6e-4a48-a1a4-ea6b14df3f3a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c51b34e7-364b-48de-86af-5b44c782189f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_cca2d76a-2959-4ccc-aaca-c9916a6db271_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf39a875-f3ab-4171-9523-53c5a4f30418_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7f95a6c5-3414-47d3-a786-61fa81760f6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a5bb0606-fa76-408f-8530-30236489ee65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average fair values of options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_08ff1485-725d-4c99-aa53-dfa4dedbcecf_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_34b794a9-2465-432c-a214-5c57f7cd913d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e51c9fa3-ea97-4c42-a126-fe9e3ca21426_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6d4c9942-d306-4b6f-a883-733b722d67ea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_599b7f59-0bee-42c0-b9df-12d7437f21c7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_c0d1d6b3-038c-4740-829d-d0384421e4d0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_67f9660f-1c6b-4d72-9567-0e5f4922f2be_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_88bd5ac6-e2c8-4263-8aad-f3939585ac6f_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_8412a18d-8d22-440b-b780-e95c1a9c62b9_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2a9af563-1dbd-43eb-844a-67002336d801_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_3afec932-efcb-4fca-abe8-1efdfc66a288_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average IBR (as percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7cec54a2-692a-4dd9-bacb-f4e66e3febc1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b3a72fdc-d9cb-43c8-a896-af16cc177e4c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_550b43b3-1b35-45c4-8ca9-735af029db68_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_457d37de-5fd6-473a-a31e-870dd8e14c29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accruals, reserve and other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_877bc20d-95aa-4c5a-8a46-1ab8db0484aa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_48d967d7-9928-4a6b-8f0a-81f437cfc75d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eaff97c5-aeb3-4e3e-845e-a579a75c14ef_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_756af94e-a8da-4165-a255-4f28c6277086_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_71d77934-1f5f-4cc7-ba09-788c16b15c94_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized gain on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_99341785-a04e-4132-8fb8-57fef8c98ad2_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized gain on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Security, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_67aa46fc-ee28-4673-a98c-a031878f8546_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_e919bb8d-4852-4d1f-98eb-c6cd8371e211_terseLabel_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of operating lease right-of-use assets</link:label>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Re-Measurement Of Operating Lease Right Of Use Assets</link:label>
    <link:label id="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Re-Measurement Of Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:to="lab_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8bbf5e21-5618-4eae-bb81-6f7d34679a68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_282cbc75-374f-4e82-abed-b8735a4610a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForTenantImprovements_a12f6409-b3a6-4f5a-bd74-4f897d7fa8ac_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for tenant improvement allowance</link:label>
    <link:label id="lab_us-gaap_PaymentsForTenantImprovements_label_en-US" xlink:label="lab_us-gaap_PaymentsForTenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForTenantImprovements" xlink:to="lab_us-gaap_PaymentsForTenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_439887af-a46a-47f9-aff0-5d66940f5cc6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_c752794b-dc48-4a02-9b4b-51e9a7f84612_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7d82dc06-3d74-4cba-b8b3-dd217fa2752c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f9a9cc42-a787-4ad5-b274-ca8e28d0d4b8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c93aa0d7-bfd8-4bc8-9bd5-b860c722e08e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_9910aa39-a2d7-4b8c-95ae-82b8eb39e9fe_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_3b056d88-d347-4f87-ae17-0316891c1eb4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2cdb9cd8-aed7-4410-bb3d-810b42c67359_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2bcfa0b4-45ea-4577-88b2-a5408f5e023f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_2a064a3c-94f8-4e7d-9b45-5ea9c500e330_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_26236346-a70a-46ab-97e1-f02e3594cc54_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_b758124b-9f8d-4d0f-b23a-af9d26831452_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_17bc5357-00c9-49ac-9b3e-411a20ca333a_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2656acbe-ce00-4e4b-94dd-44b6694ea427_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_06a1a9d0-79c7-4939-a986-5db4b219c06c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_6e271e02-8b56-4651-8ea8-0890dd5705c3_terseLabel_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award price as a percentage of grant date fair value, minimum</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_label_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Exercise Price As A Percentage Of Grant Date Fair Value, Minimum</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_documentation_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Exercise Price As A Percentage Of Grant Date Fair Value, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:to="lab_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_370bc811-5440-424e-9339-9170007f12b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_d027862f-f827-4701-91d8-1aea5017b882_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_1960b1e8-063a-46af-88ea-5ff2c86f30c5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_TwoDirectorsMember_ec88c14b-3c80-497c-bc1d-1e1feac7d64b_terseLabel_en-US" xlink:label="lab_advm_TwoDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two Directors</link:label>
    <link:label id="lab_advm_TwoDirectorsMember_label_en-US" xlink:label="lab_advm_TwoDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Directors [Member]</link:label>
    <link:label id="lab_advm_TwoDirectorsMember_documentation_en-US" xlink:label="lab_advm_TwoDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoDirectorsMember" xlink:href="advm-20241231.xsd#advm_TwoDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_TwoDirectorsMember" xlink:to="lab_advm_TwoDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_284eab1f-18b8-4198-a9e3-8510f7f75690_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b395589a-6eb7-4e65-a997-6d54f6a5c869_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_LandlordMember_2f711b69-9a3b-4808-b5ea-b08247adb41b_terseLabel_en-US" xlink:label="lab_advm_LandlordMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Landlord</link:label>
    <link:label id="lab_advm_LandlordMember_label_en-US" xlink:label="lab_advm_LandlordMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Landlord [Member]</link:label>
    <link:label id="lab_advm_LandlordMember_documentation_en-US" xlink:label="lab_advm_LandlordMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Landlord</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LandlordMember" xlink:href="advm-20241231.xsd#advm_LandlordMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_LandlordMember" xlink:to="lab_advm_LandlordMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_65e4f8d3-330f-4d3c-9182-5c0ad468f048_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_DeferredTaxAssetsLeaseObligation_4a9cc005-a859-48da-9c75-6d207a864a15_terseLabel_en-US" xlink:label="lab_advm_DeferredTaxAssetsLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease obligation</link:label>
    <link:label id="lab_advm_DeferredTaxAssetsLeaseObligation_label_en-US" xlink:label="lab_advm_DeferredTaxAssetsLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Lease Obligation</link:label>
    <link:label id="lab_advm_DeferredTaxAssetsLeaseObligation_documentation_en-US" xlink:label="lab_advm_DeferredTaxAssetsLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets lease obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsLeaseObligation" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_DeferredTaxAssetsLeaseObligation" xlink:to="lab_advm_DeferredTaxAssetsLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9865ef9c-a13e-4ab4-8652-40c56147dcf2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_e06106e6-2ba6-42d2-903c-bbd58d43535f_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ReportableSegmentMember_8987b52d-f758-41c4-8538-9185b33a9e3b_terseLabel_en-US" xlink:label="lab_advm_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_advm_ReportableSegmentMember_label_en-US" xlink:label="lab_advm_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_advm_ReportableSegmentMember_documentation_en-US" xlink:label="lab_advm_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReportableSegmentMember" xlink:href="advm-20241231.xsd#advm_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ReportableSegmentMember" xlink:to="lab_advm_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_9148b168-3043-4c16-b30f-231128c2caf9_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_4b3422b8-d8d5-4ae3-bf7a-047c51eef464_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life of assets (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_beac5748-241c-4081-aa43-2b6a10df6dcb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a20093e9-dc98-41ad-bfb9-2b22b3dd7295_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_7fddcc94-37d6-4dde-923b-074ef9cd16d5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_e88aa7ef-fae0-470f-8136-a8511c7ceca7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_d75ecd56-f217-4930-b37c-ca6829eaf8be_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_39285336-7526-4d7f-b0c8-e1bcf3d4beba_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share - basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1c96cfc1-93b8-4bcf-b3f0-f6b64af6ce1a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share - basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9c2c3043-8e78-429b-962c-0b53e601cb47_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_631d2b3e-3116-4e72-b438-7bd0b73ca126_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_697a3c35-e3c0-4de2-a2b9-12cc79b949d6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options granted period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1b5f123f-4e15-454c-93e2-bd8f18beb288_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed assets in accounts payable and current liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_fc269f76-e242-48a5-ae68-cac279249743_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ee0713aa-d6a9-471f-bfc7-0f04a84e5921_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a7db95f4-a204-413a-87e6-4e63efecc2db_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1fa9c04f-e3c7-4dbf-b073-5a060a57e1c7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized stock-based compensation expense related to awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_63a29f4d-f7c8-4248-87f0-5db56fc0a81a_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">As Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a8fa81f0-ad89-4e3e-80aa-0aa8df1d53ec_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_03a7f7fd-382a-428c-8596-70e7696b215b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of Credit Risk and Other Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4ba95afc-a52c-4ae4-bc5e-f66f362e9322_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRent_be153f69-43ff-47d1-9494-83579e777271_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for rent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent" xlink:to="lab_us-gaap_PaymentsForRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_df6ef943-feff-474b-b590-1f0aa2313eb1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentReceivablesNet_4d27af6d-7997-4132-a671-41c1fdd852b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent receivable</link:label>
    <link:label id="lab_us-gaap_DeferredRentReceivablesNet_label_en-US" xlink:label="lab_us-gaap_DeferredRentReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Rent Receivables, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentReceivablesNet" xlink:to="lab_us-gaap_DeferredRentReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_21a73cce-2d48-43cc-b4a2-d6135a9a33a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_42b73ae6-791c-4a5d-b9f9-ff86c5fe1ad8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 8)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_15e2f024-097e-4903-8d4c-9cf273353337_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c022c9b0-2b2e-443e-845a-71b9bc4c4f15_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_11bd9ede-5cb0-4a29-bb22-be774c949b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_61fa35af-937a-478a-b051-cd6b6d853fdd_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_009bf901-741b-4f67-a42e-fa7bd934af42_terseLabel_en-US" xlink:label="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facilities and IT</link:label>
    <link:label id="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_label_en-US" xlink:label="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Facilities And Information Technology Expenses</link:label>
    <link:label id="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_documentation_en-US" xlink:label="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allocated Facilities And Information Technology Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:href="advm-20241231.xsd#advm_AllocatedFacilitiesAndInformationTechnologyExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:to="lab_advm_AllocatedFacilitiesAndInformationTechnologyExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_09df577a-5f22-45a7-8c5e-9b155da147a4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Per Share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_AuditInformationAbstract_label_en-US" xlink:label="lab_advm_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_advm_AuditInformationAbstract_documentation_en-US" xlink:label="lab_advm_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AuditInformationAbstract" xlink:href="advm-20241231.xsd#advm_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_AuditInformationAbstract" xlink:to="lab_advm_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b9a0cecb-6466-441a-8e4a-7d47d815d44d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ClinicalTrialExpenses_55f269b8-1636-4c50-ae4c-c8412eea0475_terseLabel_en-US" xlink:label="lab_advm_ClinicalTrialExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial and manufacturing</link:label>
    <link:label id="lab_advm_ClinicalTrialExpenses_label_en-US" xlink:label="lab_advm_ClinicalTrialExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Trial Expenses</link:label>
    <link:label id="lab_advm_ClinicalTrialExpenses_documentation_en-US" xlink:label="lab_advm_ClinicalTrialExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Trial Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClinicalTrialExpenses" xlink:href="advm-20241231.xsd#advm_ClinicalTrialExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ClinicalTrialExpenses" xlink:to="lab_advm_ClinicalTrialExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0df60c01-204d-466b-85a6-49f3faef0a8a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_25dafa0e-7795-4ee2-baa4-15bfd55a6adb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9a32fe68-126f-41ea-8881-c7955df679c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fc30954f-a7c1-40c4-b00b-a69c91563dab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_c6774e2d-3187-4574-8994-580207cfffca_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a98aaaf0-6c8e-4044-874b-b1dea36afb83_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_bf8a2d1e-ec12-41fb-a280-4b261921c8f7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_6ed40e4d-6bbe-4aa2-a9a9-a4a6ddae6a11_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and penalties recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6479ba90-fb4a-4704-9b95-b226116b0acb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_84826045-960d-4cab-a1e9-fae7a9be174c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_9b470b6f-6cae-4853-b3f8-ac9ed738b035_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution by company</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_704f8599-4efd-456e-a252-e0e5c45ea362_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_2e0c5829-ef4a-4f87-9c7c-8d2ce71e6e8b_terseLabel_en-US" xlink:label="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued nonclinical, clinical and process development costs</link:label>
    <link:label id="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_label_en-US" xlink:label="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Nonclinical, Clinical and Process Development Costs, Current</link:label>
    <link:label id="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued preclinical costs current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:href="advm-20241231.xsd#advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:to="lab_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionTextBlock_e66eb849-b8f7-442e-a773-0482e0e059cd_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement of Previously Issued Financial Statements</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionTextBlock_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Error Correction [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionTextBlock" xlink:to="lab_us-gaap_ErrorCorrectionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_02549111-f75c-4ee8-8b6e-4d6aa3a1699a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_c177b0e7-22ac-4bb4-8ced-0e0ff69441ca_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_884df7b2-6e38-4351-8d5b-49f2f24d957f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a92ce6d9-bd47-46d5-aab9-931f5dd58fdc_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_d06f0a1f-fb80-4389-95ea-2d804c2e9d9a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a6fecd8d-19e4-4faa-a9c1-7d31d245778a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_edaec0fb-93a5-4dd4-a317-235f6fb2e2cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0c574ade-c64a-4892-9493-534f7b4ebd23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_26bd0d42-0845-489e-b18f-01a2dbdbbc56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_43de0a77-94f4-4bfb-bea2-f812c54a3ad4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_07bc2bc2-51f9-4d89-9f65-f266f779512f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b8904fbc-d4fd-4a7d-ac9f-a00c5a3135dd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_5cb3b45f-a1f1-4f22-aed3-9403fa646538_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">401(k) Savings Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_16d6b04e-0289-4e1a-bbf2-850ce870d89a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_e61816cf-1664-414b-a5f2-daf9f0143781_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_58e7baf9-c320-43ae-bc81-2358f28b9a92_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_ee15001b-8a99-40ed-a94b-45a72da84c83_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_74260d3c-bb93-4e09-912b-842030ea02ed_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_58bf0161-3d25-411f-b652-654bcdc6b6fe_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b020a6c1-da92-47a9-9a31-8a29ea51642d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_334b920c-2cf1-48a1-bd52-62a146da165f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c8848ffc-2e5a-48e0-a236-703ba7d7b460_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_308f3029-c56a-482a-9aa1-331a5d6c9343_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_ef186366-5670-4fce-9042-70a30feaa152_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease related to tax positions taken during the prior year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NC_74ccc36c-9e1c-43e8-b227-8e0980e66474_terseLabel_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NORTH CAROLINA</link:label>
    <link:label id="lab_stpr_NC_label_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NORTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NC" xlink:to="lab_stpr_NC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f279bcba-2277-4802-bd0c-7f7cca0f9f4c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_RayTherapeuticsIncMember_95c39f4b-4343-4922-9b65-2ec5bfb45e6f_terseLabel_en-US" xlink:label="lab_advm_RayTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ray Therapeutics, Inc</link:label>
    <link:label id="lab_advm_RayTherapeuticsIncMember_label_en-US" xlink:label="lab_advm_RayTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ray Therapeutics, Inc [Member]</link:label>
    <link:label id="lab_advm_RayTherapeuticsIncMember_documentation_en-US" xlink:label="lab_advm_RayTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ray Therapeutics, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RayTherapeuticsIncMember" xlink:href="advm-20241231.xsd#advm_RayTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_RayTherapeuticsIncMember" xlink:to="lab_advm_RayTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_319ff9ca-6a57-4651-8a45-bf1a1110c8b5_terseLabel_en-US" xlink:label="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash settlement of operating lease liability</link:label>
    <link:label id="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_label_en-US" xlink:label="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Non-cash Consideration, Leasehold Improvements, Value</link:label>
    <link:label id="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_documentation_en-US" xlink:label="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Non-cash Consideration, Leasehold Improvements, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:href="advm-20241231.xsd#advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:to="lab_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ca1a789e-117e-44ca-baeb-c7540bda5277_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5e509767-8614-40c4-b9e7-6ae05dffec6b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_d60abbb9-735a-401d-815c-84e4349796ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_d398facd-e387-426b-9cf8-7fed77c749c6_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fff71ec8-2aad-4f0e-ac7c-aaeca8d9000a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_fd734767-6a0b-43ae-a8a7-a44fdd7ba47d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8d53df25-8f19-40fe-b1c7-d09e9e068b04_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ClassOfWarrantOrRightWarrantsExercised_998a7590-0432-4b47-8b05-d94eeda688a8_terseLabel_en-US" xlink:label="lab_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_advm_ClassOfWarrantOrRightWarrantsExercised_label_en-US" xlink:label="lab_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Warrants Exercised</link:label>
    <link:label id="lab_advm_ClassOfWarrantOrRightWarrantsExercised_documentation_en-US" xlink:label="lab_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:href="advm-20241231.xsd#advm_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:to="lab_advm_ClassOfWarrantOrRightWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d28665f-fe4b-4e54-aed0-0ad15566065a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_82a49803-f7dd-4776-8fcc-43350da6a2c1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares used to compute net loss per share - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_60d6a915-03b7-4e45-86b2-e1ba873bb9c7_negatedLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested and released (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_330dc7e9-4ccd-4c5e-897c-c02901238427_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_fbc95e5f-7040-4b5b-ab3e-2be2fb52ccb9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2024 Reverse Stock Split</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_9c36643c-7296-4ba4-87b5-23d33b375413_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_39edae9f-01b2-41c4-90e2-93334fbbd3c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_bb6f7580-6169-4b1c-a153-a81c39c737fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_d27cf158-c4fa-455f-a333-1e22e1da4aed_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_AccruedInterestReceivablePolicyTextBlock_beef74fd-ea78-4cee-858a-848bcce09c5e_terseLabel_en-US" xlink:label="lab_advm_AccruedInterestReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Interest Receivable</link:label>
    <link:label id="lab_advm_AccruedInterestReceivablePolicyTextBlock_label_en-US" xlink:label="lab_advm_AccruedInterestReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest Receivable [Policy Text Block]</link:label>
    <link:label id="lab_advm_AccruedInterestReceivablePolicyTextBlock_documentation_en-US" xlink:label="lab_advm_AccruedInterestReceivablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedInterestReceivablePolicyTextBlock" xlink:href="advm-20241231.xsd#advm_AccruedInterestReceivablePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_AccruedInterestReceivablePolicyTextBlock" xlink:to="lab_advm_AccruedInterestReceivablePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0d4344d4-7717-422c-83df-dd62f302613a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cancelled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4087cd00-5650-4c95-9d65-a171ab35ea53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax (Benefit) Provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_3bdf2a7a-92f4-4c46-a115-3fc31ea8a1ba_terseLabel_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of annual increase in number of shares available for future issuance</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_label_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement Increase In Number Of Shares Reserved For Issuance Percentage Under Plan</link:label>
    <link:label id="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_documentation_en-US" xlink:label="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement increase in number of shares reserved for issuance percentage under plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:to="lab_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_407f6818-a82f-4fee-87ca-b080f59df84c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedGain_3e6fb6ec-7198-45a1-ae4d-a6bed1f114dc_negatedLabel_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Cash equivalents</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedGain_label_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Gross Unrealized Gain</link:label>
    <link:label id="lab_advm_CashAndCashEquivalentGrossUnrealizedGain_documentation_en-US" xlink:label="lab_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent Gross Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:to="lab_advm_CashAndCashEquivalentGrossUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_c88c34bf-75f7-4e80-9264-71055873bd85_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2ecd3447-2528-4b68-999b-4fb6d35ce109_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_38bbaf94-ac8f-47fb-8209-eb9c3826cfb6_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLicenseFeesReceived_a31dfa06-39e3-4eed-9c9f-3a5ea5819771_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLicenseFeesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License fees received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLicenseFeesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLicenseFeesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from License Fees Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLicenseFeesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLicenseFeesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLicenseFeesReceived" xlink:to="lab_us-gaap_ProceedsFromLicenseFeesReceived" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>advm-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9bf5f1ea-ecbb-49ef-a6e0-2ba3aec4266e,g:cee7bee6-a2cb-456e-a3d4-22613f4fb5fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.adverum.com/role/CoverPage" xlink:type="simple" xlink:href="advm-20241231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_18f8a66c-1154-4a89-a7dd-741ec9bb5340" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentType_18f8a66c-1154-4a89-a7dd-741ec9bb5340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_d470633b-72bb-46f2-8f34-d634afa1d5fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentAnnualReport_d470633b-72bb-46f2-8f34-d634afa1d5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_22206a13-547a-4bd0-b885-e05c1ee40538" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentPeriodEndDate_22206a13-547a-4bd0-b885-e05c1ee40538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3defd220-db37-4f3d-9a16-09a9b7e38b35" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_CurrentFiscalYearEndDate_3defd220-db37-4f3d-9a16-09a9b7e38b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ca278271-e23a-4117-8057-83b06b9ac09a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentTransitionReport_ca278271-e23a-4117-8057-83b06b9ac09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_118cd3c8-1888-447b-a96d-a31aedddbe6c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityFileNumber_118cd3c8-1888-447b-a96d-a31aedddbe6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1eddbb16-3f0e-4d42-a14a-16893db7eee0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityRegistrantName_1eddbb16-3f0e-4d42-a14a-16893db7eee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_708c69f5-629e-4ad2-bc7c-6a492c310d54" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_708c69f5-629e-4ad2-bc7c-6a492c310d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_441826f7-e543-4374-be5d-fb06032ff93a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityTaxIdentificationNumber_441826f7-e543-4374-be5d-fb06032ff93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9ef140fa-fb04-41c4-8d53-31709c38fb2d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityAddressAddressLine1_9ef140fa-fb04-41c4-8d53-31709c38fb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_33dfa2cb-b7ee-40cf-8d38-144d7c370a1c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityAddressCityOrTown_33dfa2cb-b7ee-40cf-8d38-144d7c370a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c52e12f9-0d9b-47fc-a0ea-93d56924ff79" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityAddressStateOrProvince_c52e12f9-0d9b-47fc-a0ea-93d56924ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_04a5497d-12ec-4b94-93eb-7257754bd486" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityAddressPostalZipCode_04a5497d-12ec-4b94-93eb-7257754bd486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ad0205a3-4abc-45a6-a014-142b0bc9243b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_CityAreaCode_ad0205a3-4abc-45a6-a014-142b0bc9243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f0e918d5-2526-44a1-b7c3-bd3f4c21641b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_LocalPhoneNumber_f0e918d5-2526-44a1-b7c3-bd3f4c21641b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5e6f9089-3202-4721-b277-42c5d41baab2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_Security12bTitle_5e6f9089-3202-4721-b277-42c5d41baab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e62e7ad1-0bc7-483a-a47a-98b8f6a7c102" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_TradingSymbol_e62e7ad1-0bc7-483a-a47a-98b8f6a7c102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_64b6face-c5be-424b-ba5e-176af872b229" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_SecurityExchangeName_64b6face-c5be-424b-ba5e-176af872b229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1a191577-a36e-40da-92d6-ce73ed52b925" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1a191577-a36e-40da-92d6-ce73ed52b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5999c0c0-4472-4aee-9a52-77e17dd8cabc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityVoluntaryFilers_5999c0c0-4472-4aee-9a52-77e17dd8cabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c4771e04-3411-43e3-9607-594a82c94c46" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityCurrentReportingStatus_c4771e04-3411-43e3-9607-594a82c94c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c2710eb1-05a9-4d25-a1c6-1f629e12eefb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityInteractiveDataCurrent_c2710eb1-05a9-4d25-a1c6-1f629e12eefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_efb42f66-2f46-4e42-941f-3f785b7d6330" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityFilerCategory_efb42f66-2f46-4e42-941f-3f785b7d6330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_382dd5d7-15c8-4d3d-806d-6c3d778f4210" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntitySmallBusiness_382dd5d7-15c8-4d3d-806d-6c3d778f4210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_68fd528c-5d2b-4325-b66b-348aff9d1494" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityEmergingGrowthCompany_68fd528c-5d2b-4325-b66b-348aff9d1494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_433ae7d0-5540-4700-aeff-b983a97ec9be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_433ae7d0-5540-4700-aeff-b983a97ec9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_3d6b1d3f-8641-4e90-a923-bca73a19dd85" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_3d6b1d3f-8641-4e90-a923-bca73a19dd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_aa90eaf7-6950-4f57-8578-2ce4b5ef8cd4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_IcfrAuditorAttestationFlag_aa90eaf7-6950-4f57-8578-2ce4b5ef8cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1b13092a-c247-43fc-a730-907b073c3cab" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityShellCompany_1b13092a-c247-43fc-a730-907b073c3cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_99ac2a5a-c70a-4b76-8515-bb049dba668a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityPublicFloat_99ac2a5a-c70a-4b76-8515-bb049dba668a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a34f93c7-a13f-42f7-8cb6-77f6f7209e55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a34f93c7-a13f-42f7-8cb6-77f6f7209e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7f00ebb0-9be4-49b5-8584-cce00df4258a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7f00ebb0-9be4-49b5-8584-cce00df4258a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c8c7f883-9934-40e4-9116-0d1cd10f9d8b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_AmendmentFlag_c8c7f883-9934-40e4-9116-0d1cd10f9d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_840b6e6e-fe42-4c1c-b750-74e3b08741bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentFiscalYearFocus_840b6e6e-fe42-4c1c-b750-74e3b08741bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12a63a6d-6767-4aed-aa90-259e7a4330e0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12a63a6d-6767-4aed-aa90-259e7a4330e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bfa26344-1a5b-4b07-82ce-283f1ab26ed1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_02f5c252-e85b-495b-bf7e-e95a8b025de1" xlink:to="loc_dei_EntityCentralIndexKey_bfa26344-1a5b-4b07-82ce-283f1ab26ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/AuditInformation" xlink:type="simple" xlink:href="advm-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_advm_AuditInformationAbstract_9fff4c44-7f0f-4a18-97bd-9fee7c444ecf" xlink:href="advm-20241231.xsd#advm_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c863f26f-a5e8-4e32-8618-7cb4acbabeb5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_AuditInformationAbstract_9fff4c44-7f0f-4a18-97bd-9fee7c444ecf" xlink:to="loc_dei_AuditorName_c863f26f-a5e8-4e32-8618-7cb4acbabeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_31f7c073-5ade-4dc5-9c9d-a43c954b06bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_AuditInformationAbstract_9fff4c44-7f0f-4a18-97bd-9fee7c444ecf" xlink:to="loc_dei_AuditorFirmId_31f7c073-5ade-4dc5-9c9d-a43c954b06bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_e0d9cacc-8b18-4edc-b120-e022a5b86d70" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_AuditInformationAbstract_9fff4c44-7f0f-4a18-97bd-9fee7c444ecf" xlink:to="loc_dei_AuditorLocation_e0d9cacc-8b18-4edc-b120-e022a5b86d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de2de4b3-9cc9-4f88-9b9a-a7e75275a563" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_de2de4b3-9cc9-4f88-9b9a-a7e75275a563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ba7a9eda-2bfb-48fb-9261-b995297330f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:to="loc_us-gaap_ShortTermInvestments_ba7a9eda-2bfb-48fb-9261-b995297330f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a22c6c07-38d7-42a4-bfa7-fbccde808d45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a22c6c07-38d7-42a4-bfa7-fbccde808d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0d06e768-8516-450d-b78f-ffc2a35fd7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0f4d163-aee3-44f7-ab32-3ed29f59e07b" xlink:to="loc_us-gaap_AssetsCurrent_0d06e768-8516-450d-b78f-ffc2a35fd7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_86b96c8b-8fca-4196-8055-1f63e1791471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_86b96c8b-8fca-4196-8055-1f63e1791471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_74accc82-1b42-4061-a250-e9f0487aaf21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_74accc82-1b42-4061-a250-e9f0487aaf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c7aade6d-3a77-4ac4-b206-01ded691278c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c7aade6d-3a77-4ac4-b206-01ded691278c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3c1d3ac3-f93f-403b-ac2d-0fd9c0c8ce6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3c1d3ac3-f93f-403b-ac2d-0fd9c0c8ce6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c41c3dd-3615-4bf0-b59d-3202d79880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b6985d-f028-4571-9c18-e016a76948f7" xlink:to="loc_us-gaap_Assets_8c41c3dd-3615-4bf0-b59d-3202d79880a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_40045b80-5a45-4669-966d-c57e04cbabf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:to="loc_us-gaap_AccountsPayableCurrent_40045b80-5a45-4669-966d-c57e04cbabf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_7f8c7eb7-da69-43be-9070-4bec15985549" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_7f8c7eb7-da69-43be-9070-4bec15985549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3d02dc57-9bc7-47e3-bffc-44e99147b10d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3d02dc57-9bc7-47e3-bffc-44e99147b10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5a6feb4a-7a8f-4fd6-95c6-481b2783c1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4292747d-a702-4505-b59b-75c97b780d42" xlink:to="loc_us-gaap_LiabilitiesCurrent_5a6feb4a-7a8f-4fd6-95c6-481b2783c1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_744c723f-6cbb-482d-a084-9df2ab88ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_744c723f-6cbb-482d-a084-9df2ab88ea83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_752c82e4-46d8-4316-ba07-4ebaf2206b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_744c723f-6cbb-482d-a084-9df2ab88ea83" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_752c82e4-46d8-4316-ba07-4ebaf2206b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_db29919b-1656-43bd-8818-8ba500e50eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_744c723f-6cbb-482d-a084-9df2ab88ea83" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_db29919b-1656-43bd-8818-8ba500e50eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ab15f559-ddd5-4bc7-ae16-ac549c4c882d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_744c723f-6cbb-482d-a084-9df2ab88ea83" xlink:to="loc_us-gaap_Liabilities_ab15f559-ddd5-4bc7-ae16-ac549c4c882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_11c79321-2f32-4901-9485-38a3abf17c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:to="loc_us-gaap_CommitmentsAndContingencies_11c79321-2f32-4901-9485-38a3abf17c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_caa600c2-ff20-4aa0-bef6-283a5a04de84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_PreferredStockValue_caa600c2-ff20-4aa0-bef6-283a5a04de84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_09239456-ddd1-4e1a-9089-ec2adb5c2afc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_CommonStockValue_09239456-ddd1-4e1a-9089-ec2adb5c2afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_085d0df8-eaa4-450b-837d-15f4adb4797e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_085d0df8-eaa4-450b-837d-15f4adb4797e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cdb400b-02a6-40a3-b2ae-22cf7eb5494e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4cdb400b-02a6-40a3-b2ae-22cf7eb5494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ce012f3a-9640-4bf7-88eb-c2bf684cdc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ce012f3a-9640-4bf7-88eb-c2bf684cdc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_36ebd8b9-ce6e-4c0a-b193-6983185126e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4322c2d3-d212-4894-aa53-b6459c03fda8" xlink:to="loc_us-gaap_StockholdersEquity_36ebd8b9-ce6e-4c0a-b193-6983185126e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8735a66-89af-4819-8d22-f9599f8f6410" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4efdda41-f4d8-42d3-9a52-f89ab708dcae" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a8735a66-89af-4819-8d22-f9599f8f6410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0d6ab7b0-7bd0-472b-85bd-bb1e25d4ca85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_CommonStockSharesIssued_0d6ab7b0-7bd0-472b-85bd-bb1e25d4ca85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a123aa50-2509-4451-8e80-26853753f59f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a123aa50-2509-4451-8e80-26853753f59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f218eaa6-e186-4b76-8469-b9a8cf1de196" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f218eaa6-e186-4b76-8469-b9a8cf1de196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ef57152c-5ae4-479e-b907-bc672d218407" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_64e1b539-67c7-49d3-99be-35fe57beff65" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ef57152c-5ae4-479e-b907-bc672d218407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16ba57e-11f5-4eaa-b040-c0443b583544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e16ba57e-11f5-4eaa-b040-c0443b583544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e122954b-d0fa-45f9-89d5-896795072310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e122954b-d0fa-45f9-89d5-896795072310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_198f280e-bd4e-42ba-8f3b-8dea2407e22d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_198f280e-bd4e-42ba-8f3b-8dea2407e22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6ca7e651-c848-4268-9a33-63e16319e5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6ca7e651-c848-4268-9a33-63e16319e5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_525e701e-a35f-4fdb-92c6-d90ee7ff60f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_525e701e-a35f-4fdb-92c6-d90ee7ff60f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ae34abbc-2247-4ded-bec5-cc673eb79ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ae34abbc-2247-4ded-bec5-cc673eb79ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0c218092-4bdc-4ec6-8001-7625ffa67f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_CommonStockSharesIssued_0c218092-4bdc-4ec6-8001-7625ffa67f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b8616487-6900-4909-be63-7c490c2c53b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_075e0561-e059-499c-a5f6-b5fbf16fca6f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b8616487-6900-4909-be63-7c490c2c53b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_40c396b5-2195-41df-8c12-696310577ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_40c396b5-2195-41df-8c12-696310577ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0935eb5f-ea1d-46f9-a6cc-d5e519688fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0935eb5f-ea1d-46f9-a6cc-d5e519688fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_32b50d26-e0f0-491f-b3cf-8b93db1e0ede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0935eb5f-ea1d-46f9-a6cc-d5e519688fa2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_32b50d26-e0f0-491f-b3cf-8b93db1e0ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_17a06721-da67-4ce4-8d94-d0e7a9613987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0935eb5f-ea1d-46f9-a6cc-d5e519688fa2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_17a06721-da67-4ce4-8d94-d0e7a9613987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f1822a90-6983-4607-b45a-e75c4c20035b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0935eb5f-ea1d-46f9-a6cc-d5e519688fa2" xlink:to="loc_us-gaap_OperatingExpenses_f1822a90-6983-4607-b45a-e75c4c20035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3f6500b1-1b7c-4df6-bce6-0887f4056986" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_OperatingIncomeLoss_3f6500b1-1b7c-4df6-bce6-0887f4056986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_cfd4f0c3-7922-4cab-a116-6024f427090a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_cfd4f0c3-7922-4cab-a116-6024f427090a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c976a541-0cac-4e32-b025-65801b682c80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c976a541-0cac-4e32-b025-65801b682c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f0efc128-dffe-43d4-89d8-88eccea73668" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f0efc128-dffe-43d4-89d8-88eccea73668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2f00e3b6-001b-4bfb-beff-4a3dd94a8009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_NetIncomeLoss_2f00e3b6-001b-4bfb-beff-4a3dd94a8009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_83992d7e-ba1d-4263-ad67-1d36fd3286b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_83992d7e-ba1d-4263-ad67-1d36fd3286b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_e3cb6665-54b0-44ae-9f30-3388afa0fee8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_83992d7e-ba1d-4263-ad67-1d36fd3286b5" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_e3cb6665-54b0-44ae-9f30-3388afa0fee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8a34e34f-0169-45b7-a4d2-2fa57337f99c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_83992d7e-ba1d-4263-ad67-1d36fd3286b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8a34e34f-0169-45b7-a4d2-2fa57337f99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2cc98698-19b5-49ab-9ce7-2962874594ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_83992d7e-ba1d-4263-ad67-1d36fd3286b5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2cc98698-19b5-49ab-9ce7-2962874594ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e9da51af-4f1e-4266-acb9-15494daeee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_EarningsPerShareBasic_e9da51af-4f1e-4266-acb9-15494daeee8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2d907ec8-4334-448f-a47e-fe555eee9885" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2d907ec8-4334-448f-a47e-fe555eee9885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec9c1dc0-3e3c-4013-bc58-9d853053d2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ec9c1dc0-3e3c-4013-bc58-9d853053d2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_917f77da-6a74-496e-8f7e-230aad3f9063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d28f4521-11de-4e4f-8144-b02bc6ebdf98" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_917f77da-6a74-496e-8f7e-230aad3f9063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d6fe5082-4c68-44f7-ad00-637311aaa8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d6fe5082-4c68-44f7-ad00-637311aaa8fc" xlink:to="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8f18c423-d40d-4953-b90f-70126e30de7c" xlink:to="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5024969c-7e83-41ea-be2a-76a084d25fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_CommonStockMember_5024969c-7e83-41ea-be2a-76a084d25fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7ffa72cf-7a3c-49a2-a1bb-45a02f22bcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7ffa72cf-7a3c-49a2-a1bb-45a02f22bcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bdcc7310-7a5a-4c22-99a4-c7d0747910cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_bdcc7310-7a5a-4c22-99a4-c7d0747910cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eef53fbe-a063-4fa3-8ea9-912ed19f7ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2a1cb48e-08ff-460c-9c1f-1fa5e0f44d58" xlink:to="loc_us-gaap_RetainedEarningsMember_eef53fbe-a063-4fa3-8ea9-912ed19f7ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_af210e38-42dd-4572-8546-86398232299e" xlink:to="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e65ed542-45e2-437b-b783-6accb4dc5b0a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2dfb1dc0-9ef1-40c5-9882-7957647473f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2dfb1dc0-9ef1-40c5-9882-7957647473f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88dc1cbd-b617-4a1d-ade5-2210667be588" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockholdersEquity_88dc1cbd-b617-4a1d-ade5-2210667be588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_279e89ab-2693-4460-bb0b-96bc98d5ba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_279e89ab-2693-4460-bb0b-96bc98d5ba3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8c9d64a6-c594-49f6-8306-55811f5e2519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8c9d64a6-c594-49f6-8306-55811f5e2519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9b68005-c124-43a8-8c9a-c90d64fec7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a9b68005-c124-43a8-8c9a-c90d64fec7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ed628b7-b92e-4a4a-a92f-ee9f1b8a18eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ed628b7-b92e-4a4a-a92f-ee9f1b8a18eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0a30c2fe-a995-4bd1-ba4a-604565a3692d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0a30c2fe-a995-4bd1-ba4a-604565a3692d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9e54a287-1610-4a62-9fef-7efb57d126d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9e54a287-1610-4a62-9fef-7efb57d126d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c1818b34-9ead-49a1-9986-92ea5950faf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c1818b34-9ead-49a1-9986-92ea5950faf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_52b59158-4567-4b2f-bae0-ee37234dcee3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_52b59158-4567-4b2f-bae0-ee37234dcee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_6e67bf6c-458c-469b-b928-2b00b104a66d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_6e67bf6c-458c-469b-b928-2b00b104a66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d54875be-dfe8-4254-ba1d-28d858446222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d54875be-dfe8-4254-ba1d-28d858446222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f98aed1a-3f27-44ff-b36f-942296c86ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_NetIncomeLoss_f98aed1a-3f27-44ff-b36f-942296c86ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_02348a71-21fa-4e8a-bbf6-e7c468e9d6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_02348a71-21fa-4e8a-bbf6-e7c468e9d6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_66fde7d9-c7d2-47b8-a3dc-73b0a6aace44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d61ee9a4-d96f-43e2-9e58-b3de94635d8a" xlink:to="loc_us-gaap_StockholdersEquity_66fde7d9-c7d2-47b8-a3dc-73b0a6aace44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3e2139b-cd71-40be-9519-f0b822054205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_b98c0368-7c2e-438e-8b7e-ea2ead82af7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e3e2139b-cd71-40be-9519-f0b822054205" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_b98c0368-7c2e-438e-8b7e-ea2ead82af7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="advm-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_07b49089-c7ce-459f-9b4d-e21b6642e8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:to="loc_us-gaap_NetIncomeLoss_07b49089-c7ce-459f-9b4d-e21b6642e8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c4aef698-4027-49c3-af1a-bbf313fc15da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_DepreciationAndAmortization_c4aef698-4027-49c3-af1a-bbf313fc15da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_88d2552b-fd27-42f7-983a-13c1ad2ed692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_ShareBasedCompensation_88d2552b-fd27-42f7-983a-13c1ad2ed692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b2760f69-2ef3-48a5-b9a8-cba01c98806d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b2760f69-2ef3-48a5-b9a8-cba01c98806d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b7b3bf54-3cd1-48e0-96df-9b2886c58e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b7b3bf54-3cd1-48e0-96df-9b2886c58e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_089ec0f1-f53d-45f1-b7ec-883381697c69" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_advm_NonCashSubleaseLossIncome_089ec0f1-f53d-45f1-b7ec-883381697c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_9fa7885c-fb74-4b41-a18b-6a63c05881b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_9fa7885c-fb74-4b41-a18b-6a63c05881b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_facc83d0-d014-44da-bee9-82262324c584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_305545b4-a7f0-4f73-8a09-eecc5d987b15" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_facc83d0-d014-44da-bee9-82262324c584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e28df50a-24a9-4ef9-89ea-bc1531affc06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e28df50a-24a9-4ef9-89ea-bc1531affc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_2279d145-cdca-481a-afaa-cef51055969b" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:to="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_2279d145-cdca-481a-afaa-cef51055969b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23835600-ff99-437a-b18c-4a8e5aec80ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23835600-ff99-437a-b18c-4a8e5aec80ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_05b27b53-cb5c-4a79-a897-51a436eaf2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_05b27b53-cb5c-4a79-a897-51a436eaf2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_057ce6db-fa80-4586-846f-fabf19ccde39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e42ab62c-3878-4fe7-b205-29aa0b8c8922" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_057ce6db-fa80-4586-846f-fabf19ccde39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53f57aad-a25d-4ac8-a590-c89d8f3826fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f866c46d-47cc-45fb-ae3c-f7a1b66f38b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53f57aad-a25d-4ac8-a590-c89d8f3826fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1ecff67f-c9ef-4d7d-92ea-7b0f9ca23a85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1ecff67f-c9ef-4d7d-92ea-7b0f9ca23a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2aa6ecb1-d5c1-42b8-9129-2ca174b8ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2aa6ecb1-d5c1-42b8-9129-2ca174b8ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84659e53-4d8c-4b49-908d-52c5a2448f59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84659e53-4d8c-4b49-908d-52c5a2448f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31eaf4ae-8af2-4470-bf43-578217c24344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_61e3c4bc-1561-4111-99f7-e038cee4a77c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31eaf4ae-8af2-4470-bf43-578217c24344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_94d5c42c-1d65-4d11-a671-20b21e0e21e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_94d5c42c-1d65-4d11-a671-20b21e0e21e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_9f296bf4-4470-4377-8087-d57726439976" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_9f296bf4-4470-4377-8087-d57726439976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3e564394-4771-4aff-8cc7-4c0ab2109dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3e564394-4771-4aff-8cc7-4c0ab2109dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_f091fb08-5fa3-47be-b678-d5adf5b4b010" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_f091fb08-5fa3-47be-b678-d5adf5b4b010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5f422d6-db7f-414f-a0cb-d65da193272a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6e77398-bf5c-41f4-926a-714a9c474485" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f5f422d6-db7f-414f-a0cb-d65da193272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dc6e09b-352f-4a3b-a350-4b9a2a507bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3dc6e09b-352f-4a3b-a350-4b9a2a507bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6a65148-1c4b-4604-b944-51341104d061" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6a65148-1c4b-4604-b944-51341104d061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0cfa3ec-8f51-4c9a-9840-cba64f34523b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d0cfa3ec-8f51-4c9a-9840-cba64f34523b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a900a81c-6c91-4f60-a3fc-b6fe0369b43d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a900a81c-6c91-4f60-a3fc-b6fe0369b43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3ec2821f-42db-4ff6-b8d4-ed06d3e02a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3ec2821f-42db-4ff6-b8d4-ed06d3e02a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8900ecc8-fd2a-484d-a3ca-a32c4b5ed2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8900ecc8-fd2a-484d-a3ca-a32c4b5ed2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2a249995-9b14-443b-916d-d4cd19ae272d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1f2af445-efce-430b-b1f5-35d8a6642fa2" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2a249995-9b14-443b-916d-d4cd19ae272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_2ad6c263-04ca-4618-88d4-09435d9891f5" xlink:href="advm-20241231.xsd#advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2a249995-9b14-443b-916d-d4cd19ae272d" xlink:to="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_2ad6c263-04ca-4618-88d4-09435d9891f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_e179d87f-24a8-4d27-b811-87e6828adc87" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2a249995-9b14-443b-916d-d4cd19ae272d" xlink:to="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_e179d87f-24a8-4d27-b811-87e6828adc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8bcad141-8778-404b-88ad-cc3cb4d0beec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2a249995-9b14-443b-916d-d4cd19ae272d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8bcad141-8778-404b-88ad-cc3cb4d0beec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="advm-20241231.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f693feec-5457-447e-9e98-6965a8f16940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b442f774-3235-4f43-ab03-eead0d331793" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f693feec-5457-447e-9e98-6965a8f16940" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b442f774-3235-4f43-ab03-eead0d331793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatements"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_b1226182-7d18-4fc2-bac0-7ce76643b3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionTextBlock_2590e022-a724-4f0f-bf90-f03978db191b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_b1226182-7d18-4fc2-bac0-7ce76643b3c8" xlink:to="loc_us-gaap_ErrorCorrectionTextBlock_2590e022-a724-4f0f-bf90-f03978db191b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="advm-20241231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4415bd0b-1f31-4085-bbcd-6aa93bce81de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4f815fb5-1b3a-4e6e-9330-31caccc5945c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4415bd0b-1f31-4085-bbcd-6aa93bce81de" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4f815fb5-1b3a-4e6e-9330-31caccc5945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1e97fb6a-6b56-4b6b-9641-5f2e5c65c595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_182cd905-4f01-4ef1-9732-ac81fc33c045" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e97fb6a-6b56-4b6b-9641-5f2e5c65c595" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_182cd905-4f01-4ef1-9732-ac81fc33c045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/Revenue" xlink:type="simple" xlink:href="advm-20241231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a3a3bc2-4301-45d1-b35c-f7b6f873468b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_640c4cf6-bed5-477f-8555-975944c31f13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a3a3bc2-4301-45d1-b35c-f7b6f873468b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_640c4cf6-bed5-477f-8555-975944c31f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/Leases" xlink:type="simple" xlink:href="advm-20241231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_93d0f38b-2817-417f-a459-2c3dfe35619e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_076e4181-ea34-47ea-9709-db5eaa2eee03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_93d0f38b-2817-417f-a459-2c3dfe35619e" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_076e4181-ea34-47ea-9709-db5eaa2eee03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c59a3ef6-d18d-4f95-aa32-b667adfc8494" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_3acaadaf-dc27-4012-b67e-3912b3e53441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c59a3ef6-d18d-4f95-aa32-b667adfc8494" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_3acaadaf-dc27-4012-b67e-3912b3e53441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="advm-20241231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_025cd52e-d62a-40e5-9dfe-f15f8c1db770" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7bef069f-92e8-4b52-92bd-6fe3e2028f62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_025cd52e-d62a-40e5-9dfe-f15f8c1db770" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7bef069f-92e8-4b52-92bd-6fe3e2028f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquity" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae7522fb-a258-4e6c-9386-4286c10c06fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_0ea1056d-e265-4d86-a262-ec73f75a371c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae7522fb-a258-4e6c-9386-4286c10c06fd" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_0ea1056d-e265-4d86-a262-ec73f75a371c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/A401kSavingsPlan" xlink:type="simple" xlink:href="advm-20241231.xsd#A401kSavingsPlan"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/A401kSavingsPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9fa83c4-c64b-4d13-991a-9f5a4af138a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_2134d8ac-1587-4935-b9a4-0c53b0a49674" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9fa83c4-c64b-4d13-991a-9f5a4af138a6" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_2134d8ac-1587-4935-b9a4-0c53b0a49674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SegmentReporting" xlink:type="simple" xlink:href="advm-20241231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_41ab9784-8397-4320-a2b5-c406c48928ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2449174d-2676-451f-bd10-1abc78f34231" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_41ab9784-8397-4320-a2b5-c406c48928ec" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2449174d-2676-451f-bd10-1abc78f34231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxes" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dc3ccaa8-0fbe-47af-b20e-5efad76e4728" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_777d4704-9267-4e99-9ccf-6f3bf2d58375" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dc3ccaa8-0fbe-47af-b20e-5efad76e4728" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_777d4704-9267-4e99-9ccf-6f3bf2d58375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/NetLossperShare" xlink:type="simple" xlink:href="advm-20241231.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ff0e7df-0571-4c17-90a4-4f4f2098f50c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_cef5265f-77be-4476-b46d-5b399c8fb785" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ff0e7df-0571-4c17-90a4-4f4f2098f50c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_cef5265f-77be-4476-b46d-5b399c8fb785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnaudited"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_913b40b8-3eb1-4a46-a673-647115d1ce67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_dbca2582-9cfa-40ba-8a99-27bf2fbb6907" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_913b40b8-3eb1-4a46-a673-647115d1ce67" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_dbca2582-9cfa-40ba-8a99-27bf2fbb6907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SubsequentEvents" xlink:type="simple" xlink:href="advm-20241231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0b9c195a-1ffe-4d13-b336-3179729ac69e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_a878cb91-1598-4280-a12c-14dc59fe951c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0b9c195a-1ffe-4d13-b336-3179729ac69e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_a878cb91-1598-4280-a12c-14dc59fe951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="advm-20241231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_8898fdb9-5aa6-4884-9bd6-28f3bd09aa6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_8898fdb9-5aa6-4884-9bd6-28f3bd09aa6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f8f1ee92-c753-43c1-b10a-15d503784022" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_UseOfEstimates_f8f1ee92-c753-43c1-b10a-15d503784022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_a6fba08c-0b3f-4c02-bbfa-8c7113b7aa58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_a6fba08c-0b3f-4c02-bbfa-8c7113b7aa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7439f15b-e9f1-408f-a08c-4110e7315257" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7439f15b-e9f1-408f-a08c-4110e7315257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ac233a3d-ad15-4870-999e-994d26e3533e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ac233a3d-ad15-4870-999e-994d26e3533e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3c50f71b-51a3-41d8-b185-6e18046f2bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3c50f71b-51a3-41d8-b185-6e18046f2bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_2cf3d800-e2ae-440c-b488-aa55feeea52c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_2cf3d800-e2ae-440c-b488-aa55feeea52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedInterestReceivablePolicyTextBlock_f0fc62e4-5745-4b8f-808a-9528f51fb4e0" xlink:href="advm-20241231.xsd#advm_AccruedInterestReceivablePolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_advm_AccruedInterestReceivablePolicyTextBlock_f0fc62e4-5745-4b8f-808a-9528f51fb4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_c3f09966-0e78-456b-b6c2-d38b5793012d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_c3f09966-0e78-456b-b6c2-d38b5793012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_136f98e1-0243-4658-8100-ebd040ee37d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_136f98e1-0243-4658-8100-ebd040ee37d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_55f93aa6-65af-469e-aa17-5ef79bd449dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_55f93aa6-65af-469e-aa17-5ef79bd449dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e0c4db16-48a5-4ee4-a89c-5e8230a231ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_e0c4db16-48a5-4ee4-a89c-5e8230a231ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ae4230f6-8a6a-4dfb-8d66-9cc34e5fc5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ae4230f6-8a6a-4dfb-8d66-9cc34e5fc5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_032584cf-80fb-4ee2-a828-618bf70ce085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_032584cf-80fb-4ee2-a828-618bf70ce085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_70639e23-3750-4b3a-aa43-7ae87b05d6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_70639e23-3750-4b3a-aa43-7ae87b05d6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5e4531eb-1d7e-468d-9c28-b6176435ff8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5e4531eb-1d7e-468d-9c28-b6176435ff8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cff4b4ab-7199-42d9-814e-31814566dd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cff4b4ab-7199-42d9-814e-31814566dd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_0ae4d468-9312-4b96-a9d2-a7be9a15f98c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_0ae4d468-9312-4b96-a9d2-a7be9a15f98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4920ad8-524e-4037-81ff-5aac834eee17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4920ad8-524e-4037-81ff-5aac834eee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_d8d5b7e0-887d-4170-83f5-53d95cc6eaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_d8d5b7e0-887d-4170-83f5-53d95cc6eaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_57f5cc76-8063-4b6b-bcc6-894f38118d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ab5698-9b8f-42a2-a3c7-86b48437b08a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_57f5cc76-8063-4b6b-bcc6-894f38118d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_d103c2c2-885e-4e7b-8c9c-2a786c5e6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_dd38a0eb-5111-40b9-8ada-bfb975d4841d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_d103c2c2-885e-4e7b-8c9c-2a786c5e6f44" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_dd38a0eb-5111-40b9-8ada-bfb975d4841d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_896e67e0-9f42-4118-90cf-944414029192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_106cea50-e6fc-40c1-a1dc-9d3ac25d3a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_896e67e0-9f42-4118-90cf-944414029192" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_106cea50-e6fc-40c1-a1dc-9d3ac25d3a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/LeasesTables" xlink:type="simple" xlink:href="advm-20241231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1669e10e-e906-449a-919b-58145304ec55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8bd3a8b9-46e5-45d6-b8a0-d65a4489aa9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1669e10e-e906-449a-919b-58145304ec55" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8bd3a8b9-46e5-45d6-b8a0-d65a4489aa9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_102ea66a-3051-4f99-b029-f1b5fb318d43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_da72ef95-7a8a-403e-9167-592f73949f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_102ea66a-3051-4f99-b029-f1b5fb318d43" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_da72ef95-7a8a-403e-9167-592f73949f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_bc94d87c-916b-4cfc-943c-a4908e9521fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_102ea66a-3051-4f99-b029-f1b5fb318d43" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_bc94d87c-916b-4cfc-943c-a4908e9521fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a36016-73c1-439d-9bb9-404b4a2830da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_cf5b9619-85b6-4d19-b047-fd9e92271ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a36016-73c1-439d-9bb9-404b4a2830da" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_cf5b9619-85b6-4d19-b047-fd9e92271ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_86b2f084-56a0-47cd-ba37-c2e3f964cc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a36016-73c1-439d-9bb9-404b4a2830da" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_86b2f084-56a0-47cd-ba37-c2e3f964cc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_c51887b0-b2a8-4a6d-85c8-d96957660958" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a36016-73c1-439d-9bb9-404b4a2830da" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_c51887b0-b2a8-4a6d-85c8-d96957660958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8dffddec-8f61-4d62-8aff-2c98f6f96963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f3a36016-73c1-439d-9bb9-404b4a2830da" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8dffddec-8f61-4d62-8aff-2c98f6f96963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="advm-20241231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f2795211-37ae-4c54-b6c9-63dccc215cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_01f6839e-0a27-4b6a-917a-a2324b7b7059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f2795211-37ae-4c54-b6c9-63dccc215cc1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_01f6839e-0a27-4b6a-917a-a2324b7b7059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24342c3e-77e3-4ddb-85c9-bc8ca9f147d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24342c3e-77e3-4ddb-85c9-bc8ca9f147d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_68da1995-1d1a-49c3-b549-e44ec838ad20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_68da1995-1d1a-49c3-b549-e44ec838ad20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7cd8601f-90ea-4a42-bc1a-87c3cae3690e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7cd8601f-90ea-4a42-bc1a-87c3cae3690e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f174f93b-c3c4-41f7-a9bf-baf25ac346ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f174f93b-c3c4-41f7-a9bf-baf25ac346ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_38dd14ca-f527-4683-8f34-54f3f3dde374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_487acee9-d53b-41d3-ab8c-d66060664c48" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_38dd14ca-f527-4683-8f34-54f3f3dde374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="advm-20241231.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3f8c66ac-a74a-4591-9e8a-60e15962f122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a96c6800-710f-407e-a4d9-ddd0f4ff58e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f8c66ac-a74a-4591-9e8a-60e15962f122" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a96c6800-710f-407e-a4d9-ddd0f4ff58e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_2e8ceedd-1010-417a-8c82-eb6147405a97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_6a3b9650-31c9-4e1d-8945-0c0ae38ec19a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_2e8ceedd-1010-417a-8c82-eb6147405a97" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_6a3b9650-31c9-4e1d-8945-0c0ae38ec19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#DescriptionoftheBusinessAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3cb2cd79-43a6-4aa7-9b19-e6663eb84e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f2e2768-bac4-4050-b0ef-bfbfa3d4b665" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3cb2cd79-43a6-4aa7-9b19-e6663eb84e1b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f2e2768-bac4-4050-b0ef-bfbfa3d4b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5b1a2928-d91a-4105-b98c-cceef6d37850" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3cb2cd79-43a6-4aa7-9b19-e6663eb84e1b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5b1a2928-d91a-4105-b98c-cceef6d37850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c1076898-5ef5-4bf3-b0aa-77405fb6b479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3cb2cd79-43a6-4aa7-9b19-e6663eb84e1b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c1076898-5ef5-4bf3-b0aa-77405fb6b479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_867f3e5e-d4d4-4ab7-847e-8fce080e8602" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_867f3e5e-d4d4-4ab7-847e-8fce080e8602" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:to="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_4bdee620-a0bd-4700-8723-d3be5f0c12cc" xlink:to="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_5217c8b1-08ea-4ac0-9133-3dffd146c06a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_6880b811-6113-485d-a669-d398a0c0b30c" xlink:to="loc_srt_RestatementAdjustmentMember_5217c8b1-08ea-4ac0-9133-3dffd146c06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_375bbff5-0e5b-44c1-82d2-ac3e8fda9080" xlink:to="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RedwoodCaliforniaFacilityLeaseMember_833ea63a-8e48-44b8-ae68-63556809b672" xlink:href="advm-20241231.xsd#advm_RedwoodCaliforniaFacilityLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_d99da26b-d583-4ed9-9fa5-8b846c382fa4" xlink:to="loc_advm_RedwoodCaliforniaFacilityLeaseMember_833ea63a-8e48-44b8-ae68-63556809b672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_a9892886-be30-4ce5-a3e8-5b917f1d7a8e" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_774e56a7-633b-4b4f-9dd4-16cb841fc6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_774e56a7-633b-4b4f-9dd4-16cb841fc6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ae6b7f37-56c3-43dc-99e5-376ec4b777e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ae6b7f37-56c3-43dc-99e5-376ec4b777e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c12e78dd-ea34-436f-8dea-bb32255243af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_OperatingLeaseLiability_c12e78dd-ea34-436f-8dea-bb32255243af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b49cbb2f-5dce-49e5-8d34-0436b644614b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_f5a9fd49-2fd6-4158-a7e5-93eb3a5b1a3a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b49cbb2f-5dce-49e5-8d34-0436b644614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_3f780f36-55b4-4fb9-8ffa-8cdfbffc96a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_3f780f36-55b4-4fb9-8ffa-8cdfbffc96a7" xlink:to="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:to="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_10dce007-6448-4485-87ed-49b9ba57663b" xlink:to="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_91863f9b-b1cb-4001-9415-ef1b43bb0636" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_91863f9b-b1cb-4001-9415-ef1b43bb0636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_3dcac058-3f99-4fb0-9160-927403ae1f90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7bb4b172-8318-41fa-b2e3-3e1ca1f511a0" xlink:to="loc_srt_RestatementAdjustmentMember_3dcac058-3f99-4fb0-9160-927403ae1f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_219800ef-fff3-4ed0-8c81-7540ecc0d25b" xlink:to="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_838bb818-7494-45ef-8fd8-3328c06e9ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_838bb818-7494-45ef-8fd8-3328c06e9ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_44322b11-5c03-4e6b-af6a-512c493a14f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_ShortTermInvestments_44322b11-5c03-4e6b-af6a-512c493a14f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b4411395-c7bc-4c39-a694-5937b7550d44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b4411395-c7bc-4c39-a694-5937b7550d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8feba38f-9858-435f-928a-b70bbd82bae9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_261b7430-daea-4c80-9283-67cc21694b15" xlink:to="loc_us-gaap_AssetsCurrent_8feba38f-9858-435f-928a-b70bbd82bae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9bf12be0-a0a8-422a-ba88-b2578d991338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9bf12be0-a0a8-422a-ba88-b2578d991338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f192db84-5999-40c7-ba87-f4aee62ee9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f192db84-5999-40c7-ba87-f4aee62ee9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2097ee17-c1f4-45d2-bffc-ec0ac53c2aef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2097ee17-c1f4-45d2-bffc-ec0ac53c2aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c5e76d54-381f-44d5-ba21-4b09441036ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c5e76d54-381f-44d5-ba21-4b09441036ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8039d4ad-71e9-41b4-b9dd-095b3d045bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_268a657d-cc99-41d5-a31b-84a52475e9e6" xlink:to="loc_us-gaap_Assets_8039d4ad-71e9-41b4-b9dd-095b3d045bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a6c3233e-4411-4837-b4f6-b51ce67cd0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_AccountsPayableCurrent_a6c3233e-4411-4837-b4f6-b51ce67cd0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_fc00dd8b-7f61-40d7-b67d-1dee1838e52e" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_fc00dd8b-7f61-40d7-b67d-1dee1838e52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb01f5f7-cb51-4366-bb19-40088eae7ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eb01f5f7-cb51-4366-bb19-40088eae7ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e348ee1-1152-4e4e-9690-127605323d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f7ca7ec1-ad1d-4fb7-857d-fdadfcf71941" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e348ee1-1152-4e4e-9690-127605323d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4f40d094-cfe0-4f50-a420-b1b6bcbc0d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4f40d094-cfe0-4f50-a420-b1b6bcbc0d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_583e322a-a1f2-43b1-849b-283640acc87e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_32af4812-c7e3-4583-abce-6eb6bd12ae03" xlink:to="loc_us-gaap_Liabilities_583e322a-a1f2-43b1-849b-283640acc87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fe2c2909-0e58-45d2-baca-c1a52cad937c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fe2c2909-0e58-45d2-baca-c1a52cad937c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd8aa61a-53e0-445a-aabd-3005f700afb3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_35eb5d47-1bf1-413a-ba33-f0d823cce2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_PreferredStockValue_35eb5d47-1bf1-413a-ba33-f0d823cce2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_99d91dbd-0278-4cbb-a6b0-3a74dc41bfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_CommonStockValue_99d91dbd-0278-4cbb-a6b0-3a74dc41bfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5321cbe-0e50-4d4e-9be8-2a7be6c8b056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c5321cbe-0e50-4d4e-9be8-2a7be6c8b056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d950923-8043-4527-9dc5-bf22a088c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9d950923-8043-4527-9dc5-bf22a088c92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c5967991-23ea-4fe3-a340-3de6fbd87706" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c5967991-23ea-4fe3-a340-3de6fbd87706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_626eaba2-a159-4011-8ccb-3ec00ac68ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d2f25aba-df2c-455e-9c7c-2248d6d84732" xlink:to="loc_us-gaap_StockholdersEquity_626eaba2-a159-4011-8ccb-3ec00ac68ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_49b92dfe-f5af-4415-8380-32f2c3296db0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_eaf50299-287c-4dbd-a862-97900904fc9d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_49b92dfe-f5af-4415-8380-32f2c3296db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5692e4d0-0d97-486d-b856-a631521c2b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5692e4d0-0d97-486d-b856-a631521c2b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_79574171-297e-4fe5-87e1-d8c2d1e7fe89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_79574171-297e-4fe5-87e1-d8c2d1e7fe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_68ce175d-a190-47da-ab41-af4387a40841" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_68ce175d-a190-47da-ab41-af4387a40841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_f2d15f77-61cb-4c83-9389-ed562fc630d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_f2d15f77-61cb-4c83-9389-ed562fc630d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_03a6ec3b-1bf1-439e-9ada-92a8ba2affe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_03a6ec3b-1bf1-439e-9ada-92a8ba2affe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_c440a2fd-638e-4a68-8f76-3226ddc32555" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_c440a2fd-638e-4a68-8f76-3226ddc32555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0899e63d-f145-4687-958f-267f505412f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_CommonStockSharesIssued_0899e63d-f145-4687-958f-267f505412f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e914e675-fc12-4680-a776-4bc274e616d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_fb7aac23-442b-4bb3-81bd-75a4681265b8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e914e675-fc12-4680-a776-4bc274e616d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_ef11d38a-cdc2-4e9d-af6d-0b536b7e0525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_ef11d38a-cdc2-4e9d-af6d-0b536b7e0525" xlink:to="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:to="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1c00bc09-384a-4c52-8e19-fcd6592b277d" xlink:to="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_df9a60f2-008f-4069-9517-c01405bea6e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_df9a60f2-008f-4069-9517-c01405bea6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_58fe1689-6077-43dd-89a9-5801c5930768" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0d749208-417c-4f9a-8437-3d075efb3560" xlink:to="loc_srt_RestatementAdjustmentMember_58fe1689-6077-43dd-89a9-5801c5930768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_1d8638c6-19f8-46d0-9fc0-63334500d7b3" xlink:to="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_7588663e-3bcb-44e2-847d-6def5f72ee26" xlink:to="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5fa46cf-e646-4279-8e75-08167a89f158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c5fa46cf-e646-4279-8e75-08167a89f158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ab327b8e-d7da-4394-855f-c33a188d7e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ab327b8e-d7da-4394-855f-c33a188d7e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_67938590-a104-4659-9a24-e811eb1237ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_67938590-a104-4659-9a24-e811eb1237ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_52abc791-b077-4295-aa62-5a2c787aa961" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e753be95-d7fb-444f-803f-6621e6eb74c8" xlink:to="loc_us-gaap_OperatingExpenses_52abc791-b077-4295-aa62-5a2c787aa961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dda238fa-6b8e-4f6f-8f4d-d13c5b752811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OperatingIncomeLoss_dda238fa-6b8e-4f6f-8f4d-d13c5b752811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f8b5c5e8-e2f7-482d-8f39-f10cff645bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f8b5c5e8-e2f7-482d-8f39-f10cff645bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d55afb-bb76-4fa3-bec8-8d4877d6626d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d55afb-bb76-4fa3-bec8-8d4877d6626d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d3fbf531-d4be-45d5-8dfd-9e3e5d81f64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d3fbf531-d4be-45d5-8dfd-9e3e5d81f64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6074fd74-b5f8-438c-b996-24617694ff55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_NetIncomeLoss_6074fd74-b5f8-438c-b996-24617694ff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_d6734e7f-1edd-4f35-8829-7f4c6d6c1180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_d6734e7f-1edd-4f35-8829-7f4c6d6c1180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ac3730f5-98b7-4314-9eb6-8b8493ba6385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ac3730f5-98b7-4314-9eb6-8b8493ba6385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7f6abea-670d-457f-bb98-744e43a29c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_6f5047ea-ccbd-4e64-860b-d99010171e86" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7f6abea-670d-457f-bb98-744e43a29c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_926ea90c-ac91-4e1d-8b2e-49417c8ac3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_EarningsPerShareBasic_926ea90c-ac91-4e1d-8b2e-49417c8ac3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7ada9410-6325-460e-afa8-0421b20a708b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7ada9410-6325-460e-afa8-0421b20a708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0845a2a-1510-45d5-a1a4-3e1c631d4c38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0845a2a-1510-45d5-a1a4-3e1c631d4c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e6a009d-4e9f-4dc1-bdce-bf2d0a4f45dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f586a0ba-f54c-4860-98f2-e723cce9f584" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e6a009d-4e9f-4dc1-bdce-bf2d0a4f45dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_c01bcf35-8684-48a4-b903-e7f1949b46ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_c01bcf35-8684-48a4-b903-e7f1949b46ec" xlink:to="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:to="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_4e2b988d-3754-4f2a-8415-6cc899b8d360" xlink:to="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_74613a93-3e7e-4bb2-a52c-0caf86210b2a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_74613a93-3e7e-4bb2-a52c-0caf86210b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a164641c-6b71-497e-a878-40200ad0d6a0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_ba4cd49c-39ad-497c-acb4-26e2b3356705" xlink:to="loc_srt_RestatementAdjustmentMember_a164641c-6b71-497e-a878-40200ad0d6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_d09ef6bb-b618-4490-a605-81c396c9e528" xlink:to="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16851fc0-9e9e-4d6c-979c-00000ec81cac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_NetIncomeLoss_16851fc0-9e9e-4d6c-979c-00000ec81cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8527754-815d-408d-9063-775b39e0ee58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d8527754-815d-408d-9063-775b39e0ee58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_115f40ca-4929-4066-a900-b6265be60e85" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a914f671-f19d-44e6-b5b3-e7ce9f23144d" xlink:to="loc_advm_NonCashSubleaseLossIncome_115f40ca-4929-4066-a900-b6265be60e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ac120bfe-d8ea-4ef5-8085-29daaf6c3552" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f48b7ee0-d61e-46c6-9636-024cd23eab12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2fe7b9b-b33d-4456-94cf-c0a570ac0d40" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f48b7ee0-d61e-46c6-9636-024cd23eab12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_5cbc3f15-b9c0-4d1f-b7dc-ce6842f7919f" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_c435de14-c9a6-414d-9207-90d66f74ac82" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5177ca1c-a313-4f69-aa1a-3ea09fcb8853" xlink:to="loc_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities_c435de14-c9a6-414d-9207-90d66f74ac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_52e44ec4-ff9c-453a-b99f-4c57581d198f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52e44ec4-ff9c-453a-b99f-4c57581d198f" xlink:to="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:to="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6d183e84-ca27-4f48-b725-60d3e1b5bc70" xlink:to="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c37e71e-1d44-4eac-b236-0fecec4650a3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:to="loc_srt_MinimumMember_0c37e71e-1d44-4eac-b236-0fecec4650a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c2b1695c-2d3c-42e4-bb52-e87889e0ede3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_08720817-db49-46bf-a494-c937e6af2bb2" xlink:to="loc_srt_MaximumMember_c2b1695c-2d3c-42e4-bb52-e87889e0ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:href="advm-20241231.xsd#advm_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesTable_f9d07d49-bbe4-4966-863e-772e28e4c06f" xlink:to="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_864cfe06-70af-4d23-bf51-54e9269a7c14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_864cfe06-70af-4d23-bf51-54e9269a7c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b665acda-e752-4e6c-8084-dfe39f33ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_NumberOfReportableSegments_b665acda-e752-4e6c-8084-dfe39f33ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_57621fbb-164b-4afd-a607-7a2468ab2d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_57621fbb-164b-4afd-a607-7a2468ab2d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_919fad38-47a7-4dae-ade2-6bbf05c6dcee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_SummaryOfSignificantAccountingPoliciesLineItems_7c662ecd-07df-4cc2-9770-1e038512c63f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_919fad38-47a7-4dae-ade2-6bbf05c6dcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_caf29fed-027b-4193-9b26-5793a4f8fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_caf29fed-027b-4193-9b26-5793a4f8fe2a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f0affe2e-4b16-48c5-9b7a-418db16fd3c0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2b062f94-2223-4ef5-b892-a40897f379f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2b062f94-2223-4ef5-b892-a40897f379f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a3301f9a-bde8-438b-a9c8-c8f9780b410a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7d26d018-4f97-4bc8-80df-d81023f410fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a3301f9a-bde8-438b-a9c8-c8f9780b410a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:to="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_896f7139-f0a4-4be5-91f3-8d518109e5cd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_189636b5-054c-4af7-bd70-d718d05ffd07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_MoneyMarketFundsMember_189636b5-054c-4af7-bd70-d718d05ffd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bae7f137-7345-4484-bae8-4e1518232165" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_CommercialPaperMember_bae7f137-7345-4484-bae8-4e1518232165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_faab164c-6e48-4abd-8537-ede4dcdab4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_faab164c-6e48-4abd-8537-ede4dcdab4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashEquivalentsAndShortTermInvestmentsMember_d705bf30-c4d1-40b0-adfa-f701b9ae1a3d" xlink:href="advm-20241231.xsd#advm_CashEquivalentsAndShortTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_797b0ec3-6290-4853-ad34-58fa845a592a" xlink:to="loc_advm_CashEquivalentsAndShortTermInvestmentsMember_d705bf30-c4d1-40b0-adfa-f701b9ae1a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_6737fb1a-2985-4e6a-9cff-67658c523997" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7bacae44-2aec-4715-bc63-b3e6d18b10e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7bacae44-2aec-4715-bc63-b3e6d18b10e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc996456-2d5f-47f8-8cb3-b1e221d413b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc996456-2d5f-47f8-8cb3-b1e221d413b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_51e4e48f-c7ff-423d-9e85-1e0b28c8a71a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_51e4e48f-c7ff-423d-9e85-1e0b28c8a71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99da9bd1-0f7f-441e-91d4-422f0f9483e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_99da9bd1-0f7f-441e-91d4-422f0f9483e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentAmortizedCost_667af40d-938f-40a5-874d-fbb0c66dd52e" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentAmortizedCost_667af40d-938f-40a5-874d-fbb0c66dd52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedGain_5321da63-6e39-4a8c-9e8a-4e4f57a3646c" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentGrossUnrealizedGain_5321da63-6e39-4a8c-9e8a-4e4f57a3646c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss_7962d75a-29bc-47d5-b834-5c4adae6275d" xlink:href="advm-20241231.xsd#advm_CashAndCashEquivalentGrossUnrealizedLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_advm_CashAndCashEquivalentGrossUnrealizedLoss_7962d75a-29bc-47d5-b834-5c4adae6275d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_523a5101-0d99-4848-a79a-f1809c89e138" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75809e57-7957-4e11-8944-6aa61e1dd354" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_523a5101-0d99-4848-a79a-f1809c89e138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e25a323b-e0bf-41be-b04c-264cafa6e4da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_decb5b5b-dd5d-4759-9331-736c1c7f8c54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e25a323b-e0bf-41be-b04c-264cafa6e4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_decb5b5b-dd5d-4759-9331-736c1c7f8c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_9ef72b6e-fd4a-41c1-a3ab-88ed5dbfa516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e25a323b-e0bf-41be-b04c-264cafa6e4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_9ef72b6e-fd4a-41c1-a3ab-88ed5dbfa516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_840b3c68-3898-43b9-94a1-81ca2d0fc827" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e25a323b-e0bf-41be-b04c-264cafa6e4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_840b3c68-3898-43b9-94a1-81ca2d0fc827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_7cf8c3e9-d437-4561-b7a8-e73bb79f6fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e25a323b-e0bf-41be-b04c-264cafa6e4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_7cf8c3e9-d437-4561-b7a8-e73bb79f6fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/RevenueDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_314f9b8c-da79-4347-aaaa-efa43dfabc21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_314f9b8c-da79-4347-aaaa-efa43dfabc21" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:to="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_cc5ff8a2-9303-4091-b2f4-4f786c486b94" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LexeoTherapeuticsIncMember_3a88f29c-4912-4c79-bb9b-3ea475bbf02a" xlink:href="advm-20241231.xsd#advm_LexeoTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fb5baa14-38ac-47e0-8880-1539cf1b5299" xlink:to="loc_advm_LexeoTherapeuticsIncMember_3a88f29c-4912-4c79-bb9b-3ea475bbf02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:to="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_edf43afa-5e13-4419-b38f-c830d2f68e48" xlink:to="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RayTherapeuticsIncMember_c7226b6d-8180-413b-b8da-122f02e3f724" xlink:href="advm-20241231.xsd#advm_RayTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_935feec7-c3e9-4f3e-9f8d-9f8324aa31f7" xlink:to="loc_advm_RayTherapeuticsIncMember_c7226b6d-8180-413b-b8da-122f02e3f724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d953745e-c09f-48e2-a7f9-23fe37ccf738" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLicenseFeesReceived_be50dcc8-f879-4787-b0bd-cde9400fb4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLicenseFeesReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:to="loc_us-gaap_ProceedsFromLicenseFeesReceived_be50dcc8-f879-4787-b0bd-cde9400fb4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8bfcc78-9bb0-4a17-a6d6-f4845e369169" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_263c7f49-8f94-40c9-941b-7085f56fab9c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d8bfcc78-9bb0-4a17-a6d6-f4845e369169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d45f2b6a-3f59-439d-b8ea-c087c0daa24e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d45f2b6a-3f59-439d-b8ea-c087c0daa24e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_497ae037-ea66-4699-88ca-cb9c66c45394" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_a2ae036f-9cc2-4b39-afba-3d7c38a64d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:to="loc_us-gaap_BuildingMember_a2ae036f-9cc2-4b39-afba-3d7c38a64d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_df76fc4a-8040-4449-a97b-db6b4ff93a35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e07c37bf-a58a-4b48-bd5e-ef9cf2667591" xlink:to="loc_us-gaap_ManufacturingFacilityMember_df76fc4a-8040-4449-a97b-db6b4ff93a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fb950673-ed3f-45b9-bdee-614f11d6d8d1" xlink:to="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_71de5229-e875-428b-8d42-ab5025707293" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:to="loc_stpr_NC_71de5229-e875-428b-8d42-ab5025707293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_803e1a66-cf53-4710-8770-9c0e0a291c0c" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dc809667-1438-4dc4-8dcf-128516cb6f63" xlink:to="loc_stpr_CA_803e1a66-cf53-4710-8770-9c0e0a291c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a46e9249-2f40-4606-b49a-7217e7733565" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_27685e6d-0e5e-4807-aa36-14b147561c75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ef6efe2d-d133-4b29-8266-91f6d7cc457b" xlink:to="loc_us-gaap_SubsequentEventMember_27685e6d-0e5e-4807-aa36-14b147561c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_564bc0b6-d83a-4037-b389-3aabca052276" xlink:to="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_7a3f7efe-8745-4fee-8a9b-ed658b3452ef" xlink:href="advm-20241231.xsd#advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_28ebf86f-9b21-4a68-a9e1-b5afc276fba0" xlink:to="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_7a3f7efe-8745-4fee-8a9b-ed658b3452ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6c6fcf38-9f19-4deb-90c4-98acd7a715a7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SubleaseTenantMember_c0f3d832-50de-4b56-82b2-c6200cd12def" xlink:href="advm-20241231.xsd#advm_SubleaseTenantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:to="loc_advm_SubleaseTenantMember_c0f3d832-50de-4b56-82b2-c6200cd12def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LandlordMember_cf80a007-81c8-4aae-81c8-27d5439e32cb" xlink:href="advm-20241231.xsd#advm_LandlordMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f8179db2-01f7-4214-b798-860a3eb6166d" xlink:to="loc_advm_LandlordMember_cf80a007-81c8-4aae-81c8-27d5439e32cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3f5f074f-9f56-414d-b35e-d250e76b38cf" xlink:to="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LandlordMember_812b6e62-47f0-4171-9b3b-8b5e6e3eeab1" xlink:href="advm-20241231.xsd#advm_LandlordMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:to="loc_advm_LandlordMember_812b6e62-47f0-4171-9b3b-8b5e6e3eeab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SubleaseTenantMember_e470b267-3cc6-4236-b7da-af3228412896" xlink:href="advm-20241231.xsd#advm_SubleaseTenantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c7b9a878-a766-484e-b9e8-cceeed1affe3" xlink:to="loc_advm_SubleaseTenantMember_e470b267-3cc6-4236-b7da-af3228412896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a0904026-6344-4f4c-99f0-6432e8965e89" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_61766104-633c-4823-806d-a42adef9e990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_61766104-633c-4823-806d-a42adef9e990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_08f272ea-8ed7-4b16-acac-f210701af806" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_08f272ea-8ed7-4b16-acac-f210701af806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfLease_7acdef7b-35ed-478e-9541-118acbc1d9a4" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseNumberOfLease_7acdef7b-35ed-478e-9541-118acbc1d9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_66bae250-eb56-437f-9fcc-4af7c5ed583d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_66bae250-eb56-437f-9fcc-4af7c5ed583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_5fbed259-667b-4b39-b6e0-ec016e6a9da0" xlink:href="advm-20241231.xsd#advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue_5fbed259-667b-4b39-b6e0-ec016e6a9da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts_946e07f7-b3a8-4681-971f-7d0e06ce765b" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseNumberOfRenewalContracts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseNumberOfRenewalContracts_946e07f7-b3a8-4681-971f-7d0e06ce765b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_7791f867-8b23-4c8d-8cf3-42a800aefa30" xlink:href="advm-20241231.xsd#advm_LesseeOperatingLeaseLeaseholdImprovementAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance_7791f867-8b23-4c8d-8cf3-42a800aefa30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_465cc31f-14b0-43f1-b125-2d5819ed4b6b" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification_465cc31f-14b0-43f1-b125-2d5819ed4b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_d5e7112c-929d-407a-8e48-848db4f09913" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification_d5e7112c-929d-407a-8e48-848db4f09913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_f18246ee-051a-412b-82bb-248dcdf5690d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_f18246ee-051a-412b-82bb-248dcdf5690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_25f55daf-a285-46ad-aa2a-bb215c4da863" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_25f55daf-a285-46ad-aa2a-bb215c4da863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_ece098e0-653b-4e01-8179-df26d7627b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_PaymentsForRent_ece098e0-653b-4e01-8179-df26d7627b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_0d820b88-cee5-44ac-adb8-57875d6ba3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TenantImprovements"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_TenantImprovements_0d820b88-cee5-44ac-adb8-57875d6ba3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_53566d4a-8c6a-4d3f-882c-0cfdeb18f853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_SubleaseIncome_53566d4a-8c6a-4d3f-882c-0cfdeb18f853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_57ae10ac-ff30-4802-82e4-44967f7f7351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_57ae10ac-ff30-4802-82e4-44967f7f7351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_df0a52d6-9493-479c-afe0-a26d3eb17ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_df0a52d6-9493-479c-afe0-a26d3eb17ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1fec2596-8321-4ec9-a875-b4e7d8c865cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeaseCost_1fec2596-8321-4ec9-a875-b4e7d8c865cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_d84e04dd-78de-4206-895d-34c90fa61faa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_VariableLeaseCost_d84e04dd-78de-4206-895d-34c90fa61faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_17143e3c-008c-4c0c-ac50-2512abb6b2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_OperatingLeasePayments_17143e3c-008c-4c0c-ac50-2512abb6b2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForTenantImprovements_9d2c1e7a-6ef6-4b4d-8faa-21c350ec9283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForTenantImprovements"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ee11a12d-3f47-4571-9ab6-5b3852c48426" xlink:to="loc_us-gaap_PaymentsForTenantImprovements_9d2c1e7a-6ef6-4b4d-8faa-21c350ec9283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_56a333b1-9b7b-43e1-b331-5668be0bd781" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_56a333b1-9b7b-43e1-b331-5668be0bd781" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_47127431-5c03-4e45-aa9c-24c51c31a7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_47127431-5c03-4e45-aa9c-24c51c31a7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0dbbb62b-eeaa-4428-84ff-3ee70997045e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0dbbb62b-eeaa-4428-84ff-3ee70997045e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e65657b-e708-433a-8665-6f15353b67d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9e65657b-e708-433a-8665-6f15353b67d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_952e7bdb-819d-4820-b35d-4cb41a69c9db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_952e7bdb-819d-4820-b35d-4cb41a69c9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fe8682d5-a258-4d0c-8072-d9e84028a144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fe8682d5-a258-4d0c-8072-d9e84028a144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_73c9e552-aadf-444e-afe0-0f8400478e24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_73c9e552-aadf-444e-afe0-0f8400478e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3ea849ed-f827-413a-911d-6d41f8ffc017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3ea849ed-f827-413a-911d-6d41f8ffc017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9bac7c76-3648-4e90-a867-0e7aa5c9c318" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9bac7c76-3648-4e90-a867-0e7aa5c9c318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_82180f75-4598-4496-a135-9cc6bb8f4af1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_327a4c16-d6d8-421f-99ff-c26e4724a23e" xlink:to="loc_us-gaap_OperatingLeaseLiability_82180f75-4598-4496-a135-9cc6bb8f4af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8adf175c-ae7d-47f6-8d5b-42379264c961" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8adf175c-ae7d-47f6-8d5b-42379264c961" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a094c1d3-df21-4ee2-9c54-7079d562d125" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_373b86a3-6961-4b74-9dd8-5a24c0379158" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_EquipmentMember_373b86a3-6961-4b74-9dd8-5a24c0379158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ca1ac72b-1aea-4e5d-9053-329341573316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ca1ac72b-1aea-4e5d-9053-329341573316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d92121d7-a9c8-41da-a697-9a665ae083d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_ComputerEquipmentMember_d92121d7-a9c8-41da-a697-9a665ae083d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_589301e5-0e81-4551-94a2-85b8d81c038f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96c558d6-1ad6-44b4-b352-eb9040db44e0" xlink:to="loc_us-gaap_ConstructionInProgressMember_589301e5-0e81-4551-94a2-85b8d81c038f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9442b0df-4350-4093-a399-678fb2e91be9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e50ef4ed-8eac-4318-8b4f-c8272690b801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e50ef4ed-8eac-4318-8b4f-c8272690b801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bcb8ee98-f464-4161-b520-af8a88d05f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bcb8ee98-f464-4161-b520-af8a88d05f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7e7fe22b-b9a3-4747-9697-80dce7c53b31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_63bf732f-4b28-4bfb-8223-78fce735bf7b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7e7fe22b-b9a3-4747-9697-80dce7c53b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_753cecb4-739d-489f-a992-e1fca4a96751" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_753cecb4-739d-489f-a992-e1fca4a96751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_20cf4085-44b9-4e72-89a5-bf423cda6c91" xlink:href="advm-20241231.xsd#advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent_20cf4085-44b9-4e72-89a5-bf423cda6c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_73af8616-7e39-4979-bae3-2c355e209971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_73af8616-7e39-4979-bae3-2c355e209971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_75b22aa8-07b8-4510-9856-27738a7c2361" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_us-gaap_TaxesPayableCurrent_75b22aa8-07b8-4510-9856-27738a7c2361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2e100ca6-9696-4103-9092-e1d7537cac86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2e100ca6-9696-4103-9092-e1d7537cac86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_d8758a85-c487-47e9-bd87-f8e833a87cbb" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_018111e0-cecc-48cb-9e3c-0f68390a7d25" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_d8758a85-c487-47e9-bd87-f8e833a87cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d95ab0cc-f514-422f-a0bd-3bddc11f7fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d95ab0cc-f514-422f-a0bd-3bddc11f7fe9" xlink:to="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:to="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_bb0d7de7-ccb8-48a8-bda4-69c1908b0b55" xlink:to="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RayTherapeuticsIncMember_290fb535-0ca8-48d8-8366-2d7e4f1ef7cb" xlink:href="advm-20241231.xsd#advm_RayTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:to="loc_advm_RayTherapeuticsIncMember_290fb535-0ca8-48d8-8366-2d7e4f1ef7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LexeoTherapeuticsIncMember_cd2e3c74-c351-469d-b9ee-42b5edd8b286" xlink:href="advm-20241231.xsd#advm_LexeoTherapeuticsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_0a219764-8ed0-4447-a034-51595ff1e08a" xlink:to="loc_advm_LexeoTherapeuticsIncMember_cd2e3c74-c351-469d-b9ee-42b5edd8b286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fd4b1a07-e684-431c-a40a-b3f4a86f7f2f" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ade4870-81d0-44ed-9b70-1b73e618fa35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_395ef22d-0d53-4367-b8d7-b27987cb9752" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ade4870-81d0-44ed-9b70-1b73e618fa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd2a089d-0097-489b-b084-ce7c25dd0692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd2a089d-0097-489b-b084-ce7c25dd0692" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2dbab063-89ed-4235-ad87-d8d298e6b736" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8323622e-c26b-45e7-b689-afc679823dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e91d4fa0-1ba8-40a2-b43a-b2de800ff28e" xlink:to="loc_us-gaap_PrivatePlacementMember_8323622e-c26b-45e7-b689-afc679823dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f5f9ab2d-d897-4c1f-9fea-8bc2e0ce4f1d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_PreFundedWarrantsMember_3cf857a5-5a67-474f-af02-f1fd31db9be7" xlink:href="advm-20241231.xsd#advm_PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b8489117-2a44-42bf-885b-ece3eb67ee09" xlink:to="loc_advm_PreFundedWarrantsMember_3cf857a5-5a67-474f-af02-f1fd31db9be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_4f399c01-b50c-4fbe-8201-33bd52fe8e1d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoDirectorsMember_c163677d-57a9-4661-acb5-3ebc42f77b1e" xlink:href="advm-20241231.xsd#advm_TwoDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_32e1a0e3-2daa-482e-9115-e7ff54e898b0" xlink:to="loc_advm_TwoDirectorsMember_c163677d-57a9-4661-acb5-3ebc42f77b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3aaad242-eb36-4fe3-b36e-f35986fe523b" xlink:to="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember_a97d7572-4bd2-4830-9728-79687f40f95e" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandAndFourteenEquityIncentivePlanMember_a97d7572-4bd2-4830-9728-79687f40f95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandSeventeenInducementPlanMember_7fc7f334-76ed-4be2-b89b-e19aaf3df373" xlink:href="advm-20241231.xsd#advm_TwoThousandSeventeenInducementPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandSeventeenInducementPlanMember_7fc7f334-76ed-4be2-b89b-e19aaf3df373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember_1e0ab450-e1fb-4759-9247-46bb4c1d9f5d" xlink:href="advm-20241231.xsd#advm_TwoThousandFourteenPlanAndInducementPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandFourteenPlanAndInducementPlanMember_1e0ab450-e1fb-4759-9247-46bb4c1d9f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_16ef85f7-4750-4058-bc2b-2517f62b514b" xlink:href="advm-20241231.xsd#advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember_16ef85f7-4750-4058-bc2b-2517f62b514b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_A2024EquityIncentiveAwardPlanMember_62373eab-bc08-44fa-bbb4-49b44f754f53" xlink:href="advm-20241231.xsd#advm_A2024EquityIncentiveAwardPlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_972ea926-0afa-409c-9b4d-72049e2c6058" xlink:to="loc_advm_A2024EquityIncentiveAwardPlanMember_62373eab-bc08-44fa-bbb4-49b44f754f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_13c5ca66-1756-4043-b4f1-2485fddb1301" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_StockOptionsAndRestrictedStockUnitsMember_66a0c240-ca27-4fe6-8344-41f49e9a1a3f" xlink:href="advm-20241231.xsd#advm_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_advm_StockOptionsAndRestrictedStockUnitsMember_66a0c240-ca27-4fe6-8344-41f49e9a1a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_170d181e-7003-4bce-bd5d-b816267f2d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_StockCompensationPlanMember_170d181e-7003-4bce-bd5d-b816267f2d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_39c85429-1d6c-4899-9f1b-b0792ba5fb75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_39c85429-1d6c-4899-9f1b-b0792ba5fb75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_72deb8a3-28e2-4194-9620-86b004b3fdc3" xlink:href="advm-20241231.xsd#advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember_72deb8a3-28e2-4194-9620-86b004b3fdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_10d1a7f2-4cc9-44ff-ae90-97ad1f77499c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b84e00e4-4ae3-46ce-973a-1bfd6c6d46b2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_10d1a7f2-4cc9-44ff-ae90-97ad1f77499c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c0f0cd09-87a7-4157-a513-1f2a7a63cbea" xlink:to="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6cfb90d0-9784-4cd4-a0ea-daaf5211920a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0ab6559-83fc-4b71-a94f-2ac5e707f2b0" xlink:to="loc_srt_MaximumMember_6cfb90d0-9784-4cd4-a0ea-daaf5211920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_39f27c22-7838-4a34-aa49-1d307a93f46f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b7d8b216-ad05-42fc-803a-672be4a63fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b7d8b216-ad05-42fc-803a-672be4a63fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7ff8ce23-f3f4-419e-ab83-c0e22c28b55e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7ff8ce23-f3f4-419e-ab83-c0e22c28b55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_cc197e4e-29fe-4dac-a676-8f7a1a7a2d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_cc197e4e-29fe-4dac-a676-8f7a1a7a2d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcd77ab0-c15f-44af-ac2b-b58446e6be74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bcd77ab0-c15f-44af-ac2b-b58446e6be74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_BeneficialOwnershipInterestLimitationPercent_dae0e0ba-9a12-401a-8219-20550d075db2" xlink:href="advm-20241231.xsd#advm_BeneficialOwnershipInterestLimitationPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_BeneficialOwnershipInterestLimitationPercent_dae0e0ba-9a12-401a-8219-20550d075db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClassOfWarrantOrRightWarrantsExercised_bdc9787d-f0a5-4d78-9098-bd39b19ba3a0" xlink:href="advm-20241231.xsd#advm_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ClassOfWarrantOrRightWarrantsExercised_bdc9787d-f0a5-4d78-9098-bd39b19ba3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors_3d2879b4-f690-49f3-9bf6-8dc0ab85f88d" xlink:href="advm-20241231.xsd#advm_SecuritiesPurchaseAgreementNumberOfDirectors"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_SecuritiesPurchaseAgreementNumberOfDirectors_3d2879b4-f690-49f3-9bf6-8dc0ab85f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4855fc0c-98ab-44c5-97fd-b77b16139d55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4855fc0c-98ab-44c5-97fd-b77b16139d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_57cd0265-9bdf-4dfa-aece-45d464ff014c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_57cd0265-9bdf-4dfa-aece-45d464ff014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_5fc5711e-2f8d-4260-9542-a24e1cde4f02" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan_5fc5711e-2f8d-4260-9542-a24e1cde4f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_946e1183-83c1-4a4a-a6f6-889854873297" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_946e1183-83c1-4a4a-a6f6-889854873297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4f99de3c-48a0-4199-a280-efde37e716b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4f99de3c-48a0-4199-a280-efde37e716b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_825133c2-4f1c-4dae-aed3-c0a2c3b7a429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_825133c2-4f1c-4dae-aed3-c0a2c3b7a429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8270bd16-0877-427f-87a6-32f640f1eedb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8270bd16-0877-427f-87a6-32f640f1eedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_373e1bde-debf-4958-853d-82807012f962" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum_373e1bde-debf-4958-853d-82807012f962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_648d3231-4423-4ef4-8248-cf689dd29611" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold_648d3231-4423-4ef4-8248-cf689dd29611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2de53ca1-fc97-4269-8280-062f8e8bd227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2de53ca1-fc97-4269-8280-062f8e8bd227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a098b515-32b1-4826-90cd-0162602a2df9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a098b515-32b1-4826-90cd-0162602a2df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84f4b3c1-17c1-43b0-9c7b-b3f49fa78a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_84f4b3c1-17c1-43b0-9c7b-b3f49fa78a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fb1c94ce-4cc7-4f5b-bc69-fe1eb6e73728" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fb1c94ce-4cc7-4f5b-bc69-fe1eb6e73728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4cd9b672-0c5c-4137-bae7-3319190ae26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4cd9b672-0c5c-4137-bae7-3319190ae26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f806d982-440b-4b4a-b9c6-7e98679a17bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f806d982-440b-4b4a-b9c6-7e98679a17bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3edcf690-383b-45fb-a866-2011144f5906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_3edcf690-383b-45fb-a866-2011144f5906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_7c9f630a-dc1e-48ea-a8d9-af6e538e0191" xlink:href="advm-20241231.xsd#advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage_7c9f630a-dc1e-48ea-a8d9-af6e538e0191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c4bcf7f9-f80c-45de-b2f8-a17d6201c6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c194762-eb34-44ad-af3f-4a5dfec50980" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c4bcf7f9-f80c-45de-b2f8-a17d6201c6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_901d3221-8643-4a37-942f-c248309e0863" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_901d3221-8643-4a37-942f-c248309e0863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f23108-2847-466f-bfb2-82e93bb16227" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f23108-2847-466f-bfb2-82e93bb16227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_27ac8bda-afb5-450e-be82-2a0b43f6b858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_27ac8bda-afb5-450e-be82-2a0b43f6b858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e96d533a-c7e8-4dec-b19e-04acdac94b93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e96d533a-c7e8-4dec-b19e-04acdac94b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_42ba9319-0798-49cd-b693-71d93996df49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a522d558-de60-42d1-aad1-ff2bde6c46d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_42ba9319-0798-49cd-b693-71d93996df49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_d7068bf8-fbd6-4dba-b827-7c6ce383ef5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_d7068bf8-fbd6-4dba-b827-7c6ce383ef5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6d5d5123-2989-44c6-862e-f2ac574a7f96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6d5d5123-2989-44c6-862e-f2ac574a7f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6a6b25c4-1657-4f28-8592-d8d4152dd6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6a6b25c4-1657-4f28-8592-d8d4152dd6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8fcd1524-697e-4a6a-97ca-8c970959a473" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8fcd1524-697e-4a6a-97ca-8c970959a473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20096f1d-db29-4578-9fd8-3f3fa39442e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20096f1d-db29-4578-9fd8-3f3fa39442e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d84c4378-6864-4c72-b5d6-f6f9b4453a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d84c4378-6864-4c72-b5d6-f6f9b4453a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0e74ccc-8c4f-4f31-834e-08e4935e477e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1b4eb0dd-8fde-4fe2-a2bc-30b3982f2692" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f0e74ccc-8c4f-4f31-834e-08e4935e477e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_72440794-348c-49cf-94a0-8719a975fa36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_72440794-348c-49cf-94a0-8719a975fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ddd80b2d-1ac2-4fd5-ad88-e4f311a8d53a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ddd80b2d-1ac2-4fd5-ad88-e4f311a8d53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c31dd291-f076-4204-a9c8-47a7496b28d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c31dd291-f076-4204-a9c8-47a7496b28d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c6f7341f-fbea-424a-a256-ae535cc15db9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c31dd291-f076-4204-a9c8-47a7496b28d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c6f7341f-fbea-424a-a256-ae535cc15db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9f34e58c-6a48-4a0f-bdcd-c4d2c2a63fef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c31dd291-f076-4204-a9c8-47a7496b28d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9f34e58c-6a48-4a0f-bdcd-c4d2c2a63fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_49045620-88a1-46d2-8dd9-b81973afab33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_c31dd291-f076-4204-a9c8-47a7496b28d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_49045620-88a1-46d2-8dd9-b81973afab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17545ad1-57a3-4763-b743-447141a40d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17545ad1-57a3-4763-b743-447141a40d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afd682c3-3278-4976-8db6-8a87da877990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_afd682c3-3278-4976-8db6-8a87da877990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7568170d-35f0-45e0-91a3-202c1961eb29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9e7a0baf-6007-4614-bd26-b8359cf338be" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7568170d-35f0-45e0-91a3-202c1961eb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bea95a2d-6701-4083-b164-785b1ea99268" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bea95a2d-6701-4083-b164-785b1ea99268" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:to="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_852b05fb-e7b8-4186-a226-6f55e05c98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_de73dac6-bcba-4f06-bea3-9f6464b13c35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_de73dac6-bcba-4f06-bea3-9f6464b13c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_698d7f2a-d3ca-4e49-891c-7db62b6bf443" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_724e95c9-88fc-47d6-9d84-48612ce2e69c" xlink:to="loc_us-gaap_EmployeeStockMember_698d7f2a-d3ca-4e49-891c-7db62b6bf443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e053e21-d2d4-4222-8560-3b740b2536bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03ece3a9-08af-4f16-9157-5194d9ac30de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_03ece3a9-08af-4f16-9157-5194d9ac30de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e495d1b3-f722-4704-97cf-00efe0cfc15d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e495d1b3-f722-4704-97cf-00efe0cfc15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36c7ed97-88a8-4ed8-b8e4-3ea2b6f6c02b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36c7ed97-88a8-4ed8-b8e4-3ea2b6f6c02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e6f04351-10bd-49f3-b40d-d0f06d5f3af7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_888e2e7c-8ba4-48ea-80af-a662da7037a2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_e6f04351-10bd-49f3-b40d-d0f06d5f3af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9fd9d91-379a-4e30-acb0-9d8b72cf893c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9fd9d91-379a-4e30-acb0-9d8b72cf893c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:to="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_aab3d1d5-9b4a-47ea-9fb2-0bd1b19c979c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2af0bfb2-c084-4b52-95b4-f38af5bc4260" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ad006c6c-b161-4cc3-a01d-9591f4619fce" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2af0bfb2-c084-4b52-95b4-f38af5bc4260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c3cb399-c3b5-423c-8273-2d61b8f7ac73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b62aedbf-5819-495d-a31f-821e77332d55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b62aedbf-5819-495d-a31f-821e77332d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99ad8480-df83-4226-bcf7-5917c8b5784d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99ad8480-df83-4226-bcf7-5917c8b5784d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_24640981-e799-4329-9c37-b69f69921535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_24640981-e799-4329-9c37-b69f69921535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08b65c5b-d3a0-4271-bebb-29a7c53b1ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08b65c5b-d3a0-4271-bebb-29a7c53b1ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db4fe2fa-93d8-415e-90cd-1fd9bcdd8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9b89a30c-4c0c-4a24-b0ef-f60300bf370d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db4fe2fa-93d8-415e-90cd-1fd9bcdd8c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ccdb8f11-c825-4561-bf9a-2add3315d459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ccdb8f11-c825-4561-bf9a-2add3315d459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7dcad4e5-7704-4084-9a1a-f191b2335f46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7dcad4e5-7704-4084-9a1a-f191b2335f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1fe350ab-e6ad-4b01-98e4-7dd10ca2c97b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1fe350ab-e6ad-4b01-98e4-7dd10ca2c97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bf0505fc-e39b-45c9-8229-80338444901f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bf0505fc-e39b-45c9-8229-80338444901f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59126faf-01ef-40a5-b69a-0e49075f2b80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6aa0f5c5-ed68-4837-a12e-7165c66ce554" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59126faf-01ef-40a5-b69a-0e49075f2b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e7cd7cd-b9d4-4b6e-a437-669766009d35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c8aee6a9-2dc3-427e-9361-1d88c2741b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_149ac4f1-d80d-4ff9-9a55-6c6a669de54b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_c8aee6a9-2dc3-427e-9361-1d88c2741b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_810713de-23a0-4e78-966e-ab432911410b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_810713de-23a0-4e78-966e-ab432911410b" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98915906-6733-49eb-8778-3e2fa8a19d99" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f42df903-b157-4dad-864a-772fff3b4ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f42df903-b157-4dad-864a-772fff3b4ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3695aa4b-609e-4957-9c80-52d507d3dea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b493f504-2a4b-46b1-aa4e-c68e8f38f3b0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3695aa4b-609e-4957-9c80-52d507d3dea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f12cd36f-d1ca-4fbc-9f79-62fc69d8f966" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ed25da29-66e8-4c50-8ec8-2f8a133d6b76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5965745f-4722-443f-a8bb-781d62194091" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ed25da29-66e8-4c50-8ec8-2f8a133d6b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/A401kSavingsPlanDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#A401kSavingsPlanDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/A401kSavingsPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2b1d6a8-f0a6-4b59-9c27-165ba8b2c225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f0e66f9c-2db1-4bc5-823f-7f692012b8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2b1d6a8-f0a6-4b59-9c27-165ba8b2c225" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_f0e66f9c-2db1-4bc5-823f-7f692012b8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1b46522c-0b33-401b-b42a-3dfc0db4b755" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1b46522c-0b33-401b-b42a-3dfc0db4b755" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6672fe8f-271a-4808-b9f8-3d5cdff7b37b" xlink:to="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReportableSegmentMember_9bcfe7fe-21bc-4918-8e2e-303836186b3b" xlink:href="advm-20241231.xsd#advm_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b34abbb6-6f59-4b4f-acd0-a1b286886aaf" xlink:to="loc_advm_ReportableSegmentMember_9bcfe7fe-21bc-4918-8e2e-303836186b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94999ae5-c7a2-4217-92c6-0e3490c873b4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a263a5bb-203a-450b-a0b3-df52424cec71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_NumberOfReportableSegments_a263a5bb-203a-450b-a0b3-df52424cec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce682d76-51f8-4c8b-848a-0506fb92d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ce682d76-51f8-4c8b-848a-0506fb92d15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_e2fa4859-b1ad-4198-b5a1-17c0fc0714b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_LaborAndRelatedExpense_e2fa4859-b1ad-4198-b5a1-17c0fc0714b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ClinicalTrialExpenses_91fae1d0-2ca4-4789-92d7-51fc600e81d3" xlink:href="advm-20241231.xsd#advm_ClinicalTrialExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_advm_ClinicalTrialExpenses_91fae1d0-2ca4-4789-92d7-51fc600e81d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_948de696-a852-4ea6-97b5-71173fab03a1" xlink:href="advm-20241231.xsd#advm_AllocatedFacilitiesAndInformationTechnologyExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_advm_AllocatedFacilitiesAndInformationTechnologyExpenses_948de696-a852-4ea6-97b5-71173fab03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_66b2f68d-d2e9-4d68-a19e-7f14836a5f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_66b2f68d-d2e9-4d68-a19e-7f14836a5f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_53a86a2e-45b4-41da-982c-db3825ffd275" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0a129041-d59e-4ac3-89c1-8ee985596ac2" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_53a86a2e-45b4-41da-982c-db3825ffd275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b6f9fba2-e25b-4567-90b0-0546ace4b543" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OperatingExpenses_b6f9fba2-e25b-4567-90b0-0546ace4b543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0a45f328-5a78-4093-9d1e-36b972f2a3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OperatingIncomeLoss_0a45f328-5a78-4093-9d1e-36b972f2a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_56386b80-9e52-4705-a8b9-6a2b96a1338f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_56386b80-9e52-4705-a8b9-6a2b96a1338f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3860531-e10b-4f75-919e-354c295048bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a3860531-e10b-4f75-919e-354c295048bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dce069f5-42da-4f9f-b39b-e3e290f5c608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dce069f5-42da-4f9f-b39b-e3e290f5c608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_118a3009-7685-4f04-add9-16335fd7252d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_99717871-8439-448d-a680-36171214ccf9" xlink:to="loc_us-gaap_NetIncomeLoss_118a3009-7685-4f04-add9-16335fd7252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e3c7c804-eec5-45b9-abf1-6470b793d1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2b409053-d8ba-4d66-b34b-55a5fbecd05f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3c7c804-eec5-45b9-abf1-6470b793d1e6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2b409053-d8ba-4d66-b34b-55a5fbecd05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_eff33df6-f2c2-4d9d-86f7-a942bb15db19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3c7c804-eec5-45b9-abf1-6470b793d1e6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_eff33df6-f2c2-4d9d-86f7-a942bb15db19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cff71cff-3239-4fff-a40d-a6bc3f1bd69a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3c7c804-eec5-45b9-abf1-6470b793d1e6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cff71cff-3239-4fff-a40d-a6bc3f1bd69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b6ffc997-d240-457d-9336-ee939a93ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_122018b0-39ad-43ad-bd3a-f99db466c280" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b6ffc997-d240-457d-9336-ee939a93ab5b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_122018b0-39ad-43ad-bd3a-f99db466c280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8e5909ba-ef11-4e1e-8c90-3f252a2e9213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_122018b0-39ad-43ad-bd3a-f99db466c280" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8e5909ba-ef11-4e1e-8c90-3f252a2e9213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e328414b-1155-4bef-a98b-756092e97336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_122018b0-39ad-43ad-bd3a-f99db466c280" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e328414b-1155-4bef-a98b-756092e97336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_59534eba-9534-4787-a93d-7ad05e06428a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b6ffc997-d240-457d-9336-ee939a93ab5b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_59534eba-9534-4787-a93d-7ad05e06428a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_29ea3125-8d54-4303-a05e-d528eb0cb685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_59534eba-9534-4787-a93d-7ad05e06428a" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_29ea3125-8d54-4303-a05e-d528eb0cb685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58561b27-4933-4784-a94a-1ac6da377fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_59534eba-9534-4787-a93d-7ad05e06428a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58561b27-4933-4784-a94a-1ac6da377fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b9de1b8-1173-4e19-96a3-027fcf5e4ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b6ffc997-d240-457d-9336-ee939a93ab5b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b9de1b8-1173-4e19-96a3-027fcf5e4ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c441035e-c753-4359-8fc5-2bac2c14e521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c441035e-c753-4359-8fc5-2bac2c14e521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_d5afb7a3-9c94-4a7e-bb45-f704bad4b5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_d5afb7a3-9c94-4a7e-bb45-f704bad4b5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_bbddc377-2455-41dc-a7d3-1cd1925e004b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_bbddc377-2455-41dc-a7d3-1cd1925e004b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1f46b784-2223-4a78-a789-75e6782e5cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1f46b784-2223-4a78-a789-75e6782e5cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0e20165d-23a5-4bf5-a5b3-39ef7ce62377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0e20165d-23a5-4bf5-a5b3-39ef7ce62377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_31ec552c-2d6e-4368-a647-6abd04c629ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_31ec552c-2d6e-4368-a647-6abd04c629ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_f4796a07-c623-4e89-aec1-621366e6ec6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_f4796a07-c623-4e89-aec1-621366e6ec6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_5f11432f-6c3c-4695-967f-6188d2353e3c" xlink:href="advm-20241231.xsd#advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition_5f11432f-6c3c-4695-967f-6188d2353e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_82893bb1-38bb-4997-847b-1279ad6908f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_82893bb1-38bb-4997-847b-1279ad6908f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9509325d-0548-463f-ae67-64893d3314c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_57cf8854-4103-4240-8440-57cd01b90830" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9509325d-0548-463f-ae67-64893d3314c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b981b62a-2e7b-43ec-921e-227b020de92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b981b62a-2e7b-43ec-921e-227b020de92a" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4a0e8496-f99c-4af5-af89-d0781c04e956" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4a0e8496-f99c-4af5-af89-d0781c04e956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4e19c1b6-5865-4274-82a6-57221a4076cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4e19c1b6-5865-4274-82a6-57221a4076cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_c3035648-0c0e-4190-b570-a01633574763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_c3035648-0c0e-4190-b570-a01633574763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4630da25-0a88-40df-bfe1-a1e7b061ae8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4630da25-0a88-40df-bfe1-a1e7b061ae8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_c45b06bd-9fa3-446f-9da2-94b09411b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_c45b06bd-9fa3-446f-9da2-94b09411b13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsLeaseObligation_78135cd5-b2e2-4390-903b-08ba2706f956" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsLeaseObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_advm_DeferredTaxAssetsLeaseObligation_78135cd5-b2e2-4390-903b-08ba2706f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_ad2295ac-e1b4-42a3-a5b1-503ba307f379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_ad2295ac-e1b4-42a3-a5b1-503ba307f379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_DeferredTaxAssetsCapitalizedCosts_e921f694-923d-4178-950c-036252b7a139" xlink:href="advm-20241231.xsd#advm_DeferredTaxAssetsCapitalizedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_advm_DeferredTaxAssetsCapitalizedCosts_e921f694-923d-4178-950c-036252b7a139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5cee5489-3b33-4e5c-895d-93bc5c0c913f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5cee5489-3b33-4e5c-895d-93bc5c0c913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7de45add-0cf6-44ca-b595-a22d6c93c937" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7de45add-0cf6-44ca-b595-a22d6c93c937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d269e79a-b26d-44f3-955d-7a447c41df66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d269e79a-b26d-44f3-955d-7a447c41df66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_094934bc-a657-46f7-9721-c0207dedef04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e617d3e5-2273-48d6-a11c-b9161873f88a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_094934bc-a657-46f7-9721-c0207dedef04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_fba39039-8872-4b83-b4c8-2c6b8de85f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b981b62a-2e7b-43ec-921e-227b020de92a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_fba39039-8872-4b83-b4c8-2c6b8de85f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_269dad1d-8a2e-4c96-b6ef-34b48afdb478" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_fba39039-8872-4b83-b4c8-2c6b8de85f57" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_269dad1d-8a2e-4c96-b6ef-34b48afdb478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_eb411577-d981-4698-937e-0d6274a1649b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_fba39039-8872-4b83-b4c8-2c6b8de85f57" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_eb411577-d981-4698-937e-0d6274a1649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7bf8cc6a-07fd-4789-9a53-e89007625273" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_fba39039-8872-4b83-b4c8-2c6b8de85f57" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_7bf8cc6a-07fd-4789-9a53-e89007625273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1cf6af8c-18a4-4dfd-aafa-11c8bb552229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b981b62a-2e7b-43ec-921e-227b020de92a" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1cf6af8c-18a4-4dfd-aafa-11c8bb552229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ae0c7176-470d-4c81-9e07-857f7acded58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:href="advm-20241231.xsd#advm_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae0c7176-470d-4c81-9e07-857f7acded58" xlink:to="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_da6241fb-811b-4a3c-b562-291b56801d82" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_f7ae5411-3075-446c-a0cb-305aa0dbffe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_DomesticCountryMember_f7ae5411-3075-446c-a0cb-305aa0dbffe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_a3fbbdd7-a719-4f1d-8a0c-a3ab0519116e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_a3fbbdd7-a719-4f1d-8a0c-a3ab0519116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_f0ae5856-90b6-49a1-81dc-7e827186cc24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_0bd72b4b-7c00-4c1e-bafb-4f0e4ed51701" xlink:to="loc_us-gaap_ForeignCountryMember_f0ae5856-90b6-49a1-81dc-7e827186cc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_d1e173a0-a496-49c6-9a90-c6a14450c0cb" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_0a49fcbc-be54-48c0-b2dd-563fcf87d936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_752e56c5-fb3c-4707-ae1b-15e7393b16c4" xlink:to="loc_us-gaap_ResearchMember_0a49fcbc-be54-48c0-b2dd-563fcf87d936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_06ba567f-0332-44e0-9cc9-2e909a930553" xlink:to="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_b58da6aa-92c9-4b8e-94e8-91c6369ff10b" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d78b487a-4d28-4bf7-bd1a-76d7b619dec6" xlink:to="loc_stpr_CA_b58da6aa-92c9-4b8e-94e8-91c6369ff10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:href="advm-20241231.xsd#advm_IncomeTaxesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesTable_305bd478-f772-4e05-8174-85dbd3902394" xlink:to="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ac87805b-9b69-4013-8f3f-42c4366168b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ac87805b-9b69-4013-8f3f-42c4366168b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_132dd23e-ae94-4a13-84de-b6780aad74a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_132dd23e-ae94-4a13-84de-b6780aad74a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8931354-f758-47e0-98a7-05eea2d85b73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8931354-f758-47e0-98a7-05eea2d85b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8db338ac-e844-45a9-a575-6d1261ecc579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8db338ac-e844-45a9-a575-6d1261ecc579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_OperatingLossCarryforwardsSubjectToExpiration_dfad329d-57dc-4485-9f35-91964eb56a97" xlink:href="advm-20241231.xsd#advm_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_advm_OperatingLossCarryforwardsSubjectToExpiration_dfad329d-57dc-4485-9f35-91964eb56a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_56f62005-6dd6-474e-99a6-86e24ab0139f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_56f62005-6dd6-474e-99a6-86e24ab0139f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8a893914-0bae-4f9c-a6c5-9fbf65698678" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8a893914-0bae-4f9c-a6c5-9fbf65698678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f19433e7-bcac-4b1b-ad04-ea571b129507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_f19433e7-bcac-4b1b-ad04-ea571b129507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a3fd6017-c666-401f-b6ed-d8f3fd6ec884" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_advm_IncomeTaxesLineItems_5fb82eda-42d1-4190-95a2-cc5672eda00b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a3fd6017-c666-401f-b6ed-d8f3fd6ec884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_171c5c8d-4f8d-4385-8cd0-78d3fb953267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_171c5c8d-4f8d-4385-8cd0-78d3fb953267" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_016bf9f8-1add-4bfb-8637-db4c072df63f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_016bf9f8-1add-4bfb-8637-db4c072df63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_26a35d05-cc16-4c43-afec-2b9492d00da6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_26a35d05-cc16-4c43-afec-2b9492d00da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a22e815d-5e08-47aa-99e1-26dc6295a546" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a22e815d-5e08-47aa-99e1-26dc6295a546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_60f7b38f-ebc2-49eb-a867-28f0d9b3bc64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_60f7b38f-ebc2-49eb-a867-28f0d9b3bc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_097a2402-853f-42a9-9c68-cdd458109d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_097a2402-853f-42a9-9c68-cdd458109d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9cb735ca-fff2-42b3-be3b-eb049937fa0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_67900123-a9b2-4fc2-9ddc-1d3498f311e1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9cb735ca-fff2-42b3-be3b-eb049937fa0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/NetLossperShareDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#NetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/NetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b21cfd56-dd31-48f0-925a-9b698b7373bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b21cfd56-dd31-48f0-925a-9b698b7373bc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b5c006d2-2a57-4169-b904-f04fd097528a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a073d792-32b6-473c-8475-0e8b26e8f366" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a073d792-32b6-473c-8475-0e8b26e8f366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d148c0b8-20ef-4da2-a86c-2aec5daf86d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d148c0b8-20ef-4da2-a86c-2aec5daf86d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_271ac199-3068-43ee-ba0a-f1e1b7360811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e4be4db9-f4cd-45d1-b075-f91bd1f03f2f" xlink:to="loc_us-gaap_EmployeeStockMember_271ac199-3068-43ee-ba0a-f1e1b7360811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a540d4fa-6262-4e8d-bfbe-2df8fd828345" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2b80e2ff-2fa6-4146-8b45-ad74969914fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c0371465-72e5-4720-b17c-1c22dab31977" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2b80e2ff-2fa6-4146-8b45-ad74969914fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_b3b74b39-d786-486f-96ca-b2587d3d35d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_b3b74b39-d786-486f-96ca-b2587d3d35d0" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:to="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_ef79a3f2-7028-4e56-a29f-3ec5136df7ff" xlink:to="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_fa80d4a2-f2ce-4ec8-bd7d-9bbf0260f629" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0196ae49-35fa-4c25-b084-3399d79de9f0" xlink:to="loc_srt_RestatementAdjustmentMember_fa80d4a2-f2ce-4ec8-bd7d-9bbf0260f629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_6cd9fe6a-2446-482e-8f13-1c746a3624ce" xlink:to="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_RedwoodCaliforniaFacilityLeaseMember_bb71c8ae-2d1c-40e2-a74a-82b2518ab4bf" xlink:href="advm-20241231.xsd#advm_RedwoodCaliforniaFacilityLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_79834328-65a0-4591-9064-359dc99584bd" xlink:to="loc_advm_RedwoodCaliforniaFacilityLeaseMember_bb71c8ae-2d1c-40e2-a74a-82b2518ab4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f207b5d1-053f-4d71-93fe-22298c257e9e" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_1b5b21d2-8dc6-45da-8e78-8cdc6500646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_1b5b21d2-8dc6-45da-8e78-8cdc6500646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_10f86aab-09c6-47a2-a753-d1b809b67a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_10f86aab-09c6-47a2-a753-d1b809b67a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2fabee18-4796-4ec5-81cb-19a3b36c6c01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2fabee18-4796-4ec5-81cb-19a3b36c6c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d661456a-d2a0-4c0f-b27f-9358a23e8a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_42ce0c4f-608f-42c7-86bd-50d5394a0d6e" xlink:to="loc_us-gaap_OperatingLeaseLiability_d661456a-d2a0-4c0f-b27f-9358a23e8a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_97c69a57-a8d8-4273-8bbb-10162f985100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_97c69a57-a8d8-4273-8bbb-10162f985100" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:to="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_c90822c5-5512-4a91-8d22-e6532986576b" xlink:to="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c0486d5f-0b5e-418f-8b56-f0aa809f9ce2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c0486d5f-0b5e-418f-8b56-f0aa809f9ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_8034fb7a-8c7c-4d75-b496-0e5f962156ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0a0308f3-e230-4725-80e2-9be8be166884" xlink:to="loc_srt_RestatementAdjustmentMember_8034fb7a-8c7c-4d75-b496-0e5f962156ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c0a281a4-a9b5-41b2-83b6-82c342604516" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cb8956c-5623-4c79-b78e-35abffcac0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cb8956c-5623-4c79-b78e-35abffcac0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_61cebc69-333c-4a95-acfe-5e579643d1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_ShortTermInvestments_61cebc69-333c-4a95-acfe-5e579643d1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_824c01fa-2ed8-46fe-8a58-9da3a0d1ccef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_824c01fa-2ed8-46fe-8a58-9da3a0d1ccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d73d5c20-bab6-4028-82df-6b58f5fc67b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bbcfa41e-a411-4b9f-88a4-f2986684f8f4" xlink:to="loc_us-gaap_AssetsCurrent_d73d5c20-bab6-4028-82df-6b58f5fc67b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_aae9ee15-c066-4a68-80e8-026fd3e0a064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_aae9ee15-c066-4a68-80e8-026fd3e0a064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0a8b123e-d387-4162-abf9-a6b09dbc49de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0a8b123e-d387-4162-abf9-a6b09dbc49de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentReceivablesNet_eab1304d-381d-42f3-8aa3-7eefb37d0d79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRentReceivablesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_DeferredRentReceivablesNet_eab1304d-381d-42f3-8aa3-7eefb37d0d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7f2ae2d4-2d41-4053-9146-ea7f4222dde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7f2ae2d4-2d41-4053-9146-ea7f4222dde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d259d907-0cdd-4aa8-af1d-43f3822a9e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d259d907-0cdd-4aa8-af1d-43f3822a9e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e663148a-0a3b-47bf-9001-d8dcdd241f16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8f7b9f74-b653-4e52-8287-d15758fe0a85" xlink:to="loc_us-gaap_Assets_e663148a-0a3b-47bf-9001-d8dcdd241f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_88004338-eb94-4d02-908e-0a903924a26e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_AccountsPayableCurrent_88004338-eb94-4d02-908e-0a903924a26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_266b5a36-4ac0-44d2-9f28-714e6b3a06fe" xlink:href="advm-20241231.xsd#advm_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_advm_AccruedExpensesAndOtherCurrentLiabilities_266b5a36-4ac0-44d2-9f28-714e6b3a06fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_32711f5f-5db1-4664-b185-092bf14614c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_32711f5f-5db1-4664-b185-092bf14614c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1fccedaa-f682-48d7-8024-4ec441eba529" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9d599c8b-fa6b-4c11-9d7f-74da4f0844c7" xlink:to="loc_us-gaap_LiabilitiesCurrent_1fccedaa-f682-48d7-8024-4ec441eba529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a12ae053-5bf7-4148-9ec8-af94da3623e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a12ae053-5bf7-4148-9ec8-af94da3623e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_cb874fa3-947a-44c1-bd31-54fd9cc3c782" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_97d83c96-7538-4995-87b8-fee5a9ad205f" xlink:to="loc_us-gaap_Liabilities_cb874fa3-947a-44c1-bd31-54fd9cc3c782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e76ef472-bfa4-453b-9cb5-ec2db3ec7d74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e76ef472-bfa4-453b-9cb5-ec2db3ec7d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_367892b7-7521-4a83-abd5-f89df59761bf" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2a6fcb83-5b22-468b-879c-cb45da393bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_PreferredStockValue_2a6fcb83-5b22-468b-879c-cb45da393bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_650b4460-358a-4738-b4e1-d521e6ffad80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_CommonStockValue_650b4460-358a-4738-b4e1-d521e6ffad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9d3d2df9-2741-4183-851e-3bf0122cd6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9d3d2df9-2741-4183-851e-3bf0122cd6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_502022d0-6115-4472-b200-f6b017853b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_502022d0-6115-4472-b200-f6b017853b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3feb8746-64ab-4186-a6cc-9ef434b55342" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3feb8746-64ab-4186-a6cc-9ef434b55342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_13a0294f-59db-4e69-8f46-dbeaf3aac83d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9ef96539-29ab-459d-9d86-a8387f190c06" xlink:to="loc_us-gaap_StockholdersEquity_13a0294f-59db-4e69-8f46-dbeaf3aac83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5cb68de-5512-4667-a6b2-8bf74af62c06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_32d6194c-72a9-4b72-b12b-00b71a0d367a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a5cb68de-5512-4667-a6b2-8bf74af62c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_bda67030-cb67-4062-8e68-07c15d0e4a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_bda67030-cb67-4062-8e68-07c15d0e4a00" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:to="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_df1a5b55-f9bc-4e30-a949-2c3546d624f5" xlink:to="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_aaf62875-4d23-4b6c-87b9-fc12d19ab025" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_aaf62875-4d23-4b6c-87b9-fc12d19ab025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_84eba175-bab7-4a55-98f6-d7ddebb4f79d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7e21967a-1f52-4911-bbd3-b4e3a34a3552" xlink:to="loc_srt_RestatementAdjustmentMember_84eba175-bab7-4a55-98f6-d7ddebb4f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c4f7d44d-7e45-40a4-ba42-2bdc0aa3b5fa" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_4e9711c9-8769-4384-9266-747b10716a0d" xlink:to="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a858d1af-fdbf-451d-a268-ab3996891351" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a858d1af-fdbf-451d-a268-ab3996891351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94b5fc49-c8c2-406f-aede-0784b7ec3136" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94b5fc49-c8c2-406f-aede-0784b7ec3136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1a24e8c9-ab02-4e63-96b6-44ac4e609146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1a24e8c9-ab02-4e63-96b6-44ac4e609146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d7973e36-871b-48b8-85ad-0fc2d5dfa693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a59ce836-d1ff-40cb-94f1-640f8e8e9461" xlink:to="loc_us-gaap_OperatingExpenses_d7973e36-871b-48b8-85ad-0fc2d5dfa693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b7694fa-19bd-4ae9-80e2-ab1476306059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OperatingIncomeLoss_0b7694fa-19bd-4ae9-80e2-ab1476306059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_70bbc067-aa1f-4a78-8ad8-16270abf831c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_70bbc067-aa1f-4a78-8ad8-16270abf831c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96d1ada1-1343-4e8f-b729-8213a40e6b10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96d1ada1-1343-4e8f-b729-8213a40e6b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_04f7b741-3c4e-4a33-95b5-89b5cdc51e57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_04f7b741-3c4e-4a33-95b5-89b5cdc51e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c074bbc-3809-4a2b-9eff-e46581cdb047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_NetIncomeLoss_2c074bbc-3809-4a2b-9eff-e46581cdb047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_84674cba-303f-41b0-b600-06f6ba2afea2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_84674cba-303f-41b0-b600-06f6ba2afea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_042d09c2-c4ec-4c34-89f6-a3aec93e5cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_b76919a7-011e-43e9-b617-ca527cf335fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_042d09c2-c4ec-4c34-89f6-a3aec93e5cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b0ab022-5ea2-4aad-a6ef-90bd15034eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b0ab022-5ea2-4aad-a6ef-90bd15034eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0488128b-19bc-4bf1-8ada-61f3708f1ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_EarningsPerShareBasic_0488128b-19bc-4bf1-8ada-61f3708f1ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_460c0d7b-7aee-4460-9b75-86519c1d4323" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_EarningsPerShareDiluted_460c0d7b-7aee-4460-9b75-86519c1d4323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4db13e70-033a-427b-89b3-3045670b373d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4db13e70-033a-427b-89b3-3045670b373d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f928315e-9263-40fc-a7f8-685add5599ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197b590-d00c-415d-9b44-a6964f033afe" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f928315e-9263-40fc-a7f8-685add5599ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_508b637e-c653-428a-bebb-63b23789fc78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_508b637e-c653-428a-bebb-63b23789fc78" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:to="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_e681a69b-8d20-4d9e-97af-fcd7fcdf921b" xlink:to="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_106eeef1-1d64-4c73-b5a1-c1cdf69fd8c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_106eeef1-1d64-4c73-b5a1-c1cdf69fd8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_7cde98d0-fa96-494f-9fb8-44692b58a29f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_26af1b7c-d682-45e9-8ca6-9c88e992bf5f" xlink:to="loc_srt_RestatementAdjustmentMember_7cde98d0-fa96-494f-9fb8-44692b58a29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_f09602fd-7061-4505-84e2-38665414a238" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a074fb57-f3e7-4ce7-8b08-2ad426a0eb8f" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_834366d5-d2df-46c5-97b3-6fff9fa4c39a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:to="loc_us-gaap_NetIncomeLoss_834366d5-d2df-46c5-97b3-6fff9fa4c39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_09414ebb-ecae-452a-990f-5b82776b235d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_36efcbcc-af04-49d7-8590-250749ca2d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_36efcbcc-af04-49d7-8590-250749ca2d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_NonCashSubleaseLossIncome_dd519975-3708-47a8-8cdf-f2afb3a67487" xlink:href="advm-20241231.xsd#advm_NonCashSubleaseLossIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b1986a62-2d7a-428e-9e36-ac86a4c68560" xlink:to="loc_advm_NonCashSubleaseLossIncome_dd519975-3708-47a8-8cdf-f2afb3a67487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_66eebf1f-f08a-4bf0-856f-80c3aff89225" xlink:href="advm-20241231.xsd#advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:to="loc_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets_66eebf1f-f08a-4bf0-856f-80c3aff89225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17c66c23-4df2-4ad2-8428-91b2ef08dce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f151faae-1815-485c-aa8a-9bcec486b122" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_17c66c23-4df2-4ad2-8428-91b2ef08dce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c1df6323-57bc-4825-a57c-8a2f2b620c2e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_1d9c9c0a-7aa1-4315-9b1e-7be482b8c30b" xlink:href="advm-20241231.xsd#advm_ReMeasurementOfOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_45bfbbdc-ab06-4a2d-99b7-a841264f492d" xlink:to="loc_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets_1d9c9c0a-7aa1-4315-9b1e-7be482b8c30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.adverum.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="advm-20241231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.adverum.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_6b1effa6-68b0-44cc-97eb-ed9fe58b7aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_6b1effa6-68b0-44cc-97eb-ed9fe58b7aee" xlink:to="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_15970fb8-e8f8-486f-8553-a65c450c6b2f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fba4e270-7e7c-426b-bb93-a9a35eec031a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cdc58091-25d3-4693-82dc-cada49676fd1" xlink:to="loc_us-gaap_SubsequentEventMember_fba4e270-7e7c-426b-bb93-a9a35eec031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ed345703-77de-4c40-926e-d9f8db84d320" xlink:to="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_854bb74c-1d67-4520-8493-bd1c3eaa0526" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_NC"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ed7113c-b912-460a-a67d-55e7d3fd0aa0" xlink:to="loc_stpr_NC_854bb74c-1d67-4520-8493-bd1c3eaa0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ca1cc85c-4e04-4caf-b5ac-ca4878b2cd79" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_70d57703-b097-486d-989e-4b98cbda884f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2cba0af8-4627-42db-a1fb-ea255fd369ba" xlink:to="loc_us-gaap_ManufacturingFacilityMember_70d57703-b097-486d-989e-4b98cbda884f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1a340d6c-6f8b-43b3-a952-dc246789d521" xlink:to="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_86eae42d-c74f-4ac5-b78f-7614441179c1" xlink:href="advm-20241231.xsd#advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_528e9683-7465-4e11-98aa-381d6a8a4108" xlink:to="loc_advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember_86eae42d-c74f-4ac5-b78f-7614441179c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8b94c791-baa3-4a87-9dbe-aa982e2e7912" xlink:to="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c0e6ee31-2bb9-429f-8910-32288be61f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c0e6ee31-2bb9-429f-8910-32288be61f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_85fb274e-6fec-4752-875e-0f8f2af1dc54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_PaymentsForRent_85fb274e-6fec-4752-875e-0f8f2af1dc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0da9bdbc-1d46-4397-922b-ee0339a737fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0da9bdbc-1d46-4397-922b-ee0339a737fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7a884fb3-7bb6-48db-a32f-13ca3f300271" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_157150ad-682f-4a20-990c-3d1e7a160088" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7a884fb3-7bb6-48db-a32f-13ca3f300271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>advm-20241231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +2!1X# 2(  A$! Q$!_\0
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M;?$[]H;Q/I>GV!U'P3#IINK"'SKF+YPUNI.2RR=7DX8]_I4'[>/_ "5S2/\
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M6RW+98''5L/7M*U-M=NFNI\05[I^R;\,?#GQ.\5:W;>)+!M1MK6S62*$3R1
M,7 R2C GCWQS7A=?3W[!_P#R.?B;_L'I_P"C!6M5M0;1\_DM.%;,*4*D4TWL
M]5LSM/$'@O\ 9L\,^)KCP[JL$>GZO"RI)'+<:@%C+*&&9-VSH0>N.:P?BA^R
M#HMYX8E\1_#J_>Z00_:$L3,+B*XC S^YD'.<9(!+9/&17D'[4O\ R7KQ7_UT
M@_\ 2>*O=/V$?$UW>:#XGT.9V>UL9H;FW#'(3S0X=1Z#,8.!W+&L&I0@IIGU
M%&IA,?CJF6UL/"*O)1E%6:M??[O3R/C:BOH_P9\ ;/X@?M#^-=-O28_#ND7T
MT\T=N=A</(QBA![#&<D=D.,9!KTK5/'GP"\)^*F\(3^%-.9[>7[+-?G2HI88
M9 =I5Y6/F$@C!8 ]^>M:NKK9*Y\_1R6<H.I6JQIQYG%7ZM:'Q-17T+^U%\!=
M/^'WB/1K_P .I]CTC693;M!(Q,=K/D=&.2$8$G'.-C=L >W^(? _PP_9Z\$V
M=QJ?@E_$D6X13WG]G1WLN[;R\AD(5 <=L#T%#JJR:ZE4\AKNK5IU9*"IVNWM
MKM8^%M(AM;C5K**_F:WL7G19YD&62,L S#W R:]^_:,\'_"7P[X.TN?P%>:?
M/J[WBI,EEJC79,'EN2S*7;;\P3TZFN5_:&\0_#GQ-=:%>> +*+3V,4HOX(;1
MK8*<KY>5QMS]_E<]L]J]C_;*\!>&O"OP\T6YT7P_I>D7#:FL336-G'"[)Y,A
MVDJ 2,@'GTJ'*[CT-Z.$5/#8R,>2:@H^]OO_ "OIYGQ_17V5X)\ _#;X.?!7
M2/&?B[2(M>NM3MX)V:>U6Y):5-Z11QN=BX4\DXR023T [[03\)_$GPTO/'%A
MX%TF72K2":XFA;1;99U$2EG7!&TD '^+!]:3K=D51X=E424ZT8R<>;EU;2/S
MWHKZT_92\.^$_B%XI^)E[<>&M/NM-:\AFT^UO[.*3[+#(]R0B@@A?E" [?[H
M]*Z+0;CX$>!_%UG\/DT:VUG57F6SEU*^LDNU^T$A=CR-T8M@?(NU3D';@U3J
M6;5C*CD;JT:=>5:,8S;2OW3LOOW\CXIHKZ$_:\^$.D?#O7-'U70+06.GZJLJ
MRVL8/EQ2H5.5_NA@_P!T<#8<5\]UI&2DKH\7&82I@:\L/4WC_P .%%%%(X@H
MHHH **** "BBB@ IRTVG+0,6BBBDQL****1(4444 %%%%!04444#"BBB@ IP
MZ4VG5+ 6BBBD4@HHHH ****!,****@84444 %*M)3EZ4 %**2E7K4,8ZBBBH
M9:%6G4BTM9LH*%ZT4JTF/H+1114,I!3Z;3JS904445!2'#I2TE+4,84JTE*M
M0RA:***AC0Y:6D7I2U#*"G4@ZTM04+2K24Y>E9E(*4=:2E7K4L8ZE6DI1WK-
MEBT\4VG5A(M"KUIU-6K%K;BXD*F6.$ 9W2' K"<E%.3V-8IR=D1CI5^UL(94
MW2WT,![*0Q/Z"KEJ#9Q[([K3SZETW']14T4U]=7MO:6<=K?W5PP2.&VMPS,Q
M.  -O4UXM3$5*LN2BOZ^<6COC24=9?U^)6CL+6,Y&I6Y_P!Z-C_2K:LB+A=3
MM0/:#_[&O8M._9QT[0],BU;XC^*(=!67E;*W9 _TW'()]E4_6IH_ /P+UAOL
MEEXQOK2Y/"RSN40GW+Q!?U%=,LJK5$G5FD^SY?\ (]6.#JQWM%]G*S^ZYXSY
MB_\ 04MC_P!L/_L:CDMX),[M0M3](2/Y"N\^*'[/VL?#VR_M6TN(]<T X/VV
MW&&C!Z%UR>/]H$CZ5YSH>FG6M9T_3Q)Y1N[B. 28SMW,%SC\:XI9=*C/E;L_
M2/\ D<M55:4_9U(V?J_\R5=/MO\ H(P_]\-_A5::$0OA9$E&?O)G^M?1GB+X
M _#3P=>1V>M^-+RPNWC$HCE,8)4DC<!L/&0?RK+_ .%5?!^0A8_B',KG@%WC
MQ^/R#^==_P#9U>$O>FGY-Q.N67U8OE?*G_B7^9X+2K7KOQ#_ &>KOPOH)\0Z
M%JL/B/05&]YH -\:?WN"0RCN0>/2MFQ^&?P?FLX))/']T)612XRB<XY^4QDC
MZ&I^IU>9QE9/S:_#N9K UE)PE9/S:7W=SPNG5])Z7^S[\-]:T:]U:Q\77]SI
MUEG[1<(\>V/ W'/[OTYK'_X5?\'?^A_N?^_D?_QNIEE]5)-N.OFC?^SZL;-N
M.OFCP5:=7;0^#=$U;XJ6OAS1M6EO=%N+N.!+\IARI W8& "0<@'&#C-5_BMX
M+M_A_P".]0T2UN)+FW@\MDDF WX9%;!QQQFO.G0G&#J=$[?,YW1G&+GT3M\S
MDZ<M:'AWP[J/BO5X-,TJU>[O9CA8T_4D] !W)KVN/X#^$?!-K%)X[\7+;7;K
MN^QV1 (_-69A[[144<)5Q"<H*R75Z+[S:CAZE9.45HNKT1X,M.6O>[?X;_!_
MQ1(+71_&%S97C?*GVEL*3VX=%S] :X'XE?!O7/AG*LMT%O=+D;;%?P [2>RL
M/X3^GH34UL!6I0]HK2CW3N;3PM2G'GT:[IW.%I1WI!UI5KR)&"'^E+24HYK"
M1:/#Z***_O21^2#ATK]!?V6];T_XF_L\GPS<S"2:U@N-)O8@<,L4F_8<>AC<
M#/JI]*_/JNA\#_$#Q!\-]:75?#NI2Z;=@;6*8*2+_==#D,/8CWZUX.:8)XZC
MR1=I)W3\SWLFS)9;B?:3CS0DK->3.N\0_LU_$;P_XA?2AX6U#4/WA6*\L8#+
M;R+G ;S!PH/7#$$=Z^P_@;X03]F_X(WU]XLFCL[EGDU*^7>K"(E55(5(^\V%
M48&<LQ )XKY[A_;N^(4<(C;3O#TK8QYCVLV[Z\3 ?I7F/Q.^.'B_XN21#7]1
MW6<+;XK"V3RK=&QC=M'WCUY8DC)QC->-7PV/QT8T<3RQCUMNSVL/C<JRJ<L1
M@^:=1IJ*:22OW_K_ #/8_P!BO6)?$7Q\\4ZK.JK/?:7=74BKT#/=0,0/Q-6/
MVCOVB/B%X)^,7B+0-$\0M8:3:_9_)@6TMV*;K>)V^=HRW+,QZ]Z\-^$OQ:UC
MX->)+C6]$M[*YNI[5K-X[^-WCV,Z.3A64YRB]_6L[XA>/-0^)GC+4?$NJQV\
M-_?&/S([1&6(;(UC 4,2?NH.I-7+ <V-=:I%.'+97UUTZ'#_ &LZ>5QP]&<H
MU>=MM76C3ZKSMH9WB+Q)JOBS5)=2UG4+C4[^4_-/<R%VQG.!GH!G@#@=J]D_
M8N_Y+I8_]>5S_P"@5X375?#3XC:K\*O%EOXAT>.VEO(4>/R[M"\;*RX((!!_
M(CI75BJ3J8>=*'5-(\C XA4<;2Q%5W2DF^KW/9_V\?\ DKNC_P#8#A_]*+BC
M]@[_ )*]K'_8"F_]*+>O)/BU\6-8^,?B2#6M;@L[>ZAM5M$CL8V2/8K.PX9F
M.<NW>E^$OQ8UCX-^([C6]%M[*YNI[5K-TOHW>/8SHY.%93G*+W]:\QX:I]1^
MK_:M8]?^T*']L_7=>3FOYV/9?B-XRM_A_P#MN3:[>';9VUS:I._]R.2QCC=O
MP#D_A7KO[7'P9U;XKZ!HNL^&474+[3=X-HC@&XADVG<A)P2I4'&>0QQR #\6
M?$/QUJ'Q+\8:AXDU6.WAO[XQF2.U1EC&R-8P%#$GH@ZDUV_PW_:?\=_#+2X]
M,L;RWU'3(AB&TU.(RK$/165E8#VW8'8"N.I@ZL52JTFN>"2UV>AVT<VPLWBL
M-B4_959.2:W3O?\ 1$'@_P#9G^(WC#4!;)X;NM(C#;7NM8C:UB3CK\PW,/\
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MG^)-+BMYKZR\SRX[M6:,[XVC.0K ]'/0CG%;?C[XS:Y\0O'FF^+=1M[&#4K
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M9FVE>2\C<8)Z8KRZBN[V-/FY[:GR7]H8MT/JWM'R;6Z'WY^U-_R;;+_VY?\
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MHZI\8'T%/ \6G^%+>Z9)M4NDD)> $XDCEW*A+  [0&(SS7E/[?/_ !^^"?\
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M/J_\YZ^=_''[2_B_XA^!AX7UA-/EM28VEO(X'6XE*'(+'?MY(R<*/PJ+P_\
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M^*'AS1]&U/PQX+U*WU*?Q)>MJ>M:A97 E3' 6$.I(YVC(!X Z?.:X&JDIO\
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MQ SC( YYY%9OAWXE6?Q5_:ATCQ/KUQ:Z/HT%QYD/]H3I'';QPQLT0+,0-Q<
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MCR"-,1+'N!W$QA?UY%.2U7,8Y?6Y88F6";@^563DK[ZN]H[*_P!Y0^'R6O\
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MY?\ 87D^=YVY<;O-^7;MW].<[?>N<HH-*<N22E:]NYZY_P 6(_ZJ)_Y(4?\
M%B/^JB?^2%>1T5'+YGH?7?\ IU#[CUS_ (L1_P!5$_\ )"C_ (L1_P!5$_\
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M$?\ X#6__P ?H_L?'_\ /EA_:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\
M_'Z/^&Z? ?\ T"/$?_@-;_\ Q^C^Q\?_ ,^6']I8/_GXCZ+HKYT_X;I\!_\
M0(\1_P#@-;__ !^C_ANGP'_T"/$?_@-;_P#Q^C^Q\?\ \^6']I8/_GXCZ+HK
MYT_X;I\!_P#0(\1_^ UO_P#'Z/\ ANGP'_T"/$?_ (#6_P#\?H_L?'_\^6']
MI8/_ )^(^BZ*^=/^&Z? ?_0(\1_^ UO_ /'Z/^&Z? ?_ $"/$?\ X#6__P ?
MH_L?'_\ /EA_:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\ _'Z/^&Z? ?\
MT"/$?_@-;_\ Q^C^Q\?_ ,^6']I8/_GXCZ+HKYT_X;I\!_\ 0(\1_P#@-;__
M !^C_ANGP'_T"/$?_@-;_P#Q^C^Q\?\ \^6']I8/_GXCZ+HKYT_X;I\!_P#0
M(\1_^ UO_P#'Z/\ ANGP'_T"/$?_ (#6_P#\?H_L?'_\^6']I8/_ )^(^BZ*
M^=/^&Z? ?_0(\1_^ UO_ /'Z/^&Z? ?_ $"/$?\ X#6__P ?H_L?'_\ /EA_
M:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\ _'Z/^&Z? ?\ T"/$?_@-;_\
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M$?\ X#6__P ?H_L?'_\ /EA_:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\
M_'Z/^&Z? ?\ T"/$?_@-;_\ Q^C^Q\?_ ,^6']I8/_GXCZ+HKYT_X;I\!_\
M0(\1_P#@-;__ !^C_ANGP'_T"/$?_@-;_P#Q^C^Q\?\ \^6']I8/_GXCZ+HK
MYT_X;I\!_P#0(\1_^ UO_P#'Z/\ ANGP'_T"/$?_ (#6_P#\?H_L?'_\^6']
MI8/_ )^(^BZ*^=/^&Z? ?_0(\1_^ UO_ /'Z/^&Z? ?_ $"/$?\ X#6__P ?
MH_L?'_\ /EA_:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\ _'Z/^&Z? ?\
MT"/$?_@-;_\ Q^C^Q\?_ ,^6']I8/_GXCZ+HKYT_X;I\!_\ 0(\1_P#@-;__
M !^C_ANGP'_T"/$?_@-;_P#Q^C^Q\?\ \^6']I8/_GXCZ+HKYT_X;I\!_P#0
M(\1_^ UO_P#'Z/\ ANGP'_T"/$?_ (#6_P#\?H_L?'_\^6']I8/_ )^(^BZ*
M^=/^&Z? ?_0(\1_^ UO_ /'Z/^&Z? ?_ $"/$?\ X#6__P ?H_L?'_\ /EA_
M:6#_ .?B/HNBOG3_ (;I\!_] CQ'_P" UO\ _'Z/^&Z? ?\ T"/$?_@-;_\
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M_C]'_#=/@/\ Z!'B/_P&M_\ X_1_8^/_ .?+#^TL'_S\1]%T5\Z?\-T^ _\
MH$>(_P#P&M__ (_1_P -T^ _^@1XC_\  :W_ /C]']CX_P#Y\L/[2P?_ #\1
M]%T5\Z?\-T^ _P#H$>(__ :W_P#C]'_#=/@/_H$>(_\ P&M__C]']CX__GRP
M_M+!_P#/Q'T717SI_P -T^ _^@1XC_\  :W_ /C]'_#=/@/_ *!'B/\ \!K?
M_P"/T?V/C_\ GRP_M+!_\_$?1=%?.G_#=/@/_H$>(_\ P&M__C]'_#=/@/\
MZ!'B/_P&M_\ X_1_8^/_ .?+#^TL'_S\1]%T5\Z?\-T^ _\ H$>(_P#P&M__
M (_1_P -T^ _^@1XC_\  :W_ /C]']CX_P#Y\L/[2P?_ #\1]%T5\Z?\-T^
M_P#H$>(__ :W_P#C]'_#=/@/_H$>(_\ P&M__C]']CX__GRP_M+!_P#/Q'T7
M17SI_P -T^ _^@1XC_\  :W_ /C]'_#=/@/_ *!'B/\ \!K?_P"/T?V/C_\
MGRP_M+!_\_$?1=%?.G_#=/@/_H$>(_\ P&M__C]'_#=/@/\ Z!'B/_P&M_\
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M_C]'_#=/@/\ Z!'B/_P&M_\ X_1_8^/_ .?+#^TL'_S\1]%T5\Z?\-T^ _\
MH$>(_P#P&M__ (_1_P -T^ _^@1XC_\  :W_ /C]']CX_P#Y\L/[2P?_ #\1
M]%T5\Z?\-T^ _P#H$>(__ :W_P#C]'_#=/@/_H$>(_\ P&M__C]']CX__GRP
M_M+!_P#/Q'T717SI_P -T^ _^@1XC_\  :W_ /C]'_#=/@/_ *!'B/\ \!K?
M_P"/T?V/C_\ GRP_M+!_\_$?1=%?.G_#=/@/_H$>(_\ P&M__C]'_#=/@/\
MZ!'B/_P&M_\ X_1_8^/_ .?+#^TL'_S\1]%T5\Z?\-T^ _\ H$>(_P#P&M__
M (_1_P -T^ _^@1XC_\  :W_ /C]']CX_P#Y\L/[2P?_ #\1]%T5\Z?\-T^
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M_P#XBNOHH^L5OYW][#V-+^5?<<A_PI_P'_T)'AS_ ,%-O_\ $4?\*?\  ?\
MT)'AS_P4V_\ \177T4?6*W\[^]A[&E_*ON.0_P"%/^ _^A(\.?\ @IM__B*/
M^%/^ _\ H2/#G_@IM_\ XBNOHH^L5OYW][#V-+^5?<<A_P *?\!_]"1X<_\
M!3;_ /Q%'_"G_ ?_ $)'AS_P4V__ ,177T4?6*W\[^]A[&E_*ON.0_X4_P"
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MP'_T)'AS_P %-O\ _$5U]%'UBM_._O8>QI?RK[CD/^%/^ _^A(\.?^"FW_\
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M_P"A(\.?^"FW_P#B*Z^BCZQ6_G?WL/8TOY5]QR'_  I_P'_T)'AS_P %-O\
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M^%/^ _\ H2/#G_@IM_\ XBNOHH^L5OYW][#V-+^5?<<A_P *?\!_]"1X<_\
M!3;_ /Q%'_"G_ ?_ $)'AS_P4V__ ,177T4?6*W\[^]A[&E_*ON.0_X4_P"
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MQ8^*7CKP'H]CK$&K>#IC;W]Q?6JQVTK"1D/E,'+$94\LJY&",CFO6*/K%?\
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M_P"A(\.?^"FW_P#B*Z^BCZQ6_G?WL/8TOY5]QR'_  I_P'_T)'AS_P %-O\
M_$4?\*?\!_\ 0D>'/_!3;_\ Q%=?11]8K?SO[V'L:7\J^XY#_A3_ (#_ .A(
M\.?^"FW_ /B*/^%/^ _^A(\.?^"FW_\ B*Z^BCZQ6_G?WL/8TOY5]Q\@?LUV
M=OI_[57Q&M;6".VM8$U***"% B1HM]$%55'     '3%?7]?(O[.__)VWQ-_[
MB?\ Z7Q5]=5[.>:XF+?\L?R/,RG^ _\ $_S"BBBOGCV0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Y%_8#_YGO_MP_P#;BOKJOD7]@/\
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M%#(,%MP &,UZW\./V>?B'\4/VK%^-_Q-\-:=X!@L=-DTZS\-VFHI?W$^^"6
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MJ>,VOQ _:=\1_L[7?Q[M?B)HNGV26DVKQ>!XO#L,D)LHV8,6N6S*#L4O@$\
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M0([2/Q1X:T?Q)':2&6W35["*Z$+GJR"13M/ Y%;L,*6\211(L<:*%5$& H'
M '84^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#Y%_;\_YD3_M__P#;>NO_ &Z/^22:1_V'
M(?\ TGN*Y#]OS_F1/^W_ /\ ;>NO_;H_Y))I'_8<A_\ 2>XK[C"?!EWK/_TH
M^4Q'Q8WTA^1ZY\'_ /DDG@G_ + =C_Z3I77UR'P?_P"22>"?^P'8_P#I.E=?
M7Q^(_C3]7^9]+1_A1]$%%%97B;Q9HG@O29-5\0ZQI^@Z7$0KWNIW26\*$G !
M=R%&?K7.;&K1572]4LM;T^WO].NX+^PN4$L%U:RK)%*AY#*RDA@?45E^/;O7
M=/\  ^OW7AB&VN?$<%A/+IUO>1M)#+<*A,:.JLK$,P X(/- &]17F7[-GQ@7
MX\?!'PKXV:.""]U&VQ?6]OD)#=1L8YE4$EE7>K$ DG:5Y/4^76?[07C;Q]X+
M^-&O>']1\%^%=)\.:\FA^'-<\4O);V3F&2-+N6ZEWD%6+[8BJJ-Q .[L["/I
MZBN=\0>//#_@70K;4O%OB+1O#]M(%0WFH7L=K;M(1T1Y& .>PSFN0^*7Q"NY
M/AE:^(?A_P",?!-HMQ>V\<6M>(+\'3)8FDVNB2QD@R-]U0#RW%(9ZC16/XH\
M9:!X'TLZEXCUS3?#^G!@AN]4NX[:'<>@WN0,_C2^&/%^@^-M,74O#NMZ=K^G
M,=HN]+NX[F(GTWH2/UH UZ*XN\^-GP\T^SLKNZ\>^&+:TO97@M9YM8MTCGD5
MBCHC%\,P8%2!R"".M=E'(DT:R1LKHP#*RG((/0@T .HK"UCQYX9\/7UQ9:KX
MBTG3+VWLCJ4UO>7T44D5H'V&X968$1;SMWGY<\9S5&/XM>!YO";^*4\9^'W\
M,J_E-K2ZI ;(/_=,V_9GVS0!U=%4-#U_3/%&E6^IZ-J-IJVFW"[H;RQG6:&0
M>JNI((^AK"T7XM^!O$GB"30M)\9^'M4UN/._3;+58)KE<=<Q*Y88^E '645Y
M[;^(O$#_ !ZNM#?7O"K>&$\/K=IH<<[?VZMR9POVAX^GV;;E=W]_ J_J'QI^
M'NDV<5Y?>._#-G:2W$EI'/<:Q;QQO,C;7B#%\%U;@KU!X-,#LZ*\=_:2_:4T
M+]G7X?VWB*Z;3]4O+V>&.QTN75([62\C:2-9)8B58NL:R*[;5( (R1G->@^&
M?B)X4\::'=:UX>\3Z-KNCVKM'<:AIFH17%O"RJ'97D1BJD*RL03P&![T =#1
M7,^$?B=X.\?SW4'ACQ9H?B2:U_X^(](U*&Z:'G'SB-CMY]:9K'Q4\%>'O[4.
MJ^,-!TP:5)'#J'VS4X(OL<CKNC27<P\MF7Y@&P2.12 ZFBJ6BZWIWB32[?4M
M)O[75-.N5WP7EE,LT,JYQE74D,,@]#6!HOQ;\#>)/$$FA:3XS\/:IK<>=^FV
M6JP37*XZYB5RPQ]* .LHK UCX@^%O#][>6>J>)=(TV[L[47US;WE_%%)!;EB
M@F=68%8RP*[CQD8S5CPOXNT+QOI*ZIX<UK3M?TQF*+>:7=QW,)8=0'0D9&1W
M[T :]%<GJ7Q:\#:-XD3P]J'C/P_8Z^Y 72KG5(([IB>@$3.&.?I5_P 7>//#
M/P_L8[WQ1XBTGPW9R-L2XU>^BM8V;T#2, 3[4 ;M%4=%UW3?$FEP:EI&H6NJ
MZ=<+NAN[*99H9!ZJZD@CZ&O*OVKOBMJWPG^$<MQX:95\8:Y?VV@:#YB*ZB^N
M7V(Q# @[5#N 002@!&":8'L=<M\3/ACX:^,/@^\\*^+M/;5=!O&C:>S6YFM_
M,*.'7+1.K8#*#C..*\=_:*^,'Q"^%.M?"+P=X-?0-4\0>+;R739]4\36TIB+
MQ1(?-V6[IM+%B2!D#H!3/A_\<_B/H/QZT[X5?%?2/#1O];TV;4M'UKPF]P+>
M019\R*2*<LRL &.[.. .<\%NHKGO'A/PII/@7PSI?A[0K)-.T;3+=+6TM8RS
M"*-1A1EB2>.Y))ZDDUK5\\>,OCYXX\7?%S6/AM\'-#T74-3\/11R>(/$7B:6
M4:=8/(-T=NJ0_/+*0">" -I![XSO&_Q>^.?P]^$/Q"U/6/!WAP^*O#%G%JEG
MJ6GF>XT?5+4/_I $9=)HI8XU=MK$CIR1S18+GTQ17-^#?'VE^-/AYH_C*UF2
M+2-2TV+4UD9LB.-XQ(=Q]5!(/H0:\:^&G[3.J:Q^R_XE^,WBRPLM/TR%M1OM
M'M;6-XWDL8G9+99=SMF61T(R-JG<N !R2P'T37E]C^S+\,M.^+5S\38?"EN?
M'%Q(97U66>:0ARFPNL;.8T;;QE5!Z^M<9^R)^T%XG^-&F^)])\?Z3IN@^.O#
MUS;_ &O3],$B1_9KFW2:WDVR.[ D%P?F(^4>M:B_$S7_  O^UNW@36K\7?A?
MQ3H U+P^C11H;2[MF*W4 95#.'0K+ERV""!@<4:@>WT444AA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?(O[.__)VWQ-_[B?\ Z7Q5]=5\B_L[_P#)VWQ-_P"XG_Z7Q5]=5]!G?^\Q
M_P ,?R/&RK^!+_%+\PHHHKY\]D**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ^1?V _^9[_ .W#_P!N*^NJ^1?V _\ F>_^W#_VXKZZKZ#/
M_P#D95?E_P"DH\;)_P#<:?S_ #8445Y5^U-XWUKX;_L\^._$WAV\_L_6],TY
MI[2Z\I)?+?<H#;7!4]>A!%?/GLGJM%<K\*=<O?$WPN\':QJ,WVC4-0T:SN[F
M;:%WRR0([M@  9))P!BN'^('[7OP@^%_B6?P_P"(_&MM::Q;8^TVMM:W%V;;
M./\ 7&&-Q%U!^<C@TP/8J*X?7OC=X&\-_#FW\>WWB.U_X0^X,(AU:V#W$4GF
MR"./'EJQ.78 \<<YQ@XYKPY^UM\(O%WCR'P;I'CBPO?$$\C100HDHAN'7JD4
MY012-QT1R<T:@>NT5Y]\3OCYX"^#MY86?BS7UL-0OT:2VL+>UGO+F5%^\XA@
M1WVCGYMN.#SP:J?![]I'X=_'R344\":_)K9T]4:Y+:==6RH&) P9HD#'*GA<
MX[T:@>F45Y/^U!\<K;]GOX.:UXK=X1J@C>WTF&XM9IX9[TQ.\<<@B&50^6V6
M+*O&-P)%5O@1^TUX/^-7@-]9MM9ACO-)TVUN]?::SN+&VLI)(F9\/<*JL@,<
MOS*S !02>026=KB/8:*\B\(_M9?"?QSXFL= T?Q?#-J5^Q2R6XL[FVAO&'\,
M$TL:QRGT",2>U7OB%^TQ\,_A3KUYHOBKQ5!I&JVEG%?R6CV\\CM%+(8X]@1#
MYCE@?W:9? SMQS19C/3Z*\EU7]J[X3Z%::7<ZEXSM;"WU31QK]G)=031B:R+
MB,2#*?>+,%$9^<GHO!JA8_MF_!?4/"%WXF@\>V)TNUN19RH\$Z70F.<1BU:,
M3%CM; "'.TXZ&BS%<]IHKDOAC\6/"7QE\,)XA\&:W;Z[I#2-"9X59&208)1T
M<!T8 @[6 ."#WI?B1\5?"GPCT./5_%VLPZ/933+;P[D>66>4@D1Q11JSR.0"
M=J*3P:0SK**X+PG\=O GC;PAJ_BC3/$$::%I#,FH7>HP2V/V0J@=O,6=$9?E
M8')'>N<\!?M=?"+XF^+(/#7ASQI;7NMW )MK::UN+;[3@$GR7EC59> 3\A/
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M0\,-\2V^'_\ :>WQ<NF_VO\ V<T$J[K3S/+\Q9"NQOFXVABP],4@.JHKEO\
MA9WAC_A8EQX%_M5/^$IM]*_MJ:Q\J3$5GYGE^8TFWRU.X_=+;L<XQS7":?\
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M=QSUQ7T!^P=J%SJ7[(OPTFNYWN)1I[Q!Y#D[$GD1%^@55 ]@*[?X1_ OP_\
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M .W#_P!N*^NJ^@S_ /Y&57Y?^DH\;)_]QI_/\V%>'?MO_P#)IOQ._P"P0_\
MZ&M>XUB>-?!>C?$3PGJGAKQ#9#4=$U.!K>[M6D>/S(SU&Y"&'U!!%> CV3"^
M!?\ R1+X??\ 8O:?_P"DT=>"?\$\9-.D^"/BF;56L_\ A+)/$>IOXK\PCS!<
M^:V?.W<A=@&-W&-WO7>>'_V*OA/X%U*TUKPKX:FT_7M-/G:;-<ZYJ4\$4RC]
MV6B:X*LH.,J1R*Y;QY^R9HGQ4\47'B+7OAIX836-3.9KA=2O(Q$5QDW2021K
M=F3 P<+M[[JB511TLW\CKH85UTY*<8V[NW_#]=NUMVD_D_Q@MN/^">7QE;2=
MQ\)/\2;EO#A&/+_L[[7;B/R\<;=PDZ=\U]2_ML^&=)\._#SX/VVEZ;;:=!I/
MC[0XM/CM8A&+5-[C;'C[HP!P/0>E=MXL^#][\0/AJGP_U3P1X9MO!LRPI!I$
M=U.D6G+ P9 Q@,;2ABH(V&/;GYM_.=3QYX&\1_%:QTVS\1>&=!EMK?4(-5LD
MFOK@_P!FW-N28Y)#$R&XW$G &P+GY@]1[=?RO[OZ_KYVZ/[-EUJP_P# U_7?
M;>VE^:/-XYK_ (B\2^'OV[/&6I^#?!<GQ N;?PAI]GJ%DU_;6%Q:%Y9)$:V>
M=@LD1"C> 1AF')Q@]O\ !7X8_%'X7_"/QI-86OAFV\?>)_%%YXDAT?4KF9M,
MTY+B2/=;F2%2S%41CE5P6;TR:\T^/'P%\4_$3XB:AXL\0?!/3OB+)<V5O::7
M$GB=E&EHA/FI)%)- C[SEE,97&\YR<UZ+^S;\+?&'PMN-42T\'VO@SPSJMW$
M\.A7'B*?4WTV.,#S&.YF0M)EE41,H4!2^_  ?MD^C^[^OZ]'9/+YQNW4A_X&
MOZ[^MM+\T>:O\9E^*EU^RK\95^)%KX32Y'A^Y:R7PC+=2KL$+F4R^>BD8P"-
MO& V:XG]I;4+JY_X)IZ5<:3/(UI+H.@_:IK9=_\ HI-MYA(!!*X^\ 1QD'C-
M?9.H:?;:MI]S8WMO'=V=U$T,]O,@=)8V!#*RG@@@D$'UKSSX;_LV_#;X2Z7K
M^F^%O"UO8:=KR+'J5K-/-=17$8WXC*S.X"?O9/D7"_.>*VN>98\2\;?L_P#C
M+XK> ?#L>M?'3PT?"<-W8ZCI=S8>#HK0(R.IM_(E%YA">%&!T;&.U-@T/3]8
M_P""H%Y/?6<-U-IWPZ6[M'E0,8)OMB1^8OHVR61<^C&O2_#?[%'P3\)>)+77
M=+\!VD.H6DXNK;S;JYF@@E#;@\<$DC1H00""JC!%>C0_#'PS!\2Y_B!'I:KX
MOFTP:-)J7G29:T$@E$>S=L^^ =VW=P!G'%%Q6/G+XD:+I^M_\%'OAD-0LH+U
M;7P==7,*W$8<1RK-+M< ]&&3@]NM3>!_!NA3?\%%/B1JKZ3:-J-KX8T^XAN3
M$-\<LG[MY%/9RBA2W7''<U]#WOPQ\,ZA\1=.\=W&F"3Q7I]C)IMMJ'G2 QV[
ML69-@;8<DGDJ2,\&I+'X<^'=,\?:IXUMM.$7B;5+2*QN[[SI#YL,1)C386V#
M!)Y"@GN31<=CP?\ 9;MX],_:&_:7T^V40V2>(+"Z6%  HDFM2\C8'=FY-=?^
MT;\*I_B1K7@2^\-^+-/\,_$7PW=W&J:#%J2+-#>*$5+A'AR'9,/&"Z9*;A_>
M%>D>&OAOX<\'^)O$WB#2-.^R:OXEFBN-5N?.D?[3)&FR,[68JF%XP@ ]>:RO
MBM\#? OQOL;"U\;>'X=:6P=I+27S98)K=FQN\N6)E==VU<@-@[1GH*+ZAT/"
M/^&MA:_!OXN7?Q4\&6%SJ_P]NH-/UC3-+D6ZT[49)G18#$9 =JEV7<K@E!@G
M)^4<'^T1K'Q,N_&/[/%]XWT#P7X:C;XAZ2EA;:/J\UYJ422,5EB8-"D9CV[0
M[(QPWECOFOJOP[^SW\.?"GP]O_ VF>$=/@\*:ADWFG.K2K<L<9:5G)9V^5?F
M8DC:.>*YS1?V._A!X?O-+O+/P>IO=+O+>^L;JYU&[N)K:6!]\(C>25F6-6P?
M*!V$@94X%.Z%J<=_SDH_[I+_ .YFO*?V8_#_ ,1?%7BCXUKH/Q+TKPIK4?CC
M4/[5TS4O"R:A=LNX"&0RFXC/E% 510NT;6QUK[(_X5OX=_X61_PGW]G?\5;_
M &3_ &%_:/G2?\>7G>=Y7E[MG^L^;=MW=LXXKB?B3^R?\*/BYXD/B#Q3X/M[
M[6V01R7UO=7%G+,H& )&@D3S!@ ?-G@ =J5PL?,WQZ^#_P#PIS_@G3\4?#MO
MXIM_&:MJT=_]IT^S6VAMR^J6K2P)$LD@148.2-W&3P,5] ?MA> )?BU^SGKC
MZ$_F:WI<<7B/0[B$;F%S;?OD*>[H'0?]=*]#T_X/>"M)^',G@&T\-:?!X.D@
M>W?1UB_<,CDE\CJ222=V<YYSGFL_X>_!_P *_ /P?JFG_#[PVUM"^^[&GK?2
M2O<S+&%1!)/(VW(55&2%'L*+A8^=/@S\0+?]K?\ :4\+>-;<"30/ ?A&&X\L
M<I%K6HH#*GH3'"I4]PRU]&_'OQYH7PQ^#OBOQ/XFTH:[H>GV9>YTQHDD%T&8
M(L95_EPS,H.00 2<&O/OV)O@3>_ CX-FTUO3+?2/%&MZA<:OJEE:R+)':N[8
MC@1E9@52-4'!(R6P3U/MWB+P[I?B[0K[1=:L+?5-)OHF@N;.Z0/'*A'*L#0[
M7&MCX6_:6\1_$K6-*^"FL>+O#?@OPKI__";Z-=:3;Z9J\UUJENQ<X3!A2)DV
M'YMC$<)QQQZ)X9T/3]4_X*6>-;R\LH+JZT_P7:2VDLT89H':1%+(3]UBI(R.
M<$CO7IFE_L8_!O1VLWM_!JO+9W$-S:RW.HW<\ELT3K)&L323,8T#*I\M2$.!
ME2*]"L_ACX9T_P"(VH>/+?3!'XLO[%--N=0\Z0F2W1@RIL+;!@@<A<\=:+H5
MCYB\)6]SI7QV_;6AT%&MKP:7H]S:QVHP1=2:3<.74?WVD.[/<FL_X=-\/;?_
M ()AHUX=)&B-X8N1<&XV%?[2*N#GOYWGD;?XL[<=J^L=!^&_AWPSXT\4>+--
MT[[-X@\3?9?[6O/.D;[3]FC,<'R,Q5-J,1\@&>^37G<?[&/P6C\57GB%? &G
MC4[MY))/WLWV<.X(9TM]_E(^"<,J CL11<+%C]CW_DUOX6?]B]:?^BQ7@UMI
M?C+Q!^WI\8K/0O'6G^#-772-'.F?VKH*ZF]S8BW!F%N3-$419RQ;&[<6[;>?
ML+P?X1TGP#X6TKPYH-I]@T;2[=+6TMO,>3RHE&%7<Y+' [DDUR/Q8_9X^'?Q
MPDL9?&OABWUBZL1BVO%FEMKF)<YVK-"Z.%SSMW8Y/'-%QV/+?!/P6O\ X7:=
M\>-:U;Q[8^,=8\3V0N;ZUT_2UT^.RFCM)E+F)9Y<-*K*Q)VY*9YSQPN@_P#*
M*B7_ +$BY_\ 07KZ7\!_ OP)\,?"6H^&O"_ARVTC1]2#B]AA>1I+G>NQC)*S
M&1CMXR6R.U3P_!OP?;_"D_#:/1]O@HV+::=,^TS?\>[ @IYN_P SN>=V?>BX
M6/E+]K+_ ),&^&WU\.?^@1UVK-;2?\%)2OB$1%X_ 2GPW]HSM#FZ(G,6>/-Q
MY@..=F>U>[>*O@QX-\;> ].\&:UHJWWAK3C;&UL3<2H(_L^/)^=7#G;M'4G/
M?-5_BM\!_ 7QOM;*#QMX<M];-BY>UG,DD$\!.,[)HF610<#(#8.!Z47%8X[]
MH3XH^&/A7X=LKBV\+:7XP\1ZQXFL='LM+W01AM6F4^0]Q*RMY15$SO(+ !<8
M!R/$]>OO'K?MT?L_2>.M/\(Z5JES9Z[$L7AG4)[J=K<63.JW'FQ1[5#@["N0
M2)?2OH.Q_93^$^G?#N[\"P>"K$>&+JY%[/:222N[W   F,S.9?, & ^[(YYY
MIWA']EKX7^!?$VD^(M&\++;Z_I4DTEKJDU]<W%R#)"87WR22,T@\MF4!RP7)
MV@$YHN@U/*/V*6M)/''[1#ZP+<^-?^$]OEO2W^M_L\*HM "WS>3_ *W;GC%,
M_:BBTSX9^(/@_P#&OPX+./1?#.KC1]6DTX)Y']E7K>3(WR_+B.0@@?WI*]5^
M)7[)_P )_B[XC;7_ !5X/M[_ %F2,0RWD%U<6DDZ  !93#(GFC  P^> !TK&
M_:.^%=]=?LNZY\.?AOX2L[Y[NSCTFQTOSX[>"UB9U#3%G8?ZL9<<EBP'!YHZ
MAT.:_9 C_P"%B>*OBM\9ILR)XJUMM-T:1NG]EV/[B)E[#>X<G'4J#DUE_ME/
M:GXQ?LXQ>(C;KX);Q/<-?_;.(/MBPK]C#D_+C=YG!_EFOH+X5?#ZQ^%/PW\-
M>#]-&;31K"*S5^\C*HW.?=FW,?=C5KQY\/?#?Q0\,W/A[Q7HUKKNC7!#26EX
MFY=P.0P/56'9@01ZT7U';0^=OVR%L)/BQ^SDFG%/^$W_ .$YM6A$.WS_ .RP
M&-[G^+R\;,]NM:7A[_E(EXM_[)[:?^EIKT7X6?LO_"_X+:Q+JW@_PG!INJR1
M>0;^>YGNYUCX^19)Y'95X'"D#BNMM_AOX<M/B)>>.HM.V^*KO3TTJ;4/.D.Z
MV1]ZQ^66V##<Y"Y]Z+A8/B=_R37Q9_V"+O\ ]$O7QQX+?P@O_!*O3$\;(TND
MR:1/'!'  ;A[PW<OV80C_GIYNS'T.>,U]R:EIUOK&FW5A>1^=:743P31Y(W(
MP*L,CD9!/2O/K7]G'X=6?A_P7H<?AT'1_!MW]NT.QDO;AXK6?<6$A5I#YK L
MQ!DW;23C%"8'QO\  J;Q7IOP[_:(M?%YOV_:)M_#)9Y;X[Y6TY;#%K]FVC&0
MV[=MSF4INR:]M^#?_"O8?^">VD^>VF_\(F?"!_M<DIY?VDP?Z2&_Z:>>6'/.
M[;CG%>\:C\*?"NJ_$C2?'UQI*GQ=I=K)8VNIQSRQL('SNC=58+*OS$@.&VDY
M&#S7G5U^Q#\#KSQ))KDOP\T\WDD_VIX%GG6S:3.=QM1)Y/\ XYBBXK,\X_9V
M_P"%X6_[+/PB7P3;>#IO^)-FZ_X3&>\BE">8QMA$($8%/)V?>[;:;^T8OB'X
M:Z]\#_C3XE73+;6M U,:'XI;1GD:S%C??NV=3( Q2-L$;@#NDKZYCC2&-8XU
M5$4!551@ #H *P?'W@'0/BAX/U/PMXHTY-6T'4HQ'=6;NZ"10P8?,A#*0RJ0
M0000*+ZCL?$O_$T\?? O]J3XU:<UP]UXJ6ZTW198.6&CV*& .F.@<"8MC^[G
M.>:W--^!OBGXP?LJ:-I<_P :_"]E\-[W1;5E5?!L4:6<:JC*/--X-KHR@%B
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M'B_Q9X)_9S\7ZEX/L)KG4!9S)/?6^I_89M+@\F0M=QM@EW1@@"*58[L@C%>
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M5^.=3BAGMHKWQUJ]RD-U'Y<L8=HV"NO\+#.".QS7;_M!?M-K\!_&OP]\/?\
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M,OB;1[NSD,4ZV6H1['>W?^$PRIM!ZAB#S5O7OV3_ (@^/M%?PKXU^/&K^(/
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M+O2=)32H=+TZWN!]V=H8V;S)%Y*LS<'VXK>^-W[-MO\ %3Q1H?C/0/$U_P"
M?B#HD;06?B+3(DF+P-DF&>%_EECR20I(ZGUIWZ"/9Z^5OBC_ ,I"O@I_V+NK
M?^BWKTCX=_!/Q9I'C"W\4>/OB?J7CW4[&*2'3[2#3XM*T^W#C:[FWB9O,D(R
M [L< G Z8N^*/@:/$G[0G@KXH?VT;<^&].N]/_LK[+N^T>>I&_S=XV;=W3:<
M^HJ1G$_\%"K.*\_8_P#B$9!\]O%:W$3KPR2)=PLK ]CQV[$U[GX0U*?6?">B
MZA=*4N;NR@GE5A@AVC5B#P.Y/85X#^W)'-XY\&^$?A)IY9]2^(&OVUE*D?WH
M["W=;F[G^B+&F<?WO>OI&"".U@CAB01Q1J$1%& J@8 %'0.I)1112&%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'R+^SO_R=M\3?^XG_ .E\5?75
M?(O[._\ R=M\3?\ N)_^E\5?75?09W_O,?\ #'\CQLJ_@2_Q2_,****^?/9"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D7]@/_F>_P#M
MP_\ ;BOKJOD7]@/_ )GO_MP_]N*^NJ^@S_\ Y&57Y?\ I*/&R?\ W&G\_P V
M%>8_M.^&]0\7?L[_ !(T?2K=[S4KO0+R.WMHU+/,_E,0B@#EF(P!W)%>G45\
M^>R?#WB'XS>%?BQ_P3Q\7:;X=OI+K5?#G@^RL]8LWM98VLK@1JC1,SH%9@T,
MF=I.  3@,,^E_$CX>ZS\3OV D\+Z';FXUJ\\'Z>;:U/#2R1Q0R^6,_Q-L*C/
M<BOI:BJOV%8_.WPQ??LH>+/".EZ-K6B^+KKQA<00V]]X+-[X@FO5NL*'C,7G
M;,!N=Q(7IR#Q7JW[0GQ0U#PO\<])\%Z_X^U3X0_#!= 6YMM:TFT0RZC>B79]
MF%S)%*(]D8!"A<GOG*U]>447%8^#OV9])G\4#]J_3]+O/$&N2:I!;P6-[XGA
M\K4+SS=.F$4DBB-,;PR%?D4[&3(S6G\+_BYX:\9?L!^+O!.GW4__  EOACX=
MZA9ZOI,UG-%+:2):31[6+(%R2. "3S7V]11<=CX<\?*?^'3=J,'/_")::>G_
M $U@-=O^VM'N_9Q\$ IEU\1:#@$<@^:H_.OJRBBX6/A7]HGPOX/\%_M;7/C#
MXMZ=JP^'/B#P_!:6NOZ7=7\$5C?0N08K@VCJP#(<@MD<C'1B.Z^$>F?!74O"
MOQ3USX1:7K$SG0VM+K7[^34I8;U3%,RQ0/>.Q?85^;8,#>G)S7UA11<+'QC\
M'5/_  ZLOQ@Y/@;7,#'^Q=UA_$JX;PS^S#^R3XVN8)I= \+77AO4-8GMXGD:
MTM?L*JT[*H)V*2,^[*!UK[JHHN*QS_@+Q[H7Q.\)V'B;PS??VGH=^'-M=^3)
M$)0CLC$*ZJV-R-@XP1@C((-?#GQ \,_#KX9_M5?$W4OC?9:OIWACQ5]BO] \
M1V-[J5O:;DA$<UO*;-U ?<!C?G@=MPS^@=%).PSX_P##OQ+^#7P1^"OCCQQ\
M,O#FJW46KWT.EVL>JB_D;Q)J#1[;>.'[6S22)\[ D <*_7%<9^RKX&U+]BKX
MOV'@GQA#9O:?$JP@GL]9MX=JVVJQ*QETTN."GSL8^<'C'+''WG13N%C\_P#]
MG3]I;P5\"OB#^T-:>.)[[1+*Z^(>KW-KJOV":>UGD64AK<-&K8E "MM(&0PP
M<\5@3_!WQAX\_9#^*7BJW\-:@UYXH\?S>.;/PW*'BNY=/\]&VJ!\RR,N]ACD
MA5VY)&?LOX'? M?@OJGQ&O%UHZO_ ,)AXGN_$90VOD_9//(/DYWMOVG/S?+G
MT%>J4^;705CX0\'S?LE?$#7/#6FZ-I_BC7_$ESJ%MY>AO>Z]/+8S^8N)+A))
MO+18V^9F8XPI(W"O2/!<;C_@HY\0W*,$/@>R^;''^OC_ ,#^1KZGHI7'8^6/
M&D;G_@HY\/'",4'@>]^;''^OD_Q'YBOGCX5Z%\$_@]#X@\&?':'7O#/C/3]8
MNS;S)J&LQ6VJVKR%XIK9;23RVR&QM W$XZG./TNHHY@L?"/[1OAWPCH/[)?P
MPA\ Z!J'A[PO+XXTZYM;#4EG%PH>>8EW$S-(-['<-QZ,O3I7JW[8@/\ PG'[
M.YQQ_P +"L^?^V<E?3%%%PL?&Q^(6C_LM?M??%K6OB'+=Z1X5\?6NE7>E>(I
MK:6:V$EK T4ELSQH=K98D _PJOJ,Y_[5&M:7\>OAU\-OB7HNA:[XA\!^'?$Y
MEU:W@@N;*]FL"ICDNH%4I-L4\Y&T_0 D?;-%%PL?&GP=3]E[QI\5/"I^'UMK
MWB;Q-:2R7EK=-=ZW<6^ELL3,7G-S)Y<9(&P @G<RC'.:S/@C\</#G[*^O_%/
MP!\0XM1TO7KKQ=J&MZ+%:Z9/<-KEO<E#%]G\M2'D) 7!( W 9X;'V]11<+'R
M]_P3ZFN[GX:>/IK_ $^?2;Z3QYK$D^GW./-MI"\9:)\<;E)(..XKE/VV_&,/
MP_\ VD?V9_$5S87VI6NGW6N33V^FP&>?R_(M0[J@Y;8I+D#G"G'-?9E>5_$W
MX%K\1OB]\*_'1UHZ>W@6>_F%B+7S!>_:8HX\;]X\O;Y8.=K9SCCK1?6X6T/!
MW^(6C?M6?M=_"35?A]+=ZOX6^']OJE[JVO+:306XFN84CCME,BJ2^44D8Z,W
M]TXY#6/B[J'C/Q'\1]-\??%#QEX,\36.JWFG:#\/O"6G1QS7=JN%MW4M;R-<
M>;DY;<%')RJ]/ONBBX6/SL_LV_F_X)>?#C4;.QN-071;^TU:ZAMHR\GV>+49
M#(P4#G .X^@!/:N__;#^*7ACXU? 'P3X@\%ZD=<T?_A/M*@%TEM+$"X+$@"1
M%)^^HR!C)QU!%?:E%%Q6/@[XY^%_!'@3]KKQ)XH^,=AJ]OX!\4:/9KIOB'3;
MO4(+>UNX%$;P3FS=6!8?,"X('&/XB.V\#Z3\'+OX1_&K7?A%I6KLEUX>N+:[
MUS4'U&6+4-MK.46%[QV9PF2"5 'S+R1BOKNBBX['Q=H*G_AU3*,'/_"#W)Z?
M[+FH?CE<-X9^ _[,'C:Y@FET#PMJV@ZAK$]O$\C6EK]DVM.RJ"=BDC/NR@=:
M^UZ*+A8^4_V@/BE\!_B7X-\&:MXQOM:M/#E^UQ>:!X[TJUN[8:?<12")MDZ)
MOB=B#MW(4<)GG"FM_P#8E\:>*O&7@OQ.VM:MJ?B?PS9:S);^&?$FM6C6UYJ=
MB%!$D@(!<!B0'(!;GTP/HVBE?2P!1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?(O[?G_ #(G_;__ .V]=?\
MMT?\DDTC_L.0_P#I/<5R'[?G_,B?]O\ _P"V]=?^W1_R232/^PY#_P"D]Q7W
M&$^#+O6?_I1\IB/BQOI#\CUSX/\ _))/!/\ V ['_P!)TKKZY#X/_P#))/!/
M_8#L?_2=*Z^OC\1_&GZO\SZ6C_"CZ(****YS8**** "BO%OV?_VM/ W[2&J>
M(],\,+J5GJ.AR;9[75H$B>6,LR":+:[ADW*1R00<9 R,]CX?^+VC>)/BMXM^
M']K;WR:UX9MK2ZO)I8T%NZW"ED$;!BQ( YRHZC&:=A'<4444AA1110 45YI^
MSQ\9Q\?/AG;^+ET@Z'YMY=6GV,W/VC'DS/%NW[%^]MSC'&<<]:I?'_XZS?!B
MU\+VFE>&9_&'B?Q/J:Z5I6D17:6BR2;2S-),X*HH ZX/7TR0[= /6**P? NL
M:WX@\*:??^(_#Q\*ZW,K?:M(-['>?9V#LHQ-'\KA@ P. <,,@'(&]2 ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'R+^SO_ ,G;?$W_ +B?_I?%7UU7R+^SO_R=M\3?^XG_ .E\5?75?09W
M_O,?\,?R/&RK^!+_ !2_,****^?/9"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /D7]@/_ )GO_MP_]N*^NJ^1?V _^9[_ .W#_P!N*^NJ
M^@S_ /Y&57Y?^DH\;)_]QI_/\V%%%%?/GLA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5Q:GEOP9\6>*]$_:$\-:-X=M?BYJGP\UJSNTU=OB/I=Z5TNYBB,D$L5U<)N
MD*F,H6QEAZ@"'X+^%O'?[4NAZ_\ %"Y^+'BSP?>3ZQ>6WAS2=#N533;&W@D:
M.,7%L5*W+$J=V[J.A';W+X9V/QRN/%$5Y\1=3\#V6B00.O\ 9GA."ZE>YE.
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ML;FU\7^(VUBQ2S=V>*(J?EE#(H#9/12P]Z9^SY\$];^$WPE\0^%M6N["YO\
M4=4U.^BELW=HE2XD9HPQ9%.0",X! [$T7"QX)XH_:A\7ZM^RO\$;R"\U:T\2
M>/+N/3M2U;0=/%UJ"0Q;Q<O;0*IS-)Y8VX7Y=Q( P,7_ (>>+/%/AGXY>";;
MP?;_ !FUCPCJ\LUIXBMOB)I5])!:@QYBN8KB=/W1#C#+G:0>@KJ+']CO7T_9
MG^&?A >(K+1_B+X!O1JNEZU9AY[,7 FD?RV#*C-$RN WR@Y X(R#Z3\/=/\
MC[=>+--G\?:KX!L?#MHLAN;/PO;W<L]^QC95W/<8$*ARKX4,?EQG!HT#4\-\
M ^&?&GQX^/\ \=="U'XJ>+O#OA'P_K<26]AX?U V]QODAPH2<AC%$@C)\N,
M,SY;I@Y5E-XD^)W[%_QZT'Q;XPUR^U#X>:MXBTB'6+.[-O<:G#96I9$NF4?O
M8W\PJZG[P R>]?0OP1^"NM?#3XK_ !B\3ZE=V-Q8>,M5M[^PCM7<RQ)'&ZL)
M0R  Y;C:6&!U'2LOX:_LY:AH7@/XY>%_$5]9O:_$/Q-KFIP2Z>SN8+._B2-1
M(&5,2* V0I(Z8;T+A8YC]G'X3S>$OV7=&UBP^)GB72KK7?!^FW!OM?U'[=9:
M&#:I(SVT$N(X54,0 3@!5SD+7CEQ\6/#WPW^,7PM_P"%=_M!>(/B7-K7B>UT
M'7]#UC6AJ4$L%P2@N(EV!(MCD<QG^)<< Y]4M_V:?BMXM_9?UWX+^,_$/A:V
ML(=,L],T+5M#2Z:=DMI4=#="3:H!2*-"J9X+')X%2>*/@-\9?B5<?#"/Q!=_
M#_P_HG@OQ/IFN?V1X;2ZV7*V[DNRN\8\LA"X2%5VY<EI.!0(E^%W_*0KXU_]
MB[I/_HM*J?\ !3KPHNL?LI^(]9.JZM9MH[VKK8V=XT5I>>;>VT>+F(<2A,[D
M!^ZW->E^#?@KK7AW]J;XA?$NYN["30_$6E6-C:VT3N;E)(54.9%*!0IV\88G
MU K?_:/^#X^/7P2\5>!!>KITNK0((;J12RQRQRI-&6 .=N^-<X[9Z]*5]4/H
M?/G[9WPMC^%7["_Q/L(O%'BCQ4+F?3IS<>*M6?4)X_\ 3[1=B.XRJ<9V^I)K
M*^)WA?QY^S_X/^'GQ*M_BSXIU_6I-8TRRU;2+ZX4:-=6]PRHT45HJA8@HP P
M);J<YP1Z1\4O@S\8/CA^ROXM^'_B^_\ !D/C#47LTLKK2I+M;,QPW%O*S3.Z
M%][>4_W4P,J/4UU_[0OP3UOXL?"7P_X6T>[L+>_T[5-,OI);YW2)DMI%9P"J
M,=Q .,C'J13N!Y'^T!\7-3UK]I!_AY)=?$"Q\):)HD6HWD/PYL9YK^]NIG(3
MS)H%,D,*(.Q&YCST%6?@?XX\<VL?Q=T2XC\?2^#=.T<ZAX<USQWIEQ::C%(8
M7$L!FE13-M8*RL<L!U)KOOBM\#?'$/QFM?BO\*=:T6P\32Z8-'U;2?$J3&PU
M"W5]Z/NBRZ2*>,@$8 ]PW3>$_#'Q5USPKXQMOB+K'AB2\U:R-IIVG^&[:9;6
MQS'(K,\LO[R0L73/R@#R^!\QHTL'4\4_8M\#>,_'WPF\'?%#Q/\ %CQ9?:S+
M97$5EIK7Q?3%B"S6Z-=0MDW,H;,Q=F!W*@SA>?)?C=\5-!^"^@_\)5X1_:=U
M_P <?$32+ZV>]T6XUF.YT[4HS,JSQ):1IY,> 2WRME55AG.#7U;\)_@!JGA'
M]D>#X1:SJMO%JKZ'>Z1/J6EEWCB:X\X>9&65&.T2@\@<BO&?%G[*OQK\6?LU
MCX,#4_AYHF@V=K;6T=WIT5T)M3\B2-HVGS'M@8F-9'9!(79<?*&-.ZN+H=#^
MT9>^-M>_:X^&'@7PSXZU7P9INN:%J!OY-/?=\B$NS)&V8Q,53:LC*2FXD<U!
MH=CXD^#W[3UI\)Y/B!XH\4>#_'7AJ\N;:37]1>YU'3+R(,&>&YP&5=@) !X;
M![ G*_:>TGQ5K'[;OP<B\%:S::%XECT'4IK6YU"W,]L^T,6BE0$'8Z@J2IW#
M=D<BO3_A=\$?']]\;9?BM\6-6T"XUVTTMM&T;1_"ZSFRLX6??)*7F =I&Y'3
M&#] %T'U/)O"_P"T5XC\$_L5^/8-=U*\O_B?X,OKKP>UQ,[O=7-\\OE6DP+$
MLY*RHVXD[O+8U]8?"7PSJ?@SX8^%]$UO5+S6]:L=.ABO]0OKAKB:XN-@,KM(
MQ);+EL9)XP*^0O&GPBA\8?\ !1JSTW3+U9/#OV73_&OB?38P=BW]FLT%F6XQ
MEO,C;;W!8D=#7W528(****DH**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#Y%_9W_P"3MOB;_P!Q/_TOBKZZKY%_9W_Y.V^)
MO_<3_P#2^*OKJOH,[_WF/^&/Y'C95_ E_BE^84445\^>R%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?(O[ ?_ #/?_;A_[<5]=5\+^ /A
M-^T!\+OM_P#PC&E?V9]N\O[1_I&GR[]F[;_K';&-[=,=:Z[_ (RK_P _V57V
MF9X&&-Q<Z]/$4TG;>6NB2['R^ Q4L+AHT9T9W5]H^;9]=45\B_\ &5?^?[*H
M_P",J_\ /]E5Y?\ 8_\ U$TO_ _^ =_]I?\ 3BI_X#_P3ZZHKY%_XRK_ ,_V
M51_QE7_G^RJ/['_ZB:7_ ('_ , /[2_Z<5/_  '_ ()]=45\B_\ &5?^?[*H
M_P",J_\ /]E4?V/_ -1-+_P/_@!_:7_3BI_X#_P3ZZHKY%_XRK_S_95'_&5?
M^?[*H_L?_J)I?^!_\ /[2_Z<5/\ P'_@GUU17R+_ ,95_P"?[*H_XRK_ ,_V
M51_8_P#U$TO_  /_ ( ?VE_TXJ?^ _\ !/KJBOD7_C*O_/\ 95'_ !E7_G^R
MJ/['_P"HFE_X'_P _M+_ *<5/_ ?^"?75%?(O_&5?^?[*H_XRK_S_95']C_]
M1-+_ ,#_ . ']I?].*G_ (#_ ,$^NJ*^1?\ C*O_ #_95'_&5?\ G^RJ/['_
M .HFE_X'_P  /[2_Z<5/_ ?^"?75%?(O_&5?^?[*H_XRK_S_ &51_8__ %$T
MO_ _^ ']I?\ 3BI_X#_P3ZZHKY%_XRK_ ,_V51_QE7_G^RJ/['_ZB:7_ ('_
M , /[2_Z<5/_  '_ ()]=45\B_\ &5?^?[*H_P",J_\ /]E4?V/_ -1-+_P/
M_@!_:7_3BI_X#_P3ZZHKY%_XRK_S_95'_&5?^?[*H_L?_J)I?^!_\ /[2_Z<
M5/\ P'_@GUU17R+_ ,95_P"?[*H_XRK_ ,_V51_8_P#U$TO_  /_ ( ?VE_T
MXJ?^ _\ !/KJBOD7_C*O_/\ 95'_ !E7_G^RJ/['_P"HFE_X'_P _M+_ *<5
M/_ ?^"?75%?(O_&5?^?[*H_XRK_S_95']C_]1-+_ ,#_ . ']I?].*G_ (#_
M ,$^NJ*^1?\ C*O_ #_95'_&5?\ G^RJ/['_ .HFE_X'_P  /[2_Z<5/_ ?^
M"?75%?(O_&5?^?[*H_XRK_S_ &51_8__ %$TO_ _^ ']I?\ 3BI_X#_P3ZZH
MKY%_XRK_ ,_V51_QE7_G^RJ/['_ZB:7_ ('_ , /[2_Z<5/_  '_ ()]=45\
MB_\ &5?^?[*H_P",J_\ /]E4?V/_ -1-+_P/_@!_:7_3BI_X#_P3ZZHKY%_X
MRK_S_95'_&5?^?[*H_L?_J)I?^!_\ /[2_Z<5/\ P'_@GUU17R+_ ,95_P"?
M[*H_XRK_ ,_V51_8_P#U$TO_  /_ ( ?VE_TXJ?^ _\ !/KJBOD7_C*O_/\
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M]I?].*G_ (#_ ,$^NJ*^1?\ C*O_ #_95'_&5?\ G^RJ/['_ .HFE_X'_P
M/[2_Z<5/_ ?^"?75%?(O_&5?^?[*H_XRK_S_ &51_8__ %$TO_ _^ ']I?\
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MY@X0C%T*FB_E_P""?75%?(O_ !E7_G^RJ/\ C*O_ #_959?V/_U$TO\ P/\
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M!_:7_3BI_P" _P#!/KJBOD7_ (RK_P _V51_QE7_ )_LJC^Q_P#J)I?^!_\
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M)_:$B#2M+-B$8I-_:<GFEMN0"GV? !;@G<<#G!/RU7^W>+?L)?\ L31?MGF
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M?$'QX^&&LZIXFLK.$PZU?Z1::MH8FMK/6;.)]L=]:[G:1$<$J")&.Z-B".@
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M+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .&^*WQO\#?
M_2[74/''B*VT&WNG9+<2J\DLQ7&[9'&K.V-RY('&X9ZBKWPT^*OA/XQ>&4\0
M>#=;M]=TEI#$9X RE' !*.C@,C8(.U@#@@]ZY']HCXN>%_@GX=M/$6K:5'K?
MB:4R:=X?TV&W$MY=W$P4&&(X+*K%4WD<8"\$[0?)_P!G#X5_$']F/]G[4;NS
M\'P^,?'NO:K_ &K=>&;74H=.BM5D"KY:RN"@**N2!QD[02!DU;074^@]5^+'
MA30_B-H_@2_U86OBK5[9[NPL9()0MQ&F[=MEV^66&QCLW;L#.,$4GAGXM>%/
M&7C3Q)X3T75?[0UWPXT::K;QV\H2V9P2JF4H(V;@\*Q(P0<8-?.'[4^F^*O%
MW[/6F?%35O#*?#WXD> =0&MV5BVH1Z@$C255>-IH@%99%".5'=0I[URD=UK/
M[-G_  3]U+X@Z%=^?X[\8);:_J&M,FYEFU"2,[\$=4CE"C/&\EN^"6%<^Z:*
M^$?V:[WXR^!?BAI]]XRGUZ+P'J&BW%[=IXG\;6.O2S-'$9!/:)'MD5. -J*P
M ;D],>4> ?BU\2++XC?"+Q78ZYX]E\)^+?%%OI/VSQ5XIMKRVU*%[@0RA--C
M0&W(&[YMS $#!Y%/E#F/U%KDOB;\6?"/P;\._P!N^,]=MM!TPR"))9PS-(Y!
M.Q$0%G; )PH)P":^;/A#HWBKXG?M0?%J:_\ B-XJLM \'>([:2QT"SOV6UF+
MH2T<H;.8=L>/*7 RQ/U] _:O^#,GQ>?P0^A>+=-\,>/M U!]5T"+5 DD-VZ>
M7YBF,Y9@I\HE@K8R 1\U*VNH[GIWPL^,7@[XU^'Y-;\%:Y#KNFQS&WDDCCDB
M:.0 ':R2*K*<$'D<YKLJ^#;G]J+46^!OQ?@\6:>?!_COP]K%EIE_K'@$QH=0
MN)),*T<KY"N5A='9BQ56! !PE87P)O\ XCW_ ,4OB1\*O%^N^-M#T^X\%2ZM
M'#JOBR'6-4LY1-"JR1WD2*(]RR-F/;G&,]C3Y17/KCX'_M(>'?V@)M8?PSI'
MB"'2M/;;%K&I:?Y%GJ'S,I-M)N._!7D$*1D9%>IW%Q%9V\L\\J0P1*7DDD8*
MJ*!DDD] !WK\L?AOXF\4?!7]@W2O$OA'Q%K0U3QAXEBT1H)M01+;2XEDNRSV
MF]=MN\I4*\C$C)#<;:]9^&/A7XQ&T^)OA/QUJ7BG0O"M]X3FOK3^U/&UEK.L
M0W,;QG='-$!(L+J75OW>W&!G+"AQ!,^Z/#WB32?%VCV^K:%JEEK6E7&[R;[3
M[A)X)=K%6VNA*G#*0<'@@CM6C7YM?!_P#XGTC_@GC+XU\%>.O%5MXC@=M;32
MX]5<6=K'9WMVLL4,28*)+&TDDB$L)'C4XXKW+]GOXP:G^TI^T9K'BS2=7U"#
MP!X?\,V%LNEPW++:3:C=()I"\>=KO$#)$<C@H.?5.(7/K.BOCG]LCQ1K^K?%
MKPUX#\'7OCB;Q$^C2ZM+I7A7Q);^'X3;B1E\Z6ZE1\D&-QLP.!UYKRN/XT?$
M7Q!^P_X)U@^,M3L?%7_"<PZ1_;<%QNG:(22!1*RD"<#C(;(<*-V>M'*.Y^C5
M<'\7/C)HGP8L?#EUKEO?7$>O:Y;:!;"PC1REQ.'*,^YUP@$;9(R>F :^5+;Q
MAXT_9T^.WQ+\))XW\1>/=/M_AY=^*K1?$US]JDBOX06 3CY8R5?Y% 'S*.=N
M3Y'XDT?6-0^%?P!\=ZU\6=<\8ZCXI\::;=76@ZE>)-;0RAY<O;1_>B\KF)U7
MY29!PN%%-1%<_27QUXZT/X:^$]2\3>)+X:;H>G()+JZ,3R>6I8*#M168\L!@
M ]:\_P#A7^UI\*?C7XG;P]X,\5?VSK"V[W1MO[.NX/W:E0S;I8E7@LO&<\UA
M?MX?\FD_$7_KTA_]*8JR?V?_  _\6_%GPCLM&\<:EX;T?PI?>&+:WTG4/!-Q
M>0:S;[H4".TDH**XCYR@.']J5M+CZFYX9_;&\$^*-'\;:Y!IOB.U\->%8I99
M]>N],*65[Y;;76V<,3(P.T;2%(W+G&:TO 7[57@OQQ'X5CGMM=\*ZEXIGFAT
M;3/$&ER03W@CC20RJ4WH(RDBLK,P# \5\ ^ ?AF;W_@G#XT\5'Q;XI@(OQ+_
M &-#J>W3CY<XCVF';RK^?N<9^9HHCQMY^@?#ZZW\,?$W[(7A_3O&/B:^TO7K
M?4+O4(=1U-Y%G!L;9TA8#:&BB+,(T8'8#QZU7*B;L^X**^)O@;=>)/CGXF\6
M_$/7?C'K7A2XT'QFVE6WAJVO$BTN.UCEC"P3V[8$C3!C&&R#N&?F.0/"?C3\
M;?B#:ZAXP^)/@?7O'W]@:1XGEL(]2U#Q/;1:4CB;(M5TD)OD0*P 8N?EP6 P
M0%R]!\Q^I]%?''C"Z\1?&S]K3Q_X%N?B=K_PY\/^#=(M+RP@\/7JV;W<DD*2
MR7$S$?O(T,FUE/& O*\YQ/BC\;M?_9<^,&K:EK'BR\\3>%_%G@@W>B37%R7L
M_P"U[6%1F&,LR1K,=KD)P3.O7 I<H[GW%17E7[+>A^(=!^ ?@V+Q7JVI:UXB
MN;);Z]NM5NGN+@/,3*(V=R3\BN$QGC;7JM2,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** .;\"L+BSU6[\^2<W&K7@)D!&WRIF@VC
MD\#RJXSX@_M4_"GX6^(O["\3>,K/3]7! >UCBFN&B)Z"3RD81G!!^;'!STKN
MO!@G71[C[19K8R?VC?XB6,QAE^US;),'NZX?/?=D<&OE/]@-M(FL?BY)XB:U
M;QP_B2\_MD7VTS_9=J?ZS=_RS\PSY[9'/:O4PV'IU*=6M5NU"VBT>KMO9Z+T
M['FJI.,:5.%DY+=^E]M#Z^T?5[/Q!I-EJFG7,=YI][ ES;7,1RDL3J&1U/<$
M$$?6K=?+%CXRGTG]MS2-"L==-IX!F\"+>:=IEM>;=,9%<[98HE;R\!$.& ^Z
MO'%>)7'Q4\:ZA^RV^K:=XXUB/5IOB>=/MM76_EE=;8CY(]V[YXN0?+SM([5U
M0RF=1QM*R?+O_>O^5M0EC8Q3NMK_ (6_S/T4HKXV^.'A'Q9X!UWX)^!='^*7
MC -KVM7T-]K5UJ#274D;I%E3C"D*"^P,#L+9'2N5^/.J?$JQ^,'A;X-^$M8\
M7ZY:Z?X?%\9+/Q1#I.JZG*TCCS9+V5"'VA0-@&3ACVX5+*U6Y>2JK--ZZ:)M
M7UTZ#GC/9WYH/2R[ZO4^\Z;)(D,;R2,L<: LS,<  =237P3XJ\7?%O2?V;?A
M];:WXKO-%\7M\1+?13JEAJL-Y/\ 9FCFVI<20.4E*M]Y'^]L7<*Z3PUIWB30
M_C7\5O@[?_$7Q;KNAS>#_P"V(-1OM0W7UK,&B#>5+CY ?-;@ #&!C(S5/*6H
MMNHM+[7>B:3:>W47UV[2Y'K;[VKV_ ^P?#OB?1_&&E1ZIH.K6.MZ;(65+S3K
ME+B%RIPP#H2"000>>U9-K\3_  S>_$:\\!PZF'\66=B-2GT_R)1LMRRJ'\PK
ML/+KP&SSTKYL_P"":WA--.^",6O#7M7NGU&::(Z/<WF^QM1',XWPPX^1FS\Q
MR<\5=T>^M]'_ ."D6OI?3):-J7@E(;,2MM\]_.@;:GJ<12'_ ( :B> IPQ&(
MH*3?LTVO5-#CB92I4ZC5N9K\3Z&TCXH>&==\?:[X*L=3\_Q/H<44^H6/D2KY
M*2*KH=Y4(V5=3\K'&><5U-?$VDZP;S]H[]JWQ#H=\QBLO#$4*7]G(5,5Q'8J
MORN.C*\+\@\%>*\\T_QCXU\&_#;X(?$RW^+/B'Q-KFOZU;Z5>>';S4/-LY8,
MLK)Y0Y9UV*KNQ+%I0>#UZ/[(YVE"=KJ.C_F<.:VBT6^YG]>Y;\T;ZO;LI6/T
M$\9>*;3P/X/UWQ)?I-+8Z/83ZA<);J&D:.*-I&"@D MA3C) SW%5_A_XVL?B
M1X)T3Q3ID5Q#I^K6J7D$=TJK*J.,@,%) /T)'O7PWXWOO$?Q<@_:5US5OBCK
M'AN#P?+J&D6/ANUNECL9[=$EC"30MPYG"E%;[VYB03@"GZUXLU:7X/?L]^"?
M#%YXP/B'4] >X73/"FMPZ,;E%1"&DNY58+MV.0H7D%LD<9I90N11YO>OKV2Y
M>;K9?/87U[WF[:6T\];'W=XB\3Z/X/TJ35->U:QT338RJO>:C<I;PH6.%!=R
M "20!SWK1CD2:-)(V62-P&5E.00>A!K\P?&.O>)OB5^PKXFU#Q5XBUB[O_"_
MC)M,BCEU!9_/BQ;X2YD48N-C2N5?(Y (XQ7J/QTUGQI\-]#^#OPQ\%^(_%&M
M#Q"+BYN;Z3Q#%:ZI=%5C9;:.^D3;"%WG P>-B_4>2N\8*HN;FDGVM%)WOZ L
M?O+ETLGYZNUC[OKG/B)Y,/@G6;V6T%ZVGVSZA##N9298098\,O(.Y!R.:^8?
MA#I_Q*NO@Y\4?#/Q#\<77@)K2>$:?X@U+Q%:ZCJ&DQL=S">YAE0Y^50"YC)\
MPXXKZ.O(+BS^#<\-MXA6\NHM 9(O$$DVT2N+? NC("V,GY]P)ZYR:\G$858:
M7+SJ5G;3;9.]]NO<WE5]M1D^6VCW^?1_J=G1117GG>%%%% !1110 5P_Q:^-
MO@KX%Z'::QXXUL:'IUW<BT@E^S37!>4JS[=L2,WW58Y(Q[\BNXKQ3]IKX+O\
M:H?!%G8>-X? _B'1-;CUO2[J2RCO'EFA4D!87D0-M)5C]X<8((-->8CK?A%\
M>/ WQWTW4+_P-KG]N6EA*L%S)]DGM]CL-P&)40GCTS6AXF^+'A3P=XT\-^%-
M9U4:?KOB(R+I5O);R[+ED W*)0IC#<CY68$Y& <BOFSX!_M ?%G49_C#X7O;
M*Q^+WB3P1>6T&GW6GRP:4FI>9*Z.K28\J,JB%^G\++R<&M+]HKP]XK^,?[,.
ML^*?%/A'_A6GCGP7/)XBTF%=5AU%HOLB"4N)H@%^=1(-O9E4GM3MJ*^A] Z3
M\6?"FN?$;6/ =AJHNO%6CVR7=_8QV\I6WC?;MW2[?+W$.IV;MV"3C@XZZOAW
MX;:CK'PG_8I\>?&ZVFCO/B+XQ237KJ^\O<L+23&.%54Y^2)7+A3D DCD5@?L
MP7'QUL_BG\/-7UFZUZ7P=XDMY6OV\2>-[#5H;_-N\J265NNV2':5W%$#D ')
M 4T<H7/T!HK\L+WXU?$)=>\/?$CPMX@\?2>$-1\6IIT.I:_XGMGL+Q#,0\"Z
M2J;T&W^+<0 .QP1]&:3H_BKXH_MN?%;19/B/XJT+POX7;1-1@T;2;]HX99#:
MQ.8R#D+$Q\S>B@!RX)Z4<H<Q]/\ Q"^(_AGX4^&9_$/BW6;;0]'A8(US<D\L
M>BJH!9V.#\J@G@\<5D?"7XY>!OCGI=WJ/@?Q!#KMK9R"*XVPRPO$QR5#)*JL
M,X.#C!P<5PO[6WP;MOC=X1\/:/!XIL_"WBFQU:/4]"DOBCQW%S$K?NS$WWQA
ML\ D8!P1D'PZW_:6UO1O OQUTCXCV5MX<\<>$+6SCO\ Q/X$1"][YSB.##M]
MV0-(HRQ^7>_RJ4*T6NAW/N:O*?A1^T?X>^,WB_Q%H?AW2/$!MM$EE@DUV[T_
MRM-N98W5)(X9=Q+."RG:5!P<U\C?L]:U\2G^/Q^'GB;7/&^CZ)XK\)7-T(]:
M\70:Q?P[U(CN[>:*-?LK@'*J1D$9.>,>?_"?7_$7P/\ V,?B%X[\,>)=;&L7
M?B)]"2&YNQ)9V:F2/==1QE<+.P)4R$]U..*?*+F/U/K*\,^+-#\::6NI^'M9
MT_7M-9VC%YIETEQ"64X90Z$C(/49XKXH_9]\*_&J3XA7OAGQ?JOBS0O!_B3P
M].?.U/QY8ZQJ<4WRA;NQDB DB4;@!M1E&X$DG;CSS]E_X6^(=6_8;\9>(/"/
MCCQ9I?B=_M,UCIMAJ[PVT36LBRMY,:8*O*N48[L'<N:.4+GZ7T5\9? 'XZ:W
M^T_^T!X4U33-8OK3PQX7\(1W6MV-K<LEM<ZM<@H8Y8U(5PHW,NX':8R1@UM_
MMJ^+M8F\8> / WA6\\:-XEU6.\N4TOPCKL&B&YC0(=TMY*CA=FQR%"\@MDCC
M*MK8=^I]945^:]O\;OB*_P"P+X]UB[\4ZO;^)_#OC)=(MM3&H^;>1PH]JWEO
M<QX\[F5U+]&'M7J5GJ/C3]GO]JC3_"\_Q!\2?$#3]=\)7NL7%MX@G$D8O(5E
M<&%%&(4)AP$3H&QD\8.45SZ;^,WQBT7X&^#D\2:_;WUU8->06(CT^-'EWRMM
M4X=U& >O.?8UTOBSQ5I?@?PSJGB#6[H6.CZ9;O=W=R49_+B0$LVU06/ Z $G
ML*_+[QM#K_C;]E+PU\4?$/Q:UK7=6\2>(XDN_#-W=H^GH4NG54@@(!B= @<[
M."&QC'S'[\_:V_Y-D^)W_8 N_P#T6:?*%Q?A#^V-\(/B[XVMO#'A+Q=_:VN7
M44CPVO\ 9EY#N"+O8[Y(54852>3VJYI?[7W@S5O&GCS0H-,\1_8?!,5[)K/B
M1M,/]E126@S<0B8,6,J@,=NT9"DC(QGS#]A^R^+>I?"CPI9^(I_"-K\/+CPP
ML6G3Z$]XFMQ[E01,[/\ N@P4L25Z,%Q7RU\-_@Z;C]GW]J75_P#A.O&D;:+J
M>J6/V*/6,6U_Y123SKI-G[V5]FQVR-RNPP,YHL@NS[O^'W[9?@+QYI?AZ^N+
M7Q%X27Q)JBZ3H<?B'29(FU25E5D>$Q^8IB;>,2,5&0?2O=J_.OX?KKGPM^%O
M[)%OI/C/Q1-:^*O$EK<W]O=ZH[1B&2WB4V:*NT"V7;E8FW %V/>NM\%W7B;X
M]_&+XR:WJ_QGU[X>P> O$K:5I>CZ=>QP:?%;Q2%!-=PO@3)+L_B(Y+<XP*.4
M+GW/17Y:_M-?%OQ]-XM^*OBWP!XA^(::5X-UO^S;G4?^$KMK#2+"Y218V@73
M2A>Y7<& .[G[Q&,BO:_$7B;Q5^T%^TMHWP[O?B/KGPYT&T\$6WB+_BEKP6-U
MJ-Y)L+GS"IRBAR2G(Q&>.6(7*',?;]%?#?Q#^+6N?LK_ !@\$^*M=\>:AXW^
M'GB'P;/8RW4ET6LYM3M(1(MS'&KF-'G"QJ-GWFD?D]O</V*;;Q4W[.WAO6?&
MFLZCK?B'Q#YFM32ZC</,T4<[;H8TW$[4$7ED(. 6.!1;2X[GNE%%%2,****
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M.OV,?@O\2O%VH>*/$?@.SU#7-00QW5T+BXA$N5VERD<BKOQ_'C=GG.>:S?\
MA=GQB_Z(-_Y>%G_\136^.'Q@5@&^! !/0'QC9\_^.4^67?\ %!S+^D9_[57[
M+MS\<OACX'^'WAY=)TSP]I&J6DEU-J$LQN+>QAC,>RV(5RTA1L9=@#CD\Y'T
M-86-OI=C;65I"MO:V\:PPPH,*B* %4>P  KPO_A=GQB_Z(-_Y>%G_P#$4?\
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M%%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FOQ?\
MV</AU\>IM+F\=^'?[<DTQ9$M&^VW%OY8D*EQ^YD3.=B]<XQQU-6/A#^S_P"
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M!5OX??L_^ OA'KNO:[X-\,V^CZQK(S>2)<S%)3N+ !69EC7<?X%'TKT6BB[
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<9\:_\ DC?CS_L 7_\
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M?_Y(7X9_[>?_ $JEK;_EW\SPY?\ (VC_ ->Y?^E1/4Z***Q/<"BBB@"[I/\
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M %.LK)+.%41< "K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_E:_^YZ/^'B__5/O_*U_]SU\8T4>QAV#^V\P_P"?GX1_R/L[_AXO_P!4^_\
M*U_]ST?\/%_^J??^5K_[GKXQHH]C#L']MYA_S\_"/^1]G?\ #Q?_ *I]_P"5
MK_[GH_X>+_\ 5/O_ "M?_<]?&-%'L8=@_MO,/^?GX1_R/L[_ (>+_P#5/O\
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ME?\ E5_^TT?\-Q?]25_Y5?\ [37RS11["GV#_63-?^?W_DL?\CZF_P"&XO\
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M_M-?+-%'L*?8/]9,U_Y_?^2Q_P CZF_X;B_ZDK_RJ_\ VFC_ (;B_P"I*_\
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M<7_4E?\ E5_^TU\LT4>PI]@_UDS7_G]_Y+'_ "/J;_AN+_J2O_*K_P#::/\
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M2?M%> 4\(VGB-=7NIK*[U%](AL[?2;R746O4+^9:_85A-R)D$;LT9BW*JEB
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M7*@CH WD*,]@WN:49R22[FV+P="I.M7O;D;NM.RY;>KW/AVBBBND^4"BBB@
MHHHH **** "BBB@ HHHH **** -WP/XRU'X?^*]-U_2I3%>V,HD7GAQW0^H(
MR#]:_1GQ/8:3^TY\$[;4M)*FZDB^TVA)!:"X48>)O3G*G\#7YL^']!OO%&N6
M.D:; US?WLRP0Q*,EF8X'X5^D^DZ?I'[+'P+6!2DMS;IO8\YN[QP,GZ9 ^BK
M7-5W36Y]3D_O4:\*_P#!M[W_  /Z['PU=6TMG<2V\Z-%-$YC=&ZJP."#^-1U
M;U;5+G7-4N]1O)#-=W4K3RR'^)F))/YFJE=Q^92M=\NP4444""BBB@ HHHH
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M6-_PE$'_ #[7/_?*_P#Q5'_"40?\^US_ -\K_P#%4 ;-%8W_  E$'_/M<_\
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M_P!!GPS_ .!5Q_\ &*/:0[A_96-_Y],^9:*^FO\ AW[\0_\ H,^&?_ JX_\
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M_P 8H]I#N']E8W_GTSYEHKZ:_P"'?OQ#_P"@SX9_\"KC_P",4?\ #OWXA_\
M09\,_P#@5<?_ !BCVD.X?V5C?^?3/F6BOIK_ (=^_$/_ *#/AG_P*N/_ (Q1
M_P ._?B'_P!!GPS_ .!5Q_\ &*/:0[A_96-_Y],^<-)N+:SU2SGO+7[=:13(
M\UKYGE^<@8%DW8.W(R,X.,UZ%^T!\;KCX[^-+?6Y-,&BVMK9QV5MIZW!F6-5
M+,3NVKR2Q_A'  [5Z;_P[]^(?_09\,_^!5Q_\8H_X=^_$/\ Z#/AG_P*N/\
MXQ4\\+WN:QR_,(TW25-V=K[=-CYEHKZ:_P"'?OQ#_P"@SX9_\"KC_P",4?\
M#OWXA_\ 09\,_P#@5<?_ !BJ]I#N9?V5C?\ GTSYEHKZ:_X=^_$/_H,^&?\
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M $%- _\  B?_ .,T>VAW#^P\R_Y\L\"HKWW_ (8M\;?]!30/_ B?_P",T?\
M#%OC;_H*:!_X$3__ !FCVT.X?V'F7_/EG@5%>^_\,6^-O^@IH'_@1/\ _&:/
M^&+?&W_04T#_ ,")_P#XS1[:'</[#S+_ )\L\"HKWW_ABWQM_P!!30/_  (G
M_P#C-'_#%OC;_H*:!_X$3_\ QFCVT.X?V'F7_/EG@5%>^_\ #%OC;_H*:!_X
M$3__ !FC_ABWQM_T%- _\")__C-'MH=P_L/,O^?+/ J*]]_X8M\;?]!30/\
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M!45[[_PQ;XV_Z"F@?^!$_P#\9H_X8M\;?]!30/\ P(G_ /C-'MH=P_L/,O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWC[X(>#OB9JD>I:]IMRVHI8RZ8UYIVIW6GS36DC*SV\KVTL9EB+*#L<LH))
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M6E%5*D8/JT9U).$')=$4O^%\?#O_ *'/1O\ P+7_ !H_X7Q\._\ H<]&_P#
MM?\ &OS(HK]%_P!5</\ \_)?@?%?ZP5OY%^)^F__  OCX=_]#GHW_@6O^-'_
M  OCX=_]#GHW_@6O^-?F111_JKA_^?DOP#_6"M_(OQ/TW_X7Q\._^AST;_P+
M7_&C_A?'P[_Z'/1O_ M?\:_,BBC_ %5P_P#S\E^ ?ZP5OY%^)^F__"^/AW_T
M.>C?^!:_XT?\+X^'?_0YZ-_X%K_C7YD44?ZJX?\ Y^2_ /\ 6"M_(OQ/TW_X
M7Q\._P#H<]&_\"U_QH_X7Q\._P#H<]&_\"U_QK\R**/]5</_ ,_)?@'^L%;^
M1?B?IO\ \+X^'?\ T.>C?^!:_P"-'_"^/AW_ -#GHW_@6O\ C7YD44?ZJX?_
M )^2_ /]8*W\B_$_3?\ X7Q\._\ H<]&_P# M?\ &C_A?'P[_P"AST;_ ,"U
M_P :_,BBC_57#_\ /R7X!_K!6_D7XGZ;_P#"^/AW_P!#GHW_ (%K_C1_POCX
M=_\ 0YZ-_P"!:_XU^9%%'^JN'_Y^2_ /]8*W\B_$_3?_ (7Q\._^AST;_P "
MU_QH_P"%\?#O_H<]&_\  M?\:_,BBC_57#_\_)?@'^L%;^1?B?IO_P +X^'?
M_0YZ-_X%K_C1_P +X^'?_0YZ-_X%K_C7YD44?ZJX?_GY+\ _U@K?R+\3]-_^
M%\?#O_H<]&_\"U_QH_X7Q\._^AST;_P+7_&OS(HH_P!5</\ \_)?@'^L%;^1
M?B?IO_POCX=_]#GHW_@6O^-'_"^/AW_T.>C?^!:_XU^9%%'^JN'_ .?DOP#_
M %@K?R+\3]-_^%\?#O\ Z'/1O_ M?\:/^%\?#O\ Z'/1O_ M?\:_,BBC_57#
M_P#/R7X!_K!6_D7XGZ;_ /"^/AW_ -#GHW_@6O\ C1_POCX=_P#0YZ-_X%K_
M (U^9%%'^JN'_P"?DOP#_6"M_(OQ/TW_ .%\?#O_ *'/1O\ P+7_ !H_X7Q\
M._\ H<]&_P# M?\ &OS(HH_U5P__ #\E^ ?ZP5OY%^)^F_\ POCX=_\ 0YZ-
M_P"!:_XT?\+X^'?_ $.>C?\ @6O^-?F111_JKA_^?DOP#_6"M_(OQ/TW_P"%
M\?#O_H<]&_\  M?\:/\ A?'P[_Z'/1O_  +7_&OS(HH_U5P__/R7X!_K!6_D
M7XGZ;_\ "^/AW_T.>C?^!:_XT?\ "^/AW_T.>C?^!:_XU^9%%'^JN'_Y^2_
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M?^!:_P"-'_"^/AW_ -#GHW_@6O\ C7YD44?ZJX?_ )^2_ /]8*W\B_$_3?\
MX7Q\._\ H<]&_P# M?\ &C_A?'P[_P"AST;_ ,"U_P :_,BBC_57#_\ /R7X
M!_K!6_D7XGZ;_P#"^/AW_P!#GHW_ (%K_C1_POCX=_\ 0YZ-_P"!:_XU^9%%
M'^JN'_Y^2_ /]8*W\B_$_3?_ (7Q\._^AST;_P "U_QH_P"%\?#O_H<]&_\
M M?\:_,BBC_57#_\_)?@'^L%;^1?B?IO_P +X^'?_0YZ-_X%K_C1_P +X^'?
M_0YZ-_X%K_C7YD44?ZJX?_GY+\ _U@K?R+\3]-_^%\?#O_H<]&_\"U_QH_X7
MQ\._^AST;_P+7_&OS(HH_P!5</\ \_)?@'^L%;^1?B?IO_POCX=_]#GHW_@6
MO^-'_"^/AW_T.>C?^!:_XU^9%%'^JN'_ .?DOP#_ %@K?R+\3]-_^%\?#O\
MZ'/1O_ M?\:/^%\?#O\ Z'/1O_ M?\:_,BBC_57#_P#/R7X!_K!6_D7XGZ;_
M /"^/AW_ -#GHW_@6O\ C1_POCX=_P#0YZ-_X%K_ (U^9%%'^JN'_P"?DOP#
M_6"M_(OQ/TW_ .%\?#O_ *'/1O\ P+7_ !H_X7Q\._\ H<]&_P# M?\ &OS(
MHH_U5P__ #\E^ ?ZP5OY%^)^F_\ POCX=_\ 0YZ-_P"!:_XT?\+X^'?_ $.>
MC?\ @6O^-?F111_JKA_^?DOP#_6"M_(OQ/TW_P"%\?#O_H<]&_\  M?\:/\
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MOQ/TW_X7Q\._^AST;_P+7_&C_A?'P[_Z'/1O_ M?\:_,BBC_ %5P_P#S\E^
M?ZP5OY%^)^F__"^/AW_T.>C?^!:_XT?\+X^'?_0YZ-_X%K_C7YD44?ZJX?\
MY^2_ /\ 6"M_(OQ/TW_X7Q\._P#H<]&_\"U_QH_X7Q\._P#H<]&_\"U_QK\R
M**/]5</_ ,_)?@'^L%;^1?B?IO\ \+X^'?\ T.>C?^!:_P"-'_"^/AW_ -#G
MHW_@6O\ C7YD44?ZJX?_ )^2_ /]8*W\B_$_3?\ X7Q\._\ H<]&_P# M?\
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MXU^9%%'^JN'_ .?DOP#_ %@K?R+\3]-_^%\?#O\ Z'/1O_ M?\:/^%\?#O\
MZ'/1O_ M?\:_,BBC_57#_P#/R7X!_K!6_D7XGZ;_ /"^/AW_ -#GHW_@6O\
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MKZY#XP?\DD\;?]@.^_\ 2=ZZ,/\ QH>J_,QK?PI>C/R[HHHK]X/R(***]*^
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M=[7?IW/GBBOHOQQ\%?#?_"86]AH^B:J+?_A"5UTPZ;=1EQ<>8R^9(;A_]7C
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MKJ7ECY#XB\C[6$42E-_R;^7 W<;\Y[TEYK2^'_%7B_4@+!_&%CX#%SK @4-
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M6#;'=RP)C.-@X/)SGC'L/BUX#\"Z/\.M,T[Q+=>)(] UN2XNKF2QE@8PR1R
MR*K _*ID^[G=\IXZ5\N45"R:A:W-*WRUWUV_O/:Q7]IU;WY5?YZ;>?DCZBOO
MB)\-_#OAS6K'1_%<^KSZEXGM=<8R:=-"J1_:$=T&5Y**I))QG(P*Z*']H#X?
MZAK?CVRNM1L!8ZGJ5O?6=[J^B37]I*%MX8V#0 HX8-$<$XZYKX[HI/):$D^:
M<F^^G]WRM]E= 6:58[15NVOGY^9]5:Y\9?"'CRR\<>&]=\71Z;!J$UG-::_I
M>CW$<5PL:)N0VY9G4@J5Y;!Z\8P?+/VCO&^A>//&&CWOA^_FU&SM]&M[1YKB
M)HY/,1I,A@P&6PPR1D9/!->445TX?+:6&J*I"3TZ:6V2;VZV7EV1A6QU2O!P
MDEKZWW;[^;\^Y]*^"_CMX;TKX,VS7U[*OC[0].O=)TJ/R&.Z.<Q[) P78-@4
M ;B#A&X.1FGX'^+/AK1_AW\,]+E\0SZ1JFCZK=W-W+!9M*ULCK.$;!0JZDR*
M"JY.&/0\CYVHJ'E5!J2N]6WTZIJVVWO-V[LM9A65G9:*W7NM=]]$?6MQ\:/A
MQ9>*[FZM-51FE\+7]A<7EGIUQ;6L]U++$Z+' =QC)VR%CT)(RQ[<W9_$;P1?
M:)\+-0D\7WNAZUX8@^R36MOIK2NN< R[R"A4;?NX8D-C@U\W45$<HHQ5E.7X
M=FNUMF_T*>959/6*_'NGW\CV;]HSQGX4\7-X=_X1V^AU*]@6Y;4;NRL);&UE
M>1U962"1CM8_.6(^\2#GL/&:**]/#T(X:DJ46VEW^\X*U9UZCJ25K]@HHHKI
M, HHHH **** "BBB@ HHHH **** "BBB@ K=\#+HS^+-.'B"^O-,TCS"9KRP
M&9H2%)1UX/1]N<#.,XYK"HJ91YHN-[7*C+EDG;8^LV^/GA/PY!X+LKGQ7>?$
M&ZTW6?M4NM3Z>]L]K;&)HRN&&YR-^>Y//^R*K1^-/A]9Z;J&A^'?%$VMZAK?
MBRSU5%DT^6!0&N4)C!9>2H7DG&<C KY5J2WN);6XCG@D>&:-@Z21L596!R""
M.A![UX7]CT5K&3O\K/6ZT2[]K'K?VG4>CBOQTTMW[=[GV'\8O&GA#P)XA^*S
M/XAO+_Q)KNF)I7]A&UD$=N6AP'$I^0KM<-C((RW4GCH/B5XX\)?#/XEW/B34
M]?NFUQ?#@LX/#RVLA2?<=ROYHRH!*D$''K['XCU35K[7+^:^U*\N-0O9B#)<
MW4K2R/@ #<S$D\ #GTI^L:]J?B*[%UJNHW>IW001B:\G:5PHZ+N8DX'I7/')
M(V@IS;LK2VUTBK+31:>OF;RS65Y.,%O=;Z:MWWWU]/(^G_"GQ^\&:!J/PW:>
M]:>&Q\,R:1J#"TD9;69A"1N4@;US$0=F>M:^F_'OP9H?C;PB!XBT.7P[81WI
M;^Q?#=UIZVCNBA1L9Y-P<EONJ,%>>M?'=%;RR3#R;O)ZIKIUOY>;V^9C'-*T
M>BZ=^EO/R/<M%^+6FP?";PAI%UKEP=5M/%B:G?0L)F/V8,7+EL8;YSNP"3GG
M&:]5C^/WP\U'4O&UC/J6FQVE]K$.I6=YK&@S7]K*HM88S^Y4HX=7B;DX^]D9
MKXXHK6KE%"JVVVF[O2W5I]O(SIYE6II))/;OT37?S/I7X@_&K0]=\!_$NP3Q
M!!>ZQK&H6<EK)8:?<6D=U"D=NKD*Y;9@1LI#/SCC@@5MZM\9O 7B+QIK\<_B
M%[/3-9\'QZ.VJ?89I!%<;GW!H]H9L!@<C@XQFOD^BE_8]!1Y5)_AVBNUOLH?
M]I5;W:7X^?G_ 'F?8?PM^+7PB\"Z3X;2/5+*.YTQ9[>:XN]"GEO7W,W[V*8$
MB)&W%B@#'#8XKQSXU^/O#_BSP'\/]-T6[\ZYTD7XNH! \8A$DD9C&2H!R%/W
M2<8YQ7C]%71RNE1K_6.:3E>^K7][R_O,FIF%2I2]CRI*UM+^7GY(^@[?]H#2
M_AOX#\"Z%X7TW1_$DMC%_:%_+J]C([6UZS;L1$E,.F6&]<C&W!ZUI^,?B;X"
MD?XMS:/K/F?\)5864EM#]CF3_259_.3)08/1MQP"7X)Q7S313_LJAS<Z;O>[
MUW]Y2UT[KI;07]H5;<K2MT\M''3Y,^J/^%W>#/\ A.?[2_M<_9/^%>_V'O\
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MG/*I/G<(1O9)[VWOY/L>@T5Y]_PHWPQ_STUW_P *"^_^/4?\*-\,?\]-=_\
M"@OO_CU'+A_YW_X"O_D@YJW\J^__ (!Z#17GW_"C?#'_ #TUW_PH+[_X]1_P
MHWPQ_P ]-=_\*"^_^/4<N'_G?_@*_P#D@YJW\J^__@'H-%>??\*-\,?\]-=_
M\*"^_P#CU'_"C?#'_/37?_"@OO\ X]1RX?\ G?\ X"O_ )(.:M_*OO\ ^ >@
MT5Y]_P *-\,?\]-=_P#"@OO_ (]1_P *-\,?\]-=_P#"@OO_ (]1RX?^=_\
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M'_T)'AS_ ,%-O_\ $4?ZU4?^?3^]!_J_5_Y^(_+NBOU$_P"%/^ _^A(\.?\
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M]Z#_ %?J_P#/Q'Y=T5^HG_"G_ ?_ $)'AS_P4V__ ,11_P *?\!_]"1X<_\
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M ,11_K51_P"?3^]!_J_5_P"?B/R[HK]1/^%/^ _^A(\.?^"FW_\ B*/^%/\
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M#_Z$CPY_X*;?_P"(H_UJH_\ /I_>@_U?J_\ /Q'Y=T5^HG_"G_ ?_0D>'/\
MP4V__P 16-K?PK\$V^M>'H8_!OAU([B[D251I-O\ZBWE8 _)Z@'\*J/%%&3M
M[)_>B99!5BK^T1^:E%?J)_PI_P !_P#0D>'/_!3;_P#Q%'_"G_ ?_0D>'/\
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MU?J_\_$?EW17ZB?\*?\  ?\ T)'AS_P4V_\ \11_PI_P'_T)'AS_ ,%-O_\
M$4?ZU4?^?3^]!_J_5_Y^(_+NBOU$_P"%/^ _^A(\.?\ @IM__B*/^%/^ _\
MH2/#G_@IM_\ XBC_ %JH_P#/I_>@_P!7ZO\ S\1^7=%?J)_PI_P'_P!"1X<_
M\%-O_P#$4?\ "G_ ?_0D>'/_  4V_P#\11_K51_Y]/[T'^K]7_GXC\NZ*_43
M_A3_ (#_ .A(\.?^"FW_ /B*/^%/^ _^A(\.?^"FW_\ B*/]:J/_ #Z?WH/]
M7ZO_ #\1^7=%?J)_PI_P'_T)'AS_ ,%-O_\ $4?\*?\  ?\ T)'AS_P4V_\
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M_P#L)7/_ *-:@#!HHHH **** "BBB@#]%O@#_P D9\)?]>*_S->@5Y_\ ?\
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M:S^&/I^K,X[R]?T04445D:!1110 4444 %%%% !1110 4444 %%%% !1110
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MC#K-C\2HI4DO/$PMF+&W!@C79)(Q4;9W+ ["#R%?]GZ "BBB@ HHHH ****
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MT/10!Y/KWP]U6/\ :-TCQEI]L;C1]4\-7/AS7'655:W\N87%G*%+ L,R7:'
M8@R(>!N-+I7[-WAG1_"?PI\/PWVK-9?#>YANM)DDFB,D[16LMLHN"(\,-DS$
M[ GS =!D'U>B@ KQ6W_92\-6^L9.N^()?":Z^?$\?@IYK?\ LF+4#+Y_FKB
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M=V]5_?.06=1E5/0G)->X44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA_X!'_(/KV*_Y^R^]_YE[^VKW_GX;\A1_;5[_P _#?D*HT4?V/EO_0-#_P
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MLOO?^9^FWP!\)V6H_!GPA=37&J"66P1V\G5KJ),G/15D"CZ 5W__  @VG?\
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MC4LQQG  R:Q? _C;1?B1X3TOQ-X=O?[1T34X1/:77E/%YB$D9VNJL.AX(!H
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M+S>%=%_9Q\.:=\._^%H^"O 7VR/6]&'V!_M32:>\23&&^FBBD)N7\W&?E.2
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M-2%_-IFF;@D=M)(.CJR/E,\$DD*6('V#0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'G_CC_DJ'PV_Z^+_ /\ 21Z] KS_
M ,<?\E0^&W_7Q?\ _I(]>@5UUOX=+_#_ .W2.:E\=3U_]MB%%%%<ATA1110
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M[?M9_M1ZA\6O@R^F:QX#U/P5\0? OQ$T%-6\+F]CO'S*LTMN89T"K)Y@C;!
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MQ/K^ZU@64D;W%NTBQ6L1B=9Y%A(D(DDA7YU <DG'6?LG?\FL_!O_ +$S1O\
MTAAKG]<_9OU:W\0>*)?!GC.+PIH/BK3K73M7T^;2!?3H((#;)+:3M,JQ.8-B
M'SHYQ^[4X!SGTKX3^!?^%7_"OP;X-^V_VG_PCNC6>D?;?*\K[1]G@2+S-FYM
MN[9G;N.,XR>M '5T444 %%%% !1110 4444 %%%% '/ZQ_R-WAW_ ';G_P!
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M'/AWPC_P3?TW5].TJW36]8T#PY<:AJ\D:O>W1>YLY LDY&]T0OM16)"(JJN
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M++X:^'?PJ\':KJFLMI_PS\40:W#.OA=Q-%;QPW$<%G<E+F02RO\ :"?/MP5
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M-CKOC#[9JWA/Q5#XIN+Q=,2..\9([E/LT42N/)B'VG"%FE<+&H=I&)<^N44
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M/N:FHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEZ'YJT4_S#Z+_P!\BCS#Z+_WR*_LB\^WX_\  /P;0913_,/HO_?(H\P^B_\
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MW;66I:P]I]MD@%M\\KK8S/ 8S(=HC+B3>=VS:,\/X=\;>-/"/[2W[4UQX/\
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M=<Z9!JFHV>BZ:EW$T;SVEA 5\\!@#L>XN+K8>C*JL.&!/L5%% !7EG[47_)
M?&?_ %Z+_P"C$KU.O+/VHO\ D@/C/_KT7_T8E>IE7_(PP_\ CC_Z4CBQO^ZU
M?\+_ "/R\HHHK^T3\!"BBB@ HHHH [;X._$*R^%OCNS\27N@Q^(?LBL8;62X
M\D)(1A9 VUN5YQD=\]0*Z_XC?&[PEXXOYM:MOAW)IGBB6[BNCJ\_B&XNS\CA
MBOE,H7! V@# 4=!Q7C5%>36RO"UL2L9-/VB5KJ4EI>]FE))J_1K7J=T,96IT
M70BURWOLGKWNU>Y[O\4OV@O!7Q5FU/4=1^%NSQ%=6AMX=4_X2&<^0P0K&_E+
M&J-M.#@CG'-'PZ_:%\(?#_P/J'AU?AE]M_M>TCM=8N?[?FC^W; PW;?+/E_?
M?A".OL*\(HKD_L# ?5UA+2]FFFE[2II;:WO;+=+9-)[F_P#:>)]JZ]US.^O+
M'KOTZ]SV#X1_&CPM\*?$UUKZ?#_^T=46\FFTV;^VI8OL,$B,GD[=C+)A68;V
M&>:XSXH>+M&\<>+)]8T7PY_PC$-R#)/:_;GN_,G9V9Y=[ 8SN'R@8&..M<E1
M7=3RW#4L2\9%/VC5KN<WHME9R:\]MVWNV<T\75G15!VY4[_"EKZI7"BBBO3.
M,**** "BBB@#]3_V<_\ DAO@K_L'1_UIWQ]^$\_QI^&MQX9M-8CT"]^WV&HV
M]_-9F[CCDM;R&Y4/$)(RZL8=IPZD;LYXP6_LY_\ )#?!7_8.C_K7H]?Q5F/^
M^UO\4OS9_0&$_P!WI_X5^1\^_'3P?XXU;]G'XHV'B[4[+QA>R:0TVC6_@GPS
M=6=Y'>1!I(2L;7ETTK^<L#+MV;=ASG/RP>%/V9=8T/X<_#"2R\31Z/\ $SPH
M+F]N-9N[+[=:WEU?YDU-9X%DB,B2RNS@I(A5D0@X!4_1-%>>=9A>#=,UW2]&
M$?B37(=?U>21I);FTL!96Z9Z)%#OD94 '\<DC$ECNQ@#P_3?V9/&VE^&_%_@
MZT^)UGIW@GQ-K&IZE=?V=X<>/6H8;VYDFE@BO7O'B1L2&/S?LVX DJ$;:R_1
MM% 'F?A7X&Z9X1^)&J^(K">.+1[OPQIOA>#0DMR$MH+-[EE(DWG<"MP%V[1C
MR\Y.>.(\/?LNZQIN@>$_!.I>-X=5^&/A74;>_P!-T?\ L<QZC*EK+YME;75X
M;AHY887$7"V\;.((PS'Y]_T'10!\@_#O]GSQGX\\-?$'P]X@\13:'X"UKQ_K
M=]?>'[S0BE]=6W]K33(+:[\Q-EO<*(R2T4K,K/LD4,NWTWQ)\"=;USXJ:#XZ
MUC7K'74\)7=YJ6B6MEH,5KK3^;%,@L9-0,X1[8"=U$8BBW;(3([LK._N-% '
M$?"72?%L'POTFS^(NH0ZSXKGAD?4Y(8XTC4RR.X@'EJJL(D=8MX4;_+W$98U
MYGX'_9;U;PXO@/0M8\<KK?@/P%>&^\/:1#I)MKW>BR1VBWMWY[K.D$4KJ!'#
M#N98V8G:0WT'10!Y)^TA\ 4_:"\)Z=I":[)X:N[.YD<:A#;F9VMY[::UNH,!
MTQYD%Q(N[/RG:V"5J+PG^SO:^%?CUKWQ%CUEY[*^MY%L?#_V8+#IT\T=I'=3
M(^XY\Q;"V^4*-I\SD[R![!10!\Y?"O\ 9%N?@SI_AY/"7C>31M0A\.+X?UZ\
MM]*C(UAH8BEG>B)W9(KB X 9A*&C_=L,!&3LOA!\#[SX>^._&?C36=6TG4/$
M/BE+6.\3P[HATBQ(@,I65X6GG:2X8SONF:0DJ$4 ;<GUNB@ HHHH **** .?
MUC_D;O#O^[<_^@+6[-"EQ$\4J+)&ZE61QD,#P01W%86L?\C=X=_W;G_T!:Z"
MM9_#'T_5F<=Y>OZ(^(?A/I%]J'Q@\-? VXAGDT3X3ZY?>(99;B,[9;4J&T55
M?N5^V2<?].@/ICFM!T>[UKX9^+OAMXJ^)7A'P5XKU'Q/?7%]I%WX;GNO$<EZ
MU[YMO=V^+Y&N2T8MVBEB@("*J@G837VGX2^&.F>$/&?C+Q3!<WE[K'BF>WEO
M9;QT(B2"+RH88@J+MC4%B <G<[DDDUV%1S%6/C_]HCXM;?$'Q@\%2W?A#P4J
MZ#!&L>N:/+>ZGXM6XMI1_HJ1SPLRQG,((6<APY(4+@U?">EVFO\ Q0_9!GU*
M!;Z6U\!WEY"T_P Y686=B!)SU8;FP3T//4 U]E447'8\H_:L\!ZI\3?V<_'_
M (:T2+[1J][I<GV6W[S2(1(L8_VFV;1GC+#-<9X\_:7\#>+/@YK>E>']4M]0
M\;:MI=SIEIX(MF!UF.^:)XS;2V?$L1C<,'+JH149B0!FOHJBD!\>:A\-]6T+
MXL_LR^#$\1W_ (;U31O!&HZ?-J6CI;2R[H+>QC<+]HAEC*DJ>=F?0BOH;P3\
M*]&^$_@[6K'2I+R]N=0EGU'4M4U*;S;N_NG7#S2L !N(51A550  J@<5WM%%
MP/E;X)_\HW[+_L1[[_T1-6%X,OX?A;JWP!^)'B$_9O!,_P -;?PS=ZQ(#]FT
MFZE^Q2P27+](HY2IB$APH8@,1N&?L:BG<+'+>"?BAX4^)3:@?">O6?B2VL61
M)[[2W^T6@=@2(UN$S$\@ !9%8L@="P =<_-MKXX^'OP__;0^,NJ>.;O3=&D;
M0]%@L]7U952!$,,YGMQ,WRAY J$19W2"%\ [&Q]=UR/A_P"&>E^&_B-XN\:6
MT]X^J>)X;&"\AF=#!&MHLJQ&,!0P)$S;LLV<#&.Z ^5? 'C35/@W\$_@II^H
M6FB^$QJVHZN;3Q1XWLV-IX<M2UQ-:Q,OF1%))K=E1%::/ #+\V-I\_U4P>+/
MV6?C6+NZL]:L=2^*]HSW%C92V5K=QSS:4[R10R2.R))YC.#O;=OW!B&!K]&*
M*=Q6/F+]I^*^\,_$[X-:Q'J6A>%?!NBMJ"2:KKVF/=Z7IUX\426C2HD\"Q?*
M)DCD+JJLV.K+7F/Q:\-V%Q^S+\9M9@\8Z/XXT[Q1XGT2ZG?P_I4EGI F^VZ?
M',;<M/.L^_:#(Z2,/,$BG#*RK]UT47'8\!UG3;30?VR/AU#IMK!I\+^"-4LC
M';1K&OD17-F8HL 8"(6;:O09..M5?V(-=TRW^#J>#FU*T_X2K0-5U>/5-&\Y
M?M=F6U2Z9#)%G<H964@D8(/%?1%%*X'R-^T'XLL/A1\1/%7B3P[XAT+6O$FK
M0:7I^K_"[7['S+GQ BRJL/\ 9Y!$A?9-*@*I/#OW[@&1\=?X;US3/"/[:GQ"
MMM;U*TTJY\2:#HHT>*\F6)M0:)KI9$@#$>8RDC*KDC(KZ*HHN%C\\?'WCS1/
M"_[&/Q-^'5_>A/'5IXCU"*?P_&I>\CC?6/M"W#1 ;EMS#(CB<@1G<H#%F4'W
M/5O$WAKX>_M5?$&_^)5Q9:=I^N>%=.M?#MSJHS%>6T;S_;K. -GS9#)) S6Z
M!G8,AVG(S]-T4[A8^ _AMIL?AS]CCP7\1=)L9[*?X=>+=1UM+7RFCG73O[1N
M(;VW*D97_1I),@C@QC/2OHW]DW3Y]4\#ZQ\0K^'RM1^(&K3>(1N4JZV38CL4
M.>PMHXF_X&:](^)W@&U^*7@'7?"-_?W^F:?K-LUG=7&F2(D_DM@2(K.C* Z[
MD/RGY6.,'!&]INGVVCZ?:V%E"MO9VL2P0PH,+&B@*JCV  %#86+-%%%2,*Y_
MQ%_R,'A;_K]E_P#26:N@KG_$7_(P>%O^OV7_ -)9JUI?%\G^3,ZFWS7YG044
M5X'\!_VV/AK^T9\2/%?@CPC/J)UKPZ)))6O;98X;N%)5B>:!@[%D#N@^8*?F
M!QBLC0]\HHHH ***^3-4_:,\46O[1T5\FJ(/@_#XHC^'%S:>1#C^UFM3/]K\
MTKYF!</%:;=X0$,<;J /K.BOE'XR>-?$/B']K[P=\/7\/^.)?"L.A7>J.OAK
M7H=+6^F\^U1;II([Z"9H(!)(C1N0S,V5BD4!JZ;X#_M->(?B-J?Q,'BWP-?>
M%M%\*:_>V!UB:6Q6WLK>"V@F,=WLO97:<>:[%X4,.TK\V0U 'T117CG@_P#:
M<T;Q5K?ABTNO"_B;PSI?BLRCPWKFN6UO%9ZNRH956,).\T+20J\J+<1Q%E4X
M&[Y:G^&?[2&F?%OQEX@T+PWX5\2W-MX>UN^\/:QKDT-K#8V5Y:LRLI+7 DE#
M[5*^5&Y EC,@CR< 'KE%>3^.M?TG3?VA_A9I=UJWBBVU?4[#66LM-TZY1='N
M5A2W,K7L9.YW42)Y14'!,F<9%<EX?_;7\+>(M#L?$<7A'QC:^#9M5&B7'BB[
ML;>.QL[PW1M520>?YKH9?+7S8HY(@955G5ED5 #Z%HKYY\:_%*+P)\1/C%=Z
M%'XO\3^*=#\+6&I/X?ENK<Z/"C?:1'+;QR31;7S&[3_,"RHNS<V!7/1_'2;X
M@_L^_"KQEXWTSQIX"N-8U;PV\<OAJ[M(4U*YNC$5VA+F5OL#O)AXY2LIC."N
M<T ?4]%>4?%/]H2W^$W]L7NH^"/%VH^&=$2.75_$MA:VXLK)6"LS;9IXYYUC
M1U=WMXI5&67)='1>;A\6ZA>_MNV.DV^L7<OAN?X:OJ2:>EP_V1YCJ4:K/Y>=
MN_8=N_&<'&<4 >]T5Y[\0/C';^"?%6D>%K#PUKGC+Q/J=I/J$6DZ%]E62.TA
M:-))WDNIX(E4/-$N-^XEQA2 2)[7XQ:/>?$#PWX/%CJD&JZ]H,WB&W-U:^0L
M5O$\"-',CD21RYN$^0IQA@2",$ [NBO$]>_:X\%^&?!?B_Q3J%GK<>D^%O%8
M\(:@8K-993=&6&,RQQHY9X@;A#P/,(#80G .QX0_:"T_Q)XVG\):IX6\2>#-
M=_LDZY8VWB""W7^TK-7V220F&>4*R,8]T4OER*)4)3[VT ]4HKYY\(_ML>$_
M&'AOPEXJ@\*>,+#P/XDO+?38/%6H6,$-E;W<[;(XI5\_SMOF[8C,D3P;V \W
M )%/PI\6(O!?QP_:8U+Q?XCNK?P?X7&AW$:74LLT%A&^G;Y?)B&[!=\';&N7
M8C@DB@#Z2HKR[P)\>[7Q9XNL_#&M>$/$W@#7=1TYM5TNS\416JG4;=&43>4U
MM<3*LD1DBWQ2%) )5(4@,5\_L/V[/!MYX0TCQC)X2\;6O@?4-1.D?\)))I4<
MD$-X)7B$)ACF:YES(@0/!#)'N<)NW!U4 ^D:*\Q\#_'S2?%GBK7/#6J:)K/@
MC7])T^+6);'Q(MO&9+"1G5;I'AFE39NC=2&974J=RBL7PC^U-H/BS4/"S/X9
M\3Z'X;\6RM!X;\4:O:P16&K/M9XA&JS-<1>=&CR1?:(8MZKQRR@@'M%%?/VI
M?MG>&[%?'-S#X.\9ZEHO@;5)M+\2ZU:6$'V333$5WS9>=6G0*Q<K LDB(N71
M-R;V>,?VD/$^@_M(>&? >C^ -2\2>'-5T&YU47UA)8B:Y*/;A98&FO8P(4$S
M*XD0.6VE RY- 'T)17DGQ&_:,L?A;+=WFM^#?%<?A*QNH;.^\6K;6RV%JTDB
M1AVC>=;EXU:1,R1P.G)(8@'&'H?B35IOVWO%NA2:I>OH<'@33+R+36N'-M'.
M]]=J\JQ9VARJJ"P&2% SQ0![O17D^I^(-)A_:DT'19-6\4)KEQX3O+J+2H;E
M!H3P)=0*\TL6=QN@SJJL!@(7%<CX'_;8\*^.]"\&^)+?PCXQTSP;XIOX=*L_
M$VIV%O%9Q7DI98H9%$YFPT@$0F2)H=[J/,ZD 'T-17BEG\1O"?@SXI?&S5-6
M\2^([>#P]INE7^LQ:Q<"31].@\BX97L8ERZLZHQE&,NRQ[036MX)_:"LO%7B
MG2/#^K>$?$W@?4=<LGU#15\206R#4HD"M((_(GE,<B*Z,T4PCD ;[OROM /5
M:*\B\)_M&6_CNX2X\/>!?%VK^&)YY[:R\4V]O:?8+V2(/_JP;D3B-GC9%F>)
M(B<'>%(8^5^#_P!I+7/BM\#/C'JGC7PGXH\%:3X?3Q%#)K_ANYLH;B""S:1/
M*@(O)9!?JBL=^T0;T)5\;<@'UC17CG_"]M(\,Z7X$T#1=)\3^/?$FM:+%J5K
MI%F;9]2%@L2YO+N6>:&!!N9$):0%Y'P@;#%:NI?M<^"]'^&,_C:^L=>@MK+7
MXO#.IZ2MB)=1TV_>9(C%+"CMN*^8C?NC)N5E,>_<H(![;17FOP]^.5GXY\97
M_A*^\,>(/!GB6UT^+5DTWQ#%;A[FSD=HQ/&UO/,F Z[65F5U)&5&:L_$3XQ6
MW@3Q-H?AJS\.:WXP\3ZQ!<7EOI&A"U65;: QK+.\EU/!$JJTT2XW[B9!A2 Q
M !Z#17!V7QDTB]\?>&O"'V#5K;5M?T";Q%;_ &NU\@0P1/ C1S*["2.;-PGR
M%.-K D$8/A/[3_[1$.H_L]^/=;\,7NN>'9_!_C?3_#VH7D):&9FBU&S^T>5Y
M+L[Q/',5QPS L"O/(!]945Y1X?\ VBM'U#Q=<^&]?\/>(/ VI#29-=LAXB@@
M5=1L8FVS2PF":7:T>Z,M#*(Y0)5.SAMMOX<_'6S^(6D?VU)X6\1>%O#LVFC6
M;'6M=BMDM+VS(#><K0SR&'Y&1]EP(G*MD*=C[0#TRBO&O"'[4.A^*]8\+PS^
M&/$_AW0_%DDD7AKQ)K5M!%8ZPZHTD:QA9VGA,T*22Q"YBAWJA ^8A3C^-/VR
M?#'@O2_&.N_\(MXLUOPAX3N)[+5/$VD64$MDEW"O[RW16G69R'(B,@B\E7)#
M2*%9E /?:*X72_C!HVK?$72_!D-M?+JFH>'3XFBF>-! ML)HXMC$/N\S=*IP
M%(P#\W:N:_X:B\(KX)\3^)&M=7\K1/$MUX133TM5DO-2U.&?[.L%K&KD.99,
M!"Q08.Y]BAB #U^BO([7]I+1XM-\=OKWASQ!X4USP;I+:[J'A[5DM6O)K#RY
M'6XMV@GE@E1C#-'Q+E7C(<)E2U'P3^U5H/C36?!=LWA;Q5H&E^-(G?P[KFM6
M4,-IJ+I#YYB"K,TT3F-9&0S11K((V*,X*%@#VJBOG_\ 9Z_:'\6_%SQQ\0=%
MUSX>:GH5EH&ORZ7!?&2QV6J+;02B&ZV7LK/.3*?FA1HMK)\P(;'4^+_$&DV/
M[1WPZTBXU;Q1!K&H:1JTMIIMC<HNC3QQ&W\Q[N,G<TJ[U\H@$#,F<9% 'J]%
M?/7A_P#;7\+>(M#L?$<7A'QC:^#9M5&B7'BB[L;>.QL[PW1M520>?YKH9?+7
MS8HY(@955G5ED5.B'CCPUX;^.?Q%EU'Q#XBM7T3PM8ZKJ=OJ%TIT*RM-]T?/
M@C!W+-B&0R,1@JJ8S@T >QT5Y%X._:1TKQ1XB\-Z5?\ A7Q-X2C\4133>'M0
MU^WMXX-6$:"0J@BGDDA<Q'S%CN$B=E5L+E& =HO[15IXIUZ\M_#_ (*\6:_X
M>M=6?1)/%=A;6S:<;I&$<@16N!</&DI,33+"8E97)<(C. #UNBOF?X2_M%>)
M?BYH_P 6[;Q/X'U[PKIOA_5-6TM=8TV>Q22TA@@C81,5O97-X!(QWQH8<[<-
MP:W?!/Q\\/:#\+_A-9:';>,?'VL>*-"AO-'TVX>WGURZM$@1WNKV:6:.!" R
M!Y'E4-(X5-S$"@#WNBO$M3_:V\(:#\)_%_CK5M-UW2T\(:BFEZ_H,]M$=2T^
MX::*-0R)*T<BD3Q2J\<CJR-E2Q^6MOP7^T!IWBKQX/".H^&/$G@W5KC2VUO3
MAXCMH(4U&R214DDC\N:0QLA>(M#.(I5$JY08;: >I45YG\)OCI:_&".UO=,\
M)^)=-\/:C;/>Z3X@U*W@%GJ4 8*)(_+F>2+<&5U6X2)F4DA<JP'IE !1110
M4444 >?^./\ DJ'PV_Z^+_\ ])'KT"O/_''_ "5#X;?]?%__ .DCUZ!776_A
MTO\ #_[=(YJ7QU/7_P!MB%%%%<ATA1110 4444 %%%% !1110!Y[^T"N[X,^
M+ <_\>9Z''\0KHO^$*M/^?\ UC_P:W'_ ,77/?'_ /Y(UXL_Z\C_ .A"O0:[
MN>4<-#E=O>E^43DY8RKRNNB_.1S_ /PA5I_S_P"L?^#6X_\ BZ/^$*M/^?\
MUC_P:W'_ ,77045S^VJ?S,W]G#L<_P#\(5:?\_\ K'_@UN/_ (NC_A"K3_G_
M -8_\&MQ_P#%UT%%'MJG\S#V<.QS_P#PA5I_S_ZQ_P"#6X_^+H_X0JT_Y_\
M6/\ P:W'_P 77044>VJ?S,/9P['/_P#"%6G_ #_ZQ_X-;C_XNC_A"K3_ )_]
M8_\ !K<?_%UT%%'MJG\S#V<.QS__  A5I_S_ .L?^#6X_P#BZ/\ A"K3_G_U
MC_P:W'_Q==!11[:I_,P]G#L<_P#\(5:?\_\ K'_@UN/_ (NC_A"K3_G_ -8_
M\&MQ_P#%UT%%'MJG\S#V<.QS_P#PA5I_S_ZQ_P"#6X_^+H_X0JT_Y_\ 6/\
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M^S<%_P ^8_\ @*_R/OKX$^$;6Y^$'A24WFJ1;K)?DAU&>-!R> H? 'TKO/\
MA"K3_G_UC_P:W'_Q=<_\ ?\ DC/A+_KQ7^9KT"N&O6J.K-N3W9T4J4/9QTZ(
MY_\ X0JT_P"?_6/_  :W'_Q='_"%6G_/_K'_ (-;C_XNN@HK'VU3^9FOLX=C
MG_\ A"K3_G_UC_P:W'_Q='_"%6G_ #_ZQ_X-;C_XNN@HH]M4_F8>SAV.?_X0
MJT_Y_P#6/_!K<?\ Q='_  A5I_S_ .L?^#6X_P#BZZ"BCVU3^9A[.'8Y_P#X
M0JT_Y_\ 6/\ P:W'_P 71_PA5I_S_P"L?^#6X_\ BZZ"BCVU3^9A[.'8Y_\
MX0JT_P"?_6/_  :W'_Q='_"%6G_/_K'_ (-;C_XNN@HH]M4_F8>SAV.?_P"$
M*M/^?_6/_!K<?_%T?\(5:?\ /_K'_@UN/_BZZ"BCVU3^9A[.'8Y__A"K3_G_
M -8_\&MQ_P#%T?\ "%6G_/\ ZQ_X-;C_ .+KH**/;5/YF'LX=CG_ /A"K3_G
M_P!8_P#!K<?_ !='_"%6G_/_ *Q_X-;C_P"+KH**/;5/YF'LX=CG_P#A"K3_
M )_]8_\ !K<?_%T?\(5:?\_^L?\ @UN/_BZZ"BCVU3^9A[.'8XR3P_!I/C/0
M)(KF^F+)<@BZO)9@/D7H'8@&NSKG]8_Y&[P[_NW/_H"UT%.I)R46^WZLFFE%
MR2[_ *(****P-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KG_$7_ ",'A;_K]E_])9JZ"N?\1?\ (P>%O^OV7_TE
MFK6E\7R?Y,SJ;?-?F=!7FWPV_9P^&OPA\7>(_%'@_P )V>AZ]XAD:34KV%Y&
M:4LV]@H9B(U+?,50*N0#BO2:*R- HHHH R_%%]J.E^&=7O-'TUM9U:WLYIK/
M3ED2,W4RH3'$'=E5=S +EF &<D@<U\>_\,.^,+S]E&?PA<?$SQ*GBJZMCKTV
MCJFE&Q&OF3[;_KS9FXV"[Q\WGY*CKM^6OM:B@#Y\\.^#?'7B#]HCX=?$+7_#
MG]CPP_#ZZTW6$^UP2"SU.:YM)3;@)(2X_=RX=<KA1R"0*Y_3?@KXIFLOVC?A
MS>Z+>V>C?$;4-3U/3O%\%S:O9Q+>:=;V_E21>:+@.KQOD"(J5_CKZCHH ^4O
MA%\%9DU3P';>)?ACXRM]4\,2I<R:SK_Q%N=1T:&XA@DA%Q8VQOYFD9B^$66V
M@"QR29*LHC?T?]F/X?:_\/-)^(T/B"P_L^35O'NNZU9+YT<GFV=Q=-)!+\C'
M;N4@[6PP[@&O9J* /&?B-\/M?U[]ISX,^++&P\_P_P"'M/\ $$&IWGG1K]G>
MYCM%@&PL&;<8I/N@XV\XR,^1Z?\  /QY#^P6WPZ?0MOC(ZU)=_V;]L@_U1\1
M->!O,\SR_P#CW(?&[/;[W%?85% 'S_=_!_Q%K'QV^,NJRVBVN@>*?!NGZ)8:
MBTT9#W"?;!*"@)=0HFC.2N#GC.#7 GX8?$+Q)^S#\'/!$_@:^T?Q!X)UKPM%
M?1W=_8/'<6]A)!]HNH7CN&S'MC9@K[9#T"&OKZB@#XH_:*^$/Q7^(D/QFTF;
MPYXI\63ZU:26W@^YTGQD-(T*SM#:X,%U:K=1&6?S3,?WL$J2%XD:2./+)ZYX
M5^&'B;3?VF_#WBRYTWR_#]K\-5\/S7GGQ';?"]BE,.P-N/R*QW ;>,9SQ7O=
M% '@7[4G@&3QM'ILUM\-_$'BK6]/M+M]#\2^#_$$&D:KHMY)$T1_?27%NRQ.
MKC.UI58J0\1"KNP)/ _Q1\%^,O@[X]U31Y/B5KVD^$[KPUXIAT.ZM8+@W,WV
M687<(N7MXI$,MLZL-R,/,5E4\@?3E% 'Y]?$SP+\0/ O[-?Q'N?$^B:;I/B3
MQ!\8+'7M.LX]0^T6C13:A8>1F9%W;=R%6)16^4G8 0*][B\,^,?B9\=-&\?>
M(/!USX&T;PGX9U#3X+?4KZUN;B^O;QHO,,8MI9%$$:6ZX>0H[&7_ %:[<U[S
MKWAS2?%%BMEK6EV>KV:S1W"V]_;I/&)8W#QN%8$;E958'J" 1R*ONBR(R.H9
M6&"K#((]* /S]^!?AOQ]\:OV(_A/\,E\%-9Z->OI=S=>+SJ-LUA'IMM>)>$B
M+S!<FY8P+%Y?E>7E]WF@=/2_B;^S+XO^)FI?M,6<<::5;^,I/#MSH%]+>"-+
MJ2PBB=T9HB985,D(C+;0P#%E!Q7U3H'A_2_"NC6FD:)IMGH^DV:"*VL=/@2"
M"%!T5(T 51[ 5H4 ?.WP@^&4,_Q T?Q+J/PR\;>&M3TBRG6/4O&_CV;6C!).
MJ*\=I"-0NT96"G>\@A(VQX#Y.SA?#_P"\>6/[&?@/P+-H6SQ5IGBRSU.[L/M
MD!\NW37S=N_F"38<0?/@,3VQNXK[#HH ^>/B%\$=?\>?M">+]1,36/A;7?A=
M-X3&LI+&6BO);N5BHCW;\K'('W;=O;.>*XSX-_ >YL4\ :+XK^&?C$ZIX4EM
MY)-<U3XB7-[H GM5*)=V5K]OD=MQ :.*6UA"J[ E=H5OKJB@#Y:L?@KXSA^!
M/[4GAU]&QK'C35O$MUH-M]JA_P!,CN[%(K=MV_;'O<$8D*D=6P.:U-2^'_B_
MPG\5?@WXTLO"MYXEMM'\)W/AK5['3;NTCN+.27[(R2XGFB21 8)%;8Y;[I"M
M7TC10!\)_'KX*_%[XDZ#\5]#OO#/BGQ3KFIZS+)X=U:U\:+I_AZ+2!Y3V]N;
M%;M \Z!71A-;$/)EC-MVD?0VC_#[7[7]K[Q/XVEL-OAB\\&:?I,%]YT9WW45
MY<R21[-V\821#N*[3G )(->S44 >,ZQ\/M?NOVOO#'C:*PW>&+/P9J&DSWWG
M1C9=2WEM)''LW;SE(W.X+M&,$@D5Y%X9^ 7CS3_V'_A5\/[C0O+\7:)J^BW6
MH:=]LMSY,=OJL=Q,WF"3RVVQ*6PK$G&!D\5]AT4 ?&OCOX67?QT^('[6W@C2
MM0AL-2U31?#=O;7,S,(DN$@N)8TE9 6520@8J"P5\@'@'M_A?\*(=6\;:#K>
ML?##QQX<U/2+:=EU+QC\0I]:BM9IH3#(MG%]ONEDW*SJ7E2'Y=I )^5?=O"7
M@/PSX!M;NV\,>'=)\.6]Y<-=W,.DV,5JD\[ !I7$:@,Y  +'DX%;M 'SW^S7
MIWCSX1^!O"'PLU3X>W3V_A\-ITGBV+4K(:9/:1[S'.B"4W)E<>6#&T"@,S?/
M@ GC].^%/CK2?@G^T7\,E\'WLUQXB?Q3?Z!K*WME]BU#^T%D:W@YG$L<NZ;:
MWF1+&-A._!&?K2B@#YCTOX>^-OA5\1O!/CRQ\(W?C"%O -EX/UG1=*N[**^L
M9[>0SQS(US-%%)&6DEC<"7((C(##..5U_P#9\\?:]X U_59=%CB\3^+/B7H_
MBZ?08KN G2[&WFM%V22[A')*L-L7?RV8%F*IOQN;[&HH \BG\":Z_P"UM8^-
M!8Y\-1^"+C1WOO.CXNVOX95CV;M_*(QW;=O&,YXK&_:>\!_\)Q#I#CX;:]XO
MU/38KJ;1M?\ "&OP:3JVC7DD1B)6:2XMRL;JPSM>16*#?$P537NU% 'R]!X%
M^*G@?Q5\&_'>L:/+\2O$&D^%+SPUXHAT2[M8;GSYC;3+=1?:9((I%\RV9'^=
M&^=6"MSCS[5/@%\7=8_9W^+6DR^%]-M_&WB+XG1^*-/TU-5CDM#:_;+"8.TY
MVG:JPR;LJKG82L?*@_<5% 'SJWACQU\5/CGX8\:ZOX#_ .$2T_P7X?U2UM;/
M6]3MI3JVH7WDHR(ULTVRU1+8?O9%60^</W/!QPG@O]GWQ-JEYX]\-Z%X;\1?
M!_X5^(/!-]HLGAK7-;M]0@BU:ZEE(N=/MX+FX6UCC26;>JO$C%XML/REA]BT
M4 ?)?P>^!UQ;W'@+3O%'PR\91ZIX6EAFDUK6OB)<W^AI<6\31K<V5M]OE9RQ
M(*1RVL(5)'!*E0C\#\8O#OQ"^#?[)OQU\"-X,?5-*FDU[5+;Q<=2MDL?[.NG
MDNF\R/>;G[4IEDCV"'RRRJ?- )Q]Y52UK1-.\2Z1>:5J]A:ZKI=Y$T%S8WL*
MS03QL,,CHP*LI'!!&#0!\]7GAWQ;X5^)OP^^)>@>$KSQOIG_  @[>'+W3=*O
M+2WO+=VDM[B&=?M4T,;QGRW1@'W LI (S7F4?[,?Q%UKX.:@NN:.MMXJL?BM
M?>/ET30_$#VO]I6\DDV8;:^C:-XF9)W,;/Y1W(F_RP21]MV]O%:P1P01I##&
MH1(XU"JJ@8  '0 =JDH ^63\$Y-:\"_%B[TGX<^*M \3ZUX/O/#UC-XU\9OK
M&H7C/%,5@4/?74,,.]T(<S*2S2915 9]G5OA+XKNO"_[,EI'I6ZX\&ZG87&N
MI]HB'V../2+BW<YWXDQ+(BXCW$YR. 37T;10!X7\%O"/B;X;_%_XLVE_X9O9
MM \5>(3XBL/$D%S:M:JK6=M$T$D9E$ZR!X7QB)D((^85>\=?#[7]8_:F^%?B
M^SL/.\.Z)HNMVFH7GG1KY,MQ]D\E=A8.V[RI.5! V\XR,^S44 ?'NG_ /QY#
M^P6WPZ?0MOC(ZU)=_P!F_;(/]4?$37@;S/,\O_CW(?&[/;[W%3_$3X=2_&3X
MZ_M$^";*^2QNM:^'&D::ETV62"6274MF\#G'()'7:3BOKNL+PSX#\->"9-3D
M\.^'=)T&34[AKR_?3+&*V-W.<YEE**-[G)RS9/- 'SW\(_A TWBKP7=>(?AA
MXTTO5O#@-RVK^)OB)<ZMIMO<BW>$O8P&_N#*6\QE'G008C9CPP$;:_P#TGQ[
M\$=%B^&<GP\N]5TVRUZ]:T\76^IV4>FR:=<WDEUYTB&7[2LZ+.Z&);<JTB#$
M@1O,7Z*HH ^;? 'P_P#%_@Z;X\>%I_"E[/8^*M9U37](\0PWEF;.875I JV[
M(9A.DHD5UYBV87._D9Y;X<_"/Q_\&U^!OBZ+PC<>);[1/A^O@KQ'X<T^]LTO
M;1L6\Z3PO--'!*%EMS&X\X<.K+OP<?7=% 'QK\1O@#\0?'WPG^.NL?\ "/K9
M^+?B'K6D7=CX8^V6YEM+.QEM(D\^8/Y/G-% \K*LCJN0BN^*]H\<>!/$6I_M
M,?#GQ?IVG)<Z+H_A_7+.ZN9+A(UCN)WLS A&2Y#>3)\RJP7;SU /L5% 'R_\
M$_A?XE\(?&:WOO#?@K6_A7\/#I]XVM^'-2UVWO=-NM0EF62.33;:&>86RJQG
M+$+;AE>,>4"#CZ@HHH **** "BBB@#S_ ,<?\E0^&W_7Q?\ _I(]>@5Y_P".
M/^2H?#;_ *^+_P#])'KT"NNM_#I?X?\ VZ1S4OCJ>O\ [;$****Y#I"BBB@
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MV_:S_:CU#XM?!E],UCP'J?@KX@^!?B)H*:MX7-['>/F59I;<PSH%63S!&V"
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MD&J:C9Z+IJ7<31O/:6$!7SP& .Q[BXNMAZ,JJPX8$^Q4 %>:?M(?\D2\4_\
M7&/_ -')7I=>:?M(?\D2\4_]<8__ $<E;4?XD?5&=3X)>A^>E%%%8F@4444
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M+82JA)FEFCCCP&W[I61" %#%V1&\EL? GQ/^'?PI^(WPFT;P%)XA.NZAJ_\
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MV/C+PYJ&B:D)#97T1BE\F0HX![@CH0<'TXY!'%<I_P *:M/^AJ\8?^%!<?\
MQ5=L94I45"<K--O:^Z7GY'+)5(U7.*NFEU[7_P ST&BO/O\ A35I_P!#5XP_
M\*"X_P#BJ/\ A35I_P!#5XP_\*"X_P#BJGV=#_GX_N_X)7/5_D_'_@'H-%>?
M?\*:M/\ H:O&'_A07'_Q5'_"FK3_ *&KQA_X4%Q_\51[.A_S\?W?\$.>K_)^
M/_ /0:*\^_X4U:?]#5XP_P#"@N/_ (JC_A35I_T-7C#_ ,*"X_\ BJ/9T/\
MGX_N_P""'/5_D_'_ (!Z#17GW_"FK3_H:O&'_A07'_Q5'_"FK3_H:O&'_A07
M'_Q5'LZ'_/Q_=_P0YZO\GX_\ ]!HKS[_ (4U:?\ 0U>,/_"@N/\ XJC_ (4U
M:?\ 0U>,/_"@N/\ XJCV=#_GX_N_X(<]7^3\?^ >@T5Y]_PIJT_Z&KQA_P"%
M!<?_ !5'_"FK3_H:O&'_ (4%Q_\ %4>SH?\ /Q_=_P $.>K_ "?C_P  ]!HK
MS[_A35I_T-7C#_PH+C_XJC_A35I_T-7C#_PH+C_XJCV=#_GX_N_X(<]7^3\?
M^ >@UYI^TA_R1+Q3_P!<8_\ T<E6O^%-6G_0U>,/_"@N/_BJJ:K\!-(US3Y;
M'4/$/BN\LYL"2"XUR>1' (."K$@\@5=.-",U+G>GE_P2)2K2BUR?C_P#\]:*
M^Y_^&._AU_SPU/\ \#WH_P"&._AU_P \-3_\#WJ/9T/^?C^[_@E\]7^3\?\
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MX(<]7^3\?^ >@T5Y]_PIJT_Z&KQA_P"%!<?_ !5'_"FK3_H:O&'_ (4%Q_\
M%4>SH?\ /Q_=_P $.>K_ "?C_P  ]!HKS[_A35I_T-7C#_PH+C_XJC_A35I_
MT-7C#_PH+C_XJCV=#_GX_N_X(<]7^3\?^ >@T5Y]_P *:M/^AJ\8?^%!<?\
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M-6G_ $-7C#_PH+C_ .*H]G0_Y^/[O^"'/5_D_'_@'H-%>??\*:M/^AJ\8?\
MA07'_P 51_PIJT_Z&KQA_P"%!<?_ !5'LZ'_ #\?W?\ !#GJ_P GX_\  /0:
M*\^_X4U:?]#5XP_\*"X_^*H_X4U:?]#5XP_\*"X_^*H]G0_Y^/[O^"'/5_D_
M'_@'H-%>??\ "FK3_H:O&'_A07'_ ,51_P *:M/^AJ\8?^%!<?\ Q5'LZ'_/
MQ_=_P0YZO\GX_P# /0:*\^_X4U:?]#5XP_\ "@N/_BJ/^%-6G_0U>,/_  H+
MC_XJCV=#_GX_N_X(<]7^3\?^ >@T5Y]_PIJT_P"AJ\8?^%!<?_%4?\*:M/\
MH:O&'_A07'_Q5'LZ'_/Q_=_P0YZO\GX_\ ]!HKS[_A35I_T-7C#_ ,*"X_\
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MT-7C#_PH+C_XJCV=#_GX_N_X(<]7^3\?^ >@T5Y]_P *:M/^AJ\8?^%!<?\
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M-6G_ $-7C#_PH+C_ .*H]G0_Y^/[O^"'/5_D_'_@'H-%>??\*:M/^AJ\8?\
MA07'_P 51_PIJT_Z&KQA_P"%!<?_ !5'LZ'_ #\?W?\ !#GJ_P GX_\  /0:
M*\^_X4U:?]#5XP_\*"X_^*H_X4U:?]#5XP_\*"X_^*H]G0_Y^/[O^"'/5_D_
M'_@'H-%>??\ "FK3_H:O&'_A07'_ ,51_P *:M/^AJ\8?^%!<?\ Q5'LZ'_/
MQ_=_P0YZO\GX_P# /0:*\^_X4U:?]#5XP_\ "@N/_BJ/^%-6G_0U>,/_  H+
MC_XJCV=#_GX_N_X(<]7^3\?^ >@T5Y]_PIJT_P"AJ\8?^%!<?_%4?\*:M/\
MH:O&'_A07'_Q5'LZ'_/Q_=_P0YZO\GX_\ ]!HKS[_A35I_T-7C#_ ,*"X_\
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M)&"(QRJ-C"G ![7X-\>>&?B+I!U7PIXBTGQ/I8E:$WVC7T5W )% +)OC8KN
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MXX\;?LV^(;KP0-03PU>7WB+Q)XMO[_Q:-';3)M6FT>26ZDM;&)M1+VK6Z/\
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M:9XH&HG3+DW(T^]ET^Y;RG0)/&0'0%@-V"<97(SD9X-?)\_[/OB#6/BEIO\
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MS)\/6U^/4_#MEX>\.>(KF\M/L>@3>;</<ZD8GF\Y9T%Q'Y3Q1,^Z KF-7+,
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MBN?TVV\%?!VS\/>&M(TO3?"MCJVH/8Z9I>CZ>(()+DPS7+JL<*;5/EP3.6(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>advm-20241231_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +C!2(# 2(  A$! Q$!_\0
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MM4^__ W_  /*:*Z?X=_#G6_BCXEBT30H%ENF4R222DK%#&, N[ ' R0.A.2
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M*IM\L^8X*?-@=N<\5\7K\"[7QG\;-1\'^!M634M"MECF_MB65)T2+RT+L6C
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M"]Q_Z305I^*/](_8RB,O[T_\([:'Y^>0L9!Y],#\JS/V)_\ DC.O?]A>X_\
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M_3X+7SMWE[_]:IW8VITZ;N>HKYO^+BA/VR(PHP/[8TH_G';FNW_;VC<Q^!Y
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MI]Q%Y$MS<!$D$1!#1QQH2J CC.3P2 !UKMOV#_\ D6?%?_7Y#_Z :^-*]D^
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MBXQ-86MVJ'N%>1@<?@*\K_:!^.FC?%;3]&TW0=#DTBQT^227=,$0L6 & B9
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MCSZE.=&;IU%9K=!3J;3J1#"BBB@04444%!1110 4445 !1110 4444 %%%%
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M'9ZPC:;+N8@;GP8SCU\Q47_@1KQFIK&]GTV\M[NVE:&YMY%EBD7JC*<@CW!
MKM^K2]G.$YN5^_0^<EF5-8BE7H453<'?2^NW?^M3[-^/'P9'B?\ :4\"W<<
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M=_P1[G]K8O\ F_!?Y'K?QE^,NE?$W2].M;#P\-)DMIFE:9F4L05QM&%''?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?6U]=CHIYG&I/E4='>VO;NNA^F-9'C#6)?#OA/6]5@1))K&QGND23.UF2-F
M..V17YZ_L!_LRQ?%#PGX3^)>O^+=8:7POJS1Z%I$$B_9K>.*7S9%8,"</)(_
M"[<>IS@???Q/_P"2:^+?^P1=_P#HEZ\G%X2GA,3[",^>SL]+=3MH5YUJ7M''
MEOMK<\B_8C_:%\0_M*?"C5/$WB6QTRPU"TUJ;35CTF.2.)HU@@D#$22.=V96
M'7' XKZ#K\]/V"?A5IOQL_8E^(7@S5#Y<&I^(KE(YP,F"9;2S:*4?[KJIQW
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M^MM$[?CV/V^HK\POB!^UGX]E_8)\&3_VM>0>)-9U2XT:ZUQ)"MQ+:P!B3O\
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M'_!1#P5\+=%\$1^+]%\0W.M:]X9T_P 02'1[2!X%%Q'NV@R3(<A@W0$=.<Y
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MKIW70_2NBOS2_9U_8J_X:9^%-O\ %7Q/\1?$D'C36+FXDLKZ"991;>7*\69
MWSLQ9&.%=  0*_2'1[&73-'L;.>ZDOIK>".)[J;[\S*H!=O<D9/UKQ\=A:6$
MG[.%7FDFT]&K-?F=^'K3K1YY0LGJM;GAOP-_X7W_ ,+C\??\+*^Q?\(%YDO_
M  C_ -G^R]/._=[/+_>[?*Z^=\V<>]>_5^>7[*,K_P##5'[5/SM_KM4[^E],
M!^5>3_L:_LK']J/X4^(8M;\:ZUIFBZ/>O#INCV3K]G6[>-7:>16!##[@P &X
M^\*]O$993G*=6K44(P4-H_S+M??OWWT/.I8N45&$(N3ES;OL^]C]9:*^*O\
M@EC\0=;\6_![Q#I&KWT^H0Z'J2Q64EQ(7:*&2,-Y0)_A#*2!VW$=*B_X*=^
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M.;$\_L9^S=G83XU?M$?\*Y_9?D^*>EPVES=W6FV=UIUO=!FADDN?+V A6!(
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M^(-3\<7$&G7P>2?;%!!<(GEQ1$?.C1AU^8-C@@**[O\ :N^.'BWQO\"?V?\
MPS:ZM-I5]X\LX9=9O(Y#&)F"P1 ,1CY&>5W9>GRJ.:YUDJJ2@J-7F3DXMV:L
MXJ[]=/0T_M!Q4G4A9I)K7>^GR/:?^"B7QZ\<? ?P?X/O? ^LKHUU?ZA+%<R&
MTAN/,18P0N)48 9/4 'WKZYK\C/VWOV2]/\ V9?!_A+^P_%FM:OI6HW4B3:;
MJ;*8TN%C!,T80*%R"1@@G&/F-?KG668T*%'!X:5!\U^?WK6;U6_H:86I4G7J
MJHK6Y=+WMN?,NC_M.^)M0_;BUSX,R:=I*^&;&R6XCO%BE^VES9PS_,WF;,;I
M&& @X YKZ:KX&\,_\I;/%O\ V#$_]-=K7D7QJ\5:S^P5^T=X[M_!%Q;R:1XQ
MTI[F&Q\WFQDE+^6Y4<AHI/,* ]4?%=D\JABJE.E0?+-TXRM_,^NO1]3".,E1
MC*=36/.UZ=C]5J*_,OQ3-J7[)G[".@WGAK56'B_XC7\5UJ.O6<^YXXY(6EVQ
MR@YW!55<CN\A!!Q47Q>_8>C^#'[/Y^+.B^/M?_X3K3[>UO[RX\\)%*97C5A$
MR 2(5+Y#%VSMZ#.1SQRBDVE*O92DXQ]W=K3OHKZ&CQT[>[3O97>NWX:Z'Z<T
M5\8:'_P4/\.?#OX/_#2^^(&FZ]J>OZ]HWVJ2XT>UA>-S%,\#.QDF3#,T18A1
M@;NW KR7]LKQU;?%3P%\*?VDO MIJ5A'H^JO8LNHHL<R^7,7A8A'=0HDBD&0
MQSYBCVK"CDV(G65.K[L6VE+=-J^GS:-:F/I1@Y0U:2=NMM/\S]*:*_/']J3Q
M)!^U9^T/\#/AWHLC7/A^YM8/$%^(\D"&<"5@Q'\2V\1(/_3;WKQ[X[_%3PW\
M7_VHO'&E_%[Q7XDT?P)X>O;G3-.TS0(PY,D$OE9PP9%W%'<N5).0. ..C#Y'
M.LHN4[-Q<FK7:5[+2^K?RL95,QC3;M&ZO9.]D]+OTL?K?17YE?L5?'FZ\!ZE
M\9]"T#6M2\4^ _#WAF]\2Z*=60K)$;8+A-N?DW"3!48!,>0!DTS]FW]DU_VQ
M/ VJ_$_QWX_\0CQ-=:C-!8S6LJ,MOL"DLP<$XRQ 1"@4*,'G 53)5AY3>(J\
ML(VUY6V^;5:=/,(8]U5%4H7D[Z7[>9^G%%8O@K0;CPKX-T'1+O4IM9NM-L+>
MSFU*X!$EV\<:HTK D_,Y4L>3R>IK:KYN22;2=SUEMJ%%%%2,**** "BBB@ H
MHHH ^ OVA/\ @G5XK^*OQ^UGQ9H6N:)IWA/6[BWN+ZSN;B=+G(5!-A$B96)*
MLXRPY;M7L_[:W[+.L?M&>$O"D'A*_P!-T77?#]ZTMM+?/)#$L+H RJT2,RL&
MCB(PN/EZCBOI:BO9_M;%<U&5]:>BT\K:]]#@^I4;35OCW/GW]FG]EQ/A'^SG
M??#;Q1-::I-K37C:NVGLWDOYZ>40C,JL<1*@R5'(Z<5X-H/[%/[0_P );'5?
M"WPV^+^E6'@J_F=V2[5XKE V 64""3RWV@9,<BY(SQ7WW14PS7$PG.;L^=W:
M:35^]F.6#I2C&*NN716=F?,7PY_8<T/P/^S5XH^%\NK27>H>)HS)J&LI%MQ<
M *8BB9_U<;*IP3EOFY&[CQ'3?V#?CU/\+[WX<:I\6-)A\#VZ2RV&D6?FLL\Q
M8NB3.85=(O,PY4&0 YPN>:_0NBKIYQBZ;E*Z;D^;5)Z]UV[$RP-"22M:RMH^
MA\<^.OV-O&7B?]B_P?\ "*UU70H_$NC7JW4]U-/,+-U#W#$*XB+YQ,O5!T-7
M_P!H+]BO5_BO\//AH- \06NA^/\ P386]G!?L\BV\WEQQ_QJI="LD>Y6"YY.
M1TQ];T5$<UQ4)*<7JI.6W66_R*>#HR336Z2^[8^!?%_[#7QN^)^H>%O$?CKX
MG:3XE\2:3J,+"UD,D-E;6BD-(8MD W2N5CS\B9V_,S<8^^J**Y\5CJN,48U+
M6C>R222OZ&M'#PH-N-[O>[N?FM_P5;\$V*^./A_KNES >)M6MYM+EL8/];/&
MC+Y;<>IF=.>H( R%./JS6/V3M&\3?LHZ5\';J?[ +.P@"7\*;C%>H=[S!<C<
M&D,F1GD.>1UKN_&7P!\ _$+Q]H7C7Q%X?75/$FAB,:?=2W4X2#9(TB'R@XC8
MAV)RRD]/08]"KOJYI)X;#T:3:=.[OYWTMY)=SFA@U[6K4FE:>GRZ_>?G[_PQ
M3^T=J7@F'X;:C\7M%'PVC"P"WB61KCR%(*H1Y"L5&.(S-MX Z5[5\5?V*M)\
M7?LMZ-\(O#^H_P!G-H4L=Y87]VI99+E?,\QY0O:3SI<XZ%A@'&*^F**RJ9OB
MIRC)-+E?-HDM>[[LN.!HQ35F[JVK;T['YX>,/V#?C[\3/AO8:!XO^*NC:I_8
M8BCT;2-THLU51MWRS"!79U0LJED<\XW 9S][^#]'F\.^$=$TJX=))[&Q@M9&
MC)*EDC521D XR/2MBBL,5F%;&14*EK)MJR2WWV-*.%IT&Y1O=]W<_,OXW>"O
M$?C[_@I/?Z5X1\2OX2\2?8(;BQU55+".2/3U?:P'56 *GKPW0]#[;\"_V,?'
M-A\=1\6OC)XPT_Q7XFM5/V.+3 WE!]AC5V)CB"A5)PBIC)!SQS]%_P#"C/ X
M^+)^)G]A+_PFYA^S_P!J_:9L[/+\O'E[_+SL^7.W/O7>5Z.(SB<J4*-#1*"B
MW97\[/>S.6G@8J<JE37WFUJ[>6G<^9?@;^S%XF^&/[4'Q/\ B1J>HZ3<:)XG
M^T?8K>TEE:YC\RX24>8K1A1@*1\K-S67^T5^R)XN\8?%ZS^*WPI\90>#_&\=
MNMO<?;5;R9PJE Q8*_\ !A2K(P(4>E?5U%<"S+$1K>W35[<NVC5K6:.EX2DZ
M?L^E[_,^:_@3\'_CWHOQ$C\3?%CXJ6GB&R@M98(]$T="EM([8 =P(H5RN,CY
M"<GJ.<P_L[_LQ>)OA%^T+\6?'>K:CI-UI'BV\N+BQALY96N(UDNGF E5HU4$
M!@/E9N:^FJ*4\PK34U9)223222LG?2PXX6$>5ZMIWU=SXCUC]C'XO?"_XD^)
M?$?P(^(VF>&=-\07#7-UI>KQDI$2S-M ,,RN%+MM)4$!L9/4^F>!_@-\5(_@
MU\4- ^('Q#B\8>)_%VEW%A:,_F+9:>7MI8AM^485FD!;;&.$'!-?2%%74S3$
M58I3LVK:\JYG;:[W)C@Z4&W&]M=+NVOD>(?L=_ _7/V>_@O;^$?$-YI][J:7
MUQ=-+IDDCP[7(V@%T0YP.?EKUCQAH\OB+PGK>E0.D<U]8SVJ/)G:K/&R@G';
M)K7HKAK5YUJSKS^)NYT0IQIP5..RT/CKX/\ [*_Q5^#?[*/C+X=Z-KGAN+QE
MKNJ33Q:DMS<?9K>VE@@ADP_D;Q+MB?&$P-P.<BN2\4_\$UYX_@CX)TSPCJFF
MZ;\3=#O/MUUKDTDL<-Q(^"X#I&7^1DC\LE<X0\ L:^\J*]..<8N,W4BTFY<S
MTW=K:^5NAR/ T7%1:T2M^OWGQG\7OV-_B/XU\8^&?BGX6\8Z7X4^+5K80V^J
MRQ&0V5Q.D9C,L;^66 9#M*-&01Q]9?A3^QGX_P!2^-.E?$_XW>.K/Q?KFC8.
MGV>FH?)1U),9),<0559BX54&6Y)]?L>BI_M;$^S]DFMK7LKI=D][#^I4>?G=
M][[Z7[V[A7RM^VU^R1K_ .T7=>$=:\&ZIINB^)=$:6-[K4)Y80\+%63:T:.0
MR.I(X'WVYZ5]4T5P87%5,'55:D]4=-:C"O!TY[,\!^ _[+%E\./V9)_A9XB>
MWOY=6ANAK-Q8LWER23Y4M&S*I^5!&H) .4!Q7AOA?]D?]IGX0:;-X5^'7QBT
M2U\&>:[01WT)$\2LQ)VJUO+Y9)))"2 9)/4YK[PHKMAFF(C*<G:7.[M-)J_>
MS,)8.E)12NN565G;0^8_B-^Q[J/Q<_9IT7P!XM\:3ZSXSTJ>2_B\47*/)ON&
MDE;8ZEMQCV2^7UR BD#C;7/_  ;^ /[2/AWQ9X4C\;?%S3[WP3X?D4KIVEEV
MGNXU4JL4K^1$SK]W[[O^-?7E%2LSQ"IRI.S3;>L5HWO;33Y \)2YE-735NKU
MMM?N8?CGP=IWQ"\&ZWX9U>-I-,U:SELKA5.&V.I4E3V(SD'L0*^'=%_8I_:*
M^&NA:IX*\"_%_1[3P'?R2;X[A)([E4?AB@\B0QDCKY<JY.:^_J*SPN/K82+A
M"SB];-)JZZZ]2ZV&IUFI2NFNSL>(?L^_LKZ!\#_@O?\ @*2=M:.LI-_;-XR;
M/M32Q^6RJO.U GR@9/<]Z^<OV:_^"=_B_P"%/QLT+Q1XLU_1-8\.: \\VGVE
MG<3O+YK!A&Q1XE5,%MYPQ^91U%??E%:PS3%P]K[W\3?_ (';<B6#HRY-/@V/
MEC]I;]D?Q-\0?BAI/Q1^&/BZ'P=X\L+<6SR70;R9P P5BRJV#M8H048,N..#
MF[\#_@[^T#I?Q)L_$OQ6^*]GKNF6<,J+H>BQE(+AG0JID"PPK\N=PRK'('3K
M7TU14_VC7=%4))-)63<4VEV3W']5I^T]HKK6^[M?T/F7]G?]F+Q-\(_VA/BS
MX[U?4=)NM)\67EQ<6,%E+*T\:R73S 2AHU4$*P'RLW.:^FJ**Y,1B*F*G[2I
MO9+[E8VI4HT8\L-@HHHKF-@HHHH **** (KJUBOK6:WN(UF@F0QR1N,JRD8(
M(]"*^"?V=_\ @G;XM^$OQ]T?Q7K6NZ)?^$M&NKJZLK.UN)WN"[(R1%D:)44C
MY&8ACS&!S7WW17H8;'5\)3J4Z3TFK/\ '_,YJV'IUI1G-:QV/A_]LC]A'Q=\
M>_BS%XO\&ZUHNE1W6G1V>HQ:I//$[NC, R^7$X92FP8)'*>_'MWQ,_98T?XD
M?LVZ5\*);S^STTFSM(K'4(HMWE3P1A%D*Y&X,-X;G)WGG->Y45K+,\5*%*'-
M_#^$A8.BI3E;X]S\_P"?]BK]H[Q-X/M/AUXA^+^CM\.+<1PBW@622?R8RNQ"
M# C,J[1A&E*C:/2O6OCS^P_I_P 1/V>?"OPZ\*ZDFDW?A5EDTVYOLF.<D$2B
M;:"1O+%]R@X8=,&OJ:BM99OBI3A--1Y7?1)*_=]V0L#1491:;NK:MO3L?GC\
M2?V#?CY\8O"&F1^-/BKH^NZQI<JPV5A,TJV45OM8/(9%@#/,<1C+1DD;LOTK
MW3]HC]F+Q-\7/VA/A-X[TC4=)M=)\)WEO<7T%[+*L\BQW23$1!8V4DJI'S,O
M.*^FJ*)9OB92C+1<O-:R27O;Z(%@:236NMKZ]MCXZ^.W[&_C[4?CS_PMKX.>
M,K#PIXCNXPM]'J>\1[@@C++B*17#*JY1TQD9SSQ'\(?V,/'W@3]I;0?BEXE\
M<6GC";[!.-8N;II%N6NI(Y8E6%-FWR50Q 993PV% P*^R:*G^UL5[+V-U;EY
M;V5^7M??0/J5'GY]=[[Z7[V"ORB^,GP&TSQ?_P %%#X(T>;[1I6M:E;ZOJ]I
M%]VWS'Y]RK=LE?,8'MYP'6OU=KSWP[^S_P" ?"?Q*U;X@:9X?6#QAJN_[7JD
MEU/*S[R"VU'<HF<#[JC@8Z5668_^SY5)ZWE%I6[]&_0,7AOK2A'HG=^AY_\
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M(% Z5>U+]ASQE\2/V:?#O@+QSXDTF+Q;X3NI#H.LZ;)-<1?9650()M\<;#&
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M76/V8O$VH?MQ:'\9H]1TE?#-C9-;R6;2R_;2YLYH/E7R]F-TBG)<< \4:O\
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M;DGK@_2N-4J:P^'KPIJ4KRBT]F^E]5W_  -N>3JU:<I-*R:?;O\ D>1?L_\
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MAL/*C1HM;*[L[ZVU=_O26W4Y\%5JU54J3ON[+3IT1TU%?GS^S?\ M9ZYX?\
MV4?BN?%^JWE_XU\$-)'%/JMRTUR[W!,=NKLY+,4N-RGDX&T5R;?'[XF?!#]C
M'PEJ3^)=6UCQU\0M4N);+4-8NGO)+&S4*@$9EW %L(RCH/-)ZBI_L.O[25.Z
MOS**\]+W]$M1_P!HT^52MI:_IK:WWZ'Z945^;/QH^'/[0G[+/@&R^)C_ !RU
M;Q'<6]S"NHZ1=S32V\+2-@!5ED=)5W$*?D3KD=*V_P!I#]H'Q5KGBK]F+7M
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M1@XR.>:P?VM/VXE_9=\9:-X?'@MO$\FH6'V\S_VI]D$8\QD"X\F3=]PG/%>
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MK^U-^V-=?LY>-/"WAG3_  '<>-=1U^(O!%;7Y@D,AD$:1(BPR&1F8X &#G
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M\I=%;;OOH?I#17Q[_P $^_CQXS^(0\<^!?'M\=8U[PC=)$FI-AGE0O)&Z.P
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M!HEK8^&V@^QZ1:W=LMW?R(AB6:23SFC&R-WZ.F<_<)Y'K/[6'[.?Q!^)MO\
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MM%)*OS)L3*[<98[>Q\NT7]G_ /:%TG0[;PLOP)^$L_V:-;=?%5[I&F37#JH
M#N3(=YQU9H=Q(R<D\_I=12AG5:GS)0C9N]K.R?EKU\[CEE].5FY.Z5K]_P #
MXJ_:P_9I\?\ Q!A^ %MX9T.QU+_A$RR:PVGRV]E;6Y/V/+11L8QL)AE(5%X
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MIWH-S-]Y%Z<"M3_@G;\!?''P'\'^,;'QQHRZ-=7^H12VT8NX;CS$6,@MF)V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M45B^+M>D\-Z5!=QQ+,TFH6-F58D ">ZB@+?4"0D>XK:I^9',G)PZK];_ .04
M444BPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HK%\;:])X5\&:]K442SRZ;I]Q>)$Y(5
MS'&SA21V.VMJGYD<R<G#JOUO_D%%%%(L**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **3..3P*@DOHH^,[C_LT 6**SI-3;^!
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MQL;S(>\3'C\/2LY0[&BEW/3Z*H:3K-MK$.^!OF'WHV^\M7ZQ- HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
M'XP?\DE\;?\ 8#OO_2=ZZZN1^,'_ "27QM_V [[_ -)WKKJK[*.:/\>7I'\Y
M!1114G2%%%% !1110 4444 %%%% !12,P12S$*HY)/ %<=KWC7[T&GGV,_\
M\3_C32;$W8Z#5M?M-'7]\^Z3M$G+'_"N,U3QE>W^4B/V6+TC/S'\?\*PY)&D
M8L[%V/5F.2:;6ZBD9.38K,68DDDGJ324459)Z!:S_:;6*7^^H;\Q4M9/AFX\
M[3 AZQL5_#K_ %K6KE>C-UL%<#??\?EQ_P!=&_G7?5P-]_Q^W'_71OYUI3(F
M04445L9A1110!M:7XLOM-PA?[1"/X)#G\CUKL]'\2VFL *K>5/WB<\_AZUYE
M2JQ5@0<$<@BH<4RE)H]BHKAM!\9O;;8+XM+%T$O5E^OK7;0S)<1K)$ZR(PR&
M4Y!K%Q:-4[CZ***D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%4-:UB+1K,S2<L>$
M3NQH ;K6MP:+;[Y/FD;[D8/)_P#K5YQJ6J7&K7!FN'W'H%'11Z 4S4+^;4KI
MYYVW.WY >@JO71&/*8RE<****LDDMYWMIDE0X=#N%=[;W"W4$<R?=<9'^%>?
M5TGA6^W+):,>1\Z?U']?SK.:TN7%G0T445@:A6/XJ_Y!:_\ 75?Y&MBL?Q5_
MR"U_ZZK_ "-5'<3V.2HHHKI, HHHH **** "GQ3/!(LD;,CJ<AE."*910!Z!
MX;\5)J86WN2$NNQZ!_I[UT=>.JQ5@RDA@<@CM7H'A;Q(-4C%M<-BZ4<'^^/7
MZUC*-M4:QET9T5%%%9%A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!R/Q1_Y%FR_[#FC_ /IRMJZZN1^*/_(LV7_8<T?_ -.5M775
M7V4<T?X\O2/YR"BBBI.D**** "BBB@ HHHH **** "N7\3^*Q8[[6T;-QT:3
MLGT]ZD\6>)/[-C-K;G_27'+?W!_C7 LQ8DDY)Y)-:QCU9$I=$#,TC%F)9CR2
M3DFDHHK8R"BBB@ KLO#MU]HTN,$Y:,[#^'3],5QM;GA6Z\N[D@)XD7(^H_\
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M_3%:-<KT-SEO%G_'Y#_US_J:PZW/%G_'Y#_US_J:PZZ([&4MPHHHJB0HHHH
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M/,SY/T'_ -<BN$KI/'=QYNK)%VBC'YGG_"N;KHCL8RW"BBBK)"BBB@ HHHH
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M[I_8?3]0M=6L+:^L;B*\LKF-9H+B!P\<L; %65AP00001US7\S-??G_!./\
M;GE^&>K6'PM\=7Q?PA?3"+2=2N'_ .07,YXC8GI ['_@#'/W2<>#C\#S)U:2
MUZH]'#8CE]R>Q^N5%%%?,'KA1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 <C\4?^19LO^PYH_P#Z<K:NNKD?BC_R+-E_V'-'_P#3E;5UU5]E'-'^
M/+TC^<@HHHJ3I"BBB@ HHHH *Y/X@R[;6SC_ +SLWY#_ .O765Q?Q";]Y8CV
M<_\ H-7'<F6QR%%%%=!B%%%% !1110 56U35+31=-NM0U"YBLK&UB::>XG<)
M'%&HRS,QX  !.:LDX&3P*_+C]NC]L*3XJ:M=>!/"-V4\'6,VV\NX6_Y"<RGL
M1UA4CCLQ&[IMQTX>A+$3Y5L95*BIJ[*/[8G[;E]\9KBZ\)>#Y9M-\#QOLFGY
M2;5"#U;NL6>B=3P6[*OR3117UE*E&C'E@CQY2<W=A1116I 4444 %%%% !11
M10 4444 %%%% !1110 5Z/\  ?X^^+OV=/'EMXH\(WWD3KB.ZLI<FWO8<Y,4
MJ9Y'H>JGD$&O.**F45-.,E=,:;B[H_H+_9A_:@\*?M1^ UUW0'-GJ=KMCU31
M9W!GL92#@'^\C8)5P,, > 0RCV.OYU?@/\=/$_[._P 1K#Q?X6N?+N8/W=S:
M2$^3>P$@O#*!U4X'N" 1R!7[R_ +XY^'?VB/AEIGC/PW(1;7(,=S9R,#+9W"
M@>9#)CN,@@]U*L."*^0QV#>&ES1^%_@>WAZ_M59[GHM%%%>6=@4444 %%%%
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MWQ)XGU&34M4NC\SMPL:C[L:+T5!V4?S)KF:**^F2459'EWOJPHHHIB"BBB@
MHHHH **** "BBB@ HHHH **** "OT._8-_X*-3^"&TWX=?%._>Y\.$K;Z7XB
MN&+2:?V6*<G[T/0!SRG0Y7&S\\:*PK4(8B')-&E.I*G+FB?TUQ2I-&DD;K)&
MX#*ZG(8'H0?2GU^7'_!-;]N>73KO2_@]X^OFDLIF%MX=U:X?F!C]VSD8]4)X
MC/8D)T*[?U'KXK$8>>'GR2/?IU%5CS(****YC4**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#D_B O\ H=H?20C]*XBN]\?1
MEM)A8?PS#/X@UP5=$-C&6X44459(4444 5M2U*UT?3KJ_OKB.ULK6)IYYY6V
MI'&H+,S'L  3^%?C7^UE^T=>_M$_$B6^C:2#PQIQ:WTBR?C;'GYI6']]R 3Z
M *O\.3]:?\%*OVA&T'0[?X7:+<%;[4XUNM8DC/,=MG]W#GU=EW'_ &5 Z/7Y
MNU]#E^'Y5[66[V/-Q-2[Y$%%%%>R<(4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!^Q'_!,O]KV3XP^#C\.?%5V9O&'AZV#6EU,V7U"Q4A0
M23UDCRJGN5*GD[C7W-7\WOPI^)FM?!WXB:#XR\/3>3JND7*W$><[9%Z/&^.J
MNI92/1C7]"/P?^*6C_&KX9^'O&VA,3INL6JSK&Q!:%\E9(FQ_$CAD/NIKY+,
M<+[&?M(K1_F>UA:W/'E>Z.QHHHKQSN"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#D?BC_P BS9?]AS1__3E;5UU<C\4?^19LO^PYH_\ Z<K:NNJOLHYH
M_P >7I'\Y!1114G2%%%% !1110 5QGQ"7YK%O9Q_Z#79URGQ BW6=I)_=D*_
MF/\ ZU7'<F6QP]%%%=!B%%%% !117&_&#XH:9\&_AOKGB_5OFMM.@W) #AIY
M20L<2^[,5'MDGH*<8N326XF[*[/E_P#X*&_M/O\ #_P^?AQX;NC'X@UBWW:E
M=1-\UI:-D>6".CR<_1,_W@1^8U;WCKQKJOQ&\8:OXFUN?[3JFJ7#7$[]@3T5
M1V51A0.P %8-?88>BJ%-16_4\6I4=25PHHHKI,@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OI+]AO]K"\_9?^*4<E]++-X(UIDM]9LURWEC.$
MN4']^/)X_B4L.N"/FVBLZE.-6#A/9E1DX-21_3/8WMOJ5G!=VD\=S:W$:RPS
M1,&21&&592.""""#4]?G[_P2E_:>;QQX+N/A/KUR9-9\.P_:-)ED;F:PW &+
MW,3, /\ 8=0.$-?H%7PM>C*A4=.70^BIS52*D@HHHK T"BBB@ HHHH ****
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MCZM::]I-EJ=A.MS8WL"7-O,GW9(W4,K#V((/XU<KX,^B"BBB@ HHHH ****
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M"CV KULNI<]1S?0X\3/ECRKJ<]1117TAY84444 %%%% !1110 4444 %%%%
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MD,IU+5;FZ#$_PO*S*/H 0/PKU\MA>HY=D<6*E:*1RU%%%?1GF!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?NC_ ,$W_B)_
MPL+]DGPAYDGFWFA&71)^<[?);]T/PA>&OIVOS2_X(R>+GDTSXG>%Y)3Y<,UE
MJ<$>>,NLL<I_\APU^EM?#XRG[/$3C_6NI]#0ES4XL****XC<**** "BBB@ H
MHHH **** "BBB@ HHHH Y'XH_P#(LV7_ &'-'_\ 3E;5UU<C\4?^19LO^PYH
M_P#Z<K:NNJOLHYH_QY>D?SD%%%%2=(4444 %%%% !1110!YQXQT_[%K#NHQ'
M./,'U[_K_.L.O1O%^E_VAI;2(,S0?.OT[C_/I7G-=$7=&,E9A1115DGS1_P4
M.\<?\(?^S3J]I')Y=SKUU!I<9!YVEC+)^!2)E/\ O5^1=??O_!5KQ,[:A\/O
M#J2$)'%=7\L?9BQCCC/X;9/S-? 5?4Y?#EH)]SR<1*]2W8****]$Y0HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^U?^"3?Q$_X1
M/]IJ7P]-)MMO$^E3VBH3@&>+$Z'Z[(YA_P #KXJKT3]G7Q<_@/X]?#W7TE,2
MV.O6<DK XS%YRB1?H4+#\:Y\1#VE*4.Z-:<N6:9_151117P1]&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!R/Q@_Y)+XV_[ =]_P"D[UUU<C\8
M/^22^-O^P'??^D[UUU5]E'-'^/+TC^<@HHHJ3I"BBB@ HHHH KZA:+?V,]NW
M212O^!KR:2-H9&1AAE)4CW%>PUP'C;2_LFH"Z08CGZ^S=_SK6#Z$274YNBBB
MMC(***K:GJ$6DZ;=WUP=L%M"\TC>BJI)_04 ?CW^W5XZ_P"$Z_::\6/')YEK
MI+II$(SG;Y*XD'_?TR_G7@-7M<U>X\0:UJ&J7;^9=WUQ)<S,>[NQ9C^9-4:^
MVIQ]G!1['@RES2;"BBBM"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *_?W]B7XB_P#"T/V6?AWK,DOG7<6FKIURS'+&6V)@9F]V
M\L-_P*OP"K];?^".?BY]2^#GC;PY)+O_ +*UI+M%)^XEQ"!@>VZ!S]2:\?-*
M?-0YNS.[!RM4MW/T!HHHKY(]H**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "FNBR(R,,JPP1ZBG44 >5ZWI;Z3J$D!'R9RC>J]JH5
MZ1XJT7^U['=&N;F+E/<=Q7G#*58@C!'!!KHB[HQDK,YGXF:T_AOX;^*]7C.V
M2PTF[NE/H4A=A_*OP9K]P?VEKLV7[//Q*D'4^';^/C_:@=?ZU^'U?1Y8O=DS
MR\5N@HHHKVCA"BBB@ HHHH **** .Y^$OP/\=?'779='\">&[OQ#>PH))O)*
M1Q0J<X,DKLJ)G!QN89P<9K*^(OP[\0_"?QGJ7A/Q7I_]E>(--9%NK/SHYO++
M(KK\\;,IRKJ>">M?:'_!-W]I;Q<WQ6^%OP<LEL-,\()/JEU?&UMP+G4I#:74
MRF>0DY",$P% ^XN2< #COVK/"]KXW_X*97OAV^C\VRU?Q+HFGSQY(W1RQ6D;
M#/;(8UPJO-5Y4YI62OY[V.GV<?9J47K>QYC\/_V'/CE\4/"=IXE\.> +N[T6
M[C\ZWN;B[MK4S1G.'1)I49E.,@@8(((R"*\H\1^!/$7A'QA<^%-8T6^T_P 2
M6]PMK)I<T+"<2MC:H7JV[<I7&=P8$9!%?HU_P4:_:@\?? _]I'P'I/A/6[O1
M] T;2[;4WTNQG:&&]9IY5:.91PZ;(54*00N21ST^E/B1\']$U_\ ;Z^%7BNX
MM%>]M?#.IW)R>'DMI88X6*],K]N8@]<JO]T5R+&U(I3J)6DFU;R[FWU>+;C%
MZIJY^7-U_P $^OV@[/P^^LR?#2_^QI$9C''=VKW&T#/_ ![K*92?]G;GVK@/
MA#^SK\1OCQJFHZ?X%\+76N7.G &\_>16\<&20 \DK(H8E6PN<G:>.#7WI\*/
MVIOB'XB_X*=:UX3N]?O)/",NL:IH T)YV:TBBM8YQ')'']U9"\"L6QD[F&<8
MQT/Q.?P1YO[5'P-C\9:!\-?$OB#6[+6[.^UZ\%E93K-;V5Q-&9>VYEE#+SQ-
MP&&13^M5HOEFE=I/2^B;MKZ"]C3>J>FJ/S1^*7PE\7?!7Q9+X:\:Z'/H&M1Q
M+-]GF9'#QMG:Z.A974D$94D94CJ"*O>//@;XW^&/A7PWXB\4Z&=%TOQ'&9M+
M-Q=0^?<1@ E_(#F55PR\LH'S#U%?I=\3/"_P]^,_C;PO\0O$.J6_B?X9_"G1
M(K*_UBU/G1^)-6)4QV4!R?/ ;83@D,\XCY._'P9^UUXA^*GQ*^(UUXZ^(O@W
M7_"5G?,+72K75--GMH+:W7)C@B:1%#$#+$C[S%FP,X'11Q$JS2M;O_DOS,JE
M)0N_N/"****] Y@HHHH **** "BBB@#[D_X)"^()--_:4UO3<_N-2\.7"E?]
MN.>!U/X#>/QK]BJ_$K_@EE>&U_; T&(9_P!)TZ^B/X0E_P#V2OVUKY'-%;$?
M)'MX-_NPHHHKR#M"BBB@ HHHH **** "BBB@ HHHH **** .1^*/_(LV7_8<
MT?\ ].5M775R/Q1_Y%FR_P"PYH__ *<K:NNJOLHYH_QY>D?SD%%%%2=(4444
M %%%% !1110 A&1@C(KS7Q/HQTC4#L'^CR?,A]/45Z76?KFDQZQ8M"W#CYD;
MT:KB[,F2NCRRBI+FWDM)WAE7;(AP14==!B?E)_P4OUI]3_:/2T8_)IVC6MNH
M_P!YI)2?_(GZ5\GU]%_\%!+HW'[5WC",_P#+"*QC'XV<+?\ LU?.E?9896HP
M]$>)5^-A111709!1110 4444 %2VMK/?74-M;0R7%Q,ZQQ0Q*6=V)P%4#DDD
MX %15Z+\!_CAK/[/?CH^+O#^GZ9?:REG-:VTFJ6YF6V:0 ><@!&' R >F&((
M(-3)M)N*NQJU]31^)G[+/Q3^#G@?2_%_C3PC<>'M!U*>.UMIKJX@\TRO&\BH
M\*R&6,[8W.'48VX.#Q6#\)O@CXY^.FNS:/X%\.77B&_@C\V98"D<<*DX!>1V
M5$R>FYAG!QTK]!_V^/$NI^,_^"=/P5U_6KMK_5]3U#2;R\NG !EFDTR[9V(
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M!HKS8X*2AR.?6ZTV?WG6ZZYN91Z6WZ'ZB>+/#NG?L _L)^,_A]XB\1Z;J_Q
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M *<K:NNJOLHYH_QY>D?SD%%%%2=(4444 %%%% !1110 4444 %%%% 'YF_\
M!9CP.3:?#?Q?#& BR7>E7+XY)8)+$/R2:OS#K]UO^"C'PY?XC?LE^+X[>-I;
MW1O*UF!57<?W+9D_\A-+7X4U]?EE3GP_+V/$Q<>6I?N%%%%>L<04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>J_LJ>"Y/B%^TA\
M-]"1=Z3ZY;2S#&?W,3B67_QQ&KRJOO'_ ()"_#=_$/QTU[Q?+$QM/#NEM%')
MMX^T7!V*,^OEK+^=<V)J>RHRGY&M*//-(_7VBBBO@SZ,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#D?C!_R27QM_V [[_TG>NNKD?C!_R27QM_
MV [[_P!)WKKJK[*.:/\ 'EZ1_.04445)TA1110 4444 %%%% !1110 C*&4@
MC(/!!KC?%7@&'4K6X%J@*3(R26YZ,",''X&NSHJE)QV$U<_FL\;>%[KP3XRU
MWP]>QM#=Z5?364J.""&C<H?Y5B5]8_\ !3KX;MX!_:NUV^CA>.Q\26T.KPL1
M\I9E\N4 ^OF1L2.OS#U%?)U??4:GM:<9]T?-SCR2<>P4445J0%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Z_\ _!('P7+HGP!\
M1>(9E"G7-;80\?>B@C5 ?^^VE'X5^0*@L0 ,D\ "OZ%OV5/AR?A/^SKX \,2
M1B*ZM=*BDNE"XQ/*/-ES[[W8?A7C9K4Y:*AW9WX.-ZE^QZO1117R9[(4444
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M?-'JA1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C\8/^22^-O\
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M?3&<MZM_NBOJJOC\PQ7UBIRQ^%'N8:C[.-WNPHHHKRCL"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#D?BC_R+-E_V'-'_P#3E;5UU<C\4?\ D6;+_L.:
M/_Z<K:NNJOLHYH_QY>D?SD%%%%2=(4444 %%%% !1110 4444 %%%% !7._$
M/P'I'Q/\$:UX4UZV%UI&K6S6UQ&?0]&'H5(# ]B!7144TVG="WT9_.E\>_@U
MJ_P#^*VO>"M94F;3YCY%Q@A;FW;F*5>!PRX^AR.U>?5^V?\ P4._9#7]HCX>
MKXA\/VP/COP]$[VH3 -];_>>W/J>,I[Y'\5?BA/#):S20S1M%-&Q1XY%*LK
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M_L!WW_I.]==7(_&#_DDOC;_L!WW_ *3O7757V4<T?X\O2/YR"BBBI.D****
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MBB@ HHHH **** "BBB@#D?BC_P BS9?]AS1__3E;5UU<C\4?^19LO^PYH_\
MZ<K:NNJOLHYH_P >7I'\Y!1114G2%%%% !1110 4444 %%%% !1110 4444
M%?F3_P %(/V#VDDU'XM_#RP+,V9M?T6W3VYNH5'T^=1_O#O7Z;4C*&4JP!4C
M!!Z&NG#UYX>?/$RJ4XU8\K/YDJ*_3/\ ;J_X)M&'[;\0/A%IN8^9=3\+VJ<C
MN9;91^L8^J]Q7YFLI1BK JP."".17VE#$0Q$.:!X-2G*E*TA****Z#(****
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M7X>_\$<_!6EF";QEXVU?Q!*O,EMID*64)/\ =);S&(]P5/TKZ[^%/[,OPO\
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MN/S5"!6C8_L7_'34,&+X5^)TS_SWL'A_]#Q7] U%:?VM4_E1/U*/<_#CPO\
M\$S/V@O$JI)+X0M]$A;H^J:G;H?Q1'9Q^*U[9\/?^"-_BR^D23QMX[TG1X>K
M6^BP27DA'IND$:J?P:OU;HK">:8B6UD:1PE-;ZGR/\+?^"7WP1^';QW.I:9?
M>-KY1_K->N-T(.>T,85"/9MU?5.AZ!IGAG38M/T?3K32K"+B.ULH%AB7Z*H
M%7Z*\^I6J57><KG5&$8?"K!1116)84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <C\4?^19LO^PYH
M_P#Z<K:NNKD?BC_R+-E_V'-'_P#3E;5UU5]E'-'^/+TC^<@HHHJ3I"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** .1^,'_))?&W_8#OO_2=ZZZN1^,'_))?&W_8#OO_ $G>
MNNJOLHYH_P >7I'\Y!1114G2%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '(_%'_D6;+_ +#FC_\ IRMJZZN1^*/_ "+-E_V'-'_].5M7757V4<T?X\O2
M/YR"BBBI.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH Y'XP?\DE\;?]@.^_\ 2=ZZZN1^
M,'_))?&W_8#OO_2=ZZZJ^RCFC_'EZ1_.04445)TA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!R/Q1_Y%FR_[#FC_ /IRMJZZN1^*/_(LV7_8<T?_ -.5
MM7757V4<T?X\O2/YR"BBBI.D**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y'XP?\DE\;?]
M@.^_])WKKJY'XP?\DE\;?]@.^_\ 2=ZZZJ^RCFC_ !Y>D?SD%%%%2=(4444
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MHHH **** "BBB@ HHHH Y'XP?\DE\;?]@.^_])WKKJY'XP?\DE\;?]@.^_\
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ML17AB(0C"Z=^JUV^ZQ^LE%%%?-'K!1110 4444 %%%% !1110 4444 %%%%
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MUU5]E'-'^/+TC^<@HHHJ3I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]@_:JFD;_@FG\.V+L6DTSP_O))RW^C(>?7GFO+Q.5QJ8GW)<JG4E"UMK?/\
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MC=CWKCS+*99?353FNF[:IQU\K[KS-\+CEB9.%K.U][_TST6BBBOGSTPHHHH
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M ]A7K/Q@_9'35OV45^#WP]EL]-^SO;O#<:O(X65DF$DDDKQHQ+N=QX7&3@
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M]MC\W_VXO"^I>-/V\/A?HFCZU-X=U:\T.T2TU6#.^UF%W>E)!@@\,!T->C^
M_P!B?XE^*/CEH?Q"^-WCS3?%C>'S&^GVVFJW[PQ-NB#@Q1*BA_G(4,6/4\DU
M].^)/@7X'\7?$K1/B!JVA+>>+M%B6"PU$W,R^2BL[*/+5Q&V#*YRRD_-["N\
MKIJ9Q.-"G1H:6CRMM*_6]GO9HRC@8NI*I4UN[K5V^:/F71_V8O$VG_MQ:Y\9
MI-1TEO#-]9+;QV:RR_;0XLX8/F7R]F-T;'(<\$<4?M5?LEZQ\9/%_AKQ]X%\
M3IX1\?Z"GD07<P;RI8PS.@+*"5*L[_PL&#D$5]-45Y\<QQ$:D*J>L8J*TZ)6
MLUU.IX6DX2@UHW?YGRO\)_@Q^T@GQ*T/7_B?\7=/U+1-+=W;1]"C,<=YF-E"
MRA8(%(!;=\P;[H[X(Y;XI?L8_$O3/CYJWQ-^"OCK3_"EYK@8ZC!J>[Y6?!EV
M@12K(K,H?:X&&Y!Z8^T:*TCFE>-1U(J*NK6Y5RVWV(>#IRCRMMZWO=WOZGR!
M^S_^QKXR^$/[1ES\1->\8VOBV*^TF2&^O+AY!>S7DC(6(0IM$0"X'SYP!P!P
M.E_8]_9B\3?L]^*/BAJ7B#4=)OH/%%[!<62Z;+*[1I&]RQ\S?&F"1.O"ENAY
MKZ:HJ:V9XBO&<9M>\DGITB[H=/!TJ;BXK9M_?N?'?PA_8DU[PUJ?QTA\5:QI
MC:/\0HY[>U?29)9)[=9)9F#NKQHH8"13@%AD$9Q7FVG?L'_'_3_AYJ7PUB^*
MN@VWP]?SI8;&"*0/<2-EU64^0&1&<+N D< $D*W0_H;171'.<7&3EH[V>J3L
MTK)J_6QF\!1:2UTOU[ZV/E"']C75=5_8DTWX,:OK-C!XBL7DN8M1L_,DM1,;
MR6=0=RJQ4K)L)V@@G(!Q@Y_P]_9$^(^M_!+Q)\,_B]XYT_6-"DL;2Q\/Q:/%
MYG]E_9V+)(7:*)F(Q&NTDY4$;AQ7U_16/]J8FTE=:RYME=2O>Z[&GU.C=.VR
MMONO,^%?#W[+_P"U=X1T"U\'Z/\ &K0[/PA:(+>W=48W<,(X"JQMBZ@#@*)<
M   8%?:'@O1+SPSX-T'2-1U2;6]0T^PM[2XU.XSYEY)'&JO,^23N<@L<D\GJ
M:VJ*PQ6.J8NW.HKKI%*[[NVY='#PH_"W\VV%%%%>>=04444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!R7Q9^(5G\*/AKXD\7WR^9;Z/9277EYQYK@?)'GU9R
MJ_C7!_LA_%KQ=\<?@Q9^,_&&GZ9IMUJ-W/\ 8X=*BDCC-LC",,PDD<[BZR\Y
M (V\=SYO_P %.=;FTG]EN\MHF94U+5K.TEVG&5#-+@^V8EIGQ!FOOAE_P3?L
MYO#NHW6C:C9>%M+>*^T^9H)DD=K<R.KJ0REB[]#_ !&O?HX2%3!T]/?J5.5/
MLO\ AV>;4K2C7E_+&-[=W_2/K2BORZ;1OV@/$G[+,'QJF^-.K6-OIEHKVFBV
MES,C7%O'+Y+23RJXWRDJ6^=7W=V'2OHWPOXI^.O[0W[+_P -/%'PX\6Z-X9\
M47/GKK-UJUNA2Z$4LD&Y5^SS!26B+'"K][\**V4NBE+VT6N9Q;U23M?73\NH
MJ>.]H[<CO:ZVU7WGUQ7BO[1O[5GA+]G'3XH]3CN=9\274#W-EH-@A,TL:ABT
MKM@K'&NUB6/.%. <''C$?PM_;<$BE_C#X**Y&?\ 0XCQ_P""X?SKWC]I3PUI
M+_!;XH:\VF6C:VO@W5+1=1:%3.L/V69O+#XR%R2< X)K&.%HT:].-6:J1;VB
MW^-TOP_ TE6J5*<G"+BUW7_!*_[+/[0@_:7^&<OBX:!_PCGEZA+8&S^V?:L[
M%1M^_P M.N_ICMUKRGXL?\% (/"?Q'U;P7X"^'>L?$[5-&W#4Y-,D>..W9.)
M -D,K,$.%9B  <\G'-/_ ()8_P#)M%Y_V,%U_P"BH*\__P""4;'5)OB[K%Y#
MC5+F^LS-)(/G&XW#,N3R/F)S].>E>I+!X6A5Q=64.:-)I*-VMW;??0XXUZU2
M%""E9SO=V[+[CZ ^$?[547[1OP<\6:]\/].6T\:Z+;N/[#U=3,BW!C9H03&5
M+QR%&4$;3E6XXYN_L;_M&S?M+?"4Z_J5M9V7B"RO)++4;:Q5EA###QNBNS,%
M*,O5C\RM7S?^PK#_ &1^VA^T#I5E#Y.E17E^JQKG:GEZBRQKU_NLW7GCZU=_
MX)[LWA7]HS]H+P?"W^@6NIR%$4853!>3Q @=LA_T'I58O 8>G#$1IKX5"4>Z
M3W7XBH8FI*5)S>_,GZK9GWS1117R![@4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 <C\4?^19LO\ L.:/_P"G*VKKJS/$6@Q>(]/B
MM)I'B2.[M;P-'C.Z"XCF4<]B8P#[$UIT^EC!1:JRGT:7X-_YA1112-PHHHH
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MD*_]-7A8(1[ABI_"OEO_ ()JZ^/$W[+/B/PU"V[4]+U"\MOL['!"S1*\9YZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUX&;68[/^S=1M9C:WMGOWJD@ (96P,JP.1Z<CG&3ZE0 4444 %%%% !1110
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M-#MW MD 'M5%%% !1110 4444 %%%% !1110 5^/7_!8;_DYCPS_ -BA:_\
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MCJ'QR 8FR,^^!^0I?VL/ACK/C/\ 9S\"W>B6,UY+H5O;R3V=O&6<0M;JK,%
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MA9&$@@V#RT*HCHQ=B\<T;87)4 'J]%%% !1110 4444 %%%% !1110 4444
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MH XJZ^$>@:CJWC?4+U;B[D\8:=!I6I1O(%7[+%',BQ1E0&4?Z1,V22<R'!'
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MNQ:@1P10QV\#'R+6#;(8HHPR@&,;!M&2[/Z_10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>advm-20241231_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +C!1\# 2(  A$! Q$!_\0
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M+2MTI%J62A:***@H****E@%%%%(!XZ4445FP$:FTYJ;2 <.E+116; ****D
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M-<NKJ_L8="OY+.*4P,[Y20LY&PCS(\L@)RAXXQ7N7Q^^(W@'P'-HJ^-O"_\
MPD;W2S&T/]GV]UY04IO&96&W.Y>G7'M6<JLN=**T.["Y-AY8"M/$34:D96N[
M^[9VL[:._3U/SOI:GOIHKB^N)88O(ADD9DB'.Q220OX"NA^%_@]O'WQ"T#0
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M9/QKZ;\">.#XL^-?Q L8I-UEHMO96,85L@R9F:4^QW':?]P55:;>D7L<_#N
MHPCSXNFI.<N5)I.W*FV]?2WR/D;2?AGH3_M0-X,G@DGT!=4EA^SF5@WEA694
MW@[N, 9SGBO??'OPM_9\^&,]G#XFTS^S9+Q6>!?M&H2[PI )_=LV.HZUY;I7
M_)[S_P#88F_]%-6U^WI_R'/!_P#U[W'_ *$E)WE.*OT(HQHX7 XK$*C"4HU&
MES1OI=*WXG2ZI^RO\-OB9X>DU'X>ZP+29051H+HW-N7X.V0,2ZG\01G.#7R#
MXD\/7_A/7K[1]4@-M?V<IAFC/8CN/4$8(/<$&O9_V,?$UQH_QBBTM'D-KJ]K
M+#)&OW=T:&56/TV, ?\ ;]ZF_;:TR#3_ (QP3Q1JCWNE07$I48+,'DCR??;&
MH_ 5<7*,^1NYYV.I8;&9<LPHTU"2ERR2V^2^X\2\-^'[SQ7X@T[1K! ][?W"
M6T0;.T,S  G . ,Y)[ &OL'4/@)\%O@WH5FWCN\>\N[C($]Q/.K2L,;O+B@.
M[:,CKG&1DU\G_#OQ4/ _CK0M>:$SQZ?=QSR1+U9 ?F Y'.,X]\5]V^.? /@S
M]J/PGIU_9ZP6-L&:UOK)@S0EP-R21GZ+E3AACJ*5:335W9&^0X>E6H5I0A&=
M96Y5+:WI_738^;OV@_A?\/M#\'Z7XL\ :B+BRN;P64MO%<^?&I,;OG+9=6^4
M JQ[C@=ZGPG_ &8)/BA\.[GQ2/$:Z;Y<DR+:?8C+N\L Y+^8N,_0US7QB_9^
M\1_!R2.>],>HZ/,_EPZC; A=V,A74\HV,\<@XX)K[?\ A)XP\*>*_AW)JOAG
M0_[&T)7F5K'[+%#EE WG8A*G/KGGO2E-Q@N5W.C Y?1QV85(8NDJ;4?@U6O=
M6Z?YGYI45[YXV\;_  ]^)WQ$^'=KX2\)IHEK'J:1:A%)I]O;K<K)-"%4K$Q#
M  /][^]7:?MJ>!O#OA;0?#%QHNA:;H\TMS-'(UA:I!O78IPVP#//KTYK3VFJ
M36YX+RO]S6KTZJE&G;57UO;;T/E&BOLO]F;X?>&/$'P*O+_5/#NEZC?>==+]
MJNK..24 *, .P)&/8UYO^R;\#]-^)6I:CK?B"#[5I&FND4=J20L\Q&[YL'.U
M1CCON'8$%>T6M^A4<EKS>'C3:;JIM>5NYXOX'M8;[QIH%M<1K-;S:A;QR1N,
MJRF1001Z$&OI7]M+P/X=\*Z!X9GT70M-TB66YE21K"U2 NH12 VT#/XUUY\4
M? K6/'\?A./0K/2]4L[Q$M]2M;!+:(W*.,(LJ88G<,?,-I]3FF?MFZA;:1%X
M OKRT2_M+75C/-:2*&69%V,R$'@A@".?6L>=RG'0^@AEU+"Y;B5[2,]8ZK6V
MNI\1T5]?_M8?"OPX?AGI7B[PII&G:?!;2(\LFFV\<"36\P 5R$ W8;R\>SFE
M_9B^&OAC3O@[JGC+Q9HNFZE',TUPDFH6J3>5;P@@[=X."663IUPM:^U7+S'C
M?V%6^NO!N2^'FYNEN_WZ'Q_7OO[)7PL\,_$[6/$4?B73CJ,5G!"T,?GR1!69
MF!.492?NCO7A6H72WVH7-RD$=JDTK2+!",)&"2=JCT&<#Z5]0_L&_P#(<\7_
M /7O;_\ H3T56U%M'/DE*G5S&E3J)2BV]UH]'T.GUKP;^S9X?\2W'AW4HH]/
MU:%Q'+'-<Z@JQL5##,A;8.".<XKG/BW^R+I:>&9O$OP^O9;R!(OM/]GM*)TE
MBQG,$@Y)QDX);/8]!7D'[2__ "7/Q;_U\)_Z*2OH7]A?Q-<:EX.\0:),TDD.
MFW4<L.[[JK,&RJ_\"C9L?[7O6+YHQ4TSZ2A/"9AC*F75J$8ZR4915GI??OHO
M3R/BRBOHCX5_ /3?B)\;O&UC>J8O#?A_49XY+>W;89"9Y%BC!'1<(V2,'Y0!
MUR/4I_'?P%TOQC_PAK>$M/:9)_L3WQTB)H4E#;"ID/[PX88W8([YK1U-;)7/
M H9+*I3]K6JQIQ;:5^K6A\2T5]!?M'? &P\"^._#R:!NL](\0S?9TCD+.EK-
MN12-QYVD." 3GANPX]P\6>%?A;^SUX3T^34O K^(+=R8I+W^S8KV0, ,O*\I
M 3)Z $#K@<4.HK*W4JGD5=U*T*TU!4[7;VUVL?#&DPVMQJUE%?3-;V+SHL\R
M#+)&6 9A[@9->^?M&>#_ (2^'?!VES^ [S3Y]7>\5)DLM4:[)@\MR692[;?F
M">G4UR7[0NN_#SQ%JVC7G@"TCLD:W<7L,-JUNJON&SY<!<X+9*\=*]G_ &RO
M ?AKPK\/=%N=%\/Z7I-PVIK$TUC9QPNR>3(=I*@$C(!Y]*3EK$UH814\-BXQ
MY)J"C[V^]_A?YGR O2EK[/T/P'\-/@+\)='\1^+]%BUZ_P!02'S&FM5NF>61
M"XCC1_D4!0W)QG;R<X%=QI@^%.L_#&X\=67@72;C2(();AX1HMLLX$9.\;6
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MVFQL@1E?>'^=F.0V._:NEX>I[:%1;*-OF>/',<-_9];#2O>=3F^6GXZ&O=_
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M<W/VLM; JL<F<C:"21@@8Y/2J]FY2DWU1Q+-*5#!X>E1;<J<W+Y7?YIGZ/\
MB*/1OA?IWC/QLMLJW5Q MU=L, S-%%LC0$^O ^K>]?/G["]]<:IKGCZ]NI#-
M=7'V6:61NKNS3EC^))KR;XC_ +47B_XG^$Y/#VJ6^EVUC*\;RO902)))L(8
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MV^8GAK]F7PWXVU=].\._%+3=5GM2QOD73W1HHP.9(@9,3+N*C(('S9SV.O\
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M[8Z/ID#7-_>2B&&->Y/<^@ R2>P!->W?M?7-@=>\+64DMK=>+;33%37;FT4
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M$Q[D5CZ+\(_%WB+XX7-]K6E7>G:?;ZL^H7^IWT;16ZPK*78B1N&R!@8)ZYZ
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M=L &N+N9I9" , %F)/ I^H>(-4U>UL[6^U*\O;:S3R[:&XG>1(%P!M0$X48
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUO\ 9]5:R74-35OO?:Y_WLBM[IN$?TC% %O]M3_DTCXO?]BQ?_\ HEJ^/?\
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MK6O%GP]^(^EVNF?$'PRAF=[.,Q"YB240S!XR2$DCD* [3M/F# 7'/C/["?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0?!\Q:/?:?X/\707=G-I_FH[3QK',PE6-Y(T=>1PJXSR3-_P3/\ @;X&T?\
M9)\.?%"R\/PV_CW4M+U>UNM;663S98EOKA I7=M&%AB'"Y^45]#?!#]FF_\
MA-\5?'/CW5_'E_XVUGQ=:64%X]_91P&.2W\P;D\L[5C*NJK&%&T)RSDDUE_
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M^G:U80KHD-C9,MM*'8201R?//)@+Y[,=H+83YJ .+_:B\&PZ/^T%JOC;XO\
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MJ^BJ^=?&W_)[7P__ .P'+_Z!?5M3W?HSP\V^"C_U\A_Z4CZ*HHHK$]P****
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MJ17R%\8/C)<_MC_!#]E#X46-S-)JWC.]C?Q%)&WSHMB3;32,.I#$3S#_ *Y
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M-+XLN/M>LZ7_ &+;ZM9S3$LS/'',RB,EG=N^-[ 8&  #SC]FCX2_$O\ :/\
MV!/%OPH^*%UXH\%:L^J-INGZMXBTR5+XV,;VUS&SQ2LKNI;S(OO8VC:&.VOM
M#X1^ 3\*_A;X3\''4Y=9.@Z9;Z<=0G38]QY483>5R=N<9QDXZ9/6O*O'/[*N
MJ?$#]EWQ)\)-:^)NNZOJNNLLMQXMU.)9IU87$<VQ859%6+]WL\L, %9N:]5^
M$/P__P"%4_"SPEX,_M*76/[!TNWTW^T)DV-<>5&$WE<G;G'3)QTR: .NHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9?U7]HZS^,GA_0[2TM;S5$\!_P#".VTM@B02.OV.6Z9O/\YPH P5^9E7C.:
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M%%% !1110 5\Z_LR_P#)6OCC_P!AP?\ I1>5]%5\Z_LR_P#)6OCC_P!AP?\
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M99VD]]>/$#@R>1;QR2!,Y&\KMX//!H ])HKS_3?CY\/]9^%.H?$K3_$]I?\
M@G3[::ZN]4M5>00)$NZ4/&JF0.H',>W?TXYK'\!_M5?"KXG>-)?"GA;QA;:S
MKD5C_:+PP6\XB6#;&S$S,@C#*)8]T>[>N[#*"#0!ZQ17A?A_]N'X&^*?'%IX
M1TKXAV%YK=Y=BPM0MO<"VN;@L%6**Y,8AD8L0 %<Y) %='\3OVG/AG\'=<CT
M7Q3XF6UUEX/M1TVQLKF_N8X<X\V2*VCD:-,_Q. #ZT >HT5Y[>?M!?#RQ^$,
M_P 43XIL[CP#!")Y-:LU>YC"[Q']V-6<D.0I4+D'((&#7)0_MM? ^X\>VO@V
M+XB:;)KMU.+2%5CF-L\YX\G[5L\CS,D#9OW9(&,\4 >WT5\F_'#]O;PS\%_V
MFO"_P[U&^A@T(6MU)XEN6T:_N+FTF\B.6S6 Q(5D#B3YBBR8Z$H0:^G_  SX
MCT_QAX;TG7M)F:XTK5+2*^M)GB>)GAE0.C%' 9258':P!'0@&@#3HKY=_9!\
M<Z[XE^)_[25MKNNWVI6.C>-Y;6PBOKII([*W$?\ JX@QQ&@QG:,#J>YKHX_V
M]_@#-XF70D^)>FFZ:X^RK=>1<?8&E_NB\\O[.3])* /?Z*X?XJ?&SP-\$=#M
M]7\;^)+/0+*ZD\FV\[=)+<R8SLBB0,\C8[(I/(JI\'?V@_A[\?;'4+KP%XFM
M]>73Y%BO(!%+;W%LS9V^9#*J2)G:V"5 .TXZ&@#T.BO!/&W[:WP7\/>)=7\%
M3_$73K7Q3;B2T= LOD07.U@(GN@GDQR!E(VM(&!&,9XKQWX5_$_5I/\ @GE\
M,_%/B/XO:AX'U:[G@CN/%U]9/K5Q.QOI$$+JVYF\P )O/W1R>!0!]NT5YA\1
MOVFOAA\(_$UQX>\8>+[/0-8ATD:XUM=1RY:S,_D*ZL%*NQE^41J2YP2%(&:O
M?!WX_?#_ ./VEW^H> O$D&OP:?-]GO(UBE@GMI#G DAE5)$SM;&Y1G:<=#0!
MZ#17S]XS_;V^!'@'4+^SUCQUM:PNC8W-Q8Z1?WMM'<#.83/! \7F#!RH;(QT
MKV;P5XSTCXA^%-,\2:!<O>:-J4(GM9Y+>2!G0]"8Y%5UZ=&4&@#;HKR+XL?M
M:?"3X'^([;0/&OC2TT?69XQ,+)()[F2*,G DE$*/Y*?[4FT8YS7GO[%OQ,NO
MB-K'QXU*;Q/-XCT*V\=W4>D74M\;FWALO(A9%@8L56+!W +A>2>] 'T_17@$
M?[>_P!F\3+H2?$O33=-<?95NO(N/L#2_W1>>7]G)^DE>C_%+XV>"?@OI=C?>
M,=>BTJ/4)?(LH4AEN;B[DQDK#!"KR28&"=JG&1GK0!W%%<1X/^-?@GQUX%O?
M&.E:]"/#5BTJWE_J$4EB+0Q@-()EG5&CV@@G>!@&N3\"_M??"+XD^*;+P[H'
MC&.?5[]2UA#=V-U9I? #)^S23Q(D_ S^[9N.: /8Z*\L^)G[3_PS^$/B&/0?
M$_B4VVMM!]J;3['3[K4)X82<"65+:*0Q(3T9]H/K7HF@Z[8>*-"T[6=*N4O=
M+U&VCO+2YCSMEAD4.CC/."I!_&@"_1110 4444 %%%% !1110 4444 %%%%
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M0T >!1_LY^.+SX^?#3QWX[^,NC:SJ'AIKY+#3;#PJFESW\<UN4EB,GVQRRJ
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M;X"^)GPYA\!>)/#%CJ'A&!(8[?2U#01VRQ+MB\DQE6B*+\H*$$#(Z&@#P_\
M;BF2R\7_ +-=U.WE6R_$_3HVF;A%9XI@H)[$GI]#7+_MW_VU-\?/V8;6S\0V
MGA73)M:U4'5M5TU=0L;?4?LL8LC)"TD89R6F5/G&TL6YVXKZ U#]F#X8:M\'
M;;X67OA."\\"VKF2#3)[B=VBD,CR&19R_G"0O(YWA]WSMSR:L-^S=\-)OA';
M_#"Y\)6=]X&MRS1:3?/)<!':1I#())&,F\N[MOW;LL>>: /+-(_9U\:?\-&?
M#_XA>.?C%H^NZIH%IJ%K;:3I_AA-+FU&">$JZ._VN0ND;[) -IP0>F[-<?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KYU_9E_Y*U\<?^PX/_2B\KZ*I%4+D@ $]<"K4K)KN<-;"^VKT
M:U[<C;];IK]1:***@[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M87I!+TT_(Y7_ (0O4%_U7C+7XOPM'_\ 0[<T?\(KKT?^K\::@_\ UWL[1O\
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M;D#]*/8P_P"?L?\ R;_Y$/K-7_GQ+[X?_)G545RN[QO#_P L] O/^VD\&?\
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M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*;
MN'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT .H
MINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0
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M=V[ID8QU-+J'PIN[K6)I(?$"0:1+KEOK[636.^7SHVC+)YOF ;&\O^YD'')
M(*&:-E\6M/O=4%K_ &7JD%J=5ET4:E-'$+?[4C.NSB0OABG#;-OS $@Y @TO
MXQ6.L:+:ZE;:%K3)?7"VVG0-'");^3YRXC'F\!!&[,TA1<#(+5S_ (-\!ZKJ
M5U>OJ5ZUGI-MXKO=6BL)+$I-*PGD,1$I;'E$E7^X2<</@X&G-\&+2;P+X?T*
M6ZM+VZT28SP3W^GK<6\I8N&62 O\RE9#T8$,%8'C! -%/B]I]TEI'9:1JVH:
ME,;D2Z7;QQ?:;;R&"2F0-(% #,H&UCN+#;FN<\*_&IX_"FC'4=.U;7M8FTI]
M5N'L+>%0(5D=68[G0 C:/E R<C )S6Q#\,;S2Y--O-%U+1] U.V@N+64Z=HO
MEVLL4K(WRP>=\CJR*0VX@G.01P&>'?A N@0Q1_VS]HV:%)HFYK8*3NE:3S?O
M?[6-OMU[4 ;.J?$ZPTN&UO/[/U*YT:9;9VU>*%5MHQ.RK&3O97;EESL5MN><
M<U@Z'\8;AK?Q%/K&@WMNECJ[:9:+;+$[W#DHL<.!,V927R3PF/XN#63JW[/Q
MU0V:OK=I(D%M8VXENM+$UQ#]F &()#+^Y1R-S* 226^;FMC6/@^-8@UVTDU.
MU?3]0U1=9@@N;#SC#<C9N$F9-LL3;#\FU3AR-W&: .Q\+^*H?%$5Z%M+K3KR
MQN#;75C>A!+"^U7&=C,I!5U8%6((/UKE=,^.&DZCI=OJ3Z3J]C8W=A<:A9S7
M440%RL*;Y$4+(2& SC>%#8)!(YKHO!/A>/PEILUL(-&MWDE,A_L33/L$1X &
MY/,?+<?>STP,<<^8_#_X5ZKK7PZ\.P:YJ;6?V71[FTMK%]/,4UM)<1F-FF)?
MY]BE@JA4X/))YH [NU^*45]:::]MX>UJ:\U)7FM-/VVZSR6ZJI-P=TP5(\NB
M_.RME@-M4V^-6F7'V-=-T?6=8EN+!M2\JS@C#11*[(X?S)% 960J5SR>F:NW
M'@6[M6\/WFCZO#9:KI5B=-::ZLS/#<P$)D-&)$8'?&C A^/F!SGCBK?X=:YH
M?C:SL= U:2PCA\/20RZO=6!GCEFDN7=\ ,@63<^\ -QCD,* -#_A<IL?$FOW
M;6NI:OX:ATG3]4A>QMXR+6&196DE<LRL05"':-S85B%P&KK/^%G:3YDL1BNO
MM$>KQ:-Y&Q=YDD"LD@&[_5%&\S=UV@\9XK'M_@_::?H_B73++46AM-6T.WT2
M+?"&:W6**:,2,01O)\W)&%Y7KSQ3MO!;?\+PM]25+E=/L='C=Y/+*P37G[R%
M6!(Y80LX(!X!2@"/PQ\6KC3_ (9Z3KFMV.IZNQM9+J_OK.WB6."-967<V60$
MX'W8PS87)'(STG_"T-+D\3GPW%#=?VVUP(4M_+1@8C&9!= A\&' /.=V1MVY
MP*X35OV<AJ>@V>EMKMG*D&FMIPDO-*$YBS,\AF@!E BD.X*3\Q(08Q776?PS
MGM?&$'B8Z](^I0LMN$\HB V(C"_9MF_KO_>;\_?_ (<<4 )X+^*B>*(='@@T
M^]U*[N[*&^GG@AAMHX(I7=5=HY)RV,QMD1F3&/4@5Z!7E>G_  :GL[/PC9OJ
M^G20>'6@:*Z72BM\_EMN9%F\XA$?HRA3D$C->I;AZT .HINX>M&X>M #J*;N
M'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0!0O/#NE:AG[5IEG<
MYZ^=;H_\Q63)\+_!\KESX7TA)/\ GI%91HW_ 'TH!KI=P]:-P]:WC7JP^&;7
MS9RU,)AZKO4IQ?JDSE_^%8^'U_U,%Y:?]>>I7,'_ *!(*/\ A7\,7_'OKFOV
M_I_Q-)9O_1I:NHW#UHW#UJ_K5?K-OU=_S,?[/PG2DEZ*WY'+_P#"'ZM#_J/&
MFM*/[LT-G(O_ *(#?K1_8?BR'_4^*;27_K\TD/\ ^@2I74;AZT;AZT?6:G9?
M^ Q_R#ZC2[R_\#G_ /)'+^5XWA_Y>M O/^W:>WS_ .1)*/[2\:0_?T'1;A?[
MT.KRJW_?+6^/_'JZC</6C</6CVZ?Q0B_O7Y-!]4<?@JR7S3_ /2DSE_^$G\0
MP_Z[P;>2_P#7G?6S_P#H;I1_PG4T?_'SX6U^V_[=XIO_ $5(]=1N'K1N'K1[
M:F]Z:^3?ZMA]7K+:N_FH_I%?F<O_ ,+*TA/]?;ZS:'_IOHMXJ_\ ?7E;?UH_
MX6EX27_7:_96G_7Y)Y'_ *'BNHW#UHW+ZT<V'_D?_@2_^1#DQG_/R/\ X __
M ),R+/QIX>U#'V77=,N<]/)O(W_DU:\<B3*&C974]&4Y%9]YX?TC4,_:M-LK
MG/7SK='_ )BLB3X8^#I&+_\ ",Z3%(>LD-I'&WYJ :+8=]9+Y)_J@OC(](R^
M;C^DCJ:*Y3_A6OA]/]2M_:>GV35;J#'_ 'Q**/\ A XX_P#CV\0Z_;>G_$Q:
M;_T:'HY*#VF_FO\ )L/:8N/Q4D_27^<5^9U=%<I_PBNLP_ZCQKJK#LMU;6<@
M_P#'85/ZT?V5XNA_U/B;39AZ7>D,Q_-)T_E1[&'_ #]7_DW_ ,B'UFK_ ,^)
M??#_ .3.KHKE-WC6'^+P_>_]_P"WS_Z,H_MKQ?#_ *WPYIDP];76&8G\'@7^
M='U>3^&47\TOSL'UR*^.$E_VZW_Z2F=717*?\)?K,/\ K_!FJ,.[6MU:2#_Q
MZ93^E'_"P$C_ ./GP_K]MZ_Z 9O_ $47H^JU>EGZ-/\ )A]>H+XFUZQDOS2.
MKHJM8:A%J5G%<Q++''(NX+<0O"X^J. RGV(J?</6N9IQ=F=\9*24HNZ8ZBF[
MAZT;AZTACJ*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZB
MF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #
MJ*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT
M .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'
MK0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&
MX>M #J*;N'K1N'K0 ZBF[AZT;AZT .HINX>M&X>M #J*;N'K1N'K0 ZBF[AZ
MTNX>M "T444 %%%% !1110 55F437:QL3MVD\''>K55?^8@/]P_SH 7^SX?1
MO^^C1_9\/HW_ 'T:LT4 5O[/A]&_[Z-']GP^C?\ ?1JS10!6_L^'T;_OHT?V
M?#Z-_P!]&K-% %;^SX?1O^^C1_9\/HW_ 'T:LT4 5O[/A]&_[Z-']GP^C?\
M?1JS10!6_L^'T;_OHT?V?#Z-_P!]&K-% %;^SX?1O^^C1_9\/HW_ 'T:LT4
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M ._C?XT?VI>?\_<__?QO\:JT4 6O[4O/^?N?_OXW^-']J7G_ #]S_P#?QO\
M&O)/VE/">I^+_A'K=MI_BC4?"\%M;W%Y?2:4%6XO(8[:8BV$I!,2M)Y3,RC<
M51D!&\D?,/BC5_ASX4_8T^$6K>+?#$?C;Q==^&H=(\+:!,KW)N+J>&-2T=MD
MIN4^7F787'RJIRR@@'WS_:EY_P _<_\ W\;_ !H_M2\_Y^Y_^_C?XUY[\#=
M\1>%?@[X-TCQ;=O?>);/2X(=0FDE\UC,$&X%\G>1]TMD[B,Y.:[B@"U_:EY_
MS]S_ /?QO\:/[4O/^?N?_OXW^-5:* +7]J7G_/W/_P!_&_QH_M2\_P"?N?\
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M !$\&>(/"6E:5J__ "V@&RU$JP$_,B3M-<,ZC ?S#D'L ?HE_:EY_P _<_\
MW\;_ !H_M2\_Y^Y_^_C?XU5HH M?VI>?\_<__?QO\:/[4O/^?N?_ +^-_C56
MB@"U_:EY_P _<_\ W\;_ !H_M2\_Y^Y_^_C?XU5KXP_:UM/#M]\4M'\(^ =#
M&H?';Q-?6%XWB!7>6;P[8VTJL;@2.6^SJ55E,4>T.K2%@25#@'VS_:EY_P _
M<_\ W\;_ !H_M2\_Y^Y_^_C?XU^?TWQQTSXC?MW?#/7&\6:3'X:L;O7- T[3
M6OHA)"Z6ZQ?:)5)S&UU.YCC5L%U@0@'=7WO0!:_M2\_Y^Y_^_C?XT?VI>?\
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M7_A,ZE_\CT?\+1T;_GR\1?\ A,ZE_P#(]'*^P?6J'_/Q?>CKJ*Y'_A:.C?\
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M"_"74KC4/#&C26=[+9QZ<LUU?W-XUO:1NSI;0>?(_D0!G9A%%M3./EX&-?\
MX65I'_/IK_\ X3FH?_&*/^%E:1_SZ:__ .$YJ'_QBCE?8/K5#_GXOO1U5%<K
M_P +*TC_ )]-?_\ "<U#_P",4?\ "RM(_P"?37__  G-0_\ C%'*^P?6J'_/
MQ?>CJJ*Y7_A96D?\^FO_ /A.:A_\8H_X65I'_/IK_P#X3FH?_&*.5]@^M4/^
M?B^]'545RO\ PLK2/^?37_\ PG-0_P#C%'_"RM(_Y]-?_P#"<U#_ .,4<K[!
M]:H?\_%]Z)?&7PW\.?$&Z\.W&OZ=]OF\/:G'K.F-Y\D?V>[C5E23",-V [?*
MV5YY%=+7*_\ "RM(_P"?37__  G-0_\ C%'_  LK2/\ GTU__P )S4/_ (Q1
MROL'UJA_S\7WHZJBN5_X65I'_/IK_P#X3FH?_&*/^%E:1_SZ:_\ ^$YJ'_QB
MCE?8/K5#_GXOO1U5%<K_ ,+*TC_GTU__ ,)S4/\ XQ1_PLK2/^?37_\ PG-0
M_P#C%'*^P?6J'_/Q?>AWQ+^&7AOXP>#[OPMXMT]M4T.Z>*26V2YEMV+1R+)&
M1)$ZNI#HIX8=*H>"/@SX4^'^N7NMZ7:W]SKEY;)9RZKK6KWFJW?V=&9UA6:[
MEE=(]SLVQ2%+')&>:N_\+*TC_GTU_P#\)S4/_C%'_"RM(_Y]-?\ _"<U#_XQ
M1ROL'UJA_P _%]Z)?!OPW\.?#ZZ\17&@:=]@F\0ZG)K.IMY\DGVB[D55>3#L
M=N0B_*N%XX%=+7*_\+*TC_GTU_\ \)S4/_C%'_"RM(_Y]-?_ /"<U#_XQ1RO
ML'UJA_S\7WHZJN-\0?\ (7N/^ _^@BK'_"RM(_Y]-?\ _"<U#_XQ7-ZQXOMK
MK4)9HM-\0-&V-K?\(]?C. !_SQ]11ROL'UJA_P _%]Z+=%8__"40_P#0+\0?
M^$_?_P#QFC_A*(?^@7X@_P#"?O\ _P",T<K[!]:H?\_%]Z*_CCP#H/Q(T6/2
M?$=A_:.GQW4-XL/G218FB<21ME&4\,H.,X..01705C_\)1#_ - OQ!_X3]__
M /&:/^$HA_Z!?B#_ ,)^_P#_ (S1ROL'UJA_S\7WHV**Q_\ A*(?^@7X@_\
M"?O_ /XS1_PE$/\ T"_$'_A/W_\ \9HY7V#ZU0_Y^+[T;%%9*^)(W.%TGQ"Q
M]O#U_P#_ !FG?\) /^@/XB_\)V__ /C-'*^P?6J'_/Q?>C4KGO&7P_T#X@+H
MBZ_8?;QHNJ6^M6'[Z2/R;R DQ2_(PW;23\K94YY!J[_PD _Z _B+_P )V_\
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M.W__ ,9H_P"$@'_0'\1?^$[?_P#QFCE?8/K5#_GXOO1J45E_\) /^@/XB_\
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M+[T:E8?CCP1HGQ(\)ZEX9\1V7]HZ)J4?DW5KYKQ>8F0<;D96'('0BK'_  D
M_P"@/XB_\)V__P#C-'_"0#_H#^(O_"=O_P#XS1ROL'UJA_S\7WHY?QM\"_ _
MQ$N+&;7]%-Y)9VOV%3%>3VXFMMZ/]GG$4BB>'<BMY<N],YXY.>ZCC2&-8XT5
M(U 5548  Z "LW_A(!_T!_$7_A.W_P#\9H_X2 ?] ?Q%_P"$[?\ _P 9HY7V
M#ZU0_P"?B^]&I167_P ) /\ H#^(O_"=O_\ XS1_PD _Z _B+_PG;_\ ^,T<
MK[!]:H?\_%]Z-2BLO_A(!_T!_$7_ (3M_P#_ !FC_A(!_P! ?Q%_X3M__P#&
M:.5]@^M4/^?B^]'%>*_V=? GC/Q\/&VHV&IP^*UM19+JNF:]?Z?,L S^['V>
M= %Y.<#G/-6=0^ O@;5?$]CXAO-'EN=5M/LI$LNH7+)</;;OL\MQ'YFRYECW
M';),KN#@AN!76?\ "0#_ * _B+_PG;__ .,T?\) /^@/XB_\)V__ /C-'*^P
M?6J'_/Q?>C4HK+_X2 ?] ?Q%_P"$[?\ _P 9H_X2 ?\ 0'\1?^$[?_\ QFCE
M?8/K5#_GXOO1J45E_P#"0#_H#^(O_"=O_P#XS1_PD _Z _B+_P )V_\ _C-'
M*^P?6J'_ #\7WHU*\OO/V:? %YX\U?QHEEK&G^)]7V?;]1TOQ'J5B]P%"JJL
M(+A%V@(ORXQQTKO/^$@'_0'\1?\ A.W_ /\ &:/^$@'_ $!_$7_A.W__ ,9H
MY7V#ZU0_Y^+[T4M:^'^@>(?&'AOQ3J%A]HU[PZ+I=+N_.D7[.+A%2;Y%8*VY
M54?,#C'&*Z&LO_A(!_T!_$7_ (3M_P#_ !FC_A(!_P! ?Q%_X3M__P#&:.5]
M@^M4/^?B^]&I167_ ,) /^@/XB_\)V__ /C-'_"0#_H#^(O_  G;_P#^,T<K
M[!]:H?\ /Q?>C4HK+_X2 ?\ 0'\1?^$[?_\ QFC_ (2 ?] ?Q%_X3M__ /&:
M.5]@^M4/^?B^]'!^%_V:? '@GQ-?:_H-EK&D:EJ%^=3O?LGB/4HX;NX+ER\T
M(N/+DR2?E92N"1C'%:/@WX"^!/A_X@_MG0-"%C>HLZ6ZF[GEM[)9Y/-F6U@=
MS%;*[_,RPJ@-=7_PD _Z _B+_P )V_\ _C-'_"0#_H#^(O\ PG;_ /\ C-'*
M^P?6J'_/Q?>C4HK+_P"$@'_0'\1?^$[?_P#QFC_A(!_T!_$7_A.W_P#\9HY7
MV#ZU0_Y^+[T:E%9?_"0#_H#^(O\ PG;_ /\ C-'_  D _P"@/XB_\)V__P#C
M-'*^P?6J'_/Q?>C4KRFQ_9:^&.FVNI6MOX;=+.^LKO36M3J5VT%M;73%KB&U
MC,NVU20D[A $&..G%>A?\) /^@/XB_\ "=O_ /XS1_PD _Z _B+_ ,)V_P#_
M (S1ROL'UJA_S\7WHY?X9_ _PE\'X8X/"D.K6%C% UO%I]QKU_=V<*,X<^7;
MSSO&AW#.Y5!Y89PQSWE9?_"0#_H#^(O_  G;_P#^,T?\) /^@/XB_P#"=O\
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M\A\V&$L8D\LML7:7;E5!.>2:@_X6EH7_ #SUK_P07_\ \9H_X6EH7_//6O\
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MK-\K- ) 2&2*-2#*RG@G<J@\9)! D_X137V^=_&VHK+_ '8K*T$7_?)B+?\
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ML&S&">1].XZEEX#N;*/2T'B?6IOL5X]TYGN YN5;_EE(<<H.PKK%4*H & .
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MXEL+K]S<Q'T:)L,/KC![$U-K?C#1?#J@ZCJ=O;.QVI"7W2R'^ZD8RSGV4$T
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M Z.IZ@@\$>U3T4 4K;1=/L[B.>WL+:">.!;5)8X55EA!R(P0,A >B]*NT44
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M 4444 %%%% !57_F(#_</\ZM5@Z]X6T7Q5=10ZUI%AJ\40+1QW]LDZHW3(#
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M\*?\!_\ 0D^'?_!3;_\ Q%'_  I_P'_T)/AW_P %-O\ _$4:!S5_Y5_X$_\
MY$ZZBN1_X4_X#_Z$GP[_ ."FW_\ B*/^%/\ @/\ Z$GP[_X*;?\ ^(HT#FK_
M ,J_\"?_ ,B==17(_P#"G_ ?_0D^'?\ P4V__P 11_PI_P !_P#0D^'?_!3;
M_P#Q%&@<U?\ E7_@3_\ D3KJ*Y'_ (4_X#_Z$GP[_P""FW_^(H_X4_X#_P"A
M)\._^"FW_P#B*- YJ_\ *O\ P)__ ")UU%<C_P *?\!_]"3X=_\ !3;_ /Q%
M'_"G_ ?_ $)/AW_P4V__ ,11H'-7_E7_ ($__D3KJ*Y'_A3_ (#_ .A)\._^
M"FW_ /B*/^%/^ _^A)\._P#@IM__ (BC0.:O_*O_  )__(G75@7/_'Q+_OG^
M=4/^%/\ @/\ Z$GP[_X*;?\ ^(K$N/A/X(6XD \&^'P Q_YA<'K_ +E&@<U?
M^5?^!/\ ^1.FHKE?^%4^"?\ H3M _P#!7!_\11_PJGP3_P!"=H'_ (*X/_B*
M- YJ_P#*O_ G_P#(G545RO\ PJGP3_T)V@?^"N#_ .(H_P"%4^"?^A.T#_P5
MP?\ Q%&@<U?^5?\ @3_^1.JHKE?^%4^"?^A.T#_P5P?_ !%'_"J?!/\ T)V@
M?^"N#_XBC0.:O_*O_ G_ /(G545RO_"J?!/_ $)V@?\ @K@_^(H_X53X)_Z$
M[0/_  5P?_$4:!S5_P"5?^!/_P"1.JHKE?\ A5/@G_H3M _\%<'_ ,11_P *
MI\$_]"=H'_@K@_\ B*- YJ_\J_\  G_\B=517*_\*I\$_P#0G:!_X*X/_B*/
M^%4^"?\ H3M _P#!7!_\11H'-7_E7_@3_P#D3JJ*Y7_A5/@G_H3M _\ !7!_
M\11_PJGP3_T)V@?^"N#_ .(HT#FK_P J_P# G_\ (G545RO_  JGP3_T)V@?
M^"N#_P"(H_X53X)_Z$[0/_!7!_\ $4:!S5_Y5_X$_P#Y$ZJBN5_X53X)_P"A
M.T#_ ,%<'_Q%'_"J?!/_ $)V@?\ @K@_^(HT#FK_ ,J_\"?_ ,B=517*_P#"
MJ?!/_0G:!_X*X/\ XBC_ (53X)_Z$[0/_!7!_P#$4:!S5_Y5_P"!/_Y$ZJK/
M_+&'_=/_ *$:XS_A5/@G_H3M _\ !7!_\15G_A4W@?RHC_PAOA_)7G_B5P>I
M_P!BC0.:O_*O_ G_ /(G4T5RG_"I_ __ $)OA_\ \%<'_P 11_PJ?P/_ -";
MX?\ _!7!_P#$4:!S5_Y5_P"!/_Y$ZNBN4_X5/X'_ .A-\/\ _@K@_P#B*/\
MA4_@?_H3?#__ (*X/_B*- YJ_P#*O_ G_P#(G5T5RG_"I_ __0F^'_\ P5P?
M_$4?\*G\#_\ 0F^'_P#P5P?_ !%&@<U?^5?^!/\ ^1.UT_\ US?[O]16C7!6
M/PC\#/,0W@OP\PV]]*@]1_L5?_X4_P" _P#H2?#O_@IM_P#XBC0.:O\ RK_P
M)_\ R)UU%<C_ ,*?\!_]"3X=_P#!3;__ !%'_"G_  '_ -"3X=_\%-O_ /$4
M:!S5_P"5?^!/_P"1.NHKD?\ A3_@/_H2?#O_ (*;?_XBC_A3_@/_ *$GP[_X
M*;?_ .(HT#FK_P J_P# G_\ (G745R/_  I_P'_T)/AW_P %-O\ _$4?\*?\
M!_\ 0D^'?_!3;_\ Q%&@<U?^5?\ @3_^1.NHKD?^%/\ @/\ Z$GP[_X*;?\
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MV_\ \11H'-7_ )5_X$__ )$ZZBN1_P"%/^ _^A)\._\ @IM__B*/^%/^ _\
MH2?#O_@IM_\ XBC0.:O_ "K_ ,"?_P B==17(_\ "G_ ?_0D^'?_  4V_P#\
M11_PI_P'_P!"3X=_\%-O_P#$4:!S5_Y5_P"!/_Y$ZZBN1_X4_P" _P#H2?#O
M_@IM_P#XBC_A3_@/_H2?#O\ X*;?_P"(HT#FK_RK_P "?_R)UU%<C_PI_P !
M_P#0D^'?_!3;_P#Q%'_"G_ ?_0D^'?\ P4V__P 11H'-7_E7_@3_ /D3KJ*Y
M'_A3_@/_ *$GP[_X*;?_ .(H_P"%/^ _^A)\._\ @IM__B*- YJ_\J_\"?\
M\B==17(_\*?\!_\ 0D^'?_!3;_\ Q%'_  I_P'_T)/AW_P %-O\ _$4:!S5_
MY5_X$_\ Y$ZZBN1_X4_X#_Z$GP[_ ."FW_\ B*/^%/\ @/\ Z$GP[_X*;?\
M^(HT#FK_ ,J_\"?_ ,B==17(_P#"G_ ?_0D^'?\ P4V__P 11_PI_P !_P#0
MD^'?_!3;_P#Q%&@<U?\ E7_@3_\ D3KJ*Y'_ (4_X#_Z$GP[_P""FW_^(H_X
M4_X#_P"A)\._^"FW_P#B*- YJ_\ *O\ P)__ ")UU%<C_P *?\!_]"3X=_\
M!3;_ /Q%'_"G_ ?_ $)/AW_P4V__ ,11H'-7_E7_ ($__D3KJ*Y'_A3_ (#_
M .A)\._^"FW_ /B*/^%/^ _^A)\._P#@IM__ (BC0.:O_*O_  )__(G745R/
M_"G_  '_ -"3X=_\%-O_ /$4?\*?\!_]"3X=_P#!3;__ !%&@<U?^5?^!/\
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MC0.:O_*O_ G_ /(G745R/_"G_ ?_ $)/AW_P4V__ ,11_P *?\!_]"3X=_\
M!3;_ /Q%&@<U?^5?^!/_ .1.NHKD?^%/^ _^A)\._P#@IM__ (BC_A3_ (#_
M .A)\._^"FW_ /B*- YJ_P#*O_ G_P#(G745R/\ PI_P'_T)/AW_ ,%-O_\
M$4?\*?\  ?\ T)/AW_P4V_\ \11H'-7_ )5_X$__ )$ZZBN1_P"%/^ _^A)\
M._\ @IM__B*/^%/^ _\ H2?#O_@IM_\ XBC0.:O_ "K_ ,"?_P B==17(_\
M"G_ ?_0D^'?_  4V_P#\11_PI_P'_P!"3X=_\%-O_P#$4:!S5_Y5_P"!/_Y$
MZZBN1_X4_P" _P#H2?#O_@IM_P#XBC_A3_@/_H2?#O\ X*;?_P"(HT#FK_RK
M_P "?_R)UU%<C_PI_P !_P#0D^'?_!3;_P#Q%'_"G_ ?_0D^'?\ P4V__P 1
M1H'-7_E7_@3_ /D3KJ*Y'_A3_@/_ *$GP[_X*;?_ .(H_P"%/^ _^A)\._\
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M?_$T!>?;\?\ @&[16%_P@7AG_H7-)_\  &+_ .)H_P"$"\,_]"YI/_@#%_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <[\0/\ D4;_ /[9_P#HQ:\;KV3X@?\ (HW_ /VS_P#1BUXW7;0^$^!S
M_P#WJ/\ A7YL****Z#YH**** "BBB@ HHHH **** "BBB@#T/X2_\Q7_ +9?
M^SUZ'7GGPE_YBO\ VR_]GKT.O/J_&S]*R?\ W&G\_P V%%%%9'LA1110 5Y/
M\9/^1A\-?[TO_LE>L5Y/\9/^1A\-?[TO_LE 'HOA_P#Y!L7^Z/Y5IUF>'_\
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M"LG^^!P1[@9^M>0T4 ?92L'4,I#*1D$=#2UQ'P;UB76/ ]MYS%Y+61K?<>I
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M" 0?8@&JUS_Q\2_[Y_G7(_L\^'M*\+_#V*PT[6K'7+DS-<7\VGW*31).X!*
MJ3@ !1[XSWQ777/_ !\2_P"^?YT 1UXK^T%H\OVK3-452T)C-N[#^$@[ES]<
MM^5>U51US1;3Q#I<]A>Q^;;S+@CN#V(]"#0!\A45Z#XH^"^N:-<.UA%_:MGG
M*M%CS /1E]?IFL&S^'7B:^F$<>B7B-G&9HS&OYM@4 85I:RWUU%;P(9)I6"(
MB]22< 5]=Z38_P!FZ79V8.X6\*19'?:H']*X'X;?"5/"LRZEJ3I<:D!^[1.4
MASW![M[_ /ZZ](H **** .'^,FCRZQX'N?)4O):R+<;1U(&0WY!B?PKYLK[*
M90ZE6 92,$'H:\3\<_!"Y6ZEO/#P6:!R6-DS!63V0G@CV)S]: /(:*Z#_A /
M$GG>5_8=]NZ9\AMO_?6,?K7>^!O@A=/=17GB$+# A#"R5@S/_O$< >P.?I0!
MVWP;T>71_ ]MYRE)+J1KC:>H!P%_,*#^-=Q2*H10J@*H& !T%+0 5@>/=)DU
MSP=JME"-TLD)9%_O,I# ?B16_10!\:LI5B",$<$&DKW'XB?!E]6O)M3T+RTG
MD.^6S<[59NY4] 3Z'CWKR^;X?>);>;RFT.^+9QE(2R_]]#(H YZO>O@'H\MG
MX?OKZ12@O)@(\]U0'GZ98_E7)^$/@CJ>I7"3:TO]G60.3'N!E?VP/N_CS[5[
MO9V<.GVL5M;QK#!$H1(U& H'04 359_Y8P_[I_\ 0C5:K/\ RQA_W3_Z$: /
M%_VMO#\VN_!VZFA3>VFW45ZR@9.T;HV/X"0GZ U[!\/?%EMXY\$:+KMK(LD=
M[:I(VTYVR8PZ'W5@RGW%+>6<&HV<]I<Q+-;3QM%+&PR'5A@@^Q!KYSMX_%W[
M*VLWKZ9I]QXI^'-U(9C;QDF6Q)ZG.#@@=\;6P,[36T??CR]3Y_$R> Q;QC3=
M.:2E;6S5[.W;5I]CZMHKQ/3?VP_AE?68FFU2\T^3&?L]Q8REQ[90,OZUR7BC
M]I;6/B6TOAWX4Z)?7-W,/+EUJYC\M+92<;E'.W@_>8C'92<4E2GU5C:><8&,
M;PJ*;>RCJWY67ZA'=IX^_;$N+VR(FL_"^FM:R3KROF8=64'U#3./^ -7OU<#
M\&_A/:_"?PRUH)OMNK7CB?4+TY_>R>@SSM&3C/)R3WKOJ522;LMD:Y;0J4:4
MIUE:<Y.37:_3Y))%K3_]<W^[_45A_$1QI]KHNLMQ#I.IQ7,S?W(G1X'?Z*LY
M8^RFMS3_ /7-_N_U%7+JVBO;:6WGC6:"9#')&XRK*1@@CT(K,]4EHKAK&XU3
MX>(;*\@O-;\/1\6M]:HT]S:IVCFC&7D"C@2*&)'WAQN-W_A:_@[HWB33HI/^
M>$LX27_OV<-^E '65R7A=AJGC+Q5JL?-NK6^E1OV<P!W<CV#SNGU1JKWGB+5
M/&,9L_#4%SI]K)\LNN7MNT2QIW\B-P&D?T8@(.N6Q@]/HNCVOA_2;;3K)"EM
M;IL0,Q9CW+,3R6))))Y))- %ZBBB@#R#]I+0YK_PSI^HQ(7%C.PDP/NHX W?
M3*J/QKYPK[GOK&#4K.:UNHEGMYD*21N,AE/!!KYS\;_L^ZOI5U)/H*_VG8,<
MB'<!-'[8. P^G/M0!Y)2JI9@J@DDX '>NE@^&?BNXG$2>'M0#9QF2!D7_OHX
M'ZUZ[\+_ (#OH]]!JWB(QO<1$/#8H0ZHW9G/0D'H!Q[T >C?#?19?#O@;1K"
M9=DT< :1?[K,2Y'X%B*Z6BB@ KDIG&E_%"&23Y8]8TP6T;=O-MY'D"?4I/(P
M]HVKK:R/%'AV+Q-I9M7FDM9T=9K:[A.)+>9>5D7W'H>""0>": ->BN-MO&UU
MX?C6V\66<EG,G']J6D+RV4X'\1*@F$GJ5DP!T#-UJ8_%;P@W$'B"SOI?^>%B
M_P!IF)]/+C#-GVQF@#I;V\@TVSGN[F58;:WC:661NB*HR2?8 &N?^&UK-;^#
M+"2XB:">\:;4)(G&&1KB5YRI]QYF#[BLZ:SU+XA7, O;2;2/#$;+*UI<C;<W
M[ Y42*#^[B! .T_,W1@HR#W% !1110!\R_M$:'-8>.!J!0_9[Z!"'QQO0;2O
MUP%/XUY77VAXT\&V'CC1)-.OU(&=\4RCYXG[,/\ #N*^;_$OP/\ %.@7#B"R
M;5;7/R3V?S$CW3[P/X8]Z //ZV/!^AS>)/$VFZ="A8S3J&X^ZF<LQ]@,FM;2
MOA-XMU>=8X]#NH,GE[I/)4>_S8_2OH#X6_">V^'\+W,\BWFKS+M>91\L:]U3
M/./4]\=J /0**** "N2\!N+&Z\1Z,_RS6>IS7(7^]%<N9U<>VYY%^L;5UM<S
MXJ\.WMS>6VM:)-';ZW:(8PDQ(ANX2<F&3'09Y5P"5.>""00#IJ*Y%/B9I5G^
M[UU9_#5TO#)J<92+/JDPS&X^C9]0*5OBEX>G&W2KMO$-P?NP:+&;HM]67Y%'
MN[*/>@ ^*3"?P;=Z4O-QK++I42=V,QV,?HJ%W/LAKK:Y/0=!U+4=;'B#Q $B
MN8U:.PTV)]Z6:-PS,W1Y6& 2.%'RKG)+=90 4444 ?%/C#0YO#?B;4M.F0J8
M)V"\?>3.58>Q&#6/7U=\4OA/;?$"%+F"1;/5X5VI,P^61>ROCG'H>V>]?/\
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M#:-83+LFC@#2+_=9B7(_ L17G/PO^ [Z/?0:MXB,;W$1#PV*$.J-V9ST)!Z
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M_)"['V4T:A\9O"5G$3::HNMS?P0:0/M+-_P)?E7ZLP'O7F6L:QJ7B_7!JFJ
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MTJRTF&1M[QV-ND*LV,9(4#)Q5*Y_X^)?]\_SK?K N?\ CXE_WS_.@".BBB@
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M?^V7_L]>AUY]7XV?I63_ .XT_G^;"BBBLCV0HHHH *\G^,G_ ",/AK_>E_\
M9*]8KR?XR?\ (P^&O]Z7_P!DH ]%\/\ _(-B_P!T?RK3K,\/_P#(-B_W1_*M
M.@ HHHH **** "L;6M>TSPVQO=6U&TTNS VFXO9UAC!)X&YB!DULUQGQ.\"Z
M?\0/#\FF:G:_:[5F63R_,=/F7D'*D']::M?4SJ<_(_96YNE]OF2_\+@\!_\
M0[>'?_!M;_\ Q='_  N#P'_T.WAW_P &UO\ _%U\[W?[+>D"9O*TE0F>!YTQ
M_P#9Z@_X9;TW_H%K_P!_IO\ XNM?W?F>/S9M_+3_ / I?_(GT?\ \+@\!_\
M0[>'?_!M;_\ Q='_  N#P'_T.WAW_P &UO\ _%U\X?\ #+>F_P#0+7_O]-_\
M71_PRWIO_0+7_O\ 3?\ Q='[OS#FS;^6G_X%+_Y$^C_^%P> _P#H=O#O_@VM
M_P#XNC_A<'@/_H=O#O\ X-K?_P"+KYP_X9;TW_H%K_W^F_\ BZ/^&6]-_P"@
M6O\ W^F_^+H_=^8<V;?RT_\ P*7_ ,B?1_\ PN#P'_T.WAW_ ,&UO_\ %T?\
M+@\!_P#0[>'?_!M;_P#Q=?.'_#+>F_\ 0+7_ +_3?_%T?\,MZ;_T"U_[_3?_
M !='[OS#FS;^6G_X%+_Y$^C_ /A<'@/_ *';P[_X-K?_ .+H_P"%P> _^AV\
M._\ @VM__BZ^</\ AEO3?^@6O_?Z;_XNC_AEO3?^@6O_ '^F_P#BZ/W?F'-F
MW\M/_P "E_\ (GT?_P +@\!_]#MX=_\ !M;_ /Q='_"X/ ?_ $.WAW_P;6__
M ,77SA_PRWIO_0+7_O\ 3?\ Q='_  RWIO\ T"U_[_3?_%T?N_,.;-OY:?\
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M_?Z;_P"+KG:IIVNSZVE6S:K3C/V<%?HW*Z]?=9[A_P +7\$_]#CH'_@T@_\
MBZ/^%K^"?^AQT#_P:0?_ !=>'_\ #+>F_P#0+7_O]-_\71_PRWIO_0+7_O\
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M_P ,MZ;_ - M?^_TW_Q='_#+>F_] M?^_P!-_P#%T?N_,?-FW\M/_P "E_\
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M-_\ %TOW?F;\V;?RT_\ P*7_ ,B?05G\6/ \,I+^-/#H&,?\A:W_ /BZN_\
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M_P#Q='_"X/ ?_0[>'?\ P;6__P 77SA_PRWIO_0+7_O]-_\ %T?\,MZ;_P!
MM?\ O]-_\71^[\PYLV_EI_\ @4O_ )$^C_\ A<'@/_H=O#O_ (-K?_XNC_A<
M'@/_ *';P[_X-K?_ .+KYP_X9;TW_H%K_P!_IO\ XNC_ (9;TW_H%K_W^F_^
M+H_=^8<V;?RT_P#P*7_R)]'_ /"X/ ?_ $.WAW_P;6__ ,71_P +@\!_]#MX
M=_\ !M;_ /Q=?.'_  RWIO\ T"U_[_3?_%T?\,MZ;_T"U_[_ $W_ ,71^[\P
MYLV_EI_^!2_^1/H__A<'@/\ Z';P[_X-K?\ ^+H_X7!X#_Z';P[_ .#:W_\
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M_+3_ / I?_(GT?\ \+@\!_\ 0[>'?_!M;_\ Q='_  N#P'_T.WAW_P &UO\
M_%U\X?\ #+>F_P#0+7_O]-_\71_PRWIO_0+7_O\ 3?\ Q='[OS#FS;^6G_X%
M+_Y$^C_^%P> _P#H=O#O_@VM_P#XNC_A<'@/_H=O#O\ X-K?_P"+KYP_X9;T
MW_H%K_W^F_\ BZ/^&6]-_P"@6O\ W^F_^+H_=^8<V;?RT_\ P*7_ ,B?1_\
MPN#P'_T.WAW_ ,&UO_\ %T?\+@\!_P#0[>'?_!M;_P#Q=?.'_#+>F_\ 0+7_
M +_3?_%T?\,MZ;_T"U_[_3?_ !='[OS#FS;^6G_X%+_Y$^C_ /A<'@/_ *';
MP[_X-K?_ .+H_P"%P> _^AV\._\ @VM__BZ^</\ AEO3?^@6O_?Z;_XNC_AE
MO3?^@6O_ '^F_P#BZ/W?F'-FW\M/_P "E_\ (GT?_P +@\!_]#MX=_\ !M;_
M /Q='_"X/ ?_ $.WAW_P;6__ ,77SA_PRWIO_0+7_O\ 3?\ Q='_  RWIO\
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MPRWIO_0+7_O]-_\ %T?N_,.;-OY:?_@4O_D3Z/\ ^%P> _\ H=O#O_@VM_\
MXNC_ (7!X#_Z';P[_P"#:W_^+KYP_P"&6]-_Z!:_]_IO_BZ/^&6]-_Z!:_\
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M^6G_ .!2_P#D3Z/_ .%P> _^AV\._P#@VM__ (NC_A<'@/\ Z';P[_X-K?\
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M?\,MZ;_T"U_[_3?_ !='_#+>F_\ 0+7_ +_3?_%U/[OS.OFS;^6G_P"!2_\
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MX3G\9RV7B6YT31-3\#61CLO$5O&"WVR!KJ?R88@%D4R/<F-GC*([.RH9]/\
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MP+XFL=:L/#;>)M(L]9@M8AJUI\P$\8%UE%0^6TD4YAF59%&S=\H /<_L\?\
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MX8\1K)P2MMJD>T^P\Q/_ (FOKVBM8U9QV9XF*R7 8O6I25^ZT?X?J?FKXO\
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MYKO<L@6,>8S8B"D 8&[C)Q&_X)_;O!?POT#_ (3S_D2?#&O^&_M']C_\?O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=,BTKQEH,$0O=-@74(X[?3[V1"\,DRQ;64A8B?+<O",[F /T&HKX\\?>)_\
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MZ7X?^)_@NUUCQ3?Z#I?PR_M>.WNO$.H74K3K?7#/-)(\Q>4[5(*L2-JA<;5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***H:[K%OX?T>\U*Z.(+:,R-CJ<=A
M[D\4 >>?$;]FWP1\3+XW^H64UAJ+??N]-D$3R?[P*E2??&:3X<_LV>"/AG?"
M_P!/LIK_ %%?]7=ZE()7C_W0%"@^^,UX7XS^(FL^-KZ26\NI$M=Q,5I&Q6-!
MV&.Y]S1X-^(FL^";Z.6SNI'M=P,MI(Q,;CN,=C[BKYY6M?0\[^SL'[;V_LES
M][?UJ?8]%4-!UJW\1:-9ZE:DF"YC$BYZC/8_0\5!IOB[0M:BU633]:T^^CTF
MYDL]1>VNHY!9SQJ&DBF*D^6ZJRDJV" P)'-0>B:U%>9^'?VD/AWXEL1>1:^^
MEV9TT:Q]HU_3KK28_L1D6-;C==Q1#RV9E"MT;((R.:[+P[XRT?Q9<ZW;Z5>?
M:IM%OVTN_7RG3R;E8XY3'\P&[Y)HSE<CYL9R"  ;5%%% !1110 452TG7-.U
MZ&:;3+^UU&&"XEM)9+2995CFB<QRQ,5)PZ.K*RGE64@X(JEH_C;P]XAN_LNE
M:]IFIW6R63R;.\CE?;',T$K;58G"2H\;'LZLIP010!M4G7@\BO/O$G[17PI\
M&ZU<Z1K_ ,3O!NAZM;';/8:EK]I;SQ'KAHWD#*?J*Z*/QYH%YX-/BK3M5M=9
MT!H#<0WVES)<Q7"@X_=.A*ODC P>O% $%SX+DANY;G1M6N-%"Z8]A:V,*(;*
MW<G*3B# !92>A."..*2U\%S37%K/K.L7.LE=,_LZ[LY8T6RO"2"\SP8(#MC'
M!QCCI5*Q\#MXDA2^\9*NI7<@W+I;'-G:*3D1A!Q(PX!=\Y(XVCBI+GX;6.FQ
MM<>%1'X8U) ?+-G'MMG/]V6 81E/J &'9A0!V'3@<"EK'\*:_P#\)%HZ7$D)
MM;R-VM[NV)SY,Z':Z@]QD<'N"#WJKX3^(WA/Q]-J47ACQ1HWB.73)?(ODTG4
M(;IK63D;)1&QV-\K<-@_*?2@#HJ*** "BL;4O&&D:1XFT7P_=W?E:OK*7$EC
M;^4[><L 4RG<!M7:'7[Q&<\9YK9H **** .9^)'@'3_BAX+U'PQJLUU;V%]Y
M?F26;*LHV2+(-I96'5!U!XS3?B#\/=.^)&EZ98:G-=00Z?K&GZU$UHZJQFL[
MJ.YB5MRM\A>)0P&"5)P0>1TSNL:,[L%51DLQP /6JNCZSI_B+2;/5-*OK;4]
M,O(5N+:]LYEFAGC895T=2592"""#@@T 7**Q+3QIHU]XRU+PK!>;]?TVRM]0
MNK3RG'EP3O,D+[RNT[FMYA@$D;.0,C-O1_$&E^(H[J32M2L]3CM;F6RN'LYT
MF$-Q$Q26%RI.UT8%64\J000* -"BL^3Q#I<.NP:))J5G'K-Q;O=PZ<TZ"XDA
M1E5Y5CSN**SH"P& 64'J*T* "BJ5QKFG6NKV>E37]K#JEY%+/;6,DRK//'$4
M$KHA.YE0R1AB!@>8N<;A3-!\0:7XITJ#5-%U*SU?3)]WE7EA.D\,FUBK;74D
M'# @X/!!% &A116?JWB#2]!:Q74]2L].:_N5LK1;N=(C<7#!BL4>XC>Y"L0H
MR2%/'% '/ZM\-+37/B9H/C.]U3499=#M9H+#2,PBRBEF!62YXC\UI3&?+P9"
M@7H@8ECV%<OX+^)6@?$&YUF+09[R\32;N2QN;J33KF"V::.22*1(9Y(UCGV2
M12(QB9PK+@D'%=10 45A77CSPU97UU8W'B'2H+VTN+6TN+>6]B62&:Y(6VB=
M2V5>4D!%/+DC;FMV@ HK/USQ#I?ABQ%]K&I6>DV7FQP?:+Z=(8_,D<1QIN8@
M;F=E51U)8 <FM"@ HHHH **I:EK6GZ.UFM_?VMBUY<+:VPN9EC,\S E8TR1N
M<A6(4<D*?2KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<X,;%2IJ,E=<T?\ TI%W_A1_P^_Z$O0__ &/_"C_ (4?\/O^A+T/_P  8_\
M"NWHI<TNYI]3PW_/N/W(XC_A1_P^_P"A+T/_ , 8_P#"C_A1_P /O^A+T/\
M\ 8_\*[>BCFEW#ZGAO\ GW'[D<1_PH_X??\ 0EZ'_P" ,?\ A1_PH_X??]"7
MH?\ X Q_X5V]%'-+N'U/#?\ /N/W(XC_ (4?\/O^A+T/_P  8_\ "C_A1_P^
M_P"A+T/_ , 8_P#"NWHHYI=P^IX;_GW'[D<1_P */^'W_0EZ'_X Q_X4?\*/
M^'W_ $)>A_\ @#'_ (5V]%'-+N'U/#?\^X_<CB/^%'_#[_H2]#_\ 8_\*/\
MA1_P^_Z$O0__  !C_P *[>BCFEW#ZGAO^?<?N1Q'_"C_ (??]"7H?_@#'_A1
M_P */^'W_0EZ'_X Q_X5V]%'-+N'U/#?\^X_<CB/^%'_  ^_Z$O0_P#P!C_P
MH_X4?\/O^A+T/_P!C_PKMZ*.:7</J>&_Y]Q^Y'$?\*/^'W_0EZ'_ . ,?^%'
M_"C_ (??]"7H?_@#'_A7;T4<TNX?4\-_S[C]R.(_X4?\/O\ H2]#_P# &/\
MPH_X4?\ #[_H2]#_ / &/_"NWHHYI=P^IX;_ )]Q^Y'$?\*/^'W_ $)>A_\
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MUS&-'!3FZ<8Q<ENK*Z]3C_\ A1_P^_Z$O0__  !C_P */^%'_#[_ *$O0_\
MP!C_ ,*Z/7?%&C>%X8YM9U>QTB*0X22^N4A5B.H!8C/4?G3(_%NBW&@W.MVV
MJ6MYI-M&\TMY9RB>-51=S'*9S@<X'-'-(KV&#3<7"-UY(Y__ (4?\/O^A+T/
M_P  8_\ "C_A1_P^_P"A+T/_ , 8_P#"MS2?&FB:WX:M?$%KJ4/]C7*[HKR?
M,*$;MH^^ 1R,<BMI6#*&4Y!Y!%'-+N..&PDTG&$6GKLCB?\ A1_P^_Z$O0__
M  !C_P */^%'_#[_ *$O0_\ P!C_ ,*[>JW]I6GV_P"P_:H?MNSS/LWF#S-F
M<;MN<X]Z7-+N5]4PRWIQ^Y'(_P#"C_A]_P!"7H?_ ( Q_P"%'_"C_A]_T)>A
M_P#@#'_A7;T4<TNX_J>&_P"?<?N1Q'_"C_A]_P!"7H?_ ( Q_P"%'_"C_A]_
MT)>A_P#@#'_A7;UAZ?XUT;5/%.J^'+6\\W6=+2.2\MO*<>4LBAD.XKM.00>"
M>O-/FEW(EAL)%I2A%7T6BU9B?\*/^'W_ $)>A_\ @#'_ (4?\*/^'W_0EZ'_
M . ,?^%=O535-6L=#L);[4KRWT^RA ,ES=2K%&F2 ,LQ ') Y]:7-+N4\+A8
MJ[IQ^Y')_P#"C_A]_P!"7H?_ ( Q_P"%'_"C_A]_T)>A_P#@#'_A6GI?Q*\(
MZY>1V>G>*=%O[N0X2"UU&&21C[*K$FNDI\TENR(8?!U%>$(OT2.(_P"%'_#[
M_H2]#_\  &/_  H_X4?\/O\ H2]#_P# &/\ PKMZ*7-+N:?4\-_S[C]R.(_X
M4?\ #[_H2]#_ / &/_"C_A1_P^_Z$O0__ &/_"NWHHYI=P^IX;_GW'[D<1_P
MH_X??]"7H?\ X Q_X4?\*/\ A]_T)>A_^ ,?^%;?C'QIHW@#0Y-8UZ]^P:=&
MZHTWE/)AF. -J GK[5N4^:6]R%AL(Y."A&ZZ677;\CB/^%'_  ^_Z$O0_P#P
M!C_PH_X4?\/O^A+T/_P!C_PKMZ*7-+N7]3PW_/N/W(XC_A1_P^_Z$O0__ &/
M_"C_ (4?\/O^A+T/_P  8_\ "NWHHYI=P^IX;_GW'[D<1_PH_P"'W_0EZ'_X
M Q_X4?\ "C_A]_T)>A_^ ,?^%=O11S2[A]3PW_/N/W(XC_A1_P /O^A+T/\
M\ 8_\*/^%'_#[_H2]#_\ 8_\*[>BCFEW#ZGAO^?<?N1Q'_"C_A]_T)>A_P#@
M#'_A1_PH_P"'W_0EZ'_X Q_X5V]%'-+N'U/#?\^X_<CB/^%'_#[_ *$O0_\
MP!C_ ,*/^%'_  ^_Z$O0_P#P!C_PKMZ*.:7</J>&_P"?<?N1Q'_"C_A]_P!"
M7H?_ ( Q_P"%'_"C_A]_T)>A_P#@#'_A73^(->L/"^BWFK:I/]ET^SC,T\VQ
MFV*.IPH)/X"CP_KUAXHT6SU;2Y_M6GWD8F@FV,N]3T.& (_$4^:5KW(^KX3G
MY.2-][65[=SF/^%'_#[_ *$O0_\ P!C_ ,*/^%'_  ^_Z$O0_P#P!C_PKM)I
MH[:&2::18HHU+O(Y 55 R22>@K$T?Q[X9\07IL]*\1:3J5X,YM[.^BEDXSGY
M58GL?RHYI=PEA\)%J,H13?DC&_X4?\/O^A+T/_P!C_PH_P"%'_#[_H2]#_\
M &/_  KMZ*7-+N7]3PW_ #[C]R.(_P"%'_#[_H2]#_\  &/_  H_X4?\/O\
MH2]#_P# &/\ PKMZ*.:7</J>&_Y]Q^Y'$?\ "C_A]_T)>A_^ ,?^%'_"C_A]
M_P!"7H?_ ( Q_P"%=O11S2[A]3PW_/N/W(XC_A1_P^_Z$O0__ &/_"C_ (4?
M\/O^A+T/_P  8_\ "NWHHYI=P^IX;_GW'[D<1_PH_P"'W_0EZ'_X Q_X4?\
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M]"7H?_@#'_A7;T4<TNX?4\-_S[C]R.(_X4?\/O\ H2]#_P# &/\ PH_X4?\
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MR<1_W"+3_P!&SU2DVG=G+5P]&G4I2A!)\W1+^61]"Z7<&YM$<]QFKE9GA_\
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M[2RM>?X5D<'>P[@#C-+\+/BM_P +%FURPO-&G\/ZYHDZ07VGS2K*$+@E2KJ
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M/6-8\'^&]7T,0QZI;2BVFMI3YD@21L,$)$B*W;KS@$CK-!\%^ [CXC>&I_\
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M@5'G89PSL!EB,GD^M,UKP[I/B6U6VU?2[/5;=3N$-[;I,@/KA@1FK']IV?\
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M[3Y;#4[*WU&QFQYEM=Q++&^"",JP(." >>X%/_M.S_Y^X/\ OXO^-']IV?\
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M1IUZ,J#=HRTT\]_O//?B1\*KGQIX=\-^$;*XAL/"5M-%_:4>]A/+;P@>5"@
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M#_OXO^-']IV?_/W!_P!_%_QI#YEW+-%5O[3L_P#G[@_[^+_C1_:=G_S]P?\
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M6E?] VW_ ._0KZ8VCTHVCTHYI=P^IX;_ )]Q^Y'S/_PS%I7_ $#;?_OT*/\
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M;_\ ?H4?\,Q:5_T#;?\ []"OIC:/2C:/2CFEW#ZGAO\ GW'[D?,__#,6E?\
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M%I7_ $#;?_OT*/\ AF+2O^@;;_\ ?H5],;1Z4;1Z4<TNX?4\-_S[C]R/F?\
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M/IT;1VT_V>\FMUGB5G<JDBQ+(H+M@./F/6O0J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[
MQ]X"T7XG>%+SPWXA@N+G2;MHGECM;R>TEW12I+&5FA=)$(>-#E6'3'0D5T-%
M '%VOP@\-6_A_3]%F35=4L;#4H=7M_[8UR^U"9;J&19(G,T\SR,JNJL$9BF1
M]VMFQ\&Z/IWB[5?$]O9[-=U2UMK*[O#([&2&!I6A0*254*9Y3\H&2YSGC&W1
M0!YOK?[._@'Q%XHO->U#1[F:YOKB*\OK)=5O$TZ^GB"".6XL5E%M.ZB.+YI(
MV/[M.?E7'4Z'X#T+PWXF\2>(=.L?L^L>(Y8)M4N?.D?[0\,*PQ':S%4"QHHP
M@ /).223OT4 >66_[,OP^MX?$=J;#5KG3?$0O?[3TF\\1:E<:?.;N1I+EA:2
M7#0H[N[MN1 P+$J0:OZ5^S_X&TFR:W72KJ_9]2M-7EO-6U6[O[N:ZM75[5Y+
MF>5Y76)D4HC.47G"\G/HE% 'C'Q:^!<&LZ;YOA?PWIE_J=QX@/B"]^V>(M1T
M2<W1M#:FX@O[,/-!)Y:QQE53:T>Y?ESFNI^!/PMA^#/PLT7PI$+,26OG3W']
MGP&&W\^>9YY?*0DE4#RL%!/"@5WU% 'F!_9M\ C0H](BT_5+6SAU6;6K1K3Q
M!J,$]C=2JZRM:S).)+9&664&*%DC(D?Y?F.>JT'X=Z'X<U2VU.UANYM2M]-7
M28[W4-0N+R?[,KF0*TDTCLS%CDNQ+M@98X&.EHH XOPY\'?"'A(>%QI.E-9C
MPSI<VC:3B[G;[-:RF$R)\SG>S?9XOWCY?Y3\WS-GEOB'\';G4OACX=^&7A"R
MTO3/!D36=G?27MW,\UMI]O)$_E0QE'\]Y$C:,M+*FW?O)D.5/KM% 'GWB7X"
M>!_%_C)O$^JZ1-<ZG(MLMS$FHW45G>_9W9[=KFT2407#1LV5:6-R,+@_*N+M
MM\&_!MKJT>I)H<37D=[?:B'EEDD!N+Q=ERY5F*G>ORX((5>% '%=I10!YWX$
M_9_\"_#>&XBT/2;A%FL%TI?[0U.[OS;V2C"VL!N)7,$ X_=1;4^5>/E&(_"W
M[.?PY\%W?@RYT;PQ!9S^#;6YL]!?SYI/L4=Q_KR-[G<[Y;,C[G^=_F^=L^D4
M4 <M\0OAIX?^*&EV5AX@M[N6*QNTO[6;3]1N;"XM[A59%DCGMY(Y$.V1U^5A
MD,0>M>62_LB^$&\5Z%%:Z8VB>"_#^G:@FE66AZS?:?<V][?78GNY%>"1&1"$
M"@+)C;(Z;0@ KWRB@"AH.@Z=X7T2PT?2+&#3=*L($MK6SM8PD4$2*%1%4<
M  #VJ_110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
544 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>advm-20241231_g13a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g13a.jpg
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M=Z*H*L+B&@<_>-/Q=NQ\>HAXA9FCP6KSG5NHRT2$&9BH&]H++BB[U/0,;/K
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MOYGUV$O$@EL@?VH+1+Q(8VAG4(W/.[M](L*\B8BP]$2UC97';*N<GC9=%]V
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MO85_/]6N/(@(6YL)CYAN-)-A_S=N$6$,)LC'^M@5<6TA]D^(^(F8,&V%B?T
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:01 *R/\#L),WC!Y?H&      245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>advm-20241231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +3!1@# 2(  A$! Q$!_\0
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M6$C1#EI:1>E**RD6A]*M)2K6#-4.%.J6&S>3',:C_:<#^M3_ -FM_P ][?\
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MV,4+?,V64X^8GL,UYD<TJ-J3:U>UG>WJ>W5X8H*$Z<8R32NIMQLWVMO;Y?\
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MA@ZBO>J[2^]&/\6_@MKGP9O-.MM;N;"Y:^C>2)K"1W4!2 0=R*0>1VKMKO\
M8W\?6M]I=O$^E7GVX,QE@N)-ENJ@$M(6C&/O #;N)]*[;]O3_D.>#_\ KWN/
M_0DKVC]H?XI:I\)?A?9ZIHT4+W]U<Q6223KN6+=$[EPO<_N\ 'CG/.,'+VDK
M1MU/464X"%?%QK74*7*U;?579\8^-O@;XG\$>.M.\(RQV^JZUJ$*SVT>FNSJ
MZLSKU=5Q@QL3D8 &<UW-U^Q7\0[?2VNT?1[B=4W_ &&*[;SB<?=!*!,_\"Q[
MUZ-^RKXNU7XL_$K5_$OB6>.^U;2](BT^"985C^1Y7<L0H W=1D <&N'^/'QX
M\;:#\;-4BTK6KO3;/295@@LE.(7 12QD3H^XDG+=B,8JN:;ERHY/J664L+]>
MJJ3A.5HI6NEY^>C/9?VDK>6S_9AC@GC:*:**P1XV&"K H"#[YKY.^&/P1\6?
M%IY6T.R064+;)+ZZ?RX%;&=N<$L>G"@XR,XKZW_:?U"35OV;7OI559;H6,[J
MG0%F1B![<UT_PV\)7*_L]^'-*\.:DOAV]O-)MYUU!;<3&.255DD?86&6.Y@#
MGC(/;%8QFX0^9]!C<MAF.9)2NXQIIV5KO5V6NB/E;Q1^QS\0?#>DS7T:Z;K(
MA7>T&FSNTN!U(5T7=]!DGL#7G?PP^&>J?%CQ-_8>D3VEO=^0]P9+UV2/:I /
M*JQSR.U?>_PI^&OBGX?WEX=:\?WGC"QN$^6WOK9@\4F1\RR-*YQC(VXQR#QC
MGQ?X5Z7::/\ MF>,+:R"K;^3<2A5.0&?RG8#_@3-QVZ5I&JVF>;B,BHTZF'E
MRN"G+E<6TWZIH\TTO]CKX@ZIJVH6>S3K2"TD\H7US.ZPSG&28\(7('3)4#/T
M-<;\5/@=XH^#\EL=<@@EL[D[8KZRD,D+..2F2 0V!G! R.F<''LO[5_QF\7^
M&_B9'HFC:S<:18V,,-PJV;&-I)&&[+G^(=MI^7U!KU#]IF3^W/V9Y-0NU5[E
MDL;K<%X61GC!(].'8?C2YY73?4RJY7E\X8JG0YE.C=W=K/?3\+'P57NOPY_:
M5^)%_P",?#&D3^(_,T^:_M;22$V-L-T1D52N[R\]#C.<^]>%5T_PN_Y*9X1_
M["]G_P"CDK:236I\I@L16H5HJE-QNU>S:OKUL?:O[6'Q(\1_#/PCHU[X;U'^
MS;JXOO)ED\B.7<GEL<8=6 Y Z5X+\"_B5XD^)G[1W@V]\2:D=2N;>*[AB;R8
MX@J_9ICC"*HZGKC->J_MU_\ (@^'O^PF?_13UX)^R?\ \E^\+?\ ;U_Z235S
MP2]FV?:YIB*W]N4Z/.^3FAI=VW738]M_:*^ ?BSXO?%B&YT6&V@T^#2X8GOK
MZ4I%Y@DE.P;0S$X(/ Q7S_\ %3]G_P 6?"&V@N]9BM;G3YG\H7MA*9(PY!(5
MMRJP) )Z8]Z]K_;!^+WBOPOXUT[P_HFKSZ/8K91WCM9.8Y9)&D<89P<[0$'R
MC .3G/&/1/B9>3>,_P!D:34=5?SKRXT:TO995 7=*#&^[ X&2.WJ:(RE%1[,
M>-P6!QM;%J',JL$Y7TMZ6/EOPA^S?XL\<> #XLTF33YK0LZ1V9E<7,K*VW"K
MLVY)Z984_P"(G[-?BSX7^$XO$.LS::;5I$B:"VG=Y8V8' 8% O;LQKZ?_9=U
M%M'_ &<(K]4$C6OVV<(3@,5=VQ^E>"Z#\:/%'QT\>:#X7\33VLV@WVKV\SV4
M=J@550D^6#]XJPR#N)/\JI2DV^R//JY=E]'"T'+F]K5BK=KNVK\M3'\!_LJ^
M//'ND0ZG#;VFD64Z[X7U25HVE4]&"JK, >Q(&<@CCFD\??LK^.OA_HTVJW$%
MGJMC I>>33)FD,2CJQ5E5L#N0#C&3QS7N?[9/Q.\0^";;P]I.@:A-I$=\LTL
M]Q:L8Y2$*!55QRH^8DXYZ?CI?L>_$C7/B!X7UVP\074^J-ILL2Q7=U\[/'(K
M?(S'ER"A))R?G'-+GGR\_0ZUE>6RQ3RSWO:6^+2U[7V_K]3Y;^$GP3UWXS3:
MG%HESI]J=/6-I6OY'0'>6"A=J-G[I]*YO7O!M_X=\977AF[,)U&WN_L;-&Q,
M9?=@$'&<'(/3/M7U=^R/IL&C_$;XK6%JGEVUK>I!$G]U%FN% _("O"?BQ_R<
MAK/_ &&T_P#0UJE)N31XN(RZE1R^CB/MRDT^VC:_0@^*_P"SWXD^#NDV.H:U
M=Z9<P7<WD(+&61V5MI;D,B\8!Z9K2^'_ .ROXX^(6AP:O;1V.EV%PN^WDU*9
MD,R'HRJB,<'L2!GJ..:]U_;J_P"1!\/?]A,_^BGKO_B)X?\ $OQ-^&.AGP!X
MB_X1UIHX;E9&:2V,L)0%5WH"Z8R#@#GH>*S]H[(]QY'A5C*]-*4E",6HIZN_
MF^Q\Y_\ ##?CO_H+>'?_  )G_P#C->L_L1VLME\/?$-O,NR:'6I(W7(.&$,0
M(R/>M7XO:UJ?PQ_9U>TUOQ--=>*FC2WAU"TF:WFFF,H;*E2&(5.I_B"\]<5B
M_L,_\DSUO_L+O_Z)BJ7)R@VST<)A,+@LTHTJ$6FXMN[O:_3U7J>+^'_V-OB#
MKFDQWTHTS26D7<MIJ%PZS8[9"(P'T)SZXKR;QEX-U?P#X@N=%UNT:SOX,$J2
M"K*>0RL."I]1_,&O<O@O\>/&OC3X]:/_ &CK4[6.HRR12::AQ:K'L=@JQ] 0
M0/F^]QR3S6G^W=8PQ^*O"UVJ 7$UG+$[XY*HX*C\"[?G6JE)2Y6?-5\#@JN7
MRQF$YER2L[]=M?Q/E^OJ#]D?P'9Z'IVK_$_Q /)T[3894LW=<XVJ?.E QDD#
MY!CJ2X]*^<_"N@OXH\3Z1HL4JP2:C>0V:RL,A#(X0$COC-?:GQ^^'7BZ\^'>
MA>!/ &AM<:)"BB[E^U0Q$K'C9&?,<$Y;YV/J!SR:*C^SW(R3#2O/&\CE[/9)
M7O)[:+HMV;GQ,\3/XR_9=U;77B\@ZAI:W(B!SL#.I"^^!@5^?J]*_0?4/ .O
M3?LPKX22PW>(!I$=K]C\Z/\ U@*Y7?NV]CSG%? VN:'?>&=8O-*U*W:UO[.5
MH9X6()1P<$9!(/U!P:BG:S1V<31JN5"I43^!7=NNMUZ^1[?^Q_\ $[_A#_'Q
MT"\FV:7KNV)=S?+'<C_5GD\;LE..22GI7H/Q2_9Y_P"$B_:0T2>&W_XD.MYO
MK_;T5H<><IZ8WYC&<DYD8]J^18)Y+6:.:&1HIHV#I)&Q5E8'(((Z$&OTF^&?
MQ$/B[X/Z9XPNX#Y_V&62X50 6>(LLFWG@,T9(]B*4[Q?,CIR-TLQP[P.)^PU
M->E]5_7<\/\ VRO'TU]<Z1\.]%5Y[B9DN+N"W!9F8G$,( ZG^+;_ +E>?:1^
MQ?\ $'5-/CN9I-(TR1UW?9KRZ?S5]CL1ES^/>MC]EN^?XD?M#ZOXCUE5GOQ9
MW&H)G)$<ADCC 7V5)"H] !7T%\0OA1XS\9>*!J6F?$R]\-6,07R-.L[,E%P!
MDN1,OF9.3\PQ@XQZKFY/=1UPP<<XY\PJ0E.[M&*:5HKJ[V_K\/AKXC_"WQ%\
M*]6CL-?LQ"9E+07$3;X9U&,E&]LC(.",CCD5W?@O]DOQUXUT&RU>$Z9IUG>1
M+/!]NN6#/&PRK81&P""#SSS7T)^UQHRR_ F.34YX[S4]/N+9ENE3RO,E/[MV
M"9. 0S';DXXY.*K>"?A9XIA^'.EGQK\2M4\.V-O:QK'9Z5-#9"TB51L1Y]N6
M(4#/IR,MUI\[Y;G)_8=&GCIT7&4HJ*DM4K7_ )G\GL?/?C[]E?QQ\/=#N-7N
M4L=4L;<;YWTV9G:)!U<JR*=H[D XZGC)KG?A+\%]<^,EYJ-OHMS86S6*))*U
M_(Z AB0 -J-SP:^^/"-CI<G@&XLM/\33^,;!HY8CJ-Y>1WKME<%&D0 -C/?G
MGFOG#]A#_D-^+_\ KWM__0GI*3LRJV28:&-PU-7Y*E[J][65]&<%#^R1X[?P
M_?ZO/_9MG!:K))Y-Q.XEE1 3N0!",$#(W$'D=*H_#O\ 9?\ &WQ(T6+5K.*S
MTS3YAF";4I6C\Y>?F555FQQU(&>V17=_';]I;QEI?C_Q#X<TZ>UL](M3+8M#
M]G5S,&7:79F&0>3C;@>N:]?\ ^,-"^-'PCTWP[HOB>;PIKD%I# \6GS"&Y@:
M-0IV+D%HSC^$C@@9!R*.:25S.CE^5XC$RH4W)N">C:7,T^C_ .&/E/XJ_ #Q
M1\(+&TOM9>QN+.YE\A)K&9G ?:6 (95/(![=J\W7I7O_ .T3X'^)?@_P[8VO
MB/Q')XK\+1W(:"[89DCEVD+YI8%P2"V/F8>^<5X".E7%W1\UF5"&'Q#IP@X+
M326_X;H*4=:2E7K29Y@ZBBBH9:'+2TB]*6LV4%*M)2K28Q:***AE(4=:=35Z
MTZLV4%%%%04A]%%%9L84X=*;3JEE!1114,I#Z***S8Q5I:1:6LV6+3J;3JD:
M"G+3:<M0RA:<.U-IWI6<BA5ZTZD6EK!FB'#I3XU+N%')/ J2UM9;R39$ 3C)
MW, !^)K8M]/DAB"-86LS=W>XY/Y-7FXC%0HZ-Z]KK]6CJITI5->A7AT656#,
M]JX_NFX4?UJ[-MM8]SVFG;?]F3<?T-1W 6TC\R33+,+G'RS$G\@U>Q_#?X3^
M'O"O@]?'OQ#'^@R /8Z5C_6YY4E?XBW4+TQR>.G#AZ%7,)7<M%UZ?A)GJT:#
MG+D@K=6WLEW=T>/633ZB2+71%N<=?)A=_P"5,N+HVDICGTJ*"0=5D1E/Y$U[
M)J7[7&KVS?9_#6@:7H^FQG$<4D9=L?12JCZ ?C6CH?[2ND^-BFD_$/PW8W%C
M+\OVVWC)\K/\14DL/JIR/2O0^H8-OE4]?G;\S>-/#R?+&OKYQLCP?^U(O^?"
MV_(_XTY=1C9L#3[<GV#?XUZ)\;O@ROP]FM=7T:<WWAC4"#;S;MQB)&X*6'4$
M<JW<#VR?0OV7+A-'^'OCC6$MH9KNT!E0R+G.R%F"D]<9_G6,<LA*M[&>GS?^
M84\-5EB/J]1\K]+]+GSU)<K*FW[!&GNH8'^=5,%>",5[M_PUYX@_Z &C_P#?
M$G_Q57M'_:6TSQ3>1Z?XS\)Z;+IMPP1[B%-WE9XW%6SD#U!!%..%PL?=A5W[
MI_YE>QPU1V5;7SC8^?%5G.%4L?89J7R)/^>;?]\FOH'Q=>3_ +,?C2X;P[9V
M=[I.N0++%'>JSM#L8@HK @X^8'GJ"/3-6O"/[4FN^(O%6CZ7-HNEQQ7MW%;N
M\:R;E5G"DC+=>:?U6E&7LZM2TMK6O^-RUA*4)^RJU+2O:UK_ (W/G58)/^>;
M?]\FAHW3&Y67ZBOJWXQ_'W5?AOXT?1K'2M/NH%@CE\RX5]V6SD<,!VKR#XA_
M'W5_B-H']D7FEZ=:0&593) C%\KTP2QQ6&(P^'HN4?:WDNG+^MQUL/0HN4?:
M7DNEO^">9[3MW8.W.,]J%KWJZM8?^&2+23R8_,^W;]^T9W>>RYSZXX^E>)Z'
MHUWX@U6TTVPA,]Y=2"**,=R?Y#WKAQ&'=)P2=^9)_?T,JM!TW!+7F2?WE,=:
MOQZ+J$D/G)8730_\]%A8K^>*^@+JW\&?LYZ?;17%E%XF\9RQB1O,QLASW&0=
MB^G&X^PKG6_:Q\7-<[DL=)2'/$/DN>/3.^M9X2A1]W$5;2[)7MZL[/JU*E[M
M:=I=DKV]3Q<@J2#P?2G5]"V_CWP!\:+&:T\66-OX9UI4+1ZE&P52?4/C_P =
M;/L<U\_W4<<-U-'%+Y\2N520#&\ \'';->?BL/&BE.G-2B_O^:Z&52BJ=I0D
MI)_UJB/TIX[TWN*<.E>6S(=1116+-#PU:=2+2U_?$C\CZ!3J;3JYY ?<?[-'
MQ*\)^'_V>5T[5/$VDZ=J"?;-UI=7L<<WS,Q7"$[CD$8P*X']C6U\%^$UU/QE
MXF\2:+8:FNZUL;.\O8HYHD !DE",V<MPHP,X#?WJ^6J5:^;GE<;5E&;7M'=_
MY'T\<\E&6'E*DG[%66_EJ_2Q]L?!7]K2W\2?$_Q1:^)+^'2M!U"0W&E37TJQ
M);! %$;,3@;T ;KC<&_O5SFF_$3PG^SW^T#JMUI.JV.K^"/$D*R3'2)TN!8R
M;R>0A.0K;_E'\,G )7!^3**Q>4T%*7+I&2LUZ;/U'_K!BG"'.DYPDY*777=>
MCO\ =Z'W5XR\#? +XH>)/^$JO?&6GVUS/B2YA@UF&!;D@ 9>-_G4X ^[M/XU
MPG[3_P"T'X:U3P7%\/?!)BNM,7RH[FY@0B".*(@QPQ?WN44[AQA0!G/'RDM%
M84\LC3G"4ZCDH[)]"L1GTZM.I"E1C!U/B:W??[Q:MZ7JEQH>JV6HV;^7=V<R
M7$+_ -UT8,I_,"JE*U>E+71GS,6XM-'Z;Z/\;/AUKFG:9KTWBG0;2\:TW"*Y
MU"%)X!($9XRI;<#E%!&.JU\"^*OBE=ZM\9KKQW;<SKJBWMJK@C]W&P\I&Q_L
M(H/XUP:]**\3#Y?3PKDT[WT^1])F6>U\RA",HJ/*[Z=7W/N[Q%XI^"_[2WA[
M3IM?UZ'1+^U5@@N;Q;.XMF8*74&3Y'' YPPXXQS7G/C_ .&_P'\$_#[6FTSQ
M%%K_ (@^SL+%_P"U!<2><?N_+!A,?[PQZU\L4ZN>.!=*RA4:BNA=?/%B4Y5L
M/!U&K<UOE>W<^M_V5_CWX9T[P/)X#\7W,.GP(95MIKKBWEAE)9XW;HIRS]<
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M',IP0 !T!X%>,?M >%_A+X4\+:9:^!=1BU376NP;BXBO'N<P!&SD@^6#NV=
M#^&:\'HI0P[IM>^[+H3BLWABH3OAX*<MY6U]5V9]S>$?BY\//CA\(XO#?C75
M[72KU8(H;R.]N5M29$QMFBD8A>2N<=N01@\WOA5XF^#/PDU:3PUX=UZS>XN(
M3<7>M7EY&8WVD!8VG.U"WS$A4&."3SU^"Z<M92PD;-*3L^AVPXDJQ<*DJ474
MBK<W6W]?J=U\<M2M-8^+OBN]L+J&]LYKYWBN+=P\<B\<JPX(]Q7#445TJ/*D
MNQ\K6J.M5E5?VFW]Y]A?L8>/O#/A7X>ZU::UXATO2+EM4:58;Z\CA9D,,8W
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M-5&F]O=5KO5WOTZ+J?(FBZ#J?B2^6RTG3KO5+U@66WLH&FD('4A5!.!71?\
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M[Q0&-O>0-#( >AVL <&J2UVWC"'Q=\0/BG?Z;J$S^)/%37;6!:U0;96B)3Y
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M5)4<\8Y/-<L:;O::Z]]#V,3CZ;I*>&J1345%+E?,M+-<UK:ZZI]3U#XJ7O\
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MAXX>M&G5YYU))O1I65WU6]]_P-[]G7P[:>*?C5X6T^^C$ML;AYVC;HQBB>4
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M->_:4@'AO5=%\(^!M'\(6^JP-;7DT'[R:2-E9<!E5.<,V,@XR<5RGP^^+2^
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M.6XY:<.]-6G=C7)(:'+VIU-7M3JQD:(<M%"T5@S0\.HK[$_X=Z_]3]_Y1O\
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M/\WYA_JWFO\ SY_\FC_F?(U-:OKO_A@/_J>__*/_ /;Z3_A@+_J>_P#RC_\
MV^H^M4?YOS#_ %;S7_GS_P"31_S/D2GU]<?\, _]3W_Y1_\ [?2_\,!_]3W_
M .4?_P"WTOK5'^;\P_U;S7_GS_Y-'_,^1J*^N?\ A@/_ *GO_P H_P#]OH_X
M8#_ZGO\ \H__ -OJ/K-+O^8?ZMYK_P ^?_)H_P"9\C45]<_\,!_]3W_Y1_\
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MU_Y2/_M]'M8=QKAW-/\ GU_Y-'_,^2J*^M?^&"?^IZ_\I'_V^C_A@G_J>O\
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M_DT?\SY+HKZT_P"&"_\ J>?_ "D?_;Z/^&"_^IY_\I'_ -OH]I'N'^KV9_\
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MS\2-3^(<FOW[:+<V_B2PM/#EO#:WSVZ6,FGR:C&'C\N%ED>6V,I>1V5L"-@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&6\M,,1N7;\I'-85A^SY\/\ 2])\"Z;9>'UL[7P/<?:O#_V>[G22RD*,CGS
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M2?B+K>L6WA.P\(^'=9UW0DTW^SI[BXU:.U>6-)&D-P$A7A%=#')OV2$>6&7
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M-W( '% 'U'6=>^(])TW6--TF[U2SM=5U(2FQL9KA$GNA$H:4Q(3N?8""VT'
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M>+?$5C'#+>Z1I%W?P1W"DQM)%"\BA@""5)49P0<=Q7RU^S[_ ,E>T#_MX_\
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MO)Z4*^98:C55XRG!-=TY)-'OX^<J>$K3@[-1DU]S/F?_ (;^^(7_ $!O#/\
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MBBB@#PSXY_L?^#?V@/%MIXA\0ZGKEG>VUBE@D>F3PQQF-9)'!(>)SNS*W?&
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M@?3+G2M/TK1_#?\ 9MN\4T,<1=MUS,PDQ$F<$)A0%1#DGWRB@#Y^C_9/\O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>.:U^S7!<:QXMO/#_C_P 7
M^";3Q7,UUK&FZ%)8-!<W#0K"\ZM<VDTL+M&D:DQ.@^12 &YKV.B@#&\&^#]'
M^'OA/1_#/AZQ33=#TBTCLK*T1F810QJ%5=S$LQP.68DDY))))K9HHH ****
M"BBB@ HHHH *Y'X3_#+2_@[\/]*\(:+/>76F:=YOE2W[H\S>9*\K;BJJ#\TA
M P!P!]:ZZB@ HHHH Y"?X8Z7<?%RR^(C7%X-;M-#N- CMPZ?9C;S7$,[,5V[
MMX:! #NQ@MP3@CKZ** "N;^)7@/3_BE\/?$G@[59KFWTS7M.GTVYELV59DCE
MC*,4+*RA@&."5(SV-=)10!4TC38M%TFRT^!G:&T@2!&D(+%54*"< <X'I5NB
MB@ HHHH R=6\+:7KEPL][:^=*J; WF,ORY)QP1ZFJ?\ PKW0/^?#_P C2?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=C;Q1P(&DN+J;A8H4R">=S=!UR*WQ?\ ^3IOV??^Y@_](4KO/CY_R0KXC?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KXT^)GP:_:J^-7Q&\162_%/3?A9\
M,UNY8=/&A0[]2GML_)(S+AE8KU_?+@_PU]EUYGJG[3'PIT.Z\06^H_$#0+";
MP_=1V6J+=7J1_9)WW[(W+$?,?+?C_9/I0!X5\ _V!?@7X3\57/B(:M-\5?&^
MBZ@JWNJZQJJW;V5_'M;:\,9"I(ORG;+N8<<U]@U\F?L\_$[X-_#[QG\0A:_&
MCPAK][X]\6R:Q9V=M?1I)$TXCC2W^^=[94<C&<]*^LZ "BBB@ HHHH ****
M,'6/ NAZ]XJ\/^([^R\_6= ^T?V;<^:Z^1YZ".7Y0P5MR@#Y@<=L&N?^*GP)
M\"_&J/3QXPT%=3FT]F:SO(;F:TNK?< '"3P.DBA@!E0V#CD&N^HH P? _@7P
M_P##7PO8^'/"^DVVB:'8J5M[*U7:B9)9CZDDDDL<DDDDDUO444 ?*O[1'_)]
MG[(W_<W?^FN*OJJOE7]HC_D^S]D;_N;O_37%7U50 4444 %%%% !1110 444
M4 ?CG^W]_P G;^._^W#_ -(+>OGNOH3]O[_D[?QW_P!N'_I!;U\]U][AOX$/
M1?D?(5_XL_5_F%%%%=!B%%%% !1110 4444 %%%% !1110 4444 %?L9^P#_
M ,FD>!/^W_\ ]+[BOQSK]C/V ?\ DTCP)_V__P#I?<5XN;?P%Z_HSU,N_BOT
M_5'T)1117RA]"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%% !1110 4444 %%%% 'XY_M_?\ )V_CO_MP_P#2"WKY[KZ$_;^_Y.W\=_\
M;A_Z06]?/=?>X;^!#T7Y'R%?^+/U?YA111708A1110 4444 %%%% !1110 4
M444 %%%% !7[&?L _P#)I'@3_M__ /2^XK\<Z_8S]@'_ )-(\"?]O_\ Z7W%
M>+FW\!>OZ,]3+OXK]/U1]"4445\H?0A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_R?9^R-_P!S=_Z:XJ^JJ^5?VB/^3[/V1O\ N;O_ $UQ5]54 %%%% !1110
M4444 %%%% 'XY_M_?\G;^._^W#_T@MZ^>Z^A/V_O^3M_'?\ VX?^D%O7SW7W
MN&_@0]%^1\A7_BS]7^84445T&(4444 %%%% !1110 4444 %%%% !1110 5^
MQG[ /_)I'@3_ +?_ /TON*_'.OV,_8!_Y-(\"?\ ;_\ ^E]Q7BYM_ 7K^C/4
MR[^*_3]4?0E%%%?*'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5Y1I?[47PVU;P1IGBZ/Q
M8] U/7!X;L[J2TF_>WYE,2Q;50L 74C<P"X&<XYKU>OSU_:P_P""=/P;T+0]
M4^( \6ZC\-=+CU>/5-:9[MI;,1/)^]$$6QF6=F8"/&0"0 I&!0!^A5%?E/\
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MXVMR"*]SU;5K'0-*O=3U.\M].TVRA>YNKR[E6*&")%+/([L0%55!)8G  )-
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M%%?*'T(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH *_8S]@'_DTCP)_V_P#_ *7W%?CG7[&?L _\FD>!/^W_ /\
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MBBB@ HHHH **** "OV,_8!_Y-(\"?]O_ /Z7W%?CG7[&?L _\FD>!/\ M_\
M_2^XKQ<V_@+U_1GJ9=_%?I^J/H2BBBOE#Z$***:SK&K,Q"JHR6)P /6@!U%9
MW_"2:3_T%++_ ,"$_P :/^$DTG_H*67_ ($)_C6OLJG\K^XCGCW-&BL[_A)-
M)_Z"EE_X$)_C1_PDFD_]!2R_\"$_QH]E4_E?W!SQ[FC16=_PDFD_]!2R_P#
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MO_10O"O_ (.[;_XNMO85?Y']S,O:T_YE]YW-%<-_PO;X:_\ 10O"O_@[MO\
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M7]&>IEW\5^GZH^A****^4/H0K.\2?\B[JG_7K+_Z :T:SO$G_(NZI_UZR_\
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M_P#(TG_Q5=%11]:Q'_/Q_>P]C3_E7W'._P#"O= _Y\/_ "-)_P#%4?\ "O=
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M_P!G1_9V$_Y]H\9_X95\)_\ 01UK_O\ P_\ QJC_ (95\)_]!'6O^_\ #_\
M&J]FHH_MS,O^?[#^SL)_S[1XS_PRKX3_ .@CK7_?^'_XU1_PRKX3_P"@CK7_
M '_A_P#C5>S44?VYF7_/]A_9V$_Y]H^9_%7PMTOX6_$3X>'2+J^E-]J:B4W4
MB' 66$8&U5ZAVSG-?3%>,_'+_DH7PL_["A_]'6U>S5OFE>IB<+A:M:5Y-2N_
M^WV9X.G"C6K0@K)-?^DH*\._;8_Y-C\9_P#;E_Z6P5[C7AW[;'_)L?C/_MR_
M]+8*\C _[U2_Q1_-'7BO]WJ>C_(Y7X3_ +(/PD\3?"SP;K&I>$_M.HZAHUG=
MW,W]I7:>9+) C.VU90!EB3@ #TKJO^&)_@O_ -"9_P"52]_^/5W'P*_Y(C\/
M?^Q=T[_TFCKN:VK8W%*I)*K+=]69T\+0<(MTUMV1X=_PQ/\ !?\ Z$S_ ,JE
M[_\ 'J/^&)_@O_T)G_E4O?\ X]7N-%8_7L5_S]E][_S-/JN'_P"?:^Y'AW_#
M$_P7_P"A,_\ *I>__'J/^&)_@O\ ]"9_Y5+W_P"/5[C11]>Q7_/V7WO_ ##Z
MKA_^?:^Y'AW_  Q/\%_^A,_\JE[_ /'J/^&)_@O_ -"9_P"52]_^/5W_ ,8/
MB(/A/\-];\6-8'5!IL:/]D$WE>9ND5 -^UL?>ST/2N1^&/Q8^(GCK4=%EU/X
M4?\ "/\ AG4H/M/]M?\ "1V]SY<;1%XV\E4#G<=BXX(W9/0UT1K8Z=-U55?*
MO[]O/2[N_D8RIX2,U3=-7_PW_0SO^&)_@O\ ]"9_Y5+W_P"/4?\ #$_P7_Z$
MS_RJ7O\ \>JK\3/VCO%GP_;7-0A^$VJ7WA?1YS#<ZU=:A':;P&V^9'$49GC)
MZ,.,8/&:N>(OVF!'X=\ 7?A/PG>>*M8\:1S2Z=I1NDM"JPH&FWR,& *@^F#@
M\UJGF+2:J2L_[_E?773376QG;!)M."T_N^=M--=>PW_AB?X+_P#0F?\ E4O?
M_CU'_#$_P7_Z$S_RJ7O_ ,>J:U_:BT6Y^"^G^.AIEQ_:&H3M86?AU7S<W%\)
M#&($.WGD9W <*>F?EKUW1+F^O-'LI]3LH]-U"2)7N+.*?SUA<C)02;5W8/&<
M#-8U*^.I?'4DM6OB>ZWZFL*6$J?#"+TOLNOR/'/^&)_@O_T)G_E4O?\ X]1_
MPQ/\%_\ H3/_ "J7O_QZO<:*P^O8K_G[+[W_ )FOU7#_ //M?<CP[_AB?X+_
M /0F?^52]_\ CU'_  Q/\%_^A,_\JE[_ /'J]QHH^O8K_G[+[W_F'U7#_P#/
MM?<CP[_AB?X+_P#0F?\ E4O?_CU'_#$_P7_Z$S_RJ7O_ ,>KW&BCZ]BO^?LO
MO?\ F'U7#_\ /M?<CY6_X)R?\D1UO_L8I_\ TFMJ^J:^5O\ @G)_R1'6_P#L
M8I__ $FMJ^J:WS3_ 'RIZF6 _P!VAZ!7&?&K_DC?CS_L W__ *3R5V=<9\:O
M^2-^//\ L W_ /Z3R5C@/][H_P"*/YHVQ/\  GZ/\CP#]FW]FWX<^/O@KX=U
M[7O#OV_5KO[3YUQ]NN8]VVYE1?E20*,*JC@=J],_X8\^$/\ T*/_ )4KS_X]
M1^QY_P FY^$?^WO_ -+)J]FKZC.LZS2EFF*IT\54454FDE.222D[)*^QY&7Y
M?@YX.C*5&+;C'[*[+R/&?^&//A#_ -"C_P"5*\_^/4?\,>?"'_H4?_*E>?\
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M._$KXVZ5I\/V>PL=7BM;>'<S;(TFO%1<L23@ #))-?4M?,_[*O\ R63X^?\
M8>'_ *47M?3%>AQ5)RS:I*3NW&G_ .FX'+DJ4<%%+:\O_2Y!1117R1[84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV/?@YJ_P(_9]\->$_$-Q#<^(8S<7NHM;G,2SW$[S,BG'(7>%R."5)'!KV>@
MHHHH ***\'\>?%CXB>(_BYJ?P[^%&G^'4O- L+>_UW7O%2SR6MN]QO-O:QPP
MLCO(RQERVX*JD<$G% 'O%%<#\$?'7B+X@> X[[Q=X7N/"/B:UNKC3]0T^5)!
M"TL,A3SK=W4&2"0 .CXP0W4XR>^H ^5?VB/^3[/V1O\ N;O_ $UQ5]55\J_M
M$?\ )]G[(W_<W?\ IKBKZJH **** "BBB@ HHHH **** /QS_;^_Y.W\=_\
M;A_Z06]?/=?0G[?W_)V_CO\ [</_ $@MZ^>Z^]PW\"'HOR/D*_\ %GZO\PHH
MHKH,0HHHH **** "BBB@ HHHH **** "BBB@ K]C/V ?^32/ G_;_P#^E]Q7
MXYU^QG[ /_)I'@3_ +?_ /TON*\7-OX"]?T9ZF7?Q7Z?JCZ$HHHKY0^A"L[Q
M)_R+NJ?]>LO_ * :T:SO$G_(NZI_UZR_^@&M:7\2/JB)_"S.^'O_ "*%A_VT
M_P#1C5T5<[\/?^10L/\ MI_Z,:NBK7%?[Q4]7^9%'^''T04445RFP4444 <K
M\4TDD^'NN"(,6^SY^7K@$$_IFO(VFO\ POX#\-Z[I?B2^ENI9EA_LUI@8,#.
M5$?L0 <Y^]VKZ#DC2:-XY$62-P596&00>H(]*YC3OA=X6TG4DO[71XH[I&WJ
MQ=V"GU"EB!^5>GAL5"C3Y)KK?IKI:S."OAY5)\T7TMZ:[G(^!9H]/^+7C6.Z
M=;=V_>KYIV_(#NW<]L$'Z5C_  S\)V/BCPGJUQ?S36=M'J;7-O>6\GEO$549
M8$@X&#^GM7IWB#X>^'O%5VMUJ>FI<W"C;Y@=T8@= =I&?QJY-X5TJ;03HILU
M32RH4V\3-&,9SC*D'KUYY[U;QD;>[=-\M_*W;74E8:5_>LTKV^?<\6AA.FV]
MEJ^GP&XTS^U!!I:ZG(2+FYDR&NYCQD?)@=,8SZY]2^'_ (LOO$B:K;ZG!;Q7
M^FW1MI&M-WE/CNN3GL?TK9U3PSI>M:.NEWME'-8*%"P\J%VC"[2"",#TI= \
M-Z;X7L?L>EVJVEON+E5)8ECW))))X'4U%;$TZU-IQ][IZ?UY%TJ$Z4[IZ&G1
M117F'<%%%% !1110!QGPI_Y%VX_Z^F_] 2NSKC/A3_R+MQ_U]-_Z E=G7?CO
M]YGZG/A_X40HHHK@.@\9\+_\G0^+_P#L%Q_^@VM>S5XSX7_Y.A\7_P#8+C_]
M!M:]FKW,V^.C_P!>Z?\ Z2CSL%\-3_'+\PHHHKPST0HHHH *\O\ %?PUUZ/Q
M9K'BWP[XGCTF^N+98S!-9HZ%45>"[DA0=@.=O%>H5P7B+X.:7XBU*^NSJVM:
M>M\0UU:V-[L@G( &60J<\"O4R^NL/4;E/E35G>*DFKK1I^AQXJFZD$E&]O.U
MO.YE_#'QUXE^('PSN+^V6P_X2"&Y-LDEXKK;R8V,68)R/E8CCN*X[PC'>6OQ
MVO[3QE DNO:K9O'!-828MQ'L.<+C=RL9 ).?4<YKTVZ^$>@3>&]/T6V%UID%
MC)YL%Q8SF.=7(Y8MSDGW'IC&*/"?PET?PGK4NL+<7^K:M(I3[;JEQYTJ@\'!
MP.W&>N*]B..P5..(=)6Y^9))6:O:WO7VTNU;R.%X?$2=)3UY;7=]'WTMOV9Y
M=JG@?4/!.O>']'TGQ%-J^L(D\>DVC6ZQKIT4H(EGD8$EL G&0.1GM@Z_PK^(
MMIHL>@:)!X?N+71]4FECM=9EN%9[R93AY'0#(); ZG' YQ7J&A^"['0M:U;5
MTDGN]2U)PTMQ=,K,B#[L:8 VH/3V&2<"N?\ #_P3T#PYKUOJ=O/J$PM9'EM;
M*XN ]O;L_4HF.#]2?TK2>9X;$494L5>3MH[6O*TGTLM)/2Z=_>;U9,<)6I34
MZ.BOMO9:=[]%TMT6R._HHHKX\]P**** "BBB@#QGXY?\E"^%G_84/_HZVKV:
MO&?CE_R4+X6?]A0_^CK:O9J]W&_[CA/27_I;/.P_^\5_5?\ I*"O#OVV/^38
M_&?_ &Y?^EL%>XUX=^VQ_P FQ^,_^W+_ -+8*\_ _P"]4O\ %'\T;XK_ '>I
MZ/\ ([CX%?\ )$?A[_V+NG?^DT==S7#? K_DB/P]_P"Q=T[_ -)HZ[FL*W\6
M7JS6E_#CZ(****Q-0HHHH X[XN>&/#_C;X?ZGX?\3ZE_9.CZEY<$ETMQ' P;
MS%9 K."NXLH !!SG%?,>L6^N_L\_M ?#/PKX9\?Z]XGT?6)H[2[T'6KW[4;2
M#<B9 P%1=C,R[0"/*/45]:^+O!^C>/-!N=%U_3H=4TNXQYEM.#M.#D$$<@@C
M((.17(_#[]G?X=_"W5FU3PQX8M].U$JR"Z>:6>1 >"%:5V*Y''RXXSZUZF%Q
M,*-.49W=[Z65M5:]]U\D<%>A*K-2C9;:W=]]K=3R;]JCPOXF\9^"_&&IZ5\5
M-/B\)V$1-WX:-M"J;X1^\A>Z1O,WLZ$>60/F.WM53P9X9\&_&+]FWP5XIUQ]
M1^'=OX6@N?L^H:+>-;O:HK&.5HY&#EE<1C/!8MD GOZGXD_97^%?B[Q%<Z[J
MOA"WN-4N93//,EQ/$LLA.69D20*23R<CDDYKK?$'PN\+>*/"MGX:U'1XI- L
MWBDATZ%WAA'E_<4K&R[E']TY4]P:V^N4XTH4XMJSO=)*RM9[/5ONS+ZM.524
MY):K:[?6Z]/1'QEX3L]:\'ZA\/=6T#0[))=:NKC3_!-AXGD<PV-N?GEO;CR\
M,T\Q<8(Z+P 1L ^J/V=_BO?_ !@^'IUG5;&WL-4MKV?3[I+,L8'>,CYH]Q)V
MD,.I/(/-='\0/A3X3^*>BP:3XHT6'5+"W<20QEGB:)@,?*\95EXXP#@UH^#?
M!>B?#_P_;:'X>TZ+2]*M\^7;PY(!)R2222Q)/4DFHQ6+I8FEK'W[_AKUO^F]
MWU*H8>I0J:2]W]=/ZWVTZ&W1117D'I!1110 4444 ?*W_!.3_DB.M_\ 8Q3_
M /I-;5]4U\K?\$Y/^2(ZW_V,4_\ Z36U?5->IFG^^5/4X,!_NT/0*XSXU?\
M)&_'G_8!O_\ TGDKLZXSXU?\D;\>?]@&_P#_ $GDK' ?[W1_Q1_-&V)_@3]'
M^1QG['G_ ";GX1_[>_\ TLFKV:O&?V//^3<_"/\ V]_^EDU>S5WY]_R-L7_U
M\G_Z4SGRW_<:'^"/Y(****\(]$**** ./^+VN:WX;^&NOZAX;T^?4]=BM]MG
M;6T32R&1F"!@B@EMN[=C'\-?$<^IIX+OO@K:/X.\76>HZ5JDVH:A_:&E&*?5
M+F22V9Q;*7S*1L"<[3C9GDU^AE<YXF^'?A[QAK6@ZMK&G_;-0T*8W&G3>=(G
MD2$H2<*P#<HG# CBOLLBSRCE<72K4N:+<FVGKK"44NS2YGZ7;U:1X.99=4QC
M4Z<[-65GM\2;?KHONL>1?M<?$JXT3X2VFD:9%<0ZWXN9;*"U=2DZQ,%,H(SP
MV&6,C_II6VW[//AJ/X-^'?#.KW=SI:^'E6_.K:=<"":"X52TLRR%2 -Q8\C@
M >E=UX@^%WACQ5XLTCQ-JNEB\UK2<?8KAIY0(2&+ A P0G)SD@G@>@K4\6>$
M]+\<:!=Z)K5NUUIET LT"321;P"#@LC*V,@<9YZ&N:.;4Z&&P^&PSE#EDYSD
MK7N]%RZZJ,=-;7;9K+!2J5JM:LE*Z48KI;?73J^U[61\5VMFWA^QTCQ5H5BU
M_P"'/^$C6Q\,Q^(YR5U#4)]PDU.[8;<@>4%7IC /4-N^E_@1\4M:^(D/B>P\
M1V5C:ZUX?U)M/N)-++FVEQGYDWDGJ#U/ITKK_$OPX\->,/"D?AK5](@N]#B6
M-8K/+(L808385(*X' P1Q3_ OP]\/?#713I/AK3(]+L#(96C1F<LY !9F8EF
M. !R>PKNS/.\'F6$E&=)^UO[KWM&]]7?5O6ZY=6[WV1SX/+Z^$KIQFN2VJ[N
MW:VVUM=E;S.BHHHKX@^A"BBB@ HHHH ^9_V5?^2R?'S_ +#P_P#2B]KZ8KYG
M_95_Y+)\?/\ L/#_ -*+VOIBOJ^*/^1K/_#3_P#3<#Q<G_W./K/_ -+D%%%%
M?*'M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7A/[9EO\&[KX/HGQSN9+3P4-2@*R1"Z+?:M
MK^6/]&4OTW]L>O:O=J^0?C-XW_:0U;Q1KF@V/[-GACQWX+M[UO[.N]7URQ*W
M4:DB.8PRR_*Q!Z%01F@#X\U+2?V28_B]\&'^ PU+Q1XJ/C*PCNM)>/4A!):E
M_FE9KA4*M&P1U*$C@[U*]/V!K\U/!?[67C?X>_';PQX(E_9W\ ^'M?U;4(+&
M[C\)ZC9W=]:PO(%D>1;,NT812S'S   ,GBOTKH *_*+PO\*_"?QR_P"%@^,?
MC)^T=K'@_P"(^D:U?6[:?!K,-K!I21.?*,43Y::(H R^25!! !)!)^X/VB_V
MOM)_9C\2:1#XJ\'>)KSPM?VWFOXGT>T%Q:VDN\KY4V2-IP W4D@\ X-?&=QJ
MO_!-C6'GU&[@D2\N7>>6)AXB5M[$D\(=@R?0XY[4 ?57[!_QN7QI^SYX'LO&
M'C?2M7\<3QSQI#-J4+:A=0++)Y#R1;R^\PJC'(W8Y;G-?3]?F]^S#=_LN:W^
MT-X9/P.^#'BG4-0LIIC+XR>:_P#[.TL&"0;F$T[@E@=H#HO^L4@D\5^D- !1
M110 5\,:K\*OAYK7[;'QIM/C%+;?V-K^G:-J_A_3-7OVM;"]6*U-M=2E=ZI+
M+$T* 9)*"1B!SFON>N=\9?#GPG\1K6WM?%GA?1O%%M;OYD,.LZ?#=I&QZLJR
M*P!X'(]* /%?V%=2NM0^$_B&*'4KO6O"%CXJU2S\):E?3//)<:.D@$#>:_S2
M*'\U58DY5%[8 ]V\6?VY_P (KK/_  C/]GCQ)]BF_LS^UM_V/[5Y;>3Y_E_/
MY6_;NV_-MSCFK]C8VVEV<%G9V\5I:0((XK>! D<: 8"JHX  ["IZ /@#5!\;
MQ^W9^S#_ ,+D/@ _\C1_97_"#"]_Z!8\[S_M/_;+;L_V\]J^_P"OE7]HC_D^
MS]D;_N;O_37%7U50 4444 %%%% !1110 4444 ?CG^W]_P G;^._^W#_ -(+
M>OGNOH3]O[_D[?QW_P!N'_I!;U\]U][AOX$/1?D?(5_XL_5_F%%%%=!B%%%%
M !1110 4444 %%%% !1110 4444 %?L9^P#_ ,FD>!/^W_\ ]+[BOQSK]C/V
M ?\ DTCP)_V__P#I?<5XN;?P%Z_HSU,N_BOT_5'T)1117RA]"%9WB3_D7=4_
MZ]9?_0#6C6=XD_Y%W5/^O67_ - -:TOXD?5$3^%F=\/?^10L/^VG_HQJNZEX
MHTS2=4L=-N[KRKV^.+>+8QWG..H&!^)%4OA[_P BA8?]M/\ T8U<;\1O^2J>
M!_\ KH?_ $(5W2I*MBZD9=Y?A<Y?:.G0C)>7XV/5*S/$'B33O"]A]MU2Y%K;
M;Q'O*,WS'.!A03V->:VNO>,/$7B#Q?:6.M0V%II,S;&>U21P,OM0<=#L.2<G
MI6;K7CO4=<^#,6J7"6TEZM\(':6VCE1\9.[8ZE0<$=J(X&7-%2:>JO;SU70F
M6+7*VD]G^'S/:[>>.Z@CFB;?%(H=&'<$9!J2O'?%OQ,NK'Q!9Z+#J\/ARUBM
M(Y9[XV?VAB[*&"J@!&,$>G?VJO9?&;48? ^LW,CPWVH6ETMK;WBQE$E#[B'*
M8&.$8]!U&1UI?V?6<5)=;?CMTL/ZY23<7T_3\3VB21(8VDD941069F.  .I)
MJ@_B+3%T>;51?0RZ="K.]S"XD0 =>5SG\*XNYT7QG'X=U7^TO$5O,DNGNQVV
M:!X) 02@P,,I0.N3R"00.*Y'P&NI:=\(=7U$:A'-8^1.L6GRVB,J/NY<L<[L
M\_*1CFB&$C*/-SIZI:7Z_()8B2E;E:T;Z=/F>SZ/K%IKVFP7]A-Y]I,"8Y-I
M7."1T(!Z@U<KQJU\<:LOA[P9HND-;VFI:JC%[@6Z+'$H<C*QJ O8]NWO6M9>
M)_$?AOQM+X>UC4(M86>Q>ZMKI8%A92H8C*KQ_ PQ].:4L'--V:ZZ=;)VOM8<
M<5%I77;7I=GI]%>%6'C#QO??#^Y\3?V[;QQV<FSR?L<9:?Y@"6.,+C< ,#D"
MO9?#VI/K&@:9J$B*CW5K%.RKT!9 Q _.LJ^&E05VT];:=S2E7C6T2:TN<]??
M%WPEIE]<6=SJWEW%O(T4B?9ICM93@C(3!Y':NKL[N*_M(+F!M\$R+)&V",J1
MD'!]C7C7@G5];TOQ=XX&D>'_ .VU?4W\QOMJ6_EXDDQ]X<YYZ>E:^O>)?%-Y
M\2+7P_IM]%I27%DDLBR0I-Y#8+.0<?,1C &<']:Z:F#7-RP=K*[;:[+HE='/
M3Q+Y>:?5VT3_ #;LSU2BO'/%GQ&U+2_$T?A^7Q##H@LK6/[5J1L?/:XF**QP
M@4A0<Y[8YYZ"J]O\:-1C^']_>2>3<ZG#>+9178CVHX9682%?4!6XX[<=14++
MZSBI+K;OUVZ%O&4E)Q?3]#VNBO%_"WQ0OO\ A,-*TY_$$/B6SOOW<C)8FV-O
M(>@&5&X9[GMGI7M%<U?#SP[2GU_KK9F]&M&LFX]/ZZ'&?"G_ )%VX_Z^F_\
M0$KLZXSX4_\ (NW'_7TW_H"5V=;8[_>9^HL/_"B%%%%<!T'C/A?_ ).A\7_]
M@N/_ -!M:]@O+R#3[66YNIX[:WB7=)-,X1$'J2> *\?\+_\ )T/B_P#[!<?_
M *#:UVOQ@_Y)CXD_Z\V_I7TF.IJMB<-2;^*%-?>D>5AI^SI59]I3_,ZJQOK;
M4K6.ZL[B*[MI!E)H'#HP]01P:GKP+3_B/J?P^^%GP^_LVRM[YK]VADBGR"P#
M]%(("DYZD$#TKK/#OQ$\46_Q(MO"GBC3]-BDO;0W4$NFLYV@!CAMQ.?N,.,<
MCN*QK9/7ASS@TXKFMJKM0=F[>1=/'4Y<L9;NW32[5UJ>B:;K6GZR)3I]_:WP
MA;9(;:99-C?W3M)P?8U=KY]^'WQ"T_P;X'\8:U'HUI9O!J ACM[5Y<3R'A=Q
M=WQCD\8& >*U?#_QOUC_ (2+P_9ZP?#UY:ZRZQ(-%NC)-:NQ 42@L<'+#]>>
M,5K6R3$*=3V*O&/>R;LDW]R_JY%/,*7+'G>K[;;V1[;17D-K\3/&/C+6=<'A
M#2M*N-*TN;R=]](XDN6!Q\A! &<$\]L<UR.J2>+9/VAD:T32(M7:S)@CN6E:
M%8=K'#E>2X&>G&:FEDU24I1JSC%J+E:Z;T2=FNF^Y4\?!).$6TW;_ANY[_;Z
MUI]UJ$]A#?6TU] -TMK',K2QCCEE!R.HZ^M7:\6T'Q1I^D_%CX@WDVF6UJ-.
MLVFFNX6D,TRKL)!#.4R<#&U1SBH9/BUX[7PC_P )D-%T<>'"^?LYDD^U>7OV
M!LYV]>.F>^,4I9/5E)*ELU'XFE>4E>RU_KJ"QT$FY^>UWHG:[/;Z*\DU[XL:
M_-XP\/:/X:TZQNDUG2H]0B-\64H7WG+$-]T*F2 ,GM6M\,/B+JOBC6]?T+7;
M2TM]5TF0*TECN\EQD@XW$GJ/QSVQ7+4RO$4Z+K2M9*]KJ]KVO;UT-HXRE.?L
MU?>VVE[7W]#M-7\1Z3X?\K^U-4L]-\[/E_;+A(M^,9QN(SC(Z>HHTCQ%I7B!
M93I>IV>I"+ D-G<)+LSG&=I.,X/Y5Y#^T-)##XL^'CW-C)J=NMW,9+**$3/.
MNZ#*!#PQ/3'>M:^\;6GA7X>^(-=\/>#I?#5S:M ##J>F"T6<M(JYPA!8 ,>_
M!-=<<K4\-1J0NY5-%M9/FY?4Q>,Y:U2$K6CZWVN>LT5Y!)\6/$WA_P #S>*/
M$&EZ=%:7441TVUMG?S6=\D>822 -HW<<XXZU6\._&K5O^$JT/3-:;P_>V^KG
M9&^@W1E>VD.-JRC<><D#TZX)P167]CXIQE**34;[-:V5W;O8KZ_132=U>W3O
MM]Y[117@^H?'[5[R;6KO1O\ A'8-+TUV5(-4NREW=A>IB4,,Y'(&/89/%>N^
M"_$T7C+PMIVLPQ-"EW%O,;'.Q@2&&>X!!YKGQ66XG!TU4K*R>GH[7L_D:T<7
M2KR<(/7^D>:?'+_DH7PL_P"PH?\ T=;5[-7C/QR_Y*%\+/\ L*'_ -'6U>S5
MTXW_ ''">DO_ $MF6'_WBOZK_P!)05X=^VQ_R;'XS_[<O_2V"O<:\._;8_Y-
MC\9_]N7_ *6P5Y^!_P!ZI?XH_FC?%?[O4]'^1W'P*_Y(C\/?^Q=T[_TFCK2O
M?B5X;T_X@6'@FXU+R_$]_:F]MK'R)#OA&_+;PNP?ZM^"P/R].E9OP*_Y(C\/
M?^Q=T[_TFCKQKQI_RD!\ _\ 8K2_SO:UC1C6K55+HI/[C.51TZ5-KJXK[SZ>
MKD_'_P 5/"OPMATZ7Q1JZ:5'J$_V:V+122>9)Z?(IP/4G &>M?*'A/XJ?&OX
M@>!/B1XCLO'-AI5IX1GO)E5M(@EGNEC3?Y!)7:J!$.&VEBS$$XP1;^+'QDUK
MQ1\"_@WXIGM=+.HZMJZ1W0N=-@NTRK.A9%F1_+)*9RN",X!KICEDE44)R35[
M.SV=K]5_F82QT7!RBFM+J_K;N?:%%?&GQ<_:DU5?C+XA\*VGC^U^&FB:&@A6
M]FT-M2EOKD %E*A'V*"2,\<#/.<""W_;"\7:M\ ]&O;*.S/C?4_$#>'HKTP8
M@.U(W\_8> 2)8UP1C)8XXQ4+*L0XQE_-;OUU[6];-V+>845*4>U_P^=_OL?9
M&I:G9Z+I]Q?:A=P6-C;H9)KFYD6..-1U9F8@ #U-8>O_ !+\+^&?!$WC"^UJ
MV_X1F)$<ZG:DW,15G"*5\H,6!9@/ESUKY_\ C'X+^+6E? [QW'XE^(EAK=@E
M@MQY\.CQ0SR* WG6Q50%"-E<2#YOEZ#-<3I+>)_!7[!^IZY<^(+77;*XM+$Z
M9I5]HML\.GJ;U4D5MX83[MX(,B_*5&*=/ PG&,O:)WDHZ7Z^JW]15,7*,FN1
MJT6];=/F?9^B:U9^(]%L-6TZ<7.GW]O'=6TP4J)(G4,C8(!&00>1FKM?*M]\
M6O&?B#Q%\+_AEX)U*Q\-7^H>&[75-1UDZ?'*MNI@SLB@P(QPGW0 /G4#: :B
MTCXS?$3PCKOQ>\#>)M;M-=UKPWX7N==TS7K>RC@.4A5EWQ ;#S*AP0>5898$
M5G_9]1[-7WMUM>U]K?KY%_7(=4^U^E[7MO<^KZ*^&K[XS_&O0?@7X<^+%UXR
MTVYL9[I+=M#&DQ#[1'O=#)+*%!5BR'Y4V@ @YSQ7VWI5\-4TNSO GEBXA2;9
MG.W<H.,_C6&(PD\,DY-/5K3NM]TC6CB(UVTDUHGKV>QXW-^VE\&K>:2*3QEM
MDC8JP_LN]."#@_\ +&O;J^'OV//&OC[P[X*UZS\,?#;_ (2[2I/$5P\VI_V[
M;V7DR&. ,GE2*6;"A6R.#NQVKN=<\;_%CQI^T]XT^'GA3Q=:>'='TVTM[M;B
MXTV&Y>W4V\+$(&7+EY)>=Q.!G'3![\1E\8U94Z;LHIMMR3TTZ15UOL]SDHXR
M3IJ=17<G9))KOU;L]NA]445\3_$/]J376^*7B/PT/B/9?#C3O#X%HEU)H+:C
M)J=T@Q)N C?RTW@\C&!C ;G!J'[:7B-O@!X8U8?8],\4ZKJLNE3ZK);F2W@C
MB",]P(@#D[98_EP>C$#H*S_LG$M1:^U;OU5^W;M<O^T*"<D^GITT[_G8^V**
M^2/@#^TAJ_B#XV0>";CQM;_$K1M0L'G@UF/1SIDEM.BLS1M&47(VH><'.Y3D
M8*U];UP8G#3PLU"IU5^OZV?WHZZ%>&(CS0]/ZM='RM_P3D_Y(CK?_8Q3_P#I
M-;5]4U\K?\$Y/^2(ZW_V,4__ *36U?5-=6:?[Y4]3# ?[M#T"N,^-7_)&_'G
M_8!O_P#TGDKLZXSXU?\ )&_'G_8!O_\ TGDK' ?[W1_Q1_-&V)_@3]'^1QG[
M'G_)N?A'_M[_ /2R:O0/$'Q)\.>%_$VB^'M4U+[+K&LL5L;;R9'\X@@?>52J
M\G^(BO/_ -CS_DW/PC_V]_\ I9-7%?M ?\G.?!G_ *[M_P"C%KZJM@:>89_C
M*-5M)2K2T[QYI+H^JU/&IXB>%RS#U(+6U-:^=D?3=<[XZ^(/A_X::&-8\2ZB
MNF:<95@$QB>3+MDA0J*2> >W:OG[2O&GQ6^(WQB^(GA/0?%]EH6GZ-<%H)[C
M38IY(E!94B4;<$,<;F?<1M&.X/'>)/C?XB\;?LD#Q#J::==:Q;ZZEA)-=:=!
M<1S +N#F*1&C#?,!D+VXQFJP_"U:5:E&K4BU)TU)1;4DJBO'5QMT>U[=K"JY
MS!4YN$6FE*S:5GRNSV=_R/LVQO8-2LK>[MI!-;7$:RQ2+T96&0?Q!%3U\H?%
MS]HK4O#_ (Q\.>$+'Q/;>!;!=+@NM1UM]*^VLKO'N6..$*1C&WL/O=1CG-\-
M_M;Z[:_"?QY?75W:^(=6T2\M[/3=7CM#!%=B<R!)'BPNW B=L8'501U-91X2
MS&I0AB*:5I.-EK>TI<L7?EY=[72=TG=I(MYWA8U)4I/6-[[=%=Z7O^%NESZ^
MDD2&-Y)'6.- 69F.  .I)]*P9/B%X:3PK>^)8]<LKO0;-&>>_LI1<Q(%^]S'
MNR1Z#)KQ^Q\-?&.[\$WMYJ_Q!T^>VU'17G=5TB(2V,I <+'M 60%-R$L1C=D
M D UY#\"8_$.A_LN^-?$$>NP7&BI;7D4.@W.EPRQI<9CS,TCYWC;D>6RE><]
MJK#\/4:E&=1XF,G&<(6CS6?,VMW#1Z::6T;?2ZJYI4C.,52:3C*6MM+6Z*6W
M?K^-OLGPIXKTKQQX?L]<T2[%]I=XI:"X",F\!BI^5@".01R.U:U?)=K\9O$N
MF_"WX0^&_##:=I_B7Q86C-X+*.."TC$VW<L**(QDL3PN/E;C)!KK?"_CCQ_X
M#_: TCX>^+O$-KXOL-;L9+JUOTL([26(HLC8*IQ_RQ88YZJ<CD5SXCARO3]K
M*$XI1]HU%M\SA3;3?P\NEGNTW9M(TI9K3ER*47KRIM)64I)-+>_7SMU9]#T5
M\4>&?BQ\9?$WP1UOX@CQM8VMOHMP8_LO]E0-+=X*%@[;-J "08VC)P<XX-?5
MOPK\73^//ASX=\074*07.H64<\L<?W0Y'S8]LYQ7)FF0XC*H.=2<9)2<'RMZ
M22O9W2Z=K^>IO@\RI8R2C"+5US*]M5>W1OKW.0UO]JKX6^'=9O\ 2M0\4?9[
M^QGDM;B'^S[IMDB,59<K$0<$$9!(KT[2=4M=<TNSU&RE\^RO(4N()-I7?&ZA
ME." 1D$<$9KY&^#OBKQCX;^*WQG7PKX&_P"$Q2;Q%,;AO[7AL?LY$]QM&) =
MV[+=.FWWKLOBA\0?B3<?'CPIX'\,:K;^&QK&AI=W,=S;Q70M9=\YE<,5R[*L
M6T#.TD>^:]K&\.TE76&PLE&T>=RG4B]%!2?N1CS1M?3FO=;'!A\TFZ;JUE>[
MY4HQ:UYFE[S=I;=-CZ2HKY(^)WQZ\3>#_'FG> K[Q[:^&#IUA')JOBAM%^UO
M=7#*& 2W52J@J5Z #[W/ !IZ/^UYKUG\&?%NHW$MIK>NZ7J<6FV.K);F*&Z6
M42%)FBPI!"Q.V,#JH('.>:/".8U*,*].TE/EM\6TG:+NXJ-GO:_,DTVD:O/,
M)&I*G*Z<;WVW2NU9._X6;V9]AT5\=?#O]I;74^)G@[29O'MI\0;#79!;7MO%
MHQL&TZ9R NQS&OF+N;KSD*V0."?L6O&S7)\3D]2$,1]I75N9=6MI*,EMU7FK
MH[\%CJ6.C*5+H[/;UW3:_$^9_P!E7_DLGQ\_[#P_]*+VOIBOF?\ 95_Y+)\?
M/^P\/_2B]KZ8KOXH_P"1K/\ PT__ $W YLG_ -SCZS_]+D%%%%?*'M!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7YD?M(_%+X]>,/CAXK\+ZWX*^*P^$VG7K6]I9_#?0I87U
M:%2,/)?[&8HPZJGRD-C@C-?IO7CEQ^V/\#;6XE@F^+'A&.:-BCHVK0Y5@<$'
MYO6@#YM_9Y^..G?"V^TGPKX,_9 ^(_@FRU*[@M+G5IM#FRH=U4S7-PZ;W5<[
MB7;@ ]*^]:\CTG]KKX*:YJEGING_ !3\*7E_>3);V]O#JL3/+([!511GDDD
M?6O7* &NBR(R.H96&"K#((]*XC5/@[\-?-DU+4?!'A3S=P9[NZTFVSG@ EV3
MKT'7TKN:_+G0_P!GKXG_ !2\30_"SXE^#->LOA[H/B'6/%7BGQ+#+(Y\4.Q8
MVBP;>6.W"A$W, W16&" ?I[IMG::?8P6]A!#;64:XBBMD"1JO4;0. /I5FOG
M[]@KPWXK\(_LJ^"=)\8VFHZ?JMNMRL5EJZLMY;VIN93;QS*0"K"(H-O\(VC
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M[A)=F9K?&=I.,X/7T->[U>81E#!X2,E9VE_Z6Q8:2E7KM/JO_24%>'?ML?\
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MTE(QIR17'GL-HDS*7. 2S#  QP,5K_\ #;'P7_Z'/_REWO\ \9H_X;8^"_\
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M9G3/LVWR-B0KN\S>=V?)Z;1][KQ7.?\ #;'P7_Z'/_REWO\ \9H_X;8^"_\
MT.?_ )2[W_XS3E2Q\I3FZ<KRT?NO7\/(2J8.,8Q4U:.VO_!&^)/V;M5C^(FL
M>,? 7CZ[\":AK2K_ &G NG17T,[ ??"NP"GOWP22,9JQXJ_9G3QI\.](T/6/
M&&L7_B+2KTZC9^)IR&N(IRV>$S@)TPH/&U<'BH?^&V/@O_T.?_E+O?\ XS1_
MPVQ\%_\ H<__ "EWO_QFM+9C[O[N5UL^773SM=_,B^"U]]:_WM/NOH=!\._A
M;XR\-^)!J_BOXGZEXQ\NW:WAL5L8["V&<?.Z(3O88X)YY->HUX=_PVQ\%_\
MH<__ "EWO_QFC_AMCX+_ /0Y_P#E+O?_ (S7/4PV,JRYI4G\HV_!(VA7PU-6
MC47_ (%?\V</_P $Y/\ DB.M_P#8Q3_^DUM7U37RM_P3D_Y(CK?_ &,4_P#Z
M36U?5-5FG^^5/46 _P!VAZ!7&?&K_DC?CS_L W__ *3R5V=<9\:O^2-^//\
ML W_ /Z3R5C@/][H_P"*/YHVQ/\  GZ/\CC/V//^3<_"/_;W_P"EDU;/Q ^"
MX\=?$WP9XO\ [8^Q'PXY?[']F\S[1E@V-^\;.GH:\:_9M_:2^'/@'X*^'=!U
M[Q%]@U:T^T^=;_8;F3;NN977YDC*G*LIX/>O3/\ AL+X0_\ 0W?^4V\_^,U]
MGF&7YU0S?%8C"8>I[TZEFH-IQDY)VT:LT]_N/!PN*P%3 T:5>K'2,=.9+5)>
M?1FU\/\ X+CP+\3O&?B\:P;W_A(W#_8_LWE_9\,6QOWG?U]!7S;\:OA_8_!G
MX'VGPPM]8F\0^(M6UI=3M(8[!XF>/;L(&"RY!4?Q9.[ICFO>/^&POA#_ -#=
M_P"4V\_^,T?\-A?"'_H;O_*;>?\ QFML#4X@PN)6(K82K-+D=N1QNZ::AKR/
M17UM:_5WU,\3'+*U%TJ=>$7[VO,G;F=Y?:Z_@-\6?L^7/B#6_#OBG0O$UQX-
M\7:=81V4MY!;)=1RJJXPT;$ ]QR2",<<5<F^ <_B3P#X@\.^,_&&I>*[G5Y$
MF^W2QI"MHZ<H8(1E4YZ@'!''%5?^&POA#_T-W_E-O/\ XS1_PV%\(?\ H;O_
M "FWG_QFN#V?$O+"*P]3W+6?LO>5G=)2Y>:R>RO8Z>;*;R?M8^]O[^CNK/2]
MKVZVN7?AQ\&?$?A&:"'7_B'?^*=&M;%["VTIK-;6(1L ,R%78R$*" 6.1G@U
MR_A7]EG4/"O@_P 3^$H_'EQ<>&=6M9X;>PDTU!]EED:,^<7#YD($>-ORCYB>
M":V_^&POA#_T-W_E-O/_ (S1_P -A?"'_H;O_*;>?_&:NW$RE*2P\US--_N;
M*\6VFER63NWJK-WU)_X2+).K'2Z_B='HU?FU6FS*>K_LNV^J?#KP7H,?B2YL
M-<\)LTFG:Y;6X!5V<,28BW3*I_%U4<]JU/ GP$N]%^(7_"<>+?%]UXT\20P&
MVM)I+1+2&VC(8-MC4D9PS=,#YFX).17_ .&POA#_ -#=_P"4V\_^,T?\-A?"
M'_H;O_*;>?\ QFE*/$\Z4Z,J%2TN:_[K7WG>23Y;I2>K2:3[#B\HC-352-U;
M[>FBLM+V;2V;U*OA?]F=?#7P-\0?#G_A(S<C5IWF_M+[%M\K=Y?'E^8=V/+_
M +PZUZ9\.?!__"O_  +HGAP7?V_^S;9;?[3Y?E^9C^+;DX^F37GO_#87PA_Z
M&[_RFWG_ ,9H_P"&POA#_P!#=_Y3;S_XS7-BL+Q%C8RC7P]1J4N=_NVO>M:^
MD>W3;R-:-;*L.TZ56"LN5>^MM[;F_P#"WX/#X:>*/'6L_P!K?VC_ ,)1J1U#
MR?LWE?9LO*^S=O;?_K<9PO3IS1K'P>&K?'/0OB-_:WE'2]-;3_[-^S9\W/G?
M/YF_C_7=-I^[UYK _P"&POA#_P!#=_Y3;S_XS1_PV%\(?^AN_P#*;>?_ !FB
M6%XBE6G7>'J<TX\K?LWK'EY;?#;96OO\QJME:IQI*K"T7=>^M[WOOW+7Q#^
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M]"?M_?\ )V_CO_MP_P#2"WKY[K[W#?P(>B_(^0K_ ,6?J_S"BBBN@Q"BBB@
MHHHH **** "BBB@ HHHH **** "OV,_8!_Y-(\"?]O\ _P"E]Q7XYU^QG[ /
M_)I'@3_M_P#_ $ON*\7-OX"]?T9ZF7?Q7Z?JCZ$HHHKY0^A"FLJR*RLH96&"
MI&01Z4ZB@#._X1O2?^@79?\ @.G^%'_"-Z3_ - NR_\  =/\*T:*U]K4_F?W
MD<D>QG?\(WI/_0+LO_ =/\*/^$;TG_H%V7_@.G^%:-%'M:G\S^\.2/8SO^$;
MTG_H%V7_ (#I_A1_PC>D_P#0+LO_  '3_"M&BCVM3^9_>')'L9W_  C>D_\
M0+LO_ =/\*/^$;TG_H%V7_@.G^%7IIDMX7ED;9&BEF8]@!DFN)D^)K,)9K;1
M[B>SC.&N-Q 'UPI _.NBC#$U[^S;=O,RG*E3^+\CJ/\ A&])_P"@79?^ Z?X
M4?\ "-Z3_P! NR_\!T_PIVAZS!KVG1WEON"-D%6ZJ1U!KFU^)$4VNQV$-F98
M9)U@6X\W .2!D#;TY]:<*>)J.48WO'?4)2I12;MJ=%_PC>D_] NR_P# =/\
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M1L)UVS6MW$LL4@SG#*P((R!U%7**P3:=T:[Z,X;_ (45\-?^B>^%?_!);?\
MQ%'_  HKX:_]$]\*_P#@DMO_ (BNYHK;V]7^=_>S+V5/^5?<<-_PHKX:_P#1
M/?"O_@DMO_B*/^%%?#7_ *)[X5_\$EM_\17<T4>WJ_SO[V'LJ?\ *ON.&_X4
M5\-?^B>^%?\ P26W_P 11_PHKX:_]$]\*_\ @DMO_B*[FBCV]7^=_>P]E3_E
M7W'#?\**^&O_ $3WPK_X)+;_ .(H_P"%%?#7_HGOA7_P26W_ ,17<U\XZY^V
M(IUK4[7PIX(U+Q78Z;G[1?P2LB*H."^%B?"<'#,179AJ6,Q;:HMNV^MOQ;1R
MUZF&PR3JV5_*_P"2/5?^%%?#7_HGOA7_ ,$EM_\ $4?\**^&O_1/?"O_ ()+
M;_XBH?@S\9-+^,_AR;4M/MYK&XMI?)N;.8AC&Q&00P^\I'0\=#Q7G/Q9_:_L
M/AOXRNM L?#[:^;/:EU=+>B%8Y3DF,#RVR0.O(YR,<5K3PN/JUI8>"?/'=7_
M .#8B>(P=.DJTFN5[.W_  #TS_A17PU_Z)[X5_\ !);?_$4?\**^&O\ T3WP
MK_X)+;_XBL;X@_'#_A#YO"^FZ;H,OB#Q%XA026NF1W*P!5(!RTC @<G'3^$Y
MQ5[X2_&*V^)FE:S-=:;)X=U'1;EK;4;*ZE#>0R@Y)? &/E8'(&-IK)T<9&E[
M=M\OKYVVO>U]+VL6JF%=3V2MS>GSWM;8M_\ "BOAK_T3WPK_ ."2V_\ B*/^
M%%?#7_HGOA7_ ,$EM_\ $54^%OQ:;XK:AK<VG:,\'ANQF^SVVL2S\WKC[VR/
M9PH'?<>HXZX]$K"L\10FZ=2337F;4U1JQYX)->APW_"BOAK_ -$]\*_^"2V_
M^(H_X45\-?\ HGOA7_P26W_Q%=S167MZO\[^]FGLJ?\ *ON.&_X45\-?^B>^
M%?\ P26W_P 11_PHKX:_]$]\*_\ @DMO_B*[FBCV]7^=_>P]E3_E7W&9X?\
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M5^'O_0A^&?\ P3V__P 179T5R?7\7_S^E_X$_P#,V^K4/Y%]R.,_X4K\/?\
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M10 4444 %%%% !7[&?L _P#)I'@3_M__ /2^XK\<Z_8S]@'_ )-(\"?]O_\
MZ7W%>+FW\!>OZ,]3+OXK]/U1]"4445\H?0A1110 4444 %%%% !1110!7U".
M&;3[F.X;9 T3+(V<84@Y/Y5Y+:ZCJECH>HVM@C7.CLS(UT82" >#CZCKZ9[5
MZKK6G_VMI-U9[MAFC*AO0]OUKAK/2_%NEZ7+I,%I;R6S;E$V]<@-UQEA[]1W
MKV\#.$:<E)J]UHW9>OJ>?B8R<E9/9["7&M6>C^![6UTN5FDO"T9DD^4J>-Y/
MIU ^AS6;>Q:?I>L^&XK:[MYHX6C:>:.164-Y@+$GM^/85U>B?#^SAT:&VU2)
M;J99&E^5V4(6"@@$$9X45F:U\/4_MO3O[/L/^)=N7[3^^/3=SU;/3TKKI8C#
M*;AS/>3;TL_Z6QC*E5Y5*W;Y&MJ7A^_GUB35M(N;4_:K?RG\_)4J0,,I&<\
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M_0Q7Z1@\BP=;"0K33NXWW/B,3FV)I8F5*+5D[;'ZOT445^;GVX4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMWI=GNO[V>\NY!EO,E9U3V )_6MNOS^I%1DXQ=UW/IHMR5VK!1116904444
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MP8_M&;P39?$'4+_5+72M+T+484DMYKR9BL1<,#P,-C R3@9&<@ ^.?AGIO\
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M$'QK\!_%#5K_ $#PI%\3O FI6=N+'2K;4;33;O1[M PEW/,%$L4N5;.YF4C
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M=8B4?>7]?>%%%%>:=P4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!A>-O!.C_$+PW>:%KMFMYI]RN&4\,C=G4_PL#R"*^5_AY^PG_9?Q&O+
MCQ->1:CX5L90]E"AP]]W E'\(7HP_B/3BOL6BOH,OS[,,KH5</A:G+&>_EYK
ML[:7_5)KS,5EN%QE2%6M"[C_ %9]U_7<CAACM88X88UBBC4(D:* JJ!@  =
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MK<-@Z1W)%M- 8V8$KE944\[3T':N\IRBXNTE9BA.-2*E!W3[!1114EA1110
M4444 %%%% !1110 4444 %%%% !1110 5Y+^T9\?)?@'X1EUBV\$Z_XUF2RO
M+]X])B"VUK#;1B262YN&^6%=IXX9FPVU6P:]:KRS]JS_ )-=^,/_ &)VL?\
MI%-0 O[,7QP'[1_P-\-?$4:+_P (]_;/VG_B6_:OM/D^3<RP?ZS8F[/E;ONC
M&[';-9_[2W[2ND_LW^&]&N;C2;SQ+XB\0:@FE:'X?T\A9K^Y<@!=QX102H)P
M>64 '->;_P#!,Z\@T_\ 80^'=U=31VUM FJ2RS3.$2-%U*[+,S'@  $DFG?M
M3_"%?VI]!^&?C#X8>/?#<?B'PKK@U?P_?7%PMUIM]*C*QC+Q%LX>%#\H;[K
MCG( -CX'_M>7WQ ^+VI_"KQ_\/+SX7?$"VL5U.WTV?4HM1@N[8XRR3QJJEAG
M. ".&YRI%?2%?G#\+X?B%XV_X*?:->^-M4\*:YKWAGP?,NK'P7',+#3E8SK'
M;LTQ+M+FX5SG!Q)C'RU^CU !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%8OC#QKX?^'OA^YUWQ/K5AX?T:V&9K[4KA((4ST!9B!D] .I/ H
MVJ*\]^#/Q^\ _M":)J.L?#[Q OB+3=/O&L+FX2UG@"3!58J!*BEAM=3N7*G/
M!KT"21(8VDD941069F.  .I)H =17A/A?]N7X%^-OB1:^ M!^(5CJWBBZF-O
M;VMI;7#Q32#)VI<"/R6Z'H_->[4 %%%% !1110 4444 %%%% !1110 4444
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MF?R+RU\R-D\V"3!V2KNW*V#A@#CB@#YK_:(_Y/L_9&_[F[_TUQ5]55\ :I\
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MX\>3Y\JNS3A % #8P%VC"DK7V70 4444 %%%% !1110 4444 %%%% !1110
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M?3M?DGXKU:Y\*^$_A=;ZQX$\=6'BP^+FU_7-0UK1#;_VK=/(A,=L6;=(P55
M4A<DD\;J_5W0=6_M[0].U/['=Z=]MMH[G['?Q>5<0;U#>7*F3M=<X9<\$$5I
MBJ,:48\J[_,PR_%5,1.HJC[-*VU^A?HHHKSSVPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\$_;;TOX5:C\!=0F^,<M[%X-L;N"Z(TZ1UN'N,E(
MD0+RQ)<\'CN< 9'O=>'?MA?!W6OC/\*;&Q\-K8SZ]HFNV&O6=IJ4GEVUTUO+
MEHI&P=JLC/S@\@4 ?GG\'[S]B+4/BQX.@\+^'OB-+XD;5[7^SA,2T8N!*IC9
MP)2=H8 GCH#7Z^U^=.J?LZ_%?Q/^T1=Q>%HO#E_\+KWXBV7CZ?Q5;:C%+=Z=
M<1HOGVH59-^XY*C"8("Y8!B!^BU !1110 4444 %%%% !1110 4444 ?*O[1
M'_)]G[(W_<W?^FN*OJJOE7]HC_D^S]D;_N;O_37%7U50 4444 %%%% !1110
M 4444 ?CG^W]_P G;^._^W#_ -(+>OGNOH3]O[_D[?QW_P!N'_I!;U\]U][A
MOX$/1?D?(5_XL_5_F%%%%=!B%%%% !1110 4444 %%%% !1110 4444 %?L9
M^P#_ ,FD>!/^W_\ ]+[BOQSK]C/V ?\ DTCP)_V__P#I?<5XN;?P%Z_HSU,N
M_BOT_5'T)1117RA]"%%%% !29KSOXN?\PK_MK_[)7GE>[ALK^L4E5Y[7\O/U
M/.K8SV4W#EO;S/H?-&:^>**ZO[%_Z>?A_P $Q_M#^[^/_ /H?-&:^>**/[%_
MZ>?A_P $/[0_N_C_ , ^A\T9KYXHH_L7_IY^'_!#^T/[OX_\ ^A\T9KYXHH_
ML7_IY^'_  0_M#^[^/\ P#Z'S1FOGBBC^Q?^GGX?\$/[0_N_C_P#Z'S1FOGB
MBC^Q?^GGX?\ !#^T/[OX_P# /H?-&:^>**/[%_Z>?A_P0_M#^[^/_ /H?-+7
MSO7JOPK_ .1=G_Z^F_\ 0$KCQ>6_5:7M.>_R_P""=%'%>VGR\MCLZ***\0[P
MHHHH \8_:K_Y)[IW_84C_P#14M?*U?5/[5?_ "3W3O\ L*1_^BI:^5J_:>%?
M^1:O5GP&<_[V_1!1117UYX84444 %%%% !1110 4444 %%%% !1110 5]$_L
MC_=\5?6U_P#:U?.U?1/[(_W?%7UM?_:U?,\2?\BJM_V[_P"E(]?*?]]A\_R9
M]#T445^&GZ(%%%% "4;AZBO(OVM/^3?_ !1];7_TJAK\ZJ^HRO)/[2HNM[3E
ML[;7Z)]UW/ S#-?J-54^2]U?>W?R?8_7+</44;AZBOR-HKV/]4_^G_\ Y+_]
ML>;_ *Q?].O_ ";_ (!^N6X>HHW#U%?D;11_JG_T_P#_ "7_ .V#_6+_ *=?
M^3?\ _7+</44;AZBOR-HH_U3_P"G_P#Y+_\ ;!_K%_TZ_P#)O^ ?KEN'J*-P
M]17Y&T4?ZI_]/_\ R7_[8/\ 6+_IU_Y-_P  _7+</44;AZBOR-HH_P!4_P#I
M_P#^2_\ VP?ZQ?\ 3K_R;_@'ZY;AZBC</45^1M%'^J?_ $__ /)?_M@_UB_Z
M=?\ DW_ /URW#U%&X>HK\C:*/]4_^G__ )+_ /;!_K%_TZ_\F_X!^N6X>HHW
M ]#7Y&UZ]^R7_P E_P##'TNO_266N?$<,_5Z,ZWMK\J;^'LK]S:CGOMJL:?L
MK<S2W[_(_16BBBOASZL**** "BD)V@D]*\9_X;$^$7_0V'_P6W?_ ,:KOPN
MQ>.YOJM&52V_+%NU]KV1S5L30P]O;34;[7:7YGL]%>,?\-B?"+_H;#_X+;O_
M .-4?\-B?"+_ *&P_P#@MN__ (U7=_8.;_\ 0)4_\ E_D<_]I8'_ )_P_P#
ME_F>ST5XQ_PV)\(O^AL/_@MN_P#XU1_PV)\(O^AL/_@MN_\ XU1_8.;_ /0)
M4_\  )?Y!_:6!_Y_P_\  E_F>SUG>(O#]AXL\/ZIH>JV_P!JTO4[66RNX-[)
MYD,B%'7<I##*L1D$$9X->4_\-B?"+_H;#_X+;O\ ^-4?\-B?"+_H;#_X+;O_
M .-4_P"P<W6JPE3_ , E_D)YC@6K.M#_ ,"7^9F:1^PK\#]!U:RU.Q\$>1>V
M<Z7,$O\ :U\VR1&#*V#.0<$#@C%>C^'O@]X/\*>/M=\:Z5HL=GXFUQ!'J%\L
MTK&900?N%BBY*J3M49QS7%_\-B?"+_H;#_X+;O\ ^-4?\-B?"+_H;#_X+;O_
M .-5I+)L[E\6&JO_ +<G_D<\,3E=/X)TUZ.)W/C[X3>%/BA-H<OB?21J<FB7
MBW^GL9Y8O)G4@AOD9=W0<-D<=*ZZO&/^&Q/A%_T-A_\ !;=__&J/^&Q/A%_T
M-A_\%MW_ /&JS_L+.&DGA*FG]R7^1LLPP";DJT+O^]'_ #/9Z*\8_P"&Q/A%
M_P!#8?\ P6W?_P :H_X;$^$7_0V'_P %MW_\:I?V#F__ $"5/_ )?Y%_VE@?
M^?\ #_P)?YGL]%>,?\-B?"+_ *&P_P#@MN__ (U1_P -B?"+_H;#_P""V[_^
M-4?V#F__ $"5/_ )?Y!_:6!_Y_P_\"7^9[/17C'_  V)\(O^AL/_ (+;O_XU
M5[0_VJOA=XCUJPTG3O$QN+^^GCMK>'^S[I=\CL%5<M$ ,DCDD"IED>:PBY2P
MM1)?W)?Y#68X*3LJT;_XE_F>LT445XAZ 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?
M+O\ P4>DU&/]F:[\B348?#[:O8+XEDTH-]H72#,/M)7'/]W/;&<\9KZBK\Y?
MB9_P4+^+EG^T!XV^&7A?P/X'NX](U&33K=/$FLQ:?+=IT4_Z1<Q*Y<'("@Y#
M#KU(!X!\&_%/P_;QAH7@OX32W%WK:_&FWU;PT(8IS)%H8@5+B2221<B-HQAU
M8[B$)(P*_9FO@CX1W/[2OA?QUIEU;?LK_#7P=I^I7D*:MK.ASV$,XMGD7S9,
MQ76YR%RV,-D@<&OO>@ HHHH **** "BBB@ KP[]I[]K?PA^S#X<FFU,2ZYXI
MEM)+O3_#-ADW-TB!BTC$*PBA4*Q:5A@!6P&(P?<:\,_;.T73_P#AF7XN:M]@
MMO[4_P"$3O;;[=Y*^?Y0C=A'OQNV[B3MSC))H ]ITJ^_M/2[.\V>7]HA279G
M.W<H.,]^M6JR_"O_ "+&C_\ 7G#_ .@"F^+/[<_X176?^$9_L\>)/L4W]F?V
MMO\ L?VKRV\GS_+^?R]^W=M^;;G'- 'S7^T1_P GV?LC?]S=_P"FN*OJJO@#
M5%^-R_MV?LP_\+D;P"W_ "-']E?\(.+T?\PL>=Y_VG_MEMV_[>>U??\ 0 44
M44 %%%% !1110 4444 ?CG^W]_R=OX[_ .W#_P!(+>OGNOH3]O[_ ).W\=_]
MN'_I!;U\]U][AOX$/1?D?(5_XL_5_F%%%%=!B%%%% !1110 4444 %%%% !1
M110 4444 %?L9^P#_P FD>!/^W__ -+[BOQSK]C/V ?^32/ G_;_ /\ I?<5
MXN;?P%Z_HSU,N_BOT_5'T)1117RA]"%%%% 'G7Q<_P"85_VU_P#9*\\KT/XN
M?\PK_MK_ .R5YY7W66_[I#Y_FSYW%_QI?UT"BBBO3.0**** "BBB@ HHHH *
M*** "BBB@ HHHH *]5^%?_(NS_\ 7TW_ * E>55ZK\*_^1=G_P"OIO\ T!*\
M?-O]V?JCNP7\4[.BBBOBCWPHHHH \8_:K_Y)[IW_ &%(_P#T5+7RM7U3^U7_
M ,D]T[_L*1_^BI:^5J_:>%?^1:O5GP&<_P"]OT04445]>>&%%%% !1110 44
M44 %%%% !1110 4444 %?1/[(_W?%7UM?_:U?.U?1/[(_P!WQ5];7_VM7S/$
MG_(JK?\ ;O\ Z4CU\I_WV'S_ "9]#T445^&GZ(%%%% 'D/[6G_)O_BCZVO\
MZ50U^=5?HK^UI_R;_P"*/K:_^E4-?G57ZAPO_N4_\3_*)\#G_P#O4?\ "OS8
M4445]@?-!1110 4444 %%%% !1110 4444 %%%% !7KW[)?_ "7_ ,,?2Z_]
M)9:\AKU[]DO_ )+_ .&/I=?^DLM>?F/^Y5O\,OR9VX+_ 'JE_B7YGZ*T445^
M'GZL%%%% #9/]6WT-?C77[*2?ZMOH:_&NOW/PQVQG_</_P!O/SGB_P#Y<?\
M;W_MH4445^Y'YT%%%% !1110 4444 %%%% !1110 4444 %=K\$O^2R^!/\
ML.V/_H]*XJNU^"7_ "67P)_V';'_ -'I7!F'^YUO\,OR9U87^/3]5^9^L-%%
M%?Q2?T"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7Q=^V!\?/V8[C5;CP9X[\,Q_%+Q
MK"QMET/0M,:XU*&3'W!<*4,1]563</[M?:-?%GC;_@FA8^)OBMXM\=:-\6_&
M7@^_\1WLE[<PZ+*L(#.VXKN4J64$G&: / _V9?@?^T=8_%?2M9^'FF^)O@]\
M(A>P2S>'_&FNB[#VHD!E1+5XMR,R9QNC!!;_ %G<?J?7QKX1_P"">.K>%?%F
MBZT_[0?Q)U)--O8;PV5UJ+F*X$<BOY;C?RK8P?8U]E4 %%%% !1110 4444
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M?_<I_P")_E$^!S__ 'J/^%?FPHHHK[ ^:"BBB@ HHHH **** "BBB@ HHHH
M**** "O7OV2_^2_^&/I=?^DLM>0UZ]^R7_R7_P ,?2Z_])9:\_,?]RK?X9?D
MSMP7^]4O\2_,_16BBBOP\_5@HHHH ;)_JV^AK\:Z_923_5M]#7XUU^Y^&.V,
M_P"X?_MY^<\7_P#+C_M[_P!M"BBBOW(_.@HHHH **** "BBB@ HHHH ****
M"BBB@ KM?@E_R67P)_V';'_T>E<57:_!+_DLO@3_ +#MC_Z/2N#,/]SK?X9?
MDSJPO\>GZK\S]8:***_BD_H$**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_JW+]H#_ ,(;_P"WU\X>V?55%?*O_#?7_5N7[0'_ (0W_P!OH_X;Z_ZMR_:
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M5O\ HWKXY_\ A%/_ /':/KV&_G0?5ZO\I[O17A'_  U)JW_1O7QS_P#"*?\
M^.T?\-2:M_T;U\<__"*?_P".T?7L-_.@^KU?Y3W>BO"/^&I-6_Z-Z^.?_A%/
M_P#':/\ AJ35O^C>OCG_ .$4_P#\=H^O8;^=!]7J_P I[O7JOPK_ .1=G_Z^
MF_\ 0$KXS_X:DU;_ *-Z^.?_ (13_P#QVNU\%?MM7'AO2I;:Y_9U^/;R-,9
M8O!!(P54=YAZ5Y>98JC5H<L)7=T=F%HU(5+R5C[*HKY5_P"&^O\ JW+]H#_P
MAO\ [?1_PWU_U;E^T!_X0W_V^OE#V3ZJHKY5_P"&^O\ JW+]H#_PAO\ [?1_
MPWU_U;E^T!_X0W_V^@#T/]JO_DGNG?\ 84C_ /14M?*U=-\:_P!KK4?B1X6M
M--TS]GCX[03Q7JW#-=^"65=H1UP-LK'.6';UKQ7_ (6AXL_Z(%\9O_"-F_\
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M]FXS_GVS?HK _M+Q[_T0CXN_^$?<?XT?VEX]_P"B$?%W_P (^X_QH_MC ?\
M/Y!_9N,_Y]LWZ*P/[2\>_P#1"/B[_P"$?<?XT?VEX]_Z(1\7?_"/N/\ &C^V
M,!_S^0?V;C/^?;-^BL#^TO'O_1"/B[_X1]Q_C1_:7CW_ *(1\7?_  C[C_&C
M^V,!_P _D']FXS_GVS?HK _M+Q[_ -$(^+O_ (1]Q_C1_:7CW_HA'Q=_\(^X
M_P :/[8P'_/Y!_9N,_Y]LWZ*P/[2\>_]$(^+O_A'W'^-']I>/?\ HA'Q=_\
M"/N/\:/[8P'_ #^0?V;C/^?;-^BL#^TO'O\ T0CXN_\ A'W'^-']I>/?^B$?
M%W_PC[C_ !H_MC ?\_D']FXS_GVS?KU[]DO_ )+_ .&/I=?^DLM>!?VEX]_Z
M(1\7?_"/N/\ &N[^!_Q,\6_#/XH:-XCU3X!?&:>QLQ-YD=IX-F:4[X7C& S*
M.K#OTS7%CLUP53"U80JIMQ:7W'5A<OQ4,13E*FTDU^9^J]%?*O\ PWU_U;E^
MT!_X0W_V^C_AOK_JW+]H#_PAO_M]?DA^C'U517RK_P -]?\ 5N7[0'_A#?\
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M3X;Z#\(_!.F>%/#5HUGI&GHRQK)(9)'9F+R22.>6=W9F9CU+&NGHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M52CUS3I-:FT=+^U?5H+>.[EL%F4SQPNSHDK1YW!&:.10Q&"48#H:NT %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@%^SS>'3/%&KRW\M]I]OJ?BS6KV2\FLTN;JWM[S4<3%XX%CB:281HJP1D$A
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M'!'3CFMKP;X\\,_$72#JOA3Q%I/B?2Q*T)OM&OHKN 2* 63?&Q7< 1D9SR*
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M^'7@'3_AGX3MM!TV:ZNXXY9[J>]OG5[B[N9Y7FN+B5E55+R2R2.=JJH+855
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M#O@GQ[KUQ<P-X@\57'ABVATFTME6SMTOXXI7MI+R3?>?($D>,",E<.*^WZ*
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MH\4Z+X1ATWQ1XWU6PM]4NM-G-C]O$&EVKR1LLD"I!;2RD(RL'5API<-]Q44
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M1QJ6).%3"[=S[NEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6:V&^48:>XW ;4)[K7OB5\1+WXA:IJ^G>+VL_#-O\1=+\(Z3X=AL;1DO8?\
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M==)U[P1X<UO2UO)=16QU'2;>X@%U*SO+.$="OF.TDC,^-S%V))R: /F3Q/\
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M4H[AI!\S>8^2=QR ==1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO[."339;2:[9HYQ<S1GR9#=APT/F,"CY0_+G)U:S^)_A+QY\4IM"\#S:Y?\
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MY4D^]4?C<5YT=2^%/CR\O(/B5/H'VGQ WCBW\3S>#4OH#,--BTU].BMA*S"
MW*"0W1'F"+S2RB0@+)7U%10!\M6R?%GP;)X[\5^%? /BZYN/$%U8V6F^&O$G
MBBWU)]+"^<]WJ0BEU)H A,RJMM#<1[_(1?W*DN'Z;\/-<\)Q_#CQ3IOP[\4Z
MO>Z3K&IZAK>FZE?:5_;5Y>W5HT)U)F6[%H<@M'L69=D<BJB!4"CZBHH ^2-2
M\._%G1-"G\/?\(+K-Y;>-;R[\0>+]6\)7^F"XM?/<(NE6S75W;D.+>..-[P
MD!?W0#N'@D^,?[-_C_Q)!:CP;?Z#I^@W%OI6@67AW4?#_FS>&](62V:[B29-
M12)T;R 9%2,M(J1QA\(KCZSHH CMUE6",3NDDP4!WC0HK-CDA23@9[9/U-24
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>advm-20241231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +'!0<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#AZ<M-IR]*
M_H21_,:%HHH%82#J.HHHKGD,<M+2+2USR&%.'2FTZN>0!2KUI*<M<\A]1*=3
M:=6$AA2K24Y:YY +1116# ****S&API:**@04445 T%%%%2-!1114#'-TI%H
M:E7I4LE!1114%!1114L I124J]:E@.HHHJ& TT+UI*5:E@.HHHK-@%%%%)@%
M%%%9L I5I*5:E@.HHHJ0"BBB@ HHHH ****&4%%%%2 4444 %%%% !11128T
M%.IHIU2-A1110)!11104%%%%)@%%%%2 4444 %%%% !1110 J]:=35IU!2"B
MBBI$%%%% @HHHH&@HHHH*"BBB@ HHHH ?1114#04444#"BBB@ HHHJ6)!111
M2&% HH7K0 ZBBBI8QR]*6BBLV6A1UIU-7K3JAE!110*D:'4445#*04^F4^LV
M4%%%%0-#EZ4M(*6H904JTE.7I4,H****AE(<O2EH%%0QBK2TBTM9E"TZFTZH
M*04Y:;3EJ&4+3AVIM.K.10Y>M+2+2U@S5#Q2K24JUC(M#J=3:=6$C1#EIRTU
M:<M8,T0Y>M.6D6G+VK"1HAU/IE/K"1H"]:=2+3JQD:(=2K24Y:P9:%IU-IU8
M,T'+3E[TU>E/7I6$C1#EIPZTU:<*Q9HA5I]-7M3JPD:(<M%"T5@S0\+IU-I]
M?W](_($%"]:*5:YY#/4?V=/A9IGQ@^(@T'5KJ[M+);26Y9[)E60E2H !96 ^
M]Z=J7]HSX6:7\'_B)_8.D7-W=6;6<5R'O65I 6+ C*JHQ\OI79?L.?\ );'_
M .P7<?\ H4==)^T[XBT_PG^U'H>JZMI=OK6F6]C;_:K&ZA65)8F,JM\C<%@"
M2,_Q 5\K4Q-:.9NDG>/)>WF?74\'AY9,J\DE)U+<W9'RTO2EK[A^.'[,>D?$
MC_A$=9\ V6G:=:74L<5VVF0I%"UI)AA<@+A25&>@RP8>E<E^U-HGA3P__P (
MM\-O!_AK1X/$%])"LEY':1K<*I(CB5I=NXEV.22<X7G[U13S:EB'",$[RO?^
M[;N98CA^OA8U:E22Y8VL_P"9O9(^2Z?7W5J'P_\ A!^S'X+L)_%6D0>(=3NO
MDWW-HEU-<R 9<QQR'8BC/MU7))Q4J_#+X4?M+?#V[O\ PAI-MH&H1$QQS6MH
MMK);3[0P66-/E=3D9Z\$X(/-<KSB#]_DER7MS=#?_5NM?V7M8^UM?DOK_P /
M_6VI\'TX=ZEO+.?3;R>TN8VAN8)&BEC;JK*<$'Z$5Z#^SQ=Z-;?%_P .Q>(-
M/L]3TJ\G-G)#?0":/=(I2-MI!'#E>2.!GZUZ=:?)!S2O97/F:%+VU:-)NUVE
M=]+GG ZTZOI']M3X7Z;X)\3Z%J^AZ9;:7IFH6[P26]C;K%"LT9SNPH !97'U
MV$^M=[XJ^'OA7X5?LGI=:GX;TR;Q+=6"1_:KJUC:Z6YN.>)"-P,89L8/ CKR
M7CX.G3G%7YW9(]S^Q*T:]>C.22I*[?3NOO/C&G+7VGX1^$?P[^ ?PKM/%7Q"
MTZ'6-4NUC+QW4 N LCKN6WBB8["P .6/HQR!Q6E;^ /A5^TU\/\ 4KOPAH</
MAW5;4M'$\-HEI)#-MRHD2,E'1L#UXS@@UR2S&%VU%\M[7Z'3'AVM**@ZD55:
MNH7UM_F?#=%?0G[*O[/]E\3M6U/5?$L,K:/I4@@^PY*>?.1DJY!# (,$@8)+
M#G (/JUYX\_9WU3Q%=>$+CP[IEFBLUL=6738X(-^=I"SKAUP<_.0%XSNQS2J
MXQ1FZ<8N5M[=#FPV2SK4(UZM6--2TCS/?_(^):]?_9I^#.F_&CQ9J5AJ]W=6
MFGV5GYY-BZK*SEU51EE8;<%L\9Z5YAXBM;2P\0:G;6$WVBQANI8[>8,&WQAR
M%;(X.0 <BOI+]@G_ )'7Q/\ ]@]/_1@IXJI*%"4XZ,PR?#PK9A3HUE=-Z_),
MF^.O[(^C> /A_>>(_#.I:G>/8,K7-O>M'+NC+!6*E$7!4D$YSP#TQ7R];V\M
MY<1001M+-*P1(T&2S$X  ]2:_1_PEK]MXY\1?%'P+J8$L-I<[/+QC-M<0C('
MN'\P_P# A7RM^SO\(+JX_:&?2M3A+P^%YY+BZ9HR%9XFVQ8^KE7&>JJ:\_#8
MF4:<_:N[6OR:/?S;*:53$T'@HVC4;B[='%V?]>1[%HO["OA'^RK-=6UO6FU0
MQ*T_V6:%(]^!NVJT3' )[DU\>^-M!3PKXSU_18I&FCTW4+BS61NK".1D!/N=
MM?HAX)\=?\)9\:?'FFPR%[+0[6RLU7(*^:3,TK#WR0I_ZYU\AV-SX*L_VF/&
M,_CY=^A1ZKJ3!#')(K3>>^P,J DCK[9QGBLL+6J\T_:-NR3MZG1G. P7LJ/U
M5*%Y.+;VTTNWZH\1HK[Z\/WGPS\0:Q;Z5;?!O48[2XD6)-6G\(JMK\V,%I-N
MY1S]X@ =20.:^?/VM_A#H_PO\7:;<Z#$;33=7BDD^QY)6&1& ;82<A2'4X['
M.., =5/%JI/V;BTV>'C,DGA<,\3"HIQ3L[7TOZ[FU\?O!?P;T'X<V=UX(U"Q
MGUYKB-0MIJ;7,DD94[C)&7;9V/1>>/:OFX=:^Q?VO_ 'AGPK\(="N]&\/:7I
M5VVJ01-<6=G'%(R&WF)5F4 D$J#R>H%=9X-^$GPZU;]GSP]J/B+1=.LX%T^&
M^O=3CA6*X8+AVW3*-^&Z'!R0<#M7+3Q*ITE)W=W\SU<9D]3&8Z=&')!Q@GII
M'^N[/@]JZ/X>^!=0^)7B_3_#>ER6\-]?%_+>Z9EC&R-I#N(!/1#T!K[5^'=O
M\$_CA9ZOI&B>$;&+[$H20OIR6\[(V0)$D7Y\9'4D,.,BN'_9S'ACX9_%_6O
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MUFTTN"TM+A+E9+*&1)&=49!N+2,,8<] .:EE_:4\4W'PM'@)[32SI M5L_M
MAD^T>6I!'S>9MSP/X:4<+45.$>SN*KG6$EBL163=IT^5:=3TK]@S_D=?$_\
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M%AH*/C'FK:R[OKS+C]*<E4:M9,QPM7*J=3VL9U(.+TM;5?Y]^AZ+^WC-8?\
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M:>-/$=U>K_96@Z9(KW2KU5GSY@Z_P0OQSUKH?@M^T!=>,?BKIW@RQT#3-/\
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M/_!1<?\ Q%82Q%'^=?>A_5<1_P ^W]S..IRUU_\ PIKX@?\ 0C>)/_!1<?\
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M]"3XB_\ !3<?_$4?\*?\>?\ 0D^(O_!3<?\ Q%3S+N5]5K_\^W]S.1HKKO\
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M3]6K_P#/M_<SDJ*ZW_A4/CO_ *$KQ%_X*I__ (BC_A4/CO\ Z$KQ%_X*I_\
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M^%0^._\ H2O$7_@JG_\ B*5T+ZM7O\#^YG)45UO_  J'QW_T)7B+_P %4_\
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M5]7K?R/[F<I3ATKJ?^%3^./^A-\0?^"N?_XBG?\ "I_&_P#T)OB#_P %<_\
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M_P""Z;_XFG+\-_%O_0K:U_X+YO\ XFL)8>M_(_N9HJ<_Y6<[172#X;^+<_\
M(K:U_P""^;_XFBL_J];^1_<RO9S_ )6?>5%%%?NA]R%%%% !1110 4444 97
MBSQ';>#_  MK.O7J2RV>EV4U],D !D9(D+L%!(!;"G&2!GN*^;?^'C'PV_Z
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M] 3Q5_X"6W_R17YT44>P@']OXWNON/T7_P"'C'PV_P"@)XJ_\!+;_P"2*/\
MAXQ\-O\ H">*O_ 2V_\ DBOSHHH]A /[?QO=?<?HO_P\8^&W_0$\5?\ @);?
M_)%'_#QCX;?] 3Q5_P" EM_\D5^=%%'L(!_;^-[K[C]%_P#AXQ\-O^@)XJ_\
M!+;_ .2*/^'C'PV_Z GBK_P$MO\ Y(K\Z**/80#^W\;W7W'Z+_\ #QCX;?\
M0$\5?^ EM_\ )%'_  \8^&W_ $!/%7_@);?_ "17YT44>P@']OXWNON/T7_X
M>,?#;_H">*O_  $MO_DBC_AXQ\-O^@)XJ_\  2V_^2*_.BBCV$ _M_&]U]Q^
MB_\ P\8^&W_0$\5?^ EM_P#)%'_#QCX;?] 3Q5_X"6W_ ,D5^=%%'L(!_;^-
M[K[C]%_^'C'PV_Z GBK_ ,!+;_Y(H_X>,?#;_H">*O\ P$MO_DBOSHHH]A /
M[?QO=?<?HO\ \/&/AM_T!/%7_@);?_)%6]-_X*#?#O5)VBBT;Q.K*N[Y[6W
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M (_7PS11]7@'^M69=U]Q]S?\-S^ _P#H$^(O_ :W_P#C]'_#<_@/_H$^(O\
MP&M__C]?#-%'U> ?ZU9EW7W'W-_PW/X#_P"@3XB_\!K?_P"/T?\ #<_@/_H$
M^(O_  &M_P#X_7PS11]7@'^M69=U]Q]S?\-S^ _^@3XB_P# :W_^/T?\-S^
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M?\-S^ _^@3XB_P# :W_^/U\,T4_J\##_ %JS+NON/N;_ (;G\!_] GQ%_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^%%_$G_HGOBK_P $MS_\11S+N'L*W\C^YG#T5W'_  HOXD_]$]\5?^"6Y_\
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M  HOXD_]$]\5?^"6Y_\ B*.9=P]A6_D?W,X>BNX_X47\2?\ HGOBK_P2W/\
M\11_PHOXD_\ 1/?%7_@EN?\ XBCF7</85OY']S.'HKN/^%%_$G_HGOBK_P $
MMS_\11_PHOXD_P#1/?%7_@EN?_B*.9=P]A6_D?W,X>BNX_X47\2?^B>^*O\
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MP^JU_P#GV_N9R-%==_PI_P >?]"3XB_\%-Q_\11_PI_QY_T)/B+_ ,%-Q_\
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M*KE7*X7T./ZY7>,IXV5!\Z7O;KF=K7VTTWW.1HKKO^%/^//^A)\1?^"FX_\
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M .(HYEW#ZK7_ .?;^YG(T5UW_"G_ !Y_T)/B+_P4W'_Q%'_"G_'G_0D^(O\
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M4%HE9!1112-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD E:,1NRLZ@JC$_>X^5L>I5^#'PK^,WP^^#-W\%OBOI_C)M7^*R>)KZ\\=V
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M.5"R&))92VPLH%P#D[J /T \9_ML?!#X>_$Q/ 'B'XAZ;IGBHR1PO:R1S-%
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MGPGH?CC0;K1/$FC:?X@T6ZV^?IVJ6J7-O-M8.N^-P5;#*K#(X*@]10!\U_\
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M/@WQ1X;^%/[/?@:VN9_B;87ME!H>BVMK,5MM-:WD@)>8IM\K;$F[#$@1;F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?EYXN\*_LSW?B+6M)^.W[3GBWX@^+;&ZEL=
M2M;JYN;.QM[B)BDB16T43+'AE8$!V7CZD]+\&?@?\#/&WB*73?V9?VB/&/A3
MQ;IUJU^+2RNY;NQ\E62,O-:SQHLJAI$&TOCYNG<>V_L[0^%_CM\1OCK)XI\%
M^#9KCP]XTNM$M;"30+8W8AB _P!+FD92\AN&9F#'^X<5H?#O7-(\(_MT>*OA
MIH'ASPS8Z4O@F#71<Z/I,%K<V,QNEB>UEDC4%A(ICF"MTX[8H ^H:*** /CG
MXR_\%"KKX6^/O&6FZ?\ "K4O$WA3P5>V.G^(]?CUBWMI[>6ZV>4(+)U,EP"7
M !!4$]P,-5GXL?\ !0"X^'?BSQC_ &3\*]7\5^ / ]]!IWBGQ?;:C#"MA/)L
MRD5LREY]AD4-@KM.<X&"?%OVCOV7/C9X_P#C=XQUS3OAY9>(-?O-4LY_!_Q+
MC\4IIX\,6L!5DB:RZS$'?N;:Q);/. !J?$[]FOX\M#\9?ACH/A71_$'A/XIZ
MW;ZS-XYFU:*V&E,WDFY5[,_O)/FA.W9P 0><X !^AEG=PZA:075O();>9%DC
MD7HRD9!'U!KS#]K'_DUGXR?]B9K/_I#-7HV@Z1#X?T/3M+MR3!8VT=M&6Z[4
M4*,_@*^9/V\/@'_PGOPK^(/C;_A8_P 0/#G]B^#-0_XIS0-<^RZ/?^3!<3?Z
M5;^6?,W[O+?YAN157C&: /5?V3O^36?@W_V)FC?^D,->JUY5^R=_R:S\&_\
ML3-&_P#2&&O5: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK,\0>
M*-&\)V:7>N:M8Z-:/((EGU"Y2"-G()"AG(!.%8X]CZ4>'_%&C>++-[O0]6L=
M9M$D,33Z?<I/&K@ E2R$@'#*<>X]:U]C4Y/:\KY>]M/O(]I#FY+Z]C3HHHK(
ML**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUNY4U&&"VF-Q<7RRD[S_ **JJ9,DG<3],WX[?M67'A?]IG5?%ME\4%TSPO\
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MVGB2X\.WFM>&X[+Q;I^HFY\F/>5NEC!^Q2A"7\N8$G85ZUP%K^VA^TBWP?\
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MZ\\/+%QC^[B[-]F]D<\L13C55%OWGJD>@4445Q'0%%%<9\1?C%X0^$_]G_\
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MGA</'(C#*LK#@@@@@CKFIZ@LK*WTVS@M+2"*UM+>-8H8(4"1QHHPJJHX
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MXDUS0;_1=GEQZ3?-;17'G3PQGS@O+;1G;@C!8]<U[E7C7[87_)N?B[_MT_\
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M)!PP(/H1BO<:_-+X$^#/BIX=^(.I:AX1T*1-=T"$?;K#4AY(*2J=L3H[*3N
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M1/#J_M))X1&IW9\/C1QX@,#*#(5^T^5]FWYZ=]^,XXZ_-7VW'&D,:1QHL<:
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MG1DX4VI1Y9*TH1DN:.CT34='LD<F64,PPE!JG*-1<TM'=/233L]=VKZKJ/\
MVEON_"S_ +'S2O\ VK7KU]J%KI=J]S>W,-I;I]Z:>0(B_4G@5^7/Q9\,^+/
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MK]4CZ:HKYE_X5C^T9X=YTOXDZ5J\2_\ +/4(AN;\6A;_ -"%'_"6?M,^'/\
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M_P $^F:*^9_[6_:@C_Y@OAF7_@<?_P =%'_"3?M01_\ ,I^&9?\ MK'_ /)
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M_P"#M)U.WCDL!=7DDUEOMRUFME&Y\N-&C&Z8$#,@)7B@#[.HKY'^/G[9>N_
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M%>+"<J<E*#LUV.^45)6DKHS/#_A?1O"=F]IH>DV.C6CR&5H-/MD@C9R "Q5
M 3A5&?8>E:=%%$YRJ2<IN[?<(Q45:*LCQGX7_P#)QOQN_P"X)_Z1O7IOBGP;
MH?C?338:_I-IJUH>D=U$'VGU4GE3[C!KS+X=?!'Q?X+^(VH>*]2^(_\ ;O\
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M<_\ '_N?[5?3%%%&88NCB_9>R@X\D5'62E>W72,;?B&&H3H\_/)/F;>BMO\
M-A1117DG:4M:U+^Q=&O]0^R75_\ 9+>2?[+91^9/-M4MLC3(W.<8 SR2*\-_
M9CU[4?[:\=Z?J'A#Q-H7]K:]?>(;>ZU;3&MX/)E:)5B+L?\ 6]3M (P#R<5[
M_17J8?&0HX6MAW3NZEM;O2VNQQU*$JE:%52MRWTMO<*\9^*/_)QGP1_[C?\
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M_DCOCO\ [ -__P"D[TWX*_\ )&_ G_8!L/\ TG2O=_YE/_<3_P!M/._YCO\
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MP:A;)/&K@$!@K@@'#,,^Y]:/#_A?1O"=F]IH>DV.C6CR&5H-/MD@C9R "Q5
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M?\GC+_V(?_N0KV:OF<_&+PA_PV,O_$W_ .8%_P (Q_Q[3?\ (1_M#_4?<_\
M'_N?[5?29+AZU?ZS[*#E:G+9-]CR<PJ0I^RYY)>^MSZ8HHHKYL]8*S/%'B"W
M\)^&M6UR[262TTRTFO9DA ,C)&A=@H) )PIQDCZUIUQGQJ_Y(WX\_P"P#?\
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M_P!Q/_;3#_F._P"W/U.SHHHKPCT0HHHH **** "BBB@ HHHH **** "BBB@
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M0JB@"AH.D0^']#T[2[<DP6-M';1ENNU%"C/X"OF3]O#X!_\ ">_"OX@^-O\
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M-S7TMM;U.'V-3ZU[:ZY;6\][FG1117D'<%%%% !1110 4444 %%%% !1110
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M%_Q&M_ GBCQ]IVD^*9F1?L,B2NL)< H)I50QPD@@_O&7@@]#0![-7E7[6/\
MR:S\9/\ L3-9_P#2&:O5:\J_:Q_Y-9^,G_8F:S_Z0S4 '[)W_)K/P;_[$S1O
M_2&&O5:\J_9._P"36?@W_P!B9HW_ *0PUZK0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7&?&K_DC?CS_ + -_P#^D\E=G5+6M'L_$6C7^E:A#]HL+ZWDM;B'
M<R[XW4JZY4@C()&00:Z<-45&O3JRVBT_N9E6@ZE.4%NTT?CM17Z8?\,>?"'_
M *%'_P J5Y_\>H_X8\^$/_0H_P#E2O/_ (]7]#?\1(RG_GU4^Z/_ ,F?EO\
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M )4KS_X]1_Q$C*?^?53[H_\ R8?ZIX[^>'WO_P"1/S/HK],/^&//A#_T*/\
MY4KS_P"/4?\ #'GPA_Z%'_RI7G_QZC_B)&4_\^JGW1_^3#_5/'?SP^]__(GY
MGT5^F'_#'GPA_P"A1_\ *E>?_'J/^&//A#_T*/\ Y4KS_P"/4?\ $2,I_P"?
M53[H_P#R8?ZIX[^>'WO_ .1/S/HK],/^&//A#_T*/_E2O/\ X]1_PQY\(?\
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MS?\ Q[MWRXKZJKRK]K'_ )-9^,G_ &)FL_\ I#-0 ?LG?\FL_!O_ +$S1O\
MTAAKU6O*OV3O^36?@W_V)FC?^D,->JT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7E7[6/_)K/QD_[$S6?_2&:O5:\
MJ_:Q_P"36?C)_P!B9K/_ *0S4 '[)W_)K/P;_P"Q,T;_ -(8:]5KRK]D[_DU
MGX-_]B9HW_I##7JM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5VO_  ^K^"'_ $*WQ _\%UC_ /)E??\ 10!\ ?\ #ZOX(?\ 0K?$#_P76/\
M\F4?\/J_@A_T*WQ _P#!=8__ "97W_10!\ ?\/J_@A_T*WQ _P#!=8__ "91
M_P /J_@A_P!"M\0/_!=8_P#R97W_ $4 ? '_  ^K^"'_ $*WQ _\%UC_ /)E
M'_#ZOX(?]"M\0/\ P76/_P F5]_T4 ? '_#ZOX(?]"M\0/\ P76/_P F4?\
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M]"M\0/\ P76/_P F5]_T4 ? '_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\
M0K?$#_P76/\ \F5]_P!% 'P!_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K
M?$#_ ,%UC_\ )E??]% 'P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*W
MQ _\%UC_ /)E??\ 10!\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ
M_P#!=8__ "97W_10!\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/
M_!=8_P#R97W_ $4 ? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\
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M]% 'P!_P^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E??\
M10!\ ?\ #ZOX(?\ 0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "97W_10
M!\ ?\/J_@A_T*WQ _P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R97W_ $4
M? '_  ^K^"'_ $*WQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F5]_T4 ?
M'_#ZOX(?]"M\0/\ P76/_P F4?\ #ZOX(?\ 0K?$#_P76/\ \F5]_P!% 'P!
M_P /J_@A_P!"M\0/_!=8_P#R91_P^K^"'_0K?$#_ ,%UC_\ )E??]% 'P!_P
M^K^"'_0K?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E??\ 10!\ ?\
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M?$#_ ,%UC_\ )E'_  ^K^"'_ $*WQ _\%UC_ /)E??\ 10!\ ?\ #ZOX(?\
M0K?$#_P76/\ \F4?\/J_@A_T*WQ _P#!=8__ "97W_10!\ ?\/J_@A_T*WQ
M_P#!=8__ "91_P /J_@A_P!"M\0/_!=8_P#R97W_ $4 ? '_  ^K^"'_ $*W
MQ _\%UC_ /)E'_#ZOX(?]"M\0/\ P76/_P F5]_T4 ? '_#ZOX(?]"M\0/\
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MR^(;6*.*+5'\I=UTB1DHJRG+A4)4!@ 2,5OUY_\ L_\ PSN/@U\$_!7@>[U
M:I=Z#I<%C->*"%D=5PVT'G:#D+GL!7H% !1110 4444 %%%% !1110 4444
M%0WLTMO9SRP0&ZG2-FC@#!3(P&0N3P,GC)]:FJKJES<6>EWEQ:6;:A=Q0O)#
M:)(L9G<*2L89CM4L<#)X&>: /@N+XN_M*_"OXF?!V^^)/B;1I9_B+XG;1[GX
M56VFVN[1[-I-INHKR%WDF$2;)&RQ W@,23\OW]7YV? +P=^T3I'[1-]\3OBC
M\ 7\4^+=9OEL;?Q'/XVTY;;PKI#N T-G9@R'Y%>0E@V]P2!AI)6D_1.@ HHH
MH **** "BBB@ HHHH **** "BBB@#R_]I+4OB?IOPGU-?@]I%IJWCRZDBM;-
M[^:*.&R1VQ)<L)&57,:Y(7GYBI*N 5/CG[+_ ,3?B9;_ +1GQ+^$'CKQQ9?%
M2W\.:=::DGBBVTF'39;::; -G+# 2@.,L,G=\K9)! 7U/]J_4/BK9?!75X/@
MQH8UKQY?,EG:R-=6\ L8VSYER#.Z*S*HPHSPSJV&"D'PK]C[P[\5/@;\/?$N
MCW'[.DVDZT-/EU>;6K[QU8WUYXJUC*_NYI%4F'S-SL'8E$P<Y+%B 0?M]_M/
M:O\ "#XG_#'PAI?Q7C^#^G:K:ZA?ZSX@/AY-<:.- BVRBV,;,=T@E7*D8ZG.
M,5]+?L[ZK<ZY\&?#.HW?Q#MOBM-=Q23_ /"76FGQ6$=^K3.4_P!'B)6,QJ5B
M*]<QG< V0/#_ (M:?\=--^)'@GXJ^$_A9H'C&>\\*?V1KG@F\N]-@O\ 2+J3
M,K;-4>,-+"K,8VC5]C%2P3Y]R^A?L5_ W6?V>/V?=$\(^(;FUGUH3W%_=0V&
M?LUJ\\K2>1%G^%-P'H3G'% 'NE%%% !1110 4444 %%%% !1110 4444 %?!
MWQD^,?QV^#O[2'@BSU'XC>&+I/&/BY-.TGX8V>D V[:(P\LW<VI2K'(EP&(_
M=!B#(R[=Z9C'WC7P+\7O@]^TQ\:#=_"+Q7I6E:YX1E\7Q:S9?%3^T+2V?3],
MB;S(X!8Q(LAN  4$@7!9RI.W,@ /OJBBB@ HHHH **** "BBB@ HHHH ****
M "L+QU_PDO\ PANLCP<-+_X2HVKC3#K32+9"X(PAF\L%]@/)"C)QCC.:W:X[
MXP:+XQ\0?#/Q#I_P_P!?@\+^-)K8_P!E:K=0)-##."&42*\<@V-@H3L8@,2
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M?^$?T'3=+^VWFI?8K:.V^V:A+YMS/L0+YDKX&YVQEFP,DDT :%%%% !1110
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M\8Z-KEY):6-\D]P@)*!6&0#R02 #^%;- !1110 4444 %%%% !1110 4444
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M>,A6VN,X]>?ZUM> ?^1-TG_K@/YFN@HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC\2?V+9O".KZG\,O%7CR/5_AO-X?EM_"MH+ZXTW4I-0GO!#<!3A(@LRJ9!D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MST7Q)!/:ZO'8RSR6]TA26))KF6:)&4\J5CD08/(Q@XKT3XU?\+3_ .$5M?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '"_$#X1_#GXP6T,WC+PIX=
M\6161D2*XU2RAN3;[6(D578$KAE(8 CD'/2H/@WJ7PL.B7.C?"J]\(R:5ILF
MRXLO",]L\5M(<\2+ <*QP?O<G!KY ^.FL>$+3QY\0/!GP=^(-O#XN\7+?:7X
MD^'MT)X].U.]N(W29[.\9/(M=2.]OEW[9'P'4$;J[#]AGPRFM>,-2\7W=]X2
MTO6]%TN3PY=^$_#OA8:!?6+22PRM_:,!=B77[.HC(RF))2K'<: /M"BBL?Q7
MXPT'P'H<^M>)M;TWP[H\!59=0U:[CM;>,LP50TDA"C+$ 9/)(% &Q17):_\
M%WP+X4T/2M:UOQIX=T?1M657T[4=0U6""WO590RF&1W"R J0PVDY!!J;Q5\4
M?!G@33;#4/$OB[0O#UAJ!"V=UJNI0VL5R2 0(VD8!S@@\$\&@#IZ*BMKF&\M
MXKBWE2>"5!)'+&P974C(8$<$$=ZQO'7C33OAWX1U/Q'JS.+#3XO,D$8R[$D*
MJJ.F68A1D@9/)%:4Z<ZTXTZ:O*3LEW;V)E*-.+G)V2/F+]AG_DI'[0W_ &.>
MH_\ IVU.OKNOAW]A[XAZ9;?%KXB:?.)8KOQIJ]WK5BNT%4W75W=-"QSU"7&
M<8/EGID"ON*OI.(\)7P6-C2Q$>67LZ7X4XQ?W237R/)RJO3Q&'<Z3NN:?XR;
M7X-,****^7/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*/$7P[N?C5IUMI7A:W^ ]K::#;^.($@A:Z@E:"6:V5R0TDBQ^9$R_O&C>-E
MR .;_9_7P<LG@6/]H8Z3_8:?!RX?PZ/%6T6N6U.Y,?V??P;C[.8MNW]YC;M_
MAK]7=>^#W@+Q5I.CZ5K?@CPYK&F:,JIIEE?Z3;SPV*JH55A1T*Q@*  % P !
M4_BSX6>"_'UMI]OXG\(:#XCM]/;=9Q:MID%TEL< 9C$BD(< #C'2@#QG_@G3
M'K$/[%7PK77/,^V_V=*T?F9S]F-S*;;KV\@Q8]L8KL/VIO!7Q ^(WPHN/#GP
M[3PJVI:A<QQWO_"6O<I;K:A68M$;<%A,)5A*[@5P&R#P*];AACMH8X88UBBC
M4(D: !54#   Z "GUK2JSHU(U:;M*+33[-;,B<(U(N$U=/1GYO\ [$NGR6_[
M13Z?KMO;IK&BSZMIK+9SM+ +JVEEMI'1F5"R$1R$;E!PPX!%?I!7Y=?#/XB6
M?PJ_:<\5^)M1AN+BPM/&?B=9XK15:5E?4+U!M#,HX+ \D=*_2OP?XF_X3#PY
M::O_ &5J>B?:-_\ H.L6_P!GNHMKLOSQY.,[=PYY!![U^@\84\5B%@\QK:JI
M1IW>GQ6;:M^.BMJ?+Y%*C3]OA:>CC.6GEHE_D;5%>&_$_P"('Q3\._%C0?#'
MAV'P>]AXB\_^RY-32Z,J?9X$DF\\HP R2VW:#QC.*]ET7^T?[&L/[7^R_P!K
M?9X_MGV+=Y'G;1YGE[OFV;LXSSC&:^+Q.!GA:-*M.46JBNDG=VNUJNFJ:]4?
M04L3&M4G3BG>+L[K3O\ DTSG_B;\1;?X7^&CKEWH^L:S:))MF31K43R0($=V
MED!90L:A#EB>,CUJG\+?BQ;_ !6L[F\L_#GB'0[2..&6&?7+$6\=VD@8JT+!
MV#@!021_>7UJ;XU?\D;\>?\ 8!O_ /TGDH^"O_)&_ G_ & ;#_TG2NM4\/\
MV6ZSA^\Y^6]WM:^WX&+G5^N*GS>[RWM;Y;G9T45X;X1^/'CKQ1X\O?#$GPJ^
MQ3:7<6D>KS?\)%!)]ACG&Y9,;!YGR;FVH2>,<$UQ87 5\9"I.C:T%=WE&-E>
MU_>:OK9:7U:6[5]ZV)IT)1C.]Y:*R;_)/\>S[,]RHHHKSSJ"BBB@ HHHH **
MYG_A9_@W^V?[(_X2W0_[6^T?9/L/]I0^?YV[;Y7E[MV_=\NW&<\5TU:U*-2E
M;VD6K]U8B-2$[\KO8**XSXB_&+PA\)_[/_X2K5_[*_M#S/LW^C33>9LV[_\
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M)$BP(V "\+N"C&[EL[/@O]B/P+X%T_P+9:?JWB.:+P=XANO$M@UY>12O+<W
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MOX[O/MVD_:5N?L,\U[JKR0>:@VR;&0KO7AMN1P:_7>OU'BVHIY5E45]F%O\
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M-S\7?]NG_I9#7LM>-?MA_P#)N?B[_MT_]+(:]EJ*W_(IP_\ U\J_^DT2J?\
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MU+SXC)_H<VX^=Y>-LG VL0.:_+J'X*^)9/V+_P!H;1O"?@_XAV%MJ<NA'3?
MVI^"[W31'*E_$TTMC%+?WTTVY5W2?,-NT'IC;Z-^U%\+?'>L3?MPRZ+X0\17
MTNO-X%;0Y+#3)Y&U%K<PF<VI13YIBVG?LSLQSB@#])Z*_.[7_P!FGQI\'_'W
MQV\,_!'3O$FFZ7KWP\AN;2]GNKB6.[UG[25E\N[E; NFA\SHX(,@/RC&&?\
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MC_W&_P#TC2O9J^.-1_:F\&>/OC7\*-8!O-'L](-^M]-J$:K'$]S;K&@#*QR
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M3-%+^T<GZ8#_ ,JR_P A_5<?_P!!/_DB_P SYF_X;,OG_P!5\*O$TG_ &_\
MC9H_X; \0/\ ZKX.^)I/PD_^,FOIFBC^TLHZ9>O_  9,/JF._P"@K_R2)\P7
MW[6WC9[*X^Q_!7Q%'/Y;>7+,LS(C8X9@(!D \D9'U%?,WPY^/'CVW^,-EXH1
M[[Q;K5PALY=/P9'N;8MYC01JJG8,C<-BX!&<8R#^G%>%:=X?TO1OVQI?L&FV
MECYW@MKJ3[/ L>^9K_:TAP.7(&"W4BOJ,FSO+*='%4XX"*O!OXI.Z71N5VM^
MEORMX^/R_&2G1G+$MVDNB5O/31_,YS_AJOX@_P#1!/$W_?5Q_P#(E'_#5?Q!
M_P"B">)O^^KC_P"1*^F**^7_ +4RK_H71_\ !E3_ .2/8^IXW_H*?_@,/\CY
MG_X:K^(/_1!/$W_?5Q_\B4?\-5_$'_H@GB;_ +ZN/_D2OIBBC^U,J_Z%T?\
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MS&#>)T<96=ET<;JUK:MK7R.6_P"&R-4A_P"/KX3>)H/7Y7/\XA1_PV]8P_\
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MY !KU?\ X07]J#_HHGAG_P !T_\ D.GFG#]"..K*&.I6YGNY)J_1VBUIMO\
MY"P>9U'AZ?-AI[+9*WXM?D?3%%?,_P#P@O[4'_11/#/_ (#I_P#(='_""_M0
M?]%$\,_^ Z?_ "'7E_V#2_Z#Z/\ X%/_ .0.S^TI_P#0-4^Z/_R1],45\S_\
M(+^U!_T43PS_ . Z?_(='_""_M0?]%$\,_\ @.G_ ,AT?V#2_P"@^C_X%/\
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M1J3<10P1B5U=2-N[:0H8$@GD@=*^V/!/PM\)_#FW$/AS0++2^-IFCCW3,/\
M:D;+M^)-<%\4?^3C/@C_ -QO_P!(TKV:O?S[.L?F&%P:KU6U*#;2T3?M)QNT
MM](K\;;GF9;E^&PM:NZ4-5*RZV7+%V7S;.,^-'_)'?'?_8!O_P#TGDH^"O\
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MD17YI_<%%%%?.GJA1110 445!>WUOIMG/=W<\5K:6\;2S3S.$CC11EF9CP
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M<0 -@'>OF35OVSO^%-:#^T5:Z%;>'=-^(LWQ#N-$\,>#+&S1+N\N':-&U2=
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MGR2$>9OVL."-N,\Y%?>W@_5-7UKPY:7FO:'_ ,(YJTF_SM,^UI=>3AV"_O4
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M[ZZHRJTU5@Z;>C['"_!?P_XI\)> =/T/Q8^CR7>FQQV=H^C&4QM;1Q(B&0R
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M+<N$&<%R>N!@UKC,MR+ 498C$8:G&"W?LXO\%%LSH8O,L345*E6FY/\ O/\
M5E__ (;"^+W_ $-W_E-L_P#XS1_PV%\7O^AN_P#*;9__ !FLWX7_  5L/&OA
M.^\4>(O%UKX.\/V]\FF1W4]LUPTURP#; H9< !@2V>!DG !-<M\4OA[>?"OQ
MYJOAB^F2ZFL77%Q&I5949 ZL >F0PR.<'(R<5E2P?#];$RPD,-3<X[KV:Z6O
M9\MG:ZO9NUU<TGB,SITE7E5ERO\ OOSZ7NKV=K[V.[_X;"^+W_0W?^4VS_\
MC-'_  V%\7O^AN_\IMG_ /&:U/C!^S+I_P )?"MSJ4OBR^U&_C6%H[7_ (1R
MXBMI2[*"/M>YH@0I)QG)VXP":XSXR_#?3_ C>%;_ $22]GT/Q!H\.I0/?,C2
M)(W^LB)4 ':=O;^(<FN;"4N',=R/#X:FU-M)^R2NTDW\45T=T]G9ZZ&M:>:X
M?F]K6DG&U_?ON[=&^IO_ /#87Q>_Z&[_ ,IMG_\ &:/^&POB]_T-W_E-L_\
MXS7C-%>W_8.4_P#0)3_\ C_D>?\ VECO^?\ /_P)_P"9^DG[('Q)\1_%+X:Z
MGJOB?4?[3OX=7EM4F\B.+$8AA8+B-5'5V.<9YHKF?V ?^2-ZS_V'IO\ TGMZ
M*_ESB6C3H9QB:5&*C%2T25DO1(_8LIJ3J8&E.;NVMV?3%%%%?,GKGR7^W9\2
M/''A7Q!\(?"WACX@V7PGT3Q;JEY9ZMXSO+:*?[&T< >WB"R$ "5O,&[*X*IE
ME!.;O[*G@_Q'X?\ 'VI7&K_M36OQPMFTQXUT""WMHS;.98B+HF.XE;Y0"F,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4G);QCM>VW2_6R\C,*]/$U_:TVW=):I+5)+HWO:_X!1117O'F!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KPWXD_L@>#?BEXTU'Q/JNI:Y;W]]
MY?F1V<\*Q#9&L8VAHF/1!U)YS7N5%>A@<PQ66U'6PE1PDU:Z[:.WX(Y<1A:.
M+@H5X\RWU/F?_A@'X>_]!GQ-_P"!5O\ _&*/^& ?A[_T&?$W_@5;_P#QBOIB
MBO;_ -:L[_Z"I'G_ -BY?_SY1\S_ /# /P]_Z#/B;_P*M_\ XQ1_PP#\/?\
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MX8!^'O\ T&?$W_@5;_\ QBOIBBC_ %JSO_H*D']BY?\ \^4?,_\ PP#\/?\
MH,^)O_ JW_\ C%'_  P#\/?^@SXF_P# JW_^,5],44?ZU9W_ -!4@_L7+_\
MGRCYG_X8!^'O_09\3?\ @5;_ /QBC_A@'X>_]!GQ-_X%6_\ \8KZ8HH_UJSO
M_H*D']BY?_SY1\S_ /# /P]_Z#/B;_P*M_\ XQ1_PP#\/?\ H,^)O_ JW_\
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MT3/_ ,K^J?\ R31_PZX_9B_Z)G_Y7]4_^2: /5?^&L?@A_T63X?_ /A46/\
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MT3/_ ,K^J?\ R31_PZX_9B_Z)G_Y7]4_^2: /5?^&L?@A_T63X?_ /A46/\
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MT3/_ ,K^J?\ R31_PZX_9B_Z)G_Y7]4_^2: /5?^&L?@A_T63X?_ /A46/\
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MT3/_ ,K^J?\ R31_PZX_9B_Z)G_Y7]4_^2: /5?^&L?@A_T63X?_ /A46/\
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MT3/_ ,K^J?\ R31_PZX_9B_Z)G_Y7]4_^2: /5?^&L?@A_T63X?_ /A46/\
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M?#O@V?Q[J&E(DS:':W1MY98MX$CJPCD)V*2Y 4Y"FOCK]E7XA>"?^&F/B_\
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M98,^=YSF@#]2Z*BM?/\ LL/VGR_M.Q?-\K.S=CG;GG&>F:EH **** "BBB@
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MI4MN*XR.!TYJ7POXK'B:?44%G+:"TD5!YQP[9!.2N/EZ=.: -^BBB@ HHHH
M**** "BBB@ HHHH **** "BBN=\7>,H?"EJ6^S2WEQMWB*,$*JYQN9\$*,G'
MU(H Z*BN9\1>,9=(N(+:STUM1NGMVNGC$PC$<8ZG)!S]*V=%U2/6])M;^)&1
M)T#A6ZCVH NT444 %%%% !1110 4444 %%%% !1110 455U+4(=)L9;J?=Y4
M8&1&I9B20  !U)) _&N>M/'T4WAB_P!9FLY+=;69H1;ELNS @ 'C@DL..<>]
M '5T5@>&_$T^LWE]97NG-IE[:[&:(RB4%6&0=P'7V_\ KXWZ "BBB@ HHHH
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MCDLT/WTP/F.<8[Y'7V[NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN_,SX@EB7,=NNS /E\KLW'(<$?0-K^Q6EK\0/V??$X\8,Q^$^@KH?V7^S?\
MD*A;40"7=YO[G^]MP_IGO4_[1'[*_CGXV:EKUOI'QMU3PEX.\16:V6K^%YM%
MM]3MY$"!&^SO*P:W+ 9)3^+YNM 'M_PSUFY\1?#GPOJE[JFEZY?7FEVT]SJ6
MAL6L;J5HE+RVY/)B9LE<\[2*Z6N1^$GPSTSX-_#/PUX(T:6XGTS0K*.R@FNV
M#2R!1R[D #).2< #G@"NNH **** .<\;Z3=ZQ8V$=I%YKQ7T4SC<%PBYR>36
M9XRAU[4M4BMH=':^T6/#21K=QQ?:&Z@,3SM![8Y/X5VU% $5LSM;Q-)%Y+E
M6CR#L..1D=<5+110 4444 %%%% !1110 4444 %%%% !1110!SGAW2;NQ\0^
M(KF>+9!=S1M"VX'< I!X!X_&CPUI-WI^N>(;BXB\N&ZN%>%MP.Y0""< \?C7
M1T4 %%%% !1110 4444 %%%% !1110 4444 %8/CK3+G6?"M_9V<7G7,H0(F
MX+G#J3R2!T!K>HH X[QE'KUU%:6&GZ<]S8,@-VT=RD3R#IY0).0/4@<@XSUK
MI='\P:7:K+9C3W5 OV57#B(#@*".#P!5RB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KC=%L-9\/^&]7%O8B749;R66WB:1,$,1AB<XQU..O%=E10!RG@6U
MU*SCN5U+2VM;J4B2:]DNDF>XDZ'A?N@#H.@'XD]7110 4444 %%%% !1110
M4444 %%%% !1110!F>([2ZU#1;RSM$A:6YB>$F:0HJAE(W<*V2,]/UK$U/P_
MJVH>"4T58[))_*2!I#</M 3;AA^[Y)P>.WJ:ZZB@""Q$ZV<0N$CCF PRQ.77
MCT) S^53T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[O\ LIZ7J>D?L\^!X]8L=/T_4;BQ%]-!ID[2P;IV:?<"8TVEO,R4 PI)4,P
/8E% 'K-%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>advm-20241231_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *]!.@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#B12T45_0#
M/YD!>M.I%I:YY %.7I3:<.E<\@%HHH%<\ACZ2EI*YV X=#2+UI?X:%K!E"T4
M45SR <O2EI!TI:YY %%%7]!T&_\ %&M6>DZ7;F[U"\D$,$*L%WL>@R2 /J3B
ML6[:LJ,7)J,5=LHKUIU=1X\^%_B?X87EK;>)M+;3)KI&DA'G1RAU! /*,PXR
M/SKEZS4E)7B[HNK3G1FX5(M-='HPHHHI,R"BBBH974****EC%6C^*A:/XJED
M]1:***S904444F 4445(#EZ4M Z5L7_@WQ!I6DPZK>Z%J5GIDX4Q7MQ9R)#)
MN&5VN1M.1TP>:R;148RDFTKV,9J;3FIM!(\45U/@+X7^)_B=<W=OX9TLZG+:
MHKS#SXX@@)('+LHYP>GI6)KFAWWAK6+S2M3MVM-0LY6AGA8@E&!P1D$@_4<5
MCS*]KZFKHU(TU5<7RO9VT?S*-%%%!D%%%%0P"BBE'6I =113X()+J:.&&-I9
MI&")'&I9F8G   ZDFH 916KKWA/7/"K0KK6C:AI#3 F);^U> R 8R5W 9QD=
M/6LJ@J490?+)684444$A11104%%%%2 4444 %%%% !1112&%.IM.J1L****!
M!11104%%%%)@%%%%2 4444 %%%% !1110 J]:=35IU!2"BBBI$%%%% @HHHH
M&@HHHH*"BBB@ HHI1UH =1114#04444#"BBB@&%%%%2 4444@"E6DI5H 6BB
ME%0QCJ***AEH5:=2+2UFR@I5I*5:3&+1114,M"KUIU-6G5DQA0**5>M24AU%
M%%9L84ZFTZH904HZTE*O6I92'4445DQCATHHHJ&6.6EI%I:DI!3Z:*=6;&A5
MI:1<GIR:O0Z->SKN2VD*^K#'\ZNGAZV(?+1@Y/R3?Y&T(2F[15RK2K5_^P;_
M /Y]R?HP/]:JR6LULV)8FC/^T,4L1@<7AES5Z4HKSBU^:-I4JD%[T6OD,IU-
MI]>7(2%6G4U:<.M82-$.I],I]8,T0OI3UZ4WO3ZPD:(<M+2+TI:P9HAU.6FT
MY>E8R-$**?35ZTZL)&B'+TI5I!TIRUA(M#EZTX4U:<.M82-$.IW<TE*.]8R-
M$/':BCTHK!EH\0HHHK^])'Y**M?8?_!/=1N\>M@9 L #_P"!-?'BU]B?\$]_
M^9^_[A__ +<U\UGW_(OJ?+_TI'T_#7_(UH_]O?\ I+/F7XJJ%^*'C  8 UF\
M  _Z[O7V'^PW&K?!/Q#E0=VL7 /'4?9H./U-?'OQ6_Y*EXQ_[#-Y_P"CWK[$
M_89!;X*Z^JC<QUFX  Z_\>UO7FYQ_P BZ/\ VZ>AP]_R.)?]O'PI7WMJT*-^
MP_&"BD?V! W3OE#GZU\$U]\:U^Z_8@CW_)_Q3]O][CJ4Q^>1^=+./BH?XT9<
M._#B_P#KVS*_87DBL?A/XEO&C!:/5)&9E W%5@B.,_G^=<+^VM\/+5YM%^(F
MB+%)INJQI!=26X&UW*[HI<@<[DR,_P"POK7:?L4_\D2\7?\ 80G_ /2:*LK]
MFW6K3XV_!77_ (7ZW,#>64)^QR.<L(2<QN.<GRI,>V"@KQ9.5'&5<4MHM)^C
M_P CZ",88K*\/E\OBG%N+_O1=TOFFS:^%\*']AS5LHIW:9JC'CJ0\N#]>!^0
MKXMT72;C7M8L=,LU#W=Y/';0J3@%W8*H_,BOM[P'IUSHO[&?B72[V%K>]L++
M5[:XB;^&19)@PKQ+]BWP+_PE'Q:&KS(6L]"@:Y/3!F?*1@_F[#W05TX>LJ,<
M35[2?_ /+S#"RQ<\OPRWE"*?EW^[4^S_  [-HO@:3PW\/8>9AI3O"I PT</E
MHV[_ &F+D^^UJ_.WXV^!3\.?BEX@T-8_+M(K@RVH ('D/\\8!/7"L%)]5-?5
M'C3P-\3K[]J#3?&FG^'O/T'39(;2&87MNI:TVD3':9 V?WDI''IQ6!^WEX%W
M1>'_ !?!'RI.FW3 'H<O$3^/F#/N*\[ R5&O%<U^=:Z]=SU<\I3QF"J2]FX^
MQE:-TU>%DM/GKZ(^0*^Y_P!A@K;_  ?UV<("XUF;)Z$@6\! S^)_,U\,5]T_
ML,JLGP;UM7.U&UJ<,V<8'V>WKNS3_=WZH^>X5_Y&*]&6OA1^U)H7QO\ $B^$
MM7\*BPFO8Y/(CFE6\AFVH6=&S&NWY58\@@X^E>9>)/AQI7PT_;"\'V>BQ?9M
M/OY(-02V7[L)9Y$95_V<QD@=MV.@KT#P'X?^!7P)OI_$-EXSM=4OXXV5)IM2
MANY8U(PPCC@4<GIG:3R>V:\CMOBH/C!^UEX6UN"%H-/BNX;2RCD&'\E2QRW)
MY+,Y]L@=LUYM.*YYNBFH<KW[GOXJM*5"A#'3C.O[2-N6UU&ZWM_6W8]+_;"^
M&_B;XD>*_"EIX;TB?5)H;2X:4QE42,%T W.Q"C/.,GG!]#7RWX[^$OB[X9BW
M;Q+HDVFQSG;',726-FQG;O1F7..V<\5]A?M9?'+Q'\*%T/3_  XT%I/J"R2R
M7DD8E9 A4;55@5YW<D@^V.M6OBM?/\2/V1I=:U-(UOI]-MM0)B7"K*'0DJ#T
M!^8?1C2PU>K1ITTTN5NWGN3FN78/'8G%2A.7MH+F>W+HEIW_ .'/C;P/\'_&
M7Q(MY;CPYH-QJ5M$_EO.&2.,-@';O=@"<$< \9%:_B;]G+XC^$=)GU/5/"]Q
M%90+OEE@GAN-BCJQ$;L0!U)Q@#DUZI^SE??&*^\!RZ3X(M=+L-$6XDD76-2C
M(/F$#<J9W!@,?W#@Y!/:OIOX2Z3\1=+L=1@^(>K:3K;LR&TGTY"K;2&WK(/*
MC7'W<8&>6SVK;$8RI1F_ALNG4\_+LBPN.I0;512DOBLN2_YO]3\V- \/:GXJ
MU6#3=(L)]1OYCA+>W0NQ]^.@'<G@=Z]#U#]E[XH:9I\EY/X4F\B-"[>5=02O
M@#)^19"Q^@%>F?LS>*?#'@'XY>,M.U)K?2_M4TUGI]Q-A8X]L[?NMY^[N 7'
M8[ .N*]G^(EG\9_#]YJ6L>%]:TSQ7HD@>2/1KJR2.6*,]%C9-IDP">2X)P,
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M--Q/X4\*MX/5#(UIIANDU+"C)2/>(_*Z=]N[VSWKY KJ/A9_R4[PA_V&+/\
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M#-(797!"G(*8W9XZ5[UX1\4?"G]G?PKJ(TWQ[)X@MW(D2R_M.*^D# '"11Q
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MUS#);W,+M'+#*I5T8'!5@>001@@U%75_$_Q-/XX\;ZOXFDL9+&WU6Y>:!&3
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MEI*45#*'4445+*.G\'W \NY@)YR)!_(_TJGXT5FNACO!@?K5#2[YM/O(YAR
M<,/53U%;WBB 75G;W<1WHO&X?W3T/YU^@4<5]=X>GAX_'1:=N\;WO\KO[CW:
M=3VN"<%O'\CYK Q+R,#->WPX\M=O3 Q7D_BS26TG6)0%Q%(?,C/;![?ATKT+
MPEJR:KH\+;LRQ 1R#OD=#^(KZ3CS_A1R["9E0UIZW\N9*WXJS\]#T<U_?4:=
M>&W^9]!_!<Q?\(O=!/\ 6?:CYG_?(V_U_6N^KYU\(>+[OPAJ#3VX66&0!9H'
M. X[?0CUKTG_ (75I/D;OL-YYN/]7E<9_P![/]*^/RO-L+#"QI59<KB;X''4
M8T5";LT3?&0Q?\(O;A_];]J7R_\ OD[OZ5XQ6YXL\7W?BZ^6:=1##&-L4"G(
M0=^>Y/K6&.M?%YOBX8S%2JT]MO6W4\;&5HXBLYQV'4Y>E-IXKP)'(CZX\+_\
MF?W/_7A=?^CGKY+'>OLCX6^'KCQ;^S##HUI)''<WMK<PQO*2$#&9^N 3C\*\
MN_X8\\6_]!31_P#OY+_\;KU,50JUH4G3C?W4?58S"U\13H2I1NN1'A2U]8_L
MZ_O?@'XDC3YG\V\&T=<F!,5Y!\0/V>?$'PX\.OK5_>:?<VJ2+&RVSN7&XX!P
MRCC-=1^RW\3K'POJ5]X>U>9+>RU)ED@FE.$68#:58G@!ACD]U'K7)A4\/B5&
MKI=6^\QP$987%*%=<MU;7S/"J[GX'J6^+'A@*,G[8IX]@37IGCS]D_6/[:GN
M?"]Q:W&FSN72WN)#&\.>=N<88#L<Y_G76?"+X'1?"2>;Q7XMU*TCGM8F\M4?
M]U ",%BQ RV,@ #OW-94<!7C7CS1LD[M]-"L/E^(A77/&R3NWTLCA/VNW5OB
M'IB@Y*Z:F1_VTDKNOV<_^2&^(_\ KM=?^B$KP3XN>.1\1/'FH:O$&6S.(;96
M&"(E& 3[GEOQKWK]G,X^!OB3/_/:Z_\ 1"5MAJBJX^I..S3.S#5%5Q\YQV=S
MR#X#?$@_#SQG$;F3;I%_B"[!/"\_+)_P$G\B:^@]/^':>%_CU'K]C'C3-8LY
MRVP?+'/\I;\&'S#WW5\9U]A?LT_$H>+O"O\ 8E]+OU725"J6.6D@Z*WU7[I_
M#UK'*JT:DEAZG1WCZ]5\PRRK&HU0J='=?JCP7]H3_DL/B+_?B_\ 1*5[-^R?
MH::9X-U?6YBL7VRX\M9'X CC7KGTW,WY5XS^T)_R6'Q#_OQ?^B4KV/Q]_P 6
M[_9HT[21B.ZO8H8&'?=(?-D_3</QK/#6IXW$8F2TAS/YW-,/:&*K5G]GF?XF
M=>?LU:#?7D]S-XY1Y9I&D=MD?+$Y)^_ZFO3/AY\/=/\ #?@O4O#$.M)K5K<^
M86("@QK(FTC )XX)_&OB&O7?V8_$']C_ !*BM';;%J5N]N<]-P&]?_02/QK+
M X[#?68QC1Y>;2_,WN/"XJC[9)4[7TO=]3R_4K"72]0NK*8;9K>5H7'^TI(/
MZBH5KT?]H;P__8/Q3U(JNV*^"WJ?\#&&_P#'U:O.!WKY;%4G0K3I/HVCS*D/
M9SE#L+12T5PL2/#Z**!UK^])'Y%U'5]2?#7Q)JGP[_8[U[7?#EVUMJLVN!9+
MF-$<P ^2F,,"!D =LC?QV-?+=>C?"OX\>)OA':W]EI2V-_IE\=\^GZG 98&?
M &[ 92#@ 'G!P..!7BYA0EB*:44G9IV>SMT/8RS%0PM:4IMQYHM76Z;6_0]P
M_99\;^*O$MKX[U/QGK-YJ_@FVTN7[4=6D:>+SCAMJ;\\",/E <?,O'(K#_9M
MU*;X=_!'XI>.H+@6]VJ16%E)Y88QS@':<-D'YIX^",?+SFO-OB)^T3XM^).B
M)HMS]AT?1%;<VFZ/;F"&0@Y&[+$D \XSC/.,@59^&_[1VO?#/P?)X:L=$\/Z
MEILERUU(-4M'E9W(49.)%!QM7&1GCK7C5<%5E";Y$N=Q]U;6CYVW?H>W2S+#
MPJTHNI)^SC.TVM>:2MM>]ETU(/$7[37Q*\5Z'>Z1JGB4W.G7D9AGA%C;1[T/
M4;EC!'X&O,XHWFD2.-6=V(5549))Z "O4_'7[16J^//"]YH=QX6\*Z9#=%-U
MSIFG-%.NUU<;6,AQDJ >.A(IGP[_ &@=3^&OA^+2K'PQX7U!8Y6F^UZE8/+<
M%B<\N)%Z8 ''  KJC&=&F_9T5%WV32^>QX]:5/$5TJV)E*-OB:;?I9L[G]LB
M2+0]0\">#H%Q#H.B(HYSRV$Q]<0*?QJ?5?.L_P!AW1?L,>]+K76^W,H)V*'F
MP3CI\R0CGU'M7(_$#]J+Q#\2-"O]-U/P_P"&8FO$6-[ZWL7^TJH8'Y7>1L=,
M=.A.,5C?"_X_>)_A5I=[I6G)8:EI%VWF2:?JL!FAW$ %@ RD9 &1G' XKS(X
M>NL/3BXKF@[[[]_S/5J8["2QM:HIODJ1<;V^'9+2^NBM\SO?V1=#BT'4_$'Q
M(UB/R=#\.V$H2=U^].RXVH>YV%EP.<R*.]>#:QJD^N:M?:E=$&YO)WN)2HP"
M[L6;'XDUW7Q)^/WBKXGZ9;Z5?&STO186#KIFDP&" L,D$@DDXST)QWQFO.:Z
M*5.?/*K4W=M.R1Y&,Q%)TJ>%P[;C&[;:M=OK;LDDD?3OAUA\ _V<=,\;Z+8P
MW'B_Q)<-;#59D$GV"(^9@(",9Q&#@]6;G(4"MG2]+M?VQOA[9>;<+I_Q"\/"
M.WN+V6(^7=0,?O$J,'/S-@=&!X ?->-_#?\ :,\5_#7P_)H5K'INKZ*S%UL-
M7MS-'&2<MMPRG!)S@G&>>YJ_XB_:I\>ZY;06UC=6?A>TA<2"WT&W^SJS @C)
M)9L9'3.#D@@UY4\-6YW**7->ZE?IVM;MI8]ZGF."5*,*C?L^5)T^7K_,G=:W
MUOOT+W[4WBJQNO%6D^#M'5QI'@^S&F1M*I#/* HD//481!G')5CR"*\6AB>X
ME2*)&DD=@JH@R6)X  [FNW^*7QBUOXO2:7-KEMIT=U8QM']ILK<Q23[MO,AW
M')&T8Q@#)XYK%\ ^-+SX=^+M.\16%M:W=Y8LSQ17J,\18HRY(5E.1NR,$8(%
M=%*,J=%1MJOS]?,\#&UJ>*QLJG-[C:UMLM.E^BTWUL>T>$? .B?L_:7:^-/B
M)&MWXE8";1?"BN/,W#[LL_7: >?1<=V^4>1^*O%6N_&+QY]OU&87&J:E.EO#
M&"1'$&;:D:#G:HS^I)R237IU]^V+XDU.X:XO/"/@V[G;@RSZ;*[''3),V:\]
M\0?%K4/$7Q TGQ<=(T?3K[39()(K33[4Q6SM%)O4NFXDY/!YZ#'%<U*-7F<Z
MD?>[W_!'HXNM@W3C1PU1^S36G+J^\F^K[*UET/H#]I+X[>*_A=XZLO"_A#6D
MTW3]/TR!)8EM8)3YAW8R71B/D\O@5\U^./'^O_$C65U7Q'?_ -HWZPK LWDQ
MQ80$D#"*HZL>W>O5[S]L+Q'J5R]Q=^$/!MU</C=+-IDCNV!@9)FR> *\XUCX
MG7>N?$*W\73Z-HL=Q#)%(NFPVA6R/E@ !H]V2#C)RW-9X>DZ44G!)I;]RLTQ
MD,7.3AB).#?PV=DOOMIZ'J_[':1:'J'CKQA.<0Z#HCL>,\ME\_7$+#\:^>9)
M'FD:21F=V)9F8Y))ZDFO>;;]LCQ/96]Q;V_A3P?!!<#$T46G2JL@]& FP>IZ
M^M>:^)OB==^*O'5EXHN-'T:VGM7A9=/M+0I9OY;;@'3<2P;HW/(..*=-5%4E
M.4=_/L88J>$EA:-"C4;<&[^[;XGOOT22/5/V,;2.Q\8>)_%%UL6RT/1I99)'
MXV,Q!SGL-D<E> 7MY-J-Y/=W,AEN)Y&EDD/5F8Y)_$FO=;7]LCQ/8PW$-MX4
M\'V\5PNR:.+3I561>>& FY')Z^M>5_$3Q_=?$C7DU6[TW3-*D6!8!;Z3;F&'
M ).=I8_-\QYSV%3353VDISC:]NO8,74POU.E0HU&W%MO2U[]=^B2,CP[JG]A
M^(-,U+!;['=17&%ZG8X;^E?:GQ(T6U^'/Q-\:_%J[B1Q:Z9;PZ6K\K-?21^4
M".?X45<X[.3V-?#=>E?%#X_>)_BYH^E:5K*65O9:>V]4LHG7S7V[0[EG;) W
M8Q@?,>.F)K4I5)Q:VV?IH5E^.I87#U5/65U*'^)*2O\ *]_D?1U[X+7XCZQ\
M(_&>MS*FDZ7X=34M7OI2 I,(1U#'W=F)![!ZX/X,^(IOC+^UA-XIG9H[6TCN
M+R&*0G]W B>3$O4X(\Q6..,Y/>O+M6_:"\5ZI\+[/P$3:6^C6\:0F6WC=;B:
M-3D([%B-O3HHS@>^<CX;_%35OA<^LR:/;V4EQJ=FUD\]U&S/$AY)CPPP<X/.
M1\HXKG5":A)/?9>AZ,\UPTL11DK\J:G/NY)))>BM][9Z?^SRI^(G[4DNNY)A
M%Q>ZL0PYVMN"#VP9$_+%>7:U,WQ-^+5VT$S,==UIEAD?.0LTV$X/H&''MBH/
MAM\2-9^%?BB/7=$:'[6L;0O'<(7CD1L95@"#C(!X(.0*Z77OV@-<\0>-= \2
MSZ3H<%QHLIGMK.VM&CMS(2"7<;]S-D*<[OX16O).-1M+2UCS/K%"KA8TZLFI
M<[D]-[V6]]+*YV/[9GBZ;5/B>GAV*9AINA6L426X^X)70.S>YVLB^VWZU/\
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MYAXV^,.L>/?&ND^)M1L]/2[TR.&*"VMXW$!6)RZJP+EB"6.<,./2LGXB>/\
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M'E9IRSJ1J0NE9*S5K625O,^AHI[WP+^QLDMC',DGB;572YF7(V0_,AR<=&$
M7'<.?6C]F^.;P-\-?B+XZO5\BS^P?8K)I#M$\WS?*,]?G,:Y]2?0UTOQ4^*V
ML? O2/ 'A72ULKKR=!1M1L;^W\V"8MM +#(.=T<G /\ %SVKP[XE?&[Q)\4+
M2TL=2-I8Z5:'=#INFPF&!6P0&P223@D#)P.W4U"3DCV,17H8*M%\S<Z<%%1M
MIS6U=[]VWM>YZ+?2/X7_ &,]*.GKL;Q#K+K?2(3DJK2 *3VSY$?'IGUK1^ W
MAZ^\ _!CXA>/+Q/L1N]-:TTV2088Y!&\>QD:,#U*GVKS?X=_M">)OASX=ET&
MUM],U;27D,J6NK6[3+$Q.25PR]3S@Y&>>YI?%?[17B[QKX6U;0-6>SGL]1GC
ME9EA*/"J%2D4>&VA 5!Y!/)R:;3V.>&-PD7"OS/GC#E2MHI6:O>_5N^W4[3]
MG%9/#GPQ^*WBM1Y<L.F_8[68#D2,KD_D3$:X[]F7P_\ \)#\;?#4;1>;#:RM
M>R9Z+Y:,RM_WV$_$BL_X7_&[Q!\*+74K/3(-/O[#4,&>SU.%I8B0",@!EZ@X
M/.#@>E3:%\>-?\/_ !#U3QE:V>E_VK?VQM6B:!A!"F$ \M5<$$"-0,D]^M*S
MU.>GB<+RX7FD_P!V]5;^\W>_W*UCV_X+7\7B#X\_%+QC-$MY<Z;'<?8X5.-R
MARBD'!(.R(+D?WSQS7FMC\?/"OAO4)=5\._#"RL]=9C*FH:EJL]^R2')WX<
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MU4S+LOO/@ZG#H:^[_P#A@WP!_P!!?Q)_X$V__P 8H_X8/\ _]!?Q)_X$V_\
M\8K)YUA.[^X?^JN9=E]Y\'KUIU?=W_#!_@'_ *"_B3_P)M__ (Q2_P##!_@'
M_H+^)/\ P)M__C%8O.,*^K^X/]5<R[+[SX0IR]*^[?\ A@_P#_T%_$G_ ($V
M_P#\8H_X81\ _P#07\2?^!-O_P#&*R>:X;N_N'_JKF79?>?"=%?=O_#"/@'_
M *"_B3_P)M__ (Q1_P ,(^ ?^@OXD_\  FW_ /C%9/,\/W?W!_JKF79?>?"5
M*O6ONS_AA'P#_P!!?Q)_X$V__P 8H_X82\ _]!?Q)_X$V_\ \8J?[2P_=_<'
M^JN9=E]Y\*T5]U_\,)^ O^@OXC_\";?_ .,4?\,)^ O^@OXC_P# FW_^,5/]
MI4.[^X/]5<R[+[SX4HK[K_X83\!?]!?Q'_X$V_\ \8H_X83\!?\ 07\1_P#@
M3;__ !BI_M&AW?W!_JKF79?>?"E%?=?_  PGX"_Z"_B/_P ";?\ ^,4?\,)^
M O\ H+^(_P#P)M__ (Q4_P!H4.['_JKF79?>?"E*M?=7_#"?@+_H+^(__ FW
M_P#C%'_#"G@+_H+^(_\ P)M__C%+^T*'F'^JN9=E]Y\*_P 5+7W3_P ,)^ O
M^@OXC_\  FW_ /C%+_PPKX"_Z"_B/_P)M_\ XQ4?7Z(?ZJYEV7WGPK17W5_P
MPKX"_P"@OXC_ / FW_\ C%'_  PKX"_Z"_B/_P ";?\ ^,4OKU$/]5<R[+[S
MX5HK[J_X85\!?]!?Q'_X$V__ ,8H_P"&%? 7_07\1_\ @3;_ /QBI^O40_U5
MS+LOO/A6G+TK[H_X85\!?]!?Q'_X$V__ ,8I?^&%O 7_ $%_$?\ X$V__P 8
MI?7:0?ZJYEV7WGPO2-7W3_PPMX#_ .@OXC_\";?_ .,4G_#"O@+_ *"_B/\
M\";?_P",5'URD'^JN9=E]Y\*T^ON?_AA7P%_T%_$?_@3;_\ QBE_X86\!?\
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M8/\ XQ1_PPWX$_Z"WB+_ ,"8/_C%'M(!_8.<?S?^3'R5_P +>\=_]#KXB_\
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M;Q%_X$P?_&:?M(D2X:S*3O))OU/AZBON'_AAWP)_T%O$7_@3!_\ &:/^&'?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 45AV'CKPWJGB:^\.67B#2KSQ#8IYMWI-O>Q/=VZ?+\TD0;
M>H^=.2!]X>HK<JG%QW0DT]@HK@_"WQS\#>-?B%KW@;1?$$5]XKT)6;4-.6&5
M6A"LJ,0[*$?:S*#M)P2 :[RJG3G3=III^8HRC)7B[A1116904444 %%%% !1
M110 4444 %%8>D^.O#>OZYJ.BZ9X@TK4M8TTXOM/M+V*6XM3G&)8U8LG/'S
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MH;.\@U"S@NK6>.YM9T66*>%PZ2(PRK*PX(((((ZYJ:D,**** "BBB@ HHHH
M**** "BBB@ HK#T/QUX;\3:KJ>EZ/X@TK5M2TN0Q7]G8WL4TUHX8J5E16)0Y
M5AA@#D$=JW*J47%VDK"33U04445(PHHHH **** "BBB@ HHHH **** "BF2R
MI#&\DCK'&@+,[' 4#J2?2LCPKXU\/>.]/DO_  UKVF>(;".4P/=:5>1W42R
M E"T;$!@&4XZX8>M5RMKFMH*ZO8VJ***D84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7P'_P %8U>\TGX5Z>9GCM[K4KL.JGC.V%0V.Y =L?4U]^5\#?\
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MT#VT9V[5SR1P<\]#+X^_X*(1Z=XZUWP[\/?AEKGQ+CT%G74]0T^1TBAV$AV
M2&4E 01O;:#@XR,$^2_L#_$WX8V_C.^\3^,?&BZK\9_'%\UNEJ^GW1^S*\G$
M0E\KRPTC $X;:%"+Q@UX'\&-2O?@_P")O&GA;Q)\:];^"NJ6M_Y=S'#H$VH+
M>NFX;V:-PP/<94@AL@\UU?V7A'7J1]BUR*.GOVDVW=JUY-+96TZF/URLJ<'[
M2_,WK[NBZ)[*_J?I#X-_;)\!^+O@#JOQ7+W-AI&D9BU"PE"M<0W'RA80 <,7
M+H%.0#N&<8./C_\ :/\ VY[CXV?LZ^)M$O?AAKGA;2M>-NFCZ]-*TUI=20W<
M,KH6,2*#MC;[K/R,'UK M/A?I=Q^PC\5;_P'XEU+QE9)XEMY[NXN=)_L\LL"
MQ-(R1^=(60"=7+-M/R'Y1C-:7Q._:N^'_C/]A'1/ACHL5Y=>,8]*T^SN+*.Q
M<+9FT>%YKAI,;2KB)SE23\_S8YIX7+\/1KJI1IN=JB75<B5G=KU[]NX5L55J
M4^6I-1]R_1\SU7]6/NC]D7_DV/X9?]@*V_\ 0!7KM?)W@G]H[PO^S7^Q[\(=
M<\4VVIW=M?Z=:V4,>E0I+)O\HN6(=T 4!3WSR.*^J;"]CU*QMKN'/DW$:RIN
M&#M8 C/X&OC,=1J1JSJM>ZY2L^]GJ>]AYQ<(P3U27Y'R'XE_X*()HGQ"\;>!
M]/\ AGK'B/Q1HFIMI^FV&D7#3OJ00R"65@L),(78G $A/F>Q-=S^S=^VAH?[
M0&E^*%N-!O/"WB+PY$UQ?:-+)]H<PKD%HVVH6(92I4J""5ZYKY7^%'Q^\'_
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M?_I)V7B#_@I=%)JVLR^"/A5X@\;>$M'<B^\1P2O%%$HZR%5AD"H0"079"1U
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M.>16'=_\%*)Y/$7B'P[H?PDUCQ+XATG4KFU^PZ7>/-OMH6*O<L5MR4Y'W0K
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MEEZC2CK)N3O?[-[1\M=ST\%B)XIN;V22^?46BBBOG3U0HHHH **** "BBB@
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MH?@7PUX9U;5-4T?P]I6DZGJDGFW][8V44,UVY8L6E=5#2'<S'+$\L3WIN@>
MO#/A34M1U#1/#FDZ/J&I/YE[=:?8Q02W39)W2NB@N<L3EB>2?6MZBJ=2;O=O
M47+'L<4GP3^'<=U?7*> ?#"W%\CQW<RZ-;![A7!#K(=F7# D$'.<U<U#X5^"
MM7\/V6A7W@_0;W0[$;;33+C3()+:W'I'$5VK^ %=315>VJ:/F?WB]G#L9?AO
MPMHO@[3$TW0-(L-#TY3N6TTVV2WB!P!D(@ SP.W:L'5O@O\ #[7M:;6-3\">
M&=1U9G\QK^[T>WEG+?WC(R%L^^:[*BI52<6Y*3NP<(M6:(X(([6&.&&-8H8U
M")'&H554#   Z "N0\2_!?X>^,]6DU7Q!X$\,Z[J<BJKWNI:/;W$S!1A07="
MQ   '/%=G12C4G!W@[,<HQDK-7..\,?!OP!X)U1=3\.^!O#>@:DJ-&+S2](M
M[:8*>J[T0'![C-=)K&BZ?X@T^6PU6PMM2L9AB2UO(5EB?ZJP(/XU=HIRJ3E+
MFDVV"C&*LEH<WX2^&OA'P"9CX8\*Z+X<,PQ*=)TZ&UWCT;RU&?QINJ?##P;K
MGB.'Q!J/A+0[_7X2IBU2ZTV&2ZC*\*5E92PQVP>*Z:BG[6IS.7,[^HN2-K6T
M.<\4?#?PEXXN+6X\1^%M%\03VG-O+JFGPW+0\Y^0NI*\^E6-/\#^'-)\0W.O
M6/A_2[+7;J%;:?4[>RCCN98E"A8WE"[F4!$ 4G "+Z"MNBE[2=N6[L/EC>]C
MF7^&/@Z3Q0OB5_">AMXC5MPUAM-A-V#Z^=MWY_&KWAGP?H/@JSGL_#VB:;H-
MI/.US+;Z9:1VT<DK !I&5  6(506/)P/2MBBAU)R5FW8%&*=TCX\_97_ &>_
M'&C?M(?$[XK_ !"T"'0;G5I)8])MDN8)_P!W++N9_P!TS %4CC7+8)WMQUK[
M#HHKHQ6*GC*GM)I+1*RV22L94:,:$>2/K]X4445QFX4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9OVC+S6M&;P_JS>(=-2ZTYKA;A8I$TNW1BDJ@>9&Q7<CE59D92R(Q*+M:E\
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M8O!%CX#\4CP5!IT>JV5U=^+M/U&Z-S=16EVEPCKIK6H2.27R4#)]K94+-AF
M H XGQ#XP\#R?M;?%S1_BC\4KWPAI&GZ;H,FAV$WC^]\/0;I(KDW311PW<*R
M$E82QP<9'3=S[O\ '+Q-K?@/]G+Q9KO@*2UO=0TKP]<7=C>:AJ#N$CCMF87
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M<\?>!;;P?+XPMYY-%>RUHZBZSPP^?):W:&WB$,PB#-^[:9"8Y!OX4MD? _\
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M:SW]M-=Q V[SVJP"-8))#L603LVUXV:-"Q1.+@_9QU7X?:K\2_'A\(?#_P
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M[\%DU/1?!'CWQ%X$T:XT2_T'Q,KR:1?Q3%&,D4S6\C12QO&I5S VX,ZD+D,
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MU\./%K>#/AMX&M/#.EWFG:@GA%Y9KS5998(T%Q+.UK 7^9"=CAF7<[>8Y;
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MB#X>MX6U#0?&6I2:Y;WGB#4;FVNM$OIXECN,0Q6\BW<6Z-)D7S8#EV0G #D
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M^A:K!%)?1_:,"T\L6TDL<WGL=D?E2-EP4.&4@69/VA++0?">O>(?&?A#Q3X
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MT7SH'>WOG(N'AEA(4E6A>5B5(V95@H!]245YQ^S_ *6VE_#'3/,T[Q5I=Q<
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MU\)^*/V<KS5=%^RV_A+X>7.A:T_VJ!_LEZZ606+"N2^3#)\R;E^7KR,_5M%
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M>-M1^'=SX.\*>&=/UJTN/[4U2RFO?/NH;;#&.WFE3RB8@J,KLY*R;TC&PO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !H T:*SO[0D_NK^1_QH_M"3^ZOY'_&@#1HK._M"3^ZOY'_&C^T)/[J_D?\
M&@#1HK._M"3^ZOY'_&C^T)/[J_D?\: -&BL[^T)/[J_D?\:/[0D_NK^1_P :
M -&BL[^T)/[J_D?\:/[0D_NK^1_QH T:*SO[0D_NK^1_QH_M"3^ZOY'_ !H
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M](N?$?P_U3PW'??\)Q>ZA$EP;@!56&6UQO:1URS.,*K C% 'JM%%% !1110
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M>4Z-,8RF!M4)]KR"#NR=QSD<#&3%\,_$'B;Q1X-LM2\7^$_^$(U^5I!/H?\
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MX8X.*Z6L#Q=JG]BZ5?ZCY7G?9+62X\O=MW[%9L9P<9QUQ0!\P?#O_@GC\/?
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MXL^'VM?$OXF>*?#WB*&S@=->U^.[>P6VG6:/[*&@VQ99%#?*<JH'&,U],44
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M=C]OCO/,@20K%/O0 #S$ ?9U7=@\BNCH **** "BBB@ HHHH **** "BBB@
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M-4\,?V%K5O\ 8+."\_MF>SVZ=<>8SCRH9L_/(FS++@8#+SS0!T=:.G_ZEO\
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M-DG S52P\ ^&-*_L/[%X<TFS_L**2#2?L]C$G]GQNH5TM\+^Z5E !"8!  -
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M]YYL@V6TKQR2)L#;#EHHSDJ2-O! )SXW\8/V3]%\;:=X3TG1-,TZ'18?'_\
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M?&_XI?\ "PO&/_"4^$O%6N2Z$HURX6SLXK/4&9+=K8,([B)PIC99UD 0[4V
M"OJ+P7^SGX \ ZWI6JZ1I-X;O2(9+?2EU'6+V_@TN-U".MG#<3/';90!/W*I
M\F4^Z2*W[/X$^!YOAWXH\%/H>?#/B6ZO+K5;'[7/_I,MTYDN&W[]Z;F8G",
M,\8% 'H-G<?:K2"?;M\Q%?;G.,C.*FID,*6\*11C:B*%4=< # I] !1110 4
M444 %<E\3/\ D3O$'_8,N/\ T6]=;65K%O%=;X9HTFADC*/'(H964Y!!!Z@B
M@#X@\*^*++X#?#G]G+XMZG<"S\,W/P]LO#'B"9@-JJ+!+NPD)[8ECGB'7F[
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M_P#T:=_YD?3/_C=?4=% 'RY_PT%^TO\ ]&G?^9'TS_XW1_PT%^TO_P!&G?\
MF1],_P#C=?4=% 'RY_PT%^TO_P!&G?\ F1],_P#C='_#07[2_P#T:=_YD?3/
M_C=?4=% 'RY_PT%^TO\ ]&G?^9'TS_XW1_PT%^TO_P!&G?\ F1],_P#C=?4=
M% 'RY_PT%^TO_P!&G?\ F1],_P#C='_#07[2_P#T:=_YD?3/_C=?4=% 'RY_
MPT%^TO\ ]&G?^9'TS_XW1_PT%^TO_P!&G?\ F1],_P#C=?4=% 'RY_PT%^TO
M_P!&G?\ F1],_P#C='_#07[2_P#T:=_YD?3/_C=?4=% 'RY_PT%^TO\ ]&G?
M^9'TS_XW1_PT%^TO_P!&G?\ F1],_P#C=?4=% 'RY_PT%^TO_P!&G?\ F1],
M_P#C='_#07[2_P#T:=_YD?3/_C=?4=% 'RY_PT%^TO\ ]&G?^9'TS_XW1_PT
M%^TO_P!&G?\ F1],_P#C=?4=% 'RY_PT%^TO_P!&G?\ F1],_P#C='_#07[2
M_P#T:=_YD?3/_C=?4=% 'RY_PT%^TO\ ]&G?^9'TS_XW1_PT%^TO_P!&G?\
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M$;0D\D(S':5]B1CIS0!\VU]]? "XNKKX.^&'NRQF%NR#=UV+(RI_XX%KY_\
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M_P"?'_DT/_DC/V]/N?:5%?%O_#QIO^B?_P#E9_\ N>C_ (>--_T3_P#\K/\
M]ST?ZIYS_P ^/_)H?_)![>GW/M*BOBW_ (>--_T3_P#\K/\ ]ST?\/&F_P"B
M?_\ E9_^YZ/]4\Y_Y\?^30_^2#V]/N?:5%?%O_#QIO\ HG__ )6?_N>C_AXT
MW_1/_P#RL_\ W/1_JGG/_/C_ ,FA_P#)![>GW/M*BOBW_AXTW_1/_P#RL_\
MW/1_P\:;_HG_ /Y6?_N>C_5/.?\ GQ_Y-#_Y(/;T^Y]I45\6_P##QIO^B?\
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M?<^TJ*^+?^'C3?\ 1/\ _P K/_W/1_P\:;_HG_\ Y6?_ +GH_P!4\Y_Y\?\
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M ,K/_P!ST?\ #QIO^B?_ /E9_P#N>C_5/.?^?'_DT/\ Y(/;T^Y]I45\6_\
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MKXM_X>--_P!$_P#_ "L__<]'_#QIO^B?_P#E9_\ N>C_ %3SG_GQ_P"30_\
MD@]O3[GVE17Q;_P\:;_HG_\ Y6?_ +GH_P"'C3?]$_\ _*S_ /<]'^J><_\
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M;T^Y]I5!<S>2A-?&G_#QIO\ HG__ )6?_N>H+K_@H>US&5_X0';[_P!LY_\
M;>C_ %3SG_GQ_P"30_\ D@]O3[GVJ^CWY/RO!^+-_A3?['U'^_;_ /?3?X5\
M@?\ #RQO^B=_^5O_ .YZZCX<?\%!]%\7>*+;2M>\-MX9M;@[$O\ ^T/M"*YZ
M!QY2;0?7)K.IPOF]*#J2H:+SB_P3N"K4WI<^E_['U'^_;_\ ?3?X4?V/J/\
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M[]O_ -]-_A70T4 <]_8^H_W[?_OIO\*/['U'^_;_ /?3?X5T-% '/?V/J/\
M?M_^^F_PH_L?4?[]O_WTW^%=#10!SW]CZC_?M_\ OIO\*4:/J'=[?_OIO\*Z
M"B@#G1OAG>&0@NF,[>G(S_6MC3O]2W^]_05BW7_(;NA[K_Z"*VM/_P!2W^]_
M04 6J*** "BBB@ HHHH *Q]>Z'_<_P :V*Q]>Z'_ '/\: +^F_\ (-M/^N2?
M^@BK-5M-_P"0;:?]<D_]!%6: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#T-?CW\</
M^2U?$#_L8-0_]*9*_81ONFOQ[^.'_):O'_\ V,&H?^E,E?I_ G^\U_\ "OS.
M+%;(XFBBBOV8\\Z*X^'/BRST$:W<>&-9@T4JKC4I-/F6WVGHWF%=N#D8.>]6
M='^$OCCQ#IL&H:5X,\0:GI\X)BNK/2YY8I "02KJA!Y!'![5]7^"?B5XL\'_
M  +\;>,OBKKEU?CQ7:FTT'1+X@-.3&ZF1(L8CC(=2<*!A=V#N7-^\O+*S_9;
M^$QO?BGJ7PN5HI MUIMK=3M=G)^1A ZD =>>.:^)GGF*@^3V:?O\EUS23]UM
MV27,[-6=E^1T>SCW/C#2O!/B+7=8N=(TW0-4U#5K8L)[&ULY)9XBIVL&C52R
MX/!R.#5*QT34=2U9-+L["ZNM3>0Q+9P0L\S.,Y4(!DG@\8[5]0?L.^/M>?XU
MR>'1K4U[HMZUYJ-QYBC?=S[,"61R-Y)P#AF(R<XSS7FWPI\<:YX._:$B@T:^
M:Q35O$$5C>%(T+20M>+N0,02H/?:037K/'XA5J]'D5X14EJ];WWTTVV_$CE5
MD^YY1K.BZCX=U*?3M6L+K3-0@($MI>0M#+'D C<C $9!!Y'0BM:U^'?B&]\"
MWOC*+3\^&[.Y6SFOFFC4"8[<($+;F/S+]T$#/->B?MC?\G)^-/\ KK;_ /I+
M#77_ !:M#H/[&OPDL(G#1WU_<ZA,VW!,A,FWOV60K[X[=*K^T9RHX2<4KUG&
M_DG%R=ONL@Y5>2['S317WE?? 'X-ZA\9M9^%]EX/O[34FTEM1BU==5F*VK;4
M"I'&S$,.=V7W<Y&,8QXOX'^#_@/6O"&DWVH>"?C/?WUQ;K)-<Z'I-O)92,>K
M0LR$E/0FN>CQ!AJT.?DDM(O5+:2;3T;[,;I-=3Q#PWX'\2>,O._L#P_JFN>3
M@2?V;927&S/3=L4X_&H;?PGK=YKQT.#1M0GUH,4.FQVKM<[@,D>6!NR!VQ7T
M-\&?$FE^#?'>I>'9_B1X@^&'A?3M;AO+;1=6T]EN[YCA9$NI(@!%A8HP0^4P
M^<#!->[^*8]7\-^//VA?%36=MI>O6OAJT?2+RT(DE%NT<ZF7=@$-N@&1@8V+
MU !/+BL\JX>O*G[-6:3CNM6XI;JS^*[Y;VM9ZE1IIJ]SX;TWX2^,=4\96/A-
M?#M]9^(KX,UOI^I1_8WD 5F)'G; !A&ZGG&!SQ7,ZEI]SI&H75C>0M;W=K*T
M$T+=4=2593[@@BOL6\\4:KKWPA_9U\6:K=37?B6+Q1]F749W)GEA^T,I#,>6
M!6- 2<YQSG)KQ/\ :^TN#1_VCO&L%LBI&]Q#<$+TWRV\<CGZEG8GW-=F S.K
MBL3["I%+26W>$^5_)W36EUJ3*"C&Z/'J***^D,0HHHH **** "BBB@ HHHH
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MBSX=?MA:/K%_K]_H?PEN]9'@W2Y-9N!;:9)#]L=91&&"NY^S1 [@01N.,G-
M'[%45X/^PGXOU/QU^R+\,-9UB[FOM2ETH0RW5Q(9))?*D>(,S'EB1&,D\GN2
M>:]XH **** "BBB@ HHHH YNY_Y#EW]5_P#016UI_P#J6_WOZ"L6Y_Y#EW]5
M_P#016UI_P#J6_WOZ"@"U1110 4444 %%%% !6/KW0_[G^-;%8^O=#_N?XT
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M!#0O_ B;_P",UG+'<.RE*3G"\M'_ %T^0<M8KZ3\>O\ A9GQ:^']SXZN-/\
M"_@_PW<+-#9Z+8NEK;"/]X L2[V^=HXTXX Z;>37G7QD\>?\+,^*'B7Q,JLD
M.H7C/ K##"%<)$#[[%7/O7IO_#%/CO\ Z"&A?^!$W_QFC_ABGQW_ -!#0O\
MP(F_^,U5',LBP]55:5>*M'E2Z)7N^F[>_H#A5:LT> 45[_\ \,4^._\ H(:%
M_P"!$W_QFC_ABGQW_P!!#0O_  (F_P#C->C_ *Q95_T$1(]C/L> 45[_ /\
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M:/\ ABGQW_T$-"_\")O_ (S1_K%E7_01$/8S['@%%>__ /#%/CO_ *"&A?\
M@1-_\9H_X8I\=_\ 00T+_P ")O\ XS1_K%E7_01$/8S['@%%>_\ _#%/CO\
MZ"&A?^!$W_QFC_ABGQW_ -!#0O\ P(F_^,T?ZQ95_P!!$0]C/L> 45[_ /\
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M:/\ ABGQW_T$-"_\")O_ (S1_K%E7_01$/8S['@%%>__ /#%/CO_ *"&A?\
M@1-_\9H_X8I\=_\ 00T+_P ")O\ XS1_K%E7_01$/8S['@%%>_\ _#%/CO\
MZ"&A?^!$W_QFC_ABGQW_ -!#0O\ P(F_^,T?ZQ95_P!!$0]C/L> 45[_ /\
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M:CF_8Q\<0*6;4-#Q[3S?_&:/]8LJ_P"@B(>QGV/!**^AO^&'?'W_ $$=!_\
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MGQ6\._#;4=;6W\;>(;:6[TS2_LTS&XBB61W;S%0QKA8I#AF!.TXS0!W%%%%
M!1110 4444 <W<_\AR[^J_\ H(K:T_\ U+?[W]!6+<_\AR[^J_\ H(K:T_\
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MQ,O_ .??XR_S#ZCA_P"7\7_F>^?\-31?]"F/_!A_]JH_X:FB_P"A3'_@P_\
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M ,SWS_AJ:+_H4Q_X,/\ [51_PU-%_P!"F/\ P8?_ &JO Z*/[$R__GW^,O\
M,/J.'_E_%_YGOG_#4T7_ $*8_P#!A_\ :J/^&IHO^A3'_@P_^U5X'11_8F7_
M //O\9?YA]1P_P#+^+_S/?/^&IHO^A3'_@P_^U4?\-31?]"F/_!A_P#:J\#H
MH_L3+_\ GW^,O\P^HX?^7\7_ )GOG_#4T7_0IC_P8?\ VJC_ (:FB_Z%,?\
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M?V)E_P#S[_&7^8?4</\ R_B_\SWS_AJ:+_H4Q_X,/_M5'_#4T7_0IC_P8?\
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M^8?,W;<_<7&>_6@#Y07]OSXDWW["_@3QA:)IB_$WQ5XF'A*'4Y+<"VB?<_\
MI1BP5W;54;<;=S%MN!MK.C\,_$OPC_P5$^ NF_$SQII_C_4%T+4GL];L]+33
MI'A-G?[DEA0[ 5?=AEZJ1GG->T:;_P $W](A_9.L?@Q?>-;N>]TO6FU_2_%%
MG8"WEM+K<VQA#YK9 5V4_.,YR"I K5\#_L.^(M*_:"\!_&'QG\8]3\?^*O#<
M%Y:SB\TB*UAN89;:2"*.%(Y-MN$,TCMPY<MSMZD \B^$'[4?Q4\5?M-77AOQ
MU\3=*^'VIQ^)&L(/A=K?ACR8K[3MX"RVVI8W-,PSL4G:[8(X8 ?HC7R)=?L)
M^(_%WQ!\(:IX^^->L^.?"?A'5UUG1M"OM'MH[J.5'W(LU^"99ER%!##D#L>1
M]=T %%%% !1110!S=S_R'+OZK_Z"*VM/_P!2W^]_05BW/_(<N_JO_H(K:T__
M %+?[W]!0!:HHHH **** "BBB@ K'U[H?]S_ !K8K'U[H?\ <_QH OZ;_P @
MVT_ZY)_Z"*LU6TW_ )!MI_UR3_T$59H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;[
MIK\]_B9_R4?Q7_V%KO\ ]'/7Z$-]TU^>_P 3/^2C^*_^PM=_^CGK['AO^+4]
M%^9[&6_'+T.:J:S6&2\@6Y=H[=I%$KKU5<\D<'M4-%??'T!]C>,-!\.^-/BI
M_P (QJ.AWPN%TDS6^L0WTB);IC;A(@=H'4$GJ>""*X?Q!_PB?_"C/A]_PE?]
ML^1MD\C^QO*W;N<[O,XQCTKRAOC5XW;0/[%/B"X_L_RO)V;$W[,8V^9MW]..
MM2Z#\<_''AC1[;2]-UPV]C;+MBB-K ^T9)QED)/)/4U\M#+,33C%*2]UK[3Z
M)IN]G:]]DK'E1PM6*6NWF_/RT.L_9AU*<?%*"QANKD:88[B9;9Y#LW;,!RH.
MW=C S6C\.\KX%^,;61D&I #.SJ(MTN<?AOS^%>>Z%\:?&?AEM0;3=9^S'4+I
M[VY_T6%O,F?[S?,AQG'08'M31\9O&2^)7U]=;D357A%N\RPQ!6C!R%*!=IP?
M45UUL'7JU)R2BDU'J]XN^ON]3:=&I*4GIK;\'?L=A\4VG_X4A\-!J0QJ.VXV
M;_O^3N&W\-OE_I2_$!([3]GGX>0V\F^&6XN)I.0<R;GST]"S"O-?%GC;7/'6
MH)>Z[J$FH7"+L0LJJJ+UP%4 #\!70S>/K#4?@[;^$[R&Y&I:??FZLIHE4Q&-
ML[E<EL@Y=SP/2M%A:E.-*^K4VW;97YORN/V4HJ'K?[[_ .9] 7&A^%=1^+>I
M^!QX-T6&SETTW+7<=L%F$A"@;",;  ?X<<\YZUP'@SX<_P!I^%=+N_\ A3_]
MM>= K_VA_P )/Y'VC/\ 'Y>[Y<^E>8K\7/%D?BR3Q*NK$:W)#]G:Z^SQ<Q\?
M+MV;>P[5Q]84<NKPCRNI;2/66ZO?:4=]/\B(8>I%6YNW?Y]4>R^&X=)\,^-+
MA/$VD>)-#T^#5HVT[3=,F^TVD5P#\ZNYYD;B/[F6(R/2O6O$ECJ5GK7Q=F>=
M9KZ?1+>6S^RJ5=(=DZE?7=E,\'N.G0?-OA'XK>*_ ME+9Z'K$EE:R.9&A,4<
MB[B "0'4X/ Z>E1V7Q/\4Z?XGF\0P:U<+K$R[)+E@K[EX^4J05V\#C&!BE6R
M^O5J.5UM;=ZV:?;2]M=97">'G*5[K^FONV[L];:6YA^%OP=-V66^76U:W\S_
M %GDB8[2.^W'EX]MOM7 _M#0QP?&3Q&L6-I>%CC^\88R?U)J'2_BG=:U\0M"
MU[QM>7FKVNFRB41V\: @KEEVH"B_?"YZ9 [X KF?&?B67QAXJU76IEV/>W#2
MA,YV+GY5_!<#\*Z,+A:E'$<T^TMMKRE>R]+%TJ4H5+OL_P 7<Q:***]L[@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"5GCCXS_ !"^% UGQKK^E^)/ \CWD=I?ZA>7MUXA-XLR#;*\I,7V<)YF IW
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M?MJ>)O&GQZB^%?CN]^''B*^U/27U32]<^&&K/?62M&3OM9][L5D"*S9R!P,
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M+_LVQ_O1_P#?0H_LVQ_O1_\ ?0H_UBQG\D?N?^8?VK/R_KYGQI_PJ7Q9_P!
MD_\ ?^+_ .*H_P"%2^+/^@2?^_\ %_\ %5]E_P!FV/\ >C_[Z%']FV/]Z/\
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MC_>C_P"^A1_9MC_>C_[Z%'^L6,_DC]S_ ,P_M6?E_7S/C3_A4OBS_H$G_O\
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MB_Y8_<_\P_M*MV7X_P"9\7_\*E\6?] D_P#?^+_XJC_A4OBS_H$G_O\ Q?\
MQ5?:']AP?W*/[#@_N4?ZQXO^6/W/_,/[2K=E^/\ F?%__"I?%G_0)/\ W_B_
M^*H_X5+XL_Z!)_[_ ,7_ ,57VA_8<']RC^PX/[E'^L>+_EC]S_S#^TJW9?C_
M )GQ?_PJ7Q9_T"3_ -_XO_BJ/^%2^+/^@2?^_P#%_P#%5]H?V'!_<H_L.#^Y
M1_K'B_Y8_<_\P_M*MV7X_P"9\7_\*E\6?] D_P#?^+_XJC_A4OBS_H$G_O\
MQ?\ Q5?:']AP?W*/[#@_N4?ZQXO^6/W/_,/[2K=E^/\ F?%__"I?%G_0)/\
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M#\-?"WV:YGD?:/-DNI45TPH<%(_E;=STKZMKGO[8U'^Y;_\ ?+?XT?VQJ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P \V_[Y-;%% &/Y$G_/-O\ ODT>1)_SS;_ODUL44 8_D2?\\V_[Y-'D2?\
M/-O^^36Q10!C^1)_SS;_ +Y-'D2?\\V_[Y-;%% &/Y$G_/-O^^31Y$G_ #S;
M_ODUL44 8_D2?\\V_P"^31Y$G_/-O^^36Q10!C^1)_SS;_ODT>1)_P \V_[Y
M-;%% &/Y$G_/-O\ ODT>1)_SS;_ODUL44 8_D2?\\V_[Y-'D2?\ /-O^^36Q
M10!C^1)_SS;_ +Y-'D2?\\V_[Y-;%% &/Y$G_/-O^^31Y$G_ #S;_ODUL44
M8_D2?\\V_P"^31Y$G_/-O^^36Q10!C^1)_SS;_ODT>1)_P \V_[Y-;%% &/Y
M$G_/-O\ ODT>1)_SS;_ODUL44 8_D2?\\V_[Y-7[%62$AE*G=W'L*LT4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
MPT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7
M_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4
M\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&B?B3_P!#AJ7_
M 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2_P"^U_PH_P"&
MB?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\ PT3\2?\ H<-2
M_P"^U_PH_P"&B?B3_P!#AJ7_ 'VO^%>=44?4\-_SZC]R#ZU7_P"?C^]GHO\
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MY..NO==+B>6UHW3:NKKKK9<W;L^MCYEHHHKW3R HHHH **** "BBB@ HHHH
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MHHH **** "BBB@ HHHH **** "OT"_8U_P"2'V/_ %^7'_H=?G[7Z!?L:_\
M)#['_K\N/_0Z^3XF_P!Q7^)?DSZ/(?\ >WZ/]#W&BBBORL_0 HHHH **** "
MBBB@ HHHH **** "BBB@#YQ_;J_Y)3HW_8;B_P#1$]?#5?>_[8GAS4?&7@GP
MWH>CVQO=5N]:4P6RL%+[;:=FY8@# '<U\N?\,M_%'_H4YO\ P*@_^.5^GY#B
M:%' QC5FHN[W:1\%G%"K5Q;=.#:LMDV>5T5ZI_PRW\4?^A3F_P# J#_XY1_P
MRW\4?^A3F_\  J#_ ..5]%]?PG_/Z/\ X$O\SQ?J>)_Y]R^YGE=%>J?\,M_%
M'_H4YO\ P*@_^.4?\,M_%'_H4YO_  *@_P#CE'U_"?\ /Z/_ ($O\P^IXG_G
MW+[F>5T5ZI_PRW\4?^A3F_\  J#_ ..4?\,M_%'_ *%.;_P*@_\ CE'U_"?\
M_H_^!+_,/J>)_P"?<ON9Y717JG_#+?Q1_P"A3F_\"H/_ (Y1_P ,M_%'_H4Y
MO_ J#_XY1]?PG_/Z/_@2_P P^IXG_GW+[F>5T5ZI_P ,M_%'_H4YO_ J#_XY
M1_PRW\4?^A3F_P# J#_XY1]?PG_/Z/\ X$O\P^IXG_GW+[F>5T5ZI_PRW\4?
M^A3F_P# J#_XY1_PRW\4?^A3F_\  J#_ ..4?7\)_P _H_\ @2_S#ZGB?^?<
MON9Y;'(\,BR1LR.I#*RG!!'0@U[GJ7[2&B>,K?3)_&WPYL?$^N6,8B74A?O:
M^8 21O14.X9).TG&2< 9KGO^&6_BC_T*<W_@5!_\<H_X9;^*/_0IS?\ @5!_
M\<KEK5LNQ#3J58W6S4[/[TTS>E3QM%-0INSW]VZ^YHM>$OCY;Z+I/B70=8\(
MV.M>%=:OGO\ ^QXYVM5M79@=L3J"54;5   QM&".:LZO^TA-?>*?!MW9>'H-
M*\.^%I!)9Z)!<L0W8[I2O)P, [>,GKDUF?\ #+?Q1_Z%.;_P*@_^.4?\,M_%
M'_H4YO\ P*@_^.5@UE3DYN<;O^_W5F[7M>VE]S:^8**BH2T_N^=][7M?IL96
MM_%R[U#XR-\0;2Q2RNOML=XEF\GFJ-@4;"V!D$+C.!UXKN$_:6TJS^*EIXXT
M_P "QV-[LN!?1+J;,;QY%50^XQX3;MZ!>=Q[G-<Y_P ,M_%'_H4YO_ J#_XY
M1_PRW\4?^A3F_P# J#_XY53_ ++J)*52.BY?C^SVWU^8H_7X-M0EJ^;X>O?8
MT]%_:(MO^$?U;P_XH\(6_BG0;O4I=3M[62\:W>UD=V<J)%4DC+'G@_,PZ' C
M\._M"V^BW'BBPN/!NFW7@[7BC2>'89#!' RJJADD"DY(0$G&2P##:>M#_AEO
MXH_]"G-_X%0?_'*/^&6_BC_T*<W_ (%0?_'*GERI\W[R.O\ ?ZZ:K71Z+5:C
MOF&GN/3^[^&VJUV>A;\3?'^#6%\+:5I_@_3M-\(:#<"Y30)I#<I<-SN\QV4$
MY#/R1U8D[J/&GQXL-8^'5SX,\->$(?"VD7=T+NY7^T)+O<P8-A P'EC<JG X
MXX S53_AEOXH_P#0IS?^!4'_ ,<H_P"&6_BC_P!"G-_X%0?_ !RG'^RXN+52
M/NNZ]_K>]WKJ[]7<3^OOF3@]=/AZ;66FB\D;WBC]IXZ]X@\/^*;7PI:Z?XQT
MR2/S=6^UO(ES$J2*T7DX 16\UCD$MP!G@5E^-/C1X4\36VMSV/PRT[3=?U=6
M$^J37SW(1F/S21Q%0J.>3N'<YYJK_P ,M_%'_H4YO_ J#_XY1_PRW\4?^A3F
M_P# J#_XY4QCE=-Q<:D5;^_TO>WQ:KR>@Y2S"=U*#=_[OX[;^>YF_$CXM'X@
M^#_!&A?V5]@'AFS:T\_[1YGVG*Q+NV[1L_U73)^]UXKNX?VH]/O[K1-9\0^
M+'7/%VCPK%;:T;UX02I)5VB"$,0>>3P22NW-<M_PRW\4?^A3F_\  J#_ ..4
M?\,M_%'_ *%.;_P*@_\ CE5+^RYP4'4C97M[]M]]4[Z]5L*/]H1DYJ#N[?9[
M;=.A+HW[0>H6MK\2?[3TY=3O_&D(BEN%G\I;7"RJ-J;6W "0 #(P$')K;TO]
MIJVC\/\ AFWUGP18Z[KGAN(1:;JMQ=NHBV@!6:+:=Q 5>K=5R,&N?_X9;^*/
M_0IS?^!4'_QRC_AEOXH_]"G-_P"!4'_QRE*.53U<X_*5NG+T?;2VPXRS".T9
M?^ WZWZKOJ<S\6/'_P#PM#X@:KXG^P?V9]N\K_1?.\W9LB2/[VU<YV9Z#K6S
MXP^,3>*_A3X6\%?V2+4:&Y<WOVC?Y_# #9M&W[WJ>E7?^&6_BC_T*<W_ (%0
M?_'*/^&6_BC_ -"G-_X%0?\ QRM_;9=RTX^TC:'P^\M+*W?MW,?9XV\Y<DKS
MW]W?6_;N9OP3^+1^#GB:_P!7&E?VN;K3Y+'R?M'D[=SQMOSM;./+QC'?K3_A
M'\8IOA>NM65QI,&OZ%K,(@OM-N)#&)  P!# ':<,P/!SGV%7_P#AEOXH_P#0
MIS?^!4'_ ,<H_P"&6_BC_P!"G-_X%0?_ !RE4J9;5Y^>I%\UK^\NFW72WD.$
M,=3Y>6$O=O;W>^_3J:.M?&Z'Q-8>&O"'A[PY!X1\,6NI17+VL=V]R\LF\<O(
MP!(R2<$'G'/ KVWX^?&S2?A;\78YQX+L=8\26NG+]DUB2Z:-H!)N!5HPI#8Y
MP<@@,0",G/@/_#+?Q1_Z%.;_ ,"H/_CE'_#+?Q1_Z%.;_P "H/\ XY7!4H99
M.<7[6/*E*ZYM^:UVWS7Z:WO<[(5L?",E[-W=M>7:W96M_D01?&ZZ?X7^,/"=
MYIPNKOQ)J8U.;4_/V;'\R)V'E[><F/\ O#&[IQ53QQ\79?&'A3P)H\.GMIDW
MA6!XH[Q+G>TS-Y6' VC81Y0[GK[5I?\ #+?Q1_Z%.;_P*@_^.4?\,M_%'_H4
MYO\ P*@_^.5W1J99&7/&I&][_$MVN7OVT[')*..E'E<)6M;X>E[]NYZK^VIX
MTNYM+\'>&+OR8]0^SKJFI0Q9(68IY:@'TSYWOC'2N5F_:UNSX_T+Q)!X;ACC
MT_2FTJ:SDNRYG1B&+!]@V'*KV/0^O'*?\,M_%'_H4YO_  *@_P#CE'_#+?Q1
M_P"A3F_\"H/_ (Y7%1HY73H1HU*L9<M_M)?%OU_X8ZJM7'SJRJPA)7MTOMMT
M-S6OVAM OO -[X.T[P ND:+>7L5[.L>KO))(5E1Y-SM&6+.$"[L_*,<' %:<
M_P"UQ<ZCJVN1:CX9BNO"6I::FFIH"WI06ZJ"-RR;",G<^<(/X/[G/(?\,M_%
M'_H4YO\ P*@_^.4?\,M_%'_H4YO_  *@_P#CE:>RRBUG.+Z_'?5VU^+?1:[D
M>TS&]U%_^ ^NFVVKT)=-^.\%G\/?!OA2Z\+6NJ6OA_4)+V3[;-OBO%<S$QF/
M9\N!,<-EN5!QVI_CGX[6>O?#M?!7ASPI'X6T-KK[5-']ODO"S9W84N!L7=@X
M'IVYS7_X9;^*/_0IS?\ @5!_\<H_X9;^*/\ T*<W_@5!_P#'*V_X2^=3]I&Z
M=_CTO>][7MN_ET,_]OY>3D=K6^'IM:]KE+X+_&)O@_>:Y.-)&K?VG9&TVFX\
MGRSG.[[K9^G'UJQX=^-\VC_".^\#7>F-?H;H7FG7ZW7E/82A@X*KL.X;P3U'
MWF'>I?\ AEOXH_\ 0IS?^!4'_P <H_X9;^*/_0IS?^!4'_QRJG/+*DG.52-V
MT_BZQVZ_UU)C''0BHQA*RNOA[[]#HM:_:0\/>++RWUGQ#\,=+UCQ1# L1U"6
M^D$$A P"]OMVL/8D^F:]@^#=O=S?L]^%;?1=+E\67'VV8W4&F:^^D/9JSN29
M'1U9\9'RGKD'L"?GW_AEOXH_]"G-_P"!4'_QRC_AEOXH_P#0IS?^!4'_ ,<K
M@Q%#+ZE-4Z5>,4FG\5UHGI\2:WZ-'91JXR$W.I2<KJWPV[:_"[[=4ST#Q-XR
M\._LW_'76+OPS;-X@M[[2#;W5N^HEC;7$DJLX,I5RQ'EJ2&YRYYXQ7ENN?%H
MZU\&?#G@'^RO)&CWDEW_ &A]HW>;N:5MOE[1MQYW7<?N^]:7_#+?Q1_Z%.;_
M ,"H/_CE'_#+?Q1_Z%.;_P "H/\ XY752_L^"C*=:,I*VKDM6DTGOYLYZGUV
M7,H4W&+OIR]&TWT\D;FK_M,'5?CAHGQ$_P"$<\K^S+-K3^S?MV?,RDR[O,\O
MC_79QM/W?>L_PU^T$FFIXPT[6O"]OX@\->)+^349M+ENFA:&1WW?+*JYXPO.
M <J",53_ .&6_BC_ -"G-_X%0?\ QRC_ (9;^*/_ $*<W_@5!_\ '*.7*N51
MYXZ)+X^B=UK?H^NXN;,+N7++5M_#W5GT[=-BSI/QQT;PU\1O#7B/0? EEHVG
MZ+'.@T^WNV:6Y,L;H6DN&0EL;AC*GH>>>*F@_' Z+'\3%_L7SCXT652?M6W[
M'O,I_N'S,>;_ +/W?>G?\,M_%'_H4YO_  *@_P#CE'_#+?Q1_P"A3F_\"H/_
M (Y5MY8]ZD7HE\?9\RZ]]2?]O6T'U?P]U9].QY717JG_  RW\4?^A3F_\"H/
M_CE'_#+?Q1_Z%.;_ ,"H/_CE=_U_"?\ /Z/_ ($O\SD^IXG_ )]R^YGE=%>J
M?\,M_%'_ *%.;_P*@_\ CE'_  RW\4?^A3F_\"H/_CE'U_"?\_H_^!+_ ##Z
MGB?^?<ON9Y717JG_  RW\4?^A3F_\"H/_CE'_#+?Q1_Z%.;_ ,"H/_CE'U_"
M?\_H_P#@2_S#ZGB?^?<ON9Y717JG_#+?Q1_Z%.;_ ,"H/_CE'_#+?Q1_Z%.;
M_P "H/\ XY1]?PG_ #^C_P"!+_,/J>)_Y]R^YGE=%>J?\,M_%'_H4YO_  *@
M_P#CE'_#+?Q1_P"A3F_\"H/_ (Y1]?PG_/Z/_@2_S#ZGB?\ GW+[F>5T5ZI_
MPRW\4?\ H4YO_ J#_P".4?\ #+?Q1_Z%.;_P*@_^.4?7\)_S^C_X$O\ ,/J>
M)_Y]R^YGE=%>J?\ #+?Q1_Z%.;_P*@_^.4?\,M_%'_H4YO\ P*@_^.4?7\)_
MS^C_ .!+_,/J>)_Y]R^YEG]DW_DX#PK_ -O7_I)-7Z+5^>/[+^GW&C_M)>'[
M"\B,-W:RWL$T9(.QUMIU89''!!Z5^AU?GO%#3QD&OY5^<C[/(=,-)/\ F?Y(
M*^<_VZO^21Z3_P!AR'_TGN*^C*^<_P!NK_DD>D_]AR'_ -)[BO(R?_?Z/J>C
MF7^YU/0^&**])TC]G'XC:]I5GJ5AX9FN+&\A2X@F%Q" \;*&5L%\C((ZU;_X
M9;^*/_0IS?\ @5!_\<K]:>.PD79U8_\ @2_S/SI83$-75.7W,\KHKU3_ (9;
M^*/_ $*<W_@5!_\ '*/^&6_BC_T*<W_@5!_\<I?7\)_S^C_X$O\ ,?U/$_\
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MM_ACIMCXBU:-UGU26^>=4=_O2I"5"K)R3N'.>3FJ/_#+?Q1_Z%.;_P "H/\
MXY1_PRW\4?\ H4YO_ J#_P".5TI97%J4:D4UVG;=WUUU5];/0P?U]IIP;O\
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M1:?>)6\R5U4Q[1C!E_O'.WWJQ_PRW\4?^A3F_P# J#_XY1_PRW\4?^A3F_\
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M3_S[E]S/*Z*]4_X9;^*/_0IS?^!4'_QRC_AEOXH_]"G-_P"!4'_QRCZ_A/\
MG]'_ ,"7^8?4\3_S[E]S/*Z_0+]C7_DA]C_U^7'_ *'7RC_PRW\4?^A3F_\
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MW' //%/OOBEX,TOQE:>$;WQ=H-IXLNU#V^@SZE"E],I!(*0%M[ A6Z#^$^E
M'445Y<G[5'P6DN%MT^+_ (#:X9_+$2^)K(L6SC;CS<YSVKU&@ HIKNL:,[L%
M51DLQP /6O.]!_:2^$GBK6+32-%^*7@O5]5O)!%;6-AXAM)YYW/1419"S'V
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8'A7_ (^-?_["3_\
MHN.M^L#PK_Q\:_\ ]A)__1<=:Q^&7]=3.7Q1-^BBBLC0**** "BBB@ HHHH
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MRBW]W^9Z-/"TIP4I5XQ\GSW7W1:_$^9?V2/'OQ&\:? *'P_H.HV_A/Q9X?\
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MKR:!I;ZMH\+V^FW[649GLHG7:Z0R;=T:LH (4@$#!H VZ*** "BBB@ HHHH
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M@M==G1=/TJ37&>[TN\MDNM/C&7N[1I8E%W !@^9;F12'0@G>N0#U"BO*[?\
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M'QN/AKXH>)=.G>RA\'>#_"C>(?$=\Z,T\4LCO]FB0[@H'E6UT[ @DYBQMSR
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M5%SXMU?2YKJSA>:_U2UMFT^S"KEB_ER32F-54<[I&Z$Y X !M45YIX4_:-\
M^,[QK33]4OH+C[ ^J0)JNBWVG?;+1 "\]L;B&/[3&H926AW@!U/\0SL?##XO
M^%OC)HIUCPA>W6J:04C>/4)--NK:WN%<$@PR31HLV,$-Y9;8P*MM88H [.BO
MG_X)?&KQ;\6?&VM1/JGA"TM-(UB^TW5/!;6\\>O:5!$\T=O<R2F9ED\XQQ.$
M^SQKY<Y(E8Q[9.6^&W[17Q#U*/X7ZYXCF\*ZCH_CS7+S0X=%TG3+BTU"Q,1N
MBMP)7NIEN$5;4^8!%'CS0=WRX8 ^J:*\.^#_ (U^)7Q.\1>)]1GUOPK8>%M&
M\5:GH8TJ/P]<O?2P6L[1*WVLWX178 $GR".O'IF?M(?'[QIX)\?>"?AE\+_#
MNEZ[\0?%D=U=17'B":2+3=.M8%!>:?R_G;). JD'@]R 0#Z$HKX@U/\ ;1^*
M7PSTKXQ>%_B+X9\*VWQ.\%^&5\4:7<:'+<2Z1J=JT@BW>7(PE4)(Z @L"V3]
MW )G_9._;,^(7Q;^+^E^#/%O_"NO$=IJWATZ\FH_#J\N)_[*(*?Z/?"1G"2G
M?M*Y&",9- 'VQ1110 4444 %%%% !1110 5@>%?^/C7_ /L)/_Z+CK?K \*_
M\?&O_P#82?\ ]%QUK'X9?UU,Y?%$WZ***R- HHHH **** "BBB@ HHHH ***
M* "BBB@#@?B'_P CQ\-?^PQ<?^D%S7?5P/Q#_P"1X^&O_88N/_2"YKOJZZW\
M.EZ/_P!*D<]/XZGK^B,[1O#ND^'(YH])TNSTN.>0RRK9VZ0B1SU9@H&3[FO/
M_C-\--<\6:QX)\6^$[NQA\5^#]0DN[6TU5W2ROX)H6@N;:5T5FB+(V4E"/L=
M%)1QD5ZC17(;1BHJT59'A4GP^^)GB+Q9?_$'5H/"NF>+]'T&]TCPEHEKJ-S>
MZ?!-<^4\ES=W+6\,C;G@A7RTA^5$;YF+_)R6E_ 'Q^/@OI_AV;2_"^G^*=$\
M0Z?XI@OSX@N;]==U"*[%S=2WLOV"!H6E8, R)+MW@!0J*#]144%'R]KG[/?Q
M$\<7GB?5];F\,:=J.M>)?#&M)9:?>7,T-K;Z;<QR31&9X%,KLD>5;RT!+8(4
M#<>Z\4_#SQWHOQLU/QSX(3PY?)K^@VNB7R^(;NXA;3GMIYY(KF%(HG^T*1=2
M;H"\&3$F)5W$K[/10!\=:/\ L?\ B_PAIOP]N+2>VUW4]%\%V?A/4K&U\;:Q
MX8B+VTCR)<17-BC-*I,TJF.6(?P,&&"#I>,OV1==\26G@4Z+;>&_"2_#:QM[
MSP=I/VJ;5(1JWG)-.EU<SVXF-L!#'&K*"Y+F8JKQ1*/K.B@#S/X]?#O6?BW\
M(+KPW8O8V.KW-UIMRWVB9S;IY%[;W$JAQ'N/RQ.%.P9.,A<G'$_'7]G'6/BA
M\5/#.N:1J6GV/AR[AATWQI878?S=3L;:[CO;5(=JD;A*DT3;B 8KF3'(%?05
M% 'F_P 7_AOJ?Q USX87NG3VD,7A?Q7'KMXMT[*TD"V-Y;E8]JG+[[E#AMHP
M&YS@'L/%G@W0/'FAS:-XFT/3?$6CS,K2Z?JUI'=6\A5@REHY 5)! (R."*V*
M* /)_@#^S?X0_9]\/O:Z)HNB1ZO--=-<:SI^CPV5Q/#+=23QPNR99DB5TC4%
MB,1C 7@#S7XH_L__ !)U31OCCX7\(/X3;0_B9YMW_:VMWETEWIT\FGPVDD!@
MCA998V^S+MD\U#%YS$QR^6$D^HJ* /FSXB?LV>)O%MC\9H;.^TF-O&=EHEMI
MYGFE B:S&)3-B,[0?X=N[/?%7OC!^S=K/Q.\1?%JZBU+3[.S\7>"['P]8M(9
M&DAN[>>\EWRH% \O-Q%]UB3A^!@9^A:* /CK]HCP/\0KKX;_ !F\>^-8/#.E
MQ'X8ZEHD>F:#?7%ZRN \QE:66"'<&^;Y0@*X'+YR-_7/@C\1OC%HYNO$C^%M
M*DL? 6K>&M%;2[NXE%_<ZC!#&UU<B2 &UC46\9$*-.09&S(WEC?]344 ?/7Q
M5_9YUWQ9I?PLO-,N([C5_!EI+9SZ>GB/4=!CO4FMXXG*7UD#-$5>&-AF-@Z[
ME(7<&7-TO]GWQ+X-?P-XF\)^'O#]CXET34=5NM0T+5/%VI:C;7HOHU228:G/
M;//YVZ&%OG@8$&1<C(>OI>B@#YI\+_LZ^-K7Q-X1UO6]1T"6ZT_Q[J?BV_73
MVG5/(NM.GMUBB#H27625<[B 54MD$[*D\3? 7X@QVOBP>'=7LHH=:\<OXCN-
M,M];O-&:_L&L88/L[W]M$T]LXFB$I,2MN"!2V'85])44 ?*'A?\ 9E\?>#?!
MFA-92Z#J'B/1_B'=>-(K"_UN^EMYH)[2XMS;R7\L,L[2(+DGS7C<OY8)"[_E
M;X@_9/UG4O&'C WVC6GBWPKXLU0:K>6D_P 1==T5+8R)$LT!LK:)[>Z4-'N6
M1O++!@K*-@8_6-% 'F_QZ\'^+_&_@JVT_P ':FEA>)J5M<7ML^IW.E?VA:(Q
M,ML+ZV5I[4M\K>9&I8[-G <D>,>!_P!E7QAH.A/!>WFEI<3?$^R\<&)M:OM3
M:*SCM;:-X#=7*>=/,&A<!GP&&T_)G8OU?10!\]?$#]G[Q+XXUCXRZ*;G2K;P
MA\2=)CMGU874O]H:9<)9FV&+7RMD\9*HY/GQG!9<=ZY(?LO>)?$'@WQW;:OX
M?TS3O%NK^"]3\-:=KD_Q)U[Q$B27<05T,-] !!"SI&Q9"[C8!ANM?65% &9X
M9TV71?#>DZ?.R--:6D4#M&25+*@4D9 XR/2OE^/]E?Q[X>L_$\WA[5O#Z:EI
M6IQ7'P_6Y>58M.M3?75S<Q3L(F9&>*]EM@4#@)#">NX'ZSHH ^6?$G[)NJ:'
MJW@R_P#"3MJT&B^%8?"\^G3>--7\,N_DR>8EU]JL [2L2TH:.2/DLK!P5(:#
M5_V3]5TG4O"6K^$])M[2+3_#G]A77ABW^(>N:/';L+AK@2QZE;(9KD!I9E*S
M0C=N1@5VE6^K:* /DKQ#^Q;=:SK/@?4M%>P\$/X0\-M#HT-KJEWJ:V&L"^AN
MXV8S(AO+;Y)48RX8B3*JK!73W3QU\-[OXS?"%_"GBV\D\.WNI0VYU)_#-PDR
MI(DB2/'&]S 5DB9DVD21?,C,I')KT&B@#Q#X._ GQ1\.?C!\0?%>L^/]4\4Z
M=X@6R6W@OH[%9)6B@6,R7 @LX0KJ0501L%*L2ZEL$:/Q,T/QWXF\4:3):_#_
M ,':_IOA_4DU;1K[4_&=]I]PER()(O,>"+395&%GF4*9'4@AL X"^O44 >'_
M +4TVJ7'[&_Q6EUNSL]/U9O!^IFYM=/NWNH(W^S29"2O%$SCW,:_2N1O/@Q\
M1/BQ:V^H>)V\+Z6VF^!]4\.Z,=)N[B;^T+C4(8$:ZN!) IM8U%O&1"C3D&5L
MR-Y8W_3U% 'SI\2/V<]?\1>'?A)-IUS%<ZUX(L'L+C3X_$>HZ#%>I+:Q12%+
MZR'G1E7A1AF-@Z[E(7<&6GI?[/OB7P:_@;Q-X3\/>'['Q+HFHZK=:AH6J>+M
M2U&VO1?1JDDPU.>V>?SMT,+?/ P(,BY&0]?2]% 'S3X>_9U\;1:MX4U76M1T
M"2]L/B)>^,KY;!IUC^SSV%Q;B*(,A)=7F7[Q *J6R"=E7+K]G3Q%-XRGU:.\
MTI;63XI0^. GFR!_L2:/'9-'CR\><949MN=NT@[L\5]%44 ?+.I?LO>*/&C>
M.M&F;3OAOX.\3:+JFG7.E:!X@O-9MKFZNF4QW@M)[>"&S:,^<[K;_P"N:=MS
M C<>B7X5_$OXB>(_#NL^.[?PGH,WAO1=0LK6'PYJ5S>K?WEW;K"\CF6VA^SP
MJ%)$8$I)<98>6-WT)10!X#X;_9YUG3_#'P!TK4+O3V/@/06TC5Y+:63,K-I0
MLV-LQC!(WC=EMAP <9XKEO@/^RSJ_P -=6\#VOB/1[36[7P9$T&F>(C\0=<N
M6REN]M'.FC3QM:V[/$Q5HTE98][!"0 *^IZ* /(?'?@3QKI_QBL?B%X)MM U
MJ:30VT&_TG7]0FT]?+$_GQ317$5O<'(9G5D:/!!4A@5P>4^&O[-FN^!_%'PR
MU>YU33KQ]#/B2]UKR?,0-=ZK<1W!2V0J<Q1N)%RQ4D!3C)('T310!\G>+OV:
M_B9XQ^*5IK&I:S9ZAIUCXWL_$EM?S^*M451I\%Q&Z6*Z.L?V..2.,%1/N9I&
MCW,%:5F3VGX%_#?4_AEH?BBRU2>TGEU3Q7K6NPM9NS*L%Y?2W$2MN5<.$D 8
M#(!!P2.:](HH \(T+P7\48?VE]3\>W^@^$8/#NH:):^'F6V\274MW'#;W5W.
MMP(SIZHSN+D*8O, 7:3YC9KEO _[.?CO2?#GP[^'>L7/AX^ ? FLPZG9ZQ9W
M<[ZEJ45K([V4$ELT"QP%2T9>19I-WDX"CS#M^H** /GW]K?P_/XDT?0_^$=U
MVS\/^/-*FEGTRXO(9Y#)!<V\UG<K$D2.TKJD_F!%4X>*(MM4[JY'P7X;\/>$
MOBMK&JP>(;"Y\%V-G<+X3TO38YY7$UY%:+>;$2+;.RO;%LQ-(R?:Y0P6OJUX
M8Y'C=T5GC.49@"5)&"1Z<$C\:8MG;Q^7M@C7RV9DP@&UCG)'H3DY^IK&2J7T
M:MZ?\$]&G/!*"52G)R\I)+_TA_F?#GP+^&MO\!?AW)X1L[[PQX^\/Z[X?AC\
M0:#J%S>2PWNKI!% S6$XM9FN8)(E1)(0G[CRHRH 9D7V/]G76E\%VNMV&M>)
MX[F#4+Z%M#T2WUJ]\016D7DQ1M%;ZC=1)-=YD!D=<$0>9MX45] +9V\?E[8(
MU\MF9,(!M8YR1Z$Y.?J:%L[>/R]L$:^6S,F$ VL<Y(]"<G/U-*U7NON_X);J
M9?;2G/\ \#7_ ,A_7R)J***W/+"BBB@ HHHH **** "BBB@#X/\ @Y_R>6__
M &%]6_\ 15S7WA7P?\'/^3RW_P"POJW_ **N:^\*^IXA_CTO\$?S9\_DO\&I
M_C?Y(*^<_P!NK_DD>D_]AR'_ -)[BOHROG/]NK_DD>D_]AR'_P!)[BO.R?\
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MZAX.\&Z?X?G_ +70)=WNNZO/9?9=DL4B&-(K2?S=VUP<M'MPN-V3C.U[P/\
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M"GP]_9TT.\O-)EOOAS=";59(99"DR_V;=VI%N3&"Q\RXC/SA/E5CU !^C**
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MM"\$5[=PQ*8;ZWC6+:\ID!#,^P[68\LS9^JJ* "BBB@ HHHH **** "BBB@
MK \*_P#'QK__ &$G_P#1<=;]8'A7_CXU_P#["3_^BXZUC\,OZZF<OBB;]%%%
M9&@4444 %%%% !1110 4444 %%%% !1110!P/Q#_ .1X^&O_ &&+C_T@N:[Z
MN!^(?_(\?#7_ +#%Q_Z07-=W-YGDOY6WS=IV;\[<XXSCM776_ATO3_VZ1ST_
MCJ>OZ(?17F7P/_X67]CUK_A9'V?S_M(^P^3Y.?+P=W^JXVYVXW?-][/:O,OV
MU=.L=6U3X'VFI^#_ /A/K&7QJ1+X<\FUE^VC^RK\A=EU)'"<$!OG<#Y>.<"N
M:2Y78,/6^L4U4Y7&_1JS^:/IJBOC[X/>/O\ A7'P1\2:EHMWIWA6RU7QW?6.
MB>&[S3;W4IO#R\(VG)IEHHDFG$L%Q,;:W98XUFD=)&CBR]O2?VIO'WB3P7X8
M32;'0AXGU'XBW/@6XO=5TF_L+8Q+9W5PEX+&5Q<0N!'"3!(Y+%77>F\2))T'
MUM5*SUO3M1OM0L;2_M;J]T]TBO+>&97DMG9!(JR*#E"496 .,A@>AKYL?]H;
MX@VXN/!KV_AV;Q\/'\7@J+6EL;A-+\E].74S>-:>>9-PM]\?D_:/F<*V\ E1
MSF@?$+QG\.?'7Q9MKA=!U#QQK_C71/#]K>QQ31:8DDNDVY6ZD@,AD"B*,L8!
M*26P@E .\ 'V'17RSXZ_:-^(?PML?B1HNJ6WAGQ'XK\,QZ!?V%_9VMQ86-Y;
M:C??9#%-"9IWAD1HYL.)'!#HVSY2K2:M\5OC=I.M?$O0?MG@"XOO!6A6WB0Z
MC_9%\D5]'/'<E++R/M9,3![.;-SYK@!DQ 23@ ^HJ*^9=-\<'7/C7XCUS28M
M#\)ZG>?"_1-=;Q!K$5Q>+;Q/=WS&.>);F&-HHT1B"OEMEV+.5 48$?[37Q)T
MWP#X'GUJTTV'6_'&IWLFDZA9>#M4O!;:/!&'BGFTNVGFG:>888()D"),I<AH
MV1@#ZYJEINM:?K#7BV%_:WS6=PUK<BVF60P3* 6C?!.UP&4E3R P]:^<-%_:
M"^(_BRW\'>'+/1+3P[XLUS6]3T\ZUXB\/:A:V;V5G%YHO8].FDAN!YRO$HB>
M4;&\SYY F6Z;]D_^UQ:_%1=>-DVL+XYOENGTX.+>1Q;VHWHKY9 WWMA+;<[=
MSXW$ ]VHKY=E^'/A)OVJO"?_  K?0K/3M;\-W-[J?CCQ)9+^^ECNK:416%W.
M<M<2RRR1S^7(6,20(WR;H]WI'CCP/XF^(GPU\9:+XVU:/2;.34+B6T_X0VZF
MM9;G2D(:&WNI7&]7D *S>24R#A6 )R >M50T?7M,\16LMSI6HVFIV\4\MK)-
M9SK,B31.4EC)4D!T=65EZ@J0<$5Y;^QU_P FG_![_L4],_\ 2:.O'/@K\0/$
M6B^']/\ !GA+^R[77_%'CWQDRZIK4$ES:V<%MJ=Q)*WD1RQ/,[;T55$B 99B
M3MVL ?8E%?,-O^T9XYGU#_A #;^'E^(?_";2>$?[>^RS?V1Y2Z=_:?VO[)Y_
MF;_L_P"Z\C[1_K.?,Q\M;?Q.^+7CKX>:7I.CW>M^&8O&,L%W>2-I?A36->-U
M#%(%CD&GVC^;;1L'3?+)-(J/\@\S=N4 ]U;7M-77$T5M1M1K$ENUXFGF=?M#
M0*RHTHCSN*!F52V, L!GFKU?*_P=^(S_ !>^/?PP\;2V2Z=+K_PEFU&2T1]Z
MPM)?63,@; R 2<'%=1\3OVAM=^&GB3XB:#/IMA<ZG#IFGWO@J+9(HU*>[E^Q
M+;S'>=S+>F/.P+B.X3C(+$ ^@**^1_$W[5OCRQ\5>*HM%T"76K;PKJ<6D3:'
MIO@?6[^?69$6)KJ2+4(<VMIQ*WEQR"4_NP7=1(-O70_%KXL^(?$'QG_X1O2_
M#>I67@:]ET[2M&-O-]NUBX.FP7$2-,TZQP!99QEMK^8K;<1%=[@'T517S9IG
M[1.O+X;T"4:SH_B+6;KQIIOA[5+5O"M_H%QID%TJMMEL[JYDF24JP=)&(1E=
M<*PY.IXZ^-7CNRU3XEZ;X9T6UOY?#>JZ/:17$>FSZA);6ES#%+=74EI%*DET
M8E=R(H2KD8P&(P0#WR69((GEE=8XT!9G8X"@<DD]A5;1]9T_Q%I-GJFE7UMJ
M>F7D*W%M>V<RS0SQL,JZ.I*LI!!!!P0:X7P7XR7QY\&)M8_M[3_$DTEI=QSW
MVFZ9-IL7F(9$:,VL\DDL#H1L>.1BP96R%^Z/!OV:_'OC+6?AI\(OAWX*NM!T
M*?3_ (::+K]_J^O:=-J*NLX:"&"*WBN;<@YMIF>1I,#]VH1MQ*@'U_17S'X%
M_:(\=?&;_A"M#\-V_AWPIXBU#2M2U/6;[5+:?5+2(V5__9[Q6T*36[N))MT@
MD:0!44#:Y?*T_P!H+]I[Q=\'-&O[N*30)M8\.:+;ZIK>@Z?H&KZTDLC*6DB:
M_@6.+3D.R01R7".6!#LB 8(!]-6>NZ;J&I:AIUKJ%K<ZAIYC%Y:0SJ\ML77<
M@D0'*;EY&0,CD5>KPOX,SK=?M&?'>9 0LDF@N W7!TX&L;Q=\>O'.C_M*>'/
M"MG\.?%ESH,VC:Q-)9P2Z+_Q,GAN;)(KR)WO@R1(LLF5<QN?/3]VQ4[ #Z-H
MKS3XV?$;6/!/_"&Z+X<AL?\ A(?%VMKHME>:HCR6EEB":YEFDC1T:7$5O(%C
M5TW,R@NHR:\B\9?M'?$;P'9^,- GM/"^M>,]!\0>'=-@OX[>YL].O;?5;A(E
M+P^;+)!(F9 2))1PC[3G90!]450M]>TR\UB]TFWU&TGU6QCBFN[&.=6GMTEW
M^4\B [E5_+DVD@!MC8S@U\T_'C]H;QM\%=%U4#7/#>N:[X;T-]:U.TTWP;K%
MZ+P9F=$D-O-)'I*%("JS7$LP<^8^V-8CNZ7X.ZH-;_:D^+FHK&8EO/"WA.X$
M9.2H?^U&QGVS0!] 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!_P<_Y/+?_ +"^K?\
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MZ'KWQ;\%Z=<S77A#PGXFBT[0EFF:5;*%M-LYY+*-F)(CADE=53/R*P0855
M/=Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "L#PK_P ?&O\ _82?_P!%QUOU@>%?^/C7_P#L)/\ ^BXZUC\,
MOZZF<OBB;]%%%9&@4444 %%%% !1110 4444 %%%% !1110!P/Q#_P"1X^&O
M_88N/_2"YKOJX'XA_P#(\?#7_L,7'_I!<UWU==;^'2]'_P"E2.>G\=3U_1!6
M%XC\#Z)XMU+P]J&K67VJ\\/WQU+39/-=/(N##)"7PK -^[FD7# CYLXR 1NT
M5R'0>;Z]^SOX \27&KW-WHL\-YJFJQ:Y<7=AJ=W9SI?1P+;K<0R0RHT$AA4(
MQB*;P3NW;CEV@_L\^ /#=KIL%AH<B+IVNMXG@DFU"YFE.IM \#W4DCR,TLC1
MR/N,A8,SEVRYW5Z-10!Y_P"(/@-X'\46VNPW^CR%M:U:WUV[N;:_N;>X%_!'
M%%%<0S1R+);NL<$:YA9,@,#G>V<^W_9F^&UMX;US0E\.LUCK=W#J&H22:A=/
M=3W<07R[K[2TIF6X!16\Y7$A8;BQ;)KU"B@#S:U_9V\ V_AO6-#DTBZO[36+
MJVO-1N-3U:\O;V[DMW1[<R7<TS3LL;1)M4OM ! &&(/17GPU\-WVJ^)M2GT[
M?>^)=.ATG59?/E'VFUB$XCCP&PF/M,_S( QW\DX7'3T4 >:>(OV</AYXKTW4
M-/U+09);6_T.T\-W*Q:C=0L^G6LKRP0;HY58!7D<E@0S!B&+#BBX_9U\%7FA
MPZ7=KXAOTM[S[?:WU[XJU6?4+.;9Y9:WO7N3<0 H64K'(JL&8$'<<^ET4 >=
MZI\ O!VM>&])T74(]<O(=)NVOK#4)_$FI/J=K,RLC-'?FX^TKE7=2!+C:Q7&
M.*V_AY\,/#'PITF\TWPKI2Z397EVU_<1K+)*9;AU17E9G9B68(I8Y^9LL<LQ
M)ZFB@#ROPC^S+X%\!ZPVI: /$VFROJ$FJ26T7C#6#:37,CF2222V-T89-[$E
M@R$-GD&M1_@3X._X1_7M%MK34]+L-=U:?7-1_LG7+ZQFGO)CF5S-#,DBJW>-
M6"?[->@44 <A\,/A3X=^#OAF+P]X6BU&VT:$*L%I?ZO>:@MNBH$6.(W,LACC
M"J (T(4>G)K&U#]G;P!J6@PZ0^BSVUM;ZO<Z[;W%CJ=W:W=M?7$DDD\T-S%*
MLT1=II<A' PY7&WBO2** /.)/V>? ,O@E/"IT:9=-741K"W*:E=KJ(OM^[[7
M]O$OVGSSRIE\W>5)0DJ2M5+K]F?X>W?]E,VEZC'<Z=%/;I>P:]J$5U<Q32K+
M-'=SI.)+M'D4,RW#2 G/')SZE10!Q'@WX+^#?A_=:#<:!HWV";0M$_X1W3F^
MU32>18;T?R<.YW?-$AW-EOE^]R:L^*OA/X4\;>+?#'B?6](2^USPU)+)I5V9
MI$,!DV;\JK!9!F.-@'# ,BL " :ZZB@#SW5/@/X0U3Q=<^)5BUK2M6NY8Y[M
MM#\1:CID-W*@"K)/!;7$<4S[552TBL2JJI)4 #5C^%?ARWA\6):VUYI[^*KO
M[=JUQI^I7-M/-/Y,4/F)+'(KPGRX8U_=,GW<]22>MHH \T/[.?@&3PEJ?AR?
M2KV]LM2O8=2NKN]UF]N-0DNH3&8)OMTDQN0\?E1A&$@*!0%P.*9I_P"SAX%T
M?2]5L=-M]<TO^U;F*\U"]L/$VIV]]>31H45Y;M+@3N=IP=SG=@;LX&/3J* .
M>\*^ -!\%^$U\-:/8FUT<"7=$TTDLDK2LSRR22NQDDD=W=FD=BS,Q)))S7'W
M/[-'P]FT_P ,6=OI>HZ/_P (UI@T72[K1-=U#3;N&Q&S%LUS;SI++'F*,[9'
M8;E#=>:]1HH \XU;]GGP#JFC^&]-CT6;1;?PW UMI$GAW4KK2+BSA8 /$D]I
M+%)Y;;5+(6*L55B"0",GQ-^R?\+?%D=S!?\ AR>*RNM+AT:ZT_3M7O;&SN[2
M&-HX4GMX)DCF,:,51W5G4*FUAL7'KM% &!H7@30_#/B#7-;TVQ^S:GK?V?[?
M/YTC^=Y$?E1?*S%5VH,?*!GJ<GFM&;0]-N-9MM7ET^UDU:UADMH+YX5,\44A
M1I(TDQN56,<990<$HN>@J]10!S7Q ^'/A[XH:"FD>)+%KVTBN8;V!X;F6UN+
M:XB</'-#/"R2PR*1P\;*V"1G!(//6?[/?@*RT&32/[&GNK>;5;77)[B^U.[N
MKRYO;:2.2WFFNI96FE*-#$ '=@%0+C:,5Z-10!YKX^_9S\ ?$W5M3U+Q!I%W
M-<ZK8KINI+9:O>V4.HVZB0)'<Q03(D^T2R;3(K%=QVD5TWA_X=>'O"OB'4M<
MTO3_ ++JFI65GI]U<>=(_F06@E%NFUF*C9Y\O( )W?,3@8Z2B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTC_P92__ "/1]K\4?] O2/\ P92__(];]%'.OY5^/^8<K_F?X?Y&!]K\4?\
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M]K\4?] O2/\ P92__(];]%'.OY5^/^8<K_F?X?Y&!]K\4?\ 0+TC_P &4O\
M\CT?:_%'_0+TC_P92_\ R/6_11SK^5?C_F'*_P"9_A_D8'VOQ1_T"](_\&4O
M_P CT?:_%'_0+TC_ ,&4O_R/6_11SK^5?C_F'*_YG^'^1@?:_%'_ $"](_\
M!E+_ /(]'VOQ1_T"](_\&4O_ ,CUOT4<Z_E7X_YARO\ F?X?Y&!]K\4?] O2
M/_!E+_\ (]'VOQ1_T"](_P#!E+_\CUOT4<Z_E7X_YARO^9_A_D8'VOQ1_P!
MO2/_  92_P#R/1]K\4?] O2/_!E+_P#(];]%'.OY5^/^8<K_ )G^'^1@?:_%
M'_0+TC_P92__ "/1]K\4?] O2/\ P92__(];]%'.OY5^/^8<K_F?X?Y&!]K\
M4?\ 0+TC_P &4O\ \CT?:_%'_0+TC_P92_\ R/6_11SK^5?C_F'*_P"9_A_D
M8'VOQ1_T"](_\&4O_P CT?:_%'_0+TC_ ,&4O_R/6_11SK^5?C_F'*_YG^'^
M1@?:_%'_ $"](_\ !E+_ /(]'VOQ1_T"](_\&4O_ ,CUOT4<Z_E7X_YARO\
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M/_!E+_\ (];]%'.OY5^/^8<K_F?X?Y&!]K\4?] O2/\ P92__(]'VOQ1_P!
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M2_\ R/1]K\4?] O2/_!E+_\ (];]%'.OY5^/^8<K_F?X?Y&!]K\4?] O2/\
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M^DR0$SRB<L/M-M.;@ N=.VQLHB0?NXU5 #Z^O;M-/LY[J596CAC:1EAB>5R
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M# .1LR0 1D\4>)M-\%^&M5U_6+@VNDZ7:RWMW.L3RE(HU+N0B LQP#A5!8]
M"3BOB_5OV;_$,NC:P-+^&-UX0\(ZMXE@>?P7X470)+J32X=, @,\-X7L)/\
M39)GDC);#;'4N5\PZ6N?LSZG=:WI7A^'X:MJVBV3>';72?$&M75@_P#8>E02
MQ2:C#'&LN8[N0F<-Y$2PM&54.5C2*@#[2HKYD_:0^"6I_&+XK:';:YHWB+7_
M (>_V?%;I#H7]BM'9W;SR"YN)_MX\Z(^280DUD1.@6;:58KGBK_X+^/-2\2Z
MSKZ_#2&/QS9OXGO4\83WEB)=7FF$]OI%K&XD:46R6\\?$P3RS;K\A/S$ ^O;
MSQ)INGZ]INBW%T(]3U*.:6UM]K$R)%L\QL@8 7S$ZD?>%6-6U.'1=*O-0N$N
M)+>TA>>1+2VDN9F55+$)%&K/(V!PB*68X !) KY-^*'P.TKX1^#[P>']$M[#
M3M!\.VEKH7V=HTGUG7)+ZWEVE<[I;EWTS3QOD)+F11DX;'H^I_"GQ+<_ FYT
M&6V@NO%7BS5[:^\2>7,IBB2YO86OD5V*[T@M-\$9QN988^,DT >YQ2":))%#
M!6 8!E*GGU!Y!]C27%Q%:P23SR)##&I=Y)&"JJ@9))/0 =Z^<OA]\!]1TOXM
MZ+XYU+P_%;:]=:MXBU35=7,T4DT4$DODZ=9 ABWEFV99"B9020LS ,PKE_BY
M\%/$/CCQ3\:+_3OARNH/KWA>\TZUU#Q+#I4UTU[Y4-O;II<XF9X[5HTEE>&Z
M$:B;RW7'F2X /K*RO;?4K."[M)XKJTN(UEAGA<.DB,,JRL.""""".N:I:QXF
MTW0;[1;.^N##<ZS>&PL8Q$[^=.()9RN5!V_NH)6RV!\F,Y(!^8-<^#OB)/$%
MQH/A3X:'P_X-UJT\-V+B.XL+:TTC3;>^EN=0MA%%,6-RQN90VQ6C?[WFL5"M
MQ&K? ^_FM?$VN^._ ]GX6(\/>)TUSQE>W=K)=:OJ-XRPVGE-%*\HMU@EF2%7
MVNGRQK'& H< ^ZJJ:3JUCKVE6>IZ9>6^HZ;>PI<VMY:2K+#/$ZADD1U)#*RD
M$,#@@@BO"M)\!^+=<_9Y^(>HZYH5O>_$;QMI%U<RZ!>-$T*2FR\FTL7+_NP
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M+B8LKNVQ-LE 'TIXK^)W@[P'?6-EXE\6:'X=O+Y9'M+?5M2AM9+A4&9#&LC
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M1)2B@JBU/I/@/QE\&?$6H:WH6AV\VCQZ-;Z3!HFFZO<73^(+V*.&WL99XWM
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MC5=0:R\3:Q-!?/XEM[?Q?JOAR-KNY%H@>&>SC:2>.*WM$M5255W)'&Q(;(H
M^C'^)O@^/Q9IWA9_%>AIXGU*W^UV6BMJ,(O;J':S>;%#NWNFV-SN4$81CV--
M\!_$;1/B-HFGZCI-R ;W3[?54LIV07*6LY?[/,\88E4D\J3:QX;8V.5./#+3
M]F[Q!H_B_P =:A9:7I$K7IO+WP[JDWBO4TBL[I[-;:T5]($)M(O)C A$\;%Q
M&BX49VCM?@W\!9_A5\,O$_@"'57M-,N9IX]+U[3)2NJQV\END:-+)(C S6X
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M8>"] T/P)XDT&T%QI&E&74_$&G7<LEG<7CS$@0^;!&SM(/-EDQD1$JF7+;@
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M<FYEYQTS_#JV_P"%F6WC2'5-0MKF+2O[(?3(S";.:(2&16(:,R*ZLQY1U!&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>advm-20241231_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +=!10# 2(  A$! Q$!_\0
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MW&J[A;)IK/*692HVX**<DNN  <U];:AXZO/AO^R_H6OZ?#%->V^B:<D2S@E
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M:<'%1?5,^P;?X,_L]>'Y)+N\\9P:M#][[/)K<4@'L! %<_F>E>6_ 3XR:/\
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M"]>M]:U_3-(G>_$B1WUW'"S+Y:C(#$9&0>E>"6/CP^#?C9-XIL'%Q%;:Q-<
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MK62^O;?(+),0N0<?[4DV?4UY)\4?A7JWPDUJRTO6;BSGN[JS2]"V;NX1&9E
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MS".&W0G&YW/3OP,DX. <&NL\0?LW^(M'\,ZCKMCJ_A_Q-8Z;DWO]A:A]H>V
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MX6\:9U1N(K35K<PB8^BO@<^P!->?^+_$]WXP\2W^KWLC22W$A8!CPB?PJ/0
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MXU+X/W'AJZC\)Z5XHMM=)3R)=2>+R%&X;]P5R?N[L<=2*[?X&NGB#]G7XMZ
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MROWDE96LNG1.RU(_V58;WQ=\=K;4M8O+F[N=)L);AI+ER[X1! JL3SA1(/\
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M-^OZ7(]'T74/$.H16&F65QJ%[*<);VT9D=OH!7O'@?X3W7P:N+;Q-XT\;?\
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M*8H1'A@X4LI.<Y.[MP!Y+XN^)5[%\;M5\8Z5<1M<1:K)/:2_>1XU8J@//*E
M ?4$UW6K?M'>$?$5^^J:O\)=*O\ 69 /-NVO2%D8#&2GE<_B2>G-*ST.QXZA
M5]NI2C%RG?WHMIQ6BV3V\]-2UH/C2U^/WQN\!:(VD1Z7X7TC=%9:=O\ ,/E1
M1F3#L>N1"@QZ#&3U/!_M#>,KWQE\7/$+W,CFWL+N2PMH6/RQQQ,4X';<5+'W
M:L2Q^)%YHOQ(C\8Z18V.DW,-QY\-C:PA+>-<;3&%'8J2#W.2>M>GZI^TUH5Y
MJDFNVOPPT>'Q0QWC5+BX,P64=)/+\M?F! .<YXZT[-/1'#]8I8K#SIUJW+)S
MNW9^\DK*UETZ)V0S]EB&\\6_'2VU+5[NYN[C2;&6X:2Y<NV$00*I)YPHD'Y"
MO)]6N)O'OCV\GMDQ<:UJ;O$LA_BFE) .,]VKI/A3\9M0^&?C:_\ $,EG'K)U
M&*2*]MY7\OS=[!RP8 A3N'H1@D8])M0^*F@R?$#PYK^E^![/1=.T>59_[,M;
MD[KB17WAGEV=B%P-IP 1WI=3!U*%3"4Z<JEFIMNZ=W>RO?5:)>IZ]\:-+M?&
MO[2?@OP6TJOI>GV]M;2V_8#)D=>.A:,(/RKSS]JSQ1>ZU\7M3TZ:0K8:2([6
MTME)"1KL5F('3)+'GT ':N1\4_%#4=?^*5QXXM$_LW4&NX[J&-7\P1% H52<
M#<,* >!GGBO2[W]ISP]K&IQZWJ?PMTF]\2*%8ZBUT0K.H 5BAC.<8&,L2,#G
MBLST:N*P^,5>#J<G-.][-WBDTEHNF^I;^,D<WAO]FGX9^']4DD.KR3/>B*;.
M](L2$*0>1M$T:X/ICM5O]IKQ)>>#?!O@GX=6MRT44&E0S7XC)7SB!L4'VW([
M;?7:>PKQOQ1\3M4\>>.K?Q)XC5-0:*6,FS0F.(1*V[RDSG:IYYY/))S4WQ>^
M)D_Q9\:SZ_+9C3T:*.&*U$OF^6JCINP,Y8L>@ZU)G7Q]*5.LJ3:;4(+ORQ6K
M?K9'J7BJ:7PO^Q[X7T^0;)]:U)IRC-D^4'D<$?7;&>/[U?/-=]\2/BK_ ,)]
MX=\(:-%IATVU\.V7V1,W/FF<[44N?D7:3Y8XYZFN7\-^$]7\6:C;V>E6%Q>2
MS3+"#%&S*K,>-Q X'<D] ":1PXVI'$UH1H^\HQC%?):_C<]J^*VWPM^S5\--
M #'S=2DDU5\=U(+#/_@0O_?-:7P@UJZ^%_[-OC+Q79JL&J:A>I96DS8SP%4.
M/7:9)2 >ZFL3]KO5H/\ A/=*\/6<BM:Z#ID-KY:C[DA^8C_OCRJXC6OBI_:G
MPAT'P)%IGV:/3;M[R6]^T;C<,QD(&S:-H'F$=3T%0>O5Q$,+C:CYK.$.6/JD
MH_YLZ;]EGP[%XR^-%I/J1-U]BCEU)O..XR2J0%9B>I#N&SZBMCQ#\0_A#XC\
M67GB35-.\9:]?W$GF?9;^2WCMUQ]U!Y;;@@& !D\#OS7E?PW^(6I?#'Q9:Z]
MI8CDFA#(\,P.R6-AAE..?0^Q ->EWWQ\\%WEU/?_ /"HM';4IF+O-<7?F1LY
MY+&/R@.3S^=28X7$T5A52<HQDI-OFBY7T5FK)[:[G4?"7Q2?CM^T4?$NLV4<
M$>DZ<]U:V:'>L8C950$D#<0TI;/'('3%8.J?$;X1WWBZZ\4W>F^,=>U::?[2
ML.I36\<*L#E5'EMD*.  <X  KS;X??%#4_ASXX_X2738+;S7+K-9[-L+QN<M
M& /N@$ C'3:.HX/>7GQX\%S33W<'PAT5-0ERQEN+GSHMQYSY7E =>P(J;F]+
M&PJ4+5*B4^9R?-%N][6:LFODS@/BA\1K[XI^,+K7KZ&.V:15BBMXSD11K]U<
M]SR23W)/ Z5RE.DD,TLDA55+L6*HH51D] !P![4VLI'SM2I*K-U)N[84JTE*
MM9LE"T445#&ARTM(M+4,H*?3*=4,H6E6DIR]*S*04M)2KUJ6,=2K24H[UFRQ
M:?3:=6$C1"K3J1:6LF6APIRTE*M<\C1"T^FTZL9&B'#I3NU-IWI6$C1$UO*8
MGR#@=#P#_.M./,BAE\PJ?9*R5J2*0QMG"G_>&:\[$4?::K<Z:=3ET>QZG\#O
M%%GX9\<26VK-Y6DZU:OIUQ(Y4!-^-I.. ,C&>V[-<[XU\$ZO\+?$5Q87]NS0
M,Q\BX*GR[B//RLK>N.H[5RZS1R(0^Q#_ +,0_GFO0/#/QM\4>'=*33%EM]=T
MQ!A+35;;SE0#L#G./;.!6L*E*I0^K8K2VSMIZ?TST85(3@H2=K:IK7?=-'.>
M'=!U?X@ZQ;:5I-FTTSMSL!VH.[NW8"O5_%VMV"_$[X=^$]+G6ZL_#=Q;6KSK
MTDG,B>81]-H_'-<?K?QX\5:EI\FFVBV?AZTE&'ATBV$!?/;=DD?@17&6*ZEH
M.LVUW;+_ *=9RK.NS$FQU;(W 9P<CH:VIRHX:'L\/JFU=^2=[(OVL:>D+N[5
MW:VBULD=K\<M4O;?XL>(XX[NXC03KA5D8 ?(O;->>S74UU(&GEDF;IND8L?U
MK4\2ZEJOBC7KS5=40B]NI09G:/RU5B!@>@&,=>U07GAZ_P!/8"6 L"YCW1,)
M%W#^'*DC/M7)B).I4G-7LV_S,:LG4G*:V;9GU[!^TE_R,7AO_L!V_P#Z$]>4
M?V;=G&+6;GI^[//./3UXK>\6>(=<\97UC)JL9,]O;QV46(O+^5<[<^Y.>:SC
M-1HU*;6LK?A<TIRY:4H-:NWX&_\ L_\ _)7?#O\ UTD_]%/6AX)\80>"?C=>
M7]X=MC)?7-M<-_=1W8;OH#@_A7%^%=4U?PCXBL-4TZV;[?;DR1+)"6# @@\=
MQ@FH;JQU+599M1EBWM<^;=,XP,X;YSCV)Z44Z\J=*"@O>C)R_!&].HX0BHK5
M._Y'0_%#X=WO@'Q#.AC:72+AC)8WB#,<D9Y4;AQD#J/QZ&N;T/0[_P 1:A#8
M:;:2WEW*<+%$N3]3Z#W/ KM_#WQ$\9>!=+>P)@O=+C&3I^HJDZ(N0,A<[@N3
MV.*DO_CYXEN+.6UTZ'3?#\<HP[:3:B)R/][)(^HP:SJ4\(Y<[<HK^6VOHG<T
ME&A?F;:\K?J<3X@T&\\,:U=Z7?HL=Y:OLD5'#@' /4<=ZH+0\C2NSNQ=V)+,
MQR2?4T+7BU+-OEV,-.@M%%%8C/#:5:^P_P#AWK_U/W_E&_\ NBE'_!/;'_,_
M?^4;_P"Z*_M=Y]EW_/W\)?Y'P_\ JSFW_/G_ ,FC_F?'E%?8?_#O?_J?O_*-
M_P#=%'_#O?\ ZG[_ ,HW_P!T5B\\R_\ Y^?A+_(?^K6:_P#/G_R:/^9\?T5]
M@_\ #OC_ *G[_P HW_V^C_AWQ_U/W_E&_P#M]8O.L!_S\_"7^0?ZM9K_ ,^?
M_)H_YGQ\*?7U_P#\.^?^I]_\HW_V^E_X=]?]3[_Y1O\ [?6+SC _\_/P?^0?
MZM9K_P ^?_)H_P"9\?4X=#7U_P#\.^O^I]_\HW_V^C_AWWQC_A/?_*/_ /;Z
MR>;8+^?\'_D-<-9K_P ^?_)H_P"9\?KUIU?7P_X)]_\ 4^_^4?\ ^WTO_#OS
M_J??_*/_ /;ZR>:8/^?\'_D/_5O-?^?/_DT?\SY IRU]>_\ #OS_ *GW_P H
M_P#]OI1_P3]_ZGS_ ,H__P!OK%YEA/Y_P?\ D'^K>:_\^?\ R:/^9\A45]>_
M\._?^I\_\H__ -OH_P"'?O\ U/G_ )1__M]8O,<+_/\ @_\ (/\ 5O-?^?/_
M )-'_,^0J*^O?^'?O_4^?^4?_P"WTO\ P[^_ZGS_ ,H__P!OJ?[0PW\_X/\
MR&N&\U_Y\_\ DT?\SY$HKZ\_X=__ /4^?^4?_P"WT?\ #O\ _P"I\_\ */\
M_;ZGZ_AOYOP?^0O]6\U_Y\_^31_S/D.BOKS_ (=__P#4^?\ E'_^WT?\._\
M_J?/_*/_ /;ZGZ_AOYOP?^0UPWFO_/G_ ,FC_F?(=%?7G_#O_P#ZGS_RC_\
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M/YOP8?ZMYK_SY_\ )H_YGR)17UW_ ,, _P#4]_\ E'_^WT?\, _]3W_Y1_\
M[?2^MT/YOP8?ZMYK_P ^?_)H_P"9\CT5]<_\,!_]3W_Y1_\ [?1_PP'_ -3W
M_P"4?_[?4/%4?YOS#_5O-?\ GS_Y-'_,^1&I*^N_^& O^I[_ /*/_P#;Z/\
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M9\CT5]<?\,"_]3W_ .4C_P"WT?\ # O_ %/?_E(_^WT>WI]P_P!6\U_Y\_\
MDT?\SY'HKZX_X8%_ZGO_ ,I'_P!OH_X8%_ZGO_RD?_;Z/;T^X?ZMYK_SY_\
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M -OH_P"&"_\ J>?_ "D?_;ZGGBS:GD>;T;NG!J^CM**T[?$?)=%?6G_#!?\
MU//_ )2/_M]'_#!?_4\_^4C_ .WT<\3+_5[,_P#GU_Y-'_,^2Z5:^L_^&"_^
MIY_\I'_V^@?L%_\ 4\_^4C_[?1SQ#_5[,_\ GU_Y-'_,^3:*^L_^&#/^IY_\
MI'_V^C_A@S_J>?\ RD?_ &^IYD/_ %>S/_GU_P"31_S/D^BOK'_A@[_J>/\
MRD?_ &^C_A@[_J>/_*1_]OJ')%+A_,_^?7XQ_P SY/6G5]7C]@_'_,\?^4C_
M .WTO_#"'_4\?^4G_P"WU-Q_ZOYE_P ^OQC_ )GR?79>"?C!XO\ AWIUS8>'
MM8.FVMS)YLJ+;Q2%FP!G<Z$C@#H:]^_X80_ZGC_RD_\ V^C_ (81_P"IX_\
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M?\SY<IU?47_#$/\ U.G_ )2O_MU+_P ,1?\ 4Z?^4K_[=63PM;^7\BUDN/\
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M+]2#!O,3ALJNP;5Y!( ]#@9'>O=/^&._^IN_\IO_ -NI?^&/?^IM_P#*;_\
M;JQ_LK,ND/Q7^92P.,_E_%?YG@=SX@NKNW\N386V>49-OSE<@XS]15!:^B_^
M&/?^IM_\IO\ ]NIP_8__ .IM_P#*;_\ ;:PEDV8RU=/\8_YC> Q3WC^*_P S
MYSIZ]*^BO^&0?^IM_P#*;_\ ;:7_ (9"_P"IL_\ *;_]MKG>19C_ ,^OQC_F
M4L!B?Y?Q7^9\Z45]%_\ #(?_ %-G_E-_^VT5/]@YC_SZ_&/^97U#$?R_BO\
M,^BZ***_7#ZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&7OP7@L_$-AXGMM3O-(6^OK.);">ZMBXDC219F?G8VTLBYXZ$@'JOVH_VPO
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MTG7+1;RVAOT5)T0YX<*S*#QV8CWKKJ_+[QEXD\4_"3_@GO\ L\_%CP?XRO\
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M\&_&T7@D6'B3QUXY>,3-X8\%Z4VHWT49 (=UW*J\$'&[=@@XP1GWROS_ /V
M<7'[:'[8$^L8?7T\0I':/<?ZX6?VN]&%[[-JVOX!/:OXO/WX^DO@)^U_X"_:
M$US5O#VCIK'A[Q?I*"6^\,>)[ V.HP(<#<8R6! ++G:QQN7.,C/D]Q_P5"^'
MD$WB&9?A_P#$VZT#P_J$NFZEXEM?#\4VF6TL;;3OF6<[0>" P#88<#-<)XZV
MW'_!93X=_P!@!7,'@V7_ (2'[,/NDPWVSSOP:RQ]8Z\'_9T;XR^,/A9^T/\
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MI/$KG5UN.+8J+L@>8?3RVN/P+5^R$>W8NS&S'&WICVH =1110 4444 %%%%
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M46/@!HO%?CCP_P"(O!6DIH>F^*M"UE+357LD#!8995BP0 [#Y54X8CH36O\
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MXU:K\4U^(_Q)\'^*M0MXK1I/"NNQ620PI&B>7&?(9U1O+#,N_!8L<<U].44
M?.?C[]AGP9\0%\*:A<>*_'&D^-/#NG)I4'CG2-=-OKEU O:XN-A$C$EB6V _
M,:U+']B_X>+\&_$OPXUB77O%>E^))UN]4U3Q!JLEWJ-Q<*$"3><?NNOEIC:
M/EY!!.?>** /D[0?^";/PVT?6?!.LW7B?QWX@UGP?JEGJ6DW^N:X+IX8[9P\
M5F%:+8EL& )2-5;@?-7TE\0?!=C\2? 7B7PCJDEQ#IFOZ9<Z5=26K!9EBGB:
M)RA8$!@KG!((SC@UOT4 >%7G[&_@/4?V7X/@/=SZO<^#[>!88KR2>+[>C+.9
MUD$@CV;PY_N8QP0>:Y;Q5_P3]\#^)-0\)ZM;>,?'WAKQ)X?T2#P]_P )!X?U
MP6=_J-G$H5$NI%BPYP.64(6XSG Q]/44 ?/WP]_8=^&GPX^$OCWX;V*:M?\
MA/QG=S7=_;:E>"62$R(BA89 H8!-BE2Y=LC)8UE:/^P#\.K7X,WGPRUK6/%O
MC'P\]S#=6,OB#5_.N=):%-D(LW1$$*H"V%"X^9@<@XKZ6HH \)^#G[(6@?"#
MQ=%XFD\;>/O'FL6MN]K8S>-/$+WZV,3@!EA0*BC(&.0<=JZ3X%?LZ^&_V?%\
M6KX=OM7O1XFUB76[S^UKI9O+FDZK'M1<+]<MZL<"O4J* "BBB@#Y(^)'[!<_
MQ$\::UK\WQ!-HFH7DUTEK_8_F"$2.6V;OM W8SC.!G'05S'_  [2_P"JC_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 >%_M??#3Q%\>/V?]6\-> WT2YUF[N8'M[G4[B1(H3%,&,L4D62L
MJ,H*GIE2"#TKY8\>_ 7]MKXG6/A>R\2^(?A_J=EH%_!J<=LTCHEY<PX,3W 6
M$>8%;YMG"DG)4X&/5O&'_!.#3(_$VI^(?A=\4_&WPFU+4;A[NXM])OWELVF9
MBS-Y>]'.2>5,A&., 5B+_P $_?BOK+"V\3?M9^.]4TEO]9:V$,MF[^Q?[4X(
M]BI% 'O7[,[?&$:)KL/QEU3POJ.NPWBK:Q^&2=L,/E@D2@J,,2<CVKV:O*/V
M=_V:?!W[,OA>]T;PD-0N&U"<76H:AJMV;BYNY@H7>YP%!QV50.:]7H YKX@?
M#7PQ\5-$BT;Q;HMMK^DQW,=V+*\!:%I8SE"RYPP!/W6R#W%>3_L<V\5KX5^)
M$$$:0PQ_$;Q,B1QJ%55&HR@  = !VKWVN1^&_P ,]+^%]CKMKI4]W<1ZQK=]
MKTYO'5BL]W,TTJIM5<(&8A0<D#J3UH \+U#X7>$_A7^UA\%++PGH-GH<%YIO
MBN[NOLR?/<3.-.+22.<L[$GJQ/ITKZBKD=>^&>E^(OB1X3\;7,]VFJ^&K6_M
M+.&)U$$B78A$ID!4L2/LZ;<,,9;.>,==0!XY\;OB=\6_ NMZ?:_#OX*?\+0T
MZ:W,ES?_ /"5VFD?9I=Q'E>7,I+_ "@-N''.*O\ [+OQS'[2GP*\,?$<:*?#
MHUH7/_$M-U]I\GR;F6#_ %FQ-V?*W?=&-V.V:]4KY5_X)<?\F)_#+_N)_P#I
MTNZ /JJBBB@ HHHH **** "BBB@ HHHH **** "BO+/VB_#WBW7OA[?/X6\<
M77@9;&VN+N]N-/LHYKJYC2%F6**23(@RP!+A6; P,=:^>?V%?C5X@M?V!=<^
M(GBK5M3\7:GH4>L:B\^K7DES/,ELC2",R2$MC"X'/&: /MFBORKU/5OC)I?[
M'=G^U4/C-XKD\7/?I?3>&VNQ_8(M'O\ [,L(L\;<Y9#GT)&,_-7Z<>!?$R^-
M?!'A[Q"D7V==6TZWOQ%G.P2Q*^W\-V* -RBOSE_;X\,_$#]G3X>Q?%.P_:#\
M<2>+)-<2"'23=QV^DRQOYC"**R0;<HBY)<N&"G(R<C[S^%^L:OXA^&GA+5?$
M%LMGKU]I%I=:A;*,"*Y>%&E0#V<L/PH Z>BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
MC_:E^.%S^S[\);CQ79:=;:G?-?V>GP17TY@MD:>98_,ED )5%!))QV KYO\
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MLZ3_ . <?^%/06IC?\+Z\!_]# G_ (#3?_$4?\+Z\!_]# G_ (#3?_$5L_\
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M/*^VV5O>>4=T?VB)7V$C!(R.#B@#SC_AI/P3_P _5W_X"M1_PTGX)_Y^KO\
M\!6KO_\ A&='_P"@38_^ R?X4?\ ",Z/_P! FQ_\!D_PIZ"U. _X:3\$_P#/
MU=_^ K4?\-)^"?\ GZN__ 5J[_\ X1G1_P#H$V/_ (#)_A1_PC.C_P#0)L?_
M  &3_"C0-3@/^&D_!/\ S]7?_@*U'_#2?@G_ )^KO_P%:N__ .$9T?\ Z!-C
M_P" R?X4?\(SH_\ T";'_P !D_PHT#4X#_AI/P3_ ,_5W_X"M79>"_'.E>/M
M-FOM(DDDMXIC QDC*'<%#=#[,*N_\(SH_P#T";'_ ,!D_P *\L_9< 7P;K
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M+[>M:,%4J1@]FTC.I)PA*2Z(/^&_O@+_ -#W_P"4>_\ _C%'_#?WP%_Z'O\
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MK[1=/U.YM;B\L+6[N+5M]O+/"KO"V0<H2,J<@<CT%,1=HHHI#"BBB@ HHHH
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MU?#?[4.H?"WP1\%M(\6?\)K;>)=.OVD,#6J:9:PN!.+AD<[X]APRG*8!).0
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M?B=_V*^J?^DDM:4_CCZD5/@9^&-%%%?H)\:%%%% !1110 4444 %?0G[ /\
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MAXOU+X::;;^&M4\/:1X3B%S>W&IVAM_,N!&JA(PW+9?<2WOFOH2BB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA'_!)C_FJG_<*_\ ;RO.S'_=9_+\T=N"_CQ^?Y'Z$4445\6?4!1110 4444
M%>-:#_R=!XC_ .P6G_H,%>RUXUH/_)T'B/\ [!:?^@P4T)GLM%%%(84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y[_P#!
M6?\ YI7_ -Q7_P!LZ_0BOSW_ ."L_P#S2O\ [BO_ +9UZ.7?[U#Y_DSBQO\
M E\OS/SWHHHK[0^7"BBB@ HHHH **** "OU*_P""6?\ R;[X@_[&BX_])+2O
MRUK]2O\ @EG_ ,F^^(/^QHN/_22TKRLS_P!W?JCT,!_&/L:BBBOCSZ4****
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MSJHH_P!3<J_EE_X$'UB9^BO_  \6^&__ $!/%7_@);?_ "11_P /%OAO_P!
M3Q5_X"6W_P D5^=5%'^IN5?RR_\  @^L3/T5_P"'BWPW_P"@)XJ_\!+;_P"2
M*/\ AXM\-_\ H">*O_ 2V_\ DBOSJHH_U-RK^67_ ($'UB9^BO\ P\6^&_\
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MZ 7BW_P#M?\ Y)KT/X'_ +7G@[X_>++OP]X>TW7+.]MK)[]Y-3@A2,QK)&A
M*2N=V95[8P#S7Y(U]9_\$T_^2ZZ[_P!BW/\ ^E5K7@9]P3E&7Y97Q5",N>"N
MKR/3RWB#'8K&4Z-1KED]=#]*Z***_GL_4 HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH _.K]H ^'? WQK\5ZK\4/V2)/%OA6[O/-A\<>'8S>331;5S)/$
M&VJW7[SQ_=Z=ZZ_X%C]A[XN:IIDG@[1_"5GXB69)+;3=2A:RO!,&!4(DI D8
M'!_=EOYUT?Q:_;#^+3?$S7_A_P#![X&:GXKU+2;C[)/XAUAS!IBR84C!^52O
M/\4R'@\5YEI7_!/[XJ_'/XD:)\0/CAXK\,Z'=:==QWL6D>$=&@$[;7#^7+<A
M%)Y'\1FQG@C- 'Z(4444 %4/$%UJ%CH.I7.DV$>JZK#;226EC-<?9TN9@A*1
MM+M;RPS84MM.W.<'&*OT4 ?+'C3]J3XO?#[Q!X0T;6/@?I#:EXIU(:;IUG8>
M.1//(P7=+)L^PC$<:#<[D@*,9/(KZGKYH^"]L/BW^U+\5?B1>$SV/A"8> ]
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MS?\ F3_^WS_VA7N9)_R,*?S_ /26=V!_WB/S_)GS11117ZH?5!1110 4444
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MX\/5?F>/7_A3]'^1^.=%%%?>'R(4444 %%%% !1110 5^A'_  28_P":J?\
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M\D*^(W_8MZE_Z2R5^+M?M%\?/^2%?$;_ +%O4O\ TEDK\7:_H;PQ_P!SQ/\
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M'XF\)6T%QKGAW5M&M[@XAFU"QE@20XSA2Z@'CTKH]M3YN3F5^UR;,PJ***U
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M;+>P4S!S9C9M!)W9& #R*^KOVTOA?XL^,/P#U7PSX)L]-N_$<UW:SVKZE.\
MMFBF6031NI&)$*@C.0>000<5Y!X6U#]NA-8TB+6M,^&\FEB>%;V=6?S6AW 2
M, K@;MN3P,9Z"@#[3HHKYP_: _;9T3X*^-/^$'T?P9XJ^(WCLVR79T7PWI[R
MB*-\[#)( 2,X_@5_?% 'T?17P^?VTOVCE_TS_ADC6_[/^]Y']L-Y^.F,?9\Y
MS_L?XUUO@7_@HEX5\06?BBT\4>"_%7P]\7>']#N]>GT#Q#9-"UQ!;QEW$4A
MR>,#>JY)XS0!]9T5\;^"OB5\7;[6/!^K#XG^$O%OB?5)[6ZUSX1V?]GVTFF:
M=<;2[PRM(+AI8$=6/F,5?# #IG[(H *^5?\ @EQ_R8G\,O\ N)_^G2[KZJKY
M5_X)<?\ )B?PR_[B?_ITNZ /JJBBB@ HHHH **** "BBB@ KSW]HK_DWWXG?
M]BOJG_I)+7H5>>_M%?\ )OOQ._[%?5/_ $DEK2G\<?4BI\#/PQHHHK]!/C0H
MHHH **** "BBB@ KZ$_8!_Y.W\"?]O\ _P"D%Q7SW7T)^P#_ ,G;^!/^W_\
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M?]3_ .!__!S_ /84?\*0_P"I_P# _P#X.?\ ["OI;_AF[X<_]"[_ .3US_\
M'*/^&;OAS_T+O_D]<_\ QRC^WH?SR_\  8__ "0?7X]W]R_S/FG_ (4A_P!3
M_P"!_P#P<_\ V%'_  I#_J?_  /_ .#G_P"PKZ6_X9N^'/\ T+O_ )/7/_QR
MC_AF[X<_]"[_ .3US_\ '*/[>A_/+_P&/_R0?7X]W]R_S/FG_A2'_4_^!_\
MP<__ &%'_"D/^I_\#_\ @Y_^PKZ6_P"&;OAS_P!"[_Y/7/\ \<H_X9N^'/\
MT+O_ )/7/_QRC^WH?SR_\!C_ /)!]?CW?W+_ #/FG_A2'_4_^!__  <__84?
M\*0_ZG_P/_X.?_L*^EO^&;OAS_T+O_D]<_\ QRC_ (9N^'/_ $+O_D]<_P#Q
MRC^WH?SR_P# 8_\ R0?7X]W]R_S/FG_A2'_4_P#@?_P<_P#V%'_"D/\ J?\
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MQN;IZU]+UX>:25>5/$J3?.NJ2V=NESAQ3YW&K>]_T"OGO]O[_DTCQW_VX?\
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MK2WL<]9<UH]SQ'_AES_JKGPL_P#"E_\ M5'_  RY_P!5<^%G_A2__:J^W?\
MABOX,_\ 0F_^52]_^/4?\,5_!G_H3?\ RJ7O_P >KZK_ %PI?\_9_P#@N'_R
M9A]7?9?>?$7_  RY_P!5<^%G_A2__:J/^&7/^JN?"S_PI?\ [57V[_PQ7\&?
M^A-_\JE[_P#'J/\ ABOX,_\ 0F_^52]_^/4?ZX4O^?L__!</_DP^KOLOO/B+
M_AES_JKGPL_\*7_[51_PRY_U5SX6?^%+_P#:J^W?^&*_@S_T)O\ Y5+W_P"/
M4?\ #%?P9_Z$W_RJ7O\ \>H_UPI?\_9_^"X?_)A]7?9?>?$7_#+G_57/A9_X
M4O\ ]JH_X9<_ZJY\+/\ PI?_ +57V[_PQ7\&?^A-_P#*I>__ !ZC_ABOX,_]
M";_Y5+W_ ./4?ZX4O^?L_P#P7#_Y,/J[[+[SXB_X9<_ZJY\+/_"E_P#M5'_#
M+G_57/A9_P"%+_\ :J^W?^&*_@S_ -";_P"52]_^/4?\,5_!G_H3?_*I>_\
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M>]_K_0_Y_5/_  53_P#DSS?]6:G_ #[A_P"!R_\ D3X1_P"&3_\ JL?PE_\
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MO_D3X1_X9/\ ^JQ_"7_PJ/\ [51_PR?_ -5C^$O_ (5'_P!JK[N_X89^"/\
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MG_HN.F+J>RT444AGR9_P4L_Y(5H7_8R0?^DMU7UG7R9_P4L_Y(5H7_8R0?\
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MA?\ ]A(_^C8*:$SV6BBBD,*\.\6?\G9>"_\ L$2?^@7=>XUX=XL_Y.R\%_\
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M+^/'Y_D?H11117Q9]0%%%% !1110 5XUH/\ R=!XC_[!:?\ H,%>RUXUH/\
MR=!XC_[!:?\ H,%-"9[+1112&%?+/[(O_);/VA_^QA'_ *4WU?4U?+/[(O\
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M *+T^OJ:OHL[_B4/^O5/_P!)1C3V?JPK\]_^"L__ #2O_N*_^V=?H17Y[_\
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M *!=U[C7AWBS_D[+P7_V")/_ $"[KU<O^*K_ ()_D=>'WE_A?Y'N->*>+_\
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MXLCTH)<6/B&"Q-D;J(G:0\.%VD'&.!_%UX-?2=<'\+_ /B+P:^JW/B;QS?\
MC6_OS%AKBW2U@MPF_B*%"50MO^8CKM7TKO*^-S2IAZV*E/#12CIMM>RNU[L>
MO]U>AT034=3Y9^'W_*0;XF_]B]#_ .B]/KZFKY9^'W_*0;XF_P#8O0_^B]/K
MZFKMSO\ B4/^O5/_ -)1%/9^K"OSW_X*S_\ -*_^XK_[9U^A%?GO_P %9_\
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MTYK$^$W[-WBGX7WFC67_  M?5-2\':1,\UKX?73XX,A@V$DG#EG0%L[< 9'
M%>+BL=E$J=;ZJJ<*FFKAS*24+-0_=Q49.6K]R"^6AWT<-CHSI^VYI1UVE9I\
MVG-[[NK?WI,\*_8WT7Q7::U\5-4C\7K_ &;I>H72ZGI;Z5"RZK-Y<X64R$YA
M ?#;%!!Z=*K^ ?VC?$?@O]EW09=%M-)C\6^(O$DVEV;V^FV]I;0\)F0Q0HB%
MLLHY7G.3G&#[YX+_ &7;[P#\0O$^KZ-XZN+;PMXAN+BZO?#9TY&#221RJO\
MI!?<%1I2P 49VJ#G&:Q=/_8ETI/@7;_#V_\ $MQ<W5GJ;ZM9:Y:VH@D@F( Q
MY9=LC&<_,,\'C%>M7SG)L5B9U<3*,XRE2=E!II1C)24O=5[2:;U=XV2;2LN.
MG@,?1HQA13BXJ:^+JVK6U=KJ]MK.[>]WE7'CWXK_  /^-/P]\.^-/%UEX[T'
MQA,]H&CTN*REM9@44[?+'(5I8^3G<-W -<UI7Q'^-7Q$\2?&J#1/'=AH&E>"
M]3O1;F32()YW2-YA% ,KM";83EVW-DCKS7J?A/\ 9?U3_A8NB>,OB#\0KWX@
M:CH2;=+ADT^.RA@;&-[*C-N;H<\$D*23BMGP'^SLO@F]^+$_]OM>CQY=SW17
M['Y?V'S#,=N=Y\S'G=?E^[[UY<\RRJC!R2ISK*,5=4O<<O:7=HN*2M3T;<5<
M[(X3&SDDW*,+O3G]Y+ETNTV_BVU=BU^RS\5-4^,7P7T;Q'K:1+JKO-;W$D*[
M4E:-RH<+_"2,9 XSG&!Q7@1\3>+/"_[=GQ3N/"'@O_A-[Z32K..6R_M6'3_*
MC^SV9\S?("&Y &T<_-GM7TA^S_\ !\? OX:V?A,:M_;?V>>:8WGV;[/NWN6Q
MLWMC&<=:I^&?@</#O[0'B[XG?VU]H.OV,-E_9?V7;Y'EI N[S=YW9\C.-HQN
MZ\<^;1S#+L+CLPG32=*<9*$6I).\XM+2TDK)O=;6\CJJ87%5L/A8S;4XM.3T
MNO=:;UNGJ_,\I_:$^,7Q4\/ZE\&]-\/PVW@[Q!XLGNK6^TF\:&^BBEW6Z1AI
M@AR%\TME,9]\8KG?C1\=O''P8UOPE\/-9^(UE8ZG>12:EJGCB701*8K=I)%A
MC2TC5E+9C8'@Y.W)49)]X^+'P.'Q1\??#CQ,=:.F'P??R7HM?LOF_:]S0MMW
M;UV8\GKAOO=.*I_&3]GT_$SQ5H'B[0_$]WX,\8Z*C0VNK6MNMPIB;=E'C8@,
M/F?OC#,"#GCKP.991&.%IXBG!)1J.?N7M-RER7DXS;BDUTGTYE*UC'$X3'-U
MI4IRO>/+[V\;1YK).*3;3_EZV:N>"?#O]M+6K'P9\4I=3U.U\=OX7MXKG2M=
MCL6L5O1+*L""6$!2H#R(<  XW#/0UR?AG]LKQ3H^M>"[ZY^)%AXY&K7,4.L>
M%XO#[6?]G+(0#Y=QY:^8RYQU(W#^(<U]2:;\ =1U?P;XNT'X@^/-4\=CQ'%%
M#)));QV<5H(RS*T$*$JC;F#$]]B9'%8G@?\ 9U\<^$KCP_97/QGUB_\ "NB3
M0R6^CPZ;%;/)'$RE8)+@.7>/"A2I&"N1Q7IQS'A[]^W2A=OL[27(E[K]C>+Y
MKO14M;:VT.-X7-/W:4Y62^:?-?7]YJK66KGZ7U/?:^3/VR/^2Z_LV_\ 8R-_
MZ56%?6=?)G[9'_)=?V;?^QD;_P!*K"OE>%?^1K#_  U/_34SVLY_W*7K#_TN
M)]9T445\D>V%%%% !1110 4444 %%%% !1110 4444 %%%% 'P+\>/V)/'FK
M^'_%^H>-/VM=6TOX?W+RW%W8ZQI9:RM[=I=R1.6O%4A244?*,D+@ X%>%>']
M!\%ZM\0? 2ZG^W1=^+IO#^L6L^EZ;>^'[J:/SU=44(SW#H&(^42$';N)]:^R
M?^"ET.CM^R/XEGUFZ\F*TO+&Y@M61F6^F2X0K;,%(.V3D$@_+][^'%> ?#WX
M]?#"^UCPU#;?L1:AIDTUQ;)%J<?@^W9;=BR@3"4P!B%.&WY!XSF@#]):KZA8
MV^J6-S97<2SVMQ&T,L3='1@0RGV()JQ10!\X_P##NO\ 9S_Z)?IW_@7=?_':
MZ[X7?LB_"#X+>*!XC\%>"++0=;$#VXO(9II&$;XW* [L!G YQFO8*Y;XH?$C
M1?A#\/=?\9^(IF@T;1;5KJX:-=SL!PJ*.[,Q50/5ATH -7^)WA?0O'V@>";[
M5XX?%.O0SW&G::$=GFCA7=(Y*J50 =V(S@@9(-=37YV>#?B-X#;]HSX0_$;Q
M+\2/!U[XT\0R:Q/K;6WB&TG@T2!K-4L=-#K)M58]S+GCS)7E89+5^B= !7RK
M_P $N/\ DQ/X9?\ <3_].EW7H_QN_:0;X*ZWI^G#X6?$GQ[]LMS<?:_!.@?V
MC;P?,5\N1_,7:_&<8Z$&O./^"7'_ "8G\,O^XG_Z=+N@#ZJHHHH **** "BB
MB@ HHHH *\]_:*_Y-]^)W_8KZI_Z22UZ%7GO[17_ ";[\3O^Q7U3_P!)):TI
M_''U(J? S\,:***_03XT**** "BBB@ HHHH *^A/V ?^3M_ G_;_ /\ I!<5
M\]U]"?L _P#)V_@3_M__ /2"XKGQ/\"?H_R-J'\6'JOS/V,HHHKX(^O"BBB@
M HHHH *\:^-G_)2/A?\ ]A(_^C8*]EKQKXV?\E(^%_\ V$C_ .C8*:$SV6BB
MBD,*^>_BAXDT[PC^TQX3U;5KC[)I]OI#>;-L9]N[[4HX4$GE@.!WKZ$K)UCP
MEH?B*:.75=%T_4Y8UVH]Y:QRLHSG + X%=V#KPP\VZB;336F^JL;T:BIR;DM
M&FOO.)_X:1^'/_0Q?^2-S_\ &Z/^&D?AS_T,7_DC<_\ QNNF_P"%8^#O^A3T
M/_P6P_\ Q-'_  K'P=_T*>A_^"V'_P")K?FR_P#EG]\?\C2^'[2^]?Y',_\
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M+]YY'$?\-J?!G_H<O_*7>_\ QFC_ (;4^#/_ $.7_E+O?_C-=O\ \*,^&_\
MT3[PK_X);;_XBC_A1GPW_P"B?>%?_!+;?_$4<V2?R5?_  *'_P B'[SR.(_X
M;4^#/_0Y?^4N]_\ C-'_  VI\&?^AR_\I=[_ /&:[?\ X49\-_\ HGWA7_P2
MVW_Q%'_"C/AO_P!$^\*_^"6V_P#B*.;)/Y*O_@4/_D0_>>1Q'_#:GP9_Z'+_
M ,I=[_\ &:/^&U/@S_T.7_E+O?\ XS7;_P#"C/AO_P!$^\*_^"6V_P#B*/\
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M,UV__"C/AO\ ]$^\*_\ @EMO_B*/^%&?#?\ Z)]X5_\ !+;?_$4<V2?R5?\
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M6.7?[U#Y_DSFQO\  E\OS/SWHHHK[0^7"BBB@ HHHH **** "OU*_P""6?\
MR;[X@_[&BX_])+2ORUK]2O\ @EG_ ,F^^(/^QHN/_22TKRLS_P!W?JCT,!_&
M/L:BBBOCSZ4**** "BBB@ KQK]EW_D3M9_["DG_HN.O9:\:_9=_Y$[6?^PI)
M_P"BXZ8NI[+1112&?)G_  4L_P"2%:%_V,D'_I+=5W?_  W-\$?^AV_\I-]_
M\8KV3Q%X7T;QAIW]GZ]I%CK=AO$GV74;9+B+<.C;7!&1D\^]<O\ \*#^&/\
MT3GPE_X([7_XW7U]#,,LJY?1P>/IU&Z;FTX2BOBMOS1?8\.IA<9#%3KX:4;3
M44^9-[7[-=S@_P#AN;X(_P#0[?\ E)OO_C%'_#<WP1_Z';_RDWW_ ,8KO/\
MA0?PQ_Z)SX2_\$=K_P#&Z/\ A0?PQ_Z)SX2_\$=K_P#&ZGGX<_Y]U_\ P.G_
M /(#Y<U_FI_^ R_^2.#_ .&YO@C_ -#M_P"4F^_^,4?\-S?!'_H=O_*3??\
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MCM?_ (W1S\.?\^Z__@=/_P"0#ES7^:G_ . R_P#DC@_^&YO@C_T.W_E)OO\
MXQ1_PW-\$?\ H=O_ "DWW_QBN\_X4'\,?^B<^$O_  1VO_QNC_A0?PQ_Z)SX
M2_\ !':__&Z.?AS_ )]U_P#P.G_\@'+FO\U/_P !E_\ )'!_\-S?!'_H=O\
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M!XC_ .P6G_H,%-"9[+1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^>_\ P5G_ .:5_P#<5_\ ;.OT(K\]_P#@K/\
M\TK_ .XK_P"V=>CEW^]0^?Y,XL;_  )?+\S\]Z***^T/EPHHHH **** "BBB
M@ K]2O\ @EG_ ,F^^(/^QHN/_22TK\M:_4K_ ()9_P#)OOB#_L:+C_TDM*\K
M,_\ =WZH]# ?QC[&HHHKX\^E"BBB@ HHHH *\:_9=_Y$[6?^PI)_Z+CKV6O&
MOV7?^1.UG_L*2?\ HN.F+J>RT444AA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /2"XKGQ/\"?H_R-J'\6'JOS/V,HHHKX(^O"BBB@ HHHH *\:^-G_)2/A?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC@D9_1GP;J5_K'A'0[_5;3[!JEU8P3W=K_SQF:-6=/P8D?A0!L4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7SW^W]_R:1X
M[_[</_2^WKZ$KY[_ &_O^32/'?\ VX?^E]O73AOX\/5?F85_X4_1_D?CG111
M7WA\B%%%% !1110 4444 %?H1_P28_YJI_W"O_;ROSWK]"/^"3'_ #53_N%?
M^WE>=F/^ZS^7YH[<%_'C\_R/T(HHHKXL^H"BBB@ HHHH Q/%GC+2O!-A'>ZQ
M-);VKOY8E2%Y &(R =H..AZUX1I/Q4\-6OQUUGQ')?LNCW-@L$4_D2$EPL0Q
MMV[A]QNW:OH?5M)M-<TVXL+^!;FSN$*21/T8'_/7M7SGI?[,]XOQ"EM;MV;P
MQ"1.MUD;ID)XBX/#<$$^@SW%4K$NY]!>&_$UAXMTF/4M,DDFLI"0DCQ-'NP<
M$@, <9[^U:M16MK#8VL5O;QK#!"@CCC0855 P !Z8J6I*"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/?_@K/_P TK_[B
MO_MG7Z$5^>__  5G_P":5_\ <5_]LZ]'+O\ >H?/\F<6-_@2^7YGY[T445]H
M?+A1110 4444 %%%% !7ZE?\$L_^3??$'_8T7'_I):5^6M?J5_P2S_Y-]\0?
M]C1<?^DEI7E9G_N[]4>A@/XQ]C4445\>?2A1110 5^>7_!:1%C^ ?@@*H4?\
M)-G &.3:SDG\Z_0VOC3]J/\ 83^('[4VH7%MKWQU^R^#XM1.H:7X?_X1"W?[
M =C(%^T)/')+A689;KGI0!]EU^=7_!45]=O/CM^R]I>DSV=G+<:_(;*?44+V
MHNS=6*HTR _,B%E)'!PS#/->^?$+]E'QQ\8_V<-=^&?C_P",D_B+6M0U&.\B
M\30^'8+$10(8RML]K#(JR+N1VW%P<N/[HS/\5OV)=$^+'P*\ > KWQ/JEEKG
M@>&U&C^++=0;I)H8EC,C(3RK;5;:&!!5,-\O(!Y&WQE^-W[.O[7/PW^'7Q!\
M>V'Q0\,>.E9$DBT&'3)K&4L4&P19RJOLY9FRI;A2 :^[J^8/AE^Q?J&E_&;3
MOBI\4OB7J'Q8\9Z/:&STB6;3(M,M;%2&&X01,P9\._)/5B2"V"/I^@ HHHH
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M_CB[O[2PTV^U!9H8Y9H]JQ.T)PDKQ* <D$@("?NC !^H=%%% !1110 4444
M%?*O_!+C_DQ/X9?]Q/\ ].EW7U57RK_P2X_Y,3^&7_<3_P#3I=T ?55%%% !
M1110 4444 %%%% !7GO[17_)OOQ._P"Q7U3_ -)):]"KSW]HK_DWWXG?]BOJ
MG_I)+6E/XX^I%3X&?AC1117Z"?&A1110 4444 %%%% !7T)^P#_R=OX$_P"W
M_P#](+BOGNOH3]@'_D[?P)_V_P#_ *07%<^)_@3]'^1M0_BP]5^9^QE%%%?!
M'UX4444 %<YXU^)'A+X:V5O>>+O%.B^%;2XD\F&XUK4(;..5\9VJTC*"< G
MYP*Z.N<\:_#?PE\2K*WL_%WA;1?%5I;R>=#;ZUI\-Y'$^,;E616 ."1D<X-
M'Y\?\$:O'_A?2/A?XG\,7WB32++Q+J7B)I;+1KB^BCO+I!:19:*$MO<#8_*@
M_=/H:^K/ O[;GPT\>ZY\4M/MY=5TV+X<>:^MZA?V6(#'&\B22Q>6SNRJ8FX*
MJV.@-=]X;_9[^%G@W6[76= ^&G@_0]7M26M]0TW0;6WN(25*DI(D89<J2.#T
M)%=%HO@'PQX<U36-2TGPYI.EZCK,GFZG>65C%#-?/S\T[JH,A^9N6)ZGUH _
M*[]L3PG^S!X#^'-IX]^!7BRQL?BG_:T%SIH\-^(I[VYE=I,R&2)I)&API9AD
M)R O.<']-O@7JOB;7/@QX'U'QG"UOXKNM%M)]4C>(1,+AHE,FY!]ULDY7C!R
M,#I1I7P)^&N@^(?[>TWX>^%=.UW<6_M.UT2VBN<GJ?-5 V?QKN: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>_V_O\
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MC-:\(:'\1_#_ (#\$>%-)\066N7.HZ/,SW6;>3>!'^_F.[KC 7DC+ 9KV/\
MX**ZYJWA_P#95\27.E>(9/#(:ZLXKV]M[A8+C[(TZ"9(2S+ND*9^12"P#*,Y
MP?F+P+^SC^R/;^)O#VH:9^TEK]_J$=Y;SVMG/XKLP)I0ZLD;1_9PWS' *Y!Y
MQP: /TTHHHH **** *+:[IL>N1:,VH6JZQ-;O>1Z>9U%P\",J/*(\[BBLZ*6
MQ@%U!/(J]7QU\(?@S-\(_P!MJQEU;Q=K'COQ3K/P]U&XU37M8<!IF74K!42*
M%?D@B4%ML:]-QY-?8M !7RK_ ,$N/^3$_AE_W$__ $Z7=>[^./C3\/OAC?6]
MEXP\=>&_"EY<1^=#;ZWJ]O9R2QY(WJLCJ2N01D<9%>$?\$N/^3$_AE_W$_\
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M /':^0J*[O[ P79_>=']GT/,^O?^&O?!W_0-US_OQ#_\=H_X:]\'?] W7/\
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MWNK_ (I?FSXZO_%GZO\ ,****X3 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KY[_;^_Y-(\=_]N'_ *7V]?0E?/?[?W_)I'CO_MP_]+[>NG#?
MQX>J_,PK_P *?H_R/QSHHHK[P^1"BBB@ HHHH **** "OT(_X),?\U4_[A7_
M +>5^>]?H1_P28_YJI_W"O\ V\KSLQ_W6?R_-';@OX\?G^1^A%%%%?%GU!^6
M?[:G_)S7C+_MS_\ 2*"O$*]O_;4_Y.:\9?\ ;G_Z105XA7]/Y/\ \BW#?X(?
M^DH\6I\;]0HHHKUB HHHH **** "BBB@#]NZ***_DH]T**** "BBB@ HHHH
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MGZK\S]HJ***_B _H<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .&'_P!IW_HC7_ET:7_\>H_X8?\ VG?^B-?^71I?_P >K[0_X:1^(W_0Q?\
MDC;?_&Z/^&D?B-_T,7_DC;?_ !NC^S<U_P"?L?Z_[=#^P8]E][/B_P#X8?\
MVG?^B-?^71I?_P >H_X8?_:=_P"B-?\ ET:7_P#'J^T/^&D?B-_T,7_DC;?_
M !NC_AI'XC?]#%_Y(VW_ ,;H_LW-?^?L?Z_[=#^P8]E][/B__AA_]IW_ *(U
M_P"71I?_ ,>H_P"&'_VG?^B-?^71I?\ \>K[0_X:1^(W_0Q?^2-M_P#&Z/\
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MI<V<.[;L_+_?QC':N&_X5S^T[_T;M_Y>^E__ !5>O_\ #2/Q&_Z&+_R1MO\
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MW_0Q?^2-M_\ &Z/J^=?\_H_=_P#:A[/&_P Z_KY'D'_"N?VG?^C=O_+WTO\
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M^9*TO_XW7U510!\J_P##1'[3O_1HW_F2M+_^-T?\-$?M._\ 1HW_ )DK2_\
MXW7U510!\J_\-$?M._\ 1HW_ )DK2_\ XW1_PT1^T[_T:-_YDK2__C=?55%
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MO*N(YO\ 5X3.?+V_>&,YYQBO'_\ AM3XS?\ 0Y?^4NR_^,T?\-J?&;_H<O\
MREV7_P 9JH\$9G"2E&I"Z\Y?_(DRQ%.2<6G9GC/_  P_^T[_ -$:_P#+HTO_
M ./4?\,/_M._]$:_\NC2_P#X]7LW_#:GQF_Z'+_REV7_ ,9H_P"&U/C-_P!#
ME_Y2[+_XS7?_ *KYW_S^A^/_ ,@<GL\+_(_Z^9XS_P ,/_M._P#1&O\ RZ-+
M_P#CU'_##_[3O_1&O_+HTO\ ^/5[-_PVI\9O^AR_\I=E_P#&:/\ AM3XS?\
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M_AEG]IW_ *(;_P"7=I?_ ,=KO/\ AM3XS?\ 0Y?^4NR_^,T?\-J?&;_H<O\
MREV7_P 9H^H\5_\ 05#[E_\ *PYJ'\K_ *^9]1?\-$?M._\ 1HW_ )DK2_\
MXW1_PT1^T[_T:-_YDK2__C=?+O\ PVI\9O\ H<O_ "EV7_QFC_AM3XS?]#E_
MY2[+_P",U\E_J-F7_/R'WR_^1-_K,.S/J+_AHC]IW_HT;_S)6E__ !NC_AHC
M]IW_ *-&_P#,E:7_ /&Z^7?^&U/C-_T.7_E+LO\ XS1_PVI\9O\ H<O_ "EV
M7_QFC_4;,O\ GY#[Y?\ R(?68=F?47_#1'[3O_1HW_F2M+_^-T?\-$?M._\
M1HW_ )DK2_\ XW7R[_PVI\9O^AR_\I=E_P#&:/\ AM3XS?\ 0Y?^4NR_^,T?
MZC9E_P _(??+_P"1#ZS#LSZB_P"&B/VG?^C1O_,E:7_\;H_X:(_:=_Z-&_\
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M'_VG?^B-?^71I?\ \>KTS_AN;XW?]#M_Y2;'_P",4?\ #<WQN_Z';_RDV/\
M\8KM_P!1>(?^?]/[W_\ *SE_U@RG_GU/\/\ Y(\S_P"&'_VG?^B-?^71I?\
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MX9"_:=_Z(E_Y=FE__':/^&0OVG?^B)?^79I?_P =KL_^&YOC=_T.W_E)L?\
MXQ1_PW-\;O\ H=O_ "DV/_QBC^S>./\ H.I_<O\ Y4'UKAW_ *!Y_>__ ),X
MS_AD+]IW_HB7_EV:7_\ ':/^&0OVG?\ HB7_ )=FE_\ QVNS_P"&YOC=_P!#
MM_Y2;'_XQ1_PW-\;O^AV_P#*38__ !BC^S>./^@ZG]R_^5!]:X=_Z!Y_>_\
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M/[E_\D?7G_#1'[3O_1HW_F2M+_\ C='_  T1^T[_ -&C?^9*TO\ ^-U\A_\
M#<WQN_Z';_RDV/\ \8H_X;F^-W_0[?\ E)L?_C%'_$-<W_Y^T_OE_P#(!_K;
M@?Y)_<O_ )(^O/\ AHC]IW_HT;_S)6E__&Z/^&B/VG?^C1O_ #)6E_\ QNOD
M/_AN;XW?]#M_Y2;'_P",4?\ #<WQN_Z';_RDV/\ \8H_XAKF_P#S]I_?+_Y
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M\SC[IKU6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /GS]NSX8:Y\6/V=]3TCP]I;:_?VVH6.HMHJN$.HPPW"/) "3C)
M3<0#U*COBOC#QM^SGXJ\+_M(7>@>#O@;Y%EJWC#1O$N@^,[#3TAM=$LXT4W5
MK(R(410=P,18 E20K94U]D_M]?$#Q#\-_P!FG7-4\-ZM-X=NY[RRL+C7+<$R
MZ;;37"1RSICD,%; (Y&[(P<$?#'@GXD+\+Y=5T#P=\7M7\4:Q;_%;1H-"/\
M;K7,NNV,L0$ZR(K;98&W\MC:&"<@GD _7"BBB@ HHHH **** "BBB@ HHHH
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ME>$_^PO:?^CDK"O_  I^C_(BI\#/T(HHHK\6/B@HHHH **** "BBB@ HHHH
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MP,_Y(G\/O^Q>T_\ ])HZ_,.._P#=J'^)_D=F%^)G<4445^,GHA1110 4444
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M0 4444 %%%% !1110 4444 %?M%\ _\ DA7PY_[%O3?_ $ECK\7:_:+X!_\
M)"OAS_V+>F_^DL=?B_B=_NF&_P 3_(^_X0_CU?1?F=Y1117\]'ZB%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?#?Q
MB_X* +'\4O&WPBL/@+K_ ,4DTQVL;^#3P;I+E"@+;H%@D^7!/7TKR7X+>(O#
M7P]^*&E:UX<_83\=>&]8N+N.)=8NH=0G2PWL$:5%FA*1!0Q)*[>,\BO>/VS?
M G[*37LVL_%C4M-\*^,MJS)J6B730ZV2  DGE0AFD. H#21L!@<BOFK]GGXU
M?M$7_P 4--T_X/7OC7XG_"1KJ*-]2^(VDQHJ0;PLC+=F3<VU<E<.#Q_J^U '
MZMT444 %%%% !1110 4444 %%%% 'F?[2/\ R1?Q%_V[_P#I3%7P[7W%^TC_
M ,D7\1?]N_\ Z4Q5\.U^C<.?[I+_ !/\D?1Y;_"?K^B"BBBOJCU0HHHH ***
M* "BBB@ HHHH **** "MSP3XMO/ OBBPURQ57N+1RPCDSM=2"K*<>H)%8=%3
M*,:D7"2NF)I25F>NZ[\>K6XTG7[?0?"=MX?O=>R-1O5NFF:4$$-M4J N=S=/
M4G&>:/\ A=>@:GX-T+P_K_@C^VHM)B$<4O\ :TD&2!@MA$[@="37D5%<']GX
M9))1>CO>\K[6WO?;3<Y_J]/M^+._\->//"WAWQ=<ZR/!/GPI-#/IUI_:TJ_8
MGCY)W[3YF6 /S#C&*O\ CCXQ67B;Q-9^)M*\-_V'XCANH[B2^_M!YQ,$4*J&
M/:J@85<XZ@'U->8T5I]3HN?M&FW:V\MNUKV]>[UW*]C#FYGOZL]JOOVC(/M&
MIZKI7A"UTOQ/J-N+>?5_M;2\8 RL94 '@=^PSG%>*T45=##4L,FJ2M?S;VVW
M[%4Z4*?PH****ZC4**** "BBB@ HHHH **** "BBB@ KIOAC_P E*\)_]A>T
M_P#1R5S-=-\,?^2E>$_^PO:?^CDK"O\ PI^C_(BI\#/T(HHHK\6/B@HHHH *
M*** "BBB@ HHHH _$2BBBOZU/""BBB@ HHHH **** "BBB@ HHHH **** +_
M (?U"VTG7M-OKRQ34[2VN8YIK*1MJW"*X+1DX. P!&<'K7T?\1/VM/ WQ6N+
M&7Q3\'WU,V,7DVT8\5W,,42YYVQQQ*H)XYQD@ 9P!7S#17G8G+\/BZD:M5/F
MC>S4I1M??X6BXS<59'O_ (._:6\-:%\+K_P#K/PX_M_P]<:E)?I!_;DMMY:E
MPR1[EC+'9M'S;N>XKB[CQY\.I/'MKJT7PN\GPS'9F&;P]_PD-RWFSY8B;[05
MWKP5&P#'R^]>:45$,LPU.4YPYDYWO:<]WN[<UK^:U#G;W/H+X[?M.>'OCAX9
M@L9_AU_9FL6,2PZ;JO\ ;DDOV1-Z%QY0C57W*FWYLXSD=*N?#K]J3PA\//AW
M>>$X/A5]IM]5LTMM9F_X2*9?M[^5Y<DF#$3%NRQVH1C=QTKYQHK#^Q<%]76%
MY7R)W2YY[_\ @7?6VU]=Q^TE?FZFIXHU#3=5\07]WH^D_P!AZ7-*6M].^TM<
M?9T[)YC?,WU-9=%%>S&*C%173Y_BS,****H HHHH **** "BBB@ HHHH ***
M* "OV#^!G_)$_A]_V+VG_P#I-'7X^5^P?P,_Y(G\/O\ L7M/_P#2:.OS#CO_
M ':A_B?Y'9A?B9W%%%%?C)Z(4444 %%%% !1110!^$-%%%?W:?S>%%%% !11
M10 4444 %%%% !1110 4444 :/AW4;;2/$&F7][8)JEG:W44\]C(VU;F-7#-
M&3@X# %<X/7I7TS\2/VP? /Q<N+";Q9\&)-5-A%Y-K&/%US!%"N<G;'%$J@G
MC)QD@ 9P!CY5HKR,9E.$Q]6%>NGSPO9J<XM7W^&2W.ZAC:V&A*G3:Y9;IQB[
MVVW3/?\ X<_M*>&?!_PP\2> =9^&_P#PD?AO6-9?51:_V[+:^2I$/EP[EC+M
ML,*G=N&>X]>6O/B)\+YO'&GZI!\(?LWAV&U>*YT'_A);I_M$Q)VR^>5WIMX^
M4#!Q7E-%1#)\)3J3J0YDYWO:I42;:LW92M>RW2OYE2QU>48PE9J.UXQZ:VO:
M]O+8^C/C_P#M4>&_CQX5@L+CX:_V5K-C$L&F:M_;TLWV--Z,X\H1(LFY4V_-
MG&<CD5>^&O[67@SX;_#:]\'V_P )/M-MJ]DEKK<W_"2S)_:#^5Y<DF#$QBWY
M8[4(QNXZ5\RT5R_ZNY;]5C@E"7LT^9+VE3??^:^^J6R>J5W<V_M7%^V>(YES
MM6ORQV^[Y>FFQK>*M1TO5O$6H7FBZ1_8&E32E[;3/M+W/V=.R>:PW/CU-9-%
M%?10BH145LN[;_%ZOU9Y<I.3;?4****HD**** "BBB@ HHHH **** "BBB@
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M:_1FW-9VOTWNC>_;V\'Z?X?^)FBZI964>G3ZSIBW%Y;PH%7SU=@S\=R-H/\
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MB+_MW_\ 2F*OAVOTDU+2[/6;*2SU"T@OK23&^WN8UDC;!!&58$'! /U%8?\
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M_A6/@[_H4]#_ /!;#_\ $T?ZRTO^?;^]!_:4/Y6?GO17Z$?\*Q\'?]"GH?\
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M;_XBC_7O#?\ /B7WH/JK[GX^45^P?_"C/AO_ -$^\*_^"6V_^(H_X49\-_\
MHGWA7_P2VW_Q%'^O>&_Y\2^]!]5?<_'RBOV#_P"%&?#?_HGWA7_P2VW_ ,11
M_P *,^&__1/O"O\ X);;_P"(H_U[PW_/B7WH/JK[GX^45^P?_"C/AO\ ]$^\
M*_\ @EMO_B*/^%&?#?\ Z)]X5_\ !+;?_$4?Z]X;_GQ+[T'U5]S\?**_8/\
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M#'_HG/A+_P $=K_\;H_X4'\,?^B<^$O_  1VO_QNC_B)V#_Z!I?>@_U0K_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\1?L\?\ "2?\)M]H\0D?\)5XFTG7+G_0E.RUL?L>+$?/R'^R-F0]//;Y3CD
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M#3X)^'? _A+6K&WU30]+M-.M]7U?37NX9#$J+)+);QSQ,3(%<X$HPSYRP&"
M<Y\(?'WQ!^)'PY\4ZA/'X;M]?@\0ZAH^F30PW'V".&VN?LSRN"^^X,<D=Q]T
MPB;RU7]QN+K=^ GQ.UOQUX+\1:IXIDTN5-(UN_TV#7-(MY+:RU.VMFVFZCBD
MEE9%#B6,_O'!,+,#@@#B;?\ 9O\ B)9_!*Q^'EO\3M%MDCOYI[V_M_"]S"=1
MM97:66WD$>I+(ADEDD9Y(I$)!"@+\Q;TB^^&^MZO\"]7\!W&M:/IFJ7NC7.C
M0:EH&B-9V5BDD310M#9M<28$2%<)YN"4XV@X !YQI/[;6A:YIVF7=E\/?'DI
MU?P^?$^E0-96:/?:>@C,THW706(1>:N3.8Q)E?*,N]-V[KW[6GAC2=+.K66@
M^(O$&BVFFVFK:SJ6EV\!AT2VN8UEB:Y$LR,S^4WF-' LKJF&*@.FZYXG_9Y_
MMI?&"6'B#^R4U?P5%X+TPI9;VTJ)?M/F3@B1?,9O.APOR!?LZ]<G&'>?LLW$
MVJ^)-+@\506_PV\37]IJ&L^'?[)W7MQY%K;VWV9+WS@J6\BVD =3 SE3*%D0
MN&4 WA^TYH4GQ!O?"\7AWQ'-#8^((_#-UKRV\ TZ*^D@CFC3>9A(X/F;#Y<;
M%&4[PBE&;RK4OVJO&NK_  YUG5T\):MX7FE\?VOAG0YUMK2[EN[9-26VO8UC
MCN9O,G5;>^!;:D?*%&8*SUZGI'[/']G_ /",?:/$)O/[+\9:EXRN_P#0E3[=
M-<_;/*B/SG8(?M:8;YBWV=>%SQ3\#_LYWWAN'P+:ZKXGM=6L?!_B#4==L8K?
M2#;-.;F&YC03DSN&E1KRX<R*%#%E^12I+ #[7]J?2;^UTN*T\&^*KOQ#>7^I
M6,GAN&*S:^M#8.JW<DC?:?)=4,D6!%+([^:NU6(8+V/Q2^,.E?"FW\-_;=.U
M76+_ ,1:D-(TO3-(MUDN;BY:"695VNR*BD0L#(Y5$+ NR)N9?+M7_9+O=8T7
M3-$N/%NGW6D1ZW+XANWO/#ZS7T5\^HS7K7&GW/GAK.4B;R2[";"1KL"$N6W?
MBWX1\9^,_CAX#F\+:E!H$?AK3=1U)]0U71I=0L9KF<PVT4+*DT.6$1NF^64,
M"4/*DA@!VG_M7:!K?_"*6FE>&/$VJ>(/$9U18-!MH;7[5:MIUTMM>+<.UP(8
MMDC'#&4J^PA&9F16IZ;^U%;3:*+FST#6_&^I7)U'4(M+\.V%M!/:Z7;W4MNE
MQ,9[WRB':$[") \W)6%=LBIM?#G]GN/X::O'J%CX@GO)H/#[:3#+>6X:7[7-
M>37E[?2$,%9IYI(W*!5 ,9Y(8!>-TG]DO6/"&FV&F>%/'\>BV,_A+3/!^MS2
MZ(+B\N;>S,_^D6DOGJMM/(+J?+21SJ&9#M.W! .[\+_M&:#XZ\:67AWPQH^M
MZ^T^CZ;KT^I6T$,=I9V=\LS0/,TLJ,&Q#DQJK/B12JL!(4P[_P#:*O=#^-/C
MC0]9\-7>F?#[PGHEM?7WBB3[.R)<2^<_W5N#*R-'&BHB0M(9"00JF,OV?PM^
M$%A\*]0\3S:?.&M-5GM!9V:1E4T^SMK&"T@ME)9BP A=]QQDRGCC)X[QA^SG
MJ/BJ\^*>WQ7;6ECXTDL+ZW1M(\V?3KRTCMUB+2&8+- 6ME8P[$;,DF)!D8 .
ML^''QFA^('B+5/#]WX4\0^#=<L+*VU,V'B&*V#RVL[2I'*IMYYE'S02*4<JZ
MD<J,UQ:_M1:;X7U3Q)=>-?+TCPK'XHO/#^E:O# QB3[+8I-+]I<ODR23I=QQ
MB-/F,:)R[#=VWPY^&.H>&O$VO^+?$^N6_B/QAK4-M93WEC8-8VEO:6_F&&WM
MX&EF9%WSS2,6E=F>5N0H1%\RU7]D&XU[PC'H%_XZN!!:7%_KEE)9V'D%-?N;
MZ:\74I@)3YPA:55C@.%&&9F9O+,0!T/B']JK2?#5C/=W7@SQ;)#I=E;W_B/R
M;>T)\-QS*'1;P&Y&Z01GS&BM_.=4P64;TW>F>,/'%CX)?05OX;B1=8U2'2(7
M@52L<TJN4:3+#"DIMR,G++QU(\IUG]FO5=>\1>+(KKQA:_\ "#^,-3MM6\1:
M''HQ%W=RQ6UO T$=WYY$5M*+2'>AA=]ID59%+AEV_B!^S=X<USPOK5KX)L]'
M^''B75-2L=6E\1Z/HD'GO<VUXERLDJKL\XDK(N78_P"M8\Y.0"MJ7[4OAV&&
M4:-H6O>*;Y;K4X5L=*2U1WM]/E\F\O!)//%$MNDW[H,\BLSY"JV"1;\,_M):
M)XXU#2HO"_A[Q%XCL+JWTZXO=4L;6(0:2+Z*.:V6Y6259=QCECD<1))Y2.K2
M;%(-<;XT_8WT75M:\+7NB6_@^XMM#T2/0DL?'7A0>(D$4<AD2:)C<PM'.2\G
MF2,7WD@D @ENI_X0KQ%\(_$7CSQC8:V^L>%M0NYO$=QX6LM">XU2YNA8Q6_D
M17 F(,;&!'5!!OW$#S-N10!T7P5\6:IXJT;Q*NK7/VVYTOQ-JVF1W.Q4WP17
M<GDKA0!E(V2,G&28R3DDFJ7PU\;:K\0/%7B_Q&+Y8/A_8RG2-(B\M MY+ SB
M\OC(1DQ^9^YCPP7$$CD-O4CF-,^'_CKPS^S[IOA;2<V?C;Q%=22Z[K%I<)_Q
M)YK^>2YU"ZC9B#(8C+*D. 26\G*A Q7T#Q'X%M],^#&K>#O"ME'I]M#H,VE:
M79PDJD*BW:.) >N!\HSUH \O\#_M%7LGA+2O$%WI&O\ C#4/&ANO$&B>&]#M
MK59=.T%-BPSR/,\"[61H)"'D:0R73)&K+&=N-X%_:W&F_!^P\3:]I7B#QC(=
M)N/%NKWNBV=JD>BZ1-//+9F=7EBW$6RX"1"24K S.H+ MIQ_ GQ'XL\,>'-7
M\->*V^']SJ'@2V\-7]O=:"9;RVC$9>,PAI8_L\J-(X971^   C+NJ'4OV0[Y
M]-U3P[I/C:+2/!NL6FCVNI::NC^9<SI8Q0P>2MQYX"P2PPA&C\LMEF(DP2I
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M =F\X!D\%_LZCP1#X CL]?\ -_X0SP?/X8L&DLOF:XF%KYE\Q$GWC]E7Y/\
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MDQ>+(-)MO#/B+4=,GUW_ (1J/Q':0V[:>VHARLL(S.)L1%)=\GE>6##(H<N
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M\G@FVU[Q;!XDT7P'9O9^%K*VTC["\&Z)H//NY/.D^T3B!FC#(L*8DE)0EEV
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M/%.C^!?">M6/B33-4TW47U*?5/%UA\-=;O++38;3:K0SV,-TT]M*)"ZL9I%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>advm-20241231_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *^!.@# 2(  A$! Q$!_\0
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MQ0U+X7Z9<ZY\3?\ A /#4-LAM(U"QR10=5,DBM&5!&",N3@X..E>U>&[ 0_
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M2+YOG;QN/.WY%P.W.*\W^"_Q2T'X1_';QU::P/L6EZA?W%M'=JI*V[)</M#
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M-[R21SG?<295-V>_+OGU2OIW7KS3/V@?AOXYT*Q :6TNKC34+]/M$)#1N/\
M9+!>?K7*?LK^!;_PS\#+F_L4CAU_75ENK=KK*HN%*6^X@$[.-_0G#FI?V:_@
MCXP^#>K:W_;5_I5[INI1(Q%G<3/(LR,<-AXU&"&;)SGA:SJ24I.5]5L>CE6&
MJX?"T,.Z;<*JDYOM=:?@?!LD;PR-'(K(ZDJRL,$$=013:]8_:@\#_P#"#_&+
M64CCV6>I$:E;\D\2$[_IB02<>F*\KMK>2\N(H(5WS2N$1?5B< ?G7?&7,DS\
MNQ.'EAJ\Z$MXMH^[?V9;J3_AFG_BF!:R>(H5O<QOC!N][F(2?5#%U[8K;^!>
MO_$./POK&L?%*:"PLT"S6SW<4=O-%& QD,@4 *OW<;ANX;/:L/R_#7[&WPWM
M)Q97&L:EJ5S%!=SQMM:>0!F9N>%55W[5[\9/):I?C%X-B_:6^&]CJO@SQ \C
M0YD2R\\K;W!X)CE3^&5>Q(XR0>#D>:[2;?1O<_7*+J8>C3A%WK4H:TU+1]$W
MW:WTZ_*_Q-X\U2SUOQQXBU'3AMT^[U&XN+8;=N(WE9DX[<$<5AU]:?M-^"/#
M'PV^"?AC3(-&TJ'Q%));V[WT%O''<2^7"?-D+A=S9;;GGJX-?)==\)*4;H_,
M<RPD\'B'3J-.3U=NE];'U1^QG\'M-UV.\\;:U;+=+9W'V?3X9E_=AU4,\I!^
M]C< .P(8]0,6?&_[<E_:^)IK?POHMC<:-!+L^T7^\R7*@\LH5@$!YQG=Q@D=
MJ]$_9)FCU3]G\6=LZM<1SW<#KG[KL2P!_!U/XU\'WEI-I]W/:W,30W$#M%)&
MXPR,IP01Z@BN>,54G+FZ'T^*Q-7*\MPL<&^7G3<FMV]/\_P/HK6_B)X=_:6^
M+'PXM[G1WTF196AU,2%66<9#)$KC!93M8<@$>8<5[E^T-\6?%'P7TW2&\+^&
M[2YTHH5FNYX7>"VQ@+'MC9=G48)..P%? =G=SZ?=0W5M*\%S"ZR12QL59&!R
M&!'0@C-?67PR_;:C:&WTWQUIQ8;1&^K62[@W;,D/TZE3]%HG3M:RNET%EF;0
MJQK0Q%7V=6HU[Z2Z)*S[;>6[V/.?'?[5.K>,/$G@[7[?1+33M3\.O<2)NE::
M&<RA 05PI4 (?XC][J,5[?\ LW_M(>)OC!XXOM&UFQTFVM8-.DO%>QAE1RZR
MQ( 2TC#&'/;L*Y/]K[X,^'='\,VOC/P_:0:;,URD-U#:@)#,K@E9 HX#9 Z8
MR&)/(KE?V&/^2M:M_P!@.;_THMZ34)4[I&]&KF&#SB.'KU;\S3=MFK63^Y6^
M1VOQG_:R\7?#KXF:WX=TW3M%GLK%XUCDNH)FD.Z)'.2LJCJQZ 5\CWUY)J%]
M<74H42SR-*VT8&6))Q^=>G?M2_\ )>O%?_72#_TGBKRJMJ<5&*:/F\WQ=?$8
MNI3JS;492LNVH#K3J1>M+5GA,**** 04444%!11128!1114@%%%% !1110 4
M444 .6EI%Z4M!04445)(4444 %%%%!2"BBB@84444 %*M)3EI,!:***D:"BB
MB@84444"84445 PHHHH *<.E-IU !2K24Y:AE"T445FRT.I:**@84Y>E-IPJ
M64%%%%0RD.6EI%Z4M9L84JTE.6H90M%%%9L8JTM(M+4LH*<M-IRU#+%H%%*O
M6LV-"TM)2U#*'#I1114LH5:W-%\/F]43W&4@_A4=7_P%4]"T[^TKX(W^J3YG
M^GI^-=OP     , #H*^^X8R&&/;QF*5X)V2[OS\E^+]#W,OP:K?O:FR_$;#$
MEO&(XD6-!_"HQ3\$]JS-6UR+3<QH!+<?W>R_7W]JX+7OB!;VTC+=7C2R#_EC
M#SCV]!7WV)SNEAZOU+ TG6J+[,%HO5]/TZGM3Q482]E2CS-=$>G>8@.#)&#Z
M;Q_C3L94]&7OW%>&_P#"RK4MA;.4C_>&:V=&^(%E-(HCN)+*3L)>!^?3\ZYJ
MF:9QAX^TQ672Y.O+)2:7HE_D)UL1'6=%V^\[_5/#Z2 RVJ[9.IB'0_2N>Z<'
M@UOZ7XC$S*EUA2>DR]/Q_P :C\1Z>(V%T@P'.' ]>Q_&OSS/,OP&8X66:Y3I
MR_'':WG;IYVT>ZV9YM>G2JP]M0^:,8=*<M-IRU^82/-0Y:<.M:=UX3UJPT>#
M5KG2KR#3)\>5>20,L3YZ88C!SBLU>M9236YKRN.Z%7^M/IB]JUU\*ZRVAG61
MI5X=)!P;X0-Y/7'WL8Z\?6L+-[&D8N6R,VE7K15S2=)OM<ODL].M)KZ[DSMA
MMXR[G R< >U86;T1<4V[(JT^I]1TV[T>^EL[ZVEL[N(XDAG0HZGKR#TJ['X5
MUF716UA-*O'TI20;U8&,0P<'YL8Z\5BXR=U;8U49-VL9BTZD6M+1/#FJ^)+A
MX=*TZZU&6-=[I:Q-(57U.!Q6%G)V2+BG)V10IR]*6:)[>5XI4:.1&*LC#!4C
M@@CUI!TKGD6ART]:ZJQ^$_C#4=)74;;P]?2V;+O5Q'@LOJ%ZD?05R[1M&S(Z
ME74X*L,$'TJ*E.<+.<6KF[A*-G)6 4Y>U-]:<O:N1C0ZBBBL6:(\0HHHK^])
M'Y&.'2OK#]E/XZ>"?AK\+=9TCQ'K!T_49]2FN8H?LLTN]&@B4'*(0/F1AR17
MR?17E8W"0QM+V51M+R/2R_'U<NK>WI)-V:UVU^:/H?\ 9+\9?#OX;7FJ>(_%
MFL_9-<P;6QMOL<\NR(@%Y R(RY8_+R00%/9JZSX0_M?1P_$_Q1=^+[N6S\.:
MP_G6WR/*+)D 5%VJ&.&0 -@?> ..2:^35IU>=7RVA7E4G4NW))>ENVAW8?.L
M5A84J=%)*#;Z^\W_ #:Z_@?26F_'#PK\'?CQJ^N>$)Y-<\&:Y&'O;6&!X7AD
M+%CY8E"Y*MD@<+B0KVR/4=6^)_[-WB;Q OBC4TMY];X=C+I]WEV &"Z!?+<]
M.6STZU\.4Y>E<E7*Z4VI<TE)*UT[-KST-J.?8BE&4/9PE%OF2:NHM]M=#W?]
MIK]HJ+XR7%EI.C6\MMX=L)#,K7"@27$N"H<@$[5 + #K\Q)]!X324HZUTTJ$
M,/35*FM$>/B\75QU>5>L[R9T_P ,_&4GP_\ B!H/B%-Q6PNDDE51DM$?ED4>
MY0L/QK[7\=?M<?#V'P?K<WAW73=^();1H[2-;"X0F4J0A+.@7"EL\GL:^ 3U
MIU>?BL#2Q4XU)WNOZU/2P&<XG+J4Z-&UI=[Z.UKK5'>?!/XI3_!_Q]::_'!]
MKMMC6]W;@@-)"Q!8 ]B"JL/=<5].>(OB7^SA\3KN/6?$D6W5&5=_FVEY%,<
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M5ZLZTMY-O[W<5:6D6EH,&%%%% T%%%% PHHHI, HHHJ0"BBB@ HHHH ****
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M9B/:ND[:)-NZY;/9WVUZ'A=%>T_%+X+>'=+^'6G^// FL7NK^'9I_LUQ'J"
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MQ\)_AEXT^)6I:%JGC#4I_&VIWEQ/*--C7[%%.Q:1HMS(=Y7D9R,E2.#Q7'?
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MX! =I%); .?EYP1\O3.#\3/@F/ OQ=TGPA:W[WMMJS6YMIG4"14FE,8#@?Q
M@]N>.!TI\R,ZF75Z<7)V=FDTFFTWLF>5#K3J^CO&GP+^%WPO\42VGBGQ=JT5
MO<;&LK&S1)+J./ #2S.(RN"^[ "@X'<YQR?Q ^$7A_X8_&2T\.:M=:OJ.@74
M*SQ?V:D7VUM^Y$3+X3.]>3CIV':>9,TK97B*-^>VC2>JTOM?M<\LU#0=3TBU
MLKF^TZ[LK:]3S;6:X@:-)TX^9"1AAR.1ZBJ0Z5]4?M2W/P_T^;3_  S?#Q -
M6T32/)TR/3_LXLT++B,3;OF_@3.T#CI7RQ4WNC/'X18*NZ49<UOSZW^84J]:
M]2^.7PELOAWXHT#3_#[7VH6NK:?%<Q&Y9))'F=V4HNQ1QC9CC^+J:UOCM\!;
M7X0^&_"MY;WEQ=WE\)(M1\UU,:S*J'$0"@A<^8/F)/ ]ZBY<LOQ%-56U_#M?
MY['C-=IXK^%&K>#O!GA_Q+?W-@UGK:A[:WAE9IPI7=EE*@ 8(Z$]16]XX^$^
MG^#/A;X-U66:\?Q9X@<S"Q!4Q+;X)7"[-V\[H>IZEABM7XC?"OPA\./BMHOA
MN[GUZ]TZ:RCDN_L;0/=-<.754CW!55<A#\V3@GZU!K' SA&7M(Z^[UM9RU5]
M.W3H>3ZAH.IZ3;65S?:==V5O>IYMK-<0-&DZ<?,A(PPY'(]178^$?A2?$GPV
M\5>,;C5%T^TT4I''"8=YN9&Q\F[<-G+(,X.=W3CGVC]J&X\ :?-I_AF^'B :
MMHFD>3ID>G^0+1"RXC$N[YOX$SM XZ5-X)\&:;_PRE;KK6ICP_I&I:BU_J-V
MZEI&C1]J+&O=F,4>!Z$G![R>G'*X1Q52C=248M[VUM;7M9O[EJ?*=%>V_$#X
M/>$8?A3'XY\$ZOJ=[8QW0MKB+5 @;D[<KM1<8)7@YX/7BO$ZAGBXC#3PLE&=
MM5=6=TTS0T70M1\2:E%I^E64^H7LIPD%O&78^^!V]^@KT*;]F7XF6]JUPWA:
M8QJ-Q5+J!W_[X$A8GVQ7H=SJ#?LZ_ [16TM5M_&?BU?M$MXR?O+>#:&VKD<$
M!T&#_$S'M7DO@+XC^*=-\=:1>0:YJ,UQ)>1+(LMP\@F!8 JP).X$''-2[=3T
MOJV%P[A3Q+DYNS=K+EOMNG=V]#BKBWEL[B6">)X)XF*21R*59&!P00>A![5Z
MA:_LQ_$R\M89XO#+&*5 ZEKVV4X(R,@R9'T-=I^T5X1M-7_:4TG3+>+G6/L0
MNEC!&6:0QL?;Y%4D_C3_ -HR7Q9XF^-4^G^'+75G2SA@M(18B0(S8WE@5X&&
MDP2>FVI:[F_]GTJ/M?;7ERR45RZ7W\GT1Y%-\*_%=OXQM_"LVBSPZ]<<PVLC
M*OF#:6RKD[2, \YQP1VKJ_\ AEGXG_\ 0L?^3]K_ /':[+]JG6)]/A^'VCW&
MI?:/%&DZ<QU&XA?YQ(ZQ#)8<Y)1SZX.>].^&>L7V@_LV_$/Q'<75U+=7DR:;
M \LS$@$*I*$GC_7,<C^[[5-E>S-8X'"1Q-3#SYGRINZ:5DHWL]'K?0\S\6?
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M,,09D(*[PB#>,@':V0<<BN-\1>+=7\6>(KC7]5O7N=7N'662Z55C8LH 4@(
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MTN^YP/KF$#_@5?/E=%H_Q U_0?"^J^';"_\ LVCZH0;RW6&,F7&,?.5W <=
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M12C&&W@BDP?21$# ^X.:7LY<MC59EA_K3KQ<HQ2C%1M%IQ22:=WW79^AZ/\
M!/X?Z7I'[6VHZ;IES]ITW03=30G<&_A$>PGN4:7'KE/K7A7Q 74KOQ5JVL:A
MIMYIW]IWUQ<HMY T9):0LPY')&X9QTS5;POXTUOP7KR:UHNHS6.J)N_TA<,6
MW?>#!@0P/H0?6KOCOXF>)?B9>V]WXEU1]3FMT,<1,21JBDY.%15'/'..U5RM
M2N>?6Q6'JX3V44XR4I225K:VZWOHEV.@_9SL;74?C=X1AO IA%YYH#=-Z(SI
M_P"/JM==\1/A?XP^*'[0_B.T_LJZMEFU JU]+$WD0VJX6.4OTQY:J0,\].M>
M(6=Y/I]Y!=6LSV]S!(LL4T;%61U.58$="" <UZ'K'[1WQ(UVSBM;WQ1<201N
MKA(X(8]Q4@@/M0;QD<AL@]P:4HRYKQ*PV)PJPOU?$J6DN;2VNEK.[T]==V>F
M?M,6,.O?&SP3X$M#LL+.VL]-2./K&99-I_\ '/+_ "KF?VPO$KZU\8[K3E=O
MLFCVT-I%'N^0$H)&('8Y< _[H]*\WG^)GB2Z\=#QE+J/F>)!(LHO6@B^\J!%
M.S;LX4 ?=[5EZQXDU+Q!X@N-;U"Y-SJEQ-]HEN&11N?.<[0-OX8Q2C!QM?H:
MXS,:>(C64$TZDT_^W8II+??7TTW/HGX^6EGI_B;X.> KS'V32[.U6[9^%*RR
M1QOG\(6)_P!ZJ/[47@OQ;XY^/3V6GZ'>7D7V6W@L9(HB8VCV[F8M]U0)'D!R
M1C%>'>-/'&N?$+6VU?Q!?-J.H-&L7G&-(_E7H J *._0=ZZJZ_:+^)%YH/\
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M /':_L9\3X-_9E]R_P#DCYS_ %.Q_P#/#[Y?_(GYMT5^DG_#(GPE_P"A3_\
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M\*/^A4_\J-W_ /':/^&2?A1_T*O_ )4;O_X[4_VK1[/\/\Q_ZGX_^>'WR_\
MD3\YJ*_1K_ADOX4?]"K_ .5&[_\ CM'_  R7\*/^A5_\J-W_ /':7]J4>S_#
M_,7^I^/_ )X??+_Y$_.6BOT:_P"&2_A1_P!"K_Y4;O\ ^.T?\,E_"C_H5?\
MRHW?_P =J?[3H]G^'^8_]3\?_/#[Y?\ R)^<M%?HU_PR7\*/^A5_\J-W_P#'
M:/\ ADOX4?\ 0J_^5&[_ /CM3_:5'L_P_P Q_P"J&/\ YX?>_P#Y$_.6E6OT
M9_X9+^%'_0J_^5&[_P#CM'_#)?PI_P"A5_\ *C=__':7]I4NS_#_ #%_JAC_
M .>'WO\ ^1/SF'6EK]&/^&2_A1_T*O\ Y4;O_P".T?\ #)?PI_Z%7_RHW?\
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M $*W_E1N_P#X[2^LP[,/]4,?_/#[W_\ (GYUT5^BG_#)WPJ_Z%;_ ,J-W_\
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M $*W_E1N_P#X[1]8AV#_ %1QW\\/O?\ \B?G717Z*?\ #)WPJ_Z%;_RHW?\
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M ..TO;Q#_5+'?SP^]_\ R)^=M%?HE_PR?\*_^A6_\J%W_P#':/\ AD_X5_\
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M5_\ RH77_P =H]HA_P"J>._GA][_ /D3\]!UIU?H5_PRG\+?^A7_ /*A=?\
MQVC_ (95^%O_ $*__E0NO_CM1SH?^JF-_GA][_\ D3\]:<O2OT(_X95^%O\
MT*__ )4+K_X[2_\ #*OPN_Z%?_RH77_QVIYBO]5<;_/'[W_\B?GO17Z$?\,K
M?"[_ *%?_P J%U_\=H_X96^%W_0K_P#E0NO_ ([2N'^JN-_GC][_ /D3\^%I
M:_0;_AE?X7?]"Q_Y4+K_ ..T?\,K_"[_ *%C_P J%U_\=J1_ZK8W^>/WO_Y$
M_/FE6OT%_P"&5_A=_P!"Q_Y4+K_X[2_\,L?"_P#Z%C_RH77_ ,=J;%?ZKXW^
M>/WO_P"1/S[HK]!/^&6?A?\ ]"Q_Y4+K_P".T?\ #+/PO_Z%C_RH77_QVHY6
M'^J^-_GC][_^1/S\7K3J_0'_ (99^%__ $+'_E0NO_CM+_PRS\,/^A8_\G[K
M_P".TN1E?ZL8S^>/WO\ ^1/S]H'6OT"_X99^&'_0L?\ D_=?_':/^&6OAA_T
M+'_D_=?_ !VI]FQ_ZL8S^>/WO_Y$_/\ HK] /^&6_AA_T+/_ )/W7_QVC_AE
MOX8?]"S_ .3]U_\ ':GV4A_ZLXS^:/WO_P"1/@!:=7W]_P ,M_##_H6?_)^Z
M_P#CM'_#+GPQ_P"A9_\ )^Z_^.U/L9#_ -6<9_-'[W_D? -/K[[_ .&7/AC_
M -"S_P"3]U_\=I?^&7?AC_T+/_D_=?\ QVH]A(?^K6,_FC][_P CX"IRU]]_
M\,N_#'_H6?\ R?NO_CM'_#+_ ,,O^A9_\G[K_P".U/U>?<?^K>+_ )H_>_\
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MU*&Z:(9Q\PC8[>2.M/V=/L+GGW/0_P#A+[S_ )Y0?]\M_C1_PE]Y_P \H/\
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MR3["A0IM7L'--=3T3_A+[S_GE!_WRW^-'_"7WG_/*#_OEO\ &N!\7?$CPEX
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MEO\ &O.=!^+'@CQ3>:?::+XQ\/ZO=ZC"]Q906&J03O<Q(Q5WC57)=596!*Y
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MTO@?XH^&+OQ):2Q^&_!=[=MH=E=/)&Y7>R*1$&^SD(C,IVA"1FLCX"ZT\/\
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MY>7H5S*_,?%7A'3?#WP9_;$_:+@T3P[';>&+/P''JDWAW1H_(BG*0Q.R11H
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MIZ*Z;&(4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >ET445XAZ84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5\\>/X?%VD_M>?"JYE\;7[^%]6&J6T/A:TC^S6B+'8!VDN"&)N93*-R
MLV%C4 *@;>[_ $/7DOCWX 7'CSXC:1XQ/Q*\7Z'=Z,\CZ78Z9%I1MK,RPB&;
M;YUC)(^]02?,=\%CMVC  !Y'XH^W_#OXP^._%WQ)TGXD/X*?7]/DT77]&\73
M1Z-IUJ;>TAQ/80:BC^7]J\TOFV<88ELKFOK:O*?%O[/\'CK5;L:[XW\6:AX4
MN[R.]G\'R3VG]G2,A5EC,@M_M7E>8BN8OM&PG*XV$I7JU 'BGQJ_;,^#O[._
MBJU\-_$+QA_PC^M75DFH0VW]F7ESN@:22-7W0PNHRT4@P3GY>F",^P:3JUCK
MVE6>IZ9>6^HZ;>PI<VMY:2K+#/$ZADD1U)#*RD$,#@@@BO-?VL?^36?C)_V)
MFL_^D,U'[)W_ ":S\&_^Q,T;_P!(8: /5:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HJ&VNX+R,O;S1SH"5+1L&&1U&1WJ:C8 HKSGXS_M%?#C]GK2[34/B%XK
ML_#<%XS+;1S+)+//MQN*0QJTC 9&2%(&X9ZBN*\4?MV? SP;X$\(^,M7\=QV
MWAOQ8+EM%O4TR]E^U?9W$<_R)"70H[!2'5>: />Z*\P^&7[37PQ^,'P]U;QU
MX6\6VMUX1TFYDM+[5[V*6PAMY$CCD8.;A(R %EC.[&/FQG(-6?A/^T1\._CA
MX=UK7_!/B>WUG1=&N7M+^_,,MO##(B!V^:9$!4*P;>N5QWH ]&HKQ/X8?MI?
M!3XS>.)/"'@[Q_8:QXB4.4LA#/#Y^T$MY+R1JDV I;]V6X!/3FNN^.GQK\._
ML\_#'5_'?BG[4^D:;Y8:"QC62XG=W5$CC5F4%BS#JP&,DGB@#OJ*JZ7>MJ6F
MVEVUK/9-<0I*;:Z4++"64'8X!(##.#@D9!Y-6J "BL#QWX^\._#'PK?>)?%>
ML6F@Z#8J&N+^]D"1IE@JC/<EB  .22 .37GOPG_:\^#WQPM=;N?!GCO3]4BT
M2W:[U'SXY;-K:!1EIF6=$/ECNX&T=S0![#17B_PK_;+^#'QL\93>%/!7CVQU
MOQ!&KN+(0SPF8*"6,32QJLN "3Y9;@$]!FN@^$?QX\/_ !DUGQSH^EVFHZ9J
MW@W69-%U2QU2.-)1(HRLR!)'!AD ;8Q()VG@4 >D4444 %%%5[K4+6P\O[3<
MPV_F-L3S9 NYO09ZFFDWH@+%%%4=<US3O#&BWVKZO?6^F:58P/<W5Y=2".*"
M)%+.[L> H ))/I2 O45XO\)_VRO@Q\<?%T_A?P3X\LM;U^)6?[%Y$\#2JN2Q
MB,L:B4  D["W STYKD_"W_!1S]G;QKXLTCPSHOQ#%]K>K7T.G65LNBZB@FN)
M9!'&F]K<*,LP&XD#G)..: /I2BO+_B-^TY\+_A+XPT/PIXJ\8V6F^)=:N8K6
MRTF-)+BY>25@L>](E8QJQ( =]J^]2_&C]I+X:?L\Z?;7?Q"\767AQ;HX@@D6
M2>YF&<%D@B5Y&4'JP7 [D4 >ET5%:W45]:PW$+;X9D61&P1E2,@X/M7GO@_X
M\>'O'7QA\;_#G2+;49]5\'PVLFJZ@8D%DDEPI:.!7W[C)M!)&P 8(SD8H ]'
MHHHH **\1^)_[:WP2^#7C0>$_&'Q T_2/$.462Q$,]PT!8!E\YHHV6+*LK?O
M"O!!Z<U>^+/[7?P>^!]OHTWC3QWI^E+K%NMW8+"DMV]Q WW9E2!';RSV?&TX
M.#Q0![!17COC[]JWP%X#^'O@_P =M=7&O>#/$VJ6VEV^N:,(I;:V,S,JS3EG
M4I$K(RL0&92,%<\5[%0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Q/@?XT>"OB/X7UGQ'X?UZ&[T/1KNYL=0OIHY+:.VEM_]>&,
MJKP@Y+?=QR"17;5^9/[*_P"T5\)/#7PH^,/PB\;7VHWGB'6/$/B9I_#&F:;=
M2W=U9-$WG+&ZIY8<QQS8!<'*^I&0#[>^#?[57PI_:"UC5]*^'_C&U\1:AI2B
M2[MXX)H65"VW>OFHOF)G W)D<CGD5:US]I;X:^&_C)I?PIU+Q1#:>/M3B66T
MTE[:<^8K!RH\X)Y2L0C85G!/''(S\D_L#_$62Z^,D_@;P9XGF^*OPGT7PSY>
MG^*=4\./I]_H3+,BKI37#1IYJ[0'QC^%<8"$5P?[7'P_U+Q9^U[\6/$'A^,C
MQ9X'\%:3XNT68(69;BSNTD91CD[HA*N.Y(ZXH ^]O$O[1_PX\(_%S0_AAJWB
M:*U\=:W&LMCI"VT\C2*V_;ND1#'&3Y;X#LI./<9]*K\M?!8O/B9\7O@U\=M5
MLI;._P#B3\29YM/MICF2VTBTLY;>TB/) /RRN2, [P>F#6'\!_C?\3O$'[3'
MA>T\4?%:^\._$*Z\4R6VN>!-=U/4GLGL1*X>VMK!-,^SPOY8S'*;L@[03MW<
M 'ZS45^3?P;_ &BO$>L_M?>!?[(\=^/9H-7\37FF:]X9\5:Q<3Q6J$2^7$UD
M;*.WM6PFY1'<3, !G:0PK3^%GB3XEZ/X3^ WQ3G^+OC76KCQ#\5$\&7?AW4M
M2:;33I\MY=*^Y#\TD@$1P[LVT%0,!%H _5&O%_C5^V/\'OV=_$]EX>^(7C%?
M#^LWEHM]!:_V==W):!G= Y:&)U4%HW')!^4U\Y_LY_$_4[S]LWQ#X?O/'6N?
M$2._N-5N(9M/UBZ6PT>%'Q':7VES0JENRXVQRQM\Y'<'->:_M]^+$\%_MS:3
M=W'Q/;X1VE]\,_[/?7O^$<.MBX#W]UNM!"%.TN,'S!RNT<C=0!]X^*OVE_A?
MX)^%NG_$;6O&>FV?@O4%5K+5 6D6ZW D+$B*7=L*WRJI8;3D<&LGP'^V!\(/
MB=?>%+3PQXTM]5N/%,UW;:2L=I<H)YK6));B)B\8$4BQR1MLDVL0ZD Y%? O
MA>^G^'/@+]C[XD_$+P)?6?PX\'KK5EJ216,\HL))&*VFHRV[[G <J)<\X()7
MK&I]P_:.\<>%_C-^SV?CK\)-/N'G^'/B^W\2Q:@^F/8?VRL*0K>.H=5>2(PN
M%9V4$_92O11D ^NI_C%X/M?&FN^$Y=:CCUW0M*76]3@:&41VEFQ8+))+M\L$
M[6.W=NP,XQS4/P=^-W@GX_>$3XG\ ZZGB#1%N'M&N5@E@*3*%9D9)45U.'4\
MKR&!'!K\^?%GBS6O&'[./Q+\:>'M.GU3QK^T3XQ_X1WPY:+B":31X=UO"K&3
M 0?9X;C+-A5\]6/&<^E_L@>)?%GPU_:P\:^"?&?PY;X4V?CO2K?7M$T)M8M]
M3B6:SC2VG$<T "YD0"0H1D>5GH1D ^H/C9^U%\+?V=6T]/B'XPM?#L^H M;6
MS0S7$\B@X+^5"CN%SQN( SGFD\)?M+>"O'GQ4TWP+X?N+C5;O4O":^,[35;=
M$-A+8-=?9@ ^[?YF_G:4P!WSQ7S'\0/B7X7_ &8_V^/&/CKXL6-W8^&O$?AJ
MRL_#GB@:=->06K1#;<6N8U9D=VYPHZ8S@-7'^-O"]M\??VQ=/E\&>(_%7PHT
MB;X*OJMM+X=4:5?-$-8F*1L-N8HW=DE(&UF"@97<: /TAHK\G?B)^T3XC\1_
ML]? *7Q#XZ\>>'M>UKP_>R_VMH&L7.E0:E=1SF&&.:6VLKN::<B,'9L13N)+
MKN%=9\,O$GQ%_:1O?V<M U'XK^,/"R>(O VJW.L7WAW4/L]Q=O;W>R-R2"HD
MPB9EV[\;AD;C0!^FU%?DAXF^.7Q7\2?L\_ 73!XV\0S7^H7OB2VU.\L?%4'A
MF]U1;.X6.U+:I<JT89 6S&<M(!Z_-5WXO>(OB;\'/AK\%]%\6_%WQ.OA/4M-
MO=1UOQKI?BR['FZHT@V6O]IVUE>R>5&N J!"KDR?-\H( /U>N+B.UMY9YG$<
M4:EW8] H&2?RKR[]GO\ :,\/_M*>&]0\0>&-'\0Z=HMO=&WMKW7-/^RQZB@)
M'VBV.X^9$65ER<$%2" 17E?PG;Q!\5/V 93XB\?2>(M3O]"U )XM\-RW%O-<
M1(\HB97G@BDW[45&9HE+88\YR?D7X%^$?$EM\(?V3?#.B_%'QYX:L?B!J.N/
MJ3:;K!0VL*VY40VJE=L:8C+KN5]DDKR+AL8 /UCHK\H?C[\4?$WA'Q[\2= \
M0_&#XJ>%_B!X<:WLOAQX;T59FM?$,*PQB.>X,<)6ZDE<%G+E<$L!N^X.U^,T
M_P 4/&GCKXL_;/B=XR\#WGA#X5V/BN31_#>I-:POJL=K+(Z,!G9&75PZQ[=_
MRY)VB@#]*:*_/3]G'Q%\0/#7[0WP(EUOXE^*O&MI\4? +Z_JVGZU=*UE:7/V
M=)U^S0JH2(*"J\#)Y)/.!^A= !1110 4444 %%%% !1110 4444 %%%% !11
M10 45Y7\7OVIOA1\!X)6\;^.=)T:Z1=W]G";S[UAT^6WCW2$9[[<>]=!\'?B
MOH_QP^'&D>-M M]0M='U3SC;)J=OY$Y6.9XMY3)P&,99?564\9Q0!VE%%% !
M1110 4444 >5?M8_\FL_&3_L3-9_](9J/V3O^36?@W_V)FC?^D,-'[6/_)K/
MQD_[$S6?_2&:C]D[_DUGX-_]B9HW_I##0!ZK1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!Q7Q,U7QQI<%@?!6C6.KR.SBZ%[(%\L #;M!D3.?FSSV''->2^.+_P"-WB7P
MK?Z=>>%+&TM)D_?/ILJF<J#DJH$[$YQ@@ DCBOH^BO2P^-6'4;4HMKJT[_G^
MATTZWL[>ZG;^NY\:?!G2_B?X:U&]O_#7A^2Y5D\F:+4QY4+<YR-SIE@1V/&3
MZUZU_P )9\=_^A+T/_O\G_R57N-%=>(S7ZQ4=25&#];W_-&U3%>TES."_'_,
M_./XLZ+\0?B'_P %(M/TS3?&NE_#3Q%9_#B.ZL=3O-)AU98#Y^Z=;:*9@@D+
M&4&3J(XWZUXUJGQF^*'QN\0?LJ:O9S>%[[XBZ=XK\4:38ZG>PR1:3J#Q?82+
MB18 "%8.W^K R1G R17Z7?&S]E[X7?M%?V<?B'X0M?$4NG[A:W#336\T:DY*
M^9"Z,5R,[22,]JP?'?[$GP1^)/A/PKX8U[P#:3:#X76=='L;.ZN;)+43%&FQ
MY$B%BY16)8DD@GJ23X;=W<X#L/A[H7C'Q+\.5T[XSZ?X.U779IF-U:>'H)IM
M+>-9 T)"70+%AM4G(P& (Z5^=_@EK^W_ &-?VW1I0VSCQEK",$R,0%HA-T[>
M5OK[H\-?L;_!_P '_"?Q%\--(\(?9/!/B&<7.IZ7_:=X_P!HD'EX;S6F,B_Z
MJ/A6 ^7W.<SX8?L(_ KX-^(+C6O"7@.+3M0N;*;3IVGU*\NXY;>4;98VCGF=
M"K 8.5Z4@/E[Q='X::3_ ()^KX8^S?VD);1K9;''F?8OLD!NBW?&X?-NYSOS
MSNKU3_@IA--<>&?@EI+QF32M3^)FCP7RX.V1,2D1L?0\G'^P/2O7_A1^QC\%
M_@?XPE\5>"? =EHOB"1707WGSW#1!P0PB$LC+%D$@[ O!(Z<5%^V)\ =0_:-
M^"MSX:T/4+72?%%G?VNKZ+?WI80P7<#Y4N55F *M(N0IQNS@XQ0!XA\=M,\8
M_%#_ (* :3\--,^*'B[P#X5N_AP-3O8?#-]Y+RR+J$Z[H]P98I#B,&95W[4V
M9PQKR#X>_M->)]-_9A;_ (2S]HV\^&FI>'_'FI>%X_%.H^%/^$CN-6AAACD2
M.1=K%6'FD^8W)V@9-?H)8_";0+CXB:=\2]4T>W7XC1:&NA2ZC:W4[1);F0S/
M"B%@A7S68AR@?!QD#BIOA=\'?!_P7TW6-/\ !NCC1K/5]4FUF]C%Q--YMW*$
M$DF9'8KD1I\JX48X H ^3_V=?VB_!_B#PK\0]=\>?M&6/QP\,>&[>TU&X34/
M (T./2F61VCD4&,>?([HH10"RLBXY85YWX3_ &>O%?[3<?[0GQRN+&'P GQ'
M\,R:'X6TO4\0,]F! PN[LC[GF_98N<GAW/*A-WWI\6_@]X0^.O@NX\)>.-(_
MMSP_<2QS26?VF:WRZ-N0[XG1Q@^A^M>4^"?^"?'[/_P[OM0N]!^'L=K-J%A/
MIEUYVJWUPDMM,NV6,I+.RX8<9QD=B* /CJ%?B:_[07['W@KQ1\-M(\ :UX1D
MDLX9M,URWU">_LH;:(7$QAASY$+)&Q =B26?!ZFOH?X+R-IO_!2[]H.QLHPE
MC?>'M&O;S8?E^T)#$B$CL2CN?S/>O:?@O^R3\(OV>]2N]1\ >";/0=1ND,<M
MZ9IKJ?82"4629W95) RJD X'%8O[/_P#USX>_%CXR?$7Q;>Z?>^(/'.L1-;)
MITDDB6NF6T?EVD;,Z(?-VG#@ K\BX)H ]XHHHH ^7KOQ_P#M5)=3+!\-/"K0
MAV"-]K0Y7/!R;U<\>P^@Z5\W_M)^'_C?XX\3:9J?C;P;/:S&W^RVEOH:&YMP
M V2,1R2X=B>YR<#C X_3&BOL,#Q%]1JJK3PM--=E)/[W)_D<\J/,K.3/D/PG
MXH_:K\.^&-*TR'X>Z%?0VEM'#'<:C=1FXD55 !D/VQ?FQC.0#Z\UZ)X!\4?$
MW6K;Q(GQO\'^&-!\$Q:9)+//YL<L3@$;UF0SRJ8_+WD[@!P.N>/>*P?'7@?1
M/B7X/U?PMXDL?[2T'5K=K6]M/->+S8VZKO1E9?JI!KS,3FD<3&4?JU.+EU2E
M=>GO6_ N,.7JSXN^"/A^X_:P_;*L/VBM+TEO#WPR\'Z9-H7AJZFMQ#/K\A2>
M)[C81D0*+B4*3C[J #/F!>)_X)2_\+M_X4UX9_LC_A /^%2_VO>?;?MOV[^W
M<[CO\O;^X^]MQN[9SS7TW\/_ /@GO\ /A;XSTGQ9X7\ _P!F:_I4WVBSO/[9
MU";RGP1G9)<,K<$\$$51\/?\$W/V<_"OB73-?TKX="TU;3;N*^M)UUK46$4T
M;AT;8UP5.&4'!!'&,8KPC4\V_P""D/A_2]/U7X$:G:Z;:6VI7_Q.T?[7>0P*
MDUSL5E3S' R^U0 ,DX P*U/^"K_A_2S^R!XPUHZ;:'6?,TVT_M#R%^T>2+Z-
MO*\S&[9N).W.,DFO4_BQ^PK\#_CEXVN_%WC?P1_;?B&ZCCBFO/[6OK?<L:!$
M&R*=4&% ' ^M5_&7[ OP'^(&F^&=/U_P)]OM/#>G+I.E1_VO?Q_9[569Q'E)
MP7^9F.Y\MSUH ]N\*_\ (L:/_P!></\ Z *_/_X%:YJEK\$_V[?%45Q<:9XH
MB\0>*&2^MI'AN+9H+.0P[&!W(8R3M(.5QUXK[A^$?P=\(? GP7!X3\#:1_8?
MA^"62>.S^TS7&UW;<YWRN[')]Z\E\!?LLW'ACXI?'K^U)-/U3X7?%*-)YM)6
M>:.\BN)(I(KU6VJ $E$C'>L@8'  &,T ?)OA/Q!\2OA6O[)/Q$O?C#XR\62_
M$?4M.T;6=#U>[$FG?9[A8T39#C_6*'^:5BSNPW$@YS)XT_:Q_LOQEKUG_P -
MY?V)]GO[B'^S/^%/?:/LFV1AY/F^5^\V8V[N^,]Z^[KW]FOX;ZCHOP]TBX\-
MK)I_P_N;>\\-0_;;@?8)H HA;(DS)MVKQ(6!QSFO3: /A3]M'7;3XR:?)^SE
M\,M&L/$/Q#\9?8]3\1:NMFL5OI5JAB<7MVX7B5ECC50<L%( P3&&SM?^"WQ"
M_9H^/&F>+? W@[0_BKX8L?AW8^#KE=8UZVTF;3([<(GVB8S9'E.L.6"@YRXX
MV_-[I\1/^"??P"^*WC35?%OBGP%_:GB#5)1->7G]L7\/FN%"YV1SJ@X4= *E
M\0?L!_ +Q5#X;BU;X>6UZGAVS33]-\S4+P&.W1F9(W(FS*H+-_K-W4T ?#W@
MW09F_P"",_C]]7A1+"74YKW2DR=D<2ZE %\MCR1YJ2X/?)'?%?IU\*=2O=9^
M%O@[4-1##4+K1K.>Y#')\UH$9\^^2:\G_:F_9NO_ (T?!;0OA5X1?2?#/A%]
M5L%UB'+0^7I,#B1H;6..,J9-R1;0Q5?EZU[];V\=I;Q00HL4,:A$11@*H& !
M[8H DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
M\N_VW/B%XV@_:N\;Z+I'B#XQK;:7X-M[_2M-^&-U+]FM[S+$37T2G M^?G<#
M=]T9Q0!^HE%?$NL?MQ:[\)?V??A/XA&C:1\3KG6/#<=]J>OW7BNRT"&2:- L
MPB6Y57FE+A_W:(&R#\N>*W-4_P""@T$FH?#&VT+P0L\?C;08==BNO$&OPZ1
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M9:;R9@2WE%.I%<U;_ME?M)-X%_9WU!/AS]JOO%%[Y,K?VYIJ?\)9&+1)$/\
MJ<6/F%I'Q@%?*P?O"@#]):*^(/BW_P %/M'^%GQ)UWP^?!<6IZ-X9NH;+7M2
M;Q18VMY#.P7S%M;!SYUV(RVUF3 RK= ,GN[O]L_7Y?BE\1/#6A_"+5/$N@>!
M(VN-6U_3]4A#>2=/-W"(K9T#R2R,IB$:DXR&+<[0 ?4E%>(?LJ_M(7'[2WA&
M]UZ30=+T*"$P^5'IOB&+56^=2QCG58XWMY4P T;KWX)P:]OH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP .W/H0#OOAMX'C^&O@?2/#,6M:SXB33HC$-4\07?VN^N,L6W2RX&X_-CH.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4;1E9"I'^LZC<,#!/%=5.BITIU'*W+T]36,%*+E?8]>HHHKE,@HHHH ****
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M))'T#_PE&C?]!:Q_X^_[/_X^4_X^?^>'7_6?['7VH_X2C1O^@M8_\??]G_\
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M7'_/P=@F'F?[>0?<5\]_8LZG^[5J=3R4K/[I<I?M$OB31]5?\)1HW_06L?\
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M\\/]4O[S_8^][5[C_P (OHW_ $";'_C[_M#_ (]D_P"/G_GOT_UG^WU]Z/\
MA%]&_P"@38_\??\ :'_'LG_'S_SWZ?ZS_;Z^]>#_ &C-_%3@_P#MU!]8EUBO
MN1X=_P )M\7K/_EMX5O\7?\ 9_\ Q]PC-S_SP_UB_O/]CK[4?\+A^*5G_P ?
M/AOP].!=_P!GY@OH^;G_ )X<7#?O/]CK[5[C_P (OHW_ $";'_C[_M#_ (]D
M_P"/G_GOT_UG^WU]Z/\ A%]&_P"@38_\??\ :'_'LG_'S_SWZ?ZS_;Z^]'UZ
M+^*A#[FOR8_;KK!?U\SP[_AHKQA9_P#'UX'BF_TO^SS]GO,_Z3_SPX#?O/\
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M_?N5J[XY#.:O]7JKUY5^=B?:X3N_P/KR/XH>#IL;/%>BDDX .H1 _D6JPGQ
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M]9_\MO"M_B[_ +/_ ./N$9N?^>'^L7]Y_L=?:C_A</Q2L_\ CY\-^'IP+O\
ML_,%]'S<_P#/#BX;]Y_L=?:O<?\ A%]&_P"@38_\??\ :'_'LG_'S_SWZ?ZS
M_;Z^]5KO2_#5@,W-GI5N/M?]H?OHHE_TG_GOR/\ 6?[?7WKP5CE+1T(/Y/\
M1B]NNL%_7S/%_P#AHKQA9_\ 'UX'BF_TO^SS]GO,_P"D_P#/#@-^\_V.OM3X
M_P!JJ]CW?:_ 6H0[;HV3%9RV+@=8N8A\_P#L]:]*O/$GPWT_/VK5/"UMB[_M
M ^=<6R?Z3_SWY/\ K/\ ;Z^]8=Y\6_@S8Y\WQ1X/.+O^T#Y5S;R?Z3_SW^4G
M]Y_M_>]ZZ8VJ;8._ISB]O1ZP7WO_ #.:C_:UT>/=]K\-ZQ;[9#$VT(V''5>2
M.?:KMO\ M;>"Y>)+76+<]_,MXS_*0U'>?M&? JQSYGB'0VQ=_P!H?N;)I?\
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M?LL0/^D_\]^ _P"\_P!OK[UX7]G5'\$X/TDC/ZO+I)/YH]Q_X2C1O^@M8_\
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M#U5O!_<>B?\ "4:-_P!!:Q_X^_[/_P"/E/\ CY_YX=?]9_L=?:C_ (2C1O\
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M^E?\]_DB/[S_ &^OO7?3R_&5?X=&3](M_H3SQ6[/8?\ A*-&_P"@M8_\??\
M9_\ Q\I_Q\_\\.O^L_V.OM7C7[-6J6>E_P#"U/MEW!:?:/B1JMO#Y\BIYLK>
M5M1<GEC@X Y.*\K^,O[9W@*S\(W$/P\L[6_\0RWZWD=Q=:3LA@F.=UWAU&Z8
M8 #$9R<G(&#4_8/^(TWCK6/%^@>(+&UU2YEOW\6+?RP+N6\=D21@,;5.2K*5
M"[?F]1CZ.&2XW#Y7B,16ARKW='H]'O;MJ8^TC*:2/L3_ (2C1O\ H+6/_'W_
M &?_ ,?*?\?/_/#K_K/]CK[4?\)1HW_06L?^/O\ L_\ X^4_X^?^>'7_ %G^
MQU]J/^$7T;_H$V/_ !]_VA_Q[)_Q\_\ /?I_K/\ ;Z^]'_"+Z-_T";'_ (^_
M[0_X]D_X^?\ GOT_UG^WU]Z^,.@/^$HT;_H+6/\ Q]_V?_Q\I_Q\_P#/#K_K
M/]CK[5IUF?\ "+Z-_P! FQ_X^_[0_P"/9/\ CY_Y[]/]9_M]?>M.@ KP[]KW
M_DFNF_\ 87B_]$S5[C7AW[7O_)-=-_["\7_HF:O5RK_?:7J=6%_CQ]3Y"HHH
MK];/K@HHHH **** "BBB@#J?A;X=@\6?$+0=*N@#;7%TOG*?XD7+,OXA2/QK
MWKXI0WOB;PYXTTS1?%FFSZ;HBK]H\.P:6(5M8XWW +-W8",@XXR".*^;/#^N
M77AG7+'5K(JMW9S+-'O&5)4YP1W!Z&O3/$WQZ@U72M?ATCPM;Z'J&O +J5^M
MTTS2KC!"J5 7(ST]2>O->%C</7J8F%2FKI6[63NKMWUVZK4X:U.I*I&4=EZ=
M_/R['K?Q@UWQ1H=I;/HGC+0]#T^/15DDTF]DB%U<, ^3&C1L3N "C!&2IKA/
MA!XCDU+X1_$/3/L=E:P6&D,1);0[9)F9)<O(V26.% [  5A^)OC3X6\:/:W&
MN?#[[??6]JMHEQ_;4L>%7)'RJ@'5F//KUJKX%^,/A[P7X7O-)_X0G[9)J-O]
MFU&X_M:2/[4OS#[NP[.&(^4BO.IX.K#">S]C[]T_LK9WWYM=._<YHT9QI<O)
MK==O\SH/#VO77PK^ >F>(= 6"'6=7U5HI[J2)9&\M/, 09'3]W_X\V.3D87[
M3&FV=C\1HI[.V2U^WZ?#=S)&, R,6!./4A1GWR:K>'_C%INFZ'>:!J?A*#6?
M#QOVO["QEO'0V9))">9M)< ''.,Y;.0<5ROQ$\>7OQ&\47&LWD:6^Y5BAMX^
M5AC7[J@]^I)/J3TZ5Z&'PU6.*=64;?%=W6J=K+Y?=V.BG3FJO.UWU[WM;[CF
M:***]X[PHHHH **** "BBB@#Z7_8R_YG#_MS_P#:]?2]?-'[&7_,X?\ ;G_[
M7KZ7K\KSO_D85/E_Z2CY7'?[Q+Y?D@HHHKPSA"BBB@ HHHH **** "BBB@ H
MHHH ***\R_:6M]*N/@9XM;7/&VL_#K2+>V2ZNO$WA^Y:WOK..*5)3Y3J"V7V
M>65 )8.5'6@#XQ^):Z[^TMX[^+VC^$?V8O"GB_PY8>(UT76=8U?6_P"R[O4-
M0L495F/EM&X*K<,%<')20 L0=H^T/V;_  _JGA3X)^%]'UGP=IO@#4+**6%O
M#ND77VFVLT$TGEA9<G>63:Y)).YVSS7Q/8_LU^$M+^!VH?'C3_VB_CI#X>U+
M3TU:\N[76"FH72+^[42* "[K]T;F( '!QS7VK^S/!I4/P+\(MHGC76OB)I%Q
M;/=VOB7Q#<M<7UY'+*\H\UV .4W^7@@%0@4]* (/B1^R]\(?BIK,FO>,OA_X
M?UK5=@$NI7=HHF95&!OD&"P '&XG %=KX#TKPOH/A>RTWP;:Z59>'K4&*VMM
M%6-;:/G)"B/Y1R23[DYKX^^,'C;QSKG@7Q1\+?%UYHOQ#M2(S-XH\!QI=WML
ML%Q'*4U30UE\TQ.8_+E^SNP*.PVJ2*[?]@OP-H&AZ#XI\2:!XJ\':W!KCVL4
MNF>!=-;3K"P: 2\R6SNTD=PXEP^\(<11C;QD@'U51110 45XY;_%[QQXB^+7
MC/PEX9\&>'[S3/"MU96UYJFK>)9[.:3[1;1W!:.".PF4[5DQAI1DKVSQ['0!
MY5^UC_R:S\9/^Q,UG_TAFH_9._Y-9^#?_8F:-_Z0PT?M8_\ )K/QD_[$S6?_
M $AFH_9._P"36?@W_P!B9HW_ *0PT >JT444 %%%% !1110 4444 %%%% $%
M]8VVJ6-Q97MO%=V=Q&T,UO.@>.5&!#*RG@J02"#P0:P_#OPW\)>#[Y[W0?"V
MBZ)>21F%[C3M/AMY&0D$J6102N54XZ9 ]*Z.BM(U)QBX1DTGNA604445F,HZ
M[_:7]B:A_8WV7^V/L\GV+[=N^S^?M/E^9M^;9NQG;SC.*\>_9]^'/Q(^'>M^
M*?\ A*Y_"L^CZ[J-UKDG]CO<M<)?3-'E1YBA1"%5N.6SCD\U[?17;2Q4Z-&=
M!)6G:]UKIV)<;M,****XB@KQ#]ES_FKG_90M7_\ :5>PZ[I?]N:)J&F_:[K3
M_MEO);_:[&7RKB#>I7S(WP=KKG(.." :\Z^$O[/NF_!_6]2U+3?%/BK5_P"T
M?->YM-8U%9K>2>1D9[@HL:YF.P#S"22"0:]7#U*,<)6A.5I2M96[.^Y#OS)G
MJ=%%%>4696O>$]$\50>3K6CZ?J\.,>7?VJ3KCTPP->4>)_V-?A+XGW,WA==+
MG;_EKI<\D&/H@.S_ ,=KVRBNW#X[%87^!5E'T;1+C&6Z/E=OV'KKPLS2> ?B
MCXC\,$'<L,CEU/L3&T?'U!I/^$:_:D\!_P#'AXAT'QU:I]R&[")(?8EEC/\
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M>2?ZWXM^*I/^!M_\<H_X83A?_6_$WQ5)_P!M1_B:^IJ*/]8<S_Y^_P#DL?\
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M&1H52;+* ,L0-I(;VKOHXC'8K+L3SRE**Y>[6^HI59746SZ8HHHKY4 HHHH
M*\<_:FT'4_$/P_T^VTK3KK4[A=4CD:&S@:5PHBF!8A03C) S[BO8Z\L_:+^.
M/_"@?!-EXA_L7^W?M.HI8?9_M?V?;NBE??NV/G'E8QC^+KQ7I9:JTL736'CS
M3OHMKEPJ^QDJG8^2O^%8^,?^A3US_P %LW_Q-'_"L?&/_0IZY_X+9O\ XFNJ
M_P"'EO\ U3G_ ,KG_P!S4?\ #RW_ *IS_P"5S_[FK],]AG__ $"+_P #C_\
M)'=_;*[?F<K_ ,*Q\8_]"GKG_@MF_P#B:/\ A6/C'_H4]<_\%LW_ ,375?\
M#RW_ *IS_P"5S_[FH_X>6_\ 5.?_ "N?_<U'L,__ .@1?^!Q_P#D@_ME=OS.
M5_X5CXQ_Z%/7/_!;-_\ $T?\*Q\8_P#0IZY_X+9O_B:ZK_AY;_U3G_RN?_<U
M'_#RW_JG/_E<_P#N:CV&?_\ 0(O_  ./_P D']LKM^9RO_"L?&/_ $*>N?\
M@MF_^)H_X5CXQ_Z%/7/_  6S?_$UU7_#RW_JG/\ Y7/_ +FH_P"'EO\ U3G_
M ,KG_P!S4>PS_P#Z!%_X''_Y(/[97;\SE?\ A6/C'_H4]<_\%LW_ ,31_P *
MQ\8_]"GKG_@MF_\ B:ZK_AY;_P!4Y_\ *Y_]S4?\/+?^J<_^5S_[FH]AG_\
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MCW[7GP:U#]H+]F_QQX!TBZ2SU75K6,VDDK;4,T,T<Z(QP<*[1!"<<!C7L-%
M'Q;_ ,-F?$M/#*^%1^RM\0!XR^R?81;#3T_L'S]FW'VO_5^1G\,<9[U[A^R#
M\&]1_9__ &;O W@+5[I+O5=*M9&NY(VW(LTTTD[HK8&51I2@/<**YOXE?MX?
M"/X8W7B>RO-6OM8U/P[J5IH][8:-8O<3&]N%F98(^BNRK;RE\'"X"D[B%KUW
MX7_$KP_\8O .B>,_"UY]OT'6(/M%K,4*-C)5E93R&5E92.Q4T ? 7PQ?X2_
M/1?AS\;+WXHV^M> Q<7MKX1T_3O <%CK5])MGM)1<W$8\^ZV@R,Y=4#R".1B
M6V@_8W[//Q6^%7QRA\0>-?AREI_:5U-'9Z[(;#[)?^9%O,2W*E0Q($CE2<C#
M$ \$#X?M?A'X;_9=^+WPDT[4/VH?!ESH_P -=3NI++PSKVGP17EA!?'-[$TD
M3L2[AF96E V$J1@ 5]3_ +%_PRO=*D^('Q2UOQ[X>^('B+XAWMO/=7_A,@Z7
M%%:QM%!'$1U8*YW$@'( .2"Q /IFN9\<>$M5\66]K'I?C77/!;PNS/-H<-A(
MTX(P%?[7:S@ =1M"GGDFNFHH ^5?VA/A!=_$N[\06&B?!>WM_']Q-:+I'Q<W
MZ7$UHT?DLEZTZR+?))#M8"-(6#&-5W!')7ZJHHH ^5?V\/@%_P )]\*_B#XV
M_P"%C_$#PY_8O@S4/^*<T#7/LNCW_DP7$W^E6_EGS=^[RW^8;D55XQFO5?V3
MO^36?@W_ -B9HW_I##1^UC_R:S\9/^Q,UG_TAFH_9._Y-9^#?_8F:-_Z0PT
M>JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KY9_X*+?\D3T3_L88/\ TFN:^IJ^6?\ @HM_R1/1
M/^QA@_\ 2:YKZ+A[_D:X?_$8UOX;/SJHHHK^DSR HHHH *Z[3?C!X]T:PM['
M3_&WB.QLK=!'#;6VK7$<<:CHJJK@ #T%<C16=2E3JJU2*?JKA=K8U[OQAKU_
MIMQIUUK>HW.GW%RUY-:37<C123M]Z5D)P7/=B,^]:&J?%#QEKFE-IFH^+==U
M#36 #6=UJ4TD) Z HS$?I7,45/L:3L^5::[#NSL?A#\2KSX1?$31_%5E +M[
M&1O,M6D*">-E*NA8 XRK'!P<'!P<5B>+-8MO$'BC5]4L['^S+6]NY;F.R\SS
M/(5W+! VU<@9QG Z4WPOHJ>(_$6G:7)J%II,=W.L+WU_)Y<$"DX+NW8 <U['
MXT_9JTC2_A'J?Q \)_$&S\8Z9I=TEI?1QZ?):E'9TCPI9R6^:1#R "IR":X*
MU;"87$QG4TG.T4[2L]=$VM%JW:Y24I1TV/&=#\2:MX8NI;G1]4O=)N)8F@DF
ML;AX7>-L;D)4@E3@9'0XHD\1ZM-H46B2:I>OHT,QN(].:X<VZ2D$&01YVAL$
MC(&>37O7CO\ 9F\"?#$V5KXG^+W]F:O>:>FHPV(\-7$VY'W!1YB2%1ED8<X/
M&<5@>!_V;8?&/PH\1^,O^$TTQ+K1].DU)M%LH_M,RHJN569@RB%F,;8&&..<
M=JP6:8"</K%WRMI7<)*[>BLW'7U6B^8^25['F>I?$/Q5K6C)I&H>)M8O])C"
MA+"YOY9(%V_=Q&S%1C QQ5_XF?%+6?BIK%K?:L+:VALK6.RLM/L8S';6D**
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MY],N#+YJL]U,_FN)"65I0PE*G[ID(    ^ OC;\:M3\$_MIZF?BQXX\:>%[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M45\L:]\2M;T/X]>.;?QK\0?'/@/P?9ZQI=MH'V3PM"="N(9K2TWB;4I=-E1
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M1_P]&_9B_P"BF?\ E U3_P"1J /JJBOE7_AZ-^S%_P!%,_\ *!JG_P C4?\
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M U3_ .1J /JJBOE7_AZ-^S%_T4S_ ,H&J?\ R-1_P]&_9B_Z*9_Y0-4_^1J
M/JJBOE7_ (>C?LQ?]%,_\H&J?_(U'_#T;]F+_HIG_E U3_Y&H ^JJ*^5?^'H
MW[,7_13/_*!JG_R-1_P]&_9B_P"BF?\ E U3_P"1J /JJBOE7_AZ-^S%_P!%
M,_\ *!JG_P C4?\ #T;]F+_HIG_E U3_ .1J /JJBOE7_AZ-^S%_T4S_ ,H&
MJ?\ R-1_P]&_9B_Z*9_Y0-4_^1J /JJBOE7_ (>C?LQ?]%,_\H&J?_(U'_#T
M;]F+_HIG_E U3_Y&H ^JJ*^5?^'HW[,7_13/_*!JG_R-1_P]&_9B_P"BF?\
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M2ID12,MQ]%?LX_&JS_:(^"?A3XAV-D^FPZW;N[V;OO,$L<KPRH&P-P$D;@'
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M+\8^']2\46._[5HEGJD$M[;["%?S(%<NNTD Y P2,T <I_PR=\$/^B-_#_\
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MV/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\
M\:H_X9.^"'_1&_A__P"$O8__ !JO5:* /E_]H_\ 8+^'7Q6^#'B'PMX*\#^!
M_ _B>_\ L_V37K7P];0R6NRYBD?#Q1AQN1'3@]'(/&:Z7X8_L6_"7PC\-O">
MA:[\,? >O:WI>DVEE?ZM-X:M'>]N(X422=F>,LQ=E9B6))W<\U[1'XFT>7Q%
M+X?35;%]>AMEO9-+6Y0W26[,468Q9W!"RLH8C!((SQ619_%?P1J'C2?P?:^,
M= N?%T&XS:!#JD#W\>%#'= '\P84@G*]#F@#E/\ AD[X(?\ 1&_A_P#^$O8_
M_&J/^&3O@A_T1OX?_P#A+V/_ ,:KU6B@#RK_ (9.^"'_ $1OX?\ _A+V/_QJ
MC_AD[X(?]$;^'_\ X2]C_P#&J]5HH \J_P"&3O@A_P!$;^'_ /X2]C_\:H_X
M9.^"'_1&_A__ .$O8_\ QJO5:* /E_\ :/\ V"_AU\5O@QXA\+>"O _@?P/X
MGO\ [/\ 9->M?#UM#):[+F*1\/%&'&Y$=.#T<@\9KI?AC^Q;\)?"/PV\)Z%K
MOPQ\!Z]K>EZ3:65_JTWAJT=[VXCA1))V9XRS%V5F)8DG=SS7J&B?%CP1XF\6
M7_A;1_&7A_5?$VG^9]LT6QU2":]MO+8))YD*N73:Q"G(&"0#S1HGQ8\$>)O%
ME_X6T?QEX?U7Q-I_F?;-%L=4@FO;;RV"2>9"KETVL0IR!@D \T <K_PR=\$/
M^B-_#_\ \)>Q_P#C5'_#)WP0_P"B-_#_ /\ "7L?_C5>JT4 >5?\,G?!#_HC
M?P__ /"7L?\ XU1_PR=\$/\ HC?P_P#_  E['_XU7JM% 'E7_#)WP0_Z(W\/
M_P#PE['_ .-4?\,G?!#_ *(W\/\ _P )>Q_^-5ZK10!\O_M'_L%_#KXK?!CQ
M#X6\%>!_ _@?Q/?_ &?[)KUKX>MH9+79<Q2/AXHPXW(CIP>CD'C-=+\,?V+?
MA+X1^&WA/0M=^&/@/7M;TO2;2RO]6F\-6CO>W$<*)).S/&68NRLQ+$D[N>:]
M0T3XL>"/$WBR_P#"VC^,O#^J^)M/\S[9HMCJD$U[;>6P23S(5<NFUB%.0,$@
M'FEO/BOX(T_QI!X/NO&.@6WBZ?:8= FU2!+^3*EAM@+^8<J"1A>@S0!RG_#)
MWP0_Z(W\/_\ PE['_P"-4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'E7_#)WP0_
MZ(W\/_\ PE['_P"-4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'E7_#)WP0_Z(W\
M/_\ PE['_P"-4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'R_P#M'_L%_#KXK?!C
MQ#X6\%>!_ _@?Q/?_9_LFO6OAZVADM=ES%(^'BC#C<B.G!Z.0>,UTOPQ_8M^
M$OA'X;>$]"UWX8^ ]>UO2])M+*_U:;PU:.][<1PHDD[,\99B[*S$L23NYYKU
M'2/BQX(\0>+KWPII?C'P_J7BBQW_ &K1+/5();VWV$*_F0*Y==I(!R!@D9I;
M+XJ>"M2\:7/A"T\8:#=>+;8%I]!AU.![^(  DM &\Q< @\CH10!R?_#)WP0_
MZ(W\/_\ PE['_P"-4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'E7_#)WP0_Z(W\
M/_\ PE['_P"-4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'E7_#)WP0_Z(W\/_\
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M % P  !5NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X_XN>(
M/%WA?X>ZKJG@3PK'XV\50>5]CT*6_CL5N=TR+)F:0[4VQEWYZ[,=37844 ?(
M/_"__P!K?_HU:P_\+S3_ /XJN^_8*^%OB?X+?LG^!O!OC+3/['\2:;]N^UV7
MVB*?R_,O[B5/GB9D.4D0\,<9P>017T!10 4444 %%%% !1110!^>7QJNO#MU
M\0?VIM%U;XIGP[J-W>::]GX#\VQ8>(Y5T6Q:* P-$;R999%6$I;2H6#%1R37
MK_@GXQ>&/ O[3GQ&N?B)XE\/^!-6UCPGX4D%EK6J06>Z8#4C-'%YKC?L:10<
M9QN7/45]744 %%%% '#_ !:\<^&OAKH-KXCUZR&HW]O<_9]$L;:W6>_O+Z5&
M1+:S0\F:12Z\$ )O9RL:NPQOV;?AOJGPN^%=OIFN+:PZW?:A?ZU>V=@<VMG-
M>7<MRUM#P/DB\T("  =I8 9P.L\<?#/P?\3;2VM?&'A30_%=K:N98(=<TZ&\
M2)R,%E656"G'&14W@OP!X7^&^DOI?A+PWI'A?3'F:X:RT6QBLX6D( +E(U52
MQ"J"<9PH]* -^BBB@#PW]JCQ#<+HGA_P@^F>()O#_B>\:#7]2T'0KW5&MM-B
M4// 4M(965KGY;<$@ )+*P.4%8W[ ^NZ=JO[..EVNFVE[9PV&IZM%Y=UI=Q9
M(%;4KET$?FQH'4*R@[,A6!0X92H^BZHZ+H6F^&].33](TZUTJPC=Y$M;*!88
ME9W9W8*H !9V9B>Y8D\F@"]1110!\[?M60:WJ?COX$Z7IM]I>G6MUXLED^T:
MY9M=V0O(=.NIK020I+$TC!T9XU$B?O8XVR2@![;X!_$C7O']CXRLO$?]FW6I
M^%_$=SH#ZKHL$EO9ZAY<<4GF1Q222M&5,QB=3(X$D+X;^%>\\5>$-!\=Z'<:
M+XET33O$.C7!4S:=JMI'=6\A5@REHY 5.& (R." :D\-^&='\&Z):Z-H&DV.
MAZ/:*5M]/TVV2WMX5)+$)&@"J,DG@=2: -.BBB@#YU_:N_M*_P#&/P;TOPE)
M9V_Q'?7[B^\/SZUSI2"&RF%W]J1?WDF;>601I%A]^UMRJCFKO[&MY+-X'\96
M>JV\,'C*P\8:G#XGDL91+83:F[)-+):,%4^04FB 5U#J0RN796=O8?&'@;PW
M\0]'.D>*O#^E^)M*,BRFQUBRBNX-ZYVMLD4KD9.#CC-6/#/A;1?!6AVNB^'M
M(L-!T:U#"WT_3+9+:WA#,68)&@"KEF8G ZDGO0!J4444 ?-W@SX?Z!X%_;=\
M0R:)IXM)]8\%C4]0N'E>::ZN'U*3+O)(S,< !57.U%554*J@#R/PE]CO?V7/
MV>VA\I_%C?$?3I)=N!=?;QJ<S:H6[^9Y0O?,_P!G?VQ7U=;_ +/OPNL_%0\3
M0?#;PA#XD%T;X:Q'H5JMY]H+%C-YPCW^86);=G.3G-:VG?"OP5H_C*[\76'@
M_0;+Q7>!EN==M],@COI@V-P><+O;.U<Y/.!Z4 =31110!\W>#/A_H'@7]MWQ
M#)HFGBTGUCP6-3U"X>5YIKJX?4I,N\DC,QP %5<[45550JJ +'V'3OBY\=/!
MR^#[&UM?"/PPU&^NK[6;.%8X9]3FMYK=["V90 VSSY)+AE^4.$C.7\P)Z5;_
M +/OPNL_%0\30?#;PA#XD%T;X:Q'H5JMY]H+%C-YPCW^86);=G.3G-1Z;^SG
M\)]%\00:[I_PP\&V.N03_:HM3MO#]I'<QS9W>8LJQA@^>=P.<T >AT444 ?-
MW@SX?Z!X%_;=\0R:)IXM)]8\%C4]0N'E>::ZN'U*3+O)(S,< !57.U%554*J
M@#Q70?'UKKG[4WPM\<^(]"\7:=XKUS4]6M?L>H>#M5A;3=.6U>*QM$=[51(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M070HO$'F:E!"D7V>0QA5RDKG?^]7(QC@\^LJE2EHF4YS6Z/JO_A)-._Y^/\
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M>VD=Q_PDFG?\_'_CC?X4?\))IW_/Q_XXW^%</11]7AW#VTCN/^$DT[_GX_\
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MX<L>QF?\(WIW_/O_ ./M_C1_PC>G?\^__C[?XUIT4>TGW#ECV,S_ (1O3O\
MGW_\?;_&C_A&]._Y]_\ Q]O\:TZ*/:3[ARQ[&9_PC>G?\^__ (^W^-'_  C>
MG?\ /O\ ^/M_C6G11[2?<.6/8S/^$;T[_GW_ /'V_P :/^$;T[_GW_\ 'V_Q
MK3HH]I/N'+'L9G_"-Z=_S[_^/M_C1_PC>G?\^_\ X^W^-:=%'M)]PY8]C,_X
M1O3O^??_ ,?;_&C_ (1O3O\ GW_\?;_&M.BCVD^X<L>QF?\ "-Z=_P ^_P#X
M^W^-'_"-Z=_S[_\ C[?XUIT4>TGW#ECV,S_A&]._Y]__ !]O\:/^$;T[_GW_
M /'V_P :TZ*/:3[ARQ[&9_PC>G?\^_\ X^W^-'_"-Z=_S[_^/M_C6G11[2?<
M.6/8S/\ A&]._P"??_Q]O\:/^$;T[_GW_P#'V_QK3HH]I/N'+'L9G_"-Z=_S
M[_\ C[?XT?\ "-Z=_P ^_P#X^W^-:=%'M)]PY8]C,_X1O3O^??\ \?;_ !H_
MX1O3O^??_P ?;_&M.BCVD^X<L>QF?\(WIW_/O_X^W^-'_"-Z=_S[_P#C[?XU
MIT4>TGW#ECV,S_A&]._Y]_\ Q]O\:/\ A&]._P"??_Q]O\:TZ*/:3[ARQ[&9
M_P (WIW_ #[_ /C[?XT?\(WIW_/O_P"/M_C6G11[2?<.6/8S/^$;T[_GW_\
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M (1O3O\ GW_\?;_&M.BCVD^X<L>QF?\ "-Z=_P ^_P#X^W^-'_"-Z=_S[_\
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M?XT?\(WIW_/O_P"/M_C6G11[2?<.6/8S/^$;T[_GW_\ 'V_QH_X1O3O^??\
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M=V!G;G S7H5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC1% "JJ@  #   %8_C3X<^$_B1I\5CXN\,:-XILHG\R.VUK3XKR-&_O!9%8
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M_I$S7=IHEKY+73)L-S,S&2:8KD[=\CNVW)QNQDXS7H- !1110 4444 %%%%
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M+O$NC^%=-FF%M'>:W?Q6<+RE681AY&4%BJ.=N<X4GL:^:O\ @G?JUCKVE?M
MZGIEY;ZCIM[\8/$%S:WEI*LL,\3K;,DB.I(964@A@<$$$4 ?6M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/,\L_L[D]_FYK]+;6\WW.'%87ZM;6]PHHHKPSA"BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&C&5+ J=F 0<Y]U_8NA\'0Z5XJ_X1#XY^)/C;$9K?[1<>(]7;4&T]MK[4C+
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M6:)X/L4O=>UC3]$LY)!"EQJ-TEO&SD$A0SD MA6..N ?2M6O(?VJM3\*:?\
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M_AF\\'Z;/X-UZ\7PU+JC:S:+I5PL=N 78M:JJJ L&_=F+ (;=DYS70_\(/\
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M^T-.\>VG_$W_ +6/E7D4F/\ IU^8K_H__3/]:^PF\'Z"WWM$TX_6TC_PJ)O
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M/L/Q;>[_ 'OG#;<2-EO3AS\O^ST]JF;X0?%B/'E_$8MBX^TC?-+][TZ'Y/\
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ME_;5E]G_ .$L_LC9)]K\W[+Y^_CR_+Q\N/O9S[8K*_X5CXQ_Z%/7/_!;-_\
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M2*<KKS."\!? /QRWA6S-SXZU;PH_S;=)@>1UA7<<?<F506^]@#C=SSD5T/\
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MQ\Z? ?\ 9^T#Q9X1MO$6OF2_6\+B&SCD:)8PDC(2Q4@DDKV(P/7M[=I/P?\
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M/)E*L&0YPRLI*L.",@D9!':KGPY^%/BOXM:I<:=X3T>35KJWB\Z8++'$D:9
MR7D95!)/ SDX..AJWPWD$:7MW37)O?GE:W>_-87MJM[7/K'_ (>6_P#5.?\
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MVD_%/2&\*)HETVL:Q8VZ>9]H>4-$L[AHW484MM*LKX&""3[C^S+K'CS5;/Q
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M)RIN\0HHHK S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGPM\/]/\,^,/"K:EJ]T-4\26SZF@U*?$3&&TCA 8D1DY8$J<H3CYB*^2;?\
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M\6==T^QMO,>3R8(H[6.--SDLV%4#+$DXY)- 'V!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M17V[_P .TO\ JH__ )0__NFC_AVE_P!5'_\ *'_]TUT_ZV9-_P __P#R6?\
M\B+V%3L?$5%?;O\ P[2_ZJ/_ .4/_P"Z:/\ AVE_U4?_ ,H?_P!TT?ZV9-_S
M_P#_ "6?_P B'L*G8^(J*^W?^':7_51__*'_ /=-'_#M+_JH_P#Y0_\ [IH_
MULR;_G__ .2S_P#D0]A4['Q%17V[_P .TO\ JH__ )0__NFC_AVE_P!5'_\
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M_OGTH ^</^'U?P0_Z%;X@?\ @NL?_DRC_A]7\$/^A6^('_@NL?\ Y,K[_HH
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MVZ14DD\ZYEG.0O P92/H!7I= 'P!_P /J_@A_P!"M\0/_!=8_P#R97?^%O\
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MH **** "BBB@ HHHH *AO))HK.=[>+SYU1C'$6V[V X&>V34U% 'R#_PO_\
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M8Y)3&@*[I-NU2Z D%U!UO!?C/1?B%X7T[Q'X>OX]3T;4(O-M[F-67(R0RLK
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX%\5^+8$U'3=*\-7DUG>+?VX$TACC21'B1&8NLJ2QM&!\S[U&T-Q5G0_VAO
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M#6OVAO#&A_$/7?"$L.H3W6AZ'<Z[J6H6\2-:6J0+ \EN[[PPG\NZ@D";<;)
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M(PC>F:Z*V^*W@F\U_6="M_&.@3ZWHL+W.IZ;'JD#7-C$N-\D\8;=&HW+EF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#R;5O"_CRU_: 7Q7IFF>']5\+S:-9Z.S7VMSVEW
M8@74TMW+'"MG*DQ=6M]JF6/F#!(#97Q[0OV2_%,/P[\<:!?PZ:OB+4-,U6VT
M[Q,_C#5;])[F]DD>>8Z?-$(;!IM[>8]LSL#))C=DY^E_&'Q*\(_#U]/3Q3XI
MT7PTVHR&&R76-1AM#=2#&4C\QAO;YEX7)Y'K4%Y\5O!.F^,(_"=WXQT"U\52
M!"FAS:G E\V_ 3$!;>=V1CCG(Q0!X;JWP+\<>(O^$OU;6/"W@Z[U'6_[$L['
M1M-\3WVFQ:1:Z:\UQ;R17T=D9&F2ZD$BA8(UVX4Y"8?N_!GP]\>:+\3/#NO>
M(M2TGQ1'!X0@T34M7+&TNS?+*TEQ/';)"8S',PAR/,39Y?"MT&KX[^/_ (5\
M+^%?&5_HVKZ1XIUOPP$BO-#L=4B,\-S))Y4,$^W<8"\AVY=>,'@X(KL_"7C3
MP]X^T6/6/#&NZ9XCTB5F2/4-)O([JW=E.& DC8J2#P1GB@#RKQQ\+O&7C3XN
MZ#K(M/#.DV&BZG!<VOBS3[VYCUIK!0KS:;+;B())%+(&#%IRFTJWD^8BM7E?
MACX'_$R*^LO!FIV^BV-OH/@W7H=-\1Z>\\J7FK:A,BB\G9H4\J5O](D>&/>5
M,A;S&W #W*W_ &AO".M?$FR\)>'M;T3Q#ML=2OM8OM/U>&5='6S>W1DG5"VU
MV>Y4;6*D!'/.TULVGQR^'%_X.O?%MM\0/"USX4LIQ:W6NPZU;-8P3'9B-YP^
MQ7/F1_*2#\Z^HH \/U#]GGXC>(M%U:XU./PI:WHMO#>GZ;X=MM3NI; V6FWQ
MN;BVFNFME?\ TD8!<0G "H4<*S2;NB_L\^)=<\10:YXU/AZ:XO?'(\8ZI9:>
MTDT(2#2UL["V0R1CS&ADCAD,I6/<T.X*N[8OKES\8/ =G=^';6X\;>'8+GQ)
M''+HD,FK6ZOJB28\MK92^9@VY=I3.=PQUK<U+Q+I&C2RQ:AJME8R16DE_(ES
M<)&4MH\"28AB,1IN7<_0;AD\T > >%_@!XC\/_$SQ=XCU'0])\4-=ZK?Z[IE
M[?>--4CC>X="EI'-I9MWM(S'&$@^T+O=4C5@A/RUW?[/_P //$WPO\ W6A:F
M]E;VEO*(] T&WU&;4H-&LD@CCCM1>S0Q33IO21P9$RBR",%EC4GKM<^(VBZ1
M;*UO=6^KWC&Q*6%G?6JSO'=SF&WE'FRHNQRLI7YLOY,@C#N I\R;]L?X>:EX
M9DUS0-<TG5["W\21Z!=W']KVRP6Z%W\V\>1'<+"L,,\RE]N]8NP.Z@#F/!'[
M+/B/PSK'AA[O6M,N]%M_#NFKKVFHCJ-6URRDN)8I2VSY;8S7;2L,;RUM;C&W
MS ^/:_LG>)K75/!Z:M%8>,M'M?"FG^'M4AD\7ZGH@259)7U&7R;6$QWT=R94
M+17&P'R5!X8X^C=6^(NA6'PWU'QQ::C:ZOX=M-,FU9;ZPG6:&>".-I"R2*2K
M A3@C(K+TOXS>%?.T'2->\0:%X<\9ZGIL>HGPO=ZO#]MC5HC(X6-BKNJ!)/G
M"@8C8\8. #RJU^ OC8>/XTF3PNG@[_A.3XNN;Z.><ZE=QI;,MK 8?)$<9@>.
MUC!\U@T<>?D*[&?I/[.NN:)HOAP-8>']8O+:QUZ\UFSFOI;:/4]8U.2,R,UP
MMNSB+8]VIDV;\&(!,#Y=:U_;<^#UUH.F:N/&6CQV>H:]<>'X3)JUDI\R&5XV
MN&_?X$!55E#$[C'-$=N7 KU%/B?X-D\87OA)/%NAMXJLH?M%UH:ZE";Z"+8K
M[W@W;U7:Z-DC&&!Z$4 <-X-^&/C+3O@+KW@_4-<AL-<O+2^L](>"[DOTT2%X
MVCM81=21Q2W(A&T^;(@D/0EB-S>:K^S3XU\5:3?V'B&S\(:+ILOA_0_"EKH^
MC74]S!;Z;;WIDU!#));Q[_-MU1478H!^4D!=[^^+\5O"=]X/\0>)M(\0:9K^
MDZ$DYO[C2;R.Y2%X8O-DC9D)"N$*DJ>0&!QR*SO#WQH\,WI\*Z3KNMZ)X;\<
M:]IMO?Q^$[K5H3? R1[BB1DJ\H4K(NX(,[&.!@@ 'FGBS]G?4M?^.UQXAN]'
MT_7_  ?>6VFV9MY/%NI:7]CM[9I&-NVG6\36U]%N<R!)V529'0C;R>E^-7@'
MQKK_ (^\#^*?".E^%];D\-P:AY=EXFOYK1$N[A(TBN4>*VF.8U25=N%+"=OF
M7;SV4GQG^'T,GB&.3QUX:23P[_R&D;5[<'3/FV_Z2-_[GYN/GQSQ6M#XZ\-W
M'A ^*XO$&E2^%A;->'7$O8C9>0H):7SPVS8 "2V<#!YH ^8=8_9+\;:;X;UG
MP?H%_P"'-4T/7O".G^%KW6M8EGM[NTBCEN6O1!:QQ.A6X^TLP/G)Y;;<B0(M
M=/XP^!/C_P 3:A\6!HT^C^"-+\6:5>6AMK/6;F]35;UHH;>UO)D:VB_L]EMH
M/*<6S2;O,!.YH59O2O /QX\,_$;Q!KUMH^J:1>Z)87=KIUEK5GJD4\.I7<MM
M]I>&+;P2D3(?E9B<MP-O.UX@^,'@+PCH<.LZYXW\.:+H\UU+8Q:AJ&K6\%N]
MQ$[I+"LCN%,B-'(K(#D%&! (- 'AMO\ LZ^)M-TGPWJ6E>%?#MMX@TCQ';ZE
M<:3JWC?5-9@U.TM[2XCM(VU&ZM&GA\B>Y,\<*Q-&K1[@0SL1V&G? _Q-%^S7
MXS\#S:U86WC3Q,FMSW.L622+;"ZOY[B7<J\.B*)E7@[E"\%B-Q[7XN?&[PA\
M$?#MAK7BS6+33K._O[73[8S7<$/F/-,D>\&5T79&KF5SGY8XW;!Q@Z8^*G@I
MO%]GX3'C#03XIO8?M%KH?]IP?;9XMADWI!NWLNQ6;(&-JD]!0!XGJW[.OB;X
MAPZA)XDL/"_AZWNX-%T!?#VBW4M[9PZ+:7JW5S&99+:+S&G7,(C\I41!]XEC
MCU/P7X!U7P@_Q'U&.2Q;6/$NL2:G:X+>3$J65O:6R.=@(PEK&6 !P6;!;J>C
M\3>/_"_@N\TFT\0^)-(T*[U><6NG0:G?16[WLQ*@1PJ[ R/EE&U<GYAZUFW'
MQD\ 6OB>Z\-S>.?#</B*TW&XTB35[=;N';$TS;X2^]<1(\AR.$5FZ F@#Q/P
MC^ROXC\'W^D0P:UIESX>T_PUI*R:;*C!K[Q%IZ2+!=S/LQY 9HIL;2WFP1,
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MI\:^*M)O[#Q#9^$-%TV7P_H?A2UT?1KJ>Y@M]-M[TR:@ADDMX]_FVZHJ+L4
M_*2 N]_JFB@#Q'QU\+?&E_XX\;:AX;708=,U;P*GAW29KF[D@ETV]1[QL^2M
MNZM"_GV^6$BE?(P(VSFL[PI\%?%G@;Q1XL@T^P\*ZIX;U#['<:;?ZE-*;RT-
MEI\-O9VOV?R#&J1W$)N!,)"5\QP(MQW#W^B@#XPL?V;?%VI/XJ\%V>CZ-!H2
M>$M(^&LOBC5FFBNX].CM5FO9;*(0LMSYS7CJ7,D066 $F0Q[5[^T^ OC=?'T
M:3CPS_PA_P#PG)\776H"YG?4[R-+9EM8#$80B- \=K&&\U]T<>?D(V/](44
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M^/7P#U+XS>-_",R:E;67A6+3M2TCQ':ON\^]M+B6SG2*/ P09+)4?<1^[DD
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M?[8E\+0:=X6M]<EM;S3YYY[O4-2O9%*7TR/"BQEEDN3)&&DPS##.&^3Z6HH
M^6M(^!OQ5\+^%_AHFCVO@P:WX8\&W?A0QWVK7<MK9S2?9E348B+0-<.R6QWQ
MLL1&\J)2"Q;2TW]E74-'\$^*M,T[4;#3];F^'=CX!T#58PS/8Q06\P>0G:&4
M//,&.TDD11D\@ ?2=% 'RQJ_[._Q!\46^OZE?67@W3+N2V\-:=IGABPO[E]/
M6PTR_>ZFLY;HVROMG#!=P@(50$*. S/Z);?#WQ@_Q9\#^,;G2_"\$5OI^JP:
MY:6-Y+&8+FZDM&CGA;[-_I;K':"%FD\@D,6 '$8]CHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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<O;PHL<4,2A410,!5 X  & !4M%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>advm-20241231_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ++!/8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#AZ<M-IRU_
M0LC^8T+1117/(?4=1117/(!5IU(M+7/(84X=*;3JYY %*O6DIRUSR'U$IU-I
MU82&%*M)3EKGD M%%%<[ ****@:'T445 @HHHJ!H****@84#K10O6I 5J44C
M4M2Q(****@H****E@%.6FTY:E@+0:*1NE9L!M.6FTY>E2P%HHHJ& 4445+ *
M***A@%.'2FTZI8"T445(!1110 4444 %%%%)E!1112 **** "BBB@ HHHJ64
MA5I:%Z44A!1110-!1110,****E@%%%%( HHHH **** "BBEH =11104%%%%2
M2%%%% !11104@HHHH&%%%% !3A3:?4L HHHI%!1110 4444""BBBH&%%%%
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M&+HLH7_6BWV-O]PI?9C/<''>OE72_B;XPT:S2TT_Q7KEC:QJ$2"VU&:-%4=
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M6FW2F2VMTA2%"F @VJNX;E8[BH)SCM7YOZ#XR\0>%UD71=<U+2%D.76PNY(
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MKWG]E_X:>'?B WB%]?L/M_V40K"IE= N[?D_*1S\HKP9:^H?V+/N^+/K;?\
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M36,PW0RS310>:.N4$CJ6![$ YKH/V>?AZ;_XX6VE>(]+3R-*2XN-1L=0A#*
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M7;BYT[[5&MQ%)MVF,L V>/0Y_"NO_:V\/_9]<T;6D7Y;J!K:1A_>0Y'YA_\
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M]06$[1<3$$8;N0I5F Z9?.,@5Y9XX^+6N?$+4M-N-52S%EIH"V>DVL'E6<"
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MM6AGB$H &\ ,O/RKUR/E%2^/OCKXD^)'AFVT+5TL5LK>\^V1?98#$5.PHL8
M;:$520 !GU)-3[&:]VVET_DAO,*$H^UYFI\DHI6TYI-W=_G_ %8Z_P"(0_X1
MC]F'X=:*R>7<ZQ?7.L2;>A5<HA/U25/RJ6:W;0_V3=#LK>15N/%?B)Y7\TX'
MEQ9CP#V >-#GW-<;<?'+5[_P!9^$]0T?0=3MK*V>UL]0O+'S+NVC;J(WW;5(
M  !VY^4'.1FL3Q=\2-3\9>'/#&B7D%I!9>'K=[>T^S(RLP?;N9\L06.P= /I
M35.6B?>YSU,903E.#;O3C!*VS]U/\.;[SZ'^.VL_#;PSKVE>#-<LO%4]GX;M
M(H[?3-/EAAL)2R;O,8G]XSD-@L#U!_VLT_A7\14^)WQPN_'%[IJZ;I7A/P[,
M]O LK2>5'&I4!W.-S$2RG.!T]LUYVW[3VOWRV,NK>&_"NNZI9QK'%JVIZ7YM
MT-O*G=O R#STZ\UR^E?%[7=)M_&D:+:32^+59=0N)(CY@W,[/Y>U@%W&1LY!
M'3&*P5&7(TUKZ_>=]3-*/UE582]R][<MG[J]Q-];.RTTZGJ?P \9:MK?CKQ]
MX_UJXDNFT_0+J>7!XR2ICB4'HN$8 =!@5B>$-OA?]E/QKJGS077B#5K?2HW_
M +Z1@2$#V(,H_.O./#7Q%U3PGX5\3:#81VRVWB".**[GD1C,J1LQVH=V &W$
M'(/!XQ6UX-^.&K>#_!\GAAM'T+7M(-R;R.#6[+[2(92N-RC<!^8/4^M7*F[M
MI=5]R.*CCJ7)"-23ORSN[7]Z>G_I/XFO\$?B-X<\.Z'XI\)^*H[RUT?Q''%'
M)JFF'$]N4)QN'5D^;D#/<;6#&L;XU?#^]^%OBJ+P[-J[:OIT=NMUI\A) 6&0
MD_<)(0E@V0.O![U-X3^.%]X7\/:?I$GACPOKD6GES:7&KZ;YT\.YRY 8,/XF
M)YS7*>,_&6K>/O$5WK>MW/VJ_N"-S!0JJH&%55' 4#C']<FCEESN70Y*V(HR
MP<:-^::M;2UEJVGKKJ]-/\CUC]G.-M6\$?%O188VN+JZT+SXH%4,SM'OQ@=2
M<NO3U^E>K2:7;P_"SQG\)=,A2]O-#T2VN;GR<LTVH/+YL@ ZG!$8'IG!Z8KY
MH^%?Q4U?X0^(I]9T:"SN+F:U:T>.^1GCV,RL>%93G*#O5_P!\<O$OP[\6:QX
MCL3:WNI:LCK=&^C9T9F<.7 5E^8$<=N3Q6$Z<I2;7K\STL'F6&HT*=*I>]I1
MD[;1=WIZMK[O,];\4:;%:^+?A9\&K$QW$>DW4%WK)0Y62ZD822C_ ("A?'L^
M.U6_"<T?CC]M36]79C]DT>6YE?=SE;>+[."/^!;37@?A'XEZOX/^($7C*,0:
MCK22S3EK]6='DD5E9F"LIS\Y/7K4_@3XK:Y\/O&5QXFL#;W-_=+*ES'>Q&2*
M=9#N<, 0>6 /!'2DZ<K/T_/<4,SH.I"4TTE43MVC!)17YW_X)UGP+MV^(G[1
MVD7US#Q-J4VK3*#D(R[YAD^F\*/QKN/AKXRU/XN?M86VLS7;2:=I\EW+;JK$
M)#:I&ZIM'^UE-WJ6)KR[1_CAJOAWQE>^)-)T70=*NKFP;3Q:V-D8;>%&QET5
M7!W\?>8GK],8?P_^(VJ?#6^U.\TB.V:YO["73FDN%9C$DA4ETPPPXVC!.1[4
MI0<KORL8X?'4J'LH.3:51SEIO:W+^OWF;XKUA?$/BK6=512B7U[-<JIZ@.Y8
M#]:]Q\3>)-0^&O[+O@S0[&62QO/$\US>74L)PS0!L!<]1N5HL^P(Z&OGE>E>
MMP?M*:__ &+IVC7VA>&]9T?3[2"TMK#4]/,T2>4I42\OGS&!P3G' P!SESBW
M:RV.3 XF%-UG4FXRFK)I7W:;_!6^9Z3H/AF/5O@_\&_".L';)K/B%K];>7@_
M8QYA;'3 <.I'^_QZ5SWB"^U[XG_M8)8V$EQ$NEZO]C@6!BHM+:WDVR,N/N@A
M&;W+8[UY=XD^+GB?Q1XVM?%5W?[-5LW1[3R5"Q6P0Y543H%!['.<G.<UW*_M
M8>*K?6O[5L]%\-Z=>RR+)>2VFGLCWQ4$ 3/OW$ G/RD<CTR#ER26J/4^OX2H
MHTY2<8Q<.FLHQ5EUTUN_*_6QTFN?&RR\&_M4>*?$%Y;3ZEIH\S2'6!L2Q*BI
M&S19(&0T;=QG<3GFJ[_!/3)/&'P_.B^(;C6O GBO4#.(KLE'W0G]XKKD;F*[
MU#@ C)'IGSGPW\:-3T!=7CNM%T'Q#;ZI>-?S0:U8>>BS'.77# CKZ_S.:_BC
MXR>)?%'B#1M6,UOI;Z+M&EVNF0"&WL@I! C3GC*C.<YQCIQ3Y)+8REF&'J1E
M*O[UY<R5K-7DG+6]FFE:W?L>R_$[XJ?#J/XJ7NJZAI?BG5]:T&Z-M::?-=0V
M^GP20/M7RP@WJNY,\YZ\CM5/P#XTN/$6G_&OXFW\2V5[-IBV%NT6=L;3_NU5
M2>I&R'G_ !KC[[]IW7;R]GU%?#'A.VUV92K:U#I7^EY*[=P=G(W8XSBN(L/B
M1JFF_#G4_!<,5J-+U"\2]GF*-YY90N%#;MNW* XVYSWH5-VM8VJ9G#VSJ*=U
M[STC;WFFHMO=[^BZ'HVHG_A%_P!D;288W_>^)M>DN) W>*$%,#VW1(?Q-:W[
M3FN:CHJ^$OAE83/]@TS2K1;B&(_-<7&,*' ZX ! ]7)]*\MU?XL:KK5CX,LY
M[2P%MX57%E&D;@2_,C$RY?DDH,[=O>H/$/Q-U7Q-\2?^$VO8+0ZK]J@NO)1&
M$&Z((%7:6+;<(H/S9Z\T<KO=^9S5,=2]C*E3;5U"/_;J3<OOET/J&[T?3O$?
M[6&DV5[F]3PCX=B>1'4.99HP77/J09U;ZJ*\T;XY> ]!\8W?C72=(\3:[XNE
M>1X9]?O8T@@+J5P%BZJ V I[=Q@&O.(_C5XFM_BA<>/;>:&VUNXDWR)'&?(9
M=H7RRI))3: .N> <YYK2U[X^:GK&DZI8VOAKPOH!U.,Q7=WI&F>5/*C'+*7+
M-PW?'K4*F^IVU,TI24I4WRRYY25XW[<MKO1JW7;<\YU+4)M6U&ZOK@AKBYE>
M:0J, LQ)/'U->\?M7Q-8V?PUL;-=WA^#P_']BG!^61CM#X[_ '5A/_ J^?Z]
M2\,?M%>(O#_A2#PW?:;H?BG1[8_Z/;^(+'[2(0.BKAEX';.<=!Q@5K).Z:Z'
MBX2O2]E6HUI-<]M;7V=]?)_G8\M5BK @X(Y!%?4'PT\36G[3MI<^$O&NE13:
MW8Z>\UGXGMUV31A=H'FXZC+9]#Z \UYI'^TEXKB\4V^M1V^CQK;VCV,6F)8*
MMFD+E690@.>2BG.[/&.G%)KO[1GB'4_#][HVEZ3H'A*ROLB['A[3_LK3@C!#
M-N/4<'&#CBIDI2Z'7@ZV&PDI-U'*+WCR_%VZNVO7=="/]F7P^/$7QN\,1/'Y
MD-M.UZY[+Y2,ZD_\#"_G7)?$7Q!_PE7Q \1ZN)/-CO+^>:-O^F9<[!] N!^%
M6/AQ\2-4^%^LW>J:1#:RW=Q9R66ZZ1F$:N5)9=K###:,$Y')XKE5HL^:YP3K
M0^IPH1WYFW]R2_7[S9\+^$];\9:HEAH.FW6IWIY\NV0MM&?O,>BCW) KZ1L-
M>C\!>&9M&^,?B+3?%5N$(A\-HGV_4+=R.OV@,/)89[L>.A%?-NB^+-9\.V=]
M:Z7J=UIT%\%6Y6UD,9E"YPI(YQ\QXZ'/-9%*4>;<TPN,C@X\U--S>]W[OW+X
MOF[>3.M\,>.+3P?K6I7=KX8T76;6Y)6"VUZW:Z%NFXD!<,OS8P"Q]/<U[G\7
M%3XG?"[X8:]-%)X<34-1&G?V-;R;+2.,LR^=&A V\("#@C#]^I\LT?X]:EI_
MA_3=(O\ PSX6\1PZ;'Y-K-K.EB:6-,\+N#+D?4<XYS7/_$/XH^(/B=JEO>:U
M<IMM4\NUM+5/*@MEXR(U'3.!R23P.>!A<K;3.VGBZ-##3I<_,I)>[RVL[IMM
M^6J5MSN_VL+BYU7X[:EI\<#M]DAM;*TAC0EF4Q*P"COEI&QBO>_# @T'X@^%
M/"Y2.;4O!G@NXNI1%AMMU+Y*NJC^]MR?</7S^?VI/$\LEI>W&C>&[S7[6$0P
MZ_<:;OOD ! 8/NVYY/\ #CD\<UQ/AOXJ>)?"_CEO%UKJ#3:U([-/+<_.LX;[
MRN.ZGCCC&!C&!4<C<4NQWQS+#4,5/$1;E[22;TM:*=[;ZN]O+3S.C_9S\,3>
M,/C)H3R*TMO83_VG>3NW"+$=X9B?5PH_X%7+_%#Q2OC7XA^(M<C;?!>7LDD+
M8(_=;L1\'G[@6NE\1?'_ %W6M!U#2+#2M"\+6>I'_3_[!L?L[W8.<K(Q9C@Y
M.0,9R1T)!X3PWHS^(_$6EZ3$VV2_NHK56QG!=PH/ZU2O?F9XM:I3]C'"T'S:
MW;M:[V27I^;/2OC=&-!\'?"_PT(GB:UT,ZE('!!$EW(78'/.1L_#@=JL>-;&
M3P;^SGX+TB>&2"[U_4[C6Y%?LB((H\^S*RL/QKK?CA\?WM?B%JFC6WA?PMJU
MKHLGV&SO=2TXSW$6P ,-Q?;PX; VXXKROQE\:/$'CS6/#NI:RMI<W.B*BQ8C
M8+,5<.6D7=C+$#(7:,#  J8W:1Z6+J8:C5KJ,[R:4%IHDK)_@K(],_:5U;5-
M-D\'_"W397-II^F6<4UO&V#<W)&U0_KC (!XRY/IBS^TYXAU#Q1\4M#^'5E>
MO'96/V2T95+$/<RA<2-S\Q"L@'I\WJ:\<U[XGZKXB^)B^.+R"T;51=P7?D*C
MB M%L"+MW;MN$4'YL]>:?-\4M5NOB@/'=Q;6-QJXNUO1!)&QMPZXV#;NW87
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MQD2,;LA"& &0Q!R#1J7Q&U/5/A[I'@V2*UCTK3+F2ZC>-&$LDCECER6(.-Y
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MM%;^%_#WAV6"83K=:):R03$@$ %C(W&3GIU J4FMCOQ.(HXF+G6DI3[I-/\
MR_!>I%X:\8>+/A#KMXVF33Z!JS1^1.D]JOFA20VTK(IQG"GIZ5Z5\=+:'7&^
M&OBG6 T&J>(+-7U2-I&$>U70*ZJ3\@97)P,#C('7.$W[1VM7RV\NM>&_"OB3
M4H46-=3U;2Q+<D+]W+!@#CZ5PGC3QMK/Q!UZ75]<O&O+QU" [0JQH,X1%'"J
M,G@>I/4DT6=[F<L11I8>=&$W-.UDU91UO?=Z]-.[.^_:F\]_CMXC60.0/LZQ
M*1QL^SQX"^W7I[UV>K6Z^"=%^#O@._"C4)-5AUK4X7R##YDP6-&]]A8'TV^]
M<78_M(^(;>'3VO=&\.ZUJFGQ+%;:QJ>G^=>QJN=O[S< 2,\$C/?KS7G&N>(M
M2\2:W<ZQJ=Y+>:G<2>;+<N?F+<8Z=,   #@  "IL]C:IC*$*E6O2;<JCZJUE
M?F:\WT]+G=?M QW5Y\<O%431R2W,E\(XXPI+,-JA  .N1MQZ\5N?'9%\'^%/
M ?@'S,WVCV<EYJ,88,$N+A@^PX[J,_@PJM'^TQXDWV]Y/H_AV\U^WB$4>OW&
MFA[Y< @-OW;=P!Z[:\OU;5KS7-2N=0U"XDN[VYD,LT\IRSL>I-017Q%#][*B
MVW4?56LK\UO-WM]WF>E_LR::+KXM6-^ZA[;1[:XU*8$$_*D; 8'KO9*ROA'H
M5]\1/C!HD;(;F2;4%O;Q]N0(U?S)6..F0"/3) [UV'[/^N2_#GP3X_\ '<5G
M#<75I#;:=9BY4M&[RRY=2 02  A/([5FZ5^TKKOAV_\ M.B>'?"^A!U99H=-
MTXPK-D$#>0^X[<D@;L9YP:AG326'IT</[>36KDTE>ZNE_P"VG??#7Q&;GXL?
M%KXB.([J#2+*[>!#T<EL0C/H4B(_&LWX#>--4L-,^*?Q"U.[DO-0M[!$$UVQ
M*2SRLVP$=#AE0 #H&P, UX]H?Q"U'P_X+\0>&;.&V2TUQH3=7)5O/VQMN5%8
M, %SG((/#'UIVG?$34M,^'NJ^#H8+7^S=2NDNIYF1O/W)M*J#NV[<H#]W/)Y
MI%T\RC%PE=W2G)_XY7M]VFIZA\,M7O;?X/\ Q>\4ZG<2WLNHQ0:?YDC;GEED
M+*S'/H)5/TS7A%=/#\0M2M_AW/X,BCMH]+GOQJ$TJHWG2.%"A2Q;&T;5. ,Y
M'7K7,5#/,Q%=584H1?PK7U;;?YA3QTIE/J&<84445F-#EZ4M(.E+4,H*5:2E
M6H90M%%%0RD.7I2T"BH8Q5I:1:6LV4+3J;3J@I!3EIM.7I4,HU]#UK^SW,4P
MWVLGWA_=]Q65XN\,PWUNT!8/;2?/!.O./_KCH:2IX[AXXVCSF-N2AZ9]?K7M
M4<UJTZ4*<FU*F[PDMXOMYQ?X>:T.Z&(DHJ+>L=GV_P" >2QKJ'@O5P[)C''^
MS(OUKT;1_$-GK4(:"0"7'S0L<,/\:N7%K#>1&*>)98S_  N,BL.;P'I<DF^,
M36YSG]U)_B#7T6/SK*^(:499E"5*O%6YX)23]5=/_+OT/2J8JAC(IUDXS75:
M_@=+2K659>'X[/'^EWLX_NRW#8_(8K57@5^=XF%&G*U&?,N]K?JSS9**?NNX
MZG4VG5YT@0Y:[?X:_%O7?A:U^VC"U<7H02K=1%Q\N<$8(Q]XUQ"]*>M9J<J<
MN:+LSII5)TI*<'9H]M_X:X\;_P#/#2?_  &?_P"+J*\_:L\:ZA8W%L\>EHDT
M;1EDMFW $8R,N1GFO&1T-.6JEC,1_.SN^OXIZ.HQPKUWP;^TSXO\)V,5E*]O
MK-K$H5/MRL9%4=!O!!/XYKR,=:=7%3K5*+YJ<K&5&M4H/FIRLSW'6OVMO%FH
MVKPV-EI^ELPQYR(TCK]-QQ^8->-:AJ5UK%_->WMQ)=7<[EY)I6+,['N351:<
MO6LZ^(JU_P")*YO5Q%7$?Q97.I^'_P 0]5^&NL2ZEI'D-/+"8'6XC+J5)![$
M'.0.]9?B#7KOQ1K=[JU\5:[O)3+)L7:N3V ]*S*<.E<DJDW#V;>BZ$^TFX*#
M>B-#0=<O?#>L6FIZ=,;>]M7$D<@&<'W'<$<$>]='\1/BEK7Q-FL9-8%LOV-6
M6);:,H/F(R3DGG@?E7'+UI:Q]K4C!TT_=>Z-8U)J+@GH^AW.C?%[7]!\#W7A
M6S-M'IUP)%>3RCYV'^\ V<<C(Z=ZXL=*;3JPJU9U$E-WMHBY5)324G>VP]:[
M;QE\7=?\>>'['2=5-L\%FZNDD<6V1F"E<L<^A/0"N)7I2UBJLZ<90B[)[^9I
M"<HII/1CUI:1>].KCD"'+THH%%8EGABTM?20_8(^('_08\-?^!5Q_P#&*7_A
M@GX@?]!CPU_X%7'_ ,8K^XWG& _Y_(_/_P"PLR_Y\,^;*=7TC_PP3\0/^@QX
M:_\  JX_^,4O_#!?Q _Z#'AO_P ";C_XQ6$LVP/_ #]0?V%F7_/AGS;3EKZ0
M_P"&"_B!_P!!CPW_ .!-Q_\ &*4?L%^/_P#H,>&__ FX_P#C%8RS7!?\_4']
MA9E_SX9\WT5](_\ #!GC_P#Z#'AO_P ";C_XQ1_PP9X__P"@QX;_ / FX_\
MC%82S3!_\_4/^P\R_P"?#/G =**^D/\ A@WQ_P#]!?PW_P"!-Q_\8H_X8-\?
M_P#07\-_^!-Q_P#&*Q>983_GX@_L/,K?P&?."]:*^D!^P?X__P"@OX;_ / F
MX_\ C%'_  P=X_\ ^@OX;_\  FX_^,5B\QPG_/Q#_L/,O^?#/G&BOH__ (8/
M\??]!?PW_P"!-Q_\8H_X8/\ 'W_07\-_^!-Q_P#&*QEC\+_S\0?V'F7_ #X9
M\XK3J^C1^PCX^_Z"_AO_ ,";C_XQ2_\ #"/C[_H+^&__  )N/_C%8/'8;^=#
M_L/,O^?#/G&BOH[_ (81\??]!?PW_P"!-Q_\8H_X81\??]!?PW_X$W'_ ,8K
M)XS#_P Z#^P\R_Y\,^<:?7T7_P ,(^/O^@OX;_\  FX_^,4[_AA/Q[_T%_#G
M_@3<?_&*EXS#_P Z#^P\R_Y\L^<J*^C?^&$_'O\ T%_#G_@3<?\ QBC_ (83
M\>_]!?PY_P"!-Q_\8J7C*'\Z#^P\R_Y\,^<J*^C?^&$_'O\ T%_#G_@3<?\
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M_#"OCW_H+^'/_ FX_P#C%+ZQ2_F#^P\R_P"?+/G5:6OHH?L*^/?^@OX<_P#
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M]BYC_P ^6?.]%?1'_##?CO\ Z"WAW_P)G_\ C%'_  PWX[_Z"WAW_P "9_\
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M^&)_''_05\/_ /@1/_\ &:AQ8_[(Q_\ SZ9\_4Y>E>__ /#$_CC_ *"OA_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)QV!J"CU>BO./%7QZ\,^#_BQH_P]U!+[^W=4TBZUJ"2*$- (+?/F!FW9#<'
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MY5<9W]C@#J<?6G_#+GQV_P"CG=6_\$$7_P =KZOHK3%9UB,35=7EBK_W8O\
M%ILFC@*5&"A=OYM?DSY=^-'PU\:>%_V(OBQX>U_Q;?\ Q,\0W&CWSPWAT]8I
MF5HQMA6.,L6P03GD_-["O"_B)XLB^,'[*/PIL/!NC^(M;USX9:AX:UG7M(&@
MWEO<>3;1^7,(!-$@F93GB,MP">E?HM17AU)NI)SEN_*WX+0]",5%**/B!]8D
M_:._:PL/'WA+0]?7P?X7\#:EI]QJNK:3<6"SWEQN"V\23(KNP!))"X&.O3/R
M_P"-/A!XO^'O[%?A7Q5X=\,ZI=CQEX0'A7Q7HMM:/Y\<\=PTMA>M$!NRNUX6
M./NR)7Z_T5F4?GQ\1/AW\3/VA/CEXKL=!\+Z)=>'/"_@F/P:&\83W5E#]HOX
M1)=3VICA??(BJD9/ &T<G->[?L7^)/$7B+]E'3M'\4Z=>67BGPS#<^&KV*ZA
M=6E>V!CC==P!<-'Y?S#@G-?2-% 'X\?LU^'_ !#!IO[/%OH+^-_$7C;P_P")
MG?4/!FO:%,FA:)92S3>==I,T"!) C*X8R2$,YP >#T,&G^(=8_:B\":W'X+?
MPMKMK\3R-3L[#PG>I=0V;S.HGNM9D9A<1RJ<^6OR!>FU1@_K-10!^9'PW\+:
MUH/Q3^)FB_#/0+CQ+J6K:+XANH?&6K>%[K2-<T._E5C%:S7LH"7:O)M"$9Q@
M-P <\U^S3\*#;PB^AU'5-.\5Z=X&U>PUGPU:_#N\TI[B5[1@4OK]G*74HFPR
M/@LY'09P/U<HH _,'X:^"_$,/_"L/,T'4T\KX!ZK8R;K.0;+AG;;"?EXD.1A
M>ISTJY\%_@Q+\/-9_8[UOPOX6NM#\2:IHFL1>(=26UE#R.; &%;QB.%#XVJ_
M P N  *_3*B@#\JOV._A-J=M\5OAU-XEU?5?#WQ+T;5KV?6;%?A_=QWEYO\
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M$E_I,\%KI\-N9N?M#*(Y/.WKMV,V:\M^$WQ$M[S]G/\ 9]TRS\.^)]03P/\
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MOX5^'?@WX1C\-^&+:6WTY;B>[=KB9II99II&DDD>1B2S%F/)[8':@#KZ***
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M%?\ 9[U>34/$N@:/IVI:H]]X@\+6$EW=Z>K6\2JRJL,O+'Y>4/!;CC(^W:*
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M@8DSW222H(XW)Y41NV[Y<'&%/M?P/T/4K/\ ;N_:.U&XT^Z@TZ[L/#ZV]W+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#CYBT;5(+MH><?.(W8KSZU^6GA'X&PW/\ P27M?%7@WPC]J\:ZQ)*-=O\
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M.^"M!L?#&@W?PS66;3],MQ#"[K>(!(57@O\ NU!;J><G).0#[MHHHH ****
M"BBB@#Y__:,_;D^%/[+^KVVC^,-3O)]<G@%U_9>DVAN)HX2VT22<A4!(. S
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGPG^/'B35] \!^-;'Q%J^E+YEU:P1RQGRPVTR1F1%$J D O&64;EY^89]8H
M**** "BBL+QYJFLZ+X'\1:CX=TM=<\06FG7%QIVEM((Q>7*1,T4)8D!0[A5S
MGC- 'YF_M-6?P,\9?MW?$'3/VAO'FHVNC:?I6F?\(]86<DZVUFS6X:XAF*1L
M5D)*3*1A2)<%B0%'N'[#_@C]E#PU\5]6NO@5XFGUKQ<^B2QW5O+<7,@6R,\!
M=L2QJ/\ 6"$<'//UKE?BXWQ:\1>-&U2?]BGP'XWO+S3M.N+S6M6CL)KE[EK&
M SPL\F680REX 2>5A&.,5Z)^QS8^-K7XFZFWB3]EWP=\$[$Z/*$\0>'H+-)[
MB3SH,6K&'YMC#<YSQF)>^* /L6BBB@ HHHH **** "BBB@#Y5_9W_P"3[/VN
M?^Y1_P#37+7U57RK^SO_ ,GV?M<_]RC_ .FN6OJJ@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGEV$\3_)*JN,/&XY49QD<$&OM6OE7]G?_D^S]KG_ +E'_P!-<M?55 !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY5^1O_!73_DY'PW_ -BG;?\ I9>5]#D7^^+T9YF8_P !^J/B&BBBOT<^5/T
M_9?^&?[-W[3GB+7? VD?##Q)I;:?I'VM/%]]K<IN&8,L9+PHWDQOEPRC#@[6
MR !@_!>L646FZQ?6<%TE[!;SR11W4>-LRJQ <8)X(&>IZ]:_2N3P7X4^$_[/
MY^'GP8^-7PHT[6M>4_\ "4>+M:\5107EP-N#';K&LFQ""RC+ HN< NY<?$I^
M"/AVW^$?CGQ3<_$[P\?$GAS6?[*M?#-I(DLFKQB2)#=VTAD5FBQ([!A&05B)
M)&>/"P59<\Y.3Y6TDG=OM?RN_P"D>CB*;Y8JRNKWM9?+Y'V./V8O@9\.?BI\
M.?@UK_P^UOQ5KOBC2?M=SXU75;FW2"5@X'EP1G8RADYS]P,F=^37P?\ &GX>
M?\*F^+7BWP<+@W<>BZE-9Q7#?>DC5CL9N.&*[20.^:_0+X"_%;Q!\.['PUJ_
MC7]JCPCJOPVTO3XKIO#MK)!/K4Q$.5M73R_/&UL _.S';MVC/'Y^?&CXA?\
M"U_BUXN\8"!K:+6M3GO(H' W1Q,Y\M6P<;@NT''<&IR]U_;24Y75M];7OYI6
MTZ+0>)]GR)Q5G?RVMY;^K/IK_@H%'%\,?!WP3^#MAB&VT#PZNJ7JP@+'/=3L
M4:0@?Q;XIFY_Y['UKY:^&O\ PAJ^+K5_'O\ ;3>&D5WGCT$1?:I6"DH@,AVJ
M"V 6Y('0>GV/_P %!_$A\*_'WX5_$JUTC1?%.BWWA2VEM+/7+7[587>UIB5D
MCW#>NV>)ASU(]*^?]4\2_P##5WCG1-(_LKX5_!W[/!/_ *=:V_\ 8>GR\!OW
M\F9,O\N%X_B([UK@I/ZK&ZT:;;\[NY&(BO;.VZM9'H_[?/P5^'_PEM_A9>^
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MVNB_X!RT::]JVK<OR>ESGOV1?!NC^&OVI/CA\!TO_P"U?!VN:;?Z47D(,CM
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M75AIL:;!;&21WEC(R<,)3(&P2-V<$BO3Z "BBB@ HHHH ^5?V=_^3[/VN?\
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MGHVQW!P>QQ766US#>6\5Q;RI/!*@DCEC8,KJ1D,"."".]>>_%/\ Y'GX._\
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M (NC_A1_[07_ $<S_P"6%I__ ,76?U6C_P!!$/NG_P#(%>VG_P ^I?\ DO\
M\D?1M%?.7_"C_P!H+_HYG_RPM/\ _BZ/^%'_ +07_1S/_EA:?_\ %T?5:/\
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M5ZC4[.72[Q_]WRLQ _6CZK2G_"K+T=XO\K?B/VTX_'3?RL_^#^!](45\W_\
M#3OQ$\(\>.O@#XKM(T^_=^%)X=:CQ_?VH5*COSR*U/#_ .W-\&M:N_L5YXI;
MPSJ8^_8^(K*:Q>/_ 'F==@_[ZJ7E^)M>,.9?W;2_])N"Q5'9RMZZ?F=KKO\
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M3&./^T-^/-ZC]UY?/WOO8XKIJ*\W?<ZSF=6U[Q'9_P!N_8O"WV_['Y']G_\
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M:[,9F]7$5G4A%1^46_OY;Z;+R2W>IQX3"0C2M)MZOJ[:.VU^MK_,^4YOV*?
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M;_L?D?V?_P 3&./^T-^/-ZC]UY?/WOO8XHU;7O$=G_;OV+PM]O\ L?D?V?\
M\3&./^T-^/-ZC]UY?/WOO8XKIJ* .9U;7O$=G_;OV+PM]O\ L?D?V?\ \3&.
M/^T-^/-ZC]UY?/WOO8XK.\76,OB2/6;+4_ 5AXCL;5K=;%-0E@D2^5R/..QU
M/E^6,\-]['%=O133<7=":3T9^?M]_P $W/!%A^TMH5J-:OF\*:E::AKO]B>2
MH,8M;BS7[-YV<F-C>==H8+'C)+;A^@5<M?\ A_2YO&VGR2:;9R226ES*[- A
M+.LEOM8G')&3@]LFNIKT,9CJ^,4/;2;Y5;\?^&^X\_"4HTI5%&*6O1^2?;S"
MBBBO./1"BBO(?B]X\UWPOXDMK73+[[-;O:+*R>3&^6+N"<LI/0#\JTA!U'9'
MG8_'4\NH.O53:VTWU]6CUZBOFG_A<'B[_H+?^2T/_P 11_PN#Q=_T%O_ "6A
M_P#B*W^K3[H^9_UNP/\ )/[E_P#)'TM17S3_ ,+@\7?]!;_R6A_^(H_X7!XN
M_P"@M_Y+0_\ Q%'U:?=!_K=@?Y)_<O\ Y(^EJ*^:?^%P>+O^@M_Y+0__ !%'
M_"X/%W_06_\ ):'_ .(H^K3[H/\ 6[ _R3^Y?_)'TM17S3_PN#Q=_P!!;_R6
MA_\ B*/^%P>+O^@M_P"2T/\ \11]6GW0?ZW8'^2?W+_Y(^EJ*^:?^%P>+O\
MH+?^2T/_ ,11_P +@\7?]!;_ ,EH?_B*/JT^Z#_6[ _R3^Y?_)'TM17S3_PN
M#Q=_T%O_ "6A_P#B*/\ A<'B[_H+?^2T/_Q%'U:?=!_K=@?Y)_<O_DCZ6HKY
MI_X7!XN_Z"W_ )+0_P#Q%'_"X/%W_06_\EH?_B*/JT^Z#_6[ _R3^Y?_ "1]
M+45\T_\ "X/%W_06_P#):'_XBC_A<'B[_H+?^2T/_P 11]6GW0?ZW8'^2?W+
M_P"2/I:BOFG_ (7!XN_Z"W_DM#_\11_PN#Q=_P!!;_R6A_\ B*/JT^Z#_6[
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MCPP8$9!%?3TLUJO 5*=2FIZK5_KW:MO?J<4\%#ZS&<)\NCT7Z?\ #'+?V?\
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M_'MLMGX<\/3VBQS);RSZ_/'));%X?-D=!9,$D4B/;&&8-N8ETV@-Z+6-=?\
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MA?5]<FN_LMM8[41?+WF:0X^7J,=5YYZUT?QTT^XM_&"W<D>VWN(5$3[@=Q4
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M:!]P.\+&BMP#D8([T1J<T^5;"Q.4/"X".)FI<]U?^5)IVZ;[7=[:VW.<\/\
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M$GA^WO=7B74)[R-)T&YU6)&4$+P1D\\_Y)ZI?A;X53IHT/XNY_K3FH<SLS+
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MXR.^#[5MT4[Z6,73O452[T35M+:_*_3N%%%%(V"BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&4@C(/!!I:* /C
M?QI_P2T^%FO>)M1UGPQX@\8?#C^TI?,O=.\*ZHL%G+DDG$;1L5Y8X .U<D!:
M]O\ V=_V7_ '[+WA>YT;P-IDD!O'66^U&]E\Z[O'4$*9),#@9.%4!1DD $G/
MA/Q2^+'[2/Q _::\:?#;X-#P=X=TCP?8Z?/=ZCXK24M>-=1&17CV*Y* JT?R
MI@-&V6^8 >F?L]Z%^TQI?C2]E^,WB+P%J_A=M/=;:#PM'<+<K=^9&49O,A0>
M7Y8F!YSDKQZ 'T'1110 44R600Q/(P8JH+$*I8\>@')/L*\WN[S1?VB/!NIZ
M-:7GC+P[IYFB2\D;2;_P_=3Q[@S0H]U;QR>7(JE':'# ,0'0D&@#TNBOA7P"
M$U?]E']D3PMJ.)/#7B34M/L=7M)#^ZO84T^\N4MI1T>-Y;>+=&V0X4J002#3
M\0:#IGASX[7?PFTVUAT[X6:EX^T1+KPY;J(].!DT:\NY;,1#"+#+-:VTCP8V
MOO;*XD((!][45X!^SSH-AX%^,OQJ\'^'+6+2O".FW6E7=CH]F@CM+">XLRUP
MD,:@+$&*QR%% &9"V/GKU3XI>(O$_A/P)J>J^#?"/_"=^)+?ROLGA_\ M*+3
MOM6Z5%?_ $B4%$VHSOR.=FT<D4 > ?L[_P#)]G[7/_<H_P#IKEKZJKXJ_8F\
M1>)_%G[6'[4VJ^,O"/\ P@GB2X_X17[7X?\ [2BU'[+ML)U3_2(@$?<BH_ X
MW[3R#7VK0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YC_ +<'AGX+^&_V
MG-4\2^+_ -H7QIX#\9ZE86X&E^&[>>7[#:K$B+&)(@=BR-&TFS/5RV.03UO_
M  3YU[X=:E\;]8@\%_'#XB?%6\'AV=Y[+Q1%.MC;)]IMAY@,I_UN2 N!]TR<
MCO=_:>_8[\:^*OBQ\7?%^A67A^^C\166B:]H>J:K+&DMAK&EO%$MEAR ([B
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M_:Y_[E'_ --<M?55?*O[._\ R?9^US_W*/\ Z:Y:^JJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRCL]"NIX9KJUMK2 Q*UPT+O$))':5]L<C@(8\G=N4=E\4O /_"T/ FI^&/\
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M]%? '_#E3X(?]#3\0/\ P8V/_P AT?\ #E3X(?\ 0T_$#_P8V/\ \AT ??\
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MQ _\&-C_ /(='_#E3X(?]#3\0/\ P8V/_P AT ??]%? '_#E3X(?]#3\0/\
MP8V/_P AT?\ #E3X(?\ 0T_$#_P8V/\ \AT ??\ 17P!_P .5/@A_P!#3\0/
M_!C8_P#R'1_PY4^"'_0T_$#_ ,&-C_\ (= 'W_17P!_PY4^"'_0T_$#_ ,&-
MC_\ (=>:?M'_ /!(#P;X'^#'B'6_AC<^./%7CFU^S_V=I-U=VDL<^ZYB27*I
M;1L=L32-PPY4=>A /U*HK\VOAC_P1J^%^O?#;PGJ?BK6?'FD^*+W2;2YU;3X
M;ZS1+:\>%&GB53:L0%D+* 6)&.IZUTW_  Y4^"'_ $-/Q _\&-C_ /(= 'W_
M $5\ ?\ #E3X(?\ 0T_$#_P8V/\ \AT?\.5/@A_T-/Q _P#!C8__ "'0!]_T
M5\ ?\.5/@A_T-/Q _P#!C8__ "'1_P .5/@A_P!#3\0/_!C8_P#R'0!]_P!%
M? '_  Y4^"'_ $-/Q _\&-C_ /(='_#E3X(?]#3\0/\ P8V/_P AT ??]%?
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M\):A;7-K&^J6?G7*F61F@<.?+CMVRJH/WAXY 'N'_#E3X(?]#3\0/_!C8_\
MR'0!]_T5\ ?\.5/@A_T-/Q _\&-C_P#(='_#E3X(?]#3\0/_  8V/_R'0!]_
MT5\;_!?_ ()<_#?X!_$72?&GA+QKX^M=7T^57V2W]D8KB/<"\$H%H"8W"[6
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MXJT'QM\+O#6M>&9=1ET.ZLU-M_:\TTUZFW*M'.\S-(TJLK*Q=F.Y3R>M=G0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$O@?3/"NAFY>PL?,?SKR8RSSS2R/+--(_=Y)9))&P ,N<!1@#J:** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$W]GJ'QE\+?%6GR7_P /M'U"2X\'>)FO;>0S6DCEC;O$K^8C*3N^9,;FD .
MF0#ZIHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KY[_;6US4M!^'&C3:9J%UITSZLJ-):3-$S+Y,IP2I'&0/RKZ$KYM_;L
M_P"28Z'_ -AA/_1,M>QDZ4L?23[GFYDVL)4:['R!_P +(\6_]#1K7_@PF_\
MBJ/^%D>+?^AHUK_P83?_ !5<[7N7_#(OB;[7:6)\3>$UU6[MQ=0:8^HR+=21
MD'E8S%DCAN>GRGGBOUBO4PF&M[:ROY=C\ZI0Q%>_L[NWF>7_ /"R/%O_ $-&
MM?\ @PF_^*H_X61XM_Z&C6O_  83?_%5E:UH]YX=UB]TO4(3;WUG,]O/$2#M
M=201D=>1U%4JZ52HR5U%6]$8NI43LVSHO^%D>+?^AHUK_P &$W_Q5'_"R/%O
M_0T:U_X,)O\ XJN=HI^QI?RK[A>UJ?S,Z+_A9'BW_H:-:_\ !A-_\51_PLCQ
M;_T-&M?^#";_ .*KM;[X%Q:;X)\!^);KQ'#;6GB:]CM9O.M]J6"LQ!E9R^&"
M@$GA?K7#^//#MEX2\6ZCI.G:U;^(;*V95CU*U \N<% Q(PS#@DC@GI7+2J86
MM+EII-Z].SL^G<Z*D,127--M;=>ZNNH__A9'BW_H:-:_\&$W_P 51_PLCQ;_
M -#1K7_@PF_^*KG:*ZO8TOY5]QS^UJ?S,Z+_ (61XM_Z&C6O_!A-_P#%4?\
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M;_T-&M?^#";_ .*H_P"%D>+?^AHUK_P83?\ Q5<[11[&E_*ON#VM3^9G1?\
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MLT6QO/#/Q(^&T]]<6(U"716UV1M0LXLJ"9X8X&,94LH.> 6 SS7EOQB^#?\
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MKNK:Q\,/"%_>ZQJ=S>76CV<\\TE],6DD:!&9C\W4DDU^3=?JO\&?^2/^!?\
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MH,@*\ $C-6A\(;UK WPU[039!MIN?MC>6#Z;MF,U/M_[QNL+F;DXVE=:[_\
M!.(^V7G_ $$M0_\  V;_ .*H^V7G_02U#_P-F_\ BJGOM->SU*2RCEBO9%?R
MUDM&\Q)#VVG'.:@N+>6TF>&>)X9D.&CD4JRGT(-:>TEW/.E6Q,;WF]--V'VR
M\_Z"6H?^!LW_ ,51]LO/^@EJ'_@;-_\ %5TWA_X<W_B*QM[J.^TZS6Y9D@CN
M[C8\I!P=J@$GD'\JKP> =7N/%4OA]8D^WQ<R'?\ (JX!W$^F"/SJ/;=.8Z_9
M9ARPG[UI62U>K>WWF#]LO/\ H):A_P"!LW_Q5'VR\_Z"6H?^!LW_ ,572>(/
MAWJ7A_2TU$SV>HV32>49K"8R*K9Q@\#OQ]>*T8_@[KDD*CS]/6]:+SAI[7&+
MC;_NXQ[=<9H]MUYC18;,I3<$I75GN^NWW]#BOMEY_P!!+4/_  -F_P#BJ/ME
MY_T$M0_\#9O_ (JF.C1LRLI5E."K#!!]*2KYY=SS?K-?^=_>R3[9>?\ 02U#
M_P #9O\ XJC[9>?]!+4/_ V;_P"*J.BCGEW#ZS7_ )W][)/MEY_T$M0_\#9O
M_BJ/MEY_T$M0_P# V;_XJHZ*.>7</K-?^=_>ROK&H7\&DWTD>IZBKI [*PO9
MN"%.#]ZOL]?NCZ5\5:[_ ,@/4/\ KWD_]!-?:J_='TKCQC;A"_=_H?H_"-2=
M15^>3?P[_,6BBBO+/T,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<97CB)QE&[LDKO=^;W"BBBO3. **** "BBB@ HHHH **** "BBB@#RS]HO\
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MKIPV997VY8[8@N#P03D$X(_*3Q'^T-\0O%WA7P[X;U;Q$]YHWA^[-]IMNUK
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MGK8:A6C3LX/[F?-U%?2/_#NWX^?]"0W_ ('6_P#\71_P[M^/G_0D-_X'6_\
M\76/UO#_ //R/WHZO95/Y7]S.6_9>_:,C_9G\2>(?$5OX977M=OM*DTW3[F2
M]\A+!G()E*>6WF'*IQE> 1GYJZCX"_MU_$7X1^//[;\1ZYX@^(VCR6DMK/H>
MM:]</$^_!#J9/,564J.=AX+#C-+_ ,.[?CY_T)#?^!UO_P#%T?\ #NWX^?\
M0D-_X'6__P 77)4^H57)SE%\V^J_ST^1M%XB%E%-6\AMY^U];K\"-/\ AAI?
M@E=.TZP\3G7[>Y;5#+LB%P\R6VWRAG:'5?,+<[<[>>.2_:K_ &AS^TY\4AXR
M.@#PV!80V(LA>?:ON%SNW^6G7?TV\8KK_P#AW;\?/^A(;_P.M_\ XNC_ (=V
M_'S_ *$AO_ ZW_\ BZ(/ TY^TC.-]?M=]^OD$OK$H\KB[:=.WR.6\7?M'MXJ
M_9=\#_!S_A'Q:KX9U.?4?[9^V;S<^8]R^SR?+&S'VDC.]L[.@SQ8_9A_:<;]
MG>3Q?9WGAB+Q;X>\4V L-1TXWSV4I4;P"DZ*S)\LD@.!GD$$$5T/_#NWX^?]
M"0W_ ('6_P#\71_P[M^/G_0D-_X'6_\ \73<L#*$J;G&S=W[W6]^_<2^L*2G
MRNZ\O^ ;OC?]N#1]>\(?#7POX=^%UOX1T'P-XEM=?LK.WUEYQ(D+.QA+/#NW
M.TC,926)))*DFO,/C!^T5>?$S]I"X^+UAH\6AWYO;&_M].FG-TD4EK%"B!GV
MIO!,()X'WL>]=E_P[M^/G_0D-_X'6_\ \71_P[M^/G_0D-_X'6__ ,74T_J%
M)WA./7[5]]7N^I4GB)JS3^[M\CI]>_;H\.ZG\?/"WQ:L?A';Z5XFTZXEN-5E
MCUZ1VU7=:&V1<M#MA"+@\*V<<]S6;X5_;?MK6V^)N@^,/AU:>-/ OC;7[KQ"
M^A3:I);264\TOF%4N$0D@83D*IRN01DBLK_AW;\?/^A(;_P.M_\ XNC_ (=V
M_'S_ *$AO_ ZW_\ BZS]GE]DN=:67Q=G=6=^A7/B;WL__ ?^ 6M#_;*TOPK:
M_%VPT'X8:9H&D>.M CT&WL-,OC$FFJL$T7G,3$3<.?/+$G825Y/.:^FOB3\7
M/"7PK_8^_9SN?%GP]T_XBVTMG%/;6=W?-:/;S0Q(5D5E1MR\X9""K<9]*^6_
M^'=OQ\_Z$AO_  .M_P#XNC_AW;\?/^A(;_P.M_\ XNLJE' U)1:J)6=W[V^E
MEK>Z+A4KQ33@W\MM;]CI]%_X*)>(H_C7XS\;Z]X7M=;T;Q/I:Z--X>BO&M?(
MM4SY:QW"H7##?*2V.3(Q&W"A:/CS]MC1?$/P[\"^"O#/PMM_!V@^$?$]MXAL
M[>#6I+G>L0E)A8O%N+.TS,923_NGK6-_P[M^/G_0D-_X'6__ ,71_P .[?CY
M_P!"0W_@=;__ !=:^SRY-24HZ6^UVT6E[;$>TQ-FK/[O^ = /V\W_P"&MC\;
M3X(4K_9W]G#0O[5YQY/E[O/\GKGG'E^WO6!\(_VOM.\#^"?'7@OQ;\.K3QUX
M1\4ZM_;,FGOJDEB\,^]6P9$1BRYCBX 7[IR2&Q2?\.[?CY_T)#?^!UO_ /%T
M?\.[?CY_T)#?^!UO_P#%U7)E]N7FCLE\7;;KT%SXF][/KT[[]#8^#O[9G@[X
M01Z-JEE\$=)?QMH\-Q;VGB"QUF:S5XY&? G@5"LY"L%W.Q/R@C;QCYJ\5>)+
MSQCXHUC7]0*'4-5O)KZX,:[5\R5R[X'898\5[[_P[M^/G_0D-_X'6_\ \71_
MP[M^/G_0D-_X'6__ ,76M.>"I2<XS5W_ 'K_ )O0B2KS2BXNR\O^ ?-U%?2/
M_#NWX^?]"0W_ ('6_P#\71_P[M^/G_0D-_X'6_\ \773];P__/R/WHR]E4_E
M?W,^;J_5?X,_\D?\"_\ 8"L?_2=*^.?^'=OQ\_Z$AO\ P.M__BZ^\?AO\)?&
MWAOX=^%](OO"]\E[I^E6MI.JF-@)$A56 (?D9!YKP\UK4JL(J$T]>Z/G\XPF
M(K4X*G3D]>B9L^&=8B\/Z]9:C+:"]2V?S!"7V98 [3G!Q@X/3M6U_P +.US_
M (23^T_M]WY'VCSOL/VAO*V;L^7CIC'&<>]9W_"O_%G_ $+.H?\ D/\ ^+H_
MX5_XL_Z%G4/_ "'_ /%U\RX1;N[?>CPJ5#-:,%3ITYI)WTB]_N_X!O3?$V-I
MO%#Q:3Y0UR)8V7[1D0L$92WW/FSNSCBLCQ-XP_X2/1=!T_[)]G_LN$P^9YF[
MS<A!G&!C[GOUJ#_A7_BS_H6=0_\ (?\ \71_PK_Q9_T+.H?^0_\ XNDJ<4[J
MWWFM2.;UH2ISIRL]_<[RYNW\VO\ P"UHWC4Z1X0U;0A9B7[>V[[1YF-G 'W<
M<]/451\(^)IO".O6^IPQ+.8]P:)C@,I&",]OK4G_  K_ ,6?]"SJ'_D/_P"+
MH_X5_P"+/^A9U#_R'_\ %T^2.NVOF9>PS3FIR5.5Z?P^Z]-;]N_<Z/4/BA:3
MZ%JVF66@+8IJ)WO)]K:1MY.68Y7GH..,5C>,_&I\70Z5&;/[)]A@\G/F[]_
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MRYV>_6KEK\4GM?&&J:T=-62WU"(13632]@JC[^WV].]8/_"O_%G_ $+.H?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC'- 'VK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45RGCSPMXA\5
MII]OHOC2^\%VT<C27=QI5C:SWD_RX1$>ZCEBC3));]RS-A<,F#N\+^&?[06N
M^$/"_P ?SXXU/_A,+/X5ZA="WUY8(K>XU&V%L+M8)EA58O/C#B$M&B*<*2@.
M[(!]/T5\S?!'QY/\0=6T-_$'[05A)X[N0+V_^''ANXT;[/:$+O>S,3P2WI\L
M961C,&R&(V#"B#P[XH^(W[0WB[XRP^'O'UU\.;;P;K$GAK1+/3].LKD3W4=N
MLC75\;F"5GC:25-J0F$A$8%F9@P /J"BO+/V7?C#<?'SX!^#?'=[:06.HZK:
M,+VWM2?)2YBE>&<1Y)(3S(GP"20, DXR?-M%\3?$/]H+QY\8=.\/^/KSX;67
M@S4?^$?TF#2].L;EKBZ%NLK75X;J"8M&7D0+'%Y1VJV6)(( /IRBO*?V6_C#
M>?'GX#^%O&NIVEM8:O?1S07]M9[O)CN8)Y()M@8DA"\3,H)) (Y/6N(^'5Q_
MPL7]M#XJ:U=+YEKX"TG3O"^EACN59KI/ME[(H_A8@VL9/4B/'3J ?1M%?+.E
M?%7XP_\ #7OA/PWXJCTOPSX,US3M:FLO#5D4N[EH[1H$BN;FZV\/(9&<1185
M$90Q=L[;?QQ^,E]H'[1.@^!-:^(3?![P9>>'9=5M?$BQV*-JM^D_ER6BSWT4
ML*"*(QR%=F]C*/F && /INBO%?V2?B-XF^)WPQOM4\1W*ZQ#;ZU>V&C^(EM5
MMO[>TZ)PL%^8E 53)\WW JG;N4 ,*ZWQYX'UC6KV35;;XI^)O!&G06_[VUTN
M#2&ME"Y+2L]W8S.#CK\X4!1P.20#O:*^*O!=OXT_:._8F^)FL^(_$VH:Y'K<
MFH:EX)NM1M+:UO;6UM&W:?-)]FAA7S6FMQ+D+P&7%?3OP-^(1^+'P:\$>,F3
MRI==T:UOY8QCY))(E9UX]&+#\* .XHHHH **** "BBB@ HHHH **^,_CE^T=
MX\;X]>"K#P'K$>E_#_2_'.D^#?$4QLH9CJ]]=LTEQ;1NZL8UMX8XPS)M8O<D
M9_=UWG[;7Q&^+7P[^%^NZI\-X-+T:RTO2+G5=1\5:BRW$L'E*=EM;6A!#RR,
M4)ED_=H@?Y78J  ?2%%>/_%WXS7_ ,*?V=_^$TAM(M9\0S6MC;V-K.=D=S?W
M3Q0PA]N,)YDJLV,?*#C%9/P.\16/BK7T:#]HRW^)^LVMNTVI>']$GT1K&,M\
MI98[>W-U'&CL N^=CPH9FYR >[45YO\ M$?%B7X(_!WQ#XOM;%-4U*T6&WL+
M&1BJW%W/,EO;HQ'.TRRIG'\.:X[X(^(;3Q1XEC4?M&VWQ(\06L,EQJ?AG0I]
M%:PC).QML4-N;N.*-W4*7G+9"AV;)! />:*\1_;2\>:E\._V9_&VH:([1:]>
MP1:-ITD;;62XO)DM4<''!0S;_P#@%3>-M#\9?"3X/^&O!WP@T?25-A:QZ:=7
MU>3;;:/:0PDM<F!?GN9&";5C! ,D@9V"AL@'M%%>,_LL?$/Q)\1/V6? WC'7
M)#X@\4:CHHO)V"Q6QNY_FP,*JHFX@#@ "N(_9]^)GQ9\0?M&>/?#'Q+FTFPB
MM] T_6+/PWHZ+)#I/GSW"B%KHJ'N)1'''YC_ "IOW;%"@$@'T[17S'HOB;XA
M_M!>//C#IWA_Q]>?#:R\&:C_ ,(_I,&EZ=8W+7%T+=96NKPW4$Q:,O(@6.+R
MCM5LL201Z-^RW\8;SX\_ ?PMXUU.TMK#5[Z.:"_MK/=Y,=S!/)!-L#$D(7B9
ME!)(!')ZT >K45\L_M=?%3XP_#^_T6Z\*)I?AGP3!K.D6=WK,^R\OM6>ZO(H
M6MX864I;Q(C2%Y7W.Q:,1A<,U=%^W1'<:/\  >?QUIR9UOP#J=EXIL64[3^X
MF43IGT>W>=".A#\T ?0E%5]/OHM3L+:\@;=!<1++&WJK $'\C5B@#!\??\B)
MXC_[!MS_ .BFK=7[H^E87C[_ )$3Q'_V#;G_ -%-6ZOW1]*U?\->K_0S7QOT
M7ZBT445D:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5@:__ ,C!X8_Z^I?_ $GE
MK?K U_\ Y&#PQ_U]2_\ I/+6M+XOD_R9G4V^:_,WZ_*S3OV9_'FL?L;_ !:G
MM_"^NZ3\0O#GQ5O/&/ABVET^6.[N1&EJN^",KND5D\TIM!#-&H&<5^J=%9&A
M^2?Q2_9Q^)FM?L ZGK>H>#=<U7XK>/?':^*-9TFSTV>2]MXSYZ1QM!@NB(#N
M"D?*)L'IQZ-^US\$?&6@_MD7GQ.2Q^+EWX*UOP_#8-?_  8N0FKVLZ% 8)$P
M2T!\H.1P"S*=V4(/Z344 ?F['\,_B=\(_P!C?Q%=_!GP_P#$O0]<\0>,5U/5
M8?$EQ;W?BB;3FB"SW$211+Y<SNJ?(=TF [;N1C)_9)^&OC6V_;GTKQE/X?\
MC$?",WA>XM5USXM*TM_Y@/\ JW=1MB3<<I$QW=6YSQ^G%% 'Y;?!_P""WC[2
M_P#@D_\ $_P??>!_$-KXLO-3FFMM!GTN9;Z9?.M"&2 KO8?NW(P/X2:_0_X-
M:+-9_ _P-I.J6DMM<1>';&UNK2X0I)&PMD5T93@J0<@CJ*[JB@#\Z?V9=6^(
M?[ -GXM^%?B+X/>.OB#X>;69M1\/>(O!&F#4$N(I%1 L^&41<1J26Y!9A@@
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M^'_B9?\ @J;J_BY_#NJ+X5;P(MJFN-9R"R,_F1?NA/C87P#\H.< G&*^R**
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MVN^'IK:VC\-^%]1O()[@J%(W01S) &;)"RR9 [G&:^C:* /E/XZ>&+G]HO\
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M^Z/I6%X^_P"1$\1_]@VY_P#135NK]T?2M7_#7J_T,U\;]%^HM%%%9&@4444
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M_P"#63_Y'H^W>)_^@+I?_@UD_P#D>M^BCGC_ "K\?\PY7_,_P_R,#[=XG_Z
MNE_^#63_ .1Z/MWB?_H"Z7_X-9/_ )'K?HHYX_RK\?\ ,.5_S/\ #_(P/MWB
M?_H"Z7_X-9/_ )'H^W>)_P#H"Z7_ .#63_Y'K?HHYX_RK\?\PY7_ #/\/\C
M^W>)_P#H"Z7_ .#63_Y'H^W>)_\ H"Z7_P"#63_Y'K?HHYX_RK\?\PY7_,_P
M_P C ^W>)_\ H"Z7_P"#63_Y'H^W>)_^@+I?_@UD_P#D>M^BCGC_ "K\?\PY
M7_,_P_R,#[=XG_Z NE_^#63_ .1Z/MWB?_H"Z7_X-9/_ )'K?HHYX_RK\?\
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M .#63_Y'K?HHYX_RK\?\PY7_ #/\/\C ^W>)_P#H"Z7_ .#63_Y'H^W>)_\
MH"Z7_P"#63_Y'K?HHYX_RK\?\PY7_,_P_P C ^W>)_\ H"Z7_P"#63_Y'H^W
M>)_^@+I?_@UD_P#D>M^BCGC_ "K\?\PY7_,_P_R,#[=XG_Z NE_^#63_ .1Z
M/MWB?_H"Z7_X-9/_ )'K?HHYX_RK\?\ ,.5_S/\ #_(P/MWB?_H"Z7_X-9/_
M )'H^W>)_P#H"Z7_ .#63_Y'K?HHYX_RK\?\PY7_ #/\/\C ^W>)_P#H"Z7_
M .#63_Y'H^W>)_\ H"Z7_P"#63_Y'K?HHYX_RK\?\PY7_,_P_P C ^W>)_\
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M#[=XG_Z NE_^#63_ .1Z/MWB?_H"Z7_X-9/_ )'K?HHYX_RK\?\ ,.5_S/\
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MFCV 02P[$EB 'F!F;Z9T+1++PSH>GZ/ID M=-T^WCM+:!6+".*-0J+DDDX4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>advm-20241231_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +A!2@# 2(  A$! Q$!_\0
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M*1:7^&D6DR1:***S*"BBBI8!1112 <O2EH'2BLV C=*;3FIM(!RTM(.E+6;
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M>%-3M+*:\@B.G_8;A6B#,8Y(0 #NVD#@]00:\X_8G\&Z!XN_X3,:YHFGZQY
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M)"P##K]X9QT->DZY+\%_A'XHGTO4=(M]1U*\N&FN-]FES'9+(Q95*GY8U4$
M*@+;<$@\&N>-#FCSMV1E0RV52BJTYJ*O;4^0J=7TK^U1\(=#\-Z'8>)= L(M
M.WW(MKF"U7;$P925<*.%P5QQUW"OFNN2O3=*7+(Y<5A9X.JZ4Q5I:1:=7&SG
M0ZMOPVHW3MCG"C]?_K5B5K^'I@ES)$?^6B\?4<_XU]+PK4A3SK#RJ;7:^;BT
MOQ:.["-*M%LQ_B7XB;1]-E:,X=<1Q_[Y[_@/Y5YIX!\-+K]Y+?WV98(F^ZW/
MF.>>?;_&NJ^-$+M;%Q]U;G)_%3@_Y]:3X:,C>&5"XW"5@V/7C^F*_2\?CJV
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MI5*B@^.BW%W1]_?'#P?_ ,+V^#MM/X<D6[N-T>IV"[PHF^4@H2>A*NW7'S
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M#^51:MH>H^'[UK35=/NM,NP QM[R%HI #WVL >U2VM@]G/EY[:=RG116]9^
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M;6C;[RI3E3I8:&,K<RG4YF[W24;*U]NKVT*WQLNIOB%^T#XABL5+3W>JKIL
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M+/AS&0,L2<9('.#C%><^"?'&B?"_XS67B+0XKZ^T#3[EQ$MV4%S)"T;1LQP
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M&U0. -VWW!YSUK&_9 U2[M?B%XG2TO9HO"5C:W%Z\"N1$S;E6,G/.=FXY/\
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MQU\6^.]>> ^'=$03PQ7TFR$*,K 9-W"H%C9V[;NV":Z+2/%>IZ/XX7Q7XO\
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M!CK7KOCK_D@/P^_Z[W7_ *&U>1+UKT#Q-XSTW5OA3X1T"!I#J.FS7#W"LF%
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MC_A3OCW_ *$CQ'_X*;C_ .(J74AW0OJM?_GV_N9R%%=?_P *=\??]"1XC_\
M!3<?_$4?\*=\>_\ 0D>(_P#P4W'_ ,14.I#NA_5:_P#S[?W,U/AW\6_^%>^"
M_&NAQ:3]KN/$MJ+,WAN=@MTVR*?DV'=D2'^(=!7GE=?_ ,*=\>_]"1XC_P#!
M3<?_ !%'_"G?'O\ T)'B/_P4W'_Q%97IQ;::U\SHG#%U(0IR@[1T6FUW?MW.
M0IW\-=;_ ,*=\>_]"1XC_P#!3<?_ !%*?@[X]Q_R)'B/_P %-Q_\13]I#N<[
MPM?_ )]O[F<@M+77+\'?'O\ T)'B/_P4W'_Q%+_PI[Q[_P!"1XC_ /!3<?\
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MN9=S#ZK7_P"?;^YG(T5UW_"G_'G_ $)/B+_P4W'_ ,11_P *?\>?]"3XB_\
M!3<?_$4N9=ROJM?_ )]O[F<C177?\*?\>?\ 0D^(O_!3<?\ Q%'_  I_QY_T
M)/B+_P %-Q_\14\R[C^JU_\ GV_N9R-%==_PI_QY_P!"3XB_\%-Q_P#$4?\
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MH?'?_0E>(O\ P53_ /Q%%T'U:O\ R/[F<E3EZ5U?_"H?'?\ T)7B+_P53_\
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M&1 KQXSO+*H8\\#!+D8]J5?AIXO_ .A4UO\ \%TW_P 33U^&OB__ *%76_\
MP73?_$UARUE_R[_ M1J+['X%B'5-#2,((5$OE"/S7A!7<J8#XQW+$GC^$=:P
M=2FAGO"T"@)M4$JNT,P4!B!V!.36N/AKXO\ ^A5UO_P73?\ Q-.'PU\7?]"K
MK7_@NF_^)K&I&O-6Y']S+<:DE;E_ Y[TI171?\*V\7?]"MK7_@NF_P#B:4?#
M?Q=G_D5M:_\ !?-_\37'+#UOY']S"-.?\K.>HKH_^%;^+?\ H5M:_P#!?-_\
M3167U>M_(_N9?LY]F?>=%%%?N9]R%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\
MY%_^M1[&IV#VD.YTU%<S_P )E_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.
MYTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\ Y%_^M1[&IV#VD.YTU%<S_P )E_TY
M_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?]
M.?\ Y%_^M1[&IV#VD.YTU%<S_P )E_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV
M#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\ Y%_^M1[&IV#VD.YTU%<S_P )
ME_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\
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M7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\
MY%_^M1[&IV#VD.YTU%<S_P )E_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.
MYTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\ Y%_^M1[&IV#VD.YTU%<S_P )E_TY
M_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?]
M.?\ Y%_^M1[&IV#VD.YTU%<S_P )E_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV
M#VD.YTU%<S_PF7_3G_Y%_P#K4?\ "9?].?\ Y%_^M1[&IV#VD.YTU%<S_P )
ME_TY_P#D7_ZU'_"9?].?_D7_ .M1[&IV#VD.YTU%<S_PF7_3G_Y%_P#K4?\
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MEBV5%<SL?5/AWX]?#/Q=K-MI&A?$7PGK6K7)(@L=.URUGGE(4L0L:.6; !/
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MUK]N[Q[)^SCXS\6Z;X3T?3O'_@'Q!'H_B?2;]9KBU6,NT1EBV2(RGS<##,V
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MF$>:Y8$G<.!C%>7? ']JSQ;XE^('Q+^'OQ,\/Z58>+/!%H;^:Y\-/(UI=0@
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MP3KOQ"N[F6/4+FUOKBWT:QA!8QR;9!Y\F1L4JO.XD]*\]^%'[3'Q*L_VEO\
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MEYI/C?\ 99_;$\?_ !!7X?\ B3X@^!/&]K&PF\(V7VR\M)UV':\((. RN.2
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M1_;7G?;?[&3;YWWO(WOY'X>5Y>/;%>_4 136L-SCSH8Y=O3>H./SJ+^R[/\
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M.;\T_P#BJ/>[_B'-'M^#$_LNS_Y](/\ OVO^%']EV?\ SZ0?]^U_PI?M4O\
MSYS?FG_Q5'VJ7_GSF_-/_BJ/>[_B'-'M^#$_LNS_ .?2#_OVO^%']EV?_/I!
M_P!^U_PI?M4O_/G-^:?_ !5'VJ7_ )\YOS3_ .*H][O^(<T>WX,3^R[/_GT@
M_P"_:_X4?V79_P#/I!_W[7_"E^U2_P#/G-^:?_%4?:I?^?.;\T_^*H][O^(<
MT>WX,3^R[/\ Y](/^_:_X4?V79_\^D'_ '[7_"E^U2_\^<WYI_\ %4?:I?\
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M*H][O^(<T>WX,3^R[/\ Y](/^_:_X4?V79_\^D'_ '[7_"E^U2_\^<WYI_\
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MEV?_ #Z0?]^U_P */[+L_P#GT@_[]K_A6=_PD4G_ $#IO^_B?XT?\)%)_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^6E!-\[@O>LM%>][/^NI]9T5\Z_LHZO?OJWC/1HK^XU7PWI]P%L+B=BP WR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCQIXA@\2?#BTEG\5^)]>\1B<2ZA87;N;"S ++G:1@-EE (/\1X%>M_&"-_\
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M"%K_ +S?^@-3B'5>J_,Z"BBBLST HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!SUU_Q\R_[Y_G452W7_'S+_OG^=151P/<*
M***8@HHHH **** "BBB@"#4)I[>QN9;:#[5<I&S10;@OF, 2%R>!DX&3ZUXQ
M^SO\+]?\+ZIXE\3>+K86_B#59BH7SDD(C)WNV4)&&8CC/\%>W452DTFNYQU<
M+"M6IUIMWA>RZ:]?\CP_XG?#'Q!\7/BAI]IJEI)9>!--A9A<+<1[KB9EY(4-
MN')5>1T1O6M']G?POXP\ Z;JGAOQ%9XTNUG+Z;>K/&ZNI8[E"ABR@G##('WF
MKU^BJ]HW'EZ'-#+:4,3]:4GSW=_-.VFVRMH>+?M&?#GQ!X^O/!SZ%8B]2PNY
M)+DF:./RU)CP?F89^Z>F3Q4WQ8^'VO>)OBU\/M:TVQ^TZ;I=PKWDWG1IY2B5
M6SM9@6X!^Z#TKV.BA5&K>05,NI595)2;]]Q;_P"W=K:?>?.:^#M;\"^./BMX
MOU6.32]$O--NEM-1@D223<[*4*H&W @C^+ SW'6O*/"_AB\\*_#FP\?S>'?"
M6J65O)\K7MQ<M=R-YA S&)/*)![8S@<BOMV]LK?4K.>TNX([FUG0QRPRJ&1U
M(P00>H(KSJ/]FWX;PW0N%\,0F0'=M:YG9/\ O@OM_#%:QJJVIX^*R6<I)T&F
MES?$]I2=[_"T[=M/4X36]!U_XM>./A=XZTS2&CTF..&>[,D\:F#$VXC#$,PQ
MT('/%=5XD\!ZYJ'[27A3Q5!9>9H-CICV]Q=><@V2%;D ;"VX_P"L3D CGV->
MM0PI;PI%$BQQ(H540850.  .PIU9>T?0]:.6PWG)N3E&3VWC;RV=O^"?,FC_
M  <\1?#?Q!KD,'P_T3X@Z/>3&6TN+Z6W2: <X!,H)QR,@#DC(/-;7Q*^&/BC
MQ1\%;72+'POI&F:R=4%W)I>BF."%(]KJ"2Q"E\%<D'FOH&BG[5W3,8Y/0C3E
M24GRR35M-+]G:_WMF;X8L9M-\-Z39W"[)[>TABD4'.&5 ",_45Y3^T!\.?$'
MCKQ)X"NM%L1=V^F7DDEVYFCC\I6> @X9@3PC?=R>*]HHJ(R<7S(]'$86&)H?
M5YMVT]=&G^AXOI/PY\06W[3FM>+I;$)X?N+-8XKOSHSN801)C8&W#E6ZC'%2
M?#/X>Z_X?^-GCK7[^Q\C2=2W?9+CSHV\S,@/W0Q8<#N!7LE%5[1_H<T<NHQD
MIIO23G\WOTV_JYYW\?/ -_\ $CX<W>E:85.H)-'<0QNP59"IY4D]."?Q K@?
M%/A/Q[XV^!;>&KGPM'IVJ6/V."VA74(9#<)& '<MN"KT'RDU]!441FXJP\1E
M]/$3G-R:YH\KM;5:]T]5<\*^*WPR\2>(_@%X5\-:;IXNM9L$LEN+;SXTVF.W
M*/\ ,S!3ACC@U5^)GP;UNZ\5>&O%FCZ+IWB*:SL8[2^T34BACFVJ1D;_ )<X
M;'L54\\U[_1351HSJ950JW<F]5'MIR[-:??>Z/+_ (8Z#JD/B*YOKWX=>'O!
M%HMN4B-CY,MXSEER#)$ NS /&,YQ2?M'>"]9\>_#DZ7H5G]NOOMD4OD^:D?R
MC=DY<@=QWKU&BIYWS<QT/!0EAI8:3;4KW>B>OHDOP/FCQ5\//B=X[\+>'O N
MH:/86.E:;+'YNN)=HPE2-"B'RL[@0I.1CDCJ!5SQQ\(=?L_BM#KUCX3LO'&A
M+816<&GWUW'&+<HBH"1)P<%<]"#N/0\U]%T5?M6<4LGHR3YI2;NM7;3EV6UK
M:]4[GSG\-O@?XA&C_$_3=?TZUT)?$:Q-:"QD0P1L#,^U%4DJB,Z#! X&!ZUK
M_#.'XK>"=!TOPHWA/37MK.?R_P"VIM10Q^07+-^Z4[RV"<'CH,BO=:*3J-WN
MBZ654J')[*<DXIJ^FJ;YK/3OVLSYJN/V>=5\6?$3XASZS8K:Z5JD<CZ9?F9&
MQ/YB,C;58L!@,#D#@D5Z=\";/Q?HW@U=&\8:?]FN=.80VMQ]HCE\^''R_=8X
MV].<<8]Z]'HI2J.2LS3#Y91PM7VU-N^M]M;N^NG1['BWQ0^'7B>W^*.B?$#P
MA:P:K>VL/V>YTV>98O,7#+E68@<JY'7@@'GFH/#GP_\ %OC7XP6GCGQAIMOH
M%OI<'DV.EQW2W#D_/@LR<<%V;/<X&,5[A11[1VL#RVDZKJ<SLY<W+I;F77:_
MXV/%_@[\.?$'A3XJ_$+6=4L1;:=JMW)+9S>=&_FJT[N#M5B5X8=0*])^('AM
M_&'@G7-%CD$4M]:20QN3P'*G:3[9QGVK?HJ7)M\QT4<'3HT7AU=Q=]_/?\SP
M7X>>%?'6F_"#6_ NJ>&8K-8])OX+.]6_BD-U-*7*)M!^09D;YF/ITIOAWX6^
M)M/_ &9]4\*3Z<$U^?S2EGY\9SF4,!O#;>@SUKWRBK]H^WF<D<KI12BY-VBX
M=-G\NG3\;GS7KWP&\1:A\.?A_+;V%G+XB\.AA<:5?.CPW"&3?L8Y*$<<C."&
M// KLO /A[67\56%S=_"KPSX.L[=6:6\B-O-=%]I ,1B V<D9SGC/->Q44.H
MVK,*>5T:515(-JUNVO*K+I?IK9HY;XH^"S\1/ .L>'UG6VDO(U\N5@2JNCJZ
MYQVW*,^U>)>&_ 7B_1_#]IHLWPA\)7VH6X$0UV^>V:-U' :2,#S&;U.<GTKZ
M6HI1FXJQMB,OIXFJJS;4K6TMMOU3_"S/GG]KKP\FG^&?#OB;3I$L+[1[M8(?
M* 0A&&5"X_NF,8'H6J?PA\$GUC]F>/PZ6%IJFJ*-3#R'Y5F+*T8..QC5%/7&
M3Z8KUSQI\._#WQ"@M(?$&G_VA#:R&6)#-)& Q&"2$89X]<UT2JL:JJJ%51@*
M!@ >E5[1J*2Z')_9<*F+JUZB7+*/+;UT;\M$EH?.'AWP-XLL='L-&N/@_P"$
M9KVW5(7UR\:V>.15 &]XU&\L1R3GDYXKZ/CC6*-410B*,*JC  '84M%1*7,=
M^%P<<(FHR;VWMT]$OQNPHHHJ#O"BBB@ HHHH **** "IK+_D(6O^\W_H#5#4
MUE_R$+7_ 'F_] :G$.J]5^9T%%%%9GH!1110 4444 %%%% !1110 4444 %%
M%% !7A'[6_Q0\*>%?AOK7A'Q'K4'ARY\4Z5=65CJ.J:?//IRNR["LSQQN$^^
M/O8SVYKW>N+^-'BB^\$_"7QAX@TW^S?MVF:7<7<7]L;OLF4C+?O0I#%..0#D
M]!30'R#\$]%_:%U+PWH6E>#OVA/AKXET+3((;6..QCCNIA!& H1B(2VX(,9;
MGCGFOO*ORL\;:?\ %'6/#'A7XC>*O@5\(-,TO6KBT-OJUG'=:==1-<$?9Y)G
M@N@R!B4^9@V-P# #./OG]F/XU7WQT^&LFLZQH\>A>(-.U*YT;5;&&3S(H[J!
MMK^6W=3D'OC)&3C)J2ZDH]:KY7_:R_;'\8?LM:_I4D_PA_X2#P/J5[:Z9;^*
M/^$FAMMUW,KL8?LHADD&U8G.XX4XZCBOJBOA?_@KU_R0?X=?]E!T[_TEO:@H
M]:^/O[7T_P +_B?H_P ,/ W@#4?BE\2-1LSJ1T:RO8[*&UM02/,FN'5@A.TX
M!7'3)&Y<]%^S#^U!I?[26D^(HQH5_P"$?%GAB^_L[7O#>IL&FL9OFQ\P W*2
MC@-@'*-QQS\T?%KQ1!^R3_P40U#XP^.;+4$^&_B[PFNCCQ!9V4EQ#I]TC0?)
M+L!()^S#&!D^:, [6QR/P-^/&D_!7Q!\>OVG?&&@^(M.^'WCCQ#8Z9X?@33\
MWEXJB8_:-CL@6/;@[BV"=R@E@ P!]$_%3]MK5=#^+VN?#?X7?"C5_BYXB\.6
MR76OM9:A'8V]BK*&"*[(_FRX(^0 $G(&2& U]%_;R^'6J?LNZA\;YDO[/1=-
ME:RO-(=%-[%?!E46H7.TN2Z$'(&U@QQSCYM\&_&#1?V(?VL?CQK'Q+LM6M/"
M_P 1Y;37/#NN6FFRS0W>WSY/LRE0<2_Z25P<8,>6VAE)\KD_9A^(OC;_ ()W
M?$/58?#5_;:UKWCA_&EGX<>W8WKV(41D!,!B^&=PN,E4& =P% 'U[\/?V\]6
MOOB)X+\,?$WX0:U\*[?QP=OAC5;S48[R*]<XV1RJJ(8)&W(-AR074$ '-9_C
M#_@H;J,?B3QNOP]^#FN?$?P=X%GDM_$GBBUU"*UBMWCSYOD1,C&X"!6)P5X&
M?ND,?&_BI\<-)_;V^*G[/_ASX9:3K$UQX<\0P:_XGGN]/DAAT1(BA>&5F !<
M;7 P<$A0"2W'-?!OXS:=^Q#X#^.7P:^(6BZY%XQU36]1OO#<=IILLD>O)<6\
M<$7D.H(QF-6))X$F.6!6@#])/A'\4M!^-GPVT#QQX9F>?1-:MOM$!E4*Z8)5
MXW )PR.K*0">5/)KKZ^<?^">?PKU[X._LD^!_#WB:U>PUMDN+Z>RE4J]OY\\
MDJ1N#T8(RY!Q@DCM7T=0!EZ1_P A#6_^OQ?_ $GAK4K$T]+IM2UHPS0QK]K7
M(DB+'/D1=PPJ_P"5?_\ /S;?^ [?_'*IB+E%4_*O_P#GYMO_  ';_P".4>5?
M_P#/S;?^ [?_ !RD,N453\J__P"?FV_\!V_^.4>5?_\ /S;?^ [?_'* +E%4
M_*O_ /GYMO\ P';_ ..4>5?_ //S;?\ @.W_ ,<H N453\J__P"?FV_\!V_^
M.4>5?_\ /S;?^ [?_'* +E%4_*O_ /GYMO\ P';_ ..4>5?_ //S;?\ @.W_
M ,<H N453\J__P"?FV_\!V_^.4>5?_\ /S;?^ [?_'* +E%4_*O_ /GYMO\
MP';_ ..55U*_?1K.2[O]4T^QM8QEY[B,QHOU8R8% &M17CMU\>)M8NI+/P/I
M-SXUNE.TSVMHT%DC>C3N^!^6/>IO^$5^*OC&/=K'BJP\(6[];/0K;SI<>AE<
M_*?=:0'J.J:K9Z'I\]]?W$=K:0(9))9#@*H&2?R%>7^'?VI?A]X@^U[]4DTG
M[.<#^T8O+\T>J;2V?H<'VJ.W_9G\-2/YVL2W'B6[Q@W6L3SRN<]3Q*!G\*L^
M /V=_#OPZO+RZL$BO9[C@/J,'G>4N<[4^88'N<GCK3 L3?M+?#2 X;Q3"?\
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MHJ9_Y^(GA_\ 0W%=-I_B[3M6Q]A\3:)>YZ?9W63/Y2T =+15,1WYY%U;$?\
M7NW_ ,<H\J__ .?FV_\  =O_ (Y0!<HJGY5__P _-M_X#M_\<H\J_P#^?FV_
M\!V_^.4 7**I^5?_ //S;?\ @.W_ ,<H\J__ .?FV_\  =O_ (Y0!<HJGY5_
M_P _-M_X#M_\<H\J_P#^?FV_\!V_^.4 7**I^5?_ //S;?\ @.W_ ,<H\J__
M .?FV_\  =O_ (Y0!<HJGY5__P _-M_X#M_\<H\J_P#^?FV_\!V_^.4 7**I
M^5?_ //S;?\ @.W_ ,<H\J__ .?FV_\  =O_ (Y0!<HJGY5__P _-M_X#M_\
M<H\J_P#^?FV_\!V_^.4 7**I^5?_ //S;?\ @.W_ ,<H\J__ .?FV_\  =O_
M (Y0!<HJGY5__P _-M_X#M_\<H\J_P#^?FV_\!V_^.4 7**I^5?_ //S;?\
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MZI'KO]CP_P!Z3\Q_A1_8\/\ >D_,?X5Y/]A^/M]_KM4\!Z8#_P ^EO=RD?\
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MM];QW46_ ;8ZAER.QP15[^QX?[TGYC_"D@L[NU@CAAEM(H8U")'':E550,
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MX#M_\<H#DCV&_P!CP_WI/S'^%']CP_WI/S'^%.\J_P#^?FV_\!V_^.4>5?\
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M->U$/^)CB&X4O_#47PT7@^(74_W3I]S_ /&Z/^&HOAG_ -#$W_@ON?\ XW0
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M-*UN5?<4_AAXD^#/@O1)8_"6KZ%HUI+*6D6>Z\J9VZ9;SR)"/3/'I77M\8O
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MF_U"ULAUS<3K'_,UYG>?M1?#^Q\4R:++J<A$?#:E''YEINQG:'4DGTR%Q[T
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MGKB?@GX"\40^"1) GQ$CLI[AY$;PMJR6=L_"J6",A+-E2"PX. .U??5%=?\
MK-F?U?ZJII1O?2,5K\D8?V3A/:^V<6Y6MNW^I\B?\(C>)_Q^6_QPD/JNKK+_
M " H_L.PB_ULGQ]M/]KSF(_.OKNBN3^W,Q_Y^O[E_D;_ -G87^3\SY$^RZ!!
MR_C/XX6#?]-KB3'XC8:/[5T&UZ?&'XEV?_7[#))C_P A5]=T4?VWC^LT_6,7
M^:#^S\-TC^+_ ,SY&C\9:5&VV#]H?Q! W]V[T9G_ )Q5;B\:7G_+K^TJJ>GV
MGPQ"_P#Z$!7U9)&DBX=5<>C#-4Y=#TV?_6:?:R?[T*G^E']M8OJH/UI4G^<
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MJ-^U!\-=VV/Q"T[_ -V*PN6/_HNO1X=%T^W_ -586T?^Y"H_I5M46,850H]
M,5(SRO\ X:4\)2?\>MMKE[Z?9]*F.?S H_X:#M)?^/7P1XVO?3R-%)'ZL*]6
MHH \I_X7;J\__'K\,O%S^GVBU2'^;&C_ (6CX]N/^//X3WS^GVK5K>#^8->K
M44 >4_\ "7?%FZ_U7P_TNQ_Z^M963'_? H^U?&JZ_P!78^"[$?\ 3Q-=2$?]
M\UZM10!\J>!;'X[ZA\1-3@O-3O-)A;S/.N[Z#SK%>?E\A&^4Y.,;.W6O5?\
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MJP"@X(R.O<9XIG[-OPZ\5_#O0[FV\3/Y0N+T/;67GB7R0(I-S94E1NRO /\
M#51W(GM]WYGN%%%%26%%%% !1110 4444 %%%% !1110 4444 %>;?M*1W4W
M[/WQ$ALAJ!O)="O(HAI49DNBS1,H$:@@LV3T!!/K7I-<I\5;*WU+X;^)+6Z\
M3R>"[::QE23Q##<BV?3E*\SB4LH0KUW$C%,#\Q/AGHWP3L-%\,6^O?LL?$FX
M\30Q6\=[J49U 0R7("AY@//4!2P+8V@ '&*_6:OS ^+&FV'PUTO1-9\-_MB^
M)O'5S_;-G;7&AV'B_P"TW$T$DH61HUBN&.5!W?,,$ C()%?I_52)B%%%%04%
M%%% !1110 4444 %%%% &7I'_(0UO_K\7_TGAK4K+TC_ )"&M_\ 7XO_ *3P
MUJ4V(****0PHHHH ^4?CU\"?B?XW^.6G>(/#>H^3I2" 6UY]L"?V:5 WGRR<
MG+ M\H.<X->*_M%?!'XQ:]\6(=-E_MSQQ:21Q166L+:[+<*X&\/L^2$!RX.X
MC@ ]#7MWB']M*?PK\<;WPQJND6MGX5LKUK*XO&$C7*8.#-QD%<\[0I)'>O38
M_P!K3X32_=\80C_>M+A?YQU^MQQ'$.7T\-?!J<8T[1<8<VCVO*-VGW5TG>[5
M]3Y/#U,L]M6J1K6DY.ZE*VODG;3SU. _9Z_8OTKX<Z?J$OCBVTCQ5JEQ*IA7
MRFE@MT4'IO W%B><KQM%?0VC^$="\/@#2]%T_30.GV.UCBQ_WR!7GTG[5'PJ
MCA>4^,;0JHR0L,Q8_0;,FO.-1_:NM_'5])8^&]?T?P;I:G:^M:Y(KW#=1F*
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MO?%C3XQZKX<A/\VK/NO"OQ+M<_:_CWI]ECKN\.V0_P#0GH_LW#]<;3^ZK_\
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M882M.5.G43:_KT?R.PHJ."XBNHQ)#(DL9Z-&P8'\14E>+MHST HHHI %%%%
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M .NFKL?_ &6O6J* /&Y/V5?!\W^MO=>F_P"NFHD_TJ+_ (9'^'[-F2+4IO\
MKI>L?Z5[310!X_%^R?\ #:/[VCW$O^]?3?T859_X99^&.S'_  C9S_>^WW.?
M_1E>KT4 >,7/[(_PYGSLL+VW_P"N=ZY_]"S6=-^QGX#E^[=:U#_N74?]8S7O
M%% '@</['?AFQ.;+7=9@/K)]G?\ ]I"M"#]G&\T__CQ\<7UOCIOT^V?_ -E%
M>V44 >20?"7QS9\6WQ2N(5'3_B26Q_K4O_"MOB0OW?BW,/\ >T"V/]:]6HH
M\I_X5I\17_UGQ:N#_N:%;+_6O/\ XF?LN^+?'=[87<_CF/69H5\IFU*U\CRX
M\Y^01Y!.2>"!VYKZ6HH \CL?@/J<-G;VT_Q+\6F.&-8PMG=+   , #@X'XFI
MO^&>=-F_X^_%WC'4/7[3K+'/Y**]6HH \I_X9E\"S?\ 'W;:CJ'K]IU.<Y_)
MQ5^Q_9U^'&G8\KPK:/C_ )[O)-_Z&QKT>B@#G+#X;^$M+Q]C\,:/;$?Q16$2
MG\]M;UO;0VL82&)(4_NQJ%'Y"I:* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ JM=?Z^S_ZZG_T!ZLU6NO]?9_]=3_Z ]5'<B>W
MW?F6:***DL**** "BBB@ HHHH **** "BBB@ HHHH *\(_:BU3XI-IMMH/@7
MX5Z7\3- U:UFAUF'4M4ALU0':%CP\J%@P+9QTQ[U[O7B_P"T!_PO;[=HW_"G
MO^$3^R^7+_:/_"2>9NWY7R_+V=L;LY]J:W$SXJ^"NG^+/$^LKXA\&_LD>!R=
M#UE]/FU!=8A#6=W X$FU99QN9"00P!&0"#7Z>U\(_"'X3?M<_"&#4K#2S\.S
MI^K:U<:U>^?+/(XEG<&4(<# XX!SCUK[NIR$@HHHJ2CC_BQX9\6>+O!%YIG@
MGQI_P@'B*5XV@U[^RHM2\A5<%U\B4A&W*"N2>,Y'2OGO_@FO\:O'?QR^#/BW
M5OB%X@_X276M+\6W>D0WOV*"T_<1V]JRKLA1%^])(<D$_-C. *^M*_-[X;K\
M8/\ @G_^Q+\3?$%UX.TV/Q0?'3ZC;V6JWD=Q"UC<BS@6;%O-EF+@J(]ZMDY(
MP,$ ]'\7?&#XT_M!?M/>//A=\(?&.F?#70O -K"=1UN\TB/4+B^O)5!$024%
M5CSN&0 1L)RVX >:_P##Q;XBI\ WT@Z7I+?'(>-CX!$PC8Z>9^GVO;G&<_)M
MZ;OFQM^2N\U#X4_'7X%?M">+/BS\,? FE^/+'XB:;:OK/ANZUF.QGTO4$C7+
M"24A7C#%^ 23O(PNT$\'_P .Z?B*_P  WU<ZII*_'(^-CX^$(D8:>)^OV3=C
M&<_/NZ;OESM^>@#TGPG\7?C5^SY^T]X ^&'Q=\9:7\2]!\?6T_\ 9^LV>DQZ
M?<6%W$N3&4B 5HR2JY(R=X.5VD'F=.^-'[0W[4/B3XLZ_P#"?QIHO@+P=X#U
M&?2M-TR\T>*[EUR> %G\^20,80P"X*8P' QD%JZ;PG\(OC5^T'^T]X ^)_Q=
M\&Z7\--!\ VT_P#9^C6>K1ZA<7]W*N#(7B)58P0K8)R-@&&W$CF=.^"_[0W[
M+WB3XLZ!\)_!>B^/?!WCS49]5TW4[S6(K270YYP5?SXY"IF"@K@)G(0'.25H
M ^E?V-_V@I?VFOV??#GCJ\LXM/U:X\VUU"WMP?*6XB<HQ3))VL ' R<;L9.,
MU[97B?[&_P"S]+^S+^S[X<\"WEY%J&K6_FW6H7%N28FN)7+L$R =J@A <#.W
M.!G%>V4 9>D?\A#6_P#K\7_TGAK4K$T^RCN-2UIG:8$7:C]W,Z#_ %$78$5?
M_LN'^_<_^!4O_P 55,1<HJG_ &7#_?N?_ J7_P"*H_LN'^_<_P#@5+_\52&7
M**I_V7#_ '[G_P "I?\ XJC^RX?[]S_X%2__ !5 'F^N_%?X2^'?B/\ 8]4U
M+1;3Q?Q UU+:?O$R,;'N=FU..,,XQWKY@^/G[7GB#2_B\^F^"+K2+WPW:B.-
M66RCN4O'907)<@G 8E1L(^[WS6K\9/A#\-K;X]'^V?%&J6RZA<I=7UC%9"58
MVD.XAK@R J&SGA&(!ZUQ_P ?/AHG@_\ ::\.Z?X6UW2?"MK<FU-G'#=& Z>>
M%8R8Y!8@L"3EMU?J&2T<FJ3I^_*K4]F^:,E[L6K:)VOWM:_??0\+FQKJ5%.$
M8POHUN_-_KM^IZEX1G@O+XZQ;?#/Q-\2_$,O(U'6K./3M/0GM LF45?<KD>U
M=O)X'^*'B[[WA?X?^"[9NOG6@U"Z7\E\LU[S_9</]^Y_\"I?_BJ/[+A_OW/_
M (%2_P#Q5?)K.(4?]VH)><G*;_%\O_DIN\#*I_&J-^22BOP5_P 3P"/]C;3M
M;F6?Q7XIO=5D!R8M)L;;3(2?0K&AX_$5W/AW]F'X8>&4 @\(6-V_>34@UV6]
M\2%A^0%>C?V7#_?N?_ J7_XJC^RX?[]S_P"!4O\ \565;/\ ,\1'DEB)*/:/
MNK[HV7X%T\MP=-\RI)ON]7][NSD)/@/\.)?O>!O#X_W=.B7^2U5D_9U^&<OW
MO!&CC_=M@O\ *NY_LN'^_<_^!4O_ ,51_9</]^Y_\"I?_BJXEF>.CM7G_P"!
M/_,Z'A,.]Z<?N7^1YY)^S'\+9?O>"]/'^[O7^355D_92^%$OWO!UL/\ =N)U
M_E)7IO\ 9</]^Y_\"I?_ (JC^RX?[]S_ .!4O_Q5;+.<RCMBJG_@<O\ ,S>
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MKAJ?_@+_ $D'U.72K+[U_D?.4/@'QI9_\T6\ SX]+I3_ .A*:N1Z1XVM1@?
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M:R6-85SG^"7YF]^![5ULD7P^*XG_ &?_ !\H_P"F.F2M_*<5]3?V7#_?N?\
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M6DWZ=J-I?IUW6LZR#_QTFK]>7*,H.TE9G8FI*Z"BBBI&%%%% !1110 4444
M5[_3[75+.6TO;:&\M91MD@N(PZ./0J>#18:?:Z59Q6EE;0V=K$-L<%O&$1!Z
M!1P*I>)O%6D^#='FU76KZ/3["(@--)D\GH  "23Z 9H\,^*M)\9:/#JNBWT>
MH6$I(6:/(Y!P000"#[$9H U:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I&4,I5AD'@@TM% '+:Q\+/!GB%BVI^%-%OG/\
MRTGL(F?_ +ZVYKD=0_97^%6IY,O@ZTC)[VTTT&/^^'%>KT5Z5',\=A]*-><?
M237Y,Y*F$P]7^)3B_5(^9O#O["OAO0?%%UJ?_"2ZQ]D.[[);V;BWF@SZS DO
MP2. OOFNS_X9CLH?^/7XA_$&R_Z]]?8?S0U[-17I5N(\UQ$E*K7;>VR_R.2G
ME6"I*T*:7WGC/_#.=ZOW?BQ\0A_O:NI_]DH_X9XU0?=^+7CP?[VHJ?\ V2O9
MJ*P_MO'_ ,Z_\!C_ )&O]GX;^7\7_F>,_P##.=Z_^L^+'Q"/_7/5U7_V2C_A
MFE)/]=\3_B1..ZOX@X_2.O9J*/[<S#I4_P#)8_Y!_9^&_E_%_P"9XS_PRWH$
MG_'SXI\9WGKY^NR'/Y 4?\,E_#^;_C[CUB_'?[3J]P<_DPKV:BC^W<SZ8B2]
M';\@_LW!]:2?JKGC]O\ LC_":W.1X2CD;N9;ZY?/YR&M6U_9K^&%IC9X*TMO
M^NL9D_\ 0B:]+HK*6<YG4^/$U'_V_+_,N. PD?AHQ7_;J_R.*MO@E\/;3_5>
M!O#H/JVEP,?S*UI6_P -_"5K_J?"VBP_]<]/A7^2UT=%<<L;BI_%5D_FS=8>
MC':"^Y&;;^&M(M?]3I5E#_USMT7^0JX]G;R6\ENT$;02*4>)D!5E(P01T(Q4
MU%<SJ3D[MFJC%;(H:+H.F>&[+['I.G6FEVFXO]GLH%ACW'J=J@#-7Z**4I2F
MW*3NV-)15DM HHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M37R&)S;"<D<//#3BX=?:^\[_ ,S]GKY'9../B[.M:77W7^"YM/O9\5:/\;/
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M_9M#AD_5D6O>**/[6G'^'0IQ_P"W(R_]+Y@^HQ?QU)O_ +>:_P#2;'S;JWP
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M3@B_G0!ZM17E/_">?%.X_P!7\+K>V]#/X@@;_P!!6C_A(/C!<?ZOPGX>M/\
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M10 4444 %%%% !7&?&CQ=J?@'X1>,_$NBV8O]6TG2+J]M+=E+!Y8XF9<@<D
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M+^ZVFG=GG0Q.-^MSCS3Y;*W[O_@K^O0WO^&J/"X^]H7BQ3[Z)+1_PU7X3_Z
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M.OA_<7TT.CC6GNN/^)VL=TL*YSMC4I@?4Y/'6NMD^#/P_D^_X&\-M_W"+?\
M^(KLQG]@^V?U7VO)I;X3##_VE[->VY.;YEF'XJ^"KC_5>,-!E_W-3@/_ +-6
MC;^,M N\>1KFFS?]<[N-OY&N:F^ ?PWG^]X&T$?[EA&O\A6=<?LS_"ZZSO\
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MM8=]\/?"VI9^U^&M(NL]?.L(G_FM=!10!P%[\ _AYJ&?-\):<N?^>*&+_P!
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M--AS^>VK\/@OP];?ZG0=,B_W+.,?R6MJB@"K#I=G:_ZFT@B_W(E7^0JU110
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MG9Z/8Z\*I.;Y(IZ=3W6BO,_[6^*7B#_CTT/1?#$+?QZE=-=2@>H$?&?8T?\
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M?Z+ L>?J0.:U**RJ8BM55IR;1$JDY?$PHHHKG,PHHHH **** "BBB@ HHHH
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M]ON_,LT445)84444 %%%% !1110 4444 %%%% !1110 5\F?MU_$7XM^!_\
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MPUJ53$4_[8L/^?ZV_P"_J_XT?VQ8?\_UM_W]7_&KE%(93_MBP_Y_K;_OZO\
MC1_;%A_S_6W_ ']7_&KE% %/^V+#_G^MO^_J_P"->0_$#XX>%_#/Q#LM.N]
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MC^V+#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH
MI_VQ8?\ /];?]_5_QH_MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+
M#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ
M8?\ /];?]_5_QH_MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^
MMO\ OZO^-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\
M/];?]_5_QH_MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\
MOZO^-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?
M]_5_QH_MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^
M-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_
MQH_MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7**
M *?]L6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_M
MBP_Y_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]
ML6'_ #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y
M_K;_ +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_
M #_6W_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y_K;_
M +^K_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_ #_6
MW_?U?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y_K;_ +^K
M_C5RB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U
M?\:/[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y_K;_ +^K_C5R
MB@"G_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U?\:/
M[8L/^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y_K;_ +^K_C5RB@"G
M_;%A_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U?\:/[8L/
M^?ZV_P"_J_XU<HH I_VQ8?\ /];?]_5_QH_MBP_Y_K;_ +^K_C5RB@"G_;%A
M_P _UM_W]7_&C^V+#_G^MO\ OZO^-7** *?]L6'_ #_6W_?U?\:/[8L/^?ZV
M_P"_J_XU<HH I_VQ8?\ /];?]_5_QJ-]0MKJZM$AN89F$A)6-PQQL;GBM"JU
MU_K[/_KJ?_0'JH[F<]ON_,LT445!H%%%% !1110 4444 %%%% !1110 4444
M %>8_M/,1^SI\2@MS<6C-X?O4$UI&7E4M"P&U003U['.#7IU>7_%KP#\0/%V
MK6=QX.\?_P#"'V<6FWMM-;?8EG\VYD3%O/D]/*;YMO\ %30C\]O@_P"+OV3[
M'PGX2M-?^#WBA_%L5O;Q7MT;6>57NP%#R;Q.H*E\L/E  /08Q7ZLU\B6?[-_
M[2T-Y!)/^TIY\"2*TD7_  C\0WJ#RN<\9%?7=.0D%%%%24%%%% !1110 444
M4 %%%% &7I'_ "$-;_Z_%_\ 2>&M2LO2/^0AK?\ U^+_ .D\-:E-B"BBBD,*
M*** .:^)&BZIXB\#:QIVC7/V74[B'9#)O*=P2NX=,@%<^]?&T?["OC3Q9XJL
MM8U35;'1[3SD^T022&:X1$QRFP%#GG@L,5]W45[>7YQBLLC*.&:7-UM=E2ES
M4_9-:7N5-,TFQT6U^S:?96]A;Y+>3:Q+&F3U.% &:MT45XK;;NQ;[A1112$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !14%Q?VUI+#'/<10R3MLB21PID;T4'J?
MI4].S6HKA1112&%%%% !1110 4444 %%%% !1110 4444 %%)2&1!U91^- #
MJ*B-S"O65!_P(4TWUN.MQ$/^!BJY7V%=$]%5CJ5H.MU"/^V@_P :0ZK9+UO+
M<?\ ;5?\:?)+L+F7<M453_MG3QUOK8?]ME_QIIUS31UU"U'_ &V7_&G[.?9A
MS1[EZBL\^(-+'74K,?\ ;=/\::?$FDCKJED/^WA/\:?LJG\K^X7/'N:5%9A\
M4:,.NK6(_P"WE/\ &F_\)7H@ZZQI_P#X%)_C3]C4_E?W![2'<U:*R?\ A+M"
M'76M/'_;U'_C33XRT ==<TT?]O<?^-/V%7^1_<Q>TA_,C8HK%_X3;P\.NO:8
M/^WR/_XJF_\ "<^&QU\0:6/^WV/_ .*I_5ZW\C^YA[6'\R-RBL(^//#(Z^(M
M)'_;]%_\533\0?"PZ^)=('_;_%_\53^K5_Y']S%[:G_,OO-^BN>/Q%\*#KXG
MT8?]Q"+_ .*II^)/A$=?%.BC_N(P_P#Q5/ZKB/\ GV_N8O;4OYE]YT=%<R?B
M=X.7KXLT,?\ <2A_^*II^*?@M>OB_01_W$X/_BJ?U3$_\^Y?<Q>WI?SK[T=1
M17*GXK^"%Z^,?#X_[BD'_P 73#\7/ J]?&GAX?\ <5@_^+I_4L5_SZE]S#ZQ
M1_G7WHZVBN//QB\ KU\<>&Q_W%K?_P"+KC/'O[67PY\!7%C"^L#7GNCR=">*
M[6!<XW2,' 'T!+<=*Z:&58_$S5.E0DV_[K,JF-PU*//.HDO5'L=%5=+U2UUK
M3+/4;&9;BRNX4N()ESAXW4,K#/8@@U:KRY1<6TU9HZTTU=!1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56NO]?9_]
M=3_Z ]6:K77^OL_^NI_] >JCN1/;[OS+-%%%26%%%% !1110 4444 %%%% !
M1110 4444 %>%?M=>//BOX ^&]S??"SPLOB&\:VN/M5['/&+C3,*#'/'!(K"
MX.=W[L G('!SQ[K7GG[1&O:CX7^ _P 0-6TG4DT?5+/0[R:UOY"0()1$VU\@
M'!!Q@XX.*:W$?-<'Q+_:\\?>"_#FG67PMMO"EU=BQ>X\63:W8.YBRAED>U/*
M;UW955#+N( !&*^UZ_'M-:^"OP_\ ?#WQ]X"^)FMP_&FXO["759KZYF8;F(^
MV_:EVX\H9;H6+  #?DFOU7^&/Q8\)_&3PVVO^#-9BUW2%G:V-U#&Z+YBA2RX
M=0> R]N]5)"3.MHHHJ"@HHHH **** "BBB@ HHHH R](_P"0AK?_ %^+_P"D
M\-:E9>D?\A#6_P#K\7_TGAK4IL04444AA1110 5\]?%K]L?1/A/\5;?P9=:%
M=WP7R?MM_',JB#S &&U"#YF%8$\KUQS7T+7R)^T!\7/A7X9_:!TJQ\2?#_\
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MXZ^+G[*?Q2^('BS2]3N_&5AX@D5%A:ZDA^P_9%#$_+&F01SG(YR3QWKUV/\
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MOO#^S<'_ ,^E]QXS_P ,E^ C]X:T_P#O:Q<?_%4?\,D_#L_>M=5;_>U>X_\
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M+=EI);!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#J6M!+6:<?:U.Z,H!_J(N.6%7_MTW_0/N?\ OJ+_ .+JOI'_ "$-;_Z_%_\
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M +.\_C)?#$?Q2TEM5:7R5?RI_LA;.,?:O+\C'OOQ0![W]NF_Z!]S_P!]1?\
MQ='VZ;_H'W/_ 'U%_P#%UYA\</VKOA7^SA<:/!\1/%/_  CTNKI))8@:?=77
MG+&5#G,$3@8WKUQG/%>=Z/\ \%,?V;->U:RTRP^(_GWU[.EM!%_86I+OD=@J
MKDVP R2.2<4 ?2?VZ;_H'W/_ 'U%_P#%T?;IO^@?<_\ ?47_ ,76?XW\;:'\
M-_".K>*/$NHQZ3H.E6[75Y>3!BL4:CDX4%F/8*H))( !) JM\-_B-X=^+G@G
M2O%WA/4/[5\/:I&TMG>>1)#YJJ[(3LD57'S*PY Z4 ;/VZ;_ *!]S_WU%_\
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MQ:\;_P#"(>%/B'INJ>(68K%9F*: 7# $D0O(BI*< G",W KT!?BYX2;XJ/\
M#<ZPD?C5=,&L#2I(9$9[0N8_-1RH1_F!!"L2,'(% '2?;IO^@?<_]]1?_%T?
M;IO^@?<_]]1?_%U<HH I_;IO^@?<_P#?47_Q='VZ;_H'W/\ WU%_\75RB@"G
M]NF_Z!]S_P!]1?\ Q='VZ;_H'W/_ 'U%_P#%U<HH I_;IO\ H'W/_?47_P 7
M1]NF_P"@?<_]]1?_ !=7** *?VZ;_H'W/_?47_Q='VZ;_H'W/_?47_Q=7**
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M;RSRW=U)]R-4B1B!ZL0%&1DC(KL: *?VZ;_H'W/_ 'U%_P#%T?;IO^@?<_\
M?47_ ,75RB@"G]NF_P"@?<_]]1?_ !='VZ;_ *!]S_WU%_\ %U<KS_X6_'SP
M#\:M1\3V/@GQ#'K\_AJ\^P:IY-O,B0S9<!5=T59!F-_FC++QUY% ':?;IO\
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M?A)I\?VB[UCQ,VJ74*8_<VEN$#R$=<"-IV&/^>;>U 'WE1110 4444 %%%%
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M33O$-B]EJMA:ZG9N06M[R%98R1T)5@15VANX+0****0PHHHH **** "BBB@
MHHHH R](_P"0AK?_ %^+_P"D\-:E9>D?\A#6_P#K\7_TGAK4IL04444AA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45RGQ2\"_\
M"RO FI^&_MW]G?;?*_TKRO-V;)4D^[N7.=F.O>OG_P#X87_ZG;_RD_\ V^@#
MZKHKY4_X87_ZG;_RD_\ V^C_ (87_P"IV_\ *3_]OH ^JZ*^5/\ AA?_ *G;
M_P I/_V^OH_P/X9_X0SPAI&A?:?MG]GVR6_VCR]GF;1C.W)Q],F@#<K\]/%'
M[3'[0_[4GQI\8^#/V;VT7PKX3\(W)L;[Q=K<*2">X#,I WQR@*2C[56)CM7<
MQ&X"OT+K\Q_^"?GQF\)_LM_$+XR?![XHZO8^"M=C\1RZA:W^L3+;6MU&0$QY
MKD*N56.1=Q&Y9>.AH [3X8_M7?'#]G[]H3PW\)/VE%TG6[7Q6RP:+XNT>)(X
MVF9]B@[$C5D+E4(,:,A96.5-8_Q\^,7[2GB[]NS7/@S\'_B)I?A6SATJ#4((
M=8TZU>! +>-Y?WAM)I"2SD@'(^E<C^V+\3O#O[7W[8'[/O@7X5ZFOBN;PUJD
ME[J>K:2_F6L,<DUK)(RRCAO+CM6<LN5^=0"6R*R?CK\)?$?QJ_X*J>(_#7A;
MXA:I\,=6?0+>X&O:.)#.J):0[H_W<T38;//S]NAH ]5^%7[0'[1WP-_:O\&_
M"+X\ZQH/C73_ !E [6.K:/!%&8' ?:5,<,)(W)M97C_C!#<$'E?VOO%/[:'[
M.&A^)?B#+\7O#/\ P@XU=H=/TZPTVVFO(8)IF$",)-/ )5-H8F0GCJW6O<OV
M=_\ @G;;?"7XN6_Q.\=?$K7?BWXULH7AL+[6D=%MMP92^'FE=V"NX7+X&YCC
M."*'_!77_DS/5O\ L,6'_HPT >?-J?[8WPK^"7C?XF>._BSX9UG18?"<E_I<
M&EZ?;_:;>[<PM#(RFPC4A4,@(+,,L.#U':Z]^W!KGPE_81^''Q&U>)?%_P 2
M/%MO#9V%N\2Q)=7DF\F1XXE4;%"\J@&257C=D=U^U)_RCK\5_P#8F0?^BHJ^
M,/C9I>HZ+^PY^R'\2H;&34-'\%7]M=ZE'"NXI&\B,K'T4M!LR>,R*.] 'J^L
M7'_!0OP7H*>/I]2\+>)(%"7$O@.QL89;F-6QF/:D"NQ7/(2X9NN,U]Z?##Q%
MKGB[X>Z!K'B7P]+X4\07EHDM_HLTBR-:38^=-RD@C/(/7!&0#D#QOQ+_ ,%"
MO@#X;^'@\7?\+&TC5;=X5EBTG3;A)M3D) PGV7<'1N>=X4#N17L_PU^(6C_%
MCP'HGB_P^UQ)HNL6ZW5H]U;O!(T9S@E' (!QD'H001D$&@#YC_:8_:)^(%]^
MTEX*_9[^$>I6/AOQ)K-FVJ:OXJOK-;P:;;!9&"QPO\K2;8F;# @[XQD9)&OX
M!U[]HCX?_#?XRP?%.XT_5I/#^FWMYX7\;V<5K#)?A()&5I;2,E4(*HP#*/X@
M=P )^;OVF/A;I/C#_@JAX.T?QS=W6F>#/%OAY;=OL]Y)9IJ>R.8?8VF0J0'E
MCC!4-DAE (+BJOP/N+CX<?$[]KWX.^$KVYOOA)H7A74+RP@FO&NH].NC;J##
M&[$D [YU(SG]P,Y()H K?LYZ_P#MU?M.?#.W\<^%OC3X3L-)GN9K58=7TRUC
MG#1MAB5CTUUQGI\U?8?PT\4_$?\ 9O\ V?\ Q5XJ_:7\9Z9XIO\ 2[U[S^TO
M#MH"D=BR01QQ;$MX,OYQD_@/#C+8'R_F;^R+^RE^S+\7/@S:>(?BC\8O^$+\
M627EQ#)I7_"3Z98;8D;$;^5<1,XR.<DX/:OU!_92^%GPA\%_!1_ _P .?%%C
M\2O!UK?R23SSZA9ZJ!.S++LD:!1'E3L8 KD<'T- 'SK^RI^VU\1?VB/VU]9\
M/ZA:77A;X=2>'9=2TKPW?V4*7&P-!Y-S))L\S=(KLVT/LPPQNP&-/]OO_@HI
MKWPY_M_P7\'[;4(?$?A^ZAC\0>*I=/26TTS<1L@02HR.\AXRRX !V[CDIK>#
M_P#E,?XY_P"Q*C_]%V=;_P#P5FT>PTK]C?Q ]E96]F]WKMC<7#6\2H9I3)@N
M^!\S$ <GG@4 ?7_@'4[G6O OAS4+V3SKR[TVVN)I-H7>[Q*S'   R2> ,5\_
M_MT_M ^)/A)X=\$^$/A_=QV/Q'\?ZY!HVD7<D"3_ &./S$$UQY3AE?&^-,$$
M#S">U>[?"W_DF7A'_L#V?_HE*^)_VPEN/^'CG[+C76W^RB91!YG3S_,;=UXS
MS#COG'M0!]3?$#]ISX9?!'Q1H?@[QYXW@T?Q#?V#7D#ZA;R(D\48??*\J1^3
M&28WX++SP!R!3/@Q^UI\)/VA-6O]+^'_ (UM-?U*Q0R3V?D36TP0$ NJ3(A=
M 64;E!'(YYKY"_;(TBQUW_@IM^S?9:C:0WUF]G&SV]Q&'1BMQ<,N5/!PR@_A
M5F^B33_^"SVF?98TM_M?A=FN/*4+YQ^QR\OC[Q^1.3_='I0![;>?\%//V9]/
MO)[6X^)7ESP2-%(O]@ZF<,IP1D6V.HK?7XI1?MB?#62\_9Z^,G_")3:;JZPW
MVO?\(N;W<HA8M;>1>K'C)EB?S%SC9CN:^/-8^&O[3$FKWS6_[%OP$NX&GD,=
MQ-HVF%Y%W'#,3J .2.3QWKZN_9&C\;?#GX0^+]1^*'PI\%_!^XLKJ6^&F^";
M6WM[:XMH[=&:>00SRJ9,JZY+ X4<=Z /G#4/'7[2^G_MA>'/@IX;^/P\?W-O
M''J?BBY?P;IMA;Z7:@J[(S*LC,[1LO3;@S1#/)*_0VE?'SQ/X)_;PU?X0^+]
M3%_X8\5Z+%K/@]VM8XFM)(U<7%J7109 WE32 N2PVJ/XJ\O_ ."4'A^Z\6>#
M_B1\;/$"B7Q/X]\1SLTQ);;;Q'=M4G[J^;+*N!VC3T $'[9V\_\ !03]E/\
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M*'"AP4W?>(/((KR;]AG4/^%]_P#!0;XV_&KPY!=KX#-DVEVU],AC6ZE9K94
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MOA!J'QG\+S>)?%EL]U8W5MI=HUG&J"4D2NVG!P?W+?=1NH_#T+XG?%/]I_\
M9O7X):'X_P#B1H^M:_XK\=M9WMUHFG6SPS:6?L*) =]G%L8.]R=R*&Q(/F.
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MY+.T)*KMR.=V[Y5&"?N2OS/_ &EOC!X\_;U^+6K?L]?!=OL'@;29Q'XN\5R
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M'IG@S3]4,=M\.IM&BE2:Q6X6!I'O#B7>&;! (!V,1CA3[A\??VMM<^'?AOX
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M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445X7^UC^T!XR_9S\&Q>*O#WPQ_X6#H%I!<7.MW?]OPZ9_9<:>7Y;;'C=IM^
M]^$&5\OG[PH ]THKBO@K\2/^%P?"/PAXW_L[^R?^$@TR#4OL/G^=Y'F(&V>9
MM7=C.,[1GT%=K0!EZ1_R$-;_ .OQ?_2>&M2LO2/^0AK?_7XO_I/#6I38@HHH
MI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KRKXR_LL_"C]H*2&;Q_X)T[7[N%/+COB
M9+>Z5 <A//A9)-H.?EW8Y/')KU6B@#S'X,_LS_##]GN&Y3X?>#K#PY)=*(Y[
MJ,O-<RH#D*TTK-(5SSM+8S5J']GWP#;_ !HN/BS'H.WX@3VHLI-7^V7!W0A%
M3;Y/F>4/E51D)GCK7HE% !7%?%[X-^#_ (\>#)?"?CG1_P"W- EFCN'L_M,U
MOET.4.^)T;@]LXKM:* .6\4_#'PSXT^'5WX$UG3?MGA6ZLET^;3_ #Y8]T"@
M )YBL''"CD-GCK3?#/PK\)^$?AS:> =-T2W'@^ULS81Z3=%KJ(VYR#&_FEBX
M.3G<3G-=710!\X6/_!.G]G'3?$G]N0_"S3#?;_,\N:YN9;8'(/%L\IA XZ;,
M?G7T7;V\5K!'!!&D,,:A$CC4*JJ!@  = !VJ2B@#S_XR? /X??M Z#;Z/\0?
M"]GXDL;9S);^>7CE@8C#&.6-ED3( SM89P,]!5+X>_LU?#/X4_#_ %?P5X3\
M)6>B>'-7AD@U"W@DE,MVCH4823LQE8[68 E\C/!%>FT4 ?*O_#KC]F+_ *)G
M_P"5_5/_ ))KV7X)?L]^ /V<_#]]HGP\T#_A'M+OKK[;<0?;+BYWS;%3=NFD
M=A\J*, @<=*]%HH X"S^ W@73_C)??%6#0_+\>WUD-.N-6^USG?;@( GE%_*
M'$:<A >.O)JU\7O@WX/^/'@R7PGXYT?^W- EFCN'L_M,UOET.4.^)T;@]LXK
MM:* *NEZ9;:+I=GI]E'Y-G:0I;PQ[BVQ$4*HR22< #DG-?-W[<GP#\2?%C0/
M OB_P%91ZA\0_A_K]OK>DV<DZ0?:X_,0SV_F.55=WEQ-EB ?*QWKZ;HH \W\
M2? 'P)\0/B1X5^)/B#PVTWC;P]"JZ;>/>SHUF,LVTQQR")R"[\LK=>N,5)-^
MS[X!N/C1;_%F30=WQ @M391ZO]LN!MA*,FWR?,\H_*S#)3//6O1** "L_P 0
M:#8^*=!U+1=4@^U:9J-M)9W4&]D\R*1"CKN4@C*DC(((SP:T** ./^$_PC\)
M_ _P19^$/!.E?V+X=LWDD@L_M,UQL:1R[G?*[.<LQ/)[\5X/9_ ?Q9XY_;^O
MOBUXJTD:?X/\(Z!'H_A1I+J*1KV>4.9KCRT=C&%\Z=/W@!.Z,C[O'U110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SYX\_8!_9]^)/B237]=
M^&>FR:I+(999;&XN+%97)R6>."1$<D\DL"3DYZU['X$^'_AOX8>&;3P[X3T2
MQ\/:):Y\FQT^$11J2<LV!U8GDL<DGDFN@HH \Z^"7[/?@#]G/P_?:)\/- _X
M1[2[ZZ^VW$'VRXN=\VQ4W;II'8?*BC (''2O1:** . \2? ;P+XN^*OAOXDZ
MMH?VOQIX=A:WTO4_M<Z?9XVWY'E*XC;_ %C\LI//L*/BA\!O OQFU3PKJ/C'
M0_[8O/"]Z-1TB3[7/!]FN R-OQ$ZA^8TX<,..G)KOZ* .,^*?P;\$_&WPZ-"
M\=>&K'Q+I:OYB0WD>6B?&-T;@AD;'&5(.*X;X1_L6?!/X%Z\NM^"O %AI6L)
MGR[^>:>\GBR,'RWGD<ID$CY2.":]LHH :ZB1&4Y 88.TD'\QTKY8?_@EW^S)
M([._PT+,QR6;7]4))]?^/FOJFB@#PN^_8@^"FI?"/3_AA<>"_,\#6&IG6+;2
MO[5O1LNRKH9/-$WF'Y97&TL5^;IP*XG_ (=<?LQ?]$S_ /*_JG_R37U510!D
M^$_"VE^!_"NC>&]$M?L6BZ/90Z?8VWF/)Y,$4:QQIN<EFPJ@98DG'))KE?@K
M\!? G[.WA6Z\-_#W0O\ A']%NKU]0FMOM<]SNG:..-GW32.PRL48P#CY>F2<
M^@44 >?ZS\!? GB#XR:%\5K_ $+[1X^T.R;3]/U;[7.OD0,)E*>2)!$W%S-R
MR$_/UX&/0*** /E^+X$^*/ /[>C?%+PSIOV[P9XUT!]-\3E+B*,V%Y"$,%P8
MV8,X=8DC_=AB"9&;KFO6_AS^SWX ^$WC3QAXL\*:!_97B#Q==->ZW>?;+B;[
M7,9))2VR21E3YY9#A H^;&,  >BT4 >=_!W]GWP#\ ;36;;P%H/]@P:Q=?;;
MY?MEQ<>=-C&[,TC[>.RX'M7HE%% $5U:Q7UK-;S+OAF1HW7)&5(P1D>U<5\&
M_@AX*_9_\(MX7\!:+_8.A-<O>&U^U3W/[UPH9M\SNW(1>,XXZ5W5% 'A&L?L
M+_ ?Q!\1I?'6H?#72KKQ)+/]IEF=YO(EE)R9'M@_DLQ)))*$D\FN/_;<^!/B
M[]I;5_A1X%L=*W_#V/Q -9\6:JUW%&(X($(2W6/>)',HDE&54A3L)]OJ>B@!
MJ(L:*B*%51@*HP /2G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56NO]?9
M_P#74_\ H#U9JM=?Z^S_ .NI_P#0'JH[D3V^[\RS1114EA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>!?M[?\F<_%G_L"
M2_\ H2U[[10!XM^Q7_R:1\(?^Q8L/_1*U[316=XB\1:7X1T.^UK6]0MM*TBQ
MA:XNKV\E$<4,:C)9F/  H =%836]U>2Q3Q@7,HE*O$3M(1$QD,/[@/XU-Y=W
M_P ]X?\ OR?_ (NO,?@A^U1\*_VCI-3B^'?B^W\0W&FA6NK?[-/:S1JW ?RY
MXT9ESQN4$ X!.:]7JN9D<J_ILK>7=_\ />'_ +\G_P"+H\N[_P">\/\ WY/_
M ,75FBCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y[P_\ ?D__ !=6:*.9AR+^FRMY
M=W_SWA_[\G_XNCR[O_GO#_WY/_Q=6:*.9AR+^FRMY=W_ ,]X?^_)_P#BZ/+N
M_P#GO#_WY/\ \75FBCF8<B_ILK>7=_\ />'_ +\G_P"+H\N[_P">\/\ WY/_
M ,75FBCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y[P_\ ?D__ !=>0>'?VRO@OXL^
M+$OPUTGQ_IU[XRCE>#[#'',(Y)5&6CCN"@AD<<_*KDY!&,@@>H>,/%VD> /"
M>L>)=?O%T[1-(M);Z]NF1G$4,:%W;:H+,0 ?E4$GH 2<4<S#D7]-E_R[O_GO
M#_WY/_Q='EW?_/>'_OR?_BZ\=^"O[9GP=_:(\577AOX>^,/^$@UJULGU":V_
MLR\MML"R1QL^Z:%%.&EC& <_-TP#CVNCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y
M[P_]^3_\75FBCF8<B_ILK>7=_P#/>'_OR?\ XNCR[O\ Y[P_]^3_ /%U9HHY
MF'(OZ;*WEW?_ #WA_P"_)_\ BZ/+N_\ GO#_ -^3_P#%U9HHYF'(OZ;*WEW?
M_/>'_OR?_BZ/+N_^>\/_ 'Y/_P 75FBCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y
M[P_]^3_\75FBCF8<B_ILK>7=_P#/>'_OR?\ XNCR[O\ Y[P_]^3_ /%U9KBO
M%'QF\&>#?B!X6\#ZQKL-IXK\4>=_9.EB.222X$2EG8E%(C7 .&<J&*D D@BC
MF8<B_ILZSR[O_GO#_P!^3_\ %T>7=_\ />'_ +\G_P"+JS11S,.1?TV5O+N_
M^>\/_?D__%T>7=_\]X?^_)_^+JS11S,.1?TV5O+N_P#GO#_WY/\ \71Y=W_S
MWA_[\G_XNK-%',PY%_396\N[_P">\/\ WY/_ ,71Y=W_ ,]X?^_)_P#BZLT4
M<S#D7]-E;R[O_GO#_P!^3_\ %T>7=_\ />'_ +\G_P"+JS11S,.1?TV5O+N_
M^>\/_?D__%T>7=_\]X?^_)_^+JS7*_$[XI>%?@SX+O\ Q;XSUF'0O#]CM\^\
MF5WP68*JJB L[$D *H)/I1S,.1?TV=#Y=W_SWA_[\G_XNCR[O_GO#_WY/_Q=
M)I>IVVM:79ZA92>=9W<*7$,FTKO1U#*<$ C((X(S7@_Q"_;Z^ WPJ\>:CX+\
M4>/%TWQ+I\J0W5DNDWTXC=U5U7S(X&0G#KT8XS@X((HYF'(OZ;/>?+N_^>\/
M_?D__%T>7=_\]X?^_)_^+JS11S,.1?TV5O+N_P#GO#_WY/\ \71Y=W_SWA_[
M\G_XNK-%',PY%_396\N[_P">\/\ WY/_ ,71Y=W_ ,]X?^_)_P#BZLT4<S#D
M7]-E;R[O_GO#_P!^3_\ %T>7=_\ />'_ +\G_P"+JS11S,.1?TV5O+N_^>\/
M_?D__%T>7=_\]X?^_)_^+JS11S,.1?TV5O+N_P#GO#_WY/\ \71Y=W_SWA_[
M\G_XNK-%',PY%_396\N[_P">\/\ WY/_ ,71Y=W_ ,]X?^_)_P#BZ\F^-G[7
MWP?_ &==7L-*^(/C:UT+5+Z)IX;&.VN+R<1@@;W2"-VC4DX4N &VMMSM;'J'
MAOQ)I7C#0-/US0]0M]5TC4(5N+6]M9 \4T;#*LK#J"*.9AR+^FRSY=W_ ,]X
M?^_)_P#BZ/+N_P#GO#_WY/\ \75FBCF8<B_ILK>7=_\ />'_ +\G_P"+H\N[
M_P">\/\ WY/_ ,75FBCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y[P_\ ?D__ !=6
M:*.9AR+^FRMY=W_SWA_[\G_XNCR[O_GO#_WY/_Q=6:*.9AR+^FRMY=W_ ,]X
M?^_)_P#BZ/+N_P#GO#_WY/\ \75FBCF8<B_ILK>7=_\ />'_ +\G_P"+H\N[
M_P">\/\ WY/_ ,75FLKQ3XJT?P1X>O\ 7O$&IVNC:-81&:ZOKV41Q0H.[,>!
MV'N2!1S,.1?TV7/+N_\ GO#_ -^3_P#%T>7=_P#/>'_OR?\ XNO*/@A^UU\(
M_P!H[5=3TSX>>,[?7]2TZ%;FXLVM;BTF$1;;YBI/&A=0V S("%+H&QO7/0?&
MKX]^ _V=_"]MXB^(6OKX>T>YNUL8;@VL]P7F9'<($A1V^[&YSC QUY%',PY%
M_39V_EW?_/>'_OR?_BZ/+N_^>\/_ 'Y/_P 77"_!/]H#P%^T5X;O=?\ A[KW
M_"0:39W9L9[C['<6VR8(CE-LT:,?ED0Y QSUZUZ'1S,.1?TV5O+N_P#GO#_W
MY/\ \71Y=W_SWA_[\G_XNK-%',PY%_396\N[_P">\/\ WY/_ ,71Y=W_ ,]X
M?^_)_P#BZLT4<S#D7]-E;R[O_GO#_P!^3_\ %T>7=_\ />'_ +\G_P"+JS11
MS,.1?TV5O+N_^>\/_?D__%T>7=_\]X?^_)_^+JS11S,.1?TV5O+N_P#GO#_W
MY/\ \71Y=W_SWA_[\G_XNK->7?&[]ISX8?LXV^FS?$7Q;;>'3J+LEI"8)KF>
M7:,LPBA1WV#H7*[02!G) )S,.1?TV>D>7=_\]X?^_)_^+H\N[_Y[P_\ ?D__
M !=9?@7QUH'Q,\(Z5XH\+ZK;ZWH&J0BXM+ZU;*2(>._*L""K*P#*P*D @BMV
MCF8<B_ILK>7=_P#/>'_OR?\ XNCR[O\ Y[P_]^3_ /%U9HHYF'(OZ;*WEW?_
M #WA_P"_)_\ BZ/+N_\ GO#_ -^3_P#%U9HHYF'(OZ;*WEW?_/>'_OR?_BZ/
M+N_^>\/_ 'Y/_P 75FBCF8<B_ILK>7=_\]X?^_)_^+H\N[_Y[P_]^3_\75FB
MCF8<B_ILK>7=_P#/>'_OR?\ XNCR[O\ Y[P_]^3_ /%U9HHYF'(OZ;*WEW?_
M #WA_P"_)_\ BZ/+N_\ GO#_ -^3_P#%TNH:A:Z387-]?7,-E96L333W-Q((
MXXHU!+.S'A5 !))X %>1?"']L3X.?'GQ7>^&O OCBTUW7+2-I9+/[/<6[.BG
M#-&98T$H'<QEL @]#FCF8<B_IL]<\N[_ .>\/_?D_P#Q='EW?_/>'_OR?_BZ
MYOXJ?%?PK\$_ VH>,/&NK+HGARP:-;B\:"68J9)%C0".)6=B6=1\JG')/ )'
M+_ O]J3X8?M*?VW_ ,*X\3?\)'_8OD?;_P#0+JU\GSO,\K_7Q)NSY4GW<XV\
MXR,G,PY%_39Z9Y=W_P ]X?\ OR?_ (NCR[O_ )[P_P#?D_\ Q=6:*.9AR+^F
MRMY=W_SWA_[\G_XNCR[O_GO#_P!^3_\ %U9HHYF'(OZ;*WEW?_/>'_OR?_BZ
M/+N_^>\/_?D__%U9HHYF'(OZ;*WEW?\ SWA_[\G_ .+H\N[_ .>\/_?D_P#Q
M=6:*.9AR+^FRMY=W_P ]X?\ OR?_ (NCR[O_ )[P_P#?D_\ Q=6:*.9AR+^F
MRMY=W_SWA_[\G_XNCR[O_GO#_P!^3_\ %U9KA/"'QR\#>/?B%XK\#^']?BU/
MQ/X5,:ZQ90P2@6K/]U?-*"-SD$$(Q*D$'!!%',PY%_39V7EW?_/>'_OR?_BZ
M/+N_^>\/_?D__%U9HHYF'(OZ;*WEW?\ SWA_[\G_ .+H\N[_ .>\/_?D_P#Q
M=6:*.9AR+^FRMY=W_P ]X?\ OR?_ (NCR[O_ )[P_P#?D_\ Q=6:*.9AR+^F
MRMY=W_SWA_[\G_XNCR[O_GO#_P!^3_\ %U9HHYF'(OZ;*WEW?_/>'_OR?_BZ
M/+N_^>\/_?D__%U9HHYF'(OZ;*WEW?\ SWA_[\G_ .+H\N[_ .>\/_?D_P#Q
M=6:*.9AR+^FRMY=W_P ]X?\ OR?_ (NCR[O_ )[P_P#?D_\ Q=<9\9/CIX%_
M9]\)Q^)?B!X@B\.Z-)<+:1SR0RS-),P)"+'$K.QPK'A3@*2>!7>4<S#D7]-E
M;R[O_GO#_P!^3_\ %T>7=_\ />'_ +\G_P"+KP?PC^WQ\!_'GQ$L_ N@^/%U
M'Q1>7;6,%DFE7RK),N<J)6@$>/E/S;L''!KZ!HYF'(OZ;*WEW?\ SWA_[\G_
M .+H\N[_ .>\/_?D_P#Q=6:*.9AR+^FRMY=W_P ]X?\ OR?_ (NCR[O_ )[P
M_P#?D_\ Q=6:*.9AR+^FRMY=W_SWA_[\G_XNCR[O_GO#_P!^3_\ %U9HHYF'
M(OZ;*WEW?_/>'_OR?_BZ/+N_^>\/_?D__%U9HHYF'(OZ;*WEW?\ SWA_[\G_
M .+H\N[_ .>\/_?D_P#Q=6:*.9AR+^FRMY=W_P ]X?\ OR?_ (ND^SSO-$\L
MT;+&Q;:D94GY2.NX^M<-\;/V@/ /[.OANSU_XA^(%\/:5>7:V,$WV6>Y+S%'
M<*$A1VQMC8[B,# !.2,O^"OQZ\"?M$>%;KQ)\/==_P"$@T6UO7T^:Y^QSVVV
M=8XY&3;-&C'"RQG(&/FZY!P<S#D7]-GH%%%%26%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)?\ P51^V?\ #$'C
MS[)YFWSM/\_R_P#GG]M@SGVSMKZTK.\1>'=+\7:'?:+K>GVVJZ1?0M;W5E>1
M"2*:-A@JRG@@T ?'%K_9_P#P\B^&7_",_9?LO_"JF^V?8\;?L?GG[/G;QMW>
M7MSVQ[5]L5Y1\$/V5_A7^SC)J<OP[\(6_AZXU(*MU<?:9[J:15Y">9/([*N>
M=JD G!(S7J] !1110 4444 %%%% !1110 5E^*?M?_",ZO\ 8/,^W?8YOL_E
M??\ ,V';M]\XQ6I10!^0W@W[!_P[\_93_L?[-_PE7_"V+?R/*_U_VG[=>XZ?
M-G9]GS[>7_LU]S?\%%+A?^&1_&MA)XBTWPI'JAM;!]6U>*ZDMH4>XCW!OLT,
MT@W*"@.S +#)'6NK\._L:_!?PG\6)?B5I/@#3K+QE)*\_P!NCDF,<<K##21V
MY<PQN>?F5 <DG.22=Z+]F_X;1KX_1_"MM=1>/)EG\1PW<LL\=_( 0K%'<K&1
MN)'EA<'!'(! !\\? 'Q]\2OA1^U)8_ GQ9X_TWXK^'KOP>FN:=JUGHT&F3:6
ML;F)(BD!*F-D4'+$D[HR"!D-]HUY3\$?V6?A7^SB=2?X=^$+;P]/J.T75S]H
MGNIY%'1/-G=W"9YV@A<\XS7JU !1110 4444 %%%% !1110 4444 %?GO\6O
M@GX=^%?_  4,_9XUO3'U'4->\5ZKX@U#5]6U:\>YN+@BW7R8@3PD4,;^5&B@
M;450<D9/Z$5QGBKX/^$?&OCSPEXTUK2/MGB7PF;AM&OOM,T?V4SH$E^17"/N
M50/G5L8XQ0!V=%%% !1110 4444 %%%% !1110 5\1_\%3O@GX=\2_L]^,?B
M-JKZA?:WX?TVUM=(M)+UQ8V3O?1K+<) "%,SI+L9VS\J)@ KFOMRN7^)GPS\
M-?&+P/JG@_Q?IO\ :_AS4U1;NR\^6#S DBR+\\3*XPZ*>&'3TH /A;_R3+PC
M_P!@>S_]$I7YG3>-OB+\#?!_QJ_: \$_&?PSJ^EK\09FU7P,F@L5NG>XBB6W
MDN;F.*XCD2.0?)&NW;&S+(V6K]'=>^!O@CQ-K7@75M2T3[3J'@=F;P_-]KG3
M[$61$;A7 D^6-!^\#=/<UQFK_L3_  0U[XK?\+)O_AYIMQXP-R+U[QI)A#).
M/^6KVP?R7<GYBS(26^8Y;F@#V/1[\ZII-E>M"ULUS DQAD^]'N4':?<9Q5RB
MB@ HHHH **** "BBB@ HHHH **** /C']JSQ'X/^&WQ&UG2_AYX-C\8?M'_%
M#2?[$%KY\DJ1:?L$9GN4=S'# JQY("KO,>6. S#WO]EWX+M^SS\ O!OP]EO_
M .U+G1K1EN+I<['GDE>:79D [ \C!<@':%S7*?%+]@WX&?&KQQ?^+_&G@I]<
M\17PC%Q>/K6H1;@B*B )'.J* J@851Z]237J?PM^%OACX+>!-,\&^#=,_L?P
MWIOF_9++[1+/Y?F2O*_SRLSG+R.>6.,X'  H ZNBBB@ HHHH **** "BBB@
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MG;+M9IY4M_-.7,$,DC1P'&5!B5=JLR#"L0?;: "BBB@ HHHH **** "BBB@
MHHHH ^-/VU?#.K?$;]H;X ^%]!^)VD?#77()]2U2PFOM)EU"XGN$A4(T$;1?
M9G*@."LLJ$>8"H<A0>R_8=^-?C+XJ:'\1- \<:G9>)=9\#^*+KP^/$^GVRV\
M6JQQGY93&GR*_7(3 P4XSEF]6^-/[/OP\_:'T&UT;XA^&+;Q'8VDWGV_F220
MRP.1@E)8F610<#(# -@9!P*V/AA\*_"?P8\'6?A7P5H=MX?T&TR8[2VW'+'J
M[NQ+.YXRS$L<#)H ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBL/QOX+T?XB^#]9\+^(+--0T75[62SN[9^CQNI4X/
M8C.01R" 1R* -RBOR.N/'7Q8_9_\.^*_V+-*M;K4_%>MZHMCX+\1.^R,:'=F
M1II&(&5VJK<KG89)\$>2N[W_ ,=?%JU_87L_AG^SK\*YO!>G^()M-DU*^\3?
M$34#8:5!'E]TTY1@S2SRI*%4-\F% #+C: ?>5%?('P/_ &W-=^*GP?\ BM>K
MH'A_7/B+\.Y&ANX= UR%-#U)&#F*\AO)W"1VY$<S-O<D+$3G+;1Y[\"/^"@7
MCOQ#^TSX3^%GC6Z^&/BJ'Q%:R'[9\-;J[G73+@0F94FFE=X9N$966%F"DYW_
M "[6 /T!HKXD^#_[3WQ_^.WQZ^)?A#PUHGP^L/"?@/Q?)I&HZMJR7HN9+!;J
M6(+#&DA5[GRX7;<Q1"2HPN:X+PK_ ,% OC)\6O%FLR_#_2OA3<V-EXB_LFT^
M'^NZX]AXKU*!&3>\+2RI;Y92Y# -L*L-LA7YP#]&**BM9GN+6&62"2V>1%9H
M)2I>,D9*MM)7(Z'!(XX)J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_#KPMX=U#4GUF_TC2K73[C4I00UW)%"L;3'))RY4MR>]='110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$'(K?L_B/X3U'1-0UFT\4:+=:/I]LE[>:A#J$+V]M;M")UFDD#;40PLLH8D
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M?(C?R8$:6,--)MC7>,L*K'XW>!1X?MM9_P"$DM#9W$>F2JBAC<*NHR+%8EX
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M"[N0 3@*I/'I6=J7C[0='TO0]1O+_P BTUNYMK/3V:&0M/-/_JDVA=P)Z_,
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MLT@W)M8AAD\#&A#X#T*W\76_B=+'&MV^F?V/!<M-(1#:&19&C1"VQ=S(A9@
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M+&U,8VKC0^%_P0\*_!RU2T\+#7+:PBMDLX+&_P#$>HZA:V\*8V)##<W$D<0
M  V*.!CIQ6AXK^+G@7P'I6G:GXE\:>'O#NFZD-UC>:MJL%K#=#:&S$\C@/\
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MFU2&!+J2Q653.D+LRI(4SN",R. Q&"48#H:N4 ?%*^/&^&7C"*WU/QQJVD^
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M)'OM<=\+O#'A[0=#OM0\.ZE_;EOXBOYM<GUC[1'/]NDF(PXDC 1D6-8HDVC
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MK\4)_'-YJNI:GJ*V+:=IUE=&$6NE02&)KA;=4C5R9G@A9VE>0Y0!2B_+784
M?GI\1-6M/"]Q<^&]"N[?P1JOASP5IG@R/P/>7<-SKOB:UGCMYS;Z8&3<DBAG
MM_M(299)#-NBC,"2C] -(TFTT'2;+3+"$6]C90);6\*DD)&BA57)Y.  .:2X
MUBPM=2M-.GO;>'4+Q9'MK6255EF6/;YA1"<L%W+D@<;AGK5R@ HHHH ****
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M%TU]IT=SI<$BV5PS^8TT(*GRY"_S%EP2><YH ^0;'QEXE^),GP\\0ZO\1!H
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M#-=EI?@OP]H6O:OKFFZ#IFGZUK!C.I:E:V<<5S>^6"(_.D50TFT$@;B< \4
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M)FT0ZQX0T'5CH:E-*-]ID$W]GJ0H(@W*?*!"(/DQPB^@I=2^%_@W6+Z&\O\
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MUDL/"*:9;74<<@*?+++-,D9+X?YI]I'D_+RW@'QY\1/V>_ .A27>MV^M_:/
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M_P"(VBZKKVB0>&_$^D>*H#:ZAJ>GI;W<&KPQAX#'-*FY9T4>9'M8L!\R^HH
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M%%B,.D6$5JA16=E7$:@8#22$#L78]S6_0 4444 %%%% !1110 4444 %%%%
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M@GYL9YZU/??!CX?:I;Z-!>>!?#5W!HMNUII<<^D6[K80LNUHH 4_=(5 4JN
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MS7P7X?0VQ70M-4VM_)JL!%G'^ZO)!()+E/E^65A-+ND'S'S'R?F.<GQ%\'_
M7B_1UTG7O!'AS6]+6\EU%;'4=)M[B 74K.\LX1T*^8[22,SXW,78DG)H ^8?
M%WQ"^+VA:'KEKK?CR3PU=^!_A[<>)_$-UIUCI]S=374L]R=/B+/"T*RB*RD6
M78FQV=O+"Y1U[OX9^'?$'BG]JKQ3XJU;Q1J<+:!X=TC2Y="BAL_L@N+B&6:Z
MAR83,(PWV:48D#%\@LT86-?<QX \+K875B/#>D"RNK:&RN+;[#%Y<UO$"(H7
M7;AD0$A5/"@G %30^"_#]MXKN/%$.A:;%XEN+86<VLI9QB\E@!#")I@-Y0$
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MS(A*YP2H..!0!\4_%#XA6OQR\8_#+QVL,EYX TC6&U;0[=67_3#I]A<7UWJ
M!^\%FBMK.(XX/VEL[9$-;&A?%KXYZ7X)D\?:]'>:=8:MIEC;0V.O1Z4]E!JV
MI7]K;V;V"V4C3-9P+.YD-W,))!Y6U5)?9]::9X,\/Z+%I$>G:%IMA'H\#6NF
MI:V<<8LH6"AHX0H'EH0B JN =H]!7/:)\!_AGX9T;6=(T?X=^$]*TG6D2+4[
M&QT2VA@OD3=L6>-4"R!=[8# XW'U- '@,WCOXA17WQ,T'PS\2;SQN_A^]TK3
M$FEM](@U02J6N-72U8Q16LMQ';2P;5E78A5@^6#&H[[]J2ZT#PCXH\3Q>*IM
M5T#1?AKI^OZ?-J=C#;7.I:AJ4EW_ &<)(TC'[]DMHD(CVQL\Q(11@+]#7GP/
M^'&I>&_^$=N_A_X7NO#_ )\=U_94VBVSVOG1PK!')Y13;O6%$C5L9"*JC@ 5
M;UGX3>!_$>NVVMZMX-\/ZIK-K:_88-1O-+@FN(K?YOW*2,A98_G?Y0<?.W')
MH ^=-?\ BI\3?#.G_%'Q(_B%M4M?A[:Z?I%KHT-I:PQ:UK3V,3S-<RO&"L!E
MO;?Y87CP8V^8#*F%_$GQTT.'3M-OM>U31[SQ1XCT?2-'D\66>CRZA$46>ZU6
M00Z?N@^S-;P;(T:1Y@PD)=?D8_4TWA'0[C2]7TV71=/ET[6/-_M*S>UC,-[Y
MJ[)?.0C$F]?E;<#N'!S63X5^$O@;P+;VMOX;\&>'O#T%K=/?01:5I4%LL-P\
M7DO,@1 %D:+]V7')7Y2<<4 ?-?AOQ_\ $NSU;P]=W7Q$OM<TB?XBWWA>PM9M
M+L%DU73[6.Z:[ENGBMU^=&LKD(T A4",;]Y;C&\._'+XR:C\,]3^,=Y%JVE^
M%I_"VH:W#I6I+I'V$M+$KZ4FG_9VENFDY7S6NW527.V(9"Q_8-EX-\/Z:+ 6
M>AZ;:C3YIKBS$-I&GV:68N9GCP/D9S))N(P6WMG.36%I/P1^'7A^;5)M+\ ^
M%]-EU4AM0DM-&MHFO"'\P&8J@\S#_-\V?FYZT ?+/Q7U3XCQ> OBQX%\0?$2
M^U2]D\.>'[.?4;6PL+9;74M5O)[.6W@"Q9$+J8<^86D7=E)%)&/2(]:\2_#_
M .,'@KPC)XUU6\\'-]GT/3+JWMM*G6[U&.*ZN;JUU1(XHY8F%I%#Y+6R1HI!
M,N[*J_NNM> O#/B2SU>TU?PYI.JVFL",:E!>V,4T=Z$QL$RLI$FW QNSC Q5
M;3?A?X,T?Q,OB2P\(Z%8^(EM5LAJ]MIL,=V+=555A\X*'V!550N< *!CB@#Y
MR_:BTB;QQ\9K6U_X0WP;XYTWP=X+OM8O-/\ '%V8+"W>[G5(;C_CUG#,JZ?<
M  F/AF.]:N_LT6-OJ7C?P*EK/J=]I_@_X4Z1;V]SK"&.X\S4G$CB2,DA9?+T
MV L QV[PN:]U\3?!?X?>-O$5OK_B+P)X9U[7K8(L&J:GH]O<W401BR!970LH
M5B2,'@DD4NL?!GX?^(?%UMXKU7P-X;U/Q3;212P:Y>:1;RWL3Q$&)EG9"ZE"
M 5(/RX&,4 ?+WB[P_P"#_'W[._C7XE^+M,LO$_Q#UBZU33M N+@+)>Z??+=S
M6FF:?IS$[K6572$$1%6,WF2-\Q)'5Z1H?@WQU)\2M?\ CB-%\16'@>XAT86_
MB1([BRTR&/3[6::Y\F0%%FFEGE;S=N\IY2 X&#[W:_"7P/8^-I?&-MX,\/V_
MB^7<9/$$6EP+?ON78V;@)YARORGYNG%1>)O@WX \::\NN>(? WAO7=:6 VHU
M+4](M[BY$)# QB1T+;"'<;<XPS>IH \ATOQ1XM^%?[*'PYMF5].\8ZJVD:!
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MC;V7C#PKHGBNSMY/.AM]<TZ&\CB?!&]5E5@&P2,CG!H ^</A5\1/B5\7M1\
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MJS*=N,@D=ZK:#\-?"'A61)-%\*Z)H[I=37JM8:=# 1<3*%FF!11^\=0 S=6
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M?KGP_P#"WB:PU>QUCPUI&K66L-&VI6U]8131WQC"B,S*RD2%0B8W9QM7'04
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M#N50'WDDGU/3/A+X'T70=8T/3_!GA^PT767>34]-M=+@CMKYG&UVGC5 LA8
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M1(M&T?0!\1/$L'B:WNI1JMUJ-S<:I%IH$-Q&5SC;(9!,K><D?DR#>M>MZO\
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MB[\$WD-MIOB/6&D>-7L?"FH0V%_,F\;E2XEG@$8QU994? .TYKY0TK]H_2_
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+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>advm-20241231_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 advm-20241231_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +?!2(# 2(  A$! Q$!_\0
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M)'Y"%.IHIU82 *5:2G+7/(!:*TO#OAS4_%VM6ND:/92ZAJ-T^R*WA&68]?H
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M?4****9@%%%%2P"E'6MK2? _B/7M-EU#3/#^J:C81$B2ZM+*26)"!D@NJD#
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MEL+$-M?4KLF*V3K_ !8RQXZ*&(R,BOM7P[JFE_LP^#EM?''Q#N=<NF4&&SF
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MUVFO1/%&IWO@K]C#3KOP^S65U_8=A^^M_E:/SO*\UP1T)\QSGJ"<U\^_L?\
MB;6K/XV:986UU<26.I+<"^@WDHX$3N'8=-P95^;KSCO7B.MB*L9U82LHWTMV
M/K_J66X.KA\'7I.<ZB3<N9JW-HK);Z_TS-^$?P OO%GQ>U#P=KEP-$O-'A-W
M<1R0"<2A)(ALQN4899 0V3QVYK[3^.7PCE^,WA6TT6/7'T)8;M;IY5MS,)-J
ML I7>G=@<Y[=*^9_VOH8H_VB/"[1A0\EE9M)CNWVF4<_@%KTK]N__DF.A_\
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M#5S&+VX0NTK#J(T&-P!X)) Z]2"*^C_VM?\ DW>S_P"N]G_Z":ZSPOI.C?\
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M$]F8#)@9*HWF-EO0$#/J*\,^'?P]U?XG>)X-#T:-&N9%,CR2DB.&,8R[$ X
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M'KA?+*.69=[LI)Z]4EN_\4F]_6W0UQU7ZA0C0HZ-_P!?>QT,,=O&L<2+'&O
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M3)3/I]Y>/+!*R%"ZGH<$ C\:]W^"/[3GAJU\ Q>"OB#:O-801&WCNF@\^&2
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M[@_U5S+LOO/A2BONO_AA/P%_T%_$?_@3;_\ QBC_ (83\!?]!?Q'_P"!-O\
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M_P#P)M__ (Q2_P###'@/_H+>(O\ P)M__C%+ZQ3#_57,NR^\^&:*^YO^&&/
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MXB_\"8/_ (Q1_P ,,^ _^@MXB_\  F#_ .,4>V@'^J^8]E]Y\-45]R_\,,^
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M\^)5ZTZOMC_AB3P-_P!!7Q#_ .!$'_QFE_X8E\#?]!7Q!_X$0?\ QFHY6/\
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M?]!7Q!_X$0?_ !FI]C(?^KV.[+[SXL6EK[2_X8K\$#_F*>(/_ B#_P",TO\
MPQ9X(_Z"GB#_ ,"(/_C-1["8_P#5_'=E]Y\6TZOM#_ABSP1_T%/$'_@1!_\
M&:7_ (8M\$_]!37_ /P(@_\ C-+ZO,?^K^.[+[SXNI5K[0_X8M\$_P#04U__
M ,"(/_C-'_#%_@D?\Q37_P#P(@_^,U+P]0?^K^.[+[SXQI1TK[._X8O\$_\
M04U__P "(/\ XS1_PQCX)_Z"FO\ _@1!_P#&:AX:H5_8&-[+[SXSIU?9?_#&
M/@K_ *"FO_\ @1!_\9I?^&,_!7_04U[_ ,"(/_C-9/"52_[!QO9?>?&JTM?9
M/_#&G@K_ *"FO?\ @1!_\9I?^&-?!7_04U[_ ,"(/_C-0\%5*_L+&=E]Y\<4
MJU]C_P##&W@O_H)Z]_X$0?\ QFC_ (8W\%_]!/7O_ B#_P",UB\!6+_L/&=E
M]Y\=4ZOL3_ACCP7_ -!/7O\ P(A_^,TO_#'/@S_H)Z]_X$0__&:S>7U^R^\K
M^Q,7V7WGQ[2^E?87_#'?@S_H)Z[_ .!$/_QFC_ACSP9_T$]=_P# B'_XS6;R
MW$/HOO+_ +%Q?9?>?("TY:^OO^&/O!O_ $$]=_[_ ,/_ ,9I?^&/_!H_YB>N
M_P#?^'_XU6+RO$OHOO+_ +&Q?9?>?(5.7I7UY_PR!X-_Z"6N?]_X?_C5'_#(
M/@[_ *"6N?\ ?^'_ .-5#RG$]E]Y2R?%=E]Y\B+UIU?77_#(?@[_ *"6N?\
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M2":TNHEGAD (#HP#*<'GD$5+IS45-IV>SZ#YHMN*>J+-%%%9E!1110 4444
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M]3T\(YSE4G.3=I-)=-SX&\3?\I;/"7_8,?\ ]-=U7<3?MJZW\*_VD?%'P_\
MB[::-HOAJ"TGOM&UG3X)8VGA56DB\S?*X8NBNF% _>KM&<UQ/B:-_P#A[5X2
M.UL?V4[9QV_LRZ&?SXK@OCQX;UG]OK]HCQ1I7@\0PZ!X!TJ>UAU"2, 7=V"Q
M$9;T>8%5[!8V;&6->\J%&O*DL2OW:HQO+^75V:\[Z6/-=2I34W2?O>T=EWT5
MSVOX?_MO>)/^%#>+?C#X\\/Z;8^&5OQ8^&-+T]98[K4&W,"'E=W4@=-RH/\
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MM"TC2=4\.ZA>26FJ&_AE:9& 5T6)DD50603?>!Y0>]<?X7_X)]Z%X_\ V?\
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MI2K*\&U?T:6ORW.[#1J/+TJ;M*SM]YYG^UG^UIJ7P?\ #/P_;X?VFF>(-?\
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MA!E9I&4DA0?E5>:ZO]L3XQ>+O@/\&9_&7@_3M,U*YLKZ".]35HI)(DMI"4W
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M3=1^-7CKXL?%3Q$'6\U.UAT2.XQNW;D'G$,>X6*#_OJO/_V;_CU-^P->>-?
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ME33C+F7<****XCH"BBB@ HHHH **** "BBB@ HHHH **** "BN&^+/QN\%?
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M,5FK [6;R+J5T4]"$61 ?][ZU]'_ /!,&)(_V78&1%5I-8O&<J,%C\@R?4X
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M9XVKAXT_X<;VO)\S=NUW97Z:LX?K6(CAX57/XGV6EK]]-?,^]?V<OVOM _:
MT_Q%$^C7WA;Q+X>4R:EH=Z=\B(,@LAPI;#*5(*J0<9'(KQJ__P""E&MIILGB
M&P^ WBJY\$QG+>(+B9XH@N>I(MWC'4?\M._6N$_97FT;2?B)\8_B#X.^(FJ?
M%GQ=9^$KJ=FO/#KZ?#>3Y62/EIFD=BUNJ[2BY#GG.17@FK?'"3XF?"'Q%J?C
M7XY^,F\9W;301>"[&*9-/N8R!L\S:1#Y9.<CJ!_":='*<++$5$J=X+ET?/=7
M6NED[><K6">-K*E'W[2U_EUMY[?)'U3^V'^UGK>N?LU>%O$7PZTOQ#I^D>*D
M,\GBFPN9+9](>&=4:WD:)3AG<.F=Z@[3C=SC>_9U_:V\9M^S[K&L^*OAUKWD
M>$O#::A#XAU:[FV>(64$$K+)!P6 W;@TG7\_%+/3[O4_^"3<_P!GBDN!:ZJ9
MI O)2,:@,MCT!;)QTY/0$UZ+X-^.7@[Q]^P'XD\&Z+J4EUXB\.^!V74[5K65
M! 0I3&]E"MDC/RD\'ZXFIA:$<,Z$:-U&JXMZW2NM7;RT[==QQK5'6]HYVO!.
MVG]>9:F_X*CK=>%;?7-'^$6N:K9VZJ-:NUNRMGITC,0J>>(&#DC:?F$?+8&>
MM7O$/_!4#2UTB+6/"GPQ\1>)=#MXX3J^J2N;:WT^5P/W1<1R*S G'S% 3TR.
M:YSX(1)_PZS\7?(OS6.K,>.I$K8/UX'Y"CX(1)_PZS\7?(OS6.K,>.I$K8/U
MX'Y"E/"9?%R?L/AJ<GQ/6_7Y=/QN.-;%2M^\WAS;+[CZ8N_VM/!&G_L[6/QB
MNFNHO#U[$/(M-@-R]QO:,VX&<%@Z."<XPI.<5X9I'_!3#[->:/>^,?A'XB\(
M^#-6D\NT\22RO+%*#_&JM BN .3L=B #@'I7SAXD\(ZOXB_X)F^#-0TV*:YM
M-&\37-W?11@D)$6GC$I [*SJ,]MY[9K$\7^+O"?CKX5V%AXE_:;\1:Q:QQQ2
MCPF?!<CR6\B*0J*QN%ARO*@B3&#]:VH9/@_?4HN7ORC]IN*6WPIZ];RT,ZF.
MK^[9V]U/IJWZO\C[U_:/_;6T?]G'QMX3TG4/#\NMZ1KEF]Z^J6-X-T2 D*$B
MV$2[CC!WJ.>M<A\._P#@H9'XD^+6A^"/%OPSUOP$VO21Q:7>:E,Q:8RG;"S1
M-$A"NV%#*7&3Z9->3?M1:'#HO[2G[)^C"5KZVM/[(M/-N(]K3*MY"F67)P2!
MR,GK6S_P414?\-&?L_M@;C?J">__ !^6_P#C7%A\#@IQHTI4[RJ1D^:[TM>S
MMMT.BIB,1%SFI:1:TLNMNIPGQ;_:O^*NC_MG6;6?A;Q=!::7(]G#X#@O[E4U
MI$,RK<+$L6&$@PX(C<83ACUKIOV[OB%K7Q?\)_ CPC>Z+?>$=0\7WXO+[1+H
ML9K20ND$2,"BDD>=(<%1T'%)^U-XJT_X3_\ !1/X>>,?$[R:=X<ATV"1[Y86
ME 3_ $F-B%0%CM9AD $X(..1EO[8?CG2?$OQV_9E^).DS/=^&+R\@N+>XDB:
M+>L-]"[9# $<,.HKT:,:;JX2K3I6]QM/7=*6G:_7N<M24N2M"4[^\M/*ZU_3
ML?3_ .T3^TMH/[*NA^%='M/#MWXBUC5#]BT;0--?:S+&$0 MAB!EHT4!6+$\
M X-/_9T_:3U+XZ:EXAT/Q)\-]8^'FLZ7!%/)8ZQN8312E@"-\4;?P_W<<]:\
MU_;Z;X.ZM-X/T7XF:MK'A35V6XN]'\2:5:M.MKM:,2)(JY9@3L. N1MR&7OR
M'_!/GXU>,O%OQ0\:>![KQ==?$3P+H]D9]/\ $=];21R[Q+&D:YD_> .AD.UR
M2#%QWSX4<%2GECQ"IOG6KD[KK;W?LOS3U/1>(G'&*DY>[V5NW7JO78C_ ."?
MTTGPW_: ^./PHC;.EV%])>V2'(VK%.8=P'^TDD.?]T5>_;(^&G[.WPH^!'B#
M08-'\,:'XPCM5ETFVM=AU8REP$8G)F:,X;)<E<!N]9?[*)&M_P#!0_X[:O;G
M=:6]O>V3,.1O^V6Z]?K ];OQ,T?X<>(/^"C7A.#Q)=W6H:S_ &2L,>AW6B17
M&G22>3.T9>9IL[@&W >20&53N';T*C:S'VKE)6A&;4>K45H_\_,Y8I/"\EE\
M3BK]$V>K_L!Z?KFF?LI>"HM>6:.9DGEM8Y_OK:O.[0_@5(*_[)7MQ7T-2*H1
M0J@*H& !T%+7QN(K?6*TZUK<S;^\]ZE3]E3C"][*P4445SFH4444 %%%% !1
M110 4444 %?,?Q\_;CTSX2?$%/ /AGP?JGQ%\:A5:;3-+<J(MRA@F521F?:0
MVT(< C)KZ<K\UM!^(^C_ ++'_!03XEZM\1X[BQTO7HIVLM5^SO.(XYI(IHV
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M\E\02P:G_P %8/!DZ 36\NE&:,LO4?V7<LIP1P>A]11\7U"_\%3OAP0 "UA
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MNU_LKTW-YXRI&M&$9:72MIUM\_GL=!X/_;'^+MK^U+XEU;_A!O&>N^=;NO\
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MJ93A</1=6:NZ<7SZOXVDX]?[W3L81QM:I4Y(O237+_AN[_E^)WG[>%X?B_\
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MB&/><,,YXP*X;_@G?$C?M'?'^0HID6^=0^.0#>3Y /H<#\A5GQ-_REL\)?\
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M".A>%=#71M%T73](T=0P&GV%K'!;C<26_=J O.3GCG-<_I_P/^'.DZL-4LO
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MTOX\?27YQ.NHHHJ3I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N1\$_\C-\0/^PY%_Z;
M;&NNKD?!/_(S?$#_ +#D7_IML:I;,YJWQT_7_P!MD==1114G2%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7(_"[_D6;W_L.:Q_Z<KFNNKD?A=_R+-[_
M -AS6/\ TY7-5T.:7\>/I+\XG74445)TA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7(^
M"?\ D9OB!_V'(O\ TVV-==7(^"?^1F^('_8<B_\ 3;8U2V9S5OCI^O\ [;(Z
MZBBBI.D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQC#;A^(KNJYY1<79JQJFGJ@HHHJ1A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5R/PN_Y%F]_P"PYK'_ *<KFNNKD?A=_P BS>_]
MAS6/_3E<U70YI?QX^DOSB==1114G2%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1163J7BS1M'XO-2MX6_N;P6_(<T :U%<+>_&;
MP[:DB)KJ[]X8<#_QXBLB?X[6BL?)TF:0?]-)0O\ (&@#U&BOE/\ :*_;J7X
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M&ZNC%'4Y#*<$'U%>Q?#/]L+XQ_"6>$^'_'VKBUC.18:A.;RU(Z8\J7<H_P"
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ME1AE65AP01WJY7B'>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MML?\%(-*^#ZWW@SX<S6^M>-@7@N]1X>VTMAE2/228'^'[JX^;/2N*_X*%?\
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M<1S@E&(Z9 (S7R-_P3\^+0\3> [[P1?3[M1T%O/L][<R6<C<@<Y/ER$@^TJ
M=*^L*^#Q%%T*KIOH?14Y^T@I&EKGB&]\0:L^HW4O^D$C;Y>0$ Z!?0"L;X_?
M%S7A\"OB$8?LUI>MX=O8SJ%O&4N<"!\8<'@\GD#C.1BIZX/X^?\ )#_B!_V
M;[_T0]12_B1]45/X6?D!1117Z ?-!1110 4444 %%%% !7?_  /^-GB?]G_X
MA:?XN\+7?DWML=LMO(28;J(C#12+W4@_@<$<BN HI2BI)QELQIM.Z/Z+_@7\
M:?#_ ,?_ (:Z5XR\.2[K.\7;-;LP,EK. -\+X_B4D?4$'O7?U^&O[ '[55S^
MSK\6[73]4NF7P-X@G2UU2-F.RW<_+'<@=MA(W=RN?05^X\,R7$22Q.LD;J&5
MT.0P/((/<5\5C,,\-4MT>Q[]"K[6-^H^BBBN Z HHHH **** "BBB@ HHHH
M**** "BBB@ KD?A=_P BS>_]AS6/_3E<UUU<C\+O^19O?^PYK'_IRN:KH<TO
MX\?27YQ.NHHHJ3I"BBB@ HHHH **** "BBB@ HHHH **** "BBOC/_@I9^U1
M)\#OA@OA#0+CRO%WBJ"2%9D)WV=G]V24$=&;)13V.X]A6U&E*M-0CNR)S5.+
MDSY'_P""E'[9S?%WQ-<?#7PE=G_A#=&N<7]S$W&I7<;$'D=8D/3J&8;NRU\*
MT45]S1HQH04('SU2;J2YF%%%%;&84444 %=Y\+_CAXW^$.J6-QX9\4:UI5E!
M>1W<NFV.I36]O<E64E9$1@K!@NTY!R*X.BE**DK20TVG='[::?XCC\7Z98ZW
M!=O?6VH6\=S!<2,6,D;J&0Y/L15^XU&[NH(89[F::&$8BCDD+*@]%!/'X5\Z
M?L->/#XR^!%A8SRM)>Z#<2:;(9""QC&'B(_V0CA!_P!<S7T'7P-:FZ524'T/
MI*<N>*EW/G?]N;X@>*/AY\(M)O?"OB36/#-Y-KD,,MQH]_+:221FWN"49HV!
M(R <'T%?FKJ6I7>L:A<W^H74U]?7,C2SW-S(9)978Y9F8DEB3R2:_0O_ (*+
M?\D5T/\ [&&'_P!)KFOSKKZG+$OJZ?J>/B_XE@HHHKUCB"BBB@ HHHH ****
M /I#]B']K2__ &7_ (EH][-//X(U=TBUBR3+!!T6X1?[Z9[<D9'I7[IZ3JUG
MKNF6NHZ==17MA=1K-!<0.&21&&0RD=017\SE?I]_P2A_:H:ZCF^#?B2]+/"C
MW7AZ:=\_*#F2U&?3)=1Z!AZ5X.987FC[:&ZW/1PM;E?LY;'Z84445\P>N%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5R/@G_D9OB!_V'(O_3;8
MUUU<CX)_Y&;X@?\ 8<B_]-MC5+9G-6^.GZ_^VR.NHHHJ3I"BBB@ HHHH ***
M* "BBB@ HHHH **** .-^+WQ6T'X)_#O6?&/B.Y6WTS382Y7< \TAX2)!W9F
MP /\*_ S]H+X\>(_VBOB7J7B_P 138>=MEI8QL?)LX!PD2#V'4]6.2>M?0W_
M  4N_:FD^,WQ3?P7H5Z7\'>%Y6A_=,-EY>=)93@_,%(V+]&/>OC"OKLOPOL8
M>TE\3_!'BXJM[27*MD%%%%>N<(4444 %%%% !7Z]?LQ_$2]\7? 'PE>17]TH
MET];2[7SF'FR0Y@<N >2QC)YZAJ_(6OO[_@G+XP_M#P'XG\-2,S2:;?I>1[F
MR/+G3;M7T :%B?=_>O'S2GS4.;LSNP<K5+=S[%M]0NK.*:*"YF@BG7;*D<A4
M2#GA@.HY/7UK\M_VP-8O] _:L\4ZCI=[<:;J%LUC)!=VDK12Q,+*##*ZD%3[
M@U^H%?EI^VM_R<UXR^EE_P"D4%>9E/\ 'EZ?JCKQG\->IYEXR^)/B[XC36TW
MBSQ3K7BB:U#+!)K.HS7;1!L;@ID9MH.!G'7 KG***^J225D>/ON%%%%,0444
M4 %%%% !7ZK?\$P?VRF\4:?#\(O&>H^9J]HC'0;ZZ?+7,0Y-LS'JR\E<\E>/
MX17Y4U=T76K_ ,.:O9ZII=W-8:C9RK/;W,#%7B=3D,#Z@URXG#QQ%-PE\C:E
M4=*7,C^F&BO$_P!D/]HRR_:8^#6F>)4:*+7+?_1-8LXR/W-TH&2!V5AAA[''
M:O;*^'G"5.3A+='T$9*2304445!04444 %%%% !1110 4444 %%%% !1110
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M]F?X4W#-O=O"VFJS>K+:QJ3^8->I5^>SCRR:['TT7=)A1114%!1110 4444
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MZV"^&04445X!Z04444 %%%% !1110 4444 %%%% !7(_"[_D6;W_ +#FL?\
MIRN:ZZN1^%W_ "+-[_V'-8_].5S5=#FE_'CZ2_.)UU%%%2=(4444 %%%% !1
M110 4444 %%%% !7Q9_P5LA>3]E6!EZ1^(;-F^GES#^9%?:=?)/_  5*T]K[
M]C[Q#*J%OLFH6,YP.@,ZIG_Q_P#6NO".V(AZHQK?PY>A^(]%%%?='SH4444
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MA4,/<$@_A7\YGB[PS?>"O%.K^']3B:'4=+NY;.XC8$8DC<JW7W%?TL5^./\
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M;L>LT445\B>T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZUI:WDEDLNT+%;D[O)6*-OE X$=I)D DL(2]E[CUC?IU:7_ N_/0KX_>V?\
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MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Y3XH?"[PS\8_!>H>%?%NEQ:KH]ZN'CD'S
M1L/NR1MU5U/(85^)_P"V!^Q/XH_9=\0-=HDVM>![N1A9:U''GR^1B*?'W'Y
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MZZN1^%W_ "+-[_V'-8_].5S5=#FE_'CZ2_.)UU%%%2=(4444 %%%% !1110
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M;HYK..E57."I@XO6#L?SA45^QGQ!_P""1WPC\2AI/#.I:YX.G))"1SB\@'_
M9?G_ /'Z^=O%?_!''XA6,DA\.>./#FKQ*3M&H1SV;L.W"K*,_C^->K#,<//[
M5O4XI86K'I<_/RBOJS6O^"8/[0VE3,EMX1L]71?^6MEK-H%/T$LB']*YF[_X
M)]_M"63[9/AGJ#'_ *8W5M(/S64UU+$T7M-?>C+V51?99\\T5]'V/_!.K]HG
M4 #%\-KE,\_O]2LH>V?XYA7;>&?^"4?QYUUE%]9Z!X=!/)U+55?'_?A9:3Q5
M".\U]X*C4?V6?'5%?I9X'_X(SW\DRR>,?B/;PQ ?-;Z'8M(S?224KC_O@U]-
M?#7_ ()H_ KX=3VUU-X=N/%=_" 1-X@N3.A8=S"H6(_1E-<=3,L/#9W]#>.%
MJRWT/QQ^&?P0\>_&34H['P9X4U/7Y&;:9;6 ^1'[O*<(@]V85^@'P!_X)"@?
M9]4^+FO9_B_X1_0Y/KQ+<$?3A!_P*OTJTG1[#0;"*QTRQMM.LHAB.VM(5BC0
M>@50 *N5Y%;,ZM32'NK\3NIX2$=9:G,_#WX:^%_A3X;MM \):'9Z#I-NH"V]
MI&%W$?Q.W5V/=F))[FNFHHKQVW)W9VK31!1112&%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\2^YD#^6K>6YWJ&W8/*CGBNS"X.IBE.2T48N7K;H8UL1&BXIZMM+[S[BHK
M\)_$#POX^BNI?#'B32/$<=JXCG?2;Z*Z$+'D*YC8[2<'@^E/TKQUX:UW7M0T
M/3?$.E:AK6G?\?NFVM[%+<VO./WD:L63GCY@*XW3FFTT]-S?FB[6>YN4445F
M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R/PN_Y%F]_[#FL?
M^G*YKKJY'X7?\BS>_P#8<UC_ -.5S5=#FE_'CZ2_.)UU%%%2=(4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !117Y^?M/>)?VK?@+H^M>-)_B=X?
M/A,ZH8+*QL;"WDN8HI)&\E6$ED!\J@ _.3QU/6O0P6#>-J>RC.,7TO?7TLF<
MN(KK#QYW%M>7_#GZ!T5\;?LPP?M/^-KCP3XW\5?$?P]JGP_U.$7MSI:6<,=Y
M)"\;;%^2S4!@Q4G$G8\GH?I6W^-GP\N]:_L:#Q[X8FU??Y7]GQZQ;M<;\XV^
M6'W9R1QBC$8.>'J.G&2FUORW=O71#I8B-2/,TXW[V_S.THKP;]K#]K+2/V7_
M  UIUX;*S\2:[>7<<2Z#_:J6MRMNR2DW.W8[&,-%LSMQE@,]J]&^'_Q>\)_$
MCPLNN:/XAT>]@BMXIKY;/48K@6+.F[9,RM\A'/WL?=-92PM>-&-=Q]U[,M5J
M;FZ:?O([.BN-T;XT?#[Q%K"Z3I/COPSJFJLVQ;&SUBWFG+=,!%<MG\*^6?VP
M/B)XJ\+_ +7'P"T;1_$FK:5H^I:C9I?:?97LD,%TKW\:,)8U8*X*DKA@>":U
MPV"J8BK[%^Z[-Z^2N9UL1&E#GWU2^\^V***_/#P'\?OVD/VNO$WBN_\ A/KW
MAWP9X;T695CL]0AB>61'+>4&+PS,78(23A%R" >*>$P,\6IS4E&,;7;=EKMW
MW"MB(T7&+3;>R7D?H?17SCJ7Q^\5? 3]FP^*/C!;:.WC^W:5(]&@U"&V.I[9
MPBF(C>"WELKD(IP.JKT'7_ ?]IKPE\;_ (?V6OIJNCZ/JQLI;_4="_M>&>XT
MV*.0HSS?=94 "MN95 #"IG@:\(.JE>"?+=:J_EY>>PXXBG*2A>TFKV9Z_16'
MH7CKPUXHT&77-&\0Z5J^BP[_ #-2L;V*>V38,OF16*C:.3D\=ZD\+>,M \<Z
M6=2\-ZYIOB#3A(8C=Z7=QW,.\8)7>A(R,CC/<5QN$XWNMC?F3V9L45\V_M8?
M'30O^&>/B&?!'C_36\4:?:Q$?V#K$;7MMFXB5C^Z?>AP2,\=:F_91^,FEQ?L
MW_#2X\=>-[*/Q!K$$RPR^(-51;J^<7,B *97W2'[B\9/05W?4:OU;ZQ;[7+:
MVNU[G/\ 68>U]EY7O\['T916-XJ\:>'_  )IJZCXEUW3/#VGM((5N]5O([6(
MR$$A \C ;B%)QG/!]*U8)X[J&.:&1989%#I)&P964C(((Z@BN#E:7-;0Z;J]
MB2BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<CX)
M_P"1F^('_8<B_P#3;8UUU<CX)_Y&;X@?]AR+_P!-MC5+9G-6^.GZ_P#MLCKJ
M***DZ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\B_:*\-_&'Q)HN
MD1_![Q7I'A34H[AVOYM7B6198BN%5=UO-@AN>@^M;4::JS4')1OU>WZD3ER1
M<K7]#UVBOS(^'GQ4_:S^)7QL\5?"[3/BCH<&O^'([B2[N;O3;5;5Q#-'"WEL
MMDS'+2J1E!P#TZ5]R>!_%E_\*/A?H4/QL\>>&X_%A\X7>JRW<-E;7!,SF,1[
MUB'$9C4X0<@]>I]+&994P=DYQE)VTC=NSUOLM#DH8R->[46DNKM;\SU.BN?L
M/B%X6U3PW<^(;+Q+H]YH%LC23ZK;W\3VL2*,LS2AMJ@#DDG@5\__  0_;R\(
M_%KQ[XK\.:G_ &/X0ATJY%MIM_>Z_"RZOF5XP80RIDG:I 4O]\?CQT\'B*L9
MSA!M0W\C>5>G!QC*6LMCZ@HKE?%7Q7\$^!;I;;Q)XQT#P]<,,K#JNJ06SGC/
M =@:S?B-XLM[[X)^,=>\.:O#<HFAWT]IJ6F7*NH=('*NDB$C(8=0>"*QC1G)
MQNK)]2W4BKZ['>45\J_\$W/&GB#QY^SU<ZCXEUS4O$.H)KES"MWJEW)<S",1
MPD+O<DX!8\9[TW]N;]J+Q+\"XO"?AKP5!:+XG\3RND=_?JK16J*R(" Q"[BT
M@Y;*@ Y'(QW_ -G57C'@H-.2;5^FG4Y_K4%06(EHCZLHKY:^"^C_ +5/AGXG
M:+%\2==\.^+/!5XDQU"?3TACEL3Y+F, +%"Q/F"-3@.,,?J)+/\ ;X\%W'[1
M&I?#J:?1+;PW:6XE3QM)X@@^Q3/Y,<AC&5"9#.T?^L)W(>.P4LNK.4HT6JEE
MS-Q=U;YVU\MP6*@DG43C=VU/J&BN<D^)/A&'6M+T:3Q3HL>KZK"MSI^GMJ$(
MN+R)L[9(8]VZ13M;#*"#M/I4VI>/?#.B^([#P]J'B+2;#7[]0UII5S?11W5P
MI) ,<3,&<95AP#T/I7G^SG_*SJYH]S=HKG_%GQ#\*^ 8[=_$_B;1_#B7!*PM
MJU_%:B4CJ%,C#/4=*^/?#/Q;US4/^"E'B311XPOKCP-'HZ7,-@-29M-5#IUO
M+YJIN\O[S,VX#N3FNS#8*IB8SDM%&+EZVMHOO,*V(C2<4];M+[S[BHK#\)^.
MO#?CZQEO?#'B#2O$=G%)Y4EQI-[%=1H^ =I:-B <$''7D4GA_P >>&?%FH:E
M8:)XBTG6;_37\N^M=/OHIY;5\D;951B4.588;'(/I7$Z<U>ZVW\C?FB[6>YN
MT445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^=_P ,?^4K7C/_ *XW
M'_I)%63X%^'>C?M;_MS_ !:M?B6;C4M.\-27-M8:0ER\"M%!<BW3E"&"!1N.
MTC+2 D^OU#X9_9'3PY^U9K7QH'BEKC^THI$_L0Z?M\LM$D9/G^:<CY,XV#KU
MXYYCXU?L%67Q#^)US\0?!OCO5_AMXIO#NNKG38V=7? !==DD3HS #.&P3SCK
MG[6.8X;VGNU.5NE&/-9^ZUOY_-'S[PM7EUC?WV[76J?]=3P3X>_#71_@K_P4
M.NOA=X9:XD\#^)-'GMM3TJ:X:0"&2PDF,;MG/#*-K'Y@),9YR<#]G+]FKX;^
M.?VPOB[X*USPV+[PQH!NCIM@;VY00;+M(U^=9 [X4D?,QSGFOKK]F_\ 8MT3
MX">)M0\6ZAXBU#QOXUOHVBDUG4EV;%;&\JI9VW-@ LSL<<#&3GD?B1_P3_\
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M7WW\2T^*[_KHCFA@\1:?NVOR_P O1Z[:'T97Y_\ QL_81\1?"G6-=^)OP/\
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MYXK4/^"?PM?C9J7COPG\3-;\'Z?JU_\ ;]1T73HF7SR9?->+S4E3$9?)"LC
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M]RR?,VK-7W]U:7^&PH87$>W4W"R][:W5.WG]YS'_  2Q_P"3:+S_ +&"Z_\
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M';0[CU;8@ R<#)QVK7HHHE)R=V[L222L@HHHI#"BBB@ HHHH **** "BBB@
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MVZ'&/E10H_05=KX*5N9VV/I8WLKA1114C"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /CW_@J;K4NE_LSVEM&6":EX@M;63!ZJ(IYN
M?^!1+6C\?+S4?A;_ ,$[XY/#.I7>A:AINA:)#;WVF3/;S)F>T1RKH0P+!F!Y
MYW'/6I/^"F7A*?Q-^RY?W<$?FG1-3M=2<#DA<M 2/H)\GVS5;Q=I&M?M)?\
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M45B6%%%% !1110!SGQ&\#VOQ+\"ZYX5OKV^T^QUBU>SN+C39%CG6-QAPK,K
M97*G(/!-9OP<^$>@? WX?:;X/\-)/_9EEO82W3J\\SNQ9GD954%B3V &  !@
M5VM%:^VJ>S]E?W;WMYD<D>;GMKL%%%%9%A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5Y+XH_9G\*^)_CIX?^+)N]6TSQ7H\
M0A7^SYXT@ND =<3*T;%OED93M9<K@=A7K5%;4ZU2BVZ;M=-?)[HB<(U$E)7M
MJ%%%%8EA1110 4444 %>37'[-/A6^_: C^+][=:I?>)8+46MK:W$T;65JHC,
M>Z-/+W!L,YY<C+L<=,>LT5K3K5*-_9NUU9^CZ$2A&=N97MJ%%%%9%A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!X5^V'^T]_PR?\,],\7?\ "-?\)3]MU>+2OL?V_P"Q[-\,\OF;_*DS
MCR<;<?Q9SQ@_'O\ P^F_ZHY_Y='_ -QUZ=_P6&_Y-G\,_P#8WVO_ *17M?CU
M7TF!P="M1YZD;OU9Y6(KU*=3EBS]-_\ A]-_U1S_ ,NC_P"XZ]._9I_X*>?\
M-$?&SPY\/O\ A6O_  C_ /;'VG_B8_V]]I\KRK:6?_5_9DW9\K;]X8W9YQ@_
MCU7TY_P35_Y/8^'/_<2_]-MU757P.'A2G*,=4GU?;U,J>(JRFDWU/W2HHKX]
MO/''BCX$_M?1:7K_ (BU34O _BIR;2/4+R26&U\YOE"!V(3RY1L[80@GM7R)
M[1]A45\@^%/'WB/XW?M8:M<Z;XCU'2_AYX0!^T1VUX\-K<>66 \P A6#R;VR
MP/[M,=J]A7]K3X1MK0TH>-K+[5YGE[S#,(,YQ_KMGEX]]V/>@#UVBN7\<_$[
MPK\-=%BU;Q+K=MI=A,=L,DA+F4XSA%4%FXYX!JE\./C1X+^+BW9\)Z[%JS6F
MTSQB*2*1 Q(!*2*K8.#SC% ':T444 5-7U#^RM)O;WR_-^S0/-Y><;MJDXSV
MZ5YA_P +Z_Z@?_DW_P#85Z'XN_Y%/6O^O*?_ -%M7S'0!ZS_ ,+Z_P"H'_Y-
M_P#V%'_"^O\ J!_^3?\ ]A7DU% 'UG117F?[2FL7_A_X%^,M0TR]N-/OX++=
M%=6LACEC)=1E6'(.">10!Z917Q5^QW\8/%.G^.8?"?C?6]0U>#Q-IL>IZ+=:
MG</,VX;MR*[DG!VR#']Z+C&>>T^%7C3Q!JO[;'Q'T.\UO4+G1+32W>WTV6Y=
MK:%@]H R1YVJ<,W(&?F/J: /J&BO,_''[2GPT^'&KOI?B#Q7:VFHQ\26T,4M
MR\9]'$2-M/L<&NK\$_$'PY\2-(_M/PSK%MK%D&V-);MRC?W64X93CG! H Z&
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /A;_@L-_R;/X9_P"QOM?_ $BO:_'JOW<_;T_9
MM\3?M2?"#1_"OA6^TG3]1L]=AU2276)I8HC$EO<1D QQR'=NF7C&, \]C\&?
M\.>?C-_T,W@7_P #[W_Y$KZ?+\31I4.6<K.YY.)I3G4O%'PM7TY_P35_Y/8^
M'/\ W$O_ $VW5>F_\.>?C-_T,W@7_P #[W_Y$KV']D7_ ()M_$SX!?M#>$_'
MGB'7/"=YI&D_:_/ATR[NGN&\VTFA7:KVZ*<-*I.6' /7I757Q="5&<5-7:?Y
M&-.C44XMQZGZ25\X_MX^#++7/@=<>(),Q:EX=N8;BUF3[V)98X73/8'>K?6-
M:^CJY;XG?#O3?BQX&U/PIK$UU!IVH>7YLEDZI*NR5)%VEE8?>0=0>,U\<>X?
M'.G^'SX+_P"">^IZIHRL+[Q!*LVI7 'S^6;H0[0?[NU0O?[[^M<+H'P]\4>,
M/@)#;Z3\)_#$VG.GF#Q>=5M([Q9 W+.[S I_=,;8 !Z9YK[V\*_";P_X6^&-
MOX"$,FJ>'HK>2U:/4&5WE1V9FW%0HSECR ,<8KQ>;_@GO\,9-0-PMWXAAAW9
M^R)>Q>4/;)B+X_X%0!Y_XN^!WB'XA?!OX0QQZYHLWC/0[21K?1=0U"&XAOX/
M,4IY9#,D@")$IQE2I )X&>Q_9-\=:;??$CQ5X7U#X?Z9X*\<V5H#?-HBB*UG
MCB=4*F)241@TBG*YW!CSQSZ)\1/V3? ?Q(\/>'='O$U#3;;0+8VEB^GW(#I$
M=ORL9%<-]T<D9Y/-:OP9_9Q\'? LWDWAZ&[GO[M!%-?ZA,))C&"#L&U54#(S
MPHSQGH* /4:*** ,CQ=_R*>M?]>4_P#Z+:OF.OJ77;&35-#U"SB*K+<6\D*%
MR0H+*0,^W->._P#"C]=_Y^]._P"_DG_Q% 'GE%>A_P#"C]=_Y^]._P"_DG_Q
M%'_"C]=_Y^]._P"_DG_Q% 'N%>3_ +5G_)O/CC_KQ_\ :B5ZQ7/?$#P38_$C
MP;JOAK4Y;B"PU*+R99+5E651D'*EE(!X[@T ?&-[X!OK[]D7X;?$+P_NC\3>
M#?,O4DC'S-;BZD+@^H4@-] _K6M^S[XL@\8?M;>/O$FB#S_[2\*+?0Q-SMF=
M;%VB/3.V0LG_  &OK#P'\.=(^'W@&P\'V/G7FCVD+VX%\5D>179F8/A0#DL>
M@ KAOA!^RSX/^"7B[4/$7AZYU5[J\MGM#!>SQR0Q1M(CD(!&K=8U&68\4 ?.
MG[#_ (/\%_$2#QOJ/C.QT[7_ !&;D/(NL(LK)$RLSR!7Z$MNRP&1@<BMC]C"
M.TTO]H3XJZ9X;F,GA&/S/L_E2%XB%N=L)#?Q?(9 #SD9Y->I>._V&_AKXZ\1
M7>LN-5T6YNI#-/%I5Q&D3N3EFVO&^W)YPN!S7IGPI^#?A?X+Z#)I?AFR:W29
MQ)<7$S^9-<,,X+M[ X   '/')H [>BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^T%'X<\2?%6ZU)()?!_@O3],,3V,3RWMY?W*22- @#$.662Q6-57)>8C)R,
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M;1^(/ _P]T?PJ+73_$'C'Q<KS6,NL20I))8VL/VJW 5%D0M,\Y.YA&(V.YU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\+_@/9_"?X@>+M?TG6M4O--\16EA%)I^LZA=ZE/%<6QG!F%U=3R2,'2:-=G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Apr. 04, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Adverum Biotechnologies, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-5258327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Cardinal Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">656-9323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001&#160;per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADVM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,890,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated By Reference</a></td>
<td class="text">Portions of the definitive proxy statement (the Proxy Statement) for the 2025 Annual Meeting of Stockholders of the registrant are incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed by April 30, 2025, then the registrant will file an amendment to this Form 10-K on Form 10-K/A to include the Part III information in this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001501756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 60,652<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">65,039<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,609<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">131,300<span></span>
</td>
<td class="nump">102,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">33,611<span></span>
</td>
<td class="nump">35,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,607<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">179,841<span></span>
</td>
<td class="nump">155,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">15,620<span></span>
</td>
<td class="nump">12,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">5,668<span></span>
</td>
<td class="nump">5,476<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,898<span></span>
</td>
<td class="nump">19,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">86,037<span></span>
</td>
<td class="nump">68,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">109,127<span></span>
</td>
<td class="nump">88,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,138,070<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,066,951)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">70,714<span></span>
</td>
<td class="nump">67,222<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 179,841<span></span>
</td>
<td class="nump">$ 155,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">20,848<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">20,848<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">20,848,000<span></span>
</td>
<td class="nump">10,143,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">20,848,000<span></span>
</td>
<td class="nump">10,143,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,439<span></span>
</td>
<td class="nump">$ 17,097<span></span>
</td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">20,599<span></span>
</td>
<td class="nump">20,869<span></span>
</td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="nump">41,468<span></span>
</td>
<td class="nump">52,946<span></span>
</td>
<td class="nump">62,208<span></span>
</td>
<td class="nump">77,041<span></span>
</td>
<td class="nump">77,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,999<span></span>
</td>
<td class="nump">15,807<span></span>
</td>
<td class="nump">13,789<span></span>
</td>
<td class="nump">14,319<span></span>
</td>
<td class="nump">13,481<span></span>
</td>
<td class="nump">15,586<span></span>
</td>
<td class="nump">29,596<span></span>
</td>
<td class="nump">29,067<span></span>
</td>
<td class="nump">44,595<span></span>
</td>
<td class="nump">43,386<span></span>
</td>
<td class="nump">63,118<span></span>
</td>
<td class="nump">55,056<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">35,438<span></span>
</td>
<td class="nump">32,904<span></span>
</td>
<td class="nump">29,199<span></span>
</td>
<td class="nump">35,059<span></span>
</td>
<td class="nump">34,080<span></span>
</td>
<td class="nump">36,455<span></span>
</td>
<td class="nump">62,103<span></span>
</td>
<td class="nump">70,535<span></span>
</td>
<td class="nump">97,541<span></span>
</td>
<td class="nump">105,594<span></span>
</td>
<td class="nump">140,159<span></span>
</td>
<td class="nump">132,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(34,438)<span></span>
</td>
<td class="num">(32,904)<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
<td class="num">(35,059)<span></span>
</td>
<td class="num">(34,080)<span></span>
</td>
<td class="num">(32,855)<span></span>
</td>
<td class="num">(62,103)<span></span>
</td>
<td class="num">(66,935)<span></span>
</td>
<td class="num">(96,541)<span></span>
</td>
<td class="num">(101,994)<span></span>
</td>
<td class="num">(139,159)<span></span>
</td>
<td class="num">(128,942)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">8,232<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,398)<span></span>
</td>
<td class="num">(32,504)<span></span>
</td>
<td class="num">(31,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,557)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(123,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,351)<span></span>
</td>
<td class="num">(30,498)<span></span>
</td>
<td class="num">(27,147)<span></span>
</td>
<td class="num">(33,415)<span></span>
</td>
<td class="num">(32,525)<span></span>
</td>
<td class="num">(31,672)<span></span>
</td>
<td class="num">(57,645)<span></span>
</td>
<td class="num">(64,197)<span></span>
</td>
<td class="num">(89,996)<span></span>
</td>
<td class="num">(97,612)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(122,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (32,094)<span></span>
</td>
<td class="num">$ (30,490)<span></span>
</td>
<td class="num">$ (27,207)<span></span>
</td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="num">$ (32,332)<span></span>
</td>
<td class="num">$ (30,940)<span></span>
</td>
<td class="num">$ (57,697)<span></span>
</td>
<td class="num">$ (63,272)<span></span>
</td>
<td class="num">$ (89,791)<span></span>
</td>
<td class="num">$ (96,633)<span></span>
</td>
<td class="num">$ (130,861)<span></span>
</td>
<td class="num">$ (121,058)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 170,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 985,660<span></span>
</td>
<td class="num">$ (1,531)<span></span>
</td>
<td class="num">$ (813,908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(31,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">143,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">170,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">985,660<span></span>
</td>
<td class="num">(1,531)<span></span>
</td>
<td class="num">(813,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(64,197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">116,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">170,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">985,660<span></span>
</td>
<td class="num">(1,531)<span></span>
</td>
<td class="num">(813,908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(97,612)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">87,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">170,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">985,660<span></span>
</td>
<td class="num">(1,531)<span></span>
</td>
<td class="num">(813,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">17,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued upon release of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (122,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122,116)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">10,143<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 67,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="nump">143,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="nump">116,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(33,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">87,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">67,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 163,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">10,143<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 67,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(57,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">$ 137,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">10,143<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 67,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(89,996)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="nump">$ 108,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">10,143<span></span>
</td>
<td class="nump">10,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 67,222<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">14,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs of $9 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 119,361<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">119,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Common stock issued upon exercise of stock options, shares (in shares)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common stock issued upon exercise of stock options</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued upon release of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">20,848<span></span>
</td>
<td class="nump">20,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="nump">$ 70,714<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1,138,070<span></span>
</td>
<td class="num">$ (407)<span></span>
</td>
<td class="num">$ (1,066,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2024</a></td>
<td class="nump">163,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="nump">137,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="nump">$ 108,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 8,449,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (31,672)<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (122,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,653<span></span>
</td>
<td class="nump">5,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,350<span></span>
</td>
<td class="nump">17,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net accretion of discount on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,907)<span></span>
</td>
<td class="num">(1,935)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">7,495<span></span>
</td>
<td class="nump">18,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease loss/(income)</a></td>
<td class="num">(1,567)<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets', window );">Deposit and other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(262)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(939)<span></span>
</td>
<td class="nump">3,021<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,418)<span></span>
</td>
<td class="num">(3,222)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92,462)<span></span>
</td>
<td class="num">(90,902)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101,901)<span></span>
</td>
<td class="num">(36,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,400<span></span>
</td>
<td class="nump">134,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="num">(808)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,889)<span></span>
</td>
<td class="nump">96,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,361<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock pursuant to option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,003<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,348)<span></span>
</td>
<td class="nump">6,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">70,934<span></span>
</td>
<td class="nump">76,976<span></span>
</td>
<td class="nump">70,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,628<span></span>
</td>
<td class="nump">76,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">67,552<span></span>
</td>
<td class="nump">60,652<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">2,503<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,628<span></span>
</td>
<td class="nump">76,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue', window );">Non-cash settlement of operating lease liability</a></td>
<td class="nump">$ 14,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities', window );">Remeasurement of operating lease right-of-use assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed assets in accounts payable and current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in deposits and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_NonCashSubleaseLossIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Sublease Loss (Income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_NonCashSubleaseLossIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Non-cash Consideration, Leasehold Improvements, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business</a></td>
<td class="text">Description of the Business <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of the Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Adverum Biotechnologies, Inc. (the &#8220;Company&#8221; or &#8220;Adverum&#8221;) was incorporated in Delaware on July 17, 2006 and is headquartered in Redwood City, California. The Company aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. The Company develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Going Concern, Liquidity, Risks and Uncertainties&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has devoted substantially all of its efforts to product development and has not realized product sales revenues from its planned principal operations. The Company has a limited operating history, and the sales and income potential of the Company&#8217;s business and market are unproven. The Company has experienced net losses since its inception and, as of December&#160;31, 2024, had an accumulated deficit of $1.1 billion. The Company used $92.5 million of cash in operations during the year ended December&#160;31, 2024. The Company expects to continue to incur net losses and operating cash outflows for at least the next several years. A successful transition to attaining profitable operations is dependent upon achieving a level of revenue adequate to support the Company&#8217;s cost structure. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had cash, cash equivalents and short-term investments of $125.7 million, which are expected to fund the Company&#8217;s operations into the second half of 2025. The Company has determined that its cash and cash equivalents as of December&#160;31, 2024 would be insufficient to fund its operations for a period of at least twelve months from the date these financial statements are issued, which raises substantial doubt regarding the Company&#8217;s ability to continue as a going concern. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements have been prepared using the going concern basis of accounting, which contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management expects operating losses to continue for the foreseeable future. The Company plans to raise substantial additional capital to continue as a going concern, including through </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">public or private </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equity or debt financings, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. If the Company is unable to raise capital or enter into such agreements as and when needed, it may have to delay, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limit, reduce or terminate its product development programs, commercialization efforts or other operations, or to cease operations or liquidate its assets</span>. Although the Company has been successful in raising capital in the past, there is no assurance that it will be successful in obtaining such additional financing. Therefore, it is not considered probable that the Company&#8217;s plans to raise additional capital will alleviate the substantial doubt regarding its ability to continue as a going concern.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">Restatement of Previously Issued Financial Statements</a></td>
<td class="text">Restatement of Previously Issued Financial Statements<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has restated herein its audited consolidated financial statements for the year ended December&#160;31, 2023 in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 250, Accounting Changes and Error Corrections. In March 2025, the Company discovered that there were errors in its lease accounting related to tenant improvement allowances in connection with an operating lease agreement for a building in North Carolina, which the Company entered into in January 2021 and subsequently subleased in October 2021 (the operating lease agreement and sublease agreements, with their respective amendments, collectively, the &#8220;NC Leases&#8221;). The Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for tenant improvement allowances that were conveyed to the subtenant, resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has also restated interim period financial statements for the first, second and third quarters of 2024 and 2023 as a result of these errors. See Note 14 Quarterly Financial Information (Unaudited) for additional information on the restated interim financial statements for the first, second, and third quarters of 2024 and 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this restatement, the Company has corrected certain other immaterial errors. While these other errors are quantitatively and qualitatively immaterial, individually and in the aggregate, because the Company is restating its consolidated financial statements for material errors, the Company has corrected other immaterial errors as well. These adjustments are described in more detail in references (b) and (c) and elsewhere in the section titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Other Adjustments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other Adjustments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjustments to correct other errors that are quantitatively and qualitatively immaterial, individually and in the aggregate are as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $0.2&#160;million in 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company had previously understated its right-of-use assets and lease liability by $0.3&#160;million related to its facilities in Redwood City, California at each balance sheet in 2024 and 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also identified certain errors as a result of imprecise calculations related to its research and development tax credits that should have been corrected in the consolidated financial statements for the year ended December 31, 2023. Such amounts are deemed immaterial to the Company&#8217;s income tax provision for the years ended December 31, 2024 and 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remainder of the notes to the Company&#8217;s financial statements have been restated, as applicable, to reflect the impacts from the restatement discussed above. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Impact of the Restatement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represent the restated amounts in the Consolidated Balance Sheet, Statement of Operations and Comprehensive Loss, and Statement of Cash Flows for the year ended December&#160;31, 2023 (in thousands, except per share data).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts as previously reported for fiscal year 2023 were derived from the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, filed on March 18, 2024 and the amounts previously reported for the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024 were derived from the Company&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods within those years (the &#8220;Previously Reported Amounts&#8221;). The Previously Reported Amounts are labeled as &#8220;As Reported&#8221; in the tables below. The amounts labeled &#8220;Adjustment&#8221; represent the effects of this restatement described above.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative effect of the error on periods prior to 2023 was $11.3&#160;million which is included in the beginning balance of the accumulated deficit of the restated Consolidated Balance Sheet for the year ended December 31, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Balance Sheet</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(995)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,546&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2023: 10,143 shares issued and outstanding at December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(919,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936,024)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,243)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,165)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,116)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,107)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,058)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.62)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Cash Flows</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impact on net cash used in operating activities or within any line items within investing and financing activities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company&#8217;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United&#160;States of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain, and the actual results could differ from these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 2024 Reverse Stock Split</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;On March 21, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the reverse stock split. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity related information including per share amounts for all periods presented in these consolidated financial statements and the notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where the local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Upon sale or upon complete or substantially complete liquidation of an investment in a foreign entity, the amount attributable to that entity and accumulated in the translation adjustment component of equity is removed from the separate component of equity and reported as part of the gain or loss on sale or liquidation of the investment for the period during which the sale or liquidation occurs. Income and expense accounts are translated at average exchange rates for the period. Transactions which are not in the functional currency of the entity are remeasured into the functional currency and gains or losses resulting from the remeasurement recorded in other income, net.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company considers all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks, money market accounts and highly liquid debt securities. Cash equivalents are stated at fair value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Restricted cash primarily consists of cash collateral to letter of credit provided to the landlord in relation to a lease agreement. See Note 6, Leases for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Short-Term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;All short-term investments in debt securities have been classified as &#8220;available for sale&#8221; and are carried at fair value. Unrealized gains and losses, net of any related tax effects, are excluded from earnings and are included in other comprehensive loss and reported as a separate component of stockholders&#8217; equity until realized. The cost of securities sold is based on the specific-identification method. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Interest on short-term investments is included in other income, net in the Company&#8217;s consolidated statements of operations and comprehensive loss. In accordance with the Company&#8217;s investment policy, management invests to diversify credit risk and only invests in securities with high credit quality, including U.S. government securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses available-for-sale debt securities on a quarterly basis to see whether any unrealized loss is due to credit-related factors. Factors considered in determining whether an impairment is credit-related include the extent to which the investment&#8217;s fair value is less than its cost basis, declines in published credit ratings, changes in interest rates, and any other adverse factors related to the security. If it is determined that a credit-related impairment exists, the Company will measure the credit loss based on a discounted cash flow model. Credit-related impairments on available-for-sale debt securities are recognized as an allowance for credit losses with a corresponding adjustment to other income, net in the Company&#8217;s consolidated statement of operations. The unrealized loss position that is not credit-related is recorded, net of any related tax effects, in other comprehensive income until realized. There were no credit-related losses recognized for the periods presented.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Interest Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Accrued interest receivable related to the Company&#8217;s available-for-sale debt securities is presented within prepaid expenses and other current assets on the Company&#8217;s consolidated balance sheets. The Company has elected to exclude accrued interest receivable from both the fair value and the amortized cost basis of available-for-sale debt securities for the purposes of identifying and measuring any impairment. The Company writes off accrued interest receivable once it has determined that the asset is not realizable. Any write offs of accrued interest receivable are recorded by reversing interest income, recognizing credit loss expense, or a combination of both. To date, the Company has not written off any accrued interest receivables associated with its available-for-sale debt securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing gene therapeutics. The Company&#8217;s chief executive officer, who is the chief operating decision maker (&#8220;CODM&#8221;), assesses segment performance and decides how to allocate resources based on total operating expenses as reported on the consolidated statements of operations and comprehensive loss. See Note 11, Segment Reporting, for additional information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Risks associated with cash, cash equivalents, short-term investments are mitigated by the Company&#8217;s investment policy, which limits the Company&#8217;s investing to securities having specified credit ratings. Management believes that the Company is not exposed to significant credit risk.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to certain risks and uncertainties, including, but not limited to changes in any of the following areas that the Company believes could have a material adverse effect on future financial position or results of operations: the ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, the Company&#8217;s product candidates; performance of third-party clinical research organizations and manufacturers; development of sales channels; protection of intellectual property; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; and the Company&#8217;s ability to attract and retain employees necessary to support growth.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets, generally <span style="-sec-ix-hidden:f-442">three</span> to five years. Leasehold improvements are capitalized and amortized over the shorter period of their expected lives or the lease term. Major replacements and improvements are capitalized, while general repairs and maintenance are expensed as incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there is an indication of impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For long-term operating leases, the Company recognizes a right-of-use asset and a lease liability on the Company's consolidated balance sheets. The Company determines if an arrangement contains a lease and the classification of the lease at inception. An arrangement contains a lease if there is an identified asset and if the Company controls the use of the identified asset throughout the period of use. The lease liability is determined as the present value of future lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when the Company is reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, the Company determines its credit rating, adjusts the credit rating for the nature of the collateral, and benchmarks the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. It bases the ROU asset on the lease liability adjusted for any prepaid or deferred rent. The Company elected to combine lease and non-lease components for all underlying assets groups. The Company determines the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, the Company does not recognize a right-of-use asset and lease liability and recognizes the lease expense over the term of the lease on a straight-line basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. The variable lease payments primarily consist of common area maintenance and other operating costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the probability of collecting lease payments under its sublease at each reporting date. The Company currently does not deem the collection of lease payments probable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, Revenue from Contracts with Customers, the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Research and development expenses are charged to expense as incurred. Research and development expenses include</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily personnel-related costs, stock-based compensation expense, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with contract research organizations (&#8220;CROs&#8221;), the cost of acquiring, developing and manufacturing clinical trial materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advance payments for goods or services for future research and development activities are deferred and expensed as the goods are delivered or the related services are performed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates research and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage nonclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers and the Company&#8217;s estimates of accrued expenses and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual accordingly. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The carrying amounts of the Company&#8217;s financial instruments, including cash equivalents approximate their fair values due to their short-term maturities. See Note 4, Fair Value Measurements for the methodologies and assumptions used in valuing financial instruments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Stock-based compensation expense related to stock awards to employees is measured at fair value of the award on the date of the grant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the grant-date fair value, and the resulting stock-based compensation expense, using the Black-Scholes valuation model for stock options and employee stock purchase and using intrinsic value, which is the closing price of its common stock on the date of the grant, for restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense recognition of PSU and performance-based options commences when the associated performance-based criteria are determined to be probable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes valuation model requires the use of following assumptions:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term assumption represents the period that the Company&#8217;s stock-based awards are expected to be outstanding and is determined using the simplified method.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Expected volatility is based on the Company&#8217;s historical stock price volatility. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero-coupon issues in effect at the time of grant for periods corresponding with the expected term of option.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company accounts for income taxes using the asset and liability method. The Company records deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As of December&#160;31, 2024 and 2023, the Company has recorded a full valuation allowance on its deferred tax assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained upon examination. Interest and penalties related to unrecognized tax liabilities are included within the provision for income tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Comprehensive loss comprises net loss and other comprehensive loss. Other comprehensive loss consists of foreign currency translation adjustments and unrealized gain or loss on marketable securities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic and Diluted Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. Outstanding stock options, RSUs, and employee stock purchase plan (&#8220;ESPP&#8221;) are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires disaggregated disclosures of certain categories of expenses in the notes to the financial statements that are included in expense line items on the face of the income statement in annual and interim periods. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2023-07&#8221;). The amendments in ASU 2023-07 are intended to improve reportable segment disclosure, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company retrospectively adopted ASU 2023-07 on December 31, 2024. The adoption of ASU 2023-07 did not have a material financial impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements and Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value Measurements and Fair Value of Financial Instruments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Level 1 securities is determined using quoted prices in active markets for identical assets. Level 1 securities consist of highly liquid money market funds. Financial assets and liabilities are considered Level 2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level 2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. government and agency securities, commercial paper and corporate bonds are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level 2.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s cash equivalents and short-term investments (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,974&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,039&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company may sell these securities at any time for use in current operations even if the securities have not yet reached maturity, all marketable securities are classified as current assets in the Company&#8217;s consolidated balance sheets. As of December&#160;31, 2024, all marketable securities had a remaining maturity of less than one year. The Company held 14 debt securities in an unrealized loss position with an aggregate fair value at December&#160;31, 2024 of $54.2&#160;million. These are highly liquid funds with high credit ratings with final maturity of less than one year from the balance sheet date. There were no individual securities that were in a significant unrealized loss position as of December&#160;31, 2024 and 2023. The Company has not recorded an allowance for credit losses as of December&#160;31, 2024 or 2023 related to these securities. The accrued interest receivable on available-for-sale marketable securities was immaterial at December&#160;31, 2024 or 2023. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. The Company has not recorded any impairment charges on available-for-sale securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lexeo</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2021, the Company and Lexeo Therapeutics, Inc (&#8220;Lexeo&#8221;) entered into a License Agreement pursuant to which the Company granted Lexeo an exclusive, worldwide, royalty-bearing license to certain of the Company&#8217;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat cardiomyopathy due to Friedreich&#8217;s Ataxia. Upon execution of the agreement, Lexeo paid the Company a one-time, non-creditable and non-refundable upfront payment of $7.5&#160;million.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, the Company is eligible to receive additional payments upon the achievement of certain milestones. Additionally, the Company will receive royalty payments on net sales subject to a cap and reductions based on patent expiry, anti-stacking, and a defined royalty floor percentage.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, Lexeo notified the Company that it had achieved the first development milestone; accordingly, the Company received and recognized $3.5&#160;million of license revenue during the year ended December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ray</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2023, the Company and Ray Therapeutics, Inc (&#8220;Ray&#8221;) entered into a License Agreement pursuant to which the Company granted Ray a non-exclusive, worldwide, royalty-bearing license to certain of the Company&#8217;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat retinitis pigmentosa and the right to develop the technology to treat other ocular diseases and disorders. Under the terms of the agreement, the Company is eligible to receive development, regulatory and commercial milestone payments and royalties on net sales once commercialized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, Ray notified the Company that it achieved the first development milestone. Accordingly, the Company recognized $1.0&#160;million of license revenue during the year ended December&#160;31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redwood City</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a lease for facilities in Redwood City, California (&#8220;Redwood City Premises&#8221;), which expires December&#160;31, 2031, with an option to extend for a period of eight years. Related to this lease, the Company provided the landlord with a letter of credit, as amended, in the amount of $2.0&#160;million, which is classified as restricted cash under long-term assets on the Company&#8217;s consolidated balance sheets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to September 30, 2023, the Company had two facility leases in Redwood City. In March 2023, the Company entered into an amendment to accelerate the expiration of the lease for one of the facilities in its Redwood City Premises from December 31, 2031 to September 30, 2023. Concurrently, the Company entered into an agreement for additional tenant improvement allowance towards its other Redwood City Premises. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). As a result of the modification the Company revalued the lease liability based on the new and remaining lease terms, which resulted in a reduction to the lease liability of $7.9&#160;million, and recognized the remeasurement to the lease liabilities as an adjustment to the right-of-use asset. The estimated value of non-cash consideration, composed primarily of leasehold improvements and furniture and fixtures, was $14.9&#160;million, which was fully amortized as of September 30, 2023. There was no charge recognized in the consolidated statement of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North Carolina</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has restated amounts related to this lease. See Notes 2 and 14.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 8, 2021, the Company entered into an operating lease agreement for a building in North Carolina (&#8220;NC Premises&#8221;). The lease commenced in April 2021, when the Company obtained control of the NC Premises, and the lease term expires in October 2037 with two options to extend the lease term for a period of five years each.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2021, the Company entered into a sublease agreement with Jaguar Gene Therapy, LLC (&#8220;Jaguar&#8221;) for the NC Premises through October 2037, the remainder of the lease term, and concurrently changed the terms of the head lease. In addition, the remainder of the tenant improvement allowance under the original lease of approximately $22.7&#160;million was transferred to Jaguar.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2023, the Company entered into an amendment of the lease of its NC Premises with the landlord and subtenant. Under this amendment, the parties agreed to substantially reduce the total tenant improvement allowance in exchange for lower monthly rent. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). The Company remeasured the lease liability, resulting in an increase in the lease liability with a corresponding increase of the right-of-use asset of $0.3&#160;million in the quarter ended June 30, 2023. There was no charge recognized in the consolidated statement of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, management reassessed the probability of collection of the lease payments from Jaguar over the remaining term of a sublease. At that time, management assessed the collectibility to be less than probable and recognized an adjustment to eliminate the deferred rent receivable as a current period adjustment during the year ended December 31, 2022. Deferred rent receivable was&#160;zero&#160;as of December&#160;31, 2024 and 2023. In April 2023, Jaguar assigned the sublease to Advanced Medicine Partners, LLC (at that time, a wholly-owned subsidiary of Jaguar, &#8220;AMP&#8221; or the &#8220;subtenant&#8221;) as the subtenant for the NC Premises for the remainder of the lease term. Pursuant to the sublease and the notice and waiver of assignment (the &#8220;assignment agreement&#8221;), Jaguar remained obligated for AMP&#8217;s proper performance under the sublease. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, a lien totaling $4.8&#160;million was filed by a third&#8211;party contractor against the subtenant&#8217;s interest in the NC&#160;Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. Subsequent to December 31, 2024, the subtenant made payments totaling $1.4&#160;million for January and February 2025 rent and drew $2.3&#160;million from the available tenant improvement allowance, at which point the subtenant discontinued rent payments. The Company assumed responsibility for rent payments in March 2025 and as of April 7, 2025 had made payments in the total payment of $1.9&#160;million to satisfy outstanding rent and common area management fee obligations. See Note 15 Subsequent Events.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded sublease loss of $14.0&#160;million and sublease income of $0.1&#160;million for the years ended December 31, 2024 and 2023, respectively, which was recognized in general and administrative expense.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the weighted-average remaining lease term was 11.2 years for the Company&#8217;s leases and the weighted-average Incremental Borrowing Rate (&#8220;IBR&#8221;) was 11.6%. As of December 31, 2023, the weighted-average remaining lease term was 11.6 years for the Company&#8217;s leases and the weighted-average IBR was 11.7%.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the undiscounted future non-cancellable lease payments under the lease agreements as of December&#160;31, 2024 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,460)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Rent expense for the years ended December&#160;31, 2024, and 2023 was $13.3&#160;million and $25.3&#160;million, respectively. Included in rent expense for the years ended December&#160;31, 2024, and 2023 were variable lease costs for utilities, parking, maintenance, and real estate taxes of $2.3 million and $2.4 million, respectively. Cash paid for amounts included in the measurement of lease liabilities was $5.8&#160;million and $7.5&#160;million for the twelve months ended December&#160;31, 2024 and 2023, respectively. During the years ended December&#160;31, 2024 and 2023, the landlord made payments to the subtenant on the Company&#8217;s behalf for tenant improvement allowances in the amount of $20.5&#160;million and $5.4&#160;million and the subtenant made rent payments to the landlord on the Company&#8217;s behalf in the amount of $6.5&#160;million and $5.5&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,638&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,586&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,045)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,512)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued nonclinical, clinical and process development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various agreements, principally relating to licensed technology that requires future payments relating to milestones or royalties on future sales of specified products. The Company recognized license revenue of $1.0&#160;million for the first development milestone in the Ray License Agreement and $3.5&#160;million for the first development milestone in the Lexeo License Agreement during the years ended December&#160;31, 2024 and 2023, respectively. See Note 5, Revenue, for additional information. Because achievement of these future milestones is not fixed and determinable, such amounts have not been included on the Company&#8217;s consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">February 2024 Private Placements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2024, the Company entered into a securities purchase agreement, pursuant to which the Company sold 10.5&#160;million shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase an aggregate of 75,000 shares of common stock (the &#8220;Pre-Funded Warrants&#8221;) to certain institutional and accredited investors in a private placement. The purchase price per share was $12.00, or $11.999 per Pre-Funded Warrant, which represents the purchase price per share minus the $0.001 per share exercise price of each Pre-Funded Warrant. Such Pre-Funded Warrants can be exercised at any time and have no expiration date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise of the outstanding Pre-Funded Warrants is subject to a beneficial ownership limitation of 9.99%. The Pre-Funded Warrants were classified as a component of stockholders&#8217; equity. As of December&#160;31, 2024, none of the Pre-Funded Warrants had been exercised.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently, the Company also entered into a securities purchase agreement with two directors of the Company (together with the private placement to certain institutional and accredited investors, the &#8220;Private Placements&#8221;). The Company issued and sold 23,000 shares at $13.50 per share on otherwise substantially the same terms as those set forth in the Securities Purchase Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the close of the Private Placements on February 7, 2024, the Company received total gross proceeds of $127.8&#160;million, before deducting placement agent fees and offering expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss included $0.5 million and $0.4 million of accumulated currency translation adjustments as of December&#160;31, 2024 and 2023, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company&#8217;s board of directors and its stockholders approved the establishment of the 2014 Equity Incentive Award Plan (the &#8220;2014 Plan&#8221;). The 2014 Plan provided for annual increases in the number of shares available for issuance thereunder on the first business day of each fiscal year, beginning with the year ended December 31, 2015, equal to four percent (4%) of the number of shares of the Company&#8217;s common stock outstanding as of such date or a lesser number of shares as determined by the Company&#8217;s board of directors. In June 2024, the Company adopted the 2024 Equity Incentive Award Plan (the &#8220;2024 Plan&#8221;). The Company reserved 4,688,345 shares for issuance pursuant to awards under the 2024 Plan. As of the effective date of the 2024 Plan, no further awards may be granted under the 2014 Plan. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, the Company adopted the 2017 Inducement Plan (the &#8220;Inducement Plan&#8221;). The Company originally reserved 600,000 shares for issuance pursuant to stock options and RSUs under the Inducement Plan. The only persons eligible to receive grants of stock options and RSUs under the Inducement Plan are individuals who satisfy the standards for inducement grants under Nasdaq guidance, that is, generally, a person not previously an employee or director of Adverum, or following a bona fide period of non-employment, as an inducement material to the individual&#8217;s entering into employment with Adverum.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2014 Plan, 2024 Plan and Inducement Plan are referred to collectively as the Plans. As of December&#160;31, 2024, a total of 1,277,999 shares were available for future issuance under the Plans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options under the 2024 Plan and the Inducement Plan may be granted for periods of up to 10 years and at prices no less than 100% of the estimated fair value of the shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an ISO and NSO granted to a 10% stockholder may not be less than 110% of the estimated fair value of the shares on the date of grant. Stock options granted to employees and non-employees generally vest ratably over four years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining Contract<br/>Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(a)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company&#8217;s common stock as quoted on a national exchange.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised during the years ended December&#160;31, 2024 and 2023 was not material.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair values of options granted during the years ended December&#160;31, 2024 and 2023 were $8.12 and $7.96, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, there was $17.1 million of unrecognized stock-based compensation expense related to stock options that was expected to be recognized over a weighted-average period of 2.6 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#8217;s common stock upon vesting. The fair value of RSUs is based upon the closing sales price of the Company&#8217;s common stock on the grant date. RSUs granted to employees generally vest over a three-year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the RSU activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except grant date fair value and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term<br/>(in years)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2024 and 2023, total fair value of RSUs vested was $0.8&#160;million and $1.5&#160;million, respectively. The number of RSUs vested includes shares of common stock that the Company withheld on behalf of employees or sold to cover to satisfy the minimum statutory tax withholding requirements. As of December&#160;31, 2024, there was $1.7&#160;million of unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted-average period of 1.8 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2014, the Company approved the establishment of the 2014 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The Company reserved 208,833&#160;shares of its common stock for issuance and provided for annual increases in the number of shares available for issuance on the first business day of each fiscal year, beginning in 2015, equal to the lesser of one percent (1%)&#160;of the number of the Company&#8217;s common stock shares outstanding as of such date or a number of shares as determined by the Company&#8217;s board of directors. During the years ended December&#160;31, 2024 and 2023, 88,199 and 82,422 shares were issued under the ESPP, respectively. As of December&#160;31, 2024, a total of 533,978 shares of common stock were available for future issuance under the ESPP. As of December&#160;31, 2024, there was $0.5&#160;million of unrecognized compensation cost related to the ESPP.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Recognized in the Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s stock-based compensation expense:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,569&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Savings Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">401(k) Savings Plan</a></td>
<td class="text">401(k) Savings Plan<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established a defined-contribution savings plan under Section 401(k) of the Code. The 401(k) Plan covers all employees who meet defined minimum age and service requirements, and allows participants to defer a portion of their annual compensation on a pretax basis. The amount of contributions that the Company made to the 401(k) Plan during the years ended December&#160;31, 2024 and 2023 was $0.9 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM assesses performance for the Company&#8217;s single reportable segment and decides how to allocate resources based on the Company&#8217;s total operating expenses as reported on the consolidated statements of operations and comprehensive loss. The CODM&#8217;s review of total operating expenses at the consolidated level is used to monitor the Company&#8217;s spending as well as budget versus actual results. The Company&#8217;s reportable segment primarily generates revenue through its license agreements (see Note 5).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the CODM&#8217;s review of the segment&#8217;s performance, the CODM reviews the Company&#8217;s operating expense information, grouped by certain detailed line items from the internal income statement reporting. This includes research and development costs as well as general and administrative expenses. Based upon the operating expense information, the CODM can reconcile to net loss as reported on the consolidated statements of operations and comprehensive loss, shown in the table below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the segment loss, including significant segment expenses, for the years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License Revenue</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial and manufacturing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and IT</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">140,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128,942)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (provision)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment and consolidated net loss</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(130,927)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(122,116)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other segment expenses include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, all of the Company&#8217;s property and equipment was maintained in the United States. For each of the years ended December&#160;31, 2024 and 2023, all of the Company&#8217;s license revenue was generated in the United States.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the restatement, the Company adjusted the 2023 California research and development tax credit amounts as a result of a research and development credit study performed during 2024. This resulted in a net decrease of $3.4&#160;million in the deferred tax asset balance related to the California research and development tax credit (net of a decrease in unrecognized tax benefits of $1.9&#160;million) and a corresponding decrease in valuation allowance in 2023. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents domestic and foreign components of loss before provision for income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,768)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,040)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s income tax (benefit) provision were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit) provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for the years ended December&#160;31, 2024 and 2023 differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax loss as a result of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of internal reorganization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax (benefit) provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents significant components of the Company&#8217;s deferred tax assets and liabilities:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserve and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;D capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. Based on the Company&#8217;s history of operating losses, the Company has concluded that it is more likely than not that the benefit of its deferred tax assets will not be realized. Accordingly, the Company has provided a full valuation allowance for deferred tax assets as of December&#160;31, 2024 and 2023. The valuation allowance increased approximately $26.2&#160;million and $17.7&#160;million during the years ended December&#160;31, 2024 and 2023, respectively, mainly driven by net operating losses (&#8220;NOLs&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had U.S. federal NOLs carryforwards of approximately $552.7&#160;million to offset any future federal income. Approximately $57.3&#160;million of NOLs expire at various years beginning with 2032. As of December&#160;31, 2024, the Company also had U.S. state NOL carryforwards of approximately $345.2&#160;million to offset any future state income. U.S. state NOLs expire at various years beginning with 2037. At December&#160;31, 2024, the Company also had approximately $49.5&#160;million of foreign net operating loss carryforwards which may be available to offset future foreign income; these carryforwards do not expire.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had federal research and development tax credit carryforwards of approximately $25.1&#160;million available to reduce future tax liabilities which expire at various years beginning with 2036. As of December&#160;31, 2024, the Company had state credit carryforwards of approximately $13.8&#160;million available to reduce future tax liabilities which do not expire.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section 382 and 383 of the Code, our ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company has experienced an &#8220;ownership change.&#8221; Generally, a Section 382 ownership change occurs if there is a cumulative increase of more than 50 percentage points in the stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#8217;s stock within a specified testing period. Similar rules may apply under state tax laws. The Company is conducting a Section 382 study, which is still subject to finalization, but which may show that the Company experienced an ownership change in 2024. If such an ownership change has occurred then up to vast majority of the NOLs, capital losses and research credit carryforwards presented in the consolidated financial statements would be subject to limitations and therefore may expire unutilized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal, state, and foreign jurisdictions. The federal, state and foreign income tax returns are open under the statute of limitations subject to tax examinations for the tax years ended December&#160;31, 2019 through December&#160;31, 2023. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state or foreign tax authorities to the extent utilized in a future period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has total unrecognized tax benefits as of December&#160;31, 2024 and 2023 of approximately $27.2&#160;million and $22.8&#160;million, respectively. If the unrecognized tax benefits for uncertain tax positions as of December 31, 2023, is recognized, there will be no impact to the effective tax rate as the tax benefit would increase the net deferred tax assets, which is currently offset with a full valuation allowance. A&#160;reconciliation of the unrecognized tax benefits is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the beginning of the year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax positions taken during the prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax positions taken during the prior year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax position taken during the current year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax position taken during the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the end of the year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,758&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2024 and 2023, the Company had no accrued interest and penalties related to uncertain tax positions and no amount has been recognized in the Company's consolidated statement of operations and comprehensive loss. There are no ongoing examinations by taxing authorities at this time.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text">Net Loss per Share<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2024, the Pre-Funded Warrants to purchase the Company's shares of common stock issued in the Private Placements were included in the basic and diluted net loss per share calculation as the exercise price is non-substantive and virtually assured.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents outstanding at the end of the periods presented were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information</a></td>
<td class="text">Quarterly Financial Information (Unaudited)<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The previously reported financial information for the three months ended March&#160;31, 2024, three and six months ended June&#160;30, 2024 and the three and nine months ended September&#160;30, 2024 and the comparable periods in 2023, has been restated. Relevant restated financial information for each period is included in this restatement and for other immaterial adjustments in the tables that follow. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restatement Related to NC Premises</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 2, the Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for a tenant improvement allowances that were conveyed to the subtenant resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended June 30, 2024, the Company inappropriately assessed the collectibility of the sublease payments as probable and recorded a deferred rent receivable of $7.0&#160;million. The Company corrected its collectibility assessment and recognized an adjustment to eliminate the $7.0 million and $7.1&#160;million deferred rent receivable in the second and third quarters of 2024, respectively, the amounts of which are included in the tables below with reference (b).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Adjustments</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this restatement, the Company has corrected certain other immaterial errors. These adjustments are described in more detail references (c) and (d) as follows:</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $0.2&#160;million in 2022.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company had previously understated its right-of-use assets and lease liability by $0.3&#160;million related to its facilities in Redwood City, California at each balance sheet date in 2024 and 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented (in thousands, except per share data).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,131)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,846)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,803&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,006)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,629)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,803&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,971)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,288&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,546&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,457)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(863,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,927)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,993)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,912)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(845,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,912)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly and Year to Date Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,438)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,942)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,541)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,351)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,397)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,996)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,094)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,791)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.30)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.63)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.64)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,882)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,904)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,721)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,476)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,498)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,490)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.31)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.08)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,787)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,207)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.50)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,529&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,529)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,833)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,994)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,661</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,661</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,437</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,437</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,868)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,398)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,396)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,557)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,415)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,451)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,831)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,633)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.26)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.31)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.28)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.69)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,065)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,935)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,489)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,525)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,317)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,332)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,272)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.13)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.23)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.02)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.39)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,239)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,655)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,672)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,324)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,940)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.90)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.16)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>Statements of Cash Flows<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of this restatement on certain line items of the condensed consolidated statements of cash flows are summarized in the following tables (in thousands). There was no impact on net cash used in operating activities or within any line items within investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,566)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 270<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/270/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2025, a lien in the amount of $4.8&#160;million was filed by a third-party contractor against the subtenant's interest in the NC Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the Company assumed responsibility for such payments in March 2025 and as of April 7, 2025 had made a total amount of $1.9&#160;million to satisfy outstanding rent and common area management fee obligations. The Company remains obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $119.7&#160;million for the remainder of the head lease term, of which $5.7&#160;million is due between April 8 and December 31, 2025. As a result of the uncured defaults, the Company terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce its rights under the sublease and to seek recovery of losses and damages incurred due to the defaults by the subtenant and Jaguar.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,351)<span></span>
</td>
<td class="num">$ (30,498)<span></span>
</td>
<td class="num">$ (27,147)<span></span>
</td>
<td class="num">$ (33,415)<span></span>
</td>
<td class="num">$ (32,525)<span></span>
</td>
<td class="num">$ (31,672)<span></span>
</td>
<td class="num">$ (57,645)<span></span>
</td>
<td class="num">$ (64,197)<span></span>
</td>
<td class="num">$ (89,996)<span></span>
</td>
<td class="num">$ (97,612)<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (122,116)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third-party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data (&#8220;Information Systems and Data&#8221;).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information security function, which includes our Vice President of Information Technology (&#8220;IT&#8221;) and third-party service providers, legal department and security committee, helps identify, assess, and manage the Company&#8217;s cybersecurity threats and risks. Our information security function identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example: using automated tools, conducting audits, evaluating threats, and performing vulnerability assessments.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the environment, systems, and data at issue, we implement and maintain various technical, physical, and organizational measures, processes, and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: cybersecurity insurance, physical security, incident detection and response, access controls, employee training, penetration testing, and systems monitoring.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assessment and management of material risks from cybersecurity threats are integrated into the Company&#8217;s overall risk management processes. For example, our Vice President of IT, works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party service providers to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats, including for example: cybersecurity software providers, managed cybersecurity service providers, penetration testing firms, and cybersecurity consultants. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party service providers to perform a variety of functions throughout our business, such as contract research organizations, contract manufacturing organizations, and supply chain resources. We have a vendor management process to manage cybersecurity risks associated with certain of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of diligence designed to help identify cybersecurity risks associated with a provider such as risk assessments and reviewing security assessments and reports. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including the risk factor entitled: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our information technology systems or those third parties with whom we work, or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; material disruption of our product development programs; and other adverse consequences.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third-party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data (&#8220;Information Systems and Data&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#8217;s overall risk management strategy, and helping prepare for cybersecurity incidents. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#8217;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#8217;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents. </span></div>The Board of Directors receives periodic reports from the management concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Board of Directors also has access to various reports, summaries or presentations related to cybersecurity threats, risk, and mitigation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#8217;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.</span></div>Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#8217;s overall risk management strategy, and helping prepare for cybersecurity incidents. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#8217;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#8217;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents. </span></div>The Board of Directors receives periodic reports from the management concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Board of Directors also has access to various reports, summaries or presentations related to cybersecurity threats, risk, and mitigation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies. </span></div>Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#8217;s overall risk management strategy, and helping prepare for cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#8217;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#8217;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company&#8217;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United&#160;States of America (&#8220;U.S.&#160;GAAP&#8221;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain, and the actual results could differ from these estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">March 2024 Reverse Stock Split</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 2024 Reverse Stock Split</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;On March 21, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the reverse stock split. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity related information including per share amounts for all periods presented in these consolidated financial statements and the notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where the local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Upon sale or upon complete or substantially complete liquidation of an investment in a foreign entity, the amount attributable to that entity and accumulated in the translation adjustment component of equity is removed from the separate component of equity and reported as part of the gain or loss on sale or liquidation of the investment for the period during which the sale or liquidation occurs. Income and expense accounts are translated at average exchange rates for the period. Transactions which are not in the functional currency of the entity are remeasured into the functional currency and gains or losses resulting from the remeasurement recorded in other income, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company considers all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks, money market accounts and highly liquid debt securities. Cash equivalents are stated at fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Restricted cash primarily consists of cash collateral to letter of credit provided to the landlord in relation to a lease agreement. See Note 6, Leases for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Short-Term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;All short-term investments in debt securities have been classified as &#8220;available for sale&#8221; and are carried at fair value. Unrealized gains and losses, net of any related tax effects, are excluded from earnings and are included in other comprehensive loss and reported as a separate component of stockholders&#8217; equity until realized. The cost of securities sold is based on the specific-identification method. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Interest on short-term investments is included in other income, net in the Company&#8217;s consolidated statements of operations and comprehensive loss. In accordance with the Company&#8217;s investment policy, management invests to diversify credit risk and only invests in securities with high credit quality, including U.S. government securities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses available-for-sale debt securities on a quarterly basis to see whether any unrealized loss is due to credit-related factors. Factors considered in determining whether an impairment is credit-related include the extent to which the investment&#8217;s fair value is less than its cost basis, declines in published credit ratings, changes in interest rates, and any other adverse factors related to the security. If it is determined that a credit-related impairment exists, the Company will measure the credit loss based on a discounted cash flow model. Credit-related impairments on available-for-sale debt securities are recognized as an allowance for credit losses with a corresponding adjustment to other income, net in the Company&#8217;s consolidated statement of operations. The unrealized loss position that is not credit-related is recorded, net of any related tax effects, in other comprehensive income until realized. There were no credit-related losses recognized for the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedInterestReceivablePolicyTextBlock', window );">Accrued Interest Receivable</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Interest Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Accrued interest receivable related to the Company&#8217;s available-for-sale debt securities is presented within prepaid expenses and other current assets on the Company&#8217;s consolidated balance sheets. The Company has elected to exclude accrued interest receivable from both the fair value and the amortized cost basis of available-for-sale debt securities for the purposes of identifying and measuring any impairment. The Company writes off accrued interest receivable once it has determined that the asset is not realizable. Any write offs of accrued interest receivable are recorded by reversing interest income, recognizing credit loss expense, or a combination of both. To date, the Company has not written off any accrued interest receivables associated with its available-for-sale debt securities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing gene therapeutics. The Company&#8217;s chief executive officer, who is the chief operating decision maker (&#8220;CODM&#8221;), assesses segment performance and decides how to allocate resources based on total operating expenses as reported on the consolidated statements of operations and comprehensive loss. See Note 11, Segment Reporting, for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Other Uncertainties</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Risks associated with cash, cash equivalents, short-term investments are mitigated by the Company&#8217;s investment policy, which limits the Company&#8217;s investing to securities having specified credit ratings. Management believes that the Company is not exposed to significant credit risk.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to certain risks and uncertainties, including, but not limited to changes in any of the following areas that the Company believes could have a material adverse effect on future financial position or results of operations: the ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, the Company&#8217;s product candidates; performance of third-party clinical research organizations and manufacturers; development of sales channels; protection of intellectual property; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; and the Company&#8217;s ability to attract and retain employees necessary to support growth.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets, generally <span style="-sec-ix-hidden:f-442">three</span> to five years. Leasehold improvements are capitalized and amortized over the shorter period of their expected lives or the lease term. Major replacements and improvements are capitalized, while general repairs and maintenance are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there is an indication of impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For long-term operating leases, the Company recognizes a right-of-use asset and a lease liability on the Company's consolidated balance sheets. The Company determines if an arrangement contains a lease and the classification of the lease at inception. An arrangement contains a lease if there is an identified asset and if the Company controls the use of the identified asset throughout the period of use. The lease liability is determined as the present value of future lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when the Company is reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, the Company determines its credit rating, adjusts the credit rating for the nature of the collateral, and benchmarks the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. It bases the ROU asset on the lease liability adjusted for any prepaid or deferred rent. The Company elected to combine lease and non-lease components for all underlying assets groups. The Company determines the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, the Company does not recognize a right-of-use asset and lease liability and recognizes the lease expense over the term of the lease on a straight-line basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. The variable lease payments primarily consist of common area maintenance and other operating costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the probability of collecting lease payments under its sublease at each reporting date. The Company currently does not deem the collection of lease payments probable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, Revenue from Contracts with Customers, the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Research and development expenses are charged to expense as incurred. Research and development expenses include</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily personnel-related costs, stock-based compensation expense, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with contract research organizations (&#8220;CROs&#8221;), the cost of acquiring, developing and manufacturing clinical trial materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advance payments for goods or services for future research and development activities are deferred and expensed as the goods are delivered or the related services are performed.</span></div>The Company estimates research and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage nonclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers and the Company&#8217;s estimates of accrued expenses and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual accordingly.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The carrying amounts of the Company&#8217;s financial instruments, including cash equivalents approximate their fair values due to their short-term maturities. See Note 4, Fair Value Measurements for the methodologies and assumptions used in valuing financial instruments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Stock-based compensation expense related to stock awards to employees is measured at fair value of the award on the date of the grant.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the grant-date fair value, and the resulting stock-based compensation expense, using the Black-Scholes valuation model for stock options and employee stock purchase and using intrinsic value, which is the closing price of its common stock on the date of the grant, for restricted stock units (&#8220;RSUs&#8221;) and performance stock units (&#8220;PSUs&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expense recognition of PSU and performance-based options commences when the associated performance-based criteria are determined to be probable. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes valuation model requires the use of following assumptions:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term assumption represents the period that the Company&#8217;s stock-based awards are expected to be outstanding and is determined using the simplified method.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Expected volatility is based on the Company&#8217;s historical stock price volatility. </span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the U.S. Treasury zero-coupon issues in effect at the time of grant for periods corresponding with the expected term of option.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company accounts for income taxes using the asset and liability method. The Company records deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As of December&#160;31, 2024 and 2023, the Company has recorded a full valuation allowance on its deferred tax assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained upon examination. Interest and penalties related to unrecognized tax liabilities are included within the provision for income tax.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss</span>&#8212;Comprehensive loss comprises net loss and other comprehensive loss. Other comprehensive loss consists of foreign currency translation adjustments and unrealized gain or loss on marketable securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic and Diluted Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. Outstanding stock options, RSUs, and employee stock purchase plan (&#8220;ESPP&#8221;) are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2024-03&#8221;). ASU 2024-03 requires disaggregated disclosures of certain categories of expenses in the notes to the financial statements that are included in expense line items on the face of the income statement in annual and interim periods. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2023-07&#8221;). The amendments in ASU 2023-07 are intended to improve reportable segment disclosure, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company retrospectively adopted ASU 2023-07 on December 31, 2024. The adoption of ASU 2023-07 did not have a material financial impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedInterestReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedInterestReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Restatement of Previously Issued Financial Statements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Balance Sheet</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposit and other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,933)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(995)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,546&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2023: 10,143 shares issued and outstanding at December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(919,777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936,024)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,242)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,676&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,942)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,243)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,165)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,116)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive gain:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,107)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,058)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share - basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.62)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.11)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding - basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,082&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Cash Flows</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets and liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash Equivalents and Short-term Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s cash equivalents and short-term investments (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,974&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,039&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost Basis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and short-term investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Undiscounted Future Lease Payments under Operating Lease</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the undiscounted future non-cancellable lease payments under the lease agreements as of December&#160;31, 2024 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed Interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,460)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,963&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,638&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,779&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,586&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,045)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,512)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,764&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued nonclinical, clinical and process development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,620&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except exercise prices and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining Contract<br/>Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(a)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company&#8217;s common stock as quoted on a national exchange.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Option Issued Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Stock Purchase Plan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the RSU activity under the Company&#8217;s stock plans and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except grant date fair value and years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term<br/>(in years)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s stock-based compensation expense:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,969&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,350&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,569&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the segment loss, including significant segment expenses, for the years ended December&#160;31, 2024 and 2023 (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License Revenue</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial and manufacturing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and IT</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">140,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(139,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(128,942)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (provision)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment and consolidated net loss</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(130,927)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(122,116)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other segment expenses include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Loss Before Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents domestic and foreign components of loss before provision for income taxes:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,768)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,040)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,927)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,194)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax (Benefit) Provision</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company&#8217;s income tax (benefit) provision were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax (benefit) provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax (benefit) provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for the years ended December&#160;31, 2024 and 2023 differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax loss as a result of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,871)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of internal reorganization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total tax (benefit) provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text">The following table presents significant components of the Company&#8217;s deferred tax assets and liabilities:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals, reserve and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;D capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,461&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">A&#160;reconciliation of the unrecognized tax benefits is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the beginning of the year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax positions taken during the prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax positions taken during the prior year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,880)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase related to tax position taken during the current year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease related to tax position taken during the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits as of the end of the year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,758&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents outstanding at the end of the periods presented were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Information</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented (in thousands, except per share data).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,131)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,244&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,044)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,613&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,846)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,846)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,375&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,244&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,418&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,803&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,461&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,006)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,629)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(993,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,629)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,803&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,971)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(944,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,288&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,607)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,282)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,546&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896,063)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,714&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,457)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,257&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196,770&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,158)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(863,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,927)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878,105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,927)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,054)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.646%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.584%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deposit and other long-term assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease liability, current portion</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (d)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,993)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(831,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,912)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(845,580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,912)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,905)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly and Year to Date Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,217&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,541&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,438)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76,942)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,541)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,087</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,545</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,351)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,397)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,996)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,094)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,791)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.30)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.63)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.64)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,382&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,103&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,882)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,904)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,721)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,476)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,498)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,263)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,468)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,022)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,490)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,315)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.46)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.31)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.08)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024 (unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,787)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized loss on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,847)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,207)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.50)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.65)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,529&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,059&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,529)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,059)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,833)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,994)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,661</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,661</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,437</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,437</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,868)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,398)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,396)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,557)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,415)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,451)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,831)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,633)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.26)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.31)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.28)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.69)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023 (unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,065&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,065)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,080)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,935)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,489)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,504)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,528)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,525)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,317)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,015)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,332)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(63,272)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.13)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.23)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.02)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.39)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,053&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023 (unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt 0 12.25pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,839&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,239)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,655)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,672)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain on marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,324)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,940)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.90)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.16)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares used to compute net loss per share - basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of this restatement on certain line items of the condensed consolidated statements of cash flows are summarized in the following tables (in thousands). There was no impact on net cash used in operating activities or within any line items within investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deposit and other long-term assets and deferred rent receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,787)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,566)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,631)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,079)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Restated</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,056)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,616)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (c)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sublease loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental schedule of noncash information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of operating lease right-of-use assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 1,066,951<span></span>
</td>
<td class="nump">$ 936,024<span></span>
</td>
<td class="nump">$ 1,026,020<span></span>
</td>
<td class="nump">$ 993,669<span></span>
</td>
<td class="nump">$ 963,171<span></span>
</td>
<td class="nump">$ 911,520<span></span>
</td>
<td class="nump">$ 878,105<span></span>
</td>
<td class="nump">$ 845,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash used in operations</a></td>
<td class="nump">92,462<span></span>
</td>
<td class="nump">$ 90,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and short-term investments</a></td>
<td class="nump">$ 125,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense reversal</a></td>
<td class="num">$ (20,439)<span></span>
</td>
<td class="num">$ (17,097)<span></span>
</td>
<td class="num">$ (15,410)<span></span>
</td>
<td class="num">$ (20,740)<span></span>
</td>
<td class="num">$ (20,599)<span></span>
</td>
<td class="num">$ (20,869)<span></span>
</td>
<td class="num">$ (32,507)<span></span>
</td>
<td class="num">$ (41,468)<span></span>
</td>
<td class="num">$ (52,946)<span></span>
</td>
<td class="num">$ (62,208)<span></span>
</td>
<td class="num">$ (77,041)<span></span>
</td>
<td class="num">$ (77,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">34,478<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">46,598<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">33,611<span></span>
</td>
<td class="nump">35,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">1,026,020<span></span>
</td>
<td class="nump">993,669<span></span>
</td>
<td class="nump">963,171<span></span>
</td>
<td class="nump">911,520<span></span>
</td>
<td class="nump">878,105<span></span>
</td>
<td class="nump">845,580<span></span>
</td>
<td class="nump">993,669<span></span>
</td>
<td class="nump">878,105<span></span>
</td>
<td class="nump">1,026,020<span></span>
</td>
<td class="nump">911,520<span></span>
</td>
<td class="nump">$ 1,066,951<span></span>
</td>
<td class="nump">936,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense reversal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="num">(17,015)<span></span>
</td>
<td class="num">(17,241)<span></span>
</td>
<td class="num">(17,282)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="num">(17,241)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(17,015)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 35,846<span></span>
</td>
<td class="nump">$ 30,629<span></span>
</td>
<td class="nump">$ 18,607<span></span>
</td>
<td class="nump">$ 15,457<span></span>
</td>
<td class="nump">$ 14,927<span></span>
</td>
<td class="nump">13,912<span></span>
</td>
<td class="nump">$ 30,629<span></span>
</td>
<td class="nump">$ 14,927<span></span>
</td>
<td class="nump">$ 35,846<span></span>
</td>
<td class="nump">$ 15,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,247<span></span>
</td>
<td class="nump">$ 11,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment | Redwood, California Facility Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=advm_RedwoodCaliforniaFacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=advm_RedwoodCaliforniaFacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 60,652<span></span>
</td>
<td class="nump">$ 92,851<span></span>
</td>
<td class="nump">$ 127,321<span></span>
</td>
<td class="nump">$ 149,608<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 105,366<span></span>
</td>
<td class="nump">$ 111,187<span></span>
</td>
<td class="nump">$ 67,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">65,039<span></span>
</td>
<td class="nump">60,390<span></span>
</td>
<td class="nump">46,506<span></span>
</td>
<td class="nump">43,720<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
<td class="nump">11,716<span></span>
</td>
<td class="nump">30,266<span></span>
</td>
<td class="nump">96,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,609<span></span>
</td>
<td class="nump">7,839<span></span>
</td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">5,802<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">7,514<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
<td class="nump">4,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">131,300<span></span>
</td>
<td class="nump">161,080<span></span>
</td>
<td class="nump">179,418<span></span>
</td>
<td class="nump">199,130<span></span>
</td>
<td class="nump">102,773<span></span>
</td>
<td class="nump">124,596<span></span>
</td>
<td class="nump">147,143<span></span>
</td>
<td class="nump">168,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">33,611<span></span>
</td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">34,478<span></span>
</td>
<td class="nump">35,024<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">46,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,607<span></span>
</td>
<td class="nump">12,215<span></span>
</td>
<td class="nump">13,047<span></span>
</td>
<td class="nump">13,766<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">15,497<span></span>
</td>
<td class="nump">32,041<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">179,841<span></span>
</td>
<td class="nump">210,244<span></span>
</td>
<td class="nump">229,599<span></span>
</td>
<td class="nump">250,546<span></span>
</td>
<td class="nump">155,768<span></span>
</td>
<td class="nump">179,612<span></span>
</td>
<td class="nump">224,375<span></span>
</td>
<td class="nump">252,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">2,170<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">15,620<span></span>
</td>
<td class="nump">14,886<span></span>
</td>
<td class="nump">9,912<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
<td class="nump">12,584<span></span>
</td>
<td class="nump">16,362<span></span>
</td>
<td class="nump">17,704<span></span>
</td>
<td class="nump">17,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">5,668<span></span>
</td>
<td class="nump">5,617<span></span>
</td>
<td class="nump">5,570<span></span>
</td>
<td class="nump">5,521<span></span>
</td>
<td class="nump">5,476<span></span>
</td>
<td class="nump">5,427<span></span>
</td>
<td class="nump">20,535<span></span>
</td>
<td class="nump">20,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,898<span></span>
</td>
<td class="nump">22,613<span></span>
</td>
<td class="nump">17,455<span></span>
</td>
<td class="nump">16,578<span></span>
</td>
<td class="nump">19,981<span></span>
</td>
<td class="nump">23,959<span></span>
</td>
<td class="nump">39,657<span></span>
</td>
<td class="nump">40,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">86,037<span></span>
</td>
<td class="nump">79,361<span></span>
</td>
<td class="nump">74,744<span></span>
</td>
<td class="nump">70,287<span></span>
</td>
<td class="nump">68,565<span></span>
</td>
<td class="nump">68,396<span></span>
</td>
<td class="nump">68,490<span></span>
</td>
<td class="nump">67,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">109,127<span></span>
</td>
<td class="nump">101,974<span></span>
</td>
<td class="nump">92,199<span></span>
</td>
<td class="nump">86,865<span></span>
</td>
<td class="nump">88,546<span></span>
</td>
<td class="nump">92,355<span></span>
</td>
<td class="nump">108,147<span></span>
</td>
<td class="nump">108,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,138,070<span></span>
</td>
<td class="nump">1,134,556<span></span>
</td>
<td class="nump">1,131,592<span></span>
</td>
<td class="nump">1,127,383<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="nump">999,328<span></span>
</td>
<td class="nump">994,938<span></span>
</td>
<td class="nump">990,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="num">(799)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,066,951)<span></span>
</td>
<td class="num">(1,026,020)<span></span>
</td>
<td class="num">(993,669)<span></span>
</td>
<td class="num">(963,171)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
<td class="num">(911,520)<span></span>
</td>
<td class="num">(878,105)<span></span>
</td>
<td class="num">(845,580)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">70,714<span></span>
</td>
<td class="nump">108,270<span></span>
</td>
<td class="nump">137,400<span></span>
</td>
<td class="nump">163,681<span></span>
</td>
<td class="nump">67,222<span></span>
</td>
<td class="nump">87,257<span></span>
</td>
<td class="nump">116,228<span></span>
</td>
<td class="nump">143,845<span></span>
</td>
<td class="nump">$ 170,222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 179,841<span></span>
</td>
<td class="nump">210,244<span></span>
</td>
<td class="nump">229,599<span></span>
</td>
<td class="nump">250,546<span></span>
</td>
<td class="nump">155,768<span></span>
</td>
<td class="nump">179,612<span></span>
</td>
<td class="nump">224,375<span></span>
</td>
<td class="nump">252,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,851<span></span>
</td>
<td class="nump">127,321<span></span>
</td>
<td class="nump">149,608<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">105,366<span></span>
</td>
<td class="nump">111,187<span></span>
</td>
<td class="nump">67,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,390<span></span>
</td>
<td class="nump">46,506<span></span>
</td>
<td class="nump">43,720<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
<td class="nump">11,716<span></span>
</td>
<td class="nump">30,266<span></span>
</td>
<td class="nump">96,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,839<span></span>
</td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">5,802<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">7,514<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
<td class="nump">4,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,080<span></span>
</td>
<td class="nump">179,418<span></span>
</td>
<td class="nump">199,130<span></span>
</td>
<td class="nump">102,773<span></span>
</td>
<td class="nump">124,596<span></span>
</td>
<td class="nump">147,143<span></span>
</td>
<td class="nump">168,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,695<span></span>
</td>
<td class="nump">51,237<span></span>
</td>
<td class="nump">51,760<span></span>
</td>
<td class="nump">52,266<span></span>
</td>
<td class="nump">52,757<span></span>
</td>
<td class="nump">58,287<span></span>
</td>
<td class="nump">69,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,215<span></span>
</td>
<td class="nump">13,047<span></span>
</td>
<td class="nump">13,766<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">15,497<span></span>
</td>
<td class="nump">32,041<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,375<span></span>
</td>
<td class="nump">253,803<span></span>
</td>
<td class="nump">267,828<span></span>
</td>
<td class="nump">173,010<span></span>
</td>
<td class="nump">196,770<span></span>
</td>
<td class="nump">241,429<span></span>
</td>
<td class="nump">275,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">2,170<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,886<span></span>
</td>
<td class="nump">9,912<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
<td class="nump">12,584<span></span>
</td>
<td class="nump">16,362<span></span>
</td>
<td class="nump">17,704<span></span>
</td>
<td class="nump">17,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,661<span></span>
</td>
<td class="nump">10,576<span></span>
</td>
<td class="nump">10,492<span></span>
</td>
<td class="nump">10,409<span></span>
</td>
<td class="nump">10,324<span></span>
</td>
<td class="nump">25,396<span></span>
</td>
<td class="nump">26,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,657<span></span>
</td>
<td class="nump">22,461<span></span>
</td>
<td class="nump">21,549<span></span>
</td>
<td class="nump">24,914<span></span>
</td>
<td class="nump">28,856<span></span>
</td>
<td class="nump">44,518<span></span>
</td>
<td class="nump">46,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,602<span></span>
</td>
<td class="nump">63,313<span></span>
</td>
<td class="nump">63,991<span></span>
</td>
<td class="nump">64,627<span></span>
</td>
<td class="nump">65,200<span></span>
</td>
<td class="nump">65,756<span></span>
</td>
<td class="nump">71,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,259<span></span>
</td>
<td class="nump">85,774<span></span>
</td>
<td class="nump">85,540<span></span>
</td>
<td class="nump">89,541<span></span>
</td>
<td class="nump">94,056<span></span>
</td>
<td class="nump">110,274<span></span>
</td>
<td class="nump">117,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,134,556<span></span>
</td>
<td class="nump">1,131,592<span></span>
</td>
<td class="nump">1,127,383<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="nump">999,328<span></span>
</td>
<td class="nump">994,938<span></span>
</td>
<td class="nump">990,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="num">(799)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(990,174)<span></span>
</td>
<td class="num">(963,040)<span></span>
</td>
<td class="num">(944,564)<span></span>
</td>
<td class="num">(919,777)<span></span>
</td>
<td class="num">(896,063)<span></span>
</td>
<td class="num">(863,178)<span></span>
</td>
<td class="num">(831,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,116<span></span>
</td>
<td class="nump">168,029<span></span>
</td>
<td class="nump">182,288<span></span>
</td>
<td class="nump">83,469<span></span>
</td>
<td class="nump">102,714<span></span>
</td>
<td class="nump">131,155<span></span>
</td>
<td class="nump">157,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,375<span></span>
</td>
<td class="nump">253,803<span></span>
</td>
<td class="nump">267,828<span></span>
</td>
<td class="nump">173,010<span></span>
</td>
<td class="nump">196,770<span></span>
</td>
<td class="nump">241,429<span></span>
</td>
<td class="nump">275,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,015)<span></span>
</td>
<td class="num">(17,241)<span></span>
</td>
<td class="num">(17,282)<span></span>
</td>
<td class="num">(17,242)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131)<span></span>
</td>
<td class="num">(24,204)<span></span>
</td>
<td class="num">(17,282)<span></span>
</td>
<td class="num">(17,242)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,044)<span></span>
</td>
<td class="num">(5,006)<span></span>
</td>
<td class="num">(4,971)<span></span>
</td>
<td class="num">(4,933)<span></span>
</td>
<td class="num">(4,897)<span></span>
</td>
<td class="num">(4,861)<span></span>
</td>
<td class="num">(5,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,044)<span></span>
</td>
<td class="num">(5,006)<span></span>
</td>
<td class="num">(4,971)<span></span>
</td>
<td class="num">(4,933)<span></span>
</td>
<td class="num">(4,897)<span></span>
</td>
<td class="num">(4,861)<span></span>
</td>
<td class="num">(5,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">11,431<span></span>
</td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">3,938<span></span>
</td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
<td class="num">(3,462)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">6,425<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="num">(995)<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
<td class="num">(2,127)<span></span>
</td>
<td class="num">(8,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,846)<span></span>
</td>
<td class="num">(30,629)<span></span>
</td>
<td class="num">(18,607)<span></span>
</td>
<td class="num">(16,247)<span></span>
</td>
<td class="num">(15,457)<span></span>
</td>
<td class="num">(14,927)<span></span>
</td>
<td class="num">(13,912)<span></span>
</td>
<td class="num">$ (11,300)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,846)<span></span>
</td>
<td class="num">(30,629)<span></span>
</td>
<td class="num">(18,607)<span></span>
</td>
<td class="num">(16,247)<span></span>
</td>
<td class="num">(15,457)<span></span>
</td>
<td class="num">(14,927)<span></span>
</td>
<td class="num">(13,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,131)<span></span>
</td>
<td class="num">$ (24,204)<span></span>
</td>
<td class="num">$ (17,282)<span></span>
</td>
<td class="num">$ (17,242)<span></span>
</td>
<td class="num">$ (17,158)<span></span>
</td>
<td class="num">$ (17,054)<span></span>
</td>
<td class="num">$ (22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">20,848,000<span></span>
</td>
<td class="nump">10,143,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">20,848,000<span></span>
</td>
<td class="nump">10,143,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,439<span></span>
</td>
<td class="nump">$ 17,097<span></span>
</td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">20,599<span></span>
</td>
<td class="nump">20,869<span></span>
</td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="nump">41,468<span></span>
</td>
<td class="nump">52,946<span></span>
</td>
<td class="nump">62,208<span></span>
</td>
<td class="nump">77,041<span></span>
</td>
<td class="nump">77,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,999<span></span>
</td>
<td class="nump">15,807<span></span>
</td>
<td class="nump">13,789<span></span>
</td>
<td class="nump">14,319<span></span>
</td>
<td class="nump">13,481<span></span>
</td>
<td class="nump">15,586<span></span>
</td>
<td class="nump">29,596<span></span>
</td>
<td class="nump">29,067<span></span>
</td>
<td class="nump">44,595<span></span>
</td>
<td class="nump">43,386<span></span>
</td>
<td class="nump">63,118<span></span>
</td>
<td class="nump">55,056<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">35,438<span></span>
</td>
<td class="nump">32,904<span></span>
</td>
<td class="nump">29,199<span></span>
</td>
<td class="nump">35,059<span></span>
</td>
<td class="nump">34,080<span></span>
</td>
<td class="nump">36,455<span></span>
</td>
<td class="nump">62,103<span></span>
</td>
<td class="nump">70,535<span></span>
</td>
<td class="nump">97,541<span></span>
</td>
<td class="nump">105,594<span></span>
</td>
<td class="nump">140,159<span></span>
</td>
<td class="nump">132,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(34,438)<span></span>
</td>
<td class="num">(32,904)<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
<td class="num">(35,059)<span></span>
</td>
<td class="num">(34,080)<span></span>
</td>
<td class="num">(32,855)<span></span>
</td>
<td class="num">(62,103)<span></span>
</td>
<td class="num">(66,935)<span></span>
</td>
<td class="num">(96,541)<span></span>
</td>
<td class="num">(101,994)<span></span>
</td>
<td class="num">(139,159)<span></span>
</td>
<td class="num">(128,942)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">8,232<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,398)<span></span>
</td>
<td class="num">(32,504)<span></span>
</td>
<td class="num">(31,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,557)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(123,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,351)<span></span>
</td>
<td class="num">(30,498)<span></span>
</td>
<td class="num">(27,147)<span></span>
</td>
<td class="num">(33,415)<span></span>
</td>
<td class="num">(32,525)<span></span>
</td>
<td class="num">(31,672)<span></span>
</td>
<td class="num">(57,645)<span></span>
</td>
<td class="num">(64,197)<span></span>
</td>
<td class="num">(89,996)<span></span>
</td>
<td class="num">(97,612)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(122,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (32,094)<span></span>
</td>
<td class="num">$ (30,490)<span></span>
</td>
<td class="num">$ (27,207)<span></span>
</td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="num">$ (32,332)<span></span>
</td>
<td class="num">$ (30,940)<span></span>
</td>
<td class="num">$ (57,697)<span></span>
</td>
<td class="num">$ (63,272)<span></span>
</td>
<td class="num">$ (89,791)<span></span>
</td>
<td class="num">$ (96,633)<span></span>
</td>
<td class="num">$ (130,861)<span></span>
</td>
<td class="num">$ (121,058)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,439<span></span>
</td>
<td class="nump">$ 17,097<span></span>
</td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">20,599<span></span>
</td>
<td class="nump">21,059<span></span>
</td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="nump">41,658<span></span>
</td>
<td class="nump">52,946<span></span>
</td>
<td class="nump">62,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,782<span></span>
</td>
<td class="nump">3,785<span></span>
</td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">13,789<span></span>
</td>
<td class="nump">12,466<span></span>
</td>
<td class="nump">12,780<span></span>
</td>
<td class="nump">15,214<span></span>
</td>
<td class="nump">25,246<span></span>
</td>
<td class="nump">24,996<span></span>
</td>
<td class="nump">39,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">30,221<span></span>
</td>
<td class="nump">20,882<span></span>
</td>
<td class="nump">26,839<span></span>
</td>
<td class="nump">34,529<span></span>
</td>
<td class="nump">33,065<span></span>
</td>
<td class="nump">33,839<span></span>
</td>
<td class="nump">47,721<span></span>
</td>
<td class="nump">66,904<span></span>
</td>
<td class="nump">77,942<span></span>
</td>
<td class="nump">101,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,591<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(29,221)<span></span>
</td>
<td class="num">(20,882)<span></span>
</td>
<td class="num">(26,839)<span></span>
</td>
<td class="num">(34,529)<span></span>
</td>
<td class="num">(33,065)<span></span>
</td>
<td class="num">(30,239)<span></span>
</td>
<td class="num">(47,721)<span></span>
</td>
<td class="num">(63,304)<span></span>
</td>
<td class="num">(76,942)<span></span>
</td>
<td class="num">(97,833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,868)<span></span>
</td>
<td class="num">(31,489)<span></span>
</td>
<td class="num">(29,039)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,396)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,134)<span></span>
</td>
<td class="num">(18,476)<span></span>
</td>
<td class="num">(24,787)<span></span>
</td>
<td class="num">(32,885)<span></span>
</td>
<td class="num">(31,510)<span></span>
</td>
<td class="num">(29,056)<span></span>
</td>
<td class="num">(43,263)<span></span>
</td>
<td class="num">(60,566)<span></span>
</td>
<td class="num">(70,397)<span></span>
</td>
<td class="num">(93,451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (26,877)<span></span>
</td>
<td class="num">$ (18,468)<span></span>
</td>
<td class="num">$ (24,847)<span></span>
</td>
<td class="num">$ (32,831)<span></span>
</td>
<td class="num">$ (31,317)<span></span>
</td>
<td class="num">$ (28,324)<span></span>
</td>
<td class="num">$ (43,315)<span></span>
</td>
<td class="num">$ (59,641)<span></span>
</td>
<td class="num">$ (70,192)<span></span>
</td>
<td class="num">$ (92,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (116,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (3.26)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (2.31)<span></span>
</td>
<td class="num">$ (6.02)<span></span>
</td>
<td class="num">$ (3.63)<span></span>
</td>
<td class="num">$ (9.28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11.62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (3.26)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (2.31)<span></span>
</td>
<td class="num">$ (6.02)<span></span>
</td>
<td class="num">$ (3.63)<span></span>
</td>
<td class="num">$ (9.28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">5,217<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">14,382<span></span>
</td>
<td class="nump">3,821<span></span>
</td>
<td class="nump">19,599<span></span>
</td>
<td class="nump">4,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">5,217<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">14,382<span></span>
</td>
<td class="nump">3,631<span></span>
</td>
<td class="nump">19,599<span></span>
</td>
<td class="nump">4,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,951<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(5,217)<span></span>
</td>
<td class="num">(12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(5,217)<span></span>
</td>
<td class="num">(12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (5,217)<span></span>
</td>
<td class="num">$ (12,022)<span></span>
</td>
<td class="num">$ (2,360)<span></span>
</td>
<td class="num">$ (530)<span></span>
</td>
<td class="num">$ (1,015)<span></span>
</td>
<td class="num">$ (2,616)<span></span>
</td>
<td class="num">$ (14,382)<span></span>
</td>
<td class="num">$ (3,631)<span></span>
</td>
<td class="num">$ (19,599)<span></span>
</td>
<td class="num">$ (4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,351)<span></span>
</td>
<td class="num">$ (30,498)<span></span>
</td>
<td class="num">$ (27,147)<span></span>
</td>
<td class="num">$ (33,415)<span></span>
</td>
<td class="num">$ (32,525)<span></span>
</td>
<td class="num">$ (31,672)<span></span>
</td>
<td class="num">$ (57,645)<span></span>
</td>
<td class="num">$ (64,197)<span></span>
</td>
<td class="num">$ (89,996)<span></span>
</td>
<td class="num">$ (97,612)<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (122,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">3,683<span></span>
</td>
<td class="nump">9,538<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
<td class="nump">16,382<span></span>
</td>
<td class="nump">7,495<span></span>
</td>
<td class="nump">18,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
<td class="nump">4,765<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">8,477<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(715)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,642)<span></span>
</td>
<td class="nump">3,021<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities', window );">Remeasurement of operating lease right-of-use assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,134)<span></span>
</td>
<td class="num">(18,476)<span></span>
</td>
<td class="num">(24,787)<span></span>
</td>
<td class="num">(32,885)<span></span>
</td>
<td class="num">(31,510)<span></span>
</td>
<td class="num">(29,056)<span></span>
</td>
<td class="num">(43,263)<span></span>
</td>
<td class="num">(60,566)<span></span>
</td>
<td class="num">(70,397)<span></span>
</td>
<td class="num">(93,451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,165)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">6,936<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
<td class="nump">12,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,206)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities', window );">Remeasurement of operating lease right-of-use assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,217)<span></span>
</td>
<td class="num">$ (12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">$ (530)<span></span>
</td>
<td class="num">$ (1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">2,654<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="nump">4,006<span></span>
</td>
<td class="nump">3,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
<td class="nump">$ 4,765<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">$ 8,477<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities', window );">Remeasurement of operating lease right-of-use assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,079)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_NonCashSubleaseLossIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Sublease Loss (Income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_NonCashSubleaseLossIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio</a></td>
<td class="nump">0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">$ 64,974<span></span>
</td>
<td class="nump">$ 21,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">65,039<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_CashAndCashEquivalentAmortizedCost', window );">Less: Cash equivalents, amortized cost basis</a></td>
<td class="num">(54,901)<span></span>
</td>
<td class="num">(70,972)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_CashAndCashEquivalentGrossUnrealizedGain', window );">Less: Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_CashAndCashEquivalentGrossUnrealizedLoss', window );">Less: Cash equivalents, unrealized losses</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Less: Cash equivalents, estimated fair value</a></td>
<td class="num">(54,893)<span></span>
</td>
<td class="num">(70,939)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=advm_CashEquivalentsAndShortTermInvestmentsMember', window );">Total cash equivalents and short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">119,875<span></span>
</td>
<td class="nump">92,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">119,932<span></span>
</td>
<td class="nump">92,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">10,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">10,204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">78,500<span></span>
</td>
<td class="nump">64,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">78,501<span></span>
</td>
<td class="nump">64,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost Basis</a></td>
<td class="nump">41,210<span></span>
</td>
<td class="nump">17,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 41,266<span></span>
</td>
<td class="nump">$ 17,603<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_CashAndCashEquivalentAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalent Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_CashAndCashEquivalentAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_CashAndCashEquivalentGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalent Gross Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_CashAndCashEquivalentGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_CashAndCashEquivalentGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalent Gross Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_CashAndCashEquivalentGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=advm_CashEquivalentsAndShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=advm_CashEquivalentsAndShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of securities, unrealized loss position | security</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Marketable securities in an unrealized loss</a></td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff', window );">Impairment charges on available-for-sale securities</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 25, 2021</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember', window );">Ray Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=advm_LexeoTherapeuticsIncMember', window );">Lexeo Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLicenseFeesReceived', window );">License fees received</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLicenseFeesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from licensees for license fees during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLicenseFeesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=advm_LexeoTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=advm_LexeoTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2021 </div>
<div>segment</div>
</th>
<th class="th">
<div>Apr. 07, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2023 </div>
<div>lease</div>
</th>
<th class="th">
<div>Oct. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,503<span></span>
</td>
<td class="nump">$ 2,650<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">$ 1,976<span></span>
</td>
<td class="nump">$ 2,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_LesseeOperatingLeaseNumberOfLease', window );">Number of facility leases | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Decrease in lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,418<span></span>
</td>
<td class="nump">3,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue', window );">Non-cash settlement of operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
<td class="nump">25,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=advm_SubleaseTenantMember', window );">Sublease Tenant | Landlord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForTenantImprovements', window );">Payments for tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,500<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=advm_LandlordMember', window );">Landlord | Sublease Tenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 2 months 12 days<span></span>
</td>
<td class="text">11 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average IBR (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.60%<span></span>
</td>
<td class="nump">11.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing Facility | NORTH CAROLINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_LesseeOperatingLeaseNumberOfRenewalContracts', window );">Number of renewal contracts | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance', window );">Leasehold improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification', window );">Re-measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification', window );">Re-measurement of operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing Facility | NORTH CAROLINA | Subsequent Event | Loss Contingency, Lien On Subtenant's Leasehold Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Amount of lien filed against subtenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liability Due To Lease Modification,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Right Of Use Asset Due To Lease Modification,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_LesseeOperatingLeaseLeaseholdImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Leasehold Improvement Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_LesseeOperatingLeaseLeaseholdImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_LesseeOperatingLeaseNumberOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Lease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_LesseeOperatingLeaseNumberOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_LesseeOperatingLeaseNumberOfRenewalContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_LesseeOperatingLeaseNumberOfRenewalContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Non-cash Consideration, Leasehold Improvements, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental income recognized over rental payment required by lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481123/840-20-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479341/842-30-25-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForTenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForTenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=advm_SubleaseTenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=advm_SubleaseTenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=advm_LandlordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=advm_LandlordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=advm_LandlordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=advm_LandlordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=advm_SubleaseTenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=advm_SubleaseTenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 12,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">14,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">15,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">15,677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">16,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">93,087<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">167,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed Interest</a></td>
<td class="num">(75,460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 91,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 29,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(18,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,607<span></span>
</td>
<td class="nump">$ 12,215<span></span>
</td>
<td class="nump">$ 13,047<span></span>
</td>
<td class="nump">$ 13,766<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">$ 15,497<span></span>
</td>
<td class="nump">$ 32,041<span></span>
</td>
<td class="nump">$ 33,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">14,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">13,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Employee compensation</a></td>
<td class="nump">$ 9,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent', window );">Accrued nonclinical, clinical and process development costs</a></td>
<td class="nump">4,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">State income tax payable</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 15,620<span></span>
</td>
<td class="nump">$ 14,886<span></span>
</td>
<td class="nump">$ 9,912<span></span>
</td>
<td class="nump">$ 9,160<span></span>
</td>
<td class="nump">$ 12,584<span></span>
</td>
<td class="nump">$ 16,362<span></span>
</td>
<td class="nump">$ 17,704<span></span>
</td>
<td class="nump">$ 17,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued preclinical costs current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember', window );">Ray Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=advm_LexeoTherapeuticsIncMember', window );">Lexeo Therapeutics, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=advm_RayTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=advm_LexeoTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=advm_LexeoTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 07, 2024 </div>
<div>USD ($) </div>
<div>director </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated currency translation adjustments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair values of options granted (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.12<span></span>
</td>
<td class="nump">$ 7.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense related to awards | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation, weighted-average period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock-Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum', window );">Award price as a percentage of grant date fair value, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember', window );">Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum', window );">Award price as a percentage of grant date fair value, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold', window );">Significant stockholder threshold ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Awards granted to employees and non-employees vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation, weighted-average period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair values of RSUs vested | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEquityIncentivePlanMember', window );">2014 Equity Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan', window );">Percentage of annual increase in number of shares available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_TwoThousandSeventeenInducementPlanMember', window );">2017 Inducement Plan | Stock Options and Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares available for future grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_TwoThousandFourteenPlanAndInducementPlanMember', window );">2014 Plan And Inducement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Awards granted to employees and non-employees vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_TwoThousandFourteenPlanAndInducementPlanMember', window );">2014 Plan And Inducement Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock options granted period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember', window );">2014 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares available for future grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage', window );">Percentage increase in shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,199<span></span>
</td>
<td class="nump">82,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=advm_A2024EquityIncentiveAwardPlanMember', window );">2024 Equity Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,688,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Total gross proceeds | $</a></td>
<td class="nump">$ 127.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Two Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 13.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_SecuritiesPurchaseAgreementNumberOfDirectors', window );">Number of directors | director</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock issued upon exercise of warrants (in shares)</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 11.999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price Per Share (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_BeneficialOwnershipInterestLimitationPercent', window );">Beneficial ownership interest limitation (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ClassOfWarrantOrRightWarrantsExercised', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_BeneficialOwnershipInterestLimitationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficial Ownership Interest Limitation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_BeneficialOwnershipInterestLimitationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ClassOfWarrantOrRightWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ClassOfWarrantOrRightWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_SecuritiesPurchaseAgreementNumberOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities Purchase Agreement, Number of Directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_SecuritiesPurchaseAgreementNumberOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Exercise Price As A Percentage Of Grant Date Fair Value, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award increase decrease in number of shares issued percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Significant Stockholder Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement increase in number of shares reserved for issuance percentage under plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=advm_TwoThousandSeventeenInducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=advm_TwoThousandSeventeenInducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=advm_StockOptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=advm_StockOptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=advm_TwoThousandFourteenPlanAndInducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=advm_TwoThousandFourteenPlanAndInducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=advm_A2024EquityIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=advm_A2024EquityIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=advm_TwoDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=advm_TwoDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=advm_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=advm_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/forfeited (in shares)</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">3,909<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">3,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in USD per share)</a></td>
<td class="nump">$ 48.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share)</a></td>
<td class="nump">10.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in USD per share)</a></td>
<td class="nump">9.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/forfeited (in USD per share)</a></td>
<td class="nump">50.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in USD per share)</a></td>
<td class="nump">29.39<span></span>
</td>
<td class="nump">$ 48.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest (in USD per share)</a></td>
<td class="nump">29.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in USD per share)</a></td>
<td class="nump">$ 58.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contract Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contract Life (in years)</a></td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest</a></td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details) - Restricted stock units - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested and released (in shares)</a></td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance (in USD per share)</a></td>
<td class="nump">$ 21.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in USD per share)</a></td>
<td class="nump">12.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested and released (in USD per share)</a></td>
<td class="nump">26.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in USD per share)</a></td>
<td class="nump">14.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance (in USD per share)</a></td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="nump">$ 21.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted- Average Remaining Contractual Term (in years)</a></td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 14,350<span></span>
</td>
<td class="nump">$ 17,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">4,544<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 9,806<span></span>
</td>
<td class="nump">$ 12,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Savings Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution by company</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">35,438<span></span>
</td>
<td class="nump">$ 32,904<span></span>
</td>
<td class="nump">$ 29,199<span></span>
</td>
<td class="nump">35,059<span></span>
</td>
<td class="nump">34,080<span></span>
</td>
<td class="nump">36,455<span></span>
</td>
<td class="nump">$ 62,103<span></span>
</td>
<td class="nump">70,535<span></span>
</td>
<td class="nump">97,541<span></span>
</td>
<td class="nump">105,594<span></span>
</td>
<td class="nump">140,159<span></span>
</td>
<td class="nump">132,542<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(34,438)<span></span>
</td>
<td class="num">(32,904)<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
<td class="num">(35,059)<span></span>
</td>
<td class="num">(34,080)<span></span>
</td>
<td class="num">(32,855)<span></span>
</td>
<td class="num">(62,103)<span></span>
</td>
<td class="num">(66,935)<span></span>
</td>
<td class="num">(96,541)<span></span>
</td>
<td class="num">(101,994)<span></span>
</td>
<td class="num">(139,159)<span></span>
</td>
<td class="num">(128,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(2,087)<span></span>
</td>
<td class="num">(2,406)<span></span>
</td>
<td class="num">(2,052)<span></span>
</td>
<td class="num">(1,661)<span></span>
</td>
<td class="num">(1,576)<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="num">(4,458)<span></span>
</td>
<td class="num">(2,776)<span></span>
</td>
<td class="num">(6,545)<span></span>
</td>
<td class="num">(4,437)<span></span>
</td>
<td class="num">(8,232)<span></span>
</td>
<td class="num">(5,748)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,398)<span></span>
</td>
<td class="num">(32,504)<span></span>
</td>
<td class="num">(31,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,557)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(123,194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,351)<span></span>
</td>
<td class="num">$ (30,498)<span></span>
</td>
<td class="num">$ (27,147)<span></span>
</td>
<td class="num">$ (33,415)<span></span>
</td>
<td class="num">$ (32,525)<span></span>
</td>
<td class="num">$ (31,672)<span></span>
</td>
<td class="num">$ (57,645)<span></span>
</td>
<td class="num">$ (64,197)<span></span>
</td>
<td class="num">$ (89,996)<span></span>
</td>
<td class="num">$ (97,612)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(122,116)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=advm_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Compensation and benefits expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,546<span></span>
</td>
<td class="nump">54,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ClinicalTrialExpenses', window );">Clinical trial and manufacturing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,333<span></span>
</td>
<td class="nump">20,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AllocatedFacilitiesAndInformationTechnologyExpenses', window );">Facilities and IT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,841<span></span>
</td>
<td class="nump">39,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,728<span></span>
</td>
<td class="nump">4,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,711<span></span>
</td>
<td class="nump">13,636<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,159<span></span>
</td>
<td class="nump">132,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139,159)<span></span>
</td>
<td class="num">(128,942)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,232)<span></span>
</td>
<td class="num">(5,748)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(123,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (122,116)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AllocatedFacilitiesAndInformationTechnologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocated Facilities And Information Technology Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AllocatedFacilitiesAndInformationTechnologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ClinicalTrialExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Trial Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ClinicalTrialExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=advm_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=advm_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Loss Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (130,768)<span></span>
</td>
<td class="num">$ (123,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">$ (33,398)<span></span>
</td>
<td class="num">$ (32,504)<span></span>
</td>
<td class="num">$ (31,655)<span></span>
</td>
<td class="num">$ (64,159)<span></span>
</td>
<td class="num">$ (97,557)<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (123,194)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,078)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,078)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax (benefit) provision</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,078)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal income tax benefit at statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (27,495)<span></span>
</td>
<td class="num">$ (25,871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
<td class="nump">6,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,642)<span></span>
</td>
<td class="num">(1,810)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,801<span></span>
</td>
<td class="nump">19,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges', window );">Impact of internal reorganization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition', window );">Uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
<td class="num">(1,078)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax (benefit) provision</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,078)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in state uncertain tax position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 137,140<span></span>
</td>
<td class="nump">$ 128,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals, reserve and other</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">29,263<span></span>
</td>
<td class="nump">21,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">6,349<span></span>
</td>
<td class="nump">7,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_DeferredTaxAssetsLeaseObligation', window );">Lease obligation</a></td>
<td class="nump">19,622<span></span>
</td>
<td class="nump">17,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">9,850<span></span>
</td>
<td class="nump">9,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_DeferredTaxAssetsCapitalizedCosts', window );">Section 174 R&amp;D capitalization</a></td>
<td class="nump">35,842<span></span>
</td>
<td class="nump">29,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
<td class="nump">240,050<span></span>
</td>
<td class="nump">215,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(232,058)<span></span>
</td>
<td class="num">(205,861)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">7,992<span></span>
</td>
<td class="nump">9,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use assets</a></td>
<td class="num">(7,149)<span></span>
</td>
<td class="num">(8,153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(843)<span></span>
</td>
<td class="num">(1,308)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(7,992)<span></span>
</td>
<td class="num">(9,461)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_DeferredTaxAssetsCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Capitalized Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_DeferredTaxAssetsCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_DeferredTaxAssetsLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_DeferredTaxAssetsLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="num">$ (5,642)<span></span>
</td>
<td class="num">$ (1,810)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance due to net operating loss</a></td>
<td class="nump">26,200<span></span>
</td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">27,188<span></span>
</td>
<td class="nump">22,758<span></span>
</td>
<td class="nump">$ 23,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest or penalties related to uncertain tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Decrease in unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic tax authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">552,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_OperatingLossCarryforwardsSubjectToExpiration', window );">NOL carryforwards subject to expiration</a></td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic tax authority | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">25,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">345,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State credit carryforwards | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">NOL carryforwards</a></td>
<td class="nump">$ 49,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards subject to expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits as of the beginning of the year</a></td>
<td class="nump">$ 22,758<span></span>
</td>
<td class="nump">$ 23,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to tax positions taken during the prior year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to tax positions taken during the prior year</a></td>
<td class="num">(2,880)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to tax position taken during the current year</a></td>
<td class="nump">7,310<span></span>
</td>
<td class="nump">3,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Decrease related to tax position taken during the current year</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,475)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits as of the end of the year</a></td>
<td class="nump">$ 27,188<span></span>
</td>
<td class="nump">$ 22,758<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">4,200<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">3,909<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense reversal</a></td>
<td class="num">(20,439)<span></span>
</td>
<td class="num">(17,097)<span></span>
</td>
<td class="num">$ (15,410)<span></span>
</td>
<td class="num">$ (20,740)<span></span>
</td>
<td class="num">$ (20,599)<span></span>
</td>
<td class="num">$ (20,869)<span></span>
</td>
<td class="num">(32,507)<span></span>
</td>
<td class="num">$ (41,468)<span></span>
</td>
<td class="num">(52,946)<span></span>
</td>
<td class="num">$ (62,208)<span></span>
</td>
<td class="num">$ (77,041)<span></span>
</td>
<td class="num">$ (77,486)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">34,478<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">46,598<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">33,611<span></span>
</td>
<td class="nump">35,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="num">(7,116)<span></span>
</td>
<td class="num">(6,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense reversal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="num">$ (17,015)<span></span>
</td>
<td class="num">$ (17,241)<span></span>
</td>
<td class="num">$ (17,282)<span></span>
</td>
<td class="num">$ (17,158)<span></span>
</td>
<td class="num">$ (17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="num">$ (17,241)<span></span>
</td>
<td class="num">$ (17,054)<span></span>
</td>
<td class="num">$ (17,015)<span></span>
</td>
<td class="num">$ (17,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,242)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment | Redwood, California Facility Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Interim Period, Costs Not Allocable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-to-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental income recognized over rental payment required by lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481123/840-20-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479341/842-30-25-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=advm_RedwoodCaliforniaFacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=advm_RedwoodCaliforniaFacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 60,652<span></span>
</td>
<td class="nump">$ 92,851<span></span>
</td>
<td class="nump">$ 127,321<span></span>
</td>
<td class="nump">$ 149,608<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 105,366<span></span>
</td>
<td class="nump">$ 111,187<span></span>
</td>
<td class="nump">$ 67,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">65,039<span></span>
</td>
<td class="nump">60,390<span></span>
</td>
<td class="nump">46,506<span></span>
</td>
<td class="nump">43,720<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
<td class="nump">11,716<span></span>
</td>
<td class="nump">30,266<span></span>
</td>
<td class="nump">96,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,609<span></span>
</td>
<td class="nump">7,839<span></span>
</td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">5,802<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">7,514<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
<td class="nump">4,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">131,300<span></span>
</td>
<td class="nump">161,080<span></span>
</td>
<td class="nump">179,418<span></span>
</td>
<td class="nump">199,130<span></span>
</td>
<td class="nump">102,773<span></span>
</td>
<td class="nump">124,596<span></span>
</td>
<td class="nump">147,143<span></span>
</td>
<td class="nump">168,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">33,611<span></span>
</td>
<td class="nump">33,680<span></span>
</td>
<td class="nump">33,996<span></span>
</td>
<td class="nump">34,478<span></span>
</td>
<td class="nump">35,024<span></span>
</td>
<td class="nump">35,599<span></span>
</td>
<td class="nump">41,233<span></span>
</td>
<td class="nump">46,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,607<span></span>
</td>
<td class="nump">12,215<span></span>
</td>
<td class="nump">13,047<span></span>
</td>
<td class="nump">13,766<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">15,497<span></span>
</td>
<td class="nump">32,041<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">179,841<span></span>
</td>
<td class="nump">210,244<span></span>
</td>
<td class="nump">229,599<span></span>
</td>
<td class="nump">250,546<span></span>
</td>
<td class="nump">155,768<span></span>
</td>
<td class="nump">179,612<span></span>
</td>
<td class="nump">224,375<span></span>
</td>
<td class="nump">252,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">2,170<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">15,620<span></span>
</td>
<td class="nump">14,886<span></span>
</td>
<td class="nump">9,912<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
<td class="nump">12,584<span></span>
</td>
<td class="nump">16,362<span></span>
</td>
<td class="nump">17,704<span></span>
</td>
<td class="nump">17,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">5,668<span></span>
</td>
<td class="nump">5,617<span></span>
</td>
<td class="nump">5,570<span></span>
</td>
<td class="nump">5,521<span></span>
</td>
<td class="nump">5,476<span></span>
</td>
<td class="nump">5,427<span></span>
</td>
<td class="nump">20,535<span></span>
</td>
<td class="nump">20,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,898<span></span>
</td>
<td class="nump">22,613<span></span>
</td>
<td class="nump">17,455<span></span>
</td>
<td class="nump">16,578<span></span>
</td>
<td class="nump">19,981<span></span>
</td>
<td class="nump">23,959<span></span>
</td>
<td class="nump">39,657<span></span>
</td>
<td class="nump">40,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">86,037<span></span>
</td>
<td class="nump">79,361<span></span>
</td>
<td class="nump">74,744<span></span>
</td>
<td class="nump">70,287<span></span>
</td>
<td class="nump">68,565<span></span>
</td>
<td class="nump">68,396<span></span>
</td>
<td class="nump">68,490<span></span>
</td>
<td class="nump">67,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">109,127<span></span>
</td>
<td class="nump">101,974<span></span>
</td>
<td class="nump">92,199<span></span>
</td>
<td class="nump">86,865<span></span>
</td>
<td class="nump">88,546<span></span>
</td>
<td class="nump">92,355<span></span>
</td>
<td class="nump">108,147<span></span>
</td>
<td class="nump">108,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,138,070<span></span>
</td>
<td class="nump">1,134,556<span></span>
</td>
<td class="nump">1,131,592<span></span>
</td>
<td class="nump">1,127,383<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="nump">999,328<span></span>
</td>
<td class="nump">994,938<span></span>
</td>
<td class="nump">990,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(407)<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="num">(799)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,066,951)<span></span>
</td>
<td class="num">(1,026,020)<span></span>
</td>
<td class="num">(993,669)<span></span>
</td>
<td class="num">(963,171)<span></span>
</td>
<td class="num">(936,024)<span></span>
</td>
<td class="num">(911,520)<span></span>
</td>
<td class="num">(878,105)<span></span>
</td>
<td class="num">(845,580)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">70,714<span></span>
</td>
<td class="nump">108,270<span></span>
</td>
<td class="nump">137,400<span></span>
</td>
<td class="nump">163,681<span></span>
</td>
<td class="nump">67,222<span></span>
</td>
<td class="nump">87,257<span></span>
</td>
<td class="nump">116,228<span></span>
</td>
<td class="nump">143,845<span></span>
</td>
<td class="nump">$ 170,222<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 179,841<span></span>
</td>
<td class="nump">210,244<span></span>
</td>
<td class="nump">229,599<span></span>
</td>
<td class="nump">250,546<span></span>
</td>
<td class="nump">155,768<span></span>
</td>
<td class="nump">179,612<span></span>
</td>
<td class="nump">224,375<span></span>
</td>
<td class="nump">252,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,851<span></span>
</td>
<td class="nump">127,321<span></span>
</td>
<td class="nump">149,608<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">105,366<span></span>
</td>
<td class="nump">111,187<span></span>
</td>
<td class="nump">67,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,390<span></span>
</td>
<td class="nump">46,506<span></span>
</td>
<td class="nump">43,720<span></span>
</td>
<td class="nump">21,526<span></span>
</td>
<td class="nump">11,716<span></span>
</td>
<td class="nump">30,266<span></span>
</td>
<td class="nump">96,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,839<span></span>
</td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">5,802<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
<td class="nump">7,514<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
<td class="nump">4,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,080<span></span>
</td>
<td class="nump">179,418<span></span>
</td>
<td class="nump">199,130<span></span>
</td>
<td class="nump">102,773<span></span>
</td>
<td class="nump">124,596<span></span>
</td>
<td class="nump">147,143<span></span>
</td>
<td class="nump">168,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,695<span></span>
</td>
<td class="nump">51,237<span></span>
</td>
<td class="nump">51,760<span></span>
</td>
<td class="nump">52,266<span></span>
</td>
<td class="nump">52,757<span></span>
</td>
<td class="nump">58,287<span></span>
</td>
<td class="nump">69,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,215<span></span>
</td>
<td class="nump">13,047<span></span>
</td>
<td class="nump">13,766<span></span>
</td>
<td class="nump">14,764<span></span>
</td>
<td class="nump">15,497<span></span>
</td>
<td class="nump">32,041<span></span>
</td>
<td class="nump">33,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,116<span></span>
</td>
<td class="nump">6,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">1,308<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,375<span></span>
</td>
<td class="nump">253,803<span></span>
</td>
<td class="nump">267,828<span></span>
</td>
<td class="nump">173,010<span></span>
</td>
<td class="nump">196,770<span></span>
</td>
<td class="nump">241,429<span></span>
</td>
<td class="nump">275,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">2,170<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,886<span></span>
</td>
<td class="nump">9,912<span></span>
</td>
<td class="nump">9,160<span></span>
</td>
<td class="nump">12,584<span></span>
</td>
<td class="nump">16,362<span></span>
</td>
<td class="nump">17,704<span></span>
</td>
<td class="nump">17,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,661<span></span>
</td>
<td class="nump">10,576<span></span>
</td>
<td class="nump">10,492<span></span>
</td>
<td class="nump">10,409<span></span>
</td>
<td class="nump">10,324<span></span>
</td>
<td class="nump">25,396<span></span>
</td>
<td class="nump">26,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,657<span></span>
</td>
<td class="nump">22,461<span></span>
</td>
<td class="nump">21,549<span></span>
</td>
<td class="nump">24,914<span></span>
</td>
<td class="nump">28,856<span></span>
</td>
<td class="nump">44,518<span></span>
</td>
<td class="nump">46,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,602<span></span>
</td>
<td class="nump">63,313<span></span>
</td>
<td class="nump">63,991<span></span>
</td>
<td class="nump">64,627<span></span>
</td>
<td class="nump">65,200<span></span>
</td>
<td class="nump">65,756<span></span>
</td>
<td class="nump">71,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,259<span></span>
</td>
<td class="nump">85,774<span></span>
</td>
<td class="nump">85,540<span></span>
</td>
<td class="nump">89,541<span></span>
</td>
<td class="nump">94,056<span></span>
</td>
<td class="nump">110,274<span></span>
</td>
<td class="nump">117,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,134,556<span></span>
</td>
<td class="nump">1,131,592<span></span>
</td>
<td class="nump">1,127,383<span></span>
</td>
<td class="nump">1,003,718<span></span>
</td>
<td class="nump">999,328<span></span>
</td>
<td class="nump">994,938<span></span>
</td>
<td class="nump">990,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
<td class="num">(799)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(990,174)<span></span>
</td>
<td class="num">(963,040)<span></span>
</td>
<td class="num">(944,564)<span></span>
</td>
<td class="num">(919,777)<span></span>
</td>
<td class="num">(896,063)<span></span>
</td>
<td class="num">(863,178)<span></span>
</td>
<td class="num">(831,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,116<span></span>
</td>
<td class="nump">168,029<span></span>
</td>
<td class="nump">182,288<span></span>
</td>
<td class="nump">83,469<span></span>
</td>
<td class="nump">102,714<span></span>
</td>
<td class="nump">131,155<span></span>
</td>
<td class="nump">157,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,375<span></span>
</td>
<td class="nump">253,803<span></span>
</td>
<td class="nump">267,828<span></span>
</td>
<td class="nump">173,010<span></span>
</td>
<td class="nump">196,770<span></span>
</td>
<td class="nump">241,429<span></span>
</td>
<td class="nump">275,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,015)<span></span>
</td>
<td class="num">(17,241)<span></span>
</td>
<td class="num">(17,282)<span></span>
</td>
<td class="num">(17,242)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentReceivablesNet', window );">Deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,116)<span></span>
</td>
<td class="num">(6,963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Deposit and other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131)<span></span>
</td>
<td class="num">(24,204)<span></span>
</td>
<td class="num">(17,282)<span></span>
</td>
<td class="num">(17,242)<span></span>
</td>
<td class="num">(17,158)<span></span>
</td>
<td class="num">(17,054)<span></span>
</td>
<td class="num">(22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,044)<span></span>
</td>
<td class="num">(5,006)<span></span>
</td>
<td class="num">(4,971)<span></span>
</td>
<td class="num">(4,933)<span></span>
</td>
<td class="num">(4,897)<span></span>
</td>
<td class="num">(4,861)<span></span>
</td>
<td class="num">(5,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,044)<span></span>
</td>
<td class="num">(5,006)<span></span>
</td>
<td class="num">(4,971)<span></span>
</td>
<td class="num">(4,933)<span></span>
</td>
<td class="num">(4,897)<span></span>
</td>
<td class="num">(4,861)<span></span>
</td>
<td class="num">(5,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,759<span></span>
</td>
<td class="nump">11,431<span></span>
</td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">3,938<span></span>
</td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">2,734<span></span>
</td>
<td class="num">(3,462)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">6,425<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="num">(995)<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
<td class="num">(2,127)<span></span>
</td>
<td class="num">(8,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,846)<span></span>
</td>
<td class="num">(30,629)<span></span>
</td>
<td class="num">(18,607)<span></span>
</td>
<td class="num">(16,247)<span></span>
</td>
<td class="num">(15,457)<span></span>
</td>
<td class="num">(14,927)<span></span>
</td>
<td class="num">(13,912)<span></span>
</td>
<td class="num">$ (11,300)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,846)<span></span>
</td>
<td class="num">(30,629)<span></span>
</td>
<td class="num">(18,607)<span></span>
</td>
<td class="num">(16,247)<span></span>
</td>
<td class="num">(15,457)<span></span>
</td>
<td class="num">(14,927)<span></span>
</td>
<td class="num">(13,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,131)<span></span>
</td>
<td class="num">$ (24,204)<span></span>
</td>
<td class="num">$ (17,282)<span></span>
</td>
<td class="num">$ (17,242)<span></span>
</td>
<td class="num">$ (17,158)<span></span>
</td>
<td class="num">$ (17,054)<span></span>
</td>
<td class="num">$ (22,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental income recognized over rental payment required by lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481123/840-20-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479341/842-30-25-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,439<span></span>
</td>
<td class="nump">$ 17,097<span></span>
</td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">20,599<span></span>
</td>
<td class="nump">20,869<span></span>
</td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="nump">41,468<span></span>
</td>
<td class="nump">52,946<span></span>
</td>
<td class="nump">62,208<span></span>
</td>
<td class="nump">77,041<span></span>
</td>
<td class="nump">77,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">14,999<span></span>
</td>
<td class="nump">15,807<span></span>
</td>
<td class="nump">13,789<span></span>
</td>
<td class="nump">14,319<span></span>
</td>
<td class="nump">13,481<span></span>
</td>
<td class="nump">15,586<span></span>
</td>
<td class="nump">29,596<span></span>
</td>
<td class="nump">29,067<span></span>
</td>
<td class="nump">44,595<span></span>
</td>
<td class="nump">43,386<span></span>
</td>
<td class="nump">63,118<span></span>
</td>
<td class="nump">55,056<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">35,438<span></span>
</td>
<td class="nump">32,904<span></span>
</td>
<td class="nump">29,199<span></span>
</td>
<td class="nump">35,059<span></span>
</td>
<td class="nump">34,080<span></span>
</td>
<td class="nump">36,455<span></span>
</td>
<td class="nump">62,103<span></span>
</td>
<td class="nump">70,535<span></span>
</td>
<td class="nump">97,541<span></span>
</td>
<td class="nump">105,594<span></span>
</td>
<td class="nump">140,159<span></span>
</td>
<td class="nump">132,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(34,438)<span></span>
</td>
<td class="num">(32,904)<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
<td class="num">(35,059)<span></span>
</td>
<td class="num">(34,080)<span></span>
</td>
<td class="num">(32,855)<span></span>
</td>
<td class="num">(62,103)<span></span>
</td>
<td class="num">(66,935)<span></span>
</td>
<td class="num">(96,541)<span></span>
</td>
<td class="num">(101,994)<span></span>
</td>
<td class="num">(139,159)<span></span>
</td>
<td class="num">(128,942)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">8,232<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,398)<span></span>
</td>
<td class="num">(32,504)<span></span>
</td>
<td class="num">(31,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,557)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(123,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,351)<span></span>
</td>
<td class="num">(30,498)<span></span>
</td>
<td class="num">(27,147)<span></span>
</td>
<td class="num">(33,415)<span></span>
</td>
<td class="num">(32,525)<span></span>
</td>
<td class="num">(31,672)<span></span>
</td>
<td class="num">(57,645)<span></span>
</td>
<td class="num">(64,197)<span></span>
</td>
<td class="num">(89,996)<span></span>
</td>
<td class="num">(97,612)<span></span>
</td>
<td class="num">(130,927)<span></span>
</td>
<td class="num">(122,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (32,094)<span></span>
</td>
<td class="num">$ (30,490)<span></span>
</td>
<td class="num">$ (27,207)<span></span>
</td>
<td class="num">$ (33,361)<span></span>
</td>
<td class="num">$ (32,332)<span></span>
</td>
<td class="num">$ (30,940)<span></span>
</td>
<td class="num">$ (57,697)<span></span>
</td>
<td class="num">$ (63,272)<span></span>
</td>
<td class="num">$ (89,791)<span></span>
</td>
<td class="num">$ (96,633)<span></span>
</td>
<td class="num">$ (130,861)<span></span>
</td>
<td class="num">$ (121,058)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (1.46)<span></span>
</td>
<td class="num">$ (1.65)<span></span>
</td>
<td class="num">$ (3.31)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (3.16)<span></span>
</td>
<td class="num">$ (3.08)<span></span>
</td>
<td class="num">$ (6.39)<span></span>
</td>
<td class="num">$ (4.64)<span></span>
</td>
<td class="num">$ (9.69)<span></span>
</td>
<td class="num">$ (6.62)<span></span>
</td>
<td class="num">$ (12.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="nump">19,782<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,439<span></span>
</td>
<td class="nump">$ 17,097<span></span>
</td>
<td class="nump">$ 15,410<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">20,599<span></span>
</td>
<td class="nump">21,059<span></span>
</td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="nump">41,658<span></span>
</td>
<td class="nump">52,946<span></span>
</td>
<td class="nump">62,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,782<span></span>
</td>
<td class="nump">3,785<span></span>
</td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">13,789<span></span>
</td>
<td class="nump">12,466<span></span>
</td>
<td class="nump">12,780<span></span>
</td>
<td class="nump">15,214<span></span>
</td>
<td class="nump">25,246<span></span>
</td>
<td class="nump">24,996<span></span>
</td>
<td class="nump">39,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">30,221<span></span>
</td>
<td class="nump">20,882<span></span>
</td>
<td class="nump">26,839<span></span>
</td>
<td class="nump">34,529<span></span>
</td>
<td class="nump">33,065<span></span>
</td>
<td class="nump">33,839<span></span>
</td>
<td class="nump">47,721<span></span>
</td>
<td class="nump">66,904<span></span>
</td>
<td class="nump">77,942<span></span>
</td>
<td class="nump">101,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,591<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(29,221)<span></span>
</td>
<td class="num">(20,882)<span></span>
</td>
<td class="num">(26,839)<span></span>
</td>
<td class="num">(34,529)<span></span>
</td>
<td class="num">(33,065)<span></span>
</td>
<td class="num">(30,239)<span></span>
</td>
<td class="num">(47,721)<span></span>
</td>
<td class="num">(63,304)<span></span>
</td>
<td class="num">(76,942)<span></span>
</td>
<td class="num">(97,833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2,087<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">4,458<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,868)<span></span>
</td>
<td class="num">(31,489)<span></span>
</td>
<td class="num">(29,039)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,396)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,134)<span></span>
</td>
<td class="num">(18,476)<span></span>
</td>
<td class="num">(24,787)<span></span>
</td>
<td class="num">(32,885)<span></span>
</td>
<td class="num">(31,510)<span></span>
</td>
<td class="num">(29,056)<span></span>
</td>
<td class="num">(43,263)<span></span>
</td>
<td class="num">(60,566)<span></span>
</td>
<td class="num">(70,397)<span></span>
</td>
<td class="num">(93,451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">241<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="nump">937<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (26,877)<span></span>
</td>
<td class="num">$ (18,468)<span></span>
</td>
<td class="num">$ (24,847)<span></span>
</td>
<td class="num">$ (32,831)<span></span>
</td>
<td class="num">$ (31,317)<span></span>
</td>
<td class="num">$ (28,324)<span></span>
</td>
<td class="num">$ (43,315)<span></span>
</td>
<td class="num">$ (59,641)<span></span>
</td>
<td class="num">$ (70,192)<span></span>
</td>
<td class="num">$ (92,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (116,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (3.26)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (2.31)<span></span>
</td>
<td class="num">$ (6.02)<span></span>
</td>
<td class="num">$ (3.63)<span></span>
</td>
<td class="num">$ (9.28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11.62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="num">$ (1.30)<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (3.26)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (2.90)<span></span>
</td>
<td class="num">$ (2.31)<span></span>
</td>
<td class="num">$ (6.02)<span></span>
</td>
<td class="num">$ (3.63)<span></span>
</td>
<td class="num">$ (9.28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11.62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">20,876<span></span>
</td>
<td class="nump">20,852<span></span>
</td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
<td class="nump">10,030<span></span>
</td>
<td class="nump">18,713<span></span>
</td>
<td class="nump">10,053<span></span>
</td>
<td class="nump">19,408<span></span>
</td>
<td class="nump">10,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">5,217<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">14,382<span></span>
</td>
<td class="nump">3,821<span></span>
</td>
<td class="nump">19,599<span></span>
</td>
<td class="nump">4,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">5,217<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">14,382<span></span>
</td>
<td class="nump">3,631<span></span>
</td>
<td class="nump">19,599<span></span>
</td>
<td class="nump">4,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,951<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(5,217)<span></span>
</td>
<td class="num">(12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(5,217)<span></span>
</td>
<td class="num">(12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">(530)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net unrealized gain on marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (5,217)<span></span>
</td>
<td class="num">$ (12,022)<span></span>
</td>
<td class="num">$ (2,360)<span></span>
</td>
<td class="num">$ (530)<span></span>
</td>
<td class="num">$ (1,015)<span></span>
</td>
<td class="num">$ (2,616)<span></span>
</td>
<td class="num">$ (14,382)<span></span>
</td>
<td class="num">$ (3,631)<span></span>
</td>
<td class="num">$ (19,599)<span></span>
</td>
<td class="num">$ (4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares used to compute net loss per share - basic (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,351)<span></span>
</td>
<td class="num">$ (30,498)<span></span>
</td>
<td class="num">$ (27,147)<span></span>
</td>
<td class="num">$ (33,415)<span></span>
</td>
<td class="num">$ (32,525)<span></span>
</td>
<td class="num">$ (31,672)<span></span>
</td>
<td class="num">$ (57,645)<span></span>
</td>
<td class="num">$ (64,197)<span></span>
</td>
<td class="num">$ (89,996)<span></span>
</td>
<td class="num">$ (97,612)<span></span>
</td>
<td class="num">$ (130,927)<span></span>
</td>
<td class="num">$ (122,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,666<span></span>
</td>
<td class="nump">3,683<span></span>
</td>
<td class="nump">9,538<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
<td class="nump">16,382<span></span>
</td>
<td class="nump">7,495<span></span>
</td>
<td class="nump">18,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease loss/(income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
<td class="nump">4,765<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">8,477<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets', window );">Deposit and other long-term assets and deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(715)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,642)<span></span>
</td>
<td class="nump">$ 3,021<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets', window );">Remeasurement of operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(27,134)<span></span>
</td>
<td class="num">(18,476)<span></span>
</td>
<td class="num">(24,787)<span></span>
</td>
<td class="num">(32,885)<span></span>
</td>
<td class="num">(31,510)<span></span>
</td>
<td class="num">(29,056)<span></span>
</td>
<td class="num">(43,263)<span></span>
</td>
<td class="num">(60,566)<span></span>
</td>
<td class="num">(70,397)<span></span>
</td>
<td class="num">(93,451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">6,936<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
<td class="nump">12,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease loss/(income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets', window );">Deposit and other long-term assets and deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,206)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets', window );">Remeasurement of operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (5,217)<span></span>
</td>
<td class="num">$ (12,022)<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="num">$ (530)<span></span>
</td>
<td class="num">$ (1,015)<span></span>
</td>
<td class="num">(2,616)<span></span>
</td>
<td class="num">(14,382)<span></span>
</td>
<td class="num">(3,631)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">2,654<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="nump">4,006<span></span>
</td>
<td class="nump">3,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_NonCashSubleaseLossIncome', window );">Non-cash sublease loss/(income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,567)<span></span>
</td>
<td class="nump">4,765<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
<td class="nump">8,477<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets', window );">Deposit and other long-term assets and deferred rent receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets', window );">Remeasurement of operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,079)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in deposits and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_NonCashSubleaseLossIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Sublease Loss (Income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_NonCashSubleaseLossIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_advm_ReMeasurementOfOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Re-Measurement Of Operating Lease Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">advm_ReMeasurementOfOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>advm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 07, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Remaining lease obligation due between April 8 and December 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | NORTH CAROLINA | Manufacturing Facility | Loss Contingency, Lien On Subtenant's Leasehold Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Amounts due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">119,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Remaining lease obligation due between April 8 and December 31, 2025</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>99
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -<[CUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -<[CUH-X3+'\@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=ZZ:3>0HBX7$">0D)@$XA8E
MWA;1M%%BU.[M2</6@> !.,;^\_FSY%9[H8> 3V'P&,ABO)I<UT>A_88=B+P
MB/J 3L4R)?K4W W!*4K/L >O]+O:(]15=0T.21E%"F9@X1<BDZW10@=4-(03
MWN@%[S]"EV%& W;HL*<(O.3 Y#S1'Z>NA0M@AA$&%[\*:!9BKOZ)S1U@I^04
M[9(:Q[$<FYQ+.W!X?7QXSNL6MH^D>HWI5[2"CAXW[#SYI;F]V]XS65?UNJA6
M!5]O.1=-)5;-V^SZP^\B[ 9C=_:?&=]\,SX+RA9^W87\!%!+ P04    " #7
M.X]:F5R<(Q &  "<)P  $P   'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4
M?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.'X416(UL>621A'^_1S80RY8-[9)-
MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( -<[CUIFW& G.@@  (8R   8
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MU7U=O,>HI696K*-FU0G84JM2*YV U\@)9-,1;+<D2RZTR<<1G6?.VC@(",B
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M!\#^!>=R_T6=H'CU9/ W4$L#!!0    ( -<[CUHNQRS\/P(  ,$%   8
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M]2>A^D:PO/JJ\L"$8&EUN:4A)*T4@-\W#%K3_8W\4--\F%O\"U!+ P04
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MI"/'+".V9W> O=S+ -%8VK($<,+ Y) ,D%/:$)@FB1\Q]V"I=!8+E8>YZ!X
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MW93W?U%>GQ'12\O<\E]Q[_:.AB<BK6U5;OQA2+#1A?M??O5V" Y,^P<.)/Y
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MYY/1B;-<\U"56_XYPZ*LJG+#']=*HK[2!GR_+,NJ>2 &[>];KOX+4$L#!!0
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M]%CB6DXN'L#^UMHPO$0'XT5__2]02P,$%     @ USN/6H7OK8O6"@  A1X
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M=C<BF71C^\O]KN%$3#8/*!N;#.-<T&R\.1YJLK:(30DT4;&92'HQ;_C'/4%
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ME2N^7"J)"*0%>#XO,=/Y+\2@?8_HZG]02P,$%     @ USN/6O"TDVW8 @
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M2FC%4>JS>#:.V^H?Z9Q%Z3AMG_AFXNG5"0'.5M"8 ,7'D0:<DVNXK[ NJ1[
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MT^F :?=IW]U8M:7/Z4MEK2KI<B,XY&-< .]72MGF!@]H_[[BZG]02P,$%
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M*^(&_;<W*+!= /A:9H?:5."I]@K@)E: .LUF_P=LH#J-:8B9$K<-'K,6;>9
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MENNAL^-X$D!1YG.LJ9%<QQ6:HRHK$[I?8\.PV%L3#79=%O^DX4I'Q"39?%[
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MI7R=$+<4*!#0@TN2Q[+3F=83TI<B&D8UY/MMT!W[0FCOA/^<$I;V+6E5ZL*
M(LE=^&FLAWZ9>H^E;8K6D=:\*J^-T#LQ^#)53C.BC+QLA6-/JM!7<82G$_@(
MH<0I%8K EV'H?; &7]A%078X_>VFFA-H<*_Q#RP"2*/3F_G0Y-Q[9P(>\@;W
M/&-TC<D&CL(8^AWA6+Y3!9R./1'Z2>+(PY ?QB#E]TW)!,C*,2NMA7<2^4$8
MFH6-?"WB-1UR1Y*QKZ.X;R(EZBOO0R_HT70?,$ Z ;!8YT.CET!"*?TX2GO]
MBE-?@3O#B\M#BL5 /2'\&-HD EK^D! =4;'U@F2?%0?&L&MJ\WGK2IV3O5F%
MY/7LQ;C^ET8 MZ:2[(NE$^EZ9+BO@&[3;%D0WP(J%/I1Y"IK5X)%7BU6QE'8
MM857JO,;VG*YA>"J!HY:ZF2P T.Y#1$'%5-H_4D*L8B8EE%%?A)J:Z@PHA/8
MNM3X/SBUTMRAMR(,C15VO8@@\64<;%B'/1:PQY;&Z>)W0FP!?59R#-E=V1;,
M#K4?!<-R6O)PS([\*!5]<T-MQFP80"B207$L?1!F ]M4S)@M0S'"[#35NS%;
MP;3C[L]6K-9^JI5WPG^>":N%EJ[5@%K'ZDCY2:"L?LD@9/V2*62:/CU6$^=J
M- _U6)Q._50,<S+4(2@=060$N8'N4#KJ+7(C2DL_M,!.3: %811],THK7P'K
M ;NA$@-*AWX,:WZ(#DGDQX!E[8<RHC!(8$W^N!@MH#,C;;,EAV%T)",'HYG:
MC-&:K"H@C(;KE:F#T6F*<$JGAR"T3H#EZ="'4%C?X.L0>I<%C??^OAM$ARFB
M@V0,T;9L&T0K/Y9#4&7)QT!T$D@'HHG:#-%I"DUQPFI+'PC1L0X,1"?2@>C0
M#^-D'T3'VH%40SX=[J:C: 74.NYJI!J2EJ3GGE0).!7JY\#=)(T=AHAZ-.X*
M'3BX2]0AN!L" 4Y"2$[TN"O7O?4(=P$:8=HW04 ;82F_'7=3Q @:V8H>8!=!
M5!)OAMTH#" F!=A-M)_HZ(\+NQ1I):Y/[4H.A%VE7-@E:C/L(J:--(7&(@%N
MQ-;8"(T%K=-^R$V0N2;)T%YH2GXW)2?[(7>7\3S8RU#?#7:#".F7'L.N+=L"
MNYR0.=!AR,?L9D0B='8SB-H,N_!5D0M2ECX(=B623!,9BRAQ8#=BG[<3=B,
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M9Q1H?'AXE>PW42E2:Z+T]"@].E1_3/(^:$],2>UWU9W].>1+HKM-;XZ'!&>
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MCX]<*^CX .V7UH;AA1V,7W"[?P%02P,$%     @ USN/6DJ(_PY; P  E0\
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MWF2A7Z?H.E\W4;RVW6;/E>Y==ECJGP4($Z"?YYRKX\1L,/Q^DC=02P,$%
M  @ USN/6CRE,S@1 @  W00  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&ULI53;CM,P$/T5RT@\H3I)+Z"21&IW0:S$2M4NEP?$@QM/$VM]";:S6?X>
MVTE#0=T*B9?88\\Y<X[C<=YK\V ; (>>I%"VP(US[9H06S4@J9WI%I3?.6@C
MJ?.AJ8EM#5 605*0+$E61%*N<)G'M9TI<]TYP17L#+*=E-3\W(+0?8%3?%RX
MXW7CP@(I\Y;6< _N<[LS/B(3"^,2E.5:(0.' F_2]781\F/"%PZ]/9FCX&2O
M]4,(;EB!DR (!%0N,% _/,(5"!&(O(P?(R>>2@;@Z?S(_CYZ]U[VU,*5%E\Y
M<TV!WV#$X$ [X>YT_P%&/\O 5VEAXQ?U0^YRCE'56:?E"/8*)%?#2)_&<S@!
MI*MG -D(R*+NH5!4>4T=+7.C>V1"MF<+DV@UHKTXKL)/N7?&[W*/<^6-/UX&
M!GTRE'%5HYT6O.)@$54,[8RN@'4&;$Z<+Q8@I!J)MP-Q]@QQFJ%;K5QCT3O%
M@/U)0+S*26IVE+K-+C)>0S5#\_05RI)L<8%O/EF?1[[Y_UE'WSYZ(+IQ(.WW
M<^<P5%F<KQ*::FU;6D&!?==8,(^ RY<OTE7R]H*'Q>1A<8G]GSULF&[=WW]A
MD'^Y@#,=G--)3JZ<!%/'QK*HTIURP^V;5J?>W0Q7]G?ZT/BWU-1<623@X*')
M[/42(S,TTQ XW<8+O-?.MT.<-O[] 1,2_/Y!:W<,0H'I12M_ 5!+ P04
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MLM&HV7M/!YV$5G'L$ATF^Z]9\/Z00AM7T9-DO5 +%MY1E?&[,PF3"9M>ARN
M(V$\LT9+E5Y:@MX"]]9^>*P1D$ O=0B-0:D1#67.QETC5L3DP'<^8G)^$-J+
MM]48Q9A K7F>YUR=?O26,%*XE1:3HR?_[M)";4HE0O@=3BE^+:[F7OY&&=O6
M?'6"T5S+Z#J,!8<Q)V2_'ZL$SD$9P-P]YI&\7BBEF6UP8P4H^-(7;E26D;KB
MZS)%P?0%<:\\*F2\9/]Z]J"_2KYG.?K ))YM> _\AK<K=4V<@1ER#< IT'_
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M<E)!R95,+?N1D"7U[:/#H?C(<R:#W1(:_8WCD.SQ+4CGWM;<G(GQ1SB0RYA
MOBFGU%ZQ+?-'Z"BD64B25H+\TR6CZ\OBR=F361'83*G6I41=0OU+H=[ :TA%
MRP\J?TL\)GCGK7]6/# /8S^N%\\]\ ]CKUR@/X?5P^6]HMFBEG*5'T:']"J\
MVP_8LGM#*)JEQF4W#U-78G114,9[;XWR^P# )M_9$[\'E 8^[%'. RR_I &#
M _M CM&FX#>F'C-N0/8BX[&4=9+5[2'GL2>%23<$(/F'%)-3QR>+>5"4XT6<
M P3L*VV+),K30Y]9##U(YT=X)?,-@:71E.+TA:;[!P?PV&?.@758-1=V30\D
MI$'?\^GQW*O<\KW)"KEOQ:V,6NF?A)G-B::%>14Y]=^P'+-6;A5:_#+G[3F'
M<CCA<3>4,-J4? +0%^+41M=Q%(2"F1D/"AZS*\6 "@ PZ6,+6WP#UI.QX%M3
M?P*-K\QL"Z!0%4L2ZN[",R_PY;C3.25(B@.N8@[WH??+];%W>O71I]YIF\TX
MJA+OZU$^..CXIC(_G2LT!EKJCH0VB4QG86B[UBJ_=^<[/*NGW&>6%2GS6C$>
M&=*$&&)VK5Q> 9M3W=#/,9I!'[-O%?!7*1<<)#!=_DE#5#$KRZX.Q%H$[\#+
ML(9**8P3/691B7MGEN4.?4P3V>?3$]7OL KW)]5!/J2RQ+@6_A"DV&/ME?N
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M)!LU78[KD4-1XX#3OO0! $1W5*O[JH)=FO@U'+F1T*?%[/['BK3/:T3A(JD
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M24/CS8DK^I] 93?0^D)*LU=L@/8/9?(74$L#!!0    ( -<[CUI2M)V7T (
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M#D#[M5+V.'$.QK\'ZW\ 4$L#!!0    ( -<[CUILE(O?> 8  $82   9
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M*2-1R(##U/=;3O\.B=*0 !)-6$W)G\/%J.5B]&HNM@T&V71FC.CFSEZ%W:/
MWMW50.CE7"8<,OIR.]]I;]R!='4!'60&;<1*W&7/3.7/?ZWTR^?*C\A'^!Z
MR1^* \$[MB5<ZPTT@S77*>ZE-(@\&OIXQ6*/1I2<)8DN>68\4@?!@50NW=2;
M1 R.43AQH:Y*^%]*V<1CXP#*WV.CL.+/ <[<Z2Z+QEX 6B*/12'T0@LUCPPR
M)"*4DO<"%A UR^2BDH9Z'S,P'4&),G+!5Q(K#EV")1,O'OGU\:[^4J"@]O8M
MSU?'EX#/B3?E'@"U0X8XQW%<%_*(!%V[4)VF>@[IY&/H>S[8973DH'WJD.FS
M@($0L*;/?# ^IH,]QB)O I2:>.&8[J9UIU#<E]>!FA^41C0K^YA+G* @DZ/
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M@U  WL^5LLT-&FA_'4W_ 5!+ P04    " #7.X]:>IHC9O\"  !R!@  &0
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MO0BTI;:#K@3/I'=8._HHT$V,M6)"R$H.H"LI3"'V@J[@\)@&L7;DHX&NB+P
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M03!&3 'D^SVEXMQ0 ]1_.83_ U!+ P04    " #7.X]:7]Z^%A '  !2.P
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M]@7.[1>:K:O7VQXR2K-5]7%)HCG)2P'[?9%E=/>E#+!_C7;P/U!+ P04
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MQ=\NN3CJII-X'OK&[V[ F+'F+L)48OPJ%HS1:KX"8L;B(B7&:,]Y!4\AI(^
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M_*26?;OLXLB["ZK=2.9&<C=2N)'2C51NI.8:PFGD1\L_=JX"/J<[WZZR.-#
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M"69<G\@"<WHSD2KCAKIJZNI"(8\KIRQU?<9Z;L9%[H2#:NQ6A0-9FE3D>*M
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MME?U[:?N&%E4%X@':>@Z4C43NC&BL@;T?B*E>>G8.TE[!PW_ E!+ P04
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MBWH!VN?V]I&K?6EOG[C:5_;V0EH$+O3N?_: _.:!]]*J^*%^./>4_[,G?1F
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MPH2,*T/4*")4;HY+R= GHR],K4 $T8B<$$PJE$D0D3."2452CXR<$DPJCOU
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M%BM QTC!V7?BR58".Z7'1UT52G'$Y12*MT6CV+CYAM)9(^.S%E.H%XR,3VY
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M(28QJ%8!'Q ?W.0FM>9'L)UV^_?XT69%:K-I8ON2V([/N>=<W]@>;X2\52L
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M[T776):$*T2A,-"H,S3[H?17#=_1HG+'^U)H<UEPS96YGH&T$\SW0@B]Z]@
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M'8$UV> \$1_ITQ^D2L@O^%8TX>5?\%1AG1%8Y5S0M J6"M(X._S'WZI"' 5
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M#,76+(BR?==N^[V?G.JV[D&D=0(##(8!['C*YJH=@&O? ?3I5*YN['[[.&?
M=!B_>_3LV6[\O3J5JY]SM=KID#$,.]0I;W;M!^&^C:JB"9L#K)V'#3 YP$[;
MBB9';XV*5W9WF#W*80,)V<@XYRR4CL8.;\$.%X+NRA=)2RH$3<N/6X+7A!4
M^?N&4O%\4;R;JM]%SOX#4$L#!!0    ( -<[CUH6(<*T#P,  ($(   9
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M>BXR2?.BJS[D4LX<FB"HIJ.:@6HFJEFH9M=:*R%V8Z2KU7 G1M E\U#-1[4
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MTMJ!TI0:J_):X\N'V7Q:YDEG@*#%Q:BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M05H30?(+>*\.BN[3^73_:TS*Q4,G;ZBFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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M9:C_!:7Y4!J%TAB*IO<'9:U9LV,/ U!O#4KSH30*I3$43>\8RJ.SS"8=?AB
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MMMV>6?JK%F%]",<B%G+"TNN)?>6K :RS"^N8;=RO IY#9EB%SK ."(W=6M:
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MX=8:M@SXTO2Q H4LI[+H6*JW1:\\U;VR;O@:[U4/?6TZ1W<G4S3@WPA7IXY
M*2R4I-<9J(#RHJ<M'B1;F;;PD4G59)K;&(CJ _4 ]?N",;E]T!-4_UF8_ 90
M2P,$%     @ USN/6J:SP^@Y P  Q@L  !D   !X;"]W;W)K<VAE971S+W-H
M965T-3<N>&ULQ59=3]LP%/TK5H:V(0'Y:)I2UD:"PC:D(2$*V\.T!Y/<-A9)
M'&RWA?WZ73MI2*NT&E(1+ZWMW'M\SO&-<P<++AYD J#(4Y;F<F@E2A4GMBVC
M!#(JCW@!.3Z9<)%1A5,QM64A@,8F*4MMSW$".Z,LM\*!6;L6X8#/5,IRN!9$
MSK*,BN<S2/EB:+G6<N&&31.E%^QP4- IC$'=%=<"9W:-$K,,<LEX3@1,AM:I
M>S)R'9U@(GXR6,C&F&@I]YP_Z,EE/+0<S0A2B)2&H/@WAQ&DJ49"'H\5J%7O
MJ1.;XR7Z5R,>Q=Q3"2.>_F*Q2H;6L45BF-!9JF[XXCM4@KH:+^*I-+]D4<4Z
M%HEF4O&L2D8&&<O+?_I4&=%(<(,-"5Z5X*TG^!L2.E5"QP@MF1E9YU31<"#X
M@@@=C6AZ8+PQV:B&Y?H8QTK@4X9Y*APK'CTD/(U!R$_DXG'&U#,Y)&,LEWB6
M N$38D(.M5<Q&?$,"TA2<P073WH,Y/,Y*,I2N8^)=^-S\GEOG^P1EI/;A,\D
MS6,YL!5RU3O:4<7KK.3E;>#E>N2*YRJ1Y"*/(5X%L%%DK=1;*CWSMB*>0W1$
M.NX!\1S/;R$T^O_TSA8ZG=KXCL'K;#(^H0(J5Z_I,[X9BIP*0?,IZ/'!TMV8
MH(%D1 NF:,K^0GQ 3C,^P^C?/Q"27"K(Y)\V@\O]_?;]]?5P(@L:P=#"]U^"
MF(,5?OS@!LZ7-G-V!+9BE5];Y6]##V\Y2B>R85C4+$,HC6JSH,3M&5Q]H<U#
MU^]TG8$];VIKB>IU@WX=M4*Z6Y/N;B5]@S90$27F^&*8XX59Z(-MH[D5Z;4G
MM2.P%=%!+3IXYZ(.=FG5CL!6K.K55O7>J*A+W*!1KG[7]]=JNB6HOZFDCVO*
MQULI?X,<!)+69T=C_!@QJ035G^$VFENQ7GM2.P);D=VO9???N:C[N[1J1V K
M5KG.2SOAO%%95\#-:[A_[ 1K==T2Y7J!XZQ5MMWHB#(04],H2N2"QU&V#/5J
MV8R>Z694=U1KZ]BDGIK6S'Z!*3O<*RJF+)<DA0E".D<]O'A%V326$\4+TW?=
M<X5=G!DFV&B#T 'X?,*Y6D[T!G7K'OX#4$L#!!0    ( -<[CUHW3$057@(
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MWJO=5^C\7#N^0@GCOV37QEZG 2DVQJJZ Z."FLMV9$_=/1P HN$)0-P!XM>
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MNM6:QDB;K^NF7.Z,VQHL\V+[/_NQ:XAW!IR?,. [ S[4P-@9&$,-S)V!.=3
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MM P0]U>$\'VC'* YV)W\#U!+ P04    " #7.X]:;O-)BC,%  #C'@  &0
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M$S@(8Z#?KSE7KS?FC->>Z>?_ 5!+ P04    " #7.X]:D/M)I7T%  !:(P
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M4/4!A5;EIU0?Q*X^+H5DP9*GN_:W6 ;*#[Q#<L,.=?(R U4E4&A5&DM50@:
MVQ54=8"BN5!H51Y+U4'LOSX<EWR'M:]OW5&OOD]!90046D9,:^?00<3D,CV\
MH9 G8JZSW^R+I]D!D0M\/D_/4>P]G^'S67I<HE7"9*=.OE"Y#+A"(7LTD.VS
M@0DT,CO(D=UHL4Z/-CP(K4647JX8]9E,&ICWCT+HEYND@^(XS?1_4$L#!!0
M   ( -<[CUK:2H7N*0,  .L)   9    >&PO=V]R:W-H965T<R]S:&5E=#8U
M+GAM;*V66V_3,!2 _XH5$!H26VYMTXXVTKJ!V,.D:6/P@'CPDM/&FF,'VUDW
M?CW'3AMZ20MHO+2V<V[?L8]]Q@NI'G0!8,A3R86>>(4QU:GOZZR DNH368'
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M#.8"R3Q-L?AS#91O)H[O;"?NR2I19L*=CC.\@@6H;]E<Z)%;H<0D!28)9TC
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M8>:!WH('I5F@M DHS0:E34%I#BC-!:5YH#0?E!: TD(H6G-NV-Z.Q^H/WS?
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MLD7U=4Y)1//2@/_^F&7L[:!TL'D#<OP_4$L#!!0    ( -<[CUJ<>\VW(Q4
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MM4Q4+1=5*T352E&U2DIM/"T&X](S.Y=O5ZOF8=<>G/OEEY<>L#U@^T4>=3\
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M>X2!!?@0XROP$0:6X",,K,$'&%J$CS"P"E]J>,?),#C*OME1GK,0WRPU.Q.
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M[)S#QB\[UGT5=J2T(Y740(^R0P_VKY[R2P1?S@/SYG/S0/,>&)?=$RSMN['
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M_5O5E)_6E;.KKA_J5;,:N&[PP:6C=G+1H=>2GE@ 0X6F  H">D;1&4%/8PF
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M+/(K',JQC@6K3$B>E&#E04)9<2??RT0< 11//< K =Y+@/\*H%4"6F\%^"7
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M%     @ USN/6I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M_YH\?P%02P$"% ,4    " #7.X]:1L=-2)4   #-    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -<[CUH-X3+'\@
M "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( -<[CUJ97)PC$ 8  )PG   3              "  >0!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ USN/6F;<8"<Z"   AC(  !@
M             ("!)0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( -<[CUHNQRS\/P(  ,$%   8              " @940  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #7.X]:-0=!BV(&  "D
M&P  &               @($*$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ USN/6O!RS[;Y @  40H  !@              ("!HAD
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( -<[CUKV"@;
M?0D  *XZ   8              " @=$<  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " #7.X]:Z0U@5L0.   MI   &
M@(&$)@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ USN/
M6KL.Z(-; @  S 0  !@              ("!?C4  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( -<[CUKEP,(5>0@  )<L   8
M      " @0\X  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" #7.X]:%.E@W'0'  !;$0  &               @(&^0   >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ USN/6D#P6.MO#   ZR(  !D
M             ("!:$@  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " #7.X]:@A7@@YD;  "15@  &0              @($.50  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( -<[CUIF%9 03@@
M ($6   9              " @=YP  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ USN/6L*><\&P!   ] L  !D              ("!
M8WD  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #7.X]:
MA>^MB]8*  "%'@  &0              @(%*?@  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( -<[CUJ3:W?4F ,  "8(   9
M      " @5>)  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ USN/6I5.U)=G P  M <  !D              ("!)HT  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #7.X]:S:FEEF\,  !3)
M&0              @('$D   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( -<[CUKPM)-MV (  $0&   9              " @6J=  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ USN/6F:3@69H
M!0  +@T  !D              ("!>:   'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " #7.X]:DTO)DXX+  !K(0  &0
M@($8I@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( -<[
MCUJF:C X4 ,  #L'   9              " @=VQ  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ USN/6JF?=.ZY%   ;58  !D
M         ("!9+4  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " #7.X]:'6DUHT$$  #-"0  &0              @(%4R@  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( -<[CUI*B/\.6P,  )4/
M   9              " @<S.  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ USN/6BQU:+Y# @  B@8  !D              ("!7M(
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #7.X]:/*4S
M.!$"  #=!   &0              @('8U   >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( -<[CUHXR666J0H  (4P   9
M  " @2#7  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MUSN/6OJJS87U&P  _UT  !D              ("! .(  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " #7.X]:3W_J)?P&  !Q$0  &0
M            @($L_@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( -<[CUHH=BTKE@,  *T(   9              " @5\% 0!X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ USN/6E*TG9?0 @
M*@8  !D              ("!+ D! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " #7.X]:K\6>$+<#  ">"   &0              @($S
M# $ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( -<[CUK^
M%4PN< 4  -<-   9              " @2$0 0!X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ USN/6ORE..W7 P  *@@  !D
M     ("!R!4! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -<[CUI?WKX6$ <  %([   9              "
M@04Z 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ USN/
M6C?5&Z?I%   YK\  !D              ("!3$$! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " #7.X]:T'4A.!@#  "/"@  &0
M        @(%L5@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( -<[CUHWI 7$UA(  #.J   9              " @;M9 0!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ USN/6B>>U-HM"@  YW
M !D              ("!R&P! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " #7.X]:-VW_&>H"  #\"0  &0              @($L=P$
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( -<[CUKI2<2(
M<P4  )<<   9              " @4UZ 0!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ USN/6A8APK0/ P  @0@  !D
M ("!]W\! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #7
M.X]:'NJY5SD$  "X(0  &0              @($]@P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( -<[CUH7!0EI\ P  /VX   9
M          " @:V' 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#
M%     @ USN/6D#&)*[& @  X@<  !D              ("!U)0! 'AL+W=O
M<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #7.X]:;^F]]%H%   G
M,   &0              @('1EP$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM
M;%!+ 0(4 Q0    ( -<[CUI$@EA7, 0   D7   9              " @6*=
M 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ USN/6D&7
MO H)!   U1X  !D              ("!R:$! 'AL+W=O<FMS:&5E=',O<VAE
M970U,BYX;6Q02P$"% ,4    " #7.X]:X1'>_D0,   ^?   &0
M    @($)I@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M -<[CUIWR^5/V@0  #,8   9              " @82R 0!X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ USN/6D1R>9V; P  ! X  !D
M             ("!E;<! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    " #7.X]:TJ!]#>L#  !E$   &0              @(%GNP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( -<[CUJFL\/H.0,
M ,8+   9              " @8F_ 0!X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ USN/6C=,1!5> @  I 4  !D              ("!
M^<(! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " #7.X]:
M"XH>GUP)   Z7P  &0              @(&.Q0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( -<[CUK/DO9E>0,  %L/   9
M      " @2'/ 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ USN/6@F8VJS& P  Y!4  !D              ("!T=(! 'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #7.X]:;O-)BC,%  #C'@
M&0              @('.U@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( -<[CUK_Q7;,.@0  -\/   9              " @3C< 0!X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ USN/6I#[2:5]
M!0  6B,  !D              ("!J> ! 'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    " #7.X]:VDJ%[BD#  #K"0  &0
M@(%=Y@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( -<[
MCUIN[](R: ,  ' /   9              " @;WI 0!X;"]W;W)K<VAE971S
M+W-H965T-C8N>&UL4$L! A0#%     @ USN/6NI*?AF>!@  #3D  !D
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M=#<Q+GAM;%!+ 0(4 Q0    ( -<[CUI):&\220,  / 4   -
M  "  9(L @!X;"]S='EL97,N>&UL4$L! A0#%     @ USN/6I>*NQS
M$P(   L              ( !!C " %]R96QS+RYR96QS4$L! A0#%     @
MUSN/6F4[)4)J!0  V2X   \              ( ![S " 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( -<[CUJP!0"]-@(  !PJ   :              "
M 88V @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -<[
MCUKART;(_0$  #TI   3              "  ?0X @!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !/ $\ H!4  "([ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>167</ContextCount>
  <ElementCount>353</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Restatement of Previously Issued Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements</Role>
      <ShortName>Restatement of Previously Issued Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments</Role>
      <ShortName>Fair Value Measurements and Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - 401(k) Savings Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/A401kSavingsPlan</Role>
      <ShortName>401(k) Savings Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/NetLossperShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Quarterly Financial Information (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited</Role>
      <ShortName>Quarterly Financial Information (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.adverum.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables</Role>
      <ShortName>Restatement of Previously Issued Financial Statements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value Measurements and Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/BalanceSheetComponents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/StockholdersEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/NetLossperShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/NetLossperShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables</Role>
      <ShortName>Quarterly Financial Information (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Description of the Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails</Role>
      <ShortName>Description of the Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Restatement of Previously Issued Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails</Role>
      <ShortName>Restatement of Previously Issued Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails</Role>
      <ShortName>Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails</Role>
      <ShortName>Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails</Role>
      <ShortName>Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails</Role>
      <ShortName>Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails</Role>
      <ShortName>Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/Revenue</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails</Role>
      <ShortName>Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/CommitmentsandContingencies</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - 401(k) Savings Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/A401kSavingsPlanDetails</Role>
      <ShortName>401(k) Savings Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/A401kSavingsPlan</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/SegmentReportingTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Income Taxes - Schedule of Components of Loss Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Loss Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails</Role>
      <ShortName>Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/NetLossperShareDetails</Role>
      <ShortName>Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/NetLossperShareTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Quarterly Financial Information (Unaudited) - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails</Role>
      <ShortName>Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="advm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adverum.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.adverum.com/role/SubsequentEvents</ParentRole>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="advm-20241231.htm">advm-20241231.htm</File>
    <File>advm-20241231.xsd</File>
    <File>advm-20241231_cal.xml</File>
    <File>advm-20241231_def.xml</File>
    <File>advm-20241231_lab.xml</File>
    <File>advm-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>advm-20241231_g1.jpg</File>
    <File>advm-20241231_g10.jpg</File>
    <File>advm-20241231_g11.jpg</File>
    <File>advm-20241231_g2.jpg</File>
    <File>advm-20241231_g3.jpg</File>
    <File>advm-20241231_g4.jpg</File>
    <File>advm-20241231_g5.jpg</File>
    <File>advm-20241231_g6.jpg</File>
    <File>advm-20241231_g7.jpg</File>
    <File>advm-20241231_g8.jpg</File>
    <File>advm-20241231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1621">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>106
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "advm-20241231.htm": {
   "nsprefix": "advm",
   "nsuri": "http://www.adverum.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "advm-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "advm-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "advm-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "advm-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "advm-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "advm-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 324,
   "keyCustom": 29,
   "axisStandard": 22,
   "axisCustom": 0,
   "memberStandard": 33,
   "memberCustom": 17,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "contextCount": 167,
   "entityCount": 1,
   "segmentCount": 56,
   "elementCount": 630,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1621,
    "http://xbrl.sec.gov/dei/2024": 39,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 6
   },
   "report": {
    "R1": {
     "role": "http://www.adverum.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.adverum.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OtherLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R5": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-164",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.adverum.com/role/DescriptionoftheBusiness",
     "longName": "9952157 - Disclosure - Description of the Business",
     "shortName": "Description of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements",
     "longName": "9952158 - Disclosure - Restatement of Previously Issued Financial Statements",
     "shortName": "Restatement of Previously Issued Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.adverum.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952159 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments",
     "longName": "9952160 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments",
     "shortName": "Fair Value Measurements and Fair Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.adverum.com/role/Revenue",
     "longName": "9952161 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.adverum.com/role/Leases",
     "longName": "9952162 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.adverum.com/role/BalanceSheetComponents",
     "longName": "9952163 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.adverum.com/role/CommitmentsandContingencies",
     "longName": "9952164 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.adverum.com/role/StockholdersEquity",
     "longName": "9952165 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.adverum.com/role/A401kSavingsPlan",
     "longName": "9952166 - Disclosure - 401(k) Savings Plan",
     "shortName": "401(k) Savings Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.adverum.com/role/SegmentReporting",
     "longName": "9952167 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.adverum.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.adverum.com/role/NetLossperShare",
     "longName": "9952169 - Disclosure - Net Loss per Share",
     "shortName": "Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited",
     "longName": "9952170 - Disclosure - Quarterly Financial Information (Unaudited)",
     "shortName": "Quarterly Financial Information (Unaudited)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.adverum.com/role/SubsequentEvents",
     "longName": "9952171 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-167",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-167",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables",
     "longName": "9955512 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)",
     "shortName": "Restatement of Previously Issued Financial Statements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables)",
     "shortName": "Fair Value Measurements and Fair Value of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.adverum.com/role/LeasesTables",
     "longName": "9955514 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.adverum.com/role/BalanceSheetComponentsTables",
     "longName": "9955515 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.adverum.com/role/StockholdersEquityTables",
     "longName": "9955516 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.adverum.com/role/SegmentReportingTables",
     "longName": "9955517 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.adverum.com/role/IncomeTaxesTables",
     "longName": "9955518 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.adverum.com/role/NetLossperShareTables",
     "longName": "9955519 - Disclosure - Net Loss per Share (Tables)",
     "shortName": "Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables",
     "longName": "9955520 - Disclosure - Quarterly Financial Information (Unaudited) (Tables)",
     "shortName": "Quarterly Financial Information (Unaudited) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails",
     "longName": "9955521 - Disclosure - Description of the Business - Additional Information (Details)",
     "shortName": "Description of the Business - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails",
     "longName": "9955522 - Disclosure - Restatement of Previously Issued Financial Statements (Details)",
     "shortName": "Restatement of Previously Issued Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
     "longName": "9955523 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details)",
     "shortName": "Restatement of Previously Issued Financial Statements - Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails",
     "longName": "9955524 - Disclosure - Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details)",
     "shortName": "Restatement of Previously Issued Financial Statements - Balance Sheet Additional Items (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R42": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
     "longName": "9955525 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details)",
     "shortName": "Restatement of Previously Issued Financial Statements - Consolidated Statement of Operations and Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
     "longName": "9955526 - Disclosure - Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details)",
     "shortName": "Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-33",
      "name": "advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "9955527 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails",
     "longName": "9955528 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details)",
     "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Cash Equivalents and Short-term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails",
     "longName": "9955529 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)",
     "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "unitRef": "security",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "unitRef": "security",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.adverum.com/role/RevenueDetails",
     "longName": "9955530 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-45",
      "name": "us-gaap:ProceedsFromLicenseFeesReceived",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
     "longName": "9955531 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-52",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "advm:LesseeOperatingLeaseNumberOfLease",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails",
     "longName": "9955532 - Disclosure - Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)",
     "shortName": "Leases - Schedule of Future Non-cancellable Lease Payments under Operating Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955533 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails",
     "longName": "9955534 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955535 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
     "longName": "9955536 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails",
     "longName": "9955537 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
     "longName": "9955538 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)",
     "shortName": "Stockholders' Equity - Schedule of Fair Value of Option Issued Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-89",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-89",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails",
     "longName": "9955539 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-96",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-95",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails",
     "longName": "9955540 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.adverum.com/role/A401kSavingsPlanDetails",
     "longName": "9955541 - Disclosure - 401(k) Savings Plan (Details)",
     "shortName": "401(k) Savings Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.adverum.com/role/SegmentReportingDetails",
     "longName": "9955542 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-106",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails",
     "longName": "9955543 - Disclosure - Income Taxes - Schedule of Components of Loss Before Income Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Components of Loss Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails",
     "longName": "9955544 - Disclosure - Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details)",
     "shortName": "Income Taxes- Schedule of Components of Income Tax (Benefit) Provision (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails",
     "longName": "9955545 - Disclosure - Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails",
     "longName": "9955546 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
     "longName": "9955547 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationTaxCreditsResearch",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails",
     "longName": "9955548 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.adverum.com/role/NetLossperShareDetails",
     "longName": "9955549 - Disclosure - Net Loss per Share (Details)",
     "shortName": "Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
     "longName": "9955550 - Disclosure - Quarterly Financial Information (Unaudited) - Additional Information (Details)",
     "shortName": "Quarterly Financial Information (Unaudited) - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-124",
      "name": "us-gaap:DeferredRentReceivablesNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R68": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
     "longName": "9955551 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details)",
     "shortName": "Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-123",
      "name": "us-gaap:DeferredRentReceivablesNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
     "longName": "9955552 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)",
     "shortName": "Quarterly Financial Information (Unaudited) - Schedule Of Quarterly Information - Condensed Consolidated Statements of Operations and Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R70": {
     "role": "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
     "longName": "9955553 - Disclosure - Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details)",
     "shortName": "Quarterly Financial Information (Unaudited) - Schedule Of Restatements Of Quarterly Information - Condensed Consolidated Statements of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-138",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-164",
      "name": "advm:ReMeasurementOfOperatingLeaseRightOfUseAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.adverum.com/role/SubsequentEventsDetails",
     "longName": "9955554 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "advm-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "advm_A2024EquityIncentiveAwardPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "A2024EquityIncentiveAwardPlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Equity Incentive Award Plan",
        "label": "2024 Equity Incentive Award Plan [Member]",
        "documentation": "2024 Equity Incentive Award Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r776"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net accretion of discount on marketable securities",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "advm_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "advm_AccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "AccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities",
        "label": "Accrued Expenses And Other Current Liabilities",
        "documentation": "Accrued expenses and other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "advm_AccruedInterestReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "AccruedInterestReceivablePolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Interest Receivable",
        "label": "Accrued Interest Receivable [Policy Text Block]",
        "documentation": "Accrued Interest Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "advm_AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "advm_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued nonclinical, clinical and process development costs",
        "label": "Accrued Nonclinical, Clinical and Process Development Costs, Current",
        "documentation": "Accrued preclinical costs current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "advm_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r132",
      "r590"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated currency translation adjustments",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r475"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r62",
      "r135",
      "r586",
      "r621",
      "r625"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r16",
      "r445",
      "r448",
      "r505",
      "r616",
      "r617",
      "r938",
      "r939",
      "r940",
      "r947",
      "r948",
      "r949",
      "r951"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r638",
      "r947",
      "r948",
      "r949",
      "r951",
      "r1017",
      "r1076"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r352"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r80"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r834",
      "r844",
      "r877"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r837",
      "r847",
      "r880"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r872",
      "r881",
      "r885",
      "r893"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "advm_AllocatedFacilitiesAndInformationTechnologyExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "AllocatedFacilitiesAndInformationTechnologyExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facilities and IT",
        "label": "Allocated Facilities And Information Technology Expenses",
        "documentation": "Allocated Facilities And Information Technology Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r389"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive common stock equivalents excluded from calculation of diluted net loss per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r134",
      "r157",
      "r192",
      "r199",
      "r224",
      "r228",
      "r269",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r440",
      "r442",
      "r476",
      "r582",
      "r665",
      "r736",
      "r737",
      "r776",
      "r801",
      "r975",
      "r976",
      "r1033"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r136",
      "r157",
      "r269",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r440",
      "r442",
      "r476",
      "r776",
      "r975",
      "r976",
      "r1033"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "advm_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.adverum.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.adverum.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.adverum.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost Basis",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r279",
      "r581"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r279",
      "r456",
      "r575",
      "r765",
      "r768",
      "r960",
      "r1022",
      "r1023",
      "r1024"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]",
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "advm_BeneficialOwnershipInterestLimitationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "BeneficialOwnershipInterestLimitationPercent",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beneficial ownership interest limitation (percent)",
        "label": "Beneficial Ownership Interest Limitation, Percent",
        "documentation": "Beneficial Ownership Interest Limitation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CALIFORNIA",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets in accounts payable and current liabilities",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24"
     ]
    },
    "advm_CashAndCashEquivalentAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "CashAndCashEquivalentAmortizedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Cash equivalents, amortized cost basis",
        "label": "Cash And Cash Equivalent Amortized Cost",
        "documentation": "Cash And Cash Equivalent Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "advm_CashAndCashEquivalentGrossUnrealizedGain": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "CashAndCashEquivalentGrossUnrealizedGain",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Cash equivalents",
        "label": "Cash And Cash Equivalent Gross Unrealized Gain",
        "documentation": "Cash And Cash Equivalent Gross Unrealized Gain"
       }
      }
     },
     "auth_ref": []
    },
    "advm_CashAndCashEquivalentGrossUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "CashAndCashEquivalentGrossUnrealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Cash equivalents, unrealized losses",
        "label": "Cash And Cash Equivalent Gross Unrealized Loss",
        "documentation": "Cash And Cash Equivalent Gross Unrealized Loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r130",
      "r723"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Cash equivalents, estimated fair value",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1021"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r91"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, and short-term investments",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "totalLabel": "Cash, cash equivalents and restricted cash at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r69",
      "r155"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r69"
     ]
    },
    "advm_CashEquivalentsAndShortTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "CashEquivalentsAndShortTermInvestmentsMember",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash equivalents and short-term investments",
        "label": "Cash Equivalents And Short Term Investments [Member]",
        "documentation": "Cash equivalents and short term investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental schedule of noncash information",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Per Share (in USD per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued upon exercise of warrants (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "advm_ClassOfWarrantOrRightWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ClassOfWarrantOrRightWarrantsExercised",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants exercised (in shares)",
        "label": "Class Of Warrant Or Right, Warrants Exercised",
        "documentation": "Class Of Warrant Or Right, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "advm_ClinicalTrialExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ClinicalTrialExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial and manufacturing",
        "label": "Clinical Trial Expenses",
        "documentation": "Clinical Trial Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r313",
      "r795",
      "r796",
      "r797",
      "r798"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 8)",
        "verboseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r94",
      "r583",
      "r652"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r305",
      "r306",
      "r708",
      "r969",
      "r971"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares available for future grant (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r792",
      "r793",
      "r795",
      "r796",
      "r797",
      "r798",
      "r947",
      "r948",
      "r951",
      "r1017",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in USD per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r653"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r653",
      "r671",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2024: 20,848 and 10,143 shares issued and outstanding at December 31, 2024 and 2023, respectively",
        "verboseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r585",
      "r776"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "presentation": [
      "http://www.adverum.com/role/A401kSavingsPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "401(k) Savings Plan",
        "label": "Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]",
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83",
      "r84"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r142",
      "r144",
      "r149",
      "r576",
      "r596",
      "r597"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Credit Risk and Other Uncertainties",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r115"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Principles of Consolidation",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/RevenueDetails",
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r160",
      "r161",
      "r323",
      "r327",
      "r506",
      "r526",
      "r580",
      "r724",
      "r726"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r946"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current tax (benefit) provision",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r946"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r904"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r904"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r906"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r906"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r908"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r906"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r899"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r900"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r900"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r809",
      "r898"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r809",
      "r898"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r809",
      "r898"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r812",
      "r901"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r903"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r903"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r904"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r907"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r905"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r813",
      "r902"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r279",
      "r285",
      "r287"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charges on available-for-sale securities",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of writeoff of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r286"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities in an unrealized loss",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r281",
      "r743"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of securities, unrealized loss position",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r282"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r946",
      "r1016"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax provision",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r120",
      "r946"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r93",
      "r417"
     ]
    },
    "us-gaap_DeferredRentReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRentReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred rent receivable",
        "label": "Deferred Rent Receivables, Net",
        "documentation": "Amount of excess of rental income recognized over rental payment required by lease."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r1030"
     ]
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital losses",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "advm_DeferredTaxAssetsCapitalizedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "DeferredTaxAssetsCapitalizedCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 174 R&amp;D capitalization",
        "label": "Deferred Tax Assets, Capitalized Costs",
        "documentation": "Deferred Tax Assets, Capitalized Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangibles",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets before valuation allowance",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "advm_DeferredTaxAssetsLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "DeferredTaxAssetsLeaseObligation",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease obligation",
        "label": "Deferred Tax Assets Lease Obligation",
        "documentation": "Deferred tax assets lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accruals, reserve and other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/A401kSavingsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution by company",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r36"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830",
      "r873"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830",
      "r873"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated By Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic tax authority",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share - basic (in USD per share)",
        "terseLabel": "Net loss per share - basic (in USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r174",
      "r180",
      "r182",
      "r184",
      "r185",
      "r186",
      "r191",
      "r436",
      "r439",
      "r453",
      "r454",
      "r577",
      "r598",
      "r728"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share - diluted (in USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r174",
      "r182",
      "r184",
      "r185",
      "r186",
      "r191",
      "r436",
      "r439",
      "r453",
      "r454",
      "r577",
      "r598",
      "r728"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and Diluted Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r188"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r187",
      "r189",
      "r190"
     ]
    },
    "advm_EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax positions",
        "label": "Effective Income Tax Rate Reconciliation Change In State Uncertain Tax Position",
        "documentation": "Income tax reconciliation change in state uncertain tax position."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation, weighted-average period (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized stock-based compensation expense related to awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan",
        "verboseLabel": "ESPP",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails",
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "verboseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r123",
      "r146",
      "r147",
      "r148",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r175",
      "r177",
      "r194",
      "r270",
      "r273",
      "r298",
      "r330",
      "r426",
      "r427",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r452",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r486",
      "r489",
      "r505",
      "r594",
      "r616",
      "r617",
      "r618",
      "r638",
      "r691"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r834",
      "r844",
      "r877"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r831",
      "r841",
      "r874"
     ]
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ErrorCorrectionTextBlock",
     "presentation": [
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement of Previously Issued Financial Statements",
        "label": "Error Correction [Text Block]",
        "documentation": "The entire disclosure for reporting error correction."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Period, Costs Not Allocable [Line Items]",
        "verboseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r174",
      "r175",
      "r176",
      "r177",
      "r191"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-sale Securities [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r460",
      "r768"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r466",
      "r467",
      "r469",
      "r513",
      "r514",
      "r515",
      "r746",
      "r747",
      "r756",
      "r757",
      "r758",
      "r765",
      "r768"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements and Fair Value of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r464",
      "r465",
      "r466",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r574",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r343",
      "r348",
      "r457",
      "r467",
      "r513",
      "r756",
      "r757",
      "r758",
      "r765"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r343",
      "r348",
      "r457",
      "r458",
      "r467",
      "r514",
      "r746",
      "r747",
      "r756",
      "r757",
      "r758",
      "r765"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r466",
      "r467",
      "r469",
      "r513",
      "r514",
      "r515",
      "r746",
      "r747",
      "r756",
      "r757",
      "r758",
      "r765",
      "r768"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r283",
      "r284",
      "r325",
      "r328",
      "r450",
      "r474",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r595",
      "r743",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r777",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1019",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Jurisdiction",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r881"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r881"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r881"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r881"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r881"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of property and equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r675"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r830"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "advm_IncentiveStockOptionsAndNonQualifiedStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncentiveStockOptionsAndNonQualifiedStockOptionsMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs)",
        "label": "Incentive Stock Options And Non-Qualified Stock Options [Member]",
        "documentation": "Incentive Stock Options And Non-Qualified Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r398"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss before income taxes",
        "terseLabel": "Net loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r98",
      "r102",
      "r578",
      "r592",
      "r730",
      "r736",
      "r953",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r398"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r301",
      "r302",
      "r461",
      "r463",
      "r468",
      "r613",
      "r615",
      "r676",
      "r720",
      "r767",
      "r1046"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r302",
      "r461",
      "r463",
      "r468",
      "r613",
      "r615",
      "r676",
      "r720",
      "r767",
      "r1046"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r399",
      "r400",
      "r410",
      "r422",
      "r764",
      "r1013"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r399",
      "r400",
      "r410",
      "r422",
      "r764",
      "r1013"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r393",
      "r399",
      "r406",
      "r407",
      "r408",
      "r414",
      "r421",
      "r428",
      "r430",
      "r431",
      "r432",
      "r637",
      "r764"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxBenefitProvisionDetails",
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit",
        "negatedTerseLabel": "Income tax benefit (provision)",
        "totalLabel": "Total income tax (benefit) provision",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r121",
      "r176",
      "r177",
      "r192",
      "r207",
      "r228",
      "r397",
      "r399",
      "r429",
      "r600",
      "r764"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r395",
      "r396",
      "r414",
      "r415",
      "r420",
      "r424",
      "r634"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r764",
      "r1008"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r402",
      "r764",
      "r1008"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal income tax benefit at statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r764"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r1008"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of internal reorganization",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible restructuring charges."
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1010"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r1008",
      "r1010"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.adverum.com/role/IncomeTaxesScheduleofReconciliationofIncomeTaxExpenseComputedStatutoryFederalIncomeTaxandFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r1008",
      "r1010"
     ]
    },
    "advm_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "documentation": "Income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "advm_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "documentation": "Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "advm_IncreaseDecreaseInDepositAndOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncreaseDecreaseInDepositAndOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deposit and other long-term assets",
        "negatedTerseLabel": "Deposit and other long-term assets and deferred rent receivable",
        "label": "Increase Decrease In Deposit And Other Noncurrent Assets",
        "documentation": "Increase (decrease) in deposits and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "negatedTerseLabel": "Decrease in lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r921",
      "r942"
     ]
    },
    "advm_IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Re-measurement of operating lease liabilities",
        "label": "Increase (Decrease) In Operating Lease Liability Due To Lease Modification,",
        "documentation": "Increase (Decrease) In Operating Lease Liability Due To Lease Modification,"
       }
      }
     },
     "auth_ref": []
    },
    "advm_IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Re-measurement of operating lease right-of-use assets",
        "label": "Increase (Decrease) In Operating Lease Right Of Use Asset Due To Lease Modification,",
        "documentation": "Increase (Decrease) In Operating Lease Right Of Use Asset Due To Lease Modification,"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r872",
      "r881",
      "r885",
      "r893"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r897"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r897"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r808",
      "r897"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r630",
      "r631",
      "r632",
      "r633",
      "r697",
      "r698"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits expenses",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "advm_LandlordMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LandlordMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Landlord",
        "label": "Landlord [Member]",
        "documentation": "Landlord"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Axis]",
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r920"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Domain]",
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r920"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r502"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r503"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r503"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "advm_LesseeOperatingLeaseLeaseholdImprovementAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LesseeOperatingLeaseLeaseholdImprovementAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvement allowance",
        "label": "Lessee, Operating Lease, Leasehold Improvement Allowance",
        "documentation": "Lessee, Operating Lease, Leasehold Improvement Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Undiscounted Future Lease Payments under Operating Lease",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "terseLabel": "Total undiscounted lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "verboseLabel": "Remaining lease obligation due between April 8 and December 31, 2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Imputed Interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r501"
     ]
    },
    "advm_LesseeOperatingLeaseNumberOfLease": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LesseeOperatingLeaseNumberOfLease",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of facility leases",
        "label": "Lessee, Operating Lease, Number Of Lease",
        "documentation": "Lessee, Operating Lease, Number Of Lease"
       }
      }
     },
     "auth_ref": []
    },
    "advm_LesseeOperatingLeaseNumberOfRenewalContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LesseeOperatingLeaseNumberOfRenewalContracts",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of renewal contracts",
        "label": "Lessee, Operating Lease, Number Of Renewal Contracts",
        "documentation": "Lessee, Operating Lease, Number Of Renewal Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease renewal term (in years)",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.adverum.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "advm_LexeoTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LexeoTherapeuticsIncMember",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lexeo Therapeutics, Inc",
        "label": "Lexeo Therapeutics, Inc [Member]",
        "documentation": "Lexeo Therapeutics, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r54",
      "r157",
      "r269",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r441",
      "r442",
      "r443",
      "r476",
      "r651",
      "r729",
      "r801",
      "r975",
      "r1033",
      "r1034"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r95",
      "r588",
      "r776",
      "r945",
      "r966",
      "r1027"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r129",
      "r157",
      "r269",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r441",
      "r442",
      "r443",
      "r476",
      "r776",
      "r975",
      "r1033",
      "r1034"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency Nature [Axis]",
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r312",
      "r390",
      "r626",
      "r745",
      "r973",
      "r974"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of lien filed against subtenant",
        "verboseLabel": "Amounts due",
        "label": "Loss Contingency, Damages Sought, Value",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973",
      "r974"
     ]
    },
    "advm_LossContingencyLienOnSubtenantsLeaseholdInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "LossContingencyLienOnSubtenantsLeaseholdInterestMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Lien On Subtenant's Leasehold Interest",
        "label": "Loss Contingency, Lien On Subtenant's Leasehold Interest [Member]",
        "documentation": "Loss Contingency, Lien On Subtenant's Leasehold Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Nature [Domain]",
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r312",
      "r390",
      "r626",
      "r745",
      "r973",
      "r974"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r751",
      "r786",
      "r790",
      "r978",
      "r1045",
      "r1047",
      "r1048",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_ManufacturingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManufacturingFacilityMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacturing Facility",
        "label": "Manufacturing Facility [Member]",
        "documentation": "Structure used in the manufacturing of goods."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized gain on marketable securities",
        "verboseLabel": "Net unrealized gain on marketable securities",
        "label": "Marketable Security, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r311",
      "r349",
      "r390",
      "r460",
      "r542",
      "r612",
      "r614",
      "r626",
      "r643",
      "r644",
      "r695",
      "r699",
      "r701",
      "r702",
      "r704",
      "r718",
      "r719",
      "r742",
      "r748",
      "r759",
      "r768",
      "r769",
      "r773",
      "r774",
      "r787",
      "r977",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r311",
      "r349",
      "r390",
      "r460",
      "r542",
      "r612",
      "r614",
      "r626",
      "r643",
      "r644",
      "r695",
      "r699",
      "r701",
      "r702",
      "r704",
      "r718",
      "r719",
      "r742",
      "r748",
      "r759",
      "r768",
      "r769",
      "r773",
      "r787",
      "r977",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "stpr_NC": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "NC",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NORTH CAROLINA",
        "label": "NORTH CAROLINA"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r751",
      "r786",
      "r790",
      "r978",
      "r1045",
      "r1047",
      "r1048",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Cash used in operations",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r72"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r72",
      "r99",
      "r127",
      "r141",
      "r143",
      "r148",
      "r157",
      "r165",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r176",
      "r177",
      "r183",
      "r269",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r436",
      "r439",
      "r454",
      "r476",
      "r593",
      "r673",
      "r689",
      "r690",
      "r799",
      "r975"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "advm_NonCashSubleaseLossIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "NonCashSubleaseLossIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash sublease loss/(income)",
        "verboseLabel": "Non-cash sublease income",
        "label": "Non-Cash Sublease Loss (Income)",
        "documentation": "Non-Cash Sublease Loss (Income)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r838",
      "r848",
      "r872",
      "r881"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r954"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails",
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r741",
      "r954"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r730",
      "r953",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r775"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesScheduleofFutureNoncancellableLeasePaymentsunderOperatingLeaseDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liability",
        "terseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "advm_OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash settlement of operating lease liability",
        "label": "Operating Lease, Non-cash Consideration, Leasehold Improvements, Value",
        "documentation": "Operating Lease, Non-cash Consideration, Leasehold Improvements, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease payments",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r498"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease right-of-use assets",
        "terseLabel": "Right-to-use asset",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average IBR (as percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r500",
      "r775"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r775"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "advm_OperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL carryforwards subject to expiration",
        "label": "Operating Loss Carryforwards Subject To Expiration",
        "documentation": "Operating loss carryforwards subject to expiration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.adverum.com/role/DescriptionoftheBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r89",
      "r627",
      "r628"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "advm_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposit and other long-term assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r90"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive gain (loss):",
        "verboseLabel": "Other comprehensive gain:",
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "negatedTerseLabel": "Other income, net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other research and development expense",
        "label": "Other Research and Development Expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r836",
      "r846",
      "r879"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r839",
      "r849",
      "r882"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r839",
      "r849",
      "r882"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for rent",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PaymentsForTenantImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForTenantImprovements",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for tenant improvement allowance",
        "label": "Payments for Tenant Improvements",
        "documentation": "Amount of cash outflow for the allowance granted to lessee and/or direct costs incurred by lessor used to prepare the leased premises for tenant's occupancy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of deferred offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r151",
      "r238"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "advm_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants",
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in USD per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r326"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r653"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r326"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsBalanceSheetAdditionalItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r653",
      "r671",
      "r1076",
      "r1077"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding",
        "verboseLabel": "Preferred stock",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r584",
      "r776"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from employee stock purchase plan",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total gross proceeds",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r635"
     ]
    },
    "us-gaap_ProceedsFromLicenseFeesReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLicenseFeesReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License fees received",
        "label": "Proceeds from License Fees Received",
        "documentation": "Cash received from licensees for license fees during the current period."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of marketable securities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r961"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock pursuant to option exercises",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r502"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r131",
      "r591"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r502",
      "r579",
      "r591",
      "r776"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r116",
      "r119",
      "r589"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r502"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life of assets (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "QuarterlyFinancialInformationTextBlock",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly Financial Information",
        "label": "Quarterly Financial Information [Text Block]",
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r193"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r311",
      "r342",
      "r349",
      "r379",
      "r380",
      "r381",
      "r390",
      "r460",
      "r516",
      "r525",
      "r542",
      "r612",
      "r614",
      "r626",
      "r643",
      "r644",
      "r695",
      "r699",
      "r701",
      "r702",
      "r704",
      "r718",
      "r719",
      "r742",
      "r748",
      "r759",
      "r768",
      "r769",
      "r773",
      "r774",
      "r787",
      "r793",
      "r970",
      "r977",
      "r1023",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r311",
      "r342",
      "r349",
      "r379",
      "r380",
      "r381",
      "r390",
      "r460",
      "r516",
      "r525",
      "r542",
      "r612",
      "r614",
      "r626",
      "r643",
      "r644",
      "r695",
      "r699",
      "r701",
      "r702",
      "r704",
      "r718",
      "r719",
      "r742",
      "r748",
      "r759",
      "r768",
      "r769",
      "r773",
      "r774",
      "r787",
      "r793",
      "r970",
      "r977",
      "r1023",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "advm_RayTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "RayTherapeuticsIncMember",
     "presentation": [
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
      "http://www.adverum.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ray Therapeutics, Inc",
        "label": "Ray Therapeutics, Inc [Member]",
        "documentation": "Ray Therapeutics, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "advm_ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of operating lease right-of-use assets and liabilities",
        "label": "Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities",
        "documentation": "Re-Measurement Of Operating Lease Liability And Right Of Use Assets and Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "advm_ReMeasurementOfOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ReMeasurementOfOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of operating lease right-of-use assets",
        "label": "Re-Measurement Of Operating Lease Right Of Use Assets",
        "documentation": "Re-Measurement Of Operating Lease Right Of Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationLineItems",
     "presentation": [
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification [Line Items]",
        "label": "Reclassification [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_ReclassificationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationTable",
     "presentation": [
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification [Table]",
        "label": "Reclassification [Table]",
        "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less:",
        "label": "Segment Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r831",
      "r841",
      "r874"
     ]
    },
    "advm_RedwoodCaliforniaFacilityLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "RedwoodCaliforniaFacilityLeaseMember",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redwood, California Facility Lease",
        "label": "Redwood, California Facility Lease [Member]",
        "documentation": "Redwood, California Facility Lease"
       }
      }
     },
     "auth_ref": []
    },
    "advm_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/RevenueDetails",
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r160",
      "r161",
      "r323",
      "r327",
      "r506",
      "r526",
      "r580",
      "r725",
      "r726"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "negatedTerseLabel": "Research and development expense reversal",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r720",
      "r736",
      "r1041"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Tax Credit Carryforward",
        "label": "Research Tax Credit Carryforward [Member]",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment",
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r174",
      "r175",
      "r191",
      "r452",
      "r453",
      "r487",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r924",
      "r925",
      "r959"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement",
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r191",
      "r271",
      "r272",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r451",
      "r452",
      "r453",
      "r454",
      "r485",
      "r487",
      "r504",
      "r505",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r629",
      "r959"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r832",
      "r842",
      "r875"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r833",
      "r843",
      "r876"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r840",
      "r850",
      "r883"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement",
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r191",
      "r271",
      "r272",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r451",
      "r452",
      "r453",
      "r454",
      "r485",
      "r487",
      "r504",
      "r505",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r629",
      "r959"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r935",
      "r944"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails",
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/DescriptionoftheBusinessAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r80",
      "r587",
      "r620",
      "r625",
      "r636",
      "r654",
      "r776"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r175",
      "r177",
      "r270",
      "r273",
      "r298",
      "r426",
      "r427",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r444",
      "r446",
      "r447",
      "r449",
      "r452",
      "r486",
      "r489",
      "r616",
      "r618",
      "r638",
      "r1076"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/CommitmentsandContingenciesDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RevenueDetails",
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r192",
      "r200",
      "r201",
      "r222",
      "r228",
      "r232",
      "r234",
      "r236",
      "r339",
      "r340",
      "r543"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.adverum.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r341"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r721",
      "r727"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in USD per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As Previously Reported",
        "label": "Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r162",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r177",
      "r191",
      "r434",
      "r436",
      "r437",
      "r438",
      "r439",
      "r451",
      "r452",
      "r453",
      "r485",
      "r487",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r629",
      "r919",
      "r922",
      "r923",
      "r924",
      "r950",
      "r959",
      "r967",
      "r968",
      "r1018",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.adverum.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250"
     ]
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Equivalents and Short-term Investments",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax (Benefit) Provision",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Income Tax Expense Computed Statutory Federal Income Tax and Financial Statements",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r764",
      "r1008"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedAdditionalInformationDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Period, Costs Not Allocable [Table]",
        "verboseLabel": "Error Correction [Table]",
        "label": "Error Correction [Table]",
        "documentation": "Disclosure of information about prior period adjustment to correct error in previously issued financial statement. Includes, but is not limited to, effect of correction on financial statement line item, affected per-share amount, cumulative effect of change on retained earnings and other appropriate component of equity or net assets in statement of financial position, and effect of prior period adjustment on net income of each prior period presented."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r174",
      "r175",
      "r176",
      "r177",
      "r191"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "presentation": [
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement of Previously Issued Financial Statements",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Loss Before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r502"
     ]
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quarterly Financial Information",
        "label": "Quarterly Financial Information [Table Text Block]",
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r12",
      "r86"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Option Issued Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r763"
     ]
    },
    "advm_SecuritiesPurchaseAgreementNumberOfDirectors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "SecuritiesPurchaseAgreementNumberOfDirectors",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of directors",
        "label": "Securities Purchase Agreement, Number of Directors",
        "documentation": "Securities Purchase Agreement, Number of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103",
      "r192",
      "r196",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r236",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r303",
      "r304",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r733",
      "r736",
      "r737",
      "r744",
      "r789",
      "r1045",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r640",
      "r641",
      "r642",
      "r696",
      "r700",
      "r703",
      "r705",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r722",
      "r750",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r788",
      "r793",
      "r978",
      "r1045",
      "r1047",
      "r1048",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r192",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r211",
      "r213",
      "r214",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r236",
      "r731",
      "r734",
      "r735",
      "r736",
      "r738",
      "r740",
      "r741"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/SegmentReportingDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment expenses",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r213",
      "r214",
      "r228",
      "r736"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r231",
      "r234",
      "r732",
      "r733",
      "r739"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards granted to employees and non-employees vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in shares)",
        "periodEndLabel": "Ending Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in USD per share)",
        "periodEndLabel": "Ending Balance (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r366",
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair values of RSUs vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award price as a percentage of grant date fair value, minimum",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Exercise Price As A Percentage Of Grant Date Fair Value, Minimum",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Exercise Price As A Percentage Of Grant Date Fair Value, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage increase in shares issued",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Increase Decrease In Number Of Shares Issued Percentage",
        "documentation": "Share based compensation arrangement by share based payment award increase decrease in number of shares issued percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Remaining Contract Life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Exercisable (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intrinsic value of stock options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled/forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average fair values of options granted (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in shares)",
        "periodEndLabel": "Ending Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance (in USD per share)",
        "periodEndLabel": "Ending Balance (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Vested and expected to vest (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "advm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant stockholder threshold ownership percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Significant Stockholder Threshold",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Significant Stockholder Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "advm_ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of annual increase in number of shares available for future issuance",
        "label": "Share Based Compensation Arrangement Increase In Number Of Shares Reserved For Issuance Percentage Under Plan",
        "documentation": "Share based compensation arrangement increase in number of shares reserved for issuance percentage under plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails",
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled/forfeited (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation Expense",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r357",
      "r376",
      "r377",
      "r378",
      "r379",
      "r382",
      "r385",
      "r386",
      "r387",
      "r388"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options granted period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofFairValueofOptionIssuedValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted- Average Remaining Contract Life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested and released (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityScheduleofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and released (in USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r85"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r936"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r156"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State credit carryforwards",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.adverum.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r103",
      "r126",
      "r192",
      "r196",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r236",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r300",
      "r303",
      "r304",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r733",
      "r736",
      "r737",
      "r744",
      "r789",
      "r1045",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r123",
      "r146",
      "r147",
      "r148",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r175",
      "r177",
      "r194",
      "r270",
      "r273",
      "r298",
      "r330",
      "r426",
      "r427",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r452",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r486",
      "r489",
      "r505",
      "r594",
      "r616",
      "r617",
      "r618",
      "r638",
      "r691"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r640",
      "r641",
      "r642",
      "r696",
      "r700",
      "r703",
      "r705",
      "r707",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r722",
      "r750",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r788",
      "r793",
      "r978",
      "r1045",
      "r1047",
      "r1048",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r194",
      "r489",
      "r543",
      "r630",
      "r639",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r653",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r672",
      "r674",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r691",
      "r794"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "presentation": [
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfRestatementsOfQuarterlyInformationCondensedConsolidatedStatementsofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r194",
      "r237",
      "r489",
      "r543",
      "r630",
      "r639",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r653",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r672",
      "r674",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r691",
      "r794"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r835",
      "r845",
      "r878"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs of $9 (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80",
      "r635",
      "r691",
      "r706"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued upon release of restricted stock units (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued upon exercise of stock options, shares (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80",
      "r363"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issued During Period, Value, New Issues",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r55",
      "r56",
      "r80",
      "r638",
      "r691",
      "r706",
      "r800"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued upon exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56",
      "r59",
      "r60",
      "r80"
     ]
    },
    "advm_StockOptionsAndRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "StockOptionsAndRestrictedStockUnitsMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options and Restricted Stock Units",
        "label": "Stock Options And Restricted Stock Units [Member]",
        "documentation": "Stock options and restricted stock units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r75",
      "r655",
      "r671",
      "r692",
      "r693",
      "r776",
      "r801",
      "r945",
      "r966",
      "r1027",
      "r1076"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedBalanceSheetDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2024 Reverse Stock Split",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r694"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease Income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r775"
     ]
    },
    "advm_SubleaseTenantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "SubleaseTenantMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease Tenant",
        "label": "Sublease Tenant [Member]",
        "documentation": "Sublease Tenant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r508"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r508"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r508"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r508"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails",
      "http://www.adverum.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r508"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.adverum.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r509"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "advm_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "advm_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Name",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "advm_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.adverum.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income tax payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47"
     ]
    },
    "us-gaap_TenantImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TenantImprovements",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tenant Improvements",
        "label": "Tenant Improvements",
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants."
       }
      }
     },
     "auth_ref": [
      "r1043",
      "r1044"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.adverum.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r325",
      "r328",
      "r450",
      "r474",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r595",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r777",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r962",
      "r963",
      "r964",
      "r965",
      "r1019",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "advm_TwoDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "TwoDirectorsMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Directors",
        "label": "Two Directors [Member]",
        "documentation": "Two Directors"
       }
      }
     },
     "auth_ref": []
    },
    "advm_TwoThousandAndFourteenEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "TwoThousandAndFourteenEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2014 Employee Stock Purchase Plan",
        "label": "Two Thousand And Fourteen Employee Stock Purchase Plan [Member]",
        "documentation": "Two thousand and fourteen employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "advm_TwoThousandAndFourteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "TwoThousandAndFourteenEquityIncentivePlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2014 Equity Incentive Award Plan",
        "label": "Two Thousand And Fourteen Equity Incentive Plan [Member]",
        "documentation": "Two thousand and fourteen equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "advm_TwoThousandFourteenPlanAndInducementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "TwoThousandFourteenPlanAndInducementPlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2014 Plan And Inducement Plan",
        "label": "Two Thousand Fourteen Plan And Inducement Plan [Member]",
        "documentation": "Two thousand fourteen plan and inducement plan."
       }
      }
     },
     "auth_ref": []
    },
    "advm_TwoThousandSeventeenInducementPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.adverum.com/20241231",
     "localname": "TwoThousandSeventeenInducementPlanMember",
     "presentation": [
      "http://www.adverum.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Inducement Plan",
        "label": "Two Thousand Seventeen Inducement Plan [Member]",
        "documentation": "Two thousand seventeen inducement plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.adverum.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofCashEquivalentsandShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government and agency securities",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits",
        "periodStartLabel": "Unrecognized tax benefits as of the beginning of the year",
        "periodEndLabel": "Unrecognized tax benefits as of the end of the year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r411",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease related to tax position taken during the current year",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease related to tax positions taken during the prior year",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest or penalties related to uncertain tax positions",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties recognized",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to tax position taken during the current year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to tax positions taken during the prior year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r763"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease in unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns."
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.adverum.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r113",
      "r114",
      "r117",
      "r118"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.adverum.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in valuation allowance due to net operating loss",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.adverum.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease costs",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r775"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r186"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.adverum.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS",
      "http://www.adverum.com/role/QuarterlyFinancialInformationUnauditedScheduleOfQuarterlyInformationCondensedConsolidatedStatementsofOperationsandComprehensiveLossDetails",
      "http://www.adverum.com/role/RestatementofPreviouslyIssuedFinancialStatementsConsolidatedStatementofOperationsandComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average common shares outstanding - basic (in shares)",
        "terseLabel": "Weighted-average common shares used to compute net loss per share - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r186"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "270",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/270/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481123/840-20-35-2"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1B"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-5A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479341/842-30-25-11"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>107
<FILENAME>0001628280-25-017767-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-017767-xbrl.zip
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M3;J5_7)3=-J7C?/5-?C>5ZC'OFR<Q^>;[KUP4$ZF:7(C'[\ 8Y6XWS@GRX;
M8)5T\&/X-;#K8@YR>_/X_X_ATWC:^U\E_C?.G_&-]T_U>C0,_2R&GXY2J39'
M$#3.O; I0%@E)33.VG=CH6$0BG1V)2)Y/J0FWN6KOTC#&S!] $R^?!SV4[7,
M^]V=E\M9YJ5'OVM.;^,L<XOYD5#J?/B[2%- O_/T,AR-W<+ABU1B\P89Z"?N
M(XK-0HWRJ'07VM]%CXVUR'_@2W_56'.\);'5ZQVO&NL$6/VEW_OJ>[R?U[?)
MNS"5?I:DCZU7KHZ:&^M@^+/!MP':TZOF>CK N)B'QO4XR96( [ ZWB=YFDD9
M\X2)L]C'=]X@:L0_9 CJ57.=(O.@.L:S5R!S?"O2X'' 4^:4;C71=W'*YKI!
M&D4<CW3[C?5_$"(7G@X.NJ*L.I^:-ES8'#P-_4P&],7G.%R=[GDW\*\DID8#
MZ,_B(&<A^=A0[[W$DLX5:9^-=;A4H%Y,.@+XHJ<7GJ<N;$] 8ZO3]1OK/+D;
MR0U[PZ> VAZ$ZDOIA$_5"+T)>D5C72H+*.YT,HV2F90.R_TA 7/86+=+G0"T
M.D9%$GY*XO_.<=94J&6A_NK'!%EC?2>/QT\W%%*-]8(TANNM)^?NL+$>B64
M\V/22F,]#PT R9JHI+&NB04@J3.(+Z\^_YCTLBF>BR<'SN,D:1QNFL]@/<2P
M)D[56!?#NH'S."Z=P\::\\L[K5WQ?9&G_EBHIW!=KPP&O9W&FNY-!$(#1'9O
M9T,M]P9 ;#URI;?36 O^+/:3B;1]*3XD/@4&YL2,Q.DR ,!W.#TFH0S:TZ\8
M1WB$*>R-H+'&FO:-A]BZ:*RQEO]2$/M5QC(5$8Y%"B9A'()B)]!%_6-366-=
M QL LW7166,]!A9:;W,5QE*I*UZB-%*&)M*+023UES\H8376S=!$(*V+DAKG
M;OC.N3^;"H?&NB%8"EV+K\=Y-DY2VSO#?/\.OE59Z%-:<+HQ?<!ZO<;Z'.Z[
M<:(.$/BH$$1_S]-0!:'_. '.Q[K[QGH/[KO[]TDJPU&\<<C>6.,?KOHDE4&8
MG8@TG0V3%+W,]8;DJA)"?UB.UEA_00.!_ ,PT<8Z&XYAA2",<DIOLX.53[_Z
M41[(X'V:3+C5 YFSY\-3D<9A/%(7,KT:BU2^G=4OL.X$GS794;W&.BA^4#BO
MR03H-=:I\21P_C-EO/1ZC?6-_,"P7A==-\[%LC[^_8-2<V.=-S\<A-=$P_W&
M.8NHZ@K8J':4%K575[Z,!1SM(I4W89*K:,:N;/D(/6<?IY*UUV^<>VCA;;L?
M!O_*5?8XH8+'NNC&N86:==&'*[OHQKEF&L@_5G?;C^X96>/9&N<-:" F[:[*
MQ]9OG$W>+ :YNHM^=(-XC6=KG '8-)+=726#;)PQUB"27>5%[SZZ3;3&LVV.
M!;(^DEV9&;+;FB%/=-&/;H:L\6R-"X<VD&17IM/L;HX9LA:27=U%;XX%\I1H
M777[OUS:[5]2$K[+*;S;N"#>NFF@$5!Y=&MK4RYB<PRA=7*.Y0.&JP/-WN:$
MD];$.=8"E4<W^C;E(C;''ELGY]A;'C0'*P/-Y@22UL0YU@*5)@2<&G$1FV,6
M;HC.L3K0;(XAV7R=8W50:4+<JQ$7T0;)5@R:W54EO^UMCB'9?,ZQ,JCL-R'\
MUHB+:&-U]X)F=WD7U.X*#<G]S3$DU\$YU@65)D0!&W$1;<AP&= LGW"_0M!L
MCB&Y)LZQ%J@\N@VY*1>Q.:&_=7*.95U0NRLT)/<WQY!<$^=8"U0>W8;<D(LX
MV)S0WX;H'*L#S>88DLW7.58'E4>W(3?E(C8G]+<AG&-E+JB#QL7_UG41C33;
MKNYI)_GI9"%"WKN^*8+_D"AU I<1QB,9^Z%4;V>?1):G\GQ8?#QS&HR6?S#[
M$,KX/+[*!QF03IRI#U(H.4ZBX PN. 4B6U5C+)P:+__(X39.<?)MS836\@.K
M>N]%F@ J93/LL)\=QP&.6J:.X&]G\WOX*.)\*'RX/[B>]\(/(\"E1^8=^T@'
MRY',/NF.*YDHWSMH9%RV)9F69&I)QDESKU#!=Z6Y'S0P#M[;>=Q>,B_"KT>
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M%3*5IH%,/;7,"UF!^H<,OIF5J 6\I$]/PC]V.\ NM!ZP@&_<8?TOP;5V2PA
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MZFF,D4EA/SHU!GYJTXI*#)_ZM?MYRMFGU&0RS4+V*R,.8IX>@EL)$T"Y8S'
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M3:P,.3[)$64'F<8TNK>]CNL:Z]J=6>RG.8";^'=I-*YIMHSEOC8CD[H-4;:
M>0'($-W6Y Y5"^7E/3:62<NK3I]8B)9WL:\6H5:=^%X).6(KKO0F](MHQQ>)
MO:PHD'FC(\K6$43Q$JI!PMH0;#0P'':,[J KEZCL59MQJ228<[+GA+HFV?<X
MTTZXOC3-03(Y96;% YV%.P"D55BV'M5ULL"**=FV0UEYU 8T3>R1A:V3C2 *
M==$A@LQX@75S?YUZ+V+;/=%IN.=:9BV@5FULNQ,@;*XJ2(H96+ 3/1(HF4O#
M)F/A=HSMNBEF]H5,9DH?$YGH$)&CO8.],M%. 6,G5'KL *N9CD&BI05*!07&
MB]03#M!/3#W6T%*BB2;%2FYMQ"#/B*$8E9AXBA5Y/ I$#[AAX<3VV&L/YU;S
MYZ^Q@X(IC##FUFNL:$CS:<FU4$@KBZ"OL7E<SE/5@/M@E.(U=?3B+A/L8N*0
M)(Y(?5U,$RS6KXK3NE3TUXX&6'=E+6VL-(\G2WET'7=>U%-][N@@.18*##-M
M)C..NS5$8+.-X:V@$MTDJ+-'>N[.- =5"_2TM'Y57DAWC'.Z G+'N!;DJV_R
M%[#>@%5(*YC[6=^_BZ:+SNI'BW8*IXWQ]-@N#B)VO([,HA%KEI]"6IJXU5E0
MMR*P@Q!LB\8T<%O,/'U ]VD*$PHU]H91<JO<ML)S=H$9U(1K#O5$']ACKFJ:
MH982!*J$,D\)[2B"1747=XR/>< $B8.MMEKCZ;?R:-4:ZQE)<'%\>>WUOGV,
MR>%6#5$[@PIP_L*:IBW@.('_^DOO8.=U;]M[J]7&9>;*/8ELKM_S^0T:^O*V
MV>/OCE&*Y!/NBFBL_BYW-.0T]YF.]V'Z+@@T$#% "9AD5G9ZX>^Q^QIJ58$
M\P:'R:&D1F>3UM:P1D9$Y($ (Q8GF8'Y@6TEJ$T%-:%#8>O4;I=?4N,@0W%-
M7:(Y9^T&\QR"G!MNV:'QF.B&3C)N!ZWTI#8](DA;#*+4IH_2W\)XVSMW>OR7
MWPUFT]=D(,&@P"VJ)$W H+N! _C>,S,%XVO2A;_UW(OG-!EO(E,SLBGE;</5
M';_[[6-WI]_O,!RXQP;:9=T$ST!]QE)Q$V+D-BJ6_^W:+ T/Z#E[]3<62&PP
M8GM#8<$"]<#L4HZ9N3#W!B($ "DC8AB% W96SG71%;H95L>Y5QM>IL8E:%3I
M(0,FZ;MX8)"G@=;RAU&.2:5FG#:H.(PB\'D8S+UW .J!HGFNW1NA^$EL. ++
M1ZA6:5\(E[#;"_OM]-?W]L;@]HI;PR)I!A9"0$^*CC Z%,:V?2B.GS+Q<GL$
M3K ,>: N6?(XY ]$MZF_-P<)I$Z)0""9'>'#QQ_?%1@B(I68(>T*""JQQX/'
M:&C7)T Q:N!"K=!1'8[C!'N7(G"G721Q;[\/7\@O5J6T 5)3+O[A\Z=C[P)M
M):]?R3NCEWPDIS6\8;_#57*@E]%I0,:<?CR[TG-_PU3QP.#;1*^V.]^Y;%A<
M;>SI V][2/%,O-S&FU_@'?_WY^/+L\_Z!4JB?NQ-]=*T8OV"'3LZC'\R%M$0
MG\0C;)??91SF^BA8 DY94:![:K>%V80WBI(!IDOR=BEPA/#1^,!U]]R14+/,
M:3BEGDQS00%; \^9%O.D@'HXN2/NYY7GI*]3)]HI!P+8'4@CZ,$ @<V9)A>X
M1JY;1O@T7 /NF.HO)*6/=LSJ9Y_>=27:5%0+Y_0=*/FC2\TK%'Q";&/9[AFT
ME!["_FN2!(!E;K^,"^S\09YQ0QV_?KRPY/I'+BCBH<VRI:;*/J[&0BL>X226
MT%]"TAJ<?6:%@"5SP_Z?-UM7,"< ^8"13)Z^H'$)_9%N\2R@I@KAL^/CW[9?
M3EX9PU6@T#&BPWW>$<863Y$3(X:SW@T",%9:BJ1(06@]RRA2QN--OZ=VRXZ\
MHM;+1J(Z K7$_7$D<JAJ>H*&904CG'"763!8,4T$%"4J<?!N0M8B\DQ/Y88-
M&7RE<L*A-,G;(<\3;S:@?V>>JEME2_;=\3AZ. [RB, X<*SL(\WM8)\&=[#:
M,$*GB($T,S-V_E$@\BM-"P8JZ.]X<(0HI&G@<!-AD*/8H)N]174.M)70((T5
M'\?+2EA'NN)Y;.\/!B=V*NN_>F5W,)7)-)+.RP>XP;V=3NGUI:DEZ 4O'0CP
MA8.[S-79Y>\SZ_X\Q1?O]?]:KS?@VHXSWQ'_IEJ\+.7DK!C\3K(8!3$5MZ92
M:E ,DRA*;DF-"<4H3E2HRK^!11H_HUM:P5%K7YB[,[,\0>$A3WZFNX$-)?$=
MTA=1"9Q3_CZC4Z 0QN'\O B,?&(F(J4-E513VQM:.P5-N,)P!20,[-4(2&N#
MK9@7R3\OZ;UWJ+FT;:--4(8*E>[,O87F7+-B%$6L7^!J^H(*#G1<:CF(K!C=
MFFP+6<0L^H)+=Q?VGG"3B$N,=4/TI!+2;7O_D#A'?@*OQ5EL%N-*^H[9E-%<
M'/-#T\2(MI^R@7+?J)5&H&I90>^]JJC/> ?G%]=G)ZS+=@K#3) X!2,C[H)6
MA0'V /A&%T=@D;)(JJ]1Y[3VB#FT.B?)VKIE[5BG/E98S.TX80=]*2]76VL
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MEE'._;W&3JJ"IP9""#S0:/QQ!Y0'Q1Q+HZ3NH*"9H=,-0(\NPM[R3G,'FU.
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MX51,<<#,N%OSDZ=4P6 1JH_[%]LN_8-!7+>NU6*/)/?9$0E2/Y8[<!O(XE*
M:-0NL6X^H:8"R&4J6_A2FU*$F"(+#>RC]3 =6FK%/U+U 1/WH$8'#5IA(956
MN._#M##+O$H]*(%'SS=#Z(45'XW[)..%2V((=<0Y>N9 R*5QH_T611&)BX2)
MBQ9*5]1*M_JW%IYDU1L^N=[!.O-1I+I"[K_7/\H1%]-F6,G U.\)(/GJ$O_
MU,JE+=-K#EY^4('XZ@D6!ECT\AT!>23GDDPB%T87;4CGYE'Y'T<O'C/L% \4
M_OOE8^VSJ'94!Q)][Q1(4E,+&7C]BQ=_I9>\//IK2K@@+?K2JRY*6=C/GCWE
MGSU_V?G9%JC.!PK2+T$A':M">J\*Z:OR,OX2<9P]0A/E<:PX@V7Q"(P!@?0Z
M9:MZF:QK30]A+2IUFF;+'1XV6R'Y[2"K$MPP9@@1L"A+IL(Y&\D;VB)<'! D
M,B52XU%D63 ,,E1A.:? 5_!]<^KHV%ET/_%"?]VF:/_=4K/3ZW:.&-A[V9L@
M%%,BI H7.M_ RHSC'R,_9T:!.C<JR.NX,5!-!K:_)@5W^VZ.>42JVDL33IH.
M/)Z(Z#JE>2&'&9AZ.I.R:H_?GL#L9V=[>4DT5YCEIYTGV=H%1^1P<XUE!U3N
MJ$$':>9)IT;7A\JEL 1%?7DRU QEW(#4T\<C-"$,\!>_NLGPFMD"FO4'GJ +
MADN?<X,]TG."R_NAVGO+( "M5CN)_8WSX+B"&<"$75_U]'EH(C.*!D B3HQ*
MP 5U$4,*;XE'0VN;<-/92^]60*#HZ5L4I(BC13F(O5 )$(C4#_XP7Q14R5XL
MD?N"*PCY_PGYS_\KM=K^.V!15B/P:+DRKT9L8[6LRE7WE2<=ZYG/9@@!>6AF
M=VS'I[&532?"*HZ^ $!S+0I3KEYY#_R<_"\/Y?SZ9VZC6+ZAY+_H^/4=BK4C
MC"SA':Y=5*NO[!3"8.::>2-_@?3.;&P;LY@WQSM/XF"!X^3(I%-V3R.KE]D<
MHWB=EA8A0[2/W6G_DGE!8<(H@F$\?[1(8K?HXR6R%T* $J$;*%\:5S _9)E7
M^H-X9='G-*Y#13RS3AA\G&#XRXJY# 0\+E<'W1;<?5+Q'O%"=!= :HQ$K4ZK
MO4FL5H=6))#O%#<4>-&6E5]=UA]XOYQ+,.S<@F'@E(-667U=?_&#C\V@K0&[
MMR<,ZK"A=$[Z<3QD(X"A^Z. C X5B;5]B9K?BCXE;B_V_P>8?5,. ^,^(['
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M5>/]-1-$F]\"7*ZKG/F=)78Y:6<V>\R.V0"-:7GB"6$E?CBZ+G+B2L4H8K-
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MZGQ6S(N22S?MU>)4#X7?7<2%#HYUCJ'N.1$VL6'O<-VRP?)XQQ'&-,,@V%0
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ML)&0RR!9+MP@: 8\9_O)10$;@T9!2H?EPVO"<>C8*\9_%24AW:)457]2!6F
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ME$/C,GK*,:D"-KK&LCQ*9KJ!^;:6U!O!,Q/*K9"3:>M)V-U5!X+11;X3#X5
M3,<1 4J/SP%U*C9%A/\$_>/Y >S$.&U._@Y%H7L% 54=V%K"G^[IVVZ["'+.
MF!>1S9&(Y(,N+4G1L1]M.[:&_K]HXBPBKHE=?=;RW*EA<5J+Y2#Z=YWPX&/]
M6+BA>[=Y &4G>_E6S]TO9@.E+!IMFNWH"OQ(Q;DSF=3Z:%\0O8Z7M6\#=4T!
MZX<PZ4P<+4&^?M;,L.E6?%S=L:MX"&@@NK,^PA&DNE@:P6O$UM*3^]N\[F3%
MN\,D4+@$UCN[T27CBBWH:)@= =2 ?3C"GE<FEA4'U5HC*["0W_7&LMVG]YAL
M&EPJK4(6XTL[64@GUI!BQS4;[.9!VV@4=EV&#E<!_)V@KIDUAT,\M(0,GG$M
M/]PN:E/6H*W9Q2&>O<YG 8[4#/(_#YW*0%6PX/#;5;>G3<1G$(7N>!%U$*FQ
M$^K=)K>?W9]VI#4#R%5O=/5$EV"\SO(XKE4)UXC>E.CN%V*UNCB=FD4=YNQ0
MZO6F&_ HF6Y7"WWHK>:2I"(>SB[7"..$(JZ.B7#LJ5[E.=JZ3YMK*TG@G-C\
MU.^)6TZ[=>27"U4ATTGCJAD;!=<\A<BM<3CYJ9.ZDH"ISJ(3N=*"DP.-FU'[
M.2JZV+_?H^.]<\O5#_"Y9V^YMECOK1OK5R/<H4^>'3[*K.F)M%U/'F4*T@VH
M4-?DAC N(^J@1M&^Y/!(\NBD=?3\"B?I#4&#)MBAV+XD0*%* 35L@+D?D!_$
MM5*W8/0V%([$WH4"HH]"3D1[S)<8.0V=(3M 4C]MP  X-[HL4A.!V[+S4 Y<
M_?Y!V;ZX8C<LFH$UW<,!29Q>JUS=$D6V?RE@;G*ZPI :B@4?O=*D@AA<M5"@
M"=[LMN3U)UL+&Y)E/ 0*>; FL&'"D&:%!H5UWW?9\RA[_GR7/=^&H>RRY_=E
M._AZL#I4=Z>GQ\DCJTU!5547% 1BU7OT?0?:+I^??DP6H N3GZOZ%JE3WXU
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M=HG #$9FSIAX:V 9[WKJNKGB=F)K/BFD#"Z^^/2!E6S ;>V_;27V2G?O7+F
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MC1Y=N9)!3\DCUK,<-Q-B5T2,9NT8A%>)C"0<Z7OW"/J7A R\W$$&MF$H.\C
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M,A=6LVF;16 'VB":J?:G)%*9JMP;VE4"!?=63:^TA^C\-2I@N_7CKYQY0]L
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M^"_&7XA\,)ZK#=SU#)64@#F'_^.G85J4?G'5-KBDO+18+.0[$J:>L53FI//
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M?/L-YMO;[G8.8(3!3D=_@=(,TH^9<!JZW:O_G[UW78[CN+*%7Z7#,V<^,:(
M"Z0H2]9W)@+B1:)M2CPD9<;\+'07@#*[J]IU =1^^I-[[4ONK$L#H$2I>8P_
M,S+879V5EYW[LO9:?@\,UHX3PN^CE; ]D5)?N">$[4Y]IO,N^[\ER.'1/<CA
M$(9R#W*X+<CAWA;?U18#.VJN(3!J-\3,9IDY,1OL)B54V*+ROQ79KV"TJ7%A
M2>%XW7-P[-PD9\]GT!#$'TKA$V0&7.1]3IF>\2#(^9C( NZ[*D;-V#=DZG/M
M*-8\PRYV $$2G'XE9Z*_7Y0.I2GAQ+<^D=)UXA?'3.9]=NJWR$X9E\GBE>S
M-WW5AI-4^"R5,0MK@G74M2^$>*M"0KE(^0)G76E4^HA(XN P_'/%'!ZR2Y_
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MDDUP/S*=G<(D(ZTFFU.%HF)>XT'5_/8(Q0PTDIK//B)5!V@2MSKNEG5V+Q4
M$972V>M92E-&<\@U4MI :ZW[XT#T3I CG2A%ZD!,C_H1@? ASL5EN;5-J18K
M[ODIE)R%7I,0N0=9XD3HJQF)5.1,2[GWR#08%5L)#'$*#N>.UV7=;&N!LG;%
M!0Z9^8NXBB3#$__(_:VC"MN\-(K@>B>9Z6^F7_Q0:GGC0A!N^8@<<T.T10!O
M>,DH 8/ETP,C>D!=8 _D(FMW->0^L?>-\/XH24$7"_!8Q1J;M1OXZB&0+JZ4
MJ*4--VNP:@/CPI1 D0QIO,UFB"$X!VD8:^8H7=9MM]X=NJ4:UMDGP"!G9=U%
MW@&+K 3M(=*>4<;2<=LDADJA:X:'H FR_!-*_GS0>^@K EWCL!38&@35P^^6
M+<K_X<AMZV!_! PQXVNU1?&>2:KBU1;,:J_XA*9<,O)!L7[J26$,;XH*Q[CU
M6Y:P&T*%,/NS/L=K/V0\ :8',/AQ4R.9;TR(]\5<7P(C^:^*JA=W@(5,MB)J
MRF[(4C4 *]B:JRA:0>NI)ZZLT$Q%G> %QWPQG*,^N99KE /H);<(D/>'JTCH
MDU*LOS$9B%>R'(MD'/CI08'#.!.2>R)L,4EP*G>" @ S;?IQUZPX65/>II84
M0$$IQM>C(M9%3E=IL,#MH%6#<WU$F2 <8C*@"*U5+DEE[.3%HE7I"D7J X:J
MM*=T+LAYWJ 4H"F"L&^83.B\A-V<\"0%64] N.(R7Y]S]V,R-;ODP#A/-5I;
M/P!CA+S3.&(.5'\[%6R$SA'9<#E^4Z_"O.4A6F1[5;CXUKIGRLHXEW%?C1N!
M)]WP5)D*2"GL,7?)2E\:N->U/<(]EK>D5M5R*5O))HBD'7[722K)%ZS03436
MP2*V]5A@3 %'<(+8Y@3S$8ZW9>'PIPL^#YA/8)PRX<A&0NUNRZ<[4<)V?MNC
MP38"/V\XVQ5/ 3?^UE$F3QAIBD8*5^%),LGW" V/T/CB'J%Q"$.Y1VC<"J%Q
M4.VQ3\@BA9,A';&2:S0 M^N;?5V0=5O\33VINCILE^>-2QF0J"2ND(ZZ@KA"
M:HT_2S\%33(%0!NP]D&X<=!PE&]WT>E;"*,AW.^8BW,%*$D()^(2K6NQN;;(
MQ*>,U7\&'_>JH+R=MMQI+YHTWUB>+GF+?!6N9V8]]Z\3'0*?/N;6N\'?K.SL
M$?U>YII[XU:+H0^H$&R[$]LH/"U"B*[.(PVWRO$!KH6BHPL/(>_U98&OY#PJ
MX2<7,B][8T;8)VI_FD$JP,]<1-%Y_TL$\;<>_&2B&LX!"'C>_W8>HT+_@Y-3
M2(/@>,*&2JDLXR!SWX<;;CH@)/D1-JEV8W$WHL(D-LCGD)M@-%?KM:;D$FTQ
MA*LR.S%@=5)F2=J!1VTY_& =RU:[4VXQXP;C*5$K8$>RFMN)F&#3TI0!!]]1
M/^TW:?I-3<F>%4[[AT!7%?ZKQ[&V.( #6?#^4C,J<9:4EL$B"H_"9EW$DYLB
M!*"5IIT2Q$)\5WI>O96N'(?9AY5 ^CN\V=!:N(846R*:4-EC;6>!^BZXYFTB
M))2R8*N'_>3E&_08V..2!7IR&<QI>']@L<+(@@6G7K[P+V^/W "3L.!_BC8<
M:*&Q^^MN$^;D4B*Y/.7J&:Q*.*?URCI(VL(_G/^P16MUT<9H?GE)A3&C!^+0
M_W@A.)MT%^92B)HUU8C;JF*\'S<$">#M&-Y9DYFV*+H)B^#'FH1%L&WK^J)&
M>G_N%\&*Q"VH<-O#)5/BAL2+[D0Q>':\ !625-.4Z77H"\J-4.!":RWKO&]4
MM^&"*!%HA#N1(G)F',JEI%'BHM+]$*<?LX3]*P?#,R&<6<AMY^[6MY&4V[1O
MA^^CPW8L)BP]]ZXY5LVPM=?K@GOU+6G$G!/A%)=6XE+,&M,]:>* \HU'QJB.
M#(C290]IOV-?4QD3I)$_<D+7$DZ+02-E\6ZQH:SK#!55%L")MILOU)S,DQ1P
M%,ZIT!F4'R&FHTHRA9+"BK)%@ME<%1OJ(6\T&W^7F1JHUXXF!E]+A8WFDYC!
M1?EQ\B#YJ\BQU,M USO'X053X$<J(F6CC21MV_HX=&):L]]9,7B*"%#(&["G
M%._$Q #O;+3+>.?(HQ$.1Z<3;6.*2[;V1NH4H[S>@K##G',E["[GXIE8GP!0
MCCA"IB:]=</$U-=.MQ7M=\&V4)M@W-@=O_@YT1H\9V+[+.Y1NTDX1S:8Q E/
M@Y>*KQL\G'XXF(3CQ3.QKN?Y5<T2W#=' ]3YWDEN!\Q.=W7KB9R#7-#Q;R9O
M-O<>9XXI;'Q[OM5PQ(,DI-@OH1M8;^=X>F#DVTL2V_9%5\5K0MK#$S.C-D)Y
MR3 A&\%T<4&-B*O@_:(KLJFON\NTYSNL6IFFB.LVE4U@L[EDZO V&\D$-J.
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M<R=0F2&$1.U*N'S&*8XPG61ZF2,P0JPI?3B;9#EW><T#W[#(0K4(B<;9(<[
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MKG,T#0#KQ&.B;C>:QQ#?5X!YK")Y%8]B,+W'BW>7Y7KT9[9_5.H-BW9%-%7
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MIC#O8.YNBYY"VI[>V@,UK97Z%,@'!^OR+^#4<8/6'J1KB$#.O#&?:822QEQ
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M\XO=P%BQ-TWU.8D\E39X.//@-:14QV;+!& 3Z5'Z&YIP*=H*'FXX6OFJ;MA
MTNE)NE"IQ%(1S08-@W/.+(M1$O.)%+D H;(<M(\Q_MGGU(=,$ZS)H7[+Y'R&
MF!!OWF6H*:GUC51K&IP?*B\'RU@ 3$*]EC05X1?[C;6^TH0RO/FZH?"U2N>G
M_09]"O1U73^+G0EQ517=-QS@322-V[ZY*G8'7[YY4C>4MA>@PJF!]5ZX L'!
M'TGT8X0=I.^"*LG3$$Y=2Y7XX>>??^FU 0@Y)7%^>.5U3JUX),J7TE6^J);'
MVB#PSOB9I:_6>&J8M1C7D5 AR$8A_E2^Q<JH7?7YR1=H*WP9[H,3%C/Z,EOT
M"H1*.:!1>%\&4Q\1%Z=5E8?KJ,H)=J3$R.WBS>D;OHZD\Y>^B;<,9U!?5,+N
MO:_YXVCH7@IA7;8=:P83YNF'O%WE_W2E/_@X<9;;W>:L7MO//_W[2_V9P]Y0
M/X(.)FRG<DNHG9^+9<]HSO-S9ABB^C"!)ZC:TBU"U$G2$2M@T-Z1U_6Z6%W7
M]6KQ!)G0)Z>+K[_X_$N1K.($_+K87E+>1T14PR1_]N7CSQ_\UW^<?/GY-U\^
M_I+FZ?.OO_GZ$=1M*.53G(4]4*C&-WWC^OKZ..<U/0Y+!EN\(=T<1XHF^2+^
M\K"/*,,_GK+.]NL".:'PC>>4-3_Y_.BO_.__Q\PQ?Z3UG_D_]DY/I,-R^*&O
MCKBW'"RHL5T3EUJ-QD[^?'!LN*)^'C8W=ZTAO9)SZ/!&!.A/'GV6/Z"/G3S^
M;/5 (7+A7WN!YC[3"T:4X$Z^?C3H&M8&/?=!?*"MZ48D<%5.;N 9BG!(T7()
M">Q45-VG"F0D.*.!<\;?A&+)A<O<NU#3+"&U!D.%WZ.C@,X<"H8VPC?/GC"X
M,/R'Y5$I3ZN;0?C@Y>\RD\CT_;Q3H),9<:#1AG2E_@.1KAQ90#B:R-?11FN+
MY?%%?<7C\=]":66PT1B5VZ46^6SGX-CHM()#,+_]%+'!(^6W VJ*)ES0H#;#
MXB31E(V,"UN1__[_SYH__O=]4LXGY;Z>3\K1<,O5__[#S4F6AP__<)_)._ L
MV'TF[W=PK5^\??9R<7)ZO'A-W?;/F5;P=W=][LB@\S]U3\Q0A"HU7 UEBI@4
M'=B_\'9\IY@X%ZZW%=1:SLCT%^OZ.HMU>4MQR/4]OHN ?=A[.P!#B^M!-/S0
MGX[<"(\'4 1NBLD2O*!/#!HR.I/B)Y=T#=2JA3\I]QKWNE[U M$<4F"J( @/
M93 1!GO"JX/)!Q\[9_;:ON4-,S6E]*WHC;^O2( '_-OL,C!S??S JB@V$L&7
MFRAC3SD[:A7S+S'%X?G+)VPB^+WEG?+X#P=[K'EQ7D<9>O+/G]L,O5)X/,W$
M#X7TW4B0]/LG ^Z8J;,N*X\F7]7]63?P%U-\.*=$ 2JXJ*4%(6QD1@TR6+K@
MR6MRT@GT3W?"1\3)+RAC03<.0.>64IXAYJ-/4\E7L_T"MMF%7:QH(>;Y[5*&
M7Z ]B)V9@;M%LV&R+DI'K]=#_+["])U>L,3$54%)P#PJ# S&[S#[9P7KVRCH
MB@))X/"%YQ:4<,85[#E+!Z@2+FMD$P2^BEXSI3P_$*9%7#(E<YQ@= /\LV?!
M*"PTH'2'3EB5XGLIG'[T]3<1Y8L,3=Z&*(W^+[ :C+:4>@Y1(1[19 L>3X-6
MPO2M%O]Y\O#Q\9\6&Y;L=E#0*,TPL=8:]!1"-K6XS-?G+%9.3!>*/%P5O,A(
M,^5LB0VACM$B>3D:]C2@6<F:@.GK*8%12C%N:H1ZFB@U 1582[A*W4$[U6Z\
MG+\MECG**C+1TX.VM@FH8 I5[PUCBWK(#TEDKKML!XUT2FI5K[%I5^[V<C'P
MS1X&(R%)F6ZEHM>_HAU,:'RXA0(CP+O0@\J*2P=,67Q!F;>F4+)IB*H190K5
MLTK:IA@G-\14E21+I"%F_UM:_L!-3MC'C2@ C=\W/P-WS.W?]< M1? AI>EC
M@N*VKN1=AO^4<*%[ 2&VYKS[<Y-'+[0.V-*:,H\949&SUBR^HBS@EH^W#JFH
MW&+%S2:Z'VE?590'F!Z?4,=N:/=P ;3<2-J:O&G\0+C&:#KHBA8,I'*J339V
MC2\:JZWC@/,^IET7FR5''.M_ONV%\LV6[MGJXFA=G'=_?D1_08!9XJC\^>C1
M[[>5D-W^TK+;O_T0!G/S\/@QS059%Z)QR"3=G#%]4V;*ZAFWB24N_7AKR"&I
MPJD>,"3S+AB?$ G/9@Z*QBN@3*14K[28LG1N73-%H6#LDGZZ;^[WRL?<*Y4$
M+9$P>K!1!,B@>T4DSISW.[:C4[MF?FN(JIJHO$,@@LM.TFL8-^EN]&->P&V[
MSBOI6E[V+<O-69>H$,F*6,MS*M@ JDX<YJ=)KU-TF.<HU(7/?/38A"'F@R9)
M^$GN-@3B4_?JL@60K*: )KTAL_-_Z_-U?W:&9X?/!\WLF:#>LQ0"#S@X!7KJ
M,)(HX+ HTQ5H<^NY&3_XP!TEB<*OWWYI[DW?AR]?>O?92OJV769Q\8[70$C$
M'2=O!!S?>CB3Y2KB<(0%D\&*8:7X?[C/)S]W?T0_>(T3C1CV7UOFGB&DA;4
M4(_ 5K8 G&HD8"V?P^Q5":/!V DZ<*## 2_2U$$T1EO$.3G(V(TM*!OK'VE
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MHUQ"T0SPW[;Y+C:,RF]K"38^<]DW,MYX+8SWL9VTJ=,S=>P'+%W7^&:_8=%
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MLBS&2Z/*"$B4"H5J^/O]2GVDE?IG'V+#\YV4@8/?1Q/%?\BLN:P<:!]D3OA
MJOD&EID7/)"475YN6G0A-_/@O-\?-7>+IE?QGJ/G17@/ 7$:C\A4,EOIJ5 5
MI3:D-7(75=$,*J#+83NQ1]RB/U-H!,*C[I@)-ZD[_,1-35<?34/TD%;U1X&
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MD3/!9J0E;[H -X0#/7]ZNJ=7]?3E4S5O:@L3[,U 6,W?_&Q$8Q[UBOKV9GH
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M?0-^4@Y^?%\./H2AW)>#/[T&?$)/I21*P4Y00I_<64,R4K1(X5P,G2.HF3!
M)8!6YP3;[01)2&D53AQ2ARJ#X-K.^1#N1IS2A*&O9?A.IG3-9PZ1%!L33+IQ
MABOF\*\^N&:XC"KQ!AB3%<*"1L17_ R%^XLZN!4M-+UZ'!Y- HAU48&*UB]$
M+)B$&:HYRW&$<10[8-H@J3J= 35>N+WDO0/J P#$3+W<]ZM(X2UI;'3U[E'S
MEDX'/ -TEC/<?9*P/*T=T];CBB*78YEG9V*<\F;ALKRB7J)W'#VBGNS&*3\3
M*;FY,4VJ)F0,B96!YZ_$_P(\-+@>,)33TJHT.*IG$L\DAUFL-;L4W5-2#VPJ
M$6Z9U+,C6N:D0T%!P+TX72IY*6Q$-U#>SG/GLQD16GG.NP47%^\6=F0I24V0
MS!_XB4UB):3LDCF9)"M *>793]/4B8G"Q.TB#K62)'I+A4O!C,36.:QEWPHA
MM7:(T5>DVR2;XXJ<2BI<$<(_9;3+E0/< /:[+0PV;9>?\0.X,^07C+BR%Y]6
MB.FT]S>*0O&/,Y)V6@F8M_<YVMSH5IHF =0"=]B.=D:1VDN9P+IP@4GHS]F^
M<PO_1C6H,AX5Q@)T%'$S3%_;B2'8V3)5I((#: VX<Y3_(QL0F4V_@)".4E0:
M235CFRABBIP)$QAW@&R6$KH.19W:V.PC3.T<P[ 9$N[1R#E*][0"0O!<*_E%
M6OJ(;=B0CO)V[:)W(+W#E@5M8HT,J :F1_7YT1(#B.H%]*+34>^HJ<UQZ%^@
MS-<DY*33)XAX%=.ME"\O"Y6;=N=U?CD\77U!D)PB!I=*%")() QK?,D(\YPX
M1^K,G+LBQ- 1LDV?MTDJR_RP4I>=5V3&?&#[<%K;27S[3A3+_ \T39O"]4-H
M?VE7FV1XKHR3-3AW+ZIP:9;+^5D\<-/^+3,/#OO%Q7Q<E"A&:<-9YS]']ZBT
M%H;_,A+%%U68CZX7W,]K]*\NOJTI/6/\T:^_M0ZM,&W/@ENV;"D_&,XQY4%@
M/;OAH[XM:['?\9/H:.<>6<T_,)9O\#:@HV[A(ES*D=U2\W*A<NF:>YVXW'+I
MJZ"W'*0-!TBW:5*:V;-%_\$@!1A?OL#87GUP_S"]"DZFQX7&<\XY>O.S:QAQ
MGS4;4#=..+>'O9W?ID[! .PA.V6I^T<Z\E9794N?O6CJ?MMFYFI<]&3.(<<"
M)"YED?OUA?$$K(OJHJ/J" <O]IOR,\:SJ::C;Z7#A^.5B(Z3PE9FG9HC81!Q
MS>._^]2HK'@P[YN2=6T2CS>36!1<J6VR*3*C:G,<6X.WT>Q8:UY-$^QYITQH
MHW;<:,$3"4V5Q)E/ -:-C<9?)*E,62(B@Y"1& CDNC]%"*4 A#W*(0B.^K:'
M6S&@G@T3A;2^HNFT:\@<MK4<V"S99^.-I!-@O%Z.0MUM+48T.#!LJW(L5E ,
M$U(O!)4DPY,I&/ERUX4TTWC6XI195]8KLD[=#BT4AO5T2+IJJC<91Y.&4L1^
MI>W:0PZ =M69:99U,WZN,D]S%[7PF(S\9"=*I'AL=VA<3]*4%HP^PVG"J)Q:
M*@'SR6&$>,L$WX9Z[*E0I=DINB?X D<<K2[N=+-[-D_0Z#22EHJ]=G0+T1P-
M1<L.ON_\193:PYEU4GRQ1:*6-GVNNLY0!5@1EFZ<)3L>]#G)(7&(UQ'*_P+(
M^CV<:_Z)G)&RA-26"L94!-)R\!*7>@@)RF[?B+6<SI"!?0QNR.G AW9R!":1
MD2:@?,;'[SEEF[G#[COP??)*A"KX?1@XGB=W%0L*Z@2YA1[!V5H['.0 ;LCG
MBFJ$'I)* \3,5SFF6],'(]&,3#W@G^F*W"7QK$?B2?X+Z/-U>5&*P;2\2H2_
MEJKIP0!H_>DALU2DZA^])O^A#',N\4'27:5_BXS\X*A4#DDS_+C0J1X_5.">
M)>&$ )EJB6A;SP0:(N$QKUCI@H4$X?(KZ;\OT'=1M@X#EM2"H]<3*S(42Y#@
M)99@KX2 GD^H- 4, [$(%AG<XZH/RMDL8P2)5UVD!8E]59/4ZWODYTFQ(FJ7
M#WKB((? E/P Q"$6YLM !E<J8A";R)(VAF))4C*2Z$Y*_%0>&&Q-XX8A?R^!
M\X-N,!DEGE/\'%88L R7.B3KJ2UH5XSB*S:<_A6HMJ/?&07'-S+"P!6%4#*7
M;"CA$*W&W.TAVTWS603<6-?7DF%'=AV5@.DKGL0%!O?8A-T5^%?D]!<I%Q<2
MQ^:IZ2O)\OT#Z3W]]<RNHMOO3"DZ4/7_FMN39*/C$FGQGR%"H=Z;L("4<&$6
M:.GP7%&O6DM6C)5<<7#N 0,>,/#E/6#@$(9R#Q@X\/[Q=P*LHB0$\:LHX';<
M1'X3E(DS<JB!)1 [6&\C*)^6,1WHHG)N<@3,.A??G[Z\W\ZRH[<N]D4'8]>N
MC78X5F;8(PPO=>?<Y*B*:#7=<^K?69F(.7L2R;W%==H:J(&V6^\./%(P,';I
MO"].GSGZST%K_W2(F:2/%0&O0'5QAW\=%FLC#]SV9VM^ K/Q=1-DV_*,L[).
MFTO2X8H>8UF9=I/K]*&WNYW01*9I:MUP>5NG1%02@S!EU 1_GS:?C,,FUB.R
MT,!\?1<C<$(4/HUFR!+'Q6D@3 GTNI34O#CR#<S.P39<EF2!#SZ9\M:#X+E'
M \Z9]-4W11?>UXLZ18['KKAH>.=WM67AFX(86]<=G2;:<9>$J2+V.@NLGOX0
MC!*2%6L.C;3G$UQ<LIG_-1(.9!ZMB?GF>CW8!HP&@9G&,E]YQ$!TT!1>6/_I
M6HQ:KL'>\>*'NJ)*XAKU &\4]-!1MDS[1^=EO264&IS%R'-G3/*31:>,RQA.
M8AHR$?5^_LNT'9.9(Z(JXC0SE+5H N?QR7!UGQL"RT*KG8NB;@JO71UQ5 >L
M9CO_@$BK*O2]BC-0N%1])O!J"I"$UK>8B<Q,,WU,X77;!9OLI,VFF_T5I,B(
M[T\O8SYS_/,F05P8ND6M-C-!@*H!929G$LI6W!,V7@0#1;EF8U4XQ-7Q0:[D
MFT+Q(D3/)2BX\W5K$"+SSB*V9B0&_ZE6<4>=;U,UB8E"9[[>=;XQCK@!SZC2
M%OZK#==-B'"1H*B;U='[HMCRUU9@.6CQ/ZC*6PLA,U$>=U!2Q/]W00 +UB34
ME'M:>V_83Q[XE+/X,F-?I#GZUOYUC#HDO09N*S(;7:=DH0Q"F[GZPA:D>W-?
MCW7LYPO#M2Y6MP=9_C1F*O?_Y%2KV-LT.-@+=@:#J>+;,J&F[X#11E9]%WP0
M*<620M(8UL?H8+0,3H'Z./<NN+XT_:Q,1>#YC!(P>,I8X]/EA)W[>;PX-9A?
M38Z*5H0OS#_E^YK*\Q&:L _V1(5=8I]ABDS$!\1/.803#KDOG)LZO'A61;4;
M]/R-,_#G3**[4_><RL7<WII@XGFM-&'.T<ADO7$*-]]F<UN@(I\O]E(=O)<<
M 3X?<-)I)_\J:^3VP)]O.6'?;"F(KRZ.UL5Y]^=']!>DBDJTWO[YZ.2KWVU2
M 2K[\G>DI$GGYN0+(M#YPW\S+->M)UKWR];)-O@B&[%'!]MCG.!ZM=R:@4/+
M:@/O\)O;+/"C^P6^^P+?B1Y%HOE(XIA(7=?2-QZ<D?/<2.8^' [(>CB3G?LS
M0M7T&O':NM\T'VO3?/":.B(-8I:*=R<Q@;-O)M 1@^U'L"D5M:E@6*D,G'T]
M;+=R77:17R/FJ9E/&AM3.ZTIU86R=YO@XB(KBCB)>9<X=E(_O],+WV_!C[D%
M760_Q]64&"BG0N3ZRGV=8'3=>7SQ_6)^ I?0S*5A"=<D+N>S+)TL;90^I/\A
M.P6"*_<K_SOZETP+YI';)KT$0WV[,LS]$GZL)1PR(5X@BETQ+\UYG3!A+(R9
M-V4D0[>3]<(!"RY,(3ED*-BY0R&:]P0.KD<O>C#] NU-+L&%3JZVN-\#O^DQ
MIKHXR4>AZ+ L8X/&9'<TBT2-4Z! [ _<.[K)[_"0X3/(J2N;U1%=*3OW(+I=
M4*K@;ZWS,P*0U,V@;>].MQ5:5X1V.;U\O$PPB:V$7[G?H!_37<QO2E8J+<)P
M(Z>V2CJ6@-;;4/&+'D+E;>VF__!D!RZULG*5NL3_#$^>W2 'N2-.'O[N.R(,
MX89K"T[$Y+J?%;&.6%@+PY*PM9;><)UP6+VTN:WF[IQ12U@LQM1G:]$UOZ>)
M2E&??[I'?1["4.Y1GX>.^AQH8E!//"7CV<:TV:!XM@JW4<NUQ#S$S1<IIC-C
MYDIA(9>4;DZ/I)N+[2!"X@R%'*DA)FH9VNFH#IR7OD15EAN,B01>]!81[&TB
MQG\;''D4JCTCQ(BU-WRZR9D8\Y\]_1@*E6>U*&M&O6EE&8I0(E\\!&O?.EB0
MU4XM/,]<-I"&,25: CUTA%0"2FA0_OZ BAA =2J5/5-I-AHH?JW,<<!,Y& )
MN!%^PF-=TG>98%3R;:Y3A4HA6.<6W+0G%D[Y""F8^9[AJ0<.NEA8$>"6;K62
M'=V"RNC3 _>\:D1-J8EL/$VY<3F/J0X<Y=8$G94H@P*$0R#"]E*RVE3*IF--
M_S\6YZGT7^2$NTJ;A8S5^=!1-\^'+Y?MFXJMF^"ZN=W\$L_\]+*X-/2HVTIQ
M+-H>7D)3,U$Q@)Z/4?ON7?L!' <Y<*+?X5I%51BMT;#;,=@<8L>6SK*HGA-7
M/Y5N%]X&[K#'N3QG5+A]CF73%_UV41,INAB9V@T0(U96;L4H#^RX$P$=X0$=
M(Y0HB0O6F_))5^6J!\SODLGUHGXXT\=;"QPNE%C:6=4M>C%C]C<R+YFOKWS)
M8D^@9ZLZ<,FC*-W@T-C938_%?F3LXFAI_*TD=Y>P*K6^7!'GA1;8RZ=OM?"^
MCA)4L0LB8]IY(DZ1O<%3)]U^O/^RY&2,ME_4+:/;2B>7;\-*L$8=U&D5E,28
M+#1<EU52Y\M)(/@]H07#G^AVLP95\C-&^% FFXZ[Z*5"0AWWQ^!G/ /3O@//
M4-,TQM^CU_+I72?/J?_];9,OWV.-7A="+D$&Z"69(N*:.U6V\K<"O/[LMPG8
MIX<L9$L?>0AWG,?7+T_?_NZ3<G)@D_) L#_B:OI>JU>O7[Q\YO]9__79RU,#
M [X(U_,5_^NKO&U!V"\?>_G]ZU-8!4\I1Q9&F7:"*<G;+B6V3T!V$FNX')JA
M$'<J\F*T1/23Z_)],!27=2VRDHE @>)*)]KI7-/<8?M)[YRXE;,+?I'\C(?W
M>D."**([?_+57H$Q!K]2)$0KA3K0W(]@]0#M9/G.-E).DF-##Z>6!1,7]+I8
MON#GD^JPYL."?V1BH)]<K1KN[ @WTZ:@9OT5ODI="W'TM*@A? KW+@0D^BIB
M 53^@:\0E2DU')S2N17Y1B0_W/M+:.(O^G O'3GV!030RN.02"\8_=P/3XU^
MCA@"PD-:*$ 23>,6XALG[A^XB]W]XT/[1U3.RW;9A_F@LNE.UB=CE#>3!+,?
M@HGUJ&A5UO":Q&UQ1$D(8@TPGHA,*V_TL+.RQLEIR.>8F)?(PWM6Q*9/FL57
M81<T%%L*(Q]N,>EKX3\EE+@.T^.$75GC/FQC6N&4Y>S SVSPF/_2AY=Y^/G#
M+S(,7TNL="/-GMV])_7C7"(/;R=]^'OJ+IY6B^&!PV'334B(?+_W: 9'TUR>
M_WGQV<D#(E*GX]0*!O8<#=>JH=)X/TO;V3;B;\7&00B0M.@*'%"LFN)N!_VC
M<)##7BP*K7=*+HMI$?%U;MS!9^._,TK[3%!S3A*F96DA889E@9U(;MIF*4%M
M\;/2W'RS^.SA@X3)9LIZ9\3"*XP::-KBD?3@ZU2[K@P>TH>*R6.:G<\>/4B<
M=C/R!5EF9A('JJ"0Q(<T%L09UYFVJ;^4F&GR1AA?!VWD$ID:YK_O"1J=AIHB
M8H>EC( JD>9FC1V7/PVVFVOKB?(O6380HX3-S.1W/O67-GS$'YNX( [<GK\5
M%UBMN!IL>PL-REJ[]N%*V\6?F"*Z',(N#Y?#PQN<,_;'B;V+\WK!1UGG?;6\
MC!P)-"STU%ZB/5#O>1;$B<2K0XV#\"L;&S,6G9MYO&32Z.A)FU%*0C8^AYJ4
M!^V\(;](&HO;6DDK+_P721R4&_2_ZY!&*1;R\,HVX0>5>9 M#/>%R UD E;>
MS7,RI:OP"O5%[QH@-*3QBLN4"=\2C]J_!DGL=2Y)>6;#4\[F\!-%U?8B#4#)
MICBI#5(WD8ZAE9%0!V[=MG1=?0*[_J<*=\E?PQNNZHUA,A'H#4]#&.%4;,B9
M.1\YAHWVMW))/732VWC*4ABO\N[R.OB#YCK_[?25':%P;$ZW3;FF<_/H>$'_
M)B=#OB5;GYG-[(<<%[FU.YP3DS2$$K+(S@_PQNP1R9E<+S5VUFEF;8>9HI:8
M84T;\/*E"D;8$^,;4-:K*5$L.I\-L+T!00%N\98/XU,WXE?"Z2Z=TAP124P2
MZ;AL+'GX/_7Z?=GY "'V!F6S;.FMN>$(P*;&6[:2W&M:4DPKMD8#0F]M/8%=
M4UY<%'I^>%LI'[=4CA;Y!6/1AAV$I\%_>I=3LO5M]+SXE+XE3A(F"7E"I&["
M'/Z#^H]*]<T.X_=%ONY8!N8))2V?_4R^&=.H:=+CS;+N.BI$1$O_!):G*_N-
M<JG0:#''I]3ARW\G'C&*88)W6>>K3;X=:94-+/.&\L==77D&AHN:F^S8@@QV
ME68RDI-J9^BGO^H)N@>K)&"5K^[!*H<PE'NPRH&#5;ZOKRD<S%S^)T-\K>EB
M,F"PZDE:>2H+[',[XSRP9[ ?)H$'I:&H:@#01)%J<8K'$?[UBA$PX4^2)%0P
M#8PN9Y.AEE4LJ$T-.MSVE!$)6=_46Y)YAB $I%<1(=.E-4$WIO 2W&E,F=PN
M"5\-\W]5OR_<73LQ::6R;L2;0BY"D9CVJD,N\5W5RM >$QV.8CIA-Q7-+1L!
MW^?D&?. -T2!9MDI)6+@9?=LONN2R(G.]XYABOWWTZO,I62D3JQ-@/*J'><I
M<Y7]_@J\9B/8U2?%DZ*J=0+XL6*KJMA!S1Z8"523!QSYD;15M>2'J@V.[<(
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MF@J15XFL'3.O=N\NE"")/+@O3V)C)AS5^Q!EK\O]V"@O4C" X[=H"<42S@S
M6:%)FV]NRT[V\,@L*U6WTC[9EN/P'S(8K-!6=[G*K(W9KK$C1235^WU>F4KJ
MW5A:G#5)KNI:L$Q\ \S.0 01^TEP?]G# '"ZZ$1H*)Q?2F>A0DG0LC-"X-&R
MD&T3C'A'-X[]AOY*,[\K^^"8;/7G$06T22'9"\QZ;?&3#%C#V_'E=U_3W[_Z
MYR6M>0AD&+T_,,2$_(C2]%%!P^5T%J@/FJ'OR@UO5.B(4_X#4S3S..N?0=S^
M\<CCO]R'//XUY.3N11Y+II;\BY=AS>&\I]7XBKO(#Y\<[)C>1,(>\:MQ?H^R
M5G2:*25WZ=];NN</UMI+?PBG0D\J(U"M0BO9R9/3?C\D6DSC$5$7?3HR$@VR
M>13:C'W>2[#9.W>0.=,[$MA,/CL6?RR-IN&0RW8%D3V1/5>^ O^ PKQ/5ID4
MU<*I3(E:6LC#7OK^_&V@2\=A&UD4IIIO 0\E*Q><PTB?Y8&>2V$N.7&(%2>C
MDO'O\4/^+.'O:?2(EXLSEPH=60*-L],!/R8I>&C=L>*;PE#EG_(=9B"I*0BB
M:^340[+QG1Y^SJYS"H=,BY3O3$>;B)3:A!P(O]B*B@]Z-P_C0<(HRW/*(^$)
M)+<@D\(NFRI3MLU0;Y@1,IA\C*<H#SE7-1RMR1LR[1-UH; D!%UBJ(L:XA"<
MCC/*E5VS83<)YO^V>2?!*,NXB[X5!X0S=PY70#<^-=X3=9_,(:OE*I,E:>;U
MHIBS*:AH!A_1,MTSFV"\$LLNJE&22'UPXU7VT%U 7BF6)=1A ;%-Y.7PEDR7
M>BL<-G36$4D0[>'PQW=%L<=<FAKM+2@3@Y^47Q?"LN7J 6P+W3V48&-J+>7.
M7J+K:/NL"+E:>Z^VN47]KE18(TJX6G$JDQW#6SM6O037QMF:$[?2/X;5<U<+
M)3HS*ZF#1W,D18V+9GNQ(U*2UC:%PU7R6X.)%4$'_:YFI/TBL3KI>QVYNEA1
MU_)-3K42S.3".Y%*9H=[ASBT5)R88Y,AH"\31#,]*P-&VX:T27I6C1:/=[JN
M1CMJ=,](,46Q 'E_^@9[EB;SO]?S(GB4%'8BO#J$$#;\=<-8B(([):QM0*?"
M#)[P&2C;[8R-3Z=A,L#-]B&G"YBN;-#X-C !PK4(A_=5;CUTD/LDHJK5][!5
MEJ_ZX<VKM]^/$E9DODP9ARY$M=B#L^=F\-+O*Q\FB\;BR*8S@D[1N^(!HR6'
MQ/%E[8\0-O5R5' ZVUO]<.ZM;TA,D4Z93W>;\_JCH: 4YOW;F[_/E(XD]8NU
MIC%AV9'60A?3C'-;_]O9.WH3+ZP)D6Q]*SR&TL])[$JR;5K^C)Z$A2[Q,Y.N
M(1BHDLY$@=2Y=[@9PBC'-Q"HJ>Z!H7:[@'GP#RE_J'0T$4/*'?LL=G#V=*SU
MASU>2M:X]4YH5)@[MXCCPUW^3JL_CE\O;?<E/4[*VW,,O7#F*1%U' O[L0]C
MNW6SC^J<>$P;:$\-AG>DU>_<."EAL&7F WO76*.0GT:DIJF3F2&\^D3DFH--
MK%2-.6,BESR'VEJ5+@U6XB*,;U$]$0.SNE018?M(+R((%>A$B6,H:1INHC'5
M!?U4U]+L[A#R,TJ"DK%C28V=!"4X!9++@*D\(23A&6=8/#CVCN30_BVA"7\Z
M0Q-.X5'.T(03)^AX&YTF=UI;2T79>98CHX0'VAW&RL+ I!7[6&[BKE"Z:J6!
MYL@SP00H8G>F+96CX5[80Q:<4)*343U-Z9K?%O6&M61Z+DBR7-_"JP@:D,\U
MTX8]H_H?$]4/7Q]3H?D+]=BO3<&<0B99KB$^6W/+*1.;3AI#:;U><<B"];P9
M( >R:=8#+M4>0E1>T/H_& ,+I^P1>W$:?Q-I06.V#"26DH0#L7P98CYCB.%"
MPXAK.??%D_PJW*MA2?:P&:I\;_ZJ!#!SL9FF"Y!2$_%'"6P9XA K?O)C3==P
MK!0._((R)8G;";U5YE6M&769)7[9CBXQ;8GO39)[5>0M4*Y@C&6%V5@T90$E
M5:1<!\_XC*A_K#TT%\UKNLVMO6!YY]*SYWEYW'EQ>&W*+EM*/(RL1-0;_3!F
M!3*?:,XL.YQI;IA(U]M@SFX1:F62<> DU23%G,K=<NC(.:;%C.IY43SVHA#8
M!AU@DKQ'DQ+%@ELUM#%@+PZ<1]&0T2"-Y^W[>.W&7(?4$S'CU WZ:9L='W I
M\.^:,D+<H:QPJ!O.,6X:2<:,+\!TV@[JQD@2[@Z15#JG;]*2(T-)BG=:0>*B
M1!4>8*,>L*M#L?]-+C6J-:(40R!%>$R,9JA*H6@9%2UW^;LBH\0:>_D=E3;G
MO>_S4GQ$+[DU;7F_7"A+!7:4QJ7%H]<L5(!>0#UQJ:^:C2!U6=8V2>9-2^=7
MX22A,B0?'9LIE&7+5+*0S;7,JJP_2$VX@"[CCLY87M@/5^% 7.V;\/\/4NN@
ME7_7M-7FCNYS4^05\_"%B*T^LRT\ZIJS:HGA2G.WQLSHR"JI\KMN!8Q@9*-"
MESV2P6H*&40P[&^*:I.4A+A8DQ%:'0&WJ]G$D"0GE7LL%BC.#K5"W6%WLT2<
M26*4:#\_4GKH1*"&BMZ-()$^ M88LQT1+9S6>%<W=Q<WS=V3F-U685OB\:RC
M:(2OPR]?)Z%S)Y/"X:B*GZ&6()INQQIR,X4;VT\2<"H;+%&:ZB:78N&+0E0/
M#2F)HI.@*#V!FO=S+1VERB=5)?%OO$>,6C=#1?X94NP;S6^-20:[GLY4@1VA
M5I/@;/EH7E//CL![2FY<%="*_W)"\?=@%=_?*GF8+!+ESW)C/0/=X1I);!?Q
M:3^I'"6HK*M#6MA*\>W<$\SH:?^ME"F19P9C+K?K)HL\6Q4E,W_0F2-0#L)D
M%<5$,=N>H0J'4[7:%7G-R^U.6YB&VBR?U&K"]W=<E5/&@F)T?U/B<(&8Z7#9
ME0D^</+5XDLQ6-S<4FX%, $[ YOC%:UFS W2P40L3$P? A0RD#LV9R+&T!9K
M="2Y138FY-N5'5K"]E DD?E,[CKM/Y >9#3Y,'@*S(0QC":1WCG$5/HV30JA
MBG:4!B4$]X.43$=F0[P\!!.5]G@_;.)/#LV:4B;ZN9'D;2<XK^Z&YG[^ #(-
MY]D30_'=X7!JN0"/ Q)DE!+#P-I[*\'=+*(!S3M4,8K"7[AP*T<5X!\SLWI%
MLMPXST/W@:KSB>_=KPK0**2NQD(_7\(&.9+%3*0HEEC2"XC:9M9"E\D*^*BA
M9R:_'2!0"(I'/LTL<O?@>_T>[,^@"9&5\X0N+(M(0&N'\;PEXJ:D=";Q)%%?
MP'T&E1"N8(V?Q-4G#"@3_1[G''GB#&V[TJ8[[SB9&-I5$59@+4*'VDBH:U?\
M9QM$-S%:3G//WQ_VHE<2@\J(9,;Y-UY7@.W$K?+@73ACS+\NNGW)^)&$M=8-
MG8S3AOM^0W@)M,R<JTH744):7J ?:IY&=HFJC@8S(SL/[Y".AAJURW'*B6ZY
M']I@S@JFJ8"/ \BI*:ZMF_!YFS,J1M H;ID;>AQI'A:Y$8L$:%K'2./;LJGR
MM%DVSNF3U2L.SN6G3F9FV9,GL0+Q@CIK7:']&:NQXT.437!K/4AJHP&N_GMY
M6]0.I^X6I+E+X2R]"H.-_#FF,5- KAZ_$_R_3'/PW+A)AS3.TO7HWC:=?G;.
MG%+PK NGZ.=? #C<_4SD\+\E).C/9TC0*3S*&1)TXI"@).$TX9N/I[J*E26,
M$V(??Y8S0F[; !E [A$U0<GJ,&G/.)I &IGWW-"=0^)H<7:&@U$%(EL["\X[
M:7Z%\_)D]0V52=[G!+D(%UT3<CT<B9ZGP9!.1#^07S76[17&)[R+05;$'1J_
M<![< W9K>M9_1]^J7DDID"G+LK$[B6 T8YNIS$\EW#7GYZ_EQ"S&&5/N-/7O
M"*"OO3W:C*FEO.'.\)9X,+?P%N *%=#%FY[AB\T0\L+Z@K'[-WV[,B[!2 J7
M/'E;[)K;Y3B!B3W\&8U;Y=IBZU[9H;HEP:"4-I16N*[!%],*2'I[B M/GQ@4
M=)BAASZ+PQ2Y*!&CO271R^B.N^<T<-U!4P/\(9A&U)'3#A%RLZ!BP#TG!BHR
M>)/,%- _@+@Q"._."4QID/=34]:C4&^6O\?1T?'J]B%].@!,J,H.*@0JCNO<
M^&2I<T9/.X[6  2\+RR,=33)GHV]?HRE92=FON\)"UL8-G)<(C_^/?EW;9.3
M;V,ST^[:A3 %VJFT<IQIP*:.JYH2LQ'$F=KVN#4DS^]HF]C]5>X0E@]SC!;\
M"EB7\12:NMQ@W[%$7!(_L6Q'F@'6851V2!OD$+>R?0%!1Y\D?_1 RI+3JDGW
M?H<@8=[:A:?A&W+@)3B\$"-0K"EV-*-GVP^J:D>6$;P08O8B@D]C(81%FDI(
MHIE8+R'=T?B25%A\^I<O.QN%PWP8LWYP&,-S6%OHHKR*OVK/XTEE.9]SI]BD
M(5>/9VL:L7Z6<4]MJFD8%8BWRD@K.S+V?@A/Q-!Z6YE72GJ5ZKFH#3IQJ_F6
MFS:3])S0\),B.6IRJ0YY&/)M*VQ/8<!$DLCA!A06:3F:8Z[)D]5W"G)'09I^
MI37HM&^=5VP"*D^@EYJ01D);#<'(!!?OR\Y82+:L&%@ZIJ8\XN(7:M>KRTX;
M7>?&K'@?YG!#=T+C&UQH?SO:A-3GNF*R65'5@N21O6:K:,4LIJY\-BOF8>9D
M.D<ZR;Q-^"A)^J0<P-HG"9.V>DU-SP%=<P!CN*3$'C#,VOH0G(V>_#EVMNPT
M(Z6J0;3&S?/CRMU=WA9V=SG39C&<RA @9\IHPQWI78ZM<%='7HDPXY#:!%[L
M$%PC' N8#*' ,\2H::,=69'QX2O%IXFU&:WL^^947WQT2HN+[/R%Z0A:R./&
MT7#IXEK[A>P[WT9CQ;XB YCI!"(D&^E:,8>FLN^I.#:XL_BB^:Z)?2!PHQ0^
M3]'7%7=O"MN0W1W[)N_"9U:^I;JOT [*(_'R9BJ?N-3EPV3%TY7:60H'J_0B
M^((;LI. EYM8K,HIW<W5YMR6\GCB [I%A!X^GC#+*,?S*'\P!SS5,5;"Y,DY
M"X(#U@FRB:P"<R8$GY.HS2JM,XJ&X'E&?CG0'PRM#\&9;/T\Q+]< \!'D;EY
M;T:/$#E?N(N @2K="M!*BK_8Y3,*"@K!H^,"*DN +FF;5?G=>8)_P;/#I\$4
M&E$W]87C^_*$5>SV.WIKDU)M>)JZ_H*+A!20!S^E[+X,4WJ>L<>9L2**A+7-
M(2<7L%'*L[$JS63J(G<'V!N/*$=EGPS1^/><Q4(-NP$=Y22) ;<^):M<L&.P
M>=Q_R!AM(L&]M-[$"TUW,<0R3T&D88+@7M.O-3?"32F,*L#L4=[:$P@F*K7W
MD'P):(]:%(SP2\-87AU6E%I(U3 ?LE]/2DMH!#HCU>H$,-4J<GTIA/S1@9N)
M*;PG% O2&X9#I1F@4H8T?3+(>>V8_(0I4)_'5'0Y/9]@(8W>2*,3="PMK_)\
MO2[VO5_EA);B5;X:0]HC7Q4P%K%XQE2M3+_WD(DB1JS;IMPDL19N71?TE;!2
MPR(#F7GXE$7$+8FY*;PD%6;JIV%3KJ7'VI-EWQ:.D4\U?69T:.RN.L;()<]1
MN;HLSSA]M^P,I)RVA Q^]/SKOR5RY"]GY,@I/,H9.?))ZMPXKRBE<8D,+3CN
M2H.[1K,9 1(+;H16/IU<6R?%,&VK/_62QX\^?8O*6GSKV5)%9F^M;ZA BK%&
M"1_D:?LOJA&9#TF67 Q-M\OG7.7W!7['M#?C"\;FO@F6]KIM[GJK4YL@'PK>
MJ-H>87?&3)/P2YSA3 "LD>=M]"PCS,Z1U+:^FO $KD'N.52:0&^X=&M1F"@X
M%=J*(O]VE5NNXW9%>B')?.L0*:WSC[X,(0U$\KXI580Q-LAAVB64A&C2-J\H
MRE@<!^7,K"&K7BKX)>_<YEQFR69R81<J44(O[M!Q:>#H8Y6=:]H .44X8T7?
MVS'\H&95=.1RHJ:#G^1U*4R,C$(>VFZ@YX$75UQ;SS./*80,=&4_\.ETA 1#
M!K9'REVV3&2HL/CY!W-HX%GVC160'T.G-0VN'9-MR8A*YR8R#/!X*/' K,[6
M?%68M"&QMYBWVCOF\3FY;UL$'R2:N2K27AI;M]0"(Z%5WK'CWL80PS;%(-I1
M-"^3-?]S9J2I!53$4P/7&.W$\N#$8P"WWR&OVB)$7;4:F\B]</HG!RG!L?C4
M!&HXJ5\O0!4;!&L54](G,*PF01;(:7+7EI2:GT$7%0#"Q$N'Q:]@T6SF8^L4
M'>0*80";O6+^HJIW$C#'H-1?RQ NCO J%A$C7&8>;_AD]1I@ ;2M*]Z2GV14
M&9;E.?=L] 9268\<LQ'1!_)?@-[BVH1=<G$R;XJ76ZW\QQMNFC#1V?BM&02U
MW0J4[KB=4C42.X<]JO:J:M;O-,[T&A-D,!,'X,1WQ-S@)?*NJA1HHV))CX<;
MF.BL"G*L[(23[<BOI.<^[6*E!<U4<-,^Z-R@E=89_/,#^]4ZYF^X_40\%DF"
MT+_@VWRRG:8VL;X7\4'JCR#RDQR?NI_61D6;5O71),J@@HGZW]>09MN(5)-Z
M=-X'@3=.=<Z.S]K3WD=)3$(#<U/DMR7C[TN":H#(P%[?J3JE, ]9?'-METON
M)O!&.P)[YPQSBPZGS,9HJXP@(W)+8=5W&%E_("2"X*E:ME*?ZJ;S\*@E5U>D
M&X440$=EPK)FH%?G!17*][RDX)-VJN:061&\C"#&V..7J!??".NU):],A.\-
M3T9/=$=M!C[ZFQ-'71A/PXX!+9Y%:@OIY)?WWX4M*WMD$K[=\\:-OS?0;;G8
MM6Q\I:,O$'/"[OEGL&G:Z2 D- 9''S&"A !R:.GMLIG&5:QD<'G=%1-V_ ?O
M!Z$U$" <P7N"F[7;]R)]QK@KC]67S[$K5!E00H2Q;S8LQ)96DJB#V7!>%G>F
MNM[1>VI83XY4\HKBV5^>??&(MFKUVY41U>'0WF"W)#5NR2MAW0++FS<TOO3K
MCZ0D:(LUJRGK%^':64R2PS^FI[@K4M?Q8Q^I[%<?(W0SK>[,Z#5K]<-W.SRD
M#)( TM4F]0F /\I2<7#O8:Q4>R_>AP.AHPLTK>U^;)(6&%GLI]2PLE*G&M33
M/[F)B)#T*'LII?GAR(V9)7%XW5Y7"HOH&#?63(:F /8+9GN ,B]ZYFXUVR\D
M2T/4FHO4NCEY2GM\:7'[@-IZ+*TOK<3IR:'OA\AYAIK<7E5.51-3>_ 6X4O_
MV[1&.(KY?2J_%_\*#0OM/X2Z_;+ T'&Y\5/?GC=EA3:[FAJI:,TJ4XG1AXE_
MJ/" MF&XEQ^E7*4-BYKWI<?//T3#; 0?YPP2:#"X-:!2"YS<-1Y&Z"H,-X'T
ME3,>2:F!W>PCQ1MA>E'1=2&^,%'!4=;^;JIS;P-E,BBIZN.TJ<"HECE2$Z3#
MR%UZ75P7=:0I^4'C-J2>GI.0<=/698Y[_:LD/LMWD;[+>:CBTNTA\:B2V/</
M;MGIP32Q@M* -E5/B!]K]ZK+;[*<SMP S=-OZ"R:9--1Q:]%QWP:>3/OX[(W
M/LU"C+L''^)$L.Q1)D1K2E;K_(?82G-&.J1(A[^>D0ZG\"AGI,,GBW28[7=3
M0G_M'.).W6"P;DI$9M0?*/_8.F%&3RPUFRXY=6?'L0G,C@O<!/(AP@LFE*Z^
MOSIE_+2LB_8@Q[%3Q?E5HF[9W5/^1F9$R_Z4/+,'0?& "F<+G&=IT[54.SEL
M=]#@JZ&/K UZ.$M!1PKH(RZ2>Y4C?3+'#6H<"6LI'V6,F'8CPR%O?I5T']3;
MJA1-I:M*>IPXL^NH670HR5EL.%5;WS;5+;<2N.A]"1?PS]BA*R^0I'=''6[]
M*+4ZLYT6MY)6TK8"@8T*4 :&Y<M-Z$;V^0&PY*;F*1=(KX60H*8CXD[1<ERN
M^F221^Q6+NW@]CI6@#FQ@&T<O^Z3U1N1ZFF&'IP''Y>C>2$*C%(L2W%9;J1D
M'I+1<DW6BM#5)CFG@X!V!39@@ IL )U=ZQC'KBTWO;;S/L4@=ZG3E<=(>O6]
M",O8V>4]4^4U]2^/D1M=7BG.:NP[1\<<B8G3/Q-0]]8FZW2P9C%COJM A(7[
M=N 8CLE1--F>2Y7S2.MU"G&YR4G"^4B(RM#N$O R*?U&E#YJ'[D SW:,UQ.:
M!SU[9E^(Z#GDO:F1(KP <1N, EKIGF!K.XUK,BF2"7Q2(YRPT=KAFD?,44)V
M+A1.)8S)DI=5D83*Q0YTV2R9O*;C1K,65T55%K>25USN[C81Y.,KFQ)>UX2)
M:UKJERYR\+)''5R8/E.NS7PSATR5\2+I_CB>[E@4)03[LF8^>U$J&RT6^O/7
M-+BO6A)M?:ZY:'$$1,WZ;='N5J^#%R(>\>IRC2KET__XZQ>F:OV/O%_?7/R8
MOR?%X/ %$[@NWE-)IV0%1B;X"HL'2)XHL$!0K%T),DVIO=)T!H=!S*UHGK-P
MC$+!>CH7.L4#*1B$*46[F#A-BZ,&T/WFZTM.*-Q2,\06BVQ\MZ@N0VX)-0@U
M-8Q;E,?F'D6AL^IXTPF =&'_E2H6$9[ >H)<KL14D&WG17TSV5PC<%#"]T66
M:+05&;=&_<@TQ%JWBXU'HM(4W\3*A?-WE;^"WR@^]U"[<=:V)3_*V:34#0A!
MU9=TR-^SWJ.Q/%(NL@Z;8">&5FHH>\;=;;T3,$M@T TE/])]C5!(*(%"SM$,
M1VMCXQ0']-,[_7^<35!)1O<^,)%G!+L':PK4=\,!!>OAG/AI_PV2G5G,=*)=
MZK@RJWJK\]: (K0H23,W)+%'+5SAIKPJ!:C-B[N\+6*N]CCPN.9*A!/ &>L<
MR7D"X"#JC_#PG<1-Z:1R)H<)M'+(>-!=HM"-WBWJ:?0,23H.[P/RD*"&4@@-
M'L6V"(9("*&"7][++?U#&:S!-&Y7KX<0R.:V+RD([<3,_?"N)7H=NL(WQ54[
M4'3T[(_/GF7Q@DYTBIR:JK@E(&180VM5<F%+RG?!HWT5K%)+3&CR-_J=,-($
M=X98? HM*!#I8^?2U5TL&"76-\:GP<,(D0>8W\)3#V3"PG*K#G&@4R(]?@TC
M6Q116OAG"K+8X&0(\:=&,,+LN46OH#AK"X >%:T-S\)OF^GKXXXO@E."/X;#
M,9)Z.BR6;Y-1KW?^5EQGT-D.:]&KOH93\'GX_TR;1?#<XRGV&;R+B-=KK.^T
M>B:;=+QM$/4*"SA[K=3;8-ZL%?;18CIT"[>H'<TY5IYY-9,732D5M:7%*^G1
M%9.?43&,^3 16M.XC.3T?-'$%3TX6B >0GL/B 5L=:.)X&/3]BX6=(P ":[!
MX;C2!YH\ R>:)$F$55FR8Q16;@B7B/$H[S0NB(/V5CMF=,B5';&(R@)S_K1:
MT(?EV#S'G2RQ2&0 _E33<IF5S+&ZS8D?=]]J6PZ#/C%38</33H %2B7[FK#+
M=EAZ^RAHGAZ)]QU0>FJ,ECRZ;] XWQV"\=LE"$UG^+"CUR$":\D@RN<NB^>^
M*J<15-W85W1+S>+X>S/6R8I-;L\'IB]=A]!B3TW-^;H(GD,(8D8-S^CD"%YH
M9 ASU,0][\4)S]QHT5ITJ7%46AY<C141QHH#,A4$$FVIG/\D1(?:&"XL$A@F
M=]_[IN^!634A3?+TLBEO$G8.3\4H+Q)QY-*,/O1IU:%GEK_P=5&(CB+$W(<6
MEG/8I?3/.F_;YDY0Y.XE4W*^>$'$:AVW8>5=LFRT,[XA:>-Q"LBB,LD!QXC,
MLN%"AN Y#\C?&4K7IZ5HHWC .VY-'BRCI*4<U4:A DQ@4!\R;\02\)'0P6V'
M(SP>_Y9%Y?\X%Y5/X5'.1>43%UY(T$[<I4;__;Z43H"AEB.:@4@A5@AG:EZ[
MS*!61:G@JA2M&R:/)A/ '**(1/G'F4"_B58?^CG"K FG875'<1BALZ \1Y<)
ML=[G3U8_&'O[[.^R^&3)(1"1DCWX_-D'0",)VF?HG337E/'9$P: ,U _R(TD
MR>J@EVD)E*[L#U,'X?*_?P[&L\]^>/7\]\:@&_[!O<8T($R)IN_#R6/XTW3
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M=D!U" O@-YS"0E *OYU.XWG+&8?9]<'DW,YI,6Y<=/66<0I /L?(U9%WZ7S
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MN";0\Z3_=I/^X#U[#Z6YS_HE],+JRHG[?Y[KQZQV))W5<*VT57N11<+5H[T
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M@0".,6NF\N.:[.-S?B MZ+XJL4)@04B3-)D+CUX=P:7^SY C_H*P!ZE/Z1_
M&IAKMQXT>7#4HK24HYZKQ2B> QZ63;,><%-E.@8/\\S;$+:P VR]0VL@-=F'
M73+4E+>I1S;1=FMD"+-^P5L%.J9&-?87MM%WSL0!<9<6MFF.0ID0PW/7E9U?
M#%0BG7\9X2@GHS V-1XCGLEY,R/5BB<=$F@&'KL3(-LZ9QUX=X )NE.?=72>
M34BQT_N>^%EAJV=QP$JI*L[W#U@YZ@A9U.PY/L\GD0KQ+"^"<U;OT831@D$J
ME!)D50%PW+'6=U_V%;'U\=_.F;['F@(45 G@4/\TU.N1+[0N;\N*M:T!HZ^<
MUXQ*<%WTH"NCJOIYCAYMCE@ (J-*]<&?%W,&\#P-CSP-['R+ZWS6[OZ5!A]R
M9X43.UNIT)EG(C>!X!BH)Q]ORXHQ6<-YJAY3[E34"AD+"QG.\W@_NEV*Y_8X
M7(GX-1^*2!*#,("I,^X=X[/2XZ,Z7Q!NH*;)7MJ(I:DUFCM6SC;NN18Q8/%>
M-3H=/9V$ED+?'\XE[J*-/<,<<)YXD$@4M^@L: LCP3QP2@"1/AQ0JGAVP2F]
M(EC>%9T&"-:E.#-J-WZ03(;"ZUI6QQ"MC;>2Q+D1_O(8%R(-S4W7^8I(_1@G
M'+Y'O2@,4OGJGTAW FJVI(!&VU5U?,8YYFG6H9AD+6F5.*+06X',QJ0*D+G<
M,<U#)DDCY6QWZ&#P!DF'.L!\4I$1':!-T5X3F;.T?J*+L&^Y)2Z+]TF0R:['
MH0D7+WJ[+Z7Q+NCIB>6=0+N2Z:,AL,L4FX1"@;5)61.$6[[:PY/5&P&&),.E
M798881SY]Z2:QVFX,[S2PRO_<H97GL*CG.&5IP^OC"6'\IY"C2=$R9+OQ-J*
M*Y*HH /72:*:2E(9718:C86MB7S,VX^N5;#%A>8$?F"9=GY(.DFJO-REK02[
M?$,M2.%B>BB!US$R<%#E)K9T9LZ%<6H,?!,!<E)]+Y)5)(I-4HN)"J:S>=Z\
M4P%5YE5V27@K)]HE=7JT(*+YZ*4Z]W3N,W_N&C=+N&F%EB,YJ@MJ66!I2L=I
MR>>?B&$Q*@6@!VHW[/"&5@5)GU@?EX9HVPR,L<#A;F,)KR'B?KEL:O5SM%JY
MY9:HG*AH8[J<_&!'=I;=2$EVNK"X[STL+.5SX9+C7>>OBI,^/#O</J.BMAU"
M&V_T*N@U$ZS(P08O'0S@%H/;71WBN*37F8$3^*$(!F0MW4)OK:A7; "U\7Q@
MY)W1#MQ(*S*G6U&;TWPK,JNKG#0ONMYA7+"LJJH@"1I]7O?F= VZ?%'_U( I
M7)$^[@KH+*NO4;@%OX"]HETG=8!1098@@V4#_!-Q9V=9<YVTHQ<,YK\M.%4\
MQEZT8?FBX];2SAU[F.(="_RTV*2V1'1YPI2QJ!?KL0WD458/A$J<%%3FB-B(
M+#&GSC74LV)SBBI0?IAC+:9>Z@=ZM64//A@RM+T84M:DH\+D_*%E7%>'4V^&
M^W8J$@/I#$+S/8R[*B4RD1 LZ=%%!X)0EMW'!3A#]'4O#,IZO8D+1,32Z$BS
MWDGZ7"@E/<$@="5W(>3*B1<P6**_.Q(=9WCG"<AB^'B,9E#^ED '/'5(1A:
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M&:.EA@=C- CW%IMT\"3 ^R0#_C#W0MAI)<88Q0#V$L,^M*18]$\X+,"5.EY
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MUX/)9]0-%3QK9%1TG/J([=71C)FC93@05LIVRTZWDD58F@F*G-PR$4:<6/U
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M-I&$B,YH@NGS C1#[0@RQRY3YA>WQ[I5Q$VHWD?!!_NHF+K4K<?G';%^Y&0
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M/Q>!WTJ@7$ 7U((8CA.9!7BJ<AC@A38&Y@7=/#P!>RY]CZ/(*O A5-NV8+/
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M-?&W]@B7P9M8U V'_X0./_1^LN0:X9=<@5.75XYC42$2B)$A(])&%[&VW;8
MRI2(C16B\>1L*R=1;/<+3ZF5N!IP"[$H7*VND,H1#>WJ^3:G@LN.3'>ON!"C
M\BQ7WCJ%%:4C<9L"I-W7ZACX98_PDG6S$KT/E[8'"Z93[<OCF/=Z0RF69HK]
M&ZENZ()R<0V_E8_:-EVE>N5]5M,YZBN_;A!1 )@K_3@*652_=<U*:[*M?@[9
M-V1F*;BEM_"A^@BVTGZO[7Y&>)O2'2;G6CPV7&"))(IX,H0KUA+8%P#O*&[L
M9]]D_L)42)SD\3;.==947#=<$2K*[[=B2/N+E6+)JV"Q4V_YQ:5?&4$XIY?2
MC@!)9;9%9G_%%BJ\RJ;X%DNC"$?DH4Y\HR#6IP-9M&0*:"+L^ 099RYF4]3
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M*"*P9C-) D*'4\8Z]\8D.GMT:"(M&HBP:7TF"1K?=D;X<BV#B(TGUS.=M+P
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M7^K@KD:C,9%7(QW8A/[9<5[, F<#"5Z6Q'VXIB66ALX$V1'7V&5+PWT5P6S
MF_DG@D.]BQ0Y_\JNX8N1PT"PO:&=G(FS% WC[;&K%W?1&JQ/*]$'#"O1&I@A
MZ3M]K*!7)T@Q \DC8GB?FB3[2D'.MKL\JCS]J?_Q(;H=_!CX4-?X GV-]H3L
MFWS.6XNPJOP2RA560G"@OE447EGY,G+/#L:X 88R<?:2*RMUA0AFY-OD!9'
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MH5.#KX9-$>/',6.9KIYDP HR(**QWY<,6)&U%,%<<XX!4]$)L+[NDE[*&*O
M*=P>&V,;\U>F?'=]R:&'PJ& 9WB09-&*K*4(ZCHK6?01S]S&KHWM^43?6>7Z
MWZ$5O$O>/!#>["!O:I(W*[*6(JCKK^3-=*<YR8L'P8M]Y$5=\F)%UE( =2V]
M=H%# :A9^@Q39IV]288\#(9$K&J-YBJ&7*BWX:"]^-NS]_N%S/A(9WQTRLGX
MZ,J,CZIG2YQVQD=E<AP>KN_O'I[PG/WF]NKZ'H_6;Y^4A^L_;AZ?KA^NKY3[
MGU^_WUPJ@\O+NY^W3S>W?RC?;AY^+$BME2)MVR\_4B5T16/CM-M*L:6OKN%1
MKNF5Y3$QF&6D#'"H6CA1OEIN>@27JMPXP\4<D<T!D2&I_Q7Z@35ZWT.KQBZU
MX[,<2JKF*=&9Z4/K$C&$IL)A?[,9RE_VL,ULC?2GF!%AX#&GF"MB#$72)\__
M3!ERS^)TP*?3@;7TP8<LT7S!QI=+_DSZ2_OR>6YV5Y+E@K3(*]_X !9>S3"S
M#'_&R7-G8Z3#F1@I+X/T,V(TC&(TO!:,EV:AG[C0L#MX<RE/.TZ.YQV\EZ1M
MMY)A8-'*'3*)/V&N"\,4<$8U&B*W&L<*^4H*2C/[S!J@%<&/YE%AQKW+"56-
MBO96WQXU'L=Q1)[]KM)@'-M.9H[@,"%8IQC4E3PB,K8BN AT*D:P$H<)-'R:
MZ )W6_AC%F?X49DXL&A*!R8CXT D&D7RL_Y83TU"X6.HJ;@QSF"8>A;L=6KG
M*)>I%&=G:[ZG!$GQ.*Q!,C(5=3N6=_*\[S]<! !\-F2>LW\M%6]@N2C*).YD
M:!B0^=1 #J,A6;S2U@AF*/?-LNVXRI6#X<45[T$P\)%WEC\,?3\]\BY5(+MZ
M.>K,Z\9&:M*1AR5@5%0AYB'Q II9KG!P5!4*L31KI*Z;+2K!._ =O)\UWR[.
M$@NPH '6A2T= H7]LG#H-Z]>"#)()#55=R5L?L2CO.);V:MAAT9:2+#7.,T6
M;N1S!?UH9L_\[5BMXF-- M@AHC2:IKD&-'\1:P_X>+;%(81\ZMIZ\C!=*E\0
M@R%IDKEA(I?RKPED$Z3 J%@ZKDD": $A,KXO"Z== 10"PW*"]PUEQ;R5O%]A
M(=J@\_F3(UZ E".$4PDYD<FE>D$NC4NN\@H8CT6,AHSBH<FL")H &O*3>XZ"
M/K[B-##2RY%=?% :<JF"\5DVGE':"+,E/5IQUO:))5<BS.H*3JR=N\NBB"C[
MA:872K_(9(M\"_&X_\_/7@MO9.!R:X_L=#Z7C22B,N6)F"DS9H2)F%Z2JAD/
M]10YFY%"2N5NWN'D;!)\W O\]-.QXM,4_[-(Z_S,VR)XL_.:G['N*\D1I;<)
M(S+BP>B-:&O"2SV3G(AX762:C9B)IEFZ5!W'&,8&9&HB:68!6X2;Q]E2]^M?
MO-D"K@'9,FKN0/# 31V6J;?4B4/U&O+!?C&5+(,WS>@$-,<PXX  )>KZZ6\%
MEN,9VG$-+Y@?:%MSO."K:.+O,\D^;'?A\BGF:'IY]&IN;KR-F1@ N(+K1AYC
MO%Y>."1I8:K&SQ!=,,"+PNFQ'MP&"^%V0$QM_D*Q(HIO%8<6PG;@76\XW/#%
M>!&5C'Q7*@T*I5T)9X6&R#H&-Q8]UU9PF&5J!W&Q)%F,6-$?S>_C>(AK)]-+
M$>""=U%P+IZ;BN_,^S[E&:"*>XP*BJ>A-W5YY;00-V0D+D@<-AIQ7Y1&-2Z1
M:D6V350&O]J\4#22=8[+)]&*UQ\#K]VEV4L,&!>4PWU(=\A,JA FW]Y',) F
ML?R__*6$'>$@VT!92?1JFB7GEX"<R[61R84Q4@<MI:X\THS@Y.)X.^P7 ,ZA
M\9HT)12';?)YH"I8]!:(^2&;M=/%.%TQUC55)1T-;<[8%E>5 I1DV2<+$(Y$
M]/ L%YUW5J$1LT 4U@AT X 1FWD@@'T^R/CY/:6;Q4Q4G';MS[\"21O#("(Z
M,N/$9"_^3[0#;0L\' [EE-B-2J*-M#!\CBVH5-!F"]MP7U5WJ%MQ+"O518 7
M2-[9$? U>9#1YKCXCUQ/;)T1XC#:>%P?2?/$,[5(S,;.(OGXV).%1ZEB7;)4
M[PD%Z['95[G>O*$U\[4PKOCC^4C@@#%AW1C!N?))^\S+7WDHD@029R6:N9[F
M4UJ!V!273N+IV7H:7O%)QU[ KZ[]*FP.,OEX*QLPN6P;-"N)$#]\_A=7-OA2
M#.?8[)?RK]!\$9S$??=H8X+QEJ#"=!G7ZH;-AQ*3$_]FO*>Y*M)R>5P_XR_P
MY2B^\39V;1;/(1>M#E04(:G%"7&Q9'5$&ZK@?SZ+&*P!&M/+5^;'2\M^ $H'
M)RWS%A'EBH9@<%'4ZT=V59@Y8^\N/V.7I^45/6D^D=/R YGOBBTA6^U2"J*[
M[7JGO?I1F4E]G=TE]>W*/M+:&(P<#KV0 OQB:CU9Q+QK)AGZ<;=&\K.T+TH\
MZ#Y O>LOSWJ<$^KM)AF!<PESGOO&?]>W ^#>F\ 1-*\HUC]-6^/<XLPQ*7%3
MNMEC)L(B$/39@SP\-T*90<>6.>D,NX?I\SV*EQR^\R.OA0.6YNQ)5N)DS=)N
M\LXX9$GA)N:]6C@<6_BHZ#"''G:F"Z)3)L\8@JE# :KHSV1GKO=B.*(/J[!4
M1;0K=9(TST9SL=4XJ/',P#8=U7-S6;>=Q67'1F+DS$7&[<*)8&Y20^]V'@_8
MF#CE#\QV&.:^@(.-,GG0:M8KYQ<$/$I%L><A^%;&, [$IQN.43P HR.".I<1
M9QUG_J[9"%K_\5FM2-"(R1B_3$@9_(-7YIBN1YZ,%4=-TZ<"PO,*T14 ]VCB
M.MA20-CY=( ;[T@\"^\P8><8T>$G$3:NDV TPO'SR?+,I)%T$ACDKN<*,B^5
MI*NA+/X.?OF?3!F8)L8>12X35Q?45Q\<1*+SD](=+H_>K>6F33A)38)>67%$
M%:."&-'&V"5<C!DY%@]1DJ0'*]_ %>'K8[+'(+;GOG@B+IW*;R"K?+D02M2(
M$:3R@U3:/T7!4Z^CA HPLI]!#T4Q#?0"4S?.A6]G@$<+XT)QM@O^Q/@+7V4Y
M* )$XU_+ <*PS)"44ACX4;-$'I" GZ$S#!9C@2MTDI9')^5L(!1?MD$F_Z%X
M,\UZ4RO)FVG56[W3\F;B4V506+>@7<;*I>&Y<*G!^_#/9\'NI4ZK<FY)R05-
MU54P@XST3S73C$R2UOC\!JK".G-'9Z!NTL,/YJ]+#4/@,?+?FLW4Y ;J*=W7
MDO;K:I1]0*FVLT?"L?ODI<P],3$F-6R"3I72@U3X):UZ([XD1POGUI($PLYB
M7J#A+&S; !W(C<=/(C5XS R3?QGG4.,J0KX#0WD.+=ODZF>>4\EILH)X4UR[
MX9^@T8S4.Z(+DBSC)WZ!-<&H-E\0&//N&^HN?Z;5-5FI #H@/',^\X,K;_PD
MV07')J8H@L4,S\6# ]=Y9>\8K8_.4J('B.<E*TZ>&*UY"VMW\VY[!\:M:_R\
MM+"?0]8,3Q1RZBB#.Q\599+)S)MI? 4;&H+J\=+H*"DYCL)C(3+=$D>2)]\G
M:5RCD);''YKT/8_(+J:STU-NA=VHD]%U:6<J@UEX4HU?-LFKT:2E=?Z5QUXM
M]A:1_%(&BO4*,&R2>B26[$T6LK53\T36;XN&DB1!G'3&U^*-"\^&G>&4@M=(
MT]M @#S3!7]CD9D 2BF%B5E%C1K^Q0&DFI2(E,1I%MQ4KA/7^ZJK-IQ(#IZ-
MB(?^T2<FE='9[TG>7:P<YZ!40$+5E6]8&_.+/%F>5T:"3K!I++:2I'I^HS*V
M_,#U^-28D<'+^\AEMIY#OHC%\W[8STL0%^'$SUZJ9XMZCSG* :LQ.^%W_W>E
M<,?06_@@[A?:K%U<>PY0[/\+F/NB_!-DQXOR_?O]LA:B%05$5"V(L= D,KI@
M2'  *#[R,UC"6F]9I>A'K[\P$K^[/"4E1F2K=O$(Z_Z&>:U@V;LJ&-FV!3+&
ML8RUR-Q3?<34LVQ^_*.UR3-IRX21=,)(KY2F#-B#4::95#M%XT323'(W9>"?
M6%2Y<=[\B-%91S^)XNO@^^#V\EIY_/OU=:5F4&0+OT\W>$[NAO ,$].[?V%9
M-)K-BC_&@T[3"(S/AS3,H=NH]_JM4J+]FEYO-SN%'K7\\W:S6=ZBNCL;,=$_
MS!$3@X5\EDWF3:P) PJ*)W$*3$*YQ4JTM8,"%T:G<QR#Y]KP*0&MB1%]42MM
M%J&P9V/XUXL'7I]Y)E8['#(&QL:FG>T^NB4.9S*?I:J^5]#-LMV60E#K0+GI
M_<465QCA(_JO*,(GEFG:;$_-"B]%(0L/NYUOA/FY;1=&SJ[N+XEA%?JIU_5V
MU7&)*2]QKR/,47LU[)DN#@*K10#04*HEM[*W_MM66TQOC<ZL*[4W$='ZAJE/
ME+OE6#R>%?IF;2[ U:HIX'Y:$\/V_T_MK!F%NT+_[,4PIN=((0/'Q!_7"7D,
M@DO#\[#_SC\,.P1?E>>)_9^:]2LX=\+)F>F25XN/!>X!L##B(Q$O:]<N.@VU
MTXZ')44KO> 1J6U0$[%?;A25HU,D@QPK@[3WP""=VD6WK39P-$0E&*0DN^9@
M].+CV/6",SSYQ/P!)GI!+35U]&*0R.3_PV:2-5J$X/D$X+Q)H%F4)[J@-( G
MFOUM>6(%;>Y":>2Q524!K9&R91!0#[QU36WKG8H0T!JA&D5,J3?[4GK;Y56G
MY@W=8WM(RTQ5_&#F*>6J#&><WHT405Y#\+#Y>(TB$""^YA &N^D.P<MC2"*P
M4)2M^[6+MMII;*T6JN-+2'+*JQ;*)Z=. \P,56]U*T).95K>>ING$519!C^Y
M 387VU[<"CCD/FDX0N99(XNW8A.M=J$U-;6YO8M:%%$'8*N?,M&MD=A;$1U-
M'=+5;K=Y"$3W0:=_>Q77=^OKMZ2QO*F CH'['6'[@"^Y&_T$.P?A6I1WFK6+
M9E/M:%I%#!MI)W^@U"V5DEI 26V5DD4J04FG<.A^[V$I:,!+-?"<=LJ;ESIL
M>><*&51<&XS@0+VW#2< Y_$Z@NMM<:9H@VFBJ9W&UGZCC$Y7D)#6AB'*(R0<
M.]U2NYVMI:N,4A^/F8W9A9Y%G?PQ4T>:U)N*_ 20>&!_ZSK#S3S1+G"IVN]N
M?90DC>D*TM ::5\6#?6J14.G8$9?,:I$3!WLV:[SPA,]MH\U'SE;K(M6)$<O
MF_-$'WFBN?WIB[2B*TA ZX(4)1!0MX$$I#>WCG)]C/5<2)@?SO%=MB@MI=3B
MB/-G\^__>$1"KB/*HC( SR:[?;77*BO678FSR2V2SR5GG1YGY3J'+<I9> #;
M;JO=3N\0..NX/)KL\LOOJ4:8U-)KZ5#[;0KU4FAJ B)P:K3-MJ_1+*F,K^#J
M3B%@&!5IIOJD;E:I65(9;>GWGUI%RB :_34UWK%WQC:.S+%I^:PM'H\B7V<B
M"\*XYW2Q6695MXEN<T<K*YFO G$7R1#'RA#K+-M2&*)%P7G]&.-(!Z+N9B9I
M9)3BI$P;>1Y:5'L8YNOD7 !95$_X4?F$X)B49U&4>3 9IJUV]*J4+\OCT0^0
MO[LE*4R+T=5V[\B2#@]&('^?&;OQKB;SK'&XF.O(<]-RLKPC%GG?T&[I4C7D
M]O&YZACRDI(VR_+>EI)Z2$FM[=-39![B,1_UEFR-+ST/.';67J,D4I;3ANS<
MKUWHNMKK[_SDYM"L]9,EN37:9&N2ZV$N3E_M]W9^#%\5:[[2\OI[G.FX]:%0
M2>=V']V^L_(V0N476"S.V*PZ1\S[M X+:!!P":[M:82"-G-M-\[N[&FUBUY'
M;32KTIU%!A;W[]YN3DUZ[:+34]N==D6HJ=288M6%+\6%%0#Z65DNY&G$@/)4
M8:1,]S1W+#  GOKWMV["+$.%%223/+462\@D+41'UB]FGOV'>6X&^;1J%Y1B
MJ'^I" F=9@A.AMX^*O16U,# <_!&7]7TLNS5XP^ZG0"]Y8^[%:6W#KA'8-"V
MRBHI/JKL_'V,6N6YV.YD8@7)1&BD!M@ <X:8M/_IU@V8THO'Z:V=G)[3(BHJ
M G_YUKECV?^G%G@XKV!NR$&R!9QUD-Y 3'Q=G'0Z1W85""L69<VMX=!;"H=3
M*#QX7%I_(NL/-I!>L5)+30D5CSC#Z\^U7O00,;#UK+^/0>!1__01 R="5"&I
MRF^K>.^>>8\X372E.79S^RVCYS-_"Y':O>'=>8\T>H\FK21/%=JQ$3-F?[4L
M6+:>]H[6TV_4+AIUP,CB\=C"!\K4\)17?)ZJ+-T#S6;UBS=D3ZV>ENH/PF#L
M>H!XLZ !TM=6@#A[>>L;?)>X/!U36AH9+8L7 <Y7JQCQN[X4!7PQNN%;N_']
M<'Y;&2YX0D/-P@ OQEX;+JNU'1WD7-9=&/@!6%0@# NLK?TA(-ML;6# .^YZ
MZLQ/OQ9ACF?/)RM:8VO*Z%DAH9DQX6M5V*S?K5K83$9>/[17Y#:TTZL:[7ST
MB.-#L(/12W2=K8S@=>J0OZ*HQ;FA!;Q._VVT& #5A]B_Z\8W)FO?TKK4&L6M
MWW7#5TM<'-B^S49C4^M7,0+EB@W9Y)EY2E-3%1P6?UZR+[*PW:5&5([];FD9
MYUA=EE6<8V$M'!JO]EJ+B;B+>$"[;<?TO@V,BYO215>W(8RQ6JRA:JW%.2$%
M+>5,NJ>+X)>FJL"=4P8/>F7V^Q96]6GD]^1G,&$6+2(6;.<C&AHM:6,#P;"4
M-K"?;D5HH\Q,KF[U\Q &L&J$MF$K.(X/3'!E:$RMP+!E(M?&?5UBF-X#2&^<
M2P[0%",4UHK47%=K]M1&]X@:O4B2RMT9I722TJC=;J/15+M:54J.RTP".P39
M.QR&D]!&CSMJD.).IAX;,\<'LU2Q7?_4^J-\VDH,^[!^^"VCK5 $9][2(@WE
M&P> SKX#J&]9<#=Z,GYE,8M6NVAE# CZ+"W7@Z:@!:F[.PK2@8(RAE]^. 6=
MFGV;DK$F&UE#Z]2FKNU$I#ZPP( WF=>&YP \_!28KSB4"]LCU,>PT>FH_?:B
M+YB?3:1U6T6ZRBMH=T!7K=I%O]G)''KYX51UFE4.&S2VEGGHVP0@TIF<UP3H
MPES3KEUT&^ :EM6TK>IS&"3EE1*G*('R.K6+3E?5];(."PZA$N+ !+J]\>2"
M=7 1R.( SAH)<++S4,H'T/$(I?QE@ /'+$%$=4N;4E0Z5BO:LEWRM>3K799;
MEL/7O=)F)%6"K\DX^3W 5OI1:DLJ!W-B>"^6PU^MS[+3D $6O(\G$)W*T!A3
MC"&>A!C..^;Q.&X 3P]<) X"$ 7S1I9C.$.+W$OX@ K[ZK-Y/*G-BC>T=&YB
MT2A90.NYQVP#4X"^O%EF,(Y(-'6C0%TCN<5XAD6$P?);J@+(?G\NK2GU+RX7
MJ=YJMEMFA_4,H]=IM[JL9;3ZK,&>S6[3Z \[S>'_:DU,Q^-WC;TD@?>%G3U[
MS/CKS!C!%L\-^\UX]Y'JTB0&]#4'^7F@+07-:+0):'HY(,,I'<2 BSV) */
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M>">+G4)G*'HYXQ\70P_4"G;KS$Q),Y*C95B^Q+#\Y@S=KA)#GT <?J<#6P_
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MD@PI&;+2QF6W+./R(QCR5,[ *LWC5#Z%QLF\Q;)%F+H)Q&"Z(?;[.07A5QP
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M ;=.F#)UT<1![2GD5(KEM>X77WF.!#;>!-3V%X/= #.%#J44.(L+ 8(&E##
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MK[V6BK5>=<1:F94PW>IG>0Y@U0AMPP9+US+!B5&&QM0*#%N6OVS>,3P&ZCW
M],:YY!!-<4)AVXWFJ3<:3;6K'6/-@J2IM2VW"]+42I.@+:>KRUCD'OM5ERX?
MVUKUY&.9!2.'8$D,A^$DM#$ %W6M=B=3CXV9XUNO3+%=_]0&KQ=+W5\P*I9-
MD$P S;NRIL%\XP#4V7> ]2T+[D9/QJ\L;M%K%ZWND76R.TX2*GEJ1S'"R6]/
M-&6(0888=B@<%PR*W<G&5D5DXZD%(E+F@\E&UM *3BP"L1MKX8$%!KS*O#8\
M!P#BI^!\Q<%<V-9NUR[Z6E_M=A>;<11NXU8EOU&25?[ZT1V0%9YM=52]=614
M=8+M.)YE.X[*6$0[8-0NR/]F1VWHBTUD/YQ33[,KQP;SR;>I,3^!,O-U1SKI
M.L%K@G1AMNG5+GI-M=4I:RY%;G3MVW\^0=+;C=%5 A'V2S"R#HW^]GW_"=)_
MB8=%VQ-]!YM'=E5=UP]!\I[F"(E4GS'*-LUOX:R#BT 6!_!Y$R!CNN&SS6*$
M;<=[!SPSN7P '8]0*M"W;>"8)<@H/,#N-M6&MI@EOU6S^!+0NJ<(BF1LR=@5
M:9%7#HOKR.)@>R^:(9M./SE<YM[W_5*X2.&RSV:%Y4@4G*;<;JO=3EDY;_N5
M*^3Z_!X8\,+XZ "VQ9L AL9,J=IM. %\#F<.02:&]V(YM+A.7(1[\;=G#Y^=
M/I!(W2-PW=*YIS1U?4I-//>8#2]\95_>+#,81[20NE' J)'<8CP#.,)@^2T5
M.*31<4U:HSUW0)/Z=^PE=<XO[.S98\9?9\8(5GMNV&_&NX^82@,=(#X'Q/G]
M+]WE:+3)+GLY-LFI#EC']8ANSH'6F8=7P9*,JBQ%&7LH./[+:K9;9H?U#*/7
M:;>ZK&6T^JS!GLUNT^@/.\WA_W;!44:^P#DEV,@/>_K][7?C(@N/<RPCI(7>
M;9^)TM2L;WN-,ZTF^FV&S!P$T:=Z;1F/:?HN*]WIB>>8%VP-9V#<S:1I  H)
M(TH@H3IP['N(X!*MZ>%[BBS,I 0IW]-9J?.R84&>D&A*! ")0MBR;4Q]=A[]
M\B4:KF,YM$RZZ8MXEI :R"5S8I"HA'^=,!!6J2,3B7B0>+/XN@Y?_;[X>;M1
MU[5VYE>-NI;Y^;)':5J]H_4+/6KYY\U>ZW@7U:UWND7?_1& TE<_:DVP<758
M6UNXKLH)#/.B>D&,$*?]DQF>PD! F[DJW+>!7\IS*6!4'3!L![YR[[%7RPU]
M^UUY8#AGBYFY4T6V!>8Q0=+\5^A38U\)O>+0>\!.2,P9,@F\C9CX@?G49Z>X
M/"P] VX? 8'O%L#?9PJ(,@:F<FE#7$\K<'12<:%F<W5@Z(&3TC?/G:!SAX_\
MTPK&ER#DW0GSKG\-[1#A,O!]!O\S%ZIS<L2*6CCQKI/1A*GD6<05"3!OO/Z3
MYL&C9< U_<ZV9L"5Y7&==MGE]ON?JU32V<SZC>SAU$<*A9,0"IW]*^7.!RGE
MJN395YICXAFF"OLU11/?ES-@CNG^4H?<ZW4]1V;E7ND9_'1F>,,Q'7N8(,UL
M=SH3,SJ-NMIR'34.TH%C7B4 O>;BHK#T[]8NNEVUT]UZ &$%RQZ/DY:*99HM
M.!U+:_164M4BX6"_Q/ZBT2#K9/<?1<U+2+)&=O_V?9FRO$^RO-6KBBPOLS#V
M$(R=/Y@#UKM-MHYA3BS'\@./,KA.K.E8F>:. "IPR& &I!LR2;=1NVCUU;ZV
M.%G\\+M$26I:%V0MFYHT' VHM:K2.7I/[NTQ&$/&-L:09,X2C*&R>1/'=K;5
M1GMK<ZB"W=2T?L5M(5Y2ZRZ$,[<)_&QQ-'+8C+/.1HJCQH)5_,*\@E4<>E=M
M][?69 =U.BB);G-3:GNBPS:7:K]]6B2W[_LER6]LH&Q/\3C^K*FK[8SZVZK1
M_&F=MLK.\$4MD"7G"#%(DT['A;D$NW#J3;6?88S(]O '3D=YSZ/*H*/N,OOB
MH*EHW_=+*EZT$W9(Q'C.JO?4_E8M.SXF@A$5G<(:V7*J.\6K3J$FA88=*!91
MNJHX3.;X;!'005C>NHX[*T VC83V\92BVZK*5"J98O"A<9H"M+2RA* G)_;M
M-RYSY(2\+OI2JDSL:=62B:<0;KEE 05:E&<&R&+"5E "X]>&YT)%>^$>"-/L
M)C*3^"!1.8GEA "9I#?-5T(+O^X)D7+]*_ , *[E&-[[3< F/O ?OMYS;9LX
M,& >\PN/;^AA&T*MI^JM$H9<5:(*M"3'^;0I.6]LJ$J4W"PMQG0P=+SO^R4?
ME1.=JA(;M7C(7^MO,\_G(QCIHR,YJUH7[K1!XTULG(&YYK"1M:[/CW1@"IIB
MP%'">?G* 5R8:]HT<;Q;%1]&NL,?&=?)142K SH=&="1 9T/#.CL6!QVJR4.
M3RFDLS,;[=@:G13>?[7%P6Y"54!5FY^8]_#$7.NJ6F>QQ*M:OD0)3K'D,\EG
MFP?2MN.SO@Q]?=#]DLLEEV]L76_%Y/T&!N9T5=,6J^BJQ>8G$YCC>5;#F1$2
M+X;EG&]1O[I839 Q=V??WG:U5[?O^PM"YZ.=TU3)MWC$&5Z/ R*PK\<>W=?0
M\1@L]C_,)#920.Q.#.\O)@:ML&'HT;BL+<+?AYL67692XX\8JH\Q4'_&P/\#
M8+^1AM(HZM->G"9^^"T8)$VM"X)O0E,K8^)]O;28> 4):M_W2X)>D^2X(QG9
MK):,/+4NJ-]<#_YT%, H#GUY5P(/GF;SX7?&XB =>;2^4<'$S%@][O,*R%\*
MP#\AW/GK!H[YE& AF68$)N'=Z,GX=>]Z]$40>-9S2"SYY-X;\)@@B\,P@:4B
MYT[R$//#RRL^CO+R&S*E#WRH$EWN^W[)%WFJ-?8ID#O5$<BGD @P.])6I@3(
M0XQR4P(R1$DD& I[0Y@GI'54K;'H#U7K3$,>'4JNVVN"0)E<UY/I C)=0/)\
MU=,%RF3Y/B8/8.!Q,26W6DQ_"OU9XNKK*?,4?PR.DW*F/!N^->3#F2P[3 ]4
M+MZ <,6Q\S$*D^( .&!I<L^\1R29U?:[OE2J7!N> W#PH^=\1;J+148C$AFP
MLM51B++7<<6I/FLE>*ZLU3N+;;>VGWF4GV;V%&>37'\J7+\1L[7FF"T7KZ^)
M7*<X3_^09<6LGW]AS>4A]?+[^593,NS[?BF93D4R;62/=$HW UJ;":,-%[+4
M+L)2;[VN+49/JFZ-G,+AQY_T!R@. U9EO##,SIX H9"7Y2MN&/@!^%BPG3PN
M5Y%L*8$[OOLL]&TI#ZLG%I8R(P=VT<21"'4#CKG;</+,O+L1,:-_ER NPXA9
M&P!I-3H?M5XAP!:677C%>#;24!N]'&[/9KEC)5+LOL.[DC]+X,\UZ35;\.>J
M])A6H_=12\W'FJL7V]^=XW%\;+GO^Z58V%XLK,DNVJG6UE;%(,M<;EE*6]..
M7&F3#_$[I7Q%]5>I>K*)X;U8#C\9TG=92D9//+<"6-YPAN2[F86:EZY#IU0&
MX%AY#. 'IK,I[DBY-/RQ\LUVW^:+R@!92%B6$QH<?2NW.7>U( >]USC#")JH
M7Q.8Y?@!8-C&U&?GT2]?HDD%ED,;H)N^B%<)=&-V_1QJ"'7\ZR]OEAF,D<OK
M#<[IPMD3;Q9?U^&KWQ<_;S?JNM;._*I1US(_7_8H#-9K_4*/6OYYL]<ZWD5U
MZYUNT7=_!*#TU8]:$TE8K9.UA>NVJ&!-W;*;H<6].9VZ(&"(T_[)#$]AC@GB
MY8H-&2H5I:FIBM[0FQG5JMO +V43%3B'/V#8#GSEWF.OEAOZ]KORP*:NEP[5
MK"NQWQ:8QP3)Q?HF";W<T ,#DV&F/)/ VXB)'YB/EE<6Y^:4AWL-0/=S[9/L
MR1':D\K(<R>IL=MH];]2%>GYTC!S0=F^AJY*([^C?<]!)YO-$V1);2'SUDQ5
M;:.%CV>K< ";;VO5:^W8TO0R6CM6IYQ1LL.QLL-'=&!L:24,'ZD.,WR$*OQ(
M$S4G61F?E4_/GW-;]U*^2/GR,;T?6UJKC-Z/LH8Z+P4D@1)?"5S%8X#SH64S
MG*7+*S?@4_Q]B.Y>Z#-3P79UF_IZ!WFV>HKWRZG;NYFZO?\%5O4J";C]SGG?
M?V.SG&$>USDC960SPV<*X^-;CJ6-63X8E-K%+-+EWQ&>#_B6N]%/GPU\GP6#
M"3; ^0\=]6\V]+BE819Y4VWH6S<"K*#;**EK7:>R75-7!T=JZ\W&$1+7J<4D
M=A./D+R:MWO:KED5T_Q[JKY]1]@#=>\_N!U]07/*Q^Q)M*@L"MX<5^?YCS.K
M#/-U<@Y Q>/Q1P%2#(3QD%B!_'NM=\Q-P8^2?LH]KEE'28L4TZ]=]/K;=[VI
M$IWL^WY)I^O"_H7)5&]4@TQEP$E&ZBH%N&.+U%V.#><%GC9[8(3>A$^EZ+9E
M/%OV%H='%6X9<M+W2P$A):L$W$%<55(,A%22WJYW*ZZ2!L.A%S(S.C7B>LBE
MX98I;;1-<Y0C]P9RY]R"^>^A*W#%^,\;1\#^>P+GHA%$7:-@?Z.$L;!5\G$E
M5>5.7<U'58N$@SG<_<4SHH,FFX^)5%?E>&BK=%7)A64F>.Y$M#=1M#?[%1#M
MTI:41K@$W$%<)0$G 2<!=Q!72<!)P$G '<15$G 2<!)P!W&5!)P$G 3<05PE
M 2<!)P%W$%=)P$G 2< =Q%5'U=<NN]'B8SB=VM3&V[ 5?SAF9F@S[.@-,*#*
M'<OA9VV6Z\@TRB.Z7PJ%CQ(*A]>WYP$$@N&'7MS>/\FPYE5\=,A]YH[.0O@C
M.^FZU($,Q]S7J_C^*YT44EJ9XP/[D1#AW6BV@#A*!GD?..9<,;$/'VV3*]*B
MCA+=C,&$.Y@T4H6<+\F9I\&9.R@@W1>/MFL7';71+:'.K_+<^1$F1@4S,K&)
MZ'!'69E2X)V&P"NA?<E>I=RJ6:L'LH5N[:*K=IK[&>,FDW4KZB/O?X%5O6IV
M+N#"\+Q2A>CZ.9<T]$^95<+9\_LZNYQ2N')Y3V/F,>7-\!7'5:S)%,2) H(R
M5U=AQ?64-RL8P]>&\Z[@PQ4K8!,_^M1R7IG/;W),960YAC.<?40]S[Q#E(96
ML]TR.ZQG&+U.N]5E+:/59PWV;':;1G_8:0[_5VOA!-_]#8-<.?JQ65>$+KH-
M)_"(X9SRT>;K.!Y!E%HC$*M.,!@.070C&.]=VQH"U)[@QJ^V._PKT10]KLX
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M:4*X J!<09+1'1DKJ5<\<(&&+2.RCH5?*M=*F,_D.2!;(WS^?_;>M$EM)%L
M_2L*[IWWW!$4S;[8<XDHE^V)FO#8?BY[)NZG&P(EA::%1&NI,O/KWSDG,Z74
M!@A$(2A-Q+@IT))Y\NQKR%Z1QX#]@+^8CN&A2$"+*[0CO'WT<WD* %J&'!'
M#$PPTJ%#<,/WKD,>#V9MFLB7<"EK@/$<.663CW9:6%P:  O,.HP2^<(GQP4X
MVG>!BV.D-S\4>^#6-NA/8>CD\HMN]?F%V*4FMUD!#G&;+:AXLN -*1BJ[<:E
M+/>[,;*.-3@%0,*YV)+&["?3=6S$1XE7B)&)JTS"3FT!X@E/5?FI21+,%R?.
MI3@MPP!S4G=AJ3ZH!<*J=4D"PC(X)\/?N-0FZQ$HC#%?0WII<H6)LQ5D,DB$
M?H16@C(X%1F@2<U1>.)P,]?@:P";@>MHQ,K6CBW2J, ,#E8!7RH7U_BSRT#2
M>T!=-!*MI?U<(^_347]WM0#_P*LLYM,7"&%017R3' CA+Y8)K,0(M4)=^BY)
M>2+8+P1",?1*;3ASYPP%0.&[YBP@MS/W'"#@Z#JN^RGK%IZ*;'C$MRNX&W&$
ME8-:EE09<N C;N#ZH%0I/90<(:-_U-&7Z_+I<0J<$OO'2Q4 (,/$KSC#U(S
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MNSUF65$V&& 914S1G$&K!WM5ZVK2 'DL*!1NQ<9)P&/]9VS')%+CD=+,N0E
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M)@Z)*J/)M3N:UQE@K&T;\SNC*09P/[""3F$<&5;H(,,A/$@[A/-J@I "E-\
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M:%'?TNT'#%?C^<+#2+O7?"<E0?C9Z_.Y&\ %)K8991Y*@CDSGXC-(A9).-S
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M:*$:Q2RZD.DJG_GCDI0!.!!21CJ,-6Y,_6<G';42S&3#B2+%45J@_6O_T%U
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M2/8<]5#(#HP-4_V_XI[ ?XG7W/*W?)<OH1\Q4-;)C)3A<4:8@/W\.E&OG#!
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ML+8P7<^/)6J$@)7#JK[K&RV%H<7G/_5W#/AZ"=",&]/>WK/G]@#-9_:+.1G
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MUBD?P<$'4>G$VG%]D6\&:S+#/.N8DHT53YC-@-4RH(.;'E^VO@(&Y/.,P0@
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M-&P-]EA21F=M3+*YZ;4RLB<QI9^W:GZC_U:;)<>*HV2F,B''O<]6LC*J(.O
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M7"I[[=8V/D?+S&DN-\PX^V'W)M5R[H?:!TWC_<_6+O,0X4B\F0O@ZK9/U=3
MA07(<-M8<JG;&](X1^^\>)OT;)B^3;-KCL\Y.$PKGKYP6[;)I#5JCP[HRC:>
M],MJ@#;HE=>5K5?>HD9;'_4*.ZG=$C74/=3*[Z%6]T@[ID=:W=>L[FNF;/]#
M6C2_W8<4#PJ[G./^U^;(_@*ZK[-F:&& VD8-;DFS!>WS67>-5++,T1D+E8/
M-8^N+N*3ZN\WU"2T'KY*K/D,2'.GXDQA]Q2F5/=&S4[_BM)\:D*Y5D(9G(]0
M<+IO=]SL9/22.P^AO+99F[?SN1O P3>Q SQSGQ@Y)IPZXZA4T0(?Y'=1.C="
M&UU6\@@*$P]E<T]&U<XUJ1.47H8IGP;%AHABH_[1W09+0K'79LS\"#OF;#=B
MKCP%^\2LF7<Y.4Z1P>Y<DV9W>'1I3744_AJICF'&92 5IA]WFMU!NCJW5HY?
M D6H6_+-#+NH'M\S^76H+<=KQFJ_6E!=1(:05UY#V^$$2[!ZE5%J:KVY6GKS
MR1%PU&Y,1\WNZ&BV_C):=9V,_]+X?F_[NOV(Q=^UIE^>J/F;XQC/IF4!34<
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MA4!XI#//@)DAU/DRA&.(C"AQ9"1B TX5@BQ7WO>X@A25(<<"Y[DX76*?X-Q
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M/9HT/TQ$&5F,?Z$EM;FE2YH,=G72'$:D 3Z%1_.&\($>"% 1U]U9NR%X==[
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M(5K"4;\!^=Y.JO=$J)^\VUBD*06H?.^D6E'_#\4454OEQ && ]1ER?@JHJK
M';!Y.T_Q=)X'.+=/S,?>2&H2?T9R# 5!-_/YYF6S1+3=<L+)MWI9^_@9>X'[
MBH7E*FB4*=A#5:E8/9IQ*$XU-]E+.N:;2LOYDT?$CC\387_!X=?%(_J9JR3R
M9*:K6?7H-0G',$'$FLNW&G3*^Q(:D/Q":*%= YEQ)EHTD"HG!G(4 8B4Z^#@
MA3MWPY%%'EKR%!YPB,AO.7?(]XA$@I2@/\9RKNY>4PI?31-U0VO./,'3:1&
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M0#03>DVO]43!PR&DC32_!8J%>[]$7GCC.7=;^7ZIHR/TXE07-;NQ8\3A[3^
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M8KP?F.MZ_-@PWU8\MSK236)C%5'5=>YM[!C(LN,BX]7+BQM2DO.XK(+"@3P
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M2R,'-*G=5W54H4EU@":U<P^)L7(:DYDFBXK:V&'B*W##?W+_O;\B*QF^1;=
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M#BH27W9P;(1@9!G]#3Y+")9RD:%6MKKC@)S7E^M$S GA3;!EO$FT)G5\KZY
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MV0R;UFB6>W->*+[3CD5ZXSD?]P*]BW>+ZB<#8S)3)%%3LU3+E^0,KQX88$0
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M/ "Y^$Z1J56TP2H.A!F@WBT92S"9TF1F**)J6P-L<S1(,%6D^<[<^IQ@HRN
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MS:ZT5CVXC1POZ KB+#F@R^+*DIA$5GH%JJ[' ZCKAR^:6U)+)I94%R4=+"F
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MRI9P\RV\FT"X]_&KN]H$RS?A :]7_KGDJ"K/7Q2\&H@ B]N7="VTGMG]![S
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M]?Y291T=(.*QOC\S.E_9:==GUO=3ZP4V>6X-WJQ)@,>5@,70<4\78+\(MI7
M>7G9&W $?0'#\$07SW,@:.;C7; FJS1KD?H^,M"_K3\D4-*>>>FL]R)AEU+
MN^#O9]9%&@(LT$G$)#N:>:K(@G/#)>#%X?1G91[!AY;_"N?*0^[JO'#%_%OG
M9;)WC&^G8CSLW,:F8S;"@&<"6" ^I)4[5D\5-67'\#-@_%,(#V,N<<"!:@5]
MZ<O >PO26$\2R.]\3$O_F+X2O*UBH)O.3Y[[3 )1QWH"(F'?"21L9!N!"6NX
M>R"EL)P;'Y8<['TK[D373WPTO>31!'- [B&07Q#($GI_@O$08,&+Q.&=^)87
M;P!705Q*7!@$T@=^P1O#ONS@8U."-<*#;U8@N9[D#$<@TW%=Z%KB+^<^)ZPW
MGPY_1*G_@Q<#2IXOO3FP+5>RW$ER#]&OCOL#MLL?<FWIQ7$MMS?_BN8\*FQX
MJ%'Q>RQXN,H ASNP1@$[C__Q*1:.CLN/B#_T*7I])*V0S2XH#/R#XO*, S=E
MP84CMV7TY>AR$RZ=+?]NP%,M,_62W%12?U_U*D5IMI3-7K7Z=T-+_TBAB](Z
M>BZ+:C=;[4V_O>\U(:#4]U^UQB?^OHVH+-V78LP)!>LPUEQGG0P2V4;(-K[!
M;?U N@&>9TM/; 1<! P:29,;DBICFG7"N-@%2 E#/&L:W#8!AKUKM-E >QE(
M#S[[X0"['TRD1S;R_/4!@4U 1#"^F)50K>N]0H#="+"/[(5A]1HCL.;,$QZ%
M#IK&""I=9+8X.C8= %<SG?G%]X:IFNUVK=?6)5AO@HG[<C-7<W'E75GJXBJ=
M))YM /.JWM&;;+'@7+)L&]TXE:P,^6+[&**MF8=HP=J6E9.+MMS0S-*6E>>:
M=DGT4)ZM;48/NGP8>E!/+A2S89B[##,L#ST<0AP>4NG.B%G61^E#]V-V2X98
M#+$88#'*85B,=G+1,1NFN4LM>4XLIE8&:#H.)#Q&F,WK,SCUGC-(Y//"KYD"
M,#N9J46;5/3\9E9C\5DE9;V+ $> *Q7@JM-N-:.SQW-/N3 :,"M@$A.3ZNK2
M7#4;#';TE2ST[8N%^5<$Z"-^YO[E]X!=!@$++X?8@^_?/!DF&@JXN4J' U$;
M1ENI88=*0J]EU\.AT<LXN= ;LKQL,%0?O8[-,;$?IP11ZSM6_*&IM75R88 P
M6/:H%T.M9:G\W=-4GPUUJ@!+&U"MF@NGU6)\SP$U*\O^,3P'F&)T_RF"*#K#
MA%ML@YJXMMRN\]P5PJ!5RM,F&)2%Z79.+CH-?7>F6T(D.@ROKH6*1#2YBXJ4
M-TV:Y:))\K^1X[)4@*N;X_*J;[FO\+;Y^!G:50$O21HX5M<9[!!+*W'#MZ-^
MGAA$L5VY.(-0#5' 7&(&<<UXF3IG!AX?QSWPW-=34#:'23YA8RV"SVP)Y^!@
MQ)XY/[",<*L02&55NEWS11,Z'2AP/BISUTS\_ZT;G<2E:_.A1J#TB=E^(7>#
M;9[4HN PWH;2[NS>,;U,IE<M$2O?O,M#(9C"$2REM209^-4R\'=*S#Q:HMTU
ME7$W8DVA1_7DHJ46S^U)]22CG@!7B;L(< 0X EPE[B+ $> (<)6XBP!'@"/
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M(CK\XL5H)<QN\#]G[^R!*@>/PMNB6X)&8KG3UD#X$-]V@'89=W=9KSX3CB]
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M ?+^A@G9(J!>@]0@H)+$* 90#X_W?]Q>WUQS2/T*6LN?M\^_SL$JFZ*1$\[
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MO),+0@$E#8)[](+H0(QMX0P)T8X<[A?7[R*.4M3F1[BP*M!F^C)TPC)ZDM.
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M!E2TMI@55SQ+*26-R,*=R-G=Q]OM9\Y+^>:-L#K\PIT)FL*/;_X/4$L#!!0
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M#Y?[8,^%DLO]"J=-*6Z"4.?APTF<+$N;S.;ST_B?HA_D3%D+HIA$6&0-]XT
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MG,:C 7[ \M/RR]\^O+Z-M#^<_IS[9S\O?^?G,!@0XODG3']\Q;_^:=(_^SK
M\^]]&6-9B_Y\R164KG#^1_VTGW?&](6 C-,L(M!W<5@IWA#CJD_?'?/%9T'&
M$F:#:4/$MS^[*=[16>BW%/"MCVZ =OY!<(9G$<<MH5[[W"LXST'>1%@_,F3:
M=V=G?TZCLY_GZ)Z_>_OQW9O7+YY]>OGBXR?Z\]>7;S]]?/?JXZ=WS_^___7N
MS8N7'SZ^_,_?7G_ZO_=#IP\_(WQ"<;%XQ?_'%I]^90'$E/ZP7S>?-_37Y2,J
MVFZ6@M^G.,RXV)#.,0Q&Z=HO#>IV.+K0WR!$',R_VYM-X',(7WL?IW0VU6.*
M0.-K^G+20Z,Q:R7HZ$#Z0]H(T3H))J0454XZLG!;^Y-S-I4PB7/]+Q_Q<Y7M
MSSB83LZ_,Y?V7-+K42PDVV!=GT(<8"\4P1E*!TKD3 NS IQ6!IR1W@DIA/<K
M&-UF37,$U]=SR95GX_.5+=^\K0Z0,AZ=-=7G=-1,C M-$>@__30:9QR3S40_
MFF\'?TF#T03S7_\T'<_P\INCX918_7(P?R"]K/BY?M&,"2__>]:?_G@^.OLZ
M&M)?)\^^]R<]5[@CRTE"5HQ6Y+6$Z%D!R[@P*%E&F[HBQBI #7ERQZ%^!V\>
MH.AUG-E9X*LHM",;;F!Z,3^.-@+5NV%F-&+#2D -6;#63+J# [LK;M25U/=&
M"1$X[8X.@;E20!F6P"=>@)>@D16ELG:/EPK7+-##,V$;87?  ()S-AI^G([2
M/W^=&Z8]3;KQQB>P2">EJDYW1!' FL"<RD*79!MK_Q:(EII?9<W?5GL#Y8Q:
M2O:VJMFNJGZ6\UR(8? ^]//KX?/PM3\-@R4X6TJP(A&5@TS$[" @\'K7H@,3
M18B82FO3]TY IT"!=A+OX,U_EM+L;#:H]W/OIE]P7!<^QB]UF_R&KX?DI>$2
M:,PI6<D9 =4!5!("O \*DLW,*NLY2ZT-Q8W!G01-.M'$;<J(72GS :>T5LPO
MPWC8'WZ>+%$A%BT+&=N!&=K72I#@,'CP7&#FOMB$L3$_5B,Y!3(TD/%MS<M=
M-4\L'&.8X M<_/?UXF#[,AK0YT\64O@P&@Q>C<:_AW'N9<,1*S.S-R0!2=ZW
M1^T@RHQ>&:FS:WV:; EQ_UQI?#_1I4HZL#ZNF$,?OX0Q3M[-IC7>48-(/9%+
MY#DQ0E0X*)8T>.<$6*^M4;2SR<*ZLSEOX=D_-SI5YGK#=#=-=&"4W%YUS[F<
M:#O-$ VWH +/$#)J$((S8VRD9;?V1F^C.&U&["CU#BR-9_F_9I-IW2PGGT9K
MS.@Y>6N<,M?SEZRE>?CS ](")OTI?L3QMW["]SCNC_('3*//"Y7]/0QFV!/6
MH_,A@C">SE,ZHR%&%L&;F+S+.@;9^E:\ZS6=-D>/BA$=6%ASR;V>3&:87\S&
MM!4O8"YVZ+?X^_Q'DYY+/AL5#"3M%3F-Q8"3S(#6CO-"5H3FOHO=\%YDI\V^
M#K1SFT.J(P[-^7T),OAH'&,:$A<$4@8'A#M \HS %TP66QM;&P%[D@S:03>W
M":0[W83F/WSWM:ID\O([CE.?-MH>QVR$BQ:B%TB&@@H0O"A @BH\NL!=<^=_
M>Y1/DEJMM':;9Z;+C6HU8!8D2Z(@P?0:5,P<8D5MF-)&!VF\R'O<M/Y@66.=
MW2:9[70S>WGV=3#Z@0OD[V?C](7$]WX0AI,>240%X2QPPQF]&X:$5+" Q1*U
MS5R8O%<3:SW4)TFXIOJ[33O7Y=ZV%G4O<<==E(K$$VI@.7#PWAF@[3EHKUD)
M1>UQ?UL+]$E2KJ'N;A/.=[K/?<#)=-Q/4\SS7WM61?06I^\*B:M@?SJCW^EI
M$;7G)"/:ERUMU&0(Q(",K %IA50YT1?[W/$V ?TDB=B13E=<Y.Y\W_]K&/\3
MIS6C[B,F6L*TCY/?AB2X0?]?F/]& G\SFDQZ!HV-Q22"Z>@/XV,U21V(R%CD
MC'9OT]JNVPS9:?.K ^VL(-'.X8!UX7 2 ?8_#Y_/QF,<IA^?QG3NAS17SS#/
M_S:87_U=7AK.WX]/X?O[T7C^@RF]07$VE\"GT7MZJX;37M;*65V31@O6]$^M
MZ)7A&83+3CNEC!"B,1?WNL#3IO3Q<F7%F[%S@(0P+I8W?T^+=P$S#R"+H,U>
M%=KL)4G0*R&\2<ZDT-IEN0;@M)GU<%FOT/S.@8([P[>,CG87+ ?!2P"%+D"D
M#1S0)F4<^FQ2:R)L'DAO$@XVIF2TV=><)P'*1E=+/!-8&5DP(214G3A**\+!
M__[S#;J_H;\^L*RKVG3+])!1>3_&;_W1;#+XL3 !7_6'89CZ87"10C)Y4=.$
M!I.'U'@]]%&[%WPU662CZJ^7X_&(C@LZ%.9GP80.@_=D8H\7AO:5:.,5T&\N
M$G>*#KYDY4&4;$!5.SM8U. E1AETY$&VSF_:"?#.+V+Z@GDVP'=E4QA74"SK
M:KPCTY'<XHB2@4HDK2#I[-31<UMXML$UKT/;&?6^:M?VQ\9;GN9^-7OHTKC)
M>-J[LH!Y48>*&=$(!H'%3$<*8^!LK?&0$75AB8O-\IOILZ^PDOYVR<@5CSU8
MN=N>%3YJ(_B&R68WH"R3=C<!LTTAW.9L.$3AV\[J6*W6'639N8*-<RPZSL%P
M+D$YG2$8XPD46?0LL2A9X]?\ &5LW>IU&Q%VI\_+G>F\L$IPFUSDP!R2UQ-J
M^BJ7$F0N)7-E$C,;66-;;. W(.S/ 6Z@F#4[\BY2[2!A_$UUZY_3Z3\.:3H+
M@T\X/IO365I-/FW1P%!'<L 3!R?(%PR)SJ"2@V>N=?[2.BQ/[ QOJIH.LH97
MX5J^()L@ZZC,?3VJP]2ZM]'>!I380?0=E!;<@3![GX,P$;*NA;F8/?@2-+CH
M:)N33I30^DYIWZ2XI^I]WYS81N(-N5 OP^C,R[^/1OEY&/3+:#SLAU<A]0?]
MZ8\YWN7AYZ3$8&0 A\K1NNLU(QH'1FIM'//1V!NQH-L7;1L_;?_7YZU4,^I2
MKAT8%70,(GW@%SHF7^ W'(R^SEL]?*_% MBS5J$VP1(:262/JH#/60$WB1;/
M2S*Y=1[$G8 .4,]ZL'NH=IKI@#;OR#8+T_[P\YS*'VJCRG?EMPD^FTQPVB,"
M1UND!4WO!Z@:C?">EBVMP:2BM19;5ZC=">@IT::=9CHP.:Z#>],/<;X?]LCC
M1NMR!@RR9OF; B[7;B!1"J&U4#*43@ES >7I4N5AVMA#4X4KW2!>D#Y2?]J+
MRJ=8,[AT3EB[W])IG DK([#1*&6XZKK!PFU43XDZC76TMGSPD!%EL@8GHT$_
MUT7]$@:U$_''+XC3/4::[X.P_PCT5D)I%)G^@&D0)I,^\2HL%WC>+B(4S80G
M"CN;0.68(;B:WFX]8YZIDGSK9,FU8';?]JY_\.)62G#O&,,"I92Y\\' )<?!
M:L4P)9:%;K_3K0"RK[AO&UW?WJYVE>TQAFDYHYV5,?(!U-QU=+3#6JP)]]''
MH*TQ<B-N/(XP;0,=WA%YW4:6G0?F-@%SVI'7K=1Q9X3N(;+L7,$V1A5Y;:0K
M.8&JJ8E1H 2)/ 5>-.=AHXC-<2AVB\AK.[UN(\+&^OR8<!C(PKXTES[@U]&8
M+*+EG9[GSLA2:P-XG;K!& =/]C5@X5')&)F1IH%Z[\-QZ!CL5BH:=23?AI=?
M]\6'94XA,7*C")L'56*-#QOZ0UC%9$!>?..W^MBB[@_5>"NI=M$5M-Z;39[%
MR3PRT!/&!:-MAI0J&IYKE)A'<"IHH:Q&CQN]VEO8X]<1[/^6H1N3? >Y=M$*
M>(YF41(SO0**1ZLD@QQJPD=RE76U&Z%-27#CB>NZ$V7? +)_G>^BG96*WD6T
M773Y#I,:6*G_J04,W\)@WM%\^CR,QS_ZP\^+#EA.NA@=[616U>Y%FMP,5S+M
M1%*XQ RM.K5VOC<"=B@^[*3$FTT7FVN@B^Z+7\CLJ*'@U\-ON+Q+[2DEA8B<
M@TZLNIPF0B@F@.8B*2\#5Z7UKK *QRF08&?Y=A!^(*OS:^CG9:"5*#JOH[RV
M]EY4BG/I-20;Z>!+TD.@E8+VTD:K-<O-:ZXV@'4*C&@M_0X:$UX'XPK&(%T!
M[VIO :E+72S9O9;%F)V( 5L7&)Z<TA\NT0YZ!MX=0/>Q<!&QIHZ'6N8L"%=P
MCMP<;5WV-1_XQ%,;&IJ&[43=R3DP(GC3'[6CS90VHFJE?%U6P_<*]R)'5_><
MNFJ6;,5FH:A0*PL0?6Q_ *S'\ZA9T$S0'>SUEYUEJJ'Z=C1,RTU*,&\1N87$
M2S5,LX!82@),+"0MDPC8.F-E'99'K?PF N[B%+@T.ZZ 2AJMR5J!=+Q '5M!
M;!0<5&2>C!(F36I=LKL2R*-6^>ZB[:#1ZP)/SS'ILPH9+,>ZKJ@@^IR!>1UE
M9DK3F=2)-?>H-?H X7700_4\@:V/-1'J=H^*BZ7F[$(PG#Q*2=:%4CI "#&#
M9$P7RU@HL756\Z;83N5VMQ-==%$#<XGSID-3; H6$X>0>:YQ!PNNOA\EAUQ2
ML=RKUEO!>C0'*(CH1(/K:;*+^+L9!C>:#:>3]^%'S3,Y]TV#25)(B5"O($ Y
M2>:H*@:BY@G)U<TL-P__K$1R4$+LI*O;L]YV%73K>BB"-)[A^1W4Y/P2:@GM
MBAQZ)3%&_(]@BZG#@3*A-+1PGLET==*A%O?FA&[WR$>O]PXEW,$EP)H4^7.6
M8F2\T"X'B7A9,^6)H)%7/Y4YAP$MQM;YIW<C>O3TZ$#P'5P+W%YTSZ!4CC@)
MG&L!"A6"-YX!%]8P37M9=JTO!&ZC.!GU[RC@#BX$KB"Z]%HOUBI%*,IQ <FB
MK,UA)828$ Q&$S,7 5F'+L5M0*=O+^ZHA/V=%5?N.%2A XQY!:G4I9-[!4$)
M!I$3P!03HQ=E/\?%(:^2&BIQLT/C@1KHUMWLT<I0UJ!&X*6..HT<G/*1O&UI
M% LI.=OZ+O%8[,C&:G^H5#O8 VKOU_XBCZ$FMXR&E8TX3'-3%D42GOG:.<(M
M;[1#"I!XT"*%[*5M/37\#C@G>D*T4D!7 PW7K%@4H4,,D(NHO>4UV3;))A!"
MN6RR4U:V;K1^3'>0>V%&(_%W8%J^)XTB;8>+E2\2WZ3&J+.RP&,=.\QE#7Y+
M"85E)V1*1&7;/L/H)HQ#S 1OHZ7;:44[B;B+%-3+-N$+/-YGS^LM.Q.6MJ<4
M(P03&<A@54Z*4&+K3> FAI/1]T["[61\\\KYO%=@]A+YL#Q%K*<3[6VY^K<1
M'8A@(YKD(M/-KY;O174RA&BL@"[2"B];**R;W%''+9S/XN@1H37S0H)CJEK,
MPH+/24,L9/XRYY(7K9/3MX1X.N3I4#4=V!,;-.=(VAOK/0<A:[9F(9\K2$7;
M84938G;6LM:;S3$V4.F(+XT5T-5<XQMS1(1!6J\@SUG7BW1.GG-*$20F,JR3
M<;A93?)./LC)4&!' 1\@/:97:[!%+@A%AYJ!Q34XZ8B2)(8DA3<Y-F\C? ^F
MIY(.LY7LUYJGQ](LZ>/EOUS>R-(/0[V-N7)LU@/S0)V4ML9WV#9+NXFS\QY,
M5CMGC$20L1;C*Q1 .V,&0Z+2Q0I$T=Z4V&L/)IZ=D2X9X+Z0[V@R U\2JZTW
MI=*,9=L\7_!(>S!MH^O->C!M(]NC[,%$9W=,S(-TJI8]:9((<@\E9:/)S!?6
M;A32>\P]F+;2X5T]F+:09?<]F#8 <^(]F+91Q]T]F!X@R\X53+147K#:IJ3:
M<\4'VLND)0^,68TE2FU.M =3,[UN(\)]]V#*A,:P(H Q1Q8U,QZ\KN5$C"NF
M(P:S65WN(^_!M)6*MNG!M(U\]]B#2;N"W#@/AEE;&UQG<#YXT([QI+UDUFQ4
MG_MX>S ]5..MI-I!J&QQQ7KA!UUF&&IG HN!O&9%2W6U*Y0C2J*=Q^\\_;QU
M%>X:*,=T4;&+D=Y"TIU,J?B&PQF^(BF<S^CX1W_ZY3FQE.".7WY/@UD=KUP+
MT>A_N5[")UV",JD &F5 ">OIF+,:F./&!N<+UZTK]1\ \R"#PG=7\2W?KEO]
M=#F*X*((X5P0!$)&]!JR+?7]404<DP6,$1P-1JM29RT>;H(Y#7JTD74GHP;N
MFK$2HA0V.O*,;29#67H%3NL"2<K G<L6.Y@R<%33;QHI;JO)-MM(O8-]X6\X
MI#4/"-NS?$8"KNN=]K_A.3QCO73:,PB<*5#D,8$/0@$ZSC%R(6UHG;9[#Z13
MH45+R7>9WG^^Z)X6(2;K.<2Y52QHV2$8 3J(9)T-P9O6%<*W0)R*\G>3;@?I
M.!> +O,[>CD'(5T)8.K^I$H=C%-4ALQETM%J04SL2N&7,$[,)GB@?+M0><WM
M>3L:CJY#.]]_BHLZ:72 HA AG2 GN$@/A;-4BE$ZAN;5.W<B.A$BM)-Z![E4
ME^P\=V[ZPQF!O(S$_H)E-%YF@9%?@Y.7WTDH]/S^,(Q_S%WR6N]2W:+18#!?
MWQ3'.)G69OA:!]HJ8[3D 94@(6)RX+)RUF;:-DUK0G6XG--@X['HNX.<KPO(
MRU?K%[*W2G_:R[+$HB6'K"+6LI@ZJ*MD\"A19\?I)6M=N;P&RBE1:#<Y=Y#_
M]1:G5XY:PZPJV2J(NL9LI4L0O3<@E.'6>%6*;MW$^!J TU#UPV5Z6\&VB?FR
M)C69V'BQ8%,T4Q8#I!1S[:],#K9A$;+WC#-N.;K6"3L;0CL-4G2AA]MT<;O2
MY=<P_B=.:P+'1TRS\3PY\;?A&,.@_R_,?R/I+6QR8Z5"6X!CKET<).U:3GBP
M12633>+<M<X*W0S9 3S?+A0[ZEPK75R>KY'$*[*,^I^'BY8=Z<>G<1A.PGPV
MZ;-AGO]M,#>B+@.,YS43[T?C^0^FTW$_SN8"^#1Z'Q:]H)*TDA5-KV"LT4>N
MZ,R,9CZ W<L8C'2MSZJ]+O TF7R\'.FF[O_F.B^J@>@U-?0O AC+2(B:WMH8
M?1UIH5#)('SR'=3]KX-SFF1K)?\.;I7.BX#>X_CC%R+K+V'23SU?BT$\2Q"2
MY[18GHFJHLY)KFD;CNA<6A?[K@1R&B;7[C*^K7C?6O$O^H/9%'//AAP(0<V/
M%1J480BA! =,"1X%"Y:YUF'%-5!.4_D/D?,*&VGGI)5_8!UH@/G9-QR'S_AV
M5D7SKLPQ3M[-II-I&-:DB 59$W-*!Q& :X(\OQT(/*CYZ#PC>5:I^6")K0">
M!E>ZT\D*!NUL9J]!NR3X+= ]CR08YNOAZ0NHG#C$G+#6'6<65*$5M+Y0WA+B
M2;.HB5Y6\.AXR_OJS(97@]'O1U#)=PO*T13MW2VDSNOS=(IDZ' -T:?:UH*3
M^6MS@H3&*5&LY[[]I)*]UN=EYK&8&"&:.G56U101PS0XGJ0WR:,6[3,]C[(^
M;QM=;U:?MXULC[$^3Z$@7\]ED%8K4$74;'@2D$G)>1]=EJVK?(ZO/F\K'=Y1
MG[>-+#LOW]H$S&G7YVVECCOKN!XBR\X5'(-*6?D$T@>RG+RM?GQ40$Z]B%)J
M8]E&M[['H=@MZO/:Z74;$>Z[/L\JPV7P=3:\15 Q"JA=.(&E4)P1G$41&JCW
MV.OSME+1-O5YV\AWC_5Y@1ME%$]@HN5UO0C!U8Y\3# 6ZE2/S;H,/=[ZO(=J
MO)54.P@'OL5I=7+>CT??^N3*_/+C-[+U7@\O4CR?I6G_VZ+[S;G['1(7+!:R
M:ESM?X6%S!'F- B?0R@F2:U;WW]OC_*8JOIV,>T[UD\'!7_7$VNX<9K7CA(>
M/>UEV:3:=8GVLOI_F,B.#:TC: =.5NI:8W?F,6TC[BY&;UWL;I-/(WHA1L/4
M'^ UB)]&6TO'<U4,;8Z%UWLXA7645)2 MM[U"<F5:GTUVL4Z3IZ)!U=^YX-!
M;HRY?G96LQK^-=_MSW/>L]/"5N/?<4UX&?D"GAD)]+TH/3+$YJ7+VV(\P+S2
M@S-CF^GENZJU]4R[MZ-AE<W'61S,9Z.0M!9RZW&NBR*O@,Q&4=M2&@/!,P;1
M"*,C&H8WLZO6S+!;^X@GS)6&LN]@8R(4XXKH!2[^>V7]R_[8%XM/HJ"-/@*Y
M*'7QVH!7J4!B05L6$LNJ=1KHYNA._E3L2%$=9#O=1KJ<]7AMJ*-RT2(RR(:3
M@6D28332 #$@Y=H0.?+6SM\FN X2G.Y$K_?29T>E=#$.8QDEK;53].7KX3><
MS-^DX7FH]>I;]:(_J1&EV1@O!*2YM2GP5,>6RUH\ZB$$'H"0,U]2=$ZW[M*Y
M*^93N5_8J^Y:6T8?\%=Z)PA--1?>E>M6W<4,.5K*#0NO=G*^^OXD)75&KB#Y
M8$!Q1=:=8)9,O&Q,L2HD)S:RHQH!VC^Y]DN#T8%UN):'+?-T/L[.SL+XQZA\
M['\>SM_:X70Y,9N6]WXTZ-?)9I?#35X/RVA\-G^U=TC):?#4W;-O6B]]QT2;
M.<^6F-[=C>ER4[7)&($I [.Y@$JIMHNW##@RZ307R<BRT9ZPY8-WVA W>]8B
MM:#X3$M3'F)$15X,.3"NMIZS5J!PJ!(S+1>XES2;SC5];>OJ2MI'D8P3AI]Q
M'M,VF3N)CC;6("SM[,J1=2$T&)8E<G*CDVT2]CM_X+X3<+I5Y6A7D;9.UJ@@
MEJ''36"TS,.Y?/0!,G >)OR;ZMM!<ATJDCDKF.,6<B1:*A,+!%4G)7MIT80B
M8MS(*3^T N_*M&FJOVT$UEAOOY*DSF9GYT 2/="2T\ZSHKT$0X(HJN=>,&%2
M1K.PD>=[C^:N/73/610/%?NHA<P:I\?\&KY? 9)$Y,;K!"++!$K0:1"C%H#.
M.E># AF;*._J0Q^A\AXLLPZNJF[/;WH[FN+\NQ^_DB?Y?$2>[[CN1A^J.\)[
MSJ@Z;]Z 976Z4Q828M$<M$(OC \V\=9]JK?%N#]*[,V\WHNZNLA]6983+1+Z
M%JT@YJ;XI!>-T2'E &B)[@I-JC$$!;F@]$7*A,U+1]>C.6'*-%)!%ZEV2V07
M5UP7P+0U@I<8@1L50862:Y:_!1N$,BY$D47KQK1KP3P!:NRF@ Z"N>_'M8/B
M],?[05W],->M;MY8^;<)EMG@3;]@KU[BARP=*!O([,T!(6048&(L3">3$[;F
MR :P3I@MK96R-F+;\M+Y5>B/YU/3KURJUX&#%]\?E8OJQ]?#R93^<?V-C^D+
MYMD %Q6/=:7?PF#Y3S]^H7UTBN.S15!@_OL[7%#O&>'NE]F'%&FC"M-S+._*
MLV_TD'HHOAJ-/X:KG:K>7!U"PCQJVOT\_:&P#KOUY&F9$ Q'GK/4S4W>;0#N
MNMM>*&Y5'&FIY/QN^*$^>;R(@;T=#<?G?ZW]!2;UWR_*]#!]&?;_>W9^.6BL
MM"7R ,([76V, #Z5 L8:[9(6TGO;6'A=KF=?=;'=,?3FMGXTVC_T+?\M@?SR
MX^++_]4G"VF<OOQX4X<\S*_="CE4!6L+'G+@0=%JP$<;0'&7Z3N%W/G6662;
M(3M4P>[Q$&D=P]LIM -O:.6Q>AOOLO)J$[#;A"H>PL)-@.XWL-&EQM>1JC-U
M'9QC-@N362VS+YY.E5C;>S-R&[+C3,BB."NM/:PCX-::F,O14FL;+75)J=?#
MK[/I9"X!OKS;%I$94;P"(81<I E'YP4$Q9RW15I?6J<QW@%G_TED'2IR'65V
MU$('5\"KH(GS6E\I&:]3/6/&>9?Q",'3NI,C$3@6:<T;%<[O2!#Q- GR$"UT
ML8/<OBR8;Z'.FV)Y'8_"@J+E(FVAO$AP67-:,?D[J769XQHH?UC4-]G40&4=
M7!O/.RX7'%=)?<3QMW[-TGVW\C;J$WWD9/6/EF_;)FOIR,)NN8X#&> M"#(Z
M,NUVL/<U79/U-C),$HSPC&Q.+2%DJ4"[$FKS3^TW:T-S4DR]SYP_=J)NH]0.
M"/KK:(@_%H,<7LV&>;(T&;BK]511 YMW' W%DO%@&61+_@W3I636^E9W-9+]
MVVR'T^[-\1J[JZ8#<__YZ.R,+!Q:[?M ILX25 QH"Y<6K%1D;"BG@+[EZE4U
MO4]""FY:C[U8">0)TV5WQ72PO?SV\6^C;S@>UD4^'XV_CI:#Z>K@W,\XK,'K
MRWC'$G()(7)#W#:H"&B(&4@0%C"CRBF'J'+KF4\/@/F$F=:U4AMZ#O,DBAOQ
MZ&?+>/2GZ_'H)5#:2G4LDD%2F8-BD9%@2H!B&8\^( _RAE>ZIDIHFZ<^03)U
MJYD.N@7<C-.^P#B]I/FRAPKFYZ/)=.Z8]VP,*:!2( +206UKO7(R$J+$FM(?
M.</6:07;8MP_[_87]^Y47QT85O?@36EV-AO4=NU_&X\F-^:L+>:\U@%".7EO
M:L,%D76A110'+D5:!$<A>%9<QM:&>Q/@3YB)'6BVBTYW#UQ$[2!TN0C-49$!
M4"#90HL0LHZ4=;KF)T;AD@N6M[[": +\#WJVU&P'5\/KA71].3WO<_"1# A6
M+.%4','3VT.(16'%*R>QM:>Z*;:G1+(F^FEHY5V8HV2#7K=*KUD*/6-L*(H1
MN25Q7;&@P5F5H<3(DC$YZYN5"W>X!W<_ZQ3IT(68;[- M6?!BJ.YIR6=NX$L
M1(/2DT_K4MWR:K\T5;0-TBB3'LZ%%4]\6HS85>2W>:$[Y\6\)['U1F2K:^0U
M5D<BUX2,Z@XG%7) (ZS>_ IADR<^:5YL+?+;O# M&L+=PGF9Z''9/JJGA0R:
M,SK>LB<".^4@6!^@<!)1<AYY\]&)&X,[11IUJZ';5+)=S+_[AD."N,O8NFN?
MT&+:W'I(C4IX2"/A\^<Q?I[?+=?RUODC+]D@C"170WEP-?=-L>3!*Q[!,J>+
M-B7$YJ.J[\.TZS:RYO.7D[&\EE9IA,3J8$:'@GA9/ A94-J4BFV^<]R%9U^%
M,DUY<'-7:";P0]>VU+X3SVM5*(Z_AO'TQ]MPMF@>DY(NQ05!AC23)!W/(8I2
M1S599Y)R)OJ-+J'O:=FQZMF'RJIKI]110^$VGT'V=39.7\($G]%2<1&*NPYQ
M&9S9!&33X7,; MM_2ZS==3C:EP(.QI82=0R!*Y N5$,:&3CG&' M?2H\:N']
MXV?)'7VW#D22;>3>NJOP&_R.HT]?<!R^XFS:3[7C_S+F*H-S17A"Y+D E6QM
M NAC[7*KK*Y%_S=3#M>XLNN?L>\99YUH9-1>G,T[>?W7:/Q\-IF.SFK4O[(:
M<U$RE  ::PMCQ0E-O6Y+3K(LBG&H-K(H[VWG=?/))V49["C8AK&0BJ82^%VY
MAFG)YTU -;0#U@+9_[F_JX9&78FW\2F_'IR7NB F"TFBIU-+(OA21_H4)X4*
M0?*R45; <>G\CE-\+RK?1JK-)P&$'ZN/F&2%,-%D<)P.JYH5 -'E +S&SP3*
M8H7:Z,1>]X3]GM>-I#]J+;H.$H#>CT<),4]>D0#>]%,=P_4*<?(!$_:_8>Y%
MU"RGY* XLAN4=18BBQE21J\8*U$A;WP!= ^D_5\8=WH;U%(!'?!CN=:*[OEH
M.)]"\8_^],OY:_'R>QK,<JT2G$R0_I?G24,NEI2L Q\C43IP"\%D T4Y,G6D
M\=QLY,YMP9D'P#PQ'G6MJ+U,\YB/(VD^K6.#3]T].K$M]$81BS=5F?AF,;QJ
MDL;]K]>G%B%R'KC(((NRH+3EX$,TH,D,T2*1HD7KNH9[(.VZ(ZW^^(4[%9AG
MB@D#1M:FU44E\+XP,$H*=-YH^F,OJ]UKM*(E!VYN*ZVD?>A8Q97C=G6_R5]^
MU)*#N=&NO W(:IU(, :4\;0ANQ0@T?9K3%):;A:^V,[FN0_6H>XOFC%@T\Z?
M#]1$!^G':R%6@$N/8!.('57T;P#O,(7ZS56[*75VU,N!*(3,)FEKIW]=L\IB
MG;61-0(6GXHPQFK?@8]U&.K<4SE_#,S91AT=,.:767]0#?7S/CJB+M84\+6O
MLHK20R@Q@,R$T@6CLFW=+^TZ@OW[2<V5-&HFX0X\[%_#<%;(6YO5[CJO0II/
M8CRO/BS6E*0".#IF02ER#8.W$7(T497B99"MZP;N@'-Z3&@E^\9WZA^G83HW
M>_^&H\_C\/5+/X5E!\#H-3-6 F99R)2/OO;70C!<%<ZSR2YO=%3<<Z>^%L"I
M&*'MI-PXE+8<EG 5TD5H^'Y0#4-I:X'L/Y362%&CKJ3<^NU?"RXGQSSM:,!5
MG8:0DP*74P$NG.8F15-,BU%8>U;]'1&U?6I^&^&VU/CTZ[CW]GG/\HQ:"%]G
M=&E0PD5ZO!(0HF9"6V:%OTNW$TQ__CSZ]G/]N(5NZU=7]+IXS'[C:(V$/7JX
MI%KFL]3'/W_6<TPBKYY'*EK6BGT&KDX[\8DA"\+SQ.Y* =](4<^?/7I%;2FI
M+J;0S>($_WM&ZWKY;6DRSK>.H QZ0>:<*-6P,\Q 5#Z %=RBM5+JYFVCUD Y
M%6NJI<0[:**R M:2W9L Z^CR;BVHPUS9-5'=_7380>[[V2'.G<IBL*#(D+FD
MK2O2:>/(EZSM&DVV*2EM6\\1W#,A[KF(VR\?MA%W]SPX;W%NC=-H,C#4",HQ
M"R%(0R=AY,IJPY/M^)PXU+5+(T7=K?X'2+F#V[=:R%OS)?K#91.Y7WZ\#=/9
M&-^5RV__F%-?&Q43BP:RDP%4O8&.TGF0(<04&)FDMGDH?6-TIV9*=*27AFT;
M5B-=HER^+IM Z\B^N /682R,KC1Z)W%V5T<'Q\U=$(7#6%P-1D3!007C('CD
M$'4HB>"5&%H/ -L[4^XQ/8Z *-MHH7EAU'5<;_HX?#>DLW.*PS"L0S9HJZW#
MNE_7^B&<G)^C-LABZ6RN+6LT;;9(7P4? ;/1+DJE!9;KQ%E7-/6@Y^_?2&FF
MO]%^A=^XQ&IEZ:!)IJ0B'?C"/:B,$3Q+"KP+*=M@N0XM2B^.J0"[BPC1SK)M
MV UHNSK"34 ^X?KKK73XH-+:ARC@</77CEN?HP#&BP4EN()HO0-G6) 8#3=F
MHZ%(Q\V2;>NONR?)-G)O;6;0H3:HF^6G^<EV7HS$BB132H!FN4X9U(;<>\*7
MC& L92[RAD;$JD\_VIKK;;0P:BG"AJ; PGH)PSR@3SJ'4AP+C%EP/-7V]P$7
M7PF;M9(>I4AQ,Y/PVN>>G!YW$%O#MS)CGXR8SV'PDLS/Z<*_D4479A79L85X
MI+C*Y-]HLH>$9F@-^3JIW+$QG\<:Z:,7^S)]<;DEKWC@J1AON\JR8;>^"F6!
M8DG337!L8)K=K]NK3]VOW;6S^$<-9=?X%;V&)]GH@[.U65]-178*(7ITD!(B
M9EZG]6Z2M'%(':ZQBCI3X38B:WZU<GVC=UQ$@T;4OO:U]+K61449P46-!B5B
MB/RHS\?=A'O'$;B-9%H;,2NM*E2616$LR)1,;?1NZ&S/ 4*10CA2!QT$C\ P
M;:>PG:74Q;WV_!1_1^=^J!=H\^/\ P[Q]S"HPW5ZAM,B.5-TDLM$BQ42'#,9
M@A*!I.[1^^9WVW=#.L"M9>>UFFWDWTDK@<ETW$]3G#?$?3L:UHG"9,[WF"O"
M"@S@,-O%;/N00H(B.+.,7@)"V9@7Z["<%B&:2+Q]X[?;+'T[JT)Z5^9_Z=F0
M2/(V AD7N;:\0/!:<>#<A103SSYLUDWFWD>=AKH[$&L'PU)>#]-XL>S%?U\/
MKX,]GT+^HV=,#$@V)6"]/5'25HLS+<:.)L*NW<UI>#OO!QN#.PW&=*N3UA-2
M;I!Z-*R[V?,1.3 9%U,@+^-R9U_'HV_S6Z+YD'KLZ1*1'!0/QA#UY]5]9-K2
M.A+C9.(&GV\&U-=L)KN@. W6[%<9K2>LW+5!+JVD\\8YDYY7!,O6*<<R.%#&
MD7@L+V S0V82>;MZPZO3+9YZ0BSI3-BMYZNL KJ*P,\&@]'O89CH&+6>%T=.
MEHMD0*OD,KA4Z"L1'&,!2Y";;2A;/_K$^=%.[ VO;^=H-SXF7\SPTVC^K5]'
MN5_Z:;XA]I31*4EB-%>USY8L'"(7N@Y5=-QC5M%LMIOL".2$"+1/E:P=N-(1
MG3[T/W^9OBN_3; V:YNN64'6:#D7";SP9,XS6[TYY< IEZ,JS'LNFY!J(SA/
MB%KMU7.;8&[GJ2Y8D'S]3(?M=-%+L@;3)F]QVBO<"3IQ$9CF 8@,L4:H(PA"
MEG+1QK/6[M5Z-*?!F\92O\T'WSCG^$4X"Y]Q\G$T(RXO;'.AB]8Y% C":;+"
M0H801( 8!==)Y> V*RY_>.;Q;5"GQ8ZV.EAQ+[=[-^#P8^ZMO1J-*X5[1&'F
M'3EH1DORUY!QJ$D6D(LPV1IA(VL]_ND&A--BP"[R7:'OG2,VB^C153^]Q[(3
M+#H'"9$HJ$*"D*,#;9W5V<30?I;[;12GI?4=I;Q"\3M?QIZ'#\G6&9UA3TMM
M3*Z]CI*APZFVU'".;!>62L;(77&Z]=Y_'<%I*7P'Z:Y0]L[U[]?-UW]@M5\Q
M/_M&W_V,'["*Z_R'-4[(>]H&Y*S&@XIDM293D*V"BGCJC2WT_U*W;DBX+<;3
M(DRG&EI!J9V+'N\$7.>:UA3-#V&*[W&<ZDF7"PM:9 ->^=H+Q-.&5^C@"W30
M27H);,+6,=YM,3XA2NVJH164>O U[&K \X'LO& 2VAMPLI9Q8?(0:L^?J-!F
MEYS1J;6G>AO%*=-B:RFO4/S.<ZS_'L;]ZB9?(LJ.3&&5,UA7<^@%(VQ>TWI5
M\JP$PTL(C?5^"\1IJ7TW&:_0^H-O0%<3\=PQZG'+E41)QA%S"51BM LES4!H
M+D*,)HK-&EP^^)4_1W):^F\@[14DV/F6\HH_O,))\EDDCC: P6)J9]<,CE@)
M@B>I&>U3PK7V2NX$=%J4:"?[%<SP[6?#_!(&-1#X\0OB]/GH[.MH6(%^3%\P
MSP8X*N>]@L.5-L%O<;K#W)@=G[C[3)F62VXT;V9M1^9+4AH9R?\0I;8'<O1'
MJ3?=0M)!4Q*28T(_;=T[ZWY4.U^8+(7^KJSO23TO5_)*B<@RK9[>DSJU5T*0
MWH.AY4>!GD=L/8)F4VS[FD?3F".W;E>Z4,5CFD\3F%>)9UFOB:O!C@)\T@HL
MLSYK0V>V:-V8[(CGTW1#AP<,J]E&+0>:-+()Q#^&U>RHV@>,''F(7@Y$(6^2
MUBX;X('^4&09UB)  1AKF6Z.BMS*4Z%.@V$U73-G&W5TP)@+2.>SYJV,S@0)
MQAM:;K0*?,X.=!#D74KKN6X=,+X!X3B'E&REIE$[&7?1,7-5>O=YZX3 0[(B
MTC(Q$-MU!L^T!"F\5%Q;*7G[:9-KX9P>%5K)OH.=H/JGLRF.;[(U>\$%SQ:"
MK]TT>"U'-=Z"#\;H@,S)W/J\6 /E].C00N8=5'K5:A#RE5(5[NLA">'S&"?G
M--7.2\91 T-'NY?6'+P* IR.+CM.&YB[JZ7)P_BP'L\IDJ*1]#OHQ+]V[7\;
MCR:3'FJ&16$&AR&1F\8=N*@*)">L,)Y%Q_8V"'&.Z(C8T>;NI*$".C MGJ4T
M.YL-PA3S"_PZQM1?SL_^.L"YV(?YV=EH/.W_:_[]M8OIQ10=HG=0E%&T 9K:
M^E,P",4%YS+3I?D$^E;83XYR!U'J/IWCFMUMT1849'Q%'VKRA*+#MIZXCF42
M4-(RRKWM7 ?)JC_4OK6M\->:.RU#5627G?6G<^,\#/.U7M8[A*,V^-3=0T[;
M0F\45GHW_8+C*\^^9(WT&HL0&5BN0Z2DL4"F"OTAK'<V16^U:)T0L [,SCD/
M-SYX<2]=LHH\, MHG*J';H*@6""+KZC@3+%%M+:(5P+95WBHC:YO93CL+-M#
MAX!JM\M?PW^-QL]GD^GH#,>3^0UBC"S;C!82G7^@Z*R#F(,"XQ/WS$46]4;1
MGGN:\]Y^\J$".@TT.6HFT<8]F6N[TG?E&J:ER[<)J(8=N]<"V7^'[ETU-.I*
MO'O3/0N">TM&K<,\'S5M(3"I0'/M=2D<F=LHW_&X='Y'O^V]J'P;J;9N<O4A
M_/A$NUCXBK-I/TU>#]/YN"O/2M12 TNUUX7+Y&%+8T!DBXHP%;MA3^9U3]AO
M=^9&TA^U%EWSSMKX'4>K8:4L4":K($G-01F?:PO'FE(;->;LR-G9K#7E^F<\
M>ITV$E\'7OT'_(;#&;XB"9PWI/E'?_KE?.$OOZ?!+),+5$O]Z7_Y4_C>\R&C
M<I:!XW,Q8 8?Z:\\6HF&NQ)DZ_R;!\#<_QU -X9]UQI:NU6TO!'X.!VE?];
M'1UW]>YB^N-9SO,/#8/7PS(:GRTOQ1Y\.[#E$W:_*=AE28UN#3Y^"6/\)9#2
M:R2,[(ZP(/@X##_C(A'C\E>6^<[/?@_C?,E,3M:%LJ:&5F0MGZL5]Z5.E \Z
M%TR:>=<Z/+D[ZG;)K/=BF:P#L_#*I"_")B' NCH>/) ,0U >>);,!D^^F6E]
M=]$,_+[N._;,TO7ILOM4]J$O4RY6/XN3?NZ'\8^/82Z#NFO-'0Z18XC,2'"^
MMD,59%B&["QDEX5W:.BH:)VKLA;,X7-G]\J-%8.!=]=1!\;A%3@+H_@3B6,2
MYJ'U\TF#&R#L:H+\O>@.-TJ^@3IODJ0;71R&->AY5B54@[2ZLN17050RD#V<
MT3%6BG!X(FS98,[\0<BRC0HZB2;WO]7B^T%(>"5SRTDAC1 (29@(2B/Y2,9Y
M.NV3(5=)R)S:9U>O0G* H?.-=78K@KRSP#O(>'D^")/)N_*/4 _:Z;OQO+?@
MG/Y%%Q]H8<1W;T$E7AMNUX[],0EDJ=YXM>Y]L!;,TS9/VNBHBSS+5<#.A^%M
M *TCN^0.6(<Q2!HI<!-:["#]+G*R[X 8G7*><PLBU+%Z(M:F5#H")JS#$BTB
M:YTBMW=BW&-[[)\7VPB]=4CJ_1A?S>JEVQ+9>4JP3,5I&S3H8&S-GBIT^#$!
MA9<L>8X^XHV&?VOB%VL>L']+HID&1HW%U]" 6#NU6!7I?6(U-Y(E4(5.6B?H
MKU+&K$5!AYO9#8]H]/MAS80FFFB8:[_=T-Q-0#[A0?%;Z?!!,\ ?HH#&B2F;
M@Y4">6 H0>00Z@0Y!-I,-: M12MTWL6-W-/C9LFV@^*[)\DV<F]M-WSZ??2B
M/\9$OW)1:LB---9FH(//@S*&0TA1 YV@28EB;>3WQBO7?/:Q#A??2@.C=N+K
MX,ZAYM!?<%>&$+)0\\B2(>[2"ND+A"*U=Z:@%K)YLYXKSW^:)L/.FF@X&^LF
MEG.^;X"FJTXAUY <J"G(@S6S1L4[B+6+V^?KJ'R=!>J% 19*J)UQ$OC:\<T*
MICR*9%CSK@W[4/)][3LZTO$VTNS@L/[T932KM3O/AOG5:#:>(@X7Z3FOA[7/
M;_];O0,?+H^BX&VVV@I0,=,?3C(@^ ZL-\X6Q8K7&Y_DVSSX  5J.RAIM"<)
MM\Y:O8+U8\VBJTA?#_-L$0&Y M*69(NDH\N:&FN+*" Z'P&Y#Z'(7*3=;);4
MID\\"?VWDVF'V\ Y0RLR(NQ*J!Q9B*H.=^4E@K+:@Q>UH:B)L78O\D7G;=6_
MP7-/@@2MY=LP3G37?G7V=3#Z@3@/M[Y?^D!7$1LL3I=ZH3GOE:<=Q"1B;0QL
MBQ%1<[59F<*#'G\2Q.A(V@UO"N>(GU6=W3B^YN[-%7Q&T%Z%(1(J1CZ.*G4B
M552@2"BJ6*W*S?$P:]BPP<,>K^Y;2[(#)V_AMY[WIN,RZ12, 6[K3&^FR.95
MA=>1=+KD'+ELWF[E&H"G[?P_7!>WB;'S\(V'"^)R&<-\XTW:9$U=Y49VL)[#
MW$3L0).;27''HN,N<BZ[6%NL(S)8G:H44)*QEI!<-QF QY)-,IG,M]:M)QX/
M;^^Y7#ERVFZCVM;.V=P*?#>?Y# A9!]P,AWWTQ3S_ >_D7+. P7&!):$8I""
ML/52JL[HJ6D+O) IX@,/LFQD=VW\R .D?1Y<O:/.==-!$&>.YZK$KKH3EF7N
M.()EC%8?:?4QZPS1<2.,+8)DT'K?6@_G"5.JM;*Z:.!\U35=$/\\L<DGIY6H
MQJQ)H)SWX LGSX59+V+0)=K65<YKP?S!H4:*:GV[=.'HWM@XWXZ&_SD+@W[I
M+[?.Y8_.[T9%QNB"!.%0T);I%7@C&#@3&5-1EIPVNU!XV/.?,)WVI;4.FL>N
M.HP_?/SM?!^E;330=@DJ)5]O5@H$]#78$C(OUBKO6Q]Z=P)ZPAQKK["&5V'S
MM)\JD;ECDEAA*3,/S@:RXKBV$#27P(L(-AB9(K;HO'3QP*=YY?5PF=]6_(/'
MC5Z .,_"V@!&R\S7RT?O/[?U@<*_J;X=)-<Z9?4*G,A"-%H3'%E2G8?!(7A5
M0(2DT3+:8MHDI7:MP#O23MOJ;QN!-=;;K^%[_VQV=NY#IQ(]RW7/KST=4Z:]
MA&& '$+1@G,O6(O=]]I#]YQ@^E"QCUK(K(M[ARM5NK,*:'FB3%Y/)C/,KX=7
MJG9[T=;^7=Q R$R#$K1LQ\AX,%9$5,36DEJ[D-O@.T(3K>-6,%TI;U^5T1>H
M,<W&I"N</ ^# >9??IQ792U_<=*SI;B$0@()I][*>800G83$4(@D7-0W,]NZ
MJ6_<'/*3H^,^5=QMGX_WY.;@>QS/I=5+)!.+"D'X@J!R2!",->"*#>3R!)%-
MZ[G5Z[ \.4XU4<J^:O5??B</KC_!.=*+'UX0G/=BRM:&R"!Q7:HDR$>NB4%1
M.Z4,FHA6[6,3NP_HDZ-9]^ILG>?U"PY)+:D?!N]^'^)X\J7_]74M=,+)]$W_
MK#]=Q"5H 7742@[(D,4 /G !BO$ 3G!/;-&:;$^K\\W(]YK[V6V>^F1(U*T^
M&MZ5S8&NI/HYM\\IGWLQ)_)(;(;" IF+V3KPM'B(6?K(?0PRL(THL]GSGA99
M.M!!PR2R1>3\PEY[?[.D\MRDNZB#[,DLG/5103&>@?)%@H^%#N.<R$EVNCBW
M6<+Y-D]]6I3I3!\-KV0O>W.-$F*>U![/U14-0SH_QPM3;I%0VU-.ZY)8 N]"
M)#DD#=Z6#+%6RQHN?=YL"LI6C='N0_5D&-61HFY3R38<(7C>COSK&+_4.]9O
M^'J81F?X9C29O!J-L?]Y^'PV'N,P_9C?>PP6LLS_-9M,EZ/%WI7:35S;E)DP
MM)"824ZY! B8R(G061E5"N.J=6BQ@V4\.;(>F@JWV>UV.V'O$R>M:5P'1+\>
M7K_=^X 3''_#3"L]?VF7AF7XC+\-"5H-^O;HM=66<_*0BZL--PT#KY6 (!3R
ME%$5MIG1WS'0)T/DH]/Z;4;[SA.WUXGV^F*?S:9?1N/^O\@(]N1)<^XD.)DX
MR5?5X=?5EG'>:>6L%-XVWJV;+^+)4/PX:+#B<GCW0%FC%7T+_4%-O*#7^&_5
MW>NIXGU&63/] JNWWI[>5<< "WW7HN4F-N];W]%:_J#Y(4BQ@NV[=QH=G9V-
MAHL\Y_"U/PV#6X?0J]ET-L;SHZCGA.92)@&J\%3OXY$LJ5R#-T$D&6U0HGG_
MT6U!/CE^=JO&%<3;.:XRQQ?O%UB\*;"7W[_VQ^>7K/U1II58%C,WP)RU9 C9
M4G-L#$A1C&*%D]_;NA-6,_!/CJB'4?L* N\6E'FP%*^%FIY-GEU:]N_*_$1X
M06[OJ] ?_ST,9O@KT>%L=M:KM><\9H2,D>3LM0.G909'1X5E7!1O&GEX37$_
M&78?.R=6\'^WV-*#U_JQ_WG8+_U$J[HRA^X3D792O^P9Y;(DRI+@A02%1=&"
ME(-4C/,Y"V\X[Y;I]R#\@]-[U_,*]G;?-^'.DHN_XV3:'WY>G$2\)S)JF0*'
MDFK7>6'\_"T$9D1QZ&(6XFAN+E;@?S*4/KCR5S!YYQC<@Q>SK!$[/WTFKY>6
MU:?1M X"G8[[PTD_S<^<7B!Q1LTU65>1URZZ!CQ+&5BM=64BB%Q:.WW[6-<?
MS#\T65:\$3N'$G==Y-SFNECA/[#F;&!^]@W'9)+=-LAZ3A45ZV4EM_7&4D8&
M/MD(41;E2[ NJ-;MF/:\Q#_>DR.BT(I7YL'QR5M%ZCC^1D[(ZN6_'0V_T=F'
MBV-P,G_UK_[\^6@R?3N:_E^<?L T(OOO7]>KD7LE\N15C;JF5%MOZ-I.C<[+
M@ARC02NM:-VN>"\+>W*OQ_'19<5+L7.(L[-5+G:%5Z/Q\EOU]WA/I>RCL0)8
MT@D4EQ9B0 M2<L\]"RA,Z\*7_:[PC]?D> BTHE+B<)'3\]Z;D^EX-J]DGZ?]
M?/H2ALNMX.]S 5VS.2_/SN*8R=X)4@Z+H*(*$'TR8-$[8WW@-K8>N'F8E3ZY
M]^<1$&K%>]2NM5/ST_7BDQ;_Z*94>A)SFF<22R?K4-T2(3ACZ 7@G"LZ@3UK
MG:)PL,4^N;?I<=!JQ0NU6Z>K!TO]/#_O!:[.TUO47E\&:WHV^6(D"Y 3)Z/5
M8:!EYCJ2VJ"6#AD=P]W&+K:%_&3>@2-FP@K"[]QQ:^Y&+5"]F(TO+JL7:-<V
MM9_TDHJIV$(NEJL#\71&B*(XH",O&WI;DRG-4]0>!O7),'>?*EU!Q668^-]_
MOB%G6M0_YS^8?[_*\0.6G^I_?_OP^D+FO__^^Y_IU4.RPOZ<1F<_S^5])1XX
M61AJYTVN1N7""!N5Q>&Q6'']UD+<]->SQ:GR J>A/YA<QS[IDR3N'7S4&,'/
MEX*X+J EC&LTW+M(\/L4Z_CC/QW(N;NDOW,.!=H$+@:UV!4=JZ74QH@<+),V
M[+TM][VH=]Z*FS5PT\BT1,$ABUPG8 L!3ALRJJ(E/T5H:6+S/+=6X!MNUV$P
MZ'23WH:EMS;I@RA[58N4GZK\\O0O:3"BS__KG\@1QLMOCH93VA9>#N9(:-?$
MS_6+MD-*G!:155,?;72@N#,0A#!@BJZ+2][EUI?])S:D9"L.W#FD9!M=/)8A
M#YNLZ8\A)5L-*=F*)ON8]O 0'3\6_EJAT-,2P+G:59"L<?"Y=@9TAHM$1Y!I
MWO?X\?!VJR$E1T?;;52[U]$ &:W,(1F(*090A=%7&"3X8I11D<LD_Q@-T*&N
M-QX-L(VB.NCA> W8>?]2>HUL$0&R3 0)%2W9\P0V1R.BB46IULWQ5L#X@S4[
M*^<0!^0Z$5U<;ERYQ7CY_2O6WO-_']5N#H/^],>',,4>DYA0!@_,D3>F"B>1
MU2[*FGN5?4B2Y=;I$7M8UA'RN6,7^<BHTD6KY8?6N-VUQ$\X/N,]>K%UYE%"
ML>0-*LL4>)L*,(8%62J)WQSX?+A:QWM7\S2Y?WAB/)8#X$7_6S_C,,_?:6F2
MQ>PMG9B!C'S,#J)#!1(#'7#%)"8ZJ?+M<E%/\P4X&IITT"VXZ0(_]"?_?#5&
M/&\O.E\@FL*4U!PXBWG1\2\JEB$S<A*R+C*4HZDUVW11?[P'!Z7)VH[%^XKZ
MKIHW]2Q-Z;V>_N@HS+O)([N-ZVZ]Z.,)Y#*B?:;_0?0U,!$-0E#2@C'>&L.8
MS\VOD4XID.N33%%Z#TG&.J!#TAXBK 21#8^UK7VRS<<,/,% [C8L[2Z0NXVR
MCS.0&T*4F>?:.E,%<BWHH/,E"JC=5R+WR=OF@8H3"^1NQ8$[ [G;Z.*Q!,(V
M6=,?@=RM KE;T60?$;&'Z/C1\#<S9I))4-MDUUI%"8'Q#%Y[7I3AOJ2]7TP?
M#6^W"N0>'VVW4&T'=+U[#J\(A<4JGL1JY"AJ0;CJ* #I0M$QU9; C7GW% 8G
M;Z7SK08G;Z.PKL(2G533710-?1@-!J]&X_J/>CXZ'V3-.:]#!500"B+# L4P
MR4@.TK+'4Y:Y:H5'R/>.G:+C)=#C?%T6542]:$3 ' MHQWWMY)<A2%[JI"BT
M5DK1?D3*WA;WB%Z2/;!T_R_4 RAV3.'!>Q=ZO=%.S_N0G7(,<G&RIDS7#*IB
M@<YNFUS4UJG'<^A<7]L?;])!WJ0="-95?/$A&037^AY<KU[M"644\XX#6D^;
M@Q0>?*K-0XPOQGO!=3?7^8W7\<<+<M\+<DCB-!R+VKWX2>(%^U<ZA/28BT8G
M'2'+.J=!6 X18P3A@TU:1I[SWK/UVRWOCU?G(&?+;C1K."]V_P9ICJJ@* &\
MS+5F0^.B1R@OV<>4LTOZ:'IF[N;S'*46[NU(>?7E,2&P0JP$S(9TY6B'#UP@
M6$Y<-2:AUJV'F1^9"![1_OAHKGHZH^"C\E\W%T<OI1Q=X1R2$QJ4-G0V%!]
MA)REY#HK?30]N!NN^Q&]>\= _B-\D;=B[J-Z>[=M\VQS"EFA!EL3]%4- _G
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M(XU]K2O?+U@5<@UX#WQC>Q,KVZ4+OS+HZ&E_D1+BV'PH6E47SZOP\1?NN]S
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MZR0&'.7Y+F;T!&WTF@?$II6HWWK1&R;2#!I8-5D$6W _QW<"#Q6PL/^%S;[
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M70=0[1^#_BG0,-G6H0OTG?]U=)^ELBM=(.?\=4&HHF+=]NC\ 1X()CRD+P^
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MC>9%T<K;#ZK65ZIUM32?2[T3'HSO",0A<W-=HN-KAY?/&M>1,V'SN;C+F]>
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M9H]$:Z[98G7)WP[Y4=>5CE6Q]FM Q S^=D)-@NZEVJ6!!W+]O-WI2[R38F#
MJ/[)=/YY=@LLU[1O_"*7G1K6IJ_7OGPGF/M%V!+WX0.L,;Y#X!HP1@IVL<G
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M1Z0F\D31-IS[T.1*G("HQJ\!"LNX(LB?6M=KP,D('>YVVGNT$UX'%DF@R!?
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M@J6Y"S>\II_/IE&; D-YG[[^G,W0]'88L]+K;,1?"+I6A92P"0I, M%!WM>
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MHS3.82+_#WOO'=1D]^V/QHH*B""]*RA=$!"D1D6Z$.F="$@)$9 >(!"E2XN
M@-(BTD1Z[[U$0$"ITB&A2$^H 4)R\?V><K_G/;\S[YVYO]\]Y\[[QYYY9IYD
M[?59:^VU/VMF/WOA#B)?C [V3 O/XU(C2J?,Z *L2X-: /SR3FU4=YD9=D*\
MK18%VI/-IE<FOQ["!]-D[PT+F&0EYLVF-%3[-85,,RDWXQD+H3F0Q+A9\/3]
M&#:8D?"Z'PU^_2)T1931TB3@6_,E43@MU)-A&2FOSKEAJ,8F9$]Y1\I^#/*L
M:;VOI44!W3Y+^3O+O%Y M@-IX3Q0K-ROL^9K!V,E&M_/=1O;["@^51C@/=LR
M=V9NEB& ;H63^4=1Y2XA(X/0K)<\YU)9GF9;DY :UZ\6B\SC)?G<K/&O<&6@
MM\W2FQ@P(JF6LS.8E],(EE1\49=K<IBXO)E8[0;],IG=?[P//&8*@8O@V;J2
M"]Q%0A*2S7RJYN&#E^QB]5S/>=/:\.4QM,$R]0D\HF%;0P]^$"VN5OR@A=Q:
M?WLHQ&=->)OJ?\&7K^U$NKUN8+T>,1^*KP[;I0:;#6N-M*TFX3OP@FJOSH94
MN]W0!<X4B^''6K5$6YM8ZD8*FVX2P.!DNM<>)U+XY^E:W^@WGH(>N/F__AP9
ME:_57;'EW'BEF'48)VFE0?M.G\UINRHUQ7EB5MFF5^A7<XR5/-^Q#)$/5]?U
MH]LK.E^C<,0X9]-_QVU6*\OH NY@KC\-ZT*3D^N'/]?.R6J7D,EHFK;*.Z]R
M$9,=*M&OF+ZW#JQD#/H(._PTNHL*#V""<ES7V';:?;]W:2'=3O?;HPM\PNV.
MKTE?5PP,LVQ-:==G$4E+;L]*$B!S^2-E#7&:!I6;1_O@-]LA_FR89S-4)U%P
M.9M%86E%GA&M;[U=IF+]/41/##_BK%"?(BN1OQ1/^N#MXX-%7"48MTN_JSIJ
MG.@41O'?"HQ3M'1%/?47FE&4(BBU<XKC0,$>A4(8^Y ;E;BJ]]\/W59UZJ=J
MHB\^>.0&2OII+_Q2P"B/2??:^B8ZR<H136-9IK$=G?EE= -<_'P@%OJK>?R,
M]<A&TRV8UY.[P[NW#R6ZGW+0:",62U;6P+)&50%? P0'&_CP5DNC+AL>DVR%
MLGYV-0T?K,/I=%X)=YQ)2X!E30L8SW<O,]NLR+R8;MH=6_457;>9-Q.]BB8#
M+H<6G#5?/0#_G) MD;&F;^A7*'D_X!0E-P;$N;14E07\"! ?K:1E9Z4)VG)Q
M<>9X19O)&W<)7255CCQ:UH$U8PR1.7!;@F<&(8#TDZ#4QL18U>T;)Q!JW1^*
ML3Z<#)2M_FR3#H7N)Q(RYONX5(:)=^<:-69U41U)A7EKIB$)+0EW6XR5\GC2
M,KDY 2L[R7..63ED0%/3(AE 34!ILEA!K# IANT]9  VWD*^E@S8UI?8=Q]#
MH;DXX% \I<Z#JE$O::9:>,#"74I6$JU0U+$!\N<8VG1JYB;^N;>XZDEPB5;!
M+# Q([J=_MS2ZL7ORQR*>N;@-@2=PPS-23KIMKEZGNGMQOSU(:NAB?D+[1WZ
M IY1:9VN<G$/T%_]!<?6T04P?[@0GJ^]KJC1=G[MQ%O;# HM5-%AE]/0*-PY
MS7FQL'ZUE>\_#)D,)(>43_R78,)*T>8WEP]0\C-5]=YE 0WY6S) 1OAS?!(Z
MLI"IW;=ONC34Z='=\R_-!"\D#"1FI6<!EJ,.BF$G68IR2KCFKL0Z^U#)-1:B
M.L2>76+5._:R5A;?DIJ-.;'@(16Z1F@LNDD:-]O.R8ZSWZ"9GY1#,4!D<^)S
MOU:[KV+T(W[8&B<K&\2F4(==.D-1/%CK$C[1P46K* 65=K-L9XC)R']/AZNA
M+3C3 ;EATW7V@LR*X4J;GKJHI]#),KOK^V1FT_AW6Z;N.HV;@Q&_3BR*?!$;
M/C<=?5W:G1RW>V:&.DS3W]H/-P1/)@K1 @Y:[-Y2Q:^D"RU'2H9J?F5<4HF8
MSM+AC1 W<.\^UW3!CVL#@A61[IQE8/" _A3=[9,&!?8+%-ZB>S3KTS^J^["+
MR.YM[E5T;KXZ9->%&?8.4K<<GH%KS&];3SJX7 <4LW&LY@;X+,0.5F1NZFBE
M!]B3?GS0EISPS:Y3KXAKW!_)7$5%U*%C%!E_KABA*'>G99K8)L=YLRN.89N&
MSO7I-KT)75?WY+<UC=("NA<([=C10HS?&M3/R@GJ^;EY'+L]]WKA68W.3Z=8
M?/<<9^4@_&Y*>W-Y2%/I%TOBDR%Y'?M[Y6B*L%U(\)I\5F!1#W/(?5WQ!W/;
M?IQ,<Z@WDJ@+1"9")L(U?V)RC36A;&74Z[:G66)/6=+C?HR$V,)5J>L3-7$G
M4W&61EONOU;U02R/"DU,[D#NN]_.["DJ=(K_5:U ,U^\0>V.<8GVLF3%S2!S
MC6%Z3QM2-7)F3VZN.WE#%A%;5=,_T7#VO2(*90(H$ZY^\KGAX4>3KJHFUM+&
MFIJZ"+JGPJXU1H^QKYX_:["Y OLE!-S7'*X T1"U:T8K)X\Y9&=!0_:)ET6=
MZ40&JX:OI(3WTD-DO?J,3Y(5[T!F& F%!8Z<?&DB(I4$VQAH7[.PGOSK;=!]
MO9VKQ(0!0+);9%!2N<55#>/WV!NAQBNWLW6:>>-,?6[W14/W:X8;I#%,0PW7
MLR"LWL$OLL5:'42:L4OW[D]UT$:W\\6H^/09GN3)4UAQH168M'Z\F!]Z/E;H
M]#R._^GYZ[V2L8D3=P.]\A1S^1I-3WE.*QD02@+@Z2VYQYIN_TK>C+;BKPD#
M#5G8U=0(ND7\*NB@PG)?]5DP= D+N&5"-#CY[(&\OC;&6*<8?0']@68_>(7=
M"]_.)OF@_)HT$V#ON ]-GR0('QY] WQOD.!8T50<D^R6BNTI0@F.;FDEYL&1
M^B<?%14?XL*ZWD("K@_N'B.OM4*HI)-#%BSM8P'GT<XUW#%L/LM<]]?2)4B7
MB6 \!ZJ%# @/X&E('A3RO[?@=%_XS*/I 9ZOQ\T-\MV9+4"-PP$LTYND+B[Z
M!IU\M"#H0B?QTV4>&<,WVE^_*I"43?=%0^)@X,[9\H#"N5JX03;,S!BEQV1$
MG:]=*AS!*GYE(0KWRG7:USVY7Q_+ZKA6V?=YR0 O$V)T>?R6HH&?2$&3B^JV
MO!_&J+.8EFC<4%:+I_XFT9CJQ"Y$)<3ZV28.MJI-L6B1NQ[]$>$,?SEH]\+'
M](6$90W/CRNB0U2KB"O;R&N0_0GMVL\F)K.W<Z%.+W&=?JP;)B/&KV]&I5\5
ME_D%_87ZN3F!?CPHC\ TFMJ5#&V\R"R77JUU&.F53%&AX7EAS[P[-SKBQ.KR
M#B\^(J]MKVVPZ)4VZ7+H.4*,?$D:'#0AFH:IX+1C<R8( <?&QIOV4/\#UGAU
M*=X/J5P888TC*O^+HITT ,A0P)B4+&>2$[UA==*H^Y29"N#Q5Z,DP%7QCU7
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MW^OC4CV)]3C179UQJ 2S0^FT.-]R>%-2BBQ<9@-VJ8+U6N:-TS7GHP]"%:_
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MTK]1,6N 2(IMAS\CO,'2,%N80 (DRT(GC0:IPK<KWU;7Q@?,[KUOX78Z[P2
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MG@=.*!D30O!,6KBL (Y!.YQ7MD>5>J;ZB\S>:CZV-_W2@L2.,S%B%+Z+S79
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MG!'@'VV,.QD+;K9KIE[S30N+J)AE@DWJ5$,UN=9SZ=H=<\^7B_%Z3J#O\SD
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MPYNHHZ'MV[#08TO6M,;EM/L5VX_?ON5H2)LOI9T38.%)WW5@31U%XERPS>%
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M,$E?PA?^9O0K+&IJ3MB^OAGY.(>+54F/A]+LV?WK M\$VOW%<)H]]#B)#I+
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M_G(L]GP@28UU;B>?\T>F"<XM\CA7G64K*.BOE76\!%**.9JBUGT>^X6O]\[
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MA.-$&:^!NAB1/!CKVO8E[5UA.SP5>=I[:"^/%^'8N&4]RRRYE\ [?._>?GC
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M],O/N^$5V4J^.^FU+<?MU< ]JYNI$4#2BS#((3GP4B!L=7HE./:"UKZ6XPJ
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M)BT2K6,("S8C!:+*S1]8>YIQS3)O0G-BT8P8APJ\_VI6";:,A&ST^RIN:'#
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M9*A6.J$F'%-_Q:((,?KB2.BG!QH?GM) S$Q8U('S^2"%WYXH (ZPAJQ5'CC
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MCPG"K_?+%V?LZGT==OPV4'FAIZN\-3DA+TF8[N)6U=V[8=XA#N8428"N$&9
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M;3BMAN),MV3KX;=/:SL;!C8X8.=Q;3;NF=)/NJXVS01KF,<B/.%@(EODKWA
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MX!;X0>\<#?2"/W)&JH4]XF/.=+D)VNSG;.2; M/\H6^I%&AFQ>^'LD?@026
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M<J3!9>TG9=Z?^BNH.8XF%'S*$!WEV_6M@U7\/U7._]]KK'T0, F0*+\ZA@>
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MN'8IM3# #Y*R0V&?NXMIP*UB$0H)89?+U=Y=]7$/>*V'_5[7IEXJU#5:$JT
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M,=Q37 ;Y8Z73S.]^O[,_G87*_:]+W&RVZN%EBC1K=E(DT'$C21V=PVN(*V/
M<"L^R_%(HO-G6TO?%%B(V')=,YJ1)AM4=8$(*Q1 P6NS90;_X9>.9_,;WJ<Y
M+(@!IY#1.<P0,9R1/NL<Q\3\.!-][SGEIW%%C-%I&WOE-4CV/="%]5"6B:OC
MU7%'"7+DRV^WQ!P$%][CN>O6[*P@H.,6CU^0!'G,F7?-+Q]IPQ^_T%-=3,H+
M,:/Y/F[$.%DQ7CQIA%'#Y'XA@182:+H/]5Q">2;<$5;7*8#T]*WS]U?;2[.5
M+EJE=5>,_K_UL>Q_E63S&ZH^"_PW]VC^]?VDOQW-]7]YVTFDE0)P-6)WG6;,
MP)ZLI@:>(J^/$O$0,T?TT>SC"8*1IZ>@]P;=PF):&]KZ432?3\_#X$YF-/02
M8@/^8U<?2\Y 6V4=F]W#9;R"R5@!B7J^(A\,48;I6H]W6=,UGVW42!_!91B^
M=WVK@6QTH1#^29#+]IA9MC4RUX2*%1K%XFQ)9W/ RD)@?6VGL\Q[CC25(F#<
MJKQXNIBF@(5YJ-P)_O:7KT3,7?*,)31ZN\FQR'HMXBMR6IZ%9=KFFYRW(/+V
MS[*S^ GQ\X,"_#6?OANWX)^!JN2[$EQVO]J=;SH_G\#:WG*I80I9*[%25U?;
MV%Q575O3\,8]D:7A4B]?B@)_]K,+IU]XGVH\,U2S"L]LLL&M8#@V0)>J-QEG
MVI5\N]L]@98N#:/K+/NL,<4V!F[[9SD==1_?T/Y\&?YV_9NNW6OZ\0OD<5N^
M%MQ4!,>&014V*5S%N-!IRM)D"UXX:UV8YP.ATW6K':Y-\Q1UT?Z^%/^.WG$Y
MP<9<1+)^;XD9)Q 1JDP\0MNU01/FQ";QP9[LULZA*N,RJDJ#F.G%<^66&+;D
MM/B=2DMQ$JQ2Z%$X=;2?CB9F>_HS1CZ<Q(F968,HGMD[? HKL'(.&BQ -^MK
M5(Y_;'B8TDT(3I?*KU#P:K88C]:L+99(BQPJ+X9GX^&QJ$LT'70YT=,V4Y'W
M.Y0DHJPZE,HK @NL$07]366O9UH]:M47 $*SO'W'7SY\[G&#.A_I4P"O,CT[
MUB#<#A));9P?W!<O?_-03SP(0YCNJGRZF"S=U.'0>O3]P&F)+L?+V Y$4IX@
MV6& TRCT'&R!?4\_;E8?_7-JA)MQTC4 8_$D<OJZA</K"E.QF-,,7Y.2SZV
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M>U6F&*ZFF]* 0KX_I(H'B$R=^(>/R+MD>Y(@N3?Z:.@@"5OD1Y.]D4,'D<<
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M"_"H&%R#1(R;.,]&V\A:D/6T=I+O(]#;0LBMB^_ZTG99&=*L+]!HV@D96U
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MV2)^I5K.K,%$RI_1-_8(/G _JGNL:1]A)V]LS)4;;_)FB>CGBJCQW!-:-G'
MQY*"BU ]!,]IZ:Y0)IQ/@#_YXLRJK\AWEB4$9Z/(>3?W)X'<%A97DA,GP8J/
MU7!75K[@,@7A1D -!1>]-U;._D>#M!,?@A+ST^#?3[S[-<G_\ V+6:S4ZA!F
M0"$@_'#WSJA*V].F+^R9EYC>^,[OA=1_'91.=*6-?:>3*2Z/Z(NO=_A0HU;E
MF91]&;O(0U=9C[-9Z>"$R5L</6@8/PR>4855Q.2)1'&^3SC8,@+_BH6!$M1
M%FL-4=%H%),![ 1R<:+X!Q8R!P_O<BR=CV>QU8M<?._(>ZK%I$1LBQ]1EQC
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M?)H"^,3;GD,4JJ4 ,,+0O\D7_E>QZ"S-,A_&_'%X$+:(1$,!:.A$@['W/2F
MCC^(G-28BS0&HXV(0/++)$;H?"&* GB51V8ZP3P%L'H;NT*F/9DV\7?Z!+UO
M '>X&VEB@:]4>*GEX(6NWIIB'2F\[*\[T%./Z &]QN\CB&8B=L4Y?YC 'R?I
MR'.]7;V60\+,OQ3E.5SB(+N8DJ95&+WL&87O59'&,"B;Q<[1U9=Y7%I6\(A@
M>Y<<(3Z??TF*AIT9'-]D41RPT<F1CBR5DL63"BU4$--QWX7C<]X  +T" (=L
MQ*'9OR64JD?UQT45_HA:*QH"0ZBMD1.L_L!?*S07VI:#!1V?Y^&B %H-D!3
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MKBY2'2BT)#ECRL4^OLS[J%[\';DHXKVB+E!_E@2&JS!@9"^:P=,Z#JD K*_
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M+C2;YO9=+I$9MZ:W.;M7NLQ+.;&>#7&B(@^K [5H*A^KR^E.LX: 0^(T *O
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MD'#69UL/$#Q%(01PF;/#1B1YQQ)X,,G[B;U*:)'8O/V3%N#UEBC1-N-Y.<E
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MNK%\)+7LIT"2^$Z@U^,U<:P?"):%&9$VA3^N=GME-I;MO$PFW%^HBW(SW-%
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M\[$SCM7X]Z?_V9T$Y_Y2[Y\"$C*)4U0,Z!2P&[_V6W2 XG(*$%3#UYX@H:>
M%?[Q;\86</S0*8").L.?FM+Y?/P4  LS4&?K<@O^UWP6W[,5I&J-1T+6NDX!
MRP]_7FH\_M<2%^X])S@@(67Q>BJD,R7'_\%%MO^T+!2UG*/D"$K_2?$_OV/4
M".,M*<.RL>=6_:Z0 ^>A8:E7'&<YY,MGP3:FN;62_0%&>I(:$[?.-=^*4T7[
M##7!EZO$F0C3IX#K&)Y5?R;9IE"/,<]:[_LCKT8L-[DKV*=Z$B2+?G[)?O;
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M.WJ3!PLNY,SY:(F#-F,SC32"N([^:$F)S)2#4MZ/B/Y-+1U-[@;%)/6H'S<
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M!JN089%Y&LVBH/7J+?Y3P4S2K@YDLGO8F,R]L'5A!J'8P@L WZW)F'$[!5S
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M(.P,%$X!;3TS_IW><Q&[3=?7,N[6#UGKU?@&6[RNB<$]8'NM4B%Y01HV\ 1
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M1:;C:'@(]@.Z.=4_[SGMRDVQMZ>7$(*NLI9-:5M>"RT@?!Q5J;5J(K>^>H)
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M>U+8TU.FC9Q GENW#>3:'YF:B;6+7 7\:))8089A:LVB@Z6=C@ <6VBCA:#
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M6R('?A^:#K5*I$HGDC4J(*M'@-\Q+2NZCP"<-J?_%@.W8ZJC:N (T,[N? 2
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M0FE;$BJ2WR+$&BX/"V*?\WZ!YA_/7IF($\=DLI/*E+G8'5Y,+-S<4[\\[F.
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M;I]@H(3C7N'H*7>4U)B.,(OSOQZ:^.Z_TCE\#@)Y;(<K$@9^[4!^G4?=J/R
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MQ:VSWQQ2\+K95I_W,Z:Z[!+[ H8) 2RG:)/-2)#./2J$E!V_6 9B(R=Y5YB
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M,CX;?2"L6YGE#?OQ":H]]7[;$FMLBK. V$F92YD/G8WUY7XYA@:SDPOT#@O
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M-8K$3*W^^OT3?@_.L_/@7-=][O?[];ZN<U^'OXUL$W^]J)*K__U-[U.]'%!
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ME$_'EOIW"C%<C8VYO[@N #D@EA4SQ\VN1?,CDI7LD;62RCBWG2>"G6^M[?-
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MJ?T([-I2=ZG87%_3)W02&]DV(V^0=HZ_UCO224GW:RJ%#LGO.+SMJ9+$9
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M_P#<%$#]GV4VXD8HF 'S4M?0W/%)4ZL?%3=OUAMWC>(W^O[.#)1[QRYDD[^
M6,7Y)1:H*\:3: V'7$^OW^;YB&2Q<](.":>:QG/7Y?K]BGZ1C%- 20XEQ"5P
MN00+,&G</#>=W;T4["X'&E9NAIGL'+<0Q'QD"/]#@*ZW'*$O7_Y$9%S+>98B
MFN,EMR!!$KKU3< !J[[<Q?N3LK5DW3Y%^)K"H&J)G'0R_F#%,@RYFV#]5';H
M!COV'LU]Z&91AH+F7-$E<[*05LPX0:^S$>JQ9U.XXD1*0>'Y6EB'LH?YDJ:
MMFK!<D AA;HEB3'GX8",4//H#9C.<K+--\UFQMZEV,D-S@?@T\O:%^R7[TOP
M%9T]AB)3WF'1\-:MK<0[!@WISB-68XR?RM8! L )9T&HP#'P<H&<58*]Y ==
M\E @0;5;&G?Y;XPV-3<%M;1\:7T']N(K]OPHM39< XF3?6;H!WQ+CNIIY*"
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MAZ_XVP9$3D0"$OMZ>RMMD."N'=G2"Z2Z*/FP.Q+H E=Y\P$7CT@7R'9?$+[
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M0^;8OXDP8=.USU0H#6?="!L. ?H&E'P=XPWC4N@'AZ7-G1K*T/YNN$ZHPM2
MZL #9IV@IMUR/9E O9_88"V-6>RY9@6E5J]C4K%3:=QV$L+4]]JU2BNS6XZ_
MAMPNWOLSX=?A/.0:C*^%=!+3FBQC0JI/J:]23\FMV#B%OKLA_53> 5GWZO.,
MA@/KHY> /[=,#<;?&Y)L,$M<Z+M\K@-.3"HVL3+G9OQE065X)^"8LPE\TIX.
M""X2U;-3&Z[MB,VXBU:[^]CQUJ:J0)( [>]S7;(KP>3L7';J_ 6AD='>V["O
M,Y[';<TWNI EY*GNAZ(+VY=U37QEW #^J;)MZ].=NI9Y_1 6?;6VWS*2Z_"
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M,>C?YIG4@I.])_GAK#%9H8OU_-E4I,# :P+H4-6,8B0%5[<8V]_"V=75^W(
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M]WG",:F6#0R3V_0[E88> @BA*HR EI;>S37)W;(_9T')W?)'?PN98-I@3K-
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M;.U)S2'ZY3Z-<M*OVMX'G&(&<%H;K\F'=%SB4&[$?]#^!]G_.V!A_[^0_9_
M_B]<2P!20H+;ET=("5 ";*H*TIA<$"IE @S+*^=RS<\ I8*2.8V0QW0QO%5<
M(J-3,5>0K]VUIS&A'._BU8WS<90ZHJ]6"5?-,GDR_GUKYB,Y&?#K>;S;<;6E
MU$\(CQHV86.1S4 VIY%ZQ>9S_IVXG) \^61[9/G1,Y7?R,=:X"_([#C(R&O%
M@E1VT*ADABVZ^VP=+FVMX@M^A9*"*PVP,TDX_9SZZI=.UR)E&C$!;*F?5%,\
M3TJF"?)2#4XHQ@.(\("NF"'UWXCBSO%] P/F>)E?\=FL)-$,7_+0>E.M+K:_
M+WB.#W7']ONV41@[85?E%,_3 G3-Y37[4_)48\@W>?9*E-4@O2++S+.BQ'?-
M/\P:*\B.)SP;A!21&R\9CI*L5%'J2(IYB1 VYFK_ 0]'*:\R4*VJHUN6?$+"
MF@U@[>?'X*R8A0IQFV(#8SW;9T)FL4.Z;_<-78=#TR\[$S/X9H]!3'B O2!H
M8S4UZ%=[K-F_Q0'W0")[R8C$EQQ4'A0O7G+*LWRT!_>M+V8,@>C$5:J<8FVM
M2\1H8O8,,K^_?OFDB<B8ZXY(,@#R;XLXIN  ;>GNP_8^+AY4@>:!=':T(YLS
MMV=,_!%F&\W1H>162\M'_WH0%@(,0L?;PJ39GBUW7CR.2[C/ZN*RX=[#JK[U
M:BD.#W"WH'CU6V_=V:!W%YP9=VRTTBJ]G0,7.120,2[Y!7,_R1PFC,[C/*R@
M6/);/I>O2'/& [X]^]0P[H6;UNW&S=2&V2<PKPN,G,^P$).D? [:>EI6;7%2
MXSDB)#@8JTKSMNY.S"&.'JC0@2K>BI?J3S>HKE\58Q1BU7XF4I'NP!FW07Y/
M39.04^)"?2!_T02Z_@7(4ZDE;Q7(_@WF<P"N/@8+"\ZLT*A](#(C_*ZU%>:2
M7,*1*\.K[1>$,@=3Q_WBOYC:232>NN;<'N$%OT"IP]4'0(P2,A^F.!/61E82
M&P[I7WTK@%A_2?_DHX_Z+E/-P]LG9."G3L8D(4+]MESM+(1R[Z+2RO0OFL"<
MQ.OO5L 2T".^^'LK'A \P7,!)D*%P.M 3!B3\)YS9\J#*S)/3W?N335[(T<#
M-1MZ@>_ .F+.:F\5:JT"-V%7B#IEJNWOJ0C9AN/=XT;3[A3,!&W;U/R\%;R'
M_5(1M,..!S3/_P &8;.[H1K[;?:_\( '3$=*KBV.\BD.2#]S(5C_57S2<I.H
M@/1FV4S&,[O*2PEPTBZ#J4&U:6Y!LW_B/H2FH--]X^IX=C,Q5H=ULQ0I]%ES
MHM2740Z%!Z1K?O]XLRULZ26B#P2BZ$*)#YD4FI'KR'\S',DZ>,#',_G."#61
MSOK<M5G+I7RE>CW#I)V%%FA7TT&C7C>&# \@''&LR8>N]^>Z;R9&VTR*\]*9
ME1AR)6MI#9+: MI_$Q-RD7_=_DP +C1!$K6BA;:V'",FE&;CGQ]#2DZEI*\&
M5;4N#MIULJ"B56ZRY"5LN5-'!9@E1>UBR\99C#;*H1K#AQ#;;]O6CVYZ8)-'
M)T@SF4?(]YCE(^4?(DKS@KF<$:W]<V?#7,8V7]JL5?*"&'[&'TOTU=P^BH1P
MH5H$\\!<&UVT.S+VX,QKV%FM,-W?;40AI(>1ZV&F>-JBQ]<*3>6'L.,X)H$C
M9JL%-MCQ; W0B=0D.-2Q8#IVB.*G-R]7, P,0('AW88HU<WA?XV:/UN_#S0_
M@KAION>PZ34C^LB>NNTW;"!3$S 7H>Y8/SUH)[U")F%"J3MYJ7?FP*SJS_8$
MQ;UE]3! 5YCJL(W3U+&NZE/STTVZS=>?1@32&?\<"D15[!J8BDU4JA73CQH+
M"8<8A<7PEMN_U)*=,@";OI"-X2T#%'0>0:V.BWT14M!_""U4 JOTB/V9(-FO
M[U+I6AA(A^M?PTD]%K1)V$PYGV2&2ET7>1<3S:%1?.KLW!+XX/(A_UJB?5MZ
MM9WCF+X;CT:L\!O&SY CRTNT5N@$C@TE!<WE,9@$7\J5N]6,=\2&<+FU+)AQ
M.@N1JP.GO/2=A<O?>AA5_BO_%G9E[8*!Y)45M$/"UA\N;Q''W_O<]GU*?;&H
MQ26<./=S$>G=E=:_UFOEC;1^ULIQ"%I.K:R.X@)I68&C1-0'JYL\/. L"0]8
M/OH3J@B\)=P(UJ>1W<O]9KAIZGS4Q1FII57&<K"#HD.SUI"$-<]'B!5U\A;<
M)]?Y D;;WF&5H18H2*-OFL>@KTH#^.]Z(SL_:=60>+P#70_OHIB6<&7# ]ZV
MM;1TF;VGN]%8E/RQ6G=GJ(BEM/S(2D[0CI%/H/#?T(?##><VVBZNVY[>!D)5
M:=Z\^]]ZHWUV)T; MB^4>K;#$VSF>".8D[$4T=NGEOOY<$R/0-W+B99AQ$L_
MIMU>@?92+1Y-[&Q"Y]E5OGGDPEP@^F]IH;&O_&+%0NS:1 Y!@GR.4/K:4-[(
MRJP?/O"[IW@G3/HU/0/KI&AOR]^A8T2/1'Y#!,Q[)4\UT[ 4QJVZ/&MUTGF;
M0WM9O 4-\H\*8FYXD$'8'(P<P@6**Z\YG+\IKEYMO&BJ+4Y-J@HVYEVA(XW3
M',W[ZL%OQTWKY_\![NLY&Q+/>H5.S',LB"F,XRV(25:.N9E4^I#.6XSQHJW]
M8\'SF!V<;PY)5++)?X1R4+]]#2JS4 3C%^W.G\V2YZ()[?=V24/J*%@^(MZC
M-;I*_[W](\;OZ9W&2I\%"O-7]"R($5#I?:GZ?MKG*-Y6O_%W_;=Q?U_^EZ0?
M/ELL1.BG#',E-$X%H*%Z,:$,C=\0DJD^_<$=RS@<G__Q<CO63%*D->AFJFUA
M2;Q"B[S(9L7X9$G8V.NM22WF 39G#S5;<IBQ9Y&HUER7]L'JPEUAVZ8]0>UR
M"3 L(_/W OP<8?P51X]0!!=J\D.>Y@9*9&L5$HRYO?G-%L58/)9=V_B:.^BM
M];<<UP>?+N8O10^,D].<<L++"F*2?A8T &6@J^J#;:LE247+S.-J,*3*?3N+
M8:)+&\ &6TFCO"]\?0!$Y@X[[M LR97<W522Y#XO3!7=8QP1(R\L<;+ZU5:H
MWSNK#ZRL;D!/.,?PEMCTQ0@LA!+A(,*(NF'C=MR:!9,<(]5CQ;][F21W0%TM
MA&Q89RY8I:S'@G-+6TP\;:#24?G6C,D<=6AO\K-/-HBVCMRTBX*?. Y;3.4>
M'A##_O!R_6O78R;+YH>4'-?I5QY4_U9XE-]^ER$.NT_DN1!FIZF0L&)L%-^K
MLF12:K>N?BWI>4'>\*;3.9'+ET;?8$@FR&!^4ND.R XKMTD?A@= ^1!"8,_2
M@WI&^6_'BX^.XV,:$DX8"%K?V;+WY\SG8[Q1(&A^%.[Q]$]X38<$3/1L&G(>
M.DFSPQPL)*5V)VFXU/:]Q:>@\U%/&H_)01UN^J:VQ<O:W9F;#T=ZY0Y9-/JJ
M3W[U%]/HOZ_]^9^4Z^1GM)E4#:&$=R.]X5<)BF0K 757;V:@,^ERI1H;R2+W
M14Z6O[])N0J\CE"MF5AY2E4CZD;3K+4'(9G+U3'U59%1CN%E=;X7=9M[=TET
M2\"W1;Q\HSJEPEKCJ6&IOD6W[$_(^I\*B!+6,B76$I T8-4U?4$B"?A;2;E@
M_OM/\X_$C^*%6L56T,%N5>]W@Z,?5?2*D]?>@>9>'>#.DC3-+Y_PNZ<[C[5+
MM%3JEE3+MGXT99$UJ.:6<7G ]&3TOS%X'+W7F"0_<;KH7<LW/Q,DMTQM""\6
MM!E_=.@U[30Z59M40)>OP^HT^S56N5K:MZ1:)FCNV21YZ33?)83S95_&5'+&
M5%U2 5M#0WBG[.\D1]Y2_?=IMOVW28B[2KIFJ-36:+B5NP^]+DJFH[3Z7@CJ
M./C,27TW+ZCL$'T64R-:%)Y#N>+Y9M)\BFUB'VV%],+^[#!!)&YQKW95BTNV
MO38UGQHL61QNDK!^]D&$Y]EX)&=*X@N!83S E?U:* ,/N-QSQ0-^&H./!?$
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MNEV1H[>J.?M!\&\@!VR7"OL2J*$#(GQ_/+=+ [)ZR>IBM>4 T\<#'OH/V;[
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MV_$JLP?PT>['!2/K YC52Y?\VN8OIIKBKIQ#_H\"*O^>%]9WM88IJU_%\5=
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M\8 "(0$]I$+B@#Y0*!L=#--V1P[A(&9C)X\^6;7G^;E-R/D.^BFQ= F!^G[
M<TN:L2G86F3L=OV9XO2VZRI+8KO?$.2FPY;U!F$EB%'#UG5H;PFRN8JI3_^"
MSW;VB7OKL.P&CN0]!S<J(_)>0.0IS6L-4C\EW:C)48>/UC/:',X",4W;FD?G
M"YUP](92E*+049X4@JYXD[K$<>YF=NPY=WF\%)\7]*KIA?GS8=9$B85%W%\E
M4J"9BT<>/6)P%KOB<@7M:NS0@-B,,A$F#ABK'X_#3?JD\BG<,(&;RSXS!7%C
M!Z0;#<]5'LFM?@]!2KN1JP%ZQH-*>_6BV<F UIM'6*5>11J+I\BU\:(4_43M
ML$6NV""R['^G,MRZ#*0PGL:W12?'2.DS#!M=L:R5:3'1H<7)=>YEVW$ ?:_[
M5U.Z%$2LX23&H;HFK6*?/OVTM,!"]>'::R[2S\1$OZU_P\REQJW4@<&HX T]
M-I UJ,]UTQVE'CJZ=SN-BB16<OX9W5CGW(6E7%FWO3)P-DZ(5V^9XWDA(=I6
M2RG';[<=M+PD)8)B>U&EKW.6/@S(K]]P@"LE_5HSB&U-8YSL^R"2BDU.+I5S
M07;"A/>]\^O9^YG=&5U"99KK$0[??()990-LPUSO8<R8RQ9+'DZQ%DE1ALF&
M;%F:E6 $9C#NB*BW\(04L14=6NR8>W# 8,PP2QS3^_LL><0S24>6>V@B/&#L
M$@]P4T)[FEK5T_CM;34/.C$(+Z4?VL7E=_Y>U>QF6WQP8R0CW<J2^ES<,^ 3
MS<=J")_5I%0IU$8$_00C-;E3/W79S6RA7K/"NTBQ+%@]-GZ8)%M/F;>H9(JP
M2E0B$%8D.32NR7 PF!2.)0DNT:F)DQ%I87$@?IS0(D]J\@]$!3E& 7TK07W6
MW3@J/9'0Q6ZTNER3T/HE2$@2-K0F$K.EY"P<SW8/%07?TYD"RE0V%0>[EPT_
MUZO78?LSQT>3//48LL9ZOM[XVDZ@$#A,G#%,\5[8@5$=NI.[#6M+#@G% \XS
M;I.@=BUI\S1*D7'.!^M\ S&<<86=U&3M%WU72V3;6_A"&_T78-?56$]Q[+ZA
M1^E$K]Z_]KRCH^OK#U.HT..6,!EU(Q]5HA"IC\9["<)NXGC 0LV<F5-1<^I^
MFX_=EDVIR]\[==M^_ /L;W0\UG\'2R$AL?,\3LU-7'[0(CR ^GIFS=AMSZ#_
MPY/87^$^U,@DG?8NB-V9&!Y@=\L"-W2Y"'9]/.!KK D3*%:<]<7RXD'!KCC]
M,SI5+]H,G_"X^):ME+G.C%O2ZP=%K8G// /+6V^"CTF.7-3-'$/7W=UWA30G
M%FG2]Q($AM*4<2OOW@!PDQ VY"P/;.;6<SR(BC0C=OK]G3!!E L/.$J<R*O1
M-I3UY;/V:H/[I*8^W0);&(,AF#CV+TKU@LT#B:2CFXF4SF=.L@Q.=-S-O#50
M<B9E6)H1T?-M/P61B>$!\.(\%)<"WWN/X/DJ;W/3D.5<62<!ZQQSS3#B?^W\
M/-1- 7%D% H(G6*2"@<^Q9$B0G/F99D;8ED'/!^\57_"/?4.LF:@>9#7,NBK
M1 URR"= E4([\8"$+O95;#ISL)-[1\NV?7/F([HDO^YQYL_DQ #*^,(RUT9!
M75EI(/<G8K2@](2S<!:LG&=5Z,^U4-<P]BL>L/T>88(-5;FUL4RHS?];D:\B
M]1BT^YK1\ *4(E_8*X)*UEN*0>,HUQOOR*M*+3.17MNLP\AV W.;8*OSW;J>
MEF"TG_G[1%*4*?TB$MF1MKFU2_F5  %+8=]6X!=F#%VF1OE;S?D$N]]7.W]G
M,>[8+'K(57GL9S%(I,(XY-F. &>&<@ UYD-Y7?9,YFN,G?JN/56I8#$T?^7T
M@TE39I*#LU*SG>J[:6/[K)_[_DYUEDW./IXRO<[7-P_MQ[&VM$UEC9K-/JFS
M<^@4Z]"%]2S50@'FR5ZZ)[D"(UW<N F20LS'R0Y**%]-S="O#QGQD@4C:QKK
M_.UB' ":^[T'.3G^M"?=C5??) 0)-]:RL=G!$M$=,T^:<G]ZQ2$8[&R^)GAH
M"85X)F2"!;!1N]K@;[)_6].*VZ(TSV!?$S0U.K:?T3@ /H+W3IR>PL:]NQDC
M>N0_B=[XM)IGN9D<+ I+H'+?89-"61V5;*<Q+[=<?OAF1PQX8FN6EL?=D9R^
M]IR*NQV0S:CC=?8^/( )Y28W_G9T VOV)F9.1W5DD+LB@[D_)8WHZ3LIO=1M
M4F\8B*8;^A(/Z/,MO[TYW9+ Z]*EYEOU@ =X^FV-7HLTNZ]NME(LJ=SZ4SR
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M,'J7G!Z&R*-B&67=4O1W0F3T8=WUW3!N7[@)S-05EN*<Q]:>,1%@\Z&N]RE
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M0(\W^/4 R -YQGRQ;X_:3@K+Q6WH.EJ3-X;(E4]M%B! ^S(CM1S;\L'8B=J
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M.S2>^I@W;F1D+)!T='C\:*G#/L:\8DX,-S/0=H&0,O]G;.HSCX&H(]0'P0U
MC_SA-A;1O@*D7)EU&T",OZ)<O?>Q&R \+$#BU!0"^P)'#YA^,CBT)._LG+6.
MCR/Q=G'G5^$4(O_+V$QP0L/NC+J)83$4BG2/Z6_+B0\^.3F0"-V;S'^@Y&A%
MB+*%5D=% ,V@[R_3&I*-R9#OA&Q#IL3"F]08'C?)78Q;H'+1[YR82K^X=0AL
MY%-H%BY:],S5=0[H]]4J]Y/6#C(^IGK "&$\.#B7H/$26 '#JCXZ!M]O2&MU
MMPOV:S'IQ(V#V!O8P[-TFYVJWSN;Z 2+>PW,40YMN!K<=YUH.92U[Z"*T;%X
MGQ=*36MR][U)(>)_L?>>7TU%W;MH%!0+19K2HX#217I/1*0+2.]$04"(5$%:
M( +2FU*5%ND@)0()'4(O B(U]%ZD! @U0" 7W]\[[CGWCG'_@3O.A[D_[+'V
MVC-SY7GF7'.M/1<7I).EW8H3_Z'Z1W,<VSWL\(Q*O(U[<7??E2X82W=VI+UX
M[AH/3STH[#P+_!9)333;I4[)6I>4S4//H ^\]!2VW$K\C/CN?#0<3TAA#]/8
M X9B[J"%0T%"*"RJL51<1OW!YXP$E8 ]23G@GX]^QD+:5HF)>D9RY4Q$%:X[
MY6(?4JN*M>*091@H.#1 L*HZH0-TO::Q01DH6&54'1Y68_0E<6F7<14,!,F_
MA3"("PDH[UX$/_YB:^OJ?/L75QR/@V46_7UJW[5JC=U3W;'*%37<OS^,EI1&
MCM71J0#FVT%RTIF&MWO7/&7FC02=4>JR28NQJ[:QX,IMUV9)W%GY/OQ#0^7\
M3L>YSOQ.!/=(29;YE'DXL;B8F2W[U_?E.T^E7_FR<13$0H.R\SO%^LHE>+0+
M)#(D;&TV-W<F<Q94PWDT<9!FK%1=/.!YY7I50L678>H!Q% #=.D2.D)RBV-%
MN54)N3UY)NL_&]0JDBC/PL&>WB]%-GRQB4)"BH,1_7B3.N<D3=-+]S-P:5_@
M)+!MCI%(EO_65RNVP,G3R8]]),Z'S3'M?[?P7'"36"7!#\^CC+^>Q; _,2$?
MJH9+>O%)7#O]^GW/UR.12PY&7P;,GR AM&P&<PVEA'>^*3A:O*8FH78)JF"C
M5M50A0[6T7Q671BYDJS.EB[PI)/-:\L1VXR8O'H\/XTUBI\@ 1S^>L7?M*TV
MGN#6>T7&R?$I"7#'=\&'::V'M]#&A/BLO<'"UJ%R\QO&X3)(C9^#.U0'/N8>
M?5^/T\F;]$FKL^^;JVN06E3M*)*WQ.O*V^2:524\K'PZ5EYYW5;D"JI*>CDV
M,]TX??@'JZR;3#X/(^--5-).MJ;5&I;V8ISC-IXCV(DF2I[+S<^/@_W[W5V+
MJ9-@0F)W<UPOEX*.&9($H$K*=9RD"'^'5KA[-*:9F'S[QM8H.QT7Q^@^<X8V
MKCT![7I=%MMS8+ OACSS8SN./TMNRDG)$[J?5_)M_AK_D%ZI$J\9;W96#+69
MV?^D>%-EAW_<NIODP-<[5,EW39U<2WZP$^,SSDMTE!W:W0@=*WT_GG!R%5I\
M4]E:1/PO!LW==&SCJ'N4Q$6-8\]U+6U0IZ/D=F0(8$Q!0J]WD-])MY#N<=FF
MP9<:><8P3VT7"@8$-81US=Z/'^LT);->7(\,_BM' B@2L-O,_;Z#!NY]-/5Z
ME2LZ)];5<*^%]ULB^O$K;8.#O3K/;0@Y75KD2*=7+;EL\FN9_IC.V@SPBQ&B
MEGM?R JX0SS:%<Q2FK7N4NJH:\[7;)/LHKP-Q6Z]>SU<JC<[0^[VO9GL!.&[
MW"\R_OAF6]?-E&&]=G7+GAWGG3+DVU*P::E>LNDU[<B&.<CFG@PK)+2H^ISS
M,,I7I2$ 76J_,(4# E^/F#T'[NVXURH18A$?RTB MLSKHT3M4',Y5Z&6+H38
MNQ>G9'.[Q778-@4O)33TVWW-KW=L9R>.<1RYGAT!3A$#8EO^//)*:_FGTLI=
MVRM$HR;[;_SCDW_6XAO\Q8FQ+FHC!>BIQVWT!]Y?EX'OCCD.:\L$O<:>6'5T
M_Q[>/  K61!*;[/&';#VVIV5U&//YU4/D#Q7OLHL;*Z,PL/$IXWW>AQ+ W#F
MIW;B/V9%<X_@P7SZ_U+*32!54=!GPOEN6NL%)<$F9\,7E'8DMUH3RO>(KIZ9
M,<?:ZZK:;P,.@361V::&\R+,<LQ?$N#PQ(4$R,YL4KI@V>SC8C)"&:)4Z]/T
M0^15!1F3DMN2FZ)V[5LQE!N(RE(2(+S,8T?,S!Q:F[S3[VJ88W?[([7(7NPL
M>C\;.T8"4), R\.>-*>[(^ #&0%!2AN9?G7(C*UMXI)>[LCH.?84^ BKN8M5
M1>,IXE!4DJ=B0AFCRVZ:3-;UB=5<7*FKQ14$"1+@H7[KW-&=*!+@&5(T7CM7
M?SN6_Z9LN4Z=''@2TIS*$PA3SVW+FKA]PUE(LX>E_HD@6S2Q_:AT9R)G 1%*
M],R%5FZFNF+BF7,B.8=DMZZI2T^J@A<TSZSAW:,+),#IGLLY$S3_/.X]"7!C
M)T($BQ-9NB!(;#U+DOI6(UW\8;W\0'Q=_V+8=<4(-VS3UB0( Z4M8*++#BJ8
M2]*.QQ*D\.WJ7:"<S_X=+PE>.9.$X"Y?ZC3?4$W-XO'LI"M<[LG,S.P"ZV#@
MNM$<$$374>HP*'RTFM'X2:#WYKV(U\2GY/!F?^@:XI,\3'>W1AZ(8X(?/+"R
MXJ%BD2YTW[PICBVPB:_B$"^G71FC<T JH<_SY&]G>P/;69[[LG_^&;HXD:DV
M.A'X:GR@3\<1?XB$G_\$+[_9/3[W52<!LK#!ZT=Z&\9C8Y]CABTTRN\?VMVG
M&<$^LK_&9K%PS98$N$(?$Q3[R"VRFBAR &Z%AX+N[JZUY>.KHTN'< ]U)*7S
M]=;9;*O*Z G?XI"%QP4P/8+] H2>*,,AL>M49UK"M]KPLNAY_),I"X:+N_H)
M75F;'0X7P\;E!,@")HPH]NY#26P$RBN6@>PDB5@$MF/]VZ!^&4FU@YAKG;IC
MVRX9,_/] XI#(^+FS)&'/_+(A9/@M=D/W?:S2#PO&#DQ;L-8.0U\XU/U1;PL
M3]$<<7Z7SVI7G93E=C$43[/!?PT9G#1<"?(= ZYK\/$9E[[OKHF]C&@Y!Z@N
MKV>KJLM<81J\V;7+5X>+<DIE:Y>OZ$U.]7BY,=S)BC<UX>3=,$F_<C)B6+H@
M?,(B#C\EAI$ 2HS]4F\FW"R&-&N'",?S*3$!3.O)IV$1'DKY$],:]V,AJ+;'
M%D%3KK'MK@7(/-?#8U7<.@G C7E& OS\!?\;4;R&O!/0"Q+ZT\2.8'FX'?=C
M_>J87'\=;*^A21/@-=]YG8$MTQMP:ASXJ8_1D;;(,G=Y*RZO7]3G=?G[G$_:
MND%:.,]C$_S<0A9T%,1XT7_!3ZC_/K,I:W'Z(2-_2LU:BB6]0J7B";-3O6X%
M VV\J\R1])H\V6Y*.YQ>7O%]+L%YU)/KW5Q3@]&4$\ORQXYQ2K*@IYU+P8$M
M9476?%::W_SJ3SC (^5"^HYIQQ= L%)<=E,$XN@>(82J]HOPP<UIRA.1&0VF
ML_=W@*7>D$AY@6)O8?.:(8EZ9@^<RO2BVL-.%1]RVA:*<O)@B]WVP=(\F4=6
M/,(=KX:2.=,B_?LZUJT"7^_>ZTHM"(8O"*#_F/E3;.UX'N75!8/,[-^_F\/$
M%,34+M;<.HLZ N*#H)?4@':Y/4/+Y6!\+5[2BJIA0OKXI/T;">!M?%<2]5?_
MZ+-QU468LU90UE?K)J25EJ6<V132X-2"\*$>>0U&@\>T:U$[V;2=LD+6?W8/
M*K19M-V9_DX'^#*2?E6&C#$!S],JZDW357<4R)ET5\J%P2]64S6]<RZ2$1SC
MG['(!U]0NN@N-RTZ Q4I!$T!@)2/G=V'7IT6^MP@ =Q_MENS,2ADENDH650+
MAG+FN91*YJA+XAJQ6OK[(*H";!%1[/P;T06OJ<62F0%U*5B/N?BQK_>Y/7X_
M^"=_)>U.M-_H0/A<!2:VB?5MQ<:QZ\1&J@>9Q[Z#.RI3@P3P24HRY\B]>OVF
M-&-QN][:\JJQ-+C2+3:NV@#QZ+A:^R+LLZYY)M6N-AI/9A6F\N<=]XCPRK4&
MU/UKNJ/?XF[EQ*IO4^@)3"#!UC3A'^K\IE7=LBTU?IB8M7G=_](8^+9U;6/D
MAU&!UJ1[)1=-RB+>[7V65L_C[I.CR,S3SB7-IIK*^HCO==5?LI)YF-YX<HLB
M7!49#RBV_':+#?'W8DKD[<G'-'/_8G48\"]P:W+BE%>4;RFV>&XH:SE^R:.0
M9))G?V'WB,G;>6ZZ#O-EOX/Q: >G>";KG;"(B,K&<\1YY;78V^<)TBE["48(
MU,F7J=UF)6LK9.;Z A$@BA/D+EM)#2DNG-%(,FGS-&0TU#SH[J:<&?A)?F;]
MLR B1.W][ PQ=LM9-Z+5.J L>P4>,K58;5O4H9^6YT_A<T9-?(9&.V37_T%R
MZWXAEW*G<'EE]=#B7,O;J#%K@X-YM S5:#1DSOYLE%A;NFHA"MRXT4+NJDCN
M9GQK9 -&O48M0!;9DHMGF-;??FEVF :>@"PF9]E3]8'NVE!V5SR ;KYYJ-;=
M+1H$^F2<@-0XOT? +6G9-P.OD@!5'JP#/QUUA;*Y+_34/_9EA6+U9($:*^UC
M&5(W6B>/%6 YPFTV?-C2"'>-5)T9].FQE6H'AQ#A&IZL^?1=:FCE0EJ:'V_G
MF\Q[L9[1ON4Q:6^/Y8T1V+FY"D0GE=_B<9AG#4R3P4N*Y=T7%>%D6I9IP<@)
MHY>2VY8-\U?"K!0";&L(][R6!F(S17930NS**[5 T*C$>[$]=,\K?FRQ,L8J
M?@:(_&'YG<EI,11BR2+1N<)PGL2F<J56):="&XOI'<R4LL2&!% 0ECIG61.L
M!CUNNJ 29^4/4[F%JG><C%[UQR)XY?%C]1D\1]*$P!]3&V+51[;1'[SHGV*@
M&2/3/N\,&EZI:+<J3IH[JTJW7&\D.X+7$\J%6TR[0E9V6]\:[;A_D2SD.3/+
M-#UZQRI;WKE],;)A;%&=/QA[FR^]F->&K_]1FI%9O3E&"\ZU_,O?@0!I3<7$
M>!:*9U"W.FF^3-M6NK%&5L2]^]V+^Z/ ]/?SL(#[6L[<4-SU>UR@%REZR1S3
MSU4WS;1+^.K5Q_=V)P($F-(+]=TUR_=')8I+"1&[;>V0VYZ?AAN4K)W>?-%L
M$WWBG?_25>/)_%)T; [7_3?&;O9GO(0YP]VFX++U->VF8),[J+N[?1?OH)PI
M5(^6;WV_,M#G7ZFWH<@]-1C)Q&:H_BO=H9IWN_3'"8>8^2S5KA5ZZ=Q=B%6Q
M0NHT,?+WSP@Z<)**^O0R[]((5@OO-6\?#KI=%2_1FP%:.U/3>"U)5X_;.W*F
MJKT'W+R7[X<5F]]A@8( 6.LQC]O#KXN>ET0]B>$^,7D54W8K4T'YL?/;6?(Z
MH%$[OTD-VJXV?G;6>.A(X?8%L]1B]?DMS(DNB@180L';'A&-+GVY,0G +XD@
M?FCZ>/[EXHEW_6) \:(:3*L8[J!J3RE\]3R5J>JN/?D%[IX"A=D^"1"'0>FT
M"Y,3+?#44=F$X"U?V^+V!\%;1GM.5+=$3E)%NY)Y$F9K&#5^.[-8^B),]85[
MUN<78IV1@ADI;0%-1NO3)P4ORQ&:3;65=7&_:O\QAJCBY(;:ZR]=Y"Q!C:48
M.QJ@=X[R4(,^95U X>P#CQJ3Q6^?>M?('OA<>1H)Z)$&M4GTPTP(](O"P15_
M\9OT)K.@XM7;GL.Y/M3Z=@:ARFO'4=%V=0JYYNA#D%V9960>A9G!9% 5LG)\
M/U5@!B9VQ@)[AK^;PKA5G/^WZ>UTU6E26\GW#[^R07-9+8=7:UPB@>1$P]U(
M[^N-]L )9^IQEU)(7^ X9=+O*U1;S?3!T8L%D\^T>R++S*-S-*<,<D?\QN?7
MV_)\N]H@$W&=" :/&YZE$N\$43W?DEFCSH*:[,;XV\F-I"EO+%,GU2["Q^<6
M:4)1WW;^.-3]:DZ;I)+T<M"(K3<<]&+[P);9G!JF=P_=&VL8FR'LQ"+J-GOT
MU]N6\<!^RW,7:3C68/]Z*3R_DD4EX;T"ZD\W;JT270G0?99TG]FXF#JTD?XH
M^SR3J(RG:=_W1FK6#2W^K!@*ZJ7JJQ#\;2,JTTR;)'_GNHD'SK1N4'_%WI\M
MCA9"=MC]:.8@IMIR!_Z'T!1Y0 )<#_A]P8=?^^A,-,_ML1'*J$U2_N9#-=+W
MD:XPBID\?9XR.G7S'=@:$>Z5:FVI_BC.5NSQ3OFT)3A5(7;DS0#Q5NE(T$PZ
MPUZ#YYL\[02'8MR?75F!<1C7&2_Q&=YV]$"H0"D[+[?T=O^/;AM55Y\)M,E/
M$N M54%Y&7RQNAG#0 3Z&8TM5*?^6MZ*//VEQ/WPY.'-!VKO*/>NJ[BELX&\
MJ]_TK:58KP\=[?\S^_Z&0"W!=A?2 ;E;]I"%*C+-Q/P-%BN\TL)J(Z?Y*M[7
M]?N7+YGH6>^H(S%"R/?U]U8=YRDE3"EN5<-E['E<36390?Z! _D.&KGZE7:)
M%=.VO@&3&8^69N=&!VYEUX$!!!I=0LR2 )!R?>!:59;WFQO8Z!Z6Q)B,ZCNY
ML7>.-JW2;,[8B8I->.J<O/ #PNL*6Z4B+;%25%\W,OQW/^[C.(_S%7)[SH1T
MFWK.4 K&B#@%%F>-H^%&Y D'4-E7IT-G@@3H0-QP>E4_9HVN'5Z%\[F\>RBJ
MPA;TK&K%B/RCS@L_[#BF\EYKJ<Z"R\<=073$N[)'(X^;QD/[OS7'9#]EK.;?
M_^S-S'98LF8D$B<Z<OB$^1$7<X2W8T1KK]'83%WIP "+P$@3_\7O)AZ"4O[Z
M<1WZ=YH?^V'71+:6K#JW_YDZ(#3&=_Z@W^.49LL2?]MLV+K^&RKC02YK4S_<
M?='P]%/,1]#$0"D$%8-\'RIC)6G(SJB^+X2%9E(I>R+H04R;D)M$E;K'-??/
M])NK11I1:4O>XQ5!-P&'1FR!0[6RQ?EE<: \F<&T EW3TC_Z1:B-YT^R(WGO
MZ"HS,##H*@,NY>DU!MW_)3(.J)7UIW]0NLJ/*'FS(Y_=XLW^>"E!09&\WU\K
M,[R\HI.OOV%RV53M^V4_@/_IBY'L/\U<U[4*7E[1:'3@,\I*_%=*S3:K=RCY
MLT=>22=#L;H&ZFO'OX)Q;W7',K2L4!O]_\IG!7T^Y<VNM/EOY9[DEY=]4>;*
M^.K]X2VT8?0=&A(2LGN)6AA*TR[DN_;V+=V-PRB]::HIN$C<IND!8;QS(7$A
M<=F(X#AGA-2N.Q,"UTZ/I3>F+X'ZMCT+1-:E O)$3KY8T> YG[F4ZA.,Y./:
M$;N,VWMJ$DYW5;5?E',H,+FKK@JT-W&;5*HZ>%#\JHW!?+U G\&@^C#5("3<
MW34^:K^2. SQ.=S0W$05#!98@T.3YWO\9("B/[X3U0?V&-=9+!%'H04.CMJ#
MXCT<_J)/D6($J'?YK,44?3!G**3Y<K)- F@<0/W"T#61WK^Y8X*+#NXO&Z]9
MO"M@.RTNKERI+N _=_8Q31H3J74JF/97=(%2Q308C?WE"F*\R4+]\59R.4QX
ML5?XKDGNT5YA;?-^:<_)8#U^VF_T7-\0]0=GM7CA616A$F"S#WPEFP#1O362
MIVX8G2)4O6ZSQ:5'S88/6%^ WSD(1T'N6K5<_112]2M<]O$\-5@4FJ'"K\[F
M%CF$!]7,<F*==R8^");N\1P;4/(20^R$ H2CTA^&I_]=9ZWWM2"8543_Z&F#
M1NGD#Q?__L)[1G:43P+$2^20 -@5S$6D[PG-3R02[.ARPN6K>AY@3@+\+4!^
M/A>H%+V0Z@$JIL,;89\/D:5-["1 3_X&\'"A$/[7W;A' &(>\+MRBH"=CT4N
MQ(ESX_VS1P,O&+_2E1[T2IWOFZY,CB;ZUJ",]$L=5(NCU$XDZ\'!\#V#!B$2
MX/4-S '_ZB'N^EF;["6@BLP;2U?J$[VG;? <WX\4-H<P=G-DLX241?;0W)\U
MPQ[59\^QY+#ZYI,[',OI;+YD5IXW- P7&-"U72$%?,:?Z,;^;I  [RXGBBB:
MTSWX.256Y^Q2UV[,(OCT-(H$>"K1'#":>3_,B/"%*O$QFT-5%.4GMD65A]W$
M2"S\_]5R<S ^V7%RGQ@7$)U8:81%++LBKEQPDP"MC'B6XQ<-*78)/Z91.C7$
M<LV:3_!7 >NGP9-U.LPP"1+@D_ 2"1!R*"==M2Y;EL=6R.#&,!7H<42Q0U/$
M7KQV;A-C?8;%T<'_JC35$\06>W6BFB@JJD99^\8\Y,+??.!9FV'N<X\KO*9#
MO#U6^T34)._0=.=>/W"4>3ZW_/;&_HQ<UZ%JQL4X<$_4V^^B\5*C/YMAEXX*
M3 +<I.C0NB^Z'=J'7L*?MR21 %V16+>S5_#NGH6=TX.$RWESJ? $O2)MUR*5
MKR[ZJ:;:]!'9&OP\/CM/V"EM[Z .[E[K7H 3$_"9VWX.07E](AHN@5D5S[]E
MS<XZ''TH9M%D\#&R>_@UF!!(T(?;@V\0BEN:I!,WS-AQF0@?QT%UP?(%PT#*
M7$1S7.?/0YU)1 =BTMBZQP-OOP9.:)I.GJC!]<Q@F7*TSHL:S,^SH$?MP_T%
MJ4VNFNZL=BI;[#-NJ2GAS?XNF_)[JXU'EX%4J/A1#:3$S]G>[^@)_*T.#0GP
M"J8_>JMLW.79+ ]P#BAU(<_2, -=!TX.*YENH:A\']0J0HW=II_,(GI( -E_
MN\B"TW2/F'Y],9>"8_2CF'4FL/$GYTM%__;%>KO+?+[D1CO=A<LK'*9&#"[<
M^)>$$#$NE4U%;:Q];D4W\)  7"IQ) #DTJO^M:Z ZK1YT4X2@C4S[6D[V$>T
MMV<8E8)T5BS0H+N6X%A0P12XNH 8?W[[HHV/!,A^5#(P[M+IE<FYFUF_0/5L
MHNR@7XY.2?PCTYA,E'-@J-SG/MGSU:UK^N?H@/O>-AUP:I2Y)7V[F56Y>^J/
M7W_&K53E^'U$8]KYI)GOO]\T%I_C\%8]\CK/Y.AMN^ :/(R[.]V5PN*T;$SM
M\I#I\;/X#RJR=-<_7!DM7K"Y*5\G+@,1SRM(KD?\,"B^L>8I$C#([QK6^ .K
MU7!&C(F;=-^%,1*H[!?B;IDH)*?Y\QR]MU!1O-.I)!?*$[\':P.%G% PD  3
MJ]X7P(L>+ZM'P[@<)Z6MR="\1POM\>U[G,Y'[9JGHY"KEV%=6.?.QPJ"5Q<'
MU[!'AD';$6O8B M7J,H7@(A%X0?6N%M=5?-M>>YSE> N,)4WI,UKCEK>QM^>
M$8TZOF,.L>^KK(F8B,H*^"IH$2I-_F0'RZ-=,)JGWE&K8IQRG+)Y+J8<GG5X
MZOUU1(.^H)>JL2L_$S(DCYT_QE$LC1&JOY]CVHU/2\N*"I4</.T]^;Q-W[B&
M6?N/<'U0:98AJV;$0=!QP42919I((.5P^[VHG'%'SKW),UTZ;L$OG5QO^F)O
M?611V1#99TEK UTC7-D=N'0JR9/>39VK4#V[:K2_E4!B]3L./?'S)=I,J;LR
MQT@$W $>XP:SQ2?2.0PVF-W]&G/M6^+K%4%%'S5<_2V 0J('=^ P0SE3X>]/
M%GK:VV/KIQP*#@T8H0PV6V4]]WB']^_?ICJ?)U0J^&/L(1\C<^,BB$L7P4<4
M!WN;O^!O$*PT%#"[8<Y41?;,GS'YO;7AK(CK8G$0$5WXO$J#77YY(T*KH;J^
M*BGK,LBWC53>B"ZX'^?ZM&RN6'/B-WU:TMD!R-TT22(\SRJ$4:ME3G.S&KZI
MOS47![RN&D$"..A<G>D"0(7>!ON?E12=/68_!AYECP>#9W:&RL%. PSL[SMF
MZ7>?BWU=TGM<IF;Q<:\Z!1CP(^LW>(IQ!\1*6)D'TGK#5<>$Y76R3&8;*_K&
ML&:?^"3J*ZC^&E0ILL4F[5)T#+""XP)XO(/;1;IA]5%59V*/%6D?T7%M?>"_
MD%B:7]++4]LO=A> #93]WECX6>,81\,]X_,(-\$]-TL"B!UH=H%I#A6@+1\R
MV7<+PN=:1,P_A5N83OG$WC?@YWHARW!!7\-&1,V%-I&--0 7ZONYVIL$TCK+
M7VCW[)3^DE4QIHSNF*X!K=4BN2H)I;OU1]$$N&V>]Y1>]2!:6E)3W$L*:"OR
MFZ$HGH]UQ5;&^:9T=_>Z12.V%3ZQU'*J<-C1%<6)73')R%89';*G0N%N5;6H
MKV$EFHO4E8>+/':(U42= .]?VMD=KT=L69TW:G+KI4V1S1M@:SB5B8.9</0V
MKCG9K43B8\WOQ3_MWPM *SU+2,;]QCF<#/Z6,(<E] \4^R4K(])!OQQJ$.=%
MRU1C=?WZ0NCQ@ 0VH ?,CAH(]:H+#5QD;NK)V= 3_#/K]/ 5@E6;2(E[7;V*
M0]D'J1W@[!=(@*U]FHC'1$N_17_0.OODAM9C=B.9+(?;SMS/OGU>7EO^/>M6
MS6:<):"'E#*B-D:C:O?OK':NC'O/%_,[4^WS/#:'YES4(]B\HRQJ\.!P"06[
M+95JWY"1ZO<W F]PJ#Z>4N0AXSY&&I\GP)1_3,#L=K>37(IF%?,M^\4L3)5=
M-RG;S;L5/2B@M($C'QA7.<2;A@]UF*#5J2]N0_,L( ,2N;>9HE5OJW4P\"ZX
MYE)2?RV="YH51Q/\\)IMD^=[E:9F%D#PJQX#CS=V9$UD]+$$I$J)3Y%TWO !
M2(G">'QI?201I6<<8#R:N7(&]9YJMP(2D@K6)ZTP/QSJ8*?<3D*E><M?E!\X
M%!@)1C;3/04LNP,8-ZS(:BY]K>$9EVK)V_)"#(O^!H?-?9E,;:^?.]5<R#>,
MJDL/$2WPR,&V12WS3LE'>YV=:HNQO7H1;Y)<^R('YVL??/T,H.!)/RC3/WI/
M.%D04EK $.^#I.LBNY48DHN$UMOO2>X@/F-V&<F1TO./J=_'T1;PTVH(SSB>
M K-4=+-2C=(W58_+4[@:MP[.&NK'%\#VD-@ R49"VR79^%YDE9@X5J*D[F+=
MOQG8FH0^#5BEIND-_.A=BISJ5:E"XPM"#WES;K[WL>76?W+Q@#4F]VRA^_3*
MNE78 LUMV'6"5&GO8K'PO8DYR]:R/RJ3N<9VE$$T*6Q*;M+<[VOV(1(!?Q#W
MP MNWB>'<MZI<QKH<+,)59Y9D2#U#\!9:_4C)O9*RTL>]PDWY.OL>3PF;_$F
MDX8O^1ZCH79NGD?":L4P9&#G4/Z/!W)8.!RQ&WH9VA2&7= /G-PEUKO(G7O-
MGGR %YU<',D&2)RD09P"AH"T#0+(@ %<P7HF]Y GE>)%5Y2F^?ARRHJM4**>
M6C.%# /^R_L,\7H2X$L8S>*#L#;K-0&I7R69 XM#,VK"<(>!D,L0A<CSZ-ON
MFO:91W\"FZYY#R7(#C G\(NLMIDC=XF9'1I\'NFIF0%="@L_9.V1W^QM?+2Z
MZ'"C<\WO*W/<HCHR56 68P.F=^!@)&05S4#-\C*_0!_%":HK'+8^"^G[<R?K
M:V"Z )L?"__+&'ZQE=&*)]]*WSF_#CL:B^8\4#?EJC[/NE2#F0!>C,U;P-&9
MFPO):8]'ESI7H'\3DG[O30?NSSMU::/G GH@>\['B,/9?1) D7%O#L=58@(E
M 5CE=>#Y5N8;=\74:5+>0^_'2[73%DTVS^_=6!IJ^G3^]>+!I8O#7-EY)Z%#
MZV#F>9SA,6=;UQ KH\;_Y)D(^5K5M?>C^3EA<?Q8I;%>_'!QNI'G#RN!#(%&
MNKJIY7#XJP&:R<=AB_ZNWZ%KM;%],FRYCO7=%-,_!\ZR&Z"=&)1Q7%=[J>;+
M*CP5+M&HNH*;Q5=-N:ZS[%F.\K%Y8,]]A._X>6* K ,)<.LP1E4#.ZOFH?4R
M)RI)KW72MGO:@!+WRE7MMR22J8>CHQ0F12!;%&947XQ"W'6('-9PYAE>&GNM
M]LC=75,EP"VA!Q"(>UZJC<K3D]*Q8>'WGJX($62WO:G8]&:E%PO?/! G :!1
MYG ZV!7TF//]O>WOJ6,;@M&BS  C2#ZPH) CJ?QRH&?FVG0FP*KXAY]H+69-
M_R9S\J[][A]84;G9Q4UUT@6SX6P0/BH^_XY"AALE9][=;4>\'<3E[V^[7&4P
MS7UIJ'NEJUM4VZVG4_;-$0<(?QSJ K8IMKP[URYK<3IP9)5&.[S4$%-&EOOS
MGCZ37. 5<WFWR#6#E9YK#^N)-'H^(<S6>,^W6E;BI0%[QE,8I36:\#FF!AV\
MI?@H_N&R<9B.3RI%+'EX88+=BMQ3<JJHV(O5FE^.AP7&/[)SLE57&:$&2"F]
MDO3<TT;30\@6_;\*?DQP+!IS\>EP!8*6(J9@[L*Q:N"#3/X=C#6"Z:T5/5;^
MI6>C79>J>90WN1;<]7-QDGWWM7#R/6FDQ'G.81K-'9@C7N+BF\_U+!OQSR=>
MDD,WN6"*+!DETO)!T@=E3 6'$6#A/1"27H_F?A;YZ,EL1L#@X3Q^=*X-\L^&
M[-'_GS:<[VIG]UO"= [<4%T\2_-746"8F3-'3NB"K#]^_/ 19*0V3G?SQ'_?
M,BX.YK>0-C"^/:Q<C:=. 56>I^2W>Q!VN* ?UP4?CG12SS\U&F"S;G(@Z"_U
M@)B)3P>)*E^8AW[KK[867%NRY9WWP]E$'U^M*-#&IU759<;:?O63-Z*CSEOG
M;>GAR8]#^ID"83 # F1Q .A85?EVCM8%QO7:.?B<NG,D?N^J.X[S5T@@.55!
MK #KTD[HRF5P[S(FZ(E3]W1ZUCG&1YT[>.-%)7>DDE,OP'S[,XU<W NLT)(F
M/) $0-V;D&A4[4@^-?K^,QPV#&=/7""C+Q]ZI4J>Z387I"+0TR3N+3 _$!S
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M3\S/S @576V7L4L#UZZJ%?YQZ<)<"(A^L 3G8JSZ;&\&,]'F$R(69I.H6__
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MA[?GJ"N2G/ANZ[5E7"(BD>#A_EJJTF)*R[(.K2S"^=2CX*J1PVE-"[X)I"F
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M<DZ=(O]M/V013A:ZP;,<D9?8DQT<4%,@L6"4560U'2#FVIDEV_O]P+_"43H
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M;GFZFYH*<[U+IODM)I#9T9>)*9KR;M9Q;3<OW.54E3'MF?E[ZV .>HBZ'MA
MHLLHTJ#*:>Z@W-ZE_(1/1D[7I0<_K=7D_!<:MN.+!5F0LRBWYPEJ7=)I 7OY
MJ=/,VH^^\\3=G>9VN#IVUUWVU'E*X6W. $;LYO9'P[OQ0P'6BL4*W^=*<95!
M'O-\-?_*V?YLF%4A01%-F?<*V-P-5RM'"=O+YX =) Z\C-[)614+^RC5L%+?
M;%N^E:C#E%LG#;2KJTVY\3"1YJ\;W6X$+KAMX>X'X02<#HG>"DJY0>!_A8TM
MRM]$T7O)C]19.B=JB+@OJ!,>4>7:4E35295@&>4V$>=](>&)6(^HZ$7UZO14
M\0E?9^<UUS#NMC$//>>796?DC9Y 9I1U8#A%$A<7"A<DF/?(04*41,UFE-V*
M!VB_SEJ\CO\V6(%*,;FF7)VC^IPCP)9@0&2]*)#ZA(D\F YA<;4$Q+R=)G47
M89__\T!O,I&5I_>>D?&[%:-KY@D!\-[L J(Y_0XYP=G9JG_31\>?9LO0[W3Q
MI/4,TM(4 BLCNL#[V"YDEME[Y;YS>V-^>C8A]:6CM7_9"[^W-+<9;>;&<K[^
MWE)?#L!OY 48J+B_]3!Z[&WDI&/H-95S"^NU4:5P?1FT4V&+7<7;(%;LP[.6
M*)9F[#]+%TRJ_#YH*!E6O^\O6'O.%O1,]IF'%?M*X"P0_YWP/']H!1(&8:G6
M@ESS*Q]5"[A)WU7:E5D\=7!JDZ!Q\P$KS[$LLEF@?,;N6WC_!Y]4^29M/N32
M8(>)G+Z>YG:RJ>F\\CHH'%VQEX/SQ#N.P2YAT&PZI801S2PM0K/>AS@^8FB"
M\<R6N4><32O$XE/DLU47SXO4H@ HXTKW<?8AW+BZ[B&EDW8E8+SFYIRI3]:>
MI'X) _+ORV&4[WX31?)XC5%8O$OH0^[.A,LV8X[_O+;2,VQ20]*?">.MX]KI
MO;>$C?:Y"YV]M@UG_;/J*#%D-FPN'&(0.K-EF*P8/OQ\YQDRS LR4X"/)#C_
M=,JZA17K)G-.M/D>:+3*!R?()ZNM1-)P*;-R(U.%_JZW4K*K.E:WWW*MW)9I
M>3_NM%W>HE466F!:I+E9/MP;#A]!5;9^QH*66\X!GW(S:W)*<]'STM'I2I/C
MO6N5Q8<UEV$_;$X4MS?$9I&4FVC,.2 $Q"XAQ@"M@HQ)QMUUH%&8"\C+[-H7
M2VL/?J^',7K%M.3>NZXW"48G&?\:>N*.;SW!25\XY?P'WB\YC[25J.-20(YN
ML\ N]#VX@".( <Y": 1>AQYT+)@KI#YO_MYVAS%*J/;NE,!SU3OUJU_24524
MNY11.4A7.HB.9$Q VI=OIKCW1_W\5Y$4M))YJ^BKR&/D0&:G4.\#KVV(MIX!
M.<=RS) G4<-4FF'.,G$AT*A@5S&[<8K8!!D]3<7[DK\U:V/C\,&$JM46B-ZX
M:S6"R<K"PJ3=5J1,P9EW8O#*SXMB)7SIH,HS[<PI4CB1-KPH$E%=U)) 3(XI
MTH]A.>A\DQTI_&WF_]!>Y-:4\+9IV1ZWZ8_O=SZHK@KUJ][@'HTD\.-]+R#0
MAU"W(M:[".S^.-64#2%HJ38V-E96U=1G[MVN?/K2E(U7A?NOW<.X)Y^' DY4
M/K*\]X;QRB5M*O*5G@. A[(E;S>GDNPE2WV4@.1*T%L@,\R?4,4<16(O<V@T
M]#7S\OD8;99[V+7W;Y!*+)4^5#_]VDV. A3G(DX<;S)&X8$/-8([(MQ 51,:
M5=61O;J1HDN&6%5:&^'X^L=+[!F9&QG3#7IF ^+=F@P_ATB@X) OV7FR%QQ)
M.@<@\$+DG&;M9:).F-5# BJGKC/*@X-KZ6J"!NE;_\Z+.S<&2ZK?LNGG.!PA
MS0B'1)K-"U4&V2-ND>2PY;EIVN@04YL)5[=*ZXRO+[-=?L0W5P3TWV7Q:D<6
M%9;9IF/R9+0E.<$!=)IDM,^+MC&])#/7K;G:HQTXE*1!_@)7@KW#AGX'QB@)
M_3O;J\CK_S5K\FJ\+,F8:*(0JO))?-"#94!5@[V2++P(<HB;C>I",X,<=(*7
MY,<E[_--:V SUUJZCY@K^ZM^5RSR=+UDDM+7+ **B\D@\PNS35OY]*.K+9JG
M*C7\Y_]]?N/(,]4X=X:?(6ROUNVXK>ZJK8Z01)%?LI[^PA:$[ZW>#N L:%:K
M?Q!=B1%D[!0JUYM@91U14,.&X1_C3CZ#'%VN__>W 0_'U9NM[3)3CUS35!J<
MB[A3>$T,[-"\NEW73'6H0Z@NM_;]5R,9=UIB_C3XN=G"K:;1S\Z2.>$!OO\5
MR2"40.M3V+4)!<@YX"J#THVQ=:)J<IF3\5DKTI%YL6X0'M!?]S[YD(5SR?V^
M\[%/\TDGZ@(G/L'X<<+&%X((#7B#"RU![7[,337H'VD.FM=;R+:GVBM<MLXS
M-HVCC"1K;/NIY+F2V8_N6+%O:]+^RT3_W#@'U*!W"J[OBJYH,XF"C" TT,1G
MW_,FQ#3I6<"W6Z5N!_U(>L'R(>\CQW2X$[ "U N*80L-*X Y$,H*G#GOC6_0
MBV8EE$YH?5+5V>-B[T]HM69^(&ZM2,%E9X<Z1G1.&"Y/I58Y2B%;$,\GV\=*
M^&6]T9;WFQ""\"E0Q5(=SM,$"XJ@<&S7PAEQH!!N+6>=6HF(&Y'2-#?55'R,
M54>P7Y5]>A4DXW9T<($FA%GL"08<T\JU:27RYRCFA7#,:]DK7W/OJ7!5JC@5
MW3-(7*=/CK8-NZ\=,*1BI##/J)F0QU2:"':T&O$.Z%9@9!T:0ILK'C4>W"(H
MX[]<9*0_-!%3MTOCORI*8SI6?0ZXY4PWUU=B:K'P.I6FZLTW(9%794T#=Z0?
MG\:YUIP$, Y\Z35N&YK\L3-740-35'AIZ"1*BT7ONA"I" 6KOMVK&,1U9[-'
M4?E.<@$M*25N 3QC32S? 'K6$<FI[Y1#>/VBX9P11&-XKR^(K9EY61YX;5N*
MPOFGF>Z.F6Z+\6,)%2[=4D.Z/%AX^$/UY6C/WDD&L.90A1[>.!6+GVBL;3D:
M[5LN;/5'QGDN*SKCN0F'./K>I9LXWRZ:"+GKX<?4]/I!IJ)M"0(KM;$O/?_N
M?#;*K#VXQ?\\179UIN:_U)@+V^W^2;*+TQL'=TI):;OQIFN)S6NER_XX!0_,
MQHP+]GFT*8 G# VR7"*RTGC[5VT2C%.(MV2$]/8;_8_5!CGER:G->IBX>>4.
M"+.+]WTN$/4F4WRG8NEXOQAK,I]!S4O;&V3,L<<H;KN79$6.A?.C=EF+8(8$
ME=48_D[FM"YA1LR60_?*H"-'ELE!'O@.K?GZG#+GC3;NG3,AQ_5OD:ZBYNH'
ML[D3L7B'HC>;&O)H<,!9TI&_?XDB5\_M;42M5?<51\7AT=;WGY_9MVTF)L9]
M/,U9H=GI706%G .J[;N1$:(!/RWGH&GLR)UT/87Y*5-^4UT=X@]&N 5=2)S"
MK;/8R-6\B")5\6B?M"KBGIO<DT(,>G:&X-:)QNK<5^X"TBCQ:>& X/%C1,22
M<+VT<>-0S@ /D[[@HV FE3?W^^Y>7GZ@*V>TJX7GP*5VQ<T6=+9>QHU$2'QK
M-E^1+[K[I72S4MN#>=;4\ 8?FN/]DT\_"F5H>Z?C(<YZ5E^&/6(./9TRI](=
M7>2%':U3MQA$G;VJ#K>1F2-!QSHS!:L;/:"=F-N8_>XA>0.L7:;<H.C1Z(&%
M5C5MRB#MM8#<3WO#JJO3J(4SOCC[E46F3HV)%28\DQ1N;KZCA4Y"MSCG'X#1
M)_)OMW7)NTEK>9Y:#9X:M/5'&:B>2\]N:]EBEAY1#\8 JK[>;NG;CM5R<RE:
M\//</)%6"79?4%U)JM!5O^)J\ GJV>W'O*-&Y"3$X;VG8#I(PH3QA&2FOWY=
M4,>XI92?W;UY?I'2<=4PGM)G@,=7K+%GXY&"J]L3G5HWF?>TP(3 KWFA!4+]
M358'2MQ3(&M@%/HVA>?"B0,O*W$[9K%.P)Z[3TN;62%9!6E%AJJI[O2O:-6.
M&]YC9U74*24)DA$D#_Y.%(<#D%7!AR*'Z-8+^+Y:*_)KIGNM$L'_\!G/+P6N
M3WH?IT>]C/]X*J@X" Q/3RQ5KD^X^'*QR!FN09<6RW>1\5A0\#G &C0GO_(:
MX;]"<QEF/>XU0F7Q>OP:=/'1Z).U>%CJDR=M/&I/@SR' O[\G-'.^]<8D-R]
MD'K"-(7KY%UH0(L+?;*LU!%1_9A5\S&RE_E"UZN*DXFYB6Y-M6MCG9TTN6*'
MOL2X%*6;E/X+@G;!E:SJ1!TK:JDAM'&EJ3$%W8XB91(OG"-X(3(23LR7VN2U
M/-.FR&'G +L1.O@@Y0KN6A3&F2RLVS0I*5;[\NQ5Y>_(+'T^ECXVCC6=9VHM
M =PJEA:]M&;TP7/5#6X%!SL";QTGDFPY4TF^2K;D4)2=&#UE,(L9IYJ."5#6
MF'PDJ36S]]"%S]1&1>4%ZDF"Q(._1P"R\WRK*%1' S?="63XQ[93Y):[Q>:%
M7;#0:/OL0[].?/] FG2ML7\ IQ9ZM,\*=3,8]8:R;6A.[N96-WVVA4;'RR5[
M+P0__LWC_GR]HB2R*+R+;%=RDOYZ>Z#"/8?-L"6)*6SC.HDN=2407Q#3#%YM
M0AVENS M>F7*&5_TJ*34^$3%QY'7%/DD=Q&L%V' &1<+1C.VWH$N#718/9Q,
M94Z92Y!.,@FY^YRVGQ7B\"XZV)5UY%7 $RQJ12R8<IM@3:'=O^:PF>W(Z6^1
M[I6BH:7>=LW'C_5;AE"LSK.KWL=;F*K(FB=576.S)::Y1SM32_;W.>YPA\6P
MI9>Y-IT"^> C@17HR&8Q7%!@%) )9GT]&N;*Y5"FDE87?\GF8&#/YG6XZ8MB
MH9BNX\WN+70%L'OD"LP)9Q\)IX6I32B(9D.S'&V:S6M\&D)L/^Q%AO*#YP;G
MV3\\'M']H+-P!'XZ5&$U;N B7V+6/V4N[/(3.>EP4+B=T[*W'VCP%S'KBY?#
M@=I =#"=^C\**M;(64+"[)O*9AJQN=SWO\VT0FPZ$B @810\X"-D)A#_'L>_
M,[*L<\^AE0\U7G.[15F?:*.3.R 27K3&]38Z_N>PX=$5_^EQ"6.C*A'5AX9&
M;">G_\6$I0*OT.M'PBLMK?[)-:)*\^")O5(Q+M/=1]D.?!%58:I7374FZ2$W
M_B$J@+UQ0:ES4^E8?TQK:AY4Q_!;/];):4#.'G!/(>*9^P_J?[J9.05N+?]*
ML?5;,RH"'<-/%R72)EQ8O7]A2R>2)RP-JI0\R!F!UIF@943'.8#I'UL^DJ^I
MG-#*'V7ZAU9SS4SZ6?S?A!>G"?=[$TRR9*C"R4GG %N=:$@5*H9K8@\6F+,$
M>Q2[A3FPY)KB(ZHL("_%L-9U?L/Z/+DMR/J\'5GA4&;['6-77%1-SC_1.!7V
MJ9SK<;ZIJ1 KM-#D3+:XH'21_RB=>&$-'7[_[9J:DXL^![A9=7HXDU-%D!7T
M0\-D7/[-P^M4BC22(40Y2H]<7><\*,8,$BOF5::EBCM5SX[33#-.D*GRKF^
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M49@>_"Q:G?ZFN0-/%GBPPU!JP+C'7SMJ2]<H47ELOYR[I:%%R+&A9=/QX)$
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M$%))'F/4SHI-97==\FSIJ(''B<4*=:QHL,@K@^SIW4J1K:#OAO&J,BT"8ZR
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MKS0F-IVE-]9R!G#MY1G5JU-HO/?,N?83>*+ZF:#<F4=XTZ-WJ]7U68:9V+X
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M/DW;':"PJ.VO>.WN4T!U8J?W6;=<+FL8FZOYA/YW"ZBKM5!*G,O-X_B;6J<
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MBO%JW/=!4[0\]YOV\_Y+.X.B,*9,\Z[.Z]A4P]4YKX+FD)TCKLF.B=*[.O!
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M]13 M2XF-\/[B.GVHA[4!V%&CM?[H&DK3;EN:'3O[Y6G_\]9.?2[]4859X7
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M,.^]03P[RO-NK0^OEOU?RXUQP'T=B.<IX*G*'D4HY.]"=)P"!#)Z,81SB%/
M>&!%<^EV7B:H+R,?JD0+)2._]_^I U1<Q_5:YA(E =P%'_11?/@?KF""S"D
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MWA4&Z)1*"#X5?3D70Y12A'MPL[K<C=SH2#K;[<G_P%)]$,Y)!CCTG(3U'#O
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MQ24G/U_0-Q2567/M=9P_7G0#0J>H>MZ2NO=)NL_V6<_3+WR7+^^Q+TNHQ*;
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MH5;;@,W,V2-C2F;X^#]&U&^7Y0B>E]0]@BHM;W$2;]2(OQ)V F];Y/5BGL.
M_WG;:O?SK$F\49R]'Q<9$.89(2JB59J$UZU)>5S^_;7;KD8KS8= Z"$4*TA,
MW(3;D &O78V[XW3FMXR<NDM\4#([-W8;<O%A\;+KFDH;W:U/D[@S$(RCZXU]
MV.(1:__AJ*PQ'V_UHO[2"?O-_0W6B^/CX[ROP@4>?G[A!P 0A)>8C)HST/_;
M!\L:"6+TYN"AM1(X1@-T3/@U0S) ?9!_=-W'9]2MF!].FU=_RLA$36K2HC>U
ML@2,0(PCL$\P+)LHS$4G6GVCZKYM6JV<]?KKR0]7(K'T\M=)B?,'1!:",PXT
M!QZGJBM7OH3QRBA/<@-)G!L\(?UUE$>+ TX+T!F\2 ?C(PW!B]4CX#9(EL $
M@[ #$)VE MP66L2[F\OE!3Z\3/4EH^:N6B",EHOS]B*B^2A#C)]^K=9^T\>
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M!@'Y*U[3T]%GQ<D Q5@\H;77$SF$/(=3_S_LO6=4TU_7-A@K"B*"= 140)J
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M[,,= 8@8VF!V(_?BYX@M>V]=!KV-KU0*&-J!OE))/4 S-AB1CP!9O*X)L&7
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MFC;N)G\LLH(Y_TB3^WV ,OPY\W";#DZ<=\<.H#@J*,\@MX?H%R$:M%0(7_9
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MY4O$/)X&V HOP,Z]0M[K%/MMKJ'V$I#/9V3^/'VTU4.(95-0:EPKJ2ZQ"*X
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M_%;8W^3"WF.7Z3Z\JH &GF'H6[&UM=5G8X,[9PH-5GSYIA/<1'8Q:O <3_!
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MZY%X'-D'M;5  VBNT@#2:2DT@.A4TVFY1C4%-+#74OB\$6A/ P3+T "#=C1
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M#G(6"FT,;2""VC/E?@DG@+C(*I-3AG7RQ7M\2C&7(][W]?PBTP"V8?['/I$
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M6-%K'3L#XVNC2 <P*Q2H4DD"442#1!M5W)N*X7$&HT[UZ!.6I.7C6>:"%Y.
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M**SXT[?X:!MUTG)=6+[U>IK5,3 NU]ELS(6M(X5=0W:P*X6]_=RME7GZBY6
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M*XA$"#]RN1N(9^;W30'=U.I]"]1Q=FRX;03'R3.D_US'W@A=7(FY< L%$AP
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MM0S:]PU]^@=34'U*BO/1_L\J$V.;OVFJ*D1)B\17'U[P2%KGI9@9+,9QV1I
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MT+'F7I1(?HRE0<RY3JT1:,YM.TC@VL?O\35'_Y56S-M8?%'GD+I%JC?!=[P
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M)^M/&*>\>&M;LVV/SW&;TH[7UXA/?DZ.\!BW_MSB_:4QR):KZSP@QQD\S22
MKED-V2<Q)!$:[8.JVHH]^IG O[AJ#(L5S&(";! .H(&HA5YF[ 5#*<;*;"_1
M9X\RO/&S.X\O#GAJ$,Q[#+-MZ)72 1()];54^*;-[XI<*X>,\0JB4FW=G5G5
M9:U6E"S>ZL!-SLSR;:Q4U=VBD?FUHZ,1$R>Z:D6#?B)?O4*)JBZBD.VI/\=O
M:#3VQR3A#\Y;[8_7TJJ^WVB',)GV.%X-+VE!)E09:,6'._SF:1D[I&W^CFDZ
MZZTI#UA2W&BBE!*KEBMRLHMW7@;_G'_W[B.=I5](]M<-,>GSRO2HDH,?.N_R
MW3+6!P1[0AQF>]0NLC7=TG+C(]N7.SMB[@$D$-7'X*OGY8W%UU;3(K+')1N>
M<#E]YO.:0YY],EK+71]@[5V50%R.A'?C.'OD=K/.MZC8@K<'E[[47%-Q S&7
MN>JWC?!G.^?N73+T_%"68MRUW8F>!NE<?D6S6QS_H]ZC^!Q^-&QBH'*YN.93
MXT#1/$<J9H-@*QU[0NOCV"P;T?!MHRK.:_W4EOR&2)MT.UCIK:Y><F9M;(5=
M</D*SP'9;]8[Q1#J$,0&\ JCZO/>E!SYW;@<*UK H7A^.ZW%9=IHDC<I",[U
MI(SSJ<OOO=\7(][6.T/U-/B'?AG/A=+P& C/X%0A?8Q&O;GS-FL&"7$R&@4+
M?CGJ@40N2G^7:-?J/YJPFICHXY$?KF",>EH\"PKR++50]_5WY_LS/=*BNN5Q
M>+!K?*PU6X2H_W2C6.DD53&NV QO2MK5H7VFT$K]CA@II*%36J0ILIZGLMIG
MO6==^$>UF:?5O/$RUR-X8?E8T8OLFMCT'K C<F9Y3G(/2 I9$[@F)+NE3#WI
MZ!.8E^Y=II$1L/OA3!U@WIX-[3;+GU-@41DM_BD$4J+M:927+(2PWN;)J"/=
MU.!3IZ8:0KM+AU;2MW"Z)V4N1,<IWOMX9J=5PKOU<N4[WLWGS L26@<1<:T;
MFPWS^X$#^]#5/\(ZZ'84T*"E(29(6:N#"\P6]OP9&X+)2N=W=HPP CO^;_MC
M>70R2MD,W2[V22"49?*&U<6=S=/)2'"P.1^C0?4)=(;!AR;"L-__')W;;4ES
MH[X20K_D]TVY53UP;XY)_:N::^C;H_;4+^=CFA[2]*<C6N?SZ(ABA2?N"OG&
M5-X^@:8FXA+$!'IPI95U/%H)#FSOXHK($JYFMFR$1<1;X3;V)R+@(=VPV&^0
MDD"$K]%-_-[Y4DW;] UXA4A6TJ2>Z".OX5#\HPR02C>@]P.IRA8KU>R-&+H$
MY: ^ZW5$[+>\>O>C5(&'EZS<]-7[:+]E5N+>6\G+] 0]Q%^MZ%SF&PT43V\F
M:6.Q0M&<Q78E&^R:F/?1"^_WOQB_R91>NYMOA#1R]&)'64V=$C#0GH!F798M
MV =V%'JFSW6BN'THA=]Q(/:L4TVZ5,M,GF>J<GB-O43_6042W?"A4<B!7JF@
M BG]@(AKHNV5WO>5 Y]>MP8(7$UJ2DA[(B0OF&/@LBB!#P<N_#!F;#._(0)Q
M_[71O>$T3,'&"VMQ!SR.HC>!B"W+!#B+\_)CT=F9MI<!"%]I'Z7O./%L=[N<
M*V33%R,!XJ'W .>Q:#F22:NIMFM&IZ5'%,]GK,",E #,(V5=^0$41= N1\2W
M6+<RQ=6Z&U&IWQ'8.]TN$K!D\!R'U^DLXJXR\"A:3A8BWX'D;_47[R;ZP]_%
M^_>QV2[]E\]#N@74@C)JOW ]/\[":2WJ#YBD;BL@GNM'9$O;C>K0W\9+2M;9
M[UR^"O_8;?9]AW4PXM>"T"!TS?15-;N\V6)^XK4ZJ*NG8SJHZ+QIV_&X ZG<
MQ4P%44*VWS6O[JG4TY97XK2EE7&:#,XS>)1TLF+[CM4'6NZGKEA^8F) ?TA:
MVKFJ_+P:'F_0UCBMLQIOR'/\+@Z5M@P[Q/INE?,>(KY:U2] ></1EF9)MAS]
M/2M,-FN;+507 Y J2];R)6AO\HQLP7.-:O-;#U7#)QM6_@EW-_ S[PN&#;NQ
M:>NZ"OK)-EU#!R534]Z>%K^8I"PG9:\*AWL 5HL4<&'R;[_68S]=_$SAX@&P
ML"8-0Z\=8GBLX?77&^?-Q-FJO:6GTVTZ98N[F?7[\Y$_/!8VF[(;A9FW 2L8
MG0",/FV+^@J)0 G.'"6[S\;[YF_4#'5WCFO.??>YU@S@R(Y/;>*" N>FX:V*
MGE]T#>8[R>1M!N\!P?5P"6-3"-6#C[!*6_NE'Z%;$>MR\9F.'0P=O-!>1PU
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MX$(6!6=#U8^%%8R+.+>;6XF_&#Y7&;Y\=Z>C^_NZU*?QEQ_M1CS/!I#<K]4
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MC'/T=*!)W.\! SM-&JJJ7LI4Q#U8>D31/=9L:Z4:@R)5T*E;TNMSS=O<LWL
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M2[UMRL;]<3SB*VE(NF":5$KWM>.5STJ.,\^Y0[(VH@K.CZX=Q6M!D4_RDU3
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MC6<'_/FJVL)3K9C^;/S$#G>U_U$)31N/B<[D28B0]&[<Y70,GB'U#@W=???
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M<=8W6 G63=%(+.2H >1[A:1LV_WJ9=&9R++K?EP?3]]6[D?D@2#?^F[OEQN
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M!_TY7:]Q2"'LH!4*HB\9H/ZUS_"<H9R_JX02,W-=EA'//Y.XN+SU?)HX%J(
M3L8-1.]?VF#(6)A>Q(^WMW[2>+A)-)T:!+C%>4YD6=4/I/(_U+\>KL%'-4X*
M)E@[UT[:1@E.<LE8]C\ZY.5\>G:V$[>E].[+?/MC9RS J"/Y>1/X:2\0Y9I
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MDTW;_)).C'"JYK2+860I_#MX-M&O#&6Q+>7RU*$EJ^13^%^%IALXWK44U%5
M]O8&\&%HQTH6&O>X+DM0_$Z%G36?PQ"_^*XDY<_<U=+5A-4"1JO/</+E:&Z3
MP/9YSO7)TXE35)AYU6.CYJR]Q,'TT:ZPI\,%.;Y>N><;]3[";/X%%M629LD?
MC\$70DH3>U4EJ8JRP16]1A1\D_8BN9ALD.=Q/OS[UHE4AE'#J1'"K]!H>YDA
MBR.7ETOUN[3+0X_\+ GM.#[ZO>6$CF\[R(*8OU2_Y*\6M4,LY8?D8LFPTK_^
MU<=*?+4!F%&WE^;KS0@?LO2.^9-JB:G&QCG/?'O0>%U:PB9+.;L/U,@%KN_D
M"2WTA7B]:IJ"B)_!R<I<!.:SD3,;MM3_LK>T*,X#=QD):,B_7KHD<F[9/].D
MI<8&#H-VI*]R_"YS>=MTSD>6J%6,Y7;\@SR!HA>JZK;,$I>S/(V=LL=\8_%;
MZ>R8$L3EJPI"^FJ(M7'[C)7\+G@G\TMEX*J'=,40'[W7<&;JN:^DX*43ADR7
M?>LEN/FSK/D_I?UR@[3_ %_]9&F442BKPL!<(=JH5VDF'6DOZU6HZ2#>&R:?
M_OFG?),/P/,^*'OPWS;$UG5YJ1OV_4VK@F&]$P.LU7\!K<(C[U?FK.<+ZO/W
MO2L'CK\O[:H(]C(<$W])HG:2:M-D_YZF*IL^=4+^;=L)_07>UP522F(=GAN%
M/ZQVI$ ^WRT7K2V5EK,WC%+&9.UBN1.5]%LFA1^W5C=G#^UQ?-EL^#3PF-DV
MFI0CPOG'44G%7%/>6559@\]J&"7* B0QUO'#0M>#R&R4LZ%&3.ONQ42UX!#K
MMO^/O[H)[D:Q*'^N#@TH&5L%:]FYXZI9/Y0Q&SD?EWQO$3])ZY!8&C[O;ROS
MC_ACL9V=B"AQ)YF06,/RKU:*]N8:P@SZD'M-MA09)3!GV:A<3G&C4V-]'>9W
M_]PR?*N\DC( LYV*T8ZO/ARV]%ML*0>;1;<%SF;G'8\5^7:2-/Z[NM\_O67/
MB>,]C_DHH6N%&$-<Z+>VU=>"A)!,L<O/P]U)IHG1Z@!ZUHC:+:/"ZD,=2S]A
M2?AWK>+2C-E9P5+.]D!3AB_=-6\2T6+O_Q6Y&[ M*Z%9;QV&BB,L^-7/VB]I
M7&VPZ93^M03F'Y^ K/ 4;5G&^)KI-?B+X^081<G?[70$?@.$@# %*EEXI@);
M2"FM<T?KK%A '6'[7IGX!@"\,%R?TN7J'1>HG!SFH U@3AT92-52T%73J_CK
MPRR38A'IFOU,3VX NN?51O^VH1@;&3#(A''QS<HG/J@[MU/\M^:%K$%'=([>
M+C\#K8)3#TS":1C1M.88\Y\>&0(3]__3E_IGRM?UDF*KST6P_\3)VGCKT)/5
M*8Z>I]!_KS<1';A?5Z[):U2=\N,_P;5A$\VZT/@)-9J+ZG/ _^WI\;_VO_;_
MGOD[8!,O](1W,W%1P>[!DL'ZYOHQ(/-;(2>*[XPA&R AO7 @4\"X,^!4EK_G
MJ #9TE-]/108-J#T$%EP_\\IH_:VOM,-P)'J5^6 LW*2H52+(HT_ Z<[/^F)
MP%7%<3+RL+MY/]95D06TDD@RM@YQ$>:>OD9(T/4P^ *YY8G/;LE'F /6]0"*
M2?_=WQ[PK7$\ 469AB;M#J/S7]IE>@T";J5MJP_:'21<F]'.=Y"Z>B2LK$ZV
M3IWP7Y73G701C,L((_YO""_F=D2W*-ZZ7<\W%C_5V2 ]*-KF(6(*BZD2O[4_
M_9\:3!9N_<E,EL%B!+G5#GJ3A1Z?(/05R0W *((LX<Q3ZW9KZH_Z.W):RO?O
MNSL2U7QK-[H!1/A?SRSS7L&N:0B1O:&"4^(A8OI3$AE3$]XFZTETR8-QRMJ#
MG#&^EM%^MM!_VLN^_A/WY*^MA"H$&[$1M0,)T $']48\X#>68F(*8FT[>GB[
M?Y?EAY2K8&04\0JF$35W>O)%"1[3S4;0 T4)M3ZZ 5#=K;B=US> I+46?'E6
MK5,M58AJD%-G8/;]"G3_GQ&*.]L_J;QJ"&4+'60,^>:?L@=WH[0N3!U6F?HG
M:TU9\Y#E2U22?((K#P^IHPLS(.2N6FCH%@IGF&>@!M8UQ]#M'J^Z$1%8]]0T
M@[6[33%\ _<(J<LT',3, @F!*ZQBIUC8M#'BY^*S!706[7,7RG0.]I6+E\1U
M1J2]0-JP;M(5X8>$G O%5:/KOBDA'[;="Y&LRN OV2 ^D:4<UXD]-?^P7="%
MS0V@YRU!J9?Q#\YR-G)6J\U<N<8JI)(I<;"%5SB3;:2CMW'5\W 4$,*F%N#6
MA4+ZH0L&L.:]C [O6_6:K_8BAK(3=.R\2%--\XRS;)57OJ#2.3WV^*>__]<
MU 2;5H5U\Z,M'<PNF,]C3B"?9PO>P2V&E3*9E#(B6R07@9[\FZBYM)/?-X#H
M7Q/!QM^!1,O^,M[\7R ]N@$GC:ZM?5X'@^L:,98%HBNK@5Y_WT/DORMH_7]K
MUF0W@"[;&\#:!*1CUZ[F!C!A,+M$@^NXI%6ZUJ5=N.XW%[ZB40 $DY7ZG]P
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M;+\^"D46D!KN&OE"-57N=2DQFW!%"=J:,W :BT_SAP6+P$RQY;DZR1':BGF
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MO,[M39X+"I9> A2[@\6(_@<AU/. KDRX"5$UL38 W.QW1E)Y?F#/5-A9RT1
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M.'6,[P3DOG?V1RK3WH'"SGV!!<V_I2CZX!%-F6B4:Y#Z,K+M^9+43^S8G?C
MET_4AE]&&KM9LO8JIZ5$21F+K+B&0*2WX.K2902P/A$1BA2 PULI7R1A_@9
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M5X4CF58PNR[$SJ<'IO!]28'RY<3'O':UB4'>L9Q2)P9A,5'6)QIQF&AY9ZO
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M96\KX_HRZ\;G=[;?=/C1BP=*16J$-7F;=S>%$QB^JKC$7VP7O%Q:WP1A:A#
M-4KY@(X2@X>U/@VM!X_"7=SJ.Q.-S@MWQ"3FUXMHC87("%ZB]>-[<U=QWZ8I
MS 4!A?L.I#,@7.BC[]EG[K@3C"9=,*3J+<(<6"EM^/6P,I8*A 5+X:MIY<0H
MJM5:$!^7@=V(#6;%Q7B,0S//(M8XIBTF++1.=GER?D@+.'VI5%<T+.4TPJ(?
M_* LQ (<]0[/EH>V4E3]Z:H^>)+M"GI41X;7NQ+*>E2;29=8BIEC7YW&S<UA
M^R'MUKP1YK7]OD%QFZHOUJ0?L.TFVS_MT\BK6_^RG<4>"X8:C;%8$;$')XB[
M!S8W$,UC[<]A4"@6Q2T51@4<S1Z'+Y\0S;]Z6->06!'!I'S[B4>033OD(P+1
M>!ZJSIS1"A8BR8(CMGO<# >W"RJIP&$M>XR\Q_FGIU]#.-YO?7!A4@T!MLO>
MJ8G@[C1ETA-]*/3?&R1RS?S4=>>C7$YI"/$-77VA]GWT$O<ISOFDB6&DGPR!
MA\B#VVTU$1+^W@@:LW2J@\TN=RXVT#K O@?CS^+1DB6G'@NP'CUW.D3G!K!%
M*_I8\*G-\"C4B6!%TAD\>[C:5;&%-Q7$KB_[I'IU9P&WR5>N-F[;_K 4D&@8
M=+(F4UL]@JB O]0_I]2,8O&;;?L6I#YLW3_;J*^?R!J_P7=!=V9F,7..Z;,[
MZ#C*1B8,Q-WP4"D*=F_&TD#?JF:4D/%JO52J=:KIT!Z^53AGY&B6?]0$(#$B
M_UD:H]DO);^FTB? IMXG%CHU-"9[ZDE;%J.6<=,M &"_ 53];S^WY!_Y -8@
M^\ECMJF:'Z67%FK1T<UDIXNFU9+9,B3&J6E9QW=1837_([>_6H2,IE)N#+>#
M#HZQD\\UE+TKX+HV'T)WY<F%@>+T]2=#S0=.V\[6$[$HRUR4\?_8LO__Z__[
MK[C960DST71_3EZ;VQC1&*Y[.J*) 4<73-OX$9&H>?.^UM:"I<+EF]\ME1J<
M0S<1L N9%]L*S4<1+_A3"<G82W[V0[<E)5_!4A//?*EY"><\S/0H\_*49W*[
MIU5%S,5]/4\CG+6U&\[2R=\]^;[#9V:/_I]#FUNF=<9K[Z>62AOR2,(!0V^W
MG#(E&H0^0"_J0'E^?)FG NU+<*SETF?#M[.')L</@K<=<)PSP8?J"B\$5UFN
M?IU*#S:1WP_G(SWY005.>%"!OE(/%*YT=7C=:6P?/F&_@-H6EX<W,U:3(9$[
M1"JP=@"G/,NM*SP?Y%1M#L&SYS\,N"IC !9)IN53F5N0'>M+P[,D*1 5T*RF
M#9,HTZ&4M:73R'PX4%6;%N6/+);SLU<45&5(A\'S(./LWBXJ0(^D J(>J)%@
M"009$N4"H33*QT_OLQ;IC,!<0 8.5VN$]F_V(C%K4J2BPG>(8DPA@D(/VF3/
M[U\Z#Y_QI +S<:;PV'=4(,6"$4.NR@21DW]2!O"OX7#TF%KVD*#]38K!8_ ;
M[[O&:[.[>3R[99U9^\7#: M]*D '?VW^E0HTZ\U>I@)#Q&M0\,KXK:>H[4LO
MX<W0_'8*ZDOZMO7R4"([R6,&V5=7>(XP0 46^PYH?-7)-%CD5293!R)%*4.(
M9A=U**CKP[2BHN9^!17X^6$ WMS]/94,'2B!KZSHUD?0[!%I>D_KU+80#GX>
MGOYP%>_L5+0(VDRD#;;(Y(#L-(KTKZ%6EMW9*1%1GYWGD&S3-JM3I_O6Y?J_
M?HY%)9DLW*K[[M6U2LXSK*S!0!09W7Z<^X%&?13;,MJ^VA4#<96A3#I3 5>[
MHL!\UU0O.9U+^VU?(I9N#RNXXS#-/ 9U$!;';U1@^H#!$G6E-A^%-27:P0>A
MN<.4SZYB-.DT'NI(@_;>4X&0,HJN,AZYM0XFGJ"9]EAAU (<>W^IEPKD#RB,
MN^UZUW\")76@M[,I'('Y5&!NNK6.C")7A4+(?"S&JS]1X7E3J*_8M7)98@&D
M3X_B)'Y/BX:G&&(X:$==MBZ)TKCJ0G.WQO7L [FV)U2@"'\8<7D;J1,/ZG'5
M()\C7*0"R'*:=5%['/L]D#V\3".(E#9H?+]T0P!-!22W63 '4#4^&JBM$6L(
M7DU*-=KB,6IGI5@N&''(>,<?'&X,)VQ",J[NC,A$<4((J\CY7Z/+2&+I\^"5
M!IX"5$%5?:4[%4#<C*"I<*(-05%74R@;WZ<";XM1^^?'$(4#2PX_^TFO@@(B
MQNIV8E)_)/QMO&0)'WBXM<A"B%:6]):)@'9[HT$E(%PE21BU M-\2#,]Q",2
MO*UFO'-3AW0 ]V1?8P61* @* ZI[.;_8$LQ/#+S5/NJ]=FGQBEI&Q_2>@G/K
MI9M/Y[P3C+3O))C=>(W%2PAZK=PI*E$6_[FN'G4N7^$O73_PO_[*R6)\EU$3
MT%L3\)T^/W==J-)5J!)8/E\?42(040*H1+EB5[2Q*QK'_A5/*G6>Y9K'^;D7
MKXDYNE4I9_=G):AO\IE)7-Z]/D4%<$=_[K);+"I(",2:MHUI-FAYK4GS2;>4
M]*Z+'A:EG[S5A=P=JGM"N'=RH6)X?10V%7%,+OVNU64W"2D5B#;EQL:\SIR5
M<2,(IC3H5IGA=W>)/U"AF+- ]BD_K%#C]!QP[%UMB6;[_NXSV_ K 08JFX*:
M-VL;*AOZ5W-BOL@?YS,7??[#9?E._/7HK\FG;2^NPERPO7.@(RO\H+'&=O+;
MQX1IQU%4UX1LO:NV^U+"_9YAM.I: !^\VGL\L#.[7[R_F#$YS++5;5&G_(<=
MU"HGJ(;^QZW#?IT=BR[5/CZMYW(2>T_)1#6>]WMW#\^X\"P][HU++M1$Z6+#
M$W-RIL[K\DNZI7VZ]*P,]]1<5.M"@ZZYO;"PE?VVQCC*L>+N*/4,LK/>\3:B
M9U=.>'YG!F]F.LW4^B.Z%$H%Q@7 E=LK+.QRJZ.;E)[ZQ3:*K^M20HRW?%U$
M<T9]R2/H&?RAJSGZI98K:[9#J@M;V8Y=XAD_Z,H;4.NVISPT3K]-5X1P5QY,
MWK*@ G;+\19O3*Q..MW1X:@^N"U7^DU4)OP\^O'X%J"K?(A-9HXKKOS=V++)
M&'=E9]"33V->;*>$+??4/69E?^ XM%=[SF@U=4C=IW4\,*;"95/3L@+KJLPD
ME]GZ20L)9LD;!A+,\[+'SS_VOYX,K]%K9P][FJ?T)5JO@05+/FI9I#]>PFFC
M=F)Z:<7=[?PC;(HN"^FKB6;O4U:NIW,,]%KJ,M!=/:A@2D*1$__+MGG]]^/M
M/&,N#>',Y^/EGVJP?CT\I!K-5EOJV8SBSP0?=6PW[J]R"33+N!%D@EV5PMXZ
M8RYH'K>H<61,_=8ECXO,/8\U<6U;^DD&#;W>4B"-@;6LFJJ72V,RJ<Z2MRN4
MNIC>;*I4G&>K"?6,UZ'+%"1JU#'(ZI _$F+33Z:?_?'IJ.&2A9'2!KPJMG$R
M\-;A;P5X%;1^^-#6 ?AV;6^NI8.+];E[+MDG*HIM-^Q\%E)5N3XMOO8T4P&U
M"817XT_NMX4%NJ:HU$-3HA^7JTXHGRM'/Y6SOPT1Q;VB2+/9+D]_Q ^RI3=6
M0X6ONMBXBM7UM0QSD%_118I>HBR<BNW.XM1SRT@?&5)GCWW$YM-G0.O'R)IW
MK>R/2#]6FV/K&*W12U/L.O$8?';PLH>2>SJP"I.9S8<9<_VTU"]1V6R;&;<R
MFWK&V7QPK\U'[CRCE1G7HR-@BP4O3!R_8?;[\66CG&6"HI(/#__SU\/&UQF_
M-F?,:[&<.1/R3>DY6^A5D?2?#2>P?B2QW)['IWM+IO1N1AR<N'G H!-R>'X+
M)-4^A;G)ZHYY10(330M7(,<:5 _7%E0A1[T",_2=>?J[[UCJN?/%IC^"+(Z\
M#\V_.[.I]R-$M1X290RQ@):Y8-><G'OTK)T-P"YU&+&ZPJ0GOC>Y1+K>D59+
M4NA=[KC%6MBUCPP;].Z\>609?7B@H>BR"-O)&ZMQH.X$#3O;"Z9JF6E%U4*,
M]55N[%..^PV*%J7)C[R&TI>[,6S=#&<UM46UF6".31%S/YB4YZ*JB=ZECL&*
M'\N_*T E12+0?9K29=X/'.+,<VI]84 'MP&F 9BPB6\.D0=C/3) G,Z[+LX%
M3A3^"+W^'5WKMJE+4@\3[*!B'MW%5V]%.$Z,F)QYPE^'(9J/&:5):DN45>H4
MM6;["_#X)VH4)]+5DXVUMY2\Q]CY9LO7*.QCT'WP"Z\N*:VWE8.5JD&<4KAP
M9^^H\]F<L@QNXCV=O-:F96IW/N$LX<VXZH%D:5.C\MXYWZ0N"89A9,-S,T[E
MARR73PO1W0 0:!!WJ3P5" \PK"T960ZH%S"7+MLH7ILUFXFULYL8M668"1I!
M*_*(>LCUP9N_]\WCE7$3MR;A+E5-SZ5(E0\>R:8Q?C^#>]BDMNBC/5G;5'K"
MA/PZ/"]K=,FE=/1K/+0DCUE&_JURM)Q:N"/=RR,YJJ%)6YP<-ES#YB2YS.$V
M#K]7*WWJ[UFD:HS.1;)%QLB,?G);0>UF;.U2@8A3MP[YR<R^\WLG*'1$_F#R
MQOKZ5X&EQ5!>E^S0\U:#5MF)'B/=+@E\2;P[ITVS3).7J,#AO(\?<;$9R_M>
M\7[>68ZEJ3<D8!1+5UOSAMGCH.QS=^)U>P)2_G(Z8F3!'%NR" \>S#6?6"Q[
MXXH@M=IVXE!?-FL]L4%G1*E 9H*Y=BP5"#IWN,X*/12+'JJ.#?A M!_N>5UU
M\55 Z<[YUOV<;Q *%R)BF'R3)P6YLUAP_PL5R-(]1P6>PUDA^(U29P(%B9=/
M<2/S6]3%_FV.LI5[^STH4WAW^P&8N2_1.FHZH>O791E%FI3LMO0^Q'H/V^MH
M*O"./K@2_I!802O8SE>F4E#R\51@GZ' 2OMO2N@,.?E B*SP#O5L_0843ID*
M;.K(+/A-@?8"OLN U\8"8;2J4>\<I0^? X9?[77E.?B^O%D$GY9R0Y "_ET0
MA"NR]0CJ<[ !T^"IX*,5$!I:MG^IPPGG0%/JOU0GTMJ%-SL?:76T*ZT0]Y:'
MX[>P+L'CE,G9#"J@I;LSX/HW"P<ZN04XST\OCP195XS5[^53$B!IOQ3ZVG>"
M'-3XT1&^U!CM5T2SHK\EW *,A?KIP8>="2;(G3WQ!%J]-_LW:;I6=!1!>R!:
MH;;',=\&QW10@1EV*I!T29($Q:YI@NR&O;I>;V^ZB<#G!\M.O;@4'IL\L&VG
MS(7TQY)%;F'&*L<E7N]LE=#JXU?%+]1YB2K:,E3@R+>DDQ'%\6,Z L%.=.]&
M?(?TYY'+H<2.[9A&5W!.7&[4 AAK00P"#Y20\_)&%2SS9:D [ ;-=\^.T1J1
MN?$6%7)U'NFF!<UY0G$WV*&H="IP%CWV: Y_VZ@/LLBU]\:*ZRNMNRI&TSQ7
M5W2LR]O%X32M*'YX9[^7G#S[$SY S#!X%6"UQ-J^I=>_9[SZD J 32D&5* C
M8LB)"F!>!.%H;OI6&K6@Y#<$FL61-\A4H!I#B<D^<&ZE'2K!_4B[N%,UQ/>"
M),1(\0JR-L*^A/3(?/NRTU$61ZNK5^#[-QQ,M3R0N-056LE>AK//1]=;3%KH
M@O%++RDTIS7ITO181.^3J\OVZ7YYC2=[N2K ?)_FZK,@ZZS&L\/%MBCYN-*H
MDH?Y6@7FK9Z<7:<\I&>J.1JDU?-G+B$?70A"#]6FN_LXP&QS7KY;?_5_HNE,
MW+]B"?F_<%(?[3!0^?MONIC8G; J?FPXF8-SGRJY!]F+9-]EW\IBI& B>E$;
MV3H$F/HO2N'_J 68_$OO@QR#72?7-@3.(,- G&7".,H+;SP8+:1<BZO*3"5
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M6-;S!L"5E$'Y5%6UDD9/GC;?1;[]H^L-D51@,9T&=N$:]F>H+2XJ\ ER<"5
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M'<F\3#M6Y76Z#C,>E]=*ZX[L#AXBOBI![*;G_0\N;\$^DW<=TC=69"B<=%1
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M!?<%VYM0])-0BEA%JN9A]N-.^L5.HE:&@AL\]J-S3P[>>F]^+X@L[:OE51B
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MV1H<.N_[F[".7=6H=_YZSOTJ,)WA%D4"1#>WYI$B]8D. M^_+/?RE6Q$2[7
MZ7E&=<](?>(2L<'DH/O/=X>L,3OIU3>3>T:>6[*$&@9OE\[YUS,,>C%;2 J7
M#M464&Q1?=*8TW,]  G1*-!$=W$5.<59J4H_6D[X@*:*]<, XL<%J)MZ?Q-M
M,U.]PSXM+*!7?]O<>55ZAN._'SP4$7T+,/]Z4A<.""+NH\#<=@2IAD"/I<E:
MEV0S9X$ 3#RTUYXU?#HZ=/XMP!$U"#6:\T]@#^)TS)6XXK)2.)PQREFZ.E(
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M\>N+S[NSJ[99!):5,FRGA\<2U,T8X( XY'( E?ORSP\U-NC^7IA:%4NH-P;
MRK9HF2ITE1D\#>[UYOJCS\P?EWJBU\!DV4D 0KUE;-)RI0WF3J1,LVMI9)KQ
MHH=&Q(@Y_ :#VUC&&,>^W \,@"CVP,]UL=YIF)BS?JI7YJIKU5/,<3G3!:L)
M3X>_UE)13/K2\?(;7<9]U$LN'FU3U_#L"QEYQ/EL^XM1 ;&0FNPC!86>!PM6
M(4*Y_($#:>#;!^-BO*RQ'6].@8DQJ"G<H.U0*T !0=Q;!@KX*C?&?6>87*#T
M4_[:TTYCI4HK*9!#$DX/>W"#\3.4$6N)N1=KY"Z\=$L'+!O%H?+AY4%P;!R3
MR1YM)^S%-99^_\VYDI0R9U>X0I:'=/7@VWT\Y?P*:ZJDT H[/$*6KSQ?/B2W
MXXI,RSY;K+@<.[9?8RUQ*4_WTHU=;M ]M[:^<+X8$Y-!#BSD[A%]^YIE[N;9
M"[?-NBP?>I)P+I*_:DAU%&*L<,T*'S@/'>.PO%#8.$W0\RW@.HK]LM6OHZ/3
M$O=(U$%H\T6O%P1&KXV[TCNY)P#RTR5';+OI37B LR1F$XELIC8IM&1/I62_
MJH;6.%O]V'I#[8,!C!7YFYA8]BE1DWD)X;#LR>GQR?%$6]"X?G*7:/KN(Q&1
MWH&YT:_N$E;.JIJ9"QVC-5/?>L]/1\QF^'D:H67YR8N*;KU#2@.&@P(7ZZM1
MH[L2:O394*?,P 2\LP76^VV[R)T>1S"1%[\Y!B KHS<C]=D[:B"98RW6M(#8
M%.?YD$@Z$'XY[.5[:=MFD8B ;%>+L^1JTQ[/B+T>T)=/$XI8J'FV.Z$KK(S^
M G:MI,)W?A7JD!^]$-!89[C0LY+!LQ2RH]Y<3OA@PG3'//*!-?A@H)F"[=$/
M9@!"DQ-7,A9W_,@&-CG=?]ZSX^E%NKMW.1<\>EJ3HK^?NRB(FJ,6E+BVIK+O
ME)QJ&DO6.X#DY;79W63HXH\"PJ1Q4T1.V8HEF9&C2QK[ =[,0V48@-&<CGC.
M?]!8CZ"S"VI_IS38R*5Q4IOC,,E)I$ 'Z8-@.FQE>C@L+OW5I7JIZ90.'CAT
M?&^I1,''GHJWT9B>I/^:G+AMN(68TF62]7M':R)S)K+]T!0ZF#1VPY7<B=(1
MY*&3X=SN=:Y\4W[8-BMFD,_G^VRAY6W18;;ZC.4C/4=W>].8Y?+PC:F.54E)
MGD 4%P+\;.3(F@H9H5A1X3\M6'?X>3C354/(BAWOH1&^F72X'.MBM76(^F1[
M<#VOB_H/(3=T^D(=WVJ3I>SFUK.XGU6?\N=S0(7THLX_>UU:^X+ >![*^_Q-
M;DY^WSVDIZP9#'=Z+D/(+MY][>*$<61'X.*:)S$8PQ9)?<[1M6B&4?"">,)4
M6_53>ZG)([=WTE8&D5_\+&P:94<LZUR7(U.B,NDYZM=47TC>[TWS>V17!MGA
M<M6KC:O+'#IXV:=3P+[=LVBIUZ)[=7A^=&]EA,<AS&#MQ<4[5&V.SW5.M^C#
M)?84CKJ_6Y@2-)6'2!E2>T%F )Z_.LSJFE%=59NDOQK?,=WBM'Y-(O?Q'P:H
MS?*14$3JCZ%L!>*7E/6L95O(R!%&:^T2Q&ZBX"6JB=ZEG;U*PIOQ9^[(/(Q)
M\,Q:7(;D<YY,68;Y=GWQPU[H7A287\D9/U!2?/,TNGA#J5G?BK1S\%[4DUW[
M'^>&^SETUNVD%)K==*O:[LB+C,*<_>U7E&O#2OC#]=?W=P+".1,4WC<ZWF1R
MS$TJ-JF4:*]S&#F(\!4\\Q!<#"$<'_](CA<#K:-E?HAJ^%20^_V7(<8IN-,6
MNMM()JO ^P-WM-:]#<0X21_/Y7"=)?+6_.S+&\3HS?WV*E2N]=*W!NZ8!9?W
MJ081T-MR^MB#T+!1P.)S-&T![!YN=<"2>O!BHKMN*]_:I?;4M[E^W/.Q+ \P
MLLYB\>=@T_G=HN'$74OVKK@)^_X+4&^]<U8S_U1W5%LK:]@'#AXEZ0X!G!,9
MRK#Y';-:Z05/827H<?1C0@Q0*V(]3#?QJ[L1;GMU:0+HP['V>/B$X<<<X71>
M M)Y1< &1B;)+Q3MS!W_U=7:EI:#:XJX,VSZWOJS8W'UN)Y]_)8*"E=XOMZU
M7IMH2KV+Y;?JDMV:0>RL!_(9J:0O$="V'8ABY3/';^B!8O9K.JD*H'JY693K
M:8%S26V 4EGPZJQ,PHW7HL^R;ONL6RSEG!9XN[54U#/5%4:&A#SRB9"(:11!
M#:,=<#8%_SA J.6"#]I IQ#T1U,<CF:TD-=0@G.S]D\'2Z99"4,]Z8O^[:=4
M[84>=CWH#A;&C@W=L'U(J_5\1( ;NN(FDV=F+HW]4+=US(V3Z:8&(:O\;_75
M":N+LK&NR1E1LH\X6Y:C=Q4=^S.R\LHEV0,/@^,]#)^09JS +WAXA-Q6QG:,
M]MD6U[N8X):63/;+,D9DD*SNS :MHU\9#>5/9O1DLI"C@]<-/OGIJ/0\_P@^
M&N!SP0!FMA'/SYX'[\30R&NUKY7R=S?Y04QSJER%'2_=0#E*W7%DK$6B/RF^
M&SD\(B)E_C#]:JL1:MA']\8E8F%G-MII5=/!;/3>%]B9P=9GO1\!H!?J=>HQ
M(@?R+9>YN,'APL1$3U4_QZ' BUK8(^N8\$7#L%J8"=:KVTJ\G-OD8%\D7FEQ
MXZ3S3.JQ=LW5D<MJY_-<'_G)5XT!2HLX/[K[*#E3PEJUXH(*N"W%>2@;)G8R
M'O;ES7$(7)%Z]BY8D+FSTX7=[KOXNT]2T6@R1<]ZY_WR7T\QG#@XI*DO#PRX
ML!MX3.[;1GFU),S:T.B*MI9V:O ]0YK72@^!7 &<UFEDB!9")<A#ENN8BU[$
M4ZN-+0@><)KU,?;,4X>4\?GWGXR?[3@#\T,9:=[Q)?E*R)"$W.$3]9>E>=#,
M'/%\&76]8;PB8<P_ .5N%LT:JW#9I?FZF'V T4@:W<D%. XKRP#J]0WE0UP)
MBP>+'-J.S (E(C*TS$31[:P^R#%!0]M%,)F>EHZKG8OY8!O:)9]S-SW<\+O4
MM6''MQ.A%!WGSHR:BQVO6G19!U$2PB>4)_&L*CKF6L9?#V<$#*_0WH[XAO?A
M:L2+4'L=M^^J !'.CRO>C\1X<*8GY#)3]R7+A,<+F#:Z3W%Z.BM0Q9^6/C/Z
ML<7G620PKO@G%CR>S*N(>M-P\@UFO3*EU=8@8"&D[?LZ,G+:>7E,Y[7@#DE7
M2[7@:LSWYI,0^HX$VO2?M"IB9!V2'^WN7;FD])EW+9AJWG_R?:-P0Y@J;W3+
M@GAL\G%;%MG*>72%E7V/=3^.:AG7\S&YH5V> A,%"P4'/@6! (+@:_*"QI48
MX.;C>M;]\KBT;MR-DX=0\YFGS7?DA;<K5,2\F]0Q@)M ZK4I/61BZSZ\-2)N
M(?GN6;A"C;W@=M?$QW=^@60=,W5UJA!*7D1%8.K9#LK,E;/.24]C\B?IY2&#
M;3EXWO4TOS@86'&8H]*9,#\Y%P[<,2ANJ.PHK2TW&*WX>.5YMGB&-]&VU9QC
M(CZCJA$RL?D$?6_ RF$K-/63\://'H@.$A69(Z.W-"!E510%'+)(2K Q5O$\
MVVW@RZZJY'H\34:JN[5:*V"%/4?B1"]RN9C&\@O<#+F$=$1IZPC>?1V[GK:<
M<\5U1Z/$5'0O"'[,5CMJ=:0M\7P0YVI,6IJ.V:!/_/5D^6GYI<JE<-%O$7A>
MK/LIV=^GPPA5/LA_UC8KF?0Z.!A4_%(9;KP>(-(4WIZP;8H;-2S. =<NSW1.
M1P:O6*\6*UB8.I+.3CVYLW1:(]6[B@O+]\Q]\F1LUUJ08X?O%%)9GM#QM,'*
MI4E[EE^N*A3,*X(G)+T1GI5D-<:UC_L$/3C$=4ROP\:EIS5H1)W@P#>=Z'AH
M6Q''6"C?.#]O,NHMFO" 0S-A<916\S%_6I'JVQ_D_-YR>G %J:N&6%2HZJE+
M@C6CM!,3@\03M3D<9P2[,\C)\/O)Y9F!&ZP$X_G@YH?Y=8MP:]VD&Y)=8F9J
M] 'GWY?:DYK[:VM\3H+NX?S\AJS0NMQ9+<(/2+=2&WKAPQZ#?V'_G* (NVD?
MXF=G6N*W:ID><HJ_J"[A0=5LJ45ZHYN>40J!/.%'^>7!0"-B+(1E[%MU<65Y
M](M1SOV3Q!N!G*EK%NDD3$*-S:0O;EYGME8'[9-3#NYLHR#7;SBG=Q:P^'1-
M\E]-X=^I6,.]&( [_?("GK@ZD\!,)$9:BAKQ>$NC%#@LGZK2LJ;\P!GUYCV.
MH) W^:XYL5%.G-<Y9F;M5C[41AS,%WOX#F^-AE'L9 T8*$3$%MW9X-M$L]54
MU116)SA9L%(-Z+!0E#]2>O=0.=QEX[@3)3&DZ>"3-]N:5E^1<R]V%P,\>;6L
M<X^]TV8M[HS@<->VU=$!IT,+:=U"1SK.4C2V/,RE=J(=,K?S]/!;%!6(4[F0
MQ6IH"'QI6+3@Z8J23YN:4\C2V:#HN.%.OT(HX&(@^?;&_([("=QMV5'Q;BF,
M8=S"S2F"Z-"<@-.18X.'2/:>.A?3>!]):SC_&"Y(BJ3ZEVM85>?>.JAE'I2V
M006;3%B./(-3@..(2TV8Y?GG=_!\KWAK%MH\O$$O6IY)%9(QNTE->\#%[+K<
MKI.3&;'.0;V CF!+7%C/+Z!\69!M<*KTF43+!(CI.U72I[[\? OG"G8I8Q^Z
MZ_8]1NU2/.!L;=>7]*SG./.\JFB/*!D&D!7-YB8*7SS4C;WCRJ,HRVO;+T@R
M9-<NH[+1QTZWE*XY^11,N"0JA"@-K?!-=3S_U*DZX-/,<G]%XZ8T_B<9TS$0
M*\="0V!L'T V@?2]3^XR_-8S_RY1E*?6;69##/ BJH8 N,\?#KD26]4',H]S
MLPZ(=]BJ8QMZ59T@9@'9J2*84F!YV/V.1#/^"9">G4H@FE*2BXPO*)TCI3#$
M*^<0S H:ZJRL((\G^'P#]L6;M!!5(H$!?*W*;@B:-2S<'8$;#7,9>A-J/I9[
MOQ7:19"T8]PN#MO23N .,5R8$:(G%AHDI!<I*29T:;JS'&6#_U(^=QBG;5,X
MA1GA/+F70>$2(><_.TO#R;ESJB>0Z/OSML&/AXW37LF%]F/M=SI]/N\/K<OA
M>4IGC;$L,-ZMY<G?/%=,B2"!?>V8L_)=L":*$!CDY??:/@B^ >"T,Z'^9EHH
MVQN"RW@H=-],NNAR0$NFGNG#-.O53/&\/_V\92X=\QGQ<D7)Y2>SC\E_96*U
M)ZT2+=(W3DZ$E.Z6959?3_/G]9/!!0B -?#"K;&I-2B].0?/J4%Q*1ETCNW.
M'/)2O6J?JFP^DQP9JKVI)61S7A:J2*%-N@>YP75P7LTD&J,<)?;<(JTC-/QK
MI#]!80?+H/?U94TR'1K1AQU&C_#<@AWM)/'TMK5[+)J?H"5*?T8IW$6OY.5H
M4JR'%Z=B ".JZDW@0=WQ97G\^S'J.#*MJ6R<S/BF>S^!=RF/6$G;\M1!_Y95
ME"(MJMP'!1; N6NKQ 7-#*'BZE3.RNV\P\RXYJ*%[]MN+'N*A6?&>>^^3Q_L
M=X%I)6ZK1SBLNGNOKFBC-9_9=I(T5;<JY0 TN-Y7N0 [4>.B?%/G6#JK.D+S
MXEEY.PPPF>#9$&=I08<:R)NPNJ$B*V<[%ZWCJ#16*L9#OCZ6H)9..LEI?<?4
M.(+5Z-FV'/,Y64<>!L#M\9H%!3/**0;(5Y895VAK6-4/4@F*1/ ,)]?8IYCB
M>F&W*<%D;"86CU/JL9),+!ZT=Q.>8/%@35B!%Z 4%Y&CB^U=B-XH5/O=F:J$
M$Z/M)K['+=>7K69G<[*"G0-OZY&[3"D,&.,<7=" RZS2]"-9$T^TLQE_Z'-@
M@#HZ=7TIAOC_O?',,JOGK"D>V3FR)IML-8+:1IJYOF^%6U_'BU%QE0=HQV?J
MMX1(1'.Z]H4#=E#*:=,;8[32S-WV]\X6/C%DA*QW_G@HF>8M>"\/C+?U"OFA
MJ=IQ9S!'M]18+ 92S29[_Q[3U$B1]F= #1)8MI"FT=W_F.<8?$?>TF$X1D4[
M+23J^XVU,@MUQO1&4)"X28ZY,,OCX=1!(ZK)]R>PVMK2:&-NEOCJV[T/TXM6
MO:DL\77V!>LSQA)Z9D-,LK6DF(M+7RO 197X;U-DBP6).S/8MJMO,E&.PJ=4
M:@90,G85AYIWRTI% _8LOT;:7LRDFMCC](U)CHP.2-%H,378NV;KF<55>[:6
MCCZ^>V'?1CZ[GR#1K7\6].-V,>D+1_$EIRKK0#K026R\]??)#5[S\]'H>[5#
M7V.7IPH2PVHK=WQ?DN+C2I8-:G6/415V=I(E4P;G7@,BDZZ(7IKB$OYW@G%&
M%E-[Q5\,G[VKKJF$/I@=O3K#VBOK]/W\BKP(<$7^2@TCQSRZ[+OLW9'CC,$*
M.RZ!CE@YR&GFIYN00BG\[%SP-0&1/6Y'/;)>GQ4*(9BQ!NY*RY?#ZT=<;/.>
MZ5K'6IV9<NXLXUUV.;R9=#'I/>SY-2P_RTA]SY/S9(Y@Y(+3N8.,NC,$#>5(
M5:%+IXK!RM(44T?"9%'TR+:@V!O7\F(&5):8CH9-AXU-\[J--.61I>M8&YSD
M4:U0->K9U9/P1;V'.+$5G'@=D&]S,-"L3"8!7$*Q:$*18'@Z6RY6P<+QH&@-
MJ[J<02E719LF3S6&=^ "4_<%KUZ\L-&5)\PZIWO(WFWS; E79._,F"-H</0&
M6\RHR)+*]JY-#O"3]81R4^^&AV@"Q ]>L!8@[ZFG%*K@Z)GN:U#U!G;_0XKV
M,DM*4I*MQC#L3O^I71*1;0Q]-J)]GT\@PC>$P<UB\WQEY'@DLR6JJ@QD$KY
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MAS 0FD>U$^1R,B_+7J>]3BJSH6[Z?R4;6;7 H4M"_O',I+1#>EH/727H2ZZ
MNO1A4&5-6G)X2-:&QX2&MI9MQ/3C;)3?F[3@*RIVSM&56(Z0_Z+TB:VAI<.
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MVP3I]+U@BF$#' #_SKP"H7\B48T,"%C7(#UD<9$EM%&FP#Z#=9A#8ZQ41"O
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M=*O*2*,,!"76#;?1$A M6?ZB%.3K]%KIJ9G^BJIHF ?.EX)7Q"GOPUM"V@S
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M:4N.RUYPS"9<[.>RH"<EF#0"Y@149E<&"[:&5) SK/A?'WI&TL9P#Q.%^T2
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M%I:O63]1_?SMC4Z]RIH,)L3SAK1?AP RA6-\%^D/$!E<!Y/8-<@:NT2.*WF
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M82#D?J\3@K"%TQ *&YRZ:+48'_#2?$]7>AUJI0S3W&U=;E;MM$!T!Y3HQEM
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MEH.J,5RY,J&/]UB0,VZ:GA#O"^+)Y$@<J6Y4G[\FC/>3;_TQCO?<HWLKVQ'
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M,;>= FC-(2L=-C(XX>3,Z"^@4)D<Y'-'^A*^EXX9790K) G$L3)2:.8E['!
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M&,V9-%?@B;*TF(2Q);NW[1PU2XG$'TVT[HRK!A9KL9\AHFV'?I_2C%,B2F:
M^U+[\#'[P#K&V016VE?D%[MC*^7<R #E09]?\KG(46?,!=.W:2"%G@[Y%)/1
MHT9_C=Y->$#/]T3-X#L  , 7[QK<OWSM;_U;__^MG*<3_P]02P,$%     @
MV#N/6DA E*2)Q $ WP<" !0   !A9'9M+3(P,C0Q,C,Q7V<R+FIP9YRZ5T!3
M7_0U&*1)%Z1W!:3WWH*(=.D]""B]2.\U"M*;=.G2FQ"1)C5T! 2$T#L!I9<@
MA  A&7[_;[Z9EWF8F9U[[T/.N;E[G7/V7FOG7.PB=A/P2$M-4PV @X,#>'/_
M 6!7 "H W </_CON#>_^P'^(CX^'AT],2$CPD)28E)2$F(2$C)SJ$1DY)3D)
MR2/:1Y2/J6EH:$@IZ.AIJ>FIJ&FH__L1'-S[>_#PB?#QB:C)2,BH_S\;MA=
M^? !#)\>%^<IX $E#BXE#G80P 8 X.#C_(\!_D_#>7#O(P'A0R)BDOL.+8\
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M/S^H82N^ZS.<&.KX>?MAK5S1CXD0R/'"?QP2"SUZ!KXP6HB,&,4"SFVZ!+$
M3YL;34G?/F'')61[Y=,VY!\YA=.,/$:K%7^8W0K8&?(^0@#5C;!E*J1E<I9
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M4IEMYH4"U#VO07O!>&C@?/XK!/5]\,8!)_OOA54+_F"1]RU4@/X5N$OTT$;
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MO>[\>ISK:'@VNZ18+A5#]@OM8&ZW+#U^R<HF"YJ[]KL2QS?^ZF1([U/?U$1
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M;1@/,?B0Z[96>[A=='&BI#]]DK/O0Q!DDQK'O.WXELH&J]%YEO)1LZ>"&_L
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M66SI0"!0X<.8'M$U,4ZC3X2B#%;"4[TX'')&%P]DXN9^^C[]8/_/C]S<S<\
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M^APY(*;*R((%[*(TLC]BB%TF)^#KN,9=RN]<'19MV(Z;[[.1L04XD87-?:]
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M8$,U4\+".P_3:';T35^/SIA-#D%SW0+^.ZTN@,(+L)LHD=X4(N#/(.;0^:2
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MS+P"81G-0IL2QC20Y*=Y:/GF_;J;3:X.L]=N9&F)<GS K>T+4 "O4%CH]8P
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MNKWE\,'J5V2LO!>8U73,H"^=?_N"VI;^N\)6N48[#TR_@G/5GT"I)%>!*WD
M6'59\_\ A=U+1/T%5"38$78L_E4F)HS;&;^8 )8)6."]FW_FAE)OQ(^0H?\)
MF;->/_HW];]9)N >\1^8,A^$RAGZE^@0%;@!9%"0G('^NQ=T_DVZ>+,>UK?2
M^4_ 6KV\P%N;CO4?Q2"(;@?JT+] ;,9L>PK_D\&2;VR6(<0'ZWN)L#^%*:Q
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MG; RW!HVF0M!V#@C$/S1]SW%2L.=9)LY[F>LA3I17Q=&J LI0"O)/= -.PK
MB%W1[L-NA1L"6]G!2TOL[ ;Y]N;AX^,,5I?B=$\$?7A<>+8:H(NRF8+Y<M)U
M%0N>\N[8P]2J!^X%OG#A$%<S0%K@%$GB#A^&3/6K$ID4+UL]\G>ACIEN<1\Z
M4D-GKMJ6T#0@>X9D3(P@V"@10_*6F<;/?L1'!+HDN-U1%=^7] P),Y32BQ&)
M3!4_=,'TM F=(V+H J?^DVKJ+C:!T@SW6,7"/N>0?1,]E8J7%I^K/KTS]W4?
M?&+"H:2K=?/(.;9R^#6D"'$5IW[6'3()]Y=F3"9:U)ER$=S\L27ST?N2<BD+
MGS52+_2S2\R%H9TZSUE!XY+NZ1=4ZX8TH8L5PF592=>)@Z*JPG*])"_\N(E,
M-ZY_W%*D7;=_._+#ZSL](J\^:O/9!N@=PHVRY-@!4'U-XZ8Z(NE1F;#*M%$E
MDYV:ZYFT_)<6?*>'LC3^H.>.5K1X8E?707OJH=\L1GF7=N?]E[ZJ2\@[Q!#<
M!/UZW/RD[#LS5-JUDK7Y/KJ"B8FF)NT=7O</VU"K5P^B=)_+SB17(8GQ! I0
M'Y&'A'PB6IT,]+(C"*\*TN^413.4E!A1N7'4YJK1,FI^:8J<>W#>O<0CI)U8
MLO..T%1' ?Q1G'-]=DA8)G%D*B(*/VYHJ'XR(5-!ID+O5+E1T2KW8[[0T"HG
MQW?T?L' 7F(PW@N"0]?#("13/"R@ L$<8-%3X? $Y63&Z7>TWLE*V"A9=<?#
M/.8>L_4C1^G98+JBQ[L/A*A>]X')ILZX");[>D@5;U/&PGR]X;T<E-G1'#G!
M(=;S?>,MM)CXBH*PVQ)/Q1V!<QK4O2X)GC@9'M5^D;'+Z_<+B_M<+EPM*(B;
M.N.9=";@=?V+-:_GOB.WJ\^_UPLA@YG,4HSQSW'B1]=# V2/74UO<\DP<!]*
M-$IXY$SWAV7RVDC+K;LVE<B-1NV-]&KHBS*B#[0A(FSB$R3LXB<[4>G;239E
M'PH]C@1 I-0^1[=-^)3;KUA02710*P-[W<&[;CM[A<6]TN)XW^'].C0^=JB-
MP*6LY P5&%<OR0I8%EK]XARTMOB25:\W.&/_VN PID$P]/LX'7X&"G&6$BOL
M[JSS:#6(-]&5,$BMB&%WN%1!*XVPS[E4^EHQDIJ'MPCP,I%'EDQ2@&$GG3Y9
M4:);]77B_A0F EX?(QG"7752U\J9M]RR7][H];YMNOL@L['/H<O"U1W44+S1
MM%ZX-Q.)EH@E0)NJ>#X1PD.F\E!P7WX1 ^/;;I>^ZC5*1 JDE[][])EG1A^9
M;*8+3_A\JAIJK0D70/(>9.>+8D)D(7CSK&E, /;4)8)J0AN&Q+L?UFWY74-N
M7EK;? DE>?G6E'D]CS,RHW/C0.&_;A'_R7$?6+U B&Y$'48R8]P[5?'V_C@X
MK64<:L1^>+G>2=\TADZ.^VE>:',=NZ+9M7GN!V8\0S;56 1B5Q@= MLY$DL!
M[A@"(3B%QO67< @2.K4*U\.7^#N_VT8P+,3Q:0[9B$MF%U?.MC9(B2T;J0O(
MZ[([S!U6:IZF[B?Q$!1J$F5[UM<KKN-6:>M=)3T9*DJ[7:[8IWQ^('Z:ZU[]
MA2;IZ6!\Q(B-\J<!;SJ23(\+KR)B:[F3G6@]/M<_1=4@HN[)5B:9R*H<=5SZ
ME"7!/Y<-L6J!:UZ]$-XG4'6F7.UCIN:%X!WYT%>2;_2><#['/9=IDB.63L(9
M3$R-+,=%\#L8)PL+SA0G^O"<(YU'<X,^*4CY.^J**>B>]-;*/2YQ,6$2'L)Y
MG)BTLTZ40SZ9H@!,!X$6PQ3@8[&BH'<GUK53N-5UI-QL6J*COTD.SF;@KLPA
M3J:)QR<XKW(J58B>6)#L#!8YD#T6F;\U42POFVPH>J3Y1*R;\;E,^^.XROON
MA74H)JQ-9\#P1!V_D1I!)M'O@W4_^?* M(P31_M[W6@6[R8+/D)4Z)S[L'R@
MZ^SQSN<G%:F_4>-X_/7JA(BAQ'@%3LXX^0!^HU6"5^2,%3)-/M:UMO'.*<#1
M:':YP8(X,2T.-I, MYC^1"%"9P#IJIL3:\QQT7;3\?;96T\-=/6TZJ0?Z]48
MKM?S4RD>O!11#]!C7J8 -#N1N#9>$_4Z0HK,>$)A_16RR]<'YBSZ(IY/GIX.
M[;K"_86QE)!2SQ8ZP8BU%CS>D#S2GNJ>/O)']S:_X[1*W[:2\UO4IQ3Z&TT/
M,T;OZC"9QTBD)3(94)76-A\']E2,#S**O*#3ZH%%&01(P$6B39;[G?5Z+?=$
MF]Y3@>$;P^,72V0M UL1TN&W+WV>*H=:?I.^G4;,N5?4MZ6JW*G?C3BE8N>5
MT1%=<X,S-.K"M;I1MEW7CJ8Z[\L'A;(0TR%C V**:B'1RLLM=>FKUN1U9K'(
MM*^(YM&N\K"VH4&W_)Z=V_Y\*[+\@]4A] D9]5[V4NY<+(IO$F^>R%P1EWH/
M66<#$J=W,-U(\632HU*"_6ND3"9)_'U\@HQ]Q0ZV^ W58"<M YQ(Y&FC]?M\
MJRTZ-+&U<]HML(@?4HO&?]R.@)"D"*:55G3+4^UZQC[F2L8"#^5X8IY<^WKJ
M#;RR&L-TD%QU;F'O^^K+?=DQX]1JZ_;,NJR1ILN#B.[:TUZ/+ZM%S!K3+R>^
MXTK"R RL"8A 0RA $5/$M'H0)X _X9Z_Q/(AHLGP2(F3]9Z<?JHF?VHZ><C\
M[L.GZ0Q*)Q2_&AU8^Q[:L0@C7W)7F$H(JUP/E=9)=M?JP*E?9@]ST@SHN D_
MLJ+[YC53-0_5^Q/>282SM67W(M*MOX]?[EHIRM.4&X0;PQO.@?>$E4_PG1%C
M#\6-)TJ[]TMNJ2)K\I JI43F+*0@7K0I6%IP*K 8?Q%&XIL(>L97LPV[].%E
M[B.??/X9@Y'O3A6JPA*["C%-?%4RDS#((-%OQ^T@VCG!L)6WC8&8EWFU**YK
M=?HP>]Z#QL2[+XJLTT4.\W1\2U)[:DFU)5XG>ZT+:9,TO&S*V;<BNLJV<+VD
M5Z3M=6G)6U[&1V"\!Y\\>/K,5TKO%8G_(-W>^S+2=D":1O"Y"_:$P9!E3MZ0
MM>SYB\-SY+-N_/G@Q199Q6#AW_I.N5R )DSNL%=KE>RW*FFD2!\,T;9?#@M*
M9"@OJB2B,A:9"FOR1B35O0YRG+U;0Z'T8AR0&%G$._<9#>I!T3EX(;Q^3'N:
MN09^TAUKZ-LQH-WKW3/7\"#\%2;6B4^E2/@ZE._!^^@6F/+6,%Y]4)VLJO?W
ME,MP: %ZJD*%0*54$0PYZ@Y5(8BH6']G9I9L"E*+945.G7]QJ;A..I!.R27L
MF/;)^H\*I+/$@@RD ]$(;#?LB[JQ8DQQ17],/*X 5(Z\Y)+GLPNG,>!R:9Z<
MEEEN0=D(#FLU38W-Q>([%0FN?N!M=8Z8/93@LGYJO,'&ZL/@F99+^Q[AO@:.
M' ]?0!/EVY!!?4LP8$6:.IG$@R>'X0<,>[;!G7Y1R"N@?U\-&[[-_1@F)5(0
ME7?AD4$!Z0]WAD/*FSC7+,3^'U:PD_WC7Q=BO4]5#LQ\N4(!K)A/C0]79[.[
MCOE;.-X;G1$\_YASN8$M)B6%Z$W>5.SF'MB62+X\HAKN/BG<TG6_Y<*)D.BH
MT5>'JLW\9?FS*$#+GCN"W)(.OLI0E:WT;*JZU"7--7F@K4.XM!5G[D]GA!!,
ML=)>(90>?RS(W,Z6O_+N]F$AVAB-M.?4:"+8/8(053=,D"($S(LM"G!RN3T)
M52O_T"791CW;T'B$O]KWB7G4\-AT) =NVNS8247$Z^"%*AGBI@;1"*_05'6]
M.^GSE]XMCI.;6I^#"09)'A?]$^3\GSQ*S6RF.RD5C(>\&#!E#=SY6(#P(_,@
M.(G:6OBQ%H)W\G#A,F&PC:$@3)I>2R]&DROF"_2)\)L3>>>#SACO3:R"I7H9
M30@D-\BH4P"EU \0-7Q'FD#Q5"6/1H*F>7E1L)M^S0G65]>IN G1RZ:"^_K>
M?4_)7ZN@!5^*\%_'A?OS&?-3NR<KF)*'&V]RA1N5/KZRK_DX\7CU2(S5+8Z3
M,F[5\(V+1#=RS>>)O:LV..@(5S7V#!*&QTQWAHA60FKC\JHJ=F(^[]6Z!\^8
M#"Z>,FG:4=%?I0^H5BEL.W]VLD7X_:OL*U3KK;Q2=3U+ Y+\J66K;V(2<CZ9
MXP;4*SR_<-DFGK$(ONP0ZF@&3[/\1LTXC6"'NR-T@H>'>=W"DLZ<O59PDZ^N
M$'+;F *0^.V,R%XKV/5 "H#+).91 "Y&[,$S##E@NU%O:!+O?$WC1=J1$04_
MTTK%WB@MF;;:X:+A.3\;3\ED%8&5W ?^4T'3W'MZ] 05G'?.).HEG 8I8X:P
MX(\-<8G/D]Q3>>$:)3']\<L7[=-T@!T^4\J/[FRU='C)U#HIF FZTT,![HEZ
M0%=IP&UU9 <!EGF*!@7HD5E%IE^\)IK!LA)/ZC2/=LQ@VN<:EC;(4?U U#/H
M7>WC])2ZFF]F<.B: 9<Y,.D7&F&XBR&SY32@MTYVH=;K)TBN54'$, K _;T!
MND-;1@&Z^.''!R:>5L']&S6S^.1%+\=-?-NMF&8T]%>\IE7<M158.S%,52\K
M1AA_ESQAL!AI..91/CY^E;%Q,*&1YE5XMI1>+DF#(#K@Z\WF7E*O>[V.?RTR
MU62BAJ,VFEV)0?!B .![_PUK#35' [)X7Q:L"=-OL-5I,'5F,"E82\CN>0IP
M!K9BV(O=BE$F$-&T<M2A_M+2][6#G[E5A(\F%RMOG<N6*B<'#1#A.!L,.U($
M'QN$20G@'8,K%F$3I5PNBD;I:]T[0<-]A<\A2DTJ;G=Z.G#5!#<1@&40Q= O
MQKF&R(3%1L^VN!UIOSIQQ/'<FS<*>C)ECRKK=E 4( J"GR WY(F#YIAA7E(
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MN.E_]8&)U+B(Y*-^KI5':A.Y8REW^OQ/(V4M*Q[T-04>I^KY/J'$RDKQWL5
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M$L.+3/^$CYML8/ G&:4WLB^,&I^@ Q_+<Y8__W9W-L7M-U'>C2[;H21CH^@
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M4GX(# ,]&P6%5XM.KS]3*"+[KYC6UO;0IK+'V@;/>ST6-[>%*#,)MI<SO0B
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M6O5AMY)4UF".P^-&V2*?V[T&WO;5=;N$NP].Q,Q,$1KH (.;+OY)!]HRU^F
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MSWY0<\V:A(2B[Y'QA!?&/8';E5,6([<BW=Q8WM0^U#Z4]F/D*8MPK#+WCA_
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M? +4)=[TU?(@+'7[8VE#.F&J&4[+C1,!Z-N9(:!X'\038[&^N:05_Z0EF&Q
MK9"): =/[V32VE.-0TGJ8-Q0I$VE1YDG=7DW"]YR'#].^L:R=)<!/!11&UST
MT>4AGDT#.R>ACT,*.PD;WO"3)KSW;RJ= 6>5^'B%: B1?1O-8![92]EN+NGP
M-X(](8('1K51?!6*@>[9Q9QI[^0-)#_=@7/*V?!VRF0(U7@OU%@V:4_B^Y!E
M&V5.'A<>9*)\.B3&%L:)]@]4G&H2,%E?G>6Z\)J'$RK?OPQ_]U:&;\VF2:?U
M>=^9KGP_?09>A4M7WTS*J\TZ5&VVY]13&I.GZ V)6HE+:=[*2[Y3KV)=DIZ?
MZ&LK,,C*):GVR2K]6'' D:];F=UJBA_)ULVK/E:?1RW7I$QT'][=$8G5G?:0
MYRZ06[GCT#RYM$3UYM%[N71K:=&A1XM[7O#;OVSAY25DT;3&HO?VX-0#$D7Y
MLC,02G@9:'MK:N^@F9T5>7WG[=Y[\G^7\+P$+"69(YS!G7A M!<PZPYKV1G4
MK@J(0?V&I<#4PX,U237?QV89O<YZB8&U8IM?H.P08OO/[*V6[?G;%H(-.L!-
MD1]*)SXNP$T=)Z>H7]S#C=A<-G@<%6AH%K!V\[8G4W*UV2>S0SCI%TG0D!*)
ME:(<F(7/U(DATU+%JK/OGQTV9WU/D.AO7\E5U_ZA83R0C,M(JNS)6G3%95>^
MTM4F;994K]E2KA"'0OW/(F7+L:66'.2;YRH46B_@*L=:(R/, YYJF I'X<K7
MCS1[PXBCM+ZFVR*5I)S'Q&_R+]^4G5Q5KIOUDN %XM"&G; ^Y]J3BYP(.*3'
M*7#P[:&(E"<\IV7?+)@))USJU-T1>M,D1D#768'J?/HKZ\:ARZ/%87?PE9G-
MR>(OOGW[BF_RP=6$S'XQG@UQCZ_8C=4USQF=W";UXBU;9A#(&\D7U+V=O/Q
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M^-F["GVU/BZ/J]M]^X7%_^U<_3D*5EKY3>L[E:"J*KEK6]WCXW-?F-_6,9,
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M^?3WPL):LA959A+LJA0SZ7>;A6D-ILLS?QXFI _K+Z_\#!">6%OI!O-OV>R
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M+O_I7,(\]9X&>A4;2Y845&J."A?>E*3$T#!6""SSG.0Z<-5?$<UY?==H2K.
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M@^E]7=Q'K"^?NU[9/E^8S66FMLFE<B:]BO'0KB OMRAGUK2S]_W, W3IC19
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M,E@H#WY*;"8!+@/M:P>FH!V#.#4K^?84IN2\->8,MGI$=X\7-KYXI(OMX;O
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M2(_U Z';2F R%Y"Q"04]!TR7G$0#\W-WSU,UNRY^%IDKO+%Q %!]^=%%- _
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M2L[L]/Y9,#<*'U-# _%!_I#/\'^$^-\6!([\I?LZE8%\AP!O@83S*8?NZ =
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M[/@AJRBT))+7Q%;N[8NK3H,@ PT-#P_FJ*(197DM./RX0ERWQ)&;=^5,PV9
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M#%D3;;:5Z3K@+SF!YG?'?NHH@I^<E_O*!60=JCC6:7-&MX03?&-0F?\1 W?
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M?CY12%_R+HNXP.U?NM\<8>G;,"J24@T^L!5GY7UDI6,U5;.5[9^^J]_9\E"
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M]=;B63?9K?%YE(=)IT'\ND!5]NVD24#4E![[[U])9?V!4V5!;8&W*HE^V/0
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M9)<X RV1BF2.2P>WWC+OO#7PWCF0V?\KY]?[W;6S:\RZ?_J+$N52G8PMDZ@
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MX]VI4?X_M[D<TEZ_77H*35V+!,=LYB2X/1C^&O7OK5SB9P;(+W1*JZLDE=?
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M_BE!0W^4P<#$QL3$)L/'Q2?[_YP>?@&(GST9Q,1"1WL)>$*,ADZ,]M '8 0
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ME48*J"TA38W )?<-BCQ;YC=+NQF?XXID^ZLJPZ:92A_G,_D6P:&]&>,]%IL
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M;;Z/C:L9[5[=NXY_!*P^$66PYM2Z->^HC54,/A7!:;EO8O64OQBS S!A5;[
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M,I/RGVC?6V%S-3N75Q)QS>$@O%KNW:U19UG/!P"9FS9T*E.MW/:YIB WDS8
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MOWJG3O&H\VI,Q & )9-P<A9\Q,'"."%M(;)8*@S#7GT[](P[TYLOIN6:B[!
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M9._XZL9LB@@0'XEKF[RV0HJ;S1GF9%?B/6++"=!3_;JQT,^YA7C"Z=FH2#@
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MQ\^KO^K@>DKU^:@ Q\.Q'N]JH%UMB)NH7'VUZ>97ZX^?Y5H89G81!8WBBS
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M-!M!"<N*WHU6%,)1JX[6@_,F4E2S=1R5^<-MQ"141#O?<)#F;/.P<8'I!I%
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M#UNV"DGAZM$MQ;JTQ[[F1K981$B],;K8LIU\L7',JWML6-IR27$BXA7@Z 2
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MGTE)GS=\.=8C.)[I'C1521 #??Q,4)DYV<A!8+S5+RHM5ZE5W"0BG"?X;--
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M&M0+AVP'CDNB=T,Q]80EQTR(A'ZV@PG\:#%=!_>G,<9KV1^7/W%J-JE]\MX
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MJ]O3@56D-_6VA<Y)59N0*D8V!P0H6+3(U=S&7&J69Y:V1"7Z^FN7.1>K]@_
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M^IF68'G%I#D](0"#QVP1J.&69U>IF87+IM%";>"!%F/7 RF%&7H)M?GWX3(
M;DPK[J?V+?K@DT48]R&BE/05V.N3.>]_ 0Z-"M;P:P3/*A\D-2JB4:$90;TT
M0'JW*.$:#;#[H'F[)/V8C#-#BD],;$\]"ZY;!"_L]R*"932'7>@&I4WKZG]<
M SV;B2J%O?P[=1H[(XN@]H+%:0#GJI2!?*_O=J_<4^N'Y"\&BUN=P=5BN^%X
M)YOQMQ0@';Q'6ZO)G74-$S]X^,2R^;G+^Z5K) 3;IN^IGI_Z:I5('82%+B,H
M*3DEU%$$F/EQ%$XU/N-:<$_F$,EASKL$;NLO%E?,V#<2V%#K-//M2SR>_=Y_
M/),'L*2M];<A (4+[!:=Y>&II0%>C8)ERZD3EWI7!FKVO5)5SJ&ZC?E\%0UP
MS#ICAZ!(*!MU^">JDN28[NKO0W"S!*J[U*:\34&R#KVYTY/^SJKE+JQ7&(^F
MA(-I@,.\C=8+L)4D(B?UE[+HJ7'&H<@H;)J<%4#(A<V59/>+(@[L'$W&=^CM
M.#D8^V\XK3G<+8K,ZH #B,E[]Z>:= BLMF.N>6""8+;RKH[_2=J=$JF^(*VM
M,>ENZ"U8;Q>$XW0+=JJ;L3VQC?U)#%&%R#R6>FQQ=54:.3%>S'HEONK8;J)Y
M=".P+:;4LMAVY-M$H;3T#7H0E+40-E"G,_1)#^H)^F\+D&M0=DI1BQ"1U!F0
MPQ:Y+%>[.15*SH7]G.]I]%"L'<!'\UDX]>XX9CLJXCJHQAI8U[%'-,"H'L(%
MX:K<@<%-8%GNI"5$2>PI209WF?CS_:TOKS4\JEIJ>U9FF9OADKN6-J*$JQ4I
M)[1BUO[7$UO(.-F.D36^#G[SJ"4T.$>I'L@B;EA_>?+3M'XZ_(Z^4'Z1Q6SQ
M#[<&6!QR!DFQ;)\R_YDKXER^(GW;)(9%1>PL&R-#ZOBE4;BD.B%KM:5F<<%K
M[4E]/4AV58Z-.-6Q*$_2([ U?_6$N<ZMPUP=]7Q6O8<6YOBP&G;\6Y$;=A:8
MULK\A))I,L,??V9/9KM0$M:'T/BMP"(3ZSR^F>]T)G.6Z9S:KPW'5<<8]YB2
MB![+]E&O[BL^C0LS,SOKM:G]D>6:NB)Y[F5JXH<'X_2IW!_Z]5\C'2<Z9]<V
MJXW"@<RF$*_).W8Z^]0VG[6&$VW_3B:Y/D;+OG#MYSYSW!O.==9.E1]_5J?'
M?_KHG;&]F&!8+N>Y5=.P[?MRRY#]@?\71%\N:J?F=.9P7^N4;I?!D8<I *+W
M\/T_7MH=Q;;@?2]R3[KWL2LXN]<ITT4S_PAEK\3%-?MU+NG0RV:N>&(!GH$N
M4W<:6/Z4 4=306GT**N^^6_P2_>V8KX@:0"B#0@7!6L7Q;+O@)#!CH&$ER<B
M)GDK%(2VRU[U[OK 7"+48DL)*T,#2":V_D>Z-U5D7&J9F^O(S60SM/-( ?*K
M?R! ARR;TD) ?O]#CM7#WT^&4 MQ4UV9^5QY7A!3[?1 GG0-Y1%A[(/EBY(U
MXE)^._>$UG>$\8G08?1YL@7^_(;H''KZ#5T89M#N)""\X5F*B$O/W/%!7DEQ
MX*D#;APY9_@KW[HN6F+FT\[\9RPP"?KT;RN#T@W*1ZKDWUG1-E"\+7LG<PKS
MW"PQ[<!.A;,#L1EQ.I,P.Y>VH]8^T*X_\>#&L]B%AF:7'D+P)/0LV9Z85$+6
MPKG&^X,O$2.7YJ=X:_8=%UZ/HPCU"ER\WL;]A4PNC#_XO"7N_?[,_N=4>E]N
M2;0=)KAQ!^*;H$NTPXI>)((Z@8Q*<9P&C3AJ@4M6R'!?7()PU\)<OYI5ZM,]
M79^Z'])#8=*8X5]A)H10O%P[N\#?!KV$N\'^X!B!I)X4?^G>W4L=H2)Y0I42
M'?/RR3.C#GUQW?(M3X5>) &@&::@9&"5ZZ]L.=G8A!W_009#8OWW(%[S]+::
M *QUI.DX2JW<VB#X;NW<B^ T-0?82+\.:5B>Y:;3%@QG HO6OHJ#]<@H[Q_\
MNWV?'282JPF][F#>;I79X(CRVS^[#[+W"&2^W?ZPV5;U.LNYO.]L-\]MFR2@
MD6$T0,=>(O4LT1V#/C\?-.R OZZU,Y-B&C_X=D%;C5NB_J3MX/&NTVI2<820
M$-X1#>(B/Z%D'^[QPMH,FIBP=JT7/7AG[SJ*4L<;)L=VKH]J64X^EV'6_\'A
M8"'6&=QQ)JU\$$)9@LU8=>7S42(ATN4;^6SX^* M\XGKD3WJ7($JEK.HO=BE
MUOK!C*8K\OOO323"'UW(F":W5=X3_7YHM2I%YL:+H\_"W%5;A,C2^.,(;<$M
M=<LLMG=+<([[/K*%6OOV!?4YTKK!SJ9(7]] %J$/=8ZQG>B?T']H ,Z6ZW__
M$,'=@8Z<69CVK4P2XHCIZKCF8^;H8*&:&_4,+-?%EVH7VKH T"0BJ>OAKY;S
M>-'WK+5SNBE?YS=O3&L/J_2]+YII9/ .P*JJ#C^T 5YH$4M)%&72O(;U*:$7
M$7H!O5\\MPEZ<="T)S9X;TYEQV%Z2!'I^L?J ^3N:),-?6S/DZI'_2F*%C1
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MO?#[9DT#N( &P4)9/-IN6=O[W!>PBTW*H_KSJJJ#D".2 <0:Y]\)9'&NQ8O
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M[_CN#P,>X+NK1L@N+_GC5X1+Q1IS*%8%6R:PV8O5:'B<USK4VV%DU;&#.II
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M)I8$:U4TE.&F/HZZPNIKHUW<!I-*%0LEDG2/O9W5<[^;O=BP$0WXWD]FPE*
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M$TZ.VD?\-S1.%\4N?)$&0-S1IONNK?O4PCE4-BCHD.#DYX'43@N59QL+I+"
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MUBO:@GUS7Y/PF_=>3]1?E7IE_.K^Q+G>&88?#CJ,NY^C =W__3-/A;^#<'3
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M,0B+/O#/:CW^%,&Z?A@TMX!P)8C43W",FK,M2M88ITQ@7[X83+_"</;)7;3
M<6H ]8S/4L/C<L+89L\24[WAV)(E!G#$!RCXK$XL#?I>SQ@ZO,GM(7HKWR6R
MFJ5'4Z+*?ON8+$HY#X3BH=&-$:*$-%)X7S(BB#W_R]^_I3./JP2*;"Y@5R_H
M9-^W\1583@0=RQ LN]/.(*Z/KV$(<8FJ,)Z9^<$5BZ /?F<7#85?L?_731NZ
MYO7,\6 2E@D_FJ<*(/%5\KE[(N=W"OD>Z5?6%SL$M;[3X:4'$7-7],Y$#$>
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MG_C/2;VMK'H;)EKHT9Q2%'IJ;D/G3U!?JTBFPFI7%;_'\F]]X;YV2-QORD4
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MUO4KZ%Q*.GE%GHJ=0#G*99P(QY@F-EO@8/!<H,B<"7_YU8X93;HK$LBP<+_
M?]-B.BT*<[(^\_<:?"QMMGF+0 /-WJ^-V[W\)S"T'M6X?'?-?C.Q0*-E\*GS
MSZ;9T1-A/(_0@6_VB.JT$;H+6- ]ZCD/?451&A0)*U,2_YI0]O5[HM[]30WO
MI9,?6#R\\X"'F/Y)2[V.9^$G_ZS;]&$NNL$)9I>]#7LRD_M8DG_H,#NQ'],/
M[:O=&G[TWX9?_ M6D5AO0(/L31:G<BZ R<[;$ \RF/1"#_FV)?#ESYT%3.A@
MH\ PS[A=O<Q$<: O+VK!(7[B^>[ [NT/7X;C,?PG9+V #*5R5L+(LF2#;V2-
M(]7QL#SU71K(+B4YT.W+IK,>^.^QO[L<3OYS[$OS^WEM5(N^%\2=N:V4O2]L
M?PUT9<PU9'.=8SG7/?#FY67MBXY[C54)6XMI.QZ7]HNM1VU<!H/#[0<C2B:Y
MK5UB.TZX&H:+*H:P(>SVI#!WB8K$=>S>P2E"R0H6%@K)GTAP3M/6O610OWRC
MCXZ[)LJ /BI?K[SXAJGJF_H0N\06\LNE#]X*XN>$5;E7\BR*2UI^843 _U8D
M_T^C^'\Z K@8NR0(/.V%^% [INN^!VZ1$;M;FU]W="IGYUO<A;W]W74?A,O:
M&A6]V_B(MIV:"U_12K]I%>C6._GO3=;Z3_<.^E/P"?$0B%Z& 3*A*?7E2WS^
M]E#6?227#YIOXO&90,FGK"8'VA<9[$]=6'2Y>WGYJHN":?KOW\+45_:10"WI
M(H$YQ1E_?O*^6D(.KF"&X_,'^$,_DM\UL/\KM!'#CO;A'O.5'A"BC5"++TAN
M#2#?@R/[^/*5I\0 1YROCCEOUOOC!LNMJ?''7SDE6O:,N&L'I!#+&75!<VVR
MRSD4[CYCH(?HWI7/&\AD7.2#ELGW#^"[E=3=8#^=3"S_B^Q6<$YYCHGE@<N;
M3*6,3-W:+AJH!O:L5:4,H=1:HQ5I&3<G/Q53XJ23P7__SI<$]]<[QCDY&5'9
MDF91W[JCWW $8G.VM+$%S]$R]6TC.DCB>832O48EPV5_%*=J,TN?ZDVCT>,W
M)=N%WQ0P>@8Q]XCZPK". D!&&,.)UOV%80M>BB,M\C5/B[<$:*T.]S1H=0^0
MB*K?3BC<K+^=3$KD=J812"<CCX"DLEPLIYBA ?>G913AB5;%993H!KC0ERH5
M[B?TB@:JXWF+*(YQM_<Y-++_%O FMEW;M&H:JT'A^MV.8::*P0UZ<@.3$,'E
MPUBI5FKW>/!W3X6*>W>;GF$S3W]08L_ 7>WR9?A\LZ<Z\9>.+)D7$.^$@"-X
MX%K#MZ97Q_6$_5-0Z\H_7/2]\K'%N:Z-#%?II3;CL*>$&=>J]"]CYFUZ%^5A
M9Q$73APFE,MB^;7>>?\@1Q@\<3BIQ=]!W%%$S/U0(KS#(/@K*%BMFQ(&0(AI
M6,L.Z!8J;ND<59RB/SX/:VB>5/ETC2J=9+ZW</]";<O%G$=49QD6?G=ZL0R8
M(05QG*]SGFP,W!@W('J$5@L)U6'&#^055N87'7XHFMY)IX_MV#G]ZV'ZZ=]V
MQ]$4)>D8^QN!\300MY";\VXCF+^ QR3XW2(LYV<"*6"/1 -Q#$?4T?TN2#D+
M_TTZ/TT5 S3PC3TTT#885/7^E'%H6</KC_+M/J_F_-XS>6>+=7'P/Y12@=VE
M#M) ;*M ( '=_@-8ZA6]_&7J;K1-]FZO5O6$U+.B*)T>KI<WJST\+@Y+O/GM
MF&N_]739E6\9DAC!Y>2R:?X!>+OV94K-%W5M[NW/;_,Z\SFYUSR5&WKZ+Z9J
MV5?[:.GHB8S4;4O-%CU]*N2S?=?71,&66T9.GUY3>)D%1%DB+/4J\B"@QR_Q
M0"%VP9TLW8W6 SK.3^X415W\'2 YT;!*MUK.>$6D&:3/J+^<ZK^(>$@VA&,Z
MH UI20B%:<Q]@E$<H1G?X__NCU7?ZJ(A=/$WI?;"3SH7CX]#(5ENQGC4# V$
M4Z@D7_:#G!$G%)!*7I92;*@3XZ^#9>$]B\_D,LW&.#WMC&U4$P<>'+-$3[5-
MM]- !$L:B!$NVY-_@:B*5B&N):K10&?A]S>[!&.+<:YWM==7&]\D][>]7UB]
M5';A]^=+;.\O2] /_5WN9^0E]B4HZHB[>Y*U_(-@P+1)@&4GH31^6^GCJU&G
M\*VO.O$Y$@F0U3MU?]Q#F.R[E]*F:" !-)C"")"+UU7@@?8C>F+SZX>YB-J$
MHJ@SQ9E#I"4X_8/@F2MSFGV#,%.X/<F6D/-<#14C6)S_OJ+_(6'>^,NHZLO\
M$[5D&)6X/@VZIJ%YBX%;1OG&E74W<]SPS!Z2_1?R-%H0?F')>D*'U1L_#%Q'
M&);[Y61O$8S/^$[]^+@WVUU3\W$F^9:4PZ&8: ?9A#IB2> S)/P:UY$/PR-Y
M@)Q;%N*&A..WG<YJ$UO)*ZU5IU- ;@[1R<G$3#TGH(.8U+=''8/48A+O %?*
M"T1.F!(\>P;@M+BYJ/'[:N_SXPKJYD#G+J=[1C)]3W@@D4QZ0AC>YL.&0XV)
M/$/EQ<,E,.-/Z\V]T:$D9S+K"P:YS_VQ(&S\RKF1 U#JTPYD#?0Y!8Q+ \%C
MEYR)ZI_* 741,UG_2IBU\R?%?& 5YUSJ\6,W/\:,[I</_??[F$#SP;19&NC$
MX9U[G!9GU?\)YA?J9$%-J@+*!HVB+?(77GN GS[B5>^WKF-D6./G+U-'$JR9
MIM&\"!6B?1Q: +9YU)BB5HX!ESSS+[\J$;7#<_?4=9O!;/7;F,LRIZKO/XR>
MW(00+'?I_"*$1AZWP+C@TU?:1@XJC5T^3ZNZNLJKG?9$W_O1*V'R6?SV*4)+
M5/+]G[6URYB9M'8TXSB%U;-T8U$\5Y$9'KO9W< >%L:-DO_>?GM=A;_F%[WP
M(Z')%%#8]T,*MPV9;[GA$Z[-'=O6FX%GU^B%$J(7X$Z'+HVQIQ6_>>F/;7"4
M<QK4.RMG1!H?FOBMW:.!EDNS%#OAK8YE%.7Z\6!=\VX5>.BUSWK*->H:NZ?N
M?WE;SWPM5L9J&Z:R:J?08LJ0X4\J/TZC7$4+Y.*Q$='2J??KTT1/WGQ!R&Y"
M#L^Q?7\TS*KRF]3LA[67;R7$&W75J0(1@Q$7@3:"6Y\AT%^*[/PR^5C$<[=5
M L'Z-,#SDX_5JT[\4&U"P&$F[-@%WGM&@!XDVD*^2!U7A]3S10;+A\R;4#LG
M'K^]X2IN_3G-*LGJF;2A\3<-ZX@=^$ S=CIZ^![7MEHG10BPI8%80COEW]%
MG7=PPT([34\+MJ$"?L@YOL('UC\30E!?U5<4-.7"_9O_VQ7F;Y9)R%-H,<#2
M#3C&SD"]_6&)TR<:$&R^N<V*8YX+:%U0%ZIC%9;X6EQ(UO;,6=4W@73%HIX<
MOT9Z0[@HW,?OWZ&3KC6,4N05NW1EKT]7W6.P=O:+N!!KRWDC0^KRN;A!'@'%
M?-,2UXCV" G"D\' $U<20]SM.K[X)<D8G4-V&YA\I.?@'GJU,&V7:\."%_,9
MDH" K700W4\>6^L6D83G&=7DD"\,K#^Z,9NI\:A+&/(*<E6&?LMLE>))5.R$
M<+C7(7GAY=<(G6[0G'MS0X7L[UY_^6/SS?-'F##8:5UV&0)<+(,'6I$M7K;U
M=9H@7$\RU<H.- T4DR#QJ:PXJ27):[3_>.3-UYPP*.(<GQ^(+-L+%=(3H6CG
M#D%XX(==H@+9)$B=4U^%/R\I1<>Q=Y]3\T?3CN:G QHH"<U(*(DK]G=:2M'1
M+OPU5U.^/I?ZOJR#L6VC)M:&+17KP6ARI^Y-%'N$)^(Z =6%$:!( =9X?UC"
MHC#PL H>BDUF+06T<0K1WA7JA7XHF83T!?;4(8)6;")O>+&)+0?=V'BKZS)4
M%&%.2&TBKID2IF+>N2+.Q@:P6DP&C,V;QRX/=?2\L-BK0#O<3"S0O/E>2QX4
M43SOTA46R-/3^DF'\UWF9??; QM&!J<TQ5(/Y!%X&HAA/<TACG0)L&M>>TU:
MVEIW@JI<)BLUO9@/WE[AK]Y.MB]%^!%+4UO9L<[.-%#<$@<&Z[6I[%;$Y2ON
M'&VZ=UOIZW=HWE^79CQ30C@L7^<G^M#O_>[)4$%<!=+$(!> Z6X6RZ;)^T1*
M2D3'](IN&JFD"8N*/]II+#S12F@%)G57;Z'HN/A^1)?.='-Y/W-N]+T\ 99=
M-Z'[QDP8U\T#4?F/I2\]K6%>)XE4_T7H!+"5J?/EA_^NXG&S#Q&5"-M[6,"
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MI&S'*EZNQ,P7N%Q?U7%?74%_[[T%/SO/X.B*<=^/#;D!VL7!9;J*'7-NJ _
M_:%AM[_GPXA/%BZM^2$]S&':"CW(Q\_+L&8HD9"U-M?_64/[\A?U^(&*G]:3
M_X6Q]XYJZNO6A:.HJ(#8:%*"@J#25'J16$% 1) F+2(=#!&1'A(5 6DB(*"T
MJ(B E$@-)1#I':0&0D_H$$@ 0R#MQM^Y[[WW?<\8W_G^(X.=E;77GO-YYK/7
MFG/BK>JCY*YM&W8$G7>N$>]__>#!)*08&[JSB]1D=0+Y,)JSDUX$Q8+<Y6DW
M; E%+?N+;<]B^[A\PA>7&-YFL>/'"#PAN/YD(J@,#(Y&4G4].3Y<EU8W)5ED
M5NED9N$\MSTYO9;=TSE[-- Z3T[!_X_C_]?[3=O__GYSHJ"G>28W/,>P<"XM
MKSHY<Q(%"?%,^W-OE?-L/7I/&&MH:S/W8(4L-V4*%\$D4E=PZ?=*O>P0HDQ>
MILK6/+T]T:[=XJ.BE.6U$^]\WEV@(2BR3<C3Y1X58%Y/$-[_^(1J0<^<@:#T
MT4*KDY>RWN5JM*D:_0^] 6O@J$A6SUY+#DES-\"NLH(Z7\?1T$0E#ZM5>.=J
M:@I=>P.R ?VUMMH*%V= *(@X72E/"8&A>C&$(\)Y%X%'(\9_3H3&]X1_"YLS
MEW!E?H:](?7>O_*7Y?_-E>_5J[A$M'06J<H*RPI.E,/($2F))@;H'\$Y \N]
MERRD+%^_P=^W#/&L=M[+'<\IAW9._8T3B 3N9B7 ZC\\]@3(V_-MU8I:<Q7A
MI=!T'YVD\M%I_J?I<0N'H*>+87]_D&[T@O:(#7!:2&8#*MP[3I]_]^;2#0/M
MI3^VE[O%LB,^?)%)JYS*+5S"XD&C(T \1[FQ1N@ZB*=TP0VI7KQ.GU) 3YF_
M3Y9/[+"2<& ZZS@;<,Q^A0,1-EEH:BAR2>L:%J^8,[&"E0X2:26U90%D*R"F
M#CIN0/=<C4D'$F1S4SL#+"OO4-<'HMVAI)K0NKY/KIRQC"KV2#F^MKE>X74G
M6JXP]>%<:2TWWNGLST!IJ\]6L:PV[*9W_:F]*<2R\_#:\++;:0_'LC.TX!/E
M9V4%BEA"$ ;)-XG+S.]G^<I0P(=$1'#UW\;9??\TSM9GG*_YIW%V!Q5(NO!/
MX^QIN:[)6OA&JK=REMQW%$"7A[S#4+O, 8?_@6;UG"*^1% =6M ] K(A?J3'
MC2/YMDC\^6PO$\FOF#XBNB7.:68C\ARN$"/+!AR12)* 3_LPOZ5@G;M:$V Y
M(LB0N_J=&N-]-FL8\1^>>[B(M0T_TBG6B1Y+>Y;_)VIYS>:S-:&=O/V5YG(^
M@_[:5BIDB_Q9Q]CD:FF\PS;4#UL+=X&HVUOYA3J]S;TT\!G5G3SU;B3$RPM^
M#>@*,36O*)+H:[91927GW:+&\*P&*7B?G>BJ5S<KKC8[W"[M?-SK%\B%/V)*
MC+Q>01&U&-S>*)L>I:6:_BY:V)J#I-S]7=H2\>3886Z?@W6KV?QOLFV/V)[0
MK+A@TY6LLD["7D5/=*_@,K6VE_4NYH-M25 Y;>;2WE6,&T&I=5J(ID100\[:
M:\^V43>HZ$_,I !F+1]V7"?/TJ!>[];\VH1^KQZI6J0G1#6PKT5I5P/U&F3_
M3]MZ=$>VWG<94Y2Q\7-S?V\CZ\:'8-ZO.W%9M>HC/6[QR7<'[F=,@%4L4\8Z
M[JPC$1BJYUR]#.S_QWZ%5U&Q^G_X]!2&P>LQU/(PW"*P,LG6>^T%X?R%_HS/
M:P/.6-YZ*5N&*;D=)[\=ZJ17'J36F-:3]]K@]U>M+F'>ANS'1%Y^::#AJE?,
M?[04+1[(TE)9)ORXF5C^T$.!ZC]Q>?-#7N/# ,C?SCAO_JOS^28T%BO,T">C
MK?L5MMD +D2C?N[*8(,C-)2)$B^&NKCQ0$L2XF]S!S4R1MM;@GL"^T@*.W!!
MQ.AN#H)D0]WT?.%)=+Q?IZI1NS1N+TI7 #5O438S+F\F:SZO@%C4[GX/[HWQ
M"PK-MK9;$02-I6[9MIUOB4\[3]<)OQ&X@^(K3U0_=DS9ROTKQD-5!F^I/1+=
M<.>T>>P_U9H60;1;?X TS]EOB$9?(O\:<@U),]1M8!9/Z6=225BW30IZC0ZW
M_]BK,0G6LXI%[NIP(L8G0$Z(N53J69;[YQUX=T<QIGVSA!S+Y(#))XF>.Z>M
M>K/R_G54PLBZ_P5';WN4>>P5A1?G.JKI=-FV6UHC>86]]0Z('>>7RA,@@DNR
M8G)'&0=_^_%X\=B&T(D^U-J\+Q8I1)>AE2RG?2GX(US2,R]0SU$BS'C$W"1,
M]@_FG\!YZ8)Y6@?EN/$XWFR0-5G ,EJWC[_ZS>G/GEDE)HDQRWI*];SPM1ZV
M_:^3]OQ\3%3A'Q[@FYTLV0&,0;&[^IYBG^(UF=VBKU5;N1'*BP?G*V-)#<+R
MP0MU3@WU?Z'T5I/_/Y*@B(E$[/F7^%!C\@.TU?MD#OG4NA-? D@.'O\/FQ>?
MH=ZA?ZV/KGN$2>?G1I?G][^(4ZN8UK\8NIA\_X3U7NEJ%["EBY$ZH7#:%*P5
M_.5_)WQPOX395-'BW"C9C6F"810>^BD#BFG-\7'..MO:A8:MC;23MD ]BM2)
M(#GT-<H_ <I?62@W$X_C*-B!VRA7U.?NG)[P!ILK5M_'RY^DPP=\:CUD)K^F
MH%=V(%CE(Z*6S9[3&#1D?#)F8,/8=GSS[M_C"UN#_]AF3I&]@_42;D<K-)Z:
MR5#;-( Z+;RM[Y<T,[M&:ER7Y&M[E3&,O_1UR 9B9V+AU H__9?;FI$G[1^9
MD(ETH.'@QKI*C]%#UF0$HM2N^=/%^0.6B(]?YY_K/IV;P7&"=E8/ D% ,>/3
M<ED#G)E"M>+.!(X];!I\$&O6KZF;BJV[J+VZ_'T\"PZ^E-24/YR>%# UE7F2
M,S6,5/\_$YS1U3(@:"M%U-07S,;_/46NB?C6H/9M*S1:&U6N?_KJE;"3SVK?
M#6(/Q-4=\\+^R^7_U?!VJHZWWJZJTT9V0^&,,718^[OOD^0E$UMWJC_#5'_&
MO%ZJGN;QS;->EL+/D [8*S^^8J ^FEU!UWG>)'KX"I"O?%V;?&3R]Y.Z_578
MU\A_[6$"F;*&I O=]I3DPL2=K"AI]%)RHJ" S1O5^I@ 1,O?SO5!0__L%,U-
MB\"OT.)GO4N^VBZS.#-Z$V\RG/NZ<8I.=]"VF^KL%9QVDI)X>VPK?+<D(?I/
M&@6)MUV'*; !)5N&; "^@C0WM#3<VI@9[.D3T%]9HTZU040M$N<U'.<O/9_W
MQ!<$;-W[DRFXPI%F/ZN'Y!%_I=D[HQB@RE]I]IJRX2#J(>TM)N9:W'\G<,#3
MN+PPH$C@=?2%?.&_GCG+4F5^0[T X9V:@-PZH)F"^-/@:0^CXE6MC.!8R_[E
M,R%VH1G&):^4C],Z]W^3NRA:W59EU5BSN-;AEH]HN LS(GI@3N5W?8O?7UD
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MM_N2<']PN^7%]@-N)0(BO)Z'4C)H\A8C]7EU\9[D:.;#>Q&+:V^<#BFL^+\
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MPPO5OC\,XPH>_8A0[_^:$/?Y\>E[)$E8U78[:O '&?5F[] G+[H!PS6%3VM
M!,(&E,(^2;VR^+H%>92#OTX, =@" V,S1JKU3_2GG!+Y,R$M,W0*XR1LK]FJ
MYF\_E[EG6U<DO/;#I^C6RI]Y@9[AZD>;:+^ ,=4M%0P7_1%,DS+[;E\APM&3
M[Q75^/'A8QO7=R\$D6IUAX5(Y\\9 QL_2;F\@(HORQ?F2H8MS(39Z\>SN )/
M$=P^R53/KCY2 A;]J=KT5EZQOVR[-"8Q3 :1A,A=9C1M(F*-QRO3$LK+A]:Z
MATY,,7NDQZS:=ZM@3@SP['36U]S(34:!:O<YLL5Y0P_U#CF#:PKK':HA8%?4
MD[)[ENH'([Q."&C4*KKX[10A#L$S+/GC= (^P[3[;2TI$KG'DA^+Z9U/ERX3
M>__C!\^57[* 4R]-/'>3.)3?%(_G:9[B&5 Z3XMBAA_XS260N>92G!WKK/01
MAIE[R2]O(J6S4 )78'5B!3'&7QI\_(A7B"$%5C+7M-PNDW@/+>CY\V1Q<XL%
MK,$R0/SS_:V7A#&-:7%KNT&HG:I-E.4:IA?_*>N2N;BA\",'G!5Z+I,-X,GJ
MH(NL6*9BRQ8C(:3U)VDAFHI?J^+$!,-[NHL%(I]8)%>O-=:IV]+B9DWXO%DC
M%,6$[\DK:*M^O>F$I[A6<%GJVM]1E'\9$13<FJWPKLEY[8VBXE=^>5BJNX]]
MDS_<._.+5^)0"*%N_!8SBB6XK&W<FAY:4+I37^^#S(M_7(S9XDY\V'-%N2@Z
MW?NY]Y77_6C_ZHS$_N62"'OPY91C'SSZHPTO]73Y0<03H0_;-D!>4%X;UD!I
M8(F\DK>.;MI%#EW@I5JI+7WIU/!;C&N5B<<T5S=Q7R;@$U/B]9\^DZ??,.X0
M>%[],G]U'/A]Q)\-://J=68F,#2FR]&,<S%YD[*1V%+0[%FZVD1]7_DNV)4_
M@[2!%6D3AWO2'49&>"Y8B@8ZO1:8=8JZF;>WS_[3/%R\J5 [^Z8%^-S4_8N*
MJ8-6=6L#E[OR%Y+MP1ZF-WRO)0;_J:Q1LD6F@<M1\3 /"E?+94\'Z=^J4!X/
ML]M")@,;(W?BS/?5O7*^WFTKG>%V4/^ZW"0+R(#1RF; !Y<%Z\_2[(L#WTT)
M ^Q-8?W:K4&6[P]/O__&6WFDU41U!5LIR0;$^E*@P*UE-B#G/:YTL-7GV*D3
M'QSS^[B$#EYL4?3PZ/R\GE:&0]JB_8L9*4 YE(FXI6FST:>\VC&O (7!P?OV
M"I UV# _:7)6#GQ5P:L)?FY R<)@4^+PN+1_AY_F7O06\M5TQ6*$CI!ZG)7]
MH!]/X)^BX W[5Z2;/>C>B_24 R@IZ-32\V G9#'\;"#_/5KR#-.HJ:;T2EE=
MO&.B#C3JU4%[@W5A+IHO^ JK@PTHJT_(I;6U2)S%UD+,$'RKJ34"WT[>%%1S
M?YV?&7'?P$I2Z<YJHD^8$JJIXGFWO>&'\X>J0X?5-E"U;A#%G;JUBJ$KYEO6
M3A=:!4ZGU&SF>.]8X8R+G') E3]Q!A(G:%""R8E3C8QT938 /F*S:T+DCL*$
M$I2BX_-7*[5:HXI[+M5G/FXT3QD[PL3?^J7S[.IGE]+@)'#>YX. ?2^UCO['
MQO'#IETJ-W<T<OB9H>[<Y,0$LI9;V[,(I9"9"GZ_=0]]RB$VM/(L-OA2YT4%
MYVSXG@,]P^T5XFG/*>.RP6V3MS;>);.9\*G#A)IJ3/F3Q+NG#[W/VX?S.4!T
M/12,"Z%H$W+#, 9DH];4,]!HE?2J=17;=JFQ(&'7A,_/2DBR9SN6OCGO67T+
M#&O< \7(&V=5Y#Q:&<D%5=>]<C'-FKFLH4NHEV 685W+9B;-QL%DJ\CS)GSI
MEE[;95LR@@/YKA[")PWU'HK%?WBJV:H7]#SMD:)/?.[IG,C\$/S* XB72XC*
M]!V4$^SI%N^A,\85EFJ5/4;V2CF##/Z?ND=*L0W8_0)G(ZD";V=V!)?X7FBQ
M 5'E*)YEG#J^B"%H.4)1&5 IWG?T<^+UE4#Q@[  LC+59)@!(2_>'_K#!@AZ
M:8G'+6ZL;=>*E"+=GHDX:TI?A*6T:ATWD>4:*$0\9@,B_><JAM?K\N["MXP#
MSLRQ ;^<N/\4WVM2[,@C>OX8'6$N^IT)6*V82&3T_!PM#+VG<RU+7$&PV,&^
MR+<7+L@:D1"JH"T30]T>5E0/;$-/5Z0U^5WDHT++;O:'72H.A"W.]PZ^:I\+
M7D?3O6 * P$\H?=WK%Q8HJ(BW'/.HR ;RD8XL!0:Z4HC$16 YO7I%OT,&:J9
MOI?*#3B.^C;VQWG)[7N/7^I"'1OV<+=HT%D0'X350>Y-R+VZ[64KG("]7(VR
M>BO;](+RX%FX0?U=]YS.HO9J:(_@1D=7"#Q H[1]82#[_$4]N33;@MHM[;4!
M&HH-X'/:RB5RDP0(B+=9U\Y45&8'.>9X['0$?;/6.%JYH/PQQWG^WD=-Z75Z
M,Q<ZFEX[$]_*Y";LA&_O*E1H^U/VV[3ZB>O U^]^QZLGW^HP'FOBC3TQ'3V/
M\(CG7W[NB>3YHSX($35+:JVQ+YA2.>KB;O#^8Q?Q_-5]XQD^)K0<^@5:0&M
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M7NC.)2?VDGCP+6 __SWB( 9"=PD\U80&.O[NP<7Z66J?G#:(_=@5'!09Q@8
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M"F,#%&#=Q-CUOOMRS[%7\OG=-&_NE%6F \$BOG<,1ZI,[PA\NO%_VPS.@B1
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M9=#BO9#S?H@+</Z/Q#J,R-LJ:)],KU[=X2TC(Z_D[A<%6BC'[@M=').C.*R
M,\A^@PY3RJQ+')%/0FT<H;>"IT*SY]_"E6T+'0\*ZFI';TV_0]](NH=:^UZV
M)+!HPOKX) PX LK?HIQQ?ICR0!)U*6RN98ZYTC4L@!N_E/ KCKHSAOMHO-R_
MKK%!:Y@4ST_&L10EBRZ#3D"T)[ZA*KLVD%A(+)(%+OS;8G]W2WG%Q\A@9C6@
M6H\?Y>SX/.OZ.NU+H@;_CHS4M:MG(!+7%04#036/B=T$"H#IBF@4FX<PP*)T
MB'H8*&,8&UF:P#K6'\6-'?#C?\9F):Q):_VUE\="G9_F(B@N$.$T$ .I"HE[
MY5$.$"LTB<X%TS V5Y9UT^*5H3G_YDVYR1)R?WQO4J2@ UTRE?OF[7Y 80SK
M^KVK*^#ZF(<.ZW?XB^;!  'QET*A<$4,U)7!C&6\Q-3NS0EHX]7&2+.3#P1B
MLB]*IQ<C6A1XVZK)K(@07N9=G5#?C"1T(EKL_K['5T^JHL>W2F\F&]M<>&CK
M[2KIPU7;20WX4H"-EX34X[ MZ"@-SHB=,;KV=$S:S(2-X#Q:8@>S3SC#8?S1
M+B*-N\*"O;,\SO+443I)!(H!AYMND?@/Q,;6'/$S_@E^Z2.?U?GRONM]M[5Z
MO1 -;W)7<8%S$ URX(Q$,W3Y20>M6ZF680[50YK/%1,,$@;XGYRH2W\7>UKJ
MA[']1"D #Z8 IR8)*BG8N+,D3P)/A.?>#/MC8D79&INLI9GJLN)UTVXNW',.
M]Q*&BR=O?CW=C"I/0CR![-?.'8K.\E. :=^#HO_UGK;_:T(:./KXN[$*Z%B!
M79 'JO0!;XV7$+@P"B#$\:_'6[>ANZ[TQ[]Q-B8WH8ZNTW00[ ^CP9TH89Z;
MQYGA3Y]]Q=48;*D01LI!@6OBUAP=D5FCYHD]@2TNL\'B?+Q4W"W^S42W3K=8
M-?GB(82#LS6ZO",N_"[/IZ<$QNZJY(L;$HQ[5WO]$VZ/?=?ZJK]OQ>X4';TL
MO>/).J\CF(]#6R:I*[:H"]29_JH)^&FSE;7NS)8V-Q*K$-!ON$PM;I?F\FO$
M-EL3I;F^ZII) 1R1Y^%@8B)&@L'I@#V6>J2+OCK1D\I1EE8,K;]8YGV#ZU-M
M $[%G_[%W$62(QH9CCP/DOO@Z%OA"&;TD'/PZ)6_-ZTI_A5_KN)MN+&H]@EN
M[2]^$]%#!B'=CD^O:%PH%MIX\\:U-U_6@B_1T:$L(V9&+LGL1KJCMO:9%Y4S
MY:7UKA4S!_R3 72P[!8*<+;Q$6;KPD"Q>&&!H\R.$CH)>N>1:Y[[2D5\\&)@
M('>9XM%RT035O(6GLX(@S,]D3-PD6<QR=GMMR4C@M:"QM_6/7<&Z2)'Z._[2
M=ZNN"B[J7:O&96F,&VE,51^9K=K495PW_QBD?JV:[+Q[F/!3=7#N(LA?HHTW
M9N[\LT5\2@CI@>N6$=INXN=<%4ACZ#1$N(;^0]BIW86S(_C-0GR-.O%V*D,\
M@8M\P1]J4J&$X<@9W"Q;3H\,<HZ?<,IY&B4\G=Y6N(Y,]TQ'&!"XAV><IF)F
M"]T_E6A*+^!NON)FN<GT7.YLIN4#]XN:]!IOBF[W@&K<JG+F2\IR<DIJ-*8G
M-^-_[ A?KTB-=)R=:([4WNR[16IBS(,S%\'%!G]?B+1U1%Y H5D)@E4.A66S
MZIDSECJ5T565#S,?G6=2Y+_:Y/LH+HB7#<2+'U ?D8Y"AL]>?6^ZNJTD^S*O
M)N&QP/O@1"X*4&0HMG.B[46O_WR 959>.8->^=G*M?'W2:K> 3K2T&W+\2$H
M+*?.='R3HU3#_56FMG"'R7'P5U=Z(+?V#L=[$FZ"UGE%OH[/CY207FY*WK P
M=3HP-V(261VZ81.K*.C5BTP*UWLM=4?ZNX494:DSXR)>IP5!#<O FIN5>EFH
MK)LF:L&,J+<7 -KWA<_XF7RH%H6BY^$#QK>:K(X#@CI93D]<1T@;_P/;JJ1L
M]^@;O4F7YX,4N5M*"2;7RTTPF4:6([G[/BYU=5SF-?#WFU-KI7W>A>F7VB9'
M#&VI>R?\)K=WS"!5/>73N3%]LH^"T7/M9\J<G7\BV4Q7:VZV,:TESWJF8^"$
MDAB>3<53M_=K;]^Y7>Y\A"0+$OFUB"&EQ/4.SN:T^>F&MYR=$HPK!Z*8T2NQ
MDDN9<<^U=1=U]-6_]L''E#VQGU--0C@,B@7?9_<LE'K50 W'FU,VGH9V#M!)
MWQ88]E:?G=B_10&85UP9G'CI\HC^I?#;XW WS],ISAC:J@;N &[!9Y;"-8]S
MXKK;I,[+1M=P7-X9KMN*S;B!G^C88H=U=0P2@S1%PBVGYE2'KWYTGQ@L,/26
M"JX&P0="%X)H3C<Z1;;&:IZ]&%=ZO<)]9[&ZL0QBC]LN<YG:WDXU_'95/^73
M\YAF?PD7E-WF7,Q P6Y<- \S_E<KBL-1!G&>I(C=)RD^2QXWM:PZU5 YU*^I
M*?@HG(9XXXQ>E]O7@"%]>MDO8)K*,S7BV?8?N.JPKY]FFTQJ"/_DMW[N:QPR
M=F1O.4I2]765=E;9,FR8*MR+ZIYRE'D9*"LI!'BP#H1^=41+LJP;I'DE)C:5
M38?Q$0T?): T:YKZG);T2S5TWSA[)%3]-/\QX#5+MCU>2YMS"'$HU'\,JJX=
M!2(68M;!>SS'@9TZ;J5\P?(Z!8B?%2&I;MZ1($6M'/ ^U%-FW0ZKA*<=^L&*
MT1*!F7BA<#+_JL)E D.YS526(Z=J&*NI7YJC:(^3@H,5S60[C92,HE[PB'0[
MN36 FF@\7QZ9\+MA6"%Q1Y]@ESDO+V$X#$;+U(=Z!K=-7+6-I5.Z@+9.L;K[
M49=#I25(W1XWZ8U/P48;);.!N1MYY^/"+5G(X\/W1LLQL';O9)P] BIE[RX)
M27E^JM"@TU?I$" **7\BQHM_*B0]P\=U\'(X6C)4X<N2\F!&CVQ&*LT<^1?K
M;R8*)26+M%AWSP2>^!7#8MP#QNM*1")9 ^B)-"H$H<"J&9%[P\P&E96H9#-)
M3W^YOKL?8B7YWB;(-T1)4D=\X?(1H%I;$T&CIGNQ-)W(4##S+?[Y/K-.'DZB
M1^JYE-3J*K0KU30LXDF=29J"V_NL]J ;%Y$WGC#6OXB'/"8N$@RPJA$DB7G4
M*R3+,X]P485++5ANI4[O#.Y0$\_>4%=AZT.11>?X23J9H3>B7TZRG#SQRY85
MB_I,TPD]CIWI]ISQX#C/QYEAAF/.-F8=-?J?WJ$SU 1L+5M2!9]Y]?FRQRA<
M@9FAJU/8\C%;3"MDMA';MV:J/J60#GNZGD=O57A4=!\724Z_1ZMO.% M__-F
M5GD":C[]H"JV*9<\>#?CG8]KP6H-ZB)(\074Q_%Z[SG"W6DIM=B<4"-]VB?/
M%4\9CU?^\S'O_S7RY[#C9^N?]KB*8:X4@-\)M8NC *NZ"A)1X!]/R=+[:H34
M:UFH[(&>?]Q.H]>AFYEY#$M3J__T64M[C^NK35"/VL->M\O/C:2"4\[=XU(U
MQS27$99C7246B'IH5PX=>P2! <QB.F>9FZ-W(M^,XT9ROT%,^UWN;)"0?,0^
MN"V#;Q1TM>S[^EVMKDEI$>$'@SJ?(-:Q8>=HP?=IR^\1&'%W"#<[C)Z;KF5<
M/7QX_D>'-V<4E\VTJ#:/3$\GX[D374JQT(4=^.=F.6:5W-N*G>QCU3EI6HX.
MO3/C. N+:3,Q_T8&J0S.:*RPQG9UA&##+]/5[/&>HP'KH_)FOCZ&.L]LH=BL
MB<R:L<L)KJ=_. 28>_44-K+5?9$JO-T3VB^P5X;8RYI /L;3M%A8FHG<-G66
M\>E+;U2P^$P!"A1,/X"$GMGG^^[$,9.'44P@6WMG: DL#O?:;$;9A\D_=%*F
MC\M%I:?S3,L&3+Y#KH.WLJL=R;$JE@=5$#BTC=*\U"GQ<5IH@"M,*2F:AT-Q
M?3J5@.=@N'GJH^-]]JS%;Z.EGM>V5WLUKA_,67BH=V\V$.XDG5,JW]*<TYAR
MMO=WE5W-2UU)[O(_U%J/P^B\XJ6NNB,F)LJ)&=%]"GU*&TD;"'W.ROPY$#C9
M[%;^D)""XR=P=9&Y&P8]MR[XHS3J)Y?-CD*GY*<M+ )LHF^T70/QC"UY_ISD
M86B&!!\T>;*,YDR(.)OJNYMUREE.>Z#,)/AOE.LP0Z9&G&>N%FD:)JS,[J'F
MCS-8OZZW_]B V__H$/A]G7<<L2$O2TZ<'E+=H/I]D=^$ GS\.7>@XZJ,X",8
MDV()$ S8K1NQ %$=/+"*O%;^1CY[IVT/>11-HL)7=,SR$4OS2/?PD) J>O<#
M?_U?RL3,[$FG*6=<>_0 7ZMM],!YT8[J]DN[G:>![Q0@R)WT?#! %-8 J1H)
M.$4T:_'VDF$JAAVVF$I\_]FG9>3PYDO)H$"DR:?+*E9JX0DG3+&-GL<ISC2Q
MK@2.(-2T.\MV!)P<HP#557Y1ZRP$KS3!G/'7H!+" _YDH>AG^D4W&$Y&/W&#
MZ ?T!YPZRH3S8ORR"69=ELP$B9#0C,')U8/3[_9,KM3N\%^;O'#Y^WDUF8//
M![HT@TD[<;B7AV+$FKWLX9^ES ^)N12 %AR*R]%,*[U)OK#BR5AEWG49EKMC
M^GA&!KL9'#S;')L5J.!(F-L8(+AVSG(/;]#@.$H<4]Q75=4(E_;(ERJWI1V^
M)=2DL<A]LI=4;ZP0>.;.KRU5-0!+VZ-.T7*E,X=?)R*+2#='*Y%T$L&NKN"*
MS-$T_1$E]C:1S[1+LR:-HPOVBU0GFVNR F^C@L%G/>)>4@ ZN/2\UIF\1,U!
M'-N4L NME(:[R<(S0/9FA>273K/($4)-V\!9DN9PU@@(@B[E[3!]=I/N[<9N
M,6WY%?7[GR-.JI5047MS?7HOR=WG<4N7IAN"USX2[+HWC'+@OOGP<\U(Y;1$
M-,_EZJJ*R@BK4-IXYR3^![HGBPJ :Q<!0&3=],\'& 7_7#/X?XV4TQ,3#R_#
M9#$I,=*\S&OUR76N"/_%_?C)@;/M,BJ?8C*SK(=H]'WZ_))85YZ\.&=DIC?>
M:O@\T:@>EUTS'VNNPA8K?I85^ZUF=!])ODB#WCHZ#=>B "^-* #)*H[XA#<,
M]9.#($NF-J, A,ACN]NC .,E6^2@'!\*\+T.0=I7_5V$_07,B%BYB7$EG:VA
M %@61!M DJ< 'P8B4/CK<Q0@VGB$18]<98_XR7J9W-%+ 99[_N!>.4'THP"*
M2&;$_",4!;B8_:<1_"9OV2V6.WY5(<V>.(0"*.CM@'_S1LT=G"/^.VT4[S_]
M/^O/#A9$J<G<$;4:^),[!=C?CGM' ="!OWMO#MJWSQ%9CQU8Y[4_#^ WU\N1
M4S\%6+FN>!250@$&WL '*, Y*OPO<K""( 7X4HP@2ZK^:0#^DLJ\ZT;>QZ_2
M9]PP1Y'AV4N(?\8._,__+[(:>3P$TPK4P=G7"*M%"K"SR'OL:O\9.KT__3_D
MH9[JP5CZ\;L,@P_9)2@ \MK_R\D#_\O4\?ZO3%P;G)<(SH:SXL?ZPS)_S%F8
MFEM4K2MD\H%>3EZ@I;Z@(LFYM^F3U9 JLBQY,;*VZ'.YI?EP<FES?K'&FVLM
M!GDER5^O944N2_^Q8[*?O3=UE-5\F=P?P#JT6TX+,U8;_5E77HISW76V0T?>
MLWVK\DG5E4NDX;6FJRCK_9]6SQ52RI-1+LB7"':40QS=J@(SGGXNZ%GCW9KS
M:^S;Q 2SKYODD7.9F L7]49Z^;=<.'[R!0H<?0 [Z$3>=>WDQP_,;X61;A:N
MU[N&(CM,F[:BKJ8[=Z!2AZXVBES0M[.J.]?E\+7_#O^W2N1T!<:^2UZVU0A%
M3;J*]IHH UT1BO(<)SPZAMOVI75=PECIY>W("C7;D+T*[EJ1]^ZJ.MBXR:V]
MX%&0<Q[I(7XB7(''D0)<D(:<186 ].P]6=<=17@SMKM>V'B] W6<RWZ&%%?L
M5^QX<==U0X0@.V\3P-) %,&@Z.B->&G KZ1;,+T^'8V9FS9U?KUNM%8".[9P
M?E)MI_>+>[RZ 7U@3KZCS&9JHA*&Q<A:^^Y8,6@\\G"<(SL>D_2HX:6 :_1.
MM''>1%I /^]I9PI@CWI)OD#T<_:2F'A0*:GIQ;_=/B)767';_/WI!-7+-GA5
MP1*2$Y%N7F=*J+6ZF8L8DHEH5<R:FLW+I*^96JZ>OMLEX'28&7\1;?OZR7OX
MC-1I0.')42Q9%GZ7""TB#W':1S7ZHQ%GUPS@3PBLW[Q\9RN<[6^VFU(SG8H?
M31*-E;7FT)?C/! A<W;-AQVQZ1Q'ID3#Q\>Z/+5=3O3LVN@X3O&/S5/D(/\X
M7ABB  RU1V]1*\>FOHCXS1.5"NQ"B%#>(-Z?)@J\Q_:O9TT!NGZ?$'TB7J$
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M'F\-UR>[J:[DH!<.XBA8@&($'7R25F$Y">([>.(?BA__@YB0+Q-.IZ&U&"B
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M7D VNFK=Q_/^+[<<S!V^[UF#6S!]X<Z.>#8EX:LIO;J++"?<U_=R"!)A/RG
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M5\&J^8'S-:3?S749&Q\5.[%]-&F*:7,R2I;QJC&F]]B)V)/KJ79Y<)]UF[1
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MS)0#"DE0S !B44 >LT444 %%%% '_]E02P,$%     @ V#N/6EEA24,\I (
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MSLPO-7ZY.#J:5LDJV_Y=L#53\8;P =-JU/G0;&NN.B)BP"66K=9_C)FK]?U
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MF]-RI&_?C4)H5*C1\*G PX4,64.M^C'^<2?Q\\^B.CB[R"#96.]J6)5 C*@
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MZ]&#"WUY68JU4I'M_!7P=-?@XF\31.0UURH$2-U>4'/I076&-4S-/Z1TW&_
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M$IL<>*LT[+> V!:;O]<LJ$-==$I+])YG$S='V >3/H;HL@/RBME;@)=>4O?
MN;\7%-T4IYCZ;AX$Z2U$U#<US)S7.(IM^611[F$);C+X&^U1&^V=^RO$YNQ=
M$/CC=03S+".RRC_T-=C[CS?GFR^,[MD\S* 0R(I6)-5=7F_XJ:11GZ*Z;<=<
MVU+PY;VU@X7G0A>!X,Z@+OOC5VEI[Y(M^;6B)B?,%R$\BY?CQ]R[S1Q0X0DY
M"I\04J!A]J!_KZ/.[@WI] 1E-*"DSG#C0NN#FR3"&N6\-Y5K[C/T.OXE)KK
M)^Y*LSD<LB]F>931JTK1HQU:?83O;S4>=3PT8]6!VP&FAVH)]VXH.DI-%^5=
MJ/SX#?O='N@I,^6EK/^AV<B,]>>4Q7&BVH!89?/ A1^3I:(#QE!C3,S1;W3,
M>!)4YM%+[#L36>T?ST&D<C,#'4B\A][-GCC9W*=?!N/;8X&H^' Q 7I&YEM
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M\ ZLWJ(_JL>=*FG_=*OD%%P/(S/IYBZA2S3RRV)<W9V MO,6T\6^@8_,!_Y
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M>/V+-DL+)V0]AK;7W+ S6/!:66Z+<Y2[0[9 <?E)BK#G'"9'H$_6UM /B*Q
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MV2)R0/*TR MA)85B8Z8Y^KDC$.X#S/L(I*@?CL3I@H$3%<1K0GJE1BU&0,I
MLGM^XI6D<\^3U'%;CWI6'V^L9'L<F8&/2ZL@)DI:V-PX#;Y&[O+@DPKS6&7P
ML_,<H)VN[8;]!_99N,2#P)&WR=\M:D)M';54I0R2-.]>RFR)RNKX"!.;A428
M7<"?":UZ[P-&/9H9^U)QKU,U/3H6Y3A_X:5RM@0:]FA$X3K,8!!3.:S -C66
M\_"&F8;L[;I8U5P*'<8GDP]/<?:E&+^L*WR\\#"7)2TA^66YG:"Q.B_28F,M
MPU,H*\Y#_N2%>=N])XGG*ZLU7YA47...NZ=[!'JF&V,QU<Q.^JRWIY=;?K>
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MD2^P+[DMN[!U7\RF[^\2GY^IS_.:6D\;WUX\_ITV)%Q8@I,)=H\85]Q/*,H
MJR9CGPC&]"WX?&('&:@]7Q=,.WS]N F?OW;"N@AJ(M&+NC*G5?]FKX%.,,LE
M\SZAE!*84G2>4'*B,$J!^6--!4/JK&Y]7<(ML1"SDT5G033&A5F-MD07/%B7
M:!Q08&:+,^SR#'@RHB$TY-C!8T%^+93)\<-*?*>:D[.Y.KNJ.E7AK2'65XT3
MWC\7XU?@H-RH3F35V1(L7_ST.8Y]G>C,0"5+EE.KI]]MTF,"KX[$1<AI%"VW
MJZ7M=Y5&UF@V];C_'$&T02.,.EL1%ZE=[MUD3:2\P^-]U4R:VX)<#Q0\K(-3
M5EMV1MK"+YCXC+2ARI;00L4$O4WC^]9GDH6JNS+F"RPF8GUE&P+<V1_DF87
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MP?=[U1O>4*5(@\]6";<$NI45SRW:LWBZEW]S>30L+.'P7'YG<K=B;>*'B<K
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M D4A2H ]\/\(\%5?W"K;W$_DIN7\OR*\(S$<@>+ BUZ A-0V0 .VL@+_9P1
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M!O"+YH^.PW$="L#L>_L>,/;S\\#T@!(MP6?@7[7-?B5X@DM2,Z21!/#',&1
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MKD?$8P&:PT$->T.6&;U^:[UYGI<KBP\.X-3H2LF^OQT"M=BS=#!&=(=07NE
M+9QVA%9WS-"+.'[Q6X@,V=(148:"2V$#\C"Q;7K^:'&Z[;YGM6W!;8NO)0,2
M._WBXH_)GC^/[/>;-CX4S#E'0M_Y#-;$?(6Q]]I(QD)/+U5Z%\VC6TMHF[**
M*C\8+R\G1L;=,Z<AA$_G1M3YI[Q5)\.Q-5W6E>%%>UMRJ]\AZB5E2P2_#^W
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M'(HJZ3/=CLYR9^:L$U']XY3&T_%/=[_FEA8WI[M+5=)I'\X9\6. ;T%UG0/
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M'<@S-Z,! '8 59I]G3>)?/AQB_?F./)K"5RUYR-2CMJS46OO&V5YH1'XJ \
MX,'9Y[ 4F'@%1M;Q%'"*RODF8P>O.00F9&9OU-MQ"XL*+Q61?7EB,"E^^)4J
MN.K/0Z^0Q#F]"K<61*SL^6LY6VJ(_L"+.''H'>N7B+)OMXER ?$^I4H&68:-
M5%+QM38\JV\[N/ Z78).Z!2JG0X>&1I]OQQE;OOUB;8&3@*XI;B7_M9^+G],
M'U?*VWJ5RS"FK^(F^X;1!B7#V")G9S&I)?+XW6LB=/=5^C\F1[ZA7FF<!:Z
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MHOWV>(#S<]IG^D[^HS_Q&[?C$$S,:3X2XQ6+E9'"M&$$?\>9O/<2N]3+^^S
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M[6H#D#NN,)SUCR<?0/!34-].J'T_&!407PZD=U/9R>"8WYIT0]78@=KM3+6
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M+Z#3<W'1\Q]7-:T%Q. PA=%<TMY(TC=H-\!@W7#AY0/\VTA7<RS;L#:IL(,
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MIR%2E_QP>I=Z?1EKLSE[F"%LQ@<O?'YP\R6K4)HRWST&B;H(GE7!Y+/)-Y7
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M'F;&S?:?@H!LR5E6'::Q0>$WY= -:5)%I%\Q2\U'!,U)-MKY%,2.5JX $";
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MX7E^>,\([] #YE\,U]8D"&=\95I.G2JD!Y++X:Y'&!4U#<$N$I&B AOY8KF
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M=FA=@@W#Y>"],*Q&/V76N"%IY[1GULY6BA)?EI>#MLR8VV+EJ:+NA* 4SSD
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M,Y5U>DB;@0O6#?)(M+)>4<AG$=<"O:!:B:+[RXO+CW\IU/YZYL/O*\+WZIV
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MUWB_EY.=2MPM^6DYF9H_?"A"S7J<K!9%8A4>!=7;8.BB/$*Y\*S]!;>F^0O
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M3:OAXD=FT+Q?YIVT34.8#_DOC[L'FH#7_[ 8/]@8*T%4C%F_*B@U)]1XSV?
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M3*F'*YR.%FROM#1#=LKQSMJ3]C.&H"D/#\,77S,/3L&UF9+^2N$\9H\BNA8
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MEB"-"1PPW%55QI(GV17V^\:C_>-EMC=@EP!M^[=RK>D-*MT!GN3ULL>!_9>
M?U@572]H46^8@^5CMNK]65D0W:(;QVZ3+'JK=BQ/6Z!YFM$*>9/AA:  'X,6
M_=WG(CMK- 0!#%WDZ4XIYJQ7C.]1KKMVK#[HZ91,M3>V,[B Y(7Z;6KM;'6K
MTE.E4#>$A=)US*\T)SC5;Q9SV0']<M<[-/+@I,=?$TU-)HXV%FAG$1H2K\C^
MXP:@/EC2?B(5UKF'#A$UU*UJ\1A[D%>-C])KF3UT9EASW8V?W)E[KM?/_V((
M*_$V6K0OD)I-IZ]=#-@?2H^%H14P2?W=TA9@K;XS)','8ML\NJUYIHXOGXL_
M>W/_JS!;MI$V-5,Y1BHB9Z?+O:>;&<N:7&@Z&\IHMIL[:J;2!(D\!DT[O2L*
M#C"!2<F46]748=X-37=%*%'*]D.BUNOR4/ $;_RP.>9Z>W<<,#8N)B[R\.1"
M"B(G-F4Y['-LQ=9:]3!";I.>HH?)5*4Y6*WM$I!Q?!C'G[H+I,$+'NSDK=?^
M'N(V>13)[(=32F)J=6[Z(I;.LU@_D$'Q1XNB@= ?58W-4Y]2!=J$3JTR8IA3
MZM+6>S$MI]SVFE.VIC6B_@$6T0G9_'T:HJV?RR+#K>Q34B&RI_ES426K$"CD
M7EALDEK4W*0MQ^OL]F#7;O-/_E'[ORQ?W:>X,584KK!T;!R:A@RCPP?VS!?P
M3'73E7] [LUGBM33FBVZ^EB,-_(RRJ37H 2- <+D_!L9B:(\")7"Y4O -PRW
M-/(PKIN?.%, F.XT*.NO=[T/O1.[N1/8\]U9.1(G8"A#OOE>''>O\881N [@
M:&PC.Z=,A41[(;TB7Z_8:$S[ATCT [FV,(,9L^"-K^?BZ;)FQ18J4R309(JL
MT?/2>]2VFB&#7N[.]B@7+S$B<(SLA,.[(<DT483,!1V9H/GY2]X/RDZRA1MC
MZ\".8V,C7%R)FS7#S$D>/'IH3V=6@@=U"=#(G=>#U&T%,G8--'P@P,1XJ<T2
M[/KY _\SB\DN2D.YME?)Y^J5 ^EBH)P;-B00^;[BN;->$S^QE/FX$EUKVZ R
MM):.4Z94/UO"PI)&HV4X^=P;GC+:AN(%FZ6:)"]_+RYL33\M\]O[--]_DQ>X
MCQ]VL^.%7LPTZWBITKC"7(LLBEWEFUS?6 Q7?)9XGV'Q2Q\+]F:Z_KPHU@_V
MJPY&9$PQVX=N8D)KFC[(A12X)]U?& K,;/JRM%3GM\0U^0HWN4_\3=2HSY7
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M!8I_#>HU6\Q6'HU^@GVT@BL>%(B?+ @^M';R\0<E\^%+AU?U UCV(NL1Q<@
M=<:"18O"N.PIH9J3 M);.8.>D>.@PK?)RZJCC>[RK2ZO&:!//FW8:2R>+%^A
M[@=%W,+\)?"W%WSP/>&N*)E22TAI#S5!>N"=C) _9;'B[7M10+[E /"</;5U
MK. XTA5SGH<X?Z&M6]+IP;F<ZC/<MDXG0PQ' #:6?]^.>Q7@:8??H,,*M28(
MD>T;#>ASLW:Q<^8E6+N%.O0[/(C*:CT9:G+[E2;3QY,!&L?QJ(BSM8QP%<K[
M6NDEKWT]C<I0SD?5YW',;]GS,NME5L3$RT[%>(?9N-8)^TR!(=B+.@TT &^
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MH1)-JF&-2.:E7DRS'S9:D"A%HL/4)$&XD7177=25TZ]X=C$=#,K'4M/99B*
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MO&]K$7A^OFU><55T417Z),W_YE2F(_=KL<SWA2J&"Y*Y$?[L(&.KX'9M.<Z
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M6"GRK:_)CW?$P/B1:Y8"^P* S<'=D%9KM-?=GBF>!0B^%U:"I@AZ41_XR=.
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MY#@Y VB?,L G_RBG)&H<[_HH79WL67+8M;[*]UOGW>?31S'@JI\FWA>KF-2
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M$79.4$PY#:@=)TL]C_C5VW];;PW64K?6\+:4G_2J#XR$NZ,T']S/%4G'5;*
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M.C2 4]!M3YP&[)K3@+7GT"'U>2H<,=M+ V:#QP?6_'*NPBW_6@<[HT\#KM
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M5=!BU.IB6\]V0;3:W[C*_4E$F^N"+XH:).5,'S%&F'6$YB7>CW]X5BT%L5E
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M-23BG-;<N=VZ>L4UZIE84SPF%NH XU%,+4M"68!.?5N1'9?%7EN6>'Q*>L;
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M70S ^.ETM50#IAQ:AQ2"7PFN&X,TN:@9$J3I6? P:$K"?B,WZ:N.2M25V33
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M,T\[NZ^7L<)E<M;SH:?5&Z.*>I07&$(ZX,W4BCQ:BA0: X-;TE@'MZ?S"RU
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M?\J*^8'[29\GB2QS95_.1M;5[\?#5E1D@\@^!.$,,-S7"U_<6KS$][PUX,/
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MNF3"S]VPSLERJ+M[&L6!<>X !:TAAO%OH.XGA&0Z1A*4FVU.BQP-NQT_P>J
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M.WW-B')TC"B,&<I;-5K/]+5@#<$Q1Q#:"FU+[95.OZL;9C)W.H[GN;50-0
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MBTDM#KA&G_J\WCBXW8J1^)"DL/9M556V-O9^S!&IM9]XPT6BU209-"FTP\]
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M?/AN^&7XBF$J%7#Z,Q4PG[@+!C?#^U:H@%D@N8]]S0=Q>"!1\Z\@/P3 Z:@
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M'!PXHY8BK5B(ARZ9JZI"_9ZQYW^M6[&-(C-.LCZOPL0(Q/+CU5+%0&.-$0!
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M<M#.G977 O@M'+U+YI1/9O-\4RUD+*@2&RT<^OQ]$P]#00&GX(7'6O>TVX&
M%H?UA__<6AE/\W=@VXI4 +PDI=C#3\PD"_4\[_LN96NNJM R(QC-"H4'F8+I
M'<SA0;LXN68NQL8:W=,.C%U/Y93J.VS/+$AM:YH(;F:U(WA%96)#0:H,^+%W
M_/BJ.&\/\4T0Z0&PX2>'[*4[O*93!:_EY]](&:O-)?VE..W/DZ.<O4\%=/QE
MJ\N">.*;#](P1#9:*H GCV_C^_=* ]7UVH.CF0._M:V1*;WUK4_R*AY$/XAM
M;F0G]\S-X[R8!BP3$S%WK#FI%A[ET2FPX^E261_NSI(=,> K?XJM?E3A3#7
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M%6 ?D.6=6I,#05D-5/-Z6W9LDD:3?^=#(T"2ZH6[Z?9=.A,U8N:ZPNA4A;4
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MMFN5%O]UL^G]ON/#(M1_FA?*LBL;W&25KJR.^)VJZ.$F9"/6G27CTEP,?<\
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MF?]!^.H(MLO)9JF(7%5<C+*AFU2W\\1*L?*2 DXZO1HI(SF6+I]T_5F&4"V
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M'RZ<O/@J2^R2=Z)>E9O9Q?WN8KTJ%PCW*#&'A1VVM8C\2#&<6AL/"^:**7A
MW%8T*#Q-]FH!6D5^VOZYT&D>%>+9&H=%=",$8<&X[F#I\AI]L,D(W!T[8& Z
MMD;0CTT"%_:+Z5U,WI_6<A!=T'2%XYB\\U<O]3 JE*8=Z^G^DZON$4(HTF/J
M]-@,M<[G_=)CX.0TC2;345W9)Q5C)732)^GNDC*)7]=R1@-HX2K#DLWI>B1_
MK+4R>"))-J]Z!/+->=)8ZOJ[(A4Z(TW'7>K@-,!1UG/2-H$:F]6^>&6C82$7
M5SH4F3R4;;&H63[K5 XI+,CQDN$[-/!S"...R=OO>$#4$OD6W5>47^=GT"J@
MB7--FXITA4,*8!'J&GR8@5R7 %E_'I=W/6V=';(-EE_@U3?813E-@.#@1B?1
MG_C#\UU$1=)!-R###^0NDKRUACT=WH\K-H-TZSY,$JR5[Z2)W:ND-?@<1B<:
MFZ021.$BR6&C5=QA:NU\K"&X)@?PEP,->7[QC,^7\SL>-W[L[?*U'Z;[Q3?5
M8<"U(7B-%&2'S3#J1J>D9'%7HUC]&Y@%)]*WIO@@J9]ZE%E5G_R\IDOO'LJ+
MR0%C@)? "^*V_&1]O/='N*8[KKY)J<B\/*P< 84RKWR:,^^\K1O:].SAXY]O
M&;I0-WA[>9$/$ELS^1)PX'#\SN?] 81@J72Y YMC4XRQZ$^[.@F'%UI7A+[0
M *Y267"ER685;G)/$6NY:J>FMF*\/9AN5LYQ&'ZT?RF_^H*&=Q#0FLU*?9I5
M,)R?N#Q$%G<T4,61ZHQLKS";OGQ5 #D#1""R4!3KEK;5[?F]ESTZA"DI',F@
MM=G2FC 5OHJOBZ/PD%(Z+5ZDH<+7C$^\LHJ.)DW>ZMG)[\;:L6LQ?5O0TM:.
MNG$S4VK=EA,NA!>*K9F5@7:TT.-W/WJF<[ZH&?>TEEA8P\T;1Q7%ZEZN#.SX
MWL8CEEE="1?!BRW<%51*/*<]!"\MD_I#S LZPY[HAZP899]4ML LOYWH][A
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M>.+SUX'_/#86\+<.+;2[@ 8S_<2[1(Y=Z"<@7)T+K-TW XMO"-:Q?!R-'IN
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M;<Y6SR6]+?@.D-;&3A1A%  =4$!;?W)T*WSTBOPO*./5V L2%EK"M#V=WRH
MQQ7L,6T898T=* T23"VSO-[["":D,FU4;&!]F_MF3NDGA[#;'WB?%']W6V A
MWLDJ+MFQ"ODV'^<  T+G JB /J(EEI3T]T@*H?0-7<X"1G<?GL _2]LC*=!J
M<:)X3M2("MUT;X?(O$R[D9'B?#1"I<QJH3WMLYU;>]+3+#TOLL]PNNA<XQK$
M>*YZIE?VJ1%AGJF3D=E.UK!2/!&<_N=X#;VBRW1:^%9XXX/<RD\#T-CR>$(?
M\7(9/,,9YXL2O/R*N-Y;Y*N:==,-G51+*]LA\EB!%,*YQ7Y5,:V%[9C//-V(
M2/+XQG>+O@]\T.S"Y3]<\ABUF Y>J PV/6X=9*4B.&:HB;8VPFEYE32D;SW6
M9&,/*K<!FW^X41<H($G-^$[H+E?#"^G@H"=8QLHF1;-"]_+%?N7&6D-7Q1\Q
MTD]-+(9,U/W\G9VWR3^\U@X$[_I? 03S,$&$?A6I*X!^(9P#)XPE[K,2CSJ^
M I!"#"[$YNVQNDE0IY&OP&?ZOD!7DL92;_ZJ7[HB1E*-QZ;&O$3IKYXN5Q*=
M"C >477NL:YGGM#@U*DZHS+0W'C!*8CN1=!N'<PIT* 4YGX)W\V%97;N7@%:
M#U4G"75Y4MRB(/Q37,,Z/"K++K5P>2>$-6Y LCL@D,\]A&%.9MV?TH0D4:,4
MJ98-8B<S/!R2CDTZI)%ZLP$X,YNOGYVGUP;IS #IK!O0[IO^%UKJE653T4?-
M^2ZFHO$WNERSVNV%\9RX^"L <X<*_B&VOM&@U ".%\@V3IGD?MLS96\I==>3
M\IU^=[\_-WVG&R@ 51JCRNLF]:>16?&SHDM>T%I9HUZA2>Z^?8TH8C!P:>2M
MXUA7<R)*_KN(NNJ[@@Y=K-R>]?H(-R/DJRBS>H95(Z:ZE"E9-JH$QVW=F6>9
MS"38FB*JR8%$>@L'>G\74&LC67X4#K:EZ8?'J?)@R09@.)WC3JIM,SO2]HRG
M4_6.8+G%AKCPDFYO.NE1Q4& I2LK"+XI#.K3#F@FFWQA/IKEND</%X\\OJU3
M5XB+LVS%EF2C]DQF$<*P?!OW#[8/&A<\]ZN=,@4>=$_I\+#:OJY44,Q5Q,VN
MMXG^DVL8E<,T1["GVFY5*3*G_5.W36=M9=/+T&1N8J7]0-_OE;D/[_N*Y'A2
MOIO$JP*9=V,VTN;D)YA<'=_E^^BK1)A-GN2H]5D9YI87VUM[O'7^)>P-"G*5
M'*7\O]*NW]$@N\F&@C*O"V"WNF,:DO;VU/I2]=T#.,Z07IFRV<R?KJW&:.6A
MO@CU>T_(KU?=:;7,^TFDEUGXH'515U1ICWA4"'GKA-_]:YV+S!+KA%7L(/V0
ML:UC;+=>QJX(9_M0@TI<DXNZ+I'O07UE9//'YC]"2"X+E/VQV80[532];PB<
MF-+H!BIADYF3[#T39+#)%)\S[#(7:ZV9:MT6([A\-[F(R%@=N7%8?P5P$T<&
M]:^220,OFHLF!.>4%0H6M[-6PDM_LW74IWP?MM++(I DBBI0#]WTL>%+OZG$
M2Q1&=#R;VU:RS9;^I=1JFZE),3+7D3G]PQA<M,9_*>P1V?V60%9BOF3SBAX"
MY5B3?;WK8."'.[7Z^<U4\V1/26L0MMB=046UO?NH<?(%O +6>2Q<-J'24. S
MW>].K"3$RS-%^'O.03B_7NU0FB][GHK:F_ZG732%;G!IW *6W0)CA.=I%8_B
MJ;D"O(_J1R)_-YIG%2BGIUN$ 3-=4J3]W+T9$:&.YH8_ABG*AN"\V(P]3BQ[
MUYN0AQ-"]9B.AG45LCXNSNF7G8DKF^-/VYMFO>@$Q&FR13[H97Z@X__X.JE^
MRQD0;/Q"]&1/\LBB?0ITPJY_8LV"SMH?4)@M;=(/^&O$2]QBBF^130& $N+7
MYD?5N-3<P.Q0QDG_9S+C5#M9!Y''<G,-2H9RW:W]OQ&LF9/\LD?Z7"D1=Q_4
MV1@\]-U4_3G'UU:,4_I*!3XMPK645;H((#!-[_=O.OTJ@^WI# 37J7.K&VLS
M /X/&M%_<62+4UO;PN=>4YV?]F;7<,9<YBPBV.@:FG!EX/C^UFT=VJ_-7 '8
M\1_^I6A!,.N_9"+;<KH"'!P'/UT:N1PK_;(#([U&.,DX(4)7(^R<1[BF6ND_
MY1-[">DD,,'PHJO4L)?!&80[AA67Q9W#R[--^\L7/_86FUQ9!R"CK^?-X6KF
M?[."P(Z:GUMLX,X%'9?!S,]G[GU].X@/ \-VPJ\ OP4['R*XO]I"[U\F0876
M@G50>;VYTM,()30W)>)]GB#&@TFTW))XPOF3[=V#31N83\O3HQ/!V+]R:+(]
MAW45J8$5A:B>%<[6V>/56QX2[E$:]9BG=5_M@#XBW@:O'6=$HQ8\QQ;""O1J
M4QQ7-LRT*>JP]*>?L*ZAQ=CTE%;9[$"T*$V?GN@>HOS&TF_-_H;;8C=B*%BA
M96+Y5&?07T89.?7_7$+<RJ/HX%G%/\(R)PEHUX(IW-EJW14-9UN;,M],+O:=
MF=3M/_@NF%9@F^]+L:7 N)5+>_D%H8_FM.Y5I<GJ-4@:!*';C;3G"_2*F.9.
M91^X!#5_'$($?ALM]5QZ.M=N$T9VEUO+V)X1KX#K1JL1$<;^N<$NS:FF@R$+
M%9P0RKVP2>U%9D2+2 _QI3UZK>QM6SFAO9%9!,S\Y38_TBOYBVU;O$.D*93
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M;_%D .L#QY]Z0F^0ZW@9#/@%9CQ:U'^4KW>%:_)$78:[;EQ@;^/GM.JB7U-
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M*Y=RYRJ+P:#2%0V8J^ ;&ZOA6AT</X=D"O4MOFTJ4RQS3/TJN45WP%<;]J#
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MGS$[:2HQ_;;P.+SNA1@N"4T6YJ\'U4*Y>37XHH*-ZW'5U:*_$JE<K69*6MM
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M;S4?_0LS'GV2O4JMN;?6UA=\ZT]R/_7G&BMD3-%B6=^3$L/)2 O6GW7.MC&
M\_.O=AYSBJ#^B/;EC?:J?OP <NQ^\0M@YJ/_QMEYO[/YOO\_2FVU=XT2M#5K
MMFA0M:I!M?:JJA$QJE80N_:F:'FA]I8B,8/:JZA-S,2JG5!$C7Z\_X+O<7Q_
MN'^[?[CN\[K/Q_-Y'M=QGI?[@T0I/:M/'MH7FGIS<W\,H3@^CDOV215'/HK%
M[!PEO5K\\QE>UG&YL@/O.&XJM+9X$3J5\#YW!\>2GF.]+)VFG9^O8V>9/V_^
M#T#33MM9K="UPJK2Q?/P'T!#H?W>[#M4&#>?J&:JCBV70?P+@W/-95;,KW+,
M,(T+-6LRZ>X*+;'P)2$R Y.8XGG:*M3<7'\,;U2U#_,-,R %:#,]7Y4Z-P4,
MO4C6JX;O7CRY'FODHX8;V5980QY9..?AH^87H(H3BLHM[=6R1[H^]F][5P8?
M:0HN'17H,<F@7B!B86,_V(.8)^40#$1$I[$_7US-GRMWS4SS&8D]Q[Q^\X8"
M<R5N2B:%5)WJ$*MAVJ$$KG[J(J"H"^!"_28=>L#TN,@PN8X[PW[>1?5[D0>[
M>LU(W?3[-74_'!*4?YM9O1CA_;TB KU[UPNURL<,HNO%)MW@D1[-B>4#=.-4
M2+;]*W@\N_R=S1;B+C1030]:GJS'<K(L<T/>&[NTSSSV3(8%DUR/*M8DV!;M
M<'6$(,\1\ ?8MF=GS\;9H)!JVQE);RJ)$21)M*IX^[#=W8^*%0^_G-K9SI&<
MM+$2?.-4[$FP>=1$S\Z_CEW#*KP04:SQY.<1N2QSM9HZ+5+GK)"<[J$N(8,T
MS;1AIJJ*V-805SY..#TQOY!8^*8#WQ9UNNXO45JXVZ)KXQQ#.7,"K$=.%F<$
M^0IHN+N+@O8RCT,U'.-OD9S>MB>F]6#</R&G.J;=Z%!5F<8S+W:9!U[.,O>3
M/4"IJ<C6]37WD>_]!P##S_$KJT9C8=>*OWUKB<:!SX8UQL'I_7&78->2$> L
MB8[,=JJ&C)4%^LAR"=6EP]6W$6-5"G*[TXHWZ<U]2%SUKD0 ,#PO^%AURB63
MY+CCS.!M\MQ4Y'E0YS#-'$8W8_)T:H%#">Q[,2M5$*K"Q!_)9AZ1\%_*DNQL
MU2ZS.E0L16):##[(^N*YU&.)-X]6WQ-LR#KQUL>=US038B=)I+"%UP1$/&J?
M=](<U=:,OV0WKYCG]%8J%VRJ3;TGL85ZZX!.?NE;=H>F(<"TPW'E[G8[$YI+
M(6(LRK4OLT+'$9O#=8J9FZ\I+N\$GK(=I(IYO,PP[O4M-^UI%#-\1HXG.14:
M+;=W]'.$>/BYWUY:DUY0 U;4Z1GI2FF(B#T+TU,DR4+9"#OGU>^ <8?4N[P<
MQ$?%Q-=[+>3-PMEW4R (]JB3<J[I*@?8C*9I-%O5RN^PYV:.*4G  3\5VNM1
MKJ0HN$BI_C\ ]6RO_XZS^5(^(2_J9!NMQ#/:"'6'^.!; Q--JVM,]B=[CMJ&
M.3<H?=T!#P 7,L\)PCDXP3(ZD*?'*4VSF!M]QF^V]Z3^83_<^E:EFSD'1M6J
M%<^S^K'LL7#1"R'(,F,=ODK]==Z;Q&-S?$V,YRU1T[&*N+@ET+(.[_W8P*_K
MC08_XS82OB6*,F,/][JR2J.]/A$DNUU%NZ]IN&KJ$8-8.&;$SOV)A<53$"G9
M\[[5A>*>O6\L.I0[<_RDNR]$-_7G358S_M>5R.I\+4[(3<")!D<SFZ%*\JMV
M\N8ZWD_QFAGK9"WMJ39E2?WJ_[YBOQ9?4;(X()KA/C_;YP]&K<0@Z9@O)/LQ
M)>$X:+6Z<>0168?"[.SW$5>[NQ?1&HDRH)]\#X D@XL_UTEW<_2-:\==-48+
M_=QM7>P3&>6F*KG\4A7[N>RCN;\N&6D9_@2LQUI4&P_U'0S-;!XM+^^<8)1,
M[=.-MNR?[945;40;.?![4>NKV?" +Z2[@[F&Z3M%P4J=F<OWQQTR?]3_ SCH
M -E.DRVIO*GLF.6:,W0<M!>!$TJ='&)F7PMX2PG9V*>SL>V2,/HWDY?T-X+I
MY'\'P9M=M;@PC_:7KP!7;A_5#<%[-:1^LG2ELOH^>Q;:$O+T*/:\X]2>J.:]
M.L9D0TRYO.V!)S9$0(J7+:R7,);.7"=_6X>?7BUF' W5-6Q2UPW>2_^9QD8I
M?W!\$1P. B:*7C1?,UHY6W-.*UNV1#;FKPA'WS!8K'W$^[[N?.KNWFP&807L
M]LK^Z_MY;G+Z^ &2TP@')Q!P$@YF76^Q_]6:.'H Y?QJ%&*&^Y@JPN\(O47%
MR4F1=:[I/G]F.@4"SF$6+R518!7P[!_('W>FJX894R_Q.Q,8C.;DOD('A@1:
MU)SP2S,%*1.( R36BUQEP\&X,68BB/XN,;C'/"HJ"\.CMH_T0RI%R[89[[YJ
M14_E;AS*>'"3*E,+3RX$37VHHC14!0U/H;@#!?5:.M"?U2!09GW9(B9&%C:[
M_F_DS9+_&[*H+$YXNXR(<I-CRQB]+Y)%]UH+/2G$^/)N]\-^;UH70D>F,(_:
MZ]IF7%V0O!DQO"^/! XI^=URFS@K9R6_JQ?U4@93/,CD]JFN.7N0+%]:8IN"
MC!151Q%*'P821(5:JT3ZSU2NBFOUR-<[@VX3R)NA%<Z^\LF0R5X^3&ES:ZI"
M@T6]*W_CQ<O0Y_?227P30T"#56-,L#0P/C$!5%EI&:=$24TE_' D;)11E9H*
M6'\?<*>D_25>Y0<?DU/+2K>6?E3#3$MBBIVW^$],C[_K05PAV -X9G>A'$,W
MI?!*#]\%U$:71$BI/>#4A'-?99\D2.K4-4^A%7 !?,P[YNUQDC'>] S@_/QF
MBR<)?]*H9!>?_@KXDD*SY);SZ;^<DI<A@7[%-]YL^.,O+6^.QJ;4^>MIJ'BS
M6!1968J)O[_BANE'*E:?=DGT529<:TV?:C&/B6C,>>*^1WG=33LKI3)WXOK:
MJ D][4CZ\\'F D5HJJIG\_NCF $1%-$3K_LZ[31U!NZ^]I2[Y_4NFW]DOD<1
M=.PJUFNL#D1TK5Y+Y9<3$T<6<3A<_4A66O/-F"+YX]U0?7NF-.!MRI+8:1RW
M]H3Y\%TPFJG=LBH?* @9T!2"+<7'+R'2VA_ .0F2<8@3,S=E.I$8A%PP%X\Q
M3>"+I]+'SQ(G1 ,"*!,+W95Q6@GY.@[J;M4/'PUR_G0?OYY:)B%(QGN#Q;U6
MHI(OM2?$_HCK7RCI-C<A$X?&S 6$D"U-NC&OE>R.)Q02K));\=GA /H _%B,
M["$'+*C;8D*";CDSD&G,U6,#&?3>L?#VVSN4Z^^]JOAHX6;XPWA498Z"EF+U
MPL*BOO-9U//VQ-ZBB-@!IGTLPV/:JF83_KID*O[8\V=;J]<Y^."^\)Y_ ";D
ME;$[#4QB!D-/[ZPO_$D6MO]V\ET8MYP?8"I51X*L<"#NS+#UV[WPNAP>R5.C
M:1?EVS<^@P["RX:<$+/HRK).*1\KI71Y.6FS@FEHDV H%(MSM66D?<-D+O?,
MY[L!??VN3$\0<!(M4CA2X=Q(CND33N!2X];V5:IRNE4FIN/P*D1I=@"D>)7M
M_7M/+ZF4J/[Z'^ 3^59/5DVA)S:86N/;D/[!OFWMU^H3U9DD9C%V9NF432I'
MK;[5'JM_@$B/:2 QIV@.C/_MS&4=A_A=JD/(+0^ *FVWW([X3,=:=+L8FO2H
M!ILV<IO59LQG>8U;%=13T&YZ5=!^AQB.*^T!ZTT<8O>LI28DQ63;5+1F)6K$
MKL>PQ.4#M8JA&+'<CXNRPL(_7R7O,DG@-2?G+ZF(@65.?"P@06+B62<BWV)7
M0=3#O7SW^_9A]9C@H""8JAF982,]" @?-(M.D?ZMV1,/H#=N)RR'E@Y"[F95
MMPYZEP?;]32L_P1OSMA14=Z9H8[O]Y$/T>EU-QG@I;OZ,A' (S!K0C2Q+<%8
M[ ;=(]RI?Z\1'67:[/A5EIACFQR3+[4R6E&W3_T]W=M@B%OIQS] W37*?:TC
M*B-7[J;RJ-RV9IOXH^T5L$L^;J,W"40V)JR;0#HF5SV].0?KE=XG#6J*5:@"
M+FBL9O;0,OD[7.VECU&37A=^$@>.]F*"L7)B^R%4CPWT296-LBW*#EUMFZ)K
M8]^;,=2E*VD/#/ S!$:/P&LO=. <!/K>I&BNZIS9[@%E^Z+E;8Q#=A'49)8M
MS_[7N]3]OFJ!?K%<YT59<OFEN^\5>^):^?,W4'GA"HJ1S0CH/P"C,K/]-PUG
M^"OO:N(_@$%KO7C9PFC] N3T]TT(3]_7-QFP&41P+9%/Z.%(3JM95U6HE<5Q
M)411!"RICPN$^ >@ZH_]\WMF5WN\YEZ407VH^"<&BVXQQ%V(%/>6TB)9%LZ
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MJ9$@M'1:9?TEI;K@?M4+T7X.6^LQ?#9VM!R_@,WKA5[Q83<04>W\._XUS7X
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MFU9Q'!Z[ S4Y]5FA62.H=%>.L0V7ZZY>Z%09TR2W&%4CV7UU/!X6[;@)-F6
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M OY ) :N5FR)5#0*@QZ;^HVZ'<JN9+XPS=#@"+NW,=J3_')F->*6&65IX?7
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M/HN\"NZAXEE;7M@V^6[)\QB#?O4S\R&B181>&8JL\4SVB*T/)A1B3S.KG+/
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MW/;FUJ.PS!7!>(KP9OS@YM>GUZI;$-D7"CV2Q5$$>JS9H?H >G9/./K66'^
M>9ZNB?#I[48-3VX=>N^(=ZYNQ+E!U"^^;UT@!=X()\Z3X<^/@AY>/5,LL1D
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M74!K9 VD^9?1['C:)TL=\[+UZ 43YP(K97SIYGHZ61PB-1A9(K%6L3G-\OW
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M9&X0O4-RA@+E6TH;/H?(P%>XL5=LQDX1+!_)QV:\#=87T42_B$W^;,Y!//M
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M%F]CR8&O[&SG" #<5$5$M7QA+X;_#M=GU8?A/))=KMK%JAU"2^)%OP0?#0S
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M[;*1-'5-M.6N$>1(='/ 4\_/X\6)RQ+PM6R1O[3>L<-X\EIG(L !\B$.W'F
M572J_#1PU?KFL?NF;9D YF0H%!-SFC8Z'"XM7H0+'M8/NW4PV*[%+9!U6\CU
M"5/-><Q?V[72!EP$[$+Z49OBS$71]5AD6$R=UK2*8)A@<9;+V^JX@ .<!7P/
MLBSOY1JCT&F"V6>O"#M<D.L1??NJI*<@UJKE$I,> UV&W-ELX8Q*NJ)IEZ.7
MD1>.+<P"!K\8GFP*0<,[&%:&H^&4TL:??\2M/V],4'<KAV>KEQ#ZA*[+V,>
M"5<Z_"L92 U+>/7-G^Q_H'IY?QKK-7/)K9&>:[_%"9-.&TY#9OV,&< JYL4!
MO;^7%GR/[&!-:M 2?@-QR.EI:]E28":2F@W^C@^C,9TZ&^6YF_[:1:<L)6UZ
M6$]H_:2G.>!L;VOEV:0* P95=\2;[- *&TL\UTAB!IPL\J]9-BU2$0%H\7O8
M>S7N[V8$QJD7?[L +F462]M++BZF*/@&:SO+9N/D2@.+(D7()1FOK8Q#V(.Y
MH[;7:3%X0)!3S@J38WGAR:MPR1,E>'[30^8:9@6%"2,6G&O U9325 >P MZI
M1P=U6_C38/]U/6K M6!.H9_B?2'/W@4GW1SE<K! (!T6TL[QA;S5 3@M2O//
MM03RY^,_ZH3Y#ZH!C\F6T')EC2U"@2)8U\X[)J/.'"O29Y^%1?[",_Z9QUD]
MT;7,?OVJ_-[':FR7#>$O-T<2@:WL=<442GH"1<5AEJT0__R>Q)\X@3NUPB36
MA]]H%6->3DH=L<>E^B7[!KS>A$8L-]S-,)UNUW<S-7 1T5K0-C[C64&&7B<!
MWA3KL6+W5]AHYLGLPY8&N.BM6;89,%G\6"@9 H%Q:L$"=\%8AHX+BZER(L!N
MYR'?G'/U3CCTR\&'S0_(-QX!;Z?&B0"*0![IVMV=7] 6[E9+2@(1\%+[8[X?
MMU_$ZP^^\=;6=?A.ZO3'BM3&PZ$@JD#PM;8Q:DPQQT4&H:FHOO1><IT4D,O?
M-N!Z"[7X .!YAUX?=HSX^?D\>V6T:F98?QGF&)*C:?0Y>[UT-=4@"I]>MN_0
MCZP0E()S\&H8%#?8_1;L(.,:P9J"H-<J=-M*[BI'/3P;G)+V['!A1F[L%_"A
MMOCNKQN:NR1E3W#>N3-;D)H#Q)NJY]$,3L)=AKEG+[B( .RZX]D\J+U!K35:
M27L%+!5QU%FIRI1U'@X-99:V0W!RDLO9_/;L.7-TL@E*@[]/Q$*^YM(*P8I;
MMPT28POW\5D!LX-($KP%CJ(4SUH]MC$E+?)@N2PM[I&P"]?:N;HVTUO(][?4
MB$,UOQSO5J8FPQ40"^S(N EKLGGR8\W)3^1+^RP9KY^69'N9\I"?/.]ZO>!I
MP=&AJ*]/L#?B5&5!FY:%U4L/CCS)..OYTKK:OT($5+A,$0%/HULHREJ4U(B
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M^-HZKJ).%58\!=:W*R?.F;E?KIA'T9QP\L?-A; IQQ=S^0O=(K0#G*4BO%"
M3ZV5'4K/P""_SWR( %(O/5J8JRDW9Y.SPB+[=Y-,@^(V*]-;9G>&M#W39>TK
MHG3-H',7U+IZG/9VC\:_Y["V*4_,3O;)9JJH8WUW@["D[?Y*%Q&YR!(-RJ0X
M+E$'OV<?-.];,M8HL_#/-,%5_Y[0,C@Q)ULE0/E.,[Q6Y)R7V>Q=-P%]O!@
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M?B^7NW?9RN<,S6AZ::(NN(9WD1A(IP(H1K1)K:#+U8$Y1KG[I[N#)+!:>,%
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MU^JMAS^?2G;:JH;OZO+RS)&D>T /NQJYCSUV6TH?P-@#^S,A+-IE/&LQH40
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M>35KH\)].8+P=958=DN^YM-MCZWXF>B>P <$AR@%UCRP3""BL,OGV816\M@
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M'0[)[O"2TB\!B_E*IFWX\IRR>R"?^K #^Y9$LZR/Q&ELQ26@?R3H$A 0CZ^
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MB]^YP>WR!H=LY5^+&T=D//(E;T<-W:#W?P51D/?0AICR)&F:1P[-=)!^=#5
MJ?I/ZM99X\#3YX9GTJ\J-T6OEAU8F2TX"IA_DI-S,.M"]M<XI(]IZ>/\,Q8$
M+W>]C./2%L::3\\87&QET%2EU%E>.$YB(G895X?O=W6FK^(R!YL$H@-DG+C<
MMBH8K@<(9*?/@/TCZE-XHV!SO029+P/M2Z447SQF4-W$KDL %;!#@L0X*D<.
M*0^RV901O#L'M/GP\R2QTB &POV%'LBQ(%8H8,I511X:_IB>WV"M5@A?WMQ&
MM(?G5L%$NA7HH_C$$13Z8US?DF/W=E8^2K-^H7KZZ]2 F2/<*_Z!A9R,0G)
M^=N/HGTV'_Z]B->C8S56Q\0S$M$8;V31Q@+GA#"2BKBK, 2%>(:(LOY\47KC
M):,TP&,3](N0T8=6)(-X5D4HW&BT%,()C6$-)JP-_^T^<?N3*-7?Y;=4PDA^
MPT.^*8[10NZBT(&/7_?GM(?$J=G1'MIF/1;<U50?7FFT:#RV)U8>;CE(CVON
M7/'[V,YJ%! @C<$Y[V& ._$TK1A>TI\I3QQP,.1D0C#L;;"V&KFBP+M3W/5]
M44MFRVVK.R0^&,5R<:A-^/A;L#\8 7KU(>YX]EO:@LH[-9:[6,9>M^QO<38U
M9T]HG'JAB1I"3CY[\SS@PM%%_97;;3[+%WI=6L@)%\_908C"3@+41XRF6BNN
MF35&0C[6WP,N^D<\/A+T@I#RHTN3Z%:XE60SP'@&SQW9Y01<3'W8ER$/CBM?
M4WR XK$ZUT2G[,*F^K200"[ML24,BY0*0)F<7(J<EQ7[ W!;^XP]X,/CKHZ!
M"B1TWG(LB"$1M_AG14#EK,L/E5HTX\R0;HDK#%L:0DX<[29H/\])B.QRVP#+
MM#I@;T9CAW@-\57!<IKEL\ZQ$*?;FW5U[RB7C!7TN#B$;EFO!B?]!WT?Z<W1
M]6+IV@,D CF[39SI2](%H2\!U$E8J4/S6<V,^8>]"Y-CBCBJYN*H!6.[.W4O
M;.:Z;:]Y8Z69N%E]C[MSPM,7.ZON9;%8Q#UR?6^*29D_[A&T36A4!QQ22P-6
M OA]D_R8#=LQ/_!'R4ZU538/@33.HX[5V[2%"T\2N$Z<2L2;H[WA";7JL05X
MV(B-Z>%6VX,/YUY+EX"(0)H_7A?O%Z"TH(Z+7.LB\Q):"K(V/SA2^F(3ZT&]
M_L< Q'*1#5>MA'DO6K2UC<(%_A?T0XYW%OYOZ&M<#/&$E/)G#WQE<;K"U/@^
MSF-PH[(9 ^P<\E\V0MR(JZ=[8Z&Z-CMOUI9V?7NN_)TGEO.C+UODB-V5J(![
M979CP:66P *BGT!+0#J;_4Z78/O_0_PFT7"*!WH%I2H9:W';]:4K8L;5,/(C
M7[2XR.>?Q""3)*WQPC$7R,+NS.E2J!>5!# A3,%>%UBL0R/=IWH&A/.$JJ/%
MK>XY^8 8QL7 ;C=:S!1R.*,VZNA-OAE>VYTSR?:H]3>0%OB[:6K/M376W?!_
M:,_R'^TKFAYO\VJV,BO]OVD?X!<4+P0'+W.$!5*/B?]/VF]5_W_1_O1V4D=;
M35#4N=7R!K(O]2V>E*I S< \^>OCV^+\I[?[**HY'4KZ2S94)\JT\PI5[ORZ
MDLT9J]VK&/(=SL*UB)(8Q4_'#VU,XQ;,S=NU6G%?LVU?V%S_J':=]=X$]=&0
M"PQ\!"4$1<O)YX$EJ&PAXKI<Q1D"CT+$WA>IJUOFJI,S<F?&R6!,4J@>\"?F
ME:+LFNK:IHI31D$)!(8EWD@2BZ-$T_Q\;T;9IN1]7ZL/8R[,MBKK9#_+T==M
M;6UMI+D4H&H#B-O??/<-8]/JET5N;H.D)Y/>_JG=1 I,Z9$L7@+*9&J><SX]
MYJ;^(CNYQPH7)_!V@<O!0?<V8XL&W0N7;SJNT) !EO+O]2H'2./;EMF+EQ1#
M%_@ELA_]>8=&C@BS!!@)'-U58K]I,,# OR26X\GN_6]S.86#XMP4VVK3[1=0
M6>54.;1<.[-/U<BC'OVPV_4Y2/U=5U:^]%J-?%FC1<EH42;W%M!2R Z5,M\L
ML.L;( T>5>""WT:3&#;J9,*K?8K47(H>7@)L:QJ<GGP^2NFZ\]U[!ZAK=NJP
M,X(!1[,P(;6 K_"3/4<*0S8(JQ/)^^O?*>D;%>>WMVXH207F?U[WO,AH6AQ8
M3QRUI(B5HT# *+I_;IBUYD9=2"2;#!\FF^_^O'<<3/)E>T6_\#?P=R!O^D+?
MF:8A_JJ^H%5MV%FMR4-:_BV+ S)Z\Z0^IA&Y8!UE.?;'!:N4'0NR)^PJM5O3
MA(A0+RB &+ZM/(6(11Q<MW5P;\I6*J<I4PUJ7PH18,[]IO&BF)=)0(R.IE:G
M%?S\T82NLKJ:X?9_'_!J[&Y(>1:-ES&I\0UJ%0N][,F+XC=5VE0UTS#<-GWQ
MI79U4ZLX+CDF]FY>EA:H=JM7)=+]O[LQ#+=-U$9IBFF^S@18/_ZS6DQS,+FI
M37I@TO_'?0+?R9'BI>WW3([T.MID\EM-\HSBIP9]X_.]4\<@/'=0F&_RMA3*
MI*I_NUC[M+I:).VQ\G5UP;%G;^)$GM4DN@+8AOR"SOGO<'76_1C!MM'U?;=\
M&_)F[$,^.#I,?SQ0M'Z?:R'G3'[:_!<&9V[9!*Q]$ERD&4#G<M;QA88F('RO
MCWY=DB$5)#!9A;34\&EHS%;BC@,*]M7_X/AS>X8_Y<KEB:>*^C\YN 2$^.G&
MV-S@96D$#=H5&T\<^ =]"F0FY,D%4A*^H2;I-873REY#5E+)%;E8KP71EM*O
MST##H95P:Z?E[1%18$LZ07#E?NGOM\,,W#Z]0<R;<F[Y1(?.(Q#K1 L7PM+"
MV?QZJG7#,PT 9VAP:-:<QQ^/[8V%%R;GKS!MGP*?[Z<(#+W7]&R>><:LMA)S
M18:^R%,R2^<LUM?N(>J]Z)HFIUFT88"71#+C+Z1M(0MH1"4MN HNA*<-%X]&
MB.@10SV@ 1\Z[*+/7JC,J%&4<+-3EFGAK30(/&%S"[<(D+;(2IS-"U264+/Y
M\(#,5^I Z"#[X9]S"R(7%O@ KH(6UY)4/5..[2X;U3R*3'6ES)<2I-5Q!H9?
M F@/:4-."[*?$^!UIP8/7=5^F-Z:7&M*^%JB0Y>PB!ZO%Q_##\Y*:40("E_L
M^9KZ-'O+M(9M-6C$Y@8<&EGNSL=I O$.79\KA%::";@>Y+@*0E!Q6H]#B/!/
M!$5+_P>6M+08#'_D!H&6$;<P4^:1#]=X2$/V\RP.%*N\?P@@$2]7E]VBK(]&
MR=/];#>UP5.7 ">1$\86R4O .]F@BUO;([$:>OG23;HMD//Y(!PV.[-TX&OA
MSE3*'GK-VBF;[$^+,H'K+7XW G-+_(X"'H[&.=O8OJOH>5V]'L9Z=F;,4;;9
MISDE\D'2MVC&)]25<1X9M<Y.K!PY"KH$)+8N+YYN\I*B_#8"'\("9ZV(AX$N
M?]2A-EY>?C;67WI8<>??0HG&8HZJ#RBE!*2U*IM-KSOQCT9'U;C7K^C^),K:
MY6YZS\3'R;WB".\9V(L QG&)SU:5ZAX'<>U%U3CANSJRA3W RU!F!P.7Q[63
MB-^/;3:J@D=^7$?G$-NZCP.?$81(5?Y<ZD+=81]M.GGQ)0> =T9O/AB$ZRF1
M?U'5M1COML8*JXUIR\_Z!/JTILXI.JDK&%)595T"JA)R$1OUV6R3E;5#KT4>
M[T_^=N_[XAJ8C] #U6X6)6(<4HR=;#U2?+@3 ]0+S A;9GNI-G=$OM?J*K_3
M7:XMGTI,!I\MJ*X\1N>=2Q-O8$4^)R"FLHH#HM564(B2^@3G,IDOW79M2YQG
MF):MYB!VN#T!VNV85S=Y:,S\@;_T88:S7(;)Y$N +[BCET(H46"XV]_!3F6P
M.4">P:H%UW5A)IGR2!*2.$:JRCM13-CSX6"$\^']EZ?REWH(/'T]X,;E9X*B
M*A%:M=B/<>TU3^>DC*SW"37IW?BAN/BS%^>*^+VX/<BL&0$=B9@)>#([Y(FL
M_9B7M5=_8WCZ >>A4'#,0T5Q$8UC( UI_&$./M0ID(%0''RPQVRZJ?:X.MUT
MJ*5:!7"[D7+N(Z"_]R73B/ZR4?O 5XB6-)_LB$'&^$IJ-EK^7,'A]C^7&AW7
MV-)FZ:?-B&/(K/V>PY^#5JX^BJ-RHA)6 $C7P9Y1#G.>VY(X#<N,IV^49?NJ
M%A9Y"4CY0./1T=]!/P"+<Q@+LEZ\7?CCQ$O>Y96G@;>I,"7%XG-5]/BF15!L
MF^,OKWB*D67@+:(-$"\9L3OLLOP#^@*<'4K[9+*?$P#[1<[4J\S;I3A#1Q3M
MD%2@19^+.F!IJ7\]2I>5+7VK]>!!4OC,G,,:J^U]WTK%LLE/OKE4/.(\+ CZ
MBL/9 (@_F][O9Y-/KMJEE<T&F12_NG$SJ&UR%?B$):>Z+<(F"2.^%RW2'ZJ*
M'XI!Z\_+ A*:N3A'SLF'H,0[KF;&/6WT3HKWQ-ONPLSVL=H3XH.-6=^CQ#-^
M_[,3OILO(,!:1\&T'H?\ _MW%);:S7XWZ!;1JLM;X19^;F3-TNQO6QK/H-OQ
MRDPCJS#L5_NO/OHT?#R&(X+$:+KEMSSN(J[(\G3_($G.\0/B%8 I8VW.ED/B
MYIP;.EO<<YU79O*1]\Y73S_?@_GY([D]B I_RL,P\ZLN9L2PG&2(^FP*\9EF
M)[!78;2H+/[40FR,26AB%X;>W#!%68DVO&*19T;\Y8-A_ENR04TR'R67-P-O
M$.VP02RPD0X)OQM;H(TI!OWZ:&$O=9"3RR,[59](C!S#>_6]N&EL>XL @<,(
M/]*M*<(D>X49YS_S+*7,&TGK#_O?]<W=ER]O)?#B;EA+1&,T%6\1)18[4T'<
M]J0IE.2(+W=_3W3>31TN:M.?%._=XBB7LQ]6L.5.NF0E^N"FA5)0 2.OF5*8
M*T3,IK0V>7[/01:&/"0)&ILX"'T\<U6) @,QZGB9=R<#PW%O>I"MKKS2.7RJ
M]\-Y.\1 4'%&IR9A\R-X]?0 2@>WL+H+Y\:W!0O5NEE#\M\>W[<,*.AWL86L
MU,WG0U\H,LFK%GIB2IL&GB,G)R_N8>S^?ENV,RI/+AR8"+!,7:H<;CMZA3^L
MCU(0HYI7-]L^XQ^&&-Q2@.R7/RYG/>3\U>#_$0PT)*;AH3J$K,5HJ%@;,S'"
M-!V+TZ0I%F]Q%0C]JKM:MQ0* 'A\_.X!TL=78;Q+\:F]#T])7Q.T'N<KB;>T
M[Z0_Z5WA=I<&A,C<E8D)W91<K.4(+DK'["\N#8>G?YVV$1I"9]'\&WX+TF'S
MOR80@N1K&O:&B*7$]16']OR)HQ'+Q#+Q29SDK0943":9@1LGX/<(HN>!%\41
MG[T&3?+.;F3,FYD6_T[PM=-[IL[Q7/]1P!R\BXM-X%=>"UI!%NX2[EC4>!:(
M*+T9I39+ZT3Y(:0@8)351B[(9ZHF\"'<8 )%1UQ3O.^$5Y+]0I@S>S;-6BU]
MXXO-[CX9X\;+I3B!B0^*SO.B77X89W:F*P^XP>ZYX/(=/[?;T&@1OC\%%*2<
M2.B?\9AE<^;1+I2NUV88Y5F1@64J\,=P12$&3N8*\UV,D>EUZ>#-/[/$W7("
MU5'='SF%ZK3EVL3>7@.;+_H^68_.'RKE%+KE(&^L[L4I.D* 6C^C<1[=1Z=V
M!<\OUB#E^Q?P/F>LL(*0<RS!SRKR(:'"+-3YCC];2VRKH7I[9";UQYPG,.Q8
MJZS^1?G!^I0]VC,^PLP^&6.>F(<U >?(0!K(8GQC/KQO9&D\OIDGMJ7GNAJ+
M8X$/ED9W8KDL#<M_#>EGV._1927^7 3578FH8\#-^18GO,_RYX1T%@%S<W5;
M??1PBI3Z*6DCATCO=@FHHXCB;27FD9@B)&9$(G#?ZY U\9$3M1JK(:?+R8&1
M I'$-$*H+C&4H$AZ()4K8]@M0CX]>Q("K?%]I;%<%[LH)=1/XC^ .!P5_)'3
M=;M96@D7&$5:W5-ESIUXTOA$@M/UK8IHP@85J]_$ZV0->*);:]+9M!?AFX75
M%%]99I1>;%9V==1/,X$COTRK]D'S/1:X/?Y):JGEW)R2C8Q\BX>T->NS\ ;*
M[P?ZM7A9YL(S)? @!A@;*-*BTV%T@E#9):G=7=^ MXS#90GE9J,*(B+=3)B0
M8SVG!74$8;5W8T.G]_GQ2_V/OKUDTGL>F(@>*.WYR[::AFH\3VI$WRSS/QU'
ME[=)H)J[&FD2PNV!+@"Y.G^/>L%).V%+H4L C2]JZM./%WEE_G/'D[)(L%!E
M,G)[TV,B4,81QYZ UUQNGA-JB87<:HF38_NI,=K+D:/RKWI[Z#UIVFQEBB0S
M+L?E1/J\?/$ & :IL,$\ZP$.Q>LT&_@! K1\CWMI8XRMZ.4"H!C8A[8?J\CP
MIY#<N""QGM7J=QU'5;+?LC.-OSLK(H4C,-4.OIC%L%-@)'(0EB*"HVC<[\).
MRM7U_^)UXG8'IXAM*25J2R+/7$;TZD2I/I_V\.@GJ/<.%3LPEILK>XWN.(-5
M@%2D[E/#[.)68?%8S:&?8:>1YUV<'[SU[M:?4_M-+-*WJ/OCT4?.1*]E-@FG
M#RMH(>:CP]&ZQMAJOIACLG3K'%NNW,<M-IBJ'H0'9JTA/;QRM.M&$R-.$-)A
M DF*HV-?)^?>=Y4%W-B+Y6#(P1S5%RX(IUW$.A2;%'Z5>(\=)J?NKL.53] S
M]N&CG&.JV.TFZT\9#7^7[!L:V([KQ$H=.\G^.@'->CL4PEQ4\?$[5AC9-!Z3
M L+-RA_FUP+WPV.> 8X?,P6194_^R_+CC4()T]Z#\UY1$G$0OW,&>6B4M1LX
MOL:2QN(K5/]N]G><7S9RW0OQM.&?M->'?<+AYN213L%N+F55]A[!853Q+M,Y
MQ]ECX@.5%X*29JL'Z9^JJTP?W?@;^&J)=Y&^D&#>G=IV)\B^+0)T?]P^95C+
M?;0*:LD"/H%\?NO00#U.??:([1;]*@<]2DBD.TNTTP^"BA/SYZ UH7IJ<Z:>
MV499^'FF89DA+K VASE06+$'!]5LUA(]8QX!5FL^_=#3EWF3Z3-DUKB$TX:C
M4R!-+[7Y=U/=)4!I$A&?SSAU)(I.O!MWYC2T68_Q X:O!%&2>DA<C8F&4<"[
MSMLWZH +.J/A /85)9$ET1F41]4;@G%/!T;D$XD!+UZ7<)$#R1L8;QV9@7=Y
M<$%YZG98?!-&]*=:=NL*&=CM3VL&^M#%QM.ODYH^/4;YM_7D: 3^&1M< H9R
MW)%C*$ZX$3N?,[O7DJ>:(S'A$F ,C_LKWQGD78B?1^4NB?Q=[$Y-5<85$.CW
M51U8/\5T]M!]*2Y:50>RJ8Q;7!3CQ(NWV!^,BK71$\FU")9'\90A8Z=;2R6W
M >3N=) Y_O6U#BXI^@C"E?.8( G .#3^B+-)L)A6[#'O:D;[/F?!;S-SFP<J
MOPEH\ZV).:X4U_;6 2-FY;<:?C-GO7W#/]\$KX[-3G\ZW6S>;#0^TA:$1W<S
MY-RZ\N>7@+O$\&%;Y*1XZ]L9D]\TC'?*/L4??33M/V@7USS2:@J@U2#F8&5#
M!8NUQFA_#[L)U)U02B_5O0<!N7S:%)PP5=&:5>=/\'W!D-K@*[W]_;_UEOO_
MUEO>B$#AMG 2+3&^'>\4,3Q5F>(K+MXXH_=\E;0W.#OL_6QXN2M;WOS*;3N5
M!P6/ )_E:[<R\9W5YA9= EBB]TD.;0E;BC^/\GF[+@'A00_DO"*59LS[P(YC
M!Z+P;O(=TV5LJ\Y%0B : XUC\",5>\C_GO)F8*AGT&N^_WO6YB0^D#63 ^@B
M1QK!C&U> FZ(!'+,;EX3#8"+N'AQN:O#Z1Z]\8== HPR=W=@:_^-<&/@6$X)
MQ5(QBHU[^5297$3)]C3LQQ8/+/U@T<;^"YT,Q+TM_57:['P)>.QH4Z)?^BDZ
MM5%+6IXD4$_26"\C#3:%.%L]0''"2)M& N8L+.7KM.=W!,.U40.)QK1G8C"C
M8PQ%+XY_UW%FC84EM PT/$^FWZA^_ *"W=XTN5H>2A2(#]695!][AQ9K-9HS
M7S#1/KL>)1J? ?:VOW[WU1U0Z/+(S-1LAT^8G/02F^*;T1E)$0>PQV>>;S&"
MB1HV)\DJ@9:MIX2H-!6GP607I[#N=\74LMV3]=R%? *2WC,!"#!/($I5"X]
MR 6<O8.UF;5\4FO2:6JLMUAY0-7G$GLXXT.K%*]!J+I=UT@HQR:'C3.M3HBS
M:0G;)S)12N#+P]\C)E]S8L?)63$E<&XBLA3^A%!*N%-[JU1N5(Y!9TZ:W5V:
M.M!%3399VW<3E)0?."EC]<GK6V6+"!ZKB;^HB .=ROK'C+A+\T>+I,@A[X08
M\ T_>ZZ'?5H_4/6]%./:4.9ZV@,"!NHEUD 6IOP$G*HVTLH)YD'=P%D6S;%[
MALLUS35(V?B;4NWI5A>W7\4[IQIS821QC5"R)-S#IL!<YLJ%UU0F]3\S@\;?
M?%AO[/%U""6]H+US;MM,#/;-S]+#@*,SONT,3<>H_'/A"++N-W0'S&Z.TUVE
M5AL+1SO' Z\@II'\RG*OP/KKKX[BGRIS_Z00:08[L,:\<Y!W]N5.B;9[GZ)(
MJP>?Y"DH]QA4Q2.:?'\>=\=*&A#[SM[ PON4Z\^45Z?RCJIMEU^_O@ZR81]X
M*)>T:2G9$\3@%'2KA?,20"7'XB[,"SUA1$;V3C5F$'/U%#^Y4ZZ3K_Z2K1DY
MIR.>0/"QR,&,^#M!4.?T\L!]XF*&SYN59,;8R,'[ZM<]V4/*8.N8^!"XUG)S
M\QVNY>3B""1?%-T$=B+;/IJ&Z4>1^/!+@5][FLGS3VI5%!8B?I2:T>LA]-.:
M2RUYC_0UT*G& ;6[?KCB\\=!-$'V'#0FL(3#69B</I>EI=;R(K>6"(%?^BO6
M?NAC,!K:2#%2I?""*-F!HD3#9?'_NF:26YIP;=/00WD7+R=J$[OV-SSN2FU<
MC"-*AG+T9TKFF^SD=?B(J)9'=E@A]F$EGF\-F5W<TH)NS6#/N9>]E!1L IG$
M)(* $B$EP\DZ%\:@@?]Z=W"M9:IOJ"$UY%J:=^GL+VX?*?E2%1K2_A8DLF_L
MZ'D*>X&^CFZ]P)J9::& N:67]FEV(;8T9WEQ)V?I0D0SZ-&YUO.F"=X8B)-!
M:<"G>*A00*=-;O'YK9#_;M6M07>/T,]I"2&S#NO_[I!QDS]AYGH<%[&>;*Q0
MHNP>2'^1+R1X3EX,T^\)I/I)""OZMEIAU]#XG#%"5NE.;#,35XS;1S_[/$(?
M3J@$AET>6O^T.@KQ)/(VQZG-#'4J0:&,EE^X7_E=RZV_VN1V1C+W@;FZ+>?J
M;U)#[VV,3<978SX<I HA_5UFQ_\'.^\9U>0:A(M&45'I':1$I:D(J/0:%!$0
M >F=2%&:@(A(@) HB"!50&$K0E1 I$:ZU(B4B#3I4D,2 6F24 -I]W.[B_NL
M>\X]Y_Z\Z_[XUB(K[\P\\TQY9P)D#C8<*;(U1T%21;].^NBU1!":S(P4%03>
M,1RKBJS!%][MQU[1"A_M#5E&[*>_O+G!%?L.IM;6S%%)OIOJI^7L>'K[@&#,
MLV<I)-6PT&_7\'$+CD.F^9ZPNNN^U@46UIF*RHYF/6,-=QO&E^;N0BJF2IF@
M!P@PS9C<FE<^UOI&6[#A14EP=U$W;+5J6;0A\)K6(.2&^"7S6":(G2$#6^*.
MK:Y-'NG/_WZCE;O@:V4K-GRNT8%JY@K+Q?>6X_>1-M^D7H>1\]\.SJX1JFH-
M[=8>1"#<+[^HP;_8*+/M(WS^V5<#X7L"\P[V;)*:ZH:2.J5)5V-X5HATQ^"&
M<N+SS@[+II%5DDZ<QZWW/A;6OBY6#Y:7&1I0!BM- \?XA/$CJV'9FI!6=3ES
M?EIL"1,)A2Z/;OB7T[ 83C.N@MHCD(IN8AM8! XE.L7=G7!T=%GDR+FL7>')
M19WO1BM2H.0@ALAWW3/ET:9J=N&;*5]S&YU23HS#R]CV5/V J.O8_6!8TH0H
M7;(?15>@W?WXT3L]ME^=7!Q,%3,;V8ESXY-N?W"?[_5^XC17GL$E&IN_:6,)
M9<\_Z;T1:+2[G),Y.=>HYJ&6@CCFDY$IG9=E/T0T?A:>?CH7F/VQC] >]%QM
M _R4R5::-]R48V-:?*#T=46.SAET3NMG'Y!I&Z?4$Y;T+T<(I8@SWKO0]B2A
M]EV[J)4[I1"3%%_OD5IU7M4QT-U,+_E,5JWPHP)ME,&V==A@^WA'TZT<Z_JD
MH4Q=VY5I^QM2,K?.\5_S$B]:GBRCBNE./V57+OQXV3+8]/ORD%4-730B\-4D
MC&A)@03AB]_29/-AKR=<I+4?A<@F?+)X'S@IT$EM*,=:RM52CBP0N,9&"=/W
MR)FJ[\KR<D4Z#]I[?/=OH1G 5UQ1)#FB'UQ@6,4O/;>L-O"M4\DYIVIL>E3I
MX^#RRA:WQ-#\$\U.Q]_9?T8Z694].3J84#'0HU*QJ86+L^*Z#V&IZMM[GHH2
M@#W5Q96>J^UCER+S'-WNZ%77\F1L@BLBU&+@:F3%CH]';PQ4H17&)G(UN(Y!
M>]4Q9UWER&Q8(2:(I]&M$!9KH9ZS9MK%?;/$2/VBQ.>77(BFI6:*!9EH2HF8
M$7?Z^!SU0*@M(_SIV/OLY[2)ARYO]WD>_/KXL!=:JSS^D<':1+$6<"U'(E0T
MZGQ:5-@*QO*FTL-K0]_,NNAOO:)D%]D[CSE37G3Z!XGJGTH0O2YMSWWIXK5D
MKJO!KK&D\)$?U"T32CIGFMKB#7+"Z\TS^^Z])^9<-7%6?(20A['9?U%<KEI]
ML.5HL$%6OH53>+,F++QQJ]F^4^)962 >TDX/GF'4R3,>NS\7C;&NKWR_#ZL9
MG?I"[*&(NN0;<XM4_23BZ_+LT^[YC\QY7(83$G.18>_7Y7RZ,V>4\ 7M)IB'
MBF]UWL2^]N,(EV0/2;B$^GRHX8?;J,A4G_.*Q-,E:,V^FJV:9I9WC+[!.W2'
MDB-;#!W=,7?1R>.)(=<:TJ[L-3<+CN][3\]K% JZ->I/\COO?_Z/ABOKDB?=
M@]\7I/;I;LY+:%'*D60Y;$:.-'G_TQ+"9#OXJW^+T3C_[6E7,V*OD]0\VFS(
MH>ZD8^O3<.4S5A\[:B$JI3^JKT?4%CGM..\*$5D!E/=SQ$E"#VYN9/,YYG!(
M:"A<0GL/[K^V]X">^-W9C"N;*U M^&5*8019TT5G5=E?R(@J?*LX=UR8Y<=$
MVLZ-7M7$<,_=(9P(XV07.;HC"=WI1O\C:EH+M@)?57,O,Y\>K^N\H:,U>LB,
MV\*XJ5OI= <LOK+@,K*^7_I;::!NIA8X^CD;)8M0$'-GUN9ZND7,-X[!KDN<
M3!!EL3J<"8K_@W:)7B5?*A@DW_2F8-_E P=M:O369.F;8JA'*M^@!YN/MI(:
ML+:N4IF7&5\C+CXV"-Q*D67_;G5WI?2+4E R8[B8M$3D)D':Y59%7;R[BEV<
M5=H2@#-2AE+=QM<FG-3W/SQ+LSEGME+6VD(XL_%],-_2MLG@9" IOV"N!S-N
M@CV":DM)U'SX=%^%N5?!E/BYCG[[F.G2\CC6I.Z=G::S7^V<J"Z'J@,?(7A)
M,<\<I"K?18V?ZS9>OQ[YDF_T]2N:7YLR1+ &19Q0Y,,Y(;V-.5_7)]8LR6;.
MGTGOEFO@N&=>CG:CW!E/P2+'75O;;W\?%=P-:C 9N]4C=?6@I(3]N6LLZ\?9
M/5YLY <XZ6)-M0U'FTJU:C4'DU%3#4R0RK8XJKU'H0L+KF*"[C?R29ZNM\WT
M8[=R"DH6>.,I27\[<G9#)86<CH4>UCY/EK-.;ZN95AH*K*I#F5'9%?W%T\*N
M6#R 7<.;G-3H-?LQN6<66!Z:I:?UR=L.9$3J:7?"J/6-ZG2M_@'%J;*@80=^
M3\[NL%67AVBJ$4R_S3%ZL1[ST?04$^3XF$MU937.09@]X.1L,"4M/-CJ\W#R
M&/&M=0AA5KA6B]I_VTS.H"(B;*'0[SRY&KVRA]SZ05/2AV<!(32@9G"]('"=
MZRG_C2M:$G7<+[$OL3KF^ZD7*9^W.Z!"VA>WSVG4OFM(^S@B"#EMT=:N+EXK
M<#IRO/PT0FKZ.X;7@YR<ZN&1-]EZV^MAQPAW1G^AZ!4W0_>\Z,EO.=6+1] K
M6J]<?=/\1C!L5=YP2VSWD?SVEC].Y^;E0#,P9XZ*S>MNV@:%&LW GMN7:"^,
MEG;):M5^IG][^K2D_HY9ER5DS%84)P2_6S-4G="5U9 M\]'I8=IL5S//OL,E
MYNH6P.37;! F4QJDEM(8&:%3X4YT')HB.'"134\>%?-J.+S0S$?S&=(5IA"8
MH#9+!VRI^*63[DVU3VEHM0C6T\)[^7^PE M+>0SXZQ-J[LNV@3DHT28DE9R$
M N^U/"9H+*-6-J0MGMJJW:#%_5[4#"39I*4BLQQ<_T?X^\MW\BU[3.MDLJ>6
MT9&VCW1K=:*)0.2)@>-.+;J'?6PVFG2GQ\?]$!\\/R]A+_0_ #\-&UUQ(R2L
M!!(/%!:8'G.!&/.,CSN=/"8)E7>($S]G(A&Y-WGX$ZR8D)%+X(K/E-"H,E_N
M,2@CUC]409ZY>/6$C2S+K8_W8"+S\1L3N'%DZWA'H41M(>WT@&+CY5?VB_)W
M+E3%@VQ/>&AT'#C7EL@)>SL;5%G^W;8=7YZ*9K5*?Q[:E-5HZ2,OL(&SQ'7
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M1ER^6M[UQ]P/HG%Y!CZO[O;*@_-["V5?G'B,N-"(LGV?A6W6:<P9.QM4ZAM
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MS/H\$R23LH,Z;@%U 4("</MS*/CES!DNNCERQQ!(UXWFVI\6P(O3_V;=FH[
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M,X-(H$S8A0!5?7][C=S4_JOJAJA&VT?PDWU_N_VM7F[)G'(-LYN#_%4*0)4
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M;C'PS_>1?[Z_@,3'(A=#@*0!^ \HW%+1XO ,BZ51:1X,KR[^8J@5LA68>X>
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MZW7+">:<*F79;Q\GR?YX8W?M=ER;(.@(C4J)ZC>F'F&T"^YV0BGZ>62Y;)<
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M%DUWS]*\P^C#'#L=U.<#IZ>MX;[H:(LK#A[%I25\F1UYN.9&E*@+G]G5+&F
MKHMNI';[$R2<!K!O8L*V55=*4C3&FQ^W5@:B#3S$S(MVO)1ZWKF9-3+=X15]
MIIH\ &H,(Y(-#AJ&K(AHT%,X.'_NL:A ND?TZFK==Y1&<X<2ON?:G.RR[F+S
MGC<ZOS!QL$YH(>@8*1$'%;'N?)2.#B_V6)'%1?5I';.)O))[\6:IQ/)");OB
M\PZ_-IN+XA>(U7C?%@S]TN- =!/F*8I0KK10_#U5A0804D:<(8ZIGN*PU#-)
M-$":H\JSXQ0-6*XF?@_J0='7*!)%[^4U95D*0(ER*G#G=<3+M-LTP*)4Q>G;
M^,Y5%?N/KOTR,W#2\3;R"U23PGX4#5CH60W6?/>_1+>:LNT8PDZ,SUI$92?.
M0]3&3^B^6XG\FKO2OO3LYT]Q1QW-WR;=B#Q3SXVS>']:<:#.GQ(6I.SW='#[
MP*#F,;_"6WUDFX)YXR7AF,Y"6UTO]:_WXX[$?CTJ%RO/K.X8K#G\%G-J2\-J
MZD3JOM@PM?_RE$KT--$+F[,Y(>):2GDJ)PYVK9VEK'5LYME<5V(LN7_/<Q+.
MHQ"'.(Q;X\J&.]E8&51B#CNI,9;*K)!5[@2K2*,[X*-335 NJ)-A1"G"]#WE
M-=E3*D9RD)O%.]E7K"Y9UF/V=+2,I,C#R$_'V\-9'YYYJ+E!@A>Y4(^2G'%R
ML&;^=B<TW)D_U3+L0RQ+B2VOLQ&GDRR4%5B8_U?^7@>=1@/<$D9D\+#EE4DQ
MJ^:Z0X2KJ>_F1VQR:G_,8HJQ=QB37',JK?Q6[(]9B'K<DK7@E6'G/U+LZH?>
MSH_!899=WR)<B&*A9[%8/U^#/DR9;+N.Z&"J47,[*[^LF<K7ON='M=03OS!W
MW80UCRBL>!%1N+9FA;!;<&'UXS@Q:".6.]?*YMQ<DZDU)>]&IJ'"M_BU'[*A
MR;*WE^N!TO'U1+CCDD"J<%!R@(^SPXD<'T9.V5O&JEECJ@4RPF5<KT'B=(U!
MO>O -YEI2 AH_\TT0#!H*!W3"!'Q@S91><O*NPZ]E[OOGEU;\Z0SZ4N2-=-A
M:/O),6[UNP^:??;V_KXD]E_L4D_8SB'AO/8UR<>KB#;/,]P*L,J43!0CK/>%
M7&)>FOW&\6?T9KS<NFVW969I $\05ERU@M2"0$!Q;LQ6),77I.=-C99MD4DP
M%5/;SO6OQTNYW89%GIU;1@1C3F-3]B#;=43?ILX#U,X)Z3I25K8NGI/Y2^)H
M9W9C=KN_Q+6WTE-'?ROT&&D(X:CVRI29XJ0G6Y 0 YJ,!/FT?2FR;C=9+8<4
MCS7_$-SD?=L*WW!K=O)5VO8T9()?T$B5W8AY(>??[J@A"D&DKJ(!R3PDD(UZ
M0BFJ-H/]9NMH,O<4]88A+I4"3NKF@N]%B-G_*O!,H\KGF@OJ1,F*=?P3K$3?
MN%7ER+Q>B0I"T&\^!U\[/2'*Y@M=;TM\VJ3^3/$'(G&?93[H>#_&P4.0#! A
M35A1DH)EGW?@71K@X3K"_ORQG<"IH^8]%BR.J3NC'^_/QWNU!$497X2D((>A
M@F3]?;$AZK>IR<X8681EZH*##UZO4%$\]*-SD'QHX]JC@2-AC/(/>9_IJKFN
M&K*2-IHU&4AE.,.0<YA#/H48%G.2.S<B\#G_24G%9:[#,REC5UP'+@Y[?$I(
MKVV,!LBE V0W?&<,I$)V0IW43E##4]$X3C;]LD9-WB[$<;D?N3->U,2'=^\U
M*8Z@P]@%5QA7+HILMM77R8 J=ZI1V !#22CT0^Y?.H#:5["IV%=>^8A\>N_#
MH_.K9UP?_<7=)^^25B:O37M[<.E\TC7]>#!R<OOHA6P:$+8U"=T3Y*$!=+DT
M "_C1.5+"$7.6_0@"8>@A*P_W.6]KE#$X +].*GAC#2@WAE#BH;^\19DTV'V
M.,@>OS>*S)! EO[EMDOY7_W]TERR"\&V.-_*?,356;G_>PR[\2YW7$<;<#=7
M-7,KBP:PMC5"-V47H"1F" GVG&Q*Z$C$=4;^7*K_4-ZNK];1A_'?-K^E07K.
M[L3PZB[5^YYP)E&;UT3P/T.#B#MD/IDV6^%>Y%T/,3_;C695,W14A>#F;E&Y
M\]H=O?;\09-*6>(EJX!\END41J!XWK45%)7Z>H:D#- 14(3OXMS]2C2 VYKD
M=)FP,."V65VU>O>]HA;KM^13W,:]%QSN\[$V3S'5;1+1#6@ <;WNZ7[+!!,!
M&^WA-K5N5S50'A/P52)!<OE6HF#85RF&V.1;-4<)F 84I_?2#VCCQ.&N&F6[
MQ[XVEO-[]\\E&GA6RI?FLWNV:>0S3,+!*% 9AG3V$ SZ)BY(\BT>]GMYBSI1
M/N!QNW?6 FY0&67GK-GUSDOD #=W<<A^6=L-2L,D#4C <I(#\0E"I(!+1.6*
M[>+)A1NJFR<N'+/B/]#$E-@G =@_N%X*%##S%8(/A]8QD?S]O7QP<"8_9),*
M#+XTU[U9)2=NZ[51?H_-:PD&=CVBCK_'HZ)Z%,)Q;QN6CNLH]O2PXWWHPLP8
M1'DZ:RL4T9F9-Q ,U40<);[$T0"RAGU+'6@CH4M-<$*<C9^)FEZ@T[XM=MG+
M<&8DX>0);"GJ5-.]"[N&.4')L-2F?5FR0&7:\1@<9S#^^3GV^$RA#^S9HD\Y
M4QK01J_I\Y<>SR2$;U;'Z9E465G)/!#6?<$M($E7+Z3^[/Q683_,I&=YZ^5)
MV;45NYKR9)')#(:LVT_/<#(S,I",F/EH -M2/7+SM!2509\&-!O_<G^KDRP#
M8:$!766@PTV*(G$ZO]P;:KG8(QOW"! *^T%02?<BB;Q_O.4K^Z,I&_]R^_I?
M_7T^- X5-2%$?/YZ6U4SO[)25^BWUF.)FD87I61?^]CM]F)PYB0=:EB&% T
MIL#*-N#,"[<>*ZQ(X=GT-0=$9&[V]!6=/G+%NHAQ\A"S9+H2A^&#M]$GV?\S
M1*6=J!.MA&(D>9D,;HV2O&M%]"L#"JO;0T*CE84<H<'S%S0.(+"3*))T91-4
MR*^ZZ;/L9X58Q%E[O,6/CV%X!:Y[&(>>+=TSO+(\'I(ST;$I +]0JVL?U 4>
MIAK1QCF\TTIE[G&W*^]7CH'(#^@]O1+D\OE+=#/]I=*+V9.3HI.#<U(KYS!"
M176,9&:2ZY1'N+!OZ,LFZK$>[T"%6^5$1I5*RZ*N>L+5;BW^&]=AKHJ.'>NO
MV">!H(HQ:VU7QN3.8Y?976RF$Y^^RQ>23.ZBFZ@S3J:RVA'2Y6Z=<U-IA1 B
MON8C'142H*4L73=V)>Y5*51M2H7.G^VI^XVX$V[5FGF "(EX/K4<5^A<>8Y^
M2FC]>^D9]S:$>R<.G@(15E<FYDT:DGGV8:3+4X;AG^5089L!562,<!M>VD%%
MTS&[DO6])=VLP+C$2<?1_?=M[CI'("7&-Y*;DYJ7)-T99 J^W/9G%,>CK'T;
MJD5^G,4Q/RG:8DQ2VP]D;94)354;T*Z\V%"&/3)H?_' PXGSI)2W"(U]@>WO
M9=K;/ZBPE,.(Y='J\PL[83[*)C1 M[1?'?UQV&K"7\<;>2\*;B?!&!M_2)JA
M XK+)H,!!@I#DEC[D$VZ)"EJ4 DH(_@*,:#S.NG0@-?Z"50&J9]6R=*10 ,N
MOH20F0Q_QIOSG"1G* CVG?U8*GT%A- 3!-HGJA!#/N"R1@-P0MTT8)[''C39
MKU30XL^"@-]UH@V,9<D_@\6_\,N/;-F('2E3*^=<5X[I2E9&VS,(24C['N#H
MVC]=B"'$SH-$Y6 I&)- *L&ZWCG\X #!_3U0+PQ6.5\USS"<_S;Z\K^, 8IL
MCY!<?Y*%,FH!B(*,SN<^HZ,FUGMFVU=@,A[;SL?2[O)DE;+57H_G9.2^\,-O
M[BE5*FCT<_BGW.'%(#J2P[F7?-\576#G=G+RXN7JKY&L>AA6V!\("(DJN&Q"
M2=*MM45^R&TS(OMG@SR?MUJ> ?9.!8O/M6(_/C<9:TT^/^(5RY4G=OGP1)T.
M$=F(>8(JBZ\DY+5@0(!ISNM3]_7!ZT,-;32;;&*,W2P[G.D-DG4@XXP^Y]F2
MKIZMO,>\& <R/U%8RUKT'JP!Q=2.%[O5?K.?IT//*A"J7>9:6/UI[%FBMO"6
MH\0GP/=8%7JX<BJSC&B/<Z_%8X3NO?<SV+D^X*/&EG'FG/S]J8J49]EQ2<+:
M(Y?/3'*?!V 5L'9P/!!JGOBUIQ#Q<AD3_J6;Q(38HK>2=YF35G$"6W87!4]3
M^R&\Y6"H486WUGHTV0I](*D$^C F.7\]WC HN_EUUOQMG;^*H#5Y0>)202,*
M\\QS:PMQ  ^/#H(0G<@\3A<)XJGYPV.D)>-N[TZ&)MS'5VRX=Q*7727E.+&W
M+L7/2819[PCMC[0.+M^ZM4VUUYMN+=U-$BV[;2\UUL6X]2=R:YM K,9%M&#$
M7!\'#C9UQB$)14HDM^^^YR"$Z!$7K'.JIZ9'VEGZ5US5.J*.-5/4@YXTX(04
MH9V*1^YY5[_F?)?_ZQ$,*:1B?"&&GBQ/3(B2E0AW78%<K>ESFZHRZ59*O+@N
M_8#EN*[Q*R[/,9B9;<"^-O)KW<^LZ%+X31K0H^MZW65#=^>8>[<;)!-TT,W.
M:.RF @F4_ #HK[LG$DB/G5H\]@3((J#3P)#D9+AH-]QY2Q:Z+C%#K;#:32C%
MX!90?)AY.,&#2F=# ];U(7^JI.["VX0".QJ0R#Q0B%3<5B%KG,574MBH'*#[
MR&"HNEE4\32B%36,!C"!P9$/2P,D!]N4C'^V<F2OWV-6$R1-$;F(6S3@#;(!
M0SK@2P.^*B&;>C5ED%V822R9OIH&3*>39J,U<R*H5R"6Q>2V(>R?WJ)6;]N.
M4J=YA.Q"FL&AF5S3H>'%WK6&*YK>(X'%C09U-D4?2GHV/B2DGSYTDV X@+FP
M-&\XQ$PUP-:CMG\>,IHMP!>&.,[2_>HWOAYD8K&HOO/-Z(>+"4/?I-_6G=^[
M_=>E"[0P">2TQR5P2$IH C7N:>WS&M<I)_)O/__V<YL;NG>.]=Z-;4OIM\\:
M?VX!_*/7I[5(")<2)*SN,(8(C0*QK$Q)#:*P(F![(VD9>ZP5)>OR_>%J5O#C
M/=AEN 85BUUW%E>C 96<%(7*XGL--PL$-5Y>Z\A^=?2D?"04AZFC!X'OYZF/
M 32 JJA#5MFIA^^)_SRS$DD#6F6('=%['LOI8E@<52>,D@7[0$9^I\32@' J
MB8T&7,92C<$7(+5 "%@L'7+^Y]F+&C\'2!#=IBI-_?IFG J9AHPH!RBTD3N'
M.DD>:\&8S9^G.8K_?"@61'P."D& &H$A9X$S38PF>[U-^$MC6O_JMF!O$,=)
MH$DIQ"-',(105^PH<C@(-@KM6I4CHU60J=2/2AV(RH57]J_NPG!Q0:'(AA/0
MV7?(,5!C><BD\J7VO+EJ=FQ\, ]Y.8LSMN#6N]"D,N@ET.5VIX;_AL_$8M!&
M0IJ1VVR&%";6;<L_WO]GYCI:)I/HT6S(ZL>\C"$DDU!7"7,C.Q34OI51]&#'
M:&50IV+XLKOU5"YN25]*ZNZ)GOX,#KXY#*$;SHJ<S_,#[9UY&T5^F$"ZAPZ#
M;IK6@)X;LF](O0!;GB,7H9P/S1E/&;*.^LTU/L9$H-T5Y.1\U"SD[E;USIVV
MOE*2[1ZO]:VJ0VM9VR^B"37DT:#)1%Q-FY*S;\Y4(B7CQ8Y EE^BQ5S=\N.4
M7GFQ+E_D9!!YT@#$<K%L(G]M3X>L!&M$[9V< -V\@9)' T2SACMWS0.N^2H6
M(QT]V(:I7<(TH&6K3[F2>*(BNR3.TW$G>"C[J+UUF_B/;T-QR 0A6<\D??_9
MJ)\_'R?P8:*4,@R;ZV2).\U6<L<F;9Q'(+&(2X,C/MF%.Q;'ACZU97%S7N)4
M7D+];T="IPRU_G[[V>ICOG]DW/[#IS^C6$F]3535WFD,8:(ZE_2T]<(-3I\<
M6QTO[B_ G;!GSP293..K[)9T&XUA]UR,'Y^XWZW-=^#O&<:#RR!V'7L$AE([
M7>BFM<]RQ13\PQHY:J23$B9) [H]>P5,A^_]"[F$IA6I8%_7[V.'1W2F6#7E
M%5E_"L(Y[SC2,=;$F]R"EW;7M$!443LNGV+8.'#&<^?CX'?L ;(N#@.0C7I\
M$@X%-0:=)PR4>OJ+ZA797$:>,?>//9QCK'3@&&MV$LR=R5](>1%+,#(4#>H6
MUN_/3)OD/+!+/6A%.7.O1BL7^V+-X?-&V;93W(E#QQQ9BZZ[-<R\"R_UV;^'
M<.\GR[U>H@&<2@KAEF)UE4[Y$TM[CI_#[T8+,:C2\8V6,5G'55]SISOB=1$2
M\%-\FW% FO;@$5F?$Z[WNBE]62UQJ,VX/VD>VONM92:E\<FG\2A'^Z]2DND8
M;<"+"Z% <$/'2A+O:G)WO27>"(X8E.BULYIEO!URWF8N7G70$*P0]@U#T$O8
M582&PW= YMJ;,QYH!C\%6JX\=+J9*H0<,Z0!!JG>=%MFOV:)^Z^M@&KPQ#Y1
MC=H2: J2XN/H2V@-REO,-#9("CF$?H=<D*S(@<9K9M\D"9'LM7EA\U*M8?^V
MAL"#^R!:?1TE\5!!1-Q\BJ\+0+^!WH;LJB'ID:,@1#^SAFE*D7@VD8D5G/BF
M_B"G90=>8SACH-]?UR)@<8C[-" ID8"A-H+D^FJ#;?M-=+D-U/13157-^XKJ
MJ@JW[?5.UNK&86;I:]]>/?FRR=ML\\^J,YDYS.@^55^B#;D-DM"<[:W-XXB=
M?23R:[;?&G4,NEDW\?D!MBWB'?D[B)^L00GK4-'YM]'[3=.7_BVZ82Y!)Y,A
M&V;057#4*E-VU^!O( 3=A-UWJ!U6&C#Z;:,,LF-!QB@]FL0D0%#30:'&VGQ$
MI[Z_N\Q " V0TL)#]P_D44,.!,B9)&CWXOLE^Y(:^Y6%>-H#6L*N?*]!Y!"3
MSHLZO<\]ML)K?,U.F]>([A^]X#]YT"WD;@YR!WS#454*"[H329*!DGLP^]$T
M8"7C\07?_3Y-9/+Y4DQ]:OL&5.-G+R_/_ 'C,2:8R>?(=8^Z(R#3>@O*95TY
MF?6!?Z_TVW<:,(Y]I\'.3$PH!:D=:6/A;^-5X[H-4JI$-0L:\#X;M2>ONFV9
MDS/_.2B"K2EWR'*!J+8;)U8DPUUVFZ-96N@\ \KECGRW-F\XK[$V\*^X$&O[
M".<)V3ZH8R"2>I@MT&![?62Q8W&[73L-7_/I0SQ.&'\^3?/V=7J#B4?A2UWD
M02+/=C\!NW(Y'R%'T&EPDVA!$=)'_5(-,,[L'"[I#D7RC'A<8@=I6_3,JUPZ
MR6D@J(122E5TQ3!0#RQ:TH"PJ0K-8Y]JRGN6I3!"'S\^QSO$ZBOLGSJHF=:J
M)81.0D@11Z<$&D60O.AHA)<3/L/I$@F53?(RDM*O#/-1TWN!">#5LK\%8UPS
MN4!G%>L-4"3_0LHFJ1HNU&,$T)DA$)<@[KAIHD9F6(!F>ND1W_U+C;-GW@5M
MT-.QA20!:Q?%9OAV"_$<EW&0!O@3*$>0+$*5>,,7SN.N4%[@X2.]E2:OL-4M
MFUA,AI4*'=IJTGTVR3(D;9('4%- P_D37/AL&5Q<](3+(/_?1Y%;\"B$?JX?
M5/M3?T5 ^8?WE38]UW?W & ZR0]XZ*)AVFK)%.&S[:9CW>N]G_&FYF5AU11"
M/()=J\4?N:)\+K48<3(<IUS(\G&\)<!1$JFH$.VTXUIY_(/(1QV&\TL7!4#Q
MG>W-]J@TU;BK1C?+V?>#[ .7D?",F9%2C4,KS9/QC[V%2LK:D#R;\(@?#AP[
M(Q[*,K/#SKG.A+02)XWMURNKU]"<=<24N14.O :D074U4UW(22C&Z'-Y'7:[
M$/_.X,ME:;IKDM,;\?X-?*7$@&9]'"1!7&2P/!_6_#G[L9=Y)V[_=*=WI%Y5
MRJ6"-D[L^\T+@'@,#A*G"HTF&TR(I>H/*'%X?-M(:K<LYU+/9]*U/LO0MJZ9
MHF=&>8U0RUD42*3$P&IZ[Y<\_[9D45'.Z<#8\G3%:>Q@PQ'1DTO6J(;V$&)(
MVP[\L+)(C&M W#E^,"9=8Q.ZW_>\_<8UH3ML3Y[$&^;*)&,(;9%D*4(NMC'S
M>*]==XV:0[Y(K6DS6X!H.(5Q5OO:&].:ZHQH%?O5A'J&>:2PW^AUPJ&($P6%
MU[]RV8D^:*[.R;R\8Q^'C$K(FWMB.1(X"C>W&JLM'W!3<CU:607HBE]]])XQ
M-IYTHD; D#@7,=JJBT=&IK]=V'LEDR'3M,*85)+(EOA1]]M)-K58T5)!QH #
M.Z1IW2Q="9\D%;J4WZ:Y'G,%2M-M_H/@P+>!7:& %ILXA=E_ "K)_<=[W'4!
M% QFND<=%&CND#VXA\UYCRG0T!Q!RPZ#ZNQ"XKV-M0-QZT?_ +=_A'_R#KHK
M@2391NXWW ]#KLSX#R?L%U'AZ6H/X&T)G>N_TV]2V>)?1!&G&,*D6Q/2[N"*
M</=0UIOZV'NC%W?6NK/C3+Y:0-+9#IGK$'$_1SQ1[AB1/UFN+XDEB;$NLOK"
M>5:!1[J=@FB^OAJS;#*4DD/6+O)KR"DMJ^J]'7&M+ITYZ?0YJ1?OS P.WJ9
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M0[N8NT'-U[P":0KBZU4>;?Y\LB R+"-6T>-SQK11N_!K: !SY@/% =2D1^2
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M+KT3]4SXXJ2GBD^K&AP;U(5;B2KUXU<W\-BP<@SI&L(M?SZQ07EZI*5_X_I
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M!9,Z,LS,=>[MQ]*^4\WO?@71'SM3MO5&L7(2<AZS9,+&OW+MN-9(E>ER5V6
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M3FCOFG9%:I&]:6"QP%LGY]D8^96F5R)(DFQAD,UV61K%^+(Q#<0/*=#,&AN
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MXBJ_M?R+U&.HD/$P'*\-V1>OV:!$>0 0W[#0KA6YR=\*#]^Y/8O<E,Q8#DH
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M![7##N6:QZ6?2XUSVM(0+Q1;]1@V'T9XM,"Q29#E(I@H@)63:*!R8))/5=-
MAAY86^HY-"6_80+001&B-*"#+E1#"3AQ!XQOA1^#+VK30-^R  K,A\JG@<PO
MP7M& *VH@F_:@(T#DR9AJK^U@R!:]QP4(!D@>(!:KAGN;I EH8W( Q;X9EX
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M'@VUPFNP%$' ATL7H?!YY)])A?_.B=HS_U$H/OK?H5"\$U(B04[L&053V\X
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M57^=4,\X-:7ZS)([F_06G^ZFUW6UN-5ZK],KWJ^@@1A@EYSP^S!FO@AGQ8O
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MN\?C:: ;M2AC"6(^X.7AKS'ADU L_/6Z#"Y- F T67@Y2H@P#=3G([/FU>H
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MFXP:+]"0I#0R8>'.,PT74*%N>?Z?)<'==S>>D\&/BF=WSF?/EBH?3@_,"GE
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MX1=UW+ZRI$H1N%C#QVUK>F/$4=E6^DO[.#WB8\A>W%V-L#^[PI&,[',EXD)
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M[?7U,8.P8K/OX,S*^@GLTA </&)M1[-FPNKTVX%)'GXP(KY8K90)6QMSZ9#
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MC$T".)H;XK5-C]\D%?\3#=;%MW!&&O E'!AI365=7$W37$7E6RUY^/=:\CZ
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MWB--:2V+_#D6X4"U#%BD"+11+/'7RK?1=&>B%1]HM_]E[^/S\VNPG_2$H O
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MY.3%CP,KQ;7,Y#R)_>74"H_J55U,QX0O "ZQMT\0:0XA$">$G4;S^ 4 S:'
MLU-BJ1MJ>&.ZQ*RD+3FJ)YPI16:.5D!H!5JLIMY&_>8X/P(]_S:MX%TI24H9
M>I;U6.N,G>:>7/Z782WY?&-P:Z.BBS;)PQC$;Y8.Z0[%*INR')U\E\,Y<?B8
MO-"7#23J=UA^1XX_,^W<C(Y\1?/,>:!(>[N[O6#A+5G.FX>,2Y<?*1X@?NV7
M*&O6CD*I%W64?.NWL1*6[]RPT&8#S*":9O:[FA[!>^%*$E\YA28>3UF,X>%8
M)J(L#K/*F/DPZ"-8D09*R\;E6*<=41D99R#YT;_M5?%'*NY7+RY--2W<E&<^
MD8N_JKQP?6O_ B!]3C-$.H2.OI;8MP**#"O[!$5H'L9/F2Y= /+C=[T-01Q5
M%X",$UGGUAM[&9X^!R,B/G4B^Y:-W%Z)DA]^:5.4'[VS=KAG.Z9!Q>,F'0#8
M'6(.'CM&=EP ;C\^Y\1UO\L9E0!>T<10TZU9!)7$5)HUSF"9#08.4F)-)&KJ
MA1B\&^O2.7GN9V1&8_10=ATM['B+=;)<D$5-3$!)>$10Z:3JI<KRUB;GL.;J
M]!5-^_>1"XXTW7QM@JG3@T*0](. K"XF("V](9Y!;;.K,-]B3NO:9WVNZAHC
MNA]%*RE<!N[O>%OTJNVHJW_GH3FF4JBOG;X<A_J#.4)%,6.20AG:,W,052#B
MGCS.#8(95^V9OKTS>>TRM-;YI^S\8]I3*"$,TZ@8":1NNH+^@-S[Z-OF6^@:
MS/D+^=0?7%S2KLXW#%UFX(%+E7&S6!W9O^N0?0@B<!]4C?ANLC/)5C>#3!N;
M<-C6&#$/-Y^>$G#U+-?RZKV!EV6^G!05[=+J;#^Y5P/4U):5K7"9>?AH#!QQ
MURU)'X?-R HMP 5GE&[(&560M#2DJ#6D7%^FK<:K<5:"-U2\Z,.\PX7&"*"%
MY-4W:#PTDQW/NHY**?(HL'#QHW/!F.VM"9?8A;-D<BUHAR$&V[2=W#J-B@02
M7\NTWCP?"^:$XY!O)*DIH6)XX=26N\@289&M?<Z"[;1AC+2!)JTE^O9A;=1"
MOOT1ZP,'8S;E8SU$V3O6U#!?6$2 22KH"A"2 ]21,]NFS?I9:VG^NY3%[?F5
MMW!!,E[E>S*VG?[(4)B#Y=#E[H6?U?$T:[72:<R1'O)*DAE9$12LNM/IKVH3
MYWJ'W;T=KPJ_@G^ZLWO;5'#Z(-X(3]TQ@:=&;),22JU5#:8[:I'KMS,.7G:9
M_V;B,6^:G1?M&7% ,?S>K4H@0JJ^O=:X.1&\6 <L N<BA9(^%<YB<#5<W\F9
M'N#+LF//Z.C^-EO]Q-C[%HA6U?!.?]63O/"-9EP@X@+ )&^[&,^D5$*(;F>^
MS8:;J/;QI\I"6S::[].)<";/R7(8)+\@XSD'"ASMI.=#D 3%DT>HT[OX@ABH
M.E^5:(UG"=!:JT")Y[91@&I>YQ@\<5I-NA9[*-['K=AKY@]ZS6VQJ<!X^DB1
MLNEAD*T(8=S#8S](W:RAF<9?P3[5U&L([KCR0S6!Z]8.-VD,YK4,I=U!6@5N
M.\I71'*O&8CP&L# ""I[&<24UNY$&QY9$%3[PCZPI(R&@S,AA3&VJG7)Y(/[
MQOSM8O19EF195%IP9*&5Q7J#[_)>FM'<$VLU<$RTG.R#(UBC<^Z,R9/KRN6U
M1K>V2<Z'1-"*+&OG=](1BBAQET,;KC%6OG+:(Z1%WHRW\-MM&9HGL0#]OHA!
M4S:7D?,A3J(+&<6]!OWHXXL\2U:HYXVJ'!(7=<C =KPV41?M>G1V*W:^\_%M
M[V_!HYGBN/,BW.H)K*UABWE@X4P=H7 7]SL9;+]S]#[=2),Q;3TG_%;S3-3M
METM<G+.<4];$Q%31=8C<N4J)MS:A%&3Q%.9 =+X;!S0_:E%Z!]%=M2$P*><E
M/UL)-[LWO+ZF3WJE\U<A.0M4A8M:L'?,K&71G/'6>-A;$2@_[T%6/HM=A0JS
MH\O7V()7_;&0?L;/R3N_W-T<J^053X0G"::+QH=Q/@1Y-F^2Y1W@[_$F'E'?
MH@>U"9;^)@WOZPP9(&_O&9*_M]']LTFUBC'M BNB6]]!)=';6SI.B$PN/.NL
MU*<\YP25D7Z1<5:#(8F*;M8W7-#!C?H[3CQ7>G1.+"$O8-?76[B'_X"&N'8/
MZFY,AJK$="!,6FTTPZH8KB6\OLLA^)(K8B AA@YL\F. @YU VJT@<_:U=!](
M"=I<.+%F;B_*52\$KI4%LK>UU/F+MO1#UT(&:"JKGA_YDN"&X2R]R%:[^G3U
MB28Q-.PF-26$V_*7S^P5_=%IK1.=O?*I' 2C>]/R9=D708E%*OU37NQ:N$LS
MD\'#4A:#%44NQZ:A3?J%%P#[J5PD\EZG<X+E3'/4O+K]N4-[9?^O)ICL9<"(
MX,U0>W)@53QBFQ;ZG/ P&]*(4+B9WB$75\",^EK[&5$QY,$5>2?E_JW1!U]C
M?W&(@WZ;\DF2> ^X9E59'[Y3X 1E\H^=ZCVOFG5NR RS\\Q;N^OTC;=DRB#!
M>J8XUUK=H_JZ85\\2Q^S6\4>QW6"'B*8CF"8#W$7 :DG(5C=,VNECK/7=M1?
MR%?4\DF%+-5>)B%16>2ANQ'Z^E(/E(L0@2?M)L=+2L:*=Y0#U^3J1ZH_NCG4
M,0UQ3;5)1(MTE*XS\GW*WF5BV5U.*J=_X[0 )$)#0J,5(2R;D ;F, -2;.#7
M:U'GH;:2L36+;,ZY:6)\YJM<&O:OU!P^A.C>*XX12AU1N'2J,QS,3,CI8((Q
M[ 6RVUE/E$HZX4GBP_+#S296T*OU;\4.WMRIQ=-IQ,7?LEM6<)QB'@EF@;"9
MX9@[)D^E/;\Y*X"S):3H"##5E';4W*,<=]N4#71&QV]'._Z!QH3/B9=6 V#8
MR*^;%N%)X'P"1U=:R*;W/,H93C.%.@K(Z_P<DZ1*"WIO9$L1XO+DB6GQF\H:
MAU90//4<04]O8H_C!B&G4WP@FX/6QD7.2"ID4[N"!!G4EK8B$\H<96RVF##;
MKZMO;I0 :X-5?<.I* #BAH"[,#0%#GK.4NXBW.)8]]'B*+5?)0MREARL=^Q,
MC/62O2ZME6IYZ S>/0YJR+K$$)5K,,O(J5BINFC\*G!&R>G6<'4*7"$@VB^9
M_V7G8KK+4:K+%ZIXT[/B)I$"0HBU0I\*G@ENY]J@#4>-AQ4_Z>T544T YR;D
M)=^Z !2K.0^S/BZF:A>/?T1X<_(,TLM!#+?U<-Q$'EK+@VKC&2&P W4X55(Z
MI_53I_CJ$9G\@$0(J&0MFLP@BK&*;PWY*V*KV^YV:M'ZL"M&2$2O\Q@8N1+F
MUG9;+;-6"VS7M_/:!4?9?5:6FJ8C?> [)C)5X@$U!/GGE,4MX8M-UG-95L&C
M.B]%\CX,MAWH\/#:7\\5OO0TT0] JGYBY/)@>L"#F)GY13%WWL50$]0,VXMK
MN8XMARK(MX2S7$_N :OH^2P\#Y\N!C/,$_#X="N"!ZY5'4E<?0_/ BTG]D6D
M=:I&\^($YI@;TB1N0[V&R*Y>$WH](VM]\NQAF=CB]I3-!:!KCAEO\QIJF">5
M@2DQN0#HC^>,-\G 3[0Q,MCE&A&YCZ(E7\/H9"-]9G=9ZIX](L5$M)\I=[.J
MOWT^XKM6W7@!H (QH:JE6?.27&EG/MHE/DK\DL+'<Y0.)[WZH'#U*Z!M@N@Q
M2_B?M$!6< 613A45#16C^P,&$T*:(M4/^_(C#5 +T;$C&N$0Z%"5\,:;-I&H
M.4(&GMX8EQK==.GKVL%]5[I-^"$0')N0IEH%KTQSN@_MS59+!B^2#,[/W3J.
M>Z(WU:K?C*>J  5B)OD)@8609'E3Z8C%$6V_2FLA5<$.WNU,8VPG0DNT[7+]
MC6_V@BS2.G@VM&C%HABK&2%= V]!"-0?W1/"LK9= *I,UE":?I)%.J\:/U_A
MZ@957+G\?= \-"8'X(U2Q/HN#-%!P#4#K-V6XR44KUXB4FJ'/SF-E9IZN0CD
M/PZ>C#+.-7R'H?S$\ZS8M(%@BW^"Q/C&5>/7C@LB:D3H#<#\!B.^86^M+&:N
M9W^\Z\R;PD_)@*NS3PB_177]CC^X;"M=.DP"Q*[8-B?*:F7!'Y7::7$#9$+G
M&NDB/J4)\F98FE'G;>]UJDM_M>?)DYMBV^D[1W^6#N4L:&.\ $3[!+%UVXB"
M#:R]%A&LI?%7-. [UT,UW8IO37\O9EJ+*C83IOWM]]SJM3H_5GDAW9I-9=QC
MN6G4K49(Q% _X?<+[4F+]57P&/*2%=KX0$W*G3=7/TY77.0"X(JEQ[)FIG\C
MJ'=:2$>"TW6U@%1S2LY(5#3P9N=W!'<=9-'Q1&(YQ>]=5T55#ZV2;8+G"<?D
MQFU&0FH>D!!60Q[/J.-'#/^=(4VL.M7(D0UR\!(SXN=!X9(+U;.>$)ES)59:
MOJR3!ZYI3&_0"5]<%4C^T#P\Q-RLV>3'(4,L.C0_]-GR?HCV?)$ZG?N^6_Q\
M3SMB.0;<GO'C]D]T*Q.E=WMAR08K,5*'A43&#J34<4>!@'>G;O7HSSUJY7R^
ML163>^_%=4D$$1/5-F/*KA)"NU$E"*D&J?R=>4B@[IC45*=+OOIMSA2,==C8
M4$V!([B-3N62DMI,%GT3/4;O%B2P0^%:74(-.[V!+Y 99!9WZ='GIZR6^C3@
M#JS'NX\"G+;B#J%NL[.$HJ?C->R7M3RH0;2$0*,GL6 _WK39)WEF[(E/S+74
M?H"?Q\6&O&KX3'-I-S8>:UT*\>L(ED+ZWCQ5Q/,_*4_7*L<=U"PTLGT3\0U2
M^VT:N;4XS;NHMY3%TU3NH?CP6VSNDV1'C_A,26 X]KM+VGA\E.\K/ 6KR.@Z
MC&*_,TD9R)O_J72OM;IY&III,W'VZVS+Z7U[@U#\5)9%4[01LE3>X<4\[7;-
M"0<-^XM'E$G:YB)<.YQO)Z.S[N?L:(58+-6_HFQT+;;3TR*(+&:1F;N:VMPD
M1.2C(.DV+75C-2=8TPX8J*:A+H$K3CKD:GV4ALK]MEOZ13H"DZTR"8/'@-\*
M=(2TU2X@E410@ [L*5Y_[/F)MEQF0OY _G1_C*;2@7]^FL8G]=Y>;-V]Y\8:
M@O)1AXNFB'F*345&G_02,35\2@ZZ]89ZJ=DTP5*K4<3C6]_JD87]EUZL3W\A
M/:D2.9CGXP>-NJVM<TI"5EL+;6I')@D>CSM[*T=]X)YY'!Y+>?K>E5+\IU0A
M)R5+BNF<7G+8.P5+%U('0P(,Y]>=17U*ZOMU$C+?4>Z:Y:K5(RD$H["B]102
M9XMHI=^@U_(966+?E!"]$?\I=?D+E6J+)"%;+R18%F] Z'XZ(0FDMD(5H28A
M3PX?UU?[)-YUK*VK'>-/TQZ@>/=]FONA_4QN8G&KENE@,!=!O5C=,Y_@NF)^
MJEY$F$>40R(ZSSGA%2 MEA)ADD:1!K[UJT\O $Y5< T+-3_UNO=5C-XV\PNS
MW);#/I\6D*=*%P RWMVY6=W4K!=:2K>HQ9ON77VBM)-C'^\O&Y0>S_=:VOG_
M4#?._Y,A%$KHPU_>_:% '^/\ZN X(GH__<-(DV*!]7W:&9L>,D.^ZPI&&I5Z
M?"/4J10?5R\W]NX,W8)>J22DXEGG$9D\2,GPBE$WU=+X_+6 O-]Q!UZ-]^LS
M5FOJU#_T9#/<>/66%CXG]OY2'P%XD&=9%M%Z0W3[5*@89".)[WJ/C/Q">#4G
MG(>@17@P?%I5B9+P?\FJ"5C+@S\(UW$ZZ,5E9GU9MZC-0,\S0.+(M\D*8C,D
M&BU?@B4J\V*J/A7$ZK\V.9)F A?3R%XUA%XY$1I8()?]6H-_BS2P7)-K"<VU
MLIJJKISL#H+QSAWZ?<JT8SF1@(E?)BIL1D/D=67PSUH@+HS0V/$2-*=:VHR.
MY6\7P+1IUHQNY22*L["=>]S3D?YBO1@:]U@.ZW<0AAL,=5I\6'AG3/0Y#GX0
M8"W9I)]5K07Y]CR<QHJ><]>VYV7KING5W:A48/6K).;H.R/@)G&,B+IV%M&3
MO755I$4INZ,"73E[^Z[W8]Q4#*QW_&W,[O5\[7M=\'&BU>',T@(_41$\)VL)
MN[YA(S(*M94*8THZ3Y#L_&RBWPT6^9E%[489X_ZM@M-D.L77NGB ] "(K(XU
M5**#G,M*<%"Z!M069;N\=,[F2IHG;]+TY<QXN_/$?=Z."U$W6Z]%TW,)B/;K
MCJ<C1&R]L+0LHYO=H 6UW E].KI58N(B@1A7&"A09=BQ5F:5#4O>Y2I_+W2Z
M9D2*'(6!8IDM<#:1I>MSE'CC_94*RN7]T@B:T4[DI CP_^KN/-_9<,.^'RVM
M&C5J[YHU0NV6H&JF:N]=18F(U(ZM]HK5BN)7:M<N8@=%4'M3L:.T*$UH20F]
M>Q_/R^</>([C>7&]/X]S?3_?-^?EMG0HY)CJ FNO&#[I#17635/Y;TDU\(+?
M2XF/084]@>Q[XPU#PB_^6\UKWR= \$K(H:HQK52PK,:Y[7_)G(XV]P1X,L>B
MAC>::M?5B&*)()W(OP"&0)BST<R<7GL;D?V5!AJ]626>_5!J$[H M>)>TY=[
M0KT\!Q=@O;H7^84KLH!0Z41DB"%KX!D8P3<3BA=OE$(A@+8Y84SKB13SUHL<
MWG=CNK:"X*=>HV[4M67GRFE74CJ$1!V"3D(7I)I4BCTG'Y39X3Q/"06I8X,M
MV1[>\L,\7N&H,38+LWV;:O?<%.(_$*PE%6"=Q"]DTE\_(10E8_0J$+GFLZXS
M VM3P ]->JW*3B^OK=O\> .SB4WT_NFV=N<\LHM /MBX@Q''=[1<0UWQ-_<F
M !]H1X6I3666/+]H7^;QJU^K5 \*IF]_=ENV%X)\<& 59$)2'E2VLK;K)(4H
MAB%JUZ>]GF4I5@E^BW01EQBYIT7MZ68J=)\FI"'A+Z!%MPK/0/D.CE6G6)+Z
M36^/9<]W3E P8'IQ9H>1G7C@6+27EC(SZ/-3*AMC2L>;MED%7:>_S ^,HB>5
M]C=O('!J>OU7K(N!:A[@Z?>SZI-V!E,MX4OF(9.BV3+_1E8;^=*F29[5?;>^
MU]6@X"\@,>HV6:T*ZL1$5-R(L=K%S9"--Z<.Z=7W<6XZHE M1$?'#47X0S<3
M<-0:<A40ZAV%%GVE_,G1'-]DZ\4$X8JH^S$+.:,N\CJI*\_F! ZC)M-V/?-8
M2N4:!6H8-1O$B(F#/U,*K\^V(-4P.EN6"QC^S0]D2[S]93 X&_^P05JDX]C;
MY4)M_)HPOSM*\7E3QS4YK4:1;J%M> R\XK)HDW!5Y (/5B]23YER+]D[I*.G
M;_E=^UJ8;=2A.L17_<LK;SII8[N9ULO"</% HJLS*1;/RZ]+5.H-]/>0?AW\
M 6(*]BW5@]-(",OU[-+O)KNO%SS,I',/9J1+_D=)]!)#5XO<132DY!_,9\:S
MBC"_Q7O\QK.!DJW)S)-6(6807K="EJ $=FW(M69)R>KGB(O3ZO:Y*V;2RF A
M,T&INX976O6M G3EPV%\>F4@[X =LZR?L,WLMJ=[UO.L)5&1<&;@P(6"EQF4
M_9_ R:7 *4;P(1C'VZGP,NJ?D>MG_%XZ^8?E =D<1PSY'P1T102M@BS=P\$:
M;N^<+G2)M;F1]V=*B'K)\ #H'ERAER[BM7%(P$%?4-/J<FJ)1W[PZ,2]'-I[
M:8#BR&>WOX%)R7CQ*QD$O];\#VD%1. &C5=HSGI& ! '5:TQ** >D-<2KKY>
MMYV!LN:7.)N 0YVYPC7>(XI_T=9I#&9O""<SY8_UX;H7*K[1:+*;VJ%%(EU0
M#/%?F:D?]!.4,FI)J=O6*2#[.ELP!%JZ1R!Y@+/M@V(//5X6GN\K/-=/_GH!
M@KR>6K;9B16O&XF\10J%LS$PM9;BMS[0MG0?6P^%]B^'O(JENA#H/ 9ATI\?
MGS+U.?"84#&D\,DMW"6V19,9M@Z&YGY'A!X97(QATQ]RK1@T?SD3L5S(#<@&
MP^"?MWQXWR1H.C3$17G+W"*U#@;*%B,RP--'"KQ:V""NUDH8G(4KOCPKR5%!
MP&A2Z0]QJTQ;[Z:?O(QBY;;S#:_\;\-B^5\,7=E*-PT-#%H740L5*:.;:_9%
M;PG%25F\)A_EJ)WY7V8A\0W+ZE-8=88.PF%;DO-3M'.B'UG]HV?M*Z6LSQ^:
MC >0?7%*FUBE-%W=(P1@C1AUJ+GE?'T/&59M S78(84N8?WM^[RS)UB4V6_!
M*46LM/(*]228@J_O]-QZ<)/^+\";GFO);+Y6D>$:8LZ@?5;QG:K>PM4"S*/9
M4/FG#\K_\U[ */'S$OCXL5N>4B,B$P:DBVJZJJLEY5]@U26):)7UJ@]>*JP[
MXU:=&LLPP5B#]GP\K0$B/X3K <Y6.ZZY8Y7G:P*%RJU_XH?&O#8)>P=S@^D-
MLZW+8R1?6$R<NC LPWH7HRA:6O_\F4)%:G8)7$<1^ ^!(DO87C9(_DY]E>_6
M00:G P*JMWBWY97"P2U@[7 >91.[K>,Z-&QHO4KPKD3MP2>VH[\ F,R-O4ZK
MFIH-ST+!IAD@63D$/Z%LED\+E[&;JUL7AL!,C-P<#T'JSCAFWJOG64/Z5>^O
M1LY3]SJ#8O$;W%H-).>G!1:]S<T?9^)SQIPW4E\I8D\4CFL+U%<"=^XAE7*M
M_(5$MQEB>MVTMHH2@PN9L@_Z5-R[UQ:1P(F?L1CVRU3?"'KDZ"1Q[7[7FZ>S
M<>*]M,WC;PYA7P"\$PV'%+P;J>B?] VO0 [Y[\9O1;S,H'JO$O'F-?J^HU$1
M9*-)%TRM;9US31;U@#3U'M$UV&D<39:O0L0Z8NSIA8SB*]O_*WUHR9O#PA8D
M1F&J^>(YJZ8PS4D#1SA]+[%M\"<]HLUD";TX!]((5^15IRC^L  K^'Q<N Y\
M]$0)]SDR. T[CFW*4X)9[JO+AJO 4S88%/GIAZNB7%<G@"T++<0V=EJZTS.F
MU<=33.XG=\;CE:5W1, 4;_Z+9KA+RKFPW.^$#S1PT?-_4A>;#H^JM/VB6/BZ
M7J\RU_F0TZVUJ4-5ADLT8TI7B_^M,-5+B^OYOZC)@8&$WJV-!&LG8Q92UV H
MNA\W!^[*>,HUL3,@.3J=Y3UCVY##I3^^U4^9M+.<!-SE$R>9USB&/YX&!N8=
M89SQ&XQ0G%55_0$;%TNKBAHJIQRSQ#8MI/HD^2J;Y0\,]%IU<N(5!X6:/SYC
M0,UUR$GP_Q@]2>?;!T[\J&_>N3C;WA1]'\'C'9,8SY3/]\N=_2EB:!Z  "'*
MZ1J>&4RD/YA;Q:0[ ^NRT]**AZ%G1@OPS5CP1= [WI3.M6$NQZ>$YKI/^LNG
MGPO8GL<7C*U-R1QJX@T9-H=:&ASV]R*JA[>048-6&;Z5CZ]_@CO1<U)6252S
M.>:-,]]ZJ)I9SQ^\U="W<J@\S!9*E7/4J-86BY&IV2LBO-G'/46-!==ZY6:M
M&OMSM3NC[Q\;- \]#7D;O2S%;G5PJG$<+J/^NHS4&+#'KD]81'J \FUR8)LS
ME6%)\Y7Y78N0__+8)7-&OWY["5B=CH) Z34T4<..,Z G/<"/N<9SY@8=36TI
M9_;MG4@D!D6L[1)B_F/^T#9-]"YWGI5 Y2W7"SM/N]I\MG<N6QHLSJ0:ZZX%
M;U?" B8(%DR)"QAC_9+OC+[,8S6(X9^4B-Q4=V$J#![\"V@D7ZDC%:.8#WIX
MB#)I&PY<@_.X;_%4Z\D@J(?(?TJ]RX?^O6-($0A+00+\07.V)K4:0[\&Y>M'
M1+:"&H<U2!8P,?XO8(N[;2Y<HYQ7:7(5M.Y]K,G^3NQ-0Q- :&1E)V)W$G C
ML/??UEH.4-/#FGDZ";41 NYC6OE$H _6IZQ=?'F;!KVJ))\Z@<MUDL \D4'!
MNHZ17A.YIVW3WF>VS@B#026G>_]0-T&#MB$!5*":^JTG&[N.O:[I+TS!)?5"
MZY[-V'5QI-\ 9Z^[(=R"Q%\1KK"$<2DYP%G%=%JH" ='LC- OWZ1>V- XMOI
M6=H5E% ?CM?GI*E4_.\O@(KL44;ZMM6:L04MHD&8:=RR\>HL78/PT:!6-%&[
MN_J;*2+-!GTM6,. 'U;;0?@Z9*U%-%3OPL++Z1ZQ;8!7IC^2:A%>"])1K[O\
MV*;QW!ZI)B4*57TCL"Z1F+*W*3TP;H7L#>Y^"SOHD28;$<42PEW*2=#^UL[
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M-IC[Q<5Q91)4$)4;=,LU]GB;A6(:$;4M4I1TQ0'EDV^;#DPRRCXC.'GZ7^;
M2PLG;07S>?O]*6 S2AR&'V/4758&?O7B8H>MS^&?#NK,^SHGTKOP]O:'KA:$
MR2R8AU3N:99ME3GWB-\(G#K[Z.:&PL>.^]YW#9)6E@)^OOH7__5_W!^XQ&-<
M;[=/=(#ZXN)\U8N%C\$/,GPYK=N?4_@$I7LA>S]U/P>+SLN S)\K]FT.$]Z5
M#Q65MF#8TH_&E\0YVX/Z!C\>8Z;^N+S["[A/0Y%1&[FL?GN.?-<%#Z7GQG)=
M98B^@N)A3V JM+Z7R,K5M#Z1SRC$\<_6ISH,!7>/O\0)5,$U2:E$>A!W T+F
M"?LMN%+7AS%:#"HFP!X!?-'Q[NV?F;<)7Z*9*40YWW!,_FA >?8VGA9LP9-#
MC9/1: +L=]T;+@L (J-?\H-74._S> $M]W!I5Z7E]'N?Q_U@+^W_.^1M&S)^
M=:;!VG(3DXCUT,[7H(.J4%6>4Q?].-FHO74ZZ1C,L<A&\6#J;:3+=+1OT$9K
M0D9MN/("QMYELX@5MS*P)0YRK1RNT83X!-*RT.[JI_CXE<CM&^<UAY)G."VJ
MH'JG%9V$Q']S>3'$1[6T,J1TQ0UG0B3JS%H-1C77/7<P#)H _GR3V5Q;Z!#I
M_W2T[O@.3T$ *.I"=H4T.S78FOF//.SVUV^W$.+CZ"MK1UQ8S":/]0="_Y1H
M"DNX<@-L0LG+#G\!=R+'SOCND:HJ21=F!9\Z=]M.Z55FR:3$/F?<M8= MQSR
MX<-\HM-XQ]NO\H:Q/!YBD%4*Z.!&2T)\!8[TW1.GWE4UO*4&<O12F5>ZWY)3
MEKU<-U'-@MJ])19"F=1C$277>$V+,=!O GK:.DT6J]E7L2K=FKKC%:NSZ$U6
MKC[(-RJX8U-?[DN%R=+CB?*$E$DOB?-]1EGI7I#,TB^X<G^<*L)I2!DZ!<X/
MB3=3_W5X\8/FJ0(6ZZ#CNHK9;X !* O5R30;3K[UM=%E(6[AEY _GJK+7H/;
MF33[._(3^V&#,JYGRD<#$40-(JE'O>U=MHY?^W03O"F3EN^,Q #QO#X_C>9!
MHH6\F/;&A;K .1_AYFQ*6V&I:0,IG<<JK3M^LM\U6;%.D4MV;!EE!UR%+9L_
MV3V5N*(2_FU-GO/XNNK+!N,X+,M0S<OQ[+%O])GC0KZ-<:G\G"OMET6;\^JT
MY$<$^M,VA8EM\<"J!D7]39H9[C\OGK'2*C,))W.,?-5FX/RTT\*PG.I,=%_L
MC<)O\/75>*F,JXB\274MOD1-+LX.7=97Q*RSM6=^Z##[\.-HQX:-TS'K_4TM
M^(61YY1KG>)&/,:T?+_UCDT?K'@=]ZCM_+63SX58%L?;.#GO\-I=T20A3FU-
M,$];2B_$X- TP"""X3'Q9F++ Y!# -+5<!X(=.N\OP+)J'(4#G//5J+G&F9X
MVX \=K$OM9I*[?4 &M@1(XOQAY*#02@^$?5[+42^(M'BTH(N>[?8)[ '=B/,
M4W=&RPS]I8F"C+,-'.:=J%<$L2M6J<5"V46,9C5BUO#F%;.:U3YW!/]D]_Q1
M(&W2CI4-7LI@$,[49K/]B#_RT:-K)C<6.RXL$5HZ+<WYDH;65LKY2@6U?7Q%
M+%(.7NSB,!<?@R?535-"]QVQNI0^MO. IWSW+LN X9(1E#A4;O5W LY3?O\<
ME1A<J7UVY=*5/KNXYF[? .3=E9/X#\P2G7A2JK-*-N[;6 [&1K)>OOO50+^V
M?VY-%NZ,LQJKLT>4ZAK"C;,G)5W@L HP()MWA%*2>C7['L0,3"UH9=Y1?#5J
MW<,T+5VKD,%NY\4\MG4H-L =;EXL6@51+W++?4)PT-P=<@,;?D6V\*F5"_'+
MQ=12[.$J!U,UZ,GBB^00O!JW%6$!E>H:&!55X27;#Q?49\U[$^*',1IGWQ$7
MDO2Y'N2?KC1V6D>87^P1"+N\CLT7V<V[\<X?6K'/E@7<K>,K%LZRB<@7SGFK
M,*O]6:A@%#%UOI!V3?<F5B;F'/7J0OI[[RV06D2POV](8.7W8Z^/-KD&]D%=
M8.ERQABK!V8B.69*SS^ T%)Z%L3*'P6!1'[#^0:,><-WN[^ -'B+H?H5^"=9
M\=OW!.X'.^G<NG.%.^^*!R?&$Y6Y,<NIUUBH/]W .K=4)$K:VLC$@<S6Q3N7
M?# />CC25<5EK(YI98,%I'-U-SS>S%P1GEK:/>*IY_;.=SZ\R[JP<UE>@:PF
M-=@6V?0VSH4_+%E>T0K-_/)V"X.R?=%]3*/W\@FG[=:8BNZ'B;$#!/_F,T)K
M]V:=&11Y>U&##L*%*H"7(5RUKD;FM'-S&9_,#=\LDLEM>;;2YN\V)N3F\VE'
M(6HY%QMY"W;MI)]/K6DVL,!1WF1.D?O@+X"!MM'_M&NC=<3W&FT25OY6_F/E
MO,PC[JS&SU1UKJ<]A*_JM!E8%9E$$!A_;V[@+X"0O6^RC.O/*+'EOW]+AK)9
M3/5].Y^#J"U#UEW+9Q1JP;'A_L&;?P'+&X^)P5@U@XEY&$@5_L\7I-+<#2''
MASS6C:8?'+&TY,D&?%UZ"RUJ3!O;VF D&?0[*</I2/)8+BI4?!5NK/RRP20'
MN&@AXC,^>FV"I]S-_(ZLR&BGS_8<.61SS7IX@Q$D7NZP'*).,?/D(#AC5W1"
M]UR,W[7E>,#G%FT&NE&" E$7#4P& &K^6;K!2![2OT4'YSI0D7Z%I\UY;8(R
MC)C=,)HNS7\Z2%G;%9PDY&:UNCDF^/&$4>7-<?M?@%?#'<^KZR<_-^<P.C50
M)]%_9-G3MG5(:X(:,T,;F(+R2[Y\6E*^H\EI.T]=)@@'ZF<_^'IB_1W.O:<N
MNJ!PX;]ES&2'"#-/<-SY#92_>#P;(&%1UBCU<63CI;@$XZA\AU_EB'?4BPCH
M@*RG2F]BN+LK;#M,S=Y\4>:WFK$6%*E^#M.,FGW4G+++EG3#!M/\3=8D[F'6
M?]T OZM[EZ4@\U(2>W_H0D:RPH2YX;RS69$%,3!QP-'G>,PP8<X++?]E(&!N
MY8FP=.V+K$?'9504YLY:D#,[[-7-MHY6S*SBI9\!D[ R:O^T,V*U7*[^O<)X
MEJP 89:1P:I!/.,TA*B>N)E#\$BX$D1J# 1/&_"UB5PE\BZ6^BIB9\?" F$J
M(SPO#>6-[ZJ[R9?PQIL +%M!MH2,H24GIB70PW^53\HD:3UM9U/JU';5/IG,
M<*5[\MI^6-!!1TAAT/AG6R+2)NFTW19PDT)F."K9#AX?*3)\JJ8\:->;@-&K
M] RR^YE EHWRA0I.G,);N_:(#H:@A&D#V2@)^-L/#I*2-*M-I(X&1P3[IW7!
MU,%\YV1V4V(:E\[<GCI_D;[UJW4#6V!Y:V=^2 E*O.D0I<MG-?O^QMHL*6PK
M-X/,OPGDUIH&.6^I<?TTR"E-476FGKC,$ZG2C L+FJ=;?QG>FR_]"#;1P?%N
M8?0+6;AG#@39C**VXS[H5G[<WD-L[< ;C,&RO+BZ9]KULQY1</QI8U>^(2PT
MRFA_?:#^D7I\22.&LWS_G#\.':'AO,20'-AE;X/O7J0OL;ML??8>M/XDO/'H
MH:KUJ_^L)OZO#U[\_A<L[MJ$2Q*D&_!U1KBCXRDCI&.=-RL7/LC#0G_[]FCY
M<I[%M4]NZ5#N3T4<SXF)*0T8F2J2O1/!.AGH/6?JJ.S$5KO$5KNKH2(.]"@4
MI=F&2A-&;?W>R[U.O3#XWOFO+B#.]W:>3CR]Q*>^I%R#GOF 2SD\CA.WN+CC
M4P!I+^28=*)^@_PS\.N!XFX48R0?V8+47>V\?WJN21!>%VS\"XBS8NWI2-B%
M,3R1$3[+#7Z\OJ4U\=(UAF.[-2_-2PN=8D#]24WYDP8Z*)7HVN\DN13.^AY:
M*'KU:2&JZ2^@^3"^3'Z?4]_=H,!5#>N+9J#O?Y)^5)#)3/'@!C_EU:Q=5"KH
M>A5IVY20D83AW[R0Y(3_!;0JC@3LIB"V7U@SU;6L3G5)^'98*'.#/T^);\(3
M_V5,G<NKB*.>:TIW<6=>09([@V%D:XQU]EE[3\PB?N-'"6?]KFQ3K=(C_:,/
M6J^&!E+.>_OX><";&W%1]"!%Z;QBA'._"BQGO;0:RA8%;^OI;+:9Q4W4E73$
MZ/(]+\B-Z L>H/XSH#)]LYDL2<JJ#'<@W'Z-7Y.8/>^?,K&5]:C2;5Q=P?@I
MF.E(U-RWMM8UN\[#"'T]$^59)X^U'O.M(-ECEPII(>7QX;Z\Z)M@N+2R1R:#
MZJ$H3ZG ?YH[LGW6$EH\4;$;=&3WK:G8*Q5"0IOBN\*ZX)J#[+U.9)JZ3G/Y
MCUD'*6*_2$ZQ)A#[%OG?QUL;,2%K=[1(R(:K"97<_L_DZ\JO6L*<KT]L7418
M75B@P\0P;#$XAJ;4$+?7H\)L&Q+:GY7"TPVH +]6HM*Y%(=C(OE(F1!<F2]I
MYU!P%KWGFBP]L&JO-EI;[88K?YZN^XQC&W)@RT=%N@S;;N#V*N0RCE^7G16;
ME79%+\ 5:9&\=3^$LRG?418:%0NUNF8K7>(><B\]^,91>&<ZW'S[)T^X^KQB
MU'5GQ/6!GILM^3:PP-0#@]34FC\P9'6( 03T^6[Z+6F*$(Z'<@*WHH=:U'G)
M\D0.0ANR\,1RGGRK@?1Z,#2A?BG4^HM'1_J:.]MIY5FC\:T-*,Q'7\)6"_;9
MY1^';CNGGEZQ$X6=N&=!#^M(&]C=97CE+$@=&(="U8[7@&97I^AD:U3DJO.4
M.ZPE:H7\,.-1Z-/7U1 ^QG;"SSBR(1YICBWR8?(,8EKN"W$[-1+$&!2A5P>X
M%.0^)K=^_M2V)E4F.S+W(SR$4(2_B90&AO/7D WX!#*,PWA#U;2,6J@)MN5=
M>N&\6[*Q4C!9J*<P1WM$8TPQ@]AFU++N(0A2/(SO"-1MF@%I^-]=Q&@T.$(T
MH(N*:KH&$_IBRQ[I4>*V@I\R#^].^YED4NP;$'%'WX;HM^HTMBI3?ZL]69P<
M_6FA=+P'9D/Y!/](>9'])_ASB=(+QI#W].W +,??O:EHR0F^"^NV1?3>KQJV
M=](_2SN1[]L\.5&^0K$M3[W3>9B5<@2V;V 2/_%3BK:1LK;_ OBA,]#%\X7=
M3N'9VL-P@V!Z]*+28J;]RI]6PJ3 FRX=R:M+VT8!^K1G#D2/Z,"B)/ZFH[:M
M ^.;D$AJ(E]O^01P*H%Y5[0U?3](;E53F% Q=,+Y'ZC8Z&G:ZAF@JR1R!A=9
M5X?PHVVX26K0FB8;^)XZWL&&UI5CK(*/W^+TET;O%+P%89'+D3.4MD.W;YGX
MDU4OS&P0168MK4T$L53#U@^!]WY)GCF"-.O&W":%4U8O&P+<L68*L)<?2R6^
MO?P\"4\!DD.(85;3@0\Q5%4(#6-"[%3]RM[YQ.^XW-#6#ZVS@U#*YSB\)XI*
M7K5Y1)#Y@)&VS9_6N?DOX <NDH44W-?&)T 4[< ?A@V<"T).@\Y+<9=%3X.1
MZK/ 10[7]<E1]O%WY2]KHK?]CP#N&8<N],.)9,WZM7^M69];^CW8;&_).IBA
M[#/7Z4/4=:]4^HMF??=GT=LO_%$<]056I#/(S>06H) 6(2.9['XCPY^WL+'Z
M.]LT&%KY= 6,Q(R49@?K/)ML'9$7>""@/.844D;F)SXMNA[)B7 ZTY'=9W>2
M0A/Y4^HFL)2V16W@ZG&>!,E[[)(L-AE!P=?/-(7\-]5RTR.YAP,WWUE_RC77
M#M>J\3)##"IR:WQTU P,4\.--4\H.T6*V8PJW V^BRUXZ7F]EU1'U"=+3F^8
M\=TA,J3,<H>EKB2A.6 C;6WQ6F#);NST\- .UF4\(]N40RCG\V*OIS,#1'D=
M$+-AN!3HB8$"JR%+K:%AP%JH+T^V[O&$N,Y--Z,A!:#$J^RW DO\Q',X#ZD+
M>[VOD?S@7UH)HV$F@043U\X,P+^1?^A=4@N^\W'0;.IOLF7*"_[@#"K LT3>
MF^]Y2%9(']Y*[_I?,*19=S Z[VY9?(,JL86I3]!E8<^@RKG,#@X_+W$?<4J2
M7TUNPK>=TPNY"6+8J1L(MDNXQR+9Y!C898>MHW]O^1SY<C 1)>SFE@'(=?>F
MDV0J=R5::_7,8P*]*A"O^YJ$[<KG4TH8)[QRM85NC$BR)-D+//MXX*SBU4L5
M*7<0CPGTETF<[*A"-.LM51#0^2ZPQT.CB\>*Z1.!#&V716=6=:JMG_5#1/X3
M%WVTT-R X,<#AU*)\*V=W#B?N:L[$R]^_P5L/7!\/!-P :7]()1<=N_%A741
M"_5S"QNE7&W5?N;-ZS/XR]* R^>\?/ST"#WL.G )CDXU]-O6FL6CP;_&[./6
MF#KS\7A)SZ]B MJB$&ZH7(U@<P)I[C0=3>"/KB,[5R'8A[3 Z=A]E8\7E$S@
MDD]EB= LJ>\\5=:C*WD%M.W7:M/6??$-B9'W"07AYM,!&92(6*S5NGA/AM7T
M[Y^TI!2@P+)^9T1WF=52=D03;L=,K(7^+6;!\S_Z\E?F&DD*&OP'N*4$\G6\
M\S5$*=;YMH)JA+IDM]F4Z9RHNE GTB0/SA?VY9N]YU>3'S%*V4'\2HP*_H!0
M]K1>B./-OO,6LI#64DN=$+BC&;WX^U*.@QZ5!1Q)';/%C&1;WQ5+T&/4$]?.
M,J#(L@M-');D%<._2-V\U!IPNOLQP[ZKP'A.\2 58=5_M'_/R2->K^!;1K:X
M?E8Q4^M RQ=6L<_?2![;[\QD[I UBOJM&3WSIY#E1+YR_"ZF.0S:K7H("4)-
M#^[FI?W(TO+4SA+VJO[!LZ7E3"C,)?+C/=("X8R(MK[.;]'AIFQ%81Y;T(NA
MV19ZR8$2S8^&.P/AQVN.X+@7P4@FR_!R'%W&_9M57\)?3BO"TY;XZ=$7L,<7
M5BUSN[V=\W>3Z9$=R9O6K\JD.2:N7M/"+(7H_#0IZ3>2BA@5-A*<V"."+0V2
MZWH6H&Z9.$%,TX2O+R]&_WWF+;DGL0U/E\:OF EP+,/RRK!U?GT9CC\%R&W<
M2&A+"*B3-T+U1WB=AN4='56>"'=W9O&PYX<ENUFM?T07W4,N7T:=(F?)>M5V
MI%MH?II]/FGT'-D<4NW5JN(^6":?&H;812DYHU<?IT7.MJ["OW-LIS'>_F9&
M>E6Q5\2(EKD!"KX#Y1J,WZUDSWY5FD+K\4H88N37 7V;@WCX<"_EY"^ +7*A
MD($0WEH3XE%KR#J<VKMU^\Z*)G>) Z45:F?JK=**]D3C!G>L9'B\[OXHD74)
M^2LJU8J?T;N'$]HCA.XF%)W^[ZV2A#S6HYP Z:>3;7PP_&,K2UGZZ1%INIM"
M5/[C$(WFVXUUTGGO$=TN!4^*!M9%8"].AR*(/76UZWK",<PK[BMTD:&E.0Z)
M6GT< +YM7Z+]P'G$$M+J:NO7BLS- 9[SUO* :RO:=3<+7RX+_\B *E_G7N*L
M(/.3JBK"(:2(2D07N&E>8<R^0UH 2N\DDG*$L_% B*2X63VK;^"^ILSUIVL@
MZN:5/&)@($C%I]NCG&1NM=BR2]1(:0&"V2U:.E#C]O9?EM\^ZTK^"K;"/5SY
M9D'+B'RU/N+405 =4%<DN6S^_.==$I^V+;8H$MG*:_8:OV<-O\AO,DKV>VHZ
MYBL0W8U]/9Q<SE./?YPY3Q%Z=IH]K<# [NC9(S(3^/,63C3W U0)M]X(9[9=
MM[/Y$P7-8A6!E'X1T<7.Z-KX=6RK:#!<*=LCMK'6*B+?XL.U-B]^S[DN JVQ
M3"MB*U++HR%57XW%,R"T':),[2?L.UNM?ZSC?FDP(V97AIQ$2)6$8&QG;G(@
MC!,=-*.SGKZ8M3?;F:RP(MB9O)8=/N(C)JM03L%]38?&M_+4EWA:NRY4I->\
M0!8&N;.H\UP?Y!/N6*H':93TBZ#PX+R&O+0E/Y8X+>A#F^F:/RD7'RD.U?DO
M:\-9\?!X=552O,OM&NG8+<ZCN^U:/H41A'2.;RD&%AN)!DF[\<52YH@L,&W^
M(=F6:/Z88)RD !.RR:DMGZ^%MPCY2NI^Q.&6R^"^"I,V,)T35T[.G827#QL*
M%7MC-%B OWI33LULO^?O[^>N<RYZ_P5\!++KQ9K:/\2SHTP'@*M#8A>*;V1K
M] ^X0ZKEWLLZ%B5MT)#A1 *B]U^)-LAW3QH2=>/??^\1P+2AH-EG+]<<"U[#
MA G#=!LO6N.H(-RT0O?Y)3(9C @-PV+$H+K2NH:!#2Y[1+"-'TI=M*NQ+7U2
MYWA=.VOK9&*5>HN:7A'C*A6]';H;7W2HO/7]=T3H,-:./PG#IM#-?L4L7.30
MG!;19GQ"%QE@JB7<+'GT!93LFA[^.77G:#1=M@ O74R4WL:S%1&^#>'TY]"T
MC3+Q@7#V%0[%;IVK2516'V7PB=VCK+)@JAUW9'(6A^2[_HZ"C$1U)>)2S.^)
M,&?"C<X-QHJ%7]R7ND"S;T\3U'3[ITSM2ROV\+1[B_>V+3-?J5;F"7?E7;GN
M1(>>_3,[GC:!58H7M$44I%X=HM)K#X](D'(8#"+R>U79#\S:A7W6D<W(I5^F
M*S?"D>&J$,_(QHZ1)5X,=)X-_ 4P(9JNYLP(XWR\/>US@3!5BWB^(]P^&XT+
MK<]Q[>3%]I>['M)N.@Z-*T[6]1FI**[*9$Q4,5EUGGV03U(IE+6GZ+1;+JR!
M :)4Y.GK+]&]^M(0U.PP/D;GWT0EF^MG62JUU$.#6+EBG4RL"M?0VJI9HUDQ
M7[C3=R4WMS7?$&CHHQMDL'P$:V&)/93>U=7U0.34!^=8(2F?\?TD-."!E8,-
MB><:J=X!:UK@YOF9KRE3%C;Q_1*?1U#'95GW@XZH'&(X^+T.).-)[)N.6EL9
M??^P0,^BJZ6W9T:A7>&/M-1A_AK_V*/J)YS"JJVO.MK>371\[/I'K/_OS\?_
M?_0T_B[_#U!+ P04    " #8.X]:#28&0P]D @!8P0( %    &%D=FTM,C R
M-#$R,S%?9S8N:G!GG+H'5%/-USX:I N**+VJ=!"07B4J @(O(" @-2*]2V^!
M* @HO:/T'GJDA ZA]R(UT@F]DU #A/#G_7W?=^]=MZQU[YV<66?-GGUFS;//
MGCW[F9R;OS?+@ =JRJK*  (" L#'VQ_@9@Z@"""\<^??Z[80W5[$9,3$1$3$
M=TE)2<@H[U)24MREH+AW_^&#>_>I[U-0/*![0/V(AI:6EI**GH&.AN$A#2W-
MOX,0$-X^0T1,3DQ,3G./XA[-_^=RTP:@)KO32K1%2/ 4<(>:@)":X*8+P X
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M$$P2-5&T@IY/&Q,) CA';@#00Z*L4($MT%<1GG;(3)@NQFK@6W-SM*FJOCY
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M=DLG8^_RYG[YG\HBJS.F]/] 236-G&3\=#[>$DX=\5L^2GBK__56\]V_+!<
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M,.7M!^630PP=%W_$?/AY92!X50L^M3!GRRQX_.SWV??TD$N;[+.*-/5&J=F
M[L@P]V=6>3QSZ;HX*Q0?F*/D.B-KI"[6)=31PNV2W76Q<F]3\ER[?\OWTALF
M1A$)^]J+*$-$+&1<0O,0@><R%GQC)5,:9Y8>Z]NJ:K(&@V\W59! .LC:M#CH
M\G3B!A!OT&_1$F"'L<%K6"C= &"FP LN<+(LT^X0\ ?[&_^+.HPYGD;&85<
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M;-E?M C7(M/Y,7%U# ?Y#ZF8V6BO,W!2 6@79<SH=YRB)VJ+.U.ER4;/\[E
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M.;N&V/3\T42UO^@M?P>#P9.P=BCVF<ZW5?4QW>]\7+H,>K;I1!RNL_>@3[*
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MC]]-KX(P<#WY05\'K%$AA%!1XW]2ZYC7-7ZVE:3KX1?$UF[9,:QM- ^?*J,
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M6*0V&TCB2+5:)2#U(.S#!IW)>=NWE,9&/N3*$?)5Y;L?J&RY?W\#%$\3^??
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M[WB+ZE"<U1U>JV\[7B53^"?G\$'2"ZCDXD<&_2]3W9+C7;5O AKS$&9;YXD
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MK^(1S+KG9#POAMVY%79/%<3>61O[R/XG.\Q<6_L8]!@21>,YRO(>B)ICTY(
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MTIK&><.'IDZJY[ZFCERP>3:!&&.SD?E-[O'W.1->Z)>)L38!TE'VJQ:5_-4
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M6_B9,T8U]B]TG14@FU=Y:IH7WVE[9&SOEM=0YR:YQ#G]3_NIS/RKY=IA6>)
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M1J 3SH.4:O>UDH\4A]T*6AEX/L1(?S722$S&DC[TDSQ]_/L'\'JI=I';E#A
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M0XQ_P&WD4%R92.B)OWOF*_!-$@W ;+^ PLHM%,G&[T*?)'ARN%K$?__@JYR
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M&=%NZUP_H?>)'S @5NLU!>=8-/@",6K6Q6S\EX3US];ETI:"FX6S32)F'#1
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M(/7Z#FQYEY2 <&322Z^O3@,3SR#+:(!SB=@;/RVGUX:(WLUE?>6B8QB/5#-
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M?PZ-T.M  ]0T[*"&Z6CI6CPXADMI((D (YK[PR4-;X+7_KE@=!2S2H5 2:@
M:B?8E<#V7]5Q78MX+Z)K[_:+7G8S-5W*Z@!2BI+I(Y?S*$L0G_]9U8998G.?
MORO.P >T/"\9IY<0&T=B67IUO)J?H1@L4^_ON'B+#/2W+]%%UPH[71GTYS$>
M"JLYLQ2:[?#E<A!%&"_9%G*.J(]6@[-#8GH&YEKXQQJ8!7+4D^:J9WVLO.56
M5]<!(N]/*"VBRN;CU!7P5^<Q_%*O#'QEXTK)VNY.,*;/V3&V68^R7S.\+3UG
M[)=%CJ.( 3D3"]/,VG1MY-S,DBT:S<8WP1/KB-FJS'X$41LI_(P> T1[_-67
M],'CE%BA\P^%JZN845:/H4(R:)^6R5+!E>"XC^.X80=<H\.,8DS=I20V8FT6
M_[=$W0+]JWZR*?T#.PI\FO8442LH0(=N=?L&Z- =;4D^KA&]=C/"RL?/?$Y_
M9@)R%-:")N;1OP9J\N/V%HXO66'^>T@735F7K92WCVGJ?Z]6>\&!LIBO;+6(
M[L3ITI_@B3[<-M$9P7,<IHDWF R*+$F=DK4+.@Y#Z'S#/Y#7!$W](&C,N^&X
MOIZ?SG5H=Y*.?3,N\QP((FFX3?_K%/DOY5MBB1V\/1(L+GH4.S6RH1^\>=B+
M,<!*>V)@)S=4133YZZN2#1/T51?FX+,_5%-2Y+\)D'0%RKX0$$J4=*CN0N+;
MHX'"@CGGZG,%5BVV,=1Q71''Z,^\.0XN-Q=]G)O+:BYHZ=P"FI"?C4$9<*M-
M=0DEF/Z;[3XO:G>7PE\.S6'6FJU[:E;,> ]WS@*2;I^:B [IHM[" 6-\8/RQ
MWT>RV2'I[MH&E>,<2JE3W2D/2IDYY#^]]VHK%(=_NKCWQR*M9^-ARKGK_N85
MF5FST/JG",_P:I'"C8VCK%PVK-&";LC> ;UG4*ZPKTJ!P"E+]!(JR#))]F S
MGQKE4H>(1S*[U%-GBR%"_ /*+/%*N2II]5A>M<:C"8$?Y->4+WL4>L<UX$;;
MDCHWCU3@TAL[]P,.$&)93)Q(%B7S-01UR@E[H]$$K$35SFXEW29KUI"0(J$P
M%$L1^?<38H@BA ]6CXE7A*%N@%?!&F[ BNK-Q?/;LG>X:8#]U9PH>A<%ORPU
M6R1$$56*Y:POHL4:BY3O++<(#U)(*45(%985Q'Y@T41*B)_X%%H-U72T XH1
M/)_!KVZ>D_08H/KN-O7!CQ;H;5Q#AA\D6<=]^*S6-#'!:L^@\:"Q;J(]&5+@
MUN ,+]>.^J(\6Y-*V#??85_<_Z$ !1&+$+ NX842Y"?^_.E*<1X: +GZ$+4?
MDDX5?6R ?PA?DPMZ)#G9NZ4Y@E=N]V0BFK0>I/>O5#J)9A9G/8*_^"SJJ4P-
M6  V;KYZT]VTTN!/>(:G 2)9X6V2T;[US'9%Q):#)U5ZL1_O/J\Y:V^5_)8&
M$#[YX['<EL(N/!;DB(I/GXC<<JC!$3)87K$I_IFT*=(74Y.8:VY\]>7+J^0W
M5OG-L%#0Q09]MY)U3<$1*8++ >*[S;/UY$-90E233(;\6<D:AB1-@L:KC:&N
M'>*"I&RI%K:HODC:9V.T>31O(+<'.T]E)%_<"UG%1(9M'@0@KPV-%EXW!=]_
MRCYJ>].-8Y<^<EM)EP^S1-[0N2;.F,[_V86(Y!)U1KQ32[XJO)F5W_(!#9":
M6A=7W$^4'H']5:IUPKMNM/SAF]]L#V)"6$9AESZ#\,2S]-%:U$5MSJ$!PF5=
MJ+ST#+443_G.Z=E_8$D>#&B@%#8PNL%E,$?;U)HI=CCI;XE]/\G2F8.3B^],
MF=^S-I=:8?V^0(E69?'AAO%.0B?1Z+ON)55$J[7VG<]B%PNHW55"H@*7H3WW
MV P5K!.22=;0LZ,WB\O;OR?[$W#5%I)X;_H8_Q75VO?/('=4SZKDA!4^!JO1
M &L2;NSA:\!&&J!)!H1]4#1GZT(]66<[ ;9[)EY[_?O"7B3%1GV0X UW]23+
M(*(#T\@0(OA^U1FZ)J+('YZ1H6<Y!?%_:,Y:,PU?OY!55KU)%<75O=@FW0XN
MZJW^[^:1!FA@)@T2J >-?GPV7Q<TO(&3U9H"H\K' HGM5_>IVMI_+I*!!1PG
M]5U7Y<AYQEZJ#&PL9_QJVN1;TC3%X"R^'=X&CYZ2_^/&G<5749EHR(7A\<PQ
M]CSYD^OP_'S#86+7XT!S?IQ_:Y;4\+Z _5,<(2]WS9^@^H7*E>FKDO)LR[1C
MFR7HC9E(>,?YQR,)DFNH:!MAG$&+Y[D98FR;F9D?X<)<R<)3+/M2ZCYR(V?Q
M<R((9'A")/0<0H"20+9#PZ.Y:( +D_8Q08501W^,FIL:T;3_E,FI'4>&]Y<Y
MO1XF5QPL.8VV8E[)]Q:9F2;E<Z5^./ -G,=);@S'%XH4'SV=HO/\-&8?3J["
ME5!E: "Z!UO<8L^@ZR!J&>P?'0!">Y&-CT_WAK,2 [V.+]D]O0<]5H_G9?C_
MD1*(5_\ZA5ELZ^'&0OO[LU(\-"<H7TE_<\![]$33]>]RR4Q%3_LNVQ(-H"7K
M4=<, RO0O18ZI\'N.('9,,9X[J$V=PE!=)A\.WXH0\@_*>YX@471GX-@1)/%
M.S6/^&3.+U4RC$]KH^@:97,?\; !+]X:# *YCJE+N\>BL RK5I;B1P;D@Z5_
M)!@=;W9S4$NB@CU<N5V0[58]];?FD_X&.#UAS2^+'\"QE.W M?@?[F&H_%N-
MC8(_P4$T@$)Z(J%R:'&6@&+=X"(YR-W\'1\I8)ZD0BBJH@$JJ]\N8_2LG\\<
M[$HO@GKN&<V%#,%/%GNO0"+O'8L&YY"5[KQ_AYV4T\&Q3BIFO4?X2600Q!/J
M+6=F,L;9_QKO>@7V[M[7A!'J2!,.7IS7W4,+=U8HSPVJ6WT3J8\\(!D$!*[_
M>[CB%)\^[ >NS'*F92A[T,S^KP:C^'0!72(XH>+Y&-^B\6\A$4Z_X!;C6TK;
M-V]EW=\59U[1^I&= L@6%L$%J'NW0'TH/Z@\&X(,J)&&B^@_XA.R8J>LK5QB
M3[8FIWVZ(12+ ^P/J@#"VJE]X K9,*@DI<0>+_ZP$JF;*58Q!C3@9N.]S-.S
M@(9%<0)6509YCAZJ7!ZW-H.9I[LC_*B[E54CGBF=^U\X:ZVL230 7<.'!L>*
M8^\LG%HKF.FF8K_ 1Y^X@%P1)_-UE<Z!9BMI  Y)Y@?$#;H2X-?L+X!XS!R^
M-9390Y7;T0"-GZ\:P0.W%:WMT6:-Y:3KN\T'JX.DAR7?4DNAVX=KX5102.6.
MK]?Q4?'MK:8V=3!L]@^[K/_&WG='-?5MZVY%I FA"P@$12G2!&G2(B)-!$2E
M"Q&1&GKO493>! 0$%%1$0$JD2XWT)B)=0$H(O2: (9"0O/ [][YQSKGWGMOO
M>W>,DS'V/QEK[[W6FG-^\_O67J4'F45![?147 WFKD_-Z.S15 #%[FE48>/6
M["Z!%EJU0@:G;:(?4PB&W+H1WE!]LI0_X>,F0:?Y;DTY>F#S"GJ;8M+QF?Q_
M]&O-?]:OVS8_ZY$>0(@@2F&IR3LD[7T*8*DX(6&NW.4+>&^S5)E C<O/I(YF
MZ)8G\]PG6T]WI<T=W;T]@+/)H)*AN+(:.W&6XJM._PFIH5;^C'(CG)@9595'
M!B@E.$-0E/PP"7LP&B+MRY3Z%AH0I.&)TY43]IJY]T3O)M-7SMN@!T]S"Y?4
M&(A>(R$G^ LS<&>S%B..?F;F:V12#R?J>JG9>S31]4PEST+,^U"J3 $YHCZN
M:CHS*[,R<B6/Y5KFOFE=2STJ:_Z-AE>JI=J&@MI7W%PVM\Z7XV.*FCYXM9?4
M;')%:]F>"HG0IN+J<OZ]\NCS4(O)K?"*6M/2V= ]V<-1D;8)@BJQSX32;<@(
M[EBKU:R.#T\V']HD/!$LA*C!;TU6'A6H@:=MOXU*2EREY(B2!<@AK=R*%$J?
M5=,N%&SH"T/4<L#N"_P"'[C^B:VNO9YE(HIY(_LQWY.$]F7DUVD3EU3-B$V&
MI8'\XR<D5G6#](B#N7(TC184YOA5NH2DB&<B\$-C-DPANS^KH(?,'.6@=G?Z
M!QL[C?IY/4WMSIRD"WK\L6IN!4,5[FJT :P$-8=(<4KACMO00SJ.B$""3 BD
M?B CW]#9D(AMS" #]K::%0>^60?"AV]K^'[#ME1/0C@=4SY5P)2"BZT8F/M\
MGI][-L2/7(=,K&\>R^V\8X-7_V'P8_K>>VQQS#K%XHG-HPO^D KMYYG/)M<L
M*!VS>*O_'!#,?P]2ZM!/$.UC&M@@ ^?6Y)NMOC:J7U3&?5?2:T-\AS2-)17/
MS8QNKI\]E.?_'C=9,!<T'J.B6Z"'FC:24+E7X)CA8C?\;F0A791S:-=FDOXJ
MM8-&Y,[/W7@>#&+"PIW9?"U';B1$$[T>JJT#9YU9O6/19^/N4A^!NE)AK7WY
M=:ZT/W6,5^,"6VP>%C0G%5<%IUF[IQ K4>VJQ#UUMR[<EW-QH04D;:\H%>ZE
M]SAQ^>D#_Z])H("&=HNP=R4!JGO!Z\J6HS$=V,3'9Z4+?7U.,7/??,9$2UBF
M*0W^$B(NF#&V4'SVVU"#GF&VJ:G4VLBOP#3CL"FP+;S5B.+[%G_X_G%F6CQV
M_@#?8^?_(S.)4%2#Q!^J@:*[L#M_DF7_5V4'N*=BO0T(I%.8YO?O*:D_+58@
MC$)R5,G &&(;,M6Y!L7?;O0LH'3_=@OA&M;_Z&U8'_.Q:#E>S=KX1Y8(@$Z,
M@EL4(;J"D.*^#ZD'>;_@_\I+P7]SZ*A1@716D');M][<YF8.)9E6T7%._&->
MD!4C'&OXX0Q<+.92 _6("G?PXUD7 ER>F06'.-CNHUJ"UR;,[,'MT$HW2 F0
MGJA1F$_20G#4?W00+=F"&(8W]DR2Z;8@ _G'26I?C^9(F!1,?$N1D12 JW3"
M>J,DEN2M5QW#CA/WIBH%9&[]J:ZV?\IA=D\ZNH+N$C)!(&-WFGW^F']]5.5O
M>7ZO10 2]69+I=2PS5P!/@DH?XW:A.[.TH"/K;$=/-9?$L;<W#61<?-+_RSN
MR<YS"5(JQ9X4*I#^Q\"#DU$1*%8B)/[7Q5JMC/]@K]P%G5GY)B.;S7I,5?YZ
M>&6(#/PM-&Y_!N[D&>')?>[;H'K.>MA5+NYY[JV*+RF8"QV%LBZ"\15O6MJ8
M_1#?I;\B3AZE_S;D5XAKU ]$PSG-'ZP<^N7YHNQJLXV^V&?<3=2)EA8O@(E:
MH8*ND;8M#L\]J,;4_FE:W(!^147D.D%+-[_V.O5W#Z'5;Q\P7"&=C4DXF]IA
M.8)[]' _8^F>%WZ+8%ZQFVR5?NV4/=VHF1U=V\,YEDB^A&"\;B]WF."T?G!]
M]?2Z/63&8HT"D["_;9>1?RT._^,?7T[0_/=\*EM+? =#Z0O8'_+Q=(<B"!H*
M#.SPX\C./7 ZMI2SI$'/B>#_Q/A@<?1(\T7BA2$92:+V'-[LF.*Q$XS+W:LH
M>3WT[?*?-(U7?<:F*$90;^ -8F6(Q?_H'2FAH =R:$K</[@ ^1/ ^ _W8=/@
M45J&0Q*DY[L=;@,V_TJ(H*&5)D4.E&AM'2'8_>+,=<0G?YIJ6^XN6NJ=,1EY
MD&,V-\=D(-9+DB%-S)RLQ"2T0T#BF^Y$#8G#&6U/WP\;D72)_E:H$;=7#X%V
M!V%A@8<C1\](@OKH4MN.0YIH<5=?O4SWV8XXN#A#G3M?\L6'TM4&MRK2&&J7
M?G,=*C[^\DO--+K=).KROD^0*C]NLRBI*OYCBEK[_RO_:;ZR OI;H_$6OIG_
MRB<K@__,\K%_N)1R(YKYGG7D,E?Q75ZA<O7T:?;*G=?LDR&=UR'"9II%-8+G
MW9D"AF\/AIA_'/BX$HMTQ&SPF$6XVB;L Y7^#P4%T/'ABHAL%4B958##@_+1
MDMC2Z==]LL&=]].NM?"UK,"&5?2Q:XRFM\910RH2[N_6># ,1=#2X=M#95=N
M%-TY*ZBJJKO>'V#V2S7HU:O['\O2&LR5BVM#_=:J%6'WBBXGO_2S?D,D-O#7
M8I]98;6BG%P.A>.K5$&&29KF%X?<'T=;/;@"2N61=3&8.QG/DO+QB^%S?L'4
MNWAM+.@V@2^MA)-'@^52E?+CS,Q+?=T3EQ+9F;Z>, L3P@^CW'E42SOK,(3-
M_3%<L6,&>.IN5\2#Y)U/)T9?[:Z/?<*?18.B&L^B@ON%2<RY-;J%4T<4?".-
MI4"JI;ZI;;551@HN7FA<"U#ZW!H,L=V>AE34^,]F6RGO7\O3\LSOZRD==]]5
M H%@XU!ZTHG5G/,_.&E]WT"-'0OJ4RXE-U;M NK)P_MP_*YM:G($X;93C1^$
MY7W.]PF)L-F"-G\9K2MGXLW8DNZR.\P*%0? T9S9'U?\LTX7H$3D<D'G<,C/
MY>G8'Q,ING1+KI>^TO"BK[DL\)J*8=FZ,I LC4:>)3-:Z82T1Y$S:B9<XUN%
MJH<IAD6J2J;OHMJ,$T5'7[IBK::=WY0T0_UMW[^Y]JEQTW^\:=/]RY+C^]C]
M1,R?K]-:A?_L(SF "-X47OY[KRED\"\G$O7N(@^X[A_ 5T4.'O@3VINA*127
M:KSZ_!^G7O[EU=B'2Z\=*E,['5!=/7 .!F&JB@M^7%^/58C:LI@Y_*Z8KVOX
M<HW!#A=H=_W2LS0^1RHT. 961AJ:4<8WY>&U<8\P!7'$:S;S<H.^;VQ-Q\A
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ML?*'XT\Z.C81SWV.E+]ZF*V;#KGF#!EY>W+M;M4\$[SF>WV'=N&1I2/$-FP
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M]VU7)<)?G%E^M)N[TT/I7HC4^X)HHF:!DY<S9]9M?^\2J5"X<,8I>@.&!C_
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MO[[OI<LBX?%*HHKC> "-JA?Y-[ET8S$.<U2DQA4BA3?%TJ"Z8HCZ1YEH"$O
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M&$_#&?>)6E1S$:8!9=6<6291HC2->P<OM9[XR3LYT1_H+]%GJ?'UX,+NC9,
MC=/#TQY* [PA5S'P]BD]&)0KX)X&UJJT./-AU(/A=XTZK^,YC=/,1+NX.13"
MB2=0\,A#O=4P5LQ,,BI4>@D663'H\J@RXH/ R45!X[OME\,]7XOLO64\%*%(
M+P5<(9:Q=24'C'FVFB.0W482;G24.])3_X'PU:H9?G1G]^O=(6YSB^7%VE-/
M3NJ)4;WD2"!0K=?[%1,45_WJ7?,W7\OSY)2>S?#-_V4N8#)29G4JS,61[T;%
ML\KS9NR*=I?5XCXI249\Q+L;Z$-TADM]BFFG%_0L13BYTMY,3(<7 IQ^]L)U
MCPR%GD@=SYO:K=TT/UU;A-^>,\CX..L4Y%LZ'G<I=9-G,=MJ@J';9[VH]-2+
M#^6R\7S<:*,+83C%J8MO:6KP-%A!:^Q14GQ)H_91MF\1'MKNKT2U5B_.:CFQ
MQO_ 4W=)FSWEUN#_8>^]HYKZVK3A(,5"E=Y!05%I2E5*8J.)"(@400A*)_0:
M(!"D=P0$! 140)0JO1,@%!&1WDL(H=<$) 82PI??/,]ZW]\S:_S-S#O?S/=^
M:SU_[+58B\79][[V?5_W=7'.V2=5ECO[80+-JU8^@G$SSCA,3DA@S9=7.MI+
M1[E32;[=0"&[:%K#V_6"$4-!WBN.FY9GOBX$.^HR$NPTL"[1D#Q[7IV$R+SI
MJV:!()U:[0#HD^1.4?M3GWK%7HYF D;^^-_U*GBZB?B 4G,@NI^(LUIVKCB!
M V+L+O- J6>!<,2WY[[X?/"\5I:?]?E\DT"BF4?1K6)$1>E2%52HV\B_M/DZ
M]!NRF_<M4"RY6U\R;#JK4D<B+8Y#]]5C^V!CO8U[XNDV=J[/<9$OFQ5QS!I*
M&C'-H )"U@,9B8\])I4Q.XR;V:65:N))*:$)LD8JLFAGKG93@;)8]/9%Y)VA
MTGOT@:"'M=H0Z+T;MF=Y <5IMF+4G\5: ([_ KIO*%!H39#VN YV[W)T8:S6
M02)MO*Y>O9^%0UF9T.,4J3W-[ST 6L,?HX:&>D7OF$6PZ9.[<)N!J>WW>[E=
M\3BA1\GF]5Q@5]ZW_46<NRM^=W]]I_ KW,EX;)QBRW<[-D$<S&QWL#,=+(17
MYGSH$HWWIJ6KT_2<LGX=JN3G+\Q\/%/>CM=F8\O;34%Q923SYPO'='U=OB_3
M5LWK1H03CBPG9P7=FF:4C6^I+/CKG3;XXV'8_GD& OP=E L_AV/(O)PC*3:N
MPBFO>A>][/>QL3[PP<.F7A%9?@"'L;*^H>'=HF")P,A'A ;<2'O? I'/#'R&
M='W4M:R\)NNFT4V[T96ZS+DMR8S;C%4#R=H1X-<W-7^ OY]=-_H/!S_J[[JU
MBLU5P]'P[N1BD>VU2DMLQT62CV:0^*39'@5?O]AKW=Q OUDFS]N"D?\'T:L8
MW\$=E#40#6"2N(&HG])<#O/B$_*JIA-;_I&A-29F.B-I8XL5U1H!AJP \YU+
MUA(5+=\+WER,*"^7_.-1\_#QH&N"ET,I(N "3KA1$6F2>+?&;*":4\)V/RR
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M'E45J7TT)_$@<#H_6VGKJK/A==L[4HM-$#]YMFJ-BS1I6W)NK[YV7TXJN':
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M-P^LO,+<0H.!-8O@FO)0<@\.T=&807# Z;^O&M8I :H0-#ZYC-JH<2M,L$B
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MP>+R.2C\<4 LH]K##*;G^_F:HD+VZC=%&U*G:M_&_#P!3,OBA0@.1!T(I_]
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M*<D-RZT A0+9"'5J.#YH;!=9;E2.#UQA#UGL-S%'YM\W>&YF/R[WA.]Z?3N
M*OA&IN/;LC(I[\]?X>UZB*5!$J4,G],+'0O68!!LK2SVX"KI!+C=+@^!\Y=!
M5J?%M7%G+^GS6KZ?^GQ@&JX>%_<SO9/>*&!^L#O/?G5/-25J8'K:CNGQ$01/
MOX7R\W,;"J:&HT./]AT\-/C1>6X;5%[>W1H@2;^)8,HLY0 HUR)=Y&+Y-I@#
M&D7P5TB\/=1\I[AF)??#J@MCM<T]J<%ZO>]M;NX-AFD%=,L>5J*IB0DU8 $4
MC)IB*GKP[I4969VLT$Q)O@Y\%6A (??SVVT]79%OQGUV$0T\/\N'F<-0S-M
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M![L@^8#=WIQLY^RBRDTNPK;F5^%;+>9B?PE.QN>"+]<4\G2=73H[:'>(QER
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MCUQPDSOLS!ICKL6@/#TSE _)0?<'/]WX#!4*=7'POO.#4V&[G:@("KHKHNM
M$3SMD+OKY:,?T;);?012H.BNM11\OYV_\W=S=I=>IP=)-A))[E!R#^+%N>.[
MD@#UA<%/6C2=\\UG=*Z:W_K!QO;NN*&?(B6&M(!D@)6D<6"IBWQ!_B='7*3
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MVP33/A+1@HLHH8M1ZO?HMS-S$07WJ'O+P8[QR*ZCXL*&I=\ 78?58H_AZZU
M,/FD !\(-]^#B@"9R>(MW(9FEO#WZG2LRJKVJN4*OF"F)Z1DUIC5M^WN\P@[
M&RV$'OT-ZK7WIP? +O"42TCJ#)VC495GFMF IR'@&HX9AC[%-\QFU)U*Y;#5
MATO0IVS !0=ACL+WI;CB<\@&:PZJ^]>\-GMC\:8MZ!?H.%82JH -L,WK*F#U
M7_5)\2EH.90]&7& #>#<@@A<X7B=?I4-Z)(98< T0HO#*)>?L2:OY6U 5L @
MJ!7S0P.\'%8SJ@EZ-.*LP9S=VN$#<VC"C-5ZS6LE$J6.KW,DG3[_7DOI,9U
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MCF)_EG!T)&KN'@Y,L51G X2@)7<P1L-7"9;*!26;%Q>NQK@\O6C&$7,'V]O
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M#GW9Y>4<TRK7CS=]N^PK!3G[A:M 6>U-4K>?L':SI$WQ2>_\47A6>L(\C5_
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MUYP<^),-V*.(<EIY*76"YI/GXB.NDU"VB3J_.2@\%=U9'>[Q?%3B_?,=H<M
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MHJN*(4$%'4G/46P_Q+]84@KRIQZ6++UHFGI'-_/I230 Y5S] ,./,D7G]]T
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M[L >8F8;X7$4I<B847)5W:G32PZ:O8S^!.]2"_$QJ$3KAKD_OZ*_#L\SU U
M6/Q%*K]Y?T[=>6R'>9ZVMT@F(N#.WIP"I78-.CZT&FBV$.3H,CW\ED?VL]'D
MLAJ/MH"W6%_D]=C]NVD^'&;ZRAQ2TM^/V*".E[VR:Z%>U60F>V>R[M5@;U 5
M-$9O9F[N^DS;MNU3>^KR>!"WAKO=0^G//DJI=7G1EJ1GOIB(CQ*W>7#BZ"13
M1W$<D0<57S)F,*A<S0HLN:RRC1GF?N-[7^Q'I/'(3Q;Y@ >W \PMN(4<UU07
MRX+)(M:XKZEM*SVH0-;E(B*NT=)U5*^N+M'!_+7"2JF_S)QRG9#^\]TVWJ%#
M!4\$)!AFO-Y-@(5;/@.S8I?ZF:MR*YB$S%3MDS7O^I1I\QT(Z9N7LW6DV.)5
MO\X+5K1!CQ^4(SD(+<T6=Q?AZ:+A)T=DNU&@8LVJ!$\D"XM/"&GK;Q*5#V]4
M^:3JT^TT-D;Q2F\ ??RN/JM"Z .&]^"(:!P+"%')T>=+W\PN.G.24]_C9L_P
M:,X'(\'\\5V$T?$AR;U'^EU&8P&&MX.:SH.18",<-L@?:1]AU:H:R#D&+@9C
M";YWMESZU'IXTB%-"T;/ IIZ"5JCQ0V+EFMR67S<H%XY'VX U VBQ+NIBP'=
M$;;-4_*ZX J7;-(6#-W*0%AAQ5M-9KH9L]%QN2I[FC)YD=H#H@*^B9Q7^LKL
MA.CML\!YB1QJJ* )QGLUL7S5N1X::MR>],LB8M:;M 'J$&89^#QZ>?P^2S/Y
MGOA;D^,@RB!'L'_O*AOF06HWPI)RH"UNH"H70KZ5N[%BN3YC=N$+:F6>TW:*
M>>67I,6TNJ YD)4F\V[V5.TVKLUGW\$<IET^Q,[WT;CRZ&-B%^G+P04:D'?S
MMXE-O#*EIA6ZD?0;3N:R/12BP>.Y&<5/B23\KGL?B_QU"J30*71AD V*:)"!
M/;Q72EM^)K>DC8'= %STVE/YCH7R'Q4T42M[# 2PW)9QK3+P!_/87.*&\*,U
MXX:V"$OT;%/P_'Q%+Q)I>GCX8,Z]B)2)9'I02(5.2\^.]+C$PA!#>%!?O9^#
MKG7;FCDI;1 VNK!#H*0IJ7^9 [_$5_-BU<F?E+;%RS_$X[4V\1MOWBT3P-_N
M-#]S2C/ IGM@Z%!>#V&NV>(-LQ6-II_242=0%'=]Z@_M37>6_,OG(6+'3+QW
MFSW2/&YY.<T 0Y\6Y%&U>U;C:GR!QKB:\Z1U3XM"\EI#YO@6'S_WJ3$?&AM/
M$[I\A8SM?GF+*;E=)5+O!>]Q(JC1!4'2(@>-J]73N5-2YYR##X&S<BYS^IKZ
MJIID3=L ME+[GMHN\24EQJY[^QRT,+7JE^X2FU.2PCPZ$_W29$O7(]XTBF45
M\G5*_NZUZC%?Z0E])D.MUF[+=81,^* H&@,G1\:1B%*ZOAO88/3>@2F56&G;
MN3PHD)5>$-YXH@%YJ!%OL4QPO.(93/2HX,E #@!FZ!=0MI]AV1S.-UO0B3Y
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M\[X!T((N+.-;"]9 X$IS5P@2]5+"37A*SCN 9>22ID/NCA!<YSNW#-YGO-[
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M?QM<5RE^>2$:+E19D8\A'\GTF840^;0ZHZ)QB0\%5",<^-0-D0J#T[?ZF]$
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ML?FL_8]D>XDI<,+#R/LL<UNTAZMM-]GAGR$?@9B-@,2:0>?(E5+2&"-UTEN
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MG1 0WK0A(B8C)B:CIZ*@HO__G/"_ ;2DMX:)T(0$]P&W: D(:0GPO0!. ("
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M!=%C0D+YR."*-8JX@YS60=&=IDR79K8_IW^VBAWY^>(X-,<#]]Y@:C>BX7?
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M2=:!SJV<Q<KD9WK1<O) S8UC>C,70RM:M*4\A7VB+( WE?.-A/V=1^I,^]Y
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M'QH:76MDRVQ#%Y"3M?MX0#68VP-Y])#4IS/O+6=_.$.CG4?9W@B=4W^AQW0
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MHV N&KD5*M"KHX),6IVO4ZF3<:HLR"_QO'QV0X8BL0?W(%:@4TZZ_(LWQCB
M4N_3&F>@%G+].&Q:]"GO5-Y15M-[2!1%Y,*[Q6A7_=^7F@![RD^Y81PX0'D/
M]D%5O*I..S35K$CQH#_]1BJ\,4XV V[^ZG-B-XP:-153:TP_.Z#;!,9NLD\/
M)&YT LY?;S_% 5Z:HT^1Y>>)H&'NNG-A\-9"5S+C2)!H6M4G_:&J6\ V&N:/
M3%O?+78"BO(1X3@ 4(X2!W!;/^TV_11MHW-9GUP+L3_OY3UQ:+^O=5V[66ZR
MK$EZRP52!<%'JBZ0RVY?:#>D@PF%WLTFP@&BA3*^MG# ,[Z:T_H_0'4NV!T_
M4<]7<&:X*3R7%7O-,.HZ?,WR5 =DA;@K*W ?!7S/K_1MG_D6T[<PTQ&L3%N\
MC_5)KS.]"6Q.@_H=_^<P5=IQ]MFWVJHW)'9X1K3(0ML?T+R].(8E;.;K$)YS
M2ZCTU%RL!\A$.URD8VG1Y4M3#84X@,,,_E+GXY3MX4V(CC%>700JV2/+(YB
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M=[_Y\S8W=*L3[-&VOR \7(M@VRA^OCQ$Q/3%U$I\T*Q9G4.F4\K[2RX#!Y:
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MB:UL)=_07R"7NV<;4TF?='>"ZAAUO$(XB>DS@.?=9X6RD1Y]#QPY6VDC]:>
MXP",W38DW9,Y8C.>GQJTQYH&^$U5KMP"$&JQUKS8-*\N:UJ:Q0&J-](9D:UO
M&0U?A&I (WC$Y"_[D-4C^IB=>GPZ"FPTV$/SE<D0*U-E&NQ^Q;DX0&W:2:<Y
M>4I&.)"JE44B:HN$I1^QJ##6]_*!\(8V"XAN"$T"U]#N?(3.1Q'I-,4>/*[[
M\I#"M(*+=[_JY14/">O[@ WZRX#I:%O(S1H@&5J@BXFV*N0'GVC/VWF3>&?0
M2\>&)P;W+KFG!I$1!]C->.//C$=HOR*T% T?I,J3)Z<Q_872P<G=\2)21)/;
MJXNY?9\<4YE^09?X^?'4#/2J7\",O6]H)Y_9\0*^L7;OW=[RO@4;*.B^EK&F
M,IMN:,5;TBL7I MZ-/U67XNLBT]M86D.2QPF;7O8L->3*5(4N:ZR]""8UYA>
M:5+BLB2C[[3@XQ%A<E/=8$Y%#(^YWBSDDTZOFK5<9JJ%XFT]2X7$7#[F3?7'
M_3=T<W*-0AY7/U%4X"(U^UA]@YNFV\A(,;?DQZ\7>P?]>C^Z63QQMKG"5%O5
M7/>]!0<.&'#^A#)^>8^X,\!IE(K,D6/DRO8PZ R>F5,(KP?#;0\^S<:&Y@7@
MA_XG0_;0W!MNCFHIS6QUX8AU:K1/*>G&<[:L+%C%CV-\E_;A=2@ "^B3]D6X
M8@?#C\J5QC *-J4/Z*X#$H$BO"Z=&/O5[A+Q&)K\]]81. !11%AG2KNO2:QS
MA(:3>\:\*I9Y>LSRH*3\G9V2X4=VM6;=AL6/<4?Z6IBF0UGN3T4TW_(-)88\
MC; $ZFHU\=9+Z!T4-M%/ KM31Q+][7F-_FOSM&4+I=12)?^!EM*SJJ'8L,#M
M^BU/L30SC]>D1@@L'<9X.I"JYMSVZV3WACSW_$,3_X8.&E8@>/IF"]>V86%_
M:D/6SG"R+H>:FHN7[?$"VB&:'@<8(>'  2YEX #A!>4@^Q&Z+2IQJA&FA/<B
MCK16M8[MY!$1#;1KS58>(JM%"<+DF)W=,RS7QI;@UQ;OCK;JD7 ,AR7EQW+G
MDIFN3!U$?X_BDU'G*Q3HM>8(SWQ]2JE)SE9[MXIXNDE..7NW*ME>HXO29L."
MF68Q,:/ A$'!=1:1J#:-7N G4;A12*YGB?F0GY\K^^3<KIEJ[O/!';\X7:K4
M%@<I=!A^V'_/DS+9I=L%H=*7R@C% 6X>F8<T=C4FQ*R([']]YED?T1C/QM3%
ML$)ZE+A,XKO733>_6^JO6[;'+M17X56F]4R61RA52I^M2*/S1UW6AE9U2M ;
M7U8%^6D!?_$2(WM?CQ[8\617S+=K+@&]+LI7_*:5413+"34H,0=:T=<OVRSU
M#!)FA-ZLL;*MI(.!\:X#4PD5QS6L!!H@S]U(2VU[_NL;9XS#D2@_\U%_,L\E
M8V%'IC07-OVX?CDOX![@1R\K:[[O<J^:H]278CW/6SK>M>\:GGX<U_:N[9QJ
M<J;U-YW&^"R=,W+HBHU<32G.B>FN57J6Z]8K]_;PC_KX376#HJI\V@?\?7MK
M=M?[N7(.+:<28OR@Q5'W0P74.&_KL:?35-<<?K@(DF.&C%IVFJ,I77& 'B[(
M4E#@OS_@.8]<IR$[Q42/X !?J@1.D2,I7).'T9A[6EUD9\1@!QS@CS(0NEL
M<\_\UP?.^ ^<\!]8\,Y>Q@% CR$6+\P/EC+$H FM'W" $"+T:QQ /AI_G"YJ
M].( -+G +^;1.,"&X%(;YGH]#@"GC*@RH<9<R%\$)T%&0OP7% -8<0!B6GRS
M_)=Q(+(C'80#?.X-P0&0=_'?1>C=&KH'.3@B.R<3P@$RB$_;/;)^X9&@<("+
MJQAQ'."U.!#S/!K]; &( XR:=T+0%+_H42=9@-:7R79D^A?:;8:)IL+.[@=V
M8'\:;_O'^!.\!XP_/2!"_^W!\P,&#@Q& =LYV+;>*>>:U8HG$4*&.OD="P<
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M#D;D).!JSJWIU_CPW7,?3:Q /J??XEHB>FG2).%XK+N$GBG),C_$G8#B[ [
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M2X6K__S\#>Y>.E-4*N-!_0%[D0<9,@:0A);P<S^D".N5UWN*MP9.-"6EM;1
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MBQ$MQ!G3D3HOS0]^=R=\ZCVK)AXD:C8HBUAS==<--&CWLR^G"XP;G#CZ2+L
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MP@VK[TGI:%PZXA^;-+DB=.#:Y*? +)83(4' L (J=)#MV&\(>/$H5!/E5-/
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ME*@F3&@*^.PGV6W98+W86R,,DFX@]I0,:@_MIS\IJ>6/Q4PYRC,2AMB]"A2
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M/P_HMS0.W8XP.?8P+M#E980V'70_OY&6[6I?GHV_E]RC8"M^?<@M3=#Q]OF
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M=9K_U$10TS/%>_=W,<=_I'O-^BQB*AZ&Y\']9AR8L8EYX_-)U[-_?52J>*?
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MQ"WZ^E$'ZM8//-C]O=CDV+[;JPGM*^'Y[P]9L XJD97;"(?=&T081K3 '+0
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MXN:4&!S^I4 )<()08<DYFQ1+F.:2]?LT&?XZ.@VWLA94P(+3^&4:OO/#3DN
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MG6N.X%?O)2(C$/=&DIO!H^![Y*K1ADZJLCI+0%)V.<CQ6VK# !6F^;6=44'
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M,M1X^Z3RVH@*.,M='GG[T%QO_KRKNAW]7IS>Z)?HFJ>+7Z"?" !;J)\G-)(
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M&22'!VLO8B*0B0T[E9:@69_&_IK+/ O).#-+HM!C%]8P(GN>C#-/L6([&^3
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MN5!]=:FFZP0 .*$N0:/N ^ZQ&([+M^/)B'.=#U05#N_ H@,U3Z[\\G@)G[O
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M 8.I']\$$Z=E&^P,;Y:__Q+I=B7Y7YU+2?:1P_?@4CTWOE@CLT;&D?''L03
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M#WCA.I0WC\/"E,^M(R-FJ@@S/L_OXN]E*\F?O[](<=$/Q$4 S.?JQ.L'MQ(
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M7C7Q"5.OG.!4.LNKJ)B9$A$EX^R5'"3S\_T+,O89/<%?)B$ +G=LDR[XV'6
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MY<)'N!4/K/R,*UE70YF?G#LF+N:RT@.%1*<JBBB'Z;/_:H.7;$+9.!]A<O4
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MS8:*K?1$Z]SS9JN_."G]F KIK.R6UTXJ$!/7B1Y)NB\DR_Y0*2ZG$7Y@Z<:
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MR"QZ7LQ*=<T%]1_;773W"*TX/KHH-E2(U ,B""-&JS-?4HC\'JS)='^ZJ0?
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M-]+,2 :LYOJ=$7 AX0_/V*Y--#EK'(UQ([+]@^@T?=, 69B@W-:0%AD0FDB
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M&E@[7Q<+>8*?4HA@#8CNO2^TF$4 6@F1^G!;::>ET,[YC4\-H[=W;I,!&HE
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M"'#@6.G^U/JIGO-I.$2W&'B6M[_,U_"L:6.7@'$HF:?KM6T/2@P_['+OUJX
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M]EQ+7$),00&KG;9/4/S2H1AZ!KNQD6W0V6628+[AEK()PNDL73TQ=UR,BBL
MT6-/ONZ[O8>RCGEMAS0CSN]WI;F#;=QY?P('>._HSPJ(I:I9Q'SEC<K2;4-"
M3H-)PG[ N68L70$AK4LNZT ]C#%Z3,S[P-]A:IN+ 1QN5J?P6DBODQOW3"QZ
M8Z'L3$3JA#AOOLSX ; U4+?:=.K7#VWQD!RA!D?0YZ"%@C?CUJ_W-ZSMB_/M
M<TOJITPVR8"Y2]':7FL:*1N^B-2*_8N$ZG((T^E'9?LRAW9Z)YPSZOC]&XMD
MA+3^D*!YCY"6I&:_DLJM<$KZ0887011< ]X+?1D2!ZN@]S5OC"/!<X%N[0G.
MJ67OW[Q2@9>G2]LE'BS%_ J:PZD\H)J+[=6C)_U$7VNTG ?1$MR,\3=F'6>Y
M&V2FP WF+04T?1)NLT6L@V;((Y[47VD'E02X<J<?](YRQ&2CR]7"7SQC9$ E
M%FIZ3WU(J'?G6'S%U;_TSJ=!DS>6NX'8644Y*.=5GN@H<%,54>9D\ 9&/<QM
M/O9#YMWATBX12:SQ^L@U+5G-95NKO,RWWE*#XTTV)@WX"_# K\XWV"-/UA;K
M:C^_O?QCTRP- +BOI6"D?6Q:D)/P>\?J^#R#_O.;\'%8L/*.!O$R&?!"B/N4
M7YM8]+=71YL+A-?[2@X*) [%IUT1=\_,1&%?EXD/2> L5BWD4>R=L9_GH?:\
MV@NC1W#'E7.W53JG<E44KM=(W[#X+N__XG'_]Y=/]ZEHH19[:Q,ECDI\XPKB
MKW>=DF,=M^Z=/+1[Y=7[4878,!&RTJ%'#UIG2JY<CY<:*+:Y+'C[/>^+= #%
MCX4XTYUJ[^%,(O[SFXK<!P_4O4;,>2=B#I^>3.<CUGW,9Q.R_3;:CA'APJ^6
MA_?9U<5>1WERP,=BX;7=BFHJ;F0 +]L*J5F#%%K]PR53"474<A3QYE1;0?S@
MDU)[J+F6\<4!_U4'HZLER3P<,D34L=*3;*V 'E(_Z J@W5<:--8ZE'.V-W4P
M\'QON?14W[7'2J]$:])_\A.8B*Y26W3;/:03ZQO$3BZP;*<>2%HX^A.B7KTV
M/&5_?19R;I"Z7;,F&IT?<+$R:4[&C84:&P9=7%4IM+#0\9484(!+#GJ,:':F
MQ!;S57WRCY4X'VTJQ=_7CU8_1:=N+%5,$>B>C>P%&O24$Q^X0U',9I5-3BS7
MZEK:;%P^MNQN[,$UJT9UDSO$&/FG=,?WEU,K'W4 UI6V!A7O9=1;-P:K$4(P
MW'2F(HFA>3_-R[6[;#0N)R1$][KW\,>:Y[IAHHVGS<%6\FNA.=TBKY^:XJ,X
M<.KR7G/&'H4"TD.@RZGSN*KB]L0&+9D<X^%"%V7_C=S$TC<R[YZ;0<0;93Y8
MA^]'0OR# >^$Y2NR#H$[4J4'R<VXGS0"6E>;$QIEY!]#54!]L TK(PP=FXN5
M0(SLOLY!?8Q$G:%U3O"H[+,+L*YR[O!,?K#\)K])VN:)0G-]P\$"-XR]F6/$
M:ZEDV]/4_I=I5X9T?I]N:Z&=#V9Q<WQ/+ZU!</VZAG*,J]5]+OXQLT\Q[UF?
M"J&\+S_((VP7:'^LU.!,\7W=2/%=K4?9X+R?:];]Z76FD;HVWJ_]@>^H4#F$
M$TSGWO$VT?"X(VOR:]%&S;4LV74EN]\:3^D8UM5U\QHDA!M8'T4+)KHT!>;Q
MQE?/E!]7%_J\(CQ=73OFCMV*O[N8-(M=4DNAO&LG_#QN\Z%RB.6X@F6@R[SR
MI8V[-2O/FY)D^>L=F3WYM 1EYSBN+. Z_<&HCJO08_F]M&>BB/7K<_Z:,F_O
M45_NYOK\U9=+<%RT:II3"9@SD22"G%6,D.:V6."'0\9.^&;0^]G?!]=&"S?7
M'C@Q)?5905VVI_5 C6M(R5^J-@LI47<KPN>U3.^V_/:@.15Z7W;5LX.9= =Y
M8I_O?I"6D2VS:33GQ?*,^LU0^0=^EKRAM&[C4!Y&@^H[CCTU2#M.7]+#-V&G
M 3UDP)?4$R/HZO%94K%-?+M/=_S'/4LJ4@=?3X?WRB&@5CJ38^Z UFD3,@ !
MTW?,B=BE&_G?7VX)/FU07OR\"CM@T3N](1)X!R1-FLG:>>*E?'*%GQ2>U)2>
M=4I*+EZVAVUY*]*%%>5$G*83&_]7'H/\KYZ=H2DQTN,TL9.+A:2()*0W/*?9
ML?GH^JOFS=M9QX+F1Q.-ZVA6[$M8*(.^V@N?\UY('H+# AVUXX%<3?.\KJ?J
MR/;!:?R)P6@!(FA!J-;?=9UQIS'J1K?4"&F@^1)HP:%;C)H@;Z-8D TI.*2*
MKJD(YEWA^0BI>BWGH2%UK'BBXDCB.\U%TA&AN.7">1$7;1#U^O!Z)GW6LY$[
M0?)I 7Y4'B+%@@HSL[H]5 Z1G[!O%4J-'[Q<;\NH"CCBVVR&\WR/X9YJ,SAI
MEM@U1L\IQVPAV9UFE2(?.BG<*0)%WY_6!WZ&!L0OG?,/.(Q-T?S]7*Q)GU",
MB^ULIB(^A\@LZ-Y<K?_Y3A3:[WH[Z] MHY2+S^Y!Z_84<@(')^:"Y@]/8Y_!
MUKP26V"MQK#%M=MGJ<3Y0E*8E(,&NT$!SZ^J,G\QXH4)8E]Q6)239V%Y5O10
M6J,\3AZC'"5I*I5!/4\&1'@WW0Z<?9I=Z(B08=H!6Y?5/'Y4>*64EHZ*?JI.
MT5 +^7/_<N15[<$%O68$.,%\YO&P#ON;^]^HN&U ^>@K>Z=OR  2S0E.MXH[
MXMBAC49D?Z-NR[O,T,B%(96Q$=DO>)_)9Y"]QX,QB"-3*(M0'(C;."@[A5<W
M--,1+IL3FFSR"![LDL$/&W25!K?V^3^F.-3;ZU90>4=;<'\NI/A$:=8NGER5
M^BGPURYX9'!JM@]DD!]B4>&TCB7 1;R4'ZS"?\)B015G83]1R 4G#P(!+"$*
M=7CN2!%)$5B;@4MT\>UNX3QW#UZ;7O7NN^WAU)?:\O$U:2?*1)K3\D81W*X*
M0<>_:,,'>G.4==^)J.'+X;-C ?9+O'WGL-0*W)@EWL=HI^#A$V/W-,=J4*1!
M9K0@%CB]59?6IBTVZP1&PW\0#,\P;#^%8;*B)-&7_4!Z<@5-195WRKXDR3:V
M%0VB):.^WOO:'2]G# M7D"\BJ':8EX>43+,K G4:DKIV?G^OB'#\G1>>R,MQ
M/^ZCYD(P*+>9GA=G$G,65Q68<X>\Q$4OAY6KP&Z-$[4*"1$[K/NW3C]QW2RY
M<:MF,L2BZ^@%[9LX"TDT@,1&8&[GYE02.TNDM_(7TCB%NME"P_,<P:5#%!]%
M5I*7!SQ8>OO-<&:1W!_C66J<>5)<F.]6]R?HZ,PTN 5 K0(C_"PW#]Q >G'X
ME7=*M(1VC'TPYBR",Y=W?N,0LAF37?I4]';LYK?S/N@P;[&=KI6+-$=O3-A!
M7I#+N.UVV >KRZ=%4LU43DA>W. [F[G%^LJ1Q8DMZQW[DSO36AR93UHL.I'B
M(5E0E0>4O$98EWFWS1.<PT$@07QAFX6H- ;1@6$B-:V;0E%F=8CPE$0NE^3V
M%0]1GZXT(\0U]U;FT^P^_39]\ QOO,F$# IX8]^E4TMJ8Q=A,Y<JM"W& OVA
M1(^CPT87$^2Z6ZQN$R+G>QH5Z@?3YF<$B<#/=OX*WY)E#.0^O6=9.D*X]JDK
MN7KFGZA"?T"OX++>*UTC9$ Y+8A28_O-S.:K<JB0-!#80)G/_F/P032VQ]3C
MTOTY38_[%]CZ5V6HX-M"90T@%S0.\3G0(#_OY$SW$V.'ZH7V2-L'-J?I6\I.
MT89S[T%TU2[@I[M:8&U.?ZF^H!IAF_,VH;<7[U&*U%NB95AX6):1-PC!+59G
MN5(0C*@99D[P4M H<+3BTY4WK6!;ZH0?C/<.O&):Z7]FCJ;(.9VRY1:"][LH
M8S5[^"^!T<G?1X"*9 !<5_LX3;=8RPEZ2C=H+K1'-T>W.8TKZ4)73B0L7%6>
M[T1U9EVS1 _6+Z<5^B66PKUD56N-0CG7*^]_B0KQN+S]F_8BY5RT\X0\IS5I
MBL6U#!.*T1QA'[\L=]?ZW ]J#<H@14_+,?%G\ =M H6<4H@C]';%D$%4<=?]
M0&TO?34?EO/0$B(K&1"O/ <ZH?CC^E,YDR6UO[\;<N!N#RO>?;""FU_WD?(\
MX7Y&&I0+^^4*;1W%6NGX6[H?5L0T!CI7-S4FF]"W7D].4K\8(9?$#S 99CJV
MQ?]0X'BU+*=\H/$)A=2AVATR;& 9>K Q@7R4_U2'R]XLB0QP])RI!C-E.6TV
M28[A+&7:ZT,K[&"^#FXKP%]?XN</BW[EW4B_D7"H]V0OUQ"WE9T[^<MR%G@D
M?=BS#$3N@S?>>K[U.VDOET/YXPXF=+@O0U1K4GP&KGZ+1@T']5\D=JKBY4F/
MFRG( %0";/7:R$%L5O+QK_&EJH5WQWUN:4D':S"GGFD$YO44-+AX?;@J2<Y[
M9EU@:L"-4I-BC_=2T(E>_2C?CIM(054:Z\Y*5*X-ZD(3<-[+4Q>'[M!R"^1*
MD]?=L>P3#[>1-XE?R%?N3(U)A.O.@Z]KV>)%%EE/GDP%7/!7TJMG2?=0UQJB
M\-294K(O=3E-T)V_!<P<B=>UF@#W)?7!,_OQQT(H!7W<3J\RU;I</ &J1X<V
M_U[EB&IVO-[]D4;AHRQ_K+X1T3*7H-<Z!4W@3>5 H)@G>A<#RX:?OZ5Q+8PW
MO>(%@(*-]&QM#._ -5*-'%CR$AJ6S:5'1I,.ZS?]7[E7C0@[RLA?^YI;)Q5@
M\5.,*!-XH*B-WD3)JV[^+FM=]<B+V%>.,#&W;<;%3&6(,3-?>_2B#IC$]3@@
M60"1Z]ZE)^5@A5-*=%]0M-HBSE@XU=NG(PP>'=+Q_'A-=+,7B;JUH.ANB*T!
M<][_@99<,TS]E(.!?]5>0WBA'L-SIQN&_6DCL]%^D<]T1)3HJBR^"=]X;07H
M6?PHF-]QW?RWUI62[Z:_<N'9U%0F!7ZL$$4,-[M3^Y/1;<ET5?%,WL8$5LHE
MH9LO9B3BNITME=LSN1"XY@]2&09=+JB*<=L0(WX[)^:E2WDK!: []>,!.O*2
MGJH"!U7/UP84[7Q]7=3X$2+'9$"+ C)B;P;6FBJ3-6^IH3>ZK5RYKW(RHS2K
MREO7\H*AXO#!@U6)3J<--.TKO>!]X#9!(P^WO_1E]Y9(P$&LU 4:7M>;' XQ
MW1.Q8$Z%SM/P<.C(@)(1K/HK0CIF8KI!(W;8JFJ6$Y>9 )ZG\,\=\'4O4[G4
M(-+W-?=:0Q9K#V_MPKMW1QL$&=U1!0F,&,N:NUE5VRPE?_KN-?/K$;/&\AYZ
M Q,)I65>T<6+WG<,[F68EC3(6T[6[HH((ZP<PO2M,N;.9MN SGL;,M]6-Q1_
MOVJV&V8[3:"IL@V7Y>=7]..X-$\T<Z#-P@A-!P0\V"/DOCA?W=/7O1.D\N !
MZR"M/TL9CQ1_KW\B[D;V(]DPW@7^?/C*S)U1%W2]ALQ_4E9$*/GC,D"N;#+
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M^(+B'E]VDAXLD:H9<HUSBA^_/^D.B_?]N?;J_#09\_[IQ# \# W;A]K#(^N
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MWP.]^YFUR$PG*']Q*T;Z?-456;^YG:6TBIG,1TK U6&[&&SHCD+V#ZZ4L63
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M[#N"/]39?)-%&?N00(B([CDY(W#-\!@3]Y\(G6.K#OYQ=+ZFF:J%XL]+%C/
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M9<ESB+1W/,;,OL]_LGR^ Y$_'('PZUZB@YOZO1LNI$/"D;PG*S[83JZJ_F[
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MT9!PCCA[UI]4 5L'AH&G2P1!,,?/)'3XX8UHWI ?*1=^LQ0?'S;7T2S%ROU
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M'ES7F"67$$E]>%'569D0?PL6:(#U<)UNX7S!(A7Y^6SB]7*Y2JDH+(]>O0B
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M(O/L^P27=9G)A_DG7M<,C!@<=KA%]<I%OZN'AD%)MQ)234).B!@*HQ[;H-U
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M^#Z3TW_O%ZG_GQ[@H['_ 5!+ P04    " #8.X]:R$E@Y9J] @# &@, %
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M<;Z_CKJ2RN.W$H]U5 AO/:3\9WA^VQOPOZM!J:Z@(!'[;;/&K?W3;0WY?NN
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M/1P05G25_ 2?E%V:FB><S2J>X+P6)&V.$>[11NEU]'4MT(:]QAR]9&\8<_W
M'B-;K"-.Z_"EABHT+&]_2I+Q*%T\&74#P/259]K@G,!&":R.FDY\J.;Z4NG\
MHUH]YV/Y7B Y3A0SH!_TL;O)(JP4@?XI@AJT@=&3=CQS_:$DJ]  ?I5D(;ND
MJ+V$J(]7L#M#O319&T=5Q'/W#K])VY9"D!3YZ?S899.Z;JU.X%N)7C?2L6>!
MLD'\DXKUJ.[.'M0[7QP#C2I!I)NEW6U<H]X1WTSK\C^2?_]6M91K'3$?=Q2W
M07.6'GX)PNR@HU#P+2#5/.[#?:US5&F48;O<*D6RS;7P-X\&U@<LY)#2KLU
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MC,@COP'8!T?Y^B\FP!L0K18K5IJUSX5J1747]'7J* G"CJ3$$]1_T]B!HFX
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M""["_XV,UHDS>^<1UQTA)K*N=ISJXB>2$N)V8KBOM5I;%?BZ$X,W$1&JW+!
MRUH\N?F&^2U%\(=VZ36. W)TLARUY9^]FR<IO5()N:S&LAM9^E4_+V@V]3=<
M%Q2>[3_RV+.4">2Y+I1114>^:9WT-.7C]^5W)AD9"2!.9/D0TW2W+Y\H7=]L
M9/V3KBAWJ2YI;DJ"YMF#V)(2U 4EV:Y2U-,/]V?S( Q,C_*8B5/2%M)FD!FG
M&\'16.8^"THL!CU@.'4B+0E?8AAXF3KK\8;A)<"&ACNJ[_6]B%<! 89C(;5;
M&6X%.,]9^ *"P,N^=,GTU_=MTI3>2KE7X-%@"IP;!K^K8;JSUKJV1>.U\M9
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M-!'MAY%F^O&G.*U)'JTW>G]Y*7'/Y+58N73&EX!$$\,W^]L!IN,;]I-5H+]
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M:DWLI7B# ZF31106_=KT3EGI+%.CM"HL#8#GI>_:_PTF0<JHNGD\RBA>6M&
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M#< PRFB!UDB4>PW/Q6'<&AX@[C>E%<D62DQ&?C3W7_^4^>HJE2C;@9UXV'G
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M+-G4-96=@2\O7/!#0^*U8;UD\R/*OW7N\;47SXJ1,-._>QUMN_X;/V08WND
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MONLJRUU7.?#_=S5$[BYH8;C^BHW]/^6AZMZ2)W=8'7==?V77]0)Z?\R?GG.
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M#SWAMY8+#R\7M!XOO1BO'X+7ES&]785._8$X2M&A'@-L?<F!==N1X2B7E2/
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MF%#N7>_0-:E89.YE<9'E*>+(=O+:GMM[$/\@/\R:/%A$FJ6QO25+VO=J2^<
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M;IE>6J&!VT1GP8%CWFA&WMFD8PD(AI-)QA'L,A7&M_CQT,BWO(,W1D0]I?9
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M[Y(6WVCMSU*17]^3)6X;<!M)$,1O=(WS"L?X\<B:OLD<.G[AP_?"O);2EO^
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MY2L\YO>$#0M-'6?8OJ]50'>5P//>[4!&N#DANQ!CGQ1O KNN%?S97*3#KUS
M>C&8KM;-P(>'J<E![= ;AXY2HBQ8S^3"LV1*-9C\7$.5*CF5Y\<L767__LZE
M_8;_<@4TIQ0CRVL9*B6!T>DXL]/8FY[M4[2KZ<7PBIRJPN7QU+$52MPG+&%-
MFC1U_'4"M@N[(Y]Q 6\X3@L+("RRG;&AF*/P9A$X:*QZ$EB]5F_1UK0XXV&W
M="?13-$DR(GB],M^A55.L&ZISZ5G]8DFSS^E'4V=(XSRJLGRV4LE*)KAQ&)
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MD$IDE/5*;517Y(&5P"6 @ZZEHB=^WO'5NB:8<DT6)%VO7SW@8/O;A,]7:IL
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M-7ONC-IP8+):2^%(.6#0CCN%V.G.&=H"#:W/A.]<L2O..CZ*[#G/LR^7GT0
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MIS-'C-@518GW:/7Y-YX\*G6^J'KFC&AYZ)*AOQ!1U$ON%A3D//<.592BM,@
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M)@ZG?^\*Q;YL>IW9JHE5P.2-"7;18BTJ3J3+-G^NF%E595K31DU>_X9.OOO
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M\,B%N[^Y6^:IH(NM+6YU(V3 64X>?XI_E#ORU=?!<ICRB_R%>(0SFDX1(^7
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MH1^QMETI*FO/#DT+^UWNZX_1XQ0$SL(-, IR/F&07 3 12P90K:-<<B#QX.
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MIXRV, NIS+%O0WB'HL^ED'5W[T^H*\YIZ8ID%,.G94B5I';5<=949A(H.E?
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M-TB)>G\=("4'-I76AFM6J7!N[2#]KW,ID[$&7[D(8VKY\.#/=LH.$2[BBBE
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MWJ3UV=<=%?*^CU,^\L?M'Y0M((MFV@X!?KN;CT5\N>L9,G"3([@AR1W H8@
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M7L]CE1YW.$DDLEAW1B]:R'%5?%NWM=/2+W7BLT173Q95<5>7D&52@(^JP$A
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M.S7X%QGF5IO_?5G43O9P MNP)L^%-/T^W1.]D Z+E3:XD+IP6Y\QOU!LD$G
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MZLMJEM2&N?EOLE.J)%$K,1I8%H_UHHXBZ(I0FD#F#4T1:656\%HKF=$3=8P
MR!4S;O@-2=B(J4W1Y\)IHQ?D?F$@+C1D&6"@1E7V03(18<3H:=7/#D'^WF)&
MUQ#NDX7%X6N>R+0>*E.#=Z?H\[(.85>B<8<YP,-/()0TB[ U?6T3M -I&W&%
M,/4!7&%4C=Z2&P+K2A#^;:DC0GL#.4!8OF$36&19!\J8.R@YCQQQ.W=;8^OC
M;B?;B1OAFP*7 .W#;GU[\IS'^X)E73/VSIN"?M'GN8-R98TZ3>_MS$_(M/Y5
M9I?RPH%_H,_Z6#SMV,?:D^&B%YS> OPE!J)CQF:F[V?[>F.,/_T;Y/\_'/Z
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MHN0-E5XCSD(>W(@1#5F0MMD4-%XZSR8+#*#'N]<H%X?"QB"T-P$AC#Z3P4(
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MJZ$?QH*P3"_R(NHC KC2$,0V5?5/&WR9.XD#F0AR#&AC+R%1XH9_^K+<\^K
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MP2PCE3WC^CFT6D3^]I;N(,";_/\QP?POPO^W$3Y;61]K9\U7DL0UOJ7LV*.
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MK-F- C(BO6,^38VUSMBW+XP$=@,I"E S.<C9)TTHSIJK0N.,K6.NCY]36>=
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M^&$Y:>WR7U=CEA\EBT@)]B=&"]V^ODULYM58"^A-_6A+JCG2.+"TE$U@7P/
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M6EYF\.B"A-'],]K]GT7$XZEO%'E9OEM_P7]$:O>W-HV:_:,>V[KF@QHBJSI
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MU$E[S=HP%5@QW;=@VY2F8O'8.[%_ORS3LP3PF5+,HNK_NT!EC2XZ@"&C=F\
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M"U4____+%XS+6BL0(1ST.XL('3@L04)G6)LP<CA_(>=<\(SLM5B<&EN &GN
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M&S!@A:BN*6)BGP \_G>(FH4@\>GJ;"(MJ'"HY[<NV*F;L#!?:N!Z'2(N=*B
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M3>"(#D[=#-+L"6JQ>XWO$^*%'HTBO0Z>]7HL@]VUJ+GN+_!HO5JA Y6]EZC
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M<-'@UP^>.N,M2P/6Q%WF-SHR65!U!8AA<4C$J-%4+>UTE;(%_[1*Q?  EM<
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M4$&^&2!1SY0,G,2&A!Y;S/S>_1[H.ZYD ,-[.8%Y,!&/FEJ6K@"41R1IA.1
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M1"D.H^)4;2#5+,"X2$Q14++VWQ.7N@>)#'1BTY'<TUPZ?MULSXFX])"UB#\
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M%'PX,(8SD3YA1F(T_=?%+8H,W.<HCCP9[W>Z8K*!17.F%+A9Z&8/3#5QK3E
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MZFIS0 #G#DW-S%:QTDEQT?@'#8\F:XQ5U&U^O9YG9CUUZ+N?F;C(2K$*7G$
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M+WZ$^-C0"; KL]S0AZ'8.C*C<,Q]M-0<U1[W0R1DU(</=)>;GK4X(6%1_0F
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M#7T#_%AN@R+JAU7V]+M 8O! /@/(.("PQ^YN@IA]019O4OR$1DTUQS^QW-5
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M<?H-DI6_^>A#ST-(">X =E\F5KY.\*3ZU&;['-$W6."^N@*ZF#3B);U\+.C
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MZ0Y>=PRMBHZ6EG'^C%BM)65!'/V3IQA>9E1S;*ZF3!G_L@]P_7K]%>GTM79
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M'J'4'OR%<^_R4,0SYWL(0![YI]/Q-("@A9L7:F_"?SD-W5C5QY!C=IM/N47
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M@XO!N]-3*V.PC2[R5CM_[E>X9"$B@RTQ_G.3,1^#.OOP43^+XM#FE 17Q3Z
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M% 65XS7>G\;.-F6'2V,I-R%81C[#Y@->WU>B0Z74:5;OUH,FNQCQ]/W:*@,
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M69#U6#1*7%[H\:VW%!-J!W)3%.-=PH0<K$P7HW,W0ZU4>UF'L^W&"U[5  Z
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M(4/%")U8<N^FF&2\P.'#C__/(MT9>QIR$,)Z^2[W]4S@D]E.!Y7Q^J2]DI6
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M@,#:\OFQ>0$\(RUI36+/Y.CNCP)>_3L."]H+=J9&D<PE$29";Y,'_;SN'9Y
M7PR7VMI@JGUEWB5V.-)D.\HL;'@RMKQBDB; ..$93^8H6G@.\F!0"82/F?@C
M5W0:X70B*;&R2"_E_4^-&,UNS LSNOELL+WAC8UZ%64S>&P?AQ;X0C[0;IY
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M21FFQ(V4BCZWD IRQ%SW4W('E(>U#-D>G8Q-_/%51\ Y[4?:A-E,06+">T$
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MO0&.W^.69%_PW%]_5EDM(:"D>NF=U@L#L8Z(1K]J*C+TX1G'"2S&+T=C5^(
M>@+F+#A3E;OLQ#?#8ZC)ML8%N/Z1ZO#T3<=M"LC(K:NI-0G#,^JD/XWP1_XT
MP=EL!<B&M.G5)3V5# P@:18]XIL(4%!_Q":[KR=AW8*4/WE'?E-(T1A'A%7
MA\\"&'V[5?X]Q#KQ5TYBPTM+L Z+D5JZ[CO0YG[6_>N_E5HDWP[)\W^E0(BE
MH#DT53DY6!LU!52$_W'9B\XHTR[I7P-!,Q?X# II5-(7G\OM"WTP)LYU:\2<
M,TW^DE35(UK$'.\8F0Z?3X)"I"Z?!0N(V*U= 6Y<KEW\_< Q^#]E0H,F5[L%
M>1'/NEYN9^G_ZV$=L?B4UY$&YX,M[I)(T6GP4\BG@P?1)K7(2L@1[ZCH6&:[
M-%ZC+\<H5 1>-3P0*@-VAMT[!:$^;JWI-4\=P%QB'F7U; AM<J0XB)$69=W2
MWKR[3!U8M8P0(^KEKQD '?Q7]RYM]HU[W=@Y@KQ4H\"?%7JN [NCA*\I:\?%
M&Y#55J69<*.P8K)0;Y8GJWW?5]#-W \PEL$@GICWZQ%?:)^_X'+6D+E]PU>3
MS^O,%OYLBE =3>$E=OPJ8;=3(%T.",QS<ZQ*/SDY6I'_P2=S4@L(0P^/)^N/
M=8B1TCM)P?C-1.R^F!M)!WLGBMBS/^J6RG8^WS;-QVAU+2YQ?0!%$(F0O5*T
M2A3?/TL4[#DRJ>_,'5H.WI$A8+<-THK#[U/UR'+9=@%\YJ@5/\%6I:]A;6R,
MZ6(4,EV;IS50):FJG&E%[5B./8F'1TKC'",:2K3RFOPB%#M2:6(G7IQT7ESE
MSJV>B"3SXU%8B%('[VS1= %TU"[LSGQ&ZN1B47;#4GY #>[.*WF[F#-9"BL_
M$\4J#+G5R62*-X]N94R/^ON^?\1V>^Y&?=O*(O)C78\!4RUO3K'C%/M5I?W3
M^ .ZGRJ?YU*7W;/\%YL2O>>DU8J\IS+Y1\);A#9D.T<^G96F1%H? Y[JLOV_
M!=5&&"O0GR .NP4'=W5<#Y&:PG O(?=+I4HKL:! +Q<W#P>+,,$'@G)MP[Z7
M'1#35WGS)!N$$ =$IW]H$B] O/EW([L,[O2X/7?,E)Q"L(6:->5N8ZR,0_S2
M?<!OL^2^$A>^(38"#F=O_L4=_ [-([\APGHTV*0;<&,LD'H[FRW2*(RU.\0'
MNJ$EJZV([N&Z87PYUR88G^$':_ VM6EL.KM#$2>QQS@4VL,]S"<]&\0H<NDF
MVTTU?5(Y+#71]#-W+H5)M-4IM"WPQE?0_2ZC[M\]ET5HUY.*+P!)%%#%/ X.
M[=&XMJNX%-BK$OK)OQ$\/)T.N1V;.+OR@/N;9]J:8^UW4T#]@^,0ZH$P#BF$
M%X'IBNTBG.\4HW3.HC(M@[.V[6:,SE=M" B8D]XT<'ZK(+^?9L:M266YAHL^
M^'7PIN,J2:F:P*O_;%*X)0.C8GS"5P$[.?N(0C=0153@*B,$M[DBANM'3#"T
ME^H<_V:>W](OW,%ZMO*.[EH?+1A6V'APH_9FELZL1C>M&T[E1J8,G#RI6L:^
M57 -W2L#K(=!C7G@A=UA- UOBK0#@PA+^I937N?#^*TL^BIT.<W2HM*N@?B&
M%O1EI*BJY2_%47=UX3GO3KR%A\_.(7S%BAP)/Q=L@?+J[<\9H6H;I]:S>(+%
M9BU[!C8-(:P*0\NPS+U[MP3UCY5:5I?X,5EC,;]L'XWM66!IIC-:/1.%WEP>
MNY8LOW=9G%_*BLV;CB>6$SAWI[.^J7=^KZ^5'.;)X%5NU7NCO1GGQ9X/]%VJ
MI![!J!;%*9GR3?&-"\W_TRR<22<?R>&==-F8HT1!U3.O9PSVS :Y+#-\QE?T
MO+@)>*GC"66L%+KPQ)\50RI$?LMP'."2/CZ-\=Z7IFB4V"P-NZDMSM8:*K3Z
M9C0&BC%P9AZ:I 9\F'9$+Z^=@,D^@86)*E[BSU+OI/Z#]V@2;>%)Q4&#A*&*
M[>+?PM'6]SH1E]TW A_6]+>]C*/3)Q[@$_/"<9A ([F5[=#;G<IS1Y7JSRTM
M4Z\(O)=(3AFX_%2/0U35*DG"G?J;WX(B[#KEY1R!]+ZMVKWU5^^V=6GT+T-%
M0U'BS.P'MBL%]+MO8V\9>T\)O[=R2AEQ2,=_;)4*C2%!!UYOI*S2(VRP4##\
M0Y^<C:4MQ%SYC^H%P&$!:^1_,DC@J%/Y9'<9\V07R?9-."'=?6X<=P(BV]^)
M*G<_<L]*7,X)>:%0$G> X4[HQWY3>="("FR6A-#+#K3>O^;1HV!.8Z;Y,PRO
M0U8!\:B"VFR-S< @U9TK;C.HX9V=J CBO<7J'(4Q@<6R+RP+FE<>?OD<CL@N
M)H^9M?[-^F69/J83KS=Q3$5BQ=3 LY:WGWY=\E!6YBZR=K^QJ&=Q'R>0_!BY
M*1SZ./+U''+[ M# G]00?\!KUY']I2-^-3M$:?)PP2%S<;NU;Z;N07V<EI1D
M(8NM59+BY#/J&NR2?@$YYL2%[$6H(.^CI)F W9Y[GM:3:GK;XH9.*,?9?K#S
M1UUQC.5NRGCKJD,TK0JC,9[I+2J)B9RGTS:)6%+%-!F%?+W=\LDN.**V[*/!
M+:!G 6?CQWNFP\^:;YO0I5+$D_I5QO:T"'=(C85?=KB3HA!WH6XW5V(J7>O?
M\)@T0XK?]4EB1IM#(EC;7BY6QGB<]A.;]NZN=;X[5PHD[J?P9D1&G11#%;!-
M4?["8%55]PV=Z>\%A[I>+_D(]\/KWUAKWWK[B:UB[]0XYI^R0T@26WY!@ ]*
M01"?BF'>_GQ_WV"UQ=-718Z*J5:N@8$A7ZD<#=4,1;/R\9UO0F\0<T[*U3-@
M7[5@Y2*80&Z;K#T*UMUJ<5#F?=^F$LG;<>#4ITI9AO-R!-6F??U! L5H-6E!
MBO^=/:M_+3)O%YS$,3*.->(=1576MN]H;EBMR\G1N9BT7?I:0//[%3PL-H\K
M5'0KE(OD'5LUC'<*"UL5S['F4>.;W%#-D3K9=T<J[+BEE/C(?1+^S!6A8],3
MT)^I>!P03RSMY6;J-2=>5I)?(AM6%D^!C:</JJ3CK;]5(NE3@_@>9EN6/9LW
MZTD  #8:QA:2\+-)C,1([5Q"\,:4<VOK- J,6ZCB,6Z!9DLK696X)>N*.],Z
M7OTJ,"18!CB@B.//PNCA]OKC>QIK4X_KHX?X9 _UWG </[470(B3UPC\5SR6
MU69^J9Y= -A&USBC4:M+M!N_?C )MZ)^Y;177L7\?IJIERT<I?F<23PERLG>
M!*%(]F7J76%8A%0'W2DNV^8(Y$ZO*'_1XUTM^NK(X"MG9H:HQVVGVIL<OLS-
MTQ/G-&0.K0ZBXEY2S(OH@VYNSW]$I@3B'%"#2KV_YD>3>2 BJ+M\ELW3\AMW
MFU^5<ID4@]'+.NAY#8OM;R-X!=O,^0=1C AEWC#/2L]=;\&:%$GD95)RZA(]
MM]BSYP9K;L"]J_/8TKV[(2&BD1W"'MS/7^=6?X%+&6883#HVNTNCC"Q,8XSK
MX!&5J4&O%'.ZS1B$WF90C]QV^SEJ<>)*]O]';HT^9DDN%:G8MH_FM$%:^_8^
M(F$^M],)],[1SD$%J;K7)H:L#+GZ/*#\EQ#T56"/V5,^ONC[*%4H@^'Y@$)C
MGU!M0+  ?>QTET.@JUZ\P[-7US6_,/$1!P:DX[*6]O*BN8<-C:"VTUA>#LSK
MO&C8,=3!A>;K:! PRW9T#/NY*,KA\>"-Y*%;#DXBQVC[,TUX)_X\@Z2SW?B'
M9N\T G'7Z56=M7"*=EB5K=IDWQ6FNW=9@P+@":FKBS=XB?3'1J 3!#$ 6;#%
M[86#OW<H6@3Y.Y7QLWL4/GWSXUDJU6NIT(G:CZO]S@M=:V_BL)N[@\0YS.O=
MUXWY^/YT/$TRV&]:JK!^R5T+%5975,!"\J*R=UUML=D3_E?'6Z%*)!Z$)ZGR
M-6#*B01[AXK78 ![J"163LUC<9"LEVUMS3*5[R;+<O^X/[W\#M0!<GCB!3=>
MV\1T\MG"I7O_*%,$)9'0#'6!H%^=M3:#+M?S2FR*LY9%FK W<6,YXU^#FAE$
MK^,"E9$[_/4KX;^^";Q?,VB)*ICQ1J7E#CQO:\C;LQ!)')3KN]>F?^>06_"Q
M,PW/RZ^T39$=S'!]/"4+3 [637I\/CSU),FY=E@ %*PMFN5HYGK[TBJ+SP>4
MWDL @,__#.S^RB.7:H*FI*(:$BK8.GN\Q-ZSIC4'.ZXIV3]9OOLC1=)52\Q
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M%@*!</D^Z_?<]Y_[KG7?=W)FY9PS,WOVGMGS^>R=W,_=KP$>JRFI*@&PL+
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M80&PL?ZW_/^TB^+!KD<X.-@X^/_9A?7(Z[\.%#BXSX3PGKS6PC=WH7PN_(V
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M-0EL6&N$\9S2%'#>"*=<4G01L!8X&QYD/VWJ;)](MT6GAK">G9@8AB\I?(7
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M9[]@WWB8GR$9ZI*W+Z%/&T?G=&1E^R(R5DTZOEQ8<BUX(DSF>$2DG$-6)+A
M.9[_IL3MI:.#I_SWNU#80]1 S&9XCKQK10O!1EJE^E,S3A>!7JOT5Y5-R.B8
M#?S0-A>7JEWID%)_(88\X\J49T*=W[%Z:@16KH.9APDZF9"LW+:^6_> D$L'
M4TWUUO@^S/3M7Z=GDE9 >&00.<X3<NI+:"=X\=%)CR\R"3Y&O7>:D;$7/\.L
M,>RXS/:XF#VF417;-1;/UR)..$(SC;G9283<F*#V9M)]:\2#8QKVD*,X:C*-
M&QO>E<ISV7E*;Q<Y%JZ2RG8BYQR]G V#8>_\_O"J,ZU]VY6LJ@WDN>6\!_R
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M<CHY^C5MC\F0)T_U*"RHZ3>?W0/BH[ABB\\!?SZ[Q:A-CXN15Z\^LT 7R9A
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M1>_DW;JB!@).\_KP=;-9:_:0>YN&\\=C22QNR8>F,>PQKV0,_JU@W97(XF]
M0H50X'7_]TQQ?V(U>1M/1"7, P^#!W'C4#@(01_\:M1,?&W%USS]3#O0H(RQ
MNP:K9"_\8+1]*A/#P>%^IX6$A 'MQAZVAUB66#X443DYUI(H$3_DS/NE:Q-@
M&5?0W8HU6>GY587ZK.JKOXSSAC.#W8UG4?G"[HR7\''+5 /QCY]LK\]EG-R"
M>BRQEN*.'3*929\>&(UW*9#3<SNNF)J5&[:-5DKG<X!XDAD5;2L6MQ\<5-W_
MXWC>O_J3D.Q'V>0HQ7I4K*F)T5\6F1 ZJTA)H"#^MO6.&ZM%$HKU-*43C"@1
M<W[0[[%E>K]ZUGQ.6Q!-PI8U>4R28:@!X[<%94V-0,?<YFRR]-P2TQ._RPXW
M\%&D\DPV]Y#>T)"S5\JUX]R-SOH]H(_UT9P_?1W*#G%CW*ZI^81G),"+D7.0
M71C:5JI>MX;(>;7F2YY10I.<)2V4PV)X$.!Q_&5#*$FH@5KM)P][/(@]>8#5
MT)_P8<DEBE!$ K@H#+ZX)Z*AWDMI=2S$V.U/^%M -M:"(,%3DO/9XO% X<"Q
M>P A[G$)G-@:JI.FEEA?WRQ<S?ZD] J 8_)5!8=,VJ#GPB!+%O>E:OV"IGMV
M:(URF(MN21>94$)0;4+49COSZ$$?E*HJD,W_@R;U_MJK#KNP@C;+VLY'@@L1
M!]_B->G9,TG6VX>0M2CX6L=/&.Z$Z FI_8YV:ZB6<1KE89UB#8XVO^ONK[/N
M0H<M:0]'7EFF'+YF3\EGZ9^>J35PVAP%OKBZ)@8K8/Z":63Y$"WGO:3K >_V
M?@8P__X&&^/-":>7(%\NLS@A:SCOI3K0UONU-V3MNE:3)$@7MF['OL6"MJ_8
M6CJ4%_0.[^_MH+Q5+[>+3[M #_4G$](3T>C\6XN,Z:MN$ZA2AT,H[:2G"&I'
MBDR[O<.6Z?.^K+%^#A_.C=:C*W87RK(;+:NH<[H'R"RA(3VL3# <?\/)^M8Q
MVKR[QK&K.) I:"GMN4744 M%PU2L)'MPGZ+!Z<X1'V+6#"6V3DJLW!(@OZ[^
M\O/G^H[JO\&VUY2X!I]*Z)XZK7D 3L%46F:0*;LR^XMS^703U8CXE&;B 2.8
MJ5GR]"H&/^ZDHS:FWY$3SI]3;K?R3+@W?]_,),*#REKSN>Z2O)76[Q#214EN
MR<UT*#+F5*!+X+'M/< 6\9Q]A:U]JG?Y<N*U"QV7]ON-JU]8*9:26HMBY\LR
M* =P6?\"6G?!)NVNS'@?HI7X:;W*>J;T+NTRYHC\=+%37AHE8I=CZ]MMMI_K
M8.T'J1UA^1?N]63TF^\-I1Z& #,)HV] X)@1HH+MSPU?4S1%[U7<HBR_LB9+
M/2;9\GV$M4;VW?*VM+XA9MJN-'!L=$=GK,:9\K*,_6APNMYA1#S@I_.ZYCSD
M5;;ZHCJ=0)&4\PMUF?FI[-^$@G/ UV9&"-IUFQ]MC*>3AJ<T.9Q(SM#CY$-C
MKB;KLZ1-4H;/8>*">4Q?A,R8%8G)J6EI7YPLQ^E(EG G[G<ELOT]3K2P7,TN
M*@V<6)$<ASWSUV^;$26N\RML:!-BW^:,<='KO#;!GITRJ/'_B+I<BZ'!C!'#
MVT4,["[[&FLBYQOR_^KEV0X%;8F[U%]89,]7Q=OF[RH65VT)1SN:"?>H<J /
MSIUGT X[,SN3]X#:_B-*^%@HC!:&& O?BA^=6A(;:5C_,U'(K"OZN9C8@QX?
M7R9L UL*)GBJW"DGL2X05-DF5MCK 4?;'5O-&!RZMJ@Q?U 2UQS"E8D&_#D"
M2^FD%*AW]V>-2)3DCCK<F='9O1'^T)!A8#\B8X:VLRDL1JNKGNX<+L*7?04H
M]B*H*ZL(5VD3;'P?2;PKM_*OAA AR!<X-ZC ]+)VU'=)Y<GIIHFLU@U&-=N2
M2T99-?_B?2W7L$[,C%6F!7/HU-./.H0^G8?/E0(--B.?+R^$-ZQFESL&N*!5
M_7T1RCWDWVML6\BJ9Q?BFH,4R.=?Q-@7R_RT>05\[O#_8>\]HYKLFK_16)$B
MJ/1F5%2Z%$&D2%2D2^\@1$2:B(B ! @$47J3KB @O1/I2 L=!"E2I0@DH4@)
M))002$C>X%V>N_S/.>]S/IQU/KP?KK7,OF;/_.8WLV?/#LN=>>\7VWGZR1^R
M^ ?G6]$K2('1+"UA0V///0S\7=4&E150!X@!*C[:H"H66L67V^%U7)#>-\W,
MD]7NLA_&-"JK!'*"I?".H;9(%TUXVLD&5Y:A9[?PDS.JUKC7[<:*(H14E);-
M_?B!O!DKA4\:W;IU:<''CX*X=F$!H,JEH!+H,?: I@N3#6-G[CFCZQP4_I9T
M#'.;?J:9%:DW>X3$,H:#ON(X'MPKD\)X6:UF-567X7D1H2"[TR<=Q9Q%/C9]
M6&AX+[)QU6#VR%5NFI_"'8IG"5MM,YP'&<X->NZP,M*-FJ3RS!#:S4NQ@HG2
M$QPW.W<X'KS:AO-GEAO&UM5[RI2D&!;IIZH-O9$%2BY$QOEYIPT03:#WL-2S
M_T!(-5=ZL%A4A@UC$F]%W_P7]HWC%1(<'C19\)MP<ZP,!C3GP@UAG&I+9W:F
M33XU)&N?/)$7-)??_/;IB1C<E^85R*TB],J+H02!VGP\K\(JLR:SP;G8@Z7V
MY 9P#P50L(/$>:X-(^6Y"RI+A'C-YS*F&!)-9!@L>([@T^/]'M6*3?"CTH,4
M.59F^)+:ZV*&'S4$L 92"V5]6,4Y1>5'<E%5<U*&Q"OV;#,Y#2N%<)VS=,_#
M ]?BGU8-6\(,X 0$2AC(!M7&72W+U; ?WA [;WKEL8"9CE+ $6"D#P70DAZ5
M1H>-7J, W)!])B9.O@YMD*(GHG:^G5I$@.W=AGD/Z<U(5OW<'%;VP87618]/
M[T)1#Y.DUE,WG"UG]3O3\Q\XR@56[63G<A<Y&CL\UJ55U:=+\SW%BI<"5GJV
M1H?[L567$\*M\9JUP0,\8T,]KW!!D.P0=EW8L9U5,,>W>\L%ZR*,MA9BBY%2
M.9S/LDO?[_!'0BV)((>F8^,B4,$<)=^B'^9?3A?G]CB>%^14,SGWX$4MORR-
M@JLIJ)P"P+#FD41KZJD-7:+MMU([&?&9N[E*+A=U.22C--YFK6\RV7R(3G,H
MP&LF=*QX4 !/QZ,N<23K1? 8E;#:NDCYQOM)0QD(GL6*54C1:_)]3_"VZL\N
M5"9+UQC?]#SOP W@[.G\_"P-W0=R@H59<1!2BR OP PKX$D]LQ;)K[/VB:(Y
M[]6 #4;\&<M61Y3O.PHT.26%]N,XDIG;;JJ()U2&5?<?[.\TMC913P"!.W,P
M@AV8H RJYB:?8UK3^700O18'*YF*<)FH.$\LF@\3RCDA#,YH"^@:;=XB7DZ7
M6_#$[&:M,$T,H/+:$*\1C#ORJS_T2A4LH>?51?3'G*<,GH>=O=KWX0#E%IV>
M7J]/'@!576F*\44)NYQ?<6$M.6A[PK:K(GC5=,&-V.VO^_5,!"M'\^3TIO!"
MH9"E0,_NBJ?>@(0I[%'!Y03Y"2=[W[VJ<:QB"#:],YV>Q$KHA5L2'JF.04\7
M!WH]JGF5X?/RR\.SEB87Z6\>>U55-V^2NPH\2P'8B[$X]:*T]"ZDFW:_E/QN
M&8F)L/UFTNNV/K$,9M53']*Q2%!5@*LP)E6\R?#)'AVQ&-?2\3G(1CB>:A)1
M<LEP$-=R1*XZ0L=C7:O6LSGI7KYN!;PX,A]+>^QH ZNCH$F.X:/,XFAASO"B
MR,)58\^G5;DK[%S:64Z^3OP)'DY" RRO"99JMJ!71YN(%0<E39PZ.5,S#U:U
M3E  ,9\Q6I$M[H^..+0=%QXY,L[#Z+2U'O9^V& :T^L&53'YFI^]5]*X#_TV
M] -"-$Q'L31)1.F(&3G?7A$P"S_N2VPEYB-=?TJ C7Y 801IW.L[E3KGOW,+
M=ZLH%(5[94N4 6H2I/A>#MTF+]_D9,7YLF@D)[RF339IV<J.S[HUDC#L.Y#K
M=YE0/Z>=CMTP'FK@S&[S*'[0>6YR:4V_HGVJ172Q7X;Q^B#1O1!4(8:Y:(T=
MUTYOL[IJ%A5^N42Z<5KM\8VUMB5CO2]W5?STWJK/+46G"N2LC8L)2Y._PWGN
MNTIE<=PL,A?JF7$@<I ,#](;CGBXH<08EO6><&U!ORFYV,MA7IS:4Y@[=_'+
ME]LWU[Q-NJ3T-"069%T_O\%-%^I&&+ID&R76(YKQL D$&D7B'G5Q]I#W>K9]
M^G;1_0LML;3L%]0^OCUU82[ZH<]#HD=7.WBB?[7]=8=D2?VJ#PDS^[">,TYV
MVF9J(7% /F2@$6JD+&B@[RDO_GF,CUY9US4"5?6@![\]>GZ4J$(>M$?S+N2F
MYUKTVB.GV"4[XUXM#@AR;'$<O>M/"S@V'3=^K/0@GJP \41N!.^4T'1X+G;V
MJ'?T%0?1VATOQ\2<4G[*E,"DO=ADGYE^:6%!(B_E40%:L>''TE)5=54]4-EO
M#,CCKA,:\]-<-4@LF:A9)>;F*O86=S(^,A_@0;-@>5"V-43N!U4FIE K^>V4
M5C_AFD1?1M67 :B;[0&L, 1WGO'=%Y OO><EAI<T!'UN;FXF')2%[:.[KL:G
M)2X_&UOS?7W02!2WF+V1F5B].5WSU9IX!1>M&'#CO"FIS$K&$3U 9T'^-N8G
M,.S<&8Z\Z8**X=.TY@B3CC1ZIWK>-?'$)]FEL8:P! ==S?S5Q5'AF^;Q?+U7
MQ%[>J+?<N47$5Q)RD.FADXA@6^Q8I@='\=Q[.]@EM8!$VPO0E>SM6\+-/S,+
ME)7->&Y^-<15+83DQ[[ 5(_1[8\C05WPXQ 3/"2ZS3NJ%+L:8V[5@9>N?!\N
M%:O1?2QPHMMCI8UW=;Y0Z JK*&?N,:")&+6?BG7.K5K#+-:?C\'RHX_/GB0]
M\N [9N68I+?'7MW]_.O[XY)+D3W>]OF773]$9U9MA,(J$%$[:AX8CTM)1KJT
M6\7/$J8 #]7X+&-M - )'F^3CDK]>);4_N*K+F!:U152V0<Q'W6K@>Y](#[B
M(*=$\=*R(!)&WW*ER;^TQ-55\KA39+! 87JKO[]7RV7&D[(_FXZ0AV8XAQJ.
M*W"C<QS6YD+GHA;FG$)R7X5^U1<*@##<G@MH<(WR,\Z,MN<V'9(=D[R9%^XL
M*^UDH?FRQF9MXS3T)4$,VV5678:-3)HHWEBP@166-! "C\;2]#.4)#;3G?P6
MZUO42_+"M:E4'>2(*'A^_#PF56^*CBSC;K>\K\7C3P.8I[G9O2+<[)!=D%/@
M4=&@]<0U-XLC_XNZF7G?R\T57SA*)SP=H."6;P8)ME)N&BU!T<4\^#Z=>"RN
M;(1)%*M.;'^5)IQ&."#>)?"CQ%H*W!O/[^L5/?A"/5-,;)IW1YXR85"Z\>/#
M$9*(;]%\L@#>D=L(Q:!E:ICWY41_\:2QRX#O0!8%\$B'LR^'L*6+1=,^KAQU
MCBADN2[RHB.6 QUX0O.HCOX9;Q,CHAODNX@WS9N/?NIRD3U1;?$AL)]MT=96
M1D1ID@5VH.7 WFQD9^KTW<UUU/&:*A\.M&]X;>6KFCKT9=4(^XQ2)31-.S-.
M"<56A&)5MZZNM=5TL+M0Z2H4J.O:S,]YP=-&'[TQ_9,\&"D28VVX(7NK7F67
M!%YTK5J#50R$D'D<$-BWDR2E\@"4<-7KM3@MN^$]'^B ^$E=,]KI5#D,GA4=
M;U3E8;,D7AL<6%BD(CB596)A8>B;DD-Z3A#$>BJ/I#</JGOXO#AR8U#Y!</7
MSY-<ZEUTDM[VG#>/CW=SX<MD0J3[5 UKC2S"5T.O/3;DT.WO"#D_(:T2IA<6
M.A'YM1"=Q:$A)!'5(]1K\)VZXX#"%-D)OAYP4TB-MM,!OUF4P(<]>LFKK12
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M.9 M1[._N-*CY2TY)-._TN5H%^?P"WN=]X#:WK_GV&G\(*QG1G6\#[>%U.F
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M:-8GQ!+Z(YY>U&\4>NYM)I8PD./'#WG=W,0U5-G'U!&Z.%$>5%-]5CY"Y6C
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M)![]#SNG_FZ' G!$$@_Y>W#(WYOQ$KFF%2J!9[%,!R=(?Q*81.;0:09OL^.
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M,<$:1JO@!U14EP@@<H#YT@$%0%WZD8?;5.0<!;!/ZY2^2P:2I<T4DJ@4+%
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MOA&.S!?E;_I6E:I(:^.(-'*\M"73@PS/K+.^?;""X>QS5;P:20$@,5;GY"V
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M^_ ZFMGF(T//]%%57BTW5;$<(>$S'S_[AGN2]Q&H2-NPY)3LA0T?90K ?YG
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M2O"&V_+7&<V;=U>RV=]*?C)N#[_(R=&EX &L@!]^B1E.[>,ZX$=6N5[&.>=
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M(.5(HK4AN33]N6J_"M^YF^DWF@I1A.Q@^GM-KM';CQC/\+.IQ?DN-M-_?22
M?AY./45H4K*I]XU(-$Z0V9\P-BA_9>L8; /EN/4[CUV^ZE>X\&W//[3/ADS,
M>U\:LO .LW!+I-WN$]?&!E7D;A.:)\K:)9I5^O)]D$9L&KF4',T7._MQN5S$
M4' 5Y(TL,_&DDY#BX #N:8YT#.W\9[^N57-K1NOU0.??T#R2.'5R292X1M*
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MNMD/8E@$+^L%0'KBF@\?T3TSH/T;?GAE]OX5MN34CDHN\TQQG5,=);O]PC,
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M-;<X9OLTXG)SVWU1TY+>3LTZ>*]86:N]?5[&C)<BT%N9MW%DS2<#1!2;0=8
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M3,E4AD2@)).((+Q+%YRG3:9#".=;U3*3,'D?B>+DN2GTN&]-7*B<9D ]X:-
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M6I[)!MI#M2@EP!79T!">310H]!@N (EU&'=.GC2>> B4\G]\%5."379X)B%
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MP4C6"L9 1D+UW%-]2RIAQL/BP0A0%0^!'QB%H"$R3D!MB+>I#3HU6,"@:>*
M@(5W!-P.\O#XPVW]+H-S2"/<SS[Y9O:9*5YLT:"+'\_DXD'-KQ8V++%*?</U
MO"C*QS%,9?#\\?;T!,*RT?H"<)1T7B1,Y-G ]7#!&;&S:<FR24XUT<X_'O40
M<7>C-_<IM_._8-X=F!D5UKG"3ILCLQ919[,RC"HLQMF:JHU<*&&\\^X)G,?[
M#&H.)'$?4],M&%5E?(=Q^K>ZZN)EUO@/#$_?R82.+_] 3,H?(DE=NH@J@;-"
M]Q>0K=3F^F?FX7D]?F^X0'[:'6*T6T_]NZ1W'C1DMAJ[=#9/!1YEX&-P*ACA
MT,<N-.I9II'R(]KC>M)^\?$9GZQTR?MJ,\/=66^X;.Z_$O35Q"//>(FH.7)\
M(,Z 1&,II;2#RY"-9&G' $.)[(;6447*W>>VZ*!52O" 0\5&X4:IX&JT)/<)
M' 7JG)JVJQW<1E:?HOEKQ$M'$ET&=26/AO%^KCBQHV'<0(S-S[GV;]3/Z!3B
M.$W6^QZ]\!+@Y/"-@1C#!YLKM\N);:O=/A&;\MD8-@DSB76SX#>U0<],\J4V
M[U<U\^2[F[MP.0@3Z+_'C$I+Q ?K,Y&S"7\O393G@ IWPJ_@:Q?0DX-*[Z.5
M<, PQ[<US[*L10U;?!:=>Q8%W,<OC5RM/'J,.^#%V,NX/4LEFJACR^2'#>WC
M^95@.E_@OAG" 42:T4JMZ O I0:E(G6!NL3P*MNJ7+N?UOI-T';@<83CR0ZK
MP9_F2I1_I=8G"%:'AAQJTY$ F9)^D)ECTNWIL-)@;OFQ]K4D)_]-/0_.;%OX
MT!Q+.=9EN^I,?(W9$:Z/S)ZR2]!?__"(U<LY_/22T06@$A7EH17<_(\_E=*1
MV#PY]2 MQZ3'TW-9MLGX2^W+]QD5[(8>%,5VAY\6"I]5R2VKO:\^JS=$VC _
M7M8T>=AU 7B?"7)LGA16.$^&B>7 ]/%@]SRHS@4 /'HORA>Z^R;^E>GG<N4!
M]=7W]%_*;K!\:QT<JS-/Q"XN(MN:+Q-T\3'?UKRHV4/81F8<6N6[[5;O/YY.
M4%S>GFL0B_ ?81+?0V['G!FL@2I1P0?((."U[4,:!GOIZDRZN!D5&RZ^WM2"
M^[_HFXZ8DK[P?1SP_G4*6J3P/R@-AOPHR<8((G1KJT8.D#=-UH^]QB4R-B B
MWK;&3Y(6J9.D+V^(>'/2+UC*_\#B;1>RQ@P>E)9*\I>C2LY,=[.WXHU+PC2O
M0WHWL?(V>)8<O.4FD5)=?+#U(!1_>[S79A2H?@&(YBBV?A7 GF[T\]'KFY)D
M-<N7F]4<6A$6YU2MIY M-(9_D$)EU6BN_1Y2!ZD9U;NQIY>N9YU$BU[1OYFY
M"@>T=OJ.02>K.:<7I'3@"TLHKSX_2-+:ZWQ?:0.B37].[_DM;27ZA33,O[J,
MB&)Y//L, C,N.R]SKKI&N+/(\O5[T#=(L!W"\Q.=2?R=T(]<[M$R]SF[<;3[
M!F,()I SM?#\3LC\IF_S-?ODQ&B"2L[T!A6&RFM:/"E>82_'+2608N;#M1YN
MFLM-?OAB')D2GN<"<$52BP'?Y>V!I)'X&K+=;..MC"H3":;\4,;^FK]%CB^Z
M<_ 3LU:[\'1]"YI)_)=0"1R(#U&J:1JINN3\6X?),4*AC5WQX>ME$4:* 5%E
MA$+^Q^]A\7>W'A_!>OO/^H4#+@ C\I;B!=JO[E:BTJ>FE0CH\9!Z&.=Y<S'L
M+4ZYO85=&N]7!!/#W<SHHT_U28W8V)-XSQD2QO-LR4)S^/J3A:8D7%>]-P9Q
M=3-Y )G#9G^F59Z\PR;U=B]R1#GHHT)U-9458'Y/">Y)<"39"B(*7573NBD<
M?'75,/QY;93#K,E6[+-PYAFND@E/ RKFKFZ!J^KS;@X'34U>8NW#[=)BD?(J
MW%Y7YY)/-O,W+/@&"E)-:V/?ZYSX3;'?.9,FCDL+=T=_9%Z-VGE\ < KCSR+
M]1PMTD!-O:#M9DS\C2X3I60]'^K]L6TJ'(B8_R;-GHWE,<!G+D13S4 =U /U
MI#53K*YLS [FO^"DV7O+2161NLKAY*SY"$(/\VH8![T%A:)9X$SK#+OL_HNA
M]V([K7[1MNU?O_MZY[)X9S,*1;\!J99LB=3"&&S%82V'61AJJ["_?T_-V(IF
MK"SKJ]AT8T\"GL^HL'SQZO1%3QH*VU$1Q+-JQ:=D:Q"^]M+I7BA7UO)=\MU<
MDTDX<WH:!8%N:E$U1;T)AVA%TN*MVI+C_)V*&[;O]X;@8\ROC>%7*5>_;YHW
MGRG )QB Y,Y$1K\0!0C]>I-43-.@'_4%8'*<4:%F^GX@BW=*POPMT6:O4EE8
M_YD5<0)-#9>!7:K$(@*FSO1P#_*];-=S(N6?.]R/C,V*G^HG )1-9!KY[QP-
M8*-*L<T8FJWJT[&L#JCUU9K1""NO.(D^R;V*5)M;O10E[;I:@NUZ^2I30QXS
MJ8G\+B9*E8<H1(-;Y]A'>S>]%3"/KZ#0H5FU?/-Y+LC^XWFJYR[ +J1=<($!
M9S8SWJ;@=V1ASPFEJY:M02-E7??.YQI0<F?*Q!EFKZU%G(,:UCD7HUYL.4?Z
MU8C)F<P/[MMB S%/[_%Z.4/UG.<>K=A0.-/T JN]MCGGFZ=8%E1:<?/A*?UJ
M(\]'K]<W) ^KWK]MJNZH?Z_ALN$UH*Q5SO55=N29QO,X1*NZ_'6!T'+>$4?#
MJTQ,=[VR@'D<P+:R[PG:N90@HYR35#XI_LKSV492#P78Z3+IZ.1OY68O) SZ
M#1:!;-#AQMU=+I?[2S:;*$=ER?*4?+F_#WM*N N-Z5GP#-+9W ">-48_: 8U
MNY1^DAX,!]DAK]HFE[:G*:^^P.Y\NU\VLBP*Q(.U5T++VV1+8AUI80&:6NY[
MJ TG&/69,Z)G SX .KKS@P3#+YZ=L6.YAR>:(N65124'0X<$ZOUK6AN]0F:O
M#HPWO"0A56J$.UB:@,?--(0KXT4PE05^WT@EV3M9+:\9GJ1]#J:Z.F](F+@5
MQ6B@= :"3_\AO,8G@=K1M_$T^GCOA67_U;!N[9BL.7HOT>JU10\GI$COZP_>
MZ\@'YW7R,OC"MF;VAGOS=K"W!;#'>(279:+!%#&:JK$]P9OLQQL6; KM^UQ.
M5ZM4?_.'9X\WC9TK2,1T#>MX*AE9=0$ KA,UEM1+H>&_[THRCI2X@:#JCA3^
M]6S2E >8A*'2@/3['ML\3!HR/<=V$N?HA-+\'H%7:M#0X8B2..VJ6%*H.P5J
M0%.(E(+L_CC^+G/R"KQ-(3ZPPU@^XQ2>8I<UDX36>6-]LU.?M0/P\AWYQYVC
M!^6R<J0'D!]I4,J>,9R&">/H4=$)JUM8J'%G?[O&!R^@R',FM<\*$-YT%8I4
M"^(O7":B54%>KO:50+/S5(>;F!^#*_B,4Q%(D*59G/9VJ-4XH2#CE!Q:!1I_
MPKRC6]26EGSW\2U.SJ0Z/?DT2KQ,U!4^LA!G(A1221R$5-\,.5/'([KT)=/O
M_OPC'GE[;.H"\+PA9<#(XM[8![_P6;4?;\F=V1Q6D>3XYI8YL?./39*S>!;,
M'DRN,K*A,%R[H"\O)63Z#H6HZO</E\IJOJVRV0]NK7Q'.&E-O>8%^(6_DJ4Q
MJ7S0L'ID?P'X H/!+@"ER//<*QXJUY4C<M8?)(HSQ,\FBA%@)=:;>GD9N865
M8UMU< CG")P:/G8;WG<!*$.WJO>57F]JSG P,$XK[B=X=9&],7B9>C[X\#@V
M>^)&":Q<;G,=2#*!13_.4PG\F$C-D><7@(]-%X . TLJJFO"5WXFR/E'?#^2
M5S;F )C#6OMAY]A=#) @A,!SE\1EM%(@"Z84\^Q];,D$CT+%J7(IFW;J%R\
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M,*Z][D7Z@V 0GYQ=D:5D7HK:ME'U+IF#2(O<=;;U&@0)+WG0G.D.$IL/"\'
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MY5OE8BDGSLF\',7'7K1<9=)]+)&]:VZ,/H%:)58O__E50?^5]:])[B_FR2\
MO_IQ9,3V&,1Z=5>^XX ]F@T$.:]6^6_()KV)SNC6@2]3J2?53P%'C-GPC.FO
MLJ[ L:^? :=_KB3S)S?C(S']('GK_!M%H. ;/1> ;P'\EW<7WX=?[V"H2:1
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M34X ;S?0FMCIS?I]5\:RR:AIR\&R9ZYX)E[0T_ -2R:G>ZG7R]9J5^?636J
M>4.C+<2 $T <'XZ*W"P_>WQUHZ&$>6&%^.$$\([OX%33"6"0&:*D@8_=UR@
MA< _4+0,]'7 SS_Y^2:*>(%P\"%M_K"5KH&O>#HMA@7_0)!V1\%!N$R 16%
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MJJXAW)>_59_??4_PYGIQ]-TX.L!"1@OFZ<3#AYL*-K:;OIYLTY3(@*K!K2!
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M!CG-KH=WCU,7.YY?XDV#6X;N.=25+P'[\0YSYR30D-<RS+2KI4=^MC%V/-G
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M/]]0;1H2+SR+H;,F6./M\B4I(DK><(BYST9VI%3&<ACB)W5@P#YN-R!C-'@
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M4<.ISC)[4[.I-\?\TQ)TU6S_CS--_@TWKQBMK&!4YB$3U7,W8XI]AF#A,WQ
M5L6,H)[.SM89K8^9<>H[!F^3[@1\!8 4E#U5G'ZV/)V1RRN+7& ?.D0-=7^J
MB=A@YO6^A$HF*AS3J 4X$VZU$,#XB846H#S.J!W&[ AGWK^MANE/2GK9Y2LH
MP?4"$M=WYVF'9GMZC'#&L>'L@EU;;Z,3@9.9%__<&0)+),%Y2UU07+M13<:!
MX]W<SR/5F7S\HC]9YXX1J[WV!YF2^&4%?@Q'$2:)_4,16->)MH.R(9#-">"<
M RJT9Z ]%;,TY78SF/0UJ5K,I5M47LE+B:--K5S)+8E*I7"PB8]H2=F^&(:;
MM5GX,(W&(#&?W"8S%76Q-\_[TZH>]<Q>Y29M!@Z;:#%8REA9=$W[2XTZNKBD
M0G>4%,6B!IMD H"X2]_J=.(7D(SKJ85R':7E8^++GZH?G3$2A[<VF9"^ ?E]
M"EM/ )5=S>)<&KAKQ3GVQTE9MLD3@8F;'UI>(6"<MY)DGY;0Q]4\];E6V?;T
MZ_/K!/:M>GE$7&WZB_L.]^"!>H2!*I%,I+(R#8YP\(%4TJ ]7W\">'M\&!9P
M&=UXR<9X<Y_VN:^UAOC260G&'Q9!%W18W&EI(GP>,>(</?1T(YV]II/JO:?$
MG@NH=8K+S73[\F7L&?4K)G=MLP6<(:4Q1P!OF=EC%@A>B0*#7T:N5BE^'F\5
M?1<U5YW4L\C_B>EK(PT$RW>0BDWNI(C6 ]-CQSI@3"&7J.L^#P/!\O*6S*^L
M#UG*LYZ) /K)E"> UEP?3FSPU\0YN/C85[*EI3_3[0CWN!#,-82M'XDM+,-G
MH\U2Y*<-2L;U_)IITWNF$X"T7FECA+_U+ZDC"BA/*"@H>Q<HBR^(4W4IFHPT
MR)<X-%T9?ALJX)TSW>7!A LR\KL@)75[P,W<A35JJTI^&6S[0A<B1Q[CXY&1
MP-O%O+-KX04-FW5P!A;=ASW=8*G$5+GP&X+J E=?/AC@<70=UUBXELR^.8L=
M6NBRE"^+:>=L9[TAA0\V4*MK<O/@!^0:35\EO.\$JUK,ZA;NNQ:98=PG)C#^
MGTX )F&5!Y9&R/ZNP01#^8@&!_0)X+1#83X^V6)8626O(HBM?M15H/+==]6K
M5-^;7:YJ=GJT[!4;"T>O<RR'JB5=OJBHR7764$^*5B"?OT;!U'SLYUI=8_C_
M^,:;?_T51@A^4F:#/"ZL/?5F+%_+-ML:[\61K!HO9)I1N+7)<[$0@VE7.5H7
M/^9B9_740ED:(:Y]?VBVCGFL>R6)V2(3*07D#7A"*B(+!;S &;5BI.>CP\XB
MT=^W!.MKZX>=#4?;I348?%]4/>H2OQZ;P$TUG!/8/0>[!"&*X"$9]W#E79^Y
M8CK"^MG]BJI?CIN9LTI_;/<?N]IN*WM;];N*'USK<M*3EG&%3CVO(0JYFVU6
M*(A8"5ABU++KZLUV570B5C:!5WW,GF"G!]Z]:-#*FK&_]'T(_'5RMOV@E#^R
M7":C*I\J3G/.:. $< ;D*D%+-,5M1Q 5"DX 5OB[/-<7S1RJ#^N(-^J:;'Q:
MWDKE:DYD4TL<=BUT@6G>%5[N/^]\#R;@:Y1'P]%CVFNU3B^6B#/J@)W!7UIS
M;M!<X*%J0S%*?5NOR[[4[S-PZA=G'SYJOM=_.P@JB6I0*&QS#\^8!3L4."1?
M7^>YXEX2=U7@:MAC'_[2J,O=G>O=^^(C$4WU/$ML.P@BJT?GYRNXE<U]#XH5
MF8\TW,N_5NM!/[V>[&[^0X"E]>ZVN\XIJT[_89B+Z\3[=N3I>2P\M(&-.A,/
M;]^ITX!!OPZ:9I9=N2+)4%,1G-3SFDE#@.<$,#YJ*3GW93C.&9*;K@,K5GUL
M'&X?4RB"2&IB6*6@$#@4*FQ?&J")"E":'Z"V%.QZ# <_L$IJ/[II!;CQN!3X
M-$J'*E+R./S&"< UAGH*.LB9W%:0-RC>(._@(@3FTIRG!79('TE^M[K\.(41
MPW?<ZGUUX9M>;Z'"0QD*Q_^8LAAM\D+UOC3.%TR_O^#M#,ZW+W$'AP-9PDR'
M]AR4]3.["M>_%??#\ZHR:&L:PLNK'EA-UZDIF3%^":XX?C*1'!,@G8F/;FN;
M"'M7D78.2KIGZF D/ZCA^3+[ Z.;]%FWQ&?-*LPYON1^6$]_B?VAO'T)K -^
MGB@VQX&9;2=?&R3>3CY3)%X(Z7 4$LC7%V#<YQ%;F&4DFJ%DF?&B&N$RN@L,
M&S%4&EDY/^2H]&R'#9C27252"^I["3_Z:I@6E^MO_;K^\6/_7SA^8D*BH;6*
M7^:3_ACF+RS?AH5'-\@O;%QVI;#\.;%V+S?-)4VW[)D.3T[@J0E3N2O<Y]U0
ML9H47."ER*?4T)QGF12U,N:ZA]K9+GY%6,U+&MU1'S?@2% PY'CASISCINAA
M5#<)$X#:UYMLN0RJL5'_TQ><_;%[,/T$P A;$K.4/@&4R/,=:[)9X]G1,U$$
M,_+4">!2,50H+4I+!SN2+#?&>=>\@7Y0U5U\..%J$#57])#4T&DP8@1XF10[
MW :OM*W$??')*0%59,:"2IG@U;WB%]3!\.5/,?&W?RGN+WRV6C#:9+/!,<][
M#K3SG<5O&^&=Y]/:ZM97M*/2+;"G/,<%=2*;&='?P+<WX)715J$'GS$ZAFOJ
MRF/0#;,CXN#N-H-1LO'LK O*-(_DJ<R*WFZSX)M#$"\J;J"]0TWGP53X>(W/
MD_I#N34.@% MNFN2]7;*4E%%T*>"G;[=S:1/2%M$*%F!]*WI)E[,'/NK"=OY
MVB4Z[:FKRV/5,HP )-V:":^G\:-+8;FICI1V G@^S3HG'%[)?&F=EW]$V77!
M;'5"5#9=T^N%8>?.5Y-)CZ>G?VRZ-7?J^/*%\V'!)P#\0Z"4(QF(S6N?=FW6
M=WK45S"QYG;+MQJS:W!-T^IZB9&0\:WN@4HG4J&Z@3"U16&+QN<!$^'&I'H'
M=V">KKK4J^'#M*7A^\=>RMX+BS &(HR@@Q]"/<!KS+M&0:7#^<FCU6$F\>"R
MLEM=W-16.\F^G:.,Q@N^+]Q,?A=[B_4VLG?">1ND9#:*S[9R:5J3V^IJI%7>
MQG;?@.K+G5UY/'D9*_^"VXMW":=!IB,'F."L3'"SP4!A)QC3=F69F5Z83OBG
M'C->>Y,+]N,&WZ<,JAGC)P&NT/X30.DY^.;AO 2GXZ7/$G6H*SBVUZ7&)9NM
M6F<U;V"N>"Q?T(&NDU4<P+=:2*H_H]0G(PW@<E&R)P 7A)C$QX40Q'ZB;F?/
MMH%S.AGFNPS":D*.!($R)X!O%(09\ME88Y[0.G#!KF DYWSV>-P=]@B%FMH=
MH7F.I^(F]++_/_;>,ZJI]VT7C#\+*B#2.ZB B#3I4J,BO8/4"!$0*1$B2 D0
M"(+T)B @("#2I4F7ED@-O1<)-4&*0""A!A/"\#_KS*R9]\.<=\TY[YI9:_X?
MK@\[:^^=_3S[;M?S[/N^^3\2>K46[63>]=YBC"<+40=%R>(DH/7H3%=DUQ+&
M\@S@3GY<399,)]<;M,#1(PO#7DH'Q<$3_+6J:/QEX0BH]RZ/&_+2-!QXE%NS
MY.IFE:O<O] "R7]CKV\?:89/%&".*0;)IMU)M=-N]!%5E<6CDA9TX_+"GA73
MMK@CU-;1?R5CU"2H[4#.5NYEQ$U8!MQYF=[M9>CTKUJU7W2QG%*BE-%F-IH7
M#I$/UTL*5QAF=[&GNQ26%!T"W2(_/5;<!@.:&U+TV&'1D;%^;@B"I010B>;?
MRVDX>AY6?0UF_U?:+EY%F2A@2$1W24;9S'2K0O5]TGHW^[>XM(NE:J%I%D'O
M_[FR+'WE\1\0L ZZK<?>LQNM!$ZL8^!Q S)0S)W_F6L[?'_%XDU+0W-JFGS\
M3X>6,"_ 2F50:@8V'[Q0ZGQ/1]=5]G/.\ "H\NBA6K'UQ+2"KDY)0U:C.4(-
M'4Z=MF,?A].0+8(',%=BW9J#XPL7_C1,-U ='\8(3MX!>'A9+=\H2-F$@([F
M!:C<ED>>YSZC;AMXL,H;L-LS\@MJ0/K7XN1/C 8Z3DY9DIED."7^@B@[=EH$
M2;W>$O?-5D?HXX/;>ZU[;Y\')YY[U]\@?EX2?T]F>K<XM,ON[J@/)$CW[[%5
MH\*5T]O)P@DL"U(NC_9^O:S+112S9M/YTFM^W#0_SN/LF0Y8//+;1Y7Z/#C<
M?=C#I=.]4U=?I]*"SF&80+E*DD34BI>7>+.BX0I?K>YC_@2_[5Z_ ]*2^-G_
MV'A7M%?W@VZ(S&(MG)X0V;ET";A<O,A,0(<GXW@YQ3TD'$)QCB)1?47/D]\E
M"KV=$,P)R/QK=!1W&KD=+ ]7GSBGDKL<F_P,<$>/F.3- /A=,XGV!@7NE_')
MCU 2R_,A5QZ6+X4CODOD$JI6M,+5!$"D);/I>E4)T912A-O/5UEF.2Y.L4/2
M)[DMUVL2TR$IM6GK,0E.D7\;)>M= X5OZ"F_!05CCO<GT]^7X:%]"$16YA8$
MOZ3>I<*,BP7_RCT:)65\=3,X E^!1>K_F"Y?F3>YT96\QGII?2?I+6 K62-
MDL(LW'Z<F1Y.\22"0'P>M2OT-H]JD3HN8[,%+XQ>96K14)NN8Q'+Y3822=_<
M^.G&QVR@G M]GJZLK>KBXM4B=0HJC*+V07[ PJ!N@A\6C^I(#$>R$>*_VV9J
MYK+6UAPD&S<EG0&6#:U17&C>Z-B!/!#5SD)';TA=CW(@VSD.8;T7],FVBAQ(
MJ5?FNO<5^> X]'^\^OR_NCVKZ.\1DL@2)7-AZ31\^PR093GM\_M<3M=_.IWF
M(]F,EB<J<ADX);#-("SD*+M(VG \:T+QTAG@9G< 9Y"5<?=XF0E&I&CX^3,A
MT_=87HR:'HFXDNW8CB#H+T54N^SWO?8I\<9+[+A$TS7@+]5\O^0];V^NEA>U
M:XUB SJ PW.83N. 6(4)QR8P"\BE(;/X: *L+#29?/(T+ZXQC;'Q0\LC =$!
MO[]K^T?VY\H2!73F%<4R1%463<ENT7*(6YJ&2EWJT Z9E1818UFO%GSQX6WF
MR=X2]5JB_UL()&\+R$71*27=P3PBPOS=9P7T^;$+RCW%\QI@H_#!-T0;"V^\
M2=\L,$@U+3=E=$_4WJWMS[Z=B$?;S*FORL6C]^/B*JYD&@H/*:L"I..SD@]#
M\KK;N!9(J[XW*O'WK$G#H(^UYWKG_=<OS4SP/22!"&;+X&WW4F1QX::-?#0N
MRT#"5E>5;T]'XI"V<%;6,]]PN#3-8AAP0>^X.U"XAV%6KP/!JG;Y%UPR_#>!
MFE+(\7)\O>&Q@$T?4TT9J^/^JFWGRU"_E,_[=CY?J>VNP'9;!/8X+E@0DO,
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M/@U<O!ZK,]VH<-I4C#N4[3"%,-\#1F3CSXT;A,3M;:(!M]_]7[76]]^W[(:
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MX]2!Y&Q^-]=TJF=+'W*B<L?C5CJ$U;TR3<B0T]J0X1(C!IE#RB+./"8I$'*
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M5=:HML<X_0VS.[*L$#--H"3N-#>MK:@IB>.'_BIS\C/!=8B!/;F-Z'@J%TD
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M9U_>MWB4@NF[I[:T:49$%[[ENTNB)9L$CV. X2K7B/<[GQ(:WWN#HE:SGL7
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M=++8+$WL5.&<!4P@IGC.  /Y9X ?6Q.H5[DDD76*K%;/R VXVAD@_/SRJV>
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MSHF#>,?.&3.P.E]^T=: 3\F<T'<!O$*:""-;PUYOH8/SIY;=J$^33=<67)8
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M5Z6R?H]Y^[KC6P(&8\O/<Q2HM1(P&B<5EF[?OR., =27@>;6$U^8BIQ*!3=
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M1G[IHQ%M+T_CT6W7Y](WN&)CZ.$IS0%C.[#.PKFO=^JS+.I5Z#/+W#NS41/
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M_.'7^[<P_^%__]>__=M__ \(_^^KC^_ S9*M'\1B!5Z7@JP$!U^+U1>P^B+
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MD.E)]-[(8\?X&EJ@(69^#KTO_? YM+-,=NIF*([5*?1)UIU.H?='FNP4^J0
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M^;.Q*P)A(6MO_0>3<:8K_6 AU5[5!YOW'/,8=*6K)G#9.73/,..)"",8!CR
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MT=X8Z$379@GE$NEK,!$-,$2$)9#PB$.>*+M.DX0%PNXH;)#DZ([7A@'PJ#B
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M>SM??M5-"-5?;Q<ZNUGGOB_XVV)!%#O=\G W1<7FRVI=BJTBQ8'(,AY+B%A
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MCE?X?'7!\<+3M.US?,)XU'?'Z^ .-6@)7<])^:ZH5O69I'4Q^+,#C&S86KI
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MX[ET&\;O2[O??<TRS6@D&(-9RI':@^(<4EW[1Q!)(QEG<<*HU1&T#?61S</
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MW>>,!UG*.:,P1OH" Q&IVBMRY;D$/$G#3* DMPK@NS QLM?RRZG:7SHKDRS
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M+*PGU^H\G4G=JT%Q#UVLX1<N+#&]R^FLMDX^H4%*TTR'-'27LR@@4&EP!JE
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M5+,T(@*1D.E4J12B-&"0\#2%683#/ P1HG%BE5#='7WLF&W=)E,3L\RAWD/
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M;3HMC[?LJY-B7) ZOAMKLK3Q(_:[*>/'OW0H)BN6[\F#4:IEY_&1/_2[-Q^
M)F-1#K85H_^[=I3 [JL>9-ZNANL^NVXU6]LQIJO1NL_T7DW6@U_9?['OEXN/
MZ[D( YJ$UV5Y7SXL5OSMG'PV_8;/#C#R5ZWH0DT8:,HPW+N!JY>X8J$W?>;?
M_'D@AK7 "P9V>F$F/OA=<^'IRL&@E$[J='[4R11L4+"NR@T_[+:CN5VPY8-X
MMZRJ_Y^\=VUN'$?6A/\*(_:-/3T1QBPOX&WVD[LNL]ZMKO);53T3$_U!@:M+
M,[+D0TKN]OGU+T!2$G4CD1! >_8]NU-=98O(S(=" DAD/MFFMNK,FHTZ3G7G
MJM6R_EG(527:SWTG?^A<V'5%E SUKJN7N[5XK)5R3//-K!:+AL6TC5K,LB++
M<Y*J[1G5'#!9+I#2/E:G(YI'E(5YJC-3S3E@/.H*\AIPNIC/8ATLE-X!;114
MARRM8;#6*L).63[?5YF%A*<A1HGZFB',U PO:9:A)*9A&L=2EL2(%O*MO2\+
M+_]O\;[,#M=OY"W UIE6F> GK?:? NTW@[WFP5[U[0OJ/M]H?Q,<:CL>1@4?
M\2? U%&DP*>FDP8<)H#\.&XQA4BKK;/>?XO5[?-#PQ^LZU%N']> G?/9YR?8
M.#>G*O6_+3-CRU-]R&@S')DW1\-H^WPU$/#=\_480'?/@T;:;I[/#SKEWGG0
MK*.M\_!G/=&1U9<8;IH_=#>OVR6_5U\0?99^O]+$C;,4RYS*B**8QBG"49ZC
M,A,$Y26GDN*H2!(C^@N?2GIV%(U@0*<[K^_#]/[B=5&&>:$]P,%OK2R7^9\>
MH9B*X<M&Q;=%ZG4%R& >KVMDP3QOTX/ZVX8N]%7O=[$DRW57=<**+$V$X"@C
M289P6@I$,(U16 B1EW$<\2(Q<9L7)?B^%.I$!JU,0&?XLW ,>RTG1@(OB0[M
M&Z^Y,304T.K^6H/M6MJ;OEA8P_HA6P8;TY]]<+H&]$-Z'S2:'_R@W7;MO9"B
MJ@17Q[1MELA<U/?52AWFUB_:/ZV5G]+4+$_Z-<_*(HXE23@J:<D1ECA'5.!(
M5_V$&8MS05D*RS@#:N ]UVPK.2!+'HBM6-BF"XJJV7[*!U*6'-:M(CJP%/14
MN0FVRJB_:74:##^,8@C>3EDBX6BG!)4^Z2;($IKC_8WM,/# S9?-NEZK[\E\
M^?!5L)4Z_[_<+3GDXO[R"+Z#-Z![_ %#QZ,R;FR$3?.>S& K]"908G4+>MTL
MQ%TJP+AY5A&9@6$GB\F,F]:/RAA\VG*AG]?DX:'2*V+#T/-5/(OE1GR:+T43
MD)U%4B014TMY1&BB5G:2H(*S$ FUTN.4"!I14+[FF$#/<_-0O*X/[10(?M,J
M!(T.0)*.40P-UW&'R  7[NM @:_3AI:Z6IC'Q$V[$AL:?[+TFCYW]8[_MJ[%
MNE9_V?[LPQ\ZE"$.0AI+OFWN?3[FH?M8S#*:Q2$I0H0)PPB'0B*:8X:*(A(L
M2L.$8Q 9@ \E?0<K= TP:GH3!:PGVOKDX.[M@(\7KX+Y%6>05M^;YN^[7W0Z
MWQS>(ND3R5;OFP/.@(./N>V[XQ-:]X<:=RJ^ULG'.<@#QR/WLNS\^M](-=<T
M TW%3S/ML2S*),H2)(0F6A,D1T4J$A2*1& 2%5E:4(A3/I'@V:-NY05MK) I
MB< THU-,S%SA59;"_-C.R*Y$SZWCN6B((Z]Q.OZD4_ZB><?S]?('K^52NI(8
M=<\RP24M(Y%PE(5)B7!<%*@0A"$>2QQFDA9"@,@ZW*OH>P/5X_(Y("]6VCVJ
M);DE\=$AIV>R:#C*MB9TF7!DP3:+W<GFO7Y<_4XG+>IDI4#9TZ[WMOQ+SEZU
MF1-ZW1<(O,FZ].YZQ--';VNOL7YHJ_/^+4W$Q^0:6^><3,X4?"5>)M< 7^9F
M<BX)'LQN<JB:]K*+EWLRYW^KWZV^B85@RA-U98#@_B20,3V[Z,-\O$ZG0"L5
M/-=_;N8T6;X$6^VVE8_F,7(0?N-1<U_0P9RC)6H>^I38X&$5> <)FBP4;V-^
M/SAO];Q%);>HE8]JLHB:@N8,AS(G481D5*0(DSA!94@2E&-.LRA.1!EQXWKN
MP[$]^XN>-$ E]Y'YP]/\2J-@,_FK>)[7W8[EOIJO*KU=F:^XV[+N\]9<4]Q]
M-.)T)=[G33DH]+[PD2LJ +HL*&CB_R0I;;U<=XML?J-$MBN-@LV(?NZ^.\KH
M 1.NR\R?,K=KP(BS>?A.\KEN.9_K?099Z 7J;OF./,W79-%]<1*981'KIB@R
M$PA++E$I<(:*/$MXF4<%ET8KB9$TSS-I+[O92J&[9=")!W9>&$3,[*CN# ?8
MY#N&8+Z#P -]NY&-KOHP#,J:MA6#B=DGW1B,'H(O<6WN^./#?27XNGI<@K@A
MSC[L>Y*V117SQZ9'B!(LU@T= H0+XKS1XVO@U?8")^-%4YWR/@Q:9;4XGA]Q
MLB5RT*#^0CG\0<LX_E'39C5*5^*4Y'%8EGF!4JI[FT2B1"17?^.RY"$112X2
M&'W=)4F^H^K'G< M2L@N@F08R'9A.C >?<YJ'W5=8Z9Y:H6^E_.J_=!/S!UK
MBG[Z@-V\U:?&:J[C+N](_4,7DW?-[5*F0R,%17DH8H1CFB.:"H*R",>$R%*H
M.0V9MI<$31 X:<4&3,F%S=>+X)A-5Q<F0\,J.VNUR):IPG7WOS&S',W4BV(F
MG:ACQA[/T]'/7T.C])W\H7.9EVR^F+=W+^L?HKKE_]QL^5 S4K"0<H'* D<(
MESA!)(PRQ*)$_93GL3J;PBEV1N5ZGL2-.!M>G'' S&:R!QA@$_N#E((U]\![
M)IK@*UF+X%"CFZ#1*>@I=>.<C1J(AE.FF7&IK\ :8PS%>088\\?MG,=G\7NO
MJV&U6JJ_LK:V^GR?EB*D:1S*"$69)&V^&RUD@I(,,Q+%)0FY4;FSK0+>]P2L
M:6G5:[IYH%.3VMI^:/&BIM+J22^H%S\.<TS@EV'FH7Q"# QDB]\O8S5-"QU;
M,!QY*K#X25V6+3C'OLMZ'#LG=IQDTF6ES<*0Q7F<")0)S6B#2X:*A(4H(BG)
M,4W2F(%:IUZ0X_LV:TL(^*06[[K)VD(![Q+O?IHO@U^_O=__[D\PEW,).C//
MX@ 0X%[G)(/M9IN#Z,Y%C%CER!-<DC+IA!\Q]7A>CWW<)@WC2;WJ'Z06MP^5
M:%S$NZ9U1O5$JO5+CPZ)D"3D*1&HB,M";SPPHKEN=<%C6O*R",O"J*,Y2*KG
MJ=T7"B LAP$W/)6]P0&;V"=(.(PC6IEX52:(J:P)<T2 YA]FCT ?MEO&#_OI
M?)T__%A_D;\JJ;KX1QU4J_7\OYHS4%?\,XM#EB>E%"@LU3$$IS'1!9$2$5E2
MF:=A&<>@LPA4@0G26'1@LBO-$:U0V/H.QM1LX?>)%,QQG+3?:I1!*XF4.FW-
MXDV70#9GZN3&-VRP8!2\6["%PM$V BQ^TOV%+3C'&P_K<>#7_UV.*80;I?>(
M;Y< (D/IFS(\KZ^P C9=MVG7[EA-SJAM=4/?'V>R>_DSRO=OX\_]VO(.7N=_
MWB[Y)X7EXG]OJGFMW*&>,%LVNR@D!,<,11G6Z<\A023G# F2Y3&/!(Y#T)7>
MB#S?]_%:>L JP>?K@)&J>I&K2F<V0/O*C:!FME@ZQ (VV5H8=,2R$1WT97M(
M7C.TT]5M_8BT:>_LS4P_N;DW?&RR_BIJ'R]T0[49HV&4)B)'*4N4/^ B147*
M"I23)$FRG(<%!7&-7*&+9U_QZY^__=E[7XT=KI [1>]HP;S)=7TQMOJ]:B.,
M8Y!>K]'%3I.WWLCB&#('C2I.AH2Y-]T@_(,2LWYI.EJ0YN[[/5F3KFOXK,""
M1RP72' L$*:<HA)'$K&0\$+&K!294=A_3)!GQ]2*#GJR=9-Y$KP;2=J!@37L
MD%Q" (ST6UIO[$9,31LX3*@A6O>@_K+W"J,#3S+E3<W;SF?CS]OM1;I1=EZ@
M.Z=WA#VS7)TX,,D*Q.(B1ACK;KH\%$CFO(RB4)*"24B[MF%QH(D+[[C6ME7I
MDKMTXZ[@)]H*_E/P5*W:ZD;8EF,$/K-=A3M0@+']#HE>>E(G.OBI$W[YUA*\
M+3"STM'*/R)LTL7=S/#C]=OP*<M".<:JC> ?'I\6JQ>Q';3>KCV8)()1JE9F
M0D.$(\V&FN(2"1FK'_"<1[%1#,Y,G._ENI-Z!2_A"%QFL]P="+!9WLD-=CCL
M"0"=K=DP&UW5R0T+F[90SLCPDTHYLZ?@L?)>7?G[E:@_K]9?-9E_);:TRF >
M%O,1/4_GGB(!5YH$R]4ZJ%I==D3=YJ%X %+CD7H_(,&F>Q\?K42@M B^'N'C
M@5T%;KO5;0! S&27!7#3^W<)%D];;O5)_4/_KT<B=[ODWWZLJK5NTWVW?!;;
M#'M!\HC'+$9%+BC"/%%_RT2(9)8694;3O$ABR ; 7+3OQ)ZFPJ:YO!=[76Z:
M6'RMU4&Z;C68[Q4"G@?,,38\&WA!#GA.:$#3?_8)"%O0&DV05B6X,P -?FH
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M88HPSB,U.Z5 I2 \H6DN0V9&P]".YSM <?OI[N.7KY_O;@WY%SHKAR>6A>[
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M0D@2F90*>\35MGZ8O#ZZ!J=9+YC!?./V:[C5H3GZ-%H$G1J61U%SH "'32^
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MRWZUBS 1&4D%BD2<J*-'E"(J$\T?$Q8)SR.64@SJ4F@BU?/,O]@-Q46?F&,
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MFHXV(&%I5N:)0"D/U>8IY1$J"\91DA093G@9\8A"9K^15,\^H-.AX1LA!UK
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M6UWG[)H]+?.EL@/5^=S:%BGR ^RG#*8L""!"'H$D23W(LXCZ.*-Q0(SF/0_
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M16SB9YRSE7RZ\54#D?@^B3.8X9! E'HI)*J)$/'2 "68$>3KQR4.UYY8^;3
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M&GI9A 3$"?4A\BB"Q/,(Q'%&,S^*0X:-#*<YD)Y8[=:=LI<M2/#2SA^J9I>
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M#UD/:UKFO&J"7 7,Y7&JVHQ^?'I>K5]YH;[0@JO?XN*U^U#=_'^1$>E%D5C
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MT'PLBG5QLY9+T;I):!LHY'',28HR2%*10*2Z*^,D":&'4GE <"_*J%$?KDN
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MZ&Z]6M+73IM1[D>>YQ.88C7IP%.QP4R>P"C"2<!PBFBJE:DZ"&GJP_?[NMA
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MK;2F1/0Z9_6LDVH>=3LWAV(?)VJ8D.\G'"(DCP^".8$TB9!'&(Z")#$)T&K
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M:'JM.FM-G9M2392\*Y0;MR[ P]=[L$<%U+CH>[):S!GV;%WSQ4Q'Z+#$<?-
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MIW__M_8W\G_4M?>__]O_!U!+ P04    " #8.X]:,K4F$,&Z  "'L @ %0
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M.A/=(41QE/IOK[B;^CN^Q#Q*A".K_^,RU)RD#]]/XV(V02/0ALR!;!21ZV2
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M97WV9:.;RV/!2XUT!@ &GD&9XB&8E"!KU-P;YTIH7LW\$#'CWJL. :TV<N\
M0.])%T1 G0+RG+;+;+%I8WS.U42*J%D6AGR+4ET 7B#*1'**7N;(D6%NG2__
M*$'CVJA&2K_;$KB1!CJ T[_BG&0T(UY.\NET/JWR64^_X@4[W 9F+.VY'.HL
MY(0*7/8*,D,;O.'2N];I$3\@:5S;- RD6FJA U#=$=*D<"=$G:%=<[!).#6/
M0^D :'52J=*@!VL!<T'$N.\ZPP#G.$EWD)5\R<!55=%$%J,9BW3.1YM Y1H;
M)S3 G+-%4>CL7>O[SGO(&!<N@_I !\JZ![C4:K0WB_GB)BL7=C*5K H%!&"]
M$&0G0X3 N0%#^BY*6.99ZQ>_QRD:]\%O$!"UTT ')]753K@(.J?S,V+J?*LL
MYJO?L"R6YS6/%&_BZL4W$B)I;CH/R^^O2+*;+CHU7%W,9AMY$'FX6D^2MR9H
MQ8&ED+8CQTG &HQVC$?C1'*MLV4&9&?<)\4AD-R+[CLPJY<LGF_CW\@?+=/U
MI# LB0L'N102K\RJ9ABY6GV9$@8KC1GF&O .*>.^.@X'O^-DOC]T_!8Z<_Q4
MG\R;@.<-KJ\Y%*(PAC*2!T% K[6ZL39&J2/;9::0)3BBH3%D;A P[I/B$$ Y
M7+X=6);'V@<0]B\%Y*3W(EN$N F"1!TOF"G6Y5F:DJ5P)K:N0MR1M'%?% =S
MX1KKI -?[O>P_!NNZ[2!#YC.EIO*W3_F2PRSFKSQKV$ZWVP@E"D:8S1H%1DH
M%1!\D0RD="Z4P IBZS-M-\I&OBL= A2+P374 >X>DMQ+\AVGG^;;IN'I^\=E
MF*](@E6?\[SYVVRKW?Q_SK:3F"_ZJ;Q;+#??6*^7TWBV$=C'Q;;<9N*")'>2
MMCOC=?J!CA:"R@)$"=I*:8OWK1MW/2F#(U_O/L$NZ!<O'6RF>^1RV65(I.2=
M\0ZXCQJ4#Q%\0@O"&^&LTEZEUH];CY S\G7R$P"UE2XZ<$,OF@M=I ?_%E;3
M-$&?@^:U>4?AM=[!U/;$T0.O#:MR0#IG6E\7WDO(3E#R/Y.+>;R\NYC5?)N-
MY]/9&87-$Y$]LYAJ^WRIR$-QA8PJ;;*"6FMBP[OF/5,>(&4WIY']S-@Y1.@=
MG&1_Q3JI'/,) 3)\PC=GIQ&7;\N=M,WSK9%\XCF1DTO>+RC&)<2D'?CLM&1:
M9I%;OWGM1>!N./NILLV&4U 7MNL!]LYWT]WL8<]ML38',,'2]O(&P17:7D*R
M$+(LGIG6+>KV)'$W#/Y4:6E#*NDG2_'^\/'MLW__M[>OG[]X_^'%__KCU<?_
M;)G6?<^G#YG*_2-FVC?(>*0+7C9T1#)7GV,-G9ZJ4 B8&0,CK>0\A.":]_K>
MB;#C^VR>+_*Q1KR34 1G*#=]_G*=U"W :67 &>F=D$)XWSH\O$E!-RTO&F'A
M;JO-@^7=@3]V2?U6(C6X7<RQCACY-EU-7.$N*2$A*T;,^-I]U+,"EFW:A;*,
M=K ]<A]!G6#I $T_!)JCQ=X!AF[Q\'QQ&J;SB0@\1>40F*L/<88E(%^Q "]!
M(RM*9=WZ1>%>0CK!S/&*OAT0'BWU#J!SK7+O=ZQ>WD234KWQ"2S63$V. 2**
M -;4@5M9Z)(&[#RW)6)<R#10[,/UD0=(N0.8/##RX9P96TJP(M&V"34(]4%
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M8^UJLZS_?G.%"=/GV?2_+J]"26.E+9$'$-[IZNT$\*D4,-9HE[20WMNA>#7
M>L;- 35#Y7UKWPT$.G!-KGGQT_?K;__?*?E;B_3Y^]LZK&M]J%XH+"26UBN[
MW("BA1"[;2#&NTROE"Q3ZWK,_2CK!**C(VD7Q-N)M8L2X@<WVQ]7N+V8;+,P
MF=5KI<63RQ;K. E&SF%VG E9%&>EM4]]$(&=@+<A1G;!L+FX^D+CK[.OEZOE
MFF=\FU 0D1E1O (AA-S47$?G!03%G+=%6E]:UVD^0DXG2&L/@UV .U$B/>W,
MMY8BKKHC2,EX\0%BQO4TBPC!$Y^2(Y8Y%HE'@_GD/Y(S;GWON. Z1B(]@.O'
MB'1M[)TWQ?(Z?8P%1>Q!,O:\2'!9<^*01YU:W[;=04HGH.K.L6L@N [PM^[*
M3T^NG/V BV_36NS\[L&#DH_TD<N'W[K2:6\CPR3!",_(0]$20I8*M"NA=I_5
MOOD)14OZ1]Z;6P!JWHET.T#VW^<S_+Z9U_+F<I:7V_V!NWHK*6I@ZWZWH5C:
M*2R#;,F-9KJ4S%J?##U,R;AH&P\9]R?JG"ZF#L#V>O[E"RXJ=WX/7W&Q740,
MM=VGM&"EHOU%.07TDJMS TAWA13<M)YT\R AXV[AW4#M="%U@+0_/OQM3J'S
MK#+E]7SQ=;X=^%D'L'_"64W%W8RFVBZQA!"Y(3TRJ&AA(68@QEG C"JG'*+*
MK8?3'4'FN+>YNT'IT (>NVCR7I;MU3;+]O%NEFV[,#+Y.A;)(*G,0;'(B)$E
M0+&,1Q^0!WDO#-I1,7G(4\>=?#TZ$(>54@<F]"KC^ZZ\^A:F%S44?#-?? BW
MA_K=*F?0KCK9M#]X^D*[ @?GE0(3@N'(<Y:Z>3'E(02.:S:[C<^'$W('"+Z_
MI)\QKFZ6M>UXA/GU?+E:<WAB8T@!:4$B(+G3MMZU3T9"E%BOZ43.L#6(#Z5Q
MW'AH0+C<[\DVI.PZ&%3WQ/I2NOQR>5'G?/QM,5_>&YZZF5I?I_/EY+VI34I$
MUH4671RX%&G1'(7@67$96X?I30@?-]3J!L4#2+E_L[MST;57V,VB-4=%;GJ!
M9&DO4T)F\$C[&T<6A4LN6-[ZE+0)X>,Z&OU#^W@I'PYMOX'V##]50@8!]\V2
M[S)@XGT./I*CSXJEE2F.X$E7:8VBL.*5D]CZ5&M?VL:-W,:#:!-9]7 P0.'!
MW<CSCC\T,<:&HABIDB3-4BQH<%9E*#&R9$S.^O[=CT>. QY_UEY0TL\72D.P
M?%0[MGM!#[@@$RW)OPCD11N4'E1PJ9KGVI-1%6V#-,JDXY'TP!/WPI-YB7@Z
ME?W/ U7K/O'6&Y&MK@<6L89JN58VU>.VI$(.:(35^Q]7[O/$O5!E_PU0=3#[
M.P@G'ES7\H%J^XD6,FC.:!O/GM3%*0?!^@"%$TN3\\B;3U?>F[B](.B>+P2'
ME59#X];%%;76#?J&(&/$RV9G;^'WZ-T=%#I((2-03$J^'8\(D:D$PJ@42C"H
M\G.Z478O4+]G#^[N%;_/EVM!7%UMOOIY.<F8HJ;_ [FVF381[<GUE1RL-(E3
M,.]2\WQ/$\([J2P_%6?WS>[YA=J!9W#,HB<>BQ71()2LZJV0Q"'($,$YI$7'
M0GM2ZRJ/8^CLI)ZX!YP>)++N8?GJXF+^)^UX]>?71-QTM7;*G6)1)N- .E\+
M\B.IG@J\SA4,(K.2G&B=R3F&SD[2Z.>%90.1/5-8_I-^F7RT,K&)C+]$#UE)
M"@FTX1!M<(!6QFA],27R#N!Y1>^X)]Q=P?0H$7;:$.0]?L,9L?7X0.G>)[2(
M<1XCJE%XLGW$&T+:Z_ELC:-_3E>?7U\N5_,ON+C&EN2J^.@29(JDR2(I"X'^
M!UB"DKF$F$1K+=V3M).-UW09/GU:U&B>Y%-;=ZT?NYW)Z[6T2B,D5AMK.Q00
M;/$@9$%I4RJV^;G/8_2,/46V/59^L$.MI#%R3]K7M3L3+HBQJ^^_A2^;ALPI
MZ5)<$!3Z, F*>;*3HBA0Q3J3E#/1[Q79/M&:]J%GCXN<=E*=-V3QV W*\>OE
M(GT.2WQ%K,%-N?G=)6V+B L%SB%P1>Y@J,?JR"A <0RXECX5'K7PO@%N]B9H
MO#[7I\M\/K0 QL[BO\6_</[Q,R["5[Q<35,=DK@M$Y?!N2+JK C/!:AD:Z=?
M'^N8'&5U[=YV_WKHCNS8[F>,V )]&&G.V[-V]';I_R(O?KMI+]<:A+DH22$"
M:*SSDQ0GZFNU07*295&,0[67F_-DS_3[3Q[W+&J0;>E$]HX,CJHF[\J=-6RU
MQDM=$).%=:2GBD3PI<[M+4X*%8+D9:]CI"<PLI. \2S+J1*=MV;OV%O,^_#]
M82N8K! FF@R.DSVMU<,070[ :[6;0%FL4'MM,+N>,!X(&DENWIJ-/1S_/6Q&
MWUYG_861R1;EP=6F0XJE>IS)(UCF=-&&(D*?]C$=IT?1;_NXM-5\XQE$%!U
MZ_?%/"'F93US>#M-=7;\&\3E>TPX_89Y$E&SG)*#XNI1@W46(HL94D:O&"M1
M8>MCJ2=(ZC+0/E+^/_:&;B:,#K#UQ''6+W^EB\M<;TPNETA_\OJ^C(LE)>O
MQTB6.7 +P60#13G26&D\-WM%XNV.01\BLTNON@T&AQ9:I^F)]3S:YK5=>WQJ
MBS3&H<0W2FUL'WMU*IV5+B*: ++H>BKM,SE5&&B7=3:Q'()0K5N@WJ7@5'OU
MM@(:WV[FP"_38OIU?65[[3,$YIEBPH"1=5I;40F\+PR,D@*=-YJ^-%_<3G+&
MW0-/D/M]:].*Y1WL=CL'._STO7:Q6$>URMN K+8M"<: ,IY,M$O$*C+(QB2E
MY7[YB<.\J:?(&AM-C2"P[Z"-(^71,\3J@K;!,C*;I*V3"76];1+K3-),L0X6
MGXHPQFH_@,/^%%GC0JPY%/:%VI%RZ0!J/UT21\G-N^HY*RIS3 %?A]VH*#V$
M$LGD9UJ5"T9EVWIOOTM!IP Z5L#S9MSN "M_#[/+0I[ 9>UW\R:DVAOG^U7C
MI&)-22J (T,.2E%0$KR-D*.)JA0O@VQ]E?H1<L:-VX9&42LYC)PA^4 266<7
M_X;S3XOP]?,TA>U\@.@U,U8"9EE Z>AK#VP$PU7A/)OL\EY[VQ,9DIT$C N?
MUHY2.UZ/#9C-K+[;2]AJ4TZ.>5(:X*I.4\M)@<NI !=.<Y.B*:;%J.J=!(R7
M36DDV'EK+H\)E=77Q>2WUQ/+,VHA?!VXK4$)%XE<)2!$S82VS K_&"B6F/[7
MI_FW_Z@?MP%%_>X6(#:/&5'T;00U/YYK8POY]:N)8Q)Y]>13T;*V%&/@ZHA&
MGQBR(#Q/[+&,V%Y"?OUJO+'T PCY0*YUX'A^N(Q+_*]+XL,OW[9NU-K$!670
M"W)Q1*G.CF$&HO(!K. 6K952-^]*O8.4<;.@0QVMM.![G_"Y\L*+(9)$ALPE
MZ4$DL^?(^:YC"0S%8$EIVWJR]TYB1NX:V4+43\/G"+[W!Z"KX4_6.(TF T,*
MW)1CM3I?&K+'D2NK#4]V8.O3PY%)(R$_#ITC.-X!;.K5KII;I2A]T^W\I^^_
M!8K:\5VY>?G[6LVT43&Q:" [&4#5\\DHG0<90DR!D4-F6]]XWI^Z<6_J#;6Y
M#22=[G"W7=56*87#6%P]<HR"@PK&0?#((>I0$BVCQ-!ZZNHCY(R<D1H( 8\"
M[7AQC%VL>F\=;Z<X>S<C0[W"69C5V76DH9_G%_G7>E4 EU=&VP99+)%;F^U1
M0%F0O@L^ F:C791*"RQ[E;(>]_R>(':"[.?G%42/E_Y,,B45BG5]X9X"7HS@
M&46]WH64;;!<AQ9U\T=?^ANLA>80!\(G<_CYW/ESW/H<!3!>+"C!%43K'3C#
M@L1HN#%[S9]\H7?^#I+Y<7?^#A# V'L<6=&+JF<?UZ;TZA8!*Y+V?0&:Y3JS
M6AL*9&@]R=#S4^8B[[F#/?3IS^*>WR$2G+=DY]AX>!MF^8*$<$5Z<2PP"CL=
M3W4Z5<#-=\)FK:1'*5+<SY>Y\[GC'2^? 0,GL'!$Z6><TK[[*5S\0G[6:A,$
MR*(+LXH<MD*855QE"@(T0A::H344$*3RR$YRE6N@C]YL)/3-S1[RP /';;3<
MVNLXE:,C@V%#]589DHT^.%N[H=8B,J<0HD<'*2%BYJ$4W">UN!L)MY\VS@YQ
MLKCF#7C7F?EWO+:X,Z+.=ZG7"2VGV$U&<%&C08D8[G?8:F?^!Q'P\8)YQ,(?
MPJ6Q!?R@@X+*LBB,!9F2J0-/#&UU.4 H4@A'HB0+-ZR_UWRO;R?LDSG6PP'I
M@UO;V^M[58B<!_)#0195V[!5!(=H0).%TR(1MT3ST_C'21JW._Y@1_ -Y= -
MK-Y]Q3KG=O9IO:[W.,,_PT6=-CHQG'2-,T6LDHET3DAPS&0(2@2*>3QZW_SL
M_7&2>KP1<J3X'X16&UET *WWN%PMIFF%ZZ[]O\UG=>HHL7C"7!%68 "'F7@4
MN8&00H(B.+.,[#BMJC&F=M'28]5L&S UX?[8KLY#&G'57GS]P\2&1-"W$<BG
MKZW%'8+7B@/G+J28>/9AOZ8C3SZJQW*ITZ R (L[,#N_SM)BPZ;-W[_.[B[N
M:D+R]XDQ,2"%@8#U/$])6X/$1)8U%)MHK=K='V]^LAW:F[@>ZQ?:&*9AY'/J
M))>/;0S6/3V:SZKQ?3V?+:=Y_08Q\3K3^>7K8OYM,[IDW=5YHDO$++0'8TC;
MUE>K*"BEY2?&*3@-/M^O<]AARTZAHL>T80,S=S;!]+QE;IW)J]X9RXE7M Q;
M:F%(<*",(W9:7L!FALPDM$;OF1LXX*D]'A$/O)&>Q/@>$?60LESWB9]8ZWEQ
MQH*+%*.HY#*X5.@[$1QC 4N0^QFR@Q_=XYG#0-AJ)X*Q ;:W1_#S)7Z<KU_Z
M^SQ/RS2M)3M11J<D27NXJBU^9.$0N=!UK+GC'K.*9C\K=B(AX\[B&PQ\YQ1/
M[U!\/_WT>?6N_+'$VF-JM6/%6:/E7"3PPE/$Q&P-MI4#IUR.JC#ON6P"R+W(
MV0N6_L7!LKVH.@AN?]X^EAR*U:;U7CW07OZ&JTGA3I!7@< TK].L1*PE*A$$
MK23EHHUGK:/9W=3L=TC+GA/H&HN@ S#=J\G].7P)GW#Y87Y)BK,)?(0N6N=0
M( BGR4T-&4(0 6(47">5@]OOCOKQE?<_$K4?M)YG J"I0#I V._A^SJ,?C-?
M5'69D+HP[RAR-EI2((VL3C6S'G(1)ELC;&2M)^K<(V$_]#S+$_]3F-T!5C;)
M^=N'+Q.6G6#1.4B(A'85$H0<'6CKK,XF!AE;#R_\D8K]$/.L#OX;L?QHT'S#
M19RWN^=ZL7'_TOP+3K34QM1QGBX9VH)K&Q'GR+UCJ62,W!6G6^]8=RG8#R[/
M\N3^!%9W8%_N1@?_Q!H>8'Y%6*1-]CW6"J.K-VNVG4^T#<A9S8P6R>K-74'>
M'"I2"F]LH?]+W;I;X:$T[@>V9W5:?Q9Q]0['.N"SEK2_#RO\'1>I;N>YL*!%
M-N"5K_U//%GF0KM[H-U<DK[9A*VK)@ZE<3\X/JNC_;.(JSLXOIXO5Q->, GM
M#3A9[WIB\A!J?Z6HT&:7G-&I]8'"CU3L!ZEG=:+?B.4=@.8?83&MAQ\W"\B.
MX@R5,UA7[TD)1DOQFMBCDF<E&%Y":(R9'XC8#S+/ZAR^#<,[0,Q=S%]%K!-N
MN9(HR7=D+H%*C(QET@R$YB+$:*+8KWGFT:;FBI+]L/.L#LL;LKX# -TZY'@@
M>O59)(XV@,%B:H?:#(X4  1/4C,RI\*UCOX>)6B_\M)G>0S>3A!=3UWYD#YC
MOKS >7ES6?M@U$+:FF"_N+BVPU><N)R1..]JV<GC6=H\OMT<EP'8,<S %VV"
ME#+6:URU9$O6'B52<M#&N(@L9NM:[RAM![X\G&.?XO**OS]?XLW0=6&#2MQ
M;9%;+SJ7>J&E0!(&E14J"-FZ!?XA](U]9>-H9#R^AS842@<[ZX,U1E>E';?6
M]QLI[,<_\>(;_GT^6WU>3I3EPJK*P50G<*/2$ *%NT(E3>:>!]O<YS^6UG&!
M.!QZ]KA(U%R4SPBR_P?#XN.?\PG+D3Q:$0&1?!&E1*WS()Y*1,N\MTSI]E/
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MG.;6COKV.CLNO<8B1 :6M:1=U5B(+M,787T-W[S58F W]6T?%7[MO(ZV7.\
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MD]E4M&-G.#:SV](T7+S[<T8?^7GZ]==ZPPR7J[?3+].-I$DSZRGZ) =DR&(
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MOP/_:$,Y_?*KOZ;+B=,BLMK"'&TDYXX[ T'0/FJ*KNM*WN76:G^'@)%S0>.
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MCQP>D>W%UBDX-\F>NSJ7)).:O$]@B6'M1<\@:LL@L'5_&JNL&:HL]PG2QLT
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MP(DDE3!,:=ZZK/K?+=E_" X'2/8?(N%1ZVX?2E@FSYP0Y"%IS06HX#F%B$(
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MW86YYC]NL@AT(5$1(G&<P5W">G_ %S)$1'%.P0>,G$^3[\>B7^=I*L6;$*8
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M=>N9ZY9(P2-N'7Z2P'9)E$ \-@)IGF2942EAPK5KVX$MOXZN<U7HJFH#<0E
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MGY?%4A3++BCSJ[.O5Y.HQ>GO^<T1>$7UZ"QZWW[?H4,7'"&[0O>7J WA+FK
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M)&@E<&[#@;X@=H=.^PC%#D/O'%24:CB%)?_M@%IN48!)GL$+@9(R4& [HU
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MY!E&,>#Y5N]H_&)J=(5;@)D5F%,9X2>2!]W%\H <5Z#R WU/JA(+,HEGKBK
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MBF5FRX>RAIC4IQVI]:*VGV20'SA"'9ON!YE,GYD4'F#%.7U=WQR"?R$B5&$
MF:Q@$@:8,7&VSI1$;XGW'!. 8!J?Q%9I5I?6CL,K8?J9M;"PG[ZK+5,?-Z7
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M/SQ;AC*/JR$CD&A0E&(>>N=M_)SR)/&90@6Y.-^@,-.]MB.O*):SZ-_G( 5
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MAMR 3= D1TKU2)F%[7*I<[S<;JK^))T3^%P=!\9O5)D]CO')R,5\Z>$*WE@
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MM_W3D<12H@I4&>7781WKJDD0)B&'0Y'7+LFD1F\(GF\I[!B\K.P/8UR!NC/
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MAHRP;K2MT*8B ?9*)\37H_:X=88B3^G"D(=)<#'23X3Y=IR-X=&P,),Z48K
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M2S&=F0>4SB7"V^ZPLGNDGDN\A=0GNQ6\W$;37 5"N]!TI>Q.,66>H;G)[[)
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M#J^%KZ%%Y7M_)V&71=&F3;7]9L5M;YE %HQ&Q['6$?C5N7+8A_*1-H\8.$B
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M?"4_2RQ4)L0P\33'RS(6:]%VS-A U$:>N9G8J5B26AB/^KC;SMCB">B"4T9
M%^5W3M0T*AS<=M (FC_&0(^(V(\L=W$8!%Z$*HH@(+ Y8*P%"\N$FN#VX16$
M%]@^*Y,@-F*?+#L7A:[+G!HJDVO/!7VF_:,=0P,3,N=6<,G;/"Q /RH2[[1O
MB:@\9-S:2"EIDB,#%4^+<1@^$?YQIW><>THZL<<T W484)^I$+/4#GTH4H)%
M%4/3F2>M9_[+H;VGI(A )!@&/4S)I97/&)@8VTOOQCD!U<M@G$P0N,6,>:40
M 6!U.VE ;%K*G5X)>C?7$,,MA_6LE#9BWDM$ B&.YIK*^[F'*U%NY'7)30SG
MZ,UEVJ:(3A5<R*#_<LEV*]\?_.2@0_"31ZSLQEKZZM;2!VY@PI!OQ$+''3";
MCG5?E=R![VZ%QL[>;E3M^&5<[9[LG$E^*[VV;1D2Q2H2/)B8I)T6.=CZ1-LQ
MXKQ)Q#TUW-RBR;8P5AC$H/0_QZPF)J@QYJ8,%L:P?.+/]=<SC5/AP")IST6Q
MN6>1,#[CI&^#V,^&'_%+6E%-.8"?%(8C#M43S%^JO38J6IL31T70)E7 .3:(
M9G0U=J590&9))4(;9^5IC;),,LAL5:>I//<)B[&B;/*QL"U[8=R5G.G5F8 _
M_/0.C&XR9@<O>L'>[MY^)V9B*8WXN=]]O[;.BP[9.M]N<AX\"(?]PUT40Y<G
MOYR^^^W]Z5<Y J^6'<6JQ(%^_MG" V,6N;_;VN/(>9J&L]=)1C<EM^K-K4+J
MLC"5]04-(!ME_V7_Y=[+QBV^O6)8V/WC&/2: AV8SY1-?"_8P'/??!)^VI%7
M/>KO'K[\RQL\,>;EZ9/V[/RP[.T73NS>07]O]_ O/RP<[?<G] X[*/2\K;ZW
MO]M_N1*^)GWDCZ^NCD]^^?7TP]7W+?J.E[%AYZ#;7^WW]U='N'7YR_G'JYW+
M/\X^_#VX^'C^\]E5 (KLY+_>GUU>?=X+=<M%.N9 VM!II#BG@):!6^P/XV?Z
M![TY5 3(9XT4G.Q?<F%RJ^:8;MCD_\!+;3 ;L2:F$2LB!RG'&J4A-VAUL3DC
M2L*R7[:%#^\YI"K=BGL(,KT#8=]MF#*$22\#/;<5N Y&\_23\(U8L.:!"]:D
MF#^79&<N>ZE,@?&,=8DY0:MU3'H+[F-XXN<2P7K#VUY8(1ZY70J%%D6GXANI
MV0D5:F-5.+% 8S_%G@Z@E/E$-:L ,#'3KL\L;8V^]&4TO4KP$%&90:BS'E@;
M:DN?I0,3D_4P2058*-=Y<:V(L!J,$N2JK?CM)F$5C77 9PP+K*B?%1PTJ7HW
MH1[DE;;?V</+T/=46AY34*@0%EV;;?)>S;P1UBT)O6[E=T7A!E*4"!?B 6*O
MC?(LGR21+ALUE+CN[?O/(.;TEI<Z].@5<MN!S 4N;0E*))D0,3 6Q-*0) =6
M.JW?B"0HJXS HWT[YQ';#189E::E7\7N5*\Q^D!S-]F2"+^ @AONW@_(6^1>
M/*+_O%Q5$9#?F,:X'W=@[=)P6JK7^C_>- QWNNB-GY?!KHA-4QXW"7\M]N71
M47__D$SZ"L99Q0UOK$_6Y]^JN/W=8?]H[VCAM[O]P<+O[K_K(0_GB][U:-\X
M+@_=]F\T#SP7,-LE[)G__&'_A\:"T((1#RJE?^- GROY'L_IO*]EP5_O33\%
MX&$$^.]^_\6>?X#Q[O,=N&]L 9+S\3]P*QL[D_E;/#7:FUL\.5]V\EZ][/+D
M?<B_[=PQ1>\3)G<7I_;>P_#JL8?AR6-R%WQPL-?Q)??R>1X@C\JO&OOAF\J;
MY29M82B!!97/!KT#XFM_A2G?5R_W]M\T0OL/'[2.S"=MY.]A/K^4"'C:A._W
M=^=LX+W^X>HF_)>0,6F%<,@0<9E+ZSZ_;(5H=N;8UXOSI$M,Q(O^_DJ(%/;[
M1Q0@^TQO8-NPFB+^"LL:,!@CT9B__ND0MO-RZ>/^?M.SNF^>.N%QZ:DC]C>X
MQ9T25#4XR]J=Z2W<+>BGP_#17<-R+/+J<<\U..Q:)58.=T>IJBHU5+UN^2E?
MFF&Q>'"-_![LM+ON'S- S8([W/YN<V[!7R*_USRNA6!(0$EXH.6D04#Z<)OC
M8 3;X\@'*6(0*<CH@"[^78Z_I"";A%VP?;E)Q]@;ZCB,L[<F*LP$ALY@AL/A
MSK[ 4QJA(2\VU/_&^^\1/N=J).(CZS$0Q:*$@!@I(8,XKX=5+YBFR&9*(@'A
MF;13VFP(7QM1]<CX9W,O;(S SAHM&R-P8P1^FQQ4H1J&'ZC+)$JF%.G.#4@Q
M=K51!I/@I)W8T/EB4G^C0[ZE#KD?M_;Y&N.;Q>(V.F7=9OS9:)T.Q$R?JU[Z
M)2R#I!)R6YN+MFU%#<K>*PL@5=0=3;0"=WUYY;0OX"R.%:/KV^94\<E7J]D4
M]U0Z,Y-.+3%\@ "GOME-Y6J&X((UG5%UI.M$V8FV,P1R<CG:)#8K"O>X,L^N
MN)>Z%&KH@@'*FDX+I"YFG QQ.5,T FDSF+_T%D?87Z33_D:IS W8^@'<X<L.
MX0XWF>Y-IGNIW-W>\\IT;_+8*XL$/)RE[F:T9]!93V>596)S/=R-F[59[N_#
MQUOI?C@;+?3C>M1?T2%!(4>P4!.L];>=H-S>/+K(]Z&TZV-G96G6 C Q7BR7
M1>M>@#++>UX@4LA<UB/VN&)4V-Y1_U6G;4N#"KN8A^Y8<V38QJSY,GJN$XNY
M,5J^S6)N3))'8.+:W8"7PL.U(64:4V9 9?AS%U;V *[,@Y6MQL)I%0"MBX'3
MX0SL=X;BV2CLKCBF&Y7^72UWEY5^)S!0K.@_%_^T 4"MI_I]'D&(H\/^RTYG
M<9!YZ,HM9W^6$8=O ?48])N\,ZV]"S^AVHROJNG:XVBMO![',PQ';%;Z&ZUT
M-\R6O?Y@SJ$_Z!]\HZWPH+K2"_"+Y$T,[45AHQ/(L#M*I/')O.Z=#EL]4X>
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MJ"AU@9@VCI5$D=*Q,\#1U#'D2#8D0AM;H* U0R)(P3U\<6V) C/XBP%PM#T
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MVM4NW[A_67WZRZ#[[A+J_P!02P,$%     @ V#N/6LLRB2XX"   I2H  !@
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M/8(IW1^8=FOUKIF'MTRAZ$>X;%;[/)8J)N'Z-%>[=S&9SV/ 13&2RZ4BEU
M@IIP96D/4BRU>DR5O"#,9=*5+*86:$4R78"E4A"R:>0@3]BB1,P#>S2@<D_Q
M@%-I:SWN4KY- ZG1E"N3ANW25#9G6Y(4BL$@#5(VG3(*A/MY3 VWPRUKQ"*=
MHX<K#I9K&GSSF!$$_:(_"[Z";O<+R-[^ +G@VU4<[\Q8:W#>G>MV1C56PH0'
M!JQ4B90:4J<*0#>5I4$PE4&))N";4X_'7,],AM\TK%E;%G@64VY9K(@N5:8V
M=SP4#F6YS(!I92L2WQ<RL ;8&G7,4A0:,:"-%I:9-6-$4'\[^&)M\0ST_6P
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M+L!MO9A9?+IKHL?V>NI?4$L#!!0    ( -@[CUK.T7P#E@0  '02   8
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MT&UZ;E*S0A4<MCM-%T_+R 550<F<*JHOPZCP4GI[#Q+CBC!5E QKO6G)K"B
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M=79.<8;&BP@0W$AU1V6<8]6+5JPE19H24I7EJ:OGIL8:_RJ$1C<9C?/P /6
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M2P$"% ,4    " #8.X]:;L=F$ (1  #RNP  $0              @ %_!P0
M861V;2TR,#(T,3(S,2YX<V102P$"% ,4    " #8.X]:&SH5GE,?  #?*P$
M%0              @ &P& 0 861V;2TR,#(T,3(S,5]C86PN>&UL4$L! A0#
M%     @ V#N/6M4H7#^H90  25X$ !4              ( !-C@$ &%D=FTM
M,C R-#$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( -@[CUJ-/K/]-Y," "HC P 4
M              "  1&>! !A9'9M+3(P,C0Q,C,Q7V<Q+FIP9U!+ 0(4 Q0
M   ( -@[CUH<RERJVK@! -?G 0 5              "  7HQ!P!A9'9M+3(P
M,C0Q,C,Q7V<Q,"YJ<&=02P$"% ,4    " #8.X]:TB-)OJ?Y 0"^<@( %0
M            @ &'Z@@ 861V;2TR,#(T,3(S,5]G,3$N:G!G4$L! A0#%
M  @ V#N/6DA E*2)Q $ WP<" !0              ( !8>0* &%D=FTM,C R
M-#$R,S%?9S(N:G!G4$L! A0#%     @ V#N/6M@Y13DPT@$ S3 " !0
M         ( !'*D, &%D=FTM,C R-#$R,S%?9S,N:G!G4$L! A0#%     @
MV#N/6EEA24,\I ( K1D# !0              ( !?GL. &%D=FTM,C R-#$R
M,S%?9S0N:G!G4$L! A0#%     @ V#N/6DO<V#=&!@( T6L" !0
M     ( ![!\1 &%D=FTM,C R-#$R,S%?9S4N:G!G4$L! A0#%     @ V#N/
M6@TF!D,/9 ( 6,$" !0              ( !9"83 &%D=FTM,C R-#$R,S%?
M9S8N:G!G4$L! A0#%     @ V#N/6H]$"R\PL@$ MP," !0
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M+FAT;5!+ 0(4 Q0    ( -@[CUKU\A4YXT4  .$1 @ 8              "
M <=W'0!A9'9M+3(P,C0Q,C,Q>&5X>#$Y,2YH=&U02P$"% ,4    " #8.X]:
MR7>B_-$"  !%#P  &               @ '@O1T 861V;2TR,#(T,3(S,7AE
M>'@R,3$N:'1M4$L! A0#%     @ V#N/6@/KGA"$!   J"(  !@
M     ( !Y\ = &%D=FTM,C R-#$R,S%X97AX,C,Q+FAT;5!+ 0(4 Q0    (
M -@[CUHL$@DX, @  (LJ   8              "  :'%'0!A9'9M+3(P,C0Q
M,C,Q>&5X>#,Q,2YH=&U02P$"% ,4    " #8.X]:RS*)+C@(  "E*@  &
M            @ $'SAT 861V;2TR,#(T,3(S,7AE>'@S,3(N:'1M4$L! A0#
M%     @ V#N/6L[1? .6!   =!(  !@              ( !==8= &%D=FTM
M,C R-#$R,S%X97AX,S(Q+FAT;5!+ 0(4 Q0    ( -@[CUK(D@:JAP0  #L1
M   8              "  4';'0!A9'9M+3(P,C0Q,C,Q>&5X>#,R,BYH=&U0
52P4&     !D &0"3!@  _M\=

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>advm-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:advm="http://www.adverum.com/20241231"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="advm-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">advm:RedwoodCaliforniaFacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">advm:CashEquivalentsAndShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">advm:CashEquivalentsAndShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LexeoTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-25</startDate>
            <endDate>2021-01-25</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">advm:LexeoTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">advm:RayTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-08</startDate>
            <endDate>2021-01-08</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-08</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-26</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:SubleaseTenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:LandlordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:SubleaseTenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:LandlordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LandlordMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:SubleaseTenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:LandlordMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">advm:SubleaseTenantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-07</startDate>
            <endDate>2024-02-07</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">advm:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">advm:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:TwoDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-07</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">advm:TwoDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-07</startDate>
            <endDate>2024-02-07</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:A2024EquityIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">advm:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandSeventeenInducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandFourteenPlanAndInducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">advm:IncentiveStockOptionsAndNonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandFourteenPlanAndInducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">advm:TwoThousandAndFourteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">advm:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">advm:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-04-07</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">advm:LossContingencyLienOnSubtenantsLeaseholdInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-07</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001501756</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>advm:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>advm:security</measure>
    </unit>
    <unit id="lease">
        <measure>advm:lease</measure>
    </unit>
    <unit id="director">
        <measure>advm:director</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-33">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-35">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-36">0001501756</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-35" id="f-442">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="c-1" decimals="2" id="f-454" unitRef="number">0.10</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-719"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-36579</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Adverum Biotechnologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">20-5258327</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">100 Cardinal Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">94063</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">656-9323</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.0001&#160;per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ADVM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-26">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c-1" id="f-27">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-28">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-5" id="f-30" unitRef="usd">136700000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">20890540</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">Portions of the definitive proxy statement (the Proxy Statement) for the 2025 Annual Meeting of Stockholders of the registrant are incorporated by reference into Part III of this Annual Report on Form 10-K. If the Proxy Statement is not filed by April 30, 2025, then the registrant will file an amendment to this Form 10-K on Form 10-K/A to include the Part III information in this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-37">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risk Management and Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third-party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data (&#x201c;Information Systems and Data&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our information security function, which includes our Vice President of Information Technology (&#x201c;IT&#x201d;) and third-party service providers, legal department and security committee, helps identify, assess, and manage the Company&#x2019;s cybersecurity threats and risks. Our information security function identifies and assesses risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods including, for example: using automated tools, conducting audits, evaluating threats, and performing vulnerability assessments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the environment, systems, and data at issue, we implement and maintain various technical, physical, and organizational measures, processes, and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: cybersecurity insurance, physical security, incident detection and response, access controls, employee training, penetration testing, and systems monitoring.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assessment and management of material risks from cybersecurity threats are integrated into the Company&#x2019;s overall risk management processes. For example, our Vice President of IT, works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use third-party service providers to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats, including for example: cybersecurity software providers, managed cybersecurity service providers, penetration testing firms, and cybersecurity consultants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use third-party service providers to perform a variety of functions throughout our business, such as contract research organizations, contract manufacturing organizations, and supply chain resources. We have a vendor management process to manage cybersecurity risks associated with certain of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of diligence designed to help identify cybersecurity risks associated with a provider such as risk assessments and reviewing security assessments and reports. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including the risk factor entitled: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;If our information technology systems or those third parties with whom we work, or our data, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; material disruption of our product development programs; and other adverse consequences.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-38">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third-party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and clinical trial data (&#x201c;Information Systems and Data&#x201d;).&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-41">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-42">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-43">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Governance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#x2019;s overall risk management strategy, and helping prepare for cybersecurity incidents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#x2019;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#x2019;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents. &lt;/span&gt;&lt;/div&gt;The Board of Directors receives periodic reports from the management concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Board of Directors also has access to various reports, summaries or presentations related to cybersecurity threats, risk, and mitigation.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-45">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/div&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-44">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function. The Board of Directors is responsible for overseeing Company&#x2019;s cybersecurity risk management processes, including oversight of mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-46">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies. &lt;/span&gt;&lt;/div&gt;Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#x2019;s overall risk management strategy, and helping prepare for cybersecurity incidents.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-47">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Vice President of IT, who holds a Bachelor of Science in Computer Methods from California State University-Long Beach and has previously served as a Director and Associate Director of IT for large pharmaceutical companies</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-48">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our management, including our Chief Operating Officer and Vice President of IT, is responsible for hiring appropriate information security personnel, helping to integrate cybersecurity risk considerations into the Company&#x2019;s overall risk management strategy, and helping prepare for cybersecurity incidents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#x2019;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#x2019;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents. &lt;/span&gt;&lt;/div&gt;The Board of Directors receives periodic reports from the management concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Board of Directors also has access to various reports, summaries or presentations related to cybersecurity threats, risk, and mitigation.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-49">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-50">Our cybersecurity incident response processes are designed to escalate certain cybersecurity incidents to members of management depending on the circumstances, including our Vice President of IT and General Counsel, who work with the Company&#x2019;s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company&#x2019;s incident response process includes reporting to the Audit Committee of the Board of Directors for certain cybersecurity incidents.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-51">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-52">42</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-53">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-54">San Francisco, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">60652000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">75000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">65039000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">21526000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">5609000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">6247000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">131300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">102773000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">33611000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">35024000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">11607000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">14764000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">1347000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">1231000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">179841000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">155768000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">1610000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">1921000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">15620000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">12584000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">5668000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">5476000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">22898000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">19981000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">86037000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">68565000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">192000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-84" unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">109127000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">88546000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-87" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-88" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-90"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-91" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-92" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-93" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-94" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-95" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-96" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-99"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-100"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-101" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-102" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-3" id="f-103" unitRef="shares">20848000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-3" id="f-104" unitRef="shares">20848000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="-3" id="f-105" unitRef="shares">10143000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="-3" id="f-106" unitRef="shares">10143000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-107" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-109" unitRef="usd">1138070000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">1003718000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-111" unitRef="usd">-407000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">-473000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-113" unitRef="usd">-1066951000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">-936024000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">70714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-116" unitRef="usd">67222000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">179841000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">155768000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-120" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-121" unitRef="usd">77041000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">77486000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">63118000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-124" unitRef="usd">55056000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-125" unitRef="usd">140159000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-126" unitRef="usd">132542000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">-139159000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-128" unitRef="usd">-128942000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-129" unitRef="usd">8232000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-130" unitRef="usd">5748000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">-130927000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-132" unitRef="usd">-123194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-133" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">-130927000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-137" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">105000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-6" decimals="-3" id="f-139" unitRef="usd">1057000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">-39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-141" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">-130861000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">-121058000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-144"
      unitRef="usdPerShare">-6.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-145"
      unitRef="usdPerShare">-6.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-146"
      unitRef="usdPerShare">-12.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-147"
      unitRef="usdPerShare">-12.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-148" unitRef="shares">19782000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-149" unitRef="shares">19782000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-150" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-151" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-3" id="f-152" unitRef="shares">10012000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-153" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-154" unitRef="usd">985660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-155" unitRef="usd">-1531000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-156" unitRef="usd">-813908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-157" unitRef="usd">170222000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-158" unitRef="usd">17569000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">17569000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-14" decimals="-3" id="f-160" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-13" decimals="-3" id="f-161" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-162" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-14" decimals="-3" id="f-163" unitRef="shares">82000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-13" decimals="-3" id="f-164" unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-6" decimals="-3" id="f-165" unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-14" decimals="-3" id="f-166" unitRef="shares">49000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-15" decimals="-3" id="f-167" unitRef="usd">1057000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-6" decimals="-3" id="f-168" unitRef="usd">1057000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-169" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-170" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-171" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-172" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-173" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="-3" id="f-174" unitRef="shares">10143000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-175" unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-176" unitRef="usd">1003718000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-177" unitRef="usd">-473000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-178" unitRef="usd">-936024000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-179" unitRef="usd">67222000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-3" id="f-180" unitRef="usd">14350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-181" unitRef="usd">14350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="INF" id="f-182" unitRef="usd">8449000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-21" decimals="-3" id="f-183" unitRef="shares">10573000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-184" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-185" unitRef="usd">119360000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-186" unitRef="usd">119361000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-21" decimals="-3" id="f-187" unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-20" decimals="-3" id="f-188" unitRef="usd">146000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-189" unitRef="usd">146000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-21" decimals="-3" id="f-190" unitRef="shares">88000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-20" decimals="-3" id="f-191" unitRef="usd">496000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-3" id="f-192" unitRef="usd">496000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-21" decimals="-3" id="f-193" unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-22" decimals="-3" id="f-194" unitRef="usd">105000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">105000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-22" decimals="-3" id="f-196" unitRef="usd">-39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-197" unitRef="usd">-39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-198" unitRef="usd">-130927000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">-130927000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-24" decimals="-3" id="f-200" unitRef="shares">20848000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-201" unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-202" unitRef="usd">1138070000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-203" unitRef="usd">-407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-204" unitRef="usd">-1066951000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-205" unitRef="usd">70714000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-206" unitRef="usd">-130927000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-207" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-208" unitRef="usd">3653000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-209" unitRef="usd">5644000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-210" unitRef="usd">14350000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-211" unitRef="usd">17569000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-212" unitRef="usd">1907000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-6" decimals="-3" id="f-213" unitRef="usd">1935000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">7495000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-3" id="f-215" unitRef="usd">18257000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-1" decimals="-3" id="f-216" unitRef="usd">14000000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-6" decimals="-3" id="f-217" unitRef="usd">-89000</advm:NonCashSubleaseLossIncome>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-218" unitRef="usd">-2000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-6" decimals="-3" id="f-219" unitRef="usd">-50000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">39000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-6" decimals="-3" id="f-221" unitRef="usd">-225000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-222" unitRef="usd">-638000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-6" decimals="-3" id="f-223" unitRef="usd">-298000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-224" unitRef="usd">68000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-225" unitRef="usd">-182000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-226" unitRef="usd">-262000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-6" decimals="-3" id="f-227" unitRef="usd">-369000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="-3" id="f-228" unitRef="usd">3021000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-6" decimals="-3" id="f-229" unitRef="usd">-5396000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-230" unitRef="usd">-2418000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-231" unitRef="usd">-3222000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">-92462000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-233" unitRef="usd">-90902000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">101901000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-6" decimals="-3" id="f-235" unitRef="usd">36718000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-1" decimals="-3" id="f-236" unitRef="usd">60400000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-6" decimals="-3" id="f-237" unitRef="usd">134401000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">388000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-239" unitRef="usd">808000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-240" unitRef="usd">-41889000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-241" unitRef="usd">96875000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-1" decimals="-3" id="f-242" unitRef="usd">119361000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-6" decimals="-3" id="f-243" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-244" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-6" decimals="-3" id="f-245" unitRef="usd">420000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-246" unitRef="usd">146000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-247" unitRef="usd">1000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-1" decimals="-3" id="f-248" unitRef="usd">496000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-6" decimals="-3" id="f-249" unitRef="usd">488000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-250" unitRef="usd">120003000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-251" unitRef="usd">69000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-252" unitRef="usd">-14348000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-253" unitRef="usd">6042000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-254" unitRef="usd">76976000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-3" id="f-255" unitRef="usd">70934000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-256" unitRef="usd">62628000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-257" unitRef="usd">76976000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-258" unitRef="usd">60652000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-259" unitRef="usd">75000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-260" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-262" unitRef="usd">62628000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-263" unitRef="usd">76976000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue contextRef="c-4" decimals="-3" id="f-264" unitRef="usd">0</advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue>
    <advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue contextRef="c-5" decimals="-3" id="f-265" unitRef="usd">14903000</advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-1" decimals="-3" id="f-266" unitRef="usd">0</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-6" decimals="-3" id="f-267" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-6" decimals="-3" id="f-268" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-269" unitRef="usd">201000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-6" decimals="-3" id="f-270" unitRef="usd">91000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-271">Description of the Business &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nature of the Business&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Adverum Biotechnologies, Inc. (the &#x201c;Company&#x201d; or &#x201c;Adverum&#x201d;) was incorporated in Delaware on July 17, 2006 and is headquartered in Redwood City, California. The Company aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. The Company develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Going Concern, Liquidity, Risks and Uncertainties&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company has devoted substantially all of its efforts to product development and has not realized product sales revenues from its planned principal operations. The Company has a limited operating history, and the sales and income potential of the Company&#x2019;s business and market are unproven. The Company has experienced net losses since its inception and, as of December&#160;31, 2024, had an accumulated deficit of $1.1 billion. The Company used $92.5 million of cash in operations during the year ended December&#160;31, 2024. The Company expects to continue to incur net losses and operating cash outflows for at least the next several years. A successful transition to attaining profitable operations is dependent upon achieving a level of revenue adequate to support the Company&#x2019;s cost structure. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company had cash, cash equivalents and short-term investments of $125.7 million, which are expected to fund the Company&#x2019;s operations into the second half of 2025. The Company has determined that its cash and cash equivalents as of December&#160;31, 2024 would be insufficient to fund its operations for a period of at least twelve months from the date these financial statements are issued, which raises substantial doubt regarding the Company&#x2019;s ability to continue as a going concern. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial statements have been prepared using the going concern basis of accounting, which contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management expects operating losses to continue for the foreseeable future. The Company plans to raise substantial additional capital to continue as a going concern, including through &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;public or private &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;equity or debt financings, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;third-party funding, revenue interest arrangements, collaborations, strategic alliances and licensing arrangements, or any combination of these approaches&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. If the Company is unable to raise capital or enter into such agreements as and when needed, it may have to delay, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;limit, reduce or terminate its product development programs, commercialization efforts or other operations, or to cease operations or liquidate its assets&lt;/span&gt;. Although the Company has been successful in raising capital in the past, there is no assurance that it will be successful in obtaining such additional financing. Therefore, it is not considered probable that the Company&#x2019;s plans to raise additional capital will alleviate the substantial doubt regarding its ability to continue as a going concern.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-8" id="f-272" unitRef="usd">-1100000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-273" unitRef="usd">-92500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-4" decimals="-5" id="f-274" unitRef="usd">125700000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:ErrorCorrectionTextBlock contextRef="c-1" id="f-275">Restatement of Previously Issued Financial Statements&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has restated herein its audited consolidated financial statements for the year ended December&#160;31, 2023 in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 250, Accounting Changes and Error Corrections. In March 2025, the Company discovered that there were errors in its lease accounting related to tenant improvement allowances in connection with an operating lease agreement for a building in North Carolina, which the Company entered into in January 2021 and subsequently subleased in October 2021 (the operating lease agreement and sublease agreements, with their respective amendments, collectively, the &#x201c;NC Leases&#x201d;). The Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for tenant improvement allowances that were conveyed to the subtenant, resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has also restated interim period financial statements for the first, second and third quarters of 2024 and 2023 as a result of these errors. See Note 14 Quarterly Financial Information (Unaudited) for additional information on the restated interim financial statements for the first, second, and third quarters of 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of this restatement, the Company has corrected certain other immaterial errors. While these other errors are quantitatively and qualitatively immaterial, individually and in the aggregate, because the Company is restating its consolidated financial statements for material errors, the Company has corrected other immaterial errors as well. These adjustments are described in more detail in references (b) and (c) and elsewhere in the section titled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Other Adjustments&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other Adjustments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adjustments to correct other errors that are quantitatively and qualitatively immaterial, individually and in the aggregate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $0.2&#160;million in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The Company had previously understated its right-of-use assets and lease liability by $0.3&#160;million related to its facilities in Redwood City, California at each balance sheet in 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also identified certain errors as a result of imprecise calculations related to its research and development tax credits that should have been corrected in the consolidated financial statements for the year ended December 31, 2023. Such amounts are deemed immaterial to the Company&#x2019;s income tax provision for the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remainder of the notes to the Company&#x2019;s financial statements have been restated, as applicable, to reflect the impacts from the restatement discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Impact of the Restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables represent the restated amounts in the Consolidated Balance Sheet, Statement of Operations and Comprehensive Loss, and Statement of Cash Flows for the year ended December&#160;31, 2023 (in thousands, except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts as previously reported for fiscal year 2023 were derived from the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2023, filed on March 18, 2024 and the amounts previously reported for the unaudited condensed consolidated quarterly financial information for the quarterly periods in the years ended December 31, 2023 and 2024 were derived from the Company&#x2019;s Quarterly Reports on Form 10-Q for the quarterly periods within those years (the &#x201c;Previously Reported Amounts&#x201d;). The Previously Reported Amounts are labeled as &#x201c;As Reported&#x201d; in the tables below. The amounts labeled &#x201c;Adjustment&#x201d; represent the effects of this restatement described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cumulative effect of the error on periods prior to 2023 was $11.3&#160;million which is included in the beginning balance of the accumulated deficit of the restated Consolidated Balance Sheet for the year ended December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2023: 10,143 shares issued and outstanding at December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(919,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive gain:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impact on net cash used in operating activities or within any line items within investing and financing activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-28" decimals="-5" id="f-276" unitRef="usd">-200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-29" decimals="-5" id="f-277" unitRef="usd">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability contextRef="c-29" decimals="-5" id="f-278" unitRef="usd">300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-30" decimals="-5" id="f-279" unitRef="usd">-11300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="c-1" id="f-280">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,933)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $0.0001 par value, 5,000 shares authorized; no shares issued and outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.0001 par value, 300,000 shares authorized at December 31, 2023: 10,143 shares issued and outstanding at December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(919,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Statement of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118,243)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive gain:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-3" id="f-281" unitRef="usd">75000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-32" decimals="-3" id="f-282" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-283" unitRef="usd">75000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-31" decimals="-3" id="f-284" unitRef="usd">21526000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-32" decimals="-3" id="f-285" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-3" id="f-286" unitRef="usd">21526000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-31" decimals="-3" id="f-287" unitRef="usd">6247000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-32" id="f-288" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-289" unitRef="usd">6247000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-31" decimals="-3" id="f-290" unitRef="usd">102773000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-32" decimals="-3" id="f-291" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-292" unitRef="usd">102773000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-31" decimals="-3" id="f-293" unitRef="usd">52266000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-32" decimals="-3" id="f-294" unitRef="usd">-17242000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-295" unitRef="usd">35024000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-31" decimals="-3" id="f-296" unitRef="usd">14764000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-32" decimals="-3" id="f-297" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-298" unitRef="usd">14764000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-31" decimals="-3" id="f-299" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-32" decimals="-3" id="f-300" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-301" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-31" decimals="-3" id="f-302" unitRef="usd">1231000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-32" id="f-303" unitRef="usd" xsi:nil="true"/>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-304" unitRef="usd">1231000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-31" decimals="-3" id="f-305" unitRef="usd">173010000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-32" decimals="-3" id="f-306" unitRef="usd">-17242000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-307" unitRef="usd">155768000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-31" decimals="-3" id="f-308" unitRef="usd">1921000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-32" decimals="-3" id="f-309" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-310" unitRef="usd">1921000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-31" decimals="-3" id="f-311" unitRef="usd">12584000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-32" decimals="-3" id="f-312" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-313" unitRef="usd">12584000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-31" decimals="-3" id="f-314" unitRef="usd">10409000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-32" decimals="-3" id="f-315" unitRef="usd">-4933000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-316" unitRef="usd">5476000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-31" decimals="-3" id="f-317" unitRef="usd">24914000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-32" decimals="-3" id="f-318" unitRef="usd">-4933000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-319" unitRef="usd">19981000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-31" decimals="-3" id="f-320" unitRef="usd">64627000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-32" decimals="-3" id="f-321" unitRef="usd">3938000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-322" unitRef="usd">68565000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-31" decimals="-3" id="f-323" unitRef="usd">89541000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-32" decimals="-3" id="f-324" unitRef="usd">-995000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-325" unitRef="usd">88546000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-31" id="f-326" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-32" id="f-327" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-328" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-329"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-330"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-331" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-332" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-333" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-334" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-335" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-336" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-31" decimals="-3" id="f-337" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-32" decimals="-3" id="f-338" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-339" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-340"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-341"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-342" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-343" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="-3" id="f-344" unitRef="shares">10143000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="-3" id="f-345" unitRef="shares">10143000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-31" decimals="-3" id="f-346" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-32" decimals="-3" id="f-347" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-348" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-31" decimals="-3" id="f-349" unitRef="usd">1003718000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-32" decimals="-3" id="f-350" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-351" unitRef="usd">1003718000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-31" decimals="-3" id="f-352" unitRef="usd">-473000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-32" decimals="-3" id="f-353" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-354" unitRef="usd">-473000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-31" decimals="-3" id="f-355" unitRef="usd">-919777000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-32" decimals="-3" id="f-356" unitRef="usd">-16247000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-357" unitRef="usd">-936024000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-358" unitRef="usd">83469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-359" unitRef="usd">-16247000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-360" unitRef="usd">67222000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-31" decimals="-3" id="f-361" unitRef="usd">173010000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-32" decimals="-3" id="f-362" unitRef="usd">-17242000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-363" unitRef="usd">155768000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-33" decimals="-3" id="f-364" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-34" decimals="-3" id="f-365" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-366" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-33" decimals="-3" id="f-367" unitRef="usd">77676000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-34" decimals="-3" id="f-368" unitRef="usd">-190000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-369" unitRef="usd">77486000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-33" decimals="-3" id="f-370" unitRef="usd">49915000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-34" decimals="-3" id="f-371" unitRef="usd">5141000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-372" unitRef="usd">55056000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-33" decimals="-3" id="f-373" unitRef="usd">127591000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-34" decimals="-3" id="f-374" unitRef="usd">4951000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-6" decimals="-3" id="f-375" unitRef="usd">132542000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-33" decimals="-3" id="f-376" unitRef="usd">-123991000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-34" decimals="-3" id="f-377" unitRef="usd">-4951000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-378" unitRef="usd">-128942000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-33" decimals="-3" id="f-379" unitRef="usd">5748000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-34" decimals="-3" id="f-380" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-381" unitRef="usd">5748000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-382" unitRef="usd">-118243000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-383" unitRef="usd">-4951000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-384" unitRef="usd">-123194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-33" decimals="-3" id="f-385" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-34" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-387" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-388" unitRef="usd">-117165000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-389" unitRef="usd">-4951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-390" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-33" decimals="-3" id="f-391" unitRef="usd">1057000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-34" decimals="-3" id="f-392" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-6" decimals="-3" id="f-393" unitRef="usd">1057000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-33" decimals="-3" id="f-394" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-34" decimals="-3" id="f-395" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-396" unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-33" decimals="-3" id="f-397" unitRef="usd">-116107000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-34" decimals="-3" id="f-398" unitRef="usd">-4951000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-399" unitRef="usd">-121058000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-33"
      decimals="2"
      id="f-400"
      unitRef="usdPerShare">-11.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-33"
      decimals="2"
      id="f-401"
      unitRef="usdPerShare">-11.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-34"
      decimals="2"
      id="f-402"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-34"
      decimals="2"
      id="f-403"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-404"
      unitRef="usdPerShare">-12.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-405"
      unitRef="usdPerShare">-12.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-33" decimals="-3" id="f-406" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-33" decimals="-3" id="f-407" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-34" decimals="-3" id="f-408" unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-34" decimals="-3" id="f-409" unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-410" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-411" unitRef="shares">10082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-412" unitRef="usd">-117165000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-413" unitRef="usd">-4951000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-414" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-33" decimals="-3" id="f-415" unitRef="usd">13027000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-34" decimals="-3" id="f-416" unitRef="usd">5230000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-3" id="f-417" unitRef="usd">18257000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-33" decimals="-3" id="f-418" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-34" decimals="-3" id="f-419" unitRef="usd">-89000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-6" decimals="-3" id="f-420" unitRef="usd">-89000</advm:NonCashSubleaseLossIncome>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-33" decimals="-3" id="f-421" unitRef="usd">-5206000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-34" decimals="-3" id="f-422" unitRef="usd">-190000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-6" decimals="-3" id="f-423" unitRef="usd">-5396000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-33" decimals="-3" id="f-424" unitRef="usd">13711000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-34" decimals="-3" id="f-425" unitRef="usd">-6079000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-6" decimals="-3" id="f-426" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities contextRef="c-6" decimals="-3" id="f-427" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseLiabilityAndRightOfUseAssetsAndLiabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-428">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company&#x2019;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United&#160;States of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain, and the actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March 2024 Reverse Stock Split&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;On March 21, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the reverse stock split. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All equity related information including per share amounts for all periods presented in these consolidated financial statements and the notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where the local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Upon sale or upon complete or substantially complete liquidation of an investment in a foreign entity, the amount attributable to that entity and accumulated in the translation adjustment component of equity is removed from the separate component of equity and reported as part of the gain or loss on sale or liquidation of the investment for the period during which the sale or liquidation occurs. Income and expense accounts are translated at average exchange rates for the period. Transactions which are not in the functional currency of the entity are remeasured into the functional currency and gains or losses resulting from the remeasurement recorded in other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company considers all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks, money market accounts and highly liquid debt securities. Cash equivalents are stated at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Restricted cash primarily consists of cash collateral to letter of credit provided to the landlord in relation to a lease agreement. See Note 6, Leases for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Short-Term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;All short-term investments in debt securities have been classified as &#x201c;available for sale&#x201d; and are carried at fair value. Unrealized gains and losses, net of any related tax effects, are excluded from earnings and are included in other comprehensive loss and reported as a separate component of stockholders&#x2019; equity until realized. The cost of securities sold is based on the specific-identification method. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Interest on short-term investments is included in other income, net in the Company&#x2019;s consolidated statements of operations and comprehensive loss. In accordance with the Company&#x2019;s investment policy, management invests to diversify credit risk and only invests in securities with high credit quality, including U.S. government securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses available-for-sale debt securities on a quarterly basis to see whether any unrealized loss is due to credit-related factors. Factors considered in determining whether an impairment is credit-related include the extent to which the investment&#x2019;s fair value is less than its cost basis, declines in published credit ratings, changes in interest rates, and any other adverse factors related to the security. If it is determined that a credit-related impairment exists, the Company will measure the credit loss based on a discounted cash flow model. Credit-related impairments on available-for-sale debt securities are recognized as an allowance for credit losses with a corresponding adjustment to other income, net in the Company&#x2019;s consolidated statement of operations. The unrealized loss position that is not credit-related is recorded, net of any related tax effects, in other comprehensive income until realized. There were no credit-related losses recognized for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Interest Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Accrued interest receivable related to the Company&#x2019;s available-for-sale debt securities is presented within prepaid expenses and other current assets on the Company&#x2019;s consolidated balance sheets. The Company has elected to exclude accrued interest receivable from both the fair value and the amortized cost basis of available-for-sale debt securities for the purposes of identifying and measuring any impairment. The Company writes off accrued interest receivable once it has determined that the asset is not realizable. Any write offs of accrued interest receivable are recorded by reversing interest income, recognizing credit loss expense, or a combination of both. To date, the Company has not written off any accrued interest receivables associated with its available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing gene therapeutics. The Company&#x2019;s chief executive officer, who is the chief operating decision maker (&#x201c;CODM&#x201d;), assesses segment performance and decides how to allocate resources based on total operating expenses as reported on the consolidated statements of operations and comprehensive loss. See Note 11, Segment Reporting, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Other Uncertainties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Risks associated with cash, cash equivalents, short-term investments are mitigated by the Company&#x2019;s investment policy, which limits the Company&#x2019;s investing to securities having specified credit ratings. Management believes that the Company is not exposed to significant credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to certain risks and uncertainties, including, but not limited to changes in any of the following areas that the Company believes could have a material adverse effect on future financial position or results of operations: the ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, the Company&#x2019;s product candidates; performance of third-party clinical research organizations and manufacturers; development of sales channels; protection of intellectual property; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; and the Company&#x2019;s ability to attract and retain employees necessary to support growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets, generally &lt;span style="-sec-ix-hidden:f-442"&gt;three&lt;/span&gt; to five years. Leasehold improvements are capitalized and amortized over the shorter period of their expected lives or the lease term. Major replacements and improvements are capitalized, while general repairs and maintenance are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there is an indication of impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For long-term operating leases, the Company recognizes a right-of-use asset and a lease liability on the Company's consolidated balance sheets. The Company determines if an arrangement contains a lease and the classification of the lease at inception. An arrangement contains a lease if there is an identified asset and if the Company controls the use of the identified asset throughout the period of use. The lease liability is determined as the present value of future lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when the Company is reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, the Company determines its credit rating, adjusts the credit rating for the nature of the collateral, and benchmarks the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. It bases the ROU asset on the lease liability adjusted for any prepaid or deferred rent. The Company elected to combine lease and non-lease components for all underlying assets groups. The Company determines the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, the Company does not recognize a right-of-use asset and lease liability and recognizes the lease expense over the term of the lease on a straight-line basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. The variable lease payments primarily consist of common area maintenance and other operating costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses the probability of collecting lease payments under its sublease at each reporting date. The Company currently does not deem the collection of lease payments probable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, Revenue from Contracts with Customers, the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Research and development expenses are charged to expense as incurred. Research and development expenses include&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;primarily personnel-related costs, stock-based compensation expense, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with contract research organizations (&#x201c;CROs&#x201d;), the cost of acquiring, developing and manufacturing clinical trial materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advance payments for goods or services for future research and development activities are deferred and expensed as the goods are delivered or the related services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates research and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage nonclinical studies and clinical trials on the Company&#x2019;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers and the Company&#x2019;s estimates of accrued expenses and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The carrying amounts of the Company&#x2019;s financial instruments, including cash equivalents approximate their fair values due to their short-term maturities. See Note 4, Fair Value Measurements for the methodologies and assumptions used in valuing financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Stock-based compensation expense related to stock awards to employees is measured at fair value of the award on the date of the grant.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the grant-date fair value, and the resulting stock-based compensation expense, using the Black-Scholes valuation model for stock options and employee stock purchase and using intrinsic value, which is the closing price of its common stock on the date of the grant, for restricted stock units (&#x201c;RSUs&#x201d;) and performance stock units (&#x201c;PSUs&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expense recognition of PSU and performance-based options commences when the associated performance-based criteria are determined to be probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes valuation model requires the use of following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term assumption represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding and is determined using the simplified method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Expected volatility is based on the Company&#x2019;s historical stock price volatility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the U.S. Treasury zero-coupon issues in effect at the time of grant for periods corresponding with the expected term of option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company accounts for income taxes using the asset and liability method. The Company records deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As of December&#160;31, 2024 and 2023, the Company has recorded a full valuation allowance on its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained upon examination. Interest and penalties related to unrecognized tax liabilities are included within the provision for income tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Comprehensive loss comprises net loss and other comprehensive loss. Other comprehensive loss consists of foreign currency translation adjustments and unrealized gain or loss on marketable securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. Outstanding stock options, RSUs, and employee stock purchase plan (&#x201c;ESPP&#x201d;) are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 requires disaggregated disclosures of certain categories of expenses in the notes to the financial statements that are included in expense line items on the face of the income statement in annual and interim periods. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2023-07&#x201d;). The amendments in ASU 2023-07 are intended to improve reportable segment disclosure, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company retrospectively adopted ASU 2023-07 on December 31, 2024. The adoption of ASU 2023-07 did not have a material financial impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="c-1" id="f-429">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company&#x2019;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United&#160;States of America (&#x201c;U.S.&#160;GAAP&#x201d;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-430">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain, and the actual results could differ from these estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="c-1" id="f-431">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March 2024 Reverse Stock Split&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;On March 21, 2024, the Company effected a 1-for-10 reverse stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the reverse stock split. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All equity related information including per share amounts for all periods presented in these consolidated financial statements and the notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-432">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where the local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Upon sale or upon complete or substantially complete liquidation of an investment in a foreign entity, the amount attributable to that entity and accumulated in the translation adjustment component of equity is removed from the separate component of equity and reported as part of the gain or loss on sale or liquidation of the investment for the period during which the sale or liquidation occurs. Income and expense accounts are translated at average exchange rates for the period. Transactions which are not in the functional currency of the entity are remeasured into the functional currency and gains or losses resulting from the remeasurement recorded in other income, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company considers all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks, money market accounts and highly liquid debt securities. Cash equivalents are stated at fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-434">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Restricted cash primarily consists of cash collateral to letter of credit provided to the landlord in relation to a lease agreement. See Note 6, Leases for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-435">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Short-Term Investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;All short-term investments in debt securities have been classified as &#x201c;available for sale&#x201d; and are carried at fair value. Unrealized gains and losses, net of any related tax effects, are excluded from earnings and are included in other comprehensive loss and reported as a separate component of stockholders&#x2019; equity until realized. The cost of securities sold is based on the specific-identification method. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Interest on short-term investments is included in other income, net in the Company&#x2019;s consolidated statements of operations and comprehensive loss. In accordance with the Company&#x2019;s investment policy, management invests to diversify credit risk and only invests in securities with high credit quality, including U.S. government securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses available-for-sale debt securities on a quarterly basis to see whether any unrealized loss is due to credit-related factors. Factors considered in determining whether an impairment is credit-related include the extent to which the investment&#x2019;s fair value is less than its cost basis, declines in published credit ratings, changes in interest rates, and any other adverse factors related to the security. If it is determined that a credit-related impairment exists, the Company will measure the credit loss based on a discounted cash flow model. Credit-related impairments on available-for-sale debt securities are recognized as an allowance for credit losses with a corresponding adjustment to other income, net in the Company&#x2019;s consolidated statement of operations. The unrealized loss position that is not credit-related is recorded, net of any related tax effects, in other comprehensive income until realized. There were no credit-related losses recognized for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <advm:AccruedInterestReceivablePolicyTextBlock contextRef="c-1" id="f-436">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Interest Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Accrued interest receivable related to the Company&#x2019;s available-for-sale debt securities is presented within prepaid expenses and other current assets on the Company&#x2019;s consolidated balance sheets. The Company has elected to exclude accrued interest receivable from both the fair value and the amortized cost basis of available-for-sale debt securities for the purposes of identifying and measuring any impairment. The Company writes off accrued interest receivable once it has determined that the asset is not realizable. Any write offs of accrued interest receivable are recorded by reversing interest income, recognizing credit loss expense, or a combination of both. To date, the Company has not written off any accrued interest receivables associated with its available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;</advm:AccruedInterestReceivablePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-437">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing gene therapeutics. The Company&#x2019;s chief executive officer, who is the chief operating decision maker (&#x201c;CODM&#x201d;), assesses segment performance and decides how to allocate resources based on total operating expenses as reported on the consolidated statements of operations and comprehensive loss. See Note 11, Segment Reporting, for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-438"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-439"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-440">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Other Uncertainties&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Risks associated with cash, cash equivalents, short-term investments are mitigated by the Company&#x2019;s investment policy, which limits the Company&#x2019;s investing to securities having specified credit ratings. Management believes that the Company is not exposed to significant credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to certain risks and uncertainties, including, but not limited to changes in any of the following areas that the Company believes could have a material adverse effect on future financial position or results of operations: the ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, the Company&#x2019;s product candidates; performance of third-party clinical research organizations and manufacturers; development of sales channels; protection of intellectual property; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; and the Company&#x2019;s ability to attract and retain employees necessary to support growth.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-441">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Property and equipment are recorded at cost, net of accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets, generally &lt;span style="-sec-ix-hidden:f-442"&gt;three&lt;/span&gt; to five years. Leasehold improvements are capitalized and amortized over the shorter period of their expected lives or the lease term. Major replacements and improvements are capitalized, while general repairs and maintenance are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-36" id="f-443">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-444">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there is an indication of impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-445">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For long-term operating leases, the Company recognizes a right-of-use asset and a lease liability on the Company's consolidated balance sheets. The Company determines if an arrangement contains a lease and the classification of the lease at inception. An arrangement contains a lease if there is an identified asset and if the Company controls the use of the identified asset throughout the period of use. The lease liability is determined as the present value of future lease payments and lease incentives over the expected lease term. Lease incentives are included in the measurement of the consideration in the contract at lease commencement when the Company is reasonably certain to incur costs to construct lessee assets. In order to determine the incremental borrowing rate, the Company determines its credit rating, adjusts the credit rating for the nature of the collateral, and benchmarks the borrowing rate against observable yields on comparable securities with a similar term. The incremental borrowing rate, the ROU asset and the lease liability are reevaluated upon a lease modification. It bases the ROU asset on the lease liability adjusted for any prepaid or deferred rent. The Company elected to combine lease and non-lease components for all underlying assets groups. The Company determines the lease term at the commencement date by considering whether renewal options and termination options are reasonably assured of exercise. For short term leases, the Company does not recognize a right-of-use asset and lease liability and recognizes the lease expense over the term of the lease on a straight-line basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense for operating leases is recognized on a straight-line basis over the lease term and is included in operating expenses on the statements of operations and comprehensive loss. The variable lease payments primarily consist of common area maintenance and other operating costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses the probability of collecting lease payments under its sublease at each reporting date. The Company currently does not deem the collection of lease payments probable and therefore sublease income is constrained at the lesser of cash payments or straight-line sublease income. Sublease income/loss for operating leases is classified in general and administrative expenses based on payments collected and tenant improvement allowance disbursed to the subtenant.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-446">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, Revenue from Contracts with Customers, the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price; (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies a performance obligation. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-447">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Research and development expenses are charged to expense as incurred. Research and development expenses include&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;primarily personnel-related costs, stock-based compensation expense, laboratory supplies, consulting costs, external contract research and development expenses, including expenses incurred under agreements with contract research organizations (&#x201c;CROs&#x201d;), the cost of acquiring, developing and manufacturing clinical trial materials, and overhead expenses, such as rent, equipment depreciation, insurance and utilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advance payments for goods or services for future research and development activities are deferred and expensed as the goods are delivered or the related services are performed.&lt;/span&gt;&lt;/div&gt;The Company estimates research and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage nonclinical studies and clinical trials on the Company&#x2019;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers and the Company&#x2019;s estimates of accrued expenses and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company adjusts the accrual accordingly.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-448">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The carrying amounts of the Company&#x2019;s financial instruments, including cash equivalents approximate their fair values due to their short-term maturities. See Note 4, Fair Value Measurements for the methodologies and assumptions used in valuing financial instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-449">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Stock-based compensation expense related to stock awards to employees is measured at fair value of the award on the date of the grant.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the grant-date fair value, and the resulting stock-based compensation expense, using the Black-Scholes valuation model for stock options and employee stock purchase and using intrinsic value, which is the closing price of its common stock on the date of the grant, for restricted stock units (&#x201c;RSUs&#x201d;) and performance stock units (&#x201c;PSUs&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expense recognition of PSU and performance-based options commences when the associated performance-based criteria are determined to be probable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the award that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes valuation model requires the use of following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term assumption represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding and is determined using the simplified method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Expected volatility is based on the Company&#x2019;s historical stock price volatility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the U.S. Treasury zero-coupon issues in effect at the time of grant for periods corresponding with the expected term of option.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-450">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company accounts for income taxes using the asset and liability method. The Company records deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As of December&#160;31, 2024 and 2023, the Company has recorded a full valuation allowance on its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax benefits related to uncertain tax positions are recognized when it is more likely than not that a tax position will be sustained upon examination. Interest and penalties related to unrecognized tax liabilities are included within the provision for income tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-451">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&#x2014;Comprehensive loss comprises net loss and other comprehensive loss. Other comprehensive loss consists of foreign currency translation adjustments and unrealized gain or loss on marketable securities.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-452">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. Outstanding stock options, RSUs, and employee stock purchase plan (&#x201c;ESPP&#x201d;) are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-453">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2024-03&#x201d;). ASU 2024-03 requires disaggregated disclosures of certain categories of expenses in the notes to the financial statements that are included in expense line items on the face of the income statement in annual and interim periods. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires enhanced annual disclosures regarding the rate reconciliation and income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of this guidance on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2023-07&#x201d;). The amendments in ASU 2023-07 are intended to improve reportable segment disclosure, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company retrospectively adopted ASU 2023-07 on December 31, 2024. The adoption of ASU 2023-07 did not have a material financial impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-455">Fair Value Measurements and Fair Value of Financial Instruments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Level 1 securities is determined using quoted prices in active markets for identical assets. Level 1 securities consist of highly liquid money market funds. Financial assets and liabilities are considered Level 2 when their fair values are determined using inputs that are observable in the market or can be derived principally from or corroborated by observable market data such as pricing for similar securities, recently executed transactions, cash flow models with yield curves, and benchmark securities. In addition, Level 2 financial instruments are valued using comparisons to like-kind financial instruments and models that use readily observable market data as their basis. U.S. government and agency securities, commercial paper and corporate bonds are valued primarily using market prices of comparable securities, bid/ask quotes, interest rate yields and prepayment spreads and are included in Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s cash equivalents and short-term investments (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company may sell these securities at any time for use in current operations even if the securities have not yet reached maturity, all marketable securities are classified as current assets in the Company&#x2019;s consolidated balance sheets. As of December&#160;31, 2024, all marketable securities had a remaining maturity of less than one year. The Company held 14 debt securities in an unrealized loss position with an aggregate fair value at December&#160;31, 2024 of $54.2&#160;million. These are highly liquid funds with high credit ratings with final maturity of less than one year from the balance sheet date. There were no individual securities that were in a significant unrealized loss position as of December&#160;31, 2024 and 2023. The Company has not recorded an allowance for credit losses as of December&#160;31, 2024 or 2023 related to these securities. The accrued interest receivable on available-for-sale marketable securities was immaterial at December&#160;31, 2024 or 2023. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. The Company has not recorded any impairment charges on available-for-sale securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c-1" id="f-456">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s cash equivalents and short-term investments (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-37" decimals="-3" id="f-457" unitRef="usd">165000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-37" decimals="-3" id="f-458" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-37" decimals="-3" id="f-459" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-37" decimals="-3" id="f-460" unitRef="usd">165000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-38" decimals="-3" id="f-461" unitRef="usd">78500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-38" decimals="-3" id="f-462" unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-38" decimals="-3" id="f-463" unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-38" decimals="-3" id="f-464" unitRef="usd">78501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-39" decimals="-3" id="f-465" unitRef="usd">41210000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-39" decimals="-3" id="f-466" unitRef="usd">56000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-39" decimals="-3" id="f-467" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-39" decimals="-3" id="f-468" unitRef="usd">41266000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-40" decimals="-3" id="f-469" unitRef="usd">119875000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-40" decimals="-3" id="f-470" unitRef="usd">66000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-40" decimals="-3" id="f-471" unitRef="usd">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-40" decimals="-3" id="f-472" unitRef="usd">119932000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <advm:CashAndCashEquivalentAmortizedCost contextRef="c-4" decimals="-3" id="f-473" unitRef="usd">54901000</advm:CashAndCashEquivalentAmortizedCost>
    <advm:CashAndCashEquivalentGrossUnrealizedGain contextRef="c-4" decimals="-3" id="f-474" unitRef="usd">0</advm:CashAndCashEquivalentGrossUnrealizedGain>
    <advm:CashAndCashEquivalentGrossUnrealizedLoss contextRef="c-4" decimals="-3" id="f-475" unitRef="usd">8000</advm:CashAndCashEquivalentGrossUnrealizedLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-476" unitRef="usd">54893000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-477" unitRef="usd">64974000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-478" unitRef="usd">66000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-479" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-480" unitRef="usd">65039000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-41" decimals="-3" id="f-481" unitRef="usd">10204000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-41" decimals="-3" id="f-482" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-41" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-41" decimals="-3" id="f-484" unitRef="usd">10204000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-42" decimals="-3" id="f-485" unitRef="usd">64693000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-42" decimals="-3" id="f-486" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-42" decimals="-3" id="f-487" unitRef="usd">35000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-42" decimals="-3" id="f-488" unitRef="usd">64658000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-43" decimals="-3" id="f-489" unitRef="usd">17616000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-43" decimals="-3" id="f-490" unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-43" decimals="-3" id="f-491" unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-43" decimals="-3" id="f-492" unitRef="usd">17603000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-44" decimals="-3" id="f-493" unitRef="usd">92513000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-44" decimals="-3" id="f-494" unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-44" decimals="-3" id="f-495" unitRef="usd">52000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-44" decimals="-3" id="f-496" unitRef="usd">92465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <advm:CashAndCashEquivalentAmortizedCost contextRef="c-5" decimals="-3" id="f-497" unitRef="usd">70972000</advm:CashAndCashEquivalentAmortizedCost>
    <advm:CashAndCashEquivalentGrossUnrealizedGain contextRef="c-5" decimals="-3" id="f-498" unitRef="usd">0</advm:CashAndCashEquivalentGrossUnrealizedGain>
    <advm:CashAndCashEquivalentGrossUnrealizedLoss contextRef="c-5" decimals="-3" id="f-499" unitRef="usd">33000</advm:CashAndCashEquivalentGrossUnrealizedLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-500" unitRef="usd">70939000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-5" decimals="-3" id="f-501" unitRef="usd">21541000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-5" decimals="-3" id="f-502" unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-5" decimals="-3" id="f-503" unitRef="usd">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-5" decimals="-3" id="f-504" unitRef="usd">21526000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="c-4"
      decimals="INF"
      id="f-505"
      unitRef="security">14</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-4" decimals="-5" id="f-506" unitRef="usd">54200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-4" decimals="-5" id="f-507" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-5" decimals="-5" id="f-508" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff contextRef="c-6" decimals="-5" id="f-509" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff contextRef="c-1" decimals="-5" id="f-510" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-511">Revenue&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lexeo&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 25, 2021, the Company and Lexeo Therapeutics, Inc (&#x201c;Lexeo&#x201d;) entered into a License Agreement pursuant to which the Company granted Lexeo an exclusive, worldwide, royalty-bearing license to certain of the Company&#x2019;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat cardiomyopathy due to Friedreich&#x2019;s Ataxia. Upon execution of the agreement, Lexeo paid the Company a one-time, non-creditable and non-refundable upfront payment of $7.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreement, the Company is eligible to receive additional payments upon the achievement of certain milestones. Additionally, the Company will receive royalty payments on net sales subject to a cap and reductions based on patent expiry, anti-stacking, and a defined royalty floor percentage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2023, Lexeo notified the Company that it had achieved the first development milestone; accordingly, the Company received and recognized $3.5&#160;million of license revenue during the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Ray&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 6, 2023, the Company and Ray Therapeutics, Inc (&#x201c;Ray&#x201d;) entered into a License Agreement pursuant to which the Company granted Ray a non-exclusive, worldwide, royalty-bearing license to certain of the Company&#x2019;s intellectual property to develop, manufacture, and commercialize a gene therapy product to treat retinitis pigmentosa and the right to develop the technology to treat other ocular diseases and disorders. Under the terms of the agreement, the Company is eligible to receive development, regulatory and commercial milestone payments and royalties on net sales once commercialized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2024, Ray notified the Company that it achieved the first development milestone. Accordingly, the Company recognized $1.0&#160;million of license revenue during the year ended December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ProceedsFromLicenseFeesReceived contextRef="c-45" decimals="-5" id="f-512" unitRef="usd">7500000</us-gaap:ProceedsFromLicenseFeesReceived>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-46" decimals="-5" id="f-513" unitRef="usd">3500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-47" decimals="-5" id="f-514" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-515">Leases&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redwood City&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a lease for facilities in Redwood City, California (&#x201c;Redwood City Premises&#x201d;), which expires December&#160;31, 2031, with an option to extend for a period of eight years. Related to this lease, the Company provided the landlord with a letter of credit, as amended, in the amount of $2.0&#160;million, which is classified as restricted cash under long-term assets on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to September 30, 2023, the Company had two facility leases in Redwood City. In March 2023, the Company entered into an amendment to accelerate the expiration of the lease for one of the facilities in its Redwood City Premises from December 31, 2031 to September 30, 2023. Concurrently, the Company entered into an agreement for additional tenant improvement allowance towards its other Redwood City Premises. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). As a result of the modification the Company revalued the lease liability based on the new and remaining lease terms, which resulted in a reduction to the lease liability of $7.9&#160;million, and recognized the remeasurement to the lease liabilities as an adjustment to the right-of-use asset. The estimated value of non-cash consideration, composed primarily of leasehold improvements and furniture and fixtures, was $14.9&#160;million, which was fully amortized as of September 30, 2023. There was no charge recognized in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;North Carolina&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has restated amounts related to this lease. See Notes 2 and 14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 8, 2021, the Company entered into an operating lease agreement for a building in North Carolina (&#x201c;NC Premises&#x201d;). The lease commenced in April 2021, when the Company obtained control of the NC Premises, and the lease term expires in October 2037 with two options to extend the lease term for a period of five years each.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 26, 2021, the Company entered into a sublease agreement with Jaguar Gene Therapy, LLC (&#x201c;Jaguar&#x201d;) for the NC Premises through October 2037, the remainder of the lease term, and concurrently changed the terms of the head lease. In addition, the remainder of the tenant improvement allowance under the original lease of approximately $22.7&#160;million was transferred to Jaguar.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2023, the Company entered into an amendment of the lease of its NC Premises with the landlord and subtenant. Under this amendment, the parties agreed to substantially reduce the total tenant improvement allowance in exchange for lower monthly rent. The Company accounted for this amendment as a lease modification in accordance with ASC 842-10-25-11(d). The Company remeasured the lease liability, resulting in an increase in the lease liability with a corresponding increase of the right-of-use asset of $0.3&#160;million in the quarter ended June 30, 2023. There was no charge recognized in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, management reassessed the probability of collection of the lease payments from Jaguar over the remaining term of a sublease. At that time, management assessed the collectibility to be less than probable and recognized an adjustment to eliminate the deferred rent receivable as a current period adjustment during the year ended December 31, 2022. Deferred rent receivable was&#160;zero&#160;as of December&#160;31, 2024 and 2023. In April 2023, Jaguar assigned the sublease to Advanced Medicine Partners, LLC (at that time, a wholly-owned subsidiary of Jaguar, &#x201c;AMP&#x201d; or the &#x201c;subtenant&#x201d;) as the subtenant for the NC Premises for the remainder of the lease term. Pursuant to the sublease and the notice and waiver of assignment (the &#x201c;assignment agreement&#x201d;), Jaguar remained obligated for AMP&#x2019;s proper performance under the sublease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2025, a lien totaling $4.8&#160;million was filed by a third&#x2013;party contractor against the subtenant&#x2019;s interest in the NC&#160;Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. Subsequent to December 31, 2024, the subtenant made payments totaling $1.4&#160;million for January and February 2025 rent and drew $2.3&#160;million from the available tenant improvement allowance, at which point the subtenant discontinued rent payments. The Company assumed responsibility for rent payments in March 2025 and as of April 7, 2025 had made payments in the total payment of $1.9&#160;million to satisfy outstanding rent and common area management fee obligations. See Note 15 Subsequent Events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded sublease loss of $14.0&#160;million and sublease income of $0.1&#160;million for the years ended December 31, 2024 and 2023, respectively, which was recognized in general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the weighted-average remaining lease term was 11.2 years for the Company&#x2019;s leases and the weighted-average Incremental Borrowing Rate (&#x201c;IBR&#x201d;) was 11.6%. As of December 31, 2023, the weighted-average remaining lease term was 11.6 years for the Company&#x2019;s leases and the weighted-average IBR was 11.7%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the undiscounted future non-cancellable lease payments under the lease agreements as of December&#160;31, 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Rent expense for the years ended December&#160;31, 2024, and 2023 was $13.3&#160;million and $25.3&#160;million, respectively. Included in rent expense for the years ended December&#160;31, 2024, and 2023 were variable lease costs for utilities, parking, maintenance, and real estate taxes of $2.3 million and $2.4 million, respectively. Cash paid for amounts included in the measurement of lease liabilities was $5.8&#160;million and $7.5&#160;million for the twelve months ended December&#160;31, 2024 and 2023, respectively. During the years ended December&#160;31, 2024 and 2023, the landlord made payments to the subtenant on the Company&#x2019;s behalf for tenant improvement allowances in the amount of $20.5&#160;million and $5.4&#160;million and the subtenant made rent payments to the landlord on the Company&#x2019;s behalf in the amount of $6.5&#160;million and $5.5&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-48" id="f-516">P8Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-49" decimals="-5" id="f-517" unitRef="usd">2000000</us-gaap:RestrictedCashNoncurrent>
    <advm:LesseeOperatingLeaseNumberOfLease contextRef="c-50" decimals="INF" id="f-518" unitRef="lease">2</advm:LesseeOperatingLeaseNumberOfLease>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-51" decimals="-5" id="f-519" unitRef="usd">-7900000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue contextRef="c-52" decimals="-5" id="f-520" unitRef="usd">14900000</advm:OperatingLeaseNonCashConsiderationLeaseholdImprovementsValue>
    <advm:LesseeOperatingLeaseNumberOfRenewalContracts
      contextRef="c-53"
      decimals="INF"
      id="f-521"
      unitRef="segment">2</advm:LesseeOperatingLeaseNumberOfRenewalContracts>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-54" id="f-522">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <advm:LesseeOperatingLeaseLeaseholdImprovementAllowance contextRef="c-55" decimals="-5" id="f-523" unitRef="usd">22700000</advm:LesseeOperatingLeaseLeaseholdImprovementAllowance>
    <advm:IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification contextRef="c-56" decimals="-5" id="f-524" unitRef="usd">300000</advm:IncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModification>
    <advm:IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification contextRef="c-56" decimals="-5" id="f-525" unitRef="usd">300000</advm:IncreaseDecreaseInOperatingLeaseRightOfUseAssetDueToLeaseModification>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-57" decimals="-5" id="f-526" unitRef="usd">0</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-58" decimals="-5" id="f-527" unitRef="usd">4800000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:PaymentsForRent contextRef="c-58" decimals="-5" id="f-528" unitRef="usd">1400000</us-gaap:PaymentsForRent>
    <us-gaap:TenantImprovements contextRef="c-59" decimals="-5" id="f-529" unitRef="usd">2300000</us-gaap:TenantImprovements>
    <us-gaap:PaymentsForRent contextRef="c-60" decimals="-5" id="f-530" unitRef="usd">1900000</us-gaap:PaymentsForRent>
    <us-gaap:SubleaseIncome contextRef="c-61" decimals="-5" id="f-531" unitRef="usd">14000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-62" decimals="-5" id="f-532" unitRef="usd">100000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-63" id="f-533">P11Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-63" decimals="3" id="f-534" unitRef="number">0.116</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-64" id="f-535">P11Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-64" decimals="3" id="f-536" unitRef="number">0.117</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-537">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the undiscounted future non-cancellable lease payments under the lease agreements as of December&#160;31, 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed Interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-538" unitRef="usd">12142000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-539" unitRef="usd">14892000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-540" unitRef="usd">15278000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-541" unitRef="usd">15677000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-542" unitRef="usd">16089000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-543" unitRef="usd">93087000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-544" unitRef="usd">167165000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-545" unitRef="usd">75460000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-546" unitRef="usd">91705000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-547" unitRef="usd">13300000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-5" id="f-548" unitRef="usd">25300000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-5" id="f-549" unitRef="usd">2300000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-6" decimals="-5" id="f-550" unitRef="usd">2400000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-551" unitRef="usd">5800000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-5" id="f-552" unitRef="usd">7500000</us-gaap:OperatingLeasePayments>
    <us-gaap:PaymentsForTenantImprovements contextRef="c-65" decimals="-5" id="f-553" unitRef="usd">20500000</us-gaap:PaymentsForTenantImprovements>
    <us-gaap:PaymentsForTenantImprovements contextRef="c-66" decimals="-5" id="f-554" unitRef="usd">5400000</us-gaap:PaymentsForTenantImprovements>
    <us-gaap:OperatingLeasePayments contextRef="c-67" decimals="-5" id="f-555" unitRef="usd">6500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-68" decimals="-5" id="f-556" unitRef="usd">5500000</us-gaap:OperatingLeasePayments>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-557">Balance Sheet Components&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued nonclinical, clinical and process development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-558">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-69" decimals="-3" id="f-559" unitRef="usd">14963000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-70" decimals="-3" id="f-560" unitRef="usd">14638000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-71" decimals="-3" id="f-561" unitRef="usd">13779000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-72" decimals="-3" id="f-562" unitRef="usd">13586000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-73" decimals="-3" id="f-563" unitRef="usd">901000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-74" decimals="-3" id="f-564" unitRef="usd">868000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-75" decimals="-3" id="f-565" unitRef="usd">9000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-76" decimals="-3" id="f-566" unitRef="usd">184000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-567" unitRef="usd">29652000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-5" decimals="-3" id="f-568" unitRef="usd">29276000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-569" unitRef="usd">18045000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-570" unitRef="usd">14512000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-571" unitRef="usd">11607000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-572" unitRef="usd">14764000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-573">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued nonclinical, clinical and process development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-3" id="f-574" unitRef="usd">9540000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-5" decimals="-3" id="f-575" unitRef="usd">8040000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-576" unitRef="usd">4401000</advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent>
    <advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent contextRef="c-5" decimals="-3" id="f-577" unitRef="usd">3367000</advm:AccruedNonclinicalClinicalAndProcessDevelopmentCostsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-578" unitRef="usd">554000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-579" unitRef="usd">351000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-4" decimals="-3" id="f-580" unitRef="usd">123000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-5" decimals="-3" id="f-581" unitRef="usd">101000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-582" unitRef="usd">1002000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-583" unitRef="usd">725000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-4" decimals="-3" id="f-584" unitRef="usd">15620000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-585" unitRef="usd">12584000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-586">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various agreements, principally relating to licensed technology that requires future payments relating to milestones or royalties on future sales of specified products. The Company recognized license revenue of $1.0&#160;million for the first development milestone in the Ray License Agreement and $3.5&#160;million for the first development milestone in the Lexeo License Agreement during the years ended December&#160;31, 2024 and 2023, respectively. See Note 5, Revenue, for additional information. Because achievement of these future milestones is not fixed and determinable, such amounts have not been included on the Company&#x2019;s consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-47" decimals="-5" id="f-587" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-46" decimals="-5" id="f-588" unitRef="usd">3500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-589">Stockholders&#x2019; Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;February 2024 Private Placements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2024, the Company entered into a securities purchase agreement, pursuant to which the Company sold 10.5&#160;million shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase an aggregate of 75,000 shares of common stock (the &#x201c;Pre-Funded Warrants&#x201d;) to certain institutional and accredited investors in a private placement. The purchase price per share was $12.00, or $11.999 per Pre-Funded Warrant, which represents the purchase price per share minus the $0.001 per share exercise price of each Pre-Funded Warrant. Such Pre-Funded Warrants can be exercised at any time and have no expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exercise of the outstanding Pre-Funded Warrants is subject to a beneficial ownership limitation of 9.99%. The Pre-Funded Warrants were classified as a component of stockholders&#x2019; equity. As of December&#160;31, 2024, none of the Pre-Funded Warrants had been exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently, the Company also entered into a securities purchase agreement with two directors of the Company (together with the private placement to certain institutional and accredited investors, the &#x201c;Private Placements&#x201d;). The Company issued and sold 23,000 shares at $13.50 per share on otherwise substantially the same terms as those set forth in the Securities Purchase Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the close of the Private Placements on February 7, 2024, the Company received total gross proceeds of $127.8&#160;million, before deducting placement agent fees and offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accumulated other comprehensive loss included $0.5 million and $0.4 million of accumulated currency translation adjustments as of December&#160;31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, the Company&#x2019;s board of directors and its stockholders approved the establishment of the 2014 Equity Incentive Award Plan (the &#x201c;2014 Plan&#x201d;). The 2014 Plan provided for annual increases in the number of shares available for issuance thereunder on the first business day of each fiscal year, beginning with the year ended December 31, 2015, equal to four percent (4%) of the number of shares of the Company&#x2019;s common stock outstanding as of such date or a lesser number of shares as determined by the Company&#x2019;s board of directors. In June 2024, the Company adopted the 2024 Equity Incentive Award Plan (the &#x201c;2024 Plan&#x201d;). The Company reserved 4,688,345 shares for issuance pursuant to awards under the 2024 Plan. As of the effective date of the 2024 Plan, no further awards may be granted under the 2014 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, the Company adopted the 2017 Inducement Plan (the &#x201c;Inducement Plan&#x201d;). The Company originally reserved 600,000 shares for issuance pursuant to stock options and RSUs under the Inducement Plan. The only persons eligible to receive grants of stock options and RSUs under the Inducement Plan are individuals who satisfy the standards for inducement grants under Nasdaq guidance, that is, generally, a person not previously an employee or director of Adverum, or following a bona fide period of non-employment, as an inducement material to the individual&#x2019;s entering into employment with Adverum.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2014 Plan, 2024 Plan and Inducement Plan are referred to collectively as the Plans. As of December&#160;31, 2024, a total of 1,277,999 shares were available for future issuance under the Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options under the 2024 Plan and the Inducement Plan may be granted for periods of up to 10 years and at prices no less than 100% of the estimated fair value of the shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an ISO and NSO granted to a 10% stockholder may not be less than 110% of the estimated fair value of the shares on the date of grant. Stock options granted to employees and non-employees generally vest ratably over four years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity under the Company&#x2019;s stock plans and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices and years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining Contract&lt;br/&gt;Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company&#x2019;s common stock as quoted on a national exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised during the years ended December&#160;31, 2024 and 2023 was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair values of options granted during the years ended December&#160;31, 2024 and 2023 were $8.12 and $7.96, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, there was $17.1 million of unrecognized stock-based compensation expense related to stock options that was expected to be recognized over a weighted-average period of 2.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs are share awards that entitle the holder to receive freely tradable shares of the Company&#x2019;s common stock upon vesting. The fair value of RSUs is based upon the closing sales price of the Company&#x2019;s common stock on the grant date. RSUs granted to employees generally vest over a three-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the RSU activity under the Company&#x2019;s stock plans and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except grant date fair value and years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2024 and 2023, total fair value of RSUs vested was $0.8&#160;million and $1.5&#160;million, respectively. The number of RSUs vested includes shares of common stock that the Company withheld on behalf of employees or sold to cover to satisfy the minimum statutory tax withholding requirements. As of December&#160;31, 2024, there was $1.7&#160;million of unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted-average period of 1.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2014, the Company approved the establishment of the 2014 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The Company reserved 208,833&#160;shares of its common stock for issuance and provided for annual increases in the number of shares available for issuance on the first business day of each fiscal year, beginning in 2015, equal to the lesser of one percent (1%)&#160;of the number of the Company&#x2019;s common stock shares outstanding as of such date or a number of shares as determined by the Company&#x2019;s board of directors. During the years ended December&#160;31, 2024 and 2023, 88,199 and 82,422 shares were issued under the ESPP, respectively. As of December&#160;31, 2024, a total of 533,978 shares of common stock were available for future issuance under the ESPP. As of December&#160;31, 2024, there was $0.5&#160;million of unrecognized compensation cost related to the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Recognized in the Consolidated Statements of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s stock-based compensation expense:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-77" decimals="-5" id="f-590" unitRef="shares">10500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-78"
      decimals="INF"
      id="f-591"
      unitRef="shares">75000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-79"
      decimals="2"
      id="f-592"
      unitRef="usdPerShare">12.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-78"
      decimals="3"
      id="f-593"
      unitRef="usdPerShare">11.999</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-78"
      decimals="3"
      id="f-594"
      unitRef="usdPerShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <advm:BeneficialOwnershipInterestLimitationPercent contextRef="c-80" decimals="4" id="f-595" unitRef="number">0.0999</advm:BeneficialOwnershipInterestLimitationPercent>
    <advm:ClassOfWarrantOrRightWarrantsExercised
      contextRef="c-80"
      decimals="INF"
      id="f-596"
      unitRef="shares">0</advm:ClassOfWarrantOrRightWarrantsExercised>
    <advm:SecuritiesPurchaseAgreementNumberOfDirectors
      contextRef="c-81"
      decimals="INF"
      id="f-597"
      unitRef="director">2</advm:SecuritiesPurchaseAgreementNumberOfDirectors>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-82"
      decimals="INF"
      id="f-598"
      unitRef="shares">23000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-81"
      decimals="2"
      id="f-599"
      unitRef="usdPerShare">13.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c-77" decimals="-5" id="f-600" unitRef="usd">127800000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-4" decimals="-5" id="f-601" unitRef="usd">-500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-5" id="f-602" unitRef="usd">-400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <advm:ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan contextRef="c-83" decimals="2" id="f-603" unitRef="number">0.04</advm:ShareBasedCompensationArrangementIncreaseInNumberOfSharesReservedForIssuancePercentageUnderPlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-84"
      decimals="INF"
      id="f-604"
      unitRef="shares">4688345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-85"
      decimals="INF"
      id="f-605"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-86"
      decimals="INF"
      id="f-606"
      unitRef="shares">600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-87"
      decimals="INF"
      id="f-607"
      unitRef="shares">1277999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-88" id="f-608">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum
      contextRef="c-89"
      decimals="INF"
      id="f-609"
      unitRef="number">1</advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum>
    <advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold
      contextRef="c-90"
      decimals="INF"
      id="f-610"
      unitRef="number">0.10</advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardSignificantStockholderThreshold>
    <advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum
      contextRef="c-90"
      decimals="INF"
      id="f-611"
      unitRef="number">1.10</advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfGrantDateFairValueMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-91" id="f-612">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-613">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity under the Company&#x2019;s stock plans and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.988%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.576%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.579%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except exercise prices and years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining Contract&lt;br/&gt;Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt"&gt;The aggregate intrinsic value is calculated as the difference between the stock option exercise price and the closing price of the Company&#x2019;s common stock as quoted on a national exchange.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="-3" id="f-614" unitRef="shares">2303000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-615"
      unitRef="usdPerShare">48.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-6" id="f-616">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-617" unitRef="usd">99000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-618" unitRef="shares">1971000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">10.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="-3" id="f-620" unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">9.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="-3" id="f-622" unitRef="shares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">50.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="-3" id="f-624" unitRef="shares">3909000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-625"
      unitRef="usdPerShare">29.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-626">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-627" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-4" decimals="-3" id="f-628" unitRef="shares">3909000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-629"
      unitRef="usdPerShare">29.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-630">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-4" decimals="-3" id="f-631" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-4" decimals="-3" id="f-632" unitRef="shares">1504000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-633"
      unitRef="usdPerShare">58.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-634">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-635" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-636" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-6" decimals="-5" id="f-637" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-638">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option issued was estimated at the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-89" decimals="2" id="f-639" unitRef="number">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-92" decimals="2" id="f-640" unitRef="number">0.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-93" decimals="2" id="f-641" unitRef="number">0.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-94" decimals="2" id="f-642" unitRef="number">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-89" id="f-643">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-92" id="f-644">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-93" id="f-645">P1Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-94" id="f-646">P1Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-89"
      decimals="INF"
      id="f-647"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-92"
      decimals="INF"
      id="f-648"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-93"
      decimals="INF"
      id="f-649"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-94"
      decimals="INF"
      id="f-650"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-89" decimals="3" id="f-651" unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-92" decimals="3" id="f-652" unitRef="number">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-93" decimals="3" id="f-653" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-94" decimals="3" id="f-654" unitRef="number">0.050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-655"
      unitRef="usdPerShare">8.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-6"
      decimals="2"
      id="f-656"
      unitRef="usdPerShare">7.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-4" decimals="-5" id="f-657" unitRef="usd">17100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-658">P2Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-95" id="f-659">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-660">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the RSU activity under the Company&#x2019;s stock plans and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.462%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except grant date fair value and years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-96" decimals="-3" id="f-661" unitRef="shares">154000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-96"
      decimals="2"
      id="f-662"
      unitRef="usdPerShare">21.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-97" id="f-663">P1Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-95" decimals="-3" id="f-664" unitRef="shares">160000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-95"
      decimals="2"
      id="f-665"
      unitRef="usdPerShare">12.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="c-95" decimals="-3" id="f-666" unitRef="shares">29000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-95"
      decimals="2"
      id="f-667"
      unitRef="usdPerShare">26.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-95" decimals="-3" id="f-668" unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-95"
      decimals="2"
      id="f-669"
      unitRef="usdPerShare">14.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-98" decimals="-3" id="f-670" unitRef="shares">259000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-98"
      decimals="2"
      id="f-671"
      unitRef="usdPerShare">16.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-95" id="f-672">P1Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-95" decimals="-5" id="f-673" unitRef="usd">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-97" decimals="-5" id="f-674" unitRef="usd">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-98" decimals="-5" id="f-675" unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-95" id="f-676">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-99"
      decimals="INF"
      id="f-677"
      unitRef="shares">208833</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage
      contextRef="c-99"
      decimals="INF"
      id="f-678"
      unitRef="number">0.01</advm:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseDecreaseInNumberOfSharesIssuedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-100" decimals="0" id="f-679" unitRef="shares">88199</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-101" decimals="0" id="f-680" unitRef="shares">82422</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-99"
      decimals="INF"
      id="f-681"
      unitRef="shares">533978</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-99" decimals="-5" id="f-682" unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-683">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s stock-based compensation expense:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-102" decimals="-3" id="f-684" unitRef="usd">4544000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-103" decimals="-3" id="f-685" unitRef="usd">4969000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-104" decimals="-3" id="f-686" unitRef="usd">9806000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-105" decimals="-3" id="f-687" unitRef="usd">12600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-688" unitRef="usd">14350000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-689" unitRef="usd">17569000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock contextRef="c-1" id="f-690">401(k) Savings Plan&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established a defined-contribution savings plan under Section 401(k) of the Code. The 401(k) Plan covers all employees who meet defined minimum age and service requirements, and allows participants to defer a portion of their annual compensation on a pretax basis. The amount of contributions that the Company made to the 401(k) Plan during the years ended December&#160;31, 2024 and 2023 was $0.9 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-6" decimals="-5" id="f-691" unitRef="usd">900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-5" id="f-692" unitRef="usd">900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-693">Segment Reporting&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CODM assesses performance for the Company&#x2019;s single reportable segment and decides how to allocate resources based on the Company&#x2019;s total operating expenses as reported on the consolidated statements of operations and comprehensive loss. The CODM&#x2019;s review of total operating expenses at the consolidated level is used to monitor the Company&#x2019;s spending as well as budget versus actual results. The Company&#x2019;s reportable segment primarily generates revenue through its license agreements (see Note 5).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the CODM&#x2019;s review of the segment&#x2019;s performance, the CODM reviews the Company&#x2019;s operating expense information, grouped by certain detailed line items from the internal income statement reporting. This includes research and development costs as well as general and administrative expenses. Based upon the operating expense information, the CODM can reconcile to net loss as reported on the consolidated statements of operations and comprehensive loss, shown in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the segment loss, including significant segment expenses, for the years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial and manufacturing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facilities and IT&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;140,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (provision)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment and consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other segment expenses include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, all of the Company&#x2019;s property and equipment was maintained in the United States. For each of the years ended December&#160;31, 2024 and 2023, all of the Company&#x2019;s license revenue was generated in the United States.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-694">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the segment loss, including significant segment expenses, for the years ended December&#160;31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial and manufacturing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facilities and IT&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;140,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(139,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(128,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (provision)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment and consolidated net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(122,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other segment expenses include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-3" id="f-695" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-696" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense contextRef="c-106" decimals="-3" id="f-697" unitRef="usd">56546000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-107" decimals="-3" id="f-698" unitRef="usd">54572000</us-gaap:LaborAndRelatedExpense>
    <advm:ClinicalTrialExpenses contextRef="c-106" decimals="-3" id="f-699" unitRef="usd">22333000</advm:ClinicalTrialExpenses>
    <advm:ClinicalTrialExpenses contextRef="c-107" decimals="-3" id="f-700" unitRef="usd">20235000</advm:ClinicalTrialExpenses>
    <advm:AllocatedFacilitiesAndInformationTechnologyExpenses contextRef="c-106" decimals="-3" id="f-701" unitRef="usd">37841000</advm:AllocatedFacilitiesAndInformationTechnologyExpenses>
    <advm:AllocatedFacilitiesAndInformationTechnologyExpenses contextRef="c-107" decimals="-3" id="f-702" unitRef="usd">39114000</advm:AllocatedFacilitiesAndInformationTechnologyExpenses>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c-106" decimals="-3" id="f-703" unitRef="usd">4728000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c-107" decimals="-3" id="f-704" unitRef="usd">4985000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-106" decimals="-3" id="f-705" unitRef="usd">18711000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-107" decimals="-3" id="f-706" unitRef="usd">13636000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingExpenses contextRef="c-106" decimals="-3" id="f-707" unitRef="usd">140159000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-107" decimals="-3" id="f-708" unitRef="usd">132542000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-106" decimals="-3" id="f-709" unitRef="usd">-139159000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-107" decimals="-3" id="f-710" unitRef="usd">-128942000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-106" decimals="-3" id="f-711" unitRef="usd">8232000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-107" decimals="-3" id="f-712" unitRef="usd">5748000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-106" decimals="-3" id="f-713" unitRef="usd">-130927000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-107" decimals="-3" id="f-714" unitRef="usd">-123194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-106" decimals="-3" id="f-715" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-107" decimals="-3" id="f-716" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-106" decimals="-3" id="f-717" unitRef="usd">-130927000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-107" decimals="-3" id="f-718" unitRef="usd">-122116000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-720">Income Taxes&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the restatement, the Company adjusted the 2023 California research and development tax credit amounts as a result of a research and development credit study performed during 2024. This resulted in a net decrease of $3.4&#160;million in the deferred tax asset balance related to the California research and development tax credit (net of a decrease in unrecognized tax benefits of $1.9&#160;million) and a corresponding decrease in valuation allowance in 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents domestic and foreign components of loss before provision for income taxes:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s income tax (benefit) provision were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for the years ended December&#160;31, 2024 and 2023 differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax loss as a result of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax benefit at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of internal reorganization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents significant components of the Company&#x2019;s deferred tax assets and liabilities:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals, reserve and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;D capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. Based on the Company&#x2019;s history of operating losses, the Company has concluded that it is more likely than not that the benefit of its deferred tax assets will not be realized. Accordingly, the Company has provided a full valuation allowance for deferred tax assets as of December&#160;31, 2024 and 2023. The valuation allowance increased approximately $26.2&#160;million and $17.7&#160;million during the years ended December&#160;31, 2024 and 2023, respectively, mainly driven by net operating losses (&#x201c;NOLs&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company had U.S. federal NOLs carryforwards of approximately $552.7&#160;million to offset any future federal income. Approximately $57.3&#160;million of NOLs expire at various years beginning with 2032. As of December&#160;31, 2024, the Company also had U.S. state NOL carryforwards of approximately $345.2&#160;million to offset any future state income. U.S. state NOLs expire at various years beginning with 2037. At December&#160;31, 2024, the Company also had approximately $49.5&#160;million of foreign net operating loss carryforwards which may be available to offset future foreign income; these carryforwards do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company had federal research and development tax credit carryforwards of approximately $25.1&#160;million available to reduce future tax liabilities which expire at various years beginning with 2036. As of December&#160;31, 2024, the Company had state credit carryforwards of approximately $13.8&#160;million available to reduce future tax liabilities which do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under Section 382 and 383 of the Code, our ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if the Company has experienced an &#x201c;ownership change.&#x201d; Generally, a Section 382 ownership change occurs if there is a cumulative increase of more than 50 percentage points in the stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#x2019;s stock within a specified testing period. Similar rules may apply under state tax laws. The Company is conducting a Section 382 study, which is still subject to finalization, but which may show that the Company experienced an ownership change in 2024. If such an ownership change has occurred then up to vast majority of the NOLs, capital losses and research credit carryforwards presented in the consolidated financial statements would be subject to limitations and therefore may expire unutilized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal, state, and foreign jurisdictions. The federal, state and foreign income tax returns are open under the statute of limitations subject to tax examinations for the tax years ended December&#160;31, 2019 through December&#160;31, 2023. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state or foreign tax authorities to the extent utilized in a future period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has total unrecognized tax benefits as of December&#160;31, 2024 and 2023 of approximately $27.2&#160;million and $22.8&#160;million, respectively. If the unrecognized tax benefits for uncertain tax positions as of December 31, 2023, is recognized, there will be no impact to the effective tax rate as the tax benefit would increase the net deferred tax assets, which is currently offset with a full valuation allowance. A&#160;reconciliation of the unrecognized tax benefits is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits as of the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to tax positions taken during the prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to tax positions taken during the prior year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to tax position taken during the current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to tax position taken during the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits as of the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of December&#160;31, 2024 and 2023, the Company had no accrued interest and penalties related to uncertain tax positions and no amount has been recognized in the Company's consolidated statement of operations and comprehensive loss. There are no ongoing examinations by taxing authorities at this time.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-108" decimals="-5" id="f-721" unitRef="usd">-3400000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease contextRef="c-108" decimals="-5" id="f-722" unitRef="usd">-1900000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-723">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents domestic and foreign components of loss before provision for income taxes:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-3" id="f-724" unitRef="usd">-130768000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-6" decimals="-3" id="f-725" unitRef="usd">-123040000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-3" id="f-726" unitRef="usd">-159000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-6" decimals="-3" id="f-727" unitRef="usd">-154000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-728" unitRef="usd">-130927000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-729" unitRef="usd">-123194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-730">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the Company&#x2019;s income tax (benefit) provision were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-731" unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-732" unitRef="usd">-1078000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-733" unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-734" unitRef="usd">-1078000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-735" unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-736" unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-737" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-738" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-739" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-740" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-741">&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for the years ended December&#160;31, 2024 and 2023 differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax loss as a result of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax benefit at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of internal reorganization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total tax (benefit) provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,078)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-742" unitRef="usd">-27495000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="-3" id="f-743" unitRef="usd">-25871000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-744" unitRef="usd">3189000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-6" decimals="-3" id="f-745" unitRef="usd">6001000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c-1" decimals="-3" id="f-746" unitRef="usd">41000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c-6" decimals="-3" id="f-747" unitRef="usd">21000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-748" unitRef="usd">5642000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-6" decimals="-3" id="f-749" unitRef="usd">1810000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-750" unitRef="usd">23801000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-751" unitRef="usd">19558000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-752" unitRef="usd">-14000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-6" decimals="-3" id="f-753" unitRef="usd">-14000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges contextRef="c-1" decimals="-3" id="f-754" unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges contextRef="c-6" decimals="-3" id="f-755" unitRef="usd">1323000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges>
    <advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition contextRef="c-1" decimals="-3" id="f-756" unitRef="usd">6100000</advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition>
    <advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition contextRef="c-6" decimals="-3" id="f-757" unitRef="usd">-1078000</advm:EffectiveIncomeTaxRateReconciliationChangeInStateUncertainTaxPosition>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-3" id="f-758" unitRef="usd">20000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-6" decimals="-3" id="f-759" unitRef="usd">792000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-760" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-761" unitRef="usd">-1078000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-762">The following table presents significant components of the Company&#x2019;s deferred tax assets and liabilities:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals, reserve and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;D capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-763" unitRef="usd">137140000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-764" unitRef="usd">128171000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-4" decimals="-3" id="f-765" unitRef="usd">1972000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-5" decimals="-3" id="f-766" unitRef="usd">1749000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-767" unitRef="usd">29263000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-768" unitRef="usd">21254000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="-3" id="f-769" unitRef="usd">6349000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-770" unitRef="usd">7274000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-4" decimals="-3" id="f-771" unitRef="usd">7000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-5" decimals="-3" id="f-772" unitRef="usd">11000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <advm:DeferredTaxAssetsLeaseObligation contextRef="c-4" decimals="-3" id="f-773" unitRef="usd">19622000</advm:DeferredTaxAssetsLeaseObligation>
    <advm:DeferredTaxAssetsLeaseObligation contextRef="c-5" decimals="-3" id="f-774" unitRef="usd">17322000</advm:DeferredTaxAssetsLeaseObligation>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c-4" decimals="-3" id="f-775" unitRef="usd">9850000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c-5" decimals="-3" id="f-776" unitRef="usd">9850000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <advm:DeferredTaxAssetsCapitalizedCosts contextRef="c-4" decimals="-3" id="f-777" unitRef="usd">35842000</advm:DeferredTaxAssetsCapitalizedCosts>
    <advm:DeferredTaxAssetsCapitalizedCosts contextRef="c-5" decimals="-3" id="f-778" unitRef="usd">29688000</advm:DeferredTaxAssetsCapitalizedCosts>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-779" unitRef="usd">5000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-780" unitRef="usd">3000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-781" unitRef="usd">240050000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-782" unitRef="usd">215322000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-783" unitRef="usd">232058000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-784" unitRef="usd">205861000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-3" id="f-785" unitRef="usd">7992000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-5" decimals="-3" id="f-786" unitRef="usd">9461000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-787" unitRef="usd">7149000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-5" decimals="-3" id="f-788" unitRef="usd">8153000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-789" unitRef="usd">843000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-790" unitRef="usd">1308000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-791" unitRef="usd">7992000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-792" unitRef="usd">9461000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-3" id="f-793" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-3" id="f-794" unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-795" unitRef="usd">26200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-6" decimals="-5" id="f-796" unitRef="usd">17700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards contextRef="c-109" decimals="-5" id="f-797" unitRef="usd">552700000</us-gaap:OperatingLossCarryforwards>
    <advm:OperatingLossCarryforwardsSubjectToExpiration contextRef="c-109" decimals="-5" id="f-798" unitRef="usd">57300000</advm:OperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards contextRef="c-110" decimals="-5" id="f-799" unitRef="usd">345200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-111" decimals="-5" id="f-800" unitRef="usd">49500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-112" decimals="-5" id="f-801" unitRef="usd">25100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-113" decimals="-5" id="f-802" unitRef="usd">13800000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-5" id="f-803" unitRef="usd">27200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-5" id="f-804" unitRef="usd">22800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-805">A&#160;reconciliation of the unrecognized tax benefits is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023 As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits as of the beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to tax positions taken during the prior year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to tax positions taken during the prior year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase related to tax position taken during the current year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease related to tax position taken during the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits as of the end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-806" unitRef="usd">22758000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-12" decimals="-3" id="f-807" unitRef="usd">23069000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-808" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-809" unitRef="usd">43000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-810" unitRef="usd">2880000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-811" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-812" unitRef="usd">7310000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-813" unitRef="usd">3121000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-814" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-815" unitRef="usd">3475000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-816" unitRef="usd">27188000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-3" id="f-817" unitRef="usd">22758000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-5" decimals="-5" id="f-818" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-5" id="f-819" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-6" decimals="-5" id="f-820" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-5" id="f-821" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-822">Net Loss per Share&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2024, the Pre-Funded Warrants to purchase the Company's shares of common stock issued in the Private Placements were included in the basic and diluted net loss per share calculation as the exercise price is non-substantive and virtually assured.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents outstanding at the end of the periods presented were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-823">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents outstanding at the end of the periods presented were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-114"
      decimals="-3"
      id="f-824"
      unitRef="shares">3909000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-115"
      decimals="-3"
      id="f-825"
      unitRef="shares">2303000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-116"
      decimals="-3"
      id="f-826"
      unitRef="shares">259000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-117"
      decimals="-3"
      id="f-827"
      unitRef="shares">154000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-118"
      decimals="-3"
      id="f-828"
      unitRef="shares">32000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-119"
      decimals="-3"
      id="f-829"
      unitRef="shares">17000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-3" id="f-830" unitRef="shares">4200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-6" decimals="-3" id="f-831" unitRef="shares">2474000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c-1" id="f-832">Quarterly Financial Information (Unaudited)&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The previously reported financial information for the three months ended March&#160;31, 2024, three and six months ended June&#160;30, 2024 and the three and nine months ended September&#160;30, 2024 and the comparable periods in 2023, has been restated. Relevant restated financial information for each period is included in this restatement and for other immaterial adjustments in the tables that follow. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restatement Related to NC Premises&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 2, the Company inappropriately omitted accounting for available tenant improvement allowance that resulted in a misstatement of its operating lease right-of-use asset and related lease liability. Additionally, the Company did not account for a tenant improvement allowances that were conveyed to the subtenant resulting in an overstatement of sublease income. The tables below reflect the adjustments related to this restatement, the amounts of which are included with reference (a).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended June 30, 2024, the Company inappropriately assessed the collectibility of the sublease payments as probable and recorded a deferred rent receivable of $7.0&#160;million. The Company corrected its collectibility assessment and recognized an adjustment to eliminate the $7.0 million and $7.1&#160;million deferred rent receivable in the second and third quarters of 2024, respectively, the amounts of which are included in the tables below with reference (b).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other Adjustments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of this restatement, the Company has corrected certain other immaterial errors. These adjustments are described in more detail references (c) and (d) as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;The Company had previously recorded an out of period adjustment related to research and development expenses in the first quarter of 2023 that was the result of not recording a severance accrual of $0.2&#160;million in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company had previously understated its right-of-use assets and lease liability by $0.3&#160;million related to its facilities in Redwood City, California at each balance sheet date in 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented (in thousands, except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred rent receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,026,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred rent receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(993,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(944,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.357%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(863,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.357%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(845,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Quarterly and Year to Date Condensed Consolidated Statements of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.412%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,087&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,087&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.699%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.618%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.618%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.699%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Statements of Cash Flows&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of this restatement on certain line items of the condensed consolidated statements of cash flows are summarized in the following tables (in thousands). There was no impact on net cash used in operating activities or within any line items within investing and financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets and deferred rent receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets and deferred rent receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-120" decimals="-5" id="f-833" unitRef="usd">7000000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-121" decimals="-5" id="f-834" unitRef="usd">-7000000.0</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-122" decimals="-5" id="f-835" unitRef="usd">-7100000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-28" decimals="-5" id="f-836" unitRef="usd">-200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingLeaseLiability contextRef="c-29" decimals="-5" id="f-837" unitRef="usd">300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-29" decimals="-5" id="f-838" unitRef="usd">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="c-1" id="f-839">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented (in thousands, except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred rent receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,044)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,026,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred rent receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,131,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(993,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(944,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;999,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.357%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(863,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,927)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.357%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.582%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.584%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deposit and other long-term assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease liability, current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(831,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(845,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities and stockholders&#x2019; equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Quarterly and Year to Date Condensed Consolidated Statements of Operations and Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.412%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76,942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96,541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,087&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,087&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.215%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,490)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.699%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2024 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized loss on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.618%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(101,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,661&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,437&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.69)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:3.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.618%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.437%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,065)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(66,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,489)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(63,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.699%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023 (unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,039)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,655)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive gain (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized gain on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares used to compute net loss per share - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effects of this restatement on certain line items of the condensed consolidated statements of cash flows are summarized in the following tables (in thousands). There was no impact on net cash used in operating activities or within any line items within investing and financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.069%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets and deferred rent receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deposit and other long-term assets and deferred rent receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,787)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(97,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.140%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reference&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Restated&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-cash sublease loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supplemental schedule of noncash information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-123" decimals="-3" id="f-840" unitRef="usd">92851000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-122" decimals="-3" id="f-841" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-124" decimals="-3" id="f-842" unitRef="usd">92851000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-123" decimals="-3" id="f-843" unitRef="usd">60390000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-122" decimals="-3" id="f-844" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-124" decimals="-3" id="f-845" unitRef="usd">60390000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-123" decimals="-3" id="f-846" unitRef="usd">7839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-122" decimals="-3" id="f-847" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-124" decimals="-3" id="f-848" unitRef="usd">7839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-123" decimals="-3" id="f-849" unitRef="usd">161080000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-122" decimals="-3" id="f-850" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-124" decimals="-3" id="f-851" unitRef="usd">161080000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-123" decimals="-3" id="f-852" unitRef="usd">50695000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-122" decimals="-3" id="f-853" unitRef="usd">-17015000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-124" decimals="-3" id="f-854" unitRef="usd">33680000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-123" decimals="-3" id="f-855" unitRef="usd">12215000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-122" decimals="-3" id="f-856" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-124" decimals="-3" id="f-857" unitRef="usd">12215000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-123" decimals="-3" id="f-858" unitRef="usd">7116000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-122" decimals="-3" id="f-859" unitRef="usd">-7116000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-124" decimals="-3" id="f-860" unitRef="usd">0</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-123" decimals="-3" id="f-861" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-122" decimals="-3" id="f-862" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-124" decimals="-3" id="f-863" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-123" decimals="-3" id="f-864" unitRef="usd">1293000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-122" decimals="-3" id="f-865" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-124" decimals="-3" id="f-866" unitRef="usd">1293000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-123" decimals="-3" id="f-867" unitRef="usd">234375000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-122" decimals="-3" id="f-868" unitRef="usd">-24131000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-124" decimals="-3" id="f-869" unitRef="usd">210244000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-123" decimals="-3" id="f-870" unitRef="usd">2110000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-122" decimals="-3" id="f-871" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-124" decimals="-3" id="f-872" unitRef="usd">2110000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-123" decimals="-3" id="f-873" unitRef="usd">14886000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-122" decimals="-3" id="f-874" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-124" decimals="-3" id="f-875" unitRef="usd">14886000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-123" decimals="-3" id="f-876" unitRef="usd">10661000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-122" decimals="-3" id="f-877" unitRef="usd">-5044000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-124" decimals="-3" id="f-878" unitRef="usd">5617000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-123" decimals="-3" id="f-879" unitRef="usd">27657000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-122" decimals="-3" id="f-880" unitRef="usd">-5044000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-124" decimals="-3" id="f-881" unitRef="usd">22613000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-123" decimals="-3" id="f-882" unitRef="usd">62602000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-122" decimals="-3" id="f-883" unitRef="usd">16759000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-124" decimals="-3" id="f-884" unitRef="usd">79361000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-123" decimals="-3" id="f-885" unitRef="usd">90259000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-122" decimals="-3" id="f-886" unitRef="usd">11715000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-124" decimals="-3" id="f-887" unitRef="usd">101974000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-123" id="f-888" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-122" id="f-889" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-124" id="f-890" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-123" decimals="-3" id="f-891" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-122" decimals="-3" id="f-892" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-124" decimals="-3" id="f-893" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-123" decimals="-3" id="f-894" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-122" decimals="-3" id="f-895" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-124" decimals="-3" id="f-896" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-123" decimals="-3" id="f-897" unitRef="usd">1134556000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-122" decimals="-3" id="f-898" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-124" decimals="-3" id="f-899" unitRef="usd">1134556000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-123" decimals="-3" id="f-900" unitRef="usd">-268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-122" decimals="-3" id="f-901" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-124" decimals="-3" id="f-902" unitRef="usd">-268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-123" decimals="-3" id="f-903" unitRef="usd">-990174000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-122" decimals="-3" id="f-904" unitRef="usd">-35846000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-124" decimals="-3" id="f-905" unitRef="usd">-1026020000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-123" decimals="-3" id="f-906" unitRef="usd">144116000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-122" decimals="-3" id="f-907" unitRef="usd">-35846000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-124" decimals="-3" id="f-908" unitRef="usd">108270000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-123" decimals="-3" id="f-909" unitRef="usd">234375000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-122" decimals="-3" id="f-910" unitRef="usd">-24131000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-124" decimals="-3" id="f-911" unitRef="usd">210244000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-120" decimals="-3" id="f-912" unitRef="usd">127321000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-121" decimals="-3" id="f-913" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-2" decimals="-3" id="f-914" unitRef="usd">127321000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-120" decimals="-3" id="f-915" unitRef="usd">46506000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-121" decimals="-3" id="f-916" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-2" decimals="-3" id="f-917" unitRef="usd">46506000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-120" decimals="-3" id="f-918" unitRef="usd">5591000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-121" decimals="-3" id="f-919" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-2" decimals="-3" id="f-920" unitRef="usd">5591000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-120" decimals="-3" id="f-921" unitRef="usd">179418000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-121" decimals="-3" id="f-922" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-2" decimals="-3" id="f-923" unitRef="usd">179418000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-120" decimals="-3" id="f-924" unitRef="usd">51237000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-121" decimals="-3" id="f-925" unitRef="usd">-17241000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-2" decimals="-3" id="f-926" unitRef="usd">33996000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-120" decimals="-3" id="f-927" unitRef="usd">13047000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-121" id="f-928" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-2" decimals="-3" id="f-929" unitRef="usd">13047000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-120" decimals="-3" id="f-930" unitRef="usd">6963000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-121" decimals="-3" id="f-931" unitRef="usd">-6963000</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:DeferredRentReceivablesNet contextRef="c-2" decimals="-3" id="f-932" unitRef="usd">0</us-gaap:DeferredRentReceivablesNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-120" decimals="-3" id="f-933" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-121" decimals="-3" id="f-934" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-2" decimals="-3" id="f-935" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-120" decimals="-3" id="f-936" unitRef="usd">1162000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-121" decimals="-3" id="f-937" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-2" decimals="-3" id="f-938" unitRef="usd">1162000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-120" decimals="-3" id="f-939" unitRef="usd">253803000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-121" decimals="-3" id="f-940" unitRef="usd">-24204000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-2" decimals="-3" id="f-941" unitRef="usd">229599000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-120" decimals="-3" id="f-942" unitRef="usd">1973000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-121" decimals="-3" id="f-943" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-2" decimals="-3" id="f-944" unitRef="usd">1973000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-120" decimals="-3" id="f-945" unitRef="usd">9912000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-121" decimals="-3" id="f-946" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-2" decimals="-3" id="f-947" unitRef="usd">9912000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-120" decimals="-3" id="f-948" unitRef="usd">10576000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-121" decimals="-3" id="f-949" unitRef="usd">-5006000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-2" decimals="-3" id="f-950" unitRef="usd">5570000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-120" decimals="-3" id="f-951" unitRef="usd">22461000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-121" decimals="-3" id="f-952" unitRef="usd">-5006000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-2" decimals="-3" id="f-953" unitRef="usd">17455000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-120" decimals="-3" id="f-954" unitRef="usd">63313000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-121" decimals="-3" id="f-955" unitRef="usd">11431000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-2" decimals="-3" id="f-956" unitRef="usd">74744000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-120" decimals="-3" id="f-957" unitRef="usd">85774000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-121" decimals="-3" id="f-958" unitRef="usd">6425000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-2" decimals="-3" id="f-959" unitRef="usd">92199000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-120" id="f-960" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-121" id="f-961" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-2" id="f-962" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-120" decimals="-3" id="f-963" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-121" decimals="-3" id="f-964" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-2" decimals="-3" id="f-965" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-120" decimals="-3" id="f-966" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-121" decimals="-3" id="f-967" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-2" decimals="-3" id="f-968" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-120" decimals="-3" id="f-969" unitRef="usd">1131592000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-121" decimals="-3" id="f-970" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-2" decimals="-3" id="f-971" unitRef="usd">1131592000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-120" decimals="-3" id="f-972" unitRef="usd">-525000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-121" decimals="-3" id="f-973" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-2" decimals="-3" id="f-974" unitRef="usd">-525000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-120" decimals="-3" id="f-975" unitRef="usd">-963040000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-121" decimals="-3" id="f-976" unitRef="usd">-30629000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-2" decimals="-3" id="f-977" unitRef="usd">-993669000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-120" decimals="-3" id="f-978" unitRef="usd">168029000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-121" decimals="-3" id="f-979" unitRef="usd">-30629000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-2" decimals="-3" id="f-980" unitRef="usd">137400000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-120" decimals="-3" id="f-981" unitRef="usd">253803000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-121" decimals="-3" id="f-982" unitRef="usd">-24204000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-2" decimals="-3" id="f-983" unitRef="usd">229599000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-125" decimals="-3" id="f-984" unitRef="usd">149608000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-126" decimals="-3" id="f-985" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-127" decimals="-3" id="f-986" unitRef="usd">149608000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-125" decimals="-3" id="f-987" unitRef="usd">43720000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-126" decimals="-3" id="f-988" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-127" decimals="-3" id="f-989" unitRef="usd">43720000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-125" decimals="-3" id="f-990" unitRef="usd">5802000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-126" decimals="-3" id="f-991" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-127" decimals="-3" id="f-992" unitRef="usd">5802000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-125" decimals="-3" id="f-993" unitRef="usd">199130000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-126" decimals="-3" id="f-994" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-127" decimals="-3" id="f-995" unitRef="usd">199130000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-125" decimals="-3" id="f-996" unitRef="usd">51760000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-126" decimals="-3" id="f-997" unitRef="usd">-17282000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-127" decimals="-3" id="f-998" unitRef="usd">34478000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-125" decimals="-3" id="f-999" unitRef="usd">13766000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-126" decimals="-3" id="f-1000" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-127" decimals="-3" id="f-1001" unitRef="usd">13766000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-125" decimals="-3" id="f-1002" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-126" decimals="-3" id="f-1003" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-127" decimals="-3" id="f-1004" unitRef="usd">1976000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-125" decimals="-3" id="f-1005" unitRef="usd">1196000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-126" decimals="-3" id="f-1006" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-127" decimals="-3" id="f-1007" unitRef="usd">1196000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-125" decimals="-3" id="f-1008" unitRef="usd">267828000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-126" decimals="-3" id="f-1009" unitRef="usd">-17282000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-127" decimals="-3" id="f-1010" unitRef="usd">250546000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-125" decimals="-3" id="f-1011" unitRef="usd">1897000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-126" decimals="-3" id="f-1012" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-127" decimals="-3" id="f-1013" unitRef="usd">1897000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-125" decimals="-3" id="f-1014" unitRef="usd">9160000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-126" decimals="-3" id="f-1015" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-127" decimals="-3" id="f-1016" unitRef="usd">9160000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-125" decimals="-3" id="f-1017" unitRef="usd">10492000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-126" decimals="-3" id="f-1018" unitRef="usd">-4971000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-127" decimals="-3" id="f-1019" unitRef="usd">5521000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-125" decimals="-3" id="f-1020" unitRef="usd">21549000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-126" decimals="-3" id="f-1021" unitRef="usd">-4971000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-127" decimals="-3" id="f-1022" unitRef="usd">16578000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-125" decimals="-3" id="f-1023" unitRef="usd">63991000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-126" decimals="-3" id="f-1024" unitRef="usd">6296000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-127" decimals="-3" id="f-1025" unitRef="usd">70287000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-125" decimals="-3" id="f-1026" unitRef="usd">85540000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-126" decimals="-3" id="f-1027" unitRef="usd">1325000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-127" decimals="-3" id="f-1028" unitRef="usd">86865000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-125" id="f-1029" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-126" id="f-1030" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-127" id="f-1031" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-125" decimals="-3" id="f-1032" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-126" decimals="-3" id="f-1033" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-127" decimals="-3" id="f-1034" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-125" decimals="-3" id="f-1035" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-126" decimals="-3" id="f-1036" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-127" decimals="-3" id="f-1037" unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-125" decimals="-3" id="f-1038" unitRef="usd">1127383000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-126" decimals="-3" id="f-1039" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-127" decimals="-3" id="f-1040" unitRef="usd">1127383000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-125" decimals="-3" id="f-1041" unitRef="usd">-533000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-126" decimals="-3" id="f-1042" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-127" decimals="-3" id="f-1043" unitRef="usd">-533000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-125" decimals="-3" id="f-1044" unitRef="usd">-944564000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-126" decimals="-3" id="f-1045" unitRef="usd">-18607000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-127" decimals="-3" id="f-1046" unitRef="usd">-963171000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-125" decimals="-3" id="f-1047" unitRef="usd">182288000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-126" decimals="-3" id="f-1048" unitRef="usd">-18607000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-127" decimals="-3" id="f-1049" unitRef="usd">163681000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-125" decimals="-3" id="f-1050" unitRef="usd">267828000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-126" decimals="-3" id="f-1051" unitRef="usd">-17282000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-127" decimals="-3" id="f-1052" unitRef="usd">250546000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-128" decimals="-3" id="f-1053" unitRef="usd">105366000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-129" decimals="-3" id="f-1054" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-130" decimals="-3" id="f-1055" unitRef="usd">105366000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-128" decimals="-3" id="f-1056" unitRef="usd">11716000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-129" decimals="-3" id="f-1057" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-130" decimals="-3" id="f-1058" unitRef="usd">11716000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-128" decimals="-3" id="f-1059" unitRef="usd">7514000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-129" decimals="-3" id="f-1060" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-130" decimals="-3" id="f-1061" unitRef="usd">7514000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-128" decimals="-3" id="f-1062" unitRef="usd">124596000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-129" decimals="-3" id="f-1063" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-130" decimals="-3" id="f-1064" unitRef="usd">124596000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-128" decimals="-3" id="f-1065" unitRef="usd">52757000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-129" decimals="-3" id="f-1066" unitRef="usd">-17158000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-130" decimals="-3" id="f-1067" unitRef="usd">35599000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-128" decimals="-3" id="f-1068" unitRef="usd">15497000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-129" decimals="-3" id="f-1069" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-130" decimals="-3" id="f-1070" unitRef="usd">15497000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-128" decimals="-3" id="f-1071" unitRef="usd">2650000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-129" decimals="-3" id="f-1072" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-130" decimals="-3" id="f-1073" unitRef="usd">2650000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-128" decimals="-3" id="f-1074" unitRef="usd">1270000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-129" decimals="-3" id="f-1075" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-130" decimals="-3" id="f-1076" unitRef="usd">1270000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-128" decimals="-3" id="f-1077" unitRef="usd">196770000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-129" decimals="-3" id="f-1078" unitRef="usd">-17158000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-130" decimals="-3" id="f-1079" unitRef="usd">179612000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-128" decimals="-3" id="f-1080" unitRef="usd">2170000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-129" decimals="-3" id="f-1081" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-130" decimals="-3" id="f-1082" unitRef="usd">2170000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-128" decimals="-3" id="f-1083" unitRef="usd">16362000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-129" decimals="-3" id="f-1084" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-130" decimals="-3" id="f-1085" unitRef="usd">16362000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-128" decimals="-3" id="f-1086" unitRef="usd">10324000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-129" decimals="-3" id="f-1087" unitRef="usd">-4897000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-130" decimals="-3" id="f-1088" unitRef="usd">5427000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-128" decimals="-3" id="f-1089" unitRef="usd">28856000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-129" decimals="-3" id="f-1090" unitRef="usd">-4897000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-130" decimals="-3" id="f-1091" unitRef="usd">23959000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-128" decimals="-3" id="f-1092" unitRef="usd">65200000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-129" decimals="-3" id="f-1093" unitRef="usd">3196000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-130" decimals="-3" id="f-1094" unitRef="usd">68396000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-128" decimals="-3" id="f-1095" unitRef="usd">94056000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-129" decimals="-3" id="f-1096" unitRef="usd">-1701000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-130" decimals="-3" id="f-1097" unitRef="usd">92355000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-128" id="f-1098" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-129" id="f-1099" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-130" id="f-1100" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-128" decimals="-3" id="f-1101" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-129" decimals="-3" id="f-1102" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-130" decimals="-3" id="f-1103" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-128" decimals="-3" id="f-1104" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-129" decimals="-3" id="f-1105" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-130" decimals="-3" id="f-1106" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-128" decimals="-3" id="f-1107" unitRef="usd">999328000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-129" decimals="-3" id="f-1108" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-130" decimals="-3" id="f-1109" unitRef="usd">999328000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-128" decimals="-3" id="f-1110" unitRef="usd">-552000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-129" decimals="-3" id="f-1111" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-130" decimals="-3" id="f-1112" unitRef="usd">-552000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-128" decimals="-3" id="f-1113" unitRef="usd">-896063000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-129" decimals="-3" id="f-1114" unitRef="usd">-15457000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-130" decimals="-3" id="f-1115" unitRef="usd">-911520000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-128" decimals="-3" id="f-1116" unitRef="usd">102714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-129" decimals="-3" id="f-1117" unitRef="usd">-15457000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-130" decimals="-3" id="f-1118" unitRef="usd">87257000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-128" decimals="-3" id="f-1119" unitRef="usd">196770000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-129" decimals="-3" id="f-1120" unitRef="usd">-17158000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-130" decimals="-3" id="f-1121" unitRef="usd">179612000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-131" decimals="-3" id="f-1122" unitRef="usd">111187000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-132" decimals="-3" id="f-1123" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-133" decimals="-3" id="f-1124" unitRef="usd">111187000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-131" decimals="-3" id="f-1125" unitRef="usd">30266000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-132" decimals="-3" id="f-1126" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-133" decimals="-3" id="f-1127" unitRef="usd">30266000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-131" decimals="-3" id="f-1128" unitRef="usd">5690000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-132" decimals="-3" id="f-1129" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-133" decimals="-3" id="f-1130" unitRef="usd">5690000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-131" decimals="-3" id="f-1131" unitRef="usd">147143000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-132" decimals="-3" id="f-1132" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-133" decimals="-3" id="f-1133" unitRef="usd">147143000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-131" decimals="-3" id="f-1134" unitRef="usd">58287000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-132" decimals="-3" id="f-1135" unitRef="usd">-17054000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-133" decimals="-3" id="f-1136" unitRef="usd">41233000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-131" decimals="-3" id="f-1137" unitRef="usd">32041000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-132" decimals="-3" id="f-1138" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-133" decimals="-3" id="f-1139" unitRef="usd">32041000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-131" decimals="-3" id="f-1140" unitRef="usd">2650000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-132" decimals="-3" id="f-1141" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-133" decimals="-3" id="f-1142" unitRef="usd">2650000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-131" decimals="-3" id="f-1143" unitRef="usd">1308000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-132" decimals="-3" id="f-1144" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-133" decimals="-3" id="f-1145" unitRef="usd">1308000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-131" decimals="-3" id="f-1146" unitRef="usd">241429000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-132" decimals="-3" id="f-1147" unitRef="usd">-17054000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-133" decimals="-3" id="f-1148" unitRef="usd">224375000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-131" decimals="-3" id="f-1149" unitRef="usd">1418000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-132" decimals="-3" id="f-1150" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-133" decimals="-3" id="f-1151" unitRef="usd">1418000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-131" decimals="-3" id="f-1152" unitRef="usd">17704000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-132" decimals="-3" id="f-1153" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-133" decimals="-3" id="f-1154" unitRef="usd">17704000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-131" decimals="-3" id="f-1155" unitRef="usd">25396000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-132" decimals="-3" id="f-1156" unitRef="usd">-4861000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-133" decimals="-3" id="f-1157" unitRef="usd">20535000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-131" decimals="-3" id="f-1158" unitRef="usd">44518000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-132" decimals="-3" id="f-1159" unitRef="usd">-4861000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-133" decimals="-3" id="f-1160" unitRef="usd">39657000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-131" decimals="-3" id="f-1161" unitRef="usd">65756000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-132" decimals="-3" id="f-1162" unitRef="usd">2734000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-133" decimals="-3" id="f-1163" unitRef="usd">68490000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-131" decimals="-3" id="f-1164" unitRef="usd">110274000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-132" decimals="-3" id="f-1165" unitRef="usd">-2127000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-133" decimals="-3" id="f-1166" unitRef="usd">108147000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-131" id="f-1167" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-132" id="f-1168" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-133" id="f-1169" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-131" decimals="-3" id="f-1170" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-132" decimals="-3" id="f-1171" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-133" decimals="-3" id="f-1172" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-131" decimals="-3" id="f-1173" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-132" decimals="-3" id="f-1174" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-133" decimals="-3" id="f-1175" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-131" decimals="-3" id="f-1176" unitRef="usd">994938000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-132" decimals="-3" id="f-1177" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-133" decimals="-3" id="f-1178" unitRef="usd">994938000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-131" decimals="-3" id="f-1179" unitRef="usd">-606000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-132" decimals="-3" id="f-1180" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-133" decimals="-3" id="f-1181" unitRef="usd">-606000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-131" decimals="-3" id="f-1182" unitRef="usd">-863178000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-132" decimals="-3" id="f-1183" unitRef="usd">-14927000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-133" decimals="-3" id="f-1184" unitRef="usd">-878105000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-131" decimals="-3" id="f-1185" unitRef="usd">131155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-132" decimals="-3" id="f-1186" unitRef="usd">-14927000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-133" decimals="-3" id="f-1187" unitRef="usd">116228000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-131" decimals="-3" id="f-1188" unitRef="usd">241429000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-132" decimals="-3" id="f-1189" unitRef="usd">-17054000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-133" decimals="-3" id="f-1190" unitRef="usd">224375000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-134" decimals="-3" id="f-1191" unitRef="usd">67552000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-135" decimals="-3" id="f-1192" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-52" decimals="-3" id="f-1193" unitRef="usd">67552000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-134" decimals="-3" id="f-1194" unitRef="usd">96733000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-135" decimals="-3" id="f-1195" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-52" decimals="-3" id="f-1196" unitRef="usd">96733000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-134" decimals="-3" id="f-1197" unitRef="usd">4588000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-135" decimals="-3" id="f-1198" unitRef="usd">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-52" decimals="-3" id="f-1199" unitRef="usd">4588000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-134" decimals="-3" id="f-1200" unitRef="usd">168873000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-135" decimals="-3" id="f-1201" unitRef="usd">0</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-52" decimals="-3" id="f-1202" unitRef="usd">168873000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-134" decimals="-3" id="f-1203" unitRef="usd">69503000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-135" decimals="-3" id="f-1204" unitRef="usd">-22905000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-52" decimals="-3" id="f-1205" unitRef="usd">46598000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-134" decimals="-3" id="f-1206" unitRef="usd">33347000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-135" decimals="-3" id="f-1207" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-52" decimals="-3" id="f-1208" unitRef="usd">33347000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-134" decimals="-3" id="f-1209" unitRef="usd">2503000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-135" decimals="-3" id="f-1210" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-52" decimals="-3" id="f-1211" unitRef="usd">2503000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-134" decimals="-3" id="f-1212" unitRef="usd">1351000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-135" decimals="-3" id="f-1213" unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-52" decimals="-3" id="f-1214" unitRef="usd">1351000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-134" decimals="-3" id="f-1215" unitRef="usd">275577000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-135" decimals="-3" id="f-1216" unitRef="usd">-22905000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-52" decimals="-3" id="f-1217" unitRef="usd">252672000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-134" decimals="-3" id="f-1218" unitRef="usd">2863000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-135" decimals="-3" id="f-1219" unitRef="usd">0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-52" decimals="-3" id="f-1220" unitRef="usd">2863000</us-gaap:AccountsPayableCurrent>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-134" decimals="-3" id="f-1221" unitRef="usd">17344000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-135" decimals="-3" id="f-1222" unitRef="usd">0</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <advm:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-52" decimals="-3" id="f-1223" unitRef="usd">17344000</advm:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-134" decimals="-3" id="f-1224" unitRef="usd">26265000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-135" decimals="-3" id="f-1225" unitRef="usd">-5531000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-52" decimals="-3" id="f-1226" unitRef="usd">20734000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-134" decimals="-3" id="f-1227" unitRef="usd">46472000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-135" decimals="-3" id="f-1228" unitRef="usd">-5531000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-52" decimals="-3" id="f-1229" unitRef="usd">40941000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-134" decimals="-3" id="f-1230" unitRef="usd">71348000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-135" decimals="-3" id="f-1231" unitRef="usd">-3462000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-52" decimals="-3" id="f-1232" unitRef="usd">67886000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-134" decimals="-3" id="f-1233" unitRef="usd">117820000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-135" decimals="-3" id="f-1234" unitRef="usd">-8993000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-52" decimals="-3" id="f-1235" unitRef="usd">108827000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-134" id="f-1236" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-135" id="f-1237" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-52" id="f-1238" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-134" decimals="-3" id="f-1239" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-135" decimals="-3" id="f-1240" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-52" decimals="-3" id="f-1241" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="c-134" decimals="-3" id="f-1242" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-135" decimals="-3" id="f-1243" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-52" decimals="-3" id="f-1244" unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-134" decimals="-3" id="f-1245" unitRef="usd">990223000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-135" decimals="-3" id="f-1246" unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-52" decimals="-3" id="f-1247" unitRef="usd">990223000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-134" decimals="-3" id="f-1248" unitRef="usd">-799000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-135" decimals="-3" id="f-1249" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-52" decimals="-3" id="f-1250" unitRef="usd">-799000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-134" decimals="-3" id="f-1251" unitRef="usd">-831668000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-135" decimals="-3" id="f-1252" unitRef="usd">-13912000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-52" decimals="-3" id="f-1253" unitRef="usd">-845580000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-134" decimals="-3" id="f-1254" unitRef="usd">157757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-135" decimals="-3" id="f-1255" unitRef="usd">-13912000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-3" id="f-1256" unitRef="usd">143845000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-134" decimals="-3" id="f-1257" unitRef="usd">275577000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-135" decimals="-3" id="f-1258" unitRef="usd">-22905000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-52" decimals="-3" id="f-1259" unitRef="usd">252672000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-136" decimals="-3" id="f-1260" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-3" id="f-1261" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-138" decimals="-3" id="f-1262" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-139" decimals="-3" id="f-1263" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-140" decimals="-3" id="f-1264" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-141" decimals="-3" id="f-1265" unitRef="usd">1000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-136" decimals="-3" id="f-1266" unitRef="usd">20439000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-137" decimals="-3" id="f-1267" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-138" decimals="-3" id="f-1268" unitRef="usd">20439000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-139" decimals="-3" id="f-1269" unitRef="usd">52946000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-140" decimals="-3" id="f-1270" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-141" decimals="-3" id="f-1271" unitRef="usd">52946000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-136" decimals="-3" id="f-1272" unitRef="usd">9782000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-137" decimals="-3" id="f-1273" unitRef="usd">5217000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-138" decimals="-3" id="f-1274" unitRef="usd">14999000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-139" decimals="-3" id="f-1275" unitRef="usd">24996000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-140" decimals="-3" id="f-1276" unitRef="usd">19599000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-141" decimals="-3" id="f-1277" unitRef="usd">44595000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-136" decimals="-3" id="f-1278" unitRef="usd">30221000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-137" decimals="-3" id="f-1279" unitRef="usd">5217000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-138" decimals="-3" id="f-1280" unitRef="usd">35438000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-139" decimals="-3" id="f-1281" unitRef="usd">77942000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-140" decimals="-3" id="f-1282" unitRef="usd">19599000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-141" decimals="-3" id="f-1283" unitRef="usd">97541000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-136" decimals="-3" id="f-1284" unitRef="usd">-29221000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-137" decimals="-3" id="f-1285" unitRef="usd">-5217000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-138" decimals="-3" id="f-1286" unitRef="usd">-34438000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-139" decimals="-3" id="f-1287" unitRef="usd">-76942000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-140" decimals="-3" id="f-1288" unitRef="usd">-19599000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-141" decimals="-3" id="f-1289" unitRef="usd">-96541000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-136" decimals="-3" id="f-1290" unitRef="usd">2087000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-137" decimals="-3" id="f-1291" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-138" decimals="-3" id="f-1292" unitRef="usd">2087000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-139" decimals="-3" id="f-1293" unitRef="usd">6545000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-140" decimals="-3" id="f-1294" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-141" decimals="-3" id="f-1295" unitRef="usd">6545000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-136" decimals="-3" id="f-1296" unitRef="usd">-27134000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-137" decimals="-3" id="f-1297" unitRef="usd">-5217000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-138" decimals="-3" id="f-1298" unitRef="usd">-32351000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-139" decimals="-3" id="f-1299" unitRef="usd">-70397000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-140" decimals="-3" id="f-1300" unitRef="usd">-19599000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-141" decimals="-3" id="f-1301" unitRef="usd">-89996000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-136" decimals="-3" id="f-1302" unitRef="usd">241000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-137" decimals="-3" id="f-1303" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-138" decimals="-3" id="f-1304" unitRef="usd">241000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-139" decimals="-3" id="f-1305" unitRef="usd">198000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-140" decimals="-3" id="f-1306" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-141" decimals="-3" id="f-1307" unitRef="usd">198000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-136" decimals="-3" id="f-1308" unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-137" decimals="-3" id="f-1309" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-138" decimals="-3" id="f-1310" unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-139" decimals="-3" id="f-1311" unitRef="usd">7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-140" decimals="-3" id="f-1312" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-141" decimals="-3" id="f-1313" unitRef="usd">7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-136" decimals="-3" id="f-1314" unitRef="usd">-26877000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-137" decimals="-3" id="f-1315" unitRef="usd">-5217000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-138" decimals="-3" id="f-1316" unitRef="usd">-32094000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-139" decimals="-3" id="f-1317" unitRef="usd">-70192000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-140" decimals="-3" id="f-1318" unitRef="usd">-19599000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-141" decimals="-3" id="f-1319" unitRef="usd">-89791000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-136"
      decimals="2"
      id="f-1320"
      unitRef="usdPerShare">-1.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-136"
      decimals="2"
      id="f-1321"
      unitRef="usdPerShare">-1.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-137"
      decimals="2"
      id="f-1322"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-137"
      decimals="2"
      id="f-1323"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-138"
      decimals="2"
      id="f-1324"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-138"
      decimals="2"
      id="f-1325"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-139"
      decimals="2"
      id="f-1326"
      unitRef="usdPerShare">-3.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-139"
      decimals="2"
      id="f-1327"
      unitRef="usdPerShare">-3.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-140"
      decimals="2"
      id="f-1328"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-140"
      decimals="2"
      id="f-1329"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-141"
      decimals="2"
      id="f-1330"
      unitRef="usdPerShare">-4.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-141"
      decimals="2"
      id="f-1331"
      unitRef="usdPerShare">-4.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-136"
      decimals="-3"
      id="f-1332"
      unitRef="shares">20876000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-136"
      decimals="-3"
      id="f-1333"
      unitRef="shares">20876000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-137"
      decimals="-3"
      id="f-1334"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-137"
      decimals="-3"
      id="f-1335"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-138"
      decimals="-3"
      id="f-1336"
      unitRef="shares">20876000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-138"
      decimals="-3"
      id="f-1337"
      unitRef="shares">20876000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-139"
      decimals="-3"
      id="f-1338"
      unitRef="shares">19408000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-139"
      decimals="-3"
      id="f-1339"
      unitRef="shares">19408000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-140"
      decimals="-3"
      id="f-1340"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-140"
      decimals="-3"
      id="f-1341"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-141"
      decimals="-3"
      id="f-1342"
      unitRef="shares">19408000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-141"
      decimals="-3"
      id="f-1343"
      unitRef="shares">19408000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-142" decimals="-3" id="f-1344" unitRef="usd">17097000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-143" decimals="-3" id="f-1345" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-144" decimals="-3" id="f-1346" unitRef="usd">17097000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-145" decimals="-3" id="f-1347" unitRef="usd">32507000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-146" decimals="-3" id="f-1348" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-147" decimals="-3" id="f-1349" unitRef="usd">32507000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-142" decimals="-3" id="f-1350" unitRef="usd">3785000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-143" decimals="-3" id="f-1351" unitRef="usd">12022000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-144" decimals="-3" id="f-1352" unitRef="usd">15807000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-145" decimals="-3" id="f-1353" unitRef="usd">15214000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-146" decimals="-3" id="f-1354" unitRef="usd">14382000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-147" decimals="-3" id="f-1355" unitRef="usd">29596000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-142" decimals="-3" id="f-1356" unitRef="usd">20882000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-143" decimals="-3" id="f-1357" unitRef="usd">12022000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-144" decimals="-3" id="f-1358" unitRef="usd">32904000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-145" decimals="-3" id="f-1359" unitRef="usd">47721000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-146" decimals="-3" id="f-1360" unitRef="usd">14382000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-147" decimals="-3" id="f-1361" unitRef="usd">62103000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-142" decimals="-3" id="f-1362" unitRef="usd">-20882000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-143" decimals="-3" id="f-1363" unitRef="usd">-12022000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-144" decimals="-3" id="f-1364" unitRef="usd">-32904000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-145" decimals="-3" id="f-1365" unitRef="usd">-47721000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-146" decimals="-3" id="f-1366" unitRef="usd">-14382000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-147" decimals="-3" id="f-1367" unitRef="usd">-62103000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-142" decimals="-3" id="f-1368" unitRef="usd">2406000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-143" decimals="-3" id="f-1369" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-144" decimals="-3" id="f-1370" unitRef="usd">2406000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-145" decimals="-3" id="f-1371" unitRef="usd">4458000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-146" decimals="-3" id="f-1372" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-147" decimals="-3" id="f-1373" unitRef="usd">4458000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-142" decimals="-3" id="f-1374" unitRef="usd">-18476000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-143" decimals="-3" id="f-1375" unitRef="usd">-12022000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-144" decimals="-3" id="f-1376" unitRef="usd">-30498000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-145" decimals="-3" id="f-1377" unitRef="usd">-43263000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-146" decimals="-3" id="f-1378" unitRef="usd">-14382000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-147" decimals="-3" id="f-1379" unitRef="usd">-57645000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-142" decimals="-3" id="f-1380" unitRef="usd">-2000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-143" decimals="-3" id="f-1381" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-144" decimals="-3" id="f-1382" unitRef="usd">-2000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-145" decimals="-3" id="f-1383" unitRef="usd">-43000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-146" decimals="-3" id="f-1384" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-147" decimals="-3" id="f-1385" unitRef="usd">-43000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-142" decimals="-3" id="f-1386" unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-143" decimals="-3" id="f-1387" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-144" decimals="-3" id="f-1388" unitRef="usd">10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-145" decimals="-3" id="f-1389" unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-146" decimals="-3" id="f-1390" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-147" decimals="-3" id="f-1391" unitRef="usd">-9000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-142" decimals="-3" id="f-1392" unitRef="usd">-18468000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-143" decimals="-3" id="f-1393" unitRef="usd">-12022000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-144" decimals="-3" id="f-1394" unitRef="usd">-30490000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-145" decimals="-3" id="f-1395" unitRef="usd">-43315000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-146" decimals="-3" id="f-1396" unitRef="usd">-14382000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-147" decimals="-3" id="f-1397" unitRef="usd">-57697000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-142"
      decimals="2"
      id="f-1398"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-142"
      decimals="2"
      id="f-1399"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-143"
      decimals="2"
      id="f-1400"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-143"
      decimals="2"
      id="f-1401"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-144"
      decimals="2"
      id="f-1402"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-144"
      decimals="2"
      id="f-1403"
      unitRef="usdPerShare">-1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-145"
      decimals="2"
      id="f-1404"
      unitRef="usdPerShare">-2.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-145"
      decimals="2"
      id="f-1405"
      unitRef="usdPerShare">-2.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-146"
      decimals="2"
      id="f-1406"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-146"
      decimals="2"
      id="f-1407"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-147"
      decimals="2"
      id="f-1408"
      unitRef="usdPerShare">-3.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-147"
      decimals="2"
      id="f-1409"
      unitRef="usdPerShare">-3.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-142"
      decimals="-3"
      id="f-1410"
      unitRef="shares">20852000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-142"
      decimals="-3"
      id="f-1411"
      unitRef="shares">20852000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-143"
      decimals="-3"
      id="f-1412"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-143"
      decimals="-3"
      id="f-1413"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-144"
      decimals="-3"
      id="f-1414"
      unitRef="shares">20852000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-144"
      decimals="-3"
      id="f-1415"
      unitRef="shares">20852000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-145"
      decimals="-3"
      id="f-1416"
      unitRef="shares">18713000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-145"
      decimals="-3"
      id="f-1417"
      unitRef="shares">18713000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-146"
      decimals="-3"
      id="f-1418"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-146"
      decimals="-3"
      id="f-1419"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-147"
      decimals="-3"
      id="f-1420"
      unitRef="shares">18713000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-147"
      decimals="-3"
      id="f-1421"
      unitRef="shares">18713000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-148" decimals="-3" id="f-1422" unitRef="usd">15410000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-149" decimals="-3" id="f-1423" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-150" decimals="-3" id="f-1424" unitRef="usd">15410000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-148" decimals="-3" id="f-1425" unitRef="usd">11429000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-149" decimals="-3" id="f-1426" unitRef="usd">2360000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-150" decimals="-3" id="f-1427" unitRef="usd">13789000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-148" decimals="-3" id="f-1428" unitRef="usd">26839000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-149" decimals="-3" id="f-1429" unitRef="usd">2360000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-150" decimals="-3" id="f-1430" unitRef="usd">29199000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-148" decimals="-3" id="f-1431" unitRef="usd">-26839000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-149" decimals="-3" id="f-1432" unitRef="usd">-2360000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-150" decimals="-3" id="f-1433" unitRef="usd">-29199000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-148" decimals="-3" id="f-1434" unitRef="usd">2052000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-149" decimals="-3" id="f-1435" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-150" decimals="-3" id="f-1436" unitRef="usd">2052000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-148" decimals="-3" id="f-1437" unitRef="usd">-24787000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-149" decimals="-3" id="f-1438" unitRef="usd">-2360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-150" decimals="-3" id="f-1439" unitRef="usd">-27147000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-148" decimals="-3" id="f-1440" unitRef="usd">-41000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-149" decimals="-3" id="f-1441" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-150" decimals="-3" id="f-1442" unitRef="usd">-41000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-148" decimals="-3" id="f-1443" unitRef="usd">-19000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-149" decimals="-3" id="f-1444" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-150" decimals="-3" id="f-1445" unitRef="usd">-19000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-148" decimals="-3" id="f-1446" unitRef="usd">-24847000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-149" decimals="-3" id="f-1447" unitRef="usd">-2360000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-150" decimals="-3" id="f-1448" unitRef="usd">-27207000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-148"
      decimals="2"
      id="f-1449"
      unitRef="usdPerShare">-1.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-148"
      decimals="2"
      id="f-1450"
      unitRef="usdPerShare">-1.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-149"
      decimals="2"
      id="f-1451"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-149"
      decimals="2"
      id="f-1452"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-150"
      decimals="2"
      id="f-1453"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-150"
      decimals="2"
      id="f-1454"
      unitRef="usdPerShare">-1.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-148"
      decimals="-3"
      id="f-1455"
      unitRef="shares">16479000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-148"
      decimals="-3"
      id="f-1456"
      unitRef="shares">16479000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-149"
      decimals="-3"
      id="f-1457"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-149"
      decimals="-3"
      id="f-1458"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-150"
      decimals="-3"
      id="f-1459"
      unitRef="shares">16479000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-150"
      decimals="-3"
      id="f-1460"
      unitRef="shares">16479000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-151" decimals="-3" id="f-1461" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-152" decimals="-3" id="f-1462" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-153" decimals="-3" id="f-1463" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-154" decimals="-3" id="f-1464" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-155" decimals="-3" id="f-1465" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-156" decimals="-3" id="f-1466" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-151" decimals="-3" id="f-1467" unitRef="usd">20740000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-152" decimals="-3" id="f-1468" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-153" decimals="-3" id="f-1469" unitRef="usd">20740000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-154" decimals="-3" id="f-1470" unitRef="usd">62398000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-155" decimals="-3" id="f-1471" unitRef="usd">-190000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-156" decimals="-3" id="f-1472" unitRef="usd">62208000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-151" decimals="-3" id="f-1473" unitRef="usd">13789000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-152" decimals="-3" id="f-1474" unitRef="usd">530000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-153" decimals="-3" id="f-1475" unitRef="usd">14319000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-154" decimals="-3" id="f-1476" unitRef="usd">39035000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-155" decimals="-3" id="f-1477" unitRef="usd">4351000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-156" decimals="-3" id="f-1478" unitRef="usd">43386000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-151" decimals="-3" id="f-1479" unitRef="usd">34529000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-152" decimals="-3" id="f-1480" unitRef="usd">530000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-153" decimals="-3" id="f-1481" unitRef="usd">35059000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-154" decimals="-3" id="f-1482" unitRef="usd">101433000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-155" decimals="-3" id="f-1483" unitRef="usd">4161000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-156" decimals="-3" id="f-1484" unitRef="usd">105594000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-151" decimals="-3" id="f-1485" unitRef="usd">-34529000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-152" decimals="-3" id="f-1486" unitRef="usd">-530000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-153" decimals="-3" id="f-1487" unitRef="usd">-35059000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-154" decimals="-3" id="f-1488" unitRef="usd">-97833000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-155" decimals="-3" id="f-1489" unitRef="usd">-4161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-156" decimals="-3" id="f-1490" unitRef="usd">-101994000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-151" decimals="-3" id="f-1491" unitRef="usd">1661000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-152" decimals="-3" id="f-1492" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-153" decimals="-3" id="f-1493" unitRef="usd">1661000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-154" decimals="-3" id="f-1494" unitRef="usd">4437000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-155" decimals="-3" id="f-1495" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-156" decimals="-3" id="f-1496" unitRef="usd">4437000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-151" decimals="-3" id="f-1497" unitRef="usd">-32868000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-152" decimals="-3" id="f-1498" unitRef="usd">-530000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-153" decimals="-3" id="f-1499" unitRef="usd">-33398000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-154" decimals="-3" id="f-1500" unitRef="usd">-93396000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-155" decimals="-3" id="f-1501" unitRef="usd">-4161000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-156" decimals="-3" id="f-1502" unitRef="usd">-97557000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-151" decimals="-3" id="f-1503" unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-152" id="f-1504" unitRef="usd" xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-153" decimals="-3" id="f-1505" unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-154" decimals="-3" id="f-1506" unitRef="usd">55000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-155" id="f-1507" unitRef="usd" xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-156" decimals="-3" id="f-1508" unitRef="usd">55000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-151" decimals="-3" id="f-1509" unitRef="usd">-32885000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-152" decimals="-3" id="f-1510" unitRef="usd">-530000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-153" decimals="-3" id="f-1511" unitRef="usd">-33415000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-154" decimals="-3" id="f-1512" unitRef="usd">-93451000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-155" decimals="-3" id="f-1513" unitRef="usd">-4161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-156" decimals="-3" id="f-1514" unitRef="usd">-97612000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-151" decimals="-3" id="f-1515" unitRef="usd">66000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-152" decimals="-3" id="f-1516" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-153" decimals="-3" id="f-1517" unitRef="usd">66000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-154" decimals="-3" id="f-1518" unitRef="usd">1003000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-155" decimals="-3" id="f-1519" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-156" decimals="-3" id="f-1520" unitRef="usd">1003000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-151" decimals="-3" id="f-1521" unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-152" decimals="-3" id="f-1522" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-153" decimals="-3" id="f-1523" unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-154" decimals="-3" id="f-1524" unitRef="usd">-24000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-155" decimals="-3" id="f-1525" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-156" decimals="-3" id="f-1526" unitRef="usd">-24000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-151" decimals="-3" id="f-1527" unitRef="usd">-32831000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-152" decimals="-3" id="f-1528" unitRef="usd">-530000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-153" decimals="-3" id="f-1529" unitRef="usd">-33361000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-154" decimals="-3" id="f-1530" unitRef="usd">-92472000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-155" decimals="-3" id="f-1531" unitRef="usd">-4161000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-156" decimals="-3" id="f-1532" unitRef="usd">-96633000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-151"
      decimals="2"
      id="f-1533"
      unitRef="usdPerShare">-3.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-151"
      decimals="2"
      id="f-1534"
      unitRef="usdPerShare">-3.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-152"
      decimals="2"
      id="f-1535"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-152"
      decimals="2"
      id="f-1536"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-153"
      decimals="2"
      id="f-1537"
      unitRef="usdPerShare">-3.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-153"
      decimals="2"
      id="f-1538"
      unitRef="usdPerShare">-3.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-154"
      decimals="2"
      id="f-1539"
      unitRef="usdPerShare">-9.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-154"
      decimals="2"
      id="f-1540"
      unitRef="usdPerShare">-9.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-155"
      decimals="2"
      id="f-1541"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-155"
      decimals="2"
      id="f-1542"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-156"
      decimals="2"
      id="f-1543"
      unitRef="usdPerShare">-9.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-156"
      decimals="2"
      id="f-1544"
      unitRef="usdPerShare">-9.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-151"
      decimals="-3"
      id="f-1545"
      unitRef="shares">10099000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-151"
      decimals="-3"
      id="f-1546"
      unitRef="shares">10099000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-152"
      decimals="-3"
      id="f-1547"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-152"
      decimals="-3"
      id="f-1548"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-153"
      decimals="-3"
      id="f-1549"
      unitRef="shares">10099000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-153"
      decimals="-3"
      id="f-1550"
      unitRef="shares">10099000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-154"
      decimals="-3"
      id="f-1551"
      unitRef="shares">10069000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-154"
      decimals="-3"
      id="f-1552"
      unitRef="shares">10069000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-155"
      decimals="-3"
      id="f-1553"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-155"
      decimals="-3"
      id="f-1554"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-156"
      decimals="-3"
      id="f-1555"
      unitRef="shares">10069000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-156"
      decimals="-3"
      id="f-1556"
      unitRef="shares">10069000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-157" decimals="-3" id="f-1557" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-158" decimals="-3" id="f-1558" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-159" decimals="-3" id="f-1559" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-160" decimals="-3" id="f-1560" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-161" decimals="-3" id="f-1561" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-162" decimals="-3" id="f-1562" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-157" decimals="-3" id="f-1563" unitRef="usd">20599000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-158" decimals="-3" id="f-1564" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-159" decimals="-3" id="f-1565" unitRef="usd">20599000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-160" decimals="-3" id="f-1566" unitRef="usd">41658000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-161" decimals="-3" id="f-1567" unitRef="usd">-190000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-162" decimals="-3" id="f-1568" unitRef="usd">41468000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-157" decimals="-3" id="f-1569" unitRef="usd">12466000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-158" decimals="-3" id="f-1570" unitRef="usd">1015000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-159" decimals="-3" id="f-1571" unitRef="usd">13481000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-160" decimals="-3" id="f-1572" unitRef="usd">25246000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-161" decimals="-3" id="f-1573" unitRef="usd">3821000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-162" decimals="-3" id="f-1574" unitRef="usd">29067000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-157" decimals="-3" id="f-1575" unitRef="usd">33065000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-158" decimals="-3" id="f-1576" unitRef="usd">1015000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-159" decimals="-3" id="f-1577" unitRef="usd">34080000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-160" decimals="-3" id="f-1578" unitRef="usd">66904000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-161" decimals="-3" id="f-1579" unitRef="usd">3631000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-162" decimals="-3" id="f-1580" unitRef="usd">70535000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-157" decimals="-3" id="f-1581" unitRef="usd">-33065000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-158" decimals="-3" id="f-1582" unitRef="usd">-1015000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-159" decimals="-3" id="f-1583" unitRef="usd">-34080000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-160" decimals="-3" id="f-1584" unitRef="usd">-63304000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-161" decimals="-3" id="f-1585" unitRef="usd">-3631000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-162" decimals="-3" id="f-1586" unitRef="usd">-66935000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-157" decimals="-3" id="f-1587" unitRef="usd">1576000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-158" decimals="-3" id="f-1588" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-159" decimals="-3" id="f-1589" unitRef="usd">1576000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-160" decimals="-3" id="f-1590" unitRef="usd">2776000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-161" decimals="-3" id="f-1591" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-162" decimals="-3" id="f-1592" unitRef="usd">2776000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-157" decimals="-3" id="f-1593" unitRef="usd">-31489000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-158" decimals="-3" id="f-1594" unitRef="usd">-1015000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-159" decimals="-3" id="f-1595" unitRef="usd">-32504000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-160" decimals="-3" id="f-1596" unitRef="usd">-60528000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-161" decimals="-3" id="f-1597" unitRef="usd">-3631000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-162" decimals="-3" id="f-1598" unitRef="usd">-64159000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-157" decimals="-3" id="f-1599" unitRef="usd">21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-158" id="f-1600" unitRef="usd" xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-159" decimals="-3" id="f-1601" unitRef="usd">21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-160" decimals="-3" id="f-1602" unitRef="usd">38000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-161" id="f-1603" unitRef="usd" xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-162" decimals="-3" id="f-1604" unitRef="usd">38000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-157" decimals="-3" id="f-1605" unitRef="usd">-31510000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-158" decimals="-3" id="f-1606" unitRef="usd">-1015000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-159" decimals="-3" id="f-1607" unitRef="usd">-32525000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-160" decimals="-3" id="f-1608" unitRef="usd">-60566000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-161" decimals="-3" id="f-1609" unitRef="usd">-3631000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-162" decimals="-3" id="f-1610" unitRef="usd">-64197000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-157" decimals="-3" id="f-1611" unitRef="usd">198000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-158" decimals="-3" id="f-1612" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-159" decimals="-3" id="f-1613" unitRef="usd">198000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-160" decimals="-3" id="f-1614" unitRef="usd">937000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-161" decimals="-3" id="f-1615" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-162" decimals="-3" id="f-1616" unitRef="usd">937000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-157" decimals="-3" id="f-1617" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-158" decimals="-3" id="f-1618" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-159" decimals="-3" id="f-1619" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-160" decimals="-3" id="f-1620" unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-161" decimals="-3" id="f-1621" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-162" decimals="-3" id="f-1622" unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-157" decimals="-3" id="f-1623" unitRef="usd">-31317000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-158" decimals="-3" id="f-1624" unitRef="usd">-1015000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-159" decimals="-3" id="f-1625" unitRef="usd">-32332000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-160" decimals="-3" id="f-1626" unitRef="usd">-59641000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-161" decimals="-3" id="f-1627" unitRef="usd">-3631000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-162" decimals="-3" id="f-1628" unitRef="usd">-63272000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-157"
      decimals="2"
      id="f-1629"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-157"
      decimals="2"
      id="f-1630"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-158"
      decimals="2"
      id="f-1631"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-158"
      decimals="2"
      id="f-1632"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-159"
      decimals="2"
      id="f-1633"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-159"
      decimals="2"
      id="f-1634"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-160"
      decimals="2"
      id="f-1635"
      unitRef="usdPerShare">-6.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-160"
      decimals="2"
      id="f-1636"
      unitRef="usdPerShare">-6.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-161"
      decimals="2"
      id="f-1637"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-161"
      decimals="2"
      id="f-1638"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-162"
      decimals="2"
      id="f-1639"
      unitRef="usdPerShare">-6.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-162"
      decimals="2"
      id="f-1640"
      unitRef="usdPerShare">-6.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-157"
      decimals="-3"
      id="f-1641"
      unitRef="shares">10076000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-157"
      decimals="-3"
      id="f-1642"
      unitRef="shares">10076000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-158"
      decimals="-3"
      id="f-1643"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-158"
      decimals="-3"
      id="f-1644"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-159"
      decimals="-3"
      id="f-1645"
      unitRef="shares">10076000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-159"
      decimals="-3"
      id="f-1646"
      unitRef="shares">10076000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-160"
      decimals="-3"
      id="f-1647"
      unitRef="shares">10053000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-160"
      decimals="-3"
      id="f-1648"
      unitRef="shares">10053000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-161"
      decimals="-3"
      id="f-1649"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-161"
      decimals="-3"
      id="f-1650"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-162"
      decimals="-3"
      id="f-1651"
      unitRef="shares">10053000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-162"
      decimals="-3"
      id="f-1652"
      unitRef="shares">10053000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-163" decimals="-3" id="f-1653" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-28" decimals="-3" id="f-1654" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-164" decimals="-3" id="f-1655" unitRef="usd">3600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-163" decimals="-3" id="f-1656" unitRef="usd">21059000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-28" decimals="-3" id="f-1657" unitRef="usd">-190000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-164" decimals="-3" id="f-1658" unitRef="usd">20869000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-163" decimals="-3" id="f-1659" unitRef="usd">12780000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-28" decimals="-3" id="f-1660" unitRef="usd">2806000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-164" decimals="-3" id="f-1661" unitRef="usd">15586000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-163" decimals="-3" id="f-1662" unitRef="usd">33839000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-28" decimals="-3" id="f-1663" unitRef="usd">2616000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-164" decimals="-3" id="f-1664" unitRef="usd">36455000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-163" decimals="-3" id="f-1665" unitRef="usd">-30239000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-28" decimals="-3" id="f-1666" unitRef="usd">-2616000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-164" decimals="-3" id="f-1667" unitRef="usd">-32855000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-163" decimals="-3" id="f-1668" unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-28" decimals="-3" id="f-1669" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-164" decimals="-3" id="f-1670" unitRef="usd">1200000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-163" decimals="-3" id="f-1671" unitRef="usd">-29039000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-1672" unitRef="usd">-2616000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-164" decimals="-3" id="f-1673" unitRef="usd">-31655000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-163" decimals="-3" id="f-1674" unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-28" decimals="-3" id="f-1675" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-164" decimals="-3" id="f-1676" unitRef="usd">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-163" decimals="-3" id="f-1677" unitRef="usd">-29056000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-28" decimals="-3" id="f-1678" unitRef="usd">-2616000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-164" decimals="-3" id="f-1679" unitRef="usd">-31672000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-163" decimals="-3" id="f-1680" unitRef="usd">739000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-28" decimals="-3" id="f-1681" unitRef="usd">0</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="c-164" decimals="-3" id="f-1682" unitRef="usd">739000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-163" decimals="-3" id="f-1683" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-28" decimals="-3" id="f-1684" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-164" decimals="-3" id="f-1685" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-163" decimals="-3" id="f-1686" unitRef="usd">-28324000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-28" decimals="-3" id="f-1687" unitRef="usd">-2616000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-164" decimals="-3" id="f-1688" unitRef="usd">-30940000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-163"
      decimals="2"
      id="f-1689"
      unitRef="usdPerShare">-2.90</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-163"
      decimals="2"
      id="f-1690"
      unitRef="usdPerShare">-2.90</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-28"
      decimals="2"
      id="f-1691"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-28"
      decimals="2"
      id="f-1692"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-164"
      decimals="2"
      id="f-1693"
      unitRef="usdPerShare">-3.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-164"
      decimals="2"
      id="f-1694"
      unitRef="usdPerShare">-3.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-163"
      decimals="-3"
      id="f-1695"
      unitRef="shares">10030000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-163"
      decimals="-3"
      id="f-1696"
      unitRef="shares">10030000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-28"
      decimals="-3"
      id="f-1697"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-28"
      decimals="-3"
      id="f-1698"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-164"
      decimals="-3"
      id="f-1699"
      unitRef="shares">10030000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-164"
      decimals="-3"
      id="f-1700"
      unitRef="shares">10030000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-139" decimals="-3" id="f-1701" unitRef="usd">-70397000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-140" decimals="-3" id="f-1702" unitRef="usd">-19599000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-141" decimals="-3" id="f-1703" unitRef="usd">-89996000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-139" decimals="-3" id="f-1704" unitRef="usd">1571000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-140" decimals="-3" id="f-1705" unitRef="usd">4006000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-141" decimals="-3" id="f-1706" unitRef="usd">5577000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-139" decimals="-3" id="f-1707" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-140" decimals="-3" id="f-1708" unitRef="usd">8477000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-141" decimals="-3" id="f-1709" unitRef="usd">8477000</advm:NonCashSubleaseLossIncome>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-139" decimals="-3" id="f-1710" unitRef="usd">7178000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-140" decimals="-3" id="f-1711" unitRef="usd">-7116000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-141" decimals="-3" id="f-1712" unitRef="usd">62000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <us-gaap:NetIncomeLoss contextRef="c-145" decimals="-3" id="f-1713" unitRef="usd">-43263000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-146" decimals="-3" id="f-1714" unitRef="usd">-14382000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-147" decimals="-3" id="f-1715" unitRef="usd">-57645000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-145" decimals="-3" id="f-1716" unitRef="usd">1029000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-146" decimals="-3" id="f-1717" unitRef="usd">2654000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-147" decimals="-3" id="f-1718" unitRef="usd">3683000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-145" decimals="-3" id="f-1719" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-146" decimals="-3" id="f-1720" unitRef="usd">4765000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-147" decimals="-3" id="f-1721" unitRef="usd">4765000</advm:NonCashSubleaseLossIncome>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-145" decimals="-3" id="f-1722" unitRef="usd">6894000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-146" decimals="-3" id="f-1723" unitRef="usd">-6963000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets contextRef="c-147" decimals="-3" id="f-1724" unitRef="usd">-69000</advm:IncreaseDecreaseInDepositAndOtherNoncurrentAssets>
    <us-gaap:NetIncomeLoss contextRef="c-148" decimals="-3" id="f-1725" unitRef="usd">-24787000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-149" decimals="-3" id="f-1726" unitRef="usd">-2360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-150" decimals="-3" id="f-1727" unitRef="usd">-27147000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-148" decimals="-3" id="f-1728" unitRef="usd">506000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-149" decimals="-3" id="f-1729" unitRef="usd">1314000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-150" decimals="-3" id="f-1730" unitRef="usd">1820000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-148" decimals="-3" id="f-1731" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-149" decimals="-3" id="f-1732" unitRef="usd">1046000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-150" decimals="-3" id="f-1733" unitRef="usd">1046000</advm:NonCashSubleaseLossIncome>
    <us-gaap:NetIncomeLoss contextRef="c-154" decimals="-3" id="f-1734" unitRef="usd">-93451000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-155" decimals="-3" id="f-1735" unitRef="usd">-4161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-156" decimals="-3" id="f-1736" unitRef="usd">-97612000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-154" decimals="-3" id="f-1737" unitRef="usd">12466000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-155" decimals="-3" id="f-1738" unitRef="usd">3916000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-156" decimals="-3" id="f-1739" unitRef="usd">16382000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-154" decimals="-3" id="f-1740" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-155" decimals="-3" id="f-1741" unitRef="usd">435000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-156" decimals="-3" id="f-1742" unitRef="usd">435000</advm:NonCashSubleaseLossIncome>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-154" decimals="-3" id="f-1743" unitRef="usd">-1452000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-155" decimals="-3" id="f-1744" unitRef="usd">-190000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-156" decimals="-3" id="f-1745" unitRef="usd">-1642000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-154" decimals="-3" id="f-1746" unitRef="usd">13711000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-155" decimals="-3" id="f-1747" unitRef="usd">-6079000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-156" decimals="-3" id="f-1748" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <us-gaap:NetIncomeLoss contextRef="c-160" decimals="-3" id="f-1749" unitRef="usd">-60566000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-161" decimals="-3" id="f-1750" unitRef="usd">-3631000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-162" decimals="-3" id="f-1751" unitRef="usd">-64197000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-160" decimals="-3" id="f-1752" unitRef="usd">6936000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-161" decimals="-3" id="f-1753" unitRef="usd">2602000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-162" decimals="-3" id="f-1754" unitRef="usd">9538000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-160" decimals="-3" id="f-1755" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-161" decimals="-3" id="f-1756" unitRef="usd">1219000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-162" decimals="-3" id="f-1757" unitRef="usd">1219000</advm:NonCashSubleaseLossIncome>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-160" decimals="-3" id="f-1758" unitRef="usd">-525000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-161" decimals="-3" id="f-1759" unitRef="usd">-190000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-162" decimals="-3" id="f-1760" unitRef="usd">-715000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-160" decimals="-3" id="f-1761" unitRef="usd">13711000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-161" decimals="-3" id="f-1762" unitRef="usd">-6079000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-162" decimals="-3" id="f-1763" unitRef="usd">7632000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <us-gaap:NetIncomeLoss contextRef="c-163" decimals="-3" id="f-1764" unitRef="usd">-29056000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-28" decimals="-3" id="f-1765" unitRef="usd">-2616000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-164" decimals="-3" id="f-1766" unitRef="usd">-31672000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-163" decimals="-3" id="f-1767" unitRef="usd">1427000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-28" decimals="-3" id="f-1768" unitRef="usd">1239000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-164" decimals="-3" id="f-1769" unitRef="usd">2666000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <advm:NonCashSubleaseLossIncome contextRef="c-163" decimals="-3" id="f-1770" unitRef="usd">0</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-28" decimals="-3" id="f-1771" unitRef="usd">-1567000</advm:NonCashSubleaseLossIncome>
    <advm:NonCashSubleaseLossIncome contextRef="c-164" decimals="-3" id="f-1772" unitRef="usd">-1567000</advm:NonCashSubleaseLossIncome>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-163" decimals="-3" id="f-1773" unitRef="usd">-749000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-28" decimals="-3" id="f-1774" unitRef="usd">-190000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-164" decimals="-3" id="f-1775" unitRef="usd">-939000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-163" decimals="-3" id="f-1776" unitRef="usd">8004000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-28" decimals="-3" id="f-1777" unitRef="usd">-104000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <advm:ReMeasurementOfOperatingLeaseRightOfUseAssets contextRef="c-164" decimals="-3" id="f-1778" unitRef="usd">7900000</advm:ReMeasurementOfOperatingLeaseRightOfUseAssets>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1779">Subsequent Events&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2025, a lien in the amount of $4.8&#160;million was filed by a third-party contractor against the subtenant's interest in the NC Premises. The Company discharged the lien in March 2025 by depositing cash in the full amount with the applicable court in order to avoid a default under the head lease. Subsequently, the subtenant and Jaguar failed to remit the March 2025 rent and subsequent rent payments and defaulted, and failed to cure such defaults, under the sublease and the assignment agreement for the NC Premises. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result, the Company assumed responsibility for such payments in March 2025 and as of April 7, 2025 had made a total amount of $1.9&#160;million to satisfy outstanding rent and common area management fee obligations. The Company remains obligated under the head lease, including for all future remaining rent payments in an aggregate amount of up to $119.7&#160;million for the remainder of the head lease term, of which $5.7&#160;million is due between April 8 and December 31, 2025. As a result of the uncured defaults, the Company terminated the sublease and initiated a lawsuit against the subtenant and Jaguar in the Superior Court of Wake County, North Carolina to enforce its rights under the sublease and to seek recovery of losses and damages incurred due to the defaults by the subtenant and Jaguar.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c-58" decimals="-5" id="f-1780" unitRef="usd">4800000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:PaymentsForRent contextRef="c-165" decimals="-5" id="f-1781" unitRef="usd">1900000</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-166" decimals="-5" id="f-1782" unitRef="usd">119700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-166" decimals="-5" id="f-1783" unitRef="usd">5700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-167" id="f-1784">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-167" id="f-1785">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-167" id="f-1786">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-167" id="f-1787">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1788">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1789">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
